{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pymed in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (0.8.9)\n",
      "Requirement already satisfied: requests>=2.20.0 in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (from pymed) (2.31.0)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (from requests>=2.20.0->pymed) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (from requests>=2.20.0->pymed) (3.6)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (from requests>=2.20.0->pymed) (2.1.0)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /Users/dominikpichler/anaconda3/envs/knowledge-graph/lib/python3.11/site-packages (from requests>=2.20.0->pymed) (2023.11.17)\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install pymed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'pubmed_id': '38369615', 'title': 'Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics.', 'abstract': \"Aspergillus fumigatus-specific IgG estimation is crucial for diagnosing allergic bronchopulmonary aspergillosis (ABPA). A point-of-care LDBio immunochromatographic lateral flow assay (LFA) had 0%-90% sensitivity to detect IgG/IgM antibodies against A. fumigatus.\\nTo assess the accuracy of LDBio-LFA in diagnosing ABPA, using the modified ISHAM-ABPA working group criteria as the reference standard. The secondary objective was to compare the diagnostic performance between LDBio-LFA and A. fumigatus-specific IgG (cut-offs, 27 and 40\\u2009mgA/L), using a multidisciplinary team (blinded to A. fumigatus-IgG and LDBio-LFA results) diagnosis of ABPA as the reference standard.\\nWe prospectively enrolled adult subjects with asthma and ABPA. We performed the LDBio-LFA per the manufacturer's recommendations. We used the commercially available automated fluorescent enzyme immunoassay for measuring serum A. fumigatus-specific IgG. We used the same serum sample to perform both index tests. The tests were performed by technicians blinded to the results of other tests and clinical diagnoses.\\nWe included 123 asthmatic and 166 ABPA subjects, with a mean\\u2009±\\u2009SD age of 37.4\\u2009±\\u200914.4\\u2009years. Bronchiectasis and high-attenuation mucus were seen in 93.6% (146/156) and 24.3% (38/156) of the ABPA subjects. The sensitivity and specificity of LDBio-LFA in diagnosing ABPA were 84.9% and 82.9%, respectively. The sensitivity of serum A. fumigatus-specific IgG ≥27\\u2009mgA/L was 13% better than LDBio-LFA, with no difference in specificity. There was no significant difference in sensitivity and specificity between LDBio-LFA and serum A. fumigatus-IgG ≥40\\u2009mgA/L.\\nLDBio-LFA is a valuable test for diagnosing ABPA. However, a negative test should be confirmed using an enzyme immunoassay.\", 'keywords': ['allergic bronchopulmonary mycosis', 'aspergillosis', 'asthma', 'bronchiectasis', 'lateral flow assay'], 'journal': 'Mycoses', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'Sehgal', 'firstname': 'Inderpaul Singh', 'initials': 'IS', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Muthu', 'firstname': 'Valliappan', 'initials': 'V', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Dhooria', 'firstname': 'Sahajal', 'initials': 'S', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Prasad', 'firstname': 'Kuruswamy Thurai', 'initials': 'KT', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Rudramurthy', 'firstname': 'Shivaprakash M', 'initials': 'SM', 'affiliation': 'Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Aggarwal', 'firstname': 'Ashutosh Nath', 'initials': 'AN', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Garg', 'firstname': 'Mandeep', 'initials': 'M', 'affiliation': 'Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}, {'lastname': 'Gangneux', 'firstname': 'Jean-Pierre', 'initials': 'JP', 'affiliation': 'CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Univ Rennes, Rennes, France.\\nLaboratoire de Parasitologie-Mycologie, ECMM Excellence Center in Medical Mycology, French National Reference Center on Mycoses and Antifungals (CNRMA LA-Asp C), Centre Hospitalier Universitaire de Rennes, Rennes, France.'}, {'lastname': 'Chakrabarti', 'firstname': 'Arunaloke', 'initials': 'A', 'affiliation': 'Doodhadhari Burfani Hospital, Haridwar, Uttarakhand, India.'}, {'lastname': 'Agarwal', 'firstname': 'Ritesh', 'initials': 'R', 'affiliation': 'Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.'}], 'methods': None, 'conclusions': 'LDBio-LFA is a valuable test for diagnosing ABPA. However, a negative test should be confirmed using an enzyme immunoassay.', 'results': 'We included 123 asthmatic and 166 ABPA subjects, with a mean\\u2009±\\u2009SD age of 37.4\\u2009±\\u200914.4\\u2009years. Bronchiectasis and high-attenuation mucus were seen in 93.6% (146/156) and 24.3% (38/156) of the ABPA subjects. The sensitivity and specificity of LDBio-LFA in diagnosing ABPA were 84.9% and 82.9%, respectively. The sensitivity of serum A. fumigatus-specific IgG ≥27\\u2009mgA/L was 13% better than LDBio-LFA, with no difference in specificity. There was no significant difference in sensitivity and specificity between LDBio-LFA and serum A. fumigatus-IgG ≥40\\u2009mgA/L.', 'copyrights': '© 2024 Wiley-VCH GmbH. Published by John Wiley & Sons Ltd.', 'doi': '10.1111/myc.13700', 'xml': <Element 'PubmedArticle' at 0x108e502c0>}\n",
      "{'pubmed_id': '38369457\\n25364142\\n29861575\\n37905236\\n37978504\\n24421162\\n33822936\\n24105352\\n22296719\\n26775003\\n25664694\\n33073746\\n29206635\\n32044526\\n26284203\\n22397465\\n19317340\\n26073963\\n31841764\\n28808144', 'title': 'Assessment of the association between health problems and cooking fuel type, and barriers towards clean cooking among rural household people in Bangladesh.', 'abstract': 'In low- and middle-income countries, households mainly use solid fuels like wood, charcoal, dung, agricultural residues, and coal for cooking. This poses significant public health concerns due to the emission of harmful particles and gases. To address these issues and support Sustainable Development Goals (SDGs), adopting cleaner cooking fuels like electricity and gas are acknowledged as a viable solution. However, access to these cleaner fuels is limited, especially in rural areas.\\nThis study conducted a face-to-face survey with 1240 individuals in rural Bangladesh to explore the link between health issues and cooking fuel type, as well as barriers to transitioning to clean cooking. Using a convenient sampling technique across four divisions/regions, the survey gathered socio-demographic and health data, along with information on clean cooking barriers through a semi-structured questionnaire. Binary and multivariable logistic regression analyses were then employed to identify significant associations between cooking fuel type and health problems.\\nThe study revealed that a majority of participants (73.3%) relied on solid fuel for cooking. The use of solid fuel was significantly correlated with factors such as lower education levels, reduced family income, location of residence, and the experience of health issues such as cough, chest pressure while breathing, eye discomfort, diabetes, asthma, and allergies. Economic challenges emerged as the foremost obstacle to the adoption of clean cooking, accompanied by other contributing factors.\\nThe use of solid fuel in rural Bangladeshi households poses substantial health risks, correlating with respiratory, eye, cardiovascular, and metabolic issues. Lower education and income levels, along with specific residential locations, were associated with higher solid fuel usage. Economic challenges emerged as the primary obstacle to adopting clean cooking practices. These findings emphasize the need for implementing strategies to promote clean cooking, address barriers, and contribute to achieving Sustainable Development Goal targets for health and sustainable energy access in Bangladesh.', 'keywords': ['Bangladesh', 'Barriers', 'Clean cooking', 'Cooking fuel type', 'Health problems', 'Solid fuel'], 'journal': 'BMC public health', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'Rasel', 'firstname': 'Sayed Mohammad', 'initials': 'SM', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.\\nAir Pollution, Climate Change and Health (ACH) Lab, Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.'}, {'lastname': 'Siddique', 'firstname': 'Abu Bakkar', 'initials': 'AB', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.\\nCentre for Advanced Research Excellence in Public Health, Savar, Dhaka, 1342, Bangladesh.'}, {'lastname': 'Nayon', 'firstname': 'Md Fahad Shahariar', 'initials': 'MFS', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.\\nAir Pollution, Climate Change and Health (ACH) Lab, Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.'}, {'lastname': 'Suzon', 'firstname': 'Md Shakil Mahmud', 'initials': 'MSM', 'affiliation': 'Department of Public Health, School of Pharmacy and Public Health, Independent University, Bangladesh (IUB), Dhaka, Bangladesh.'}, {'lastname': 'Amin', 'firstname': 'Sanzida', 'initials': 'S', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.'}, {'lastname': 'Mim', 'firstname': 'Sadia Sultana', 'initials': 'SS', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh.'}, {'lastname': 'Hossain', 'firstname': 'Md Shakhaoat', 'initials': 'MS', 'affiliation': 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh. shakhaoat@juniv.edu.\\nAir Pollution, Climate Change and Health (ACH) Lab, Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh. shakhaoat@juniv.edu.'}], 'methods': None, 'conclusions': 'The use of solid fuel in rural Bangladeshi households poses substantial health risks, correlating with respiratory, eye, cardiovascular, and metabolic issues. Lower education and income levels, along with specific residential locations, were associated with higher solid fuel usage. Economic challenges emerged as the primary obstacle to adopting clean cooking practices. These findings emphasize the need for implementing strategies to promote clean cooking, address barriers, and contribute to achieving Sustainable Development Goal targets for health and sustainable energy access in Bangladesh.', 'results': 'The study revealed that a majority of participants (73.3%) relied on solid fuel for cooking. The use of solid fuel was significantly correlated with factors such as lower education levels, reduced family income, location of residence, and the experience of health issues such as cough, chest pressure while breathing, eye discomfort, diabetes, asthma, and allergies. Economic challenges emerged as the foremost obstacle to the adoption of clean cooking, accompanied by other contributing factors.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12889-024-17971-7\\n10.1007/s11150-015-9318-5\\n10.4103/0970-0218.143019\\n10.1007/s42452-019-0405-8\\n10.1016/S0973-0826(08)60462-7\\n10.1016/j.esd.2017.11.003\\n10.1007/s11356-021-15344-w\\n10.1016/j.cegh.2022.101134\\n10.1371/journal.pone.0231757\\n10.1186/s12940-017-0272-y\\n10.3390/su10114322\\n10.3389/fenrg.2020.564104\\n10.3389/fpubh.2022.985445\\n10.3389/fpubh.2023.1299521\\n10.1186/s12889-023-17173-7\\n10.3390/su132112080\\n10.1186/s12199-019-0827-3\\n10.1093/ije/dyab037\\n10.1186/1471-2415-11-16\\n10.1007/s12199-013-0364-4\\n10.1016/j.enpol.2018.02.044\\n10.5547/2160-5890.9.1.GTIM\\n10.3390/en14217242\\n10.1289/ehp.1104194\\n10.1016/j.envres.2016.01.002\\n10.1016/j.energy.2022.123696\\n10.1088/1748-9326/ab7b25\\n10.3390/ijerph120201834\\n10.1093/pubmed/fdaa182\\n10.3390/ijerph18041453\\n10.1080/13811118.2020.1833800\\n10.5696/2156-9614-9.23.190911\\n10.1016/j.rser.2018.10.011\\n10.1038/s41598-021-92193-0\\n10.1016/j.esd.2014.08.006\\n10.1016/j.esd.2019.09.003\\n10.1016/j.esr.2019.03.005\\n10.1016/j.rmed.2017.07.014\\n10.1016/j.envint.2020.105471\\n10.1371/journal.pmed.1003716\\n10.3109/02770903.2012.663030\\n10.1016/j.rmed.2015.05.017\\n10.1016/j.envpol.2019.113589\\n10.1161/CIRCULATIONAHA.116.026796\\n10.4103/jfmpc.jfmpc', 'xml': <Element 'PubmedArticle' at 0x10b392520>}\n",
      "{'pubmed_id': '38369256', 'title': 'Assessing Meaningful Change in the Asthma Impairment and Risk Questionnaire.', 'abstract': 'The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Seven impairment items reflect prior 2-week symptoms, and three risk items assess prior 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items.\\nTo evaluate the responsiveness of the AIRQ over time and identify a minimal important difference (MID).\\nAIRQ longitudinal study data were analyzed from patients with asthma aged ≥12 years. Anchor-based methods assessed differences in AIRQ scores relative to Patient Global Impression of Change (PGIC), the accepted MIDs for St. George\\'s Respiratory Questionnaire (SGRQ) and Asthma Control Test (ACT), and exacerbation occurrence over 12 months. Baseline and 12-month data reflected 12-month recall AIRQ scores; Follow-up AIRQ scores were utilized for 3-, 6-, and 9-month analyses.\\n1070 patients were included. PGIC \"much improved\" was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of -2.0, -1.9, -1.9, and -1.8, respectively. Mean AIRQ score change among patients who met the SGRQ MID (≥4-point decrease) was -1.8 at 6 and 12 months. AIRQ mean scores decreased from baseline by -2.2 to -2.5 points at months 3, 6, 9, and 12 for patients who met the ACT MID (≥3 point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI 1.53-1.89).\\nA change score of 2 is recommended as the AIRQ MID.', 'keywords': ['ACT', 'AIRQ', 'Asthma Control', 'Minimally Important Difference', 'Responsiveness', 'SGRQ'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'McCann', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Allergy Partners, Asheville, NC, United States. Electronic address: bmccann@allergypartners.com.'}, {'lastname': 'Murphy', 'firstname': 'Kevin R', 'initials': 'KR', 'affiliation': 'Boys Town National Research Hospital, Boys Town, NE, United States.'}, {'lastname': 'Zeiger', 'firstname': 'Robert S', 'initials': 'RS', 'affiliation': 'Departments of Allergy and Research and Evaluation, Kaiser Permanente Southern California, San Diego and Pasadena, CA, United States.'}, {'lastname': 'Beuther', 'firstname': 'David A', 'initials': 'DA', 'affiliation': 'National Jewish Health, Denver, CO, United States.'}, {'lastname': 'Wise', 'firstname': 'Robert A', 'initials': 'RA', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.'}, {'lastname': 'Reibman', 'firstname': 'Joan', 'initials': 'J', 'affiliation': 'New York University School of Medicine, New York, NY, United States.'}, {'lastname': 'George', 'firstname': 'Maureen', 'initials': 'M', 'affiliation': 'Columbia University School of Nursing, New York, NY, United States.'}, {'lastname': 'Gilbert', 'firstname': 'Ileen', 'initials': 'I', 'affiliation': 'AstraZeneca, Wilmington, DE, United States.'}, {'lastname': 'Eudicone', 'firstname': 'James M', 'initials': 'JM', 'affiliation': 'AstraZeneca, Wilmington, DE, United States.'}, {'lastname': 'Gandhi', 'firstname': 'Hitesh N', 'initials': 'HN', 'affiliation': 'AstraZeneca, Wilmington, DE, United States.'}, {'lastname': 'Cutts', 'firstname': 'Katelyn', 'initials': 'K', 'affiliation': 'Evidera, Bethesda, MD, United States.'}, {'lastname': 'Coyne', 'firstname': 'Karin S', 'initials': 'KS', 'affiliation': 'Evidera, Bethesda, MD, United States.'}, {'lastname': 'Chipps', 'firstname': 'Bradley', 'initials': 'B', 'affiliation': 'Capital Allergy & Respiratory Disease Center, Sacramento, CA, United States.'}], 'methods': None, 'conclusions': 'A change score of 2 is recommended as the AIRQ MID.', 'results': '1070 patients were included. PGIC \"much improved\" was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of -2.0, -1.9, -1.9, and -1.8, respectively. Mean AIRQ score change among patients who met the SGRQ MID (≥4-point decrease) was -1.8 at 6 and 12 months. AIRQ mean scores decreased from baseline by -2.2 to -2.5 points at months 3, 6, 9, and 12 for patients who met the ACT MID (≥3 point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI 1.53-1.89).', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.anai.2024.02.013', 'xml': <Element 'PubmedArticle' at 0x109b5b790>}\n",
      "{'pubmed_id': '38369009', 'title': 'Characterization and applicability of a novel physiologically relevant 3D-tetraculture bronchial model for in vitro assessment of respiratory sensitization.', 'abstract': \"Chemical Respiratory Allergy (CRA) is triggered after exposure to Low Molecular Weight (LMW) sensitizers and manifests clinically as asthma and rhinitis. From a risk/toxicity assessment point of view, there are few methods, none of them validated, for evaluating the respiratory sensitization potential of chemicals once the in vivo-based models usually employed for inhalation toxicity addressment do not comprise allergenicity endpoints specifically. Based on that, we developed, characterized, and evaluated the applicability of a 3D-tetraculture airway model reconstructed with bronchial epithelial, fibroblasts, endothelial and monocytic cell lines. Moreover, we exposed the tissue to maleic anhydride (MA) aerosols to challenge the model and subsequently assessed inflammatory and functional aspects of the tissue. The reconstructed tissue presented phenotypic biomarkers compatible with human bronchial epithelium, and MA aerosol exposure triggered an increased IL-8 and IL-6 production, reactive oxygen species (ROS) formation, and apoptosis of epithelial cells. Besides, augmented IL-8 production by monocytic cells was also found, correlating with dendritic cell activation within the co-culture model after MA exposure. Our results demonstrated that the 3D-tetraculture bronchial model presents hallmarks related to human airways' structure and function. Additionally, exposure to a respiratory sensitizer induced inflammatory and functional alterations in the reconstructed tissue, rendering it a valuable tool for exploring the mechanistic framework of chemically induced respiratory sensitization.\", 'keywords': ['Chemical respiratory allergy', 'air-liquid interface', 'new approach methodologies', 'pulmonary toxicity', 'respiratory sensitization'], 'journal': 'Toxicology', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'da Silva', 'firstname': 'Artur Christian Garcia', 'initials': 'ACG', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.'}, {'lastname': 'de Mendonça', 'firstname': 'Izadora Caroline Furtado', 'initials': 'ICF', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.'}, {'lastname': 'Valadares', 'firstname': 'Marize Campos', 'initials': 'MC', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil. Electronic address: marizecv@ufg.br.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.tox.2024.153756', 'xml': <Element 'PubmedArticle' at 0x10b461ad0>}\n",
      "{'pubmed_id': '38369255', 'title': 'Early solid introduction to prevent IgE-mediated food allergy should continue unabated while we learn more about FPIES prevalence.', 'abstract': None, 'keywords': ['Food protein-induced enterocolitis syndrome', 'peanut', 'prevalence'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'Ye', 'firstname': 'Linlei', 'initials': 'L', 'affiliation': 'Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Electronic address: linlei@ualberta.ca.'}, {'lastname': 'Erdle', 'firstname': 'Stephanie C', 'initials': 'SC', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada. Electronic address: stephanie.erdle@cw.bc.ca.\"}, {'lastname': 'Abrams', 'firstname': 'Elissa M', 'initials': 'EM', 'affiliation': 'Department of Pediatrics and Child Health, Section of Allergy and Immunology, University of Manitoba, Winnipeg, Canada. Electronic address: elissa.abrams@gmail.com.'}, {'lastname': 'Chan', 'firstname': 'Edmond S', 'initials': 'ES', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada. Electronic address: EChan5@cw.bc.ca.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.02.012', 'xml': <Element 'PubmedArticle' at 0x10a018a40>}\n",
      "{'pubmed_id': '38369030', 'title': 'Epithelial-neuronal-immune cell interactions: implications for immunity, inflammation, and tissue homeostasis at mucosal sites.', 'abstract': 'The epithelial lining of the respiratory tract and intestine provides a critical physical barrier to protect host tissues against environmental insults including dietary antigens, allergens, chemicals, and microorganisms. In addition, specialized epithelial cells directly communicate with hematopoietic and neuronal cells. These epithelial-immune and epithelial-neuronal interactions control host immune responses and have important implications for inflammatory conditions associated with defects in the epithelial barrier, including asthma, allergy, and inflammatory bowel diseases (IBD). In this review, we discuss emerging research that identifies the mechanisms and impact of epithelial-immune and epithelial-neuronal crosstalk in regulating immunity, inflammation, and tissue homeostasis at mucosal barrier surfaces. Understanding the regulation and impact of these pathways could provide new therapeutic targets for inflammatory diseases at mucosal sites.', 'keywords': ['airway inflammation', 'allergy', 'asthma', 'epithelium', 'immune regulation', 'intestinal inflammation', 'mucosal immunity', 'neuroimmunity'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 19), 'authors': [{'lastname': 'Emanuel', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine; New York, NY 10021, USA.'}, {'lastname': 'Arifuzzaman', 'firstname': 'Mohammad', 'initials': 'M', 'affiliation': 'Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.'}, {'lastname': 'Artis', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine; New York, NY 10021, USA; Friedman Center for Nutrition and Inflammation, Joan and Sanford I. Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Allen Discovery Center for Neuroimmune Interactions, New York, NY 10029, USA. Electronic address: dartis@med.cornell.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.02.004', 'xml': <Element 'PubmedArticle' at 0x10a019cb0>}\n",
      "{'pubmed_id': '38368569\\n33846604\\n32595361\\n33722710\\n35265071\\n35220042\\n36564016\\n34203876\\n35605293\\n37531845\\n35108405\\n35288721\\n33836012\\n35794601\\n32600125\\n34677611\\n34310928\\n33542675\\n35792976\\n32487019\\n27781554\\n33590776\\n34018444\\n33709404\\n36686672\\n34006584\\n36631857\\n11262530\\n33495515\\n35729584\\n33396964\\n35508737\\n34664313\\n30465441\\n33687943\\n34696775\\n35464005\\n36033385\\n35645794\\n35598608\\n38313434\\n32537469\\n35252072\\n34490119\\n36301619\\n36113229\\n35082169\\n38198887\\n33676971\\n33651651\\n35974910\\n32754917\\n33975252\\n35434682\\n34002024\\n36743312\\n35095914\\n34560105\\n35585245\\n34566952\\n35233003\\n36076157\\n34988877\\n20664075\\n30525742\\n32639108\\n34481968\\n36084869\\n35652642\\n33046682\\n32522072\\n34943813\\n33360370\\n36508041\\n35655708\\n33323004\\n33227982\\n34381785\\n35105664\\n33995087\\n34916790\\n36090099\\n33599402\\n35425720\\n32971520\\n36507590\\n35782123\\n36824270\\n36894277\\n35025938\\n36115151\\n31501577\\n33495652\\n36495667\\n36495667\\n33738881\\n35495940\\n35850746\\n32889295\\n35343370\\n33431578\\n34687739\\n36150095\\n34527604\\n35308540\\n32240032\\n34740809\\n35662725\\n32873292\\n34745150\\n34384038\\n34867963\\n36530439', 'title': 'A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases.', 'abstract': \"The highly diverse microbial ecosystem of the human body colonizes the gastrointestinal tract has a profound impact on the host's immune, metabolic, endocrine, and other physiological processes, which are all interconnected. Specifically, gut microbiota has been found to play a crucial role in facilitating the adaptation and initiation of immune regulatory response through the gastrointestinal tract affecting the other distal mucosal sites such as lungs. A tightly regulated lung-gut axis during respiratory ailments may influence the various molecular patterns that instructs priming the disease severity to dysregulate the normal function. This review provides a comprehensive summary of current research on gut microbiota dysbiosis in respiratory diseases including asthma, pneumonia, bronchopneumonia, COPD during infections and cancer. A complex-interaction among gut microbiome, associated metabolites, cytokines, and chemokines regulates the protective immune response activating the mucosal humoral and cellular response. This potential mechanism bridges the regulation patterns through the gut-lung axis. This paper aims to advance the understanding of the crosstalk of gut-lung microbiome during infection, could lead to strategize to modulate the gut microbiome as a treatment plan to improve bad prognosis in various respiratory diseases.\", 'keywords': ['Gut microbiota', 'Gut-lung axis', 'Inflammation', 'Intestinal microecology', 'Mechanism', 'Respiratory diseases'], 'journal': 'Archives of microbiology', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Xu', 'firstname': 'Cong', 'initials': 'C', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.'}, {'lastname': 'Hao', 'firstname': 'Mengqi', 'initials': 'M', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.'}, {'lastname': 'Zai', 'firstname': 'Xiaohu', 'initials': 'X', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.'}, {'lastname': 'Song', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.'}, {'lastname': 'Huang', 'firstname': 'Yuzhe', 'initials': 'Y', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.\\nMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, Hefei, 230012, Anhui, China.\\nAnhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei, 230012, Anhui, China.'}, {'lastname': 'Gui', 'firstname': 'Shuangying', 'initials': 'S', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.\\nMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, Hefei, 230012, Anhui, China.\\nAnhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei, 230012, Anhui, China.'}, {'lastname': 'Chen', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'A. P. College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China. ichenjuan319@163.com.\\nMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, Hefei, 230012, Anhui, China. ichenjuan319@163.com.\\nAnhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei, 230012, Anhui, China. ichenjuan319@163.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.', 'doi': '10.1007/s00203-024-03843-6\\n10.1038/s41577-021-00538-7\\n10.3906/biy-2005-102\\n10.1016/j.phrs.2021.105548\\n10.3389/fimmu.2022.805770\\n10.1016/j.ebiom.2022.103891\\n10.1080/14787210.2023.2162879\\n10.1038/s41467-020-19701-0\\n10.3390/microorganisms9061302\\n10.1016/j.biopha.2022.113081\\n10.1016/j.imbio.2023.152721\\n10.1111/all.15240\\n10.1038/s42255-022-00547-3\\n10.1371/journal.pone.0249944\\n10.1186/s12931-022-01928-8\\n10.1177/1753466620937170\\n10.1128/IAI.00321-21\\n10.1084/jem.20210235\\n10.1016/j.jaci.2021.07.011\\n10.1155/2021/4080935\\n10.1186/s13568-022-01428-4\\n10.1186/s12866-020-01816-5\\n10.1080/1040841x.2016.1176988\\n10.1080/19490976.2021.1882927\\n10.1177/09603271211017325\\n10.1002/jsfa.11207\\n10.3389/fphar.2022.1104280\\n10.1136/gutjnl-2020-321031\\n10.1186/s12931-023-02312-w\\n10.1002/rmv.307\\n10.1038/s41401-020-00573-5\\n10.1186/s12967-022-03481-w\\n10.1038/s41598-0\\n10.3390/nu12051427\\n10.1016/j.jaci.2022.02.005\\n10.1007/s00284-022-02877-7\\n10.1111/apt.16610\\n10.3920/BM2017.0146\\n10.1136/gutjnl-2020-322599\\n10.1186/s12931-021-01872-z\\n10.3389/fnut.2022.862934\\n10.1155/2022/8447603\\n10.3389/fphar.2022.854544\\n10.1016/S0140-6736(22)00478-0\\n10.3389/fimmu.2023.1148684\\n10.1155/2020/6841078\\n10.3389/fped.2021.645060\\n10.3389/fonc.2021.720842\\n10.1093/jpp/rgac078\\n10.1016/j.clnu.2022.08.029\\n10.1136/gutjnl-2021-325989\\n10.1016/j.jpba.2023.115728\\n10.1053/j.gastro.2021.02.056\\n10.1016/j.jff.2020.104286\\n10.1080/19490976.2020.1870402\\n10.1007/s12088-022-01003-2\\n10.1111/bph.15226\\n10.1016/j.ebiom.2021.103374\\n10.1016/j.medj.2022.04.001\\n10.1038/s41396-021-00998-8\\n10.3389/fcimb.2023.1091825\\n10.1128/spectrum\\n10.3389/fimmu.2021.620943\\n10.1016/j.jaci.2021.09.013\\n10.1038/s41598-022-12413-z\\n10.3389/fimmu.2021.671331\\n10.1038/s41598-022-07398-8\\n10.1186/s12885-022-10050-3\\n10.1007/s12325-021-01990-6\\n10.1152/physrev.00045.2009\\n10.1128/IAI.00734-20\\n10.12932/AP-120417-0072\\n10.1111/jcmm.15574\\n10.1016/j.ijid.2021.08.064\\n10.1016/j.ijbiomac.2022.09.015\\n10.1128/spectrum.01693-21\\n10.4014/jmb.2009.09019\\n10.1186/s12951-020-00750-y\\n10.1080/19490976.2020.1766345\\n10.3390/cells10123305\\n10.1016/j.jaci.2022.11.007\\n10.1016/j.intimp.2020.107272\\n10.1007/s00284-022-02811-x\\n10.1080/2162402X.2022.2081010\\n10.1080/19490976.2020.1849998\\n10.3390/ijms21228730\\n10.3389/fcell.2021.703218\\n10.1136/gutjnl-2021-326789\\n10.3389/fphar.2021\\n10.2147/COPD.S337181\\n10.3389/fmicb.2022.1001313\\n10.1111/1751-7915.13761\\n10.3389/fcimb.2022.836987\\n10.1183/13993003\\n10.1159/000510536\\n10.1111/1759-7714.14765\\n10.3389/fcimb.2022.856633\\n10.1016/j.isci.2023.105991\\n10.1016/j.jaip.2023.01.007\\n10.1371/journal.pone.0262057\\n10.1016/j.ecoenv.2022.114060\\n10.1038/s41590-019-0451-9\\n10.1038/s41590-020-00856-3\\n10.12114/j.issn.1007-9572.2021.00.003\\n10.1016/j.biopha.2022.114073\\n10.1016/j.biopha.2022.114073\\n10.1111/cpr.13028\\n10.3389/fnut.2022.899842\\n10.1016/j.alit.2022.06.005\\n10.1016/j.mib.2020.08.003\\n10.1111/cpr.12958\\n10.1080/19490976.2022.2029997\\n10.1136/gutjnl-2020-323020\\n10.1053/j.gastro.2021.10.013\\n10.1165/rcmb.2021-0515OC\\n10.3389/fcimb.2021.725284\\n10.3389/fmed.2022.811176\\n10.1080/19490976.2020.1737487\\n10.1016/j.micpath.2021.105272\\n10.3389/fphar.2022.819747\\n10.1186/s12934-020-01430-0\\n10.3389/fimmu.2021.774966\\n10.1080/21505594.2021.1962137\\n10.3389/fimmu.2021.741233\\n10.3389/fcimb.2022.1022511', 'xml': <Element 'PubmedArticle' at 0x10b0b96c0>}\n",
      "{'pubmed_id': '38367901', 'title': 'House dust mite allergens induce Ca', 'abstract': 'Type 2 inflammation in asthma develops with exposure to stimuli to include inhaled allergens from house dust mites (HDM). Features include mucus hypersecretion and the formation of pro-secretory ion transport characterised by elevated basal Cl', 'keywords': ['Asthma', 'Bronchial epithelial cells', 'House dust mite', 'IL-33', 'PAR-2', 'PAR-4', 'Serine proteases', 'TRPV1', 'TSLP', 'Trypsin-like proteases'], 'journal': 'Biochimica et biophysica acta. Molecular basis of disease', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Ouyang', 'firstname': 'Xuan', 'initials': 'X', 'affiliation': \"School of Pharmacy, Queen's University Belfast, BT9 7BL, UK.\"}, {'lastname': 'Reihill', 'firstname': 'James A', 'initials': 'JA', 'affiliation': \"School of Pharmacy, Queen's University Belfast, BT9 7BL, UK.\"}, {'lastname': 'Douglas', 'firstname': 'Lisa E J', 'initials': 'LEJ', 'affiliation': \"School of Pharmacy, Queen's University Belfast, BT9 7BL, UK.\"}, {'lastname': 'Dunne', 'firstname': 'Orla M', 'initials': 'OM', 'affiliation': \"Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.\"}, {'lastname': 'Sergeant', 'firstname': 'Gerard P', 'initials': 'GP', 'affiliation': 'Smooth Muscle Research Centre, Dundalk Institute of Technology, Dublin Road, Dundalk, Co. Louth, Ireland.'}, {'lastname': 'Martin', 'firstname': 'S Lorraine', 'initials': 'SL', 'affiliation': \"School of Pharmacy, Queen's University Belfast, BT9 7BL, UK. Electronic address: l.martin@qub.ac.uk.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.bbadis.2024.167079', 'xml': <Element 'PubmedArticle' at 0x109c1a250>}\n",
      "{'pubmed_id': '38367605', 'title': 'The joint effect of cumulative doses for outdoor air pollutants exposure in early life on asthma and wheezing among young children.', 'abstract': \"Constrained by no proper way to assess cumulative exposure, the joint effect of air pollution cumulative exposure doses on childhood asthma and wheezing (AW) was not understood.\\nTo assess the association between cumulative exposure to multiple air pollutants in early life and childhood AW.\\nWe designed a nested case-control study based on the birth cohort in Jinan City. Children with AW followed up within 2 years after birth were treated as cases, and non-cases in this cohort were treated as the control source population, and the propensity score matching method was used to match each case to 5 controls. We calculated the individual cumulative outdoor exposure doses for each period using an inverse distance weighted model, alongside the complex Simpson's formula, accounting for outdoor time and respiratory volume. The Least absolute shrinkage and selection operator (Lasso) regression was performed to screen for covariates. To analyze the joint effects of pollutants, we employed the weighted quantile sum (WQS) regression model in conjunction with conditional logistic regression.\\n84 cases and 420 controls were included in this study. The odds ratio (OR) with 95% confidence interval (CI) of the impact of cumulative exposure (mg/m\\nThere was a joint effect of the cumulative exposure dose of outdoor air pollutants after birth on AW in children aged 0-2 years. And traffic-related pollutants (SO\", 'keywords': ['Air pollutant', 'Asthma', 'Child', 'Cumulative exposure', 'Joint effect'], 'journal': 'Ecotoxicology and environmental safety', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Bai', 'firstname': 'Shuoxin', 'initials': 'S', 'affiliation': 'Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China; Qilu Hospital of Shandong University, Jinan, Shandong, 250012, PR China.'}, {'lastname': 'Zhang', 'firstname': 'Jiatao', 'initials': 'J', 'affiliation': 'Department of Occupational and Environmental Health, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.'}, {'lastname': 'Cui', 'firstname': 'Liangliang', 'initials': 'L', 'affiliation': 'Jinan Municipal Center for Disease Control and Prevention, Jinan, Shandong, PR China; Jinan Mental Health Center, Jinan, Shandong, P.R. China.'}, {'lastname': 'Du', 'firstname': 'Shuang', 'initials': 'S', 'affiliation': 'Department of Occupational and Environmental Health, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China; Department of Environmental Health, Fudan University, Shanghai, PR China.'}, {'lastname': 'Lin', 'firstname': 'Shaoqian', 'initials': 'S', 'affiliation': 'Jinan Municipal Center for Disease Control and Prevention, Jinan, Shandong, PR China.'}, {'lastname': 'Liang', 'firstname': 'Yuxiu', 'initials': 'Y', 'affiliation': 'Department of Occupational and Environmental Health, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.'}, {'lastname': 'Liu', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China. Electronic address: liuyi@sdu.edu.cn.'}, {'lastname': 'Wang', 'firstname': 'Zhiping', 'initials': 'Z', 'affiliation': 'Department of Occupational and Environmental Health, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China. Electronic address: zhipingw@sdu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': '84 cases and 420 controls were included in this study. The odds ratio (OR) with 95% confidence interval (CI) of the impact of cumulative exposure (mg/m', 'copyrights': 'Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.ecoenv.2024.116097', 'xml': <Element 'PubmedArticle' at 0x109c190d0>}\n",
      "{'pubmed_id': '38367563', 'title': 'Development of validated sandwich ELISA for detecting peanut allergen Ara h 3 in food.', 'abstract': 'Peanut is an important food that can cause food allergies, often leading to moderate and severe allergic symptoms such as skin rashes, asthma, and even anaphylactic shock.Research indicates that Ara h 3 is one of the major peanut allergen. In order to establish a simple analytical method for detecting Ara h 3, we developed a sandwich enzyme-linked immunosorbent assay (ELISA) with antibodies that were induced from purified Ara h 3. The experimental results showed that the purified Ara h 3 had good purity, and we successfully prepared capture and detection antibodies. The method established in this study exhibited high specificity and did not cross-react with soybeans, cashew nuts, and sesame. For validation, including precision, recovery and sensitivity were in good condition. We also detected the Ara h 3 in peanut related foods. Overall, the ELISA developed in this study is a reliable method for Ara h 3 detection.', 'keywords': ['Allergen', 'Antibody', 'Ara h 3', 'ELISA', 'Peanut', 'Purification'], 'journal': 'Food chemistry', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Lin', 'firstname': 'Jia-Fong', 'initials': 'JF', 'affiliation': 'Department of Food Science, National Pingtung University of Science and Technology, Pingtung 912, Taiwan; Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: ty0987359136@gmail.com.'}, {'lastname': 'Chang', 'firstname': 'Kee-Lung', 'initials': 'KL', 'affiliation': 'Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: keeluch@kmu.edu.tw.'}, {'lastname': 'Hsieh', 'firstname': 'Bau-Shan', 'initials': 'BS', 'affiliation': 'Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: hsiehbs@gmail.com.'}, {'lastname': 'Hu', 'firstname': 'Yu-Chen', 'initials': 'YC', 'affiliation': 'Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: huyujena@gmail.com.'}, {'lastname': 'Huang', 'firstname': 'Edward S', 'initials': 'ES', 'affiliation': 'Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: HuangE3@pamf.org.'}, {'lastname': 'Yu', 'firstname': 'Hsu-Sheng', 'initials': 'HS', 'affiliation': 'Department of Food Science, National Pingtung University of Science and Technology, Pingtung 912, Taiwan; Department of Gastroenterology, Palo Alto Medical Foundation, Mountain View, CA 94040, USA. Electronic address: hsyu@mail.npust.edu.tw.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.foodchem.2024.138757', 'xml': <Element 'PubmedArticle' at 0x10a21dda0>}\n",
      "{'pubmed_id': '38367551', 'title': 'Subpopulations of children with multiple chronic health outcomes in relation to chemical exposures in the ECHO-PATHWAYS consortium.', 'abstract': 'A multimorbidity-focused approach may reflect common etiologic mechanisms and lead to better targeting of etiologic agents for broadly impactful public health interventions. Our aim was to identify clusters of chronic obesity-related, neurodevelopmental, and respiratory outcomes in children, and to examine associations between cluster membership and widely prevalent chemical exposures to demonstrate our epidemiologic approach. Early to middle childhood outcome data collected 2011-2022 for 1092 children were harmonized across the ECHO-PATHWAYS consortium of 3 prospective pregnancy cohorts in six U.S. cities. 15 outcomes included age 4-9 BMI, cognitive and behavioral assessment scores, speech problems, and learning disabilities, asthma, wheeze, and rhinitis. To form generalizable clusters across study sites, we performed k-means clustering on scaled residuals of each variable regressed on study site. Outcomes and demographic variables were summarized between resulting clusters. Logistic weighted quantile sum regressions with permutation test p-values associated odds of cluster membership with a mixture of 15 prenatal urinary phthalate metabolites in full-sample and sex-stratified models. Three clusters emerged, including a healthier Cluster 1 (n\\xa0=\\xa0734) with low morbidity across outcomes; Cluster 2 (n\\xa0=\\xa0192) with low IQ and higher levels of all outcomes, especially 0.4-1.8-standard deviation higher mean neurobehavioral outcomes; and Cluster 3 (n\\xa0=\\xa0179) with the highest asthma (92\\xa0%), wheeze (53\\xa0%), and rhinitis (57\\xa0%) frequencies. We observed a significant positive, male-specific stratified association (odds ratio\\xa0=\\xa01.6; p\\xa0=\\xa00.01) between a phthalate mixture with high weights for MEP and MHPP and odds of membership in Cluster 3 versus Cluster 1. These results identified subpopulations of children with co-occurring elevated levels of BMI, neurodevelopmental, and respiratory outcomes that may reflect shared etiologic pathways. The observed association between phthalates and respiratory outcome cluster membership could inform policy efforts towards children with respiratory disease. Similar cluster-based epidemiology may identify environmental factors that impact multi-outcome prevalence and efficiently direct public policy efforts.', 'keywords': ['Asthma', 'Behavior', 'Clustering', 'Multi-morbidity', 'Multi-outcome', 'Phthalates'], 'journal': 'Environment international', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Day', 'firstname': 'Drew B', 'initials': 'DB', 'affiliation': \"Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, 1920 Terry Avenue, Seattle, Washington 98101, USA. Electronic address: drew.day@seattlechildrens.org.\"}, {'lastname': 'LeWinn', 'firstname': 'Kaja Z', 'initials': 'KZ', 'affiliation': 'Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, 675 18th Street, San Francisco, CA 94143, USA.'}, {'lastname': 'Karr', 'firstname': 'Catherine J', 'initials': 'CJ', 'affiliation': 'Department of Environmental and Occupational Health, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA; Department of Epidemiology, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA; Department of Pediatrics, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA.'}, {'lastname': 'Loftus', 'firstname': 'Christine T', 'initials': 'CT', 'affiliation': 'Department of Environmental and Occupational Health, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA.'}, {'lastname': 'Carroll', 'firstname': 'Kecia N', 'initials': 'KN', 'affiliation': 'Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.'}, {'lastname': 'Bush', 'firstname': 'Nicole R', 'initials': 'NR', 'affiliation': 'Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, 675 18th Street, San Francisco, CA 94143, USA; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.'}, {'lastname': 'Zhao', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'Department of Preventive Medicine, Division of Preventive Medicine, University of Tennessee Health Science Center, 66 North Pauline Street, Memphis, TN 38163, USA.'}, {'lastname': 'Barrett', 'firstname': 'Emily S', 'initials': 'ES', 'affiliation': 'Department of Biostatistics and Epidemiology, Rutgers School of Public Health, 683 Hoes Lane West, Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.'}, {'lastname': 'Swan', 'firstname': 'Shanna H', 'initials': 'SH', 'affiliation': 'Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.'}, {'lastname': 'Nguyen', 'firstname': 'Ruby H N', 'initials': 'RHN', 'affiliation': 'Department of Epidemiology and Community Health, University of Minnesota, 420 Delaware Street Southeast, Minneapolis, Minnesota 55455, USA.'}, {'lastname': 'Trasande', 'firstname': 'Leonardo', 'initials': 'L', 'affiliation': 'Department of Pediatrics, New York University Grossman School of Medicine, 550 First Avenue, New York, NY 10016, USA.'}, {'lastname': 'Moore', 'firstname': 'Paul E', 'initials': 'PE', 'affiliation': \"Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children's Way, Nashville, TN 37232, USA.\"}, {'lastname': 'Adams Ako', 'firstname': 'Ako', 'initials': 'A', 'affiliation': \"Department of Pediatrics, Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY 10467, USA.\"}, {'lastname': 'Ji', 'firstname': 'Nan', 'initials': 'N', 'affiliation': 'Division of Environmental Health, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, 1845 N Soto St, MC 9239, Los Angeles, CA, 90039, USA.'}, {'lastname': 'Liu', 'firstname': 'Chang', 'initials': 'C', 'affiliation': 'Department of Psychology, Washington State University, Johnson Tower, Pullman, WA 99164, USA.'}, {'lastname': 'Szpiro', 'firstname': 'Adam A', 'initials': 'AA', 'affiliation': 'Department of Biostatistics, University of Washington, 3980 15th Avenue NE, Seattle, WA 98195, USA.'}, {'lastname': 'Sathyanarayana', 'firstname': 'Sheela', 'initials': 'S', 'affiliation': \"Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, 1920 Terry Avenue, Seattle, Washington 98101, USA; Department of Environmental and Occupational Health, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA; Department of Epidemiology, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA; Department of Pediatrics, University of Washington, 4245 Roosevelt Way NE, Seattle, WA 98105, USA.\"}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.', 'doi': '10.1016/j.envint.2024.108486', 'xml': <Element 'PubmedArticle' at 0x10b942ac0>}\n",
      "{'pubmed_id': '38367463', 'title': 'Punicalagin from pomegranate ameliorates TNF-α/IFN-γ-induced inflammatory responses in HaCaT cells via regulation of SIRT1/STAT3 axis and Nrf2/HO-1 signaling pathway.', 'abstract': 'Punicalagin (PUN) was isolated from the peel of pomegranate (Punica granatum L.), is a polyphenol with anti-inflammatory, hepatoprotective, and antioxidant activities. However, it remains unclear whether PUN alleviates the inflammation and anti-inflammatory mechanisms in pro-inflammatory cytokines-induced human keratinocyte HaCaT cells. Here, we investigated that tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) mixture-stimulated HaCaT cells were treated with various concentrations of PUN, followed by analyzed the expression of inflammation-related mediators and evaluate anti-inflammatory-related pathways. Our results demonstrated that PUN\\xa0≤\\xa0100\\xa0μM did not reduce HaCaT cell viability, and PUN\\xa0≥\\xa03\\xa0μM was sufficient to decrease interleukin-6 (IL-6), IL-8, monocyte chemoattractant protein-1 (MCP-1), chemokine ligand 5 (CCL5), CCL17 and CCL20 concentrations. We found that PUN\\xa0≥\\xa010\\xa0μM and\\xa0≥\\xa03\\xa0μM significantly increased sirtuin 1 (SIRT1) expression and inhibited signal transducer and activator of transcription 3 (STAT3) phosphorylation, respectively. PUN downregulated inflammation-related proteins cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), enhanced nuclear factor erythroid-2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression. Moreover, PUN decreased intercellular adhesion molecule-1 (ICAM-1) expression and inhibited monocyte adhesion to inflamed HaCaT cells. PUN also suppressed inflammatory-related pathways, including mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) signaling pathways in TNF-α/IFN-γ- stimulated HaCat cells. Collectively, there is significant evidence that PUN has effective protective defenses against TNF-α/IFN-γ-induced skin inflammation by enhancing SIRT1 to mediate STAT3 and Nrf2/HO-1 signaling pathway.', 'keywords': ['HaCaT cells', 'MAPKs', 'NF-κB', 'Nrf2/HO-1', 'Punicalagin', 'SIRT1/STAT3 axis'], 'journal': 'International immunopharmacology', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Huang', 'firstname': 'Wen-Chung', 'initials': 'WC', 'affiliation': 'Graduate Institute of Health Industry Technology, Research Center for Food and Cosmetic Safety, Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City 33303, Taiwan, ROC; Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City 33303, Taiwan, ROC.'}, {'lastname': 'Liou', 'firstname': 'Chian-Jiun', 'initials': 'CJ', 'affiliation': 'Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City 33303, Taiwan, ROC; Department of Nursing, Division of Basic Medical Sciences, Research Center for Food and Cosmetic Safety, and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City 33303, Taiwan, ROC.'}, {'lastname': 'Shen', 'firstname': 'Szu-Chuan', 'initials': 'SC', 'affiliation': 'Graduate Program of Nutrition Science, National Taiwan Normal University, 88 Ting-Chow Rd, Sec 4, Taipei 11677, Taiwan, ROC.'}, {'lastname': 'Hu', 'firstname': 'Sindy', 'initials': 'S', 'affiliation': 'Department of Cosmetic Science, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City, Taiwan, ROC; Department of Dermatology, Aesthetic Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan, ROC.'}, {'lastname': 'Chao', 'firstname': 'Jane C-J', 'initials': 'JC', 'affiliation': 'School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan, ROC.'}, {'lastname': 'Huang', 'firstname': 'Chun-Hsun', 'initials': 'CH', 'affiliation': 'Department of Cosmetic Science, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City, Taiwan, ROC; Department of Dermatology, Aesthetic Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan, ROC.'}, {'lastname': 'Wu', 'firstname': 'Shu-Ju', 'initials': 'SJ', 'affiliation': 'Department of Dermatology, Aesthetic Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan, ROC; Department of Nutrition and Health Sciences, Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City, Taiwan, ROC. Electronic address: sjwu@mail.cgust.edu.tw.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.intimp.2024.111665', 'xml': <Element 'PubmedArticle' at 0x109f6b920>}\n",
      "{'pubmed_id': '38367422', 'title': 'Protopine ameliorates OVA-induced asthma through modulatingTLR4/MyD88/NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis.', 'abstract': 'Chronic airway inflammation and hyperresponsiveness are characteristics of asthma. The isoquinoline alkaloid protopine (PRO) has been shown to exert anti-inflammatory effects, but its mechanism of action in asthma is not known.\\nInvestigate the protective properties of PRO upon asthma and elucidate its mechanism.\\nThe effects of PRO in asthma treatment were assessed by histology, biochemical analysis, and real-time reverse transcription-quantitative polymerase chain reaction. Then, we integrated molecular docking, western blotting, cellular experiments, immunohistochemistry, immunofluorescence analysis, flow cytometry, and metabolomics analysis to reveal its mechanism.\\nIn vivo, PRO therapy reduced the number of inflammatory cells (eosinophils, leukocytes, monocytes) in bronchoalveolar lavage fluid (BALF), ameliorated pathologic alterations in lung tissues, and inhibited secretion of IgG and histamine. Molecular docking showed that PRO could dock with the proteins of TLR4, MyD88, TRAF6, TAK1, IKKα, and TNF-α. Western blotting displayed that PRO inhibited the TLR4/NF-κB signaling pathway. PRO regulated expression of the pyroptosis-related proteins NLR family pyrin domain containing 3 (NLRP3) inflammasome, gasdermin D, caspase-1, and drove caspase-1 inactivation to affect inflammatory responses by inhibiting the NLRP3 inflammasome. In vitro, 24 h after treatment with PRO, cell activity, as well as levels of reactive oxygen species (ROS) and interleukin (IL)-1β and IL-18, decreased significantly. Immunofluorescence staining showed that PRO decreased expression of TLR4 and MyD88 in vitro. PRO decreased nuclear translocation of NF-κB p65. Twenty-one potential biomarkers in serum were identified using metabolomics analysis, and they predominantly controlled the metabolism of phenylalanine, tryptophan, glucose, and sphingolipids.\\nPRO reduced OVA-induced asthma. The underlying mechanism was associated with the TLR4/MyD88/NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis.', 'keywords': ['Metabolomics', 'Molecular docking', 'NLRP3 inflammasome', 'Protopine', 'TLR4/NF-κB pathway'], 'journal': 'Phytomedicine : international journal of phytotherapy and phytopharmacology', 'publication_date': datetime.date(2024, 2, 18), 'authors': [{'lastname': 'Yang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Zhang', 'firstname': 'Meixian', 'initials': 'M', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Luo', 'firstname': 'Yumeng', 'initials': 'Y', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Xu', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Gao', 'firstname': 'Fan', 'initials': 'F', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Sun', 'firstname': 'Yanping', 'initials': 'Y', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Yang', 'firstname': 'Bingyou', 'initials': 'B', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China.'}, {'lastname': 'Kuang', 'firstname': 'Haixue', 'initials': 'H', 'affiliation': 'Key Laboratory of Chinese Materia Medica (Ministry of Education), Heilongjiang University of Chinese Medicine, Harbin 150040, China. Electronic address: hxkuang@hljucm.net.'}], 'methods': None, 'conclusions': 'PRO reduced OVA-induced asthma. The underlying mechanism was associated with the TLR4/MyD88/NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis.', 'results': 'In vivo, PRO therapy reduced the number of inflammatory cells (eosinophils, leukocytes, monocytes) in bronchoalveolar lavage fluid (BALF), ameliorated pathologic alterations in lung tissues, and inhibited secretion of IgG and histamine. Molecular docking showed that PRO could dock with the proteins of TLR4, MyD88, TRAF6, TAK1, IKKα, and TNF-α. Western blotting displayed that PRO inhibited the TLR4/NF-κB signaling pathway. PRO regulated expression of the pyroptosis-related proteins NLR family pyrin domain containing 3 (NLRP3) inflammasome, gasdermin D, caspase-1, and drove caspase-1 inactivation to affect inflammatory responses by inhibiting the NLRP3 inflammasome. In vitro, 24 h after treatment with PRO, cell activity, as well as levels of reactive oxygen species (ROS) and interleukin (IL)-1β and IL-18, decreased significantly. Immunofluorescence staining showed that PRO decreased expression of TLR4 and MyD88 in vitro. PRO decreased nuclear translocation of NF-κB p65. Twenty-one potential biomarkers in serum were identified using metabolomics analysis, and they predominantly controlled the metabolism of phenylalanine, tryptophan, glucose, and sphingolipids.', 'copyrights': 'Copyright © 2024 The Author(s). Published by Elsevier GmbH.. All rights reserved.', 'doi': '10.1016/j.phymed.2024.155410', 'xml': <Element 'PubmedArticle' at 0x10b62e700>}\n",
      "{'pubmed_id': '38367077\\n24024169\\n27372567\\n32736106\\n31922608\\n29689377\\n33576199\\n15819224\\n27057569\\n25898232\\n29264025\\n29724254\\n31536730\\n32822929\\n35536454\\n31812526\\n23069488\\n25826816\\n31437488\\n32586874\\n34162152\\n28935613\\n35366721', 'title': \"Investigation analysis of the acute asthma risk factor and phenotype based on relational analysis with outdoor air pollutants in Xi'an, China.\", 'abstract': \"Asthma is a common chronic heterogeneous disease. Outdoor air pollutants are an important cause of acute asthma. Until now, the association between the risk of acute asthma and outdoor air pollutants is unclear. And the relationship between the different phenotypes of asthma and outdoor air pollutants has not been reported. Thus, an analysis of the association between outdoor air pollutants and daily acute asthma inpatient and outpatient visits in Xi'an, China, from January 1 to December 31, 2018, was conducted. A total of 3395 people were included in the study. The statistical analysis and relational analysis based on the logistic regression were used for illustrating the relatedness of the acute asthma risk factor and phenotype with outdoor air pollutants, while the age, gender, pollen peak and non-pollen peak periods, high type 2 (T2) asthma and non-high T2 asthma were also stratified. Results showed that particulate matter with particle size below 10\\xa0μm and 2.5\\xa0μm (PM\", 'keywords': ['Acute asthma', 'Air pollution', 'Asthma phenotype', 'Lung function'], 'journal': 'Environmental geochemistry and health', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Lu', 'firstname': 'Yiyi', 'initials': 'Y', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\\nDepartment of Respiratory and Critical Care Medicine, Ganzhou Institute of Respiratory Diseases, Ganzhou Fifth People's Hospital, Ganzhou, 341007, Jiangxi Province, China.\"}, {'lastname': 'Jie', 'firstname': 'Xueyan', 'initials': 'X', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Zou', 'firstname': 'Fan', 'initials': 'F', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Wang', 'firstname': 'Dan', 'initials': 'D', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Da', 'firstname': 'Hongju', 'initials': 'H', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Li', 'firstname': 'Hongxin', 'initials': 'H', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Zhao', 'firstname': 'Hongyan', 'initials': 'H', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'He', 'firstname': 'Jin', 'initials': 'J', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Liu', 'firstname': 'Jianghao', 'initials': 'J', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Fan', 'firstname': 'Xinping', 'initials': 'X', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China.\"}, {'lastname': 'Liu', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China. yunliusx@163.com.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Nature B.V.', 'doi': '10.1007/s10653-023-01816-0\\n10.1016/j.redox.2013.05.003\\n10.1016/j.jaci.2016.05.008\\n10.1016/j.scitotenv.2020.140982\\n10.1111/all.14181\\n10.1016/j.toxlet.2018.04.020\\n10.1016/j.envpol.2016.09.070\\n10.23736/S0026-4806.21.07332-8\\n10.1021/es0488737\\n10.1016/S2213-2600(15)00426-9\\n10.1016/j.envpol.2015.04.010\\n10.1002/jgf2.7\\n10.1186/s12989-018-0255-3\\n10.1016/j.jaci.2019.08.037\\n10.1164/rccm.201504-0658OC\\n10.1016/j.chemosphere.2020.127856\\n10.1007/s12519-022-00548-y\\n10.1016/j.envpol.2019.113638\\n10.3109/14767058.2012.733751\\n10.1016/j.jaci.2012.08.044\\n10.1289/ehp.1408700\\n10.1016/j.jaci.2019.07.044\\n10.1183/13993003.00913-2019\\n10.1016/S0140-6736(20)30925-9\\n10.1016/j.intimp.2021.107788\\n10.1289/EHP685\\n10.1007/s11356-022-19928-y\\n10.3389/fpubh.2022.1017105', 'xml': <Element 'PubmedArticle' at 0x10b30a2f0>}\n",
      "{'pubmed_id': '38366983', 'title': 'A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.', 'abstract': 'Food allergy is common in childhood with some children having a low threshold and being difficult to protect from accidental ingestion of the offending food. Therapies for this potentially life-threatening condition are highly needed. The aim of this study was to evaluate the efficacy of Omalizumab in food-allergic children.\\nThis is a single-center, double-blind, placebo-controlled study. Food allergic children with a cumulative threshold ≤443\\u2009mg food protein at DBPCFC were randomized to Omalizumab (asthma dose) or placebo (3:1). After 3\\u2009months, a second DBPCFC was performed (steps 3, 10, 30, 100, 300, 1000, and 3000\\u2009mg food protein), followed by a separate open challenge up to 10,000 and 30,000\\u2009mg food protein if negative. Responders were defined as ≥2-step increases in threshold. Non-responders received high-dose Omalizumab. A third DBPCFC was performed after 6\\u2009months. Skin testing, blood samples, and the severity of atopic co-morbidity were registered during the study and 3\\u2009months after treatment.\\nIn total, 20 children were evaluated at 3\\u2009months (14 Omalizumab, 6 placebo). All treated with Omalizumab increased their threshold at least two steps and with a significant difference between the Omalizumab and the placebo group (p\\u2009=\\u2009.003), although the intended number of included children was not reached. The threshold before Omalizumab treatment was 13-443\\u2009mg food protein while the threshold after 3\\u2009months of treatment increased up to 44,000\\u2009mg (1143-44,000). In the placebo group, two children improved threshold during the study.\\nAn increase in the threshold level during Omalizumab treatment significantly improve patient safety and protected all children against small amount of allergen.', 'keywords': ['Omalizumab', 'food allergy', 'threshold value', 'treatment'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Mortz', 'firstname': 'Charlotte G', 'initials': 'CG', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.'}, {'lastname': 'Parke', 'firstname': 'Louise', 'initials': 'L', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.'}, {'lastname': 'Rasmussen', 'firstname': 'Helene M', 'initials': 'HM', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.'}, {'lastname': 'Kjaer', 'firstname': 'Henrik Fomsgaard', 'initials': 'HF', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.'}, {'lastname': 'Bindslev-Jensen', 'firstname': 'Carsten', 'initials': 'C', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, University of Southern Denmark, Odense, Denmark.'}], 'methods': None, 'conclusions': 'An increase in the threshold level during Omalizumab treatment significantly improve patient safety and protected all children against small amount of allergen.', 'results': 'In total, 20 children were evaluated at 3\\u2009months (14 Omalizumab, 6 placebo). All treated with Omalizumab increased their threshold at least two steps and with a significant difference between the Omalizumab and the placebo group (p\\u2009=\\u2009.003), although the intended number of included children was not reached. The threshold before Omalizumab treatment was 13-443\\u2009mg food protein while the threshold after 3\\u2009months of treatment increased up to 44,000\\u2009mg (1143-44,000). In the placebo group, two children improved threshold during the study.', 'copyrights': '© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/all.16046', 'xml': <Element 'PubmedArticle' at 0x10b85ec50>}\n",
      "{'pubmed_id': '38366746', 'title': 'Maternal mental health disorders and offspring asthma and allergic diseases: The role of child mental health.', 'abstract': \"Maternal psychological stress during pregnancy and postnatally has been shown to be associated with offspring atopic diseases (asthma, atopic dermatitis and allergic rhinitis). The aim of this study was to assess whether this association may be attributable to the child's own mental health disorders.\\nThe study population included 15,092 twin children born 2002-2010 in Sweden. Questionnaire data at age 9\\u2009years was linked to national patient- and prescription registers. Maternal mental health during pregnancy and 3\\u2009years postnatally were identified from diagnosis and medication data (depression, anxiety and stress disorders). Atopic diseases in children were identified from questionnaires, diagnosis and medication data. Child mental health status (depression and anxiety) was identified from questionnaires. Three-way decomposition methods tested for mediation or interaction by child mental health disorders.\\nMaternal mental health disorders were associated with most child atopic diseases including asthma aRR1.36 (95% CI 1.12, 1.60), and child mental health disorders, aRR1.73 (95% CI 1.56, 1.92). Children with mental health disorders were comorbid for atopic diseases with only asthma reaching statistical significance, aRR1.29 (95% CI 1.14, 1.47). Three-way decomposition found that mediation or interaction by child mental health disorders did not account for the mother mental health and child atopy associations except in parent-report asthma, where child mental health disorders mediated 13.4% (95% CI 2.1, 24.7) of the effect, but not for objectively defined (diagnosis and medication) asthma.\\nThe associations between maternal mental health and child asthma and allergic diseases do not appear to be attributable to child mental health disorders.\", 'keywords': ['allergic rhinitis', 'allergy', 'anxiety', 'asthma', 'atopic dermatitis', 'depression', 'maternal'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Brew', 'firstname': 'Bronwyn K', 'initials': 'BK', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\\nCentre for Big Data Research in Health and School of Clinical Medicine, University of New South Wales, Sydney, Australia.'}, {'lastname': 'Gong', 'firstname': 'Tong', 'initials': 'T', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Ohlin', 'firstname': 'Emma', 'initials': 'E', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\\nSurgical Unit, Mora Hospital, Mora, Sweden.'}, {'lastname': 'Hedman', 'firstname': 'Anna M', 'initials': 'AM', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Larsson', 'firstname': 'Henrik', 'initials': 'H', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\\nSchool of Medical Sciences, Orebro University, Orebro, Sweden.'}, {'lastname': 'Curman', 'firstname': 'Philip', 'initials': 'P', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\\nDepartment of Dermatology, Karolinska University Hospital, Stockholm, Sweden.'}, {'lastname': 'Lundholm', 'firstname': 'Cecilia', 'initials': 'C', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Almqvist', 'firstname': 'Catarina', 'initials': 'C', 'affiliation': \"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.\\nPediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.\"}], 'methods': 'The study population included 15,092 twin children born 2002-2010 in Sweden. Questionnaire data at age 9\\u2009years was linked to national patient- and prescription registers. Maternal mental health during pregnancy and 3\\u2009years postnatally were identified from diagnosis and medication data (depression, anxiety and stress disorders). Atopic diseases in children were identified from questionnaires, diagnosis and medication data. Child mental health status (depression and anxiety) was identified from questionnaires. Three-way decomposition methods tested for mediation or interaction by child mental health disorders.', 'conclusions': 'The associations between maternal mental health and child asthma and allergic diseases do not appear to be attributable to child mental health disorders.', 'results': 'Maternal mental health disorders were associated with most child atopic diseases including asthma aRR1.36 (95% CI 1.12, 1.60), and child mental health disorders, aRR1.73 (95% CI 1.56, 1.92). Children with mental health disorders were comorbid for atopic diseases with only asthma reaching statistical significance, aRR1.29 (95% CI 1.14, 1.47). Three-way decomposition found that mediation or interaction by child mental health disorders did not account for the mother mental health and child atopy associations except in parent-report asthma, where child mental health disorders mediated 13.4% (95% CI 2.1, 24.7) of the effect, but not for objectively defined (diagnosis and medication) asthma.', 'copyrights': '© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14085', 'xml': <Element 'PubmedArticle' at 0x10b95ae80>}\n",
      "{'pubmed_id': '38366695', 'title': 'The impact of indoor pollution on asthma-related outcomes: A\\xa0systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.', 'abstract': 'Systematic review using GRADE of the impact of exposure to volatile organic compounds (VOCs), cleaning agents, mould/damp, pesticides on the risk of (i) new-onset asthma (incidence) and (ii) adverse asthma-related outcomes (impact). MEDLINE, EMBASE and Web of Science were searched for indoor pollutant exposure studies reporting on new-onset asthma and critical and important asthma-related outcomes. Ninety four studies were included: 11 for VOCs (7 for incidenceand 4 for impact), 25 for cleaning agents (7 for incidenceand 8 for impact), 48 for damp/mould (26 for incidence and 22 for impact) and 10 for pesticides (8 for incidence and 2 for impact). Exposure to damp/mould increases the risk of new-onset wheeze (moderate certainty evidence). Exposure to cleaning agents may be associated with a higher risk of new-onset asthma and with asthma severity (low level of certainty). Exposure to pesticides and VOCs may increase the risk of new-onset asthma (very low certainty evidence). The impact on asthma-related outcomes of all major indoor pollutants is uncertain. As the level of certainty is low or very low for most of the available evidence on the impact of indoor pollutants on asthma-related outcomes more rigorous research in the field is warranted.', 'keywords': ['GRADE', 'asthma', 'guideline', 'indoor pollution', 'systematic review'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Agache', 'firstname': 'Ioana', 'initials': 'I', 'affiliation': 'Faculty of Medicine, Transylvania University, Brasov, Romania.'}, {'lastname': 'Canelo-Aybar', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Annesi-Maesano', 'firstname': 'Isabella', 'initials': 'I', 'affiliation': 'Institute Desbrest of Epidemiology and Public Health, University of Montpellier and INSERM, Montpellier, France.'}, {'lastname': 'Cecchi', 'firstname': 'Lorenzo', 'initials': 'L', 'affiliation': 'Centre of Bioclimatology, University of Florence, Florence, Italy.'}, {'lastname': 'Biagioni', 'firstname': 'Benedetta', 'initials': 'B', 'affiliation': 'Allergy and Clinical Immunology Unit, San Giovanni di Dio Hospital, Florence, Italy.'}, {'lastname': 'Chung', 'firstname': 'Fan', 'initials': 'F', 'affiliation': 'Imperial College, London, UK.'}, {'lastname': \"D'Amato\", 'firstname': 'Gennaro', 'initials': 'G', 'affiliation': 'Respiratory Disease Department, Hospital Cardarelli, Naples, Italy.\\nMedical School of Respiratory Allergy, University of Naples Federico II, Naples, Italy.'}, {'lastname': 'Damialis', 'firstname': 'Athanasios', 'initials': 'A', 'affiliation': 'Department of Ecology, School of Biology, Faculty of Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.'}, {'lastname': 'Del Giacco', 'firstname': 'Stefano', 'initials': 'S', 'affiliation': 'Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.'}, {'lastname': 'De Las Vecillas', 'firstname': 'Leticia', 'initials': 'L', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Dominguez-Ortega', 'firstname': 'Javier', 'initials': 'J', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Galàn', 'firstname': 'Carmen', 'initials': 'C', 'affiliation': 'Department of Botany, Ecology and Plant Physiology, International Campus of Excellence on Agrifood (ceiA3), University of Córdoba, Córdoba, Spain.'}, {'lastname': 'Gilles', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Environmental Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.'}, {'lastname': 'Giovannini', 'firstname': 'Mattia', 'initials': 'M', 'affiliation': \"Allergy Unit, Meyer Children's University Hospital IRCCS, Florence, Italy.\\nDepartment of Health Sciences, University of Florence, Florence, Italy.\"}, {'lastname': 'Holgate', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'Faculty of Medicine, University of Southampton, Southampton, UK.'}, {'lastname': 'Jeebhay', 'firstname': 'Mohamed', 'initials': 'M', 'affiliation': 'Occupational Medicine Division and Centre for Environmental & Occupational Health Research, University of Cape Town, Cape Town, South Africa.'}, {'lastname': 'Nadeau', 'firstname': 'Kari', 'initials': 'K', 'affiliation': 'Department of Environmental Health, Center for Climate, Health, and the Global Environment, Climate and Population Studies, Harvard T.H. Chan School of Public Health, Boston, USA.'}, {'lastname': 'Papadopoulos', 'firstname': 'Nikos', 'initials': 'N', 'affiliation': 'Allergy and Clinical Immunology Unit, Second Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.\\nUniversity of Manchester, Manchester, UK.'}, {'lastname': 'Quirce', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Sastre', 'firstname': 'Joaquin', 'initials': 'J', 'affiliation': 'Allergy Service, Fundación Jiménez Díaz, Faculty of Medicine Universidad Autónoma de Madrid and CIBERES, Instituto Carlos III, Ministry of Science and Innovation, Madrid, Spain.'}, {'lastname': 'Traidl-Hoffmann', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Department of Environmental Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.\\nInstitute of Environmental Medicine, Helmholtz Center Munich -German Research Center for Environmental Health, Augsburg, Germany.\\nChristine Kühne Center for Allergy Research and Education, Davos, Switzerland.'}, {'lastname': 'Walusiak-Skorupa', 'firstname': 'Jolanta', 'initials': 'J', 'affiliation': 'Department of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, Lodz, Poland.'}, {'lastname': 'Sousa-Pinto', 'firstname': 'Bernardo', 'initials': 'B', 'affiliation': 'MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Salazar', 'firstname': 'Josefina', 'initials': 'J', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Rodríguez-Tanta', 'firstname': 'L Yesenia', 'initials': 'LY', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Cantero', 'firstname': 'Yahveth', 'initials': 'Y', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Montesinos-Guevara', 'firstname': 'Camila', 'initials': 'C', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.\\nCentro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.'}, {'lastname': 'Song', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Alvarado-Gamarra', 'firstname': 'Giancarlo', 'initials': 'G', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Sola', 'firstname': 'Ivan', 'initials': 'I', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Alonso-Coello', 'firstname': 'Pablo', 'initials': 'P', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.\\nCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.'}, {'lastname': 'Nieto-Gutierrez', 'firstname': 'Wendy', 'initials': 'W', 'affiliation': 'Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.\\nCentro Cochrane Iberoamericano, Sant Antoni Maria Claret, Barcelona, Spain.'}, {'lastname': 'Jutel', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Department of Clinical Immunology, Wrocław Medical University, and ALL-MED Medical Research Institute, Wroclaw, Poland.'}, {'lastname': 'Akdis', 'firstname': 'Cezmi A', 'initials': 'CA', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/all.16051', 'xml': <Element 'PubmedArticle' at 0x10b650950>}\n",
      "{'pubmed_id': '38366192', 'title': 'Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages.', 'abstract': \"CRISPR-Cas systems are defense mechanisms against phages and other nucleic acids that invade bacteria and archaea. In Escherichia coli, it is generally accepted that CRISPR-Cas systems are inactive in laboratory conditions due to a transcriptional repressor. In natural isolates, it has been shown that CRISPR arrays remain stable over the years and that most spacer targets (protospacers) remain unknown. Here, we re-examine CRISPR arrays in natural E. coli isolates and investigate viral and bacterial genomes for spacer targets using a bioinformatics approach coupled to a unique biological dataset. We first sequenced the CRISPR1 array of 1769 E. coli isolates from the fecal samples of 639 children obtained during their first year of life. We built a network with edges between isolates that reflect the number of shared spacers. The isolates grouped into 34 modules. A search for matching spacers in bacterial genomes showed that E. coli spacers almost exclusively target prophages. While we found instances of self-targeting spacers, those involving a prophage and a spacer within the same bacterial genome were rare. The extensive search for matching spacers also expanded the library of known E. coli protospacers to 60%. Altogether, these results suggest that E. coli's CRISPR-Cas is an anti-prophage system and highlight the importance of reconsidering the criteria use to deem CRISPR-Cas systems active.\", 'keywords': ['CRISPR', 'E. coli', 'bacteriophage', 'gut', 'microbiome', 'phage', 'phage resistance', 'virome'], 'journal': 'The ISME journal', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Dion', 'firstname': 'Moïra B', 'initials': 'MB', 'affiliation': 'Département de biochimie, de microbiologie, et de bio-informatique, Faculté des sciences et de génie, Université Laval, Québec, QC, G1V 0A6, Canada.\\nGroupe de recherche en écologie buccale, Faculté de médecine dentaire, Université Laval, Québec, QC, G1V 0A6, Canada.'}, {'lastname': 'Shah', 'firstname': 'Shiraz A', 'initials': 'SA', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Ledreborg Alle 34, 2820, Gentofte, Denmark.'}, {'lastname': 'Deng', 'firstname': 'Ling', 'initials': 'L', 'affiliation': 'Food Science, University of Copenhagen, Frederiksberg, Denmark.'}, {'lastname': 'Thorsen', 'firstname': 'Jonathan', 'initials': 'J', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Ledreborg Alle 34, 2820, Gentofte, Denmark.\\nNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen.'}, {'lastname': 'Stokholm', 'firstname': 'Jakob', 'initials': 'J', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Ledreborg Alle 34, 2820, Gentofte, Denmark.\\nFood Science, University of Copenhagen, Frederiksberg, Denmark.'}, {'lastname': 'Krogfelt', 'firstname': 'Karen A', 'initials': 'KA', 'affiliation': 'Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej5, 2300S, Copenhagen, Denmark.\\nDepartment of Science and Environment, Roskilde University, Denmark.'}, {'lastname': 'Schjørring', 'firstname': 'Susanne', 'initials': 'S', 'affiliation': 'Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Artillerivej5, 2300S, Copenhagen, Denmark.'}, {'lastname': 'Horvath', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'IFF Danisco, Health & Biosciences, France, 86220 Dangé-Saint-Romain, France.'}, {'lastname': 'Allard', 'firstname': 'Antoine', 'initials': 'A', 'affiliation': \"Département de physique, de génie physique et d'optique, Université Laval, Québec, QC G1V 0A6, Canada.\\nCentre interdisciplinaire en modélisation mathématique, Université Laval, Québec, QC G1V 0A6, Canada.\"}, {'lastname': 'Nielsen', 'firstname': 'Dennis S', 'initials': 'DS', 'affiliation': 'Food Science, University of Copenhagen, Frederiksberg, Denmark.'}, {'lastname': 'Petit', 'firstname': 'Marie-Agnès', 'initials': 'MA', 'affiliation': 'Université Paris-Saclay, INRAE, AgroParisTech, Institut Micalis, 78350, Jouy-en-Josas, France.'}, {'lastname': 'Moineau', 'firstname': 'Sylvain', 'initials': 'S', 'affiliation': \"Département de biochimie, de microbiologie, et de bio-informatique, Faculté des sciences et de génie, Université Laval, Québec, QC, G1V 0A6, Canada.\\nGroupe de recherche en écologie buccale, Faculté de médecine dentaire, Université Laval, Québec, QC, G1V 0A6, Canada.\\nFélix d'Hérelle Reference Center for Bacterial Viruses, Faculté de médecine dentaire, Université Laval, Québec, QC, G1V 0A6, Canada.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© The Author(s) [2024]. Published by Oxford University Press on behalf of the International Society for Microbial Ecology.', 'doi': '10.1093/ismejo/wrae005', 'xml': <Element 'PubmedArticle' at 0x10a83ae30>}\n",
      "{'pubmed_id': '38365985\\n30504949\\n31645084\\n32598948\\n31841642\\n29707350\\n28677827\\n34174807\\n25156764\\n23230237\\n28082337\\n29311954\\n33428855\\n15313740\\n15099316\\n23641263\\n8230564\\n21836140\\n21220055\\n25620198\\n10573240\\n14680096\\n31613151\\n15255795\\n19762522\\n25585327', 'title': 'A pilot study to assess the effects of preventing fluid retention in the legs by wearing compression stockings on overnight airway narrowing in mild asthma.', 'abstract': 'Nocturnal asthma is a sign of asthma worsening and could be partially due to more fluid drawn into the thorax during sleep by gravitational force and/or pharyngeal collapse in those with obstructive sleep apnea. Wearing compression stockings during the day reduces fluid shift from the legs to the neck overnight. However, the potential effect of wearing compression stockings to reduce fluid accumulation in the leg and to improve nocturnal small airway narrowing in patients with asthma has not been investigated. This study investigates whether reducing leg fluid volume by wearing compression stockings during the day would attenuate small airway narrowing in patients with asthma before and after sleep.\\nWe enrolled 11 participants with asthma. All participants underwent overnight polysomnography with or without wearing compression stockings for 2\\xa0weeks. Before and after sleep, leg fluid volume (LFV) was measured by bioelectrical impedance, and airway narrowing was primarily assessed by respiratory system resistance and reactance at 5\\xa0Hz (R5 and X5 respectively) using oscillometry.\\nAfter 2\\xa0weeks of wearing compression stockings, the LFV measured in the evening was reduced (∆\\u2009=\\u2009\\u2009-\\u2009192.6\\u2009±\\u2009248.3\\xa0ml, p\\u2009=\\u20090.02), and R5 and X5 improved (∆\\u2009=\\u2009\\u2009-\\u20090.7\\u2009±\\u20090.9 cmH\\nPreventing fluid retention in the legs by wearing compression stockings for 2\\xa0weeks during the day, reduced LFV and airway narrowing in the evening in all participants with asthma, but not in the morning after sleep.', 'keywords': ['Airway narrowing', 'Compression stockings', 'Leg fluid volume', 'Nocturnal asthma'], 'journal': 'Sleep & breathing = Schlaf & Atmung', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Cao', 'firstname': 'Xiaoshu', 'initials': 'X', 'affiliation': 'Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.\\nKITE- Toronto Rehabilitation Institute, University Health Network, Room 12-106, 550 University Ave., Toronto, ON, M5G 2A2, Canada.'}, {'lastname': 'Francisco', 'firstname': 'Cristina O', 'initials': 'CO', 'affiliation': 'KITE- Toronto Rehabilitation Institute, University Health Network, Room 12-106, 550 University Ave., Toronto, ON, M5G 2A2, Canada.'}, {'lastname': 'Bhatawadekar', 'firstname': 'Swati A', 'initials': 'SA', 'affiliation': 'KITE- Toronto Rehabilitation Institute, University Health Network, Room 12-106, 550 University Ave., Toronto, ON, M5G 2A2, Canada.'}, {'lastname': 'Makanjuola', 'firstname': 'Joseph', 'initials': 'J', 'affiliation': 'KITE- Toronto Rehabilitation Institute, University Health Network, Room 12-106, 550 University Ave., Toronto, ON, M5G 2A2, Canada.'}, {'lastname': 'Tarlo', 'firstname': 'Susan M', 'initials': 'SM', 'affiliation': 'Department of Medicine, University of Toronto, Toronto, ON, Canada.\\nDepartment of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.\\nDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Stanbrook', 'firstname': 'Matthew B', 'initials': 'MB', 'affiliation': 'Department of Medicine, University of Toronto, Toronto, ON, Canada.\\nDepartment of Medicine, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.'}, {'lastname': 'Inman', 'firstname': 'Mark D', 'initials': 'MD', 'affiliation': 'Faculty of Medicine (Respirology), McMaster University, Hamilton, ON, Canada.'}, {'lastname': 'Yadollahi', 'firstname': 'Azadeh', 'initials': 'A', 'affiliation': 'Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada. azadeh.yadollahi@uhn.ca.\\nKITE- Toronto Rehabilitation Institute, University Health Network, Room 12-106, 550 University Ave., Toronto, ON, M5G 2A2, Canada. azadeh.yadollahi@uhn.ca.'}], 'methods': None, 'conclusions': None, 'results': 'After 2\\xa0weeks of wearing compression stockings, the LFV measured in the evening was reduced (∆\\u2009=\\u2009\\u2009-\\u2009192.6\\u2009±\\u2009248.3\\xa0ml, p\\u2009=\\u20090.02), and R5 and X5 improved (∆\\u2009=\\u2009\\u2009-\\u20090.7\\u2009±\\u20090.9 cmH', 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.', 'doi': '10.1007/s11325-023-02976-0\\n10.3949/ccjm.87a.19136\\n10.1002/alr.22464\\n10.1016/j.bcp.2020.114112\\n10.1164/rccm.201810-1838TR\\n10.21037/jtd.2018.03.135\\n10.1111/resp.13107\\n10.1016/j.ccm.2014.06.004\\n10.1113/jphysiol.2012.245159\\n10.1152/japplphysiol.00969.2016\\n10.3389/fphys.2017.01012\\n10.1164/rccm.202012-4321LE\\n10.7326/0003-4819-141-4-200408170-00004\\n10.3400/avd.ra.12.00068\\n10.1016/0741-5214(93)90332-G\\n10.1164/rccm.201102-0350OC\\n10.1016/j.resp.2011.01.001\\n10.1016/j.sleep.2014.12.005\\n10.1034/j.1399-3003.1999.14d29.x\\n10.1007/s10439-015-1264-0\\n10.1183/09031936.03.00089403\\n10.1164/rccm.201908-1590ST\\n10.1111/j.1365-2125.2004.02105.x\\n10.1152/japplphysiol.00562.2009\\n10.1017/CBO9780511627156\\n10.1001/jama.2014.17822\\n10.1016/j.rmed.2016.06.020', 'xml': <Element 'PubmedArticle' at 0x108fbc7c0>}\n",
      "{'pubmed_id': '38365966\\n29447365\\n26427721\\n28472373\\n26686842\\n19651626\\n24774473\\n28705514\\n26584963\\n31572014\\n34798196\\n28843039\\n22905105\\n30600132\\n29951281\\n35245655\\n32203929\\n17447148\\n31361936\\n35165983\\n25095894\\n33045495\\n35902208\\n25040583\\n23806243\\n6823524\\n30109418\\n8333427\\n21205403\\n4053261\\n7791232\\n6059863\\n32935015\\n29557321\\n30258022\\n20071664\\n20011725\\n16374899', 'title': 'Cohort Profile Update: The Québec Birth Cohort on Immunity and Health (CO·MMUNITY).', 'abstract': None, 'keywords': ['Administrative health databases', 'Bacillus Calmette-Guerin (BCG)', 'asthma', 'cohort', 'diabetes', 'inflammatory bowel disease', 'lymphoma', 'multiple sclerosis', 'nested case-control study', 'two-stage sampling'], 'journal': 'International journal of epidemiology', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Rousseau', 'firstname': 'Marie-Claude', 'initials': 'MC', 'affiliation': \"Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.\\nDepartment of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, QC, Canada.\\nCarrefour de l'innovation, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.\"}, {'lastname': 'Parent', 'firstname': 'Marie-Elise', 'initials': 'ME', 'affiliation': \"Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.\\nDepartment of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, QC, Canada.\\nCarrefour de l'innovation, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.\"}, {'lastname': 'Corsenac', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'Department of Nursing Sciences, Population Health, Université du Québec en Outaouais, Saint-Jérôme, QC, Canada.'}, {'lastname': 'Salmon', 'firstname': 'Charlotte', 'initials': 'C', 'affiliation': 'Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.'}, {'lastname': 'Mésidor', 'firstname': 'Miceline', 'initials': 'M', 'affiliation': \"Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.\\nDepartment of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, QC, Canada.\\nCarrefour de l'innovation, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.\"}, {'lastname': 'Fantodji', 'firstname': 'Canisius', 'initials': 'C', 'affiliation': 'Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.\\nResearch Centre, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.'}, {'lastname': 'Conus', 'firstname': 'Florence', 'initials': 'F', 'affiliation': 'Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.'}, {'lastname': 'Richard', 'firstname': 'Hugues', 'initials': 'H', 'affiliation': 'Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), Laval, QC, Canada.'}, {'lastname': 'Jantchou', 'firstname': 'Prévost', 'initials': 'P', 'affiliation': 'Research Centre, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.\\nDepartment of Pediatric Gastroenterology, Hepatology, and Nutrition, Centre Hospitalier Universitaire Sainte-Justine, and Université de Montréal, Montréal, QC, Canada.'}, {'lastname': 'Benedetti', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, QC, Canada.\\nDepartment of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, QC, Canada.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1093/ije/dyae014', 'xml': <Element 'PubmedArticle' at 0x10b2a38d0>}\n",
      "{'pubmed_id': '38365763\\n29627041\\n31506820\\n37893170\\n19622089\\n28945977\\n16460286\\n29797770\\n32808447\\n30509734\\n25585581\\n31669095\\n34436475\\n33759390\\n30480592\\n31285286\\n34408442\\n33418879\\n32437299\\n22837379\\n32411099\\n32569352\\n19357406\\n31590292\\n34345212\\n34918742\\n36646290\\n31029506\\n36613991\\n19123432\\n23278876\\n30229891\\n29178573\\n22404118\\n17515919\\n30639344\\n29922964\\n29383778\\n35305295\\n35422761\\n30340925\\n30995510\\n9144295\\n34084149\\n29684429\\n32215785\\n29334696\\n24166975\\n28880992\\n23420878\\n30619305\\n25414012\\n24962029\\n28537058\\n34445677\\n34512346\\n32069871\\n35377454\\n36551211\\n29283409\\n16083784\\n26220361\\n27562191\\n32265845\\n32004524\\n29902480\\n16286016\\n28045397\\n30050954\\n34074279\\n33692628\\n32586877\\n28030376\\n30759802\\n22788947\\n34921631\\n34293503\\n32930511\\n32801785\\n5344615\\n30976490\\n30624591\\n29700598\\n36714578\\n36847817\\n27106804\\n36139480\\n34795674\\n36552524\\n35126384\\n36606511\\n33917551\\n31417159\\n28464448\\n34648704\\n26381274\\n11882888\\n35233801\\n26982596\\n32798733\\n32400133\\n30505271\\n11893340\\n34816101\\n30293012\\n31092255\\n22797250\\n31182642\\n27573536\\n25774551\\n34971020\\n34897856\\n31670612\\n32641724\\n34564707\\n34705006\\n29928281', 'title': 'TRP channels associated with macrophages as targets for the treatment of obese asthma.', 'abstract': 'Globally, obesity and asthma pose significant health challenges, with obesity being a key factor influencing asthma. Despite this, effective treatments for obese asthma, a distinct phenotype, remain elusive. Since the discovery of transient receptor potential (TRP) channels in 1969, their value as therapeutic targets for various diseases has been acknowledged. TRP channels, present in adipose tissue cells, influence fat cell heat production and the secretion of adipokines and cytokines, which are closely associated with asthma and obesity. This paper aims to investigate the mechanisms by which obesity exacerbates asthma-related inflammation and suggests that targeting TRP channels in adipose tissue could potentially suppress obese asthma and offer novel insights into its treatment.', 'keywords': ['Asthma', 'Inflammation', 'Obese asthma', 'Obesity', 'TRP channels'], 'journal': 'Lipids in health and disease', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Zhu', 'firstname': 'Wenzhao', 'initials': 'W', 'affiliation': 'Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China.'}, {'lastname': 'Bai', 'firstname': 'Dinxi', 'initials': 'D', 'affiliation': 'Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China.'}, {'lastname': 'Ji', 'firstname': 'Wenting', 'initials': 'W', 'affiliation': 'Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China. 1422407135@qq.com.'}, {'lastname': 'Gao', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China. 19942021@cdutcm.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12944-024-02016-0\\n10.1016/j.jaci.2018.02.004\\n10.1007/s11882-019-0877-z\\n10.1111/j.1365-2222.2009.03321.x\\n10.1146/annurev-pharmtox-010617-052832\\n10.1111/obr.12703\\n10.1111/obr.13129\\n10.1016/j.alit.2018.10.004\\n10.3238/arztebl.20144.07\\n10.1016/j.jaci.2019.09.035\\n10.3390/metabo11080534\\n10.1002/oby.23107\\n10.1097/ACI.0000000000000494\\n10.1183/16000617.0003-2019\\n10.2147/JAA.S318017\\n10.3390/jcm10020169\\n10.1161/CIRCRESAHA.119.315896\\n10.1164/Rccm.201203-0573OC\\n10.3389/Fendo.2020.00270\\n10.1093/jmcb/mjaa029\\n10.1056/NEJMoa0810780\\n10.3390/ijms20194924\\n10.7150/ijbs.60354\\n10.1042/CS20210790\\n10.1016/j.imlet.2023.01.004\\n10.1016/j.alit.2019.04.002\\n10.3390/ijms24010546\\n10.1111/j.1365-2222.2012.04040.x\\n10.1111/imm.13002\\n10.1111/all.13369\\n10.1146/XXXhermo-nutr-071811-150623\\n10.1038/nature05894\\n10.1016/j.jaci.2018.12.995\\n10.1007/s11154-018-9451-6\\n10.1111/cea.13109\\n10.1016/j.cmet.2022.02.016\\n10.3389/fendo.2022.859044\\n10.1016/j.cytogfr.2018.10.002\\n10.1016/j.immuni.2019.03.018\\n10.1038/387206a0\\n10.3389/fendo.2021.585887\\n10.1016/j.jim.2018.04.005\\n10.1007/s12016-020-08785-7\\n10.1111/obr.12670\\n10.4049/jimmunol.1301176\\n10.1111/imm.12832\\n10.1084/jem.20121964\\n10.3389/fimmu.2018.02945\\n10.2337/db14-0272\\n10.1002/oby.20823\\n10.4093/dmj.2017.41.4.229\\n10.3390/ijms22168971\\n10.3389/fphar.2021.718929\\n10.3390/nu12020472\\n10.2337/db21-0842\\n10.3390/biom12121780\\n10.3390/ijms19010073\\n10.1016/j.jaci.2005.03.024\\n10.1002/eji.201545502\\n10.1530/JOE-16-0229\\n10.3389/fendo.2020.00156\\n10.1016/j.jaci.2020.01.021\\n10.1016/j.jaci.2018.05.026\\n10.1016/j.immuni.2005.09.015\\n10.1172/JCI88876\\n10.1155/2018/1943497\\n10.1186/s12931-021-01763-3\\n10.2147/JAA.S282284\\n10.1183/13993003.00528-2020\\n10.1097/ACI.0000000000000339\\n10.3390/biology8010009\\n10.1586/ers.12.22\\n10.1007/s11882-021-01024-9\\n10.1016/j.jaip.2021.07.007\\n10.1002/ppul.25053\\n10.2147/JAA.S208823\\n10.1038/224285a0\\n10.1016/j.apsb.2018.09.007\\n10.1093/advances/nmy067\\n10.1007/s00424-018-2145-9\\n10.3389/fendo.2022.1065263\\n10.1289/EHP11076\\n10.1002/oby.21486\\n10.3390/cells11182907\\n10.3389/fimmu.2021.767319\\n10.3390/antiox11122315\\n10.3389/fimmu.2021.828115\\n10.1111/apha.13926\\n10.3390/cells10040822\\n10.1038/s41374-019-0305-y\\n10.1002/cbin.10783\\n10.3803/EnM.2021.1167\\n10.1002/jcp.25187\\n10.1038/nature719\\n10.1002/JLB.1HI0421-181R\\n10.1038/mi.2016.16\\n10.1016/j.etap.2020.103469\\n10.4168/aair.2020.12.4.684\\n10.3389/fphar.2018.01244\\n10.1016/s0092-8674(02)00652-9\\n10.1016/j.isci.2021.103339\\n10.1016/j.isci.2018.09.014\\n10.1186/s12931-019-1050-x\\n10.1152/ajplung.00389.2011\\n10.1242/jcs.231878\\n10.1080/19336950.2016.1228401\\n10.1210/en.2014-1831\\n10.1111/cas.15257\\n10.1111/mmi.14863\\n10.1152/physrev.00005.2019\\n10.1038/s41598-020-68013-2\\n10.1038/s41366-021-00967-3\\n10.1039/d1fo01792f\\n10.3389/fimmu.2018.01273', 'xml': <Element 'PubmedArticle' at 0x10a111f80>}\n",
      "{'pubmed_id': '38365713\\n23395811\\n32539659\\n30564454\\n16722594\\n26434992\\n21857367\\n24326482\\n23642042\\n32859237\\n31383717\\n26200625\\n12794256\\n16761508\\n31998955\\n32838625\\n31507091\\n32809534\\n36730335\\n24834926\\n19671784\\n32816709\\n28471259\\n30567600\\n33961687\\n11157140\\n15173602\\n16540552', 'title': 'Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis.', 'abstract': 'This study aimed to assess the comorbidity profile, use of healthcare resources and medical costs of patients with systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) treated at the hospital level in Spain.\\nAdmission records of patients with SLE and CLE that were registered between January 2016 and December 2020 were obtained from a Spanish hospital discharge database and analyzed in a retrospective multicenter study.\\n329 patients met the criteria; 64.44% were female and 35.56% were male, with a median age of 54.65 years. Mean Charlson comorbidity index (CCI) was 2.75 in the index admission. 31.61% of the patients suffered essential hypertension, 21.96% suffered asthma and 19.76% suffered hyperlipidemia. Mortality rate was 3.95%. The most common medical procedure was heart ultrasound (19.45%) and introduction in peripheral vein of anti-inflammatory with a percutaneous approach (17.93%). Mean admission cost was €6355.99.\\nLupus patients showed a higher incidence and prevalence in the female population, with associated cardiac diseases as the main secondary conditions.', 'keywords': ['Comorbidity', 'Cutaneous lupus erythematosus: CLE', 'Incidence', 'SLE', 'Spain', 'Systemic lupus erythematosus'], 'journal': 'Orphanet journal of rare diseases', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Darba', 'firstname': 'Josep', 'initials': 'J', 'affiliation': 'Department of Economics, University of Barcelona, Diagonal 690, 08034, Barcelona, Spain. darba@ub.edu.'}, {'lastname': 'Ascanio', 'firstname': 'Meritxell', 'initials': 'M', 'affiliation': 'BCN Health Economics & Outcomes Research S.L., Travessera de Gràcia, 62, 08006, Barcelona, Spain.'}, {'lastname': 'Agüera', 'firstname': 'Ainoa', 'initials': 'A', 'affiliation': 'BCN Health Economics & Outcomes Research S.L., Travessera de Gràcia, 62, 08006, Barcelona, Spain.'}], 'methods': None, 'conclusions': None, 'results': '329 patients met the criteria; 64.44% were female and 35.56% were male, with a median age of 54.65 years. Mean Charlson comorbidity index (CCI) was 2.75 in the index admission. 31.61% of the patients suffered essential hypertension, 21.96% suffered asthma and 19.76% suffered hyperlipidemia. Mortality rate was 3.95%. The most common medical procedure was heart ultrasound (19.45%) and introduction in peripheral vein of anti-inflammatory with a percutaneous approach (17.93%). Mean admission cost was €6355.99.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13023-024-03077-1\\n10.1186/1750-1172-1-6\\n10.1191/0961203306lu2305xx\\n10.1371/journal.pone.0280809\\n10.1177/0961203309106831\\n10.1371/journal.pone.0251409\\n10.1093/rheumatology/40.1.37\\n10.1093/rheumatology/keh229\\n10.1136/ard.2005.046367', 'xml': <Element 'PubmedArticle' at 0x10aca7ab0>}\n",
      "{'pubmed_id': '38365643\\n29988370\\n19237391\\n30741507\\n26110689\\n11790957\\n36739315\\n28382891\\n33116657\\n35801383\\n24950203\\n24461761\\n17353499\\n15575349\\n19375453\\n24708388\\n25176184\\n23415502\\n30061487\\n24506700\\n36075638\\n30061501\\n23426535\\n29699517\\n28411906\\n36564884\\n34761656\\n26278484\\n21457335\\n25176184\\n26419585\\n28315941\\n10479232\\n18782109\\n21185068\\n23941862\\n34528308', 'title': \"Evaluation of Healthy Eating Index and Children's Diet Inflammatory Index according to asthma severity group.\", 'abstract': \"Diet may contribute to better asthma control in children by impacting the immune and inflammatory pathophysiology. Therefore, this study aimed to investigate differences in nutrient intake, Children's Dietary Inflammatory Index (C-DII), and dietary quality according to asthma severity.\\nAsthma severity, dietary inflammatory status, and diet quality were assessed in a sample of 202 children with asthma (55.6% males, aged 5-18\\xa0years) attending a pediatric allergy outpatient clinic. Asthma severity was evaluated according to the Global Initiative for Asthma criteria and categorized as mild, moderate, or severe. The Children's Dietary Inflammatory Index (C-DII) and Healthy Eating Index (HEI-2010) were calculated based on information collected by the 24-h dietary recall method. Dietary quality was categorized as poor, moderate, or good diet according to HEI-2010.\\nThe mean age of the participants was 9.6\\u2009±\\u20093.2\\xa0years. Children with severe asthma were younger on average (p\\u2009<\\u20090.05). Children with mild asthma had significantly higher fiber and iron intake than those with moderate asthma (p\\u2009<\\u20090.05). C-DII values did not differ significantly according to asthma severity (p\\u2009>\\u20090.05). Dietary quality was evaluated as moderate in 89.1% of the participants and also showed no difference based on asthma severity.\\nThese findings suggest that inflammatory status and diet quality may not affect asthma severity in children, highlighting the influence of various genetic and environmental factors on the association between diet and asthma severity. More comprehensive and longitudinal studies are needed to investigate the mechanisms linking diet and asthma.\", 'keywords': ['Asthma', 'Asthma severity', 'Children’s dietary inflammatory index', 'Healthy eating index', 'Nutrients'], 'journal': 'BMC pediatrics', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Koç', 'firstname': 'Nevra', 'initials': 'N', 'affiliation': 'Department of Nutrition and Dietetics, Gülhane Health Sciences of Faculty, Sağlık Bilimleri University, İstanbul, Turkey. nevra.koc@sbu.edu.tr.'}, {'lastname': 'Ersoy', 'firstname': 'Nursena', 'initials': 'N', 'affiliation': 'Ankara University, Institute of Health Sciences, Ankara, Turkey.'}, {'lastname': 'Yardimci', 'firstname': 'Hülya', 'initials': 'H', 'affiliation': 'Department of Nutrition and Dietetics, Faculty of Health Sciences, Ankara University, Ankara, Turkey.'}, {'lastname': 'Külhaş Çelik', 'firstname': 'İlknur', 'initials': 'İ', 'affiliation': 'Division of Pediatric Allergy Immunology, Faculty of Medicine, Selcuk University, Konya, Turkey.'}, {'lastname': 'Civelek', 'firstname': 'Ersoy', 'initials': 'E', 'affiliation': 'Division of Pediatric Allergy Immunology, Sağlık Bilimleri University, Ankara City Hospital, Ankara, Turkey.'}], 'methods': None, 'conclusions': None, 'results': 'The mean age of the participants was 9.6\\u2009±\\u20093.2\\xa0years. Children with severe asthma were younger on average (p\\u2009<\\u20090.05). Children with mild asthma had significantly higher fiber and iron intake than those with moderate asthma (p\\u2009<\\u20090.05). C-DII values did not differ significantly according to asthma severity (p\\u2009>\\u20090.05). Dietary quality was evaluated as moderate in 89.1% of the participants and also showed no difference based on asthma severity.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12887-023-04507-y\\n10.3389/fped.2018.00186\\n10.1136/thx.2008.106609\\n10.5334/aogh.2416\\n10.1097/ACI.0000000000000179\\n10.1097/00041433-200202000-00002\\n10.1007/s00394-023-03091-2\\n10.1017/S0007114517000368\\n10.2147/JAA.S261441\\n10.1111/all.15430\\n10.1016/j.immuni.2014.05.014\\n10.1016/S2213-2600(13)70126-7\\n10.1001/archinte.167.5.502\\n10.1007/s10654-004-5760-z\\n10.1016/J.PHARMTHERA.2009.03.015\\n10.1111/CEA.12323\\n10.1007/s00038-012-0424-3\\n10.1016/J.JAND.2012.12.016\\n10.3390/nu10080993\\n10.3109/02770903.2014.892966\\n10.1016/J.JACI.2022.07.014\\n10.3390/nu10080995\\n10.1186/s12887-018-1093-z\\n10.1016/j.aller.2016.09.004\\n10.1111/PAI.13892\\n10.15586/aei.v49i6.338\\n10.1016/j.aller.2015.04.007\\n10.1111/J.1399-3038.2010.01113.X\\n10.2174/1871530314666140826102514\\n10.3390/nu11123050\\n10.1007/s00394-017-1419-x\\n10.1093/AJCN/70.3.560S\\n10.1111/j.1398-9995.2008.01722.x\\n10.1016/j.jaci.2010.11.001\\n10.1017/S1368980013002115\\n10.1111/pai.13667', 'xml': <Element 'PubmedArticle' at 0x109ebe4d0>}\n",
      "{'pubmed_id': '38365468', 'title': 'Analysis of risk factors for depression and anxiety related to the degree of asthma control in children according to gender.', 'abstract': \"The purpose of the study was to investigate whether risk factors involved in the degree of asthma control were the same for children of both genders.\\nThis cross-sectional study collected relevant data from 320 children with asthma attending the respiratory asthma clinic at a local children's hospital. All the patients passed the Asthma Control Test (ACT) or the Childhood Asthma Control Test (cACT), lung-function-related tests, the Children's Depression Inventory (CDI), the Screening Scale for Anxiety-Related Mood Disorders (SCARED), and the Family Personal Information Questionnaire.\\nThe study found that gender (p=0.034) was a risk factor for poor asthma control and that girls (odds ratio [OR]=1.669, p=0.042) were more likely to have poor asthma control than boys. Univariate logistic regression analysis found that severe wasting (OR=0.075, p=0.021), depression (OR=43. 550, p<0.001), anxiety (OR=4.769, p=0.036), FEV1% (OR=0.970, p=0.043), FEV1/FVC% (OR=0.921, p=0. 008), and PEF% (OR=0.961, p=0.012) were risk factors for poor asthma control in girls.\\nThe risk factors for the degree of asthma control in children with asthma appeared to vary according to gender.\", 'keywords': ['Anxiety', 'Asthma', 'Children', 'Depression', 'Obesity'], 'journal': 'Archives de pediatrie : organe officiel de la Societe francaise de pediatrie', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Wang', 'firstname': 'Ning', 'initials': 'N', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China.\"}, {'lastname': 'Zhao', 'firstname': 'Long', 'initials': 'L', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China.\"}, {'lastname': 'Liu', 'firstname': 'Cuicui', 'initials': 'C', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China.\"}, {'lastname': 'Shi', 'firstname': 'Xiaolan', 'initials': 'X', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China.\"}, {'lastname': 'Wang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China.\"}, {'lastname': 'Wu', 'firstname': 'Shouzhen', 'initials': 'S', 'affiliation': \"Asthma Center, Xi'an Children's Hospital, China; Experimental Research Center, Yan'an Key Laboratory of Immune and Metabolism, Yan'an People's Hospital, China; Medicine and Technology Department, Shannxi University of Chinese Medicine, China. Electronic address: wushouzhen@qq.com.\"}], 'methods': None, 'conclusions': 'The risk factors for the degree of asthma control in children with asthma appeared to vary according to gender.', 'results': 'The study found that gender (p=0.034) was a risk factor for poor asthma control and that girls (odds ratio [OR]=1.669, p=0.042) were more likely to have poor asthma control than boys. Univariate logistic regression analysis found that severe wasting (OR=0.075, p=0.021), depression (OR=43. 550, p<0.001), anxiety (OR=4.769, p=0.036), FEV1% (OR=0.970, p=0.043), FEV1/FVC% (OR=0.921, p=0. 008), and PEF% (OR=0.961, p=0.012) were risk factors for poor asthma control in girls.', 'copyrights': 'Copyright © 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.', 'doi': '10.1016/j.arcped.2023.09.017', 'xml': <Element 'PubmedArticle' at 0x10a094630>}\n",
      "{'pubmed_id': '38365323', 'title': 'Asthma: a complex disease from causes to phenotype.', 'abstract': None, 'keywords': [], 'journal': 'EBioMedicine', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'eBioMedicine', 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.ebiom.2024.105022', 'xml': <Element 'PubmedArticle' at 0x10a095e40>}\n",
      "{'pubmed_id': '38365317', 'title': 'Evaluation of fractional exhaled nitric oxide measurement in defence primary healthcare.', 'abstract': None, 'keywords': ['Asthma', 'OCCUPATIONAL & INDUSTRIAL MEDICINE', 'PRIMARY CARE'], 'journal': 'BMJ military health', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Willman', 'firstname': 'A S', 'initials': 'AS', 'affiliation': 'Applied Health Research, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK a.willman@bham.ac.uk.\\nAcademic Department of Military General Practice, Royal Defence Medical College, Tidworth, UK.'}, {'lastname': 'Howard-Harwood', 'firstname': 'B', 'initials': 'B', 'affiliation': 'QEMHC Tidworth, DPHC, Lichfield, UK.'}, {'lastname': 'Blackadder-Weinstein', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Academic Department of Military General Practice, Royal Defence Medical College, Birmingham, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1136/military-2024-002675', 'xml': <Element 'PubmedArticle' at 0x10966ecf0>}\n",
      "{'pubmed_id': '38365175', 'title': 'An Update on Patient-Reported Outcomes in Asthma.', 'abstract': 'Patient-reported outcomes (PROs) are information provided by patients on their condition, function, well-being, or experience. Instruments to quantify PROs, called patient-reported outcome measures (PROMs), allow standardized assessment of a unique dimension of health which cannot be physically measured. Here, we discuss how to critically appraise PROMs and provide an update on their use in asthma clinical practice and research.\\nAsthma-specific PROMs have been developed to measure a wide array of disease characteristics, including symptoms, medication use, exacerbations, and impairments to emotional and physical function. Some PROMs also include spirometry or expand questions to overlap with rhinitis symptoms. Use of PROMs to understand asthma control is included in management guidelines, yet real-world evidence of their effectiveness in improving asthma care is still limited. These instruments may be less accurate in characterizing patients with poorly controlled asthma and have modest correlation with exacerbation risk. Two new PROMs are highlighted, the Asthma Impairment and Risk Questionnaire (AIRQ) as an instrument to assess asthma control which incorporates domains related to exacerbation risk and functional impairment, and the CompEx as a composite of daily diary reporting combined with exacerbation events as an early efficacy signal for interventional trials.\\nPROMs are fundamental to asthma assessment. Novel instruments may improve the detection of patients at-risk for poor outcomes and shorten the drug discovery pipeline. However, urgent research is needed to understand their practical utility in clinical settings.', 'keywords': ['PRO', 'PROM', 'asthma', 'narrative review', 'outcomes', 'validity'], 'journal': 'Chest', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Wu', 'firstname': 'Tianshi David', 'initials': 'TD', 'affiliation': 'Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston TX. Electronic address: david.wu@bcm.edu.'}, {'lastname': 'Diamant', 'firstname': 'Zuzana', 'initials': 'Z', 'affiliation': 'Dept of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen, The Netherlands; Department of Respiratory Medicine & Allergology, Skåne University Hospital, Lund, Sweden.'}, {'lastname': 'Hanania', 'firstname': 'Nicola A', 'initials': 'NA', 'affiliation': 'Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston TX.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.chest.2024.02.010', 'xml': <Element 'PubmedArticle' at 0x10966cc70>}\n",
      "{'pubmed_id': '38364368', 'title': 'Risk Factors Associated With Distress Among Postoperative Patients in an Academic Gynecologic Oncology Practice.', 'abstract': 'Distress among gynecologic oncology patients correlates with poor clinical outcomes and decreased quality of life. The purpose of this study was to determine risk factors for elevated NCCN Distress Thermometer (DT) results among postoperative gynecologic oncology patients.\\nWe performed a retrospective chart review of all postoperative visits over a 5-year period. NCCN DT results were analyzed as both discretized values (DT ≤3 = low distress; DT 4-8 = moderate distress; DT ≥9 = high distress) and continuous variables. Patients with a DT score ≥4 were referred to social work. Univariate and multivariate regression analyses were performed to compare NCCN DT results with clinical and sociodemographic variables. Statistical significance was P<.05.\\nIn total, 1,795 NCCN DT results were included, with uterine (37.72%) being the most common disease site. Benign pathology was known prior to completion of the NCCN DT in 13.15% of patients. Most patients (71.75%) endorsed low levels of distress. Moderate/High levels of distress were reported by 28.25% of patients. Increasing levels of distress were significantly associated with younger age (P=.006), history of depression (P≤.001), status as a current smoker (P=.028), and history of asthma (P=.041). Knowledge of benign pathology was associated with low levels of distress (P=.002). Procedure type and disease site were not associated with distress.\\nMore than one-fourth of postoperative patients in a gynecologic oncology practice reported moderate or high distress. Distress was highest among those with malignancy regardless of disease site or surgical intervention. Benign pathology correlated with decreased distress. Identified associations with distress provide opportunities for prevention, early intervention, and tailored counseling.', 'keywords': ['Distress', 'Distress Thermometer', 'postoperative outcomes'], 'journal': 'Journal of the National Comprehensive Cancer Network : JNCCN', 'publication_date': datetime.date(2024, 2, 17), 'authors': [{'lastname': 'Gross', 'firstname': 'Maya E', 'initials': 'ME', 'affiliation': '1Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI.'}, {'lastname': 'Sobecki', 'firstname': 'Janelle N', 'initials': 'JN', 'affiliation': '2Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI.'}, {'lastname': 'Park', 'firstname': 'Chan', 'initials': 'C', 'affiliation': '3Department of Statistics, University of Wisconsin, Madison, WI.'}, {'lastname': 'Yu', 'firstname': 'Menggang', 'initials': 'M', 'affiliation': '4Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI.'}, {'lastname': 'Wallace', 'firstname': 'Sumer K', 'initials': 'SK', 'affiliation': '2Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI.'}], 'methods': None, 'conclusions': None, 'results': 'In total, 1,795 NCCN DT results were included, with uterine (37.72%) being the most common disease site. Benign pathology was known prior to completion of the NCCN DT in 13.15% of patients. Most patients (71.75%) endorsed low levels of distress. Moderate/High levels of distress were reported by 28.25% of patients. Increasing levels of distress were significantly associated with younger age (P=.006), history of depression (P≤.001), status as a current smoker (P=.028), and history of asthma (P=.041). Knowledge of benign pathology was associated with low levels of distress (P=.002). Procedure type and disease site were not associated with distress.', 'copyrights': None, 'doi': '10.6004/jnccn.2023.7093', 'xml': <Element 'PubmedArticle' at 0x10b7a9580>}\n",
      "{'pubmed_id': '38364351', 'title': 'Ayurveda management of a patient having bronchial asthma and hemorrhoids- A case report.', 'abstract': 'Ayurveda is a holistic science that treats root cause of diseases. One disease can become a causative factor for another disease. This concept is fundamentally described as Nidanarthakar Vyadhi in Ayurveda. In the same way, treating causative diseases is helpful in managing another diseases. However, many published clinical trials on Ayurveda management of Bronchial asthma and Hemorrhoids exist. There is a dearth of published case reports or clinical trials showing an association between Arsha (hemorrhoids) and Shwasa (bronchial asthma). This case report gives important viewpoints about the role of hemorrhoids and its treatment in pathogenesis and treatment of bronchial asthma. This case report of a 38-year-old female patient known case of bronchial asthma who came to the OPD of Kayachikitsa Government Ayurved College and Hospital, Nagpur with complaints of cough with sputum, breathlessness, chest pain (on/off) for three years. The severity of these symptoms increased for three months. The patient was treated with conventional Shwasghna Chikitsa (treatment of bronchial asthma) for five days, but the response was unsatisfactory. After five days of Shwasghna treatment, the patient gave a history of hemorrhoids. Considering Nidanarthakar Roga (one disease can cause of another disease), treatment was planned. The treatment principle is the treatment of causative disease (Arsha). Hence, Arshoghna treatment was added. Significant increases in peak expiratory flow rate (PEFR), Sustained minimal inspiration (SMI), and Modified Medical Research Council Dyspnoea scale (mMRC) were observed. The respiratory rate was also reduced from 28/min to 18/min. Improvement in the subjective and objective parameters of the patient was observed. The inclusion of Arsha treatment can be helpful in the management of Tamakshwas (Bronchial Asthma). The need for further research in this direction is warranted.', 'keywords': ['Arsha', 'Bronchial asthma', 'Case report', 'Gut –lung axis', 'Hemorrhoids', 'Tamakshwas', 'mMRC scale'], 'journal': 'Journal of Ayurveda and integrative medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Khobarkar', 'firstname': 'Punam', 'initials': 'P', 'affiliation': 'Kayachikitsa, All India Institute of Ayurveda, New Delhi, India; Kayachikitsa, Government Ayurved College, Nagpur, India. Electronic address: poonamkhobarkar10@gmail.com.'}, {'lastname': 'Nakanekar', 'firstname': 'Amit', 'initials': 'A', 'affiliation': 'Kayachikitsa, Government Ayurved College, Nagpur, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jaim.2023.100863', 'xml': <Element 'PubmedArticle' at 0x10b7aade0>}\n",
      "{'pubmed_id': '38364218', 'title': 'Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.', 'abstract': \"Some patients with severe asthma may benefit from treatment with biologics, but evidence has been mostly collected from randomized controlled trials (RCTs), in which patients' characteristics are different from those encountered in asthma patients in the real-world setting. The aim of this study was to describe the clinical features of complete responders versus non-complete responders to long-term treatment with biologics in patients with severe asthma attended in routine daily practice.\\nData of a cohort of 90 patients with severe asthma who were treated with biologics (omalizumab, benralizumab, and mepolizumab) for at least 12\\u2009months and were followed up to March 2022. Data recorded included clinical characteristics and effectiveness of treatment (exacerbation, Asthma Control Test [ACT] score, lung function, use of maintenance oral corticosteroids [mOCS]), FeNO, and blood eosinophils at baseline, at 12\\u2009months, and at the end of follow-up. Complete response is considered if, in addition to not presenting exacerbations or the use of mOCS, the ACT score was >20 and, the FEV\\nAn improvement in all asthma control parameters was observed after 12\\u2009months of treatment and a mean follow-up of 55\\u2009months. After 12\\u2009months of treatment 27.2% of patients met the criteria of complete response and this percentage even increased to 35.3% at the end of follow-up. Long-term complete response was associated to better lung function with mepolizumab and omalizumab treatment and to less previous exacerbations in the benralizumab group. The main cause of not achieving a complete response was the persistence of an airflow obstructive pattern.\\nThis study shows that omalizumab, benralizumab, and mepolizumab improved the clinical outcomes of patients with severe asthma in a clinic environment with similar effect sizes to RCTs in the long term follow-up. Airflow obstruction, however, was a predictor of a non-complete response to biologics.\\nTreatment with anti-IgE and anti-IL-5 biologics significantly improved clinical outcomes in severe asthma patients.The rate of complete responders of 27.2% at 12 months even increased to 35.3% at the end of a mean follow-up of 55 months.The persistence of an airflow obstructive pattern was the main cause of the failure to achieve complete response.\", 'keywords': ['Severe asthma', 'benralizumab', 'biologics', 'mepolizumab', 'omalizumab', 'retrospective analysis'], 'journal': 'Annals of medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Basagaña', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Allergy Section, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Martínez-Rivera', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Pneumology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Padró', 'firstname': 'Clara', 'initials': 'C', 'affiliation': 'Allergy Section, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Garcia-Olivé', 'firstname': 'Ignasi', 'initials': 'I', 'affiliation': 'Pneumology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Martínez-Colls', 'firstname': 'Mimar', 'initials': 'M', 'affiliation': 'Pediatric Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Navarro', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Pediatric Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Pardo', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Otorhinolaryngology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Cruz', 'firstname': 'Paula', 'initials': 'P', 'affiliation': 'Otorhinolaryngology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Cardona Peitx', 'firstname': 'Gloria', 'initials': 'G', 'affiliation': 'Pharmacy Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Carabias', 'firstname': 'Lídia', 'initials': 'L', 'affiliation': 'Pharmacy Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Roger', 'firstname': 'Albert', 'initials': 'A', 'affiliation': 'Allergy Section, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Abad', 'firstname': 'Jorge', 'initials': 'J', 'affiliation': 'Pneumology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Rosell', 'firstname': 'Antoni', 'initials': 'A', 'affiliation': 'Pneumology Department, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.'}], 'methods': None, 'conclusions': None, 'results': 'An improvement in all asthma control parameters was observed after 12\\u2009months of treatment and a mean follow-up of 55\\u2009months. After 12\\u2009months of treatment 27.2% of patients met the criteria of complete response and this percentage even increased to 35.3% at the end of follow-up. Long-term complete response was associated to better lung function with mepolizumab and omalizumab treatment and to less previous exacerbations in the benralizumab group. The main cause of not achieving a complete response was the persistence of an airflow obstructive pattern.', 'copyrights': None, 'doi': '10.1080/07853890.2024.2317356', 'xml': <Element 'PubmedArticle' at 0x124c16ed0>}\n",
      "{'pubmed_id': '38364200', 'title': 'Susceptible Young Adults and Development of COPD Later in Life.', 'abstract': 'Chronic obstructive pulmonary disease (COPD) has its origin in early life, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposes a pre-disease state \"pre-COPD\".\\nWe tested the hypothesis that susceptible young adults identified with chronic bronchitis and subtle lung function impairment will develop COPD later in life.\\nWe followed random non-obstructive individuals aged 20-50years from two population-based cohorts from different smoking eras, the Copenhagen General Population Study from 2003(N=5497) and Copenhagen City Heart Study from 1976-78(N=2609), for 10 and 25years for development of COPD(forced expiratory volume in one second[FEV\\nAfter 10 years follow-up, 28% developed COPD and 13% COPD GOLD 2-4 in individuals susceptible to COPD compared to 8% and 1% in those without any susceptibility to COPD. Correspondingly, after 25years, 22% versus 13% developed COPD and 20% versus 8% developed COPD GOLD 2-4. More than half of incident COPD cases developed from a susceptible state. Compared to those without susceptibility to COPD, multivariable adjusted odds ratios in those susceptible to COPD were 3.42(95% confidence interval:2.78-4.21) for COPD and 10.1(6.77-15.2) for COPD GOLD 2-4 after 10years, and 1.54(1.23-1.93) and 2.12(1.64-2.73) after 25years. The ability of a COPD risk score consisting of the susceptibility state to COPD with smoking and asthma as risk factors to predict COPD later in life was high.\\nOur study suggests the existence of a pre-disease state of COPD, which can be used for early identification of susceptible individuals at risk for COPD later in life.', 'keywords': ['Airway Obstruction', 'Chronic Bronchitis', 'Early Diagnosis', 'Forced Expiratory Volume', 'Spirometry'], 'journal': 'American journal of respiratory and critical care medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Çolak', 'firstname': 'Yunus', 'initials': 'Y', 'affiliation': 'Copenhagen University Hospital - Herlev and Gentofte, Department of Respiratory Medicine, Copenhagen, Denmark.\\nCopenhagen University Hospital - Herlev and Gentofte, The Copenhagen General Population Study, Copenhagen, Denmark.\\nUniversity of Copenhagen, 4321, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark.'}, {'lastname': 'Lange', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Copenhagen University Hospital - Herlev and Gentofte, Department of Respiratory Medicine, Copenhagen, Denmark.\\nCopenhagen University Hospital - Herlev and Gentofte, The Copenhagen General Population Study, Copenhagen, Denmark.\\nUniversity of Copenhagen, 4321, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark.\\nUniversity of Copenhagen, 4321, Department of Public Health, Section of Epidemiology, Copenhagen, Denmark.'}, {'lastname': 'Vestbo', 'firstname': 'Jørgen', 'initials': 'J', 'affiliation': 'The University of Manchester, 5292, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Nordestgaard', 'firstname': 'Børge G', 'initials': 'BG', 'affiliation': 'Copenhagen University Hospital - Herlev and Gentofte, Department of Clinical Biochemistry, Copenhagen, Denmark.\\nCopenhagen University Hospital - Herlev and Gentofte, The Copenhagen General Population Study, Copenhagen, Denmark.\\nUniversity of Copenhagen, 4321, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark.'}, {'lastname': 'Afzal', 'firstname': 'Shoaib', 'initials': 'S', 'affiliation': 'Copenhagen University Hospital - Herlev and Gentofte, Department of Clinical Biochemistry, Copenhagen, Denmark.\\nCopenhagen University Hospital - Herlev and Gentofte, The Copenhagen General Population Study, Copenhagen, Denmark.\\nUniversity of Copenhagen, 4321, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark; shoaib.afzal@regionh.dk.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1164/rccm.202308-1452OC', 'xml': <Element 'PubmedArticle' at 0x1090402c0>}\n",
      "{'pubmed_id': '38364198', 'title': 'Ambient temperature and risk of cardiovascular and respiratory adverse health outcomes: a nationwide cross-sectional study from Spain.', 'abstract': 'We assessed the association of temperature and temperature variability with cause-specific emergency hospitalizations and mortality from cardiovascular and respiratory diseases in Spain, as well as the effect modification of this association by individual and contextual factors.\\nWe collected data on health (hospital admissions and mortality), weather (temperature and relative humidity), and relevant contextual indicators for 48 Spanish provinces during 2004-2019. The statistical analysis was separately performed for the summer (June-September) and winter (December-March) seasons. We first applied a generalized linear regression model with quasi-Poisson distribution to estimate daily province-specific temperature-health associations, and then we fitted multilevel multivariate meta-regression models to the evaluate effect modification of the contextual characteristics on heat- and cold-related risks. High temperature increased the risk of mortality across all cardiovascular and respiratory diseases, with the strongest effect for hypertension (relative risk (RR) at 99th temperature percentile vs. optimum temperature: 1.510 [95% empirical confidence interval {eCI} 1.251 to 1.821]), heart failure (1.528 [1.353 to 1.725]), and pneumonia (2.224 [1.685 to 2.936]). Heat also had an impact on all respiratory hospitalization causes (except asthma), with similar risks between pneumonia (1.288 [1.240 to 1.339]), acute bronchitis and bronchiolitis (1.307 [1.219 to 1.402]), and chronic obstructive pulmonary disease (1.260 [1.158 to 1.372]). We generally found significant risks related to low temperature for all cardiovascular and respiratory causes, with heart failure (RR at 1st temperature percentile vs. optimum temperature: 1.537 [1.329 to 1.779]) and chronic obstructive pulmonary disease (1.885 [1.646 to 2.159]) exhibiting the greatest risk for hospitalization, and acute myocardial infarction (1.860 [1.546 to 2.238]) and pneumonia (1.734 [1.219 to 2.468]) for mortality. Women and the elderly were more vulnerable to heat, while people with secondary education were less susceptible to cold compared to those not achieving this educational stage. Results from meta-regression showed that increasing heating access to the highest current provincial value (i.e. 95.6%) could reduce deaths due to cold by 59.5% (57.2 to 63.5).\\nExposure to low and high temperatures was associated with a greater risk of morbidity and mortality from multiple cardiovascular and respiratory conditions, and heating was the most effective societal adaptive measure to reduce cold-related mortality.\\nExposure to low and high temperatures increases the risk of morbidity and mortality from several cardiovascular and respiratory diseases, especially among the elderly. Increasing access to heating could substantially reduce cold-related mortality burden.', 'keywords': ['Cardiovascular disease', 'Respiratory disease', 'Socioeconomic factors', 'Temperature'], 'journal': 'European journal of preventive cardiology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Achebak', 'firstname': 'Hicham', 'initials': 'H', 'affiliation': 'Inserm, France Cohortes, 48-50 rue Albert, 75013 Paris, France.\\nISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.'}, {'lastname': 'Rey', 'firstname': 'Grégoire', 'initials': 'G', 'affiliation': 'Inserm, France Cohortes, 48-50 rue Albert, 75013 Paris, France.'}, {'lastname': 'Lloyd', 'firstname': 'Simon J', 'initials': 'SJ', 'affiliation': 'ISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.'}, {'lastname': 'Quijal-Zamorano', 'firstname': 'Marcos', 'initials': 'M', 'affiliation': 'ISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.\\nUniversitat Pompeu Fabra (UPF), Doctor Aiguader 80, 08003 Barcelona, Spain.'}, {'lastname': 'Méndez-Turrubiates', 'firstname': 'Raúl Fernando', 'initials': 'RF', 'affiliation': 'ISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.'}, {'lastname': 'Ballester', 'firstname': 'Joan', 'initials': 'J', 'affiliation': 'ISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.'}], 'methods': None, 'conclusions': 'Exposure to low and high temperatures was associated with a greater risk of morbidity and mortality from multiple cardiovascular and respiratory conditions, and heating was the most effective societal adaptive measure to reduce cold-related mortality.', 'results': None, 'copyrights': '© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.\\n© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.', 'doi': '10.1093/eurjpc/zwae021', 'xml': <Element 'PubmedArticle' at 0x10a1ad260>}\n",
      "{'pubmed_id': '38364038', 'title': \"Risk factors and effect of dyspnea inappropriate treatment in adults' emergency department: a retrospective cohort study.\", 'abstract': \"Dyspnea is a frequent symptom in adults' emergency departments (EDs). Misdiagnosis at initial clinical examination is common, leading to early inappropriate treatment and increased in-hospital mortality. Risk factors of inappropriate treatment assessable at early examination remain undescribed herein. The objective of this study was to identify clinical risk factors of dyspnea and inappropriate treatment in patients admitted to ED. This is an observational retrospective cohort study. Patients over the age of 15 who were admitted to adult EDs of the University Hospital of Toulouse (France) with dyspnea were included from 1 July to 31 December 2019. The primary end-point was dyspnea and inappropriate treatment was initiated at ED. Inappropriate treatment was defined by looking at the final diagnosis of dyspnea at hospital discharge and early treatment provided. Afterward, this early treatment at ED was compared to the recommended treatment defined by the International Guidelines for Acute Heart Failure, bacterial pneumonia, chronic obstructive pulmonary disease, asthma or pulmonary embolism. A total of 2123 patients were analyzed. Of these, 809 (38%) had inappropriate treatment in ED. Independent risk factors of inappropriate treatment were: age over 75\\u2009years (OR, 1.46; 95% CI, 1.18-1.81), history of heart disease (OR, 1.32; 95% CI, 1.07-1.62) and lung disease (OR, 1.47; 95% CI, 1.21-1.78), SpO2 <90% (OR, 1.64; 95% CI, 1.37-2.02), bilateral rale (OR, 1.25; 95% CI, 1.01-1.66), focal cracklings (OR, 1.32; 95% CI, 1.05-1.66) and wheezing (OR, 1.62; 95% CI, 1.31-2.03). In multivariate analysis, under-treatment significantly increased in-hospital mortality (OR, 2.13; 95% CI, 1.29-3.52) compared to appropriate treatment. Over-treatment nonsignificantly increased in-hospital mortality (OR, 1.43; 95% CI, 0.99-2.06). Inappropriate treatment is frequent in patients admitted to ED for dyspnea. Patients older than 75 years, with comorbidities (heart or lung disease), hypoxemia (SpO2 <90%) or abnormal pulmonary auscultation (especially wheezing) are at risk of inappropriate treatment.\", 'keywords': [], 'journal': 'European journal of emergency medicine : official journal of the European Society for Emergency Medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Balen', 'firstname': 'Frederic', 'initials': 'F', 'affiliation': 'Emergency Department, Toulouse University Hospital.\\nCERPOP - EQUITY, INSERM.'}, {'lastname': 'Lamy', 'firstname': 'Sebastien', 'initials': 'S', 'affiliation': 'CERPOP - EQUITY, INSERM.'}, {'lastname': 'Froissart', 'firstname': 'Léa', 'initials': 'L', 'affiliation': 'Emergency Department, Toulouse University Hospital.'}, {'lastname': 'Mesnard', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Emergency Department, Toulouse University Hospital.'}, {'lastname': 'Sanchez', 'firstname': 'Benjamin', 'initials': 'B', 'affiliation': 'Emergency Department, Toulouse University Hospital.'}, {'lastname': 'Dubucs', 'firstname': 'Xavier', 'initials': 'X', 'affiliation': 'Emergency Department, Toulouse University Hospital.\\nCERPOP - EQUITY, INSERM.\\nToulouse III - Paul Sabatier University, Toulouse, France.'}, {'lastname': 'Charpentier', 'firstname': 'Sandrine', 'initials': 'S', 'affiliation': 'Emergency Department, Toulouse University Hospital.\\nCERPOP - EQUITY, INSERM.\\nToulouse III - Paul Sabatier University, Toulouse, France.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/MEJ.0000000000001129', 'xml': <Element 'PubmedArticle' at 0x10a6f9940>}\n",
      "{'pubmed_id': '38363941\\n16388197\\n18331513\\n17131787\\n17215318\\n28942987\\n33273461\\n29438600\\n25304232\\n29083406\\n25537150\\n32744037\\n19222116\\n36330091\\n30445434\\n11752295\\n16939800\\n23193258\\n27312411\\n31375807\\n33590861\\n30357393\\n24227677\\n25516281\\n22247279\\n19114008\\n16646834\\n30365030\\n29106634\\n24735618\\n21253603\\n33151290\\n28256516\\n27218427\\n11259830\\n10746014\\n12036371\\n11052792\\n11384230\\n31106366\\n30395287\\n20430828\\n28472422\\n30380087\\n33264402\\n21715386\\n33125081\\n10592173\\n34788843\\n10802651\\n33290552\\n29800320\\n16199517\\n22455463\\n34557778\\n23323831\\n27271570\\n32102931\\n35576187\\n28919117\\n33069326\\n32412646\\n22189254\\n10719286\\n10782526\\n15585605\\n12897738\\n15356557\\n16266379\\n19995952\\n24514067\\n30995505\\n18768888\\n35863378\\n23470321\\n11905831\\n29713322\\n24232184\\n37889962', 'title': 'Molecular characterization of allergic constitution based on network pharmacology and multi-omics analysis methods.', 'abstract': 'The objective of this study was to identify critical pathways associated with allergic constitution. Shared genes among allergic rhinitis (AR), asthma (AA), and atopic dermatitis (AD) were extracted from the GWAS catalog. RNA-seq data of AR, AA, and AD from gene expression omnibus (GEO) database were preprocessed and subjected to differential gene expression analysis. The differentially expressed genes (DEGs) were merged using the Robust Rank Aggregation (RRA) algorithm. Weighted gene co-expression network analysis (WGCNA) was performed to identify modules associated with allergies. Components of Guominkang (GMK) were obtained from 6 databases and activate components were identified by SwissADME website. Utilizing the SwissTarget Prediction, PharmMapper, SymMap, and HERB, the targets of GMK were predicted and subsequently validated using gene chip data from our team previous study. Differentially expressed proteins (DEPs) related to the allergic constitution were also extracted based on a previous study. Pathway enrichment analysis was performed using KOBAS-i on the GWAS, RRA, WGCNA modules, DEPs, and GMK targets. P values from multi-omics datasets were combined by meta-analysis, and Bonferroni correction was applied. The significant pathways were further validated using Gene Set Enrichment Analysis (GSEA) with intervention data of GMK. The GWAS results yielded 172 genes. Four datasets AR1, AA1, AD1, and AD2 were acquired from GSE75011, GSE125916, and GSE184237. The RRA algorithm identified 19 upregulated and 20 downregulated genes. WGCNA identified 5 significant modules, with the blue and turquoise modules displaying a moderate correlation with allergies. By performing network pharmacology analysis, we identified 127 active ingredients of GMK and predicted 618 targets. Validation using gene chip data confirmed 107 GMK targets. Single-omics pathway analysis was conducted using KOBAS-i, and 39 significant pathways were identified across multiple omics datasets. GSEA analysis using GMK intervention data identified 11 of 39 significant pathways as the final key pathways associated with the allergic constitution. Through multi-omics integrated pathway analysis, we identified 11 critical pathways of allergic constitution, including TH1 and TH2 cell differentiation, TLR cascade, and TH17 cell differentiation. Identifying these pathways suggests that the observed alterations at the pathway level may play significant roles in the molecular characteristics of the allergic constitution.', 'keywords': [], 'journal': 'Medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Sun', 'firstname': 'Pengcheng', 'initials': 'P', 'affiliation': 'College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.\\nNational Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Xing', 'initials': 'X', 'affiliation': 'College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.\\nNational Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.\\nNational Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Shen', 'firstname': 'Rongmin', 'initials': 'R', 'affiliation': 'Beijing Heniantang Traditional Chinese Medicine Hospital, Beijing, China.'}, {'lastname': 'Chen', 'firstname': 'Xuemei', 'initials': 'X', 'affiliation': 'National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Zhuqing', 'initials': 'Z', 'affiliation': 'College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.\\nNational Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Cui', 'firstname': 'Diankun', 'initials': 'D', 'affiliation': 'College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.\\nNational Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Ji', 'initials': 'J', 'affiliation': 'National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.', 'doi': '10.1097/MD.0000000000036892\\n10.18129/B9.bioc.sva\\n10.18129/b9.bioc.org.hs.eg.db\\n10.18129/B9.bioc.GSEABase', 'xml': <Element 'PubmedArticle' at 0x109aa10d0>}\n",
      "{'pubmed_id': '38363933\\n32242117\\n12823154\\n21465223\\n29193245\\n19887939\\n29193785\\n34574556\\n21799648\\n30561415\\n15846735\\n28882408\\n33088466\\n16052787\\n11250627\\n31524644\\n18410559\\n35585481\\n34409990\\n11812579\\n32000624\\n35082398\\n15075143\\n35119566\\n36523763\\n36214830\\n36911112\\n24221340\\n34187846\\n29686387\\n24114802\\n29961852\\n27061298\\n26050253\\n33027558\\n35992145\\n34619639\\n31733335\\n17577320\\n22442097\\n19371399\\n28463855\\n33420219\\n19654570\\n15016918\\n16805363\\n21851356\\n36013245\\n35689682\\n36338479\\n34203134\\n35594317\\n28378957\\n24516699\\n28784097\\n18284539', 'title': 'Identifying causal relationships between gastroesophageal reflux and extraesophageal diseases: A Mendelian randomization study.', 'abstract': 'Traditional observational and in vivo studies have suggested an etiological link between gastroesophageal reflux disease (GERD) and the development of extraesophageal diseases (EEDs), such as noncardiac chest pain. However, evidence demonstrating potential causal relationships is lacking. This study evaluated the potential causal relationship between GERD and EEDs, including throat and chest pain, asthma, bronchitis, chronic rhinitis, nasopharyngitis and pharyngitis, gingivitis and periodontal disease, cough, using multiple Mendelian randomization (MR) methods, and sensitivity analysis was performed. The Mendelian randomization Pleiotropy RESidual Sum and Outlier and PhenoScanner tools were used to further check for heterogeneous results and remove outliers. MR with inverse-variance weighted (IVW) showed a significant causal relationship between GERD and EEDs after Bonferroni correction. IVW results indicated that GERD increased the risk of chronic rhinitis, nasopharyngitis and pharyngitis (odds ratio [OR]\\u2005=\\u20051.482, 95% confidence interval [CI]\\u2005=\\u20051.267-1.734, P\\u2005<\\u2005.001], gingivitis and periodontal disease (OR\\u2005=\\u20051.166, 95% CI\\u2005=\\u20051.046-1.190, P\\u2005=\\u2005.001), throat and chest pain (OR\\u2005=\\u20051.585, 95% CI\\u2005=\\u20051.455-1.726, P\\u2005<\\u2005.001), asthma (OR\\u2005=\\u20051.539, 95% CI\\u2005=\\u20051.379-1.717, P\\u2005<\\u2005.001), and bronchitis (OR\\u2005=\\u20051.249, 95% CI\\u2005=\\u20051.168-1.335, P\\u2005<\\u2005.001). Sensitivity analysis did not detect pleiotropy. Leave-one-out analysis shows that MR results were not affected by individual single nucleotide polymorphisms. The funnel plot considers the genetic instrumental variables to be almost symmetrically distributed. This MR supports a causal relationship among GERD and EEDs. Precise moderation based on causality and active promotion of collaboration among multidisciplinary physicians ensure high-quality diagnostic and treatment recommendations and maximize patient benefit.', 'keywords': [], 'journal': 'Medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Yao', 'firstname': 'Peishan', 'initials': 'P', 'affiliation': 'Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.'}, {'lastname': 'Liao', 'firstname': 'Xiaomin', 'initials': 'X', 'affiliation': 'Guangxi Medical University, Nanning, Guangxi, China.'}, {'lastname': 'Huang', 'firstname': 'Junming', 'initials': 'J', 'affiliation': 'The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.'}, {'lastname': 'Dang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Gastroenterology, Yulin Red Cross Hospital, Yulin, Guangxi, China.'}, {'lastname': 'Jiang', 'firstname': 'Haixing', 'initials': 'H', 'affiliation': 'Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.', 'doi': '10.1097/MD.0000000000037054', 'xml': <Element 'PubmedArticle' at 0x10ab4d620>}\n",
      "{'pubmed_id': '38363652', 'title': 'Approach to difficult-to-treat asthma in childhood: a narrative review.', 'abstract': 'Asthma is a major chronic disease affecting children, and children with difficult-to-treat asthma account for a disproportionate share of resource utilisation and healthcare costs. This review presents a comprehensive and up-to-date overview of the treatment strategies in difficult-to-treat paediatric asthma. Mimickers of asthma must first be ruled out, and the diagnosis confirmed with objective tests whenever possible. The effect of comorbid conditions such as obesity, smoking, other atopic conditions and psychosocial factors on asthma control and severity should be considered. Treatment can then be optimised by implementing personalised strategies, including the use of appropriate drug delivery devices and adherence monitoring. Biologics can be an alternative treatment option for selected patients but should not be a substitute for addressing poor adherence. Many patients with difficult-to-treat asthma may not have severe asthma, and the physician should work with patients and families to achieve good asthma control via an individualised approach.', 'keywords': [], 'journal': 'Singapore medical journal', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Cheng', 'firstname': 'Duo-Tong', 'initials': 'DT', 'affiliation': \"Department of Paediatrics, Respiratory Medicine Service, KK Women's and Children's Hospital, Singapore.\"}, {'lastname': 'Wee', 'firstname': 'Liang Yi Justin', 'initials': 'LYJ', 'affiliation': None}, {'lastname': 'Teoh', 'firstname': 'Oon Hoe', 'initials': 'OH', 'affiliation': None}, {'lastname': 'Thomas', 'firstname': 'Biju', 'initials': 'B', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Copyright: © 2024 Singapore Medical Journal.', 'doi': '10.4103/singaporemedj.SMJ-2023-137\\n10.1183/1393003.congress-2017.PA595\\n10.1183/23120541.00571-2022', 'xml': <Element 'PubmedArticle' at 0x10afd6390>}\n",
      "{'pubmed_id': '38363325\\n32078669\\n27544740\\n28987810\\n34473358\\n29331025\\n28665518\\n20973804\\n29066321\\n26022180\\n30335467\\n22673904\\n35765979\\n26342525\\n33023995\\n32198936\\n32483332\\n37205104\\n35809382\\n30281939\\n35395283\\n36138182\\n37734174\\n32145873\\n35728655\\n32631807\\n31688152\\n37466661\\n27173434\\n32540397\\n34390596\\n25907676\\n22647600\\n33860870\\n31637021\\n24280772\\n26360589\\n21469115\\n29880482\\n31106362\\n36078080\\n33664865\\n34769080\\n32276966\\n31059133\\n15086343\\n25264308\\n12629149\\n29746583\\n33340608\\n21943944', 'title': 'Deficiency of INPP4A promotes M2 macrophage polarization in eosinophilic chronic rhinosinusitis with nasal polyps.', 'abstract': 'The treatment of eosinophilic chronic rhinosinusitis with nasal polyps (E-CRSwNP) remains a challenge due to its complex pathogenesis. Inositol polyphosphate-4-phosphatase type IA (INPP4A), a lipid phosphatase, has been implicated in allergic asthma. However, the expression and function of INPP4A in E-CRSwNP remain unclear. This study aims to investigate the role of INPP4A in macrophages in E-CRSwNP.\\nWe assessed the expression of INPP4A in human and mouse nasal mucosal tissues via immunofluorescence staining. THP-1 cells were cultured and exposed to various cytokines to investigate the regulation of INPP4A expression and its functional role. Additionally, we established a murine nasal polyp (NP) model and administrated an INPP4A-overexpressing lentivirus evaluate its impact on NP.\\nThe percentage of INPP4A\\u2009+\\u2009CD68\\u2009+\\u2009macrophages among total macrophages decreased in the E-CRSwNP group compared to the control and the non-eosinophilic CRSwNP (NE-CRSwNP) groups, exhibiting an inverse correlation with an increased percentage of CD206\\u2009+\\u2009CD68\\u2009+\\u2009M2 macrophages among total macrophages. Overexpression of INPP4A led to a reduced percentage of THP-1 cells polarizing towards the M2 phenotype, accompanied by decreased levels of associated chemotactic factors including CCL18, CCL22, CCL24, and CCL26. We also validated the involvement of the PI3K-AKT pathway in the function of INPP4A in vitro. Furthermore, INPP4A overexpression in the murine NP model resulted in the attenuation of eosinophilic inflammation in the nasal mucosa.\\nINPP4A deficiency promotes macrophage polarization towards the M2 phenotype, leading to the secretion of chemokines that recruit eosinophils and Th2 cells, thereby amplifying eosinophilic inflammation in E-CRSwNP. INPP4A may exert a suppressive role in eosinophilic inflammation and could potentially serve as a novel therapeutic strategy.', 'keywords': ['E-CRSwNP', 'Eosinophil', 'INPP4A', 'Macrophage', 'Polarization'], 'journal': 'Inflammation research : official journal of the European Histamine Research Society ... [et al.]', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Xu', 'firstname': 'Yingying', 'initials': 'Y', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Tong', 'firstname': 'Xiaoting', 'initials': 'X', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Liu', 'firstname': 'Peiqiang', 'initials': 'P', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Huang', 'firstname': 'Jingyu', 'initials': 'J', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Chen', 'firstname': 'Siyuan', 'initials': 'S', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Liu', 'firstname': 'Duo', 'initials': 'D', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Gu', 'firstname': 'Tian', 'initials': 'T', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Xie', 'firstname': 'Yulie', 'initials': 'Y', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Guo', 'firstname': 'Duo', 'initials': 'D', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China.'}, {'lastname': 'Xu', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Rhinology and Allergy, Otolaryngology-Head and Neck Surgery Center, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, China. xuy@whu.edu.cn.\\nHubei Province Key Laboratory of Allergy and Immunity, Wuhan, China. xuy@whu.edu.cn.\\nResearch Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, China. xuy@whu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': 'The percentage of INPP4A\\u2009+\\u2009CD68\\u2009+\\u2009macrophages among total macrophages decreased in the E-CRSwNP group compared to the control and the non-eosinophilic CRSwNP (NE-CRSwNP) groups, exhibiting an inverse correlation with an increased percentage of CD206\\u2009+\\u2009CD68\\u2009+\\u2009M2 macrophages among total macrophages. Overexpression of INPP4A led to a reduced percentage of THP-1 cells polarizing towards the M2 phenotype, accompanied by decreased levels of associated chemotactic factors including CCL18, CCL22, CCL24, and CCL26. We also validated the involvement of the PI3K-AKT pathway in the function of INPP4A in vitro. Furthermore, INPP4A overexpression in the murine NP model resulted in the attenuation of eosinophilic inflammation in the nasal mucosa.', 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.', 'doi': '10.1007/s00011-024-01855-y\\n10.4193/Rhin20.600\\n10.1016/j.jaci.2016.05.041\\n10.1016/j.jaci.2017.09.009\\n10.1111/all.15074\\n10.1111/all.13411\\n10.1002/alr.21984\\n10.1111/j.1398-9995.2010.02498.x\\n10.1016/j.trsl.2017.09.002\\n10.1016/j.cellsig.2015.05.013\\n10.1165/rcmb.2017-0353OC\\n10.1038/ncomms1880\\n10.2217/epi-2022-0053\\n10.1016/j.jaci.2015.07.026\\n10.1136/thoraxjnl-2019-213916\\n10.1111/all.14287\\n10.1038/s41592-020-0837-5\\n10.3389/fimmu.2023.1168920\\n10.1016/j.intimp.2022.109012\\n10.1002/alr.22218\\n10.4049/jimmunol.1601515\\n10.1016/j.ijcard.2022.04.007\\n10.1038/s41590-022-01312-0\\n10.1016/j.bjorl.2023.101328\\n10.1016/j.jaci.2020.01.027\\n10.1016/j.jaci.2022.02.016\\n10.1016/j.bjorl.2020.05.020\\n10.1097/ACI.0000000000000602\\n10.1007/s00405-023-08129-z\\n10.1002/alr.21793\\n10.1016/j.jaci.2020.04.064\\n10.1111/all.15050\\n10.1002/alr.21530\\n10.1073/pnas.1119038109\\n10.1007/s10753-021-01466-3\\n10.1038/s41392-019-0079-0\\n10.1038/ncomms3834\\n10.1016/j.smim.2015.08.001\\n10.1002/eji.201041105\\n10.1158/0008-5472.CAN-17-3841\\n10.1093/rheumatology/kez165\\n10.3390/cells11172674\\n10.7150/thno.53749\\n10.3390/ijms222111648\\n10.1126/sciimmunol.aaz4415\\n10.1111/all.13852\\n10.1111/j.0906-6705.2004.00149.x\\n10.1002/jbmr.2376\\n10.1189/jlb.0502243\\n10.1371/journal.pone.0197355\\n10.1016/j.jaci.2020.12.623\\n10.1016/j.jaci.2011.08.021', 'xml': <Element 'PubmedArticle' at 0x109c4a3e0>}\n",
      "{'pubmed_id': '38363050', 'title': 'Age-specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5\\u2009years of age.', 'abstract': 'Respiratory syncytial virus (RSV) infection is associated with significant morbidity in infants. Risk factors for severe disease beyond the first 2\\u2009years of life have not been fully defined.\\nChildren <5\\u2009years hospitalized with virologically confirmed RSV infection were identified over six respiratory seasons (10/2012-4/2018) and their medical records manually reviewed. Multivariable analyses were performed to define the age-specific (<6, 6-24, and >24-59\\u2009months) risk factors associated with oxygen administration, PICU admission, mechanical ventilation, and duration of hospitalization.\\nWe identified 5143 children hospitalized with RSV infection: 53.5% (n\\u2009=\\u20092749) <6\\u2009months; 31.7% (n\\u2009=\\u20091631) 6-24\\u2009months; and 14.8% (n\\u2009=\\u2009763) >24-59\\u2009months. Rates of ICU admission were high (35%-36%) and comparable across age groups, while children >24-59 and 6-24 versus those <6\\u2009months required supplemental oxygen more frequently (73%; 71%; 68%, respectively; p\\u2009=\\u2009.003). The presence of comorbidities increased with age (25%, <6\\u2009months; 46%, 6-24\\u2009months; 70%, >24-59\\u2009months; p\\u2009<\\u2009.001). Specifically, neuromuscular disorders, chronic lung disease, and reactive airway disease/asthma were predictive of worse clinical outcomes in children aged 6-24 and >24-59\\u2009months, while RSV-viral codetections increased the risk of severe outcomes in children aged <6 and 6-24\\u2009months of age.\\nAlmost half of children hospitalized with RSV infection were >6\\u2009months. Underlying comorbidities increased with age and remained associated with severe disease in older children, while RSV-viral codetections were predictive of worse clinical outcomes in the youngest age groups. These data suggest the importance of defining the clinical phenotype associated with severe RSV according to age, and the persistent burden associated with RSV beyond infancy.', 'keywords': ['RSV', 'children', 'clinical outcomes', 'disease severity'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Brenes-Chacon', 'firstname': 'Helena', 'initials': 'H', 'affiliation': \"Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.\\nDepartment of Pediatrics, Division of Infectious Diseases, Hospital Nacional de Niños Dr. Carlos Sáenz Herrera, San José, Costa Rica.\"}, {'lastname': 'Eisner', 'firstname': 'Mariah', 'initials': 'M', 'affiliation': 'Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University College of Medicine, Columbus, Ohio, USA.'}, {'lastname': 'Acero-Bedoya', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': \"Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.\"}, {'lastname': 'Ramilo', 'firstname': 'Octavio', 'initials': 'O', 'affiliation': \"Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.\\nDepartment of Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.\\nDepartment of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.\"}, {'lastname': 'Mejias', 'firstname': 'Asuncion', 'initials': 'A', 'affiliation': \"Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.\\nDepartment of Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.\\nDepartment of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.\"}], 'methods': None, 'conclusions': None, 'results': 'We identified 5143 children hospitalized with RSV infection: 53.5% (n\\u2009=\\u20092749) <6\\u2009months; 31.7% (n\\u2009=\\u20091631) 6-24\\u2009months; and 14.8% (n\\u2009=\\u2009763) >24-59\\u2009months. Rates of ICU admission were high (35%-36%) and comparable across age groups, while children >24-59 and 6-24 versus those <6\\u2009months required supplemental oxygen more frequently (73%; 71%; 68%, respectively; p\\u2009=\\u2009.003). The presence of comorbidities increased with age (25%, <6\\u2009months; 46%, 6-24\\u2009months; 70%, >24-59\\u2009months; p\\u2009<\\u2009.001). Specifically, neuromuscular disorders, chronic lung disease, and reactive airway disease/asthma were predictive of worse clinical outcomes in children aged 6-24 and >24-59\\u2009months, while RSV-viral codetections increased the risk of severe outcomes in children aged <6 and 6-24\\u2009months of age.', 'copyrights': '© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14083', 'xml': <Element 'PubmedArticle' at 0x10b22c2c0>}\n",
      "{'pubmed_id': '38362649', 'title': 'Probabilistic precision calculations for the planning of studies assessing negative binomial rates.', 'abstract': 'Outcome variables that are assumed to follow a negative binomial distribution are frequently used in both clinical and epidemiological studies. Epidemiological studies, particularly those performed by pharmaceutical companies often aim to describe a population rather than compare treatments. Such descriptive studies are often analysed using confidence intervals. While precision calculations and sample size calculations are not always performed in these settings, they have the important role of setting expectations of what results the study may generate. Current methods for precision calculations for the negative binomial rate are based on plugging in parameter values into the confidence interval formulae. This method has the downside of ignoring the randomness of the confidence interval limits. To enable better practice for precision calculations, methods are needed that address the randomness.\\nUsing the well-known delta-method we develop a method for calculating the precision probability, that is, the probability of achieving a certain width. We assess the performance of the method in smaller samples through simulations.\\nThe method for the precision probability performs well in small to medium sample sizes, and the usefulness of the method is demonstrated through an example.\\nWe have developed a simple method for calculating the precision probability for negative binomial rates. This method can be used when planning epidemiological studies in for example, asthma, while correctly taking the randomness of confidence intervals into account.', 'keywords': ['negative binomial', 'precision probability', 'sample size'], 'journal': 'Pharmacoepidemiology and drug safety', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Hedberg', 'firstname': 'Jonatan', 'initials': 'J', 'affiliation': 'Medical and Payer Evidence Statistics, AstraZeneca, Gothenburg, Sweden.'}, {'lastname': 'Franzén', 'firstname': 'Stefan', 'initials': 'S', 'affiliation': 'Medical and Payer Evidence Statistics, AstraZeneca, Gothenburg, Sweden.'}], 'methods': None, 'conclusions': None, 'results': 'The method for the precision probability performs well in small to medium sample sizes, and the usefulness of the method is demonstrated through an example.', 'copyrights': '© 2024 John Wiley & Sons Ltd.', 'doi': '10.1002/pds.5750', 'xml': <Element 'PubmedArticle' at 0x10a59dcb0>}\n",
      "{'pubmed_id': '38362254\\n28919116\\n26933642\\n21371494\\n28513338\\n23245609\\n29755883\\n26857715\\n32338357\\n34073621\\n27919275\\n27932337\\n33781348\\n32873674\\n28345328\\n25605213\\n29138737\\n26074219\\n29693980\\n28008193\\n30155287\\n28127468\\n29138711\\n24754870\\n34994966\\n34090532\\n32304214\\n30219626\\n27039726\\n33538338\\n26263031\\n34484706\\n30604700\\n35261410\\n17822448\\n34212763\\n33388044\\n33357635\\n32303254\\n34708726\\n34790639\\n27169347\\n36796852\\n35860160\\n31165100\\n30657043\\n32257513\\n29619218\\n32768024\\n22797984\\n17212790\\n24004968\\n28542119\\n25183954', 'title': 'Prevalence of major non-communicable diseases and their associated risk factors in Afghanistan: a systematic review and meta-analysis.', 'abstract': 'Non-communicable diseases (NCDs) are the leading cause of mortality worldwide, and increasingly so in low- and middle-income countries. Afghanistan is dealing with a double burden of diseases, yet there has been no evidence synthesis on the prevalence of major NCDs and their risk factors.\\nThis study aims to provide a comprehensive synthesis of the existing data on the prevalence of major NCDs and the common related risk factors in Afghanistan.\\nWe systematically reviewed scientific articles from 2000 to 2022 that reported the prevalence of diabetes, chronic respiratory diseases (CRDs), cardiovascular diseases (CVDs) or cancer, and their risk factors in Afghanistan. Four online databases (PubMed, Web of Science, Cochrane and Google Scholar) and two local journals in Afghanistan (not indexed online) were systematically searched and screened. Two reviewers independently screened and appraised the quality of the articles. Data extraction and synthesis were performed using tabulated sheets.\\nAmong 51 eligible articles, 10 (19.6%) focused on cancer, 10 (19.6%) on diabetes, 4 (7.8%) on CVDs, 4 (7.8%) on CRDs and 23 (45.1%) on risk factors as the primary outcome. Few articles addressed major NCD prevalence; no evidence of CVDs, cancer was 0.15%, asthma ranged between 0.3% and 17.3%, and diabetes was 12%. Pooled prevalence of hypertension and overweight were 31% and 35%, respectively. Central obesity was twice as prevalent in females (76% \\nOnly little evidence is available on the prevalence of major NCDs in Afghanistan; however, the NCD risk factors are prevalent across the country. The quality of the available data, especially those of the local resources, is poor; therefore, further research should generate reliable evidence in order to inform policymakers on prioritizing interventions for controlling and managing NCDs.', 'keywords': ['Afghanistan', 'NCD risk factors', 'cancer', 'cardiovascular disease', 'chronic respiratory diseases', 'diabetes'], 'journal': 'Therapeutic advances in chronic disease', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Noormal', 'firstname': 'Ahmad Siyar', 'initials': 'AS', 'affiliation': 'Ministry of Public Health, Sehat-e-Ama Square, Wazir Akbar khan Road, 1001, Kabul, Afghanistan.\\nHeidelberg Institute of Global Health, University Hospital Heidelberg, Im Neuenheimer Feld 130.3, Heidelberg 69120, Germany.'}, {'lastname': 'Winkler', 'firstname': 'Volker', 'initials': 'V', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Bhusari', 'firstname': 'Sneha Bansi', 'initials': 'SB', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Horstick', 'firstname': 'Olaf', 'initials': 'O', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Louis', 'firstname': 'Valérie R', 'initials': 'VR', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Deckert', 'firstname': 'Andreas', 'initials': 'A', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Antia', 'firstname': 'Khatia', 'initials': 'K', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Wasko', 'firstname': 'Zahia', 'initials': 'Z', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Rai', 'firstname': 'Pratima', 'initials': 'P', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Mocruha', 'firstname': 'Aline Frare', 'initials': 'AF', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}, {'lastname': 'Dambach', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Heidelberg Institute of Global Health, Heidelberg, Germany.'}], 'methods': 'We systematically reviewed scientific articles from 2000 to 2022 that reported the prevalence of diabetes, chronic respiratory diseases (CRDs), cardiovascular diseases (CVDs) or cancer, and their risk factors in Afghanistan. Four online databases (PubMed, Web of Science, Cochrane and Google Scholar) and two local journals in Afghanistan (not indexed online) were systematically searched and screened. Two reviewers independently screened and appraised the quality of the articles. Data extraction and synthesis were performed using tabulated sheets.', 'conclusions': 'Only little evidence is available on the prevalence of major NCDs in Afghanistan; however, the NCD risk factors are prevalent across the country. The quality of the available data, especially those of the local resources, is poor; therefore, further research should generate reliable evidence in order to inform policymakers on prioritizing interventions for controlling and managing NCDs.', 'results': 'Among 51 eligible articles, 10 (19.6%) focused on cancer, 10 (19.6%) on diabetes, 4 (7.8%) on CVDs, 4 (7.8%) on CRDs and 23 (45.1%) on risk factors as the primary outcome. Few articles addressed major NCD prevalence; no evidence of CVDs, cancer was 0.15%, asthma ranged between 0.3% and 17.3%, and diabetes was 12%. Pooled prevalence of hypertension and overweight were 31% and 35%, respectively. Central obesity was twice as prevalent in females (76% ', 'copyrights': '© The Author(s), 2024.', 'doi': '10.1177/20406223241229850', 'xml': <Element 'PubmedArticle' at 0x108d23c90>}\n",
      "{'pubmed_id': '38362154\\n37298915\\n32890711\\n18281172\\n32781744\\n35458612\\n32901685\\n37390874\\n36113677\\n35326762\\n36923827\\n17029841\\n37447058\\n9428232\\n11001173\\n28421121\\n3614974\\n23348408\\n25184525\\n32115044\\n21958968\\n34466063\\n33681255\\n33354139\\n21160452\\n33532705\\n4083185\\n33610703\\n14062605\\n36252876', 'title': 'Exploring the impact of seasonal variations on the chemical composition, antinociceptive, and anti-inflammatory properties of ', 'abstract': '', 'keywords': ['analgesic activity', 'oriza', 'patchouli alcohol', 'sesquiterpenes', 'volatile constituents'], 'journal': 'Frontiers in pharmacology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Santos', 'firstname': 'Paulo Vinicius Lima', 'initials': 'PVL', 'affiliation': 'Programa de Pós-graduação em Ciências Farmacêuticas, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil.\\nLaboratório de Química dos Produtos Naturais, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'Jerônimo', 'firstname': 'Lucas Botelho', 'initials': 'LB', 'affiliation': 'Laboratório de Química dos Produtos Naturais, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'Ribeiro', 'firstname': 'Weyda Suyane Campos', 'initials': 'WSC', 'affiliation': 'Laboratório de Química dos Produtos Naturais, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'Lopes', 'firstname': 'Gustavo Moraes', 'initials': 'GM', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'Leão Neto', 'firstname': 'João Henrique de Castro', 'initials': 'JHC', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'da Silva', 'firstname': 'Hugo Borges Oliveira', 'initials': 'HBO', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'da Silva', 'firstname': 'Pedro Iuri C', 'initials': 'PIC', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.\\nPrograma de Pós-graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.'}, {'lastname': 'Silva', 'firstname': 'Renata Cunha', 'initials': 'RC', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'da Silva', 'firstname': 'Joyce Kelly', 'initials': 'JK', 'affiliation': 'Programa de Pós-graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.'}, {'lastname': 'Freitas', 'firstname': 'Jofre Jacob S', 'initials': 'JJS', 'affiliation': 'Laboratório de Morfofisiologia Aplicada a Saúde, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará, Belém, Brazil.'}, {'lastname': 'Mourão', 'firstname': 'Rosa Helena V', 'initials': 'RHV', 'affiliation': 'Laboratório de Bioprospecção e Biologia Experimental, Universidade Federal do Oeste do Pará, Santarém, Brazil.'}, {'lastname': 'Setzer', 'firstname': 'William N', 'initials': 'WN', 'affiliation': 'Aromatic Plant Research Center, Lehi, UT, United States.'}, {'lastname': 'Maia', 'firstname': 'José Guilherme S', 'initials': 'JGS', 'affiliation': 'Programa de Pós-graduação em Ciências Farmacêuticas, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil.'}, {'lastname': 'Figueiredo', 'firstname': 'Pablo Luis B', 'initials': 'PLB', 'affiliation': 'Programa de Pós-graduação em Ciências Farmacêuticas, Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil.\\nLaboratório de Química dos Produtos Naturais, Universidade do Estado do Pará, Belém, Brazil.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Santos, Jerônimo, Ribeiro, Lopes, Leão Neto, da Silva, da Silva, Silva, da Silva, Freitas, Mourão, Setzer, Maia and Figueiredo.', 'doi': '10.3389/fphar.2024.1336878\\n10.1016/j.bse.2022.104503\\n10.3390/molecules28114439\\n10.1007/978-3-030-99476-1_3\\n10.1016/j.jep.2020.113344\\n10.1016/j.jep.2007.12.016\\n10.3390/biom10081155\\n10.3390/molecules27082417\\n10.1590/1414-431x202010204\\n10.1016/j.jep.2023.116859\\n10.1016/j.jep.2022.115720\\n10.3390/antibiotics11030298\\n10.1016/j.heliyon.2023.e14185\\n10.1016/j.jep.2006.08.018\\n10.3390/plants12132497\\n10.1016/S0016-5085(98)70646-8\\n10.1254/jjp.83.286\\n10.1155/2017/4850612\\n10.1016/0304-3959(87)90088-1\\n10.1016/j.fct.2012.12.062\\n10.1371/journal.pone.0106536\\n10.1016/j.cps.2019.11.001\\n10.1016/j.fitote.2011.09.003\\n10.1016/j.sjbs.2021.06.021\\n10.3389/fmed.2021.627725\\n10.3897/phytokeys.169.58107\\n10.1590/0102-778620130054\\n10.1590/S0100-40422009000300006\\n10.3390/molecules15129252\\n10.31788/RJC.2021.1415928\\n10.1787/9789264071001-en\\n10.7324/JAPS.2016.60811\\n10.1016/j.bse.2022.104528\\n10.3390/horticulturae9070768\\n10.1002/ame2.12139\\n10.1007/BF01966691\\n10.1016/j.jep.2021.113941\\n10.1590/S0044-59672009000200018\\n10.1016/s0021-9673(01)80947-x\\n10.1016/j.jep.2022.115829', 'xml': <Element 'PubmedArticle' at 0x10acfde40>}\n",
      "{'pubmed_id': '38362034\\n34990443\\n1242427\\n9989552\\n20438238\\n26385066\\n8956681\\n9723140\\n17721766\\n21733212\\n15166638\\n21041247\\n12082566\\n20163786\\n22030708\\n21423239\\n23453640\\n24461634\\n25453484\\n26079190\\n28786528\\n28769055\\n30145303\\n30381879\\n31085640\\n31578828\\n30655502\\n31164008\\n30116032\\n31830721\\n35948661\\n32959503\\n30017463\\n34335334\\n33432681\\n19201395\\n33421543\\n29594136\\n29230398\\n204499\\n35356712\\n25458810\\n8375247\\n35459900\\n12511175\\n23814104\\n32561344\\n1378370\\n32854532\\n34256608\\n28670505\\n18023123\\n23794635\\n17636794\\n23173093\\n30120140\\n23700438\\n2721931\\n29584785\\n28698386\\n14762140\\n971028\\n1903019\\n7667171\\n17178471\\n21732403\\n31850963\\n19322168\\n22778838\\n27270172\\n13583250\\n11375373\\n28348533\\n15798135\\n27956934\\n24204385\\n33486786\\n12659861\\n21623373\\n21215634\\n29621484\\n33526688\\n32377000\\n37777856\\n24671950\\n35119366\\n18817737\\n32471987', 'title': 'Evolutionary conservation of putative suicidality-related risk genes that produce diminished motivation corrected by clozapine, lithium and antidepressants.', 'abstract': 'Genome wide association studies (GWAS) and candidate gene analyses have identified genetic variants and genes that may increase the risk for suicidal thoughts and behaviors (STBs). Important unresolved issues surround these tentative risk variants such as the characteristics of the associated genes and how they might elicit STBs.\\nPutative suicidality-related risk genes (PSRGs) were identified by comprehensive literature search and were characterized with respect to evolutionary conservation, participation in gene interaction networks and associated phenotypes. Evolutionary conservation was established with database searches and BLASTP queries, whereas gene-gene interactions were ascertained with GeneMANIA. We then examined whether mutations in risk-gene counterparts in \\nFrom the analysis, 105 risk-gene candidates were identified and found to be: 1) highly conserved during evolution, 2) enriched for essential genes, 3) involved in significant gene-gene interactions, and 4) associated with psychiatric disorders, metabolic disturbances and asthma/allergy. Evaluation of 17 mutant strains with loss-of-function/deletion mutations in PSRG orthologs revealed that 11 mutants showed significant evidence of diminished motivation that manifested as immobility in a foraging assay. Immobility was corrected in some or all of the mutants with clozapine, lithium and tricyclic antidepressant drugs. In addition, 5-HT2 receptor and muscarinic receptor antagonists restored goal-directed behavior in most or all of the mutants. These studies increase confidence in the validity of the PSRGs and provide initial clues about possible mechanisms that mediate STBs.', 'keywords': ['C. elegans', 'antidepressants', 'clozapine', 'diminished motivation', 'lithium', 'suicide'], 'journal': 'Frontiers in psychiatry', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Ajayi', 'firstname': 'Titilade', 'initials': 'T', 'affiliation': 'Department of Pharmacology, Toxicology and Neuroscience, LSU Health Shreveport, Shreveport, LA, United States.'}, {'lastname': 'Thomas', 'firstname': 'Alicia', 'initials': 'A', 'affiliation': 'Department of Pharmacology, Toxicology and Neuroscience, LSU Health Shreveport, Shreveport, LA, United States.'}, {'lastname': 'Nikolic', 'firstname': 'Marko', 'initials': 'M', 'affiliation': 'Department of Psychiatry and Behavioral Medicine, LSU Health Shreveport, Shreveport, LA, United States.'}, {'lastname': 'Henderson', 'firstname': 'Lauryn', 'initials': 'L', 'affiliation': 'Department of Psychiatry and Behavioral Medicine, LSU Health Shreveport, Shreveport, LA, United States.'}, {'lastname': 'Zaheri', 'firstname': 'Alexa', 'initials': 'A', 'affiliation': 'Department of Psychiatry and Behavioral Medicine, LSU Health Shreveport, Shreveport, LA, United States.'}, {'lastname': 'Dwyer', 'firstname': 'Donard S', 'initials': 'DS', 'affiliation': 'Department of Pharmacology, Toxicology and Neuroscience, LSU Health Shreveport, Shreveport, LA, United States.\\nDepartment of Psychiatry and Behavioral Medicine, LSU Health Shreveport, Shreveport, LA, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Ajayi, Thomas, Nikolic, Henderson, Zaheri and Dwyer.', 'doi': '10.3389/fpsyt.2024.1341735\\n10.15585/mmwr.ss7101a1\\n10.1001/jama.1975.03260240050026\\n10.1176/ajp.156.2.181\\n10.1037/a0018697\\n10.1521/ijct.2015.8.2.114\\n10.1016/S0140-6736(15)00234-2\\n10.1001/archpsyc.1996.01830120085015\\n10.1017/S0033291798006916\\n10.1007/s00508-007-0823-2\\n10.1017/S0033291711000833\\n10.1097/01.ALC.0000127416.92128.B0\\n10.1176/appi.ajp.2010.10040541\\n10.1038/sj.mp.4000978\\n10.1016/j.biopsych.2009.12.031\\n10.1038/npp.2011.257\\n10.1038/mp.2011.4\\n10.1016/j.euroneuro.2013.01.007\\n10.1016/j.jad.2013.12.018\\n10.1016/j.euroneuro.2014.10.006\\n10.1002/ajmg.b.32330\\n10.1002/ajmg.b.32577\\n10.1038/s41598-017-06522-3\\n10.1016/j.psychres.2018.07.017\\n10.1002/ajmg.b.32694\\n10.1073/pnas.1818871116\\n10.1002/mgg3.983\\n10.1038/s41398-018-0340-2\\n10.1176/appi.ajp.2019.18080957\\n10.1038/s41380-018-0218-y\\n10.1016/j.jpsychires.2019.11.009\\n10.1038/s41380-022-01722-4\\n10.1111/bdi.12996\\n10.1016/j.schres.2018.07.017\\n10.3389/fpsyt.2021.698029\\n10.1111/bdi.13044\\n10.1016/j.biopsych.2008.11.021\\n10.1016/j.neubiorev.2020.12.033\\n10.1159/000485423\\n10.1159/000478049\\n10.1016/0014-2999(78)90118-8\\n10.3389/fpsyt.2022.817224\\n10.1016/j.jagp.2014.09.010\\n10.2337/diacare.16.8.1167\\n10.1038/s41380-022-01573-z\\n10.1001/archpsyc.60.1.82\\n10.1136/bmj.f3646\\n10.1016/j.neubiorev.2020.06.017\\n10.2165/00003495-199200432-00005\\n10.1176/appi.ajp.2020.20010017\\n10.1176/appi.ajp.2020.20121705\\n10.1177/2167702616686854\\n10.1895/wormbook.1.57.1\\n10.1093/nar/gkt533\\n10.1002/14651858.CD005353\\n10.1534/g3.112.003830\\n10.1534/genetics.118.301307\\n10.1371/journal.pone.0063851\\n10.1093/genetics/121.4.703\\n10.1371/journal.pone.0193619\\n10.1523/JNEUROSCI.2636-16.2017\\n10.1523/JNEUROSCI.1569-03.2004\\n10.1001/archpsyc.1976.01770100055005\\n10.1111/j.1600-0447.1991.tb05533.x\\n10.1002/j.1875-9114.1995.tb04374.x\\n10.1016/S0074-7742(06)77002-7\\n10.1002/jnr.22705\\n10.1097/FBP.0000000000000526\\n10.1038/npp.2009.35\\n10.1021/cn100010p\\n10.1172/JCI85033\\n10.1176/ajp.115.5.459\\n10.2337/diacare.24.6.1069\\n10.3389/fpsyt.2017.00040\\n10.2105/AJPH.2003.019109\\n10.1186/s12991-016-0122-2\\n10.1155/2013/627384\\n10.1111/all.14748\\n10.1016/S0006-291X(03)00400-5\\n10.1038/ng.841\\n10.1016/j.cub.2010.12.014\\n10.1016/j.neuron.2018.03.008\\n10.1073/pnas.2019409118\\n10.1038/s41380-020-0753-1\\n10.1176/appi.ajp.21121266\\n10.1242/dev.103846\\n10.7554/eLife.74557\\n10.1016/j.neuron.2008.07.023\\n10.1038/s41467-020-16473-5', 'xml': <Element 'PubmedArticle' at 0x108eaf7e0>}\n",
      "{'pubmed_id': '38361997\\n35119430\\n25851391\\n31676680\\n15064029\\n23248226\\n24488647\\n36696549\\n34516052\\n16040885\\n29916205\\n25307417\\n29367319\\n24168782\\n36312682\\n32584231\\n10997834\\n25303775\\n28580865\\n30767343\\n37571996\\n30813530\\n23777248\\n31300308\\n3203526\\n10480833\\n12505244\\n37601138\\n25804317\\n27364223\\n35364095\\n33038972\\n33406325\\n33603207\\n36975216\\n34390694\\n22416603\\n37235647\\n36661420\\n28546374\\n32695992\\n37097029\\n34083239\\n30458264\\n21615299\\n34960124\\n37515016\\n30904601', 'title': 'Reporting of social determinants of health in randomized controlled trials conducted in the pediatric intensive care unit.', 'abstract': 'The influence of social determinants of health (SDOH) on access to care and outcomes for critically ill children remains an understudied area with a paucity of high-quality data. Recent publications have highlighted the importance of incorporating SDOH considerations into research but the frequency with which this occurs in pediatric intensive care unit (PICU) research is unclear. Our objective was to determine the frequency and categories of SDOH variables reported and how these variables were defined in published PICU randomized controlled trials (RCTs).\\nWe searched Medline, Embase, Lilacs, and Central from inception to Dec 2022. Inclusion criteria were randomized controlled trials of any intervention on children or their families in a PICU. Data related to study demographics and nine WHO SDOH categories were extracted, and descriptive statistics and qualitative data generated.\\n586 unique RCTs were included. Studies had a median sample size of 60 patients (IQR 40-106) with 73.0% of studies including ≤100 patients and 41.1% including ≤50 patients. A total of 181 (181/586, 30.9%) studies reported ≥1 SDOH variable of which 163 (163/586, 27.8%) reported them by randomization group. The most frequently reported categories were food insecurity (100/586, 17.1%) and social inclusion and non-discrimination (73/586, 12.5%). Twenty-five of 57 studies (43.9%) investigating feeding or nutrition and 11 of 82 (13.4%) assessing mechanical ventilation reported baseline nutritional assessments. Forty-one studies investigated interventions in children with asthma or bronchiolitis of which six reported on smoking in the home (6/41, 14.6%).\\nReporting of relevant SDOH variables occurs infrequently in PICU RCTs. In addition, when available, categorizations and definitions of SDOH vary considerably between studies. Standardization of SDOH variable collection along with consistent minimal reporting requirements for PICU RCT publications is needed.', 'keywords': ['children', 'critical illness', 'pediatric intensive care unit', 'randomized controlled trial', 'social determinants of health'], 'journal': 'Frontiers in pediatrics', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Huang', 'firstname': 'Emma', 'initials': 'E', 'affiliation': 'Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.'}, {'lastname': 'Albrecht', 'firstname': 'Lisa', 'initials': 'L', 'affiliation': \"Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.\"}, {'lastname': \"O'Hearn\", 'firstname': 'Katie', 'initials': 'K', 'affiliation': \"Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.\"}, {'lastname': 'Nicolas', 'firstname': 'Naisha', 'initials': 'N', 'affiliation': \"Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.\"}, {'lastname': 'Armstrong', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': \"Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.\"}, {'lastname': 'Weinberg', 'firstname': 'Maya', 'initials': 'M', 'affiliation': 'Faculty of Science, University of Ottawa, Ottawa, ON, Canada.'}, {'lastname': 'Menon', 'firstname': 'Kusum', 'initials': 'K', 'affiliation': \"Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.\\nDepartment of Pediatrics, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada.\"}], 'methods': None, 'conclusions': None, 'results': '586 unique RCTs were included. Studies had a median sample size of 60 patients (IQR 40-106) with 73.0% of studies including ≤100 patients and 41.1% including ≤50 patients. A total of 181 (181/586, 30.9%) studies reported ≥1 SDOH variable of which 163 (163/586, 27.8%) reported them by randomization group. The most frequently reported categories were food insecurity (100/586, 17.1%) and social inclusion and non-discrimination (73/586, 12.5%). Twenty-five of 57 studies (43.9%) investigating feeding or nutrition and 11 of 82 (13.4%) assessing mechanical ventilation reported baseline nutritional assessments. Forty-one studies investigated interventions in children with asthma or bronchiolitis of which six reported on smoking in the home (6/41, 14.6%).', 'copyrights': \"© 2024 Huang, Albrecht, O'Hearn, Nicolas, Armstrong, Weinberg and Menon.\", 'doi': '10.3389/fped.2024.1329648\\n10.1097/PCC.0000000000002869\\n10.1007/s00134-015-3780-7\\n10.1542/peds.2019-0748\\n10.1016/S0140-6736(04)15894-7\\n10.1542/peds.2012-1215\\n10.1007/s10900-014-9823-0\\n10.1097/PCC.0000000000003184\\n10.1056/NEJMe2114651\\n10.1136/adc.2004.058222\\n10.1111/1471-0528.15199\\n10.1007/s11121-014-0513-z\\n10.1136/ebmed-2017-110800\\n10.1186/cc13083\\n10.7759/cureus.29500\\n10.5152/TurkThoracJ.2019.180168\\n10.1023/A:1007658411953\\n10.1289/ehp.1307922\\n10.1080/17476348.2017.1338949\\n10.1111/tmi.13218\\n10.1111/jcpp.13872\\n10.3390/ijerph16050677\\n10.1186/1477-7525-11-99\\n10.1016/j.jpeds.2019.06.005\\n10.1016/0197-2456(88)90049-9\\n10.1136/bmj.319.7211.703\\n10.1016/S0197-2456(02)00242-8\\n10.3389/fped.2023.1179721\\n10.1007/s12098-015-1738-y\\n10.1016/j.nut.2016.05.002\\n10.1016/j.jpeds.2022.03.049\\n10.1016/S0140-6736(20)32076-6\\n10.1056/NEJMms2029562\\n10.1038/s41390-021-01386-w\\n10.1097/CCM.0000000000005866\\n10.1016/j.jpeds.2021.08.004\\n10.1051/ject/201143232\\n10.1126/sciadv.add2704\\n10.1097/PCC.0000000000003147\\n10.4187/respcare.05591\\n10.1097/CCE.0000000000000123\\n10.1097/PCC.0000000000003263\\n10.1136/bmjgh-2021-005190\\n10.1016/j.jclinepi.2018.11.014\\n10.1056/NEJMoa1101549\\n10.3390/vaccines11071200\\n10.1016/j.ypmed.2019.03.033', 'xml': <Element 'PubmedArticle' at 0x10b484040>}\n",
      "{'pubmed_id': '38361745\\n36924389\\n30079223\\n65572\\n14424947\\n33204386\\n29331045\\n33767801\\n34293502\\n20144472\\n28065342\\n22808958\\n35026206\\n37172716\\n33476673\\n23683513\\n17073865\\n16197464\\n32436290\\n21195945\\n36050126', 'title': 'Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.', 'abstract': 'There is a lack of consensus over the description and severity assignment of allergic adverse reactions to immunotherapy, although there seems to be a consensus at least in terms of using the World Allergy Organization (WAO) grading systems to describe local adverse events for Sublingual Immunotherapy (SLIT) and Systemic Allergic Reactions (SARs) to Subcutaneous Immunotherapy (SCIT) amongst the major national/regional allergy societies. In this manuscript, we propose a modification of the previous WAO Grading system for SARs, which aligns with the newly-proposed Consortium for Food Allergy Research (CoFAR) Grading Scale for Systemic Allergic Reactions in Food Allergy (version 3.0). We hope this can facilitate a unified grading system appropriate to SARs due to allergen immunotherapy, independent of allergen and route of administration, and across clinical and research practice.', 'keywords': ['Adverse events', 'Allergen immunotherapy', 'Anaphylaxis', 'Clinical trials', 'Safety reporting'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Turner', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'National Heart Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Ansotegui', 'firstname': 'Ignacio J', 'initials': 'IJ', 'affiliation': 'Dept. Allergy and Immunology, Hospital Quironsalud Bizkaia, Bilbao, Spain.'}, {'lastname': 'Campbell', 'firstname': 'Dianne E', 'initials': 'DE', 'affiliation': 'Discipline of Paediatrics and Child Health, School of Medicine, University of Sydney, Sydney, Australia.\\nDBV Technologies, Montrouge, France.'}, {'lastname': 'Cardona', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': \"Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.\"}, {'lastname': 'Carr', 'firstname': 'Stuart', 'initials': 'S', 'affiliation': 'Snö Asthma & Allergy, Abu Dhabi, United Arab Emirates.'}, {'lastname': 'Custovic', 'firstname': 'Adnan', 'initials': 'A', 'affiliation': 'National Heart Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Durham', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'National Heart Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Ebisawa', 'firstname': 'Motohiro', 'initials': 'M', 'affiliation': 'Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.'}, {'lastname': 'Geller', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Division of Medicine, Academy of Medicine of Rio de Janeiro, Rio de Janeiro, Brazil.'}, {'lastname': 'Gonzalez-Estrada', 'firstname': 'Alexei', 'initials': 'A', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA.'}, {'lastname': 'Greenberger', 'firstname': 'Paul A', 'initials': 'PA', 'affiliation': 'Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.'}, {'lastname': 'Hossny', 'firstname': 'Elham', 'initials': 'E', 'affiliation': \"Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.\"}, {'lastname': 'Irani', 'firstname': 'Carla', 'initials': 'C', 'affiliation': 'Hotel Dieu de France Hospital, St Joseph University, Beirut, Lebanon.'}, {'lastname': 'Leung', 'firstname': 'Agnes S Y', 'initials': 'ASY', 'affiliation': 'Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.'}, {'lastname': 'Levin', 'firstname': 'Michael E', 'initials': 'ME', 'affiliation': 'Division of Paediatric Allergy, Department of Paediatrics, University of Cape Town, Cape Town, South Africa.'}, {'lastname': 'Muraro', 'firstname': 'Antonella', 'initials': 'A', 'affiliation': 'Department of Woman and Child Health, Food Allergy Referral Centre, Padua University Hospital, Padua, Italy.'}, {'lastname': 'Oppenheimer', 'firstname': 'John J', 'initials': 'JJ', 'affiliation': 'Rutgers New Jersey Medical School, Atlantic Health System Morristown, NJ, USA.'}, {'lastname': 'Ortega Martell', 'firstname': 'José Antonio', 'initials': 'JA', 'affiliation': 'Universidad Autónoma del Estado de Hidalgo, Hidalgo, Mexico.'}, {'lastname': 'Pouessel', 'firstname': 'Guillaume', 'initials': 'G', 'affiliation': \"Department of Paediatrics, Children's Hospital, Roubaix, France.\\nPaediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.\"}, {'lastname': 'Rial', 'firstname': 'Manuel J', 'initials': 'MJ', 'affiliation': 'Allergy department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.'}, {'lastname': 'Senna', 'firstname': 'Gianenrico', 'initials': 'G', 'affiliation': 'Asthma Center and Allergy Unit, Verona University and General Hospital, Verona, Italy.'}, {'lastname': 'Tanno', 'firstname': 'Luciana K', 'initials': 'LK', 'affiliation': 'Hospital Sírio Libanês, São Paulo, Brazil.\\nUniversity Hospital of Montpellier, Montpellier, and Sorbonne Universités, Paris, France.'}, {'lastname': 'Wallace', 'firstname': 'Dana V', 'initials': 'DV', 'affiliation': 'Nova Southeastern University College of Allopathic Medicine, Fort Lauderdale, FL, USA.'}, {'lastname': 'Worm', 'firstname': 'Margitta', 'initials': 'M', 'affiliation': 'Department of Dermatology and Allergology, Charite-Universitätsmedizin, Berlin, Germany.'}, {'lastname': 'Morais-Almeida', 'firstname': 'Mário', 'initials': 'M', 'affiliation': 'Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.waojou.2024.100876\\n10.1097/ACI.0000000000000901\\n10.1186/s13601-018-0215-x\\n10.1016/j.waojou.2020.100472\\n10.1111/all.13408\\n10.1016/j.waojou.2020.100503\\n10.1016/j.jaip.2021.06.056\\n10.1016/j.jaci.2009.10.060\\n10.1016/j.jaip.2016.11.009\\n10.1056/NEJMoa1200435\\n10.1016/j.jaci.2021.12.789\\n10.1016/j.jaip.2023.04.037\\n10.1016/j.jaci.2021.01.003\\n10.1016/j.jaci.2013.03.039\\n10.1111/j.1398-9995.2006.01136.x\\n10.1007/s40521-016-0108-y\\n10.1111/j.1398-9995.2005.00963.x\\n10.1111/pai.13189\\n10.1016/j.anai.2010.10.025\\n10.1016/j.jaci.2022.07.012', 'xml': <Element 'PubmedArticle' at 0x10ba636a0>}\n",
      "{'pubmed_id': '38361249', 'title': 'Pla2g5 contributes to viral-like-induced lung inflammation through macrophage proliferation and LA/Ffar1 lung cell recruitment.', 'abstract': 'Macrophages expressing group V phospholipase A', 'keywords': ['asthma', 'lipid mediators', 'lung', 'macrophage', 'virus'], 'journal': 'Immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Koganesawa', 'firstname': 'Masaya', 'initials': 'M', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Dwyer', 'firstname': 'Daniel F', 'initials': 'DF', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Alhallak', 'firstname': 'Kinan', 'initials': 'K', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Nagai', 'firstname': 'Jun', 'initials': 'J', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Zaleski', 'firstname': 'Kendall', 'initials': 'K', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Samuchiwal', 'firstname': 'Sachin', 'initials': 'S', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Hiroaki', 'firstname': 'Hayashi', 'initials': 'H', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Nishida', 'firstname': 'Airi', 'initials': 'A', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Hirsch', 'firstname': 'Thomas I', 'initials': 'TI', 'affiliation': \"Department of Surgery and Vascular Biology Program, Boston Children's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Brennan', 'firstname': 'Patrick J', 'initials': 'PJ', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Puder', 'firstname': 'Mark', 'initials': 'M', 'affiliation': \"Department of Surgery and Vascular Biology Program, Boston Children's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Balestrieri', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': \"Division of Allergy and Clinical Immunology, Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Boston, Massachusetts, USA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 John Wiley & Sons Ltd.', 'doi': '10.1111/imm.13766', 'xml': <Element 'PubmedArticle' at 0x125257010>}\n",
      "{'pubmed_id': '38361030', 'title': 'The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip.', 'abstract': 'The COVID-19 pandemic illustrated an urgent need for sophisticated, human tissue models to rapidly test and develop effective treatment options against this newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Thus, in particular, the last 3 years faced an extensive boost in respiratory and pulmonary model development. Nowadays, 3D models, organoids and lung-on-chip, respiratory models in perfusion, or precision-cut lung slices are used to study complex research questions in human primary cells. These models provide physiologically relevant systems for studying SARS-CoV-2 and, of course, other respiratory pathogens, but they are, too, suited for studying lung pathologies, such as CF, chronic obstructive pulmonary disease, or asthma, in more detail in terms of viral infection. With these models, the cornerstone has been laid for further advancing the organs by, for example, inclusion of several immune cell types or humoral immune components, combination with other organs in microfluidic organ-on-chip devices, standardization and harmonization of the devices for reliable and reproducible drug and vaccine testing in high throughput.', 'keywords': ['Infectious diseases', 'Lung inflammation', 'Virology'], 'journal': 'European journal of immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Dichtl', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.'}, {'lastname': 'Posch', 'firstname': 'Wilfried', 'initials': 'W', 'affiliation': 'Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.'}, {'lastname': 'Wilflingseder', 'firstname': 'Doris', 'initials': 'D', 'affiliation': 'Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.', 'doi': '10.1002/eji.202250356', 'xml': <Element 'PubmedArticle' at 0x10b673970>}\n",
      "{'pubmed_id': '38360901\\n35461560\\n35391695\\n37406667\\n36716752\\n37984349\\n34362839\\n21292833\\n36368906\\n37792612\\n35039665\\n33359090\\n34235894\\n34061770\\n38071999\\n35636402\\n28732821\\n27115376\\n32918892\\n37301433\\n38071986', 'title': '[Precision medicine in the diagnosis and treatment of asthma].', 'abstract': 'Due to the availability of disease-modifying anti-asthmatic drugs (DMAADs), especially inhaled steroids (alone or in combination with long-acting bronchodilators), biologics and modern allergen immunotherapy, the treatment of asthma has fundamentally changed. The aims of modern asthma precision medicine are prevention of symptoms and the induction and maintenance of asthma remission (long-term asthma control, freedom from exacerbations and stable lung function without the use of systemic steroids). A treat to target approach is used as for other chronic inflammatory diseases in internal medicine: the aim is to achieve remission by an individually tailored treatment with DMAADs; however, the prerequisite for modern asthma precision medicine is asthma phenotyping, including a detailed medical history, lung function testing, allergological diagnostics and measurement of type 2 markers (blood eosinophils and, if available, exhaled nitric oxide, FeNO).\\nDurch die Verfügbarkeit von „disease-modifying anti-asthmatic drugs“ (DMAAD), insbesondere von inhalativen Steroiden (allein oder in Kombination mit langwirksamen Bronchodilatatoren), Biologika und modernen Allergenimmuntherapien, hat sich die Asthmatherapie grundsätzlich gewandelt. Ziele einer modernen Asthmapräzisionsmedizin sind die Symptomprävention und das Erreichen einer Asthmaremission (langfristige Symptomfreiheit, Exazerbationsfreiheit und stabile Lungenfunktion ohne Einsatz systemischer Steroide). Es wird, wie bei anderen chronisch-entzündlichen Erkrankungen der Inneren Medizin, ein Treat-to-target-Ansatz verfolgt: Ziel ist das Erreichen einer Remission durch eine individuell maßgeschneiderte Therapie mit DMAADs. Voraussetzung für die moderne Asthmapräzisionsmedizin ist jedoch die genaue Phänotypisierung der Patienten, inklusive sorgfältiger Anamneseerhebung, Lungenfunktionsprüfung, allergologischer Diagnostik und Bestimmung von Typ-2-Markern (Bluteosinophile und, falls verfügbar, Fraktion des exhalierten Stickstoffmonoxids [FeNO]).', 'keywords': ['Allergen immunotherapy', 'Asthma remission', 'Disease-modifying anti-asthmatic drugs', 'Patient phenotyping', 'Symptom prevention'], 'journal': 'Innere Medizin (Heidelberg, Germany)', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Lommatzsch', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Abteilung für Pneumologie, Zentrum für Innere Medizin, Universitätsmedizin Rostock, Ernst-Heydemann-Str.\\xa06, 18057, Rostock, Deutschland. marek.lommatzsch@med.uni-rostock.de.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.\\n© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.', 'doi': '10.1007/s00108-024-01666-7\\n10.1056/NEJMra1102783\\n10.1016/S0140-6736(22)00331-2\\n10.1007/s15006-022-0992-y\\n10.1007/s10405-022-00433-5\\n10.1001/archinte.1918.00090150111007\\n10.1016/S2213-2600(22)00490-8\\n10.1159/000534922\\n10.1136/thoraxjnl-2021-217325\\n10.1136/ard.2011.149765\\n10.1136/ard-2022-223365\\n10.1056/NEJMoa2303452\\n10.1038/s41584-021-00739-3\\n10.1053/j.gastro.2020.12.031\\n10.1002/art.41773\\n10.1530/EJE-21-0077\\n10.1016/S2213-2600(23)00415-0\\n10.1159/000524712\\n10.1016/j.rmed.2017.06.009\\n10.5414/ALX02331E\\n10.1001/jama.2016.3964\\n10.1016/S2213-2600(20)30389-1\\n10.1016/j.jaip.2023.05.047\\n10.1016/S0140-6736(23)02284-5', 'xml': <Element 'PubmedArticle' at 0x10b120360>}\n",
      "{'pubmed_id': '38360857\\n19935804\\n22903050\\n34380063\\n32385053\\n33098663\\n31117010\\n36070826\\n19628815\\n19608860\\n24035365\\n26957522\\n27080143\\n9211847\\n11071893\\n17568779\\n1423591\\n7859290\\n7623806\\n9724642\\n8849728\\n11135581\\n34919144\\n33295943\\n35603192\\n33864944\\n31477921\\n30220084\\n17136045\\n25646266\\n32348365\\n26410627\\n34996938\\n22987803\\n32820125\\n12833157\\n35081372\\n30446717\\n36206356\\n38047912\\n34623911\\n34647971\\n35277664\\n32144185\\n22018468\\n17698588\\n25712216\\n33536617\\n31371561\\n28533444\\n27325434\\n18981236\\n27559335\\n32694782\\n35145086\\n30988188\\n32399548\\n25347469\\n33571536\\n25829231\\n26825674\\n29335749\\n16618596\\n34556886\\n26481684\\n29343554\\n25824819\\n32572238\\n33232656', 'title': 'Bob1 maintains T follicular helper cells for long-term humoral immunity.', 'abstract': 'Humoral immunity is vital for host protection, yet aberrant antibody responses can trigger harmful inflammation and immune-related disorders. T follicular helper (Tfh) cells, central to humoral immunity, have garnered significant attention for unraveling immune mechanisms. This study shows the role of B-cell Oct-binding protein 1 (Bob1), a transcriptional coactivator, in Tfh cell regulation. Our investigation, utilizing conditional Bob1-deficient mice, suggests that Bob1 plays a critical role in modulating inducible T-cell costimulator expression and cellular respiration in Tfh cells. This regulation maintains the long-term functionality of Tfh cells, enabling their reactivation from central memory T cells to produce antibodies during recall responses. In a bronchial asthma model induced by house dust mite (HDM) inhalation, Bob1 is observed to enhance HDM-specific antibodies, including IgE, highlighting its pivotal function in Tfh cell regulation. Further exploration of Bob1-dependent mechanisms in Tfh cells holds promise for governing protective immunity and addressing immune-related disorders.', 'keywords': [], 'journal': 'Communications biology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Yanagi', 'firstname': 'Masahiro', 'initials': 'M', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.\\nDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Ikegami', 'firstname': 'Ippei', 'initials': 'I', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Kamekura', 'firstname': 'Ryuta', 'initials': 'R', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.\\nDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Sato', 'firstname': 'Tatsuya', 'initials': 'T', 'affiliation': 'Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Sato', 'firstname': 'Taiki', 'initials': 'T', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Kamiya', 'firstname': 'Shiori', 'initials': 'S', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Murayama', 'firstname': 'Kosuke', 'initials': 'K', 'affiliation': 'Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Jitsukawa', 'firstname': 'Sumito', 'initials': 'S', 'affiliation': 'Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Ito', 'firstname': 'Fumie', 'initials': 'F', 'affiliation': 'Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Yorozu', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.\\nDepartment of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Kihara', 'firstname': 'Miho', 'initials': 'M', 'affiliation': 'Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Kobe, 650-0047, Japan.'}, {'lastname': 'Abe', 'firstname': 'Takaya', 'initials': 'T', 'affiliation': 'Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Kobe, 650-0047, Japan.'}, {'lastname': 'Takaki', 'firstname': 'Hiromi', 'initials': 'H', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Kawata', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Shigehara', 'firstname': 'Katsunori', 'initials': 'K', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.\\nDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Miyajima', 'firstname': 'Satsuki', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Nishikiori', 'firstname': 'Hirotaka', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Sato', 'firstname': 'Akinori', 'initials': 'A', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.\\nDepartment of Rehabilitation, Faculty of Healthcare and Science, Hokkaido Bunkyo University, Eniwa, 061-1449, Japan.'}, {'lastname': 'Tohse', 'firstname': 'Noritsugu', 'initials': 'N', 'affiliation': 'Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Takano', 'firstname': 'Ken-Ichi', 'initials': 'KI', 'affiliation': 'Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Chiba', 'firstname': 'Hirofumi', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.'}, {'lastname': 'Ichimiya', 'firstname': 'Shingo', 'initials': 'S', 'affiliation': 'Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan. ichimiya@sapmed.ac.jp.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s42003-024-05827-0\\n10.1038/nri2637\\n10.1038/cmi.2012.31\\n10.1016/j.immuni.2021.07.015\\n10.1126/sciimmunol.aay2754\\n10.1111/all.14639\\n10.1016/j.immuni.2019.04.011\\n10.1016/j.jaci.2022.08.023\\n10.1126/science.1176676\\n10.1126/science.1175870\\n10.1016/j.immuni.2013.08.031\\n10.15252/embj.201591459\\n10.1002/eji.201545499\\n10.1126/science.277.5323.221\\n10.1074/jbc.M008391200\\n10.1038/sj.emboj.7601742\\n10.1016/0092-8674(92)90352-D\\n10.1016/0092-8674(95)90500-6\\n10.1128/MCB.15.8.4115\\n10.1093/emboj/17.17.5066\\n10.1038/383542a0\\n10.1038/83190\\n10.1084/jem.20211406\\n10.1084/jem.20200533\\n10.3389/fimmu.2022.889564\\n10.1016/j.autrev.2021.102833\\n10.1038/s41590-019-0472-4\\n10.1111/all.13602\\n10.1038/ni1428\\n10.1084/jem.20141432\\n10.1371/journal.ppat.1008527\\n10.1016/j.immuni.2015.08.017\\n10.1038/s41598-021-03832-5\\n10.1084/jem.20120219\\n10.1126/science.aba6652\\n10.1038/ng1206\\n10.1016/j.immuni.2021.12.015\\n10.1038/s41374-018-0152-2\\n10.1126/sciimmunol.abm2084\\n10.1084/jem.20221927\\n10.1126/sciadv.abj1249\\n10.1084/jem.20211327\\n10.1038/s41577-022-00693-5\\n10.1126/sciimmunol.aay5552\\n10.1016/j.immuni.2011.09.009\\n10.1084/jem.20062571\\n10.4049/jimmunol.1401225\\n10.1038/s41586-021-03187-x\\n10.1126/science.aaw6433\\n10.4049/jimmunol.1700141\\n10.1016/j.jaci.2016.04.021\\n10.1084/jem.20080840\\n10.3389/fimmu.2016.00304\\n10.1038/s42255-018-0025-4\\n10.1038/s41467-022-28378-6\\n10.1073/pnas.1811702116\\n10.1084/jem.20190742\\n10.1172/JCI76861\\n10.1016/j.jaci.2021.01.027\\n10.1016/j.clim.2015.02.016\\n10.1016/j.immuni.2015.11.017\\n10.1007/s00018-018-2748-5\\n10.1016/j.immuni.2006.03.007\\n10.1038/s41590-021-01025-w\\n10.1084/jem.20150363\\n10.4049/jimmunol.1700257\\n10.1084/jem.20141380\\n10.1038/s41590-020-0706-5\\n10.1016/j.molcel.2020.10.036', 'xml': <Element 'PubmedArticle' at 0x10b6440e0>}\n",
      "{'pubmed_id': '38360807\\n36283868\\n26654193\\n23012896\\n27393771\\n28765816\\n27393770\\n35434319\\n34134450\\n27042129\\n37698095\\n36740870\\n31904028\\n24980235\\n30353741\\n27712762\\n33336180\\n19379609\\n19793277\\n17521312\\n31317972\\n35008843\\n31801366\\n35330446\\n33116654\\n26143392\\n31235242\\n35418991\\n33328726\\n33065294\\n32199912\\n26067893\\n26691435\\n34364539\\n16455376\\n34953792\\n31394895\\n23640795\\n22460066\\n33189729\\n30002685\\n22186234\\n32001254\\n36848270\\n25379119\\n30326322\\n27544740\\n23816657', 'title': 'Immune endotyping and gene expression profile of patients with chronic rhinosinusitis with nasal polyps in the aspirin-exacerbated respiratory disease (AERD) and the non-AERD subgroups.', 'abstract': 'Chronic Rhinosinusitis (CRS) is a paranasal sinus inflammatory disease and is divided into two subgroups defined as CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). CRSwNP displays a T helper (Th)2 biased phenotype, and based on sensitivity or tolerance to aspirin or non-steroidal anti-inflammatory drugs (NSAID), is further subdivided into Aspirin-exacerbated respiratory disease (AERD) and non-AERD groups. Considering the challenge of diagnosis and treatment in patients with CRSwNP, particularly the AERD subtype, and the significance of endotyping in these patients, we examined the immune profile and endotyping based on gene expression analysis in the AERD and the non-AERD groups of patients with CRSwNP.\\nIn this study, 21 patients were enrolled and were categorized into AERD (N\\u2009=\\u200910) and non-AERD (N\\u2009=\\u200911) groups based on their sensitivity to aspirin. After the special washing period, nasal polyps were biopsied in both groups, and the infiltration of eosinophils, neutrophils, plasma cells, and lymphocytes was compared between the AERD and the non-AERD groups. Also, gene expression levels of transcription factors including Tbet, GATA3, RoRγt, and FoxP3 and inflammatory cytokines including interleukin (IL)1β, IL1RAP (IL1 receptor accessory protein), IL2, IL4, IL5, IL10, IL13, IL17, TNFα, and IFNγ were investigated by quantitative Real-time PCR (qRT-PCR). Statistical analyses were performed using analytical tests including Kolmogorov-Smirnov, Mann-Whitney, and T-test. A P value less than 0.05 was considered statistically significant.\\nThe mean\\u2009±\\u2009SD age of the studied groups was 37\\u2009±\\u20098.7 years old (21-50) for the AERD, and 40.4\\u2009±\\u20097.7 years old (31-52) for the non-AERD. LMS/EPOS/SNOT scores and pulmonary function tests showed no difference between the two groups. Serum immunoglobulin E (IgE) levels were found to be higher in patients with AERD (p\\u2009=\\u20090.04), however, the peripheral blood counts of eosinophils were comparable in the two groups. In the histopathologic analysis, the AERD group showed higher percentages of eosinophils (p\\u2009=\\u20090.04), neutrophils (p\\u2009=\\u20090.04), and plasma cells (p\\u2009=\\u20090.04) than the non-AERD group. Additionally, the gene expression levels of GATA3 (p\\u2009=\\u20090.001), IL4 (p\\u2009=\\u20090.04), IL5 (p\\u2009=\\u20090.007), and IL17 (p\\u2009=\\u20090.03) were significantly higher in the AERD than the non-AERD groups.\\nHigher gene expression levels of GATA3, IL4, IL5, and IL17 were observed in the AERD group compared with the non-AERD group. These findings point to distinct patterns of inflammation in patients with AERD, with a predominance of Th2 inflammation.', 'keywords': [], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Nazari', 'firstname': 'Javad', 'initials': 'J', 'affiliation': 'Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.\\nDepartment of Pediatrics, Arak University of Medical Science, Arak, Iran.'}, {'lastname': 'Shahba', 'firstname': 'Faezeh', 'initials': 'F', 'affiliation': 'Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.\\nDepartment of immunology, school of medicine, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Jafariaghdam', 'firstname': 'Negin', 'initials': 'N', 'affiliation': 'Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Mohebbi', 'firstname': 'Saleh', 'initials': 'S', 'affiliation': 'Skull Base Research Center, Five Sense Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Arshi', 'firstname': 'Saba', 'initials': 'S', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran.'}, {'lastname': 'Bemanian', 'firstname': 'Mohammad Hassan', 'initials': 'MH', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran.'}, {'lastname': 'Fallahpour', 'firstname': 'Morteza', 'initials': 'M', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran.'}, {'lastname': 'Shokri', 'firstname': 'Sima', 'initials': 'S', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran.'}, {'lastname': 'Atashrazm', 'firstname': 'Fatemeh', 'initials': 'F', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran.'}, {'lastname': 'Amini', 'firstname': 'Saeed', 'initials': 'S', 'affiliation': 'Department of Public Health, Khomein University of Medical Sciences, Khomein, Iran.'}, {'lastname': 'Roomiani', 'firstname': 'Maryam', 'initials': 'M', 'affiliation': 'ENT and Head and Neck Research Center and Department, Firoozgar Hospital, Five Senses Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Jamee', 'firstname': 'Mahnaz', 'initials': 'M', 'affiliation': \"Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical center, Leiden, Netherlands.\"}, {'lastname': 'Babaheidarian', 'firstname': 'Pegah', 'initials': 'P', 'affiliation': 'Department of Pathology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Khoshmirsafa', 'firstname': 'Majid', 'initials': 'M', 'affiliation': 'Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran. khoshmirsafa.m@iums.ac.ir.\\nDepartment of immunology, school of medicine, Iran University of Medical Sciences, Tehran, Iran. khoshmirsafa.m@iums.ac.ir.'}, {'lastname': 'Nabavi', 'firstname': 'Mohammad', 'initials': 'M', 'affiliation': 'Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, 14456 13131, Iran. m.nabavi44@yahoo.com.'}], 'methods': None, 'conclusions': 'Higher gene expression levels of GATA3, IL4, IL5, and IL17 were observed in the AERD group compared with the non-AERD group. These findings point to distinct patterns of inflammation in patients with AERD, with a predominance of Th2 inflammation.', 'results': 'The mean\\u2009±\\u2009SD age of the studied groups was 37\\u2009±\\u20098.7 years old (21-50) for the AERD, and 40.4\\u2009±\\u20097.7 years old (31-52) for the non-AERD. LMS/EPOS/SNOT scores and pulmonary function tests showed no difference between the two groups. Serum immunoglobulin E (IgE) levels were found to be higher in patients with AERD (p\\u2009=\\u20090.04), however, the peripheral blood counts of eosinophils were comparable in the two groups. In the histopathologic analysis, the AERD group showed higher percentages of eosinophils (p\\u2009=\\u20090.04), neutrophils (p\\u2009=\\u20090.04), and plasma cells (p\\u2009=\\u20090.04) than the non-AERD group. Additionally, the gene expression levels of GATA3 (p\\u2009=\\u20090.001), IL4 (p\\u2009=\\u20090.04), IL5 (p\\u2009=\\u20090.007), and IL17 (p\\u2009=\\u20090.03) were significantly higher in the AERD than the non-AERD groups.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00876-w\\n10.1016/j.otc.2022.09.008\\n10.1016/j.jaci.2015.10.009\\n10.1177/000348941212100904\\n10.5415/apallergy.2017.7.3.121\\n10.1002/lio2.758\\n10.14639/0392-100X-suppl.1-43-2023-01\\n10.1177/19458924231154066\\n10.2500/ajra.2014.28.4034\\n10.1177/1945892418807590\\n10.1016/j.wjorl.2020.07.009\\n10.2500/ajra.2009.23.3255\\n10.1111/j.1749-4486.2009.01995.x\\n10.1111/j.1398-9995.2007.01409.x\\n10.3390/ijms23010417\\n10.1177/0145561319893163\\n10.2147/JAA.S237463\\n10.1007/s11882-015-0540-2\\n10.1016/j.alit.2019.05.001\\n10.3389/fimmu.2022.850494\\n10.1016/j.anai.2020.09.016\\n10.1016/j.jaci.2020.02.035\\n10.1164/rccm.201412-2278OC\\n10.1016/j.jaci.2015.10.020\\n10.1016/j.jaci.2021.06.016\\n10.1016/j.otohns.2005.09.026\\n10.1016/j.jaci.2021.11.023\\n10.1016/j.jaci.2012.01.079\\n10.1016/j.jaci.2020.11.001\\n10.1016/j.jaci.2012.12.1510\\n10.1186/s13223-018-0270-9\\n10.2500/ajra.2011.25.3645\\n10.1016/j.jaci.2020.01.019\\n10.1177/19458924221149003\\n10.1186/1939-4551-7-25\\n10.1016/j.anai.2018.10.014\\n10.1016/j.jaci.2016.05.041\\n10.2500/ajra.2013.27.3922', 'xml': <Element 'PubmedArticle' at 0x10b75f9c0>}\n",
      "{'pubmed_id': '38360670\\n16980551\\n19892012\\n20333651\\n17311279\\n17303384\\n22773695\\n26747779\\n20167866\\n37703677\\n35155966\\n23690670\\n23326583\\n29756563\\n21268080\\n21520062\\n19616091\\n18336852\\n15389584\\n37442359\\n18227124\\n19281832\\n37798799\\n9231657\\n9065481\\n36963510\\n36723831\\n36551260\\n37146924\\n36768666\\n37369936\\n11921435\\n11735645\\n35059243\\n10529898\\n8041794\\n1349185\\n9607781\\n8695669\\n11089900\\n31073335\\n17532302\\n18628217\\n19703165\\n23646053\\n25619395\\n19734319\\n17413033\\n24412385\\n10206339\\n27100828\\n21414301\\n16177082\\n25014792\\n25640654\\n16329999\\n22481913\\n16020742\\n26801686\\n22966222\\n21664456\\n20803017\\n30088830\\n15203187\\n24824657\\n12650641\\n17686966\\n25148934\\n19131585\\n25921464\\n29309760\\n16487036\\n24440741\\n23099255\\n24302926\\n18691009\\n25883219\\n17582782\\n16814105\\n12417014\\n16397146\\n18357586\\n22838648\\n20814441\\n21037234\\n19050283\\n21431325\\n25653691\\n27707958\\n28186975\\n16179588\\n20205235\\n16990612\\n17143561\\n15925327\\n21333731\\n12637567\\n10933875\\n12709591\\n12570874\\n17631927\\n12660731\\n20162662\\n14688281\\n16601269\\n15024026\\n20083195\\n23525690\\n25969626\\n15240748\\n16971418\\n16510205\\n19129475\\n7538129\\n11007950\\n16513826\\n12359864\\n16968214\\n10631150\\n15451051\\n9887101\\n23942037\\n23986495\\n17701549\\n26233704\\n19996381\\n25659903\\n21295052\\n19864008\\n17041012\\n20103737\\n27568287\\n19903700\\n19299558\\n15744310\\n24481447\\n17560826\\n24757676\\n26722219\\n12736330\\n21441538\\n19273606\\n11988536\\n12847250\\n14561868\\n14684628\\n15777659\\n7622446\\n15564374\\n1400499\\n19534727\\n20351094\\n26300638\\n25024717\\n33267895\\n33926423\\n16312170\\n19357642\\n19944580\\n19641141\\n23794466\\n15293600\\n16083301\\n30544130\\n20163460\\n16307220\\n26713087\\n15788448\\n12813370\\n20101262\\n32622513\\n24338629\\n34182323\\n12709566\\n31425676\\n15486963\\n36058936', 'title': 'Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders.', 'abstract': 'The activation of peroxisome proliferator-activated receptor (PPAR)-γ has been extensively shown to attenuate inflammatory responses in conditions such as asthma, acute lung injury, and acute respiratory distress syndrome, as demonstrated in animal studies. However, the precise molecular mechanisms underlying these inhibitory effects remain largely unknown. The upregulation of heme oxygenase-1 (HO-1) has been shown to confer protective effects, including antioxidant, antiapoptotic, and immunomodulatory effects in vitro and in vivo. PPARγ is highly expressed not only in adipose tissues but also in various other tissues, including the pulmonary system. Thiazolidinediones (TZDs) are highly selective agonists for PPARγ and are used as antihyperglycemic medications. These observations suggest that PPARγ agonists could modulate metabolism and inflammation. Several studies have indicated that PPARγ agonists may serve as potential therapeutic candidates in inflammation-related diseases by upregulating HO-1, which in turn modulates inflammatory responses. In the respiratory system, exposure to external insults triggers the expression of inflammatory molecules, such as cytokines, chemokines, adhesion molecules, matrix metalloproteinases, and reactive oxygen species, leading to the development of pulmonary inflammatory diseases. Previous studies have demonstrated that the upregulation of HO-1 protects tissues and cells from external insults, indicating that the induction of HO-1 by PPARγ agonists could exert protective effects by inhibiting inflammatory signaling pathways and attenuating the development of pulmonary inflammatory diseases. However, the mechanisms underlying TZD-induced HO-1 expression are not well understood. This review aimed to elucidate the molecular mechanisms through which PPARγ agonists induce the expression of HO-1 and explore how they protect against inflammatory and oxidative responses.', 'keywords': [], 'journal': 'Cell communication and signaling : CCS', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Lee', 'firstname': 'I-Ta', 'initials': 'IT', 'affiliation': 'School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, 110301, Taiwan.'}, {'lastname': 'Yang', 'firstname': 'Chien-Chung', 'initials': 'CC', 'affiliation': 'Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Taoyuan, Taoyuan, 333008, Taiwan.\\nSchool of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, 333323, Taiwan.'}, {'lastname': 'Yang', 'firstname': 'Chuen-Mao', 'initials': 'CM', 'affiliation': 'Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, 242062, Taiwan. chuenmao@mail.cmu.edu.tw.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12964-024-01501-4\\n10.1165/rcmb.2006-0331TR\\n10.1016/j.freeradbiomed.2009.10.047\\n10.1002/jcp.22142\\n10.1002/jcp.20992\\n10.1016/j.cellsig.2007.01.009\\n10.1152/ajplung.00090.2012\\n10.1152/ajplung.00109.2014\\n10.2353/ajpath.2010.090714\\n10.1016/j.cyto.2023.156352\\n10.1155/2013/791231\\n10.1371/journal.pone.0054125\\n10.2174/0929867325666180514112124\\n10.1002/jcb.22949\\n10.1002/jcp.22537\\n10.1016/j.cellsig.2009.07.002\\n10.1016/j.taap.2008.01.032\\n10.1002/jcp.20142\\n10.1016/j.cca.2023.117487\\n10.1124/mol.107.038091\\n10.1016/j.taap.2009.02.025\\n10.1186/s12985-023-02194-w\\n10.2337/diab.46.8.1319\\n10.1074/jbc.272.12.8071\\n10.1016/j.pharmthera.2023.108391\\n10.1007/s11011-022-01139-6\\n10.3390/biom12121832\\n10.1016/j.phrs.2023.106786\\n10.3390/ijms24032345\\n10.1002/cbin.12065\\n10.1002/dmrr.252\\n10.2165/00002018-200124120-00002\\n10.1007/s13340-021-00519-0\\n10.1073/pnas.91.15.7355\\n10.1098/rspb.1992.0012\\n10.1210/endo.139.6.6049\\n10.1016/0005-2760(96)00066-5\\n10.1007/s000110050622\\n10.1186/s13098-019-0432-z\\n10.1016/j.bbrc.2007.05.057\\n10.1111/j.1476-5381.2009.00373.x\\n10.3345/kjp.2013.56.4.151\\n10.1038/aps.2014.128\\n10.1152/ajplung.00148.2009\\n10.1161/ATVBAHA.107.142638\\n10.1016/j.lfs.2013.12.208\\n10.1016/S0898-6568(98)00037-0\\n10.1007/s00018-016-2223-0\\n10.1016/j.bbrc.2011.03.053\\n10.4049/jimmunol.175.7.4408\\n10.2119/molmed.2014.00103\\n10.1038/cmi.2015.02\\n10.1016/j.bcp.2005.10.042\\n10.1155/2012/641087\\n10.1124/mol.105.012260\\n10.1016/j.bcp.2016.01.011\\n10.1155/2012/809164\\n10.1016/j.freeradbiomed.2011.05.027\\n10.1007/s00281-010-0221-0\\n10.1111/bph.14465\\n10.1016/j.freeradbiomed.2004.04.020\\n10.1152/ajpendo.00044.2014\\n10.1042/bj20021629\\n10.1124/mol.107.037549\\n10.1007/s12035-014-8869-4\\n10.1124/jpet.108.145557\\n10.1002/jcp.24912\\n10.1016/j.bcp.2017.12.024\\n10.1089/ars.2006.8.43\\n10.1016/j.bcp.2014.01.006\\n10.1016/j.ejphar.2012.10.019\\n10.3389/fimmu.2013.00384\\n10.2174/138945008785132411\\n10.1093/cvr/cvv131\\n10.1016/j.phrs.2007.04.010\\n10.1016/j.freeradbiomed.2006.04.002\\n10.1093/oxfordjournals.jbchem.a003272\\n10.1161/01.RES.0000202706.70992.95\\n10.1002/jcp.21206\\n10.1021/jf301511m\\n10.1155/2010/549101\\n10.1152/ajpheart.00749.2010\\n10.4049/jimmunol.181.12.8633\\n10.1007/s00109-011-0748-0\\n10.4046/trd.2015.78.1.8\\n10.1177/0394632016673369\\n10.18632/oncotarget.15116\\n10.1161/01.RES.0000187458.77026.10\\n10.1002/jcp.22093\\n10.1165/rcmb.2006-0340TR\\n10.1016/j.bcp.2005.03.033\\n10.1016/j.tiv.2011.02.004\\n10.1074/jbc.M203929200\\n10.1006/abbi.2000.1921\\n10.1177/15353702-0322805-51\\n10.1042/bj20021619\\n10.1016/j.taap.2007.04.019\\n10.1038/ni0403-313\\n10.1002/bies.200900150\\n10.1074/jbc.M309660200\\n10.1152/physrev.00011.2005\\n10.1016/j.freeradbiomed.2010.01.017\\n10.1007/s10565-013-9242-5\\n10.1155/2015/380218\\n10.1189/jlb.0104046\\n10.1096/fj.06-5668fje\\n10.1016/j.jhep.2005.12.019\\n10.1091/mbc.e08-10-1005\\n10.1016/S0006-2952(00)00443-3\\n10.1210/en.2006-0070\\n10.1146/annurev.pharmtox.43.100901.140229\\n10.1146/annurev.pharmtox.46.120604.141046\\n10.1086/302729\\n10.1016/j.freeradbiomed.2004.07.008\\n10.1101/gad.13.1.76\\n10.1016/j.phrs.2013.07.010\\n10.1073/pnas.1305687110\\n10.1080/15216540701225941\\n10.1016/j.redox.2015.07.008\\n10.1152/ajpendo.00417.2009\\n10.1152/ajplung.00274.2014\\n10.1016/j.taap.2011.01.018\\n10.1016/j.jaci.2009.08.009\\n10.1152/ajplung.00308.2006\\n10.1152/ajpendo.00745.2009\\n10.1016/j.bbrc.2016.08.132\\n10.1093/cvr/cvp365\\n10.1101/gad.1773109\\n10.1038/nature03354\\n10.1038/cddis.2013.514\\n10.1016/j.bbalip.2007.04.018\\n10.7150/ijbs.13188\\n10.1523/JNEUROSCI.23-09-03597.2003\\n10.1093/nar/gkr161\\n10.1128/MCB.01828-08\\n10.1126/science.1072613\\n10.4049/jimmunol.171.2.821\\n10.1523/JNEUROSCI.23-28-09403.2003\\n10.1161/01.RES.0000113781.08139.81\\n10.1016/j.gene.2005.01.013\\n10.1074/jbc.270.28.16483\\n10.1242/jcs.01589\\n10.1016/S0021-9258(19)36696-7\\n10.1042/BJ20090339\\n10.1074/jbc.M109.058586\\n10.2147/COPD.S82643\\n10.1186/1710-1492-10-34\\n10.1186/s12931-020-01547-1\\n10.1186/s12890-021-01505-7\\n10.1016/S1081-1206(10)61173-8\\n10.1038/clpt.2009.41\\n10.1016/j.rmed.2009.11.006\\n10.4049/jimmunol.0900231\\n10.1183/09031936.00187812\\n10.1183/09031936.04.00098303\\n10.33549/physiolres.930822\\n10.12659/MSM.910766\\n10.1111/j.1742-4658.2010.07581.x\\n10.1007/s00011-005-1379-0\\n10.1155/2015/549691\\n10.1096/fj.04-3309fje\\n10.1097/01.shk.0000070903.21762.f8\\n10.1038/cr.2010.13\\n10.1016/j.jaut.2020.102510\\n10.1189/jlb.0613326\\n10.1016/j.intimp.2021.107809\\n10.1177/15353702-0322805-02\\n10.1016/j.abb.2019.108073\\n10.1002/hep.20450\\n10.1186/s12967-022-03589-z', 'xml': <Element 'PubmedArticle' at 0x10ad0c5e0>}\n",
      "{'pubmed_id': '38360617\\n33773121\\n26809127\\n32592398\\n36597456\\n29685458\\n31357057\\n31492099\\n30947695\\n36407409\\n30759187\\n35248168\\n33204120\\n30339803\\n22371724\\n36460406\\n24903793\\n26284920\\n18514008\\n27045684\\n19046064\\n21256367\\n29606112', 'title': 'Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey.', 'abstract': 'The magnitude of MDR-TB cases was noticeable in Egypt. However, the last national survey was 11-years ago. The current survey was conducted to determine the prevalence of rifampicin resistance among sputum smear-positive pulmonary tuberculosis patients in Egypt.\\nA national health facility-based cross-sectional study was conducted in 14 randomly selected governorates in Egypt between August 2020 and September 2021. All presumptive TB cases, either new or previously treated according to WHO definitions, with no gender, age, or nationality limitations, and provided informed consent were included in the study. Each patient completed a case report form (CRF). The CRF included socio-demographic and clinical data. Sputum samples were collected according to standard techniques and cultured on Lowenstein-Jensen (L-J) medium. Gene X-pert test was carried out first on the samples for simultaneous identification of MTB and rifampicin resistance. The prevalence of RR was calculated using crude, cluster, and weighted methods. Factors associated with RR were analyzed by bivariate and multivariate techniques.\\nAmong the total 849 presumptive TB patients enrolled in the study, 710 (83.6%) patients were subjected to Gene X-pert testing (MTB/RIF). The crude prevalence of RR was 3.32% (95% CI: 1.89-4.76%) among the new cases and 9.46% (95% CI: 2.63-16.29%) among the retreated cases with an overall estimate of 3.99%; (95% CI: 2.51-5.47%). By cluster analysis the overall prevalence of RR was 5.01% (95% CI: 2.90-7.13). Factors associated with the prevalence of RR were co-morbidity with bronchial asthma, drug abuse and history of contact with a family member with TB.\\nThe prevalence of RR among either new or retreated cases TB patients was lower than the previous Egyptian rates in 2010-2012. The strongest predictor associated with RR was comorbidity with bronchial asthma.', 'keywords': ['Mycobacterium tuberculosis', 'Prevalence', 'Rifampicin resistance', 'Survey'], 'journal': 'BMC infectious diseases', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Amin', 'firstname': 'Wagdy', 'initials': 'W', 'affiliation': 'Chest Diseases Department, Ministry of Health and Population, Cairo, Egypt.'}, {'lastname': 'Gadallah', 'firstname': 'Mohsen', 'initials': 'M', 'affiliation': 'Community, Environmental and Occupational medicine department, Faculty of Medicine-Ain, Shams University, Cairo, Egypt.'}, {'lastname': 'Salah', 'firstname': 'Amal', 'initials': 'A', 'affiliation': 'National TB Control Program (NTP), Cairo, Egypt.'}, {'lastname': 'Rady', 'firstname': 'Mervat', 'initials': 'M', 'affiliation': 'Community, Environmental and Occupational medicine department, Faculty of Medicine-Ain, Shams University, Cairo, Egypt. mervathassan@med.asu.edu.eg.'}], 'methods': None, 'conclusions': 'The prevalence of RR among either new or retreated cases TB patients was lower than the previous Egyptian rates in 2010-2012. The strongest predictor associated with RR was comorbidity with bronchial asthma.', 'results': 'Among the total 849 presumptive TB patients enrolled in the study, 710 (83.6%) patients were subjected to Gene X-pert testing (MTB/RIF). The crude prevalence of RR was 3.32% (95% CI: 1.89-4.76%) among the new cases and 9.46% (95% CI: 2.63-16.29%) among the retreated cases with an overall estimate of 3.99%; (95% CI: 2.51-5.47%). By cluster analysis the overall prevalence of RR was 5.01% (95% CI: 2.90-7.13). Factors associated with the prevalence of RR were co-morbidity with bronchial asthma, drug abuse and history of contact with a family member with TB.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12879-023-08807-7\\n10.1016/S2213-2600(21)00161-2\\n10.4103/ejcdt.ejcdt_125_20\\n10.21608/SCUMJ.2019.110680\\n10.4103/ejcdt.ejcdt_120_19\\n10.18203/2394-6040.ijcmph20182039\\n10.3126/ajms.v14i1.47930\\n10.1371/journal.pone.0147529\\n10.1093/trstmh/traa044\\n10.2147/IDR.S394089\\n10.1016/S1473-3099(18)30222-6\\n10.1016/j.ijid.2019.07.021\\n10.1186/s12879-019-4375-7\\n10.1186/s12879-019-3943-1\\n10.4314/ahs.v22i2.18\\n10.1093/cid/ciy1105\\n10.1016/S1473-3099(21)00808-2\\n10.2147/IDR.S277477\\n10.4236/ojrd.2016.62003\\n10.1016/j.jinf.2018.10.004\\n10.5114/aoms.2010.13511\\n10.1371/journal.pone.0135205\\n10.4236/jtr.2014.23014\\n10.1016/j.ijid.2008.03.012\\n10.1371/journal.pone.0152933\\n10.1086/594126\\n10.1016/j.puhe.2010.09.002\\n10.1186/s12889-018-5371-3', 'xml': <Element 'PubmedArticle' at 0x10998d3a0>}\n",
      "{'pubmed_id': '38360544', 'title': 'The Immunobiology and Treatment of Food Allergy.', 'abstract': 'IgE-mediated food allergy (IgE-FA) occurs due to a breakdown in immune tolerance that leads to a detrimental type 2 helper T\\xa0cell (T', 'keywords': [], 'journal': 'Annual review of immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Barshow', 'firstname': 'Suzanne', 'initials': 'S', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.'}, {'lastname': 'Tirumalasetty', 'firstname': 'Jyothi', 'initials': 'J', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.'}, {'lastname': 'Sampath', 'firstname': 'Vanitha', 'initials': 'V', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.\\nDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.'}, {'lastname': 'Zhou', 'firstname': 'Xiaoying', 'initials': 'X', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.\\nDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.'}, {'lastname': 'Seastedt', 'firstname': 'Hana', 'initials': 'H', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.'}, {'lastname': 'Schuetz', 'firstname': 'Jackson', 'initials': 'J', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.'}, {'lastname': 'Nadeau', 'firstname': 'Kari', 'initials': 'K', 'affiliation': 'Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, California, USA; email: jtsetty@stanford.edu.\\nDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1146/annurev-immunol-090122-043501', 'xml': <Element 'PubmedArticle' at 0x10b2b3740>}\n",
      "{'pubmed_id': '38360325', 'title': 'How climate change degrades child health: A systematic review and meta-analysis.', 'abstract': 'Children are more vulnerable than adults to climate-related health threats, but reviews examining how climate change affects human health have been mainly descriptive and lack an assessment of the magnitude of health effects children face. This is the first systematic review and meta-analysis that identifies which climate-health relationships pose the greatest threat the children.\\nWe reviewed epidemiologic studies to analyse various child-health outcomes due to climate change and identify the relationships with the largest effect size. We identify population-specific risks and provide recommendations for future research.\\nWe searched four large online databases for observational studies published up to 5 January 2023 following PRISMA (systematic review) guidelines. We evaluated each included study individually and aggregated relevant quantitative data. We used quantitative data in our meta-analysis, where we standardised effect sizes and compared them among different groupings of climate variables and health outcomes.\\nOf 1301 articles we identified, 163 studies were eligible for analysis. We identified many relationships between climate change and child health, the strongest of which was increasing risk (60\\u202f% on average) of preterm birth from exposure to temperature extremes. Respiratory disease, mortality, and morbidity, among others, were also influenced by climate changes. The effects of different air pollutants on health outcomes were considerably smaller compared to temperature effects, but with most (16/20\\u202f=\\u202f80\\u202f%) pollutant studies indicating at least a weak effect. Most studies occurred in high-income regions, but we found no geographical clustering according to health outcome, climate variable, or magnitude of risk. The following factors were protective of climate-related child-health threats: (i) economic stability and strength, (ii) access to quality healthcare, (iii) adequate infrastructure, and (iv) food security. Threats to these services vary by local geographical, climate, and socio-economic conditions. Children will have increased prevalence of disease due to anthropogenic climate change, and our quantification of the impact of various aspects of climate change on child health can contribute to the planning of mitigation that will improve the health of current and future generations.', 'keywords': ['Air pollution', 'Asthma', 'Birth weight', 'Heatwave', 'Morbidity', 'Mortality', 'Particulate matter', 'Pregnancy', 'Preterm birth', 'Respiratory disease', 'Stunting', 'Temperature extremes'], 'journal': 'The Science of the total environment', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Weeda', 'firstname': 'Lewis J Z', 'initials': 'LJZ', 'affiliation': 'School of Medicine, University of Western Australia, Perth, Western Australia, Australia. Electronic address: lewisweeda3@gmail.com.'}, {'lastname': 'Bradshaw', 'firstname': 'Corey J A', 'initials': 'CJA', 'affiliation': 'Global Ecology|Partuyarta Ngadluku Wardli Kuu, College of Science and Engineering, Flinders University, Adelaide, South Australia, Australia; Australian Research Council Centre of Excellence for Australian Biodiversity and Heritage, EpicAustralia.org.au, Australia.'}, {'lastname': 'Judge', 'firstname': 'Melinda A', 'initials': 'MA', 'affiliation': 'Telethon Kids Institute, Perth, Western Australia, Australia; Department of Mathematics and Statistics, University of Western Australia, Perth, Western Australia, Australia.'}, {'lastname': 'Saraswati', 'firstname': 'Chitra M', 'initials': 'CM', 'affiliation': 'Telethon Kids Institute, Perth, Western Australia, Australia.'}, {'lastname': 'Le Souëf', 'firstname': 'Peter N', 'initials': 'PN', 'affiliation': 'School of Medicine, University of Western Australia, Perth, Western Australia, Australia; Telethon Kids Institute, Perth, Western Australia, Australia.'}], 'methods': None, 'conclusions': None, 'results': 'Of 1301 articles we identified, 163 studies were eligible for analysis. We identified many relationships between climate change and child health, the strongest of which was increasing risk (60\\u202f% on average) of preterm birth from exposure to temperature extremes. Respiratory disease, mortality, and morbidity, among others, were also influenced by climate changes. The effects of different air pollutants on health outcomes were considerably smaller compared to temperature effects, but with most (16/20\\u202f=\\u202f80\\u202f%) pollutant studies indicating at least a weak effect. Most studies occurred in high-income regions, but we found no geographical clustering according to health outcome, climate variable, or magnitude of risk. The following factors were protective of climate-related child-health threats: (i) economic stability and strength, (ii) access to quality healthcare, (iii) adequate infrastructure, and (iv) food security. Threats to these services vary by local geographical, climate, and socio-economic conditions. Children will have increased prevalence of disease due to anthropogenic climate change, and our quantification of the impact of various aspects of climate change on child health can contribute to the planning of mitigation that will improve the health of current and future generations.', 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.scitotenv.2024.170944', 'xml': <Element 'PubmedArticle' at 0x147aebbf0>}\n",
      "{'pubmed_id': '38360295', 'title': 'Identification of toxicity-induced biomarkers in human non-immune airway cells exposed to respiratory sensitizers: a mechanistic approach.', 'abstract': 'Occupational asthma covers a group of work-related diseases whose clinical manifestations include airway hyperresponsiveness and airflow limitation. Although the chemical respiratory allergy (CRA) induced by Low Molecular Weight (LMW) sensitizers is a major concern, especially in terms of the regulatory framework, to date there are no methods available for preclinically addressing this toxicological outcome, as its mechanistic background is not fully understood at molecular or cellular levels. This paper proposes a mechanistic study applying New Approach Methodologies (NAM) of the pro-inflammatory and functional effects triggered by LMW respiratory allergens in different respiratory tract cell lines, including bronchial epithelial (BEAS-2B), lung fibroblast (MRC-5), and endothelial cells (EA.hy926), and an analysis of the capacity of such chemicals to interact with the mucin protein, to address certain toxicodynamic aspects of such compounds. The results showed that some of the sensitizers evaluated interact with mucin, the main protein mucus component, but the toxicant-mucin complex formation does not seem to be a common feature of different chemical classes of allergens. At a cellular level, sensitizers promoted an increase in IL-8, IL-6, and IL-1β production in the evaluated cell types. It also impaired the MUC1 expression by bronchial cells and activated endothelial cells, thereby increasing the ICAM-I surface expression. Taken together, our results showed that these aforementioned cell types participate in the CRA Adverse Outcome Pathway and must be considered when developing preclinical testing strategies, particularly investigating danger signal production after exposure to LMW sensitizers in different tissue compartments.', 'keywords': ['Respiratory sensitization', 'new approach methodologies', 'occupational asthma', 'pulmonary toxicity'], 'journal': 'Toxicology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Garcia da Silva', 'firstname': 'Artur Christian', 'initials': 'AC', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.'}, {'lastname': 'Carvalho Filho', 'firstname': 'Sérgio de Morais', 'initials': 'SM', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.'}, {'lastname': 'Furtado de Mendonça', 'firstname': 'Izadora Caroline', 'initials': 'IC', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil.'}, {'lastname': 'Valadares', 'firstname': 'Marize Campos', 'initials': 'MC', 'affiliation': 'Laboratory of Education and Research in In vitro Toxicology, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO, Brazil. Electronic address: marizeufg@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.tox.2024.153750', 'xml': <Element 'PubmedArticle' at 0x10a169fd0>}\n",
      "{'pubmed_id': '38360214', 'title': 'Vitamin D primary prevention of respiratory infections and asthma in early childhood: evidence and mechanisms.', 'abstract': 'Respiratory infections are a leading cause of child morbidity worldwide and asthma is the most common chronic disorder in childhood. Both conditions associate with high socioeconomic costs and are major reasons for medication prescriptions and hospitalizations in children. Vitamin D deficiency has concomitantly increased with asthma prevalence and is hypothesized to play a key role in the development. Current evidence suggests that high prenatal and early childhood vitamin D could be protective against respiratory infections and asthma in some studies where several mechanisms are proposed. However, other studies have reported no effects on these outcomes. Therefore, future large intervention studies on this topic are warranted. Mechanistic studies have shown that vitamin D holds antimicrobial properties by inducing production of several peptides through altered gene expression. Others have shown a complex interplay between asthma risk genotypes, the sphingolipid pathway and prenatal vitamin D in early childhood asthma. Vitamin D has also been suggested to change both airway immune- and microbiota profiles, which are directly related to asthma risk. Finally, systemic low-grade inflammation seems to be regulated by vitamin D exposure. This review presents current literature of the primary preventive effect of vitamin D on early childhood asthma and respiratory infections. Mechanisms of actions are discussed and gaps in knowledge are highlighted to facilitate planning of future intervention trials.', 'keywords': ['asthma', 'child', 'infections', 'prevention', 'vitaminD'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Brustad', 'firstname': 'Nicklas', 'initials': 'N', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Electronic address: Nicklas.brustad@dbac.dk.'}, {'lastname': 'Chawes', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.02.005', 'xml': <Element 'PubmedArticle' at 0x10a16a1b0>}\n",
      "{'pubmed_id': '38360213', 'title': 'Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.', 'abstract': 'LAVOLTA (L)I, LII, and ACOUSTICS were randomized, placebo-controlled, Phase 3 trials of lebrikizumab, a monoclonal antibody targeting interleukin-13, in patients with uncontrolled asthma. Failure to demonstrate efficacy may have been related to patient selection in those trials.\\nTo assess the efficacy in a well-defined subpopulation of patients with elevated blood eosinophil counts and a minimum number of prior asthma exacerbations. An additional analysis in a subpopulation of patients with elevated fractional exhaled nitric oxide (FeNO) and prior exacerbations was performed.\\nAdult (LI and LII) and adolescent patients (12-17 years weighing ≥40kg, ACOUSTICS) with uncontrolled asthma received lebrikizumab (125mg, N=832 or 37.5mg, N=829) or placebo (N=833) subcutaneously every 4 weeks. Post-hoc analysis of the annualized adjusted exacerbation rate (AER) was performed in a subpopulation of patients with baseline blood eosinophils ≥300 cells/μL and history of ≥1 exacerbation. In this subpopulation, there were 227 patients in the placebo group, 222 patients in the lebrikizumab 37.5mg group, and 217 patients in the lebrikizumab 125mg group. Safety in patients who received at least 1 dose of lebrikizumab was summarized using adverse events (AEs).\\nLebrikizumab significantly reduced AER vs. placebo in adults (AER reduction:125mg, 38%; 37.5mg, 41%) and adolescents (AER reduction:125mg, 59%; 37.5mg, 64%) with baseline blood eosinophils ≥300 cells/μL and ≥1 exacerbation. Most AEs were mild or moderate in severity and did not lead to treatment discontinuation.\\nLebrikizumab significantly reduced asthma exacerbations in a subpopulation of patients with elevated blood eosinophils, elevated FeNO, and a history of asthma exacerbation.', 'keywords': ['Allergic asthma', 'IL-13', 'efficacy', 'lebrikizumab', 'post-hoc analysis', 'safety'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Corren', 'firstname': 'Jonathan', 'initials': 'J', 'affiliation': 'David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: jcorren@ucla.edu.'}, {'lastname': 'Szefler', 'firstname': 'Stanley J', 'initials': 'SJ', 'affiliation': \"Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: Stanley.Szefler@childrenscolorado.org.\"}, {'lastname': 'Sher', 'firstname': 'Ellen', 'initials': 'E', 'affiliation': 'Allergy Partners of NJ, Ocean, NJ, USA. Electronic address: ersher@allergypartners.com.'}, {'lastname': 'Korenblat', 'firstname': 'Phillip', 'initials': 'P', 'affiliation': 'Phillip Korenblat LLC, St. Louis, MO, USA. Electronic address: phillip.korenblat@gmail.com.'}, {'lastname': 'Soong', 'firstname': 'Weily', 'initials': 'W', 'affiliation': 'Allervie Clinical Research-Alabama Allergy & Asthma Center, Birmingham, AL, USA. Electronic address: wsoong@allervie.com.'}, {'lastname': 'Hanania', 'firstname': 'Nicola A', 'initials': 'NA', 'affiliation': 'Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: hanania@bcm.edu.'}, {'lastname': 'Berman', 'firstname': 'Gary', 'initials': 'G', 'affiliation': 'Clinical Research Institute and Allergy & Asthma Specialists, Minneapolis, MN, USA. Electronic address: gdb@allergy-asthma-docs.com.'}, {'lastname': 'Brusselle', 'firstname': 'Guy', 'initials': 'G', 'affiliation': 'Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium. Electronic address: guy.brusselle@uzgent.be.'}, {'lastname': 'Zitnik', 'firstname': 'Ralph', 'initials': 'R', 'affiliation': 'Valerio Consulting, LLC, Santa Barbara, CA, USA. Electronic address: rzitnik@valerio-consulting.com.'}, {'lastname': 'Natalie', 'firstname': 'Chitra R', 'initials': 'CR', 'affiliation': 'Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: natalie_chitra_r@lilly.com.'}, {'lastname': 'Sun', 'firstname': 'Luna', 'initials': 'L', 'affiliation': 'Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: sun_luna@lilly.com.'}, {'lastname': 'Siu', 'firstname': 'Kimberly', 'initials': 'K', 'affiliation': 'Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: siu_kimberly@lilly.com.'}, {'lastname': 'Wu', 'firstname': 'Wen-Shuo', 'initials': 'WS', 'affiliation': 'Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: wu_marco@lilly.com.'}, {'lastname': 'Lio', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Northwestern University Feinberg School of Medicine, Medical Dermatology Associates of Chicago, Chicago, IL, USA. Electronic address: peterlio@gmail.com.'}, {'lastname': 'Armstrong', 'firstname': 'April W', 'initials': 'AW', 'affiliation': 'Keck School of Medicine at University of Southern California and Clinical Research for the Southern California Clinical and Translational Research Institute (SC CTSI), Los Angeles, CA, USA. Electronic address: aprilarmstrong@post.harvard.edu.'}], 'methods': None, 'conclusions': 'Lebrikizumab significantly reduced asthma exacerbations in a subpopulation of patients with elevated blood eosinophils, elevated FeNO, and a history of asthma exacerbation.', 'results': 'Lebrikizumab significantly reduced AER vs. placebo in adults (AER reduction:125mg, 38%; 37.5mg, 41%) and adolescents (AER reduction:125mg, 59%; 37.5mg, 64%) with baseline blood eosinophils ≥300 cells/μL and ≥1 exacerbation. Most AEs were mild or moderate in severity and did not lead to treatment discontinuation.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.02.007', 'xml': <Element 'PubmedArticle' at 0x10a14de40>}\n",
      "{'pubmed_id': '38360190', 'title': 'The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.', 'abstract': 'Impulse oscillometry (IOS) is an effective tool for assessing airway mechanics and diagnosing obstructive airway disease (OAD) in children with sickle cell disease (C-SCD). Obesity is known to be associated with OAD, and untreated OAD often leads to hypoxia-related complications in C-SCD. Considering the increasing prevalence of obesity in C-SCD, It is important to explore the influence of body mass index (BMI) on OAD in this disease population.\\nA longitudinal retrospective chart review was conducted on 55 C-SCD (161 IOS observations) and 35 non-SCD asthmatic children (C-Asthma) (58 observations), primarily to investigate the association between BMI and airway resistance in C-SCD and C-Asthma. We conducted generalized linear mixed models (GLMM), adjusted for pharmacotherapies, to demonstrate the influence of BMI on total (R\\nAge and BMI were not statistically different between the two groups. In C-SCD, BMI was associated with R\\nBMI significantly influenced total and central airway resistance in C-SCD. While higher airway resistances reflected increased OAD in C-SCD than asthmatics, higher Fres perhaps indicated progressive pulmonary involvement in C-SCD.', 'keywords': ['Asthma', 'BMI', 'Impulse oscillometry', 'Pulmonary function test', 'Sickle cell disease'], 'journal': 'Respiratory medicine', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Mondal', 'firstname': 'Pritish', 'initials': 'P', 'affiliation': 'Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA. Electronic address: pmondal@pennstatehealth.psu.edu.'}, {'lastname': 'Lopez', 'firstname': 'Stephanie Padilla', 'initials': 'SP', 'affiliation': 'Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.'}, {'lastname': 'Khokhar', 'firstname': 'Arshjot', 'initials': 'A', 'affiliation': 'Department of Medicine, Yale School of Medicine, New Haven, CT, USA.'}, {'lastname': 'Snyder', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Neurology, Walter Reed National Military Medical Center, Bethesda, MD, USA.'}, {'lastname': 'Kitch', 'firstname': 'Diane', 'initials': 'D', 'affiliation': 'Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.'}, {'lastname': 'Veten', 'firstname': 'Ahmed', 'initials': 'A', 'affiliation': 'Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.'}], 'methods': None, 'conclusions': 'BMI significantly influenced total and central airway resistance in C-SCD. While higher airway resistances reflected increased OAD in C-SCD than asthmatics, higher Fres perhaps indicated progressive pulmonary involvement in C-SCD.', 'results': 'Age and BMI were not statistically different between the two groups. In C-SCD, BMI was associated with R', 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.rmed.2024.107564', 'xml': <Element 'PubmedArticle' at 0x146a15990>}\n",
      "{'pubmed_id': '38360181', 'title': 'Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on Basophils (CytoBas).', 'abstract': 'House dust mite (HDM) is the most common allergen trigger globally for allergic rhinitis and atopic asthma. To expedite accurate confirmation of allergen sensitization, we designed fluorescent allergen tetramers to directly stain specific IgE on basophils to detect specific allergen sensitization using the flow cytometric CytoBas assay.\\nRecombinant proteins of major HDM allergens (component), Der f 1, Der p 1 and Der p 2 were biotinylated and conjugated with fluorochrome streptavidins as tetramers. Blood samples from 64 HDM-allergic patients and 26 non-HDM-sensitized controls were incubated with allergen tetramers for evaluation of basophil binding (CytoBas) and activation (BAT) with flow cytometry.\\nThe tetramers effectively bound and activated basophils from allergic patients but not non-sensitized controls. CytoBas with Der p 1 as a single allergen had comparable sensitivity and specificity (92% and 100%) to BAT (91% and 100%) in detecting allergen sensitization, as did CytoBas with Der p 2 (95% and 96%) to BAT (95% and 87%). A positive staining for Der p 1 and/or Der p 2 in CytoBas was 100% sensitive and 96% specific for HDM allergy.\\nCytoBas has diagnostic accuracy for group 1 and group 2 HDM allergens that is comparable to BAT, but with additional advantages of multiple allergen components in a single tube and no requirement for in vitro basophil activation. These findings endorse a single, multiplex CytoBas assay for accurate and component-resolved diagnosis of aeroallergen sensitization in patients with allergic asthma and/or rhinitis.', 'keywords': ['Der p 1', 'Der p 2', 'House dust mite', 'allergic rhinitis', 'asthma'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Hsin', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Varese', 'firstname': 'Nirupama', 'initials': 'N', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia;; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia;; Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.'}, {'lastname': 'Aui', 'firstname': 'Pei Mun', 'initials': 'PM', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Wines', 'firstname': 'Bruce D', 'initials': 'BD', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia;; Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia;; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.'}, {'lastname': 'von Borstel', 'firstname': 'Anouk', 'initials': 'A', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Mascarell', 'firstname': 'Laurent', 'initials': 'L', 'affiliation': 'Innovation & Science Department, Stallergenes Greer, Antony, France.'}, {'lastname': 'Hogarth', 'firstname': 'P Mark', 'initials': 'PM', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia;; Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia;; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.'}, {'lastname': 'Hew', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia;; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.'}, {'lastname': \"O'Hehir\", 'firstname': 'Robyn E', 'initials': 'RE', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia;; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.'}, {'lastname': 'van Zelm', 'firstname': 'Menno C', 'initials': 'MC', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia;; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia;; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. Electronic address: m.vanzelm@erasmusmc.nl.'}], 'methods': None, 'conclusions': None, 'results': 'The tetramers effectively bound and activated basophils from allergic patients but not non-sensitized controls. CytoBas with Der p 1 as a single allergen had comparable sensitivity and specificity (92% and 100%) to BAT (91% and 100%) in detecting allergen sensitization, as did CytoBas with Der p 2 (95% and 96%) to BAT (95% and 87%). A positive staining for Der p 1 and/or Der p 2 in CytoBas was 100% sensitive and 96% specific for HDM allergy.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.02.002', 'xml': <Element 'PubmedArticle' at 0x1252b6160>}\n",
      "{'pubmed_id': '38360106', 'title': 'Constant Vigilance! Managing Threats to the Skin Barrier.', 'abstract': 'Skin barrier defects are one of the primary causes of atopic dermatitis (AD). The basis of skin barrier defects in AD is due to a deficiency in various barrier proteins including filaggrin, involucrin, claudins, and lipids including ceramide, fatty acids and cholesterol. This review updates a more detailed lipid dysregulation in the skin barrier of AD based on recent lipidomic analysis. The clinical implications, treatments, prevention and predictive capability of skin barrier defects are also reviewed. DATA;: Sources: Published literature obtained through PubMed searches. STUDY;: Selection: Studies relevant to the mechanisms, clinical implications, treatments, prevention and predictors of AD development.\\nSkin barrier defects contribute to transepidermal water loss, infections, IgE sensitizations and cutaneous inflammation in AD. Preventive treatments include daily hydration and application of moisturizers. Since skin barrier defects precede the development of AD, they provide an opportunity for prediction and intervention.\\nSkin barrier defects play an important role in the co-morbidities of AD including infectious complications, disease flare and allergic diathesis. Current research focuses on prevention and prediction of AD development.', 'keywords': ['S. aureus', 'ceramide', 'eczema', 'filaggrin', 'food allergy', 'infants', 'lipid', 'lipidomic', 'moisturizer', 'skin barrier defects', 'skin tape strip'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Chu', 'firstname': 'Vanessa', 'initials': 'V', 'affiliation': 'Department of Pediatrics, Kaiser Permanente Los Angeles Medical Center, Los Angeles.'}, {'lastname': 'Ong', 'firstname': 'Peck Y', 'initials': 'PY', 'affiliation': \"Division of Clinical Immunology and Allergy, Children's Hospital Los Angeles; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California. Electronic address: pyong@chla.usc.edu.\"}], 'methods': None, 'conclusions': 'Skin barrier defects play an important role in the co-morbidities of AD including infectious complications, disease flare and allergic diathesis. Current research focuses on prevention and prediction of AD development.', 'results': 'Skin barrier defects contribute to transepidermal water loss, infections, IgE sensitizations and cutaneous inflammation in AD. Preventive treatments include daily hydration and application of moisturizers. Since skin barrier defects precede the development of AD, they provide an opportunity for prediction and intervention.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.anai.2024.02.004', 'xml': <Element 'PubmedArticle' at 0x10b350f90>}\n",
      "{'pubmed_id': '38360105', 'title': 'Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor α.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Akamatsu', 'firstname': 'Taisuke', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan. Electronic address: taisuke-akamatsu@i.shizuoka-pho.jp.'}, {'lastname': 'Shirai', 'firstname': 'Toshihiro', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan. Electronic address: toshihiro-shirai@i.shizuoka-pho.jp.'}, {'lastname': 'Okawa', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan. Electronic address: kohei.okawa@gmail.com.'}, {'lastname': 'Hirai', 'firstname': 'Keita', 'initials': 'K', 'affiliation': 'Department of Clinical Pharmacology and Therapeutics, Shinshu University Graduate School of Medicine, Matsumoto, Japan. Electronic address: hiraik@u-shizuoka-ken.ac.jp.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.02.006', 'xml': <Element 'PubmedArticle' at 0x109d4ebb0>}\n",
      "{'pubmed_id': '38360002', 'title': 'RNA therapeutics for respiratory diseases.', 'abstract': 'It has become increasingly common to utilize RNA treatment to treat respiratory illnesses. Experimental research on both people and animals has advanced quickly since the turn of the twenty-first century in an effort to discover a treatment for respiratory ailments that could not be accomplished with earlier techniques, specifically in treating prevalent respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), respiratory infections caused by viruses, and asthma. This chapter has provided a comprehensive overview of the scientific evidence in applying RNA therapy to treat respiratory diseases. The chapter describes the development of this therapy for respiratory diseases. At the same time, the types of RNA therapy for respiratory diseases have been highlighted. In addition, the mechanism of this therapy for respiratory diseases has also been covered. These insights are indispensable if this therapy is to be developed widely.', 'keywords': ['Chronic respiratory diseases', 'RNA therapeutics', 'RNA-based therapeutics', 'Viral respiratory diseases'], 'journal': 'Progress in molecular biology and translational science', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Vu Thi', 'firstname': 'Hue', 'initials': 'H', 'affiliation': 'Center for Biomedicine and Community Health, International School, Vietnam National University, Hanoi, Vietnam; Faculty of Applied Sciences, International School, Vietnam National University, Hanoi, Vietnam.'}, {'lastname': 'Tran', 'firstname': 'Linh Thao', 'initials': 'LT', 'affiliation': 'Center for Biomedicine and Community Health, International School, Vietnam National University, Hanoi, Vietnam.'}, {'lastname': 'Nguyen', 'firstname': 'Huy Quang', 'initials': 'HQ', 'affiliation': 'LMI DRISA, Department of Life Sciences, University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi, Vietnam.'}, {'lastname': 'Chu', 'firstname': 'Dinh-Toi', 'initials': 'DT', 'affiliation': 'Center for Biomedicine and Community Health, International School, Vietnam National University, Hanoi, Vietnam; Faculty of Applied Sciences, International School, Vietnam National University, Hanoi, Vietnam. Electronic address: toicd@vnu.edu.vn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/bs.pmbts.2023.12.021', 'xml': <Element 'PubmedArticle' at 0x109d4d760>}\n",
      "{'pubmed_id': '38359922', 'title': 'Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.', 'abstract': None, 'keywords': ['Allergic lung disease', 'Asthma', 'Asthma Mechanisms', 'Asthma Pharmacology', 'Eosinophil Biology'], 'journal': 'Thorax', 'publication_date': datetime.date(2024, 2, 16), 'authors': [{'lastname': 'Celis-Preciado', 'firstname': 'Carlos Andrés', 'initials': 'CA', 'affiliation': 'Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.\\nInternal Medicine-Pulmonary Unit, Hospital Universitario San Ignacio, Bogota, Colombia.'}, {'lastname': 'Lachapelle', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.'}, {'lastname': 'Couillard', 'firstname': 'Simon', 'initials': 'S', 'affiliation': 'Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada s.couillard@usherbrooke.ca.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1136/thorax-2023-221274', 'xml': <Element 'PubmedArticle' at 0x12528e660>}\n",
      "{'pubmed_id': '38359103', 'title': 'Update on occupational allergy and asthma, to soluble platinum salts.', 'abstract': 'This review aims to evaluate recent literature on occupational platinum salt exposure and allergy and asthma in the context of existing evidence.\\nA major recent development is that large quantitative platinum salt exposure datasets have become available and are finding applications in epidemiological studies. These exposure data are expected to lead to higher quality epidemiological studies focusing on exposure response relations, modifiers of exposure and sensitization risk. The exposure data might also improve medical referral advice as part of medical surveillance studies and contribute to improved evidence on the effectiveness of exposure referral.\\nHopefully, the availability of exposure databases form a stimulus for more exposure response studies and risk assessments leading to science based primary prevention approaches. The availability of more detailed exposure data can guide job transfer decisions in occupational clinical practice.', 'keywords': [], 'journal': 'Current opinion in allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Heederik', 'firstname': 'Dick', 'initials': 'D', 'affiliation': 'Institute for Risk Assessment Sciences, Division of Environmental Allergy.'}, {'lastname': 'van Rooy', 'firstname': 'Frits', 'initials': 'F', 'affiliation': 'Arbounie, Expert Center for Chemical Risk Management, Utrecht, The Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/ACI.0000000000000963', 'xml': <Element 'PubmedArticle' at 0x12528cdb0>}\n",
      "{'pubmed_id': '38359101', 'title': 'Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma.', 'abstract': 'To review the current state of knowledge on the relationship between allergic sensitization and asthma; to lay out a roadmap for the development of IgE biomarkers that differentiate, in individual sensitized patients, whether their sensitization is important for current or future asthma symptoms, or has little or no relevance to the disease.\\nThe evidence on the relationship between sensitization and asthma suggests that some subtypes of allergic sensitization are not associated with asthma symptoms, whilst others are pathologic. Interaction patterns between IgE antibodies to individual allergenic molecules on component-resolved diagnostics (CRD) multiplex arrays might be hallmarks by which different sensitization subtypes relevant to asthma can be distinguished. These different subtypes of sensitization are associated amongst sensitized individuals at all ages, with different clinical presentations (no disease, asthma as a single disease, and allergic multimorbidity); amongst sensitized preschool children with and without lower airway symptoms, with different risk of subsequent asthma development; and amongst sensitized patients with asthma, with differing levels of asthma severity.\\nThe use of machine learning-based methodologies on complex CRD data can help us to design better diagnostic tools to help practising physicians differentiate between benign and clinically important sensitization.', 'keywords': [], 'journal': 'Current opinion in allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Custovic', 'firstname': 'Adnan', 'initials': 'A', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Custovic', 'firstname': 'Darije', 'initials': 'D', 'affiliation': None}, {'lastname': 'Fontanella', 'firstname': 'Sara', 'initials': 'S', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.', 'doi': '10.1097/ACI.0000000000000967', 'xml': <Element 'PubmedArticle' at 0x10a7c5210>}\n",
      "{'pubmed_id': '38359086', 'title': \"Evaluation of the quality and content of YouTube videos as an educational resource in developing patients' inhaler use skills.\", 'abstract': '', 'keywords': ['YouTube', 'content', 'education', 'inhaler', 'patient', 'quality'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Canbolat', 'firstname': 'Ozlem', 'initials': 'O', 'affiliation': 'Faculty of Nursing, Gazi University, Ankara, Turkey.'}, {'lastname': 'DoganAktas', 'firstname': 'Ayse Buket', 'initials': 'AB', 'affiliation': 'Vocational School of Health Services, Balıkesir University, Balikesir, Turkey.'}, {'lastname': 'Sipal', 'firstname': 'Gulhayat', 'initials': 'G', 'affiliation': 'Ankara University Faculty of Medicine, Cebeci Research and Application Hospital, Ankara, Turkey.'}, {'lastname': 'Nurdan', 'firstname': 'Kokturk', 'initials': 'K', 'affiliation': 'Gazi University, Faculty of Medicine, Internal Medicine Ankara, Turkey.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/02770903.2024.2319846', 'xml': <Element 'PubmedArticle' at 0x10b236fc0>}\n",
      "{'pubmed_id': '38359083', 'title': 'The Turkish Adaptation of The Adherence to Asthma Medication Questionnaire.', 'abstract': '', 'keywords': ['Medication adherence', 'asthma', 'nurse', 'questionnaire', 'scale'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'İnan', 'firstname': 'Döndü Erdoğan', 'initials': 'DE', 'affiliation': '(Lecturer) Niğde Ömer Halisdemir University, Zubeyde Hanim Faculty of Health Sciences, Derbent Yerleşkesi, Atatürk Blv., 51200 Merkez/Niğde.'}, {'lastname': 'Polat', 'firstname': 'Ülkü', 'initials': 'Ü', 'affiliation': '(Ph.D. Proffesor) Gazi University, Nursing Faculty, Emek, 06490 Çankaya/Ankara/Turkey.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/02770903.2024.2319848', 'xml': <Element 'PubmedArticle' at 0x10a025fd0>}\n",
      "{'pubmed_id': '38358788', 'title': 'Early Diagnosis and Treatment of COPD: The Costs and Benefits of Case-Finding.', 'abstract': None, 'keywords': ['COPD', 'case finding', 'screening'], 'journal': 'American journal of respiratory and critical care medicine', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Aaron', 'firstname': 'Shawn D', 'initials': 'SD', 'affiliation': 'Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.'}, {'lastname': 'Montes de Oca', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Hospital Universitario de Caracas, 198370, Servicio de Neumonología , Caracas, Venezuela, Bolivarian Republic of; montesdeoca.maria@gmail.com.'}, {'lastname': 'Celli', 'firstname': 'Bartolome', 'initials': 'B', 'affiliation': \"Brigham and Women's Hospital, Pulmonary, Wellesley, Massachusetts, United States.\\nHarvard Medical School.\"}, {'lastname': 'Bhatt', 'firstname': 'Surya P', 'initials': 'SP', 'affiliation': 'University of Alabama at Birmingham, Pulmonary, Allergy and Critical Care Medicine, Birmingham, Alabama, United States.'}, {'lastname': 'Bourbeau', 'firstname': 'Jean', 'initials': 'J', 'affiliation': 'Montreal Chest Institute, CORE, Montreal, Quebec, Canada.\\nMcGill University Health Centre, 54473, Montreal, Quebec, Canada.'}, {'lastname': 'Criner', 'firstname': 'Gerard J', 'initials': 'GJ', 'affiliation': 'Temple University Hospital, Pulm & Crit Care Medicine, Philadelphia, Pennsylvania, United States.\\nLewis Katz School of Medicine at Temple University, 12314, Philadelphia, Pennsylvania, United States.'}, {'lastname': 'DeMeo', 'firstname': 'Dawn L', 'initials': 'DL', 'affiliation': 'Brigham and Womens, Channing Division of Network Medicine, Boston, Massachusetts, United States.'}, {'lastname': 'Halpin', 'firstname': 'David M G', 'initials': 'DMG', 'affiliation': 'University of Exeter College of Medicine, University of Exeter Medical School, Exeter, United Kingdom of Great Britain and Northern Ireland.\\nRoyal Devon and Exeter Hospital, 159028, Exeter, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Han', 'firstname': 'MeiLan K', 'initials': 'MK', 'affiliation': 'University of Michigan, 1259, Division of Pulmonary and Critical Care Medicine, Ann Arbor, Michigan, United States.'}, {'lastname': 'Hurst', 'firstname': 'John R', 'initials': 'JR', 'affiliation': 'University College London, 4919, UCL Respiratory, London, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Krishnan', 'firstname': 'Jamuna K', 'initials': 'JK', 'affiliation': 'Weill Cornell Medical College, Pulmonary and Critical Care Medicine, New York, New York, United States.'}, {'lastname': 'Mannino', 'firstname': 'David', 'initials': 'D', 'affiliation': 'University of Kentucky Medical Center, 12253, Medicine, Lexington, Kentucky, United States.'}, {'lastname': 'van Boven', 'firstname': 'Job F M', 'initials': 'JFM', 'affiliation': 'Universitair Medisch Centrum Groningen Groningen Research Institute for Asthma and COPD, 577277, Department of General Practice & Elderly Care Medicine, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, 10173, Department of Clinical Pharmacy & Pharmacology, Groningen, Netherlands.'}, {'lastname': 'Vogelmeier', 'firstname': 'Claus F', 'initials': 'CF', 'affiliation': 'University of Marburg, 9377, Department of Medicine, Pulmonary and Critical Care Medicine, Marburg, Hessen, Germany.'}, {'lastname': 'Wedzicha', 'firstname': 'Jadwiga A', 'initials': 'JA', 'affiliation': 'Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Yawn', 'firstname': 'Barbara P', 'initials': 'BP', 'affiliation': 'University of Minnesota Medical Center, 14400, Minneapolis, Minnesota, United States.'}, {'lastname': 'Martinez', 'firstname': 'Fernando J', 'initials': 'FJ', 'affiliation': 'Cornell Medical College, New York, New York, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1164/rccm.202311-2120PP', 'xml': <Element 'PubmedArticle' at 0x10a5b67f0>}\n",
      "{'pubmed_id': '38358481\\n15516669\\n25457152\\n12359002\\n2377175\\n26867532\\n7499674\\n12673517\\n15744168\\n25115684\\n24139829\\n7874602\\n22722650\\n31283524\\n19021722\\n23632872\\n22081096\\n17845417\\n23460742\\n27505432\\n2498214\\n27793411\\n26602749\\n30887524\\n32554970\\n26079606\\n25572562\\n31017109\\n26764559\\n27373988\\n12086371\\n34019148\\n26120539\\n29377177\\n27430124', 'title': '[Pitfalls in the diagnosis of house dust mite allergy].', 'abstract': 'House dust mite (HDM) is the most significant indoor allergen, responsible for not only many cases of rhinoconjunctivitis but also for many cases of bronchial asthma, rendering it of considerable socioeconomic relevance. Besides symptomatic treatment and avoidance measures, allergen immunotherapy (AIT) is crucial, as the only causal, disease-modifying therapeutic approach. However, high diagnostic certainty is essential for initiating AIT. The challenge in making a\\xa0correct diagnosis lies in interpreting the demonstrated HDM sensitization regarding its clinical relevance (clinically silent sensitization vs. allergy). While the risk of allergy increases with the level of IgE titers against HDM extract, Der p\\xa01, or Der p\\xa02, as well as with the breadth of the molecular sensitization profile against HDM components (Der p\\xa01, Der p\\xa02, Der p\\xa023), no threshold can be defined for the presence of allergy, nor can sensitization to a\\xa0specific component be confidently considered allergy inducing. It should be noted that at least in Southern Bavaria, the prevalence of Der p\\xa023 sensitization is too low to be considered a\\xa0major allergen, and Der p\\xa023 is not able to molecularly differentiate all HDM sensitizations when added to the two major allergens Der p\\xa01 and Der p\\xa02. Evidently, HDM possesses a\\xa0diverse profile of allergens, with some relevant ones possibly yet to be described. Unfortunately, patient history does not provide a\\xa0sufficient assessment of the clinical relevance of a\\xa0demonstrated HDM sensitization, necessitating allergen provocation testing before initiating AIT with HDM, despite the relatively large effort involved.\\nBei der Hausstaubmilbe (HSM) handelt es sich um das bedeutendste Innenraumallergen, das für viele Fälle nicht nur von Rhinoconjunctivitis allergica, sondern auch Asthma bronchiale verantwortlich und somit von erheblicher sozioökonomischer Relevanz ist. Neben symptomatischer Therapie und Karenzmaßnahmen ist v.\\u202fa. die Allergenimmuntherapie (AIT) als einziger kausaler, krankheitsmodifizierender Therapieansatz von großer Bedeutung. Für die Einleitung einer AIT ist allerdings eine hohe diagnostische Sicherheit unerlässlich. Die Schwierigkeit einer korrekten Diagnosestellung liegt darin, die nachgewiesene HSM-Sensibilisierung hinsichtlich ihrer klinischen Relevanz (klinisch stumme Sensibilisierung vs. Allergie) richtig zu interpretieren. Das Allergierisiko steigt zwar mit der Höhe des IgE-Titers gegen HSM-Extrakt, Der p\\xa01 oder Der p\\xa02, wie auch mit der Breite des molekularen Sensibilisierungsprofils gegen HSM-Komponenten (Der p\\xa01, Der p\\xa02, Der p\\xa023) an, jedoch kann weder bezüglich der Titer ein Schwellenwert für das Vorliegen einer Allergie definiert werden, noch kann eine Sensibilisierung gegen eine spezifische Komponente als sicher allergieauslösend bewertet werden. Zudem muss festgehalten werden, dass –\\xa0zumindest in Südbayern\\xa0– die Prävalenz der Der-p-23-Sensibilisierung zu niedrig ist, um als Majorallergen zu gelten, noch ist Der p\\xa023 als Ergänzung zu den beiden Majorallergenen Der p\\xa01 und Der p\\xa02 in der Lage, alle HSM-Sensibilisierungen molekular aufzulösen. Offensichtlich verfügt die HSM über ein sehr diverses Profil an Allergenen, von denen einige relevante noch nicht beschrieben zu sein scheinen. Auch anamnestische Angaben erlauben keine ausreichend sichere Bewertung der klinischen Relevanz einer nachgewiesenen HSM-Sensibilisierung, sodass –\\xa0trotz des relativ großen Aufwands\\xa0– vor Einleitung einer AIT mit HSM eine Allergen-Provokationstestung empfohlen werden muss.', 'keywords': ['Allergen nasal provocation test', 'Dermatophagoides pteronyssinus', 'Diagnostic techniques and procedures', 'House dust mite allergy', 'Molecular diagnostic testing'], 'journal': 'HNO', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Huber', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr.\\xa015, 81377, München, Deutschland.'}, {'lastname': 'Becker', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Klinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinik Tübingen, Tübingen, Deutschland.'}, {'lastname': 'Gröger', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr.\\xa015, 81377, München, Deutschland. moritz.groeger@med.uni-muenchen.de.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.\\n© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.', 'doi': '10.1007/s00106-024-01425-y\\n10.1183/09031936.04.00013904\\n10.1016/j.jaci.2014.10.012\\n10.1034/j.1398-9995.2002.23664.x\\n10.1056/NEJM199008233230802\\n10.2500/ajra.2016.30.4262\\n10.1016/S0091-6749(95)70256-3\\n10.1055/s-2003-38411\\n10.1097/01.MLG.0000149682.56426.6B\\n10.1097/ACI.0000000000000104\\n10.1016/j.jaci.2013.09.004\\n10.1111/j.1365-2222.1994.tb02741.x\\n10.1159/000337654\\n10.18176/jiaci.0431\\n10.1111/j.1365-2362.2008.02048.x\\n10.1007/s00405-013-2516-y\\n10.1007/s00405-011-1826-1\\n10.1111/j.1365-2222.2007.02786.x\\n10.4049/jimmunol.1202288\\n10.1159/000447694\\n10.1159/000234724\\n10.1016/j.jaci.2016.08.014\\n10.1111/cea.12680\\n10.1111/all.13776\\n10.1159/000508522\\n10.1016/j.imlet.2015.06.004\\n10.1016/j.alit.2014.08.004\\n10.18176/jiaci.0299\\n10.1111/all.12841\\n10.18176/jiaci.0048\\n10.1016/S1081-1206(10)61895-9\\n10.1007/s00405-021-06862-x\\n10.1007/s40629-014-0032-2\\n10.1007/s15007-013-0090-7\\n10.1111/all.13416\\n10.1111/all.12986', 'xml': <Element 'PubmedArticle' at 0x10a5b6610>}\n",
      "{'pubmed_id': '38358156\\n17503876\\n12091180\\n12917227\\n15640329\\n16778159\\n16825656\\n20413545\\n28571188\\n26435980\\n27445533\\n19070473\\n20957072\\n22106764', 'title': 'Study the association between spirometry based functional grading and six minute walk distance in chronic respiratory disease patients at a rural tertiary care centre of India.', 'abstract': 'Six-min walk test (6MWT) is easy to use, the least expensive, and a quick measure of physical function and it reflects the capacity to perform our day-to-day activities hence quality of life can be assessed with 6MWT. This study was planned to assess the role of 6MWT in chronic respiratory disease patients and its association with spirometry-based functional grading at a rural tertiary care center of northern India.\\nThis was a hospital-based cross-sectional study done between December 2019 and July 2021. In this study, 110 patients were included as per inclusion and exclusion criteria. 6MWT and spirometry were conducted as per the American Thoracic Society/European Research Society recommendation using Spiropalm 6MWT and the association between 6MWT and spirometry was assessed.\\nA total of 110 chronic respiratory disease patients were included in the study. There were 69 (63%) males while 41 (37%) were females. Among study participants, chronic obstructive pulmonary disease patients were the most common 48 (43.6%) patients, followed by asthma 28 (25.5%), posttuberculosis sequelae patients 22 (20%), interstitial lung disease 9 (8.2%), and bronchiectasis 3 (2.7%) patients were found. There was a significant positive correlation of 6-min walk distance (6MWD) and % predicted 6MWD with spirometric parameters, forced expiratory volume in 1 s (FEV\\nThe 6MWD traveled by chronic respiratory disease patients was significantly lower than the predicted 6MWD and 6MWD correlated with spirometric variables well. Therefore, it can conclude that 6MWT is a useful alternative of spirometry in the management of chronic respiratory disease patients in resource-limited settings.', 'keywords': ['6-min walk distance', '6-min walk test', 'chronic respiratory diseases', 'spirometry'], 'journal': 'Annals of African medicine', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Yadav', 'firstname': 'Prashant', 'initials': 'P', 'affiliation': 'Department of Respiratory Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}, {'lastname': 'Mishra', 'firstname': 'Ajay Kumar', 'initials': 'AK', 'affiliation': 'Department of Respiratory Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}, {'lastname': 'Kumar', 'firstname': 'Adesh', 'initials': 'A', 'affiliation': 'Department of Respiratory Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}, {'lastname': 'Gupta', 'firstname': 'Ashish Kumar', 'initials': 'AK', 'affiliation': 'Department of Respiratory Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}, {'lastname': 'Gautam', 'firstname': 'Aditya Kumar', 'initials': 'AK', 'affiliation': 'Department of Respiratory Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}, {'lastname': 'Singh', 'firstname': 'Naresh Pal', 'initials': 'NP', 'affiliation': 'Community Medicine, UP University of Medical Sciences, Etawah, Uttar Pradesh, India.'}], 'methods': None, 'conclusions': 'The 6MWD traveled by chronic respiratory disease patients was significantly lower than the predicted 6MWD and 6MWD correlated with spirometric variables well. Therefore, it can conclude that 6MWT is a useful alternative of spirometry in the management of chronic respiratory disease patients in resource-limited settings.', 'results': 'A total of 110 chronic respiratory disease patients were included in the study. There were 69 (63%) males while 41 (37%) were females. Among study participants, chronic obstructive pulmonary disease patients were the most common 48 (43.6%) patients, followed by asthma 28 (25.5%), posttuberculosis sequelae patients 22 (20%), interstitial lung disease 9 (8.2%), and bronchiectasis 3 (2.7%) patients were found. There was a significant positive correlation of 6-min walk distance (6MWD) and % predicted 6MWD with spirometric parameters, forced expiratory volume in 1 s (FEV', 'copyrights': None, 'doi': '10.4103/aam.aam_19_23', 'xml': <Element 'PubmedArticle' at 0x109bbae30>}\n",
      "{'pubmed_id': '38358039', 'title': 'Allergen immunotherapy in patients with severe asthma: A need for prospective trials.', 'abstract': None, 'keywords': ['allergy shots', 'clinical trials'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Huntwork', 'firstname': 'Margaret P', 'initials': 'MP', 'affiliation': 'Tulane University School of Medicine, New Orleans, Louisiana, USA.'}, {'lastname': 'Carlson', 'firstname': 'John C', 'initials': 'JC', 'affiliation': 'Ochsner Health System, New Orleans, Louisiana, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1002/ppul.26918', 'xml': <Element 'PubmedArticle' at 0x10a4d2750>}\n",
      "{'pubmed_id': '38358037', 'title': 'Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia.', 'abstract': \"Respiratory syncytial virus infection is the leading cause of lower respiratory infection globally. Recently, nirsevimab has been approved to prevent respiratory syncytial virus (RSV) infection. This study explores the economically justifiable price of nirsevimab for preventing RSV infection in Colombia's children under 1 year of age.\\nA static model was developed using the decision tree microsimulation to estimate the quality-adjusted costs and life years of two interventions: a single intramuscular dose of nirsevimab versus not applying nirsevimab. This analysis was made during a time horizon of 1 year and from a societal perspective.\\nThe annual savings in Colombia associated with this cost per dose ranged from U$ 2.5 to 4.1 million. Based on thresholds of U$ 4828, U$ 5128, and U$ 19 992 per QALY evaluated in this study, we established economically justifiable drug acquisition prices of U$ 21.88, U$ 25.04, and U$ 44.02 per dose of nirsevimab.\\nthe economically justifiable cost for nirsevimab in Colombia is between U$ 21 to U$ 44 per dose, depending on the willingness to pay used to decide its implementation. This result should encourage more studies in the region that optimize decision-making processes when incorporating this drug into the health plans of each country.\", 'keywords': ['TB', 'asthma and early wheeze', 'cost', 'epidemiology', 'infections: pneumonia', 'nirsevimab', 'respiratory syncytial virus', 'viral'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Buendía', 'firstname': 'Jefferson Antonio', 'initials': 'JA', 'affiliation': 'Departamento de Farmacología y Toxicología, Facultad de Medicina, Grupo de Investigación en Farmacología y Toxicología, Universidad de Antioquia, Medellín, Colombia.'}, {'lastname': 'Acuña-Cordero', 'firstname': 'Ranniery', 'initials': 'R', 'affiliation': 'Departamento de Neumología Pediátrica, Hospital Militar Central, Departamento de Pediatría, Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, Colombia.'}, {'lastname': 'Rodriguez-Martinez', 'firstname': 'Carlos E', 'initials': 'CE', 'affiliation': 'Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.'}], 'methods': None, 'conclusions': 'the economically justifiable cost for nirsevimab in Colombia is between U$ 21 to U$ 44 per dose, depending on the willingness to pay used to decide its implementation. This result should encourage more studies in the region that optimize decision-making processes when incorporating this drug into the health plans of each country.', 'results': 'The annual savings in Colombia associated with this cost per dose ranged from U$ 2.5 to 4.1 million. Based on thresholds of U$ 4828, U$ 5128, and U$ 19 992 per QALY evaluated in this study, we established economically justifiable drug acquisition prices of U$ 21.88, U$ 25.04, and U$ 44.02 per dose of nirsevimab.', 'copyrights': '© 2024 Wiley Periodicals LLC.', 'doi': '10.1002/ppul.26920', 'xml': <Element 'PubmedArticle' at 0x10a4d0040>}\n",
      "{'pubmed_id': '38357871', 'title': 'Medicaid Expansion and Health Care Use Among Adults With Asthma and Low Incomes: The Adult Asthma Call-Back Survey.', 'abstract': 'Asthma disproportionately affects Black people and people with low incomes, but Medicaid expansion (hereinafter, expansion) data on these populations are limited. We investigated health care use among adults with asthma, before and after expansion, and examined whether asthma-related health care use after expansion varied by demographic characteristics.\\nWe analyzed data from the 2011-2013 and 2015-2019 Behavioral Risk Factor Surveillance System Adult Asthma Call-Back Survey on participants aged 18-64 years with current asthma and low incomes in 23 US states. We assessed 5 asthma-related outcomes, including medical visits (routine and emergency) and medication use, for expansion and nonexpansion groups. We used \\nPrimary analyses (N = 10 796) found no significant associations between expansion and any outcome. Analyses stratified by race and ethnicity found no significant changes (eg, asthma controller medication use among non-Hispanic Black participants in the expansion group was 24.1% [95% CI, 14.4%-37.5%] in 2011-2013 and 35.5% [95% CI, 27.0%-45.1%] in 2015-2019; \\nInvestigating factors other than health insurance (eg, social determinants of health) that influence the use of asthma-related health care could advance knowledge of potential strategies to advance health equity for adults with asthma and lower incomes.', 'keywords': ['Medicaid', 'asthma', 'disparities', 'health equity', 'race and ethnicity'], 'journal': 'Public health reports (Washington, D.C. : 1974)', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Qin', 'firstname': 'Xiaoting', 'initials': 'X', 'affiliation': 'Asthma and Air Quality Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.'}, {'lastname': 'Mirabelli', 'firstname': 'Maria C', 'initials': 'MC', 'affiliation': 'Asthma and Air Quality Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.'}, {'lastname': 'Flanders', 'firstname': 'W Dana', 'initials': 'WD', 'affiliation': 'Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.'}, {'lastname': 'Hsu', 'firstname': 'Joy', 'initials': 'J', 'affiliation': 'Asthma and Air Quality Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.'}], 'methods': None, 'conclusions': None, 'results': 'Primary analyses (N = 10 796) found no significant associations between expansion and any outcome. Analyses stratified by race and ethnicity found no significant changes (eg, asthma controller medication use among non-Hispanic Black participants in the expansion group was 24.1% [95% CI, 14.4%-37.5%] in 2011-2013 and 35.5% [95% CI, 27.0%-45.1%] in 2015-2019; ', 'copyrights': None, 'doi': '10.1177/00333549241228501', 'xml': <Element 'PubmedArticle' at 0x109675030>}\n",
      "{'pubmed_id': '38357755', 'title': 'Evaluation of two different remineralising toothpastes in children with drug-controlled asthma and allergic rhinitis: a randomised clinical trial.', 'abstract': \"To compare the efficacy of two remineralising toothpastes in children suffering from asthma and allergic rhinitis after a 6-month study.\\n40 patients aged between 6-14 years with enamel demineralisations were enrolled for the study at the Unit of Dental Hygiene of the University of Pavia (Italy). The following indices were collected: Schiff air index (SAI), plaque index (PI), bleeding on probing (BoP), salivary pH, Basic Erosive Wear Examination (BEWE), susceptibility index (SI) for hard and soft tissues' pathologies, and decayed missing filled teeth (DMFT). After mechanical debridement with piezoelectric instrumentation and glycine powder, patients were equally divided into two groups: Group 1 using a toothpaste with zinc hydroxyapatite, and Group 2 using a toothpaste containing calcium sodium phosphosilicate. The toothpaste had to be used twice a day. The time frames of the study were: baseline (T0), after 1 month (T1), after 3 months (T2), after 6 months (T3).\\nThe tested toothpastes can be proposed for home use in children with asthma and allergic rhinitis as they significantly reduced dental sensitivity and periodontal indices.\", 'keywords': [], 'journal': 'European journal of paediatric dentistry', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Scribante', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy - Unit of Orthodontics and Paediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.'}, {'lastname': 'Pascadopoli', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Unit of Orthodontics and Paediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.'}, {'lastname': 'Bergomi', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.'}, {'lastname': 'Licari', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy - Paediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.'}, {'lastname': 'Marseglia', 'firstname': 'G L', 'initials': 'GL', 'affiliation': 'Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy - Paediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.'}, {'lastname': 'Bizzi', 'firstname': 'F M', 'initials': 'FM', 'affiliation': 'Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy.'}, {'lastname': 'Butera', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy.'}], 'methods': None, 'conclusions': 'The tested toothpastes can be proposed for home use in children with asthma and allergic rhinitis as they significantly reduced dental sensitivity and periodontal indices.', 'results': None, 'copyrights': None, 'doi': '10.23804/ejpd.2024.2130', 'xml': <Element 'PubmedArticle' at 0x10afd1120>}\n",
      "{'pubmed_id': '38357399\\n37356446\\n29650248\\n26599154\\n18579551\\n22561964\\n17311843\\n31553837\\n29611719\\n28751416\\n25675282\\n24219412\\n23392440\\n30282634\\n33664099\\n29150410\\n32092320\\n36701677\\n26250499\\n26160874\\n18252918\\n32982210\\n24200283\\n32979314\\n32598906\\n24488571\\n20871122\\n26978269\\n36102236\\n30165984\\n21653926\\n37311251\\n35861464\\n27061878\\n15249443\\n33863744\\n21297068\\n26343936\\n10899238\\n36483008\\n33157415\\n36464040\\n37385629\\n28784329\\n31553836\\n26154786\\n32289231\\n32972984\\n31000131\\n30765254', 'title': 'Sociodemographic correlates with prevalence of comorbidities in patients with chronic obstructive pulmonary disease: a study from a Chinese National Survey.', 'abstract': 'An increase in the prevalence of comorbidities has been reported in patients with chronic obstructive pulmonary disease (COPD). However, contemporary estimates of the overall prevalence of the sociodemographic correlates of COPD comorbidities are scarce and inconsistent in China. This study aimed to investigate the prevalence of sociodemographic correlates of comorbidities in patients with COPD across China.\\nThis was a cross-sectional study. We used data from the Enjoying Breathing Program between May 2020 and April 2022. Participants with COPD from 17 provinces (or equivalent) were included. Comorbidity clusters were stratified based on the number of comorbidities per person. Univariable and multivariable analyses were used to determine the sociodemographic associations of patients with COPD with specific clusters of comorbidities after adjusting for age, sex, and other prespecified covariates. Tetrachoric correlation analyses were performed to determine the associations between specific comorbidities.\\nA total of 3913 participants with COPD were included, of whom 1744 (44.7%) had at least one comorbidity; 25.4% had one comorbid disease, 12.9% had two, and 6.4% had three or more concurrent diseases. The most common comorbidities were hypertension (17.8%), asthma (9.9%), bronchiectasis (8.2%), diabetes (8.2%), and coronary artery disease (7.7%). In the logistic regression models adjusted for a broad set of factors, patients with COPD residing in the east region of China and having health insurance experienced a decreased likelihood of comorbidities (from OR\\xa0=\\xa00.70 [95% confidence interval [CI], 0.53-0.93] to OR\\xa0=\\xa00.50 [95% CI, 0.25-0.99]). However, patients over 80 years had increased risk (OR 1.43 [95% CI 1.01-2.03]), as did those in all Modified Medical Research Council (mMRC) grade categories (grade 1: OR\\xa0=\\xa01.30 [95% CI, 1.02-1.65]; grade 2: OR\\xa0=\\xa01.39 [95% CI, 1.07-1.8]; grade 3: OR\\xa0=\\xa01.67 [95% CI, 1.23-2.26]; and grade 4: OR\\xa0=\\xa01.81 [95% CI, 1.00-3.28]) and in Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2 classification (OR\\xa0=\\xa01.30 [95% CI, 1.03-1.65]) relative to their respective references. The associations observed in these subgroups were consistent regardless of the number of comorbidities per person. Tetrachoric correlations demonstrated negative associations in pairwise comparisons of the top five comorbidities, ranging from\\xa0-0.03 to\\xa0-0.31 (p\\xa0<\\xa00.001 in all groups).\\nIn China, comorbidities are highly prevalent among patients with COPD, with older age, higher mMRC grade, and lung function decline being the major risk factors. Studies with larger sample sizes are required to elucidate the complex mechanisms underlying COPD comorbidities.\\nThis study was funded by CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-049 and 2022-I2M-C&T-B-107).', 'keywords': ['Chronic obstructive pulmonary disease', 'Comorbidity', 'Prevalence'], 'journal': 'The Lancet regional health. Western Pacific', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Huang', 'firstname': 'Ke', 'initials': 'K', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Zheng', 'firstname': 'Zhoude', 'initials': 'Z', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.\\nPeking University China-Japan Friendship School of Clinical Medicine, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Niu', 'firstname': 'Hongtao', 'initials': 'H', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Lei', 'firstname': 'Jieping', 'initials': 'J', 'affiliation': 'Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Dong', 'firstname': 'Fen', 'initials': 'F', 'affiliation': 'Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Yang', 'firstname': 'Ting', 'initials': 'T', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.\\nSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 The Author(s).', 'doi': '10.1016/j.lanwpc.2023.100937', 'xml': <Element 'PubmedArticle' at 0x10afd2980>}\n",
      "{'pubmed_id': '38357283\\n31917152\\n28947075\\n26841800\\n33285579\\n28019026\\n22517680\\n18708586\\n24098382\\n25416380\\n31530895\\n31626791\\n33860179\\n35546383\\n33486786\\n7996545\\n17000863\\n11172168\\n23140569\\n19575684\\n21682737\\n35695515\\n29619377\\n24931609\\n32876692\\n34845229\\n15380933\\n29283260\\n15192232\\n19286931\\n23831616\\n26296094\\n34066250\\n29233108\\n24290289\\n35628512\\n27957324\\n19360123\\n23924659\\n27043409\\n23552798\\n30865303\\n19228260\\n25038996\\n21034223\\n30102081\\n22561832\\n34195595\\n33792403\\n19345318\\n22293022\\n9309991\\n19615378\\n31105836\\n32627074\\n23407781\\n32433580\\n31373289\\n38057718\\n25605792\\n30476243\\n33237311\\n31114916', 'title': 'Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression.', 'abstract': 'Functional selectivity in the context of serotonin 2A (5-HT', 'keywords': [], 'journal': 'ACS pharmacology & translational science', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Flanagan', 'firstname': 'Thomas W', 'initials': 'TW', 'affiliation': 'Department of Pharmacology and Experimental TherapeuticsLouisiana State University Health Sciences CenterNew Orleans, Louisiana70112, United States.'}, {'lastname': 'Foster', 'firstname': 'Timothy P', 'initials': 'TP', 'affiliation': 'Department of Microbiology, Immunology, and ParasitologyLouisiana State University Health Sciences CenterNew Orleans, Louisiana70112, United States.'}, {'lastname': 'Galbato', 'firstname': 'Thomas E', 'initials': 'TE', 'affiliation': 'Department of Microbiology, Immunology, and ParasitologyLouisiana State University Health Sciences CenterNew Orleans, Louisiana70112, United States.'}, {'lastname': 'Lum', 'firstname': 'Pek Yee', 'initials': 'PY', 'affiliation': 'Auransa Inc.Palo Alto, California94301, United States.'}, {'lastname': 'Louie', 'firstname': 'Brent', 'initials': 'B', 'affiliation': 'Auransa Inc.Palo Alto, California94301, United States.'}, {'lastname': 'Song', 'firstname': 'Gavin', 'initials': 'G', 'affiliation': 'Auransa Inc.Palo Alto, California94301, United States.'}, {'lastname': 'Halberstadt', 'firstname': 'Adam L', 'initials': 'AL', 'affiliation': 'Department of PsychiatryUniversity of San Diego, California, San Diego, California92093, United States.'}, {'lastname': 'Billac', 'firstname': 'Gerald B', 'initials': 'GB', 'affiliation': 'Department of Pharmacology and Experimental TherapeuticsLouisiana State University Health Sciences CenterNew Orleans, Louisiana70112, United States.'}, {'lastname': 'Nichols', 'firstname': 'Charles D', 'initials': 'CD', 'affiliation': 'Department of Pharmacology and Experimental TherapeuticsLouisiana State University Health Sciences CenterNew Orleans, Louisiana70112, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 American Chemical Society.', 'doi': '10.1021/acsptsci.3c00297\\n10.1016/j.neuropharm.2019.107933\\n10.1016/j.tips.2017.08.003\\n10.1124/pr.115.011478\\n10.1055/a-1310-3990\\n10.1002/cpt.557\\n10.1002/dta.1333\\n10.1124/jpet.108.143461\\n10.1371/journal.pone.0075426\\n10.1152/ajplung.00138.2013\\n10.1038/s41598-019-49987-0\\n10.1016/j.lfs.2019.116790\\n10.1021/acsptsci.0c00063\\n10.1007/7854_2022_367\\n10.1111/all.14748\\n10.1021/jm00051a011\\n10.1124/mol.106.028720\\n10.1056/NEJM200102013440507\\n10.2174/187221313804004682\\n10.1146/annurev.physiol.010908.163200\\n10.1111/j.1600-065X.2011.01020.x\\n10.1042/BCJ20220075\\n10.1155/2018/7969068\\n10.1016/j.celrep.2014.05.030\\n10.1083/jcb.201911049\\n10.1038/s41467-021-27124-8\\n10.1016/j.tips.2004.08.002\\n10.1021/acs.jmedchem.7b01051\\n10.1126/science.1095336\\n10.1152/ajplung.00025.2009\\n10.1152/ajplung.00341.2012\\n10.1586/17476348.2015.1081064\\n10.3390/ijms22105133\\n10.1186/s12890-017-0515-2\\n10.1016/j.jaci.2013.09.040\\n10.3390/ijms23105703\\n10.1002/iid3.104\\n10.1371/journal.ppat.1000371\\n10.1189/jlb.0213084\\n10.1038/ni.3421\\n10.1038/jid.2013.164\\n10.1111/all.13770\\n10.1111/j.1582-4934.2009.00707.x\\n10.1007/978-3-319-07320-0_9\\n10.1146/annurev-pathol-011110-130138\\n10.1080/09540261.2018.1481827\\n10.1038/nm.2737\\n10.1016/j.mbplus.2021.100058\\n10.1152/japplphysiol.00554.2020\\n10.1016/j.tcm.2009.01.003\\n10.1016/j.tcm.2011.11.005\\n10.1164/ajrccm.156.3.9606031\\n10.1016/j.yjmcc.2009.07.005\\n10.1007/s00204-020-02836-w\\n10.1007/s00213-013-3006-z\\n10.1038/s41598-020-65264-x\\n10.3390/ijms20143401\\n10.1186/s12859-023-05578-5\\n10.1093/nar/gkv007\\n10.1093/nar/gky1131\\n10.1093/nar/gkaa1074\\n10.1093/nar/gkz401', 'xml': <Element 'PubmedArticle' at 0x10a5d5bc0>}\n",
      "{'pubmed_id': '38357136\\n25519785\\n28797514\\n24382846\\n25853516\\n28464036\\n29361510\\n29752346\\n28482967\\n30745247\\n8970487\\n27574988\\n30810421\\n31613151\\n29108757\\n31949118\\n32054641\\n26216220\\n31278168\\n31048346\\n31949111\\n23510684\\n28286157\\n31559008', 'title': 'Factors associated with poor asthma symptom control in adult Angolan regularly seen at an outpatient respiratory clinic.', 'abstract': \"Asthma is one of the most common chronic respiratory diseases and one of the most frequent causes of hospital care.\\nTo describe the clinical characteristics of asthma and factors associated with its control.\\nA cross-sectional study was conducted at the Military Hospital in Luanda, from April 2018 to March 2019. Data collection was performed using questionnaires on asthma symptoms and treatment, socio-demographic and environmental questions, and a Global Initiative for Asthma (GINA) questionnaire to assess the level of asthma control. Ordinal logistic regression analyses were performed. We estimated odds ratios, for higher categories of asthma control. P<0.05 was considered significant.\\nThe sample consisted of 305 asthmatics ≥18-years-old, 56% women, with a mean age of 41.3 years. About 28% of patients had controlled asthma, 36% partially controlled and 35% uncontrolled. Poor asthma control was associated with frequent use of short-acting beta-2 agonists [OR 5.70 (95%CI 2.37;13.7)], oral corticosteroids [OR 3.68 (95%CI 2.24;6.04)], and incorrect inhaler technique [OR 4.08 (95%CI 1.25;13.3)].\\nA significant number of adults living in Luanda have uncontrolled asthma due to the under-use of inhaled corticosteroid therapy. It is necessary to develop strategic management and prevention plans to improve Angolan asthmatics' medical care.\", 'keywords': ['Angola', 'Asthma', 'inhalers', 'symptom control'], 'journal': 'African health sciences', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Arrais', 'firstname': 'Margarete L T', 'initials': 'MLT', 'affiliation': 'Department of Pulmonology, Military Hospital Luanda, Angola.\\nCentro de Investigação em Saúde de Angola - CISA, Caxito, Bengo, Angola.'}, {'lastname': 'Maricoto', 'firstname': 'Tiago J P', 'initials': 'TJP', 'affiliation': 'Aveiro Healthcare Centre, Aradas Family Health Unit, Aveiro, Portugal.\\nFaculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.\\nUBIAir - Clinical & Experimental Lung Centre, UBIMedical, University of Beira Interior, Covilhã, Portugal.'}, {'lastname': 'Lulua', 'firstname': 'Ofélia M', 'initials': 'OM', 'affiliation': 'Department of Pulmonology, Military Hospital Luanda, Angola.'}, {'lastname': 'Quifica', 'firstname': 'Francisca G S', 'initials': 'FGS', 'affiliation': 'Department of Pulmonology, Military Hospital Luanda, Angola.'}, {'lastname': 'Gama', 'firstname': 'Jorge M R', 'initials': 'JMR', 'affiliation': 'Centre of Mathematics and Applications, Faculty of Sciences, University of Beira Interior, Covilhã, Portugal.'}, {'lastname': 'Brito', 'firstname': 'Miguel D', 'initials': 'MD', 'affiliation': 'Centro de Investigação em Saúde de Angola - CISA, Caxito, Bengo, Angola.\\nHealth and Technology Research Centre - H&TRC, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Portugal.'}, {'lastname': 'Taborda-Barata', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.\\nUBIAir - Clinical & Experimental Lung Centre, UBIMedical, University of Beira Interior, Covilhã, Portugal.\\nDepartment of Allergy & Clinical Immunology, Cova da Beira University Hospital Centre, Covilhã, Portugal.'}], 'methods': None, 'conclusions': None, 'results': 'The sample consisted of 305 asthmatics ≥18-years-old, 56% women, with a mean age of 41.3 years. About 28% of patients had controlled asthma, 36% partially controlled and 35% uncontrolled. Poor asthma control was associated with frequent use of short-acting beta-2 agonists [OR 5.70 (95%CI 2.37;13.7)], oral corticosteroids [OR 3.68 (95%CI 2.24;6.04)], and incorrect inhaler technique [OR 4.08 (95%CI 1.25;13.3)].', 'copyrights': '© 2023 Arrais MLT et al.', 'doi': '10.4314/ahs.v23i3.78\\n10.1016/j.jaip.2017.11.032\\n10.1080/02770903.2019.1582063\\n10.1016/j.arbr.2018.01.014\\n10.1183/13993003.01831-2019\\n10.1186/s12890-015-0080-5\\n10.1183/13993003.00491-2019\\n10.1183/13993003.01872-2019\\n10.1186/s13601-019-0286-3', 'xml': <Element 'PubmedArticle' at 0x109f414e0>}\n",
      "{'pubmed_id': '38356668\\n17595277\\n15845336\\n23878802\\n23697835\\n25632930\\n33485903\\n24965208\\n27815534\\n29466173\\n21168405\\n28018919\\n32670176\\n21709277\\n28082463\\n28280903\\n22829805\\n23321698\\n24937532\\n31091851\\n28382463\\n24412919\\n25487473\\n22167021\\n24569080\\n25450715\\n22266786\\n22374434\\n23465054\\n25501551\\n25403145\\n30981701\\n28110885\\n26901347\\n21917308\\n27059796\\n22895815\\n30046607\\n31520422\\n26910006\\n23315173\\n22019057\\n32384924\\n27793495\\n15145345\\n21592778\\n20614100\\n19255566\\n25537714\\n24357215\\n24315621\\n29392352\\n26132277\\n17462994\\n22539037\\n19289822\\n29257914\\n21146880\\n35194770\\n15538371\\n36481963\\n24146179\\n30939839\\n30551536\\n28446969\\n33022373\\n32952941\\n33460581\\n26734643\\n28123459\\n27313801\\n25344195\\n24481529\\n23839576\\n18288184\\n35806173\\n21146323\\n23707860\\n26641319\\n27801781\\n33334622\\n32861550\\n34360904\\n33127832\\n19914515\\n29604222\\n17661405\\n31832574\\n28355202\\n25238119\\n28083843\\n34546403\\n36644163\\n34353423\\n26795543\\n25625579\\n31703832\\n29273246\\n35656293\\n25780877\\n26422695\\n31099080\\n28948946\\n28658543\\n32101904\\n30394902\\n33488613\\n33357010\\n33132251\\n24427167\\n24772440\\n34215386\\n31773374\\n28676013\\n28104433\\n30321815\\n35088379\\n17595275\\n35303998\\n32331346\\n35642640\\n26869172', 'title': 'MicroRNAs in chronic pediatric diseases (Review).', 'abstract': \"MicroRNAs are small non-coding RNAs with a length of 20-24 nucleotides. They bind to the 3'-untranslated region of target genes to induce the degradation of target mRNAs or inhibit their translation. Therefore, they are involved in the regulation of development, apoptosis, proliferation, differentiation and other biological processes (including hormone secretion, signaling and viral infections). Chronic diseases in children may be difficult to treat and are often associated with malnutrition resulting from a poor diet. Consequently, further complications, disease aggravation and increased treatment costs impose a burden on patients and their families. Existing evidence suggests that microRNAs are involved in various chronic non-neoplastic diseases in children. The present review discusses the roles of microRNAs in five major chronic diseases in children, namely, diabetes mellitus, congenital heart diseases, liver diseases, bronchial asthma and epilepsy, providing a theoretical basis for them to become therapeutic biomarkers in chronic pediatric diseases.\", 'keywords': ['childhood asthma', 'chronic childhood diseases', 'congenital heart disease', 'diabetes', 'epilepsy', 'microRNAs'], 'journal': 'Experimental and therapeutic medicine', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Zhang', 'firstname': 'Mingyao', 'initials': 'M', 'affiliation': 'Department of Pediatrics, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.'}, {'lastname': 'Han', 'firstname': 'Yanhua', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © Zhang and Han.', 'doi': '10.3892/etm.2024.12388\\n10.1001/jama.297.24.2755\\n10.1016/j.jclinepi.2004.09.010\\n10.1155/2013/291826\\n10.1021/cr300362f\\n10.1055/s-0034-1397344\\n10.1016/j.cca.2021.01.008\\n10.1016/j.semcdb.2014.05.015\\n10.1152/physiolgenomics.00079.2016\\n10.18087/cardio.2018.1.10083\\n10.1016/j.yexmp.2010.12.002\\n10.1155/2016/9869208\\n10.3389/fneur.2020.00462\\n10.2337/db11-0171\\n10.1373/clinchem.2016.267625\\n10.1007/s00125-017-4237-z\\n10.1155/2012/896362\\n10.1210/en.2012-1744\\n10.1210/jc.2013-3868\\n10.31083/j.jin.2019.01.13\\n10.1007/s00246-017-1607-8\\n10.1016/j.cellsig.2014.01.003\\n10.1016/j.jpedsurg.2014.09.009\\n10.1097/MPG.0b013e318244148b\\n10.1016/j.bbrc.2014.02.065\\n10.1016/j.jhep.2014.10.033\\n10.3892/ijmm.2012.888\\n10.1007/s10495-012-0704-7\\n10.1111/ajt.12183\\n10.1152/ajpgi.00346.2014\\n10.1038/ncomms6408\\n10.1016/j.clinbiochem.2019.04.007\\n10.1016/j.cellimm.2017.01.005\\n10.1371/journal.pone.0148821\\n10.1016/j.jaci.2011.08.011\\n10.1111/all.12907\\n10.3892/mmr.2012.1030\\n10.1155/2018/7632487\\n10.1111/cea.13498\\n10.4238/gmr.15017798\\n10.1007/s12031-013-9953-3\\n10.1016/j.brainres.2011.09.039\\n10.1186/s13000-020-00944-w\\n10.1016/j.tplants.2016.09.003\\n10.1016/j.ceb.2004.04.003\\n10.1016/j.gde.2011.04.010\\n10.1007/s00109-010-0650-1\\n10.1038/ncb0309-228\\n10.2337/dc15-S005\\n10.2337/dc14-S081\\n10.1016/S0140-6736(13)62219-9\\n10.1007/s00125-018-4557-7\\n10.1074/jbc.M611841200\\n10.1210/me.2011-1205\\n10.1073/pnas.0810550106\\n10.1080/14728222.2018.1420168\\n10.1016/j.diabres.2010.11.006\\n10.1007/s12020-022-03016-9\\n10.1038/nature03076\\n10.1007/s12519-022-00654-x\\n10.1007/s12519-013-0434-0\\n10.3390/jcdd6020015\\n10.1016/j.biopha.2018.10.110\\n10.21037/jtd.2017.03.149\\n10.1016/j.carpath.2020.107296\\n10.22038/ijbms.2020.40974.10015\\n10.1016/j.abb.2021.108763\\n10.3978/j.issn.2305-5839.2015.12.25\\n10.3892/etm.2016.3932\\n10.5847/wjem.j.1920-8642.2016.02.001\\n10.1038/cr.2014.12\\n10.1038/nrm3619\\n10.1038/nature06801\\n10.3390/ijms23137167\\n10.1016/j.mehy.2010.11.010\\n10.1016/j.cca.2013.05.010\\n10.1586/17474124.2016.1129274\\n10.3390/ijms17111795\\n10.1016/j.arcmed.2020.11.010\\n10.1016/j.jfma.2020.08.019\\n10.3390/ijms22158139\\n10.1136/gutjnl-2020-322526\\n10.1016/S0140-6736(09)60946-6\\n10.1002/hep.29905\\n10.1002/hep.21790\\n10.1002/hep4.1433\\n10.1038/pr.2017.87\\n10.1097/MPG.0000000000000573\\n10.1007/s10620-016-4411-z\\n10.1007/s00383-021-05009-7\\n10.1155/2023/4835839\\n10.3967/bes2021.080\\n10.1016/j.dld.2015.11.014\\n10.1097/MPG.0000000000000600\\n10.1016/j.smim.2019.101333\\n10.1016/S0140-6736(17)33311-1\\n10.3389/fphar.2022.856104\\n10.1002/ppul.23331\\n10.1002/jcp.28781\\n10.4103/ijmr.IJMR_420_17\\n10.1111/imr.12549\\n10.1097/MCP.0000000000000673\\n10.1097/MCP.0000000000000532\\n10.3389/fimmu.2020.608666\\n10.1177/1753466620981863\\n10.1254/fpj.20053\\n10.3389/fgene.2013.00307\\n10.1155/2014/945169\\n10.1016/j.ncl.2021.04.002\\n10.1007/s11064-019-02917-y\\n10.2174/1570159X15666170703102410\\n10.1016/j.neulet.2017.01.017\\n10.1016/j.omtn.2018.09.008\\n10.1007/s11033-022-07188-5\\n10.1001/jama.297.24.2741\\n10.1016/j.tig.2022.02.006\\n10.3390/cells9041044\\n10.1172/JCI159179\\n10.1002/ejhf.495', 'xml': <Element 'PubmedArticle' at 0x109693e70>}\n",
      "{'pubmed_id': '38356163', 'title': 'Feasibility of Constant Work Rate Testing to Detect Exercise-Induced Laryngeal Obstruction.', 'abstract': 'Exercise-induced laryngeal obstruction (EILO) is a condition in which laryngeal structures inappropriately obstruct the upper airway during exercise. The standard diagnostic test for EILO is the continuous laryngoscopy during exercise (CLE) test, usually performed with an incremental work rate protocol regardless of the nature of the triggering event. Typically, laryngeal obstruction occurs only briefly at the end of an incremental test, near peak work capacity. We aimed to investigate constant work rate (CWR) protocols for CLE testing to expand diagnostic test modalities and improve the understanding of EILO.\\nIn this prospective, self-controlled feasibility study, 10 patients with EILO performed both an incremental and a CWR CLE test at 70%, 80%, and 90% of maximal exercise capacity. Laryngoscopic video data were recorded and compared, and we evaluated the ability of CWR to reproduce the symptoms and laryngeal obstruction seen in incremental testing.\\nIn 70%-90% of cases, CWR testing induced at least the same severity of obstruction as incremental testing and CLE scores remained comparable across test modalities. CWR at 70% allowed observation of laryngeal obstruction for a significantly longer duration than in incremental testing (158 s; 95% confidence interval, 25-291 s; P = 0.027). Dyspnea intensity appeared higher during CWR testing compared with incremental testing.\\nSubmaximal CWR CLE testing is feasible and able to induce EILO equivalent to the standard incremental CLE test. This is the first step toward tailored CLE exercise protocols, and further studies are now needed to establish the utility of CWR in clinical and research settings.', 'keywords': [], 'journal': 'Medicine and science in sports and exercise', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Thougaard', 'firstname': 'Jens', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, DENMARK.'}, {'lastname': 'Pedersen', 'firstname': 'Lars', 'initials': 'L', 'affiliation': None}, {'lastname': 'Walsted', 'firstname': 'Emil', 'initials': 'E', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'In 70%-90% of cases, CWR testing induced at least the same severity of obstruction as incremental testing and CLE scores remained comparable across test modalities. CWR at 70% allowed observation of laryngeal obstruction for a significantly longer duration than in incremental testing (158 s; 95% confidence interval, 25-291 s; P = 0.027). Dyspnea intensity appeared higher during CWR testing compared with incremental testing.', 'copyrights': 'Copyright © 2023 by the American College of Sports Medicine.', 'doi': '10.1249/MSS.0000000000003319', 'xml': <Element 'PubmedArticle' at 0x1096615d0>}\n",
      "{'pubmed_id': '38356031\\n28730933\\n14616418\\n30634631\\n31815554\\n29678544\\n15481287\\n31377981\\n24357110\\n28536654\\n23499756\\n20223286\\n17084567\\n24440344\\n24841045\\n26794744\\n26998555\\n35560136\\n17561423\\n22036988\\n23389937\\n18281169\\n23905970\\n23178339\\n21575719\\n21839157\\n29691812\\n26142249\\n20093186\\n33946414\\n30025210\\n24732364\\n27061412\\n20933073\\n23876499\\n25534396\\n20565920\\n22820646\\n34765995\\n23258576\\n19025706\\n32801643\\n19854252\\n36159727\\n35552983\\n31478131\\n31581469\\n31321552\\n23529740\\n24312791\\n31445157\\n30900903\\n29491463\\n26818876\\n29663290\\n33831485\\n27179407\\n30658914\\n29341619\\n30187353\\n36559211\\n29881970\\n30012897\\n36986858\\n27253493\\n27148629\\n25789998', 'title': 'Excipients for Novel Inhaled Dosage Forms: An Overview.', 'abstract': 'Pulmonary drug delivery is a form of local targeting to the lungs in patients with respiratory disorders like cystic fibrosis, pulmonary arterial hypertension (PAH), asthma, chronic pulmonary infections, and lung cancer. In addition, noninvasive pulmonary delivery also presents an attractive alternative to systemically administered therapeutics, not only for localized respiratory disorders but also for systemic absorption. Pulmonary delivery offers the advantages of a relatively low dose, low incidence of systemic side effects, and rapid onset of action for some drugs compared to other systemic administration routes. While promising, inhaled delivery of therapeutics is often complex owing to factors encompassing mechanical barriers, chemical barriers, selection of inhalation device, and limited choice of dosage form excipients. There are very few excipients that are approved by the FDA for use in developing inhaled drug products. Depending upon the dosage form, and inhalation devices such as pMDIs, DPIs, and nebulizers, different excipients can be used to provide physical and chemical stability and to deliver the dose efficiently to the lungs. This review article focuses on discussing a variety of excipients that have been used in novel inhaled dosage forms as well as inhalation devices.', 'keywords': ['excipients', 'inhalation', 'lungs', 'nanoparticles', 'novel dosage forms'], 'journal': 'AAPS PharmSciTech', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Yousry', 'firstname': 'Carol', 'initials': 'C', 'affiliation': \"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.\\nDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini, Cairo, 11562, Egypt.\\nDepartment of Pharmaceutics and Industrial Pharmacy, School of Pharmacy, Newgiza University, Giza, Egypt.\"}, {'lastname': 'Goyal', 'firstname': 'Mimansa', 'initials': 'M', 'affiliation': \"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.\"}, {'lastname': 'Gupta', 'firstname': 'Vivek', 'initials': 'V', 'affiliation': \"Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA. guptav@stjohns.edu.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.', 'doi': '10.1208/s12249-024-02741-w\\n10.4155/tde-2017-0037\\n10.1046/j.1365-2125.2003.01892.x\\n10.3390/ijerph16020185\\n10.1080/17425247.2020.1702643\\n10.1016/j.ijpharm.2018.04.034\\n10.1016/j.rmed.2004.07.014\\n10.1183/09059180.05.00009605\\n10.1007/s40261-019-00835-z\\n10.1208/s12249-013-0062-y\\n10.1186/s40248-017-0092-5\\n10.1016/j.cocis.2021.101497\\n10.1016/j.ijpharm.2013.02.031\\n10.1016/j.ijpharm.2010.03.017\\n10.1016/j.ijpharm.2006.10.009\\n10.1016/j.toxlet.2014.01.009\\n10.3109/10837450.2014.920360\\n10.1016/j.carbpol.2015.11.072\\n10.1021/acs.molpharmaceut.5b00859\\n10.1016/j.ijpharm.2014.02.030\\n10.1371/journal.pone.0267257\\n10.1016/j.pupt.2007.04.002\\n10.1016/j.ejpb.2011.10.011\\n10.1002/jps.23463\\n10.1016/j.ijpharm.2008.01.008\\n10.3109/08958378.2013.810315\\n10.1016/j.ejps.2012.10.025\\n10.1016/j.ejpb.2011.04.017\\n10.1016/j.ijpharm.2011.07.040\\n10.1007/s13346-018-0526-4\\n10.1016/j.ijpharm.2015.06.041\\n10.1016/j.ejps.2010.01.001\\n10.3390/ijms22094783\\n10.1016/j.jconrel.2019.10.012\\n10.1080/17425247.2018.1503251\\n10.1016/j.addr.2014.03.006\\n10.1111/jphp.12541\\n10.1016/j.ijpharm.2010.09.042\\n10.1016/j.ijpharm.2013.07.024\\n10.1002/phar.1929\\n10.1517/17425247.2015.995087\\n10.1186/1465-9921-11-81\\n10.1016/j.ejpb.2012.07.004\\n10.1186/s43556-020-00014-z\\n10.4187/respcare.01753\\n10.2147/DDDT.S262141\\n10.1016/j.ijpharm.2009.10.032\\n10.1016/j.jddst.2022.103805\\n10.1016/j.jconrel.2015.07.024\\n10.1007/s11095-022-03286-y\\n10.1007/s12325-019-01066-6\\n10.3390/pharmaceutics11100502\\n10.1007/s11095-019-2666-8\\n10.1177/2040622319857617\\n10.1128/AAC.02346-12\\n10.1016/j.powtec.2015.10.008\\n10.1016/j.ejpb.2019.08.012\\n10.1016/j.jconrel.2020.08.050\\n10.1016/j.nano.2019.102125\\n10.1021/acs.molpharmaceut.8b01256\\n10.1016/j.jconrel.2014.11.022\\n10.1038/s41598-018-22172-5\\n10.2174/1381612822666160128145356\\n10.1208/s12249-018-1002-7\\n10.1016/j.ijpharm.2021.120572\\n10.1016/j.chemphyslip.2016.05.003\\n10.1016/S2213-2600(18)30427-2\\n10.1021/acs.molpharmaceut.7b00846\\n10.1016/j.jconrel.2020.06.004\\n10.1007/s13346-018-0583-8\\n10.3390/pharmaceutics14122717\\n10.1007/s13346-018-0550-4\\n10.5650/jos.ess17253\\n10.1155/2022/3549061\\n10.3390/pharmaceutics15030996\\n10.1021/acs.molpharmaceut.6b00126\\n10.1021/acs.molpharmaceut.6b00036\\n10.1021/nl5048972', 'xml': <Element 'PubmedArticle' at 0x109838c20>}\n",
      "{'pubmed_id': '38355591\\n17303796\\n26526201\\n29326334\\n24053239\\n27776981\\n24752575\\n16635588\\n29526822\\n30889835\\n22106016\\n31273044\\n31515400\\n33374433\\n24421258\\n30224127\\n33761469\\n18938115\\n29292699\\n30779905\\n31588813\\n30156012\\n26693732\\n25738426\\n30745111\\n16154390\\n20149763\\n19036381\\n21598081\\n11334339\\n12015272\\n27584001\\n19906520\\n27082437\\n29295966\\n22835687', 'title': 'A Clinical Breathomics Dataset.', 'abstract': \"This study entailed a comprehensive GC‒MS analysis conducted on 121 patient samples to generate a clinical breathomics dataset. Breath molecules, indicative of diverse conditions such as psychological and pathological states and the microbiome, were of particular interest due to their non-invasive nature. The highlighted noninvasive approach for detecting these breath molecules significantly enhances diagnostic and monitoring capacities. This dataset cataloged volatile organic compounds (VOCs) from the breath of individuals with asthma, bronchiectasis, and chronic obstructive pulmonary disease. Uniform and consistent sample collection protocols were strictly adhered to during the accumulation of this extensive dataset, ensuring its reliability. It encapsulates extensive human clinical breath molecule data pertinent to three specific diseases. This consequential clinical breathomics dataset is a crucial resource for researchers and clinicians in identifying and exploring important compounds within the patient's breath, thereby augmenting future diagnostic and therapeutic initiatives.\", 'keywords': [], 'journal': 'Scientific data', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Kuo', 'firstname': 'Ping-Hung', 'initials': 'PH', 'affiliation': 'National Taiwan University Hospital, No. 1, Changde St., Zhongzheng Dist., Taipei City, 100229, Taiwan.'}, {'lastname': 'Jhong', 'firstname': 'Yue-Chen', 'initials': 'YC', 'affiliation': 'Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan.'}, {'lastname': 'Kuo', 'firstname': 'Tien-Chueh', 'initials': 'TC', 'affiliation': 'Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan.\\nThe Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan.'}, {'lastname': 'Hsu', 'firstname': 'Yu-Ting', 'initials': 'YT', 'affiliation': 'Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan.'}, {'lastname': 'Kuo', 'firstname': 'Ching-Hua', 'initials': 'CH', 'affiliation': 'The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan.\\nDrug Research Center, College of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Road, Taipei, 10055, Taiwan.\\nDepartment of Pharmacy, School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Road, Taipei, 10055, Taiwan.'}, {'lastname': 'Tseng', 'firstname': 'Yufeng Jane', 'initials': 'YJ', 'affiliation': 'Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan. yjtseng@csie.ntu.edu.tw.\\nDepartment of Computer Science and Information Engineering, College of Electrical Engineering and Computer Science, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei, 10617, Taiwan. yjtseng@csie.ntu.edu.tw.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s41597-024-03052-2\\n10.1164/rccm.200606-769OC\\n10.1038/aps.2015.102\\n10.4155/bio.13.184\\n10.1016/j.chest.2016.10.008\\n10.1371/journal.pone.0095668\\n10.1016/j.tube.2006.03.004\\n10.1016/j.jtho.2018.02.026\\n10.3390/metabo9030052\\n10.1136/thoraxjnl-2011-200072\\n10.3390/jcm10010032\\n10.1016/j.aca.2018.06.056\\n10.1016/j.jchromb.2008.08.031\\n10.1088/1752-7163/aaa492\\n10.1016/j.clinbiochem.2019.02.009\\n10.1080/15412555.2019.1669550\\n10.1111/all.13596\\n10.2174/1568026616666151223113540\\n10.3390/metabo5010140\\n10.1016/j.jchromb.2019.01.029\\n10.1016/j.jchromb.2005.08.013\\n10.1016/j.jchromb.2010.01.022\\n10.1016/j.chroma.2008.10.125\\n10.1007/s00216-011-4950-2\\n10.1016/S0378-4347(00)00554-5\\n10.1016/S1570-0232(02)00143-5\\n10.1021/acs.analchem.6b02927\\n10.6084/m9.figshare.23522490.v6\\n10.1016/j.rmed.2009.10.018\\n10.1088/1752-7155/10/2/026006\\n10.1088/1752-7163/aaa4c5\\n10.1016/j.chroma.2012.07.023', 'xml': <Element 'PubmedArticle' at 0x10a2bcb80>}\n",
      "{'pubmed_id': '38355588\\n33567194\\n28724246\\n28784798\\n28541391\\n29440150\\n31915891\\n27379667\\n31427142\\n16596302\\n21745709\\n27386582\\n36656943\\n29181445\\n34625399\\n21164152\\n32639562\\n37428317\\n35750915\\n32497902\\n35417728\\n34656111\\n38103071\\n21458659\\n30293559\\n32595651\\n35853794\\n25689046\\n30156881\\n16337443\\n32613762\\n29534090\\n27231897\\n30231558\\n33782057\\n35886376\\n10827061\\n16784338\\n12958120\\n18436948\\n9310563\\n7786990\\n35121380\\n30083295\\n35282724\\n35932593\\n32665950\\n32357431\\n24131153\\n11665457\\n34926376\\n32316146\\n33089169\\n33199525\\n27043528\\n7990870\\n34596053\\n25780233\\n14046403\\n22045347\\n27885003\\n17936039\\n26568120\\n26953619\\n25175755\\n32526187\\n29344005\\n30662675\\n35644424\\n32586876\\n17900748\\n10988127\\n31221808\\n34821064\\n36119067\\n25093714\\n11564182\\n17520784\\n29231268\\n18433872\\n25022734\\n22607991\\n26929420\\n27026587\\n28614111\\n27881237\\n31916265\\n36064186\\n35754123\\n36265977', 'title': 'Influence of light at night on allergic diseases: a systematic review and meta-analysis.', 'abstract': 'Allergic diseases impose a significant global disease burden, however, the influence of light at night exposure on these diseases in humans has not been comprehensively assessed. We aimed to summarize available evidence considering the association between light at night exposure and major allergic diseases through a systematic review and meta-analysis.\\nWe completed a search of six databases, two registries, and Google Scholar from inception until December 15, 2023, and included studies that investigated the influence of artificial light at night (ALAN, high vs. low exposure), chronotype (evening vs. morning chronotype), or shift work (night vs. day shift work) on allergic disease outcomes (asthma, allergic rhinitis, and skin allergies). We performed inverse-variance random-effects meta-analyses to examine the association between the exposures (ALAN exposure, chronotype, or shiftwork) and these allergic outcomes. Stratification analyses were conducted by exposure type, disease type, participant age, and geographical location along with sensitivity analyses to assess publication bias.\\nWe included 12 publications in our review. We found that exposure to light at night was associated with higher odds of allergic diseases, with the strongest association observed for ALAN exposure (OR: 1.88; 95% CI: 1.04 to 3.39), followed by evening chronotype (OR: 1.35; 95% CI: 0.98 to 1.87) and exposure to night shift work (OR: 1.33; 95% CI: 1.06 to 1.67). When analyses were stratified by disease types, light at night exposure was significantly associated with asthma (OR: 1.62; 95% CI: 1.19 to 2.20), allergic rhinitis (OR: 1.89; 95% CI: 1.60 to 2.24), and skin allergies (OR: 1.11; 95% CI: 1.09 to 1.91). We also found that the association between light at night exposure and allergic diseases was more profound in youth (OR: 1.63; 95% CI: 1.07 to 2.48) than adults (OR: 1.30; 95% CI: 1.03 to 1.63). Additionally, we observed significant geographical variations in the association between light at night exposure and allergic diseases.\\nLight at night exposure was associated with a higher prevalence of allergic diseases, both in youth and adults. More long-term epidemiological and mechanistic research is required to understand the possible interactions between light at night and allergic diseases.', 'keywords': ['Allergic rhinitis', 'Asthma', 'Chronotype', 'Shift work', 'Skin allergies'], 'journal': 'BMC medicine', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Deprato', 'firstname': 'Andy', 'initials': 'A', 'affiliation': 'Alberta Respiratory Centre and Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada.\\nMichael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.'}, {'lastname': 'Maidstone', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Division of Immunology, Immunity to Infection, and Respiratory Medicine, University of Manchester, Manchester, UK.'}, {'lastname': 'Cros', 'firstname': 'Anna Palomar', 'initials': 'AP', 'affiliation': 'Non-Communicable Diseases and Environment Programme, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.\\nDepartment of Experimental and Health Sciences, University of Pompeu Fabra (UPF), Barcelona, Spain.\\nConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain.'}, {'lastname': 'Adan', 'firstname': 'Ana', 'initials': 'A', 'affiliation': 'Department of Clinical Psychology and Psychobiology, University of Barcelona, Barcelona, Spain.\\nInstitute of Neurosciences, University of Barcelona, Barcelona, Spain.'}, {'lastname': 'Haldar', 'firstname': 'Prasun', 'initials': 'P', 'affiliation': 'Department of Medical Laboratory Technology, Supreme Institute of Management and Technology, Mankundu, India.'}, {'lastname': 'Harding', 'firstname': 'Barbara N', 'initials': 'BN', 'affiliation': 'Non-Communicable Diseases and Environment Programme, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.\\nDepartment of Experimental and Health Sciences, University of Pompeu Fabra (UPF), Barcelona, Spain.\\nConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain.'}, {'lastname': 'Lacy', 'firstname': 'Paige', 'initials': 'P', 'affiliation': 'Alberta Respiratory Centre and Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada.'}, {'lastname': 'Melenka', 'firstname': 'Lyle', 'initials': 'L', 'affiliation': 'Synergy Respiratory and Cardiac Care, Sherwood Park, Alberta, Canada.'}, {'lastname': 'Moitra', 'firstname': 'Saibal', 'initials': 'S', 'affiliation': 'Department of Allergy and Immunology, Apollo Multispeciality Hospitals, Kolkata, India.'}, {'lastname': 'Navarro', 'firstname': 'José Francisco', 'initials': 'JF', 'affiliation': 'Department of Psychobiology and Methodology of Behavioural Sciences, University of Málaga, Málaga, Spain.'}, {'lastname': 'Kogevinas', 'firstname': 'Manolis', 'initials': 'M', 'affiliation': 'Non-Communicable Diseases and Environment Programme, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.\\nDepartment of Experimental and Health Sciences, University of Pompeu Fabra (UPF), Barcelona, Spain.\\nConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, Madrid, Spain.\\nHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.'}, {'lastname': 'Durrington', 'firstname': 'Hannah J', 'initials': 'HJ', 'affiliation': 'Division of Immunology, Immunity to Infection, and Respiratory Medicine, University of Manchester, Manchester, UK.'}, {'lastname': 'Moitra', 'firstname': 'Subhabrata', 'initials': 'S', 'affiliation': 'Alberta Respiratory Centre and Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada. moitra@ualberta.ca.\\nCanadian VIGOUR Centre, Department of Medicine, University of Alberta, Edmonton, AB, Canada. moitra@ualberta.ca.'}], 'methods': None, 'conclusions': None, 'results': 'We included 12 publications in our review. We found that exposure to light at night was associated with higher odds of allergic diseases, with the strongest association observed for ALAN exposure (OR: 1.88; 95% CI: 1.04 to 3.39), followed by evening chronotype (OR: 1.35; 95% CI: 0.98 to 1.87) and exposure to night shift work (OR: 1.33; 95% CI: 1.06 to 1.67). When analyses were stratified by disease types, light at night exposure was significantly associated with asthma (OR: 1.62; 95% CI: 1.19 to 2.20), allergic rhinitis (OR: 1.89; 95% CI: 1.60 to 2.24), and skin allergies (OR: 1.11; 95% CI: 1.09 to 1.91). We also found that the association between light at night exposure and allergic diseases was more profound in youth (OR: 1.63; 95% CI: 1.07 to 2.48) than adults (OR: 1.30; 95% CI: 1.03 to 1.63). Additionally, we observed significant geographical variations in the association between light at night exposure and allergic diseases.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12916-024-03291-5\\n10.1056/NEJMra1802337\\n10.1016/j.scitotenv.2017.07.056\\n10.1073/pnas.1606037114\\n10.1093/aje/kwx140\\n10.2337/dc17-1933\\n10.1007/s00125-019-05059-6\\n10.1007/s00420-016-1150-6\\n10.1016/j.tem.2019.07.008\\n10.1007/s10552-005-9015-4\\n10.1016/j.jenvman.2011.06.029\\n10.1046/j.1365-8711.2001.04882.x\\n10.1126/sciadv.1600377\\n10.1126/science.adf4952\\n10.1126/sciadv.1701528\\n10.1016/S2589-7500(21)00135-7\\n10.1152/japplphysiol.01413.2009\\n10.1001/jamapsychiatry.2020.1935\\n10.1007/s11356-023-28684-6\\n10.1007/s11356-022-21587-y\\n10.1016/j.envres.2020.109637\\n10.1016/j.scitotenv.2022.155185\\n10.1186/s12942-021-00297-7\\n10.1016/j.jaci.2011.02.006\\n10.1016/j.jaci.2018.08.007\\n10.3389/fimmu.2020.01237\\n10.1016/j.alit.2022.06.008\\n10.1111/all.12596\\n10.1164/rccm.201807-1289LE\\n10.1016/j.jaci.2005.09.028\\n10.1002/alr.22607\\n10.1371/journal.pone.0194018\\n10.1136/bmj.n71\\n10.1136/bmj.320.7247.1468\\n10.1037/1082-989X.11.2.193\\n10.1136/bmj.327.7414.557\\n10.1136/bmj.39489.470347.AD\\n10.1136/bmj.315.7109.629\\n10.2307/2533446\\n10.1016/j.ijheh.2022.113932\\n10.5935/1984-0063.20180017\\n10.1080/07420528.2022.2040527\\n10.1016/j.sleep.2022.07.007\\n10.3109/07420528.2013.826672\\n10.1097/00043764-200110000-00007\\n10.3389/fpubh.2021.751579\\n10.3390/clockssleep1020023\\n10.1136/thoraxjnl-2020-215218\\n10.3390/ijms17040462\\n10.1056/NEJM199501053320102\\n10.1016/0021-8707(63)90049-2\\n10.1097/MCP.0b013e32834d098e\\n10.1126/science.aal2613\\n10.1016/j.smrv.2007.07.005\\n10.1016/j.jsmc.2015.08.002\\n10.3109/07420528.2016.1144608\\n10.1002/ijop.12098\\n10.1186/s12948-018-0080-0\\n10.1016/j.cellsig.2022.110362\\n10.1016/j.addr.2007.08.016\\n10.1164/ajrccm.162.3.9911107\\n10.1002/alr.22914\\n10.3389/fimmu.2022.776917\\n10.3390/ijms150813482\\n10.1046/j.0022-202x.2001.01433.x\\n10.1093/sleep/30.4.401\\n10.1111/pde.13364\\n10.1016/j.molimm.2008.03.004\\n10.1542/peds.2014-0376\\n10.1016/j.jaci.2012.03.042\\n10.1183/16000617.0082-2015\\n10.1007/s11882-016-0609-6\\n10.1097/DER.0000000000000305\\n10.1016/j.envint.2016.11.012\\n10.1111/all.14177\\n10.1016/j.jaip.2022.08.031\\n10.1016/j.iac.2022.06.004', 'xml': <Element 'PubmedArticle' at 0x109848e00>}\n",
      "{'pubmed_id': '38355550\\n34699773\\n19000318\\n15080825\\n29273246\\n32526187\\n34789462\\n15516665\\n33961039\\n35533997\\n29327949\\n32627764\\n33161958\\n26335830\\n35027030\\n33069327\\n33069326\\n33032723\\n25146089\\n29883409\\n28928313\\n32843181\\n20510323\\n34051883\\n32075787\\n27694437\\n31606435\\n31730381\\n28363924\\n31910429\\n34051921\\n28390697\\n33533185\\n31378429\\n17662882\\n17263280\\n28089117\\n34948791\\n33889955\\n32054818\\n32599814\\n23949964\\n21907258\\n21298697\\n27608865', 'title': 'Global patterns of asthma burden related to environmental risk factors during 1990-2019: an age-period-cohort analysis for global burden of disease study 2019.', 'abstract': 'Change in asthma burden attributed to specific environmental risk factor has not been evaluated.\\nWe aimed to explore the age, period, and cohort effects on asthma burden attributable to smoking and occupational asthmagens in different socio-demographic index (SDI) regions and the region and sex disparities.\\nRisk factor-specific asthma deaths and disability-adjusted life years (DALYs) rates were extracted from Global Burden of Disease study 2019, estimated by standard Combined Cause of Death Model and DisMod-MR 2.1 modeling tool. Age-period-cohort analysis was conducted to decompose age, period, and cohort effects on asthma burden.\\nSmoking- and occupational asthmagens-related asthma deaths and DALYs rates dropped by >\\u200945% during 1990-2019. In 2019, Africa, South and Southeast Asia had higher asthma burden than other regions. Male had higher asthma burden than female. Among nearly all age groups, low-middle SDI region had the highest smoking-related asthma burden, and low SDI region had the highest occupational asthmagens-related asthma burden. Inverse \"V\" shaped trend was observed in the above regions with increasing age. For smoking-related asthma deaths and DALYs rates, the most significant improvement of period rate ratio (RR) occurred in high SDI region, decreased from 1.67 (1.61, 1.74) to 0.34 (0.33, 0.36) and 1.61 (1.57, 1.66) to 0.59 (0.57, 0.61), respectively, as well as the cohort effect on smoking-related asthma burden. For occupational asthmagens-related asthma deaths and DALYs rates, the most sharply decrease of period and cohort RR appeared in the high and high-middle SDI regions. Low SDI region showed least progress in period and cohort RR of smoking- and occupational asthmagens-linked asthma burden.\\nSmoking- and occupational asthmagens-related asthma burden sharply decreases, but region and sex disparities exist. Policy makers from low SDI region should reinforce tobacco control and prioritize workplace protection.', 'keywords': ['Age-period-cohort analysis', 'Asthma', 'Disability-adjusted life years', 'Occupational asthmagens', 'Smoking'], 'journal': 'Environmental health : a global access science source', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Zhang', 'firstname': 'Siying', 'initials': 'S', 'affiliation': \"Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.\\nKey Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, No 81 Meishan Road, Hefei, Anhui, 230032, China.\\nAnhui Provincial Key Laboratory of Environment and Population Health across the Life Course, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.\"}, {'lastname': 'Gao', 'firstname': 'Zongshi', 'initials': 'Z', 'affiliation': 'The First Clinical College of Anhui Medical University, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.'}, {'lastname': 'Wu', 'firstname': 'Lihong', 'initials': 'L', 'affiliation': 'Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.'}, {'lastname': 'Zhong', 'firstname': 'Yumei', 'initials': 'Y', 'affiliation': 'Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.'}, {'lastname': 'Gao', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei, Anhui, 230022, China.'}, {'lastname': 'Tao', 'firstname': 'Fang-Biao', 'initials': 'FB', 'affiliation': \"Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.\\nKey Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, No 81 Meishan Road, Hefei, Anhui, 230032, China.\\nAnhui Provincial Key Laboratory of Environment and Population Health across the Life Course, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China.\"}, {'lastname': 'Wu', 'firstname': 'Xiulong', 'initials': 'X', 'affiliation': \"Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China. wuxiulong6@126.com.\\nKey Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, No 81 Meishan Road, Hefei, Anhui, 230032, China. wuxiulong6@126.com.\\nAnhui Provincial Key Laboratory of Environment and Population Health across the Life Course, Anhui Medical University, No 81 Meishan Road, Hefei, Anhui, 230032, China. wuxiulong6@126.com.\"}], 'methods': None, 'conclusions': 'Smoking- and occupational asthmagens-related asthma burden sharply decreases, but region and sex disparities exist. Policy makers from low SDI region should reinforce tobacco control and prioritize workplace protection.', 'results': 'Smoking- and occupational asthmagens-related asthma deaths and DALYs rates dropped by >\\u200945% during 1990-2019. In 2019, Africa, South and Southeast Asia had higher asthma burden than other regions. Male had higher asthma burden than female. Among nearly all age groups, low-middle SDI region had the highest smoking-related asthma burden, and low SDI region had the highest occupational asthmagens-related asthma burden. Inverse \"V\" shaped trend was observed in the above regions with increasing age. For smoking-related asthma deaths and DALYs rates, the most significant improvement of period rate ratio (RR) occurred in high SDI region, decreased from 1.67 (1.61, 1.74) to 0.34 (0.33, 0.36) and 1.61 (1.57, 1.66) to 0.59 (0.57, 0.61), respectively, as well as the cohort effect on smoking-related asthma burden. For occupational asthmagens-related asthma deaths and DALYs rates, the most sharply decrease of period and cohort RR appeared in the high and high-middle SDI regions. Low SDI region showed least progress in period and cohort RR of smoking- and occupational asthmagens-linked asthma burden.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12940-024-01060-8\\n10.1016/j.chest.2021.09.042\\n10.1186/1476-069X-7-57\\n10.1111/j.1398-9995.2004.00526.x\\n10.1016/S0140-6736(17)33311-1\\n10.1016/S2213-2600(20)30105-3\\n10.1183/16000617.0067-2021\\n10.1183/09031936.04.00116903\\n10.1001/jamanetworkopen.2021.8060\\n10.1016/j.jaip.2022.04.034\\n10.1164/rccm.1972P1\\n10.3390/ijerph17134713\\n10.1016/j.jaip.2020.06.031\\n10.1186/s12889-021-12484-z\\n10.1016/S0140-6736(20)30752-2\\n10.1016/S0140-6736(20)30925-9\\n10.1016/j.jaci.2020.08.011\\n10.1158/1055-9965.EPI-14-0300\\n10.3390/ijerph15051033\\n10.4103/ijph.IJPH_241_17\\n10.1016/j.rmed.2020.106066\\n10.1016/j.yrtph.2010.05.006\\n10.1016/S0140-6736(21)01169-7\\n10.1136/bmj.m234\\n10.1016/S2213-2600(19)30276-0\\n10.1146/annurev-physiol-021119-034610\\n10.1136/bmjopen-2016-013817\\n10.1159/000505024\\n10.1016/S2468-2667(21)00102-X\\n10.1016/S0140-6736(17)30819-X\\n10.1002/1878-0261.12918\\n10.1016/S2213-2600(19)30257-7\\n10.1016/S0140-6736(07)61164-7\\n10.1016/S2213-2600(16)30426-X\\n10.3390/ijerph182413181\\n10.1093/annweh/wxab021\\n10.1136/oemed-2019-106013\\n10.3390/ijerph17124553\\n10.1183/09031936.00034913\\n10.1016/j.yrtph.2011.08.011\\n10.1002/ajim.20925', 'xml': <Element 'PubmedArticle' at 0x10a5973d0>}\n",
      "{'pubmed_id': '38355192\\n29196355\\n36864977\\n22579043\\n34350127\\n35721799\\n22003315\\n26228650\\n33849921\\n29492397\\n32043136\\n28096249\\n35534145\\n33596898\\n23692896\\n37227692', 'title': 'How far back do we need to look to capture diagnoses in electronic health records? A retrospective observational study of hospital electronic health record data.', 'abstract': 'Analysis of routinely collected electronic health data is a key tool for long-term condition research and practice for hospitalised patients. This requires accurate and complete ascertainment of a broad range of diagnoses, something not always recorded on an admission document at a single point in time. This study aimed to ascertain how far back in time electronic hospital records need to be interrogated to capture long-term condition diagnoses.\\nRetrospective observational study of routinely collected hospital electronic health record data.\\nQueen Elizabeth Hospital Birmingham (UK)-linked data held by the PIONEER acute care data hub.\\nPatients whose first recorded admission for chronic obstructive pulmonary disease (COPD) exacerbation (n=560) or acute stroke (n=2142) was between January and December 2018 and who had a minimum of 10 years of data prior to the index date.\\nWe identified the most common International Classification of Diseases version 10-coded diagnoses received by patients with COPD and acute stroke separately. For each diagnosis, we derived the number of patients with the diagnosis recorded at least once over the full 10-year lookback period, and then compared this with shorter lookback periods from 1 year to 9 years prior to the index admission.\\nSeven of the top 10 most common diagnoses in the COPD dataset reached >90% completeness by 6 years of lookback. Atrial fibrillation and diabetes were >90% coded with 2-3 years of lookback, but hypertension and asthma completeness continued to rise all the way out to 10 years of lookback. For stroke, 4 of the top 10 reached 90% completeness by 5 years of lookback; angina pectoris was >90% coded at 7 years and previous transient ischaemic attack completeness continued to rise out to 10 years of lookback.\\nA 7-year lookback captures most, but not all, common diagnoses. Lookback duration should be tailored to the conditions being studied.', 'keywords': ['Electronic Health Records', 'Hospitals', 'Information Extraction'], 'journal': 'BMJ open', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Lewis', 'firstname': 'Jadene', 'initials': 'J', 'affiliation': 'PIONEER Hub, University of Birmingham, Birmingham, UK.\\nHealth Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.'}, {'lastname': 'Evison', 'firstname': 'Felicity', 'initials': 'F', 'affiliation': 'PIONEER Hub, University of Birmingham, Birmingham, UK.\\nHealth Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.'}, {'lastname': 'Doal', 'firstname': 'Rominique', 'initials': 'R', 'affiliation': 'PIONEER Hub, University of Birmingham, Birmingham, UK.\\nHealth Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.'}, {'lastname': 'Field', 'firstname': 'Joanne', 'initials': 'J', 'affiliation': 'Digital Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.'}, {'lastname': 'Gallier', 'firstname': 'Suzy', 'initials': 'S', 'affiliation': 'PIONEER Hub, University of Birmingham, Birmingham, UK.\\nHealth Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.'}, {'lastname': 'Harris', 'firstname': 'Steve', 'initials': 'S', 'affiliation': 'Critical Care Department, University College London Hospitals NHS Foundation Trust, London, UK.\\nInstitute of Health Informatics, University College London, London, UK.'}, {'lastname': 'le Roux', 'firstname': 'Peta', 'initials': 'P', 'affiliation': 'Digital Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.'}, {'lastname': 'Osman', 'firstname': 'Mohammed', 'initials': 'M', 'affiliation': 'AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.\\nNIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.'}, {'lastname': 'Plummer', 'firstname': 'Chris', 'initials': 'C', 'affiliation': 'Digital Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.\\nNIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.'}, {'lastname': 'Sapey', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'PIONEER Hub, University of Birmingham, Birmingham, UK.\\nInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.'}, {'lastname': 'Singer', 'firstname': 'Mervyn', 'initials': 'M', 'affiliation': 'Critical Care Department, University College London Hospitals NHS Foundation Trust, London, UK.\\nBloomsbury Institute of Intensive Care Medicine, University College London, London, UK.'}, {'lastname': 'Sayer', 'firstname': 'Avan A', 'initials': 'AA', 'affiliation': 'AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.\\nNIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.'}, {'lastname': 'Witham', 'firstname': 'Miles D', 'initials': 'MD', 'affiliation': 'AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK miles.witham@newcastle.ac.uk.\\nNIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, UK.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': 'A 7-year lookback captures most, but not all, common diagnoses. Lookback duration should be tailored to the conditions being studied.', 'results': 'Seven of the top 10 most common diagnoses in the COPD dataset reached >90% completeness by 6 years of lookback. Atrial fibrillation and diabetes were >90% coded with 2-3 years of lookback, but hypertension and asthma completeness continued to rise all the way out to 10 years of lookback. For stroke, 4 of the top 10 reached 90% completeness by 5 years of lookback; angina pectoris was >90% coded at 7 years and previous transient ischaemic attack completeness continued to rise out to 10 years of lookback.', 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.', 'doi': '10.1136/bmjopen-2023-080678\\n10.7861/clinmedicine.17-6-537\\n10.1016/j.eclinm.2023.101860\\n10.1016/S0140-6736(12)60240-2\\n10.1177/26335565211032880\\n10.1177/26335565221104407\\n10.1016/j.ijmedinf.2015.06.011\\n10.1136/bmjhci-2020-100294\\n10.15256/joc.2018.8.129\\n10.1093/ageing/afaa018\\n10.1136/bmjopen-2016-012012\\n10.1016/j.artmed.2022.102307\\n10.1186/s12911-021-01416-x\\n10.1136/bmj.f2350\\n10.1007/s41999-023-00753-6', 'xml': <Element 'PubmedArticle' at 0x109f55620>}\n",
      "{'pubmed_id': '38355020', 'title': 'Predicting exacerbations in COPD in the Danish general population.', 'abstract': 'Risk of exacerbations in individuals with mild chronic obstructive pulmonary disease (COPD) in the general population is less well described than in more advanced disease. We hypothesized that in addition to history of previous exacerbation also other clinical characteristics predict future moderate exacerbations.\\nIn 96,462 individuals in the Copenhagen General Population Study, we identified 3175 with clinical COPD defined as forced expiratory volume in 1\\u202fs (FEV\\nWe observed 265 exacerbations in 2543 maintenance treatment naïve individuals with COPD and 197 exacerbations in 632 individuals with COPD on maintenance treatment. In the maintenance treatment naïve group, exacerbation history (hazard ratio (HR): 8.53), low FEV\\nIn addition to exacerbation history also higher age and lower FEV', 'keywords': ['Chronic obstructive pulmonary disease', 'Exacerbation', 'Mild disease', 'Risk score'], 'journal': 'Respiratory medicine', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Marott', 'firstname': 'Jacob Louis', 'initials': 'JL', 'affiliation': 'Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Copenhagen City Heart Study, Copenhagen University Hospital - Frederiksberg and Bispebjerg, Copenhagen, Denmark.'}, {'lastname': 'Ingebrigtsen', 'firstname': 'Truls Sylvan', 'initials': 'TS', 'affiliation': 'Copenhagen City Heart Study, Copenhagen University Hospital - Frederiksberg and Bispebjerg, Copenhagen, Denmark; Medical Department, Respiratory Section, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.'}, {'lastname': 'Çolak', 'firstname': 'Yunus', 'initials': 'Y', 'affiliation': 'Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Medical Department, Respiratory Section, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Vestbo', 'firstname': 'Jørgen', 'initials': 'J', 'affiliation': 'Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, United Kingdom.'}, {'lastname': 'Nordestgaard', 'firstname': 'Børge Grønne', 'initials': 'BG', 'affiliation': 'Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Copenhagen City Heart Study, Copenhagen University Hospital - Frederiksberg and Bispebjerg, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.'}, {'lastname': 'Lange', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Copenhagen City Heart Study, Copenhagen University Hospital - Frederiksberg and Bispebjerg, Copenhagen, Denmark; Medical Department, Respiratory Section, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: peter.lange.01@regionh.dk.'}], 'methods': None, 'conclusions': None, 'results': 'We observed 265 exacerbations in 2543 maintenance treatment naïve individuals with COPD and 197 exacerbations in 632 individuals with COPD on maintenance treatment. In the maintenance treatment naïve group, exacerbation history (hazard ratio (HR): 8.53), low FEV', 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.rmed.2024.107557', 'xml': <Element 'PubmedArticle' at 0x10a23b920>}\n",
      "{'pubmed_id': '38355013', 'title': 'Systemic Inflammation in Asthma: What are the risks and impacts outside the airway?', 'abstract': 'Airway inflammation in asthma has been well recognized for several decades, with general agreement on its role in asthma pathogenesis, symptoms, propensity toward exacerbation, and decline in lung function. This has led to universal recommendation in asthma management guidelines to incorporate the use of inhaled corticosteroid as an anti-inflammatory therapy for all patients with persistent asthma symptoms. However, there has been limited attention paid to the presence and potential impact of systemic inflammation in asthma. Accumulating evidence from epidemiological observations and cohort studies points to a host of downstream organ dysfunction in asthma especially among patients with longstanding or more severe disease, frequent exacerbations, and underlying risk factors for organ dysfunction. Most studies to date have focused on cognitive impairment, depression/anxiety, metabolic syndrome, and cardiovascular abnormalities. In this review, we summarize some of the evidence demonstrating these abnormalities, highlight the proposed mechanisms and potential benefits of treatment in limiting these extrapulmonary abnormalities in patients with asthma. The goal of this commentary is to raise awareness of the importance of recognizing potential extra-pulmonary conditions associated with systemic inflammation of asthma. This area of treatment of patients with asthma is a large unmet need.', 'keywords': ['Alzheimer’s disease', 'Anxiety', 'Asthma', 'Cardiovascular events', 'Cognitive impairment', 'Dementia', 'Depression', 'Severe asthma', 'Systemic inflammation'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 15), 'authors': [{'lastname': 'Tattersall', 'firstname': 'Matthew C', 'initials': 'MC', 'affiliation': 'Department of Medicine, UW School of Medicine and Public Health, Madison, WI; and. Electronic address: mtattersall@medicine.wisc.edu.'}, {'lastname': 'Jarjour', 'firstname': 'Nizar N', 'initials': 'NN', 'affiliation': 'Department of Medicine, UW School of Medicine and Public Health, Madison, WI; and.'}, {'lastname': 'Busse', 'firstname': 'Paula J', 'initials': 'PJ', 'affiliation': 'Department of Medicine, Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai School of Medicine, New York, NY.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.02.004', 'xml': <Element 'PubmedArticle' at 0x10aefc130>}\n",
      "{'pubmed_id': '38354442', 'title': 'Comparative effectiveness of selective serotonin reuptake inhibitors (SSRIs) for depression in 43,061 older adults with chronic somatic diseases: A Danish target trial emulation study.', 'abstract': 'To investigate the comparative effectiveness of commonly used selective serotonin reuptake inhibitors (SSRIs) for comorbid depression in older adults with chronic somatic diseases by applying a target-trial-emulation framework.\\nDanish target-trial-emulation study including 43,061 individuals aged ≥65\\xa0years (54.1% females, mean age 77.8\\xa0years) with a first redeemed prescription for depression with sertraline (n\\xa0=\\xa06673), escitalopram (n\\xa0=\\xa07104) or citalopram (n\\xa0=\\xa029,284) in 2006-2017. Individuals had cancer, cardiovascular diseases (CVD), chronic-obstructive-pulmonary-disease (COPD)/asthma, diabetes, neurodegenerative disorders, or osteoporosis. Outcomes were treatment switching, combination/augmentation, psychiatric hospital contact for depression, and any psychiatric in-patient care. Follow-up was one year and adjusted Cox regression analyses calculated hazard rate ratios (HRR) within each somatic disease.\\nAcross all six disease groups and four outcomes, we found that citalopram use, compared with sertraline, was associated with lower risks in several analyses, with statistically significant results in cancer, CVD, COPD/asthma, and diabetes (e.g., HRRs for psychiatric hospital contacts for depression/any psychiatric in-patient care ranging between 0.47 and 0.61). For escitalopram, compared with sertraline, some analyses indicated poorer outcomes with significantly higher risks for combination/augmentation treatment (HRRs ranging between 1.15 and 1.40).\\nAlthough observational studies are prone to confounding, these findings indicate clinically relevant differences between the SSRIs, with better outcomes in citalopram users and poorer outcomes in escitalopram users than sertraline, urging the need for clinical studies in this vulnerable patient population.', 'keywords': ['Antidepressants', 'Comorbid depression', 'Comparative effectiveness', 'Depressive disorders', 'Geriatric psychiatry', 'SSRIs'], 'journal': 'General hospital psychiatry', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Ishtiak-Ahmed', 'firstname': 'Kazi', 'initials': 'K', 'affiliation': 'Department of Affective Disorders, Aarhus University Hospital Psychiatry, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark. Electronic address: kazahm@rm.dk.'}, {'lastname': 'Rohde', 'firstname': 'Christopher', 'initials': 'C', 'affiliation': 'Department of Affective Disorders, Aarhus University Hospital Psychiatry, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.'}, {'lastname': 'Otte', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Department of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany; German Center for Mental Health (DZPG), Berlin, Germany.'}, {'lastname': 'Gasse', 'firstname': 'Christiane', 'initials': 'C', 'affiliation': 'Department of Affective Disorders, Aarhus University Hospital Psychiatry, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark; Department of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.'}, {'lastname': 'Köhler-Forsberg', 'firstname': 'Ole', 'initials': 'O', 'affiliation': 'Psychosis Research Unit, Aarhus University Hospital - Psychiatry, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.'}], 'methods': None, 'conclusions': None, 'results': 'Across all six disease groups and four outcomes, we found that citalopram use, compared with sertraline, was associated with lower risks in several analyses, with statistically significant results in cancer, CVD, COPD/asthma, and diabetes (e.g., HRRs for psychiatric hospital contacts for depression/any psychiatric in-patient care ranging between 0.47 and 0.61). For escitalopram, compared with sertraline, some analyses indicated poorer outcomes with significantly higher risks for combination/augmentation treatment (HRRs ranging between 1.15 and 1.40).', 'copyrights': 'Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.genhosppsych.2024.02.002', 'xml': <Element 'PubmedArticle' at 0x1250a4180>}\n",
      "{'pubmed_id': '38354337', 'title': 'The impact of different data handling strategies in exploratory and confirmatory factor analysis of diary measures: an evaluation using simulated and real-world asthma nighttime symptoms diary data.', 'abstract': 'Daily diaries are an important modality for patient-reported outcome assessment. They typically comprise multiple questions, so understanding their underlying structure is key to appropriate analysis and interpretation. Structural evaluation of such measures poses challenges due to the high volume of repeated measurements. Potential strategies include selecting a single day, averaging item-level observations over time, or using all data while accounting for its multilevel structure.\\nThe above strategies were evaluated in a simulated dataset via exploratory and confirmatory factor modelling by comparing their impact on various estimates (i.e., inter-item correlations, factor loadings, model fit). Each strategy was additionally explored using real-world data from an observational study (the Asthma Nighttime Symptoms Diary).\\nBoth single day and item average strategies resulted in biased factor loadings. The former displayed lower overall bias (single day: 0.064; item average: 0.121) and mean square error (single day: 0.007; item average: 0.016) but greater frequency of incorrect factor number identification compared with the latter (single day: 46.4%; item average: 0%). Increased estimated inter-item correlations were apparent in the item-average method. Non-trivial between- and within-person variance highlighted the utility of a multilevel approach. However, convergence issues and Heywood cases were more common under the multilevel approach (90.2% and 100.0%, respectively).\\nOur findings suggest that a multilevel approach can enhance our insight when evaluating the structural properties of daily diary data; however, implementation challenges still remain. Our work offers guidance on the impact of data handling decisions in diary assessment.', 'keywords': ['Daily diary data', 'Factor analysis', 'Multilevel modelling', 'Patient-reported outcome'], 'journal': 'Journal of biopharmaceutical statistics', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Dumi', 'firstname': 'Gerasimos', 'initials': 'G', 'affiliation': 'Patient-Centered Solutions, IQVIA, Athens, Greece.'}, {'lastname': \"O'Neill\", 'firstname': 'Dara', 'initials': 'D', 'affiliation': 'Patient-Centered Solutions, IQVIA, Barcelona, Spain.'}, {'lastname': 'Daskalopoulou', 'firstname': 'Christina', 'initials': 'C', 'affiliation': 'Patient-Centered Solutions, IQVIA, Athens, Greece.'}, {'lastname': 'Keeley', 'firstname': 'Tom', 'initials': 'T', 'affiliation': 'Patient Centered Outcomes, R&D Global Medical, GSK, London, UK.'}, {'lastname': 'Rhoten', 'firstname': 'Stephanie', 'initials': 'S', 'affiliation': 'Patient-Centered Solutions, IQVIA, San Francisco, California, USA.'}, {'lastname': 'Sauriyal', 'firstname': 'Dharmraj', 'initials': 'D', 'affiliation': 'GSK, Global capability centre, Bangalore, India.'}, {'lastname': 'Fromy', 'firstname': 'Piper', 'initials': 'P', 'affiliation': 'Patient-Centered Solutions, IQVIA, Courbevoie, France.\\nSeeingTheta, Saumur, France.'}], 'methods': 'The above strategies were evaluated in a simulated dataset via exploratory and confirmatory factor modelling by comparing their impact on various estimates (i.e., inter-item correlations, factor loadings, model fit). Each strategy was additionally explored using real-world data from an observational study (the Asthma Nighttime Symptoms Diary).', 'conclusions': None, 'results': 'Both single day and item average strategies resulted in biased factor loadings. The former displayed lower overall bias (single day: 0.064; item average: 0.121) and mean square error (single day: 0.007; item average: 0.016) but greater frequency of incorrect factor number identification compared with the latter (single day: 46.4%; item average: 0%). Increased estimated inter-item correlations were apparent in the item-average method. Non-trivial between- and within-person variance highlighted the utility of a multilevel approach. However, convergence issues and Heywood cases were more common under the multilevel approach (90.2% and 100.0%, respectively).', 'copyrights': None, 'doi': '10.1080/10543406.2024.2310312', 'xml': <Element 'PubmedArticle' at 0x1250a62a0>}\n",
      "{'pubmed_id': '38353432', 'title': '[Asthma: a respiratory pathology with a high risk for mental health].', 'abstract': 'The subjective experience of asthma can be accompanied by significant emotional suffering. The presence of psychiatric comorbidities in asthma is common and worsens the prognosis of asthma. Bidirectional relationships between psychiatric disorders and asthma via inflammatory mechanisms are highlighted. Systematic screening for the most common psychiatric comorbidities such as depression, anxiety disorders and post-traumatic stress disorder is recommended. A multidisciplinary collaboration with a mental health specialist in the presence of psychiatric comorbidity has proven necessary to improve the quality of life and both the somatic and psychiatric prognosis of patients suffering from asthma.\\nLe vécu subjectif de l’asthme peut s’accompagner d’une importante souffrance émotionnelle. La présence de comorbidités psychiatriques dans l’asthme est fréquente et péjore le pronostic de l’asthme. On note des relations bidirectionnelles entre troubles psychiatriques et asthme via des mécanismes inflammatoires. Un dépistage systématique des comorbidités psychiatriques les plus fréquentes comme la dépression, les troubles anxieux et le trouble de stress post-traumatique est recommandé. Une collaboration multidisciplinaire avec un-e spécialiste de santé mentale en présence de comorbidité psychiatrique avérée est nécessaire pour améliorer la qualité de vie et le pronostic tant somatique que psychiatrique des patients souffrant d’asthme.', 'keywords': [], 'journal': 'Revue medicale suisse', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Benzakour', 'firstname': 'Lamyae', 'initials': 'L', 'affiliation': \"Service de psychiatrie de liaison et d'intervention de crise, Département de psychiatrie, Hôpitaux universitaires de Genève, 1211 Genève 14.\"}, {'lastname': 'Charbonnier', 'firstname': 'Florian', 'initials': 'F', 'affiliation': 'Service de pneumologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.53738/REVMED.2024.20.861.333', 'xml': <Element 'PubmedArticle' at 0x109eff8d0>}\n",
      "{'pubmed_id': '38353391', 'title': 'Impulse oscillometry bronchodilator response in preschool children.', 'abstract': 'In preschoolers, performing an acceptable spirometry and measuring bronchodilator response (BDR) is challenging; in this context, impulse oscillometry (IOS) represents a valid alternative. However, more studies on the standardization of BDR for IOS in young children are required.\\nThe objective of the study was to identify optimal thresholds to define a positive BDR test with IOS in preschoolers with suspected asthma.\\nChildren aged 3-6 years with suspected asthma and their lung function investigated with both IOS and spirometry pre- and post-BDR were retrospectively analyzed. The spirometric BDR was defined as positive when the change of FEV\\nAmong 72 patients, 36 (age 5.2\\u2009±\\u20091 years; 64% boys) were selected for the subsequent analysis according to ATS/ERS quality criteria of measurements; specifically, 19 patients did not meet IOS and 36 did not meet spirometry criteria. The spirometric BDR was found positive in seven subjects (19.4%); conversely, a positive oscillometric BDR was identified in four patients (11.1%). No patient presented a positive BDR response with both methods. In IOS, the mean decrease in R5 and AX was 19.9%\\u2009±\\u200910% and 44%\\u2009±\\u200922.1%, and the mean increase in X5 was 23.3%\\u2009±\\u200917.8%, respectively. A decrease in R5 of 25.7% (AUC 0.77, p\\u2009=\\u2009.03) and an increase in X5 of 25.7% (AUC 0.75, p\\u2009=\\u2009.04) showed the best combination of sensitivity and specificity to detect an increase of FEV\\nThe IOS represents a valid alternative to spirometry to measure BDR in preschool children and should be the gold standard in this age group. We are considering a decrease of 26% in R5 and an increase of 26% in X5 as diagnostic threshold for BDR.', 'keywords': ['bronchodilator response', 'oscillometry', 'preschool asthma', 'spirometry'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Meoli', 'firstname': 'Aniello', 'initials': 'A', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.\\nDepartment of Medicine and Surgery, Pediatric Clinic, University Hospital of Parma, Parma, Italy.'}, {'lastname': 'Trischler', 'firstname': 'Jordis', 'initials': 'J', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}, {'lastname': 'Hutter', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}, {'lastname': 'Dressler', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}, {'lastname': 'Esposito', 'firstname': 'Susanna', 'initials': 'S', 'affiliation': 'Department of Medicine and Surgery, Pediatric Clinic, University Hospital of Parma, Parma, Italy.'}, {'lastname': 'Blümchen', 'firstname': 'Katharina', 'initials': 'K', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}, {'lastname': 'Zielen', 'firstname': 'Stefan', 'initials': 'S', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}, {'lastname': 'Schulze', 'firstname': 'Johannes', 'initials': 'J', 'affiliation': 'Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.'}], 'methods': None, 'conclusions': 'The IOS represents a valid alternative to spirometry to measure BDR in preschool children and should be the gold standard in this age group. We are considering a decrease of 26% in R5 and an increase of 26% in X5 as diagnostic threshold for BDR.', 'results': 'Among 72 patients, 36 (age 5.2\\u2009±\\u20091 years; 64% boys) were selected for the subsequent analysis according to ATS/ERS quality criteria of measurements; specifically, 19 patients did not meet IOS and 36 did not meet spirometry criteria. The spirometric BDR was found positive in seven subjects (19.4%); conversely, a positive oscillometric BDR was identified in four patients (11.1%). No patient presented a positive BDR response with both methods. In IOS, the mean decrease in R5 and AX was 19.9%\\u2009±\\u200910% and 44%\\u2009±\\u200922.1%, and the mean increase in X5 was 23.3%\\u2009±\\u200917.8%, respectively. A decrease in R5 of 25.7% (AUC 0.77, p\\u2009=\\u2009.03) and an increase in X5 of 25.7% (AUC 0.75, p\\u2009=\\u2009.04) showed the best combination of sensitivity and specificity to detect an increase of FEV', 'copyrights': '© 2024 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.', 'doi': '10.1002/ppul.26909', 'xml': <Element 'PubmedArticle' at 0x10b455df0>}\n",
      "{'pubmed_id': '38353300\\n34536239\\n31494963\\n28543019\\n24522090\\n34962721\\n30033911\\n28299827\\n35048385\\n36810982\\n36241154\\n36109590\\n27038243\\n32427616\\n27040372\\n36140253\\n34212792\\n35503509\\n31374358\\n30222111\\n36481420\\n37240667\\n26483177\\n27377155\\n31762438\\n33190334\\n30478912', 'title': 'A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study.', 'abstract': 'Although there have been significant advances in the treatment of chronic spontaneous urticaria (CSU) in recent years, there remains a lack of clear guidance on when and how to step down treatment in responders. This study aims to investigate stepping down approaches of different steps of CSU treatment from a global perspective.\\n\"Stepping down chronic spontaneous urticaria treatment\" (SDown-CSU) is an international, multicenter, observational, cross-sectional, survey-based study of the Urticaria Centers of Reference and Excellence (UCARE) network. The questionnaire included 48 questions completed by physicians in the UCARE network.\\nSurveys completed by 103 physicians from 81 UCAREs and 34 countries were analyzed. Seventy-eight percent of the participants responded that they had a national urticaria management guideline written by their professional societies and 28% responded that they had to operate under a regulatory guideline proposed by central health funding organizations. Seventy-two and 58.7% of these national recommendations do not contain any detailed information on when and/or how CSU treatment should be discontinued. There was a lack of detailed information on antihistamines and cyclosporine in particular. A predefined maximum duration was generally not applicable to omalizumab and cyclosporine (81% and 82%, respectively). Nearly all UCAREs step down omalizumab within 6\\xa0months from the first controlled status and 42% discontinue cyclosporine after 6\\xa0months regardless of the control status.\\nThe findings from the SDown-CSU study clearly highlight a global need for guidance on the process of stepping down treatment in CSU. Additionally, the study offers a step-down algorithm applicable to all stages of CSU treatment.', 'keywords': ['antihistamine', 'chronic urticaria', 'cyclosporine', 'guideline', 'omalizumab', 'step down', 'urticaria control test'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Türk', 'firstname': 'Murat', 'initials': 'M', 'affiliation': 'Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Turkey.\\nClinic of Allergy and Clinical Immunology, Kayseri City Education and Research Hospital, Kayseri, Turkey.'}, {'lastname': 'Kocatürk', 'firstname': 'Emek', 'initials': 'E', 'affiliation': 'Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.'}, {'lastname': 'Ertaş', 'firstname': 'Ragıp', 'initials': 'R', 'affiliation': 'Department of Dermatology, Chronic Skin Diseases Unit, University of Health Sciences, Kayseri City Education and Research Hospital, Kayseri, Turkey.'}, {'lastname': 'Ensina', 'firstname': 'Luis Felipe', 'initials': 'LF', 'affiliation': 'Division of Allergy, Immunology, Rheumatology, Federal University of São Paulo, Sao Paulo, Brazil.'}, {'lastname': 'Mariel Ferrucci', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': \"Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.\"}, {'lastname': 'Grattan', 'firstname': 'Clive', 'initials': 'C', 'affiliation': \"St John's Institute of Dermatology, Guy's Hospital, London, UK.\"}, {'lastname': 'Vestergaard', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Department of Dermatology, Aarhus University Hospital Denmark, Aarhus, Denmark.'}, {'lastname': 'Zuberbier', 'firstname': 'Torsten', 'initials': 'T', 'affiliation': 'Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.'}, {'lastname': 'Maurer', 'firstname': 'Marcus', 'initials': 'M', 'affiliation': 'Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.'}, {'lastname': 'Giménez-Arnau', 'firstname': 'Ana Maria', 'initials': 'AM', 'affiliation': 'Department of Dermatology, Hospital del Mar & Research Institute, Barcelona, Spain.\\nUniversitat Pompeu Fabra, Barcelona, Spain.'}], 'methods': None, 'conclusions': None, 'results': 'Surveys completed by 103 physicians from 81 UCAREs and 34 countries were analyzed. Seventy-eight percent of the participants responded that they had a national urticaria management guideline written by their professional societies and 28% responded that they had to operate under a regulatory guideline proposed by central health funding organizations. Seventy-two and 58.7% of these national recommendations do not contain any detailed information on when and/or how CSU treatment should be discontinued. There was a lack of detailed information on antihistamines and cyclosporine in particular. A predefined maximum duration was generally not applicable to omalizumab and cyclosporine (81% and 82%, respectively). Nearly all UCAREs step down omalizumab within 6\\xa0months from the first controlled status and 42% discontinue cyclosporine after 6\\xa0months regardless of the control status.', 'copyrights': '© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12343\\n10.1111/all.15090\\n10.1111/all.14037\\n10.1111/all.13209\\n10.1016/j.jaci.2013.12.1076\\n10.1002/clt2.12089\\n10.21911/aai.003\\n10.1016/j.jaip.2018.04.013\\n10.1111/jdv.14221\\n10.1111/all.15227\\n10.1007/s40257-023-00761-z\\n10.1016/j.jaip.2022.09.038\\n10.1038/s41572-022-00389-z\\n10.1111/all.12901\\n10.1097/mjt.0000000000000912\\n10.1016/j.jaci.2015.12.1342\\n10.3390/biomedicines10092152\\n10.1080/15569527.2021.1945618\\n10.18176/jiaci.0820\\n10.1016/j.jaip.2019.07.021\\n10.18176/jiaci.0323\\n10.1016/j.jaip.2022.11.016\\n10.3390/jcm12103561\\n10.1016/j.jaci.2015.08.023\\n10.1111/cea.12774\\n10.18176/jiaci.0464\\n10.1111/dth.14543\\n10.1111/all.13675', 'xml': <Element 'PubmedArticle' at 0x10a78c770>}\n",
      "{'pubmed_id': '38353268', 'title': 'Therapeutic potential of flavonoids in ovalbumin induced asthma in mice model.', 'abstract': 'The study used an aerosolized ovalbumin-induced asthma model to evaluate the effects of the flavonoids on various substances in bronchoalveolar lavage fluid, including total differential leukocyte, nitrite, nitrate, TNF, IL-4, and IL-13. The researchers also measured the levels of myeloperoxidase and malondialdehyde in the lungs.\\nThe results showed that ovalbumin-induced airway hyper-responsiveness led to a significant increase in pro-inflammatory cytokine levels. However, the flavonoids significantly decreased the severity of airway inflammation. Histopathology results also supported the effectiveness of the flavonoids. These findings suggest that these flavonoids could be a supplementary and alternative treatment for asthma by inhibiting the pro-inflammatory pathway.\\nThe findings suggest that the isolated compounds have the potential to act cumulatively to decrease the levels of the tested cytokines, normalize eosinophil and activated lymphocyte counts, and significantly reduce MPO and MDA. This indicates a possible respiratory mechanism of action for the drugs.', 'keywords': ['Asthma', 'inflammation', 'myloperoxidase', 'ovalbumin; flavonoids'], 'journal': 'Journal of complementary & integrative medicine', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Singh', 'firstname': 'Vedpal', 'initials': 'V', 'affiliation': 'Department of Pharmacognosy, College of Pharmacy, JSS Academy of Technical Education, Noida, UP, India.'}, {'lastname': 'Singh', 'firstname': 'Rohit', 'initials': 'R', 'affiliation': 'Department of Pharmaceutical Chemistry, College of Pharmacy, JSS Academy of Technical Education, Noida, UP, India.'}, {'lastname': 'Dhanabal', 'firstname': 'Sangai P', 'initials': 'SP', 'affiliation': 'Department of Pharmacognosy, College of Pharmacy, Jagadguru Sri Shivarathreeshwara Academy of Higher Education & Research, Ooty, Tamil Nadu, India.'}, {'lastname': 'Katrolia', 'firstname': 'Archita', 'initials': 'A', 'affiliation': 'Department of Pharmaceutics, College of Pharmacy, JSS Academy of Technical Education, Noida, UP, India.'}], 'methods': None, 'conclusions': None, 'results': 'The results showed that ovalbumin-induced airway hyper-responsiveness led to a significant increase in pro-inflammatory cytokine levels. However, the flavonoids significantly decreased the severity of airway inflammation. Histopathology results also supported the effectiveness of the flavonoids. These findings suggest that these flavonoids could be a supplementary and alternative treatment for asthma by inhibiting the pro-inflammatory pathway.', 'copyrights': '© 2024 Walter de Gruyter GmbH, Berlin/Boston.', 'doi': '10.1515/jcim-2023-0371\\n10.1016/j.mehy.2015.11.020\\n10.1111/j.1398-9995.2004.00526.x\\n10.1007/s12098-017-2400-7\\n10.1080/14786419.2017.1410813\\n10.1080/14786419.2018.1561679\\n10.4103/0250-474X.95652\\n10.1080/14786419.2019.1634716\\n10.1016/j.jep.2005.11.034\\n10.1007/s12272-009-1112-6\\n10.1076/phbi.39.3.181.5932\\n10.1080/14786419.2014.1003136\\n10.1016/j.pupt.2014.07.007\\n10.1038/ncomms1880', 'xml': <Element 'PubmedArticle' at 0x109de8ae0>}\n",
      "{'pubmed_id': '38353177', 'title': 'Acute exposure to pollen and airway inflammation in adolescents.', 'abstract': 'Pollen exposure is known to exacerbate allergic asthma and allergic rhinitis symptoms, yet few studies have investigated if exposure to pollen affects lung function or airway inflammation in healthy children.\\nWe evaluated the extent to which higher pollen exposure was associated with differences in airway inflammation and lung function among 490 early adolescent participants (mean age of 12.9 years) in Project Viva, a prebirth cohort based in Massachusetts. We obtained regional daily total pollen counts, including tree, grass, and weed pollen, from a Rotorod pollen counter. We evaluated associations of 3- and 7-day moving averages of pollen with fractional exhaled nitric oxide (FeNO) and lung function using linear regression models and evaluated the linearity of associations with penalized splines. We tested if associations of pollen with FeNO and lung function were modified by current asthma diagnosis, history of allergic rhinitis, aeroallergen sensitivity, temperature, precipitation, and air pollution.\\nThree- and 7-day median pollen concentrations were 19.0\\u2009grains/m\\nShort-term exposure to pollen was associated with higher FeNO in early adolescents, even in the absence of allergic sensitization and asthma.', 'keywords': ['aeroallergen', 'asthma', 'climate change', 'exhaled nitric oxide', 'lung function'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Nassikas', 'firstname': 'Nicholas J', 'initials': 'NJ', 'affiliation': 'Beth Israel Deaconess Medical Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, Massachusetts, USA.'}, {'lastname': 'Luttmann-Gibson', 'firstname': 'Heike', 'initials': 'H', 'affiliation': 'Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.'}, {'lastname': 'Rifas-Shiman', 'firstname': 'Sheryl L', 'initials': 'SL', 'affiliation': 'Department of Population Medicine, Harvard Medical School, Division of Chronic Disease Research Across the Lifecourse, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.'}, {'lastname': 'Oken', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Department of Population Medicine, Harvard Medical School, Division of Chronic Disease Research Across the Lifecourse, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.'}, {'lastname': 'Gold', 'firstname': 'Diane R', 'initials': 'DR', 'affiliation': \"Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.\\nHarvard Medical School, Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, Massachusetts, USA.\"}, {'lastname': 'Rice', 'firstname': 'Mary B', 'initials': 'MB', 'affiliation': 'Beth Israel Deaconess Medical Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Boston, Massachusetts, USA.'}], 'methods': None, 'conclusions': 'Short-term exposure to pollen was associated with higher FeNO in early adolescents, even in the absence of allergic sensitization and asthma.', 'results': 'Three- and 7-day median pollen concentrations were 19.0\\u2009grains/m', 'copyrights': '© 2024 Wiley Periodicals LLC.', 'doi': '10.1002/ppul.26908', 'xml': <Element 'PubmedArticle' at 0x10b2489f0>}\n",
      "{'pubmed_id': '38353126', 'title': 'Comparative effectiveness and tolerability of dual and triple combination inhaler therapies for adolescents and adults with asthma.', 'abstract': None, 'keywords': ['allergens', 'asthma', 'epitopes', 'pediatrics', 'pneumology', 'quality-of-life'], 'journal': 'Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Dashti', 'firstname': 'Fares', 'initials': 'F', 'affiliation': 'North Middlesex University Hospital NHS Trust, London, UK.'}, {'lastname': 'Gregory', 'firstname': 'Ian', 'initials': 'I', 'affiliation': 'North Middlesex University Hospital NHS Trust, London, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/cea.14458', 'xml': <Element 'PubmedArticle' at 0x10af5ab10>}\n",
      "{'pubmed_id': '38353099', 'title': 'EPI-SURVEY. Grade of awareness of Spanish allergist, hospital pharmacist, and pulmonologists on the relevance of bronchial epithelium and alarmins in the pathogenesis and management of severe asthma.', 'abstract': None, 'keywords': ['Alarmins', 'Epithelium', 'Pathogenesi', 'Tezepelumab', 'Treatment'], 'journal': 'Journal of investigational allergology & clinical immunology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Plaza', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Director of the Executive Committee of the Spanish Guide for the Management of Asthma (GEMA). Pneumology and Allergy Service, Hospital de la Santa Creu i Sant Pau. Sant Pau Institute of Biomedical Research (IIB Sant Pau). Department of Medicine, Universit.'}, {'lastname': 'Eguíluz', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Allergy Unit and Research Laboratory, Malaga Regional University Hospital and IBIMA-Plataforma BIONAND. RICORS Inflammatory Diseases Network. Málaga, Spain.'}, {'lastname': 'Garin', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona. Barcelona, Spain.'}, {'lastname': 'Martínez Moragón', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Pneumology Service, Dr Peset University Hospital. Valencia, Spain.'}, {'lastname': 'Palomares', 'firstname': 'O', 'initials': 'O', 'affiliation': 'Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University. Madrid, Spain.'}, {'lastname': 'Dávila', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Allergy Service, University Hospital of Salamanca. Biomedical and Diagnostics Sciences, Faculty of Medicine, University of Salamanca. RICORS Inflammatory Diseases Network RD21/0002/000. Salamanca, Spain.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.18176/jiaci.0997', 'xml': <Element 'PubmedArticle' at 0x10af58810>}\n",
      "{'pubmed_id': '38352910\\n32997808\\n32020334\\n30619350\\n0\\n21682736\\n19769993\\n19575684\\n33303090\\n19280828\\n17088145\\n8910830\\n29926951\\n1058834\\n14158464\\n15643744\\n29667525\\n9783301\\n12889707\\n6583212\\n327753\\n19186958\\n20949732\\n27028763\\n9542614\\n0\\n8164120\\n18294228\\n18672981\\n21523216', 'title': 'Association between asthma and periodontitis.', 'abstract': 'The association between asthma and periodontitis is of interest. 20 periodontitis patients with asthma (asthma group) and 20 patients without asthma (non-asthma group) were included based on inclusion and inclusion criteria. Periodontitis was classified according to 2017 periodontal classification and periodontal parameters such as tooth loss, pocket depth, clinical attachment loss, alveolar bone loss, bone reduction index, plaque index, bleeding index and periodontal risk were assessed. Effect of anti-asthmatic drugs and asthma control on periodontal parameters was also assessed. Inter-group comparison of all the continuous variables was done using independent \"t\" test. Comparison of categorical variables was done using Chi-square test. P value <0.05 was considered statistically significant. Results showed greater severity and higher grade of periodontitis with asthma group as well as with patients on anti-asthmatic drugs and patients with poor controlled asthma. Hence, there is an association between asthma and periodontitis.', 'keywords': ['Periodontitis', 'anti-asthmatic drugs', 'asthma', 'clinical attachment loss', 'periodontal risk', 'pocket depth'], 'journal': 'Bioinformation', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Ibraheem', 'firstname': 'Wael I', 'initials': 'WI', 'affiliation': 'Department of Preventive Dental Sciences, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Bhati', 'firstname': 'Ashok Kumar', 'initials': 'AK', 'affiliation': 'Department of Preventive Dental Sciences, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Essa Ageeli', 'firstname': 'Fai Mohammed', 'initials': 'FM', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Sufyani', 'firstname': 'Rehab Abdu', 'initials': 'RA', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Ahmed Darraj', 'firstname': 'Maram', 'initials': 'M', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Ageeli', 'firstname': 'Enas Omar', 'initials': 'EO', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Mobarki', 'firstname': 'Khalid Mohammed', 'initials': 'KM', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Alhazmi', 'firstname': 'Majed Yahya', 'initials': 'MY', 'affiliation': 'College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}, {'lastname': 'Mohamed Beshir', 'firstname': 'Saiid Elshafey', 'initials': 'SE', 'affiliation': 'Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral and Maxillofacial Surgery, College of Dentistry, Jazan University, Jazan 45142, Saudi Arabia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Biomedical Informatics.', 'doi': '10.6026/973206300200059\\n10.4103/jiaphd.jiaphd_85_16', 'xml': <Element 'PubmedArticle' at 0x109b413f0>}\n",
      "{'pubmed_id': '38352722\\n27167208\\n26836926\\n31534319\\n19184517\\n20418367\\n32278779\\n31769330\\n28733370\\n35300019\\n36996030\\n18929686\\n31078660\\n31298684\\n35274083\\n36094566\\n34279657\\n27123913\\n34752567\\n34334137\\n35300019', 'title': 'Pharmacist Review of Chronic Inhaler Therapy Appropriateness for Hospitalized Patients with COPD or Asthma.', 'abstract': \"Patients with asthma and chronic obstructive pulmonary disease rely on inhaler therapy to reduce disease progression and exacerbation risk. Patients admitted to the hospital are at an increased risk for exacerbations and readmission if their inhaler therapy upon discharge is not aligned with current guidelines and/or affordable.\\nAssess the appropriateness of the chronic inhaler regimen for patients admitted to the hospital based on clinical practice guidelines and insurance coverage.\\nA sub-study was designed to analyze a cohort of a single-center, pragmatic, prospective randomized controlled trial at a large academic medical center. Patients admitted to a medicine service with a pharmacist and prescribed a long-acting inhaler were included. Participants randomized to a pharmacist-led intervention were assessed for inhaler appropriateness based on clinical guidelines and patient insurance. The objective of this sub-study is to assess the number of inhalers identified as inappropriate based on the pharmacist's review. A patient was considered to have an inappropriate inhaler regimen if any of their inhalers were inconsistent with guideline recommendations or not covered by insurance. Descriptive statistics were used to characterize appropriate inhaler use.\\nThe study pharmacist reviewed 552 unique inhalers for 348 patients. Overall, 42% of inhalers were inappropriate, affecting 50.3% of participants. 20% of inhalers were inappropriate based on insurance, 26% were inappropriate based on guidelines, and 7% were inappropriate based on both criteria. Recommendations were placed via a pharmacy consult for 198 patients (57%), most recommending an inhaler initiation (55%), followed by inhaler discontinuation (38%).\\nA pharmacist-led review of chronic inhaler therapy for patients admitted to the hospital identified the need for a change in therapy based on financial or clinical guidelines in over half of the patients reviewed. Interventions to increase the appropriateness of prescribed inhalers are needed to reduce disease progression and disease exacerbation.\", 'keywords': ['Asthma', 'COPD', 'Discharge', 'Hospital', 'Hospital-based', 'Inhalers', 'Pharmacist Intervention', 'Pharmacy Service'], 'journal': 'Journal of the American College of Clinical Pharmacy : JACCP', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Parrott', 'firstname': 'Tate D', 'initials': 'TD', 'affiliation': 'Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232; 615-875-1537.'}, {'lastname': 'Wallace', 'firstname': 'Matthew D', 'initials': 'MD', 'affiliation': 'Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232.'}, {'lastname': 'Niehoff', 'firstname': 'Kristina M', 'initials': 'KM', 'affiliation': 'Vanderbilt Home Care Services, 2120 Belcourt Avenue, Nashville, TN 37212.'}, {'lastname': 'Eble', 'firstname': 'Sarah H', 'initials': 'SH', 'affiliation': 'Vanderbilt Complex Care Service, Vanderbilt University Medical Center 1301 Medical Center Drive, Nashville, TN 37232.'}, {'lastname': 'Blumenfeld', 'firstname': 'Lauren', 'initials': 'L', 'affiliation': 'PGY-1 Pharmacy Resident, Veterans Affairs Tennessee Valley Healthcare System, 1310 24 Ave S, Nashville, TN 37212.'}, {'lastname': 'Sevin', 'firstname': 'Carla M', 'initials': 'CM', 'affiliation': 'Pulmonary Patient Care Center, Vanderbilt Lung Institute, Vanderbilt University Medical Center, Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, 1161 21 Avenue S, T-1218 MCN, Nashville, TN 37232.'}, {'lastname': 'Choma', 'firstname': 'Neesha N', 'initials': 'NN', 'affiliation': 'Vanderbilt University Hospital & Clinics, 2135 Blakemore Avenue, Nashville, TN 37212; 615-343-1203; Department of Medicine, Department of Quality, Safety & Risk Prevention.'}, {'lastname': 'Gao', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'Department of Biostatistics, Vanderbilt University School of Medicine, 2525 West End Ave, Suite 1100, Nashville, TN 37203.'}, {'lastname': 'Choi', 'firstname': 'Leena', 'initials': 'L', 'affiliation': 'Department of Biostatistics, Vanderbilt University School of Medicine, 2525 West End Ave, Suite 1100, Nashville, TN 37203.'}, {'lastname': 'Lindsell', 'firstname': 'Christopher J', 'initials': 'CJ', 'affiliation': 'Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232.'}, {'lastname': 'Zuckerman', 'firstname': 'Autumn D', 'initials': 'AD', 'affiliation': 'Specialty Pharmacy Services, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232.'}], 'methods': None, 'conclusions': 'A pharmacist-led review of chronic inhaler therapy for patients admitted to the hospital identified the need for a change in therapy based on financial or clinical guidelines in over half of the patients reviewed. Interventions to increase the appropriateness of prescribed inhalers are needed to reduce disease progression and disease exacerbation.', 'results': 'The study pharmacist reviewed 552 unique inhalers for 348 patients. Overall, 42% of inhalers were inappropriate, affecting 50.3% of participants. 20% of inhalers were inappropriate based on insurance, 26% were inappropriate based on guidelines, and 7% were inappropriate based on both criteria. Recommendations were placed via a pharmacy consult for 198 patients (57%), most recommending an inhaler initiation (55%), followed by inhaler discontinuation (38%).', 'copyrights': None, 'doi': '10.1002/jac5.1862\\n10.1016/j.chest.2016.05.002\\n10.1016/j.chest.2015.12.039\\n10.2147/PPA.S209532\\n10.1007/s11096-009-9280-5\\n10.1378/chest.09-3031\\n10.1016/j.chest.2020.02.073\\n10.1177/0897190019889440\\n10.1136/bmjqs-2017-006529\\n10.1177/17151635211061141\\n10.1177/08971900231168927\\n10.1016/j.jbi.2019.103208', 'xml': <Element 'PubmedArticle' at 0x109daa390>}\n",
      "{'pubmed_id': '38352545', 'title': 'Benefits of Aeroallergen Testing on Oral Corticosteroid Bursts in Adults with Asthma.', 'abstract': 'Aeroallergen testing can improve precision care for persistent asthma and is recommended by the U.S. clinical guidelines. How testing benefits diverse populations of adults with asthma, and the importance of the testing modality used, are not fully understood.\\nWe sought to evaluate whether receipt of aeroallergen testing was associated with a reduction in oral corticosteroid (OCS) bursts.\\nWe used electronic health record data to conduct a retrospective, observational cohort study of adults with asthma who were prescribed an inhaled corticosteroid and had an Allergy/Immunology visit in a large health system between 1/1/2017-6/30/2022. Negative binomial regression models were used to evaluate whether OCS bursts in the 12-month period after an initial visit were reduced for patients who received aeroallergen testing. We also measured differences in benefit after excluding patients with chronic obstructive pulmonary disease (COPD) and smoking histories, and whether testing receipt was via skin prick or serum.\\n668/1,383 (48.3%) patients received testing. Receipt of testing was not associated with fewer bursts in all patients (incidence rate ratio (IRR)=0.83 versus no testing, p=0.059), but it was among never smokers without COPD (417/844 tested, IRR=0.68, p=0.004). The receipt of \\nGuideline-concordant aeroallergen testing in the context of Allergy/Immunology care was associated with clinical benefit in a real-life, diverse cohort of adults with asthma. This benefit varied according to patient comorbidities and the testing modality.', 'keywords': [], 'journal': 'medRxiv : the preprint server for health sciences', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Gleeson', 'firstname': 'Patrick K', 'initials': 'PK', 'affiliation': None}, {'lastname': 'Morales', 'firstname': 'Knashawn H', 'initials': 'KH', 'affiliation': None}, {'lastname': 'Buckey', 'firstname': 'Timothy M', 'initials': 'TM', 'affiliation': None}, {'lastname': 'Fadugba', 'firstname': 'Olajumoke O', 'initials': 'OO', 'affiliation': None}, {'lastname': 'Apter', 'firstname': 'Andrea J', 'initials': 'AJ', 'affiliation': None}, {'lastname': 'Christie', 'firstname': 'Jason D', 'initials': 'JD', 'affiliation': None}, {'lastname': 'Himes', 'firstname': 'Blanca E', 'initials': 'BE', 'affiliation': None}], 'methods': None, 'conclusions': 'Guideline-concordant aeroallergen testing in the context of Allergy/Immunology care was associated with clinical benefit in a real-life, diverse cohort of adults with asthma. This benefit varied according to patient comorbidities and the testing modality.', 'results': '668/1,383 (48.3%) patients received testing. Receipt of testing was not associated with fewer bursts in all patients (incidence rate ratio (IRR)=0.83 versus no testing, p=0.059), but it was among never smokers without COPD (417/844 tested, IRR=0.68, p=0.004). The receipt of ', 'copyrights': None, 'doi': '10.1101/2024.01.29.24301962', 'xml': <Element 'PubmedArticle' at 0x109a1f8d0>}\n",
      "{'pubmed_id': '38352523', 'title': 'Spatiotemporal Clusters of ERK Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells.', 'abstract': 'Spatially coordinated ERK signaling events (\"SPREADs\") transmit radially from a central point to adjacent cells via secreted ligands for EGFR and other receptors. SPREADs maintain homeostasis in non-pulmonary epithelia, but it is unknown whether they play a role in the airway epithelium or are dysregulated in inflammatory disease.\\n(1) To characterize the spatial heterogeneity of ERK activity in response to pro-inflammatory ligands, and (2) to assess the effects of pharmacological and metabolic regulators on cytokine-mediated SPREADs.\\nLive-cell ERK biosensor activity and SPREAD events were measured in human bronchial epithelial cell lines (HBE1 and 16HBE) and primary human bronchial epithelial cells (pHBE), in both submerged and biphasic Air-Liquid Interface (ALI) culture conditions (i.e., differentiated cells). Cells were exposed to pro-inflammatory cytokines relevant to asthma and chronic obstructive pulmonary disease (COPD), and to pharmacological treatments (gefitinib, tocilizumab, hydrocortisone) and metabolic modulators (insulin, 2-deoxyglucose) to probe the airway epithelial mechanisms of SPREADs. Phospho-STAT3 immunofluorescence was used to measure localized inflammatory responses to IL-6.\\nPro-inflammatory cytokines significantly increased the frequency of SPREADs. Notably, differentiated pHBE cells display increased SPREAD frequency that coincides with airway epithelial barrier breakdown. SPREADs correlate with IL-6 peptide secretion and localized pSTAT3. Hydrocortisone, inhibitors of receptor signaling, and suppression of metabolic function decreased SPREADs and local STAT3 activation.\\nPro-inflammatory cytokines modulate SPREADs in human airway epithelial cells via both secreted EGFR and IL6R ligands. SPREADs correlate with changes in epithelial barrier permeability, implying a role for spatiotemporal ERK signaling in barrier homeostasis and dysfunction during inflammation. The involvement of SPREADs in airway inflammation suggests a novel signaling mechanism that could be exploited clinically to supplement corticosteroid treatment for asthma and COPD.\\nWe demonstrate that proinflammatory cytokines cause spatiotemporally organized ERK signaling events called \"SPREADs\" in human airway epithelial cells, correlating with conditions that disrupt epithelial barrier function.', 'keywords': [], 'journal': 'bioRxiv : the preprint server for biology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'DeCuzzi', 'firstname': 'Nicholaus L', 'initials': 'NL', 'affiliation': None}, {'lastname': 'Oberbauer', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': None}, {'lastname': 'Chmiel', 'firstname': 'Kenneth J', 'initials': 'KJ', 'affiliation': None}, {'lastname': 'Pargett', 'firstname': 'Michael', 'initials': 'M', 'affiliation': None}, {'lastname': 'Ferguson', 'firstname': 'Justa M', 'initials': 'JM', 'affiliation': None}, {'lastname': 'Murphy', 'firstname': 'Devan', 'initials': 'D', 'affiliation': None}, {'lastname': 'Zeki', 'firstname': 'Amir A', 'initials': 'AA', 'affiliation': None}, {'lastname': 'Albeck', 'firstname': 'John G', 'initials': 'JG', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1101/2024.02.03.578773', 'xml': <Element 'PubmedArticle' at 0x109a1d1c0>}\n",
      "{'pubmed_id': '38352284\\n35965041\\n34064650\\n35965043\\n18026814\\n32789027\\n26113674\\n32568483\\n35307034\\n28893870\\n28089081\\n28003742\\n24792855\\n27556408\\n16268861\\n33781348\\n32981430\\n26379270\\n31931747\\n110216\\n31897973\\n29615204\\n34861442\\n28542337\\n35901603\\n32816816\\n32857432\\n16225388\\n34277075\\n34954637\\n34111571\\n31426658\\n35227902\\n35629128\\n9448515\\n32498942\\n36196224\\n35616887\\n33752530\\n34333291\\n32278916\\n31593836\\n33601224\\n32526832', 'title': 'Air quality self-management in asthmatic patients with COPD: An integrative review for developing nursing interventions to prevent exacerbations.', 'abstract': \"Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) patients experience a lower quality of life, frequent exacerbations, and worse pulmonary function. Environmental management is essential in a complex chronic condition, as pollutant exposure can worsen symptoms and increase morbidity and mortality. We aimed to identify evidence that informs nursing interventions in promoting self-management of air quality in asthmatic people with COPD.\\nWe conducted an integrative review in March of 2023. We searched the databases CINAHL, MEDLINE, Academic Search Complete, Cochrane Database of Systematic Reviews (CDSR), Scopus, Web of Science, Joanna Briggs Institute (JBI) Evidence-Based Practice Database, and Google Scholar. We included articles whose participants were adults with asthma, COPD, or both; the intervention was air quality management and the outcome of any exacerbations. We excluded editorials, letters, commentaries, opinion papers, position papers, study protocols, conference abstracts, and reviews. Data extraction and synthesis were performed, categorizing interventions according to nursing actions. Methodological quality assessment was conducted using the JBI Critical Appraisal Checklist tools. The review protocol was registered at Open Science Framework (https://doi.org/10.17605/OSF.IO/5Y4KW).\\nWe included five articles from different countries. The interventions promoting air quality self-management for individuals with asthma and COPD included vigilance interventions (health professional regular visits, assessment of symptoms), monitoring interventions (measurement of indoor and outdoor trigger factors), and educational interventions (air quality alerts, allergen avoidance). Policy interventions such as smoke-free policies and comprehensive strategies to improve air quality were also identified. These areas of focus represent critical components of nurses' interventions and can integrate the fundamental patterns of knowing in nursing. Although the studies reveal heterogeneous interventions and the methodological quality is variable, these interventions showed potential for preventing exacerbations, reducing emergency department visits, and minimizing hospitalizations.\\nThe study emphasizes the need for a comprehensive approach involving nurses in multidisciplinary teams to air quality self-management. They can use these results to inform their interventions and ways of knowing, benefiting individuals with asthma and COPD. Further research is needed to expand the evidence base and refine these interventions.\", 'keywords': ['Air quality', 'Asthma', 'Asthma-COPD overlap', 'Chronic disease', 'Chronic obstructive pulmonary disease', 'Nursing care', 'Self-management'], 'journal': 'International journal of nursing sciences', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Sebastião', 'firstname': 'Bruna F', 'initials': 'BF', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nHospital Center of Central Lisbon, Portugal.'}, {'lastname': 'Hortelão', 'firstname': 'Raquel M', 'initials': 'RM', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nCUF Tejo Hospital, Lisbon, Portugal.'}, {'lastname': 'Granadas', 'firstname': 'Sara S', 'initials': 'SS', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nUniversity Hospital Center of Northern Lisbon, Lisbon, Portugal.'}, {'lastname': 'Faria', 'firstname': 'José M', 'initials': 'JM', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nHospital Center of Central Lisbon, Portugal.\\nNursing Research, Innovation and Development Centre of Lisbon (CIDNUR), Lisbon, Portugal.'}, {'lastname': 'Pinto', 'firstname': 'Joana R', 'initials': 'JR', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nHospital Center of Central Lisbon, Portugal.\\nNursing Research, Innovation and Development Centre of Lisbon (CIDNUR), Lisbon, Portugal.'}, {'lastname': 'Henriques', 'firstname': 'Helga Rafael', 'initials': 'HR', 'affiliation': 'Nursing School of Lisbon, Lisbon, Portugal.\\nNursing Research, Innovation and Development Centre of Lisbon (CIDNUR), Lisbon, Portugal.'}], 'methods': None, 'conclusions': None, 'results': \"We included five articles from different countries. The interventions promoting air quality self-management for individuals with asthma and COPD included vigilance interventions (health professional regular visits, assessment of symptoms), monitoring interventions (measurement of indoor and outdoor trigger factors), and educational interventions (air quality alerts, allergen avoidance). Policy interventions such as smoke-free policies and comprehensive strategies to improve air quality were also identified. These areas of focus represent critical components of nurses' interventions and can integrate the fundamental patterns of knowing in nursing. Although the studies reveal heterogeneous interventions and the methodological quality is variable, these interventions showed potential for preventing exacerbations, reducing emergency department visits, and minimizing hospitalizations.\", 'copyrights': '© 2023 The Authors.', 'doi': '10.1016/j.ijnss.2023.12.003\\n10.1016/j.iac.2022.04.007\\n10.3390/diagnostics11050859\\n10.1016/j.iac.2022.03.001\\n10.1007/s11606-007-0316-z\\n10.1155/2020/6164343\\n10.1183/09031936.00008615\\n10.1186/s12931-022-01983-1\\n10.1183/13993003.00644-2017\\n10.1016/j.rppnen.2016.11.005\\n10.2147/COPD.S122282\\n10.1016/S0140-6736(14)60617-6\\n10.1164/rccm.201605-1014OC\\n10.1111/j.1365-2648.2005.03621.x\\n10.1186/s13643-021-01626-4\\n10.1098/rsta.2019.0314\\n10.1371/journal.pone.0138237\\n10.1186/s12874-020-0897-3\\n10.1191/1478088706qp063oa\\n10.1097/00012272-197810000-00004\\n10.46658/JBIMES-20-08\\n10.2478/inmed-2021-0155\\n10.1007/s11046-019-00417-9\\n10.1016/S2542-5196(17)30185-7\\n10.1016/j.ecoenv.2021.113034\\n10.1371/journal.pone.0177979\\n10.1016/j.hrtlng.2022.07.005\\n10.1136/bmj.m2521\\n10.1111/jan.14505\\n10.3912/ojin.vol10no03ppt01\\n10.21037/jtd-20-2360\\n10.1016/j.rmed.2021.106724\\n10.1016/j.jaip.2021.05.025\\n10.1177/1742395319869443\\n10.1007/s42452-019-0405-8\\n10.1016/j.anai.2022.02.009\\n10.3390/jpm12050708\\n10.1080/10473289.1997.10464074\\n10.1016/j.amjms.2020.03.016\\n10.1186/s43088-022-00305-0\\n10.1080/15412555.2022.2070062\\n10.1177/00368504211000906\\n10.1016/j.envint.2021.106790\\n10.1016/j.chemosphere.2020.126667\\n10.1016/j.envres.2019.108777\\n10.1016/j.envint.2021.106435\\n10.3390/atmos12060790\\n10.3390/ijerph17114103\\n10.15171/ipp.2018.14', 'xml': <Element 'PubmedArticle' at 0x10ad13dd0>}\n",
      "{'pubmed_id': '38352244\\n18398010\\n28793924\\n33824932\\n16641153\\n31375134\\n11832527\\n16936160\\n30076075\\n36490316\\n37296776\\n35210321\\n34755626\\n30657220\\n29928921\\n15705988\\n18188020\\n35485959\\n31275909\\n34822880\\n19562233\\n12893649\\n24404796\\n20528587\\n31916265\\n24057650\\n10807819\\n21422092\\n11770219\\n33498608\\n15790982\\n22970659\\n32341110\\n36668804\\n28554933\\n23962958\\n16935684\\n32071109\\n28141626\\n30829650\\n25405670\\n21377715\\n37445432\\n17493786\\n36649753\\n35304842\\n25366866\\n37464122\\n36434743\\n29083406\\n26542096\\n31887393\\n35616899\\n32112994\\n36572354\\n17430343\\n20132157\\n28089118\\n33087044\\n30680016\\n23661040\\n10586888\\n15223862\\n18547625\\n15764725\\n30927345\\n20860503\\n18760831\\n31676793\\n30728087\\n28399567\\n20233433\\n19052046\\n36706985\\n34929071\\n28987219\\n37086744\\n33764693\\n34953518\\n28646947\\n31985546\\n34843132\\n34648974\\n25705822\\n31812184\\n24481186\\n24727807\\n36084766\\n36727912\\n17919709\\n35055391\\n34841728\\n26399697\\n25049351\\n32391012\\n37150361\\n25907459\\n32524677\\n34018205\\n19134022\\n29678946\\n33446576\\n26192405\\n33829032\\n33014920\\n37607492\\n33509958\\n20604800\\n34224213\\n34773648\\n33746954\\n32485264\\n37488734\\n22534534\\n11597666\\n21112617\\n12239255\\n27518660\\n17928596\\n20921080\\n32784540\\n35724951\\n37181685\\n33418320\\n34868440\\n26073754\\n15131576\\n25282563\\n32087126\\n30796980\\n18805333\\n21051078\\n27184199\\n35238663\\n11240947\\n17133119\\n11799366\\n37916606\\n30589088\\n30183091\\n28561266\\n26371838\\n34901915\\n27653623\\n11842293\\n16792584\\n17620073\\n28689794\\n36702170\\n22036094\\n32147137\\n33965232\\n26382999\\n35470937\\n33705665\\n29592924\\n20805175\\n15536406\\n26853126\\n35344293\\n37545142\\n35387065\\n33078171\\n37577332', 'title': 'Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma.', 'abstract': \"Asthma, which affects some 300 million people worldwide and caused 455,000 deaths in 2019, is a significant burden to suffers and to society. It is the most common chronic disease in children and represents one of the major causes for years lived with disability. Significant efforts are made by organizations such as WHO in improving the diagnosis, treatment and monitoring of asthma. However asthma prevention has been less studied. Currently there is a concept of pre- diabetes which allows a reduction in full blown diabetes if diet and exercise are undertaken. Similar predictive states are found in Alzheimer's and Parkinson's diseases. In this paper we explore the possibilities for asthma prevention, both at population level and also investigate the possibility of defining a state of pre-asthma, in which intensive treatment could reduce progression to asthma. Since asthma is a heterogeneous condition, this paper is concerned with allergic asthma. A subsequent one will deal with late onset eosinophilic asthma.\", 'keywords': ['asthma', 'asthma natural history', 'pre-asthma', 'predisposition', 'quality of life', 'risk factors'], 'journal': 'Frontiers in allergy', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Scadding', 'firstname': 'G K', 'initials': 'GK', 'affiliation': 'Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.\\nDivision of Immunity and Infection, University College, London, United Kingdom.'}, {'lastname': 'McDonald', 'firstname': 'M', 'initials': 'M', 'affiliation': 'The Allergy Clinic, Blairgowrie, Randburg, South Africa.'}, {'lastname': 'Backer', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.'}, {'lastname': 'Scadding', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Allergy, Royal Brompton Hospital, London, United Kingdom.'}, {'lastname': 'Bernal-Sprekelsen', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Head of ORL-Deptartment, Clinic Barcelona, Barcelona, Spain.\\nChair of ORL, University of Barcelona, Barcelona, Spain.'}, {'lastname': 'Conti', 'firstname': 'D M', 'initials': 'DM', 'affiliation': 'The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.'}, {'lastname': 'De Corso', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Otolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.'}, {'lastname': 'Diamant', 'firstname': 'Z', 'initials': 'Z', 'affiliation': 'Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.\\nDepartment of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.\\nDepartment Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.\\nDeptarment of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.'}, {'lastname': 'Gray', 'firstname': 'C', 'initials': 'C', 'affiliation': \"Paediatric Allergist, Red Cross Children's Hospital and University of Cape Town, Cape Town, South Africa.\\nKidsallergy Centre, Cape Town, South Africa.\"}, {'lastname': 'Hopkins', 'firstname': 'C', 'initials': 'C', 'affiliation': \"Department of Rhinology and Skull Base Surgery, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom.\"}, {'lastname': 'Jesenak', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Clinical Immunology and Allergology, University Teaching Hospital in Martin, Martin, Slovakia.\\nDepartment of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia.\\nDepartment of Pulmonology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin, Martin, Slovakia.'}, {'lastname': 'Johansen', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Department of Dermatology, University of Zurich, Zurich, Switzerland.\\nDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.'}, {'lastname': 'Kappen', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Department of Pulmonology, STZ Centre of Excellence for Asthma, COPD and Respiratory Allergy, Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands.'}, {'lastname': 'Mullol', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain.'}, {'lastname': 'Price', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Observational and Pragmatic Research Institute, Singapore, Singapore.\\nDivision of Applied Health Sciences, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom.'}, {'lastname': 'Quirce', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.'}, {'lastname': 'Reitsma', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Otorhinolarynogology and Head/Neck Surgery, Amsterdam University Medical Centres, Location AMC, University of Amsterdam, Amsterdam, Netherlands.'}, {'lastname': 'Salmi', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Otorhinolaryngology, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.\\nDepartment of Allergy, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Senior', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.'}, {'lastname': 'Thyssen', 'firstname': 'J P', 'initials': 'JP', 'affiliation': 'Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Wahn', 'firstname': 'U', 'initials': 'U', 'affiliation': 'Former Head of the Department for Pediatric Pneumology and Immunology, Charite University Medicine, Berlin, Germany.'}, {'lastname': 'Hellings', 'firstname': 'P W', 'initials': 'PW', 'affiliation': 'Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals, Leuven, Belgium.\\nLaboratory of Allergy and Clinical Immunology, University Hospitals Leuven, Leuven, Belgium.\\nUpper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Scadding, McDonald, Backer, Scadding, Bernal-Sprekelsen, Conti, De Corso, Diamant, Gray, Hopkins, Jesenak, Johansen, Kappen, Mullol, Price, Quirce, Reitsma, Salmi, Senior, Thyssen, Wahn and Hellings.', 'doi': '10.3389/falgy.2023.1291185\\n10.1093/bmb/ldn013\\n10.1186/s13195-017-0283-5\\n10.21037/tgh.2020.04.04\\n10.1681/ASN.2005060638\\n10.1186/s13024-019-0333-5\\n10.1056/NEJMoa012512\\n10.2337/dc06-0560\\n10.1016/j.pcd.2018.07.003\\n10.1073/pnas.2213157119\\n10.3390/diagnostics13111924\\n10.1183/13993003.03179-2021\\n10.1016/S0140-6736(21)01450-1\\n10.1111/cea.13336\\n10.1016/j.jaci.2018.06.008\\n10.1378/chest.127.2.502\\n10.1097/ACI.0b013e3282f3b5b5\\n10.1111/all.15328\\n10.3389/fped.2019.00246\\n10.1016/j.jaci.2021.11.010\\n10.4104/pcrj.2009.00037\\n10.1164/rccm.200304-503OC\\n10.3109/02770903.2014.880718\\n10.3109/02770901003692819\\n10.1111/all.14177\\n10.1007/s11882-013-0389-1\\n10.1378/chest.117.5.1330\\n10.1542/peds.2010-2850\\n10.3390/ijerph18030992\\n10.1136/thx.2004.033688\\n10.1185/03007995.2012.722991\\n10.1183/13993003.01857-2019\\n10.3390/toxics11010077\\n10.1136/bmjopen-2016-015486\\n10.1093/ije/dyt150\\n10.1016/S0140-6736(06)69283-0\\n10.1503/cmaj.200025\\n10.1097/ACI.0000000000000349\\n10.1172/JCI124609\\n10.1097/MCP.0000000000000119\\n10.1016/j.jaci.2011.01.036\\n10.3390/jcm12134398\\n10.1016/j.bbi.2007.03.009\\n10.1016/j.chest.2023.01.015\\n10.1016/j.jaip.2022.02.040\\n10.1111/resp.12423\\n10.1007/978-3-031-32259-4_9\\n10.1002/clt2.12207\\n10.1038/ng.3985\\n10.1038/ncomms9804\\n10.1016/j.jaci.2019.12.899\\n10.1111/pai.13780\\n10.1016/j.jaad.2020.02.055\\n10.1016/j.jaci.2022.11.023\\n10.1111/j.1365-2222.2007.02675.x\\n10.1111/j.1398-9995.2009.02301.x\\n10.1016/S2213-2600(16)30424-6\\n10.1186/s12865-020-00384-7\\n10.3892/etm.2018.7096\\n10.1007/s00251-013-0706-9\\n10.1038/35037000\\n10.1136/thx.2003.016667\\n10.1016/j.jaci.2008.04.039\\n10.1164/rccm.200410-1312OC\\n10.1002/ppul.24292\\n10.1056/NEJMoa0906312\\n10.1016/j.jaci.2008.07.027\\n10.1038/s41467-019-13014-7\\n10.1017/S2040174419000047\\n10.1093/aje/kwx021\\n10.1186/1471-2466-10-14\\n10.1136/thx.2008.100875\\n10.1016/j.jaip.2023.01.014\\n10.1515/jpm-2021-0226\\n10.1016/j.jaci.2017.08.003\\n10.1016/S0140-6736(23)00811-5\\n10.1111/irv.12850\\n10.1016/S2214-109X(21)00464-2\\n10.1016/S0163-4453(17)30185-8\\n10.1097/ACI.0000000000000627\\n10.1111/pai.13707\\n10.1016/j.anai.2021.10.005\\n10.1056/NEJMoa1414850\\n10.1016/j.jaci.2019.06.045\\n10.1093/emph/eot004\\n10.1093/aje/kwu072\\n10.1016/j.jaci.2022.08.026\\n10.1111/all.15666\\n10.1016/j.jaci.2007.07.034\\n10.3390/jpm12010075\\n10.1002/clt2.12076\\n10.1038/jid.2015.333\\n10.1542/peds.2014-0439\\n10.3389/fimmu.2020.00700\\n10.1016/j.jaci.2023.02.034\\n10.1038/nri3830\\n10.1111/pai.13303\\n10.1111/all.14949\\n10.1111/j.1365-2222.2008.03125.x\\n10.1183/13993003.02070-2017\\n10.1183/13993003.00937-2020\\n10.1111/apa.13132\\n10.3389/fnut.2021.629740\\n10.3389/fped.2020.00480\\n10.1159/000531970\\n10.1183/13993003.03633-2020\\n10.1111/j.1365-2222.2010.03560.x\\n10.15586/aei.v49i4.69\\n10.1111/cea.14050\\n10.3389/fimmu.2021.611474\\n10.1016/j.jaci.2020.05.023\\n10.1002/clt2.12274\\n10.1016/j.jaci.2012.03.013\\n10.1016/S0140-6736(01)06252-3\\n10.1016/j.jaci.2010.10.010\\n10.1056/NEJMoa020057\\n10.1056/NEJMoa1508749\\n10.1056/NEJMoa052632\\n10.1136/bmj.c4978\\n10.3390/ijerph17165700\\n10.1016/j.jaip.2022.05.038\\n10.3389/fpubh.2023.1123555\\n10.1016/j.imbio.2020.152052\\n10.1155/2021/5434315\\n10.1016/j.jaci.2015.04.045\\n10.1016/j.jaci.2004.01.778\\n10.1016/j.jaci.2014.08.005\\n10.1016/S0140-6736(19)32984-8\\n10.1016/j.jaci.2019.02.007\\n10.1016/S0140-6736(08)61446-4\\n10.1016/j.jaci.2010.09.008\\n10.1016/j.anai.2016.04.016.E\\n10.1177/19458924221080260\\n10.1067/mai.2001.113046\\n10.1097/MCP.0b013e328010d0db\\n10.1067/mai.2002.120554\\n10.1111/all.15927\\n10.1111/all.13705\\n10.1111/all.13598\\n10.1111/all.13213\\n10.1016/j.jaci.2015.07.038\\n10.1016/j.lanepe.2021.100275\\n10.1111/pai.12661\\n10.1067/mai.2002.121317\\n10.1111/j.1398-9995.2006.01068.x\\n10.1111/j.1398-9995.2007.01451.x\\n10.1016/j.jaci.2017.06.014\\n10.1016/j.rmed.2023.107125\\n10.1016/j.jaci.2011.09.020\\n10.1016/j.jaip.2019.11.029\\n10.1016/j.jaci.2021.03.037\\n10.1016/S0140-6736(15)00156-7\\n10.1111/pai.13773\\n10.1164/rccm.202003-0520OC\\n10.3399/bjgp18X695369\\n10.1136/thx.2009.126912\\n10.1016/j.jaci.2004.05.072\\n10.1016/j.jaci.2015.12.1298\\n10.1002/clt2.12129\\n10.1111/all.15835\\n10.3389/falgy.2021.706589\\n10.4193/Rhin20.246\\n10.3389/falgy.2023.1236977', 'xml': <Element 'PubmedArticle' at 0x109fbe250>}\n",
      "{'pubmed_id': '38352238\\n24184873\\n33322971\\n33744451\\n32432948\\n19688599\\n19628035\\n18842334\\n25698556\\n32670826\\n9620844\\n31275909\\n14516139\\n35932929\\n9422506\\n33342315\\n34964423\\n29029547\\n19935772\\n9659349\\n27782356\\n19111365\\n18029123\\n25307458\\n24121507\\n11050261\\n25107441\\n28493079\\n19427028\\n23328619\\n29209456\\n26253578\\n16487041\\n9765397\\n10604474\\n26156213\\n25371580\\n19713971\\n23580257\\n20558157\\n20923401\\n16271733\\n23960751\\n21799018\\n25684443\\n11182682\\n11025169\\n12587963\\n12810348\\n32733448\\n19911854\\n19061976\\n25479317\\n18276094\\n25305594\\n17059340\\n29130366\\n17292351\\n20163942\\n19205849\\n30159729\\n28811706\\n34484407\\n17101734\\n18179617\\n16677071\\n18177234\\n26546895\\n16923830\\n12593938\\n11256890\\n34624416\\n21364619\\n28846632\\n20846953\\n26997868\\n26335713\\n32920093\\n21504350\\n21203962', 'title': 'Preparation and in vivo evaluation of nano sized cubosomal dispersion loaded with Ruta graveolens extracts as a novel approach to reduce asthma-mediated lung inflammation.', 'abstract': 'Asthma is a chronic disease affecting people of all ages. Asthma medications are associated with adverse effects restricting their long-term usage, demanding newer alternative therapies. This study aimed to investigate the anti-asthmatic properties of ', 'keywords': ['Apoptosis', 'Autophagy', 'Beclin-1', 'Behavior scoring', 'Ovalbumin Allergic airway', 'Respiratory function'], 'journal': 'Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Alyami', 'firstname': 'Mohammad H', 'initials': 'MH', 'affiliation': 'Department of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.'}, {'lastname': 'Hamdan', 'firstname': 'Dalia I', 'initials': 'DI', 'affiliation': 'Department of Pharmacognosy and Natural Products, Faculty of Pharmacy, Menoufia University, Shibin Elkom 32511, Egypt.'}, {'lastname': 'Khalil', 'firstname': 'Heba M A', 'initials': 'HMA', 'affiliation': 'Department of Veterinary Hygiene and Management, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.'}, {'lastname': 'Orabi', 'firstname': 'Mohamed A A', 'initials': 'MAA', 'affiliation': 'Department of Pharmacognosy, College of Pharmacy, Najran University, Najran, Saudi Arabia.\\nDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut-branch, Assiut 71524, Egypt.'}, {'lastname': 'Aborehab', 'firstname': 'Nora M', 'initials': 'NM', 'affiliation': 'Department of Biochemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza 12451, Egypt.'}, {'lastname': 'Osama', 'firstname': 'Nada', 'initials': 'N', 'affiliation': 'Biochemistry Department, Faculty of Pharmacy, Menoufia University, Gamal Abd El Nasr st., Shibin Elkom, 32511 Menoufia, Egypt.'}, {'lastname': 'Abdelhafez', 'firstname': 'Mai M', 'initials': 'MM', 'affiliation': 'Department of Pharmacology and Toxicology, Faculty of Pharmacy, MSA University, Egypt.'}, {'lastname': 'Al-Mahallawi', 'firstname': 'Abdulaziz Mohsen', 'initials': 'AM', 'affiliation': 'Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.'}, {'lastname': 'Alyami', 'firstname': 'Hamad S', 'initials': 'HS', 'affiliation': 'Department of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Author(s).', 'doi': '10.1016/j.jsps.2024.101968\\n10.1080/10717544.2020.1859000\\n10.1080/13880209.2020.1762669\\n10.1208/s12249-009-9296-0\\n10.1016/j.freeradbiomed.2009.07.023\\n10.1016/j.canlet.2008.09.004\\n10.1016/j.intimp.2015.01.031\\n10.1016/j.jtcme.2020.05.002\\n10.1101/gad.12.11.1551\\n10.3389/fped.2019.00246\\n10.1016/j.ijpharm.2022.122080\\n10.3390/pr8050531\\n10.21608/blj.2014.63402\\n10.1038/34112\\n10.1080/10717544.2020.1858997\\n10.1080/10717544.2021.2018522\\n10.18632/oncotarget.19164\\n10.1136/thx.53.3.166\\n10.1111/resp.12926\\n10.1016/j.lungcan.2008.11.005\\n10.1016/j.jep.2007.09.004\\n10.1111/crj.12227\\n10.1074/jbc.M113.518134\\n10.1136/thorax.55.11.925\\n10.1016/j.intimp.2014.07.029\\n10.1007/s10753-017-0581-x\\n10.1016/j.cell.2009.03.015\\n10.1016/j.intimp.2012.12.018\\n10.4162/nrp.2017.11.6.461\\n10.1016/j.jep.2015.07.049\\n10.1128/jvi.72.11.8586-8596.1998\\n10.1038/45257\\n10.1038/srep11758\\n10.1038/cdd.2009.121\\n10.1002/ptr.4983\\n10.1016/j.phytochem.2005.09.019\\n10.1016/j.jsps.2011.04.001\\n10.1074/jbc.R110.197046\\n10.1067/mda.2000.da0470005\\n10.1016/0927-7757(96)03563-7\\n10.1016/s0378-8741(00)00279-8\\n10.1053/rmed.2003.1439\\n10.1016/S1567-5769(02)00235-7\\n10.2165/11319930-000000000-00000\\n10.1016/j.intimp.2008.10.021\\n10.1097/ACI.0000000000000129\\n10.1016/j.jep.2007.12.013\\n10.1016/j.intimp.2014.09.013\\n10.1016/j.ejphar.2007.01.002\\n10.1007/s10787-009-8044-0\\n10.1007/s00405-018-5104-3\\n10.3748/wjg.v23.i28.5097\\n10.1111/j.1399-3038.2007.00668.x\\n10.1083/jcb.200605036\\n10.1016/j.fct.2021.112592\\n10.1038/cddis.2009.16\\n10.3390/ijms18091865\\n10.1093/jmcb/mjq028\\n10.4137/BCBCR.S32791\\n10.1016/j.jaci.2020.08.033\\n10.1007/s13238-010-0048-4', 'xml': <Element 'PubmedArticle' at 0x10a9a6cf0>}\n",
      "{'pubmed_id': '38351904\\n30991176\\n29859815\\n27639458\\n35193145\\n28181676\\n36813908\\n35125993\\n31002320\\n29175685\\n36056058\\n36767660\\n34118634\\n19796226\\n25809555\\n34140239\\n36828882\\n22430451\\n35498955\\n29664587\\n24618794\\n25136039\\n25976706\\n26869575\\n31671856\\n34698778\\n30927373\\n29094161\\n36653562\\n30305743\\n37813672\\n33556963\\n35234877\\n36192375\\n32667747\\n33542091\\n27542586\\n26475651\\n26192405\\n36075638\\n36670399\\n34857474\\n36320027', 'title': 'Maternal smoking around birth and its influence on offspring allergic diseases: A mendelian randomization study.', 'abstract': \"The influence of maternal smoking around birth (MSAB) on offspring allergic diseases, specifically childhood asthma (CA), allergic rhinitis (AR), allergic conjunctivitis (AC), and atopic dermatitis (AD) remains incompletely understood. We performed a rigorous mendelian randomization (MR) study to obtain the unconfounded association between MSAB and allergic diseases in offspring with and without adjustment for the effect of breastfeeding.\\nUtilizing publicly available information of MSAB, breastfeeding, CA, AR, AC, and AD from large-scale genome-wide association studies (GWAS), we performed a two-sample mendelian randomization (TSMR) analysis to assess the respective causal relationship of MSAB and breastfeeding to allergic diseases in offspring. To get a reliable conclusion, MR Egger regression, weighted median, and inverse variance weighted (IVW) were employed to estimate the causality, with IVW as the primary analysis. Multivariate MR (MVMR) analysis was used to assess the effect of MSAB on allergic diseases after adjusting for breastfeeding's impact. Sensitivity analysis was conducted using the Cochran Q test, MR-Egger, and leave-one-out approaches to ensure the reliability and stability of results.\\nThe TSMR analysis demonstrated MSAB increased the risks of CA (P\\nOur findings provided robust evidence of the adverse effects of MSAB on offspring. We emphasized the urgency of smoking cessation around birth and the importance of breastfeeding even in smoking mothers.\", 'keywords': ['Allergic diseases', 'Breastfeeding', 'Maternal smoking around birth', 'Mendelian randomization'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Ruan', 'firstname': 'Qiqi', 'initials': 'Q', 'affiliation': \"Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, People's Republic of China.\"}, {'lastname': 'Jiang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': \"Department of Pediatrics, Women and Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China.\"}, {'lastname': 'Shi', 'firstname': 'Yuan', 'initials': 'Y', 'affiliation': \"Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, People's Republic of China.\"}], 'methods': None, 'conclusions': 'Our findings provided robust evidence of the adverse effects of MSAB on offspring. We emphasized the urgency of smoking cessation around birth and the importance of breastfeeding even in smoking mothers.', 'results': 'The TSMR analysis demonstrated MSAB increased the risks of CA (P', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.waojou.2024.100875', 'xml': <Element 'PubmedArticle' at 0x146f5dcb0>}\n",
      "{'pubmed_id': '38351903\\n31002957\\n36736958\\n27522159\\n32247684\\n36738781\\n34655480\\n31917365\\n30253936\\n25589011\\n33166672\\n20144472\\n23342293\\n29751156\\n32259567\\n35387028\\n35387013', 'title': 'Bypassing the build-up phase for oral immunotherapy in shrimp-allergic children.', 'abstract': 'Oral immunotherapy is an effective treatment for food allergies; however, its use in clinical practice is limited by resources and lack of standardized protocols for foods other than peanut. Previous studies have suggested that shrimp has a higher threshold for reaction than other allergenic foods, suggesting it may be safe to directly administer maintenance doses of immunotherapy.\\nChildren aged 3-17 years who had 1) skin prick test ≥3\\xa0mm and/or specific IgE level ≥0.35\\xa0kU/L and convincing objective IgE-mediated reaction to shrimp, or 2) no ingestion history and specific IgE level ≥5\\xa0kU/L, underwent a low-dose oral food challenge to 300\\xa0mg shrimp protein, with the goal of continuing daily ingestion of the 300 mg maintenance dose as oral immunotherapy.\\nBetween January 2020 and April 2023, 17 children completed the low-dose oral food challenge. Nine (53%) tolerated this amount with no reaction, and 8 (47%) had a mild reaction (isolated oral pruritis or redness on chin). Sixteen (94%) continued maintenance low-dose oral immunotherapy eating 300\\xa0mg shrimp protein daily. None of the patients developed anaphylaxis related to the immunotherapy.\\nOur case series suggests that some shrimp allergic patients being considered for oral immunotherapy should be offered a low-dose oral food challenge, to potentially bypass the build-up phase of immunotherapy.', 'keywords': ['Build-up phase', 'Children', 'Eliciting dose', 'Food allergy', 'Oral food challenge', 'Oral immunotherapy', 'Shrimp'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Schoos', 'firstname': 'Ann-Marie M', 'initials': 'AM', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.\\nDepartment of Pediatrics, Slagelse Hospital, Slagelse, Denmark.\\nDepartment of Clinical Medicine, University of Copenhagen, Denmark.'}, {'lastname': 'Chan', 'firstname': 'Edmond S', 'initials': 'ES', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\\nBritish Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.\"}, {'lastname': 'Wong', 'firstname': 'Tiffany', 'initials': 'T', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\\nBritish Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.\"}, {'lastname': 'Erdle', 'firstname': 'Stephanie C', 'initials': 'SC', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\\nBritish Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.\"}, {'lastname': 'Chomyn', 'firstname': 'Alanna', 'initials': 'A', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\"}, {'lastname': 'Soller', 'firstname': 'Lianne', 'initials': 'L', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\\nBritish Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.\"}, {'lastname': 'Mak', 'firstname': 'Raymond', 'initials': 'R', 'affiliation': \"Division of Allergy, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.\\nBritish Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.\"}], 'methods': None, 'conclusions': 'Our case series suggests that some shrimp allergic patients being considered for oral immunotherapy should be offered a low-dose oral food challenge, to potentially bypass the build-up phase of immunotherapy.', 'results': 'Between January 2020 and April 2023, 17 children completed the low-dose oral food challenge. Nine (53%) tolerated this amount with no reaction, and 8 (47%) had a mild reaction (isolated oral pruritis or redness on chin). Sixteen (94%) continued maintenance low-dose oral immunotherapy eating 300\\xa0mg shrimp protein daily. None of the patients developed anaphylaxis related to the immunotherapy.', 'copyrights': '© 2023 The Author(s).', 'doi': '10.1016/j.waojou.2023.100865', 'xml': <Element 'PubmedArticle' at 0x109c9ecf0>}\n",
      "{'pubmed_id': '38351891', 'title': 'Immune modulation by rural exposures and allergy protection.', 'abstract': 'Growing up on traditional farms protects children from the development of asthma and allergies. However, we have identified distinct asthma-protective factors, such as poultry exposure. This study aims to examine the biological effect of rural exposure in China.\\nWe recruited 67 rural children (7.4\\u2009±\\u20090.9\\u2009years) and 79 urban children (6.8\\u2009±\\u20090.6\\u2009years). Depending on the personal history of exposure to domestic poultry (DP), rural children were further divided into those with DP exposure (DP\\nThere was a stepwise increase in the percentage of eosinophils (%) from rural DP\\nImmune responses of rural children were dampened compared to urban children and those exposed to DP had further downregulated immune responsiveness. DP dust extracts ameliorated Th2-driven allergic airway inflammation in mice. Determining active protective components in the rural environment may provide directions for the development of primary prevention of asthma.', 'keywords': ['asthma', 'environment', 'immune', 'protection', 'rural'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Xing', 'firstname': 'Yuhan', 'initials': 'Y', 'affiliation': 'School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.\\nDepartment of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}, {'lastname': 'Tsang', 'firstname': 'Miranda Sin-Man', 'initials': 'MS', 'affiliation': 'Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}, {'lastname': 'Yang', 'firstname': 'Zhaowei', 'initials': 'Z', 'affiliation': 'Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Wang', 'firstname': 'Maggie Haitian', 'initials': 'MH', 'affiliation': 'Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China.'}, {'lastname': 'Pivniouk', 'firstname': 'Vadim', 'initials': 'V', 'affiliation': 'Department of Cellular and Molecular Medicine, Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona, USA.'}, {'lastname': 'Leung', 'firstname': 'Agnes Sze-Yin', 'initials': 'AS', 'affiliation': 'Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}, {'lastname': 'Leung', 'firstname': 'Ting-Fan', 'initials': 'TF', 'affiliation': 'Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}, {'lastname': 'Roponen', 'firstname': 'Marjut', 'initials': 'M', 'affiliation': 'Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland.'}, {'lastname': 'Schaub', 'firstname': 'Bianca', 'initials': 'B', 'affiliation': \"Pediatric Allergology, Department of Pediatrics, Dr von Hauner Children's Hospital, University Hospital, Munich, Germany.\"}, {'lastname': 'Vercelli', 'firstname': 'Donata', 'initials': 'D', 'affiliation': 'Department of Cellular and Molecular Medicine, Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona, USA.'}, {'lastname': 'Wong', 'firstname': 'Chun-Kwok', 'initials': 'CK', 'affiliation': 'Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}, {'lastname': 'Li', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Wong', 'firstname': 'Gary Wing-Kin', 'initials': 'GW', 'affiliation': 'Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.'}], 'methods': None, 'conclusions': None, 'results': 'There was a stepwise increase in the percentage of eosinophils (%) from rural DP', 'copyrights': '© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14086', 'xml': <Element 'PubmedArticle' at 0x109b3ebb0>}\n",
      "{'pubmed_id': '38351820', 'title': 'Characteristics of patients with severe asthma in primary and secondary care settings considered eligible for biological therapy - the Bulgarian RECOGNISE study.', 'abstract': 'Asthma is a major non-communicable disease. It affects both children and adults, but is the most common chronic condition among the former. While inhaled controller drugs stabilize the disease in most asthma patients, there are a certain number of people who suffer from severe asthma, which requires treatment escalation. Oral corticosteroids are usually added, but they are associated with various side effects that may limit their application. The introduction of biologicals targeting inflammatory mediators has opened a new era of asthma treatment highlighting the importance of patient characterization.', 'keywords': ['asthma specialist biological therapy eligibility severe asthma'], 'journal': 'Folia medica', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Ivanov', 'firstname': 'Yavor', 'initials': 'Y', 'affiliation': 'Dr G. Stranski University Hospital, Pleven, Bulgaria.'}, {'lastname': 'Hodzhev', 'firstname': 'Vladimir', 'initials': 'V', 'affiliation': 'Medical University of Plovdiv, Plovdiv, Bulgaria.'}, {'lastname': 'Vulkova-Gospodinova', 'firstname': 'Diana', 'initials': 'D', 'affiliation': 'Medical University of Varna, Varna, Bulgaria.'}, {'lastname': 'Stoyanova', 'firstname': 'Anelia', 'initials': 'A', 'affiliation': 'MHAT, Pleven, Bulgaria.'}, {'lastname': 'Mihaylov', 'firstname': 'Svetlan', 'initials': 'S', 'affiliation': 'MC New Rehabilitation Centre EOOD, Stara Zagora, Bulgaria.'}, {'lastname': 'Dzhambazova', 'firstname': 'Veselka', 'initials': 'V', 'affiliation': 'St Ivan Rilski University Hospital, Sofia, Bulgaria.'}, {'lastname': 'Aleksandrova', 'firstname': 'Radka', 'initials': 'R', 'affiliation': 'DCC Ascendent, Sofia, Bulgaria.'}, {'lastname': 'Aron', 'firstname': 'Erdal', 'initials': 'E', 'affiliation': 'AstraZeneca EOOD, Sofia, Bulgaria.'}, {'lastname': 'Zhelev', 'firstname': 'Filip', 'initials': 'F', 'affiliation': 'AstraZeneca EOOD, Sofia, Bulgaria.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.3897/folmed.65.e94233', 'xml': <Element 'PubmedArticle' at 0x10addb1a0>}\n",
      "{'pubmed_id': '38351552\\n20309010\\n21717064\\n12531790\\n28396662\\n23890062\\n27084743\\n25001465\\n23582482\\n31981982\\n9885236\\n33854509\\n28192720\\n8145033\\n30719026\\n24872109\\n26078335\\n9650914\\n10706088\\n33634564\\n22579107\\n10837075\\n17898760\\n12576425\\n36341366\\n33042791\\n12598895\\n8665590\\n32590296\\n16469120\\n9628653\\n32764681\\n9259401\\n22636320\\n29632307\\n19837091\\n37951911\\n31980913\\n32565925\\n34363009\\n34257408', 'title': 'Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors.', 'abstract': 'Dendritic cells (DCs) play a crucial role in immunity. Research on monocyte-derived DCs (Mo-DCs) cancer vaccines is in progress despite limited success in clinical trials. This study focuses on Mo-DCs generated from prostate cancer (PCA) patients, comparing them with DCs from healthy donors (HD-DCs).\\nMo-DCs were isolated from PCA patient samples, and their phenotype was compared to HD-DCs. Key parameters included monocyte count, CD14 expression, and the levels of maturation markers (HLA-DR, CD80, CD86) were assessed.\\nPCA samples exhibited a significantly lower monocyte count and reduced CD14 expression compared to healthy samples (p\\u2009⟨\\u20090.0001). Additionally, PCA-DCs expressed significantly lower levels of maturation markers, including HLA-DR, CD80, and CD86, when compared to HD-DCs (p\\u2009=\\u20090.123, p\\u2009=\\u20090.884, and p\\u2009=\\u20090.309, respectively).\\nThe limited success of DC vaccines could be attributed to impaired phenotypic characteristics. These observations suggest that suboptimal characteristics of Mo-DCs generated from cancer patient blood samples might contribute to the limited success of DC vaccines. Consequently, this study underscores the need for alternative strategies to enhance the features of Mo-DCs for more effective cancer immunotherapies.', 'keywords': ['co-stimulatory molecules', 'dendritic cells', 'prostate cancer'], 'journal': 'Cancer reports (Hoboken, N.J.)', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Bakhshi', 'firstname': 'Parisa', 'initials': 'P', 'affiliation': 'Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Nourizadeh', 'firstname': 'Maryam', 'initials': 'M', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Sharifi', 'firstname': 'Laleh', 'initials': 'L', 'affiliation': 'Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Nowroozi', 'firstname': 'Mohammad R', 'initials': 'MR', 'affiliation': 'Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Mohsenzadegan', 'firstname': 'Monireh', 'initials': 'M', 'affiliation': 'Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Farajollahi', 'firstname': 'Mohammad M', 'initials': 'MM', 'affiliation': 'Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.'}], 'methods': None, 'conclusions': 'The limited success of DC vaccines could be attributed to impaired phenotypic characteristics. These observations suggest that suboptimal characteristics of Mo-DCs generated from cancer patient blood samples might contribute to the limited success of DC vaccines. Consequently, this study underscores the need for alternative strategies to enhance the features of Mo-DCs for more effective cancer immunotherapies.', 'results': 'PCA samples exhibited a significantly lower monocyte count and reduced CD14 expression compared to healthy samples (p\\u2009⟨\\u20090.0001). Additionally, PCA-DCs expressed significantly lower levels of maturation markers, including HLA-DR, CD80, and CD86, when compared to HD-DCs (p\\u2009=\\u20090.123, p\\u2009=\\u20090.884, and p\\u2009=\\u20090.309, respectively).', 'copyrights': '© 2024 The Authors. Cancer Reports published by Wiley Periodicals LLC.', 'doi': '10.1002/cnr2.1996', 'xml': <Element 'PubmedArticle' at 0x10b5dfec0>}\n",
      "{'pubmed_id': '38351296\\n28919117\\n28797514\\n31273040\\n28658552\\n31904412\\n31734128\\n19114008\\n23323831\\n32948685\\n34144112\\n23193258\\n28933920\\n29485622\\n25822800\\n31641033\\n27765066\\n29141660\\n22455463\\n20576703\\n32313938\\n30931480\\n14597658\\n19465376\\n17186018\\n33068428\\n29126136\\n36271366\\n30639343\\n14644132\\n7722165\\n34082773\\n31678077\\n25511380\\n19699683\\n8735867\\n8609992\\n2469965\\n11726393\\n9300714\\n16750987\\n12752581\\n27256370\\n28888782\\n22754556\\n4911896\\n19238166\\n33039479\\n21917308\\n11520715\\n32072647\\n28877019\\n27883241\\n24332216\\n10619791\\n25162311\\n23160983\\n34342773\\n12867228\\n13769788\\n19077699\\n17463395\\n11179132\\n11799369\\n15957953\\n18432192\\n37146737\\n14656045\\n19704417\\n21517900\\n30334401\\n22868264\\n36911742\\n34512623\\n9164921\\n9647200\\n36002854\\n11114420\\n17084101\\n23860188\\n22461430\\n8306047\\n16516193\\n21804549\\n11244038\\n15696085\\n21828035\\n28948004\\n28529521\\n29662003\\n22382683\\n28252317\\n28356505\\n33640900\\n30691461\\n33679708\\n20442749\\n15479265\\n8240722\\n34025668\\n30703432', 'title': 'Bronchial epithelial transcriptomics and experimental validation reveal asthma severity-related neutrophilc signatures and potential treatments.', 'abstract': 'Airway epithelial transcriptome analysis of asthma patients with different severity was used to disentangle the immune infiltration mechanisms affecting asthma exacerbation, which may be advantageous to asthma treatment. Here we introduce various bioinformatics methods and develop two models: an OVA/CFA-induced neutrophil asthma mouse model and an LPS-induced human bronchial epithelial cell damage model. Our objective is to investigate the molecular mechanisms, potential targets, and therapeutic strategies associated with asthma severity. Multiple bioinformatics methods identify meaningful differences in the degree of neutrophil infiltration in asthma patients with different severity. Then, PTPRC, TLR2, MMP9, FCGR3B, TYROBP, CXCR1, S100A12, FPR1, CCR1 and CXCR2 are identified as the hub genes. Furthermore, the mRNA expression of 10 hub genes is determined in vivo and in vitro models. Reperixin is identified as a pivotal drug targeting CXCR1, CXCR2 and MMP9. We further test the potential efficiency of Reperixin in 16HBE cells, and conclude that Reperixin can attenuate LPS-induced cellular damage and inhibit the expression of them. In this study, we successfully identify and validate several neutrophilic signatures and targets associated with asthma severity. Notably, Reperixin displays the ability to target CXCR1, CXCR2, and MMP9, suggesting its potential therapeutic value for managing deteriorating asthma.', 'keywords': [], 'journal': 'Communications biology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Yan', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nGuangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Xinxin', 'initials': 'X', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nGuangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Xie', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Yang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nGuangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Chengxin', 'initials': 'C', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Miaofen', 'initials': 'M', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nGuangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Zheng', 'firstname': 'Wenjiang', 'initials': 'W', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Lin', 'firstname': 'Xueying', 'initials': 'X', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Huang', 'firstname': 'Hui-Ting', 'initials': 'HT', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Xiaohong', 'initials': 'X', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.'}, {'lastname': 'Jiang', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': 'Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China. jiangyongszzxy@163.com.'}, {'lastname': 'Zhan', 'firstname': 'Shao-Feng', 'initials': 'SF', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. zsfstone@163.com.'}, {'lastname': 'Huang', 'firstname': 'Xiufang', 'initials': 'X', 'affiliation': 'The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. huangxiufang@gzzyydx17.wecom.work.\\nThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, China. huangxiufang@gzzyydx17.wecom.work.\\nLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, China. huangxiufang@gzzyydx17.wecom.work.\\nGuangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou, China. huangxiufang@gzzyydx17.wecom.work.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s42003-024-05837-y', 'xml': <Element 'PubmedArticle' at 0x10a0ca020>}\n",
      "{'pubmed_id': '38350817', 'title': 'Role of diesel exhaust particle-induced cellular senescence in the development of asthma in young and old mice.', 'abstract': 'Although it has been reported that cellular senescence is important in the pathogenesis of asthma, the differential effects of diesel exhaust particle (DEP)-induced cellular senescence on the development of asthma according to age have not been thoroughly studied.\\nWe first confirmed that DEP induced cellular senescence in mouse lungs, and then that DEP-induced cellular senescence followed by intranasal instillation of a low-dose house dust mite (HDM) allergen resulted in murine asthma. Second, we examined age-dependent differential effects using 6-week-old (young) and 18-month-old mice (old), and tested whether the mammalian target of the rapamycin (mTOR) pathway plays an important role in this process. Finally, we performed in\\xa0vitro experiments using human bronchial epithelial cells (HBEC) originating from young and elderly adults to identify the underlying mechanisms.\\nDEP induced cellular senescence in the airway epithelial cells of young and old mice characterized by increased senescence-associated beta-galactosidase, S100A8/9, and high mobility group box 1 (HMGB1) expressions. DEP-induced cellular senescence with subsequent exposure to a low-dose HDM allergen resulted in asthma in young and old mice. Rapamycin (mTOR pathway inhibitor) administration before DEP instillation significantly attenuated these asthmatic features. In addition, after treatment with a low-dose HDM allergen, S100A9 and HMGB1 over-expressed HBEC originating from young and elderly adults greatly activated co-cultured monocyte-derived dendritic cells (DCs).\\nThis study showed that DEP-induced senescence made both young and old mice susceptible to allergic sensitization and resultant asthma development by enhancing DC activation. Public health efforts to reduce DEP exposure are warranted.', 'keywords': ['Animal model', 'Asthma', 'Cellular senescence', 'Diesel exhaust particles', 'mTOR protein'], 'journal': 'Allergology international : official journal of the Japanese Society of Allergology', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Lee', 'firstname': 'Hyun Seung', 'initials': 'HS', 'affiliation': 'Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.'}, {'lastname': 'Park', 'firstname': 'Heung-Woo', 'initials': 'HW', 'affiliation': 'Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea. Electronic address: guinea71@snu.ac.kr.'}], 'methods': None, 'conclusions': None, 'results': 'DEP induced cellular senescence in the airway epithelial cells of young and old mice characterized by increased senescence-associated beta-galactosidase, S100A8/9, and high mobility group box 1 (HMGB1) expressions. DEP-induced cellular senescence with subsequent exposure to a low-dose HDM allergen resulted in asthma in young and old mice. Rapamycin (mTOR pathway inhibitor) administration before DEP instillation significantly attenuated these asthmatic features. In addition, after treatment with a low-dose HDM allergen, S100A9 and HMGB1 over-expressed HBEC originating from young and elderly adults greatly activated co-cultured monocyte-derived dendritic cells (DCs).', 'copyrights': 'Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.alit.2024.01.010', 'xml': <Element 'PubmedArticle' at 0x10961c8b0>}\n",
      "{'pubmed_id': '38350732', 'title': 'Female reproductive histories and the risk of chronic obstructive pulmonary disease.', 'abstract': 'Female reproductive factors may influence the development of chronic obstructive pulmonary disease (COPD) through the female hormonal environment, but studies on this topic are limited. This study aimed to assess whether age at menarche, number of children, infertility, miscarriage, stillbirth and age at natural menopause were associated with the risk of COPD.\\nWomen from three cohorts with data on reproductive factors, COPD and covariates were included. Cause specific Cox regression models were adjusted for birth year, race, educational level, body mass index and pack years of smoking, stratified by asthma, and incorporating interaction between birth year and time. Between cohort differences and within cohort correlations were taken into account.\\nOverall, 2\\u200983\\u2009070\\u2009women were included and 10\\u2009737 (3.8%) developed COPD after a median follow-up of 11 (IQR 10-12) years. Analyses revealed a U shaped association between age at menarche and COPD (≤11 vs 13: HR 1.17, 95% CI 1.11 to 1.23; ≥16 vs 13: HR 1.24, 95% CI 1.21 to 1.27). Women with three or more children (3 vs 2: HR 1.14, 95% CI 1.12 to 1.17; ≥4 vs 2: HR 1.34, 95% CI 1.28 to 1.40), multiple miscarriages (2 vs 0: HR 1.28, 95% CI 1.24 to 1.32; ≥3 vs 0: HR 1.36, 95% CI 1.30 to 1.43) or stillbirth (1 vs 0: HR 1.38, 95% CI 1.25 to 1.53; ≥2 vs 0: HR 1.67, 95% CI 1.32 to 2.10) were at a higher risk of COPD. Among postmenopausal women, earlier age at natural menopause was associated with an increased risk of COPD (<40\\u2009vs 50-51: HR 1.69, 95% CI 1.63 to 1.75; 40-44 vs 50-51: HR 1.42, 95% CI 1.38 to 1.47).\\nMultiple female reproductive factors, including age at menarche, number of children, miscarriage, stillbirth, and age at natural menopause were associated with the risk of COPD.', 'keywords': ['COPD epidemiology'], 'journal': 'Thorax', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Liang', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.'}, {'lastname': 'Chung', 'firstname': 'Hsin-Fang', 'initials': 'HF', 'affiliation': 'School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.'}, {'lastname': 'Dobson', 'firstname': 'Annette', 'initials': 'A', 'affiliation': 'School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.'}, {'lastname': 'Sandin', 'firstname': 'Sven', 'initials': 'S', 'affiliation': 'Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.'}, {'lastname': 'Weiderpass', 'firstname': 'Elisabete', 'initials': 'E', 'affiliation': 'International Agency for Research on Cancer, World Health Organization, Lyon, France.'}, {'lastname': 'Mishra', 'firstname': 'Gita D', 'initials': 'GD', 'affiliation': 'School of Public Health, The University of Queensland, Brisbane, Queensland, Australia g.mishra@uq.edu.au.'}], 'methods': None, 'conclusions': None, 'results': 'Overall, 2\\u200983\\u2009070\\u2009women were included and 10\\u2009737 (3.8%) developed COPD after a median follow-up of 11 (IQR 10-12) years. Analyses revealed a U shaped association between age at menarche and COPD (≤11 vs 13: HR 1.17, 95% CI 1.11 to 1.23; ≥16 vs 13: HR 1.24, 95% CI 1.21 to 1.27). Women with three or more children (3 vs 2: HR 1.14, 95% CI 1.12 to 1.17; ≥4 vs 2: HR 1.34, 95% CI 1.28 to 1.40), multiple miscarriages (2 vs 0: HR 1.28, 95% CI 1.24 to 1.32; ≥3 vs 0: HR 1.36, 95% CI 1.30 to 1.43) or stillbirth (1 vs 0: HR 1.38, 95% CI 1.25 to 1.53; ≥2 vs 0: HR 1.67, 95% CI 1.32 to 2.10) were at a higher risk of COPD. Among postmenopausal women, earlier age at natural menopause was associated with an increased risk of COPD (<40\\u2009vs 50-51: HR 1.69, 95% CI 1.63 to 1.75; 40-44 vs 50-51: HR 1.42, 95% CI 1.38 to 1.47).', 'copyrights': '© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/thorax-2023-220388', 'xml': <Element 'PubmedArticle' at 0x104578e50>}\n",
      "{'pubmed_id': '38350681', 'title': 'Challenges in diagnosing asthma in children.', 'abstract': None, 'keywords': [], 'journal': 'BMJ (Clinical research ed.)', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Chisholm', 'firstname': 'Kendra', 'initials': 'K', 'affiliation': \"Women and Children's Division, NHS Grampian, Aberdeen, UK.\"}, {'lastname': 'Daines', 'firstname': 'Luke', 'initials': 'L', 'affiliation': 'Usher Institute, University of Edinburgh, Edinburgh.'}, {'lastname': 'Turner', 'firstname': 'Steve', 'initials': 'S', 'affiliation': \"Women and Children's Division, NHS Grampian, Aberdeen, UK s.w.turner@abdn.ac.uk.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1136/bmj-2023-075924', 'xml': <Element 'PubmedArticle' at 0x10b3b1210>}\n",
      "{'pubmed_id': '38350556', 'title': 'Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.', 'abstract': 'Idiopathic pulmonary fibrosis (IPF), for which effective treatments are limited, results in excessive and disorganized deposition of aberrant extracellular matrix (ECM). An altered ECM microenvironment is postulated to contribute to disease progression through inducing profibrotic behavior of lung fibroblasts, the main producers and regulators of ECM. Here, we examined this hypothesis in a 3D in vitro model system by growing primary human lung fibroblasts in ECM-derived hydrogels from non-fibrotic (control) or IPF lung tissue. Using this model, we compared how control and IPF lung-derived fibroblasts responded in control and fibrotic microenvironments in a combinatorial manner. Culture of fibroblasts in fibrotic hydrogels did not alter in the overall amount of collagen or glycosaminoglycans but did cause a drastic change in fiber organization compared to culture in control hydrogels. High-density collagen percentage was increased by control fibroblasts in IPF hydrogels at day 7, but decreased at day 14. In contrast, IPF fibroblasts only decreased the high-density collagen percentage at day 14, which was accompanied by enhanced fiber alignment in IPF hydrogels. Similarly, stiffness of fibrotic hydrogels was increased only by control fibroblasts by day 14 while those of control hydrogels were not altered by fibroblasts. These data highlight how the ECM-remodeling responses of fibroblasts are influenced by the origin of both the cells and the ECM. Moreover, by showing how the 3D microenvironment plays a crucial role in directing cells, our study paves the way in guiding future investigations examining fibrotic processes with respect to ECM remodeling responses of fibroblasts. STATEMENT OF SIGNIFICANCE: In this study, we investigated the influence of the altered extracellular matrix (ECM) in Idiopathic Pulmonary Fibrosis (IPF), using a 3D in vitro model system composed of ECM-derived hydrogels from both IPF and control lungs, seeded with human IPF and control lung fibroblasts. While our results indicated that fibrotic microenvironment did not change the overall collagen or glycosaminoglycan content, it resulted in a dramatically alteration of fiber organization and mechanical properties. Control fibroblasts responded differently from IPF fibroblasts, highlighting the unique instructive role of the fibrotic ECM and the interplay with fibroblast origin. These results underscore the importance of 3D microenvironments in guiding pro-fibrotic responses, offering potential insights for future IPF therapies as well as other fibrotic diseases and cancer.', 'keywords': ['ECM-derived hydrogels', 'biomechanics', 'collagen organization', 'crosslinking', 'fibrosis', 'idiopathic pulmonary fibrosis'], 'journal': 'Acta biomaterialia', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Nizamoglu', 'firstname': 'Mehmet', 'initials': 'M', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands. Electronic address: m.nizamoglu@umcg.nl.'}, {'lastname': 'Alleblas', 'firstname': 'Frederique', 'initials': 'F', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.'}, {'lastname': 'Koster', 'firstname': 'Taco', 'initials': 'T', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.'}, {'lastname': 'Borghuis', 'firstname': 'Theo', 'initials': 'T', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.'}, {'lastname': 'Vonk', 'firstname': 'Judith M', 'initials': 'JM', 'affiliation': 'University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.'}, {'lastname': 'Thomas', 'firstname': 'Matthew J', 'initials': 'MJ', 'affiliation': 'Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.'}, {'lastname': 'White', 'firstname': 'Eric S', 'initials': 'ES', 'affiliation': 'Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States.'}, {'lastname': 'Watson', 'firstname': 'Carolin K', 'initials': 'CK', 'affiliation': 'Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.'}, {'lastname': 'Timens', 'firstname': 'Wim', 'initials': 'W', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands.'}, {'lastname': 'El Kasmi', 'firstname': 'Karim C', 'initials': 'KC', 'affiliation': 'Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.'}, {'lastname': 'Melgert', 'firstname': 'Barbro N', 'initials': 'BN', 'affiliation': 'University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, Department of Molecular Pharmacology, Groningen Research Institute for Pharmacy, Groningen, the Netherlands.'}, {'lastname': 'Heijink', 'firstname': 'Irene H', 'initials': 'IH', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Pulmonology, Groningen, the Netherlands.'}, {'lastname': 'Burgess', 'firstname': 'Janette K', 'initials': 'JK', 'affiliation': 'University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, W.J. Kolff Institute for Biomedical Engineering and Materials Science-FB41, Groningen, the Netherlands. Electronic address: j.k.burgess@umcg.nl.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Ltd.', 'doi': '10.1016/j.actbio.2024.02.008', 'xml': <Element 'PubmedArticle' at 0x10a288810>}\n",
      "{'pubmed_id': '38350365', 'title': 'Evaluation of health status of transgender sex workers in Turkey: A qualitative study.', 'abstract': \"Sex workers can be disadvantaged in terms of overall health due to challenging living and working conditions. This research aimed to evaluate the health status and experiences related to sexually transmitted infections (STDs) of unregistered transgender sex workers in Turkey.\\nIt employed a phenomenological qualitative research design. SITE: Data were collected in Istanbul between March 2021 and November 2021.\\nData were collected through in-depth interviews involving 24 people (19 sex workers and 5 physicians).\\nKey statements were listed during data analysis, and clusters of meanings were formed based on these statements. The participants' statements were used for contextual and structural descriptions.\\nSex workers suffer from chronic illnesses such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, allergic diseases, and neurological disorders. Among the health issues affecting them, the most notable ones are STDs, psychological problems, and the risk of suicide. Sex workers also face a dilemma between choosing public hospitals and private hospitals. Majority of sex workers undergo regular testing for STDs, with the frequency varying from person to person. Reasons for not undergoing regular testing include lack of social security coverage, financial constraints, lack of information, and feeling undervalued. Some individuals are being subjected to mandatory testing.\\nIt is recommended that sex workers who seek and request healthcare services should be provided with detailed information and education, particularly regarding psychological problems and STDs.\", 'keywords': ['Health service research', 'Infecciones de transmisión sexual', 'Investigación en servicios de salud', 'Public health', 'Salud pública', 'Sex workers', 'Sexually transmitted diseases', 'Trabajadoras sexuales', 'Transgender', 'Transgénero'], 'journal': 'Atencion primaria', 'publication_date': datetime.date(2024, 2, 14), 'authors': [{'lastname': 'Onur Şimşek', 'firstname': 'Kadir', 'initials': 'K', 'affiliation': 'Silopi District Health Directorate, 73400 Sirnak, Turkey. Electronic address: onrsimsek@yahoo.com.'}, {'lastname': 'Özgülnar', 'firstname': 'Nuray', 'initials': 'N', 'affiliation': 'Istanbul University, Istanbul Faculty of Medicine, Department of Public Health, Fatih 34390, Istanbul, Turkey.'}], 'methods': None, 'conclusions': None, 'results': 'Sex workers suffer from chronic illnesses such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, allergic diseases, and neurological disorders. Among the health issues affecting them, the most notable ones are STDs, psychological problems, and the risk of suicide. Sex workers also face a dilemma between choosing public hospitals and private hospitals. Majority of sex workers undergo regular testing for STDs, with the frequency varying from person to person. Reasons for not undergoing regular testing include lack of social security coverage, financial constraints, lack of information, and feeling undervalued. Some individuals are being subjected to mandatory testing.', 'copyrights': 'Copyright © 2024. Publicado por Elsevier España, S.L.U.', 'doi': '10.1016/j.aprim.2024.102875', 'xml': <Element 'PubmedArticle' at 0x10b287a10>}\n",
      "{'pubmed_id': '38350189', 'title': 'A transformer-based diffusion probabilistic model for heart rate and blood pressure forecasting in Intensive Care Unit.', 'abstract': \"Vital sign monitoring in the Intensive Care Unit (ICU) is crucial for enabling prompt interventions for patients. This underscores the need for an accurate predictive system. Therefore, this study proposes a novel deep learning approach for forecasting Heart Rate (HR), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) in the ICU.\\nWe extracted 24,886 ICU stays from the MIMIC-III database which contains data from over 46 thousand patients, to train and test the model. The model proposed in this study, Transformer-based Diffusion Probabilistic Model for Sparse Time Series Forecasting (TDSTF), merges Transformer and diffusion models to forecast vital signs. The TDSTF model showed state-of-the-art performance in predicting vital signs in the ICU, outperforming other models' ability to predict distributions of vital signs and being more computationally efficient. The code is available at https://github.com/PingChang818/TDSTF.\\nThe results of the study showed that TDSTF achieved a Standardized Average Continuous Ranked Probability Score (SACRPS) of 0.4438 and a Mean Squared Error (MSE) of 0.4168, an improvement of 18.9% and 34.3% over the best baseline model, respectively. The inference speed of TDSTF is more than 17 times faster than the best baseline model.\\nTDSTF is an effective and efficient solution for forecasting vital signs in the ICU, and it shows a significant improvement compared to other models in the field.\", 'keywords': ['Deep learning', 'ICU', 'Sparse data', 'Time series forecasting', 'Vital signs'], 'journal': 'Computer methods and programs in biomedicine', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Chang', 'firstname': 'Ping', 'initials': 'P', 'affiliation': 'Department of Electrical & Computer Engineering, The University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Li', 'firstname': 'Huayu', 'initials': 'H', 'affiliation': 'Department of Electrical & Computer Engineering, The University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Quan', 'firstname': 'Stuart F', 'initials': 'SF', 'affiliation': \"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Asthma and Airway Disease Research Center, College of Medicine, The University of Arizona, Tucson, AZ, USA.\"}, {'lastname': 'Lu', 'firstname': 'Shuyang', 'initials': 'S', 'affiliation': 'Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, PR China; The Shanghai Institute of Cardiovascular Diseases, Shanghai, PR China.'}, {'lastname': 'Wung', 'firstname': 'Shu-Fen', 'initials': 'SF', 'affiliation': 'Bio5 Institute, The University of Arizona, Tucson, AZ, USA; College of Nursing, The University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Roveda', 'firstname': 'Janet', 'initials': 'J', 'affiliation': 'Department of Electrical & Computer Engineering, The University of Arizona, Tucson, AZ, USA; Bio5 Institute, The University of Arizona, Tucson, AZ, USA; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Li', 'firstname': 'Ao', 'initials': 'A', 'affiliation': 'Department of Electrical & Computer Engineering, The University of Arizona, Tucson, AZ, USA; Bio5 Institute, The University of Arizona, Tucson, AZ, USA. Electronic address: aoli1@arizona.edu.'}], 'methods': None, 'conclusions': 'TDSTF is an effective and efficient solution for forecasting vital signs in the ICU, and it shows a significant improvement compared to other models in the field.', 'results': 'The results of the study showed that TDSTF achieved a Standardized Average Continuous Ranked Probability Score (SACRPS) of 0.4438 and a Mean Squared Error (MSE) of 0.4168, an improvement of 18.9% and 34.3% over the best baseline model, respectively. The inference speed of TDSTF is more than 17 times faster than the best baseline model.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.cmpb.2024.108060', 'xml': <Element 'PubmedArticle' at 0x10ad1d1c0>}\n",
      "{'pubmed_id': '38350129', 'title': 'Case Report: Allergic Bronchopulmonary Aspergillosis and Tropical Pulmonary Eosinophilia Co-Occurrence Masquerading as Refractory Allergic Bronchopulmonary Aspergillosis.', 'abstract': 'Pulmonary infiltrates with eosinophilia are a heterogeneous group of disorders that are characterized by pulmonary infiltrates on chest radiograph and elevated levels of eosinophils in the peripheral blood. Among patients with these disorders, reports of either allergic bronchopulmonary aspergillosis (ABPA) or tropical pulmonary eosinophilia (TPE) are common. However, the simultaneous occurrence of ABPA and TPE is not often reported. We present the case of a young man with a history of asthma who was diagnosed with ABPA and TPE. Initially, the patient exhibited a partial response to treatment of ABPA, but persistent symptoms and eosinophilia led to suspicion and subsequent diagnosis of TPE. With implementation of antifilarials and steroids, the patient experienced satisfactory clinical and serological improvements. This case underscores the importance of considering multiple diagnoses in patients with overlapping symptoms and highlights the need for comprehensive management strategies in complex lung diseases.', 'keywords': [], 'journal': 'The American journal of tropical medicine and hygiene', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Singh', 'firstname': 'Manish', 'initials': 'M', 'affiliation': 'Department of Pulmonary Medicine, Command Hospital (NC), Udhampur, India.'}, {'lastname': 'Peter', 'firstname': 'Deepu K', 'initials': 'DK', 'affiliation': 'Department of Pulmonary Medicine, Command Hospital (NC), Udhampur, India.'}, {'lastname': 'Gupta', 'firstname': 'Simple', 'initials': 'S', 'affiliation': 'Department of Ophthalmology, Command Hospital (NC), Udhampur, India.'}, {'lastname': 'Rani V', 'firstname': 'Vandana', 'initials': 'V', 'affiliation': 'Department of Pediatrics, Command Hospital (NC), Udhampur, India.'}, {'lastname': 'Singh', 'firstname': 'Shalendra', 'initials': 'S', 'affiliation': 'Deparment of Anaesthesia and Critical Care, Command Hospital (NC), Udhampur, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.4269/ajtmh.23-0450', 'xml': <Element 'PubmedArticle' at 0x108e89490>}\n",
      "{'pubmed_id': '38349900\\n29420459\\n26712860\\n23518824\\n37086744\\n7038043\\n22071328\\n35952703\\n33782057\\n24278725\\n23420236\\n32040885\\n31370064\\n37015894\\n34150683\\n21700604\\n30517699\\n34522963\\n36802679\\n32546583\\n32763206\\n14985651\\n36375000\\n23802827', 'title': 'Association between age of respiratory syncytial virus infection hospitalization and childhood asthma: A systematic review.', 'abstract': 'Identifying child age of RSV infection associated with increased risk of asthma is important for developing asthma prevention strategies. Our systematic review aimed to comprehensively summarize studies of the association between age of RSV infection and childhood asthma risk. The study protocol was pre-registered, and our study report adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA). Inclusion criteria were prospective and retrospective cohort studies and case-control studies which assessed the association of age of RSV infection before age 2 years and risk of childhood asthma after age two years. Relevant studies were identified through MEDLINE, Embase, Cochrane and International Clinical Trials Registry Platform (ICTRP) from study inception through May 5, 2023. Studies were evaluated with the Quality In Prognosis Studies (QUIPS) tool. From 149 studies screened, five studies (two prospective cohort studies and three retrospective cohort studies) were included in our systematic review, including 47,603 participants. Available studies only assessed age of severe RSV infection and asthma risk. The included studies used different age categories and outcome definitions, and were rated as having high risk of bias. Two studies had sample sizes of less than 300 and did not provide conclusive results related to age of RSV hospitalization and asthma risk. The other three studies reported RSV hospitalization between age 6 months and 23 months compared with age 0-6 months being associated with a higher odds ratio, hazard ratio, or incidence rate ratio of asthma diagnosis/hospitalization. Due to the heterogeneous epidemiological designs, including exposures and outcome ascertainments of the included studies, we could not perform a meta-analysis, or calculate weighted averages of the effect estimates. Our systematic review highlights a major gap in our knowledge about the relationship between age of RSV infection and asthma risk.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Shiroshita', 'firstname': 'Akihiro', 'initials': 'A', 'affiliation': 'Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.\\nDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}, {'lastname': 'Gebretsadik', 'firstname': 'Tebeb', 'initials': 'T', 'affiliation': 'Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}, {'lastname': 'Wu', 'firstname': 'Pingsheng', 'initials': 'P', 'affiliation': 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}, {'lastname': 'Kubilay', 'firstname': 'Nejla Zeynep', 'initials': 'NZ', 'affiliation': 'Division of General Internal Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}, {'lastname': 'Hartert', 'firstname': 'Tina V', 'initials': 'TV', 'affiliation': 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.\\nDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © 2024 Shiroshita et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0296685\\n10.15585/mmwr.mm6705e1\\n10.1542/peds.2015-2354\\n10.1097/INF.0b013e31829061e8\\n10.1002/jmv.1890070403\\n10.1164/rccm.201107-1348OC\\n10.1016/S1473-3099(22)00291-2\\n10.1136/bmj.n71\\n10.6064/2012/674204\\n10.7326/0003-4819-158-4-201302190-00009\\n10.1002/ppul.24676\\n10.1093/infdis/jiz311\\n10.1093/infdis/jiad093\\n10.3389/fped.2021.649003\\n10.1183/09031936.00040211\\n10.1093/infdis/jiy671\\n10.1093/infdis/jiab308\\n10.1542/peds.2019-3611\\n10.1016/S2213-2600(20)30109-0\\n10.1093/infdis/jiac442\\n10.1513/AnnalsATS.201303-054FR', 'xml': <Element 'PubmedArticle' at 0x108e8a660>}\n",
      "{'pubmed_id': '38349898\\n33098982\\n21890053\\n12510689\\n19654385\\n27788891\\n31550944\\n30755198\\n26544749\\n26481549\\n19892860\\n22594878\\n21281866\\n9309987\\n7491553\\n10712320\\n34534721\\n10573240\\n23058645\\n10489826\\n32010723\\n31490607\\n33729681\\n26606250\\n26653052\\n20398920\\n27725186\\n17940277\\n25539137\\n35927237\\n34107349\\n37580015\\n19221161\\n24759737\\n18157997', 'title': 'Inflammatory markers in world trade center workers with asthma: Associations with post traumatic stress disorder.', 'abstract': 'Post-traumatic stress disorders (PTSD) is associated with worse asthma outcomes in individuals exposed to the World Trade Center (WTC) site.\\nDo WTC workers with coexisting PTSD and asthma have a specific inflammatory pattern that underlies the relationship with increased asthma morbidity?\\nWe collected data on a cohort of WTC workers with asthma recruited from the WTC Health Program. Diagnosis of PTSD was ascertained with a Structured Clinical Interview for DSM-5 (Diagnostic and Statistical Manuel of Mental Disorders) and the severity of PTSD symptoms was assessed with the PTSD Checklist 5. We obtained blood and sputum samples to measure cytokines levels in study participants.\\nOf the 232 WTC workers with diagnosis of asthma in the study, 75 (32%) had PTSD. PTSD was significantly associated with worse asthma control (p = 0.002) and increased resource utilization (p = 0.0002). There was no significant association (p>0.05) between most blood or sputum cytokines with PTSD diagnosis or PCL-5 scores both in unadjusted and adjusted analyses.\\nOur results suggest that PTSD is not associated with blood and sputum inflammatory markers in WTC workers with asthma. These findings suggest that other mechanisms likely explain the association between PTSD and asthma control in WTC exposed individuals.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Wisnivesky', 'firstname': 'Juan P', 'initials': 'JP', 'affiliation': 'Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.\\nDivision of Pulmonary and Critical Care Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}, {'lastname': 'Agrawal', 'firstname': 'Nikita', 'initials': 'N', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}, {'lastname': 'Ankam', 'firstname': 'Jyoti', 'initials': 'J', 'affiliation': 'Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}, {'lastname': 'Gonzalez', 'firstname': 'Adam', 'initials': 'A', 'affiliation': 'Barry Commoners Center for Health and Environment, Queens College, City University of NY, NY, NY, United States of America.'}, {'lastname': 'Federman', 'firstname': 'Alex', 'initials': 'A', 'affiliation': 'Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}, {'lastname': 'Markowitz', 'firstname': 'Steven B', 'initials': 'SB', 'affiliation': 'Department of Psychiatry and Behavioral Health, Stony Brook University, Stony Brook, NY, United States of America.'}, {'lastname': 'Birmingham', 'firstname': 'Janette M', 'initials': 'JM', 'affiliation': 'Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}, {'lastname': 'Busse', 'firstname': 'Paula J', 'initials': 'PJ', 'affiliation': 'Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, NY, NY, United States of America.'}], 'methods': None, 'conclusions': None, 'results': 'Of the 232 WTC workers with diagnosis of asthma in the study, 75 (32%) had PTSD. PTSD was significantly associated with worse asthma control (p = 0.002) and increased resource utilization (p = 0.0002). There was no significant association (p>0.05) between most blood or sputum cytokines with PTSD diagnosis or PCL-5 scores both in unadjusted and adjusted analyses.', 'copyrights': 'Copyright: © 2024 Wisnivesky et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0297616\\n10.1016/j.anai.2020.10.007\\n10.1016/S0140-6736(11)61180-X\\n10.1001/jama.2009.1121\\n10.1016/j.anai.2016.08.033\\n10.1080/02770903.2019.1672722\\n10.1186/s12940-019-0449-7\\n10.1016/S2215-0366(15)00309-0\\n10.1016/j.pharep.2015.05.023\\n10.1164/rccm.200906-0896OC\\n10.1111/j.1398-9995.2012.02832.x\\n10.1016/j.jaci.2010.11.037\\n10.1164/ajrccm.156.3.9610046\\n10.1136/thx.50.10.1057\\n10.1164/ajrccm.161.3.9809071\\n10.1016/j.jaip.2021.08.035\\n10.1034/j.1399-3003.1999.14d29.x\\n10.1016/j.jaci.2012.08.023\\n10.1034/j.1399-3003.1999.14a08.x\\n10.1183/23120541.00289-2019\\n10.1111/pcn.12931\\n10.1002/brb3.1894\\n10.1002/jts.22059\\n10.1037/pas0000254\\n10.1016/j.jaci.2010.02.008\\n10.1016/j.jaci.2016.09.015\\n10.1093/annhyg/mem045\\n10.3109/02770903.2014.999083\\n10.1038/s41398-022-02094-7\\n10.1016/j.bbi.2021.06.001\\n10.1016/j.anai.2023.08.005\\n10.1542/peds.2008-2233H\\n10.1371/journal.pone.0094075\\n10.1016/j.jpsychores.2007.07.006', 'xml': <Element 'PubmedArticle' at 0x10b3cf1f0>}\n",
      "{'pubmed_id': '38349777', 'title': 'Living with Asthma in Low- and Middle-Income Countries in the Six WHO Regions.', 'abstract': 'In the Patient Platform article, \"Living with Asthma in Low- and Middle-Income Countries in the Six WHO Regions\", originally published December 26, 2023 (DOI: https://doi.org/10.1056/EVIDpp2300292), in the section \"Aydın P. Turkey, European Region\", where it reads \"…there was a big earthquake in September 2023…\", it should have read, \"…there was a big earthquake in February 2023…\". A corrected version of the article has been posted at evidence.nejm.org.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 13), 'authors': [], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDx2400008', 'xml': <Element 'PubmedArticle' at 0x1099ce200>}\n",
      "{'pubmed_id': '38349560\\n33625306\\n31178414\\n29617182\\n34389053\\n28855973\\n31655122\\n32398176\\n30661627\\n33758515\\n24979285\\n34486912\\n35046670\\n35728746\\n36176349\\n31440040\\n31070048\\n36474912\\n31145939\\n33834052\\n25201169\\n26141573\\n28332107', 'title': 'Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma.', 'abstract': 'Biologic therapies have demonstrated benefits for individuals with severe asthma, including reduced daily symptoms and severe exacerbations. However, data describing patient perspectives on these treatments are limited. This study sought to understand the preferences and priorities of Canadians with severe asthma in the context of novel biologic treatment options.\\nSemi-structured, qualitative interviews were conducted among Canadians with severe asthma from July to August 2022. Purposeful sampling included individuals with and without biologic therapy experience. All participants described daily life with severe asthma, experiences and priorities related to asthma treatment and their impressions of biologics. Reflexive thematic analysis was used to explore patterns in the data.\\nAmong 18 individuals included, 10 were currently taking or had prior experience with biologic treatment for asthma. Those who had never been treated with biologics were unfamiliar with them, considering treatment, or believed that they may not be eligible. Four themes were developed to convey the perspectives of participants on biologics: (1) life-changing benefits, but not for all; (2) navigating barriers to being prescribed and remaining adherent to biologic treatments; (3) treatment administration preferences are not only about convenience; (4) concerns about safety and the unknown as a source of treatment hesitancy.\\nFindings suggest that the clinical benefits of biologics align with patient perceptions of achieving good asthma control. However, treatment gaps persist among individuals who do not experience a meaningful improvement in their asthma symptoms and those who face barriers accessing biologics. People with severe asthma attributed importance to greater availability of at-home treatment options, improved access to financial support to cover treatment costs and support to address safety concerns. This research provides insight into patient-based treatment priorities and preferences for biologics, which may help inform decision-making related to emerging therapies for severe asthma.\\nFor people with severe asthma, biologics are a treatment option that can be taken in addition to their regular medication. In this study, we asked 18 Canadians with severe asthma about how having severe asthma affects their lives, their current and previous asthma treatments, and their views on biologics. Ten people in this study were currently taking or had previously taken biologics for severe asthma. We found that biologics can be life changing. Also, people with severe asthma can find it difficult to get on and stay on biologics. They would like financial and educational support when considering biologics and prefer to take biologics at home, if possible. This study helps us understand the priorities and preferences related to biologics of patients with severe asthma.', 'keywords': ['Biologic treatment', 'Biologics', 'Canada', 'Health-related quality-of-life', 'Patient perspectives', 'Qualitative research', 'Severe asthma'], 'journal': 'Advances in therapy', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Bever', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Broadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada.'}, {'lastname': 'Dunne', 'firstname': 'Jessica', 'initials': 'J', 'affiliation': 'Broadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada.'}, {'lastname': 'Reynolds', 'firstname': 'Jenna', 'initials': 'J', 'affiliation': 'Asthma Canada, Toronto, ON, Canada.'}, {'lastname': 'Waserman', 'firstname': 'Susan', 'initials': 'S', 'affiliation': 'Department of Medicine, Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, Canada.'}, {'lastname': 'Kaplan', 'firstname': 'Alan G', 'initials': 'AG', 'affiliation': 'Family Physician Airways Group of Canada, Respiratory Effectiveness Group, Department of Family and Community Medicine, University of Toronto, Toronto, Canada.'}, {'lastname': \"O'Keefe\", 'firstname': 'Andrew', 'initials': 'A', 'affiliation': \"Department of Pediatrics, Faculty of Medicine, Memorial University, St. John's, NL, Canada.\"}, {'lastname': 'McNeilly', 'firstname': 'Stacey', 'initials': 'S', 'affiliation': 'Ridge Meadows Hospital, Maple Ridge, BC, Canada.'}, {'lastname': 'Szabo', 'firstname': 'Shelagh M', 'initials': 'SM', 'affiliation': 'Broadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada. sszabo@broadstreetheor.com.'}], 'methods': None, 'conclusions': None, 'results': 'Among 18 individuals included, 10 were currently taking or had prior experience with biologic treatment for asthma. Those who had never been treated with biologics were unfamiliar with them, considering treatment, or believed that they may not be eligible. Four themes were developed to convey the perspectives of participants on biologics: (1) life-changing benefits, but not for all; (2) navigating barriers to being prescribed and remaining adherent to biologic treatments; (3) treatment administration preferences are not only about convenience; (4) concerns about safety and the unknown as a source of treatment hesitancy.', 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.\\n© 2024. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.', 'doi': '10.1007/s12325-024-02803-2\\n10.1080/02770903.2021.1888976\\n10.1016/j.jaip.2019.04.026\\n10.1080/02770903.2018.1452034\\n10.1186/s40733-021-00078-w\\n10.1016/j.jaip.2021.10.059\\n10.1186/s40413-017-0159-y\\n10.1016/j.anai.2019.10.016\\n10.1017/S0266462320000215\\n10.1016/j.jval.2018.08.010\\n10.2147/JAA.S296147\\n10.1080/2159676X.2019.1704846\\n10.1191/1478088706qp063oa\\n10.1080/2159676X.2019.1628806\\n10.21105/joss.03522\\n10.1097/ACM.0000000000000388\\n10.1080/02770903.2021.1971700\\n10.2147/JAA.S328653\\n10.1016/j.anai.2022.06.012\\n10.2147/PPA.S365117\\n10.2147/PPA.S198953\\n10.1080/14737167.2019.1612242\\n10.3389/fmed.2020.543046\\n10.1016/j.waojou.2022.100721\\n10.1016/j.jaci.2019.05.019\\n10.1183/23120541.00528-2020\\n10.1007/s11136-014-0801-x\\n10.1007/s11882-015-0528-y\\n10.1007/s11882-017-0686-1', 'xml': <Element 'PubmedArticle' at 0x10a1a16c0>}\n",
      "{'pubmed_id': '38349456\\n25299857\\n11483811\\n24491312\\n24488745\\n19221161\\n29323930\\n19905909\\n31238163\\n32035604\\n19240948\\n17353040\\n8901365\\n12641893\\n25393915\\n20716014\\n17603828\\n18369409\\n17332210\\n33394296', 'title': 'Comparison of Telemedicine versus In-Person Visit for Control of Asthma in Children aged 7-17\\xa0years: A Randomized Controlled Trial.', 'abstract': 'To compare asthma control between telemedicine and in-person visit in children aged 7 to 17 y.\\nA non-inferiority randomized-controlled trial was conducted at a pediatric chest clinic, involving a total of 192 patients, with 96 children in each group of telemedicine and in-person follow-up.\\nThere was a significant improvement in the mean asthma control test (ACT)/ Childhood asthma control test (C-ACT) scores from baseline to three months in both groups, with no significant difference in the change of means between the two groups. The mean difference in ACT/C-ACT score at three months in the telemedicine and in-person visit group was -0.35; 95% CI (-1.30 to\\u2009+0.10) [p-value 0.09]. There was a significant change in the mean Pediatric Quality of Life index (PQLI) scores from 57.2\\u2009±\\u200910.2 to 66.82\\u2009±\\u20097.99 in the telemedicine group and from 56.1\\u2009±\\u200911.7 to 66.71\\u2009±\\u20094.66 in the in-person visit group, however the mean difference in PQLI score in both the groups was not significant (p\\u2009=\\u20090.91). There was no significant difference in the number of asthma exacerbations (4 vs. 1) between telemedicine and in-person visit (p\\u2009=\\u20090.10). The mean telemedicine satisfaction questionnaire score in this study was 3.8\\u2009±\\u20090.7, which indicates that most of the parents were satisfied with the telemedicine follow-up process.\\nThis study revealed that telemedicine is non-inferior to in-person visit for follow-up of children with asthma and can be used as an alternative to in-person visit for the management of asthma, especially in remote settings and pandemic situations.', 'keywords': ['Asthma control', 'In-person visit', 'PQLI', 'Pediatric Quality of Life index', 'Telemedicine'], 'journal': 'Indian journal of pediatrics', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Suvarna', 'firstname': 'Kkomal C', 'initials': 'KC', 'affiliation': 'Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India.'}, {'lastname': 'Kumar', 'firstname': 'Prawin', 'initials': 'P', 'affiliation': 'Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India.'}, {'lastname': 'Singh', 'firstname': 'Kuldeep', 'initials': 'K', 'affiliation': 'Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India.'}, {'lastname': 'Kumar', 'firstname': 'Jogender', 'initials': 'J', 'affiliation': 'Department of Pediatrics, PGIMER, Chandigarh, India.'}, {'lastname': 'Goyal', 'firstname': 'Jagdish Prasad', 'initials': 'JP', 'affiliation': 'Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Jodhpur, Rajasthan, India. jpgoyal@rediffmail.com.'}], 'methods': None, 'conclusions': None, 'results': 'There was a significant improvement in the mean asthma control test (ACT)/ Childhood asthma control test (C-ACT) scores from baseline to three months in both groups, with no significant difference in the change of means between the two groups. The mean difference in ACT/C-ACT score at three months in the telemedicine and in-person visit group was -0.35; 95% CI (-1.30 to\\u2009+0.10) [p-value 0.09]. There was a significant change in the mean Pediatric Quality of Life index (PQLI) scores from 57.2\\u2009±\\u200910.2 to 66.82\\u2009±\\u20097.99 in the telemedicine group and from 56.1\\u2009±\\u200911.7 to 66.71\\u2009±\\u20094.66 in the in-person visit group, however the mean difference in PQLI score in both the groups was not significant (p\\u2009=\\u20090.91). There was no significant difference in the number of asthma exacerbations (4 vs. 1) between telemedicine and in-person visit (p\\u2009=\\u20090.10). The mean telemedicine satisfaction questionnaire score in this study was 3.8\\u2009±\\u20090.7, which indicates that most of the parents were satisfied with the telemedicine follow-up process.', 'copyrights': '© 2024. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.', 'doi': '10.1007/s12098-024-05028-x\\n10.5588/ijtld.14.0170\\n10.1542/peds.108.2.432\\n10.1016/j.anai.2014.01.002\\n10.1542/peds.2013-2437\\n10.1542/peds.2008-2233H\\n10.1513/AnnalsATS.201703-259OC\\n10.3109/02770900903184237\\n10.1016/j.jaip.2019.06.012\\n10.1016/j.jaci.2019.12.903\\n10.4104/pcrj.2009.00010\\n10.1016/j.jaci.2006.12.662\\n10.1007/BF00435967\\n10.1258/135763303321159693\\n10.1089/tmj.2014.0119\\n10.3109/02770903.2010.493966\\n10.1089/tmj.2006.0053\\n10.1542/peds.2006-1884\\n10.1007/s12098-020-03590-8', 'xml': <Element 'PubmedArticle' at 0x10b6674c0>}\n",
      "{'pubmed_id': '38349366', 'title': 'Toll-like receptor 4 Mediated Autophagy regulates Airway Smooth Muscle Cells behavior.', 'abstract': '', 'keywords': ['Airway Smooth Muscle Cell', 'Autophagy', 'Behavior', 'Toll-like receptor 4'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Hou', 'firstname': 'LiXia', 'initials': 'L', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, 541199, Guilin, China.\\nKey Laboratory of Respiratory Diseases, Affiliated Hospital of Guilin Medical University, 541004, Guilin, China.\\nKey Laboratory of Basic Research on Respiratory Diseases, Guangxi Health Commission, Affiliated Hospital of Guilin Medical University, 541004, Guilin, China.'}, {'lastname': 'Zuo', 'firstname': 'HuiQing', 'initials': 'H', 'affiliation': 'Key Laboratory of Respiratory Diseases, Affiliated Hospital of Guilin Medical University, 541004, Guilin, China.'}, {'lastname': 'Xiao', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Key Laboratory of Respiratory Diseases, Affiliated Hospital of Guilin Medical University, 541004, Guilin, China.'}, {'lastname': 'Yao', 'firstname': 'Dong', 'initials': 'D', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, 541199, Guilin, China.\\nGuangxi Clinical Research Center for Diabetes and Metabolic Diseases, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, 541199, Guilin, China.\\nGuangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The key laboratory of Respiratory Diseases, Education Department of Guangxi Zhuang Autonomous Region, Guilin Medical University, 541000, Guilin, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/02770903.2024.2316728', 'xml': <Element 'PubmedArticle' at 0x10adea930>}\n",
      "{'pubmed_id': '38349007', 'title': 'Is there a direct link between skin barrier dysfunction and asthma?', 'abstract': None, 'keywords': [], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Santos', 'firstname': 'Alexandra F', 'initials': 'AF', 'affiliation': \"Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.\\nPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.\\nChildren's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/all.16055', 'xml': <Element 'PubmedArticle' at 0x109df4400>}\n",
      "{'pubmed_id': '38348787', 'title': 'Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores.', 'abstract': None, 'keywords': [], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Farhan', 'firstname': 'Abdal J', 'initials': 'AJ', 'affiliation': \"The David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, Newport, UK.\\nClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\"}, {'lastname': 'Kothalawala', 'firstname': 'Dilini M', 'initials': 'DM', 'affiliation': 'NIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.\\nHuman Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.'}, {'lastname': 'Kurukulaaratchy', 'firstname': 'Ramesh J', 'initials': 'RJ', 'affiliation': \"The David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, Newport, UK.\\nClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nNIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.\"}, {'lastname': 'Granell', 'firstname': 'Raquel', 'initials': 'R', 'affiliation': 'MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.'}, {'lastname': 'Simpson', 'firstname': 'Angela', 'initials': 'A', 'affiliation': 'Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, and Manchester University NHS Foundation Trust, Manchester, UK.'}, {'lastname': 'Murray', 'firstname': 'Clare', 'initials': 'C', 'affiliation': 'Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, and Manchester University NHS Foundation Trust, Manchester, UK.'}, {'lastname': 'Custovic', 'firstname': 'Adnan', 'initials': 'A', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Roberts', 'firstname': 'Graham', 'initials': 'G', 'affiliation': \"The David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, Newport, UK.\\nClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nNIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.\"}, {'lastname': 'Zhang', 'firstname': 'Hongmei', 'initials': 'H', 'affiliation': 'Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA.'}, {'lastname': 'Arshad', 'firstname': 'S Hasan', 'initials': 'SH', 'affiliation': \"The David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, Newport, UK.\\nClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nNIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/all.16059', 'xml': <Element 'PubmedArticle' at 0x109df5670>}\n",
      "{'pubmed_id': '38348785', 'title': 'The impact of perinatal and at birth risk factors on the progression from preschool wheezing to adolescent asthma.', 'abstract': 'Asthma is a global health concern affecting millions of children and adolescents. This review focuses on the possible factors that are associated with the transition from preschool wheezing to childhood asthma and highlights the significance of early-life environmental exposures during pregnancy and the first 6\\u2009months of life in shaping allergies and asthma. We observed a scarcity of studies investigating this subgroup, with most focusing on wheezing trajectories. We undertook a thorough investigation of diverse perinatal exposures that have the potential to impact this transition. These factors include maternal asthma, smoking during pregnancy, diet, prepregnancy weight, infant birthweight, gestational age, and breastfeeding. Although limited, studies do suggest that maternal asthma increases the likelihood of preschool wheeze in offspring that persists through childhood with potential asthma progression. Findings concerning other perinatal exposures remain inconsistent. Further research is needed to identify asthma progression risk factors and assess perinatal exposure effects.', 'keywords': ['adolescents', 'asthma', 'children', 'maternal', 'perinatal', 'persistent wheezing', 'preschool wheezing'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Gallagher', 'firstname': 'Claire', 'initials': 'C', 'affiliation': 'Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.'}, {'lastname': 'Batra', 'firstname': 'Mehak', 'initials': 'M', 'affiliation': 'Department of Public Health, School of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia.'}, {'lastname': 'Malamardi', 'firstname': 'Sowmya Nagappa', 'initials': 'SN', 'affiliation': 'Department of Public Health, School of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia.'}, {'lastname': 'Erbas', 'firstname': 'Bircan', 'initials': 'B', 'affiliation': 'Department of Public Health, School of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14081', 'xml': <Element 'PubmedArticle' at 0x10a129da0>}\n",
      "{'pubmed_id': '38348623', 'title': 'Why is Pet (cat/dog) allergen immunotherapy (ait) such a controversial topic? current perspectives and future directions.', 'abstract': 'Dogs and cats are the most common pets worldwide. In Italy, the prevalence of allergic sensitization to cats and dogs is 16% and 9% respectively. The limited standardization of allergenic extracts, especially for dogs, emphasizes the importance of Component Resolved Diagnosis (CRD) for accurate diagnosis and subsequent prescription of allergen immunotherapy (AIT). However, this low standardization is the main factor contributing to the unsatisfactory clinical efficacy of traditional AIT, AIT with modified allergens, and intralymphatic allergen-specific immunotherapy (ILAIT). Emerging immunological approaches, particularly for controlling the primary cat allergen, show promise but are hindered by high costs (e.g., use of anti-Fel d 1 monoclonal antibodies in humans) or by exclusively targeting Fel d 1 produced by one\\'s own animal (e.g., immunizing cats to induce neutralizing antibodies against Fel d 1 or including an egg product with anti Fel d 1 IgY antibodies in feline diet). Further studies are imperative for standardizing pet allergens, enhancing the efficacy of various AIT modalities, and exploring other immunological approaches, to optimize the relationship between pets and their owners and prevent distressing \"forced removals.\"', 'keywords': ['Allergic sensitization', 'allergic rhinitis', 'bronchial asthma', 'cat', 'cat allergen', 'dog', 'dog allergen', 'hypersensitivity', 'immunotherapy', 'molecular diagnosis'], 'journal': 'European annals of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Liccardi', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Department of Experimental Medicine, Postgraduate School of Respiratory Medicine, University of Rome Tor Vergata, Rome, Italy.'}, {'lastname': 'Martini', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.\\nAllergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy.'}, {'lastname': 'Bilò', 'firstname': 'M B', 'initials': 'MB', 'affiliation': 'Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.\\nAllergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy.'}, {'lastname': 'Cecchi', 'firstname': 'L', 'initials': 'L', 'affiliation': 'SOS Allergy and Clinical Immunology, USL Toscana Centro, Prato, Italy.'}, {'lastname': 'Milanese', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Division of Pulmonology, S. Corona Hospital, Pietra Ligure, Savona, Italy.'}, {'lastname': 'Brussino', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Allergy and Clinical Immunology Unit, Department of Medical Sciences, University of Torino and Mauriziano Hospital, Turin, Italy.'}, {'lastname': 'Motta', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Respiratory Medicine Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.'}, {'lastname': 'Rogliani', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Department of Experimental Medicine, Postgraduate School of Respiratory Medicine, University of Rome Tor Vergata, Rome, Italy.\\nRespiratory Medicine Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.23822/EurAnnACI.1764-1489.330', 'xml': <Element 'PubmedArticle' at 0x10b178fe0>}\n",
      "{'pubmed_id': '38348340\\n12572699\\n17197483\\n35514930\\n36790726\\n27282212\\n31767622\\n34261543\\n36425334\\n37000943\\n11562286\\n0\\n32613116\\n13177802\\n36405039', 'title': 'Prioritizing Asthma Treatment Drugs through Multicriteria Decision Making.', 'abstract': \"Asthma is a medical condition characterized by inflammation, narrowing, and swelling of a person's airways, leading to increased mucus production and difficulties in breathing. Topological indices are instrumental in assessing the physical and chemical attributes of these asthma drugs. As resistance to current treatments continues to emerge and undesirable side effects are linked to certain medications, the search for novel and enhanced drugs becomes a top priority. In this study, the examination of 19 distinct asthma medications was focused. In this study, quantitative structure-activity relationship (QSAR) and quantitative structure-property relationship (QSPR) modeling, in combination with multicriteria decision-making (MCDM) technique VIKOR (VIekriterijumsko KOmpromisno Rangiranje) were employed on asthma drugs, to achieve the most favorable rankings for each asthma drug, taking into account their distinct properties. The topological indices employed for QSPR modeling were Randic index, reciprocal Randic index, Zagreb indices, hyper-Zagreb index, harmonic index, geometric arithmetic index, and forgotten index.\", 'keywords': [], 'journal': 'International journal of analytical chemistry', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Sultana', 'firstname': 'Sobia', 'initials': 'S', 'affiliation': 'Department of Mathematics and Statistics, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Sobia Sultana.', 'doi': '10.1155/2024/6516976\\n10.1183/09031936.03.00404903\\n10.1183/09031936.00087906\\n10.1039/d0ra09051d\\n10.1016/j.cjche.2020.09.043\\n10.1007/s10653-023-01499-7\\n10.1016/j.alit.2016.04.011\\n10.1016/j.molstruc.2021.130226\\n10.1007/s12161-021-02062-9\\n10.1124/pr.118.016899\\n10.1186/s40733-021-00075-z\\n10.1155/2022/2106974\\n10.1155/2022/9749575\\n10.1080/07391102.2023.2195944\\n10.1155/2022/5915740\\n10.1088/1402-4896/acb327\\n10.1039/cs9952400279\\n10.2174/0929867013371923\\n10.26637/mjm0802/0003\\n10.26637/mjm0801/0018\\n10.58250/jnanabha.2020.50111\\n10.1080/10406638.2023.2217990\\n10.1037/h0053870\\n10.1140/epjp/s13360-022-03469-x\\n10.1080/00268976.2023.2222345\\n10.1016/0305-0548(94)00059-h\\n10.1007/s11269-010-9663-3\\n10.1080/17509653.2019.1633964\\n10.1021/ja00856a001\\n10.1016/0012-365x(93)90156-n\\n10.5562/cca2294\\n10.1007/s10910-009-9520-x\\n10.1007/s10910-009-9542-4', 'xml': <Element 'PubmedArticle' at 0x10a0749a0>}\n",
      "{'pubmed_id': '38348241\\n18086309\\n31467119\\n32795139\\n34368950\\n30464445\\n32554540\\n19213769\\n23766138\\n17565016\\n36030774\\n24912564\\n10453883\\n3342669\\n7633704\\n12954467\\n1759018\\n20954780\\n1741532\\n8642881\\n11115443\\n12358325\\n17218570\\n18710905\\n24293994\\n25066329\\n25456710\\n28490871\\n24781217\\n28528348\\n20392360\\n31086540\\n11029341\\n22135493\\n15115864\\n20378728\\n15591470\\n15821196\\n24876770\\n18385168\\n15893921\\n20388753\\n12195837\\n34836922\\n35834844', 'title': 'Home noninvasive ventilation in severe COPD: in whom does it work and how?', 'abstract': 'Not all hypercapnic COPD patients benefit from home noninvasive ventilation (NIV), and mechanisms through which NIV improves clinical outcomes remain uncertain. We aimed to identify \"responders\" to home NIV, denoted by a beneficial effect of NIV on arterial partial pressure of carbon dioxide (\\nWe used individual patient data from previous published trials collated for a systematic review. Linear mixed-effect models were conducted to compare the effect of NIV on \\nData of 1142 participants from 16 studies were used. Participants treated with lower pressure support (<14 \\nWith greater pressure support and better daily NIV usage, a larger improvement in ', 'keywords': [], 'journal': 'ERJ open research', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Raveling', 'firstname': 'Tim', 'initials': 'T', 'affiliation': 'Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.\\nGroningen Research Institute of Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Vonk', 'firstname': 'Judith M', 'initials': 'JM', 'affiliation': 'Groningen Research Institute of Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.\\nDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Hill', 'firstname': 'Nicholas S', 'initials': 'NS', 'affiliation': 'Division of Pulmonary, Critical Care and Sleep Medicine, Tufts University Medical Center Boston, Boston, MA, USA.'}, {'lastname': 'Gay', 'firstname': 'Peter C', 'initials': 'PC', 'affiliation': 'Department of Pulmonary and Critical Care Medicine and the Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Casanova', 'firstname': 'Ciro', 'initials': 'C', 'affiliation': 'Department of Pulmonary, Research Unit, Hospital Universitario La Candelaria, Universidad de La Laguna, Tenerife, Spain.'}, {'lastname': 'Clini', 'firstname': 'Enrico', 'initials': 'E', 'affiliation': 'Respiratory Diseases Unit, Dept of Medical and Surgical Sciences SMECHIMAI, University Hospital of Modena Policlinico, University of Modena Reggio-Emilia, Modena, Italy.'}, {'lastname': 'Köhnlein', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Pneumological Specialist Center, Teuchern, Germany.'}, {'lastname': 'Márquez-Martin', 'firstname': 'Eduardo', 'initials': 'E', 'affiliation': 'Medical-Surgical Unit of Respiratory diseases, University Hospital Virgen del Rocío, Seville, Spain.\\nCIBER-ES, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Schneeberger', 'firstname': 'Tessa', 'initials': 'T', 'affiliation': 'Department of Pulmonary Rehabilitation, Philipps-University of Marburg, Marburg, Germany.\\nInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.'}, {'lastname': 'Murphy', 'firstname': 'Patrick B', 'initials': 'PB', 'affiliation': \"Lane Fox Clinical Respiratory Physiology Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.\"}, {'lastname': 'Struik', 'firstname': 'Fransien M', 'initials': 'FM', 'affiliation': 'Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Kerstjens', 'firstname': 'Huib A M', 'initials': 'HAM', 'affiliation': 'Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.\\nGroningen Research Institute of Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Duiverman', 'firstname': 'Marieke L', 'initials': 'ML', 'affiliation': 'Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.\\nGroningen Research Institute of Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Wijkstra', 'firstname': 'Peter J', 'initials': 'PJ', 'affiliation': 'Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.\\nGroningen Research Institute of Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright ©The authors 2024.', 'doi': '10.1183/23120541.00600-2023\\n10.1186/1465-9921-8-92\\n10.1183/13993003.01003-2019\\n10.1164/rccm.202006-2382ST\\n10.1002/14651858.CD002878.pub3\\n10.2147/COPD.S169951\\n10.1183/13993003.01334-2020\\n10.1136/thx.2008.108274\\n10.1002/14651858.CD002878.pub2\\n10.1378/chest.06-2124\\n10.1159/000525865\\n10.1111/resp.12327\\n10.1378/chest.116.2.521\\n10.1378/chest.93.3.580\\n10.1164/ajrccm.152.2.7633704\\n10.1016/S0895-4356(03)00088-X\\n10.1016/S0954-6111(06)80166-6\\n10.1037/a0020761\\n10.1164/ajrccm/144.6.1234\\n10.4065/71.6.533\\n10.1378/chest.118.6.1582\\n10.1183/09031936.02.02162001\\n10.1378/chest.06-1423\\n10.1136/thx.2008.099044\\n10.2147/COPD.S53619\\n10.1016/S2213-2600(14)70153-5\\n10.1016/j.rmed.2014.10.005\\n10.2147/COPD.S127540\\n10.1136/thoraxjnl-2014-205126\\n10.1001/jama.2017.4451\\n10.12669/pjms.35.2.459\\n10.1016/j.ejcdt.2015.02.004\\n10.1164/ajrccm.162.4.9912029\\n10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A3344\\n10.2147/COPD.S22823\\n10.1136/thx.2003.008730\\n10.1164/rccm.200912-1869OC\\n10.1164/rccm.200407-867OC\\n10.1378/chest.127.4.1205\\n10.2147/COPD.S58136\\n10.1183/09031936.00163607\\n10.1016/j.rmed.2005.04.003\\n10.1136/thx.2009.124263\\n10.1053/rmed.2002.1326\\n10.1136/thoraxjnl-2021-217463\\n10.1016/j.rmed.2022.106920', 'xml': <Element 'PubmedArticle' at 0x10a368770>}\n",
      "{'pubmed_id': '38348152\\n13478578\\n19196675\\n27216929\\n28105323\\n15816153\\n15338801\\n16323132\\n9086135\\n2115082\\n2230258\\n27740723\\n28689664\\n7365274\\n28500974\\n24901443\\n8414800\\n23878043\\n29346336\\n29390105\\n34292924\\n33986150\\n32888007\\n32986818\\n32986804\\n33517482\\n34108234\\n30116126\\n11113845\\n14615710\\n21187309\\n25941331\\n26379160\\n29728782\\n28653300\\n27864751\\n8804328\\n25189655\\n20666690\\n28070870\\n18172683\\n15629968\\n30062859\\n30561563\\n27025960\\n28060016\\n30093540\\n26682048\\n19925369\\n12402189\\n12508140\\n15144474\\n14722888\\n12964123\\n16388492\\n11807709\\n12032263\\n15143473\\n16645504\\n19914637\\n32740454\\n30723301\\n23283306\\n24362685\\n26658574\\n17005642\\n25972545\\n12663767\\n24251370\\n32556372\\n11106388\\n30274351\\n34063087\\n33956914\\n27187445\\n15298168\\n33813989\\n27310438\\n18664927\\n24622396\\n27755464\\n29405612\\n9738173\\n11996400\\n23637810\\n31698410\\n20971883\\n20553229\\n2911387\\n8855290\\n10224367\\n19649262\\n25324843\\n28179378\\n2010624\\n763253\\n7229749\\n19150677\\n15207824\\n17143259\\n4909103\\n7826113\\n2320967\\n15545869\\n6243354\\n7876605\\n7664179\\n9135260\\n11471095\\n12150192\\n15602730\\n20065326\\n19647839\\n18648081\\n463835\\n6702769\\n839330\\n7086623\\n1570205\\n24586581\\n22240853\\n31257127\\n3706232\\n11512084\\n16859512\\n12801108\\n2123382\\n27585385\\n23584584\\n26354816\\n25764205\\n15125873\\n30689772\\n29955859\\n30189412\\n28574729\\n29079159\\n15494991\\n9421694\\n21139081\\n23024295\\n12150196\\n30817023\\n20564430\\n6343860\\n3550679\\n1904551\\n6356005\\n8143465\\n8774517\\n10471604\\n26104207\\n9359721\\n15295219\\n30760509\\n26923867\\n23633336\\n8989345\\n3439796\\n26986236\\n32726528\\n35235726\\n27417364\\n2677595\\n2348292\\n15048056\\n29914800\\n15747245\\n26537255\\n31605113\\n31340042\\n32726529\\n31371616\\n12235218\\n8345194', 'title': 'Respiratory Syncytial Virus Infections in Neonates: A Persisting Problem.', 'abstract': 'Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in young infants. It is an enveloped, single-stranded, nonsegmented, negative-strand RNA virus, a member of the family Pneumoviridae. Globally, RSV is responsible for 2.3% of deaths among neonates 0-27 days of age. Respiratory syncytial virus infection is most common in children aged below 24 months. Neonates present with cough and fever. Respiratory syncytial virus-associated wheezing is seen in 20% infants during the first year of life of which 2-3% require hospitalization. Reverse transcriptase polymerase chain reaction (RT-PCR) gives fast results and has higher sensitivity compared with culture and rapid antigen tests and are not affected by passively administered antibody to RSV. Therapy for RSV infection of the LRT is mainly supportive, and preventive measures like good hygiene and isolation are the mainstay of management. Standard precautions, hand hygiene, breastfeeding and contact isolation should be followed for RSV-infected newborns. Recent AAP guidelines do not recommend pavilizumab prophylaxis for preterm infants born at 29-35 weeks without chronic lung disease, hemodynamically significant congenital heart disease and coexisting conditions. RSV can lead to long-term sequelae such as wheezing and asthma, associated with increased healthcare costs and reduced quality of life.', 'keywords': ['Arexvy', 'Bronchiolitis', 'Lower respiratory tract infection', 'Neonate', 'Nerve growth factor/TrkA receptor axis', 'Newborn', 'Nirsevimab', 'Palivizumab', 'Perinatal RSV infection', 'Pneumoviridae'], 'journal': 'Newborn (Clarksville, Md.)', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Singh', 'firstname': 'Srijan', 'initials': 'S', 'affiliation': 'Neonatologist, Kailash Hospital, Noida, Uttar Pradesh, India.\\nGlobal Newborn Society (https://www.globalnewbornsociety.org/).'}, {'lastname': 'Maheshwari', 'firstname': 'Akhil', 'initials': 'A', 'affiliation': 'Global Newborn Society (https://www.globalnewbornsociety.org/).\\nDepartment of Pediatrics, Louisiana State University, Shreveport, Louisiana, United States of America.'}, {'lastname': 'Namazova', 'firstname': 'Ilhama', 'initials': 'I', 'affiliation': 'Global Newborn Society (https://www.globalnewbornsociety.org/).\\nDepartment of Pediatrics, Azerbaijan Tibb Universiteti, Baku, Azerbaijan.'}, {'lastname': 'Benjamin', 'firstname': 'John T', 'initials': 'JT', 'affiliation': 'Global Newborn Society (https://www.globalnewbornsociety.org/).\\nDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.'}, {'lastname': 'Wang', 'firstname': 'Yuping', 'initials': 'Y', 'affiliation': 'Department of Obstetrics and Gynaecology, Louisiana State University, Shreveport, Louisiana, United States of America.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.5005/jp-journals-11002-0073\\n10.1093/oxfordjournals.aje.a119901\\n10.1056/NEJMOA0804877\\n10.1007/S00705-016-2880-1/TABLES/1\\n10.12688/F1000RESEARCH.9637.1\\n10.1017/S0950268804003450\\n10.1016/J.RMED.2004.01.009\\n10.1086/498526\\n10.1086/513976\\n10.1016/S0022-3476(05)82443-6\\n10.1093/INFDIS/162.6.1283\\n10.1002/PPUL.23570\\n10.1016/S0140-6736(17)30938-8\\n10.1093/INFDIS/141.1.98\\n10.1016/J.COVIRO.2017.03.015\\n10.1017/S0950268814001393\\n10.1097/00006454-19930900000006\\n10.1542/PEDS.2013-0303\\n10.15585/MMWR.MM6702A4\\n10.1093/INFDIS/JIY056\\n10.15585/MMWR.MM7029A1\\n10.1542/PEDS.2021-051462\\n10.1093/CID/CIAA1328\\n10.1093/CID/CIAA1458\\n10.1093/CID/CIAA1475\\n10.1007/S00431-021-03968-6\\n10.1542/PEDS.2021052089\\n10.5152/TURKPEDIATRIARS.2018.6939\\n10.1067/MPD.2000.110531\\n10.1067/s0022-3476(03)00511-0\\n10.1542/PEDS.2010-0581\\n10.1093/INFDIS/JIV263\\n10.1097/INF.0000000000000918\\n10.1007/S10096-018-3256-0\\n10.1007/S40121-017-0160-3\\n10.1007/S40121-016-0137-7\\n10.1016/S0022-3476(96)70071-9\\n10.1007/S00431-0142415-2\\n10.1185/03007995.2010.505126\\n10.1007/S40121-016-0142-X\\n10.1007/S00431-007-0643-4\\n10.1542/PEDS.2004-0059\\n10.1002/PPUL.24137\\n10.1093/CID/CIY1071\\n10.1542/PEDS.2015-3272\\n10.1097/QAD.0000000000001393\\n10.1542/PEDS.2018-0225\\n10.7189/JOGH.05.020416\\n10.1080/14767050903194438\\n10.1086/344310\\n10.1086/345859\\n10.1111/J.1365-2222.2004.1947.X\\n10.1086/380908\\n10.1086/377587\\n10.1086/499316\\n10.1086/338473\\n10.1203/00006450200206000-00006\\n10.1086/420830\\n10.1097/01.INF.0000214998.16248.B7\\n10.1016/J.JPEDS.2009.09.043\\n10.1097/INF.0000000000002827\\n10.1038/s41579-019-0149-x\\n10.1097/WOX.0B013E31816549A2\\n10.1007/978-3-642-38919-1_4.\\n10.1371/JOURNAL.PPAT.1005318\\n10.1128/JVI.00643-06\\n10.1128/JVI.00349-15\\n10.1128/JVI.77.8.4609-4616.2003\\n10.1111/JMI.12095\\n10.1007/S00018-020-03557-0\\n10.1073/PNAS.260499197\\n10.3390/V10100535\\n10.3390/V13050834\\n10.1371/JOURNAL.PPAT.1009562\\n10.3390/V8050124\\n10.1007/978-3-662-06099-5_3\\n10.1080/03007995.2021.191\\n10.1371/JOURNAL.PONE.0157446\\n10.1097/INF.0B013E3181710990\\n10.1097/INF.0000000000000219\\n10.2147/PHMT.S59572\\n10.1097/INF.0000000000001377\\n10.1002/PPUL.23960\\n10.1016/S0954-6111(02)90066-1\\n10.1371/journal.pone.0061309\\n10.1038/S41390-019-0657-4\\n10.1165/RCMB.2010-0121OC\\n10.2174/187152810792231913\\n10.1038/337362A0\\n10.1073/PNAS.93.20.10955\\n10.1159/000024056\\n10.1371/JOURNAL.PONE.0006444\\n10.3389/FIMMU.2014.00466\\n10.1128/CMR.00090-16\\n10.1093/INFDIS/163.4.693\\n10.1056/NEJM197903083001004\\n10.1016/S0022-3476(81)80829-3\\n10.1016/J.JPEDS.2008.07.053\\n10.1016/j.micinf.2004.03.010\\n10.1038/MODPATHOL.3800725\\n10.1136/JCP.23.1.7\\n10.1136/ADC.71.5.428\\n10.3109/00365549009023125\\n10.1097/01.INF.0000143654.12493.C9\\n10.1016/S0022-3476(80)80799-2\\n10.1093/INFDIS/171.3.584\\n10.1128/CDLI.2.3.322-324.1995\\n10.1136/ADC.76.3.210\\n10.1086/322788\\n10.1097/00006454-200205000-00033\\n10.1002/JMV.20268\\n10.1128/CMR.00032-09\\n10.1016/J.JPEDS.2009.04.063\\n10.1177/0009922808320699\\n10.1001/ARCHPEDI.1979.02130080038006\\n10.1001/ARCHPEDI.1984.02140410027010\\n10.1016/S0022-3476(77)80697-5\\n10.1016/S0022-3476(82)80184-4\\n10.1203/00006450-199204000-00015\\n10.1371/JOURNAL.PONE.0089186\\n10.1007/S10096-011-1529-Y\\n10.1016/S0140-6736(19)30721-4\\n10.1001/ARCHPEDI.1986.02140200053026\\n10.1086/322657\\n10.1186/CC4984\\n10.1111/J.16512227.2003.TB00573.X\\n10.1136/ADC.65.11.1237\\n10.1164/RCCM.201604-0753OC\\n10.1128/JCM.00698-11\\n10.1097/INF.0B013E31829561DD\\n10.1128/JCM.01816-15\\n10.1097/PAT.0000000000000240\\n10.1016/j.jcv.2003.10.003\\n10.1093/CID/CIZ056\\n10.1093/CID/CIY381\\n10.1016/J.JCV.2018.08.009\\n10.1080/17476348.2017.1338567\\n10.1016/J.IDC.2017.07.006\\n10.1002/14651858.CD000181.PUB2\\n10.2165/00003495-199754060-00006\\n10.1182/BLOOD-2010-08-263400\\n10.1093/CID/CIS844\\n10.1097/00006454200205000-00037\\n10.1111/CTR.13511\\n10.1002/BDRA\\n10.1056/NEJM198306163082403\\n10.1097/00006454-19870200000004\\n10.1056/NEJM199107043250105\\n10.1097/00003246199404000-00010\\n10.1016/S0022-3476(96)70294-9\\n10.1164/AJRCCM.160.3.9810013\\n10.1128/MICROBIOLSPEC.AID-0014-2014\\n10.1086/514115\\n10.1097/01.INF.0000133165.85909.08\\n10.1542/PEDS.2018-2308\\n10.1111/TID.12510\\n10.1002/14651858.CD006602.PUB4\\n10.1542/PEDS.99.1.93\\n10.1128/AAC.31.12.1882\\n10.1016/J.COVIRO.2016.01.003\\n10.1056/NEJMOA1913556\\n10.1056/NEJMOA2110275\\n10.3390/CHILDREN2030289\\n10.1097/00005792-198909000-00002\\n10.1016/S0022-3476(05)80646-8\\n10.1016/S1473-3099(18)30292-5\\n10.1086/427813\\n10.1126/SCITRANSLMED.AAC8463\\n10.1093/INFDIS/JIZ408\\n10.1093/CID/CIZ653\\n10.1056/NEJMOA1908380\\n10.1126/SCIENCE.AAV9033\\n10.1084/JEM.20020781', 'xml': <Element 'PubmedArticle' at 0x109f44e00>}\n",
      "{'pubmed_id': '38347965\\n28144210\\n31885942\\n16702451\\n22929138\\n15759123\\n19152443\\n6593028\\n21452514\\n35663708\\n31011846\\n21830152\\n32607307\\n33511490\\n25663210\\n24732742\\n24844945\\n34528873\\n35127899\\n15674172\\n15749793', 'title': 'A Case of Long-Tract Ileocolic Intussusception Secondary to Well-Differentiated Cecal Adenocarcinoma.', 'abstract': 'Intussusception denotes the intricate phenomenon wherein one segment of the bowel undergoes invagination or telescoping into its contiguous distal segment. The ensuing invaginated segment may be propelled forward through peristaltic movements, potentially precipitating bowel obstruction or ischemia, culminating in necrosis of the affected bowel segment. Although the precise etiology of intussusception remains elusive, particularly in cases devoid of an identifiable lead point, dysrhythmic contractions and lymphoid hyperplasia have been implicated in the pathophysiology of this condition. We present the case of an 86-year-old African American female with a past medical history of hypertension and asthma who presented to our emergency room with a seven-day history of worsening abdominal. The pain was described as sharp and intermittent, and it would worsen with every meal or drink. A physical exam demonstrated the right lower quadrant with vague abdominal tenderness, especially below the umbilical region. Computed tomography of the abdomen and pelvis revealed a long segment of ileocolic obstructing intussusception in the ascending colon, with a 2.6 cm solid mass serving as a lead point.\\xa0Swift intervention ensued with an urgent exploratory laparotomy, culminating in a right hemicolectomy to excise the intussuscepted segment of the bowel. The pathological examination identified a well-differentiated adenocarcinoma of the cecum, categorized as T1N0M0, with all 20 resected lymph nodes yielding negative results. This illustrative case presents a unique insight into a patient with ileocolic obstructing intussusception, caused by a well-differentiated adenocarcinoma acting as the lead point, a relatively uncommon occurrence in adults. Diagnosing intussusception in adults is challenging due to its nonspecific symptoms, which are similar to those of various other gastrointestinal disorders. Therefore, it is crucial for medical providers to be acutely aware of the possibility that adenocarcinoma can trigger obstructing intussusception in various parts of the bowel.', 'keywords': ['adult intestinal invagination', 'adult intussusception', 'cecal adenocarcinoma', 'ileocolic intussusception', 'ileocolic type'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Ballan', 'firstname': 'Mohamad', 'initials': 'M', 'affiliation': 'Surgery, William Carey University College of Osteopathic Medicine, Hattiesburg, USA.'}, {'lastname': 'Aghababaei', 'firstname': 'Mahroo', 'initials': 'M', 'affiliation': 'Surgery, William Carey University College of Osteopathic Medicine, Hattiesburg, USA.'}, {'lastname': 'Chin', 'firstname': 'An Guo Michael', 'initials': 'AGM', 'affiliation': \"Surgery, St. John's Episcopal Hospital, Queens, USA.\"}, {'lastname': 'Kim', 'firstname': 'Dmitriy', 'initials': 'D', 'affiliation': \"Surgery, St. John's Episcopal Hospital, Queens, USA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024, Ballan et al.', 'doi': '10.7759/cureus.52208', 'xml': <Element 'PubmedArticle' at 0x108d66930>}\n",
      "{'pubmed_id': '38347929\\n32007172\\n34667060\\n36682372\\n28722758\\n33878830\\n29605212\\n31230828\\n27751401\\n24792855\\n28694047\\n32233861\\n33461908\\n31724961\\n32020334\\n29147496\\n30741503\\n29883872\\n31342347\\n29074814\\n30858785\\n31536730\\n32184587\\n28654880\\n31753527\\n24836410\\n32330717\\n34154551\\n30885130\\n30121467\\n30871339\\n27351879\\n30544078\\n29440305\\n35219742\\n37164512\\n24758509\\n32447079\\n32109812\\n25512430\\n35396614\\n29778811\\n30812001\\n35220536\\n30852202\\n9739623\\n9351613\\n17646040\\n26382947\\n38026400\\n26680605\\n33601224\\n36684992\\n29382596\\n24223075\\n30680626\\n17637911\\n23665383\\n30741719\\n25571792\\n33168238\\n15743717\\n15824556\\n28069303\\n34761318\\n25585158\\n35425736', 'title': 'Short-term effects of air pollutants on hospital admissions for asthma among older adults: a multi-city time series study in Southwest, China.', 'abstract': 'This study aimed to explore the relationship between air pollution and hospital admissions for asthma in older adults, and to further assess the health and economic burden of asthma admissions attributable to air pollution.\\nWe collected information on asthma cases in people over 65\\u2009years of age from nine cities in Sichuan province, as well as air pollution and meteorological data. The relationship between short-term air pollutant exposure and daily asthma hospitalizations was analyzed using the generalized additive model (GAM), and stratified by gender, age, and season. In addition, we assessed the economic burden of hospitalization for air pollution-related asthma in older adults using the cost of disease approach.\\nThe single pollutant model showed that every 1\\u2009mg/m\\nThis study suggests that short-term exposure to air pollutants is positively associated with an increase in numbers of asthma of people over 65\\u2009years of age in Sichuan province, and short-term exposure to excessive PM and NO', 'keywords': ['air pollution', 'asthma in older adults', 'economic cost', 'generalized additive model', 'time-series study'], 'journal': 'Frontiers in public health', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Zhang', 'firstname': 'Yuqin', 'initials': 'Y', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Yang', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Jiang', 'firstname': 'Wanyanhan', 'initials': 'W', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Gao', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Yang', 'firstname': 'Biao', 'initials': 'B', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Feng', 'firstname': 'Xing Lin', 'initials': 'XL', 'affiliation': 'School of Public Health, Peking University, Beijing, China.'}, {'lastname': 'Yang', 'firstname': 'Lian', 'initials': 'L', 'affiliation': 'School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}], 'methods': None, 'conclusions': 'This study suggests that short-term exposure to air pollutants is positively associated with an increase in numbers of asthma of people over 65\\u2009years of age in Sichuan province, and short-term exposure to excessive PM and NO', 'results': 'The single pollutant model showed that every 1\\u2009mg/m', 'copyrights': 'Copyright © 2024 Zhang, Yang, Jiang, Gao, Yang, Feng and Yang.', 'doi': '10.3389/fpubh.2024.1346914\\n10.1016/S0140-6736(19)33005-3\\n10.1183/13993003.02730-2021\\n10.1016/S0140-6736(22)02125-0\\n10.3760/cma.j.cn112137-2020723-02200\\n10.1111/all.13258\\n10.3760/cma.j.cn112137-20200914-0639\\n10.1016/j.rmed.2018.02.010\\n10.1016/S0140-6736(19)31147-X\\n10.1016/S0140-6736(16)31597-5\\n10.1016/S0140-6736(14)60617-6\\n10.1016/j.jaip.2017.05.019\\n10.1513/AnnalsATS.202001-046ST\\n10.1016/j.chest.2020.10.053\\n10.1097/MCP.0000000000000644\\n10.1007/s00281-020-00785-1\\n10.1155/2017/2463065\\n10.5334/aogh.2412\\n10.1016/j.ecoenv.2018.05.089\\n10.1007/s11356-019-05971-9\\n10.1136/thoraxjnl-2017-210650\\n10.5114/ada.2018.73330\\n10.1016/j.jaci.2019.08.037\\n10.2147/COPD.S231317\\n10.1016/j.envpol.2017.06.029\\n10.1016/j.ijheh.2019.11.001\\n10.1016/j.envpol.2014.04.028\\n10.1016/j.scitotenv.2020.138584\\n10.1186/s12889-021-11220-x\\n10.1186/s12199-019-0773-0\\n10.1007/s11869-021-00997-w\\n10.1016/j.envres.2018.08.011\\n10.1164/rccm.201810-1823OC\\n10.1007/s11356-016-7066-6\\n10.1016/j.envres.2018.11.043\\n10.13213/j.cnki.jeom.2019.18744\\n10.1136/jech-2017-209948\\n10.1016/j.jad.2022.02.064\\n10.1016/S2542-5196(23)00053-0\\n10.1186/1471-2288-14-55\\n10.1016/j.scitotenv.2020.139114\\n10.1016/j.scitotenv.2020.137274\\n10.1136/tobaccocontrol-2014-051821\\n10.1007/s12519-022-00537-1\\n10.1016/j.envpol.2018.05.029\\n10.1016/j.scitotenv.2019.02.256\\n10.1007/s11356-022-19086-1\\n10.1016/j.scitotenv.2019.02.333\\n10.1080/10473289.1998.10463718\\n10.1164/ajrccm.156.4.96-08056\\n10.1016/j.envpol.2007.06.012\\n10.1371/journal.pone.0138146\\n10.3389/fpubh.2023.1215224\\n10.15244/pjoes/132796\\n10.1164/rccm.201508-1633OC\\n10.1016/j.envint.2021.106435\\n10.3389/fpubh.2022.1070231\\n10.1016/j.jaci.2018.01.006\\n10.1007/s11869-013-0195-x\\n10.1007/s00484-018-01665-y\\n10.1289/ehp.9621\\n10.1016/j.molimm.2013.04.002\\n10.1172/JCI124612\\n10.1016/j.annepidem.2014.11.006\\n10.1016/j.scitotenv.2020.143135\\n10.1289/ehp.7300\\n10.1097/01.ede.0000155505.04775.33\\n10.1016/j.atmosenv.2016.04.037\\n10.1016/j.scitotenv.2016.12.151\\n10.1007/s11356-021-17303-x\\n10.1016/j.scitotenv.2015.01.005\\n10.3389/fpubh.2022.869656', 'xml': <Element 'PubmedArticle' at 0x109cf6660>}\n",
      "{'pubmed_id': '38347908\\n29894209\\n31275909\\n27168434\\n11149992\\n30359613\\n26595730\\n24706858\\n24706856\\n28277826\\n34879449\\n10489824\\n15696076\\n34949706\\n29782217\\n35789920', 'title': 'Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study.', 'abstract': 'Severe, uncontrolled asthma and asthma exacerbations in children are associated with abnormal lung function and airway development, and increased risk of chronic obstructive lung disease in adulthood. The rationale for this post hoc analysis was to explore the relationship between changes in asthma exacerbation rates and lung function in children treated with dupilumab.\\nThis post hoc analysis included children aged 6 to 11 years with uncontrolled, moderate-to-severe type 2 asthma (blood eosinophils ≥150 cells/μL or fractional exhaled nitric oxide ≥20 ppb) who received dupilumab or placebo in the phase 3 LIBERTY ASTHMA VOYAGE study (NCT02948959). Endpoints were the proportion of patients achieving clinically meaningful improvements (≥5% or ≥10%) in pre-bronchodilator percent-predicted forced expiratory volume in 1 second (ppFEV\\nAt Week 12 of VOYAGE, 141/236 (60%) of children treated with dupilumab and 57/114 (50%) of children receiving placebo showed improvements of ≥5% in ppFEV\\nDupilumab vs placebo significantly improved pre-bronchodilator ppFEV\\nNCT02948959.', 'keywords': ['asthma', 'children', 'dupilumab', 'exacerbations', 'lung function', 'moderate-to-severe asthma', 'percent-predicted FEV1', 'uncontrolled asthma'], 'journal': 'Journal of asthma and allergy', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Guilbert', 'firstname': 'Theresa W', 'initials': 'TW', 'affiliation': \"Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.\"}, {'lastname': 'Murphy', 'firstname': 'Kevin R', 'initials': 'KR', 'affiliation': 'Boys Town National Research Hospital, Omaha, NE, USA.'}, {'lastname': 'Hamelmann', 'firstname': 'Eckard', 'initials': 'E', 'affiliation': \"Department of Pediatrics, Children's Center Bethel, University of Bielefeld, Bielefeld, Germany.\"}, {'lastname': 'Ross', 'firstname': 'Kristie R', 'initials': 'KR', 'affiliation': \"UH Rainbow Babies and Children's Hospital, Cleveland, OH, USA.\"}, {'lastname': 'Gupta', 'firstname': 'Atul', 'initials': 'A', 'affiliation': \"King's College Hospital, London, UK.\"}, {'lastname': 'Fiocchi', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': \"Bambino Gesù Children's Hospital IRCCS, Rome, Italy.\"}, {'lastname': 'Xia', 'firstname': 'Changming', 'initials': 'C', 'affiliation': 'Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.'}, {'lastname': 'Gall', 'firstname': 'Rebecca', 'initials': 'R', 'affiliation': 'Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.'}, {'lastname': 'Ledanois', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': 'Sanofi, Paris, France.'}, {'lastname': 'Radwan', 'firstname': 'Amr', 'initials': 'A', 'affiliation': 'Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.'}, {'lastname': 'Jacob-Nara', 'firstname': 'Juby A', 'initials': 'JA', 'affiliation': 'Sanofi, Bridgewater, NJ, USA.'}, {'lastname': 'Rowe', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'Sanofi, Bridgewater, NJ, USA.'}, {'lastname': 'Deniz', 'firstname': 'Yamo', 'initials': 'Y', 'affiliation': 'Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.'}], 'methods': None, 'conclusions': 'Dupilumab vs placebo significantly improved pre-bronchodilator ppFEV', 'results': 'At Week 12 of VOYAGE, 141/236 (60%) of children treated with dupilumab and 57/114 (50%) of children receiving placebo showed improvements of ≥5% in ppFEV', 'copyrights': '© 2024 Guilbert et al.', 'doi': '10.2147/JAA.S425101\\n10.1513/annalsats.201806-374oc\\n10.3389/fped.2019.00246\\n10.1056/nejmoa1513737\\n10.1067/mai.2001.111590\\n10.1016/j.chest.2018.10.009\\n10.1513/annalsats.201506-377aw\\n10.1073/pnas.1323896111\\n10.1073/pnas.1324022111\\n10.1080/1744666x.2017.1298443\\n10.1056/nejmoa2106567\\n10.1034/j.1399-3003.1999.14a06.x\\n10.1016/j.jaci.2004.11.014\\n10.1183/13993003.01499-2021\\n10.1056/nejmoa1804092\\n10.2147/jaa.s354013', 'xml': <Element 'PubmedArticle' at 0x10970a480>}\n",
      "{'pubmed_id': '38347809', 'title': 'A Survey on the association of seizure disorders with asthma and allergies in children.', 'abstract': '', 'keywords': ['Allergy', 'asthma', 'atopy', 'epilepsy', 'seizure'], 'journal': 'European annals of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Sadri', 'firstname': 'H', 'initials': 'H', 'affiliation': 'Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Madanipour', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Toami', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Department of Pediatrics, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Bakhtiari', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Montazerlotfelahi', 'firstname': 'H', 'initials': 'H', 'affiliation': 'Department of Pediatric Neurology, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Zahmatkesh', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Pediatrics, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Zandifar', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Psychiatry, Imam Hossein Hospital, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.'}, {'lastname': 'Tavakol', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.23822/EurAnnACI.1764-1489.328', 'xml': <Element 'PubmedArticle' at 0x10b149120>}\n",
      "{'pubmed_id': '38347725', 'title': 'Rechallenges without desensitization following platinum-based chemotherapy reactions.', 'abstract': \"There is increasing interest in non-desensitization protocols as a potential way to reintroduce chemotherapy following hypersensitivity reactions (HSR).\\nTo provide insight into the potential utility of non-desensitization reintroduction, particularly at institutions where allergy consultation may not be available.\\nFor 70 patients with platinum HSR who underwent rechallenge with standard (≤2\\u2005hours), extended (1-bag, 1-step, 4-6\\u2005hours), or titrated (4-to-5-bag and -step, 6-7.5\\u2005hours) infusions between 1/2014 and 7/2019, demographics and clinical characteristics were reviewed and initial and breakthrough reactions (BTR) were graded using Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v5.0). Tolerance (no BTR) and completion (dose completed despite BTR) were compared using Fisher's exact test.\\nPatients (mean [standard deviation] age 57 [13] years, initial HSR grade 2 [1]), were rechallenged with standard (\\nExtended and titrated infusions may increase reintroduction safety compared to standard infusions. Further investigation into extended infusions may provide a safe alternative to standard infusions in patients who may not have access to desensitization at their institution.\", 'keywords': ['Chemotherapy reactions', 'extended infusions', 'platinum chemotherapy', 'rechallenge', 'titrated infusions'], 'journal': 'Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Young', 'firstname': 'Fernanda D', 'initials': 'FD', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.\\nAllergy and Immunology Fellowship Training Program, Department of Medicine, UCSF, San Francisco, CA, USA.'}, {'lastname': 'Aung', 'firstname': 'Sidney', 'initials': 'S', 'affiliation': 'Internal Medicine Residency Training Program, Department of Medicine, UCSF, San Francisco, CA, USA.'}, {'lastname': 'Tang', 'firstname': 'Monica', 'initials': 'M', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, UCSF, San Francisco, CA, USA.'}, {'lastname': 'Anstey', 'firstname': 'Karen M', 'initials': 'KM', 'affiliation': 'Division of Pulmonary and Critical Care, Section of Allergy and Clinical Immunology, OHSU, Portland, OR, USA.'}, {'lastname': 'Lee', 'firstname': 'Michael C', 'initials': 'MC', 'affiliation': 'Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, CA, USA.'}, {'lastname': 'Alfaro', 'firstname': 'Emely', 'initials': 'E', 'affiliation': 'Adult Infusion Services, UCSF Medical Center, San Francisco, CA.'}, {'lastname': 'Cinar', 'firstname': 'Pelin', 'initials': 'P', 'affiliation': 'UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.\\nGilead Sciences Inc, Foster City, CA, USA.'}, {'lastname': 'Ho', 'firstname': 'Hansen', 'initials': 'H', 'affiliation': 'University of California San Francisco School of Pharmacy, San Francisco, CA, USA.'}, {'lastname': 'Otani', 'firstname': 'Iris M', 'initials': 'IM', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, UCSF, San Francisco, CA, USA.'}], 'methods': None, 'conclusions': None, 'results': 'Patients (mean [standard deviation] age 57 [13] years, initial HSR grade 2 [1]), were rechallenged with standard (', 'copyrights': None, 'doi': '10.1177/10781552241229024', 'xml': <Element 'PubmedArticle' at 0x10b68eb10>}\n",
      "{'pubmed_id': '38347595\\n36891081\\n26194859\\n35779843\\n28756800\\n35477559\\n35843518\\n35609927\\n31593836\\n20650027\\n33046071\\n34046485\\n33263068\\n28872981', 'title': 'Acuity of asthma exacerbations in Alberta, Canada is increasing: a population-based study.', 'abstract': 'Asthma is a common respiratory illness affecting 2.8\\xa0million Canadians, including 9.7% of Albertans. Prior studies showed a substantial decrease in ED visits for asthma in the decade preceding 2010, followed by a stabilization. This was attributed to improvements in the pharmacologic and non-pharmacologic treatments for asthma during that period followed by a balance between epidemiologic drivers and protective factors in the population.\\nWe assessed whether this trend continued in Alberta from 2010 to 2022 using population level data for the volume of daily ED visits, acuity of asthma exacerbations in the ED, and hospitalization rate.\\nThe mean number of ED visits decreased from 4.5 to 2.2 per million persons per day, but the acuity of exacerbations and the proportion requiring hospitalization increased. The number of patients presenting with the highest level of acuity increased by over 300%, and the percentage of patients requiring hospitalization increased from 6.8 to 11.3%.\\nTotal ED visits for asthma exacerbations continues to decline in Alberta. The reasons for an increase in more severe exacerbations requires further attention.', 'keywords': ['Asthma', 'Asthma exacerbations', 'Critical care', 'Emergency department', 'Epidemiology', 'Hospitalization'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Adatia', 'firstname': 'Adil', 'initials': 'A', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada. adatia@ualberta.ca.\\nAlberta Respiratory Centre, Edmonton, AB, Canada. adatia@ualberta.ca.'}, {'lastname': 'Moolji', 'firstname': 'Jalal', 'initials': 'J', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.'}, {'lastname': 'Satia', 'firstname': 'Imran', 'initials': 'I', 'affiliation': 'Department of Medicine, McMaster University, Hamilton, ON, Canada.'}], 'methods': None, 'conclusions': 'Total ED visits for asthma exacerbations continues to decline in Alberta. The reasons for an increase in more severe exacerbations requires further attention.', 'results': 'The mean number of ED visits decreased from 4.5 to 2.2 per million persons per day, but the acuity of exacerbations and the proportion requiring hospitalization increased. The number of patients presenting with the highest level of acuity increased by over 300%, and the percentage of patients requiring hospitalization increased from 6.8 to 11.3%.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00872-0\\n10.1183/23120541.00489-2022\\n10.1111/acem.12725\\n10.1016/j.anai.2022.06.022\\n10.1017/cem.2017.365\\n10.1136/thoraxjnl-2021-217867\\n10.1016/j.anai.2022.07.005\\n10.1016/j.envres.2019.108777\\n10.1017/S1481803500012434\\n10.1186/s12913-020-05774-6\\n10.1183/23120541.00053-2021\\n10.1183/23120541.00593-2020\\n10.1080/02770903.2017.1373805', 'xml': <Element 'PubmedArticle' at 0x10a036020>}\n",
      "{'pubmed_id': '38347498\\n24247148\\n27658738\\n23744504\\n32516936\\n29617173\\n34377999\\n33669441\\n33719898\\n33861765\\n31647790\\n20843472\\n26978210\\n22819634\\n25474033\\n7915354\\n26613666\\n24312488\\n33292194\\n33373268\\n18332402\\n18416923\\n17238221\\n14751919\\n34454441\\n33023774\\n28474295\\n33551522\\n34957038\\n35287066\\n32414654\\n33022806\\n28746348\\n25063570\\n21722445\\n25485326\\n32235360\\n16223649\\n32529178\\n17972971\\n29426662\\n33207667\\n29738898\\n25236585\\n23747452\\n26740249\\n12112494\\n28408120\\n31945596\\n32719055\\n21071107\\n23181391\\n28408011\\n20380596\\n34202298\\n33445581\\n29074176\\n30711059\\n10726935\\n24161969', 'title': 'Vaccine decision making in New Zealand: a discrete choice experiment.', 'abstract': 'Vaccine hesitancy is a significant threat to global health. A key part of addressing hesitancy is to ensure that public health messaging prioritises information that is considered important to the public. This study aimed to examine how different vaccine characteristics affect public preferences for vaccines in New Zealand, what trade-offs they are willing to make between different vaccine characteristics, and how their preferences are affected by their vaccine-related conspiracy beliefs and COVID-19 vaccination status.\\nAn online discrete choice experiment (DCE) was designed to elicit individual preferences about vaccines using the 1000minds platform. Members of the general population of New Zealand aged\\u2009≥\\u200918 years were invited to complete the DCE. Participants were asked to indicate their preference between two options showing different combinations of vaccine characteristics. Data on sociodemographic characteristics were collected. Beliefs were measured using the vaccine conspiracy beliefs scale (VCBS) with scores\\u2009≥\\u200919 indicating strong vaccine-related conspiracy beliefs. The DCE was analysed using the PAPRIKA method (Potentially All Pairwise RanKings of all possible Alternatives) and preferences compared between respondents with high versus low VCBS scores and vaccinated versus unvaccinated respondents for COVID-19.\\nA total of 611 respondents from 15 regions completed the DCE. Mean (SD) age was 45.9 (14.7) years with most having had 2 or more doses of the coronavirus vaccine (86%). Mean (SD) VCBS score was 18.5 (12.4) indicating moderate vaccine-related conspiracy beliefs. Risk of severe adverse effects was the most highly valued vaccine characteristic, followed by vaccine effectiveness and duration of protection. Vaccine origin and route of administration were ranked least important. Respondents scoring high on the VCBS placed less value on the effectiveness of vaccines but greater value on development time and total number of doses (p\\u2009<\\u20090.001). COVID-19 unvaccinated respondents ranked development time and total number of doses more highly than those vaccinated respondents (p\\u2009<\\u20090.001).\\nRisk of severe adverse effects, vaccine effectiveness and duration of protection were rated by the New Zealand public as the top three most important vaccine characteristics. This information is important for informing public health messaging to promote vaccine uptake and inform vaccine decision-making.', 'keywords': ['Attributes', 'Decision making', 'Discrete choice', 'Preferences', 'Vaccination'], 'journal': 'BMC public health', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Chan', 'firstname': 'Amy Hai Yan', 'initials': 'AHY', 'affiliation': 'School of Pharmacy, University of Auckland, Level 3, Building 505, 85 Park Road, Grafton, 1023, Auckland, New Zealand. a.chan@auckland.ac.nz.'}, {'lastname': 'Tao', 'firstname': 'Marvin', 'initials': 'M', 'affiliation': 'School of Medicine, University of Auckland, Building 505, 85 Park Road, Grafton, 1023, Auckland, New Zealand.'}, {'lastname': 'Marsh', 'firstname': 'Samantha', 'initials': 'S', 'affiliation': 'School of Population Health, University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.'}, {'lastname': 'Petousis-Harris', 'firstname': 'Helen', 'initials': 'H', 'affiliation': 'School of Population Health, University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 611 respondents from 15 regions completed the DCE. Mean (SD) age was 45.9 (14.7) years with most having had 2 or more doses of the coronavirus vaccine (86%). Mean (SD) VCBS score was 18.5 (12.4) indicating moderate vaccine-related conspiracy beliefs. Risk of severe adverse effects was the most highly valued vaccine characteristic, followed by vaccine effectiveness and duration of protection. Vaccine origin and route of administration were ranked least important. Respondents scoring high on the VCBS placed less value on the effectiveness of vaccines but greater value on development time and total number of doses (p\\u2009<\\u20090.001). COVID-19 unvaccinated respondents ranked development time and total number of doses more highly than those vaccinated respondents (p\\u2009<\\u20090.001).', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12889-024-17865-8\\n10.4161/hv.27243\\n10.1016/j.ebiom.2016.08.042\\n10.4161/hv.25085\\n10.1080/21645515.2018.1460987\\n10.1016/j.lanwpc.2021.100241\\n10.3390/vaccines9020160\\n10.1080/10810730.2021.1899346\\n10.1371/journal.pone.0250123\\n10.2807/ese.15.36.19656-en\\n10.1001/jama.2016.1353\\n10.1016/j.jpeds.2012.05.041\\n10.1016/S0140-6736(94)92091-5\\n10.1016/j.pec.2015.11.004\\n10.1371/journal.pone.0080633\\n10.1186/s12913-020-05911-1\\n10.1509/jppm.19.1.106.16946\\n10.1370/afm.816\\n10.1258/jhsrp.2007.007087\\n10.1002/hec.1193\\n10.1136/bmj.37972.497234.44\\n10.1186/s12879-021-06398-9\\n10.1016/j.vaccine.2020.08.078\\n10.1007/s40271-017-0244-x\\n10.1016/j.econlet.2021.109747\\n10.3389/fpubh.2021.793533\\n10.1016/j.socscimed.2022.114800\\n10.1016/j.vaccine.2020.05.012\\n10.1111/hex.13140\\n10.1371/journal.pone.0181073\\n10.1016/j.vaccine.2014.07.002\\n10.3399/bjgp11X583155\\n10.1071/HC14304\\n10.3390/vaccines8020152\\n10.1016/j.jclinepi.2005.09.002\\n10.1016/j.eclinm.2020.100387\\n10.1016/j.vaccine.2018.01.054\\n10.3390/vaccines8040687\\n10.1016/j.socscimed.2018.04.038\\n10.1016/j.vaccine.2014.09.004\\n10.1016/j.vaccine.2013.05.089\\n10.1016/j.vaccine.2015.11.075\\n10.1002/hec.694\\n10.1016/j.vaccine.2017.03.086\\n10.1016/j.socscimed.2019.112707\\n10.1002/mcda.428\\n10.1136/thoraxjnl-2019-214343\\n10.1016/j.healthpol.2010.10.012\\n10.1186/2045-4015-1-44\\n10.1016/j.jval.2016.12.008\\n10.3109/09638281003775535\\n10.2501/S1470785310201673\\n10.1016/j.ecolecon.2022.107665\\n10.3390/vaccines9070701\\n10.3390/vaccines9010042\\n10.1016/j.pvr.2016.09.001\\n10.1016/j.jval.2018.07.876\\n10.1258/0956462001915570\\n10.1038/nmeth.2659', 'xml': <Element 'PubmedArticle' at 0x10b854680>}\n",
      "{'pubmed_id': '38347197\\n33136523\\n33236525\\n32926406\\n27959637\\n23883597\\n27859303\\n24337046\\n31090937\\n33548517\\n32524991\\n31452831\\n33263506\\n33423452\\n34607329\\n36848277\\n38108602\\n34543652\\n35398492\\n37226507\\n31407311\\n28687232\\n37515811\\n35880360\\n35769474\\n33349889\\n35764984', 'title': 'Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP.', 'abstract': 'Nowadays, several efficacious biologic drugs are used for severe asthma with or without chronic rhinosinusitis with nasal polyps (CRSwNP). However, it has been observed that not all comorbid patients (asthma/CRSwNP) receiving biologic treatment for asthma experience satisfactory control of both conditions equally.\\nWe selected 20 patients who had both severe asthma and comorbid CRSwNP under biological treatment with benralizumab, omalizumab or mepolizumab with adequate control of asthma but inadequate control of nasal symptoms. Patients were switched to dupilumab and outcomes were evaluated at baseline (T0), at 3\\xa0months (T1), at 6\\xa0months (T2), at 12\\xa0months (T3) and finally at 18\\xa0months (T4). Data were collected at each time point including blood tests measuring eosinophil levels and total IgE, SNOT22, ACT, NPS score, rhinomanometry, olfactory testing, and nasal cytology.\\nThe results showed an overall improvement in all the outcomes. Peripheral eosinophilia was observed consistently with existing literature. All patients registered an improvement in sinonasal outcomes, while only one patient had a worsening of asthma. Three patients interrupted the therapy due to various causes: poor asthma control, onset of psoriasis and thrombocytopenia.\\nThe response to a biologic treatment for CRSwNP control may be heterogenous and it seems that patients may benefit from switching improving control in equal measure in the upper and lower airway. Further studies to explore the endotype/phenotype which best fits with each biologic are mandatory to personalize the therapy.', 'keywords': ['Benralizumab', 'Biological therapy', 'CRSwNP', 'Dupilumab', 'Mepolizumab', 'Monoclonal antibodies', 'Nasal polyps', 'Omalizumab'], 'journal': 'European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Rosso', 'firstname': 'Cecilia', 'initials': 'C', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy. rosso.cecilia1@gmail.com.\\nDepartment of Otolaryngology, San Paolo Hospital, University of Milan, via di Rudinì 8, 20154, Milan, Italy. rosso.cecilia1@gmail.com.'}, {'lastname': 'De Corso', 'firstname': 'Eugenio', 'initials': 'E', 'affiliation': 'Unit of Otorhinolaryngology-Head and Neck Surgery, A. Gemelli Hospital Foundation IRCCS, 00168, Rome, Italy.'}, {'lastname': 'Conti', 'firstname': 'Valerio', 'initials': 'V', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Nitro', 'firstname': 'Letizia', 'initials': 'L', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Saibene', 'firstname': 'Alberto Maria', 'initials': 'AM', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Parazzini', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Pulmonology Department, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Rinaldo', 'firstname': 'Rocco', 'initials': 'R', 'affiliation': 'Pulmonology Department, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'De Pascalis', 'firstname': 'Sabrina', 'initials': 'S', 'affiliation': 'Pulmonology Department, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Arnone', 'firstname': 'Flavio', 'initials': 'F', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Centanni', 'firstname': 'Stefano', 'initials': 'S', 'affiliation': 'Pulmonology Department, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Montuori', 'firstname': 'Claudio', 'initials': 'C', 'affiliation': 'Department of Head-Neck and Sensory Organs, Catholic University of Sacred Heart, 00168, Rome, Italy.'}, {'lastname': \"D'Auria\", 'firstname': 'Leandro Maria', 'initials': 'LM', 'affiliation': 'Department of Head-Neck and Sensory Organs, Catholic University of Sacred Heart, 00168, Rome, Italy.'}, {'lastname': 'Felisati', 'firstname': 'Giovanni', 'initials': 'G', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}, {'lastname': 'Pipolo', 'firstname': 'Carlotta', 'initials': 'C', 'affiliation': 'Otolaryngology Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.'}], 'methods': None, 'conclusions': None, 'results': 'The results showed an overall improvement in all the outcomes. Peripheral eosinophilia was observed consistently with existing literature. All patients registered an improvement in sinonasal outcomes, while only one patient had a worsening of asthma. Three patients interrupted the therapy due to various causes: poor asthma control, onset of psoriasis and thrombocytopenia.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s00405-024-08461-y\\n10.1080/03007995.2020.1815682\\n10.4193/Rhin20.600\\n10.1002/alr.22741\\n10.1002/14651858.CD013513.pub2\\n10.1146/annurev-pathol-052016-100401\\n10.2500/aap.2013.34.3675\\n10.1002/lary.26391\\n10.1007/978-1-4939-0265-1_11\\n10.1183/09031936.00202013\\n10.1111/all.13875\\n10.1016/j.jaip.2021.01.031\\n10.1016/j.jaci.2020.05.032\\n10.4193/Rhin20.570\\n10.1177/1753466620965151\\n10.23812/20-323-L\\n10.1159/000519228\\n10.1177/19458924221147758\\n10.1111/all.15772\\n10.1016/j.jaci.2021.09.009\\n10.1016/j.anai.2022.04.004\\n10.1080/1744666x.2023.2218617\\n10.1016/j.jaip.2021.09.037\\n10.1111/bjd.18434\\n10.1016/j.jaci.2017.05.044\\n10.4193/Rhin22.408\\n10.14639/0392-100x-n1911\\n10.3389/fimmu.2022.928621\\n10.1080/09546634.2020.1871463\\n10.2340/00015555-3734\\n10.1186/s12890-022-02046-', 'xml': <Element 'PubmedArticle' at 0x10a8989f0>}\n",
      "{'pubmed_id': '38347162\\n14005590\\n4564685\\n24673696\\n35192447\\n34756186\\n35361992\\n20052417\\n28316330\\n21402903\\n29142211\\n12949249\\n35058634\\n22412951\\n25575312\\n21680950\\n25803243\\n34425308\\n29062070\\n36338247\\n21543571\\n32540174\\n29905870\\n22170421\\n31647096\\n18024473\\n35511986\\n32252376\\n33653689\\n8845445\\n23684303\\n19128474\\n18216770\\n33446545\\n32425895\\n32477967\\n17611496\\n20182505\\n23534543\\n32424203\\n31071294\\n35123653\\n35926021\\n29985183\\n21823229\\n29593104\\n35197636\\n22914092\\n31607545\\n32046217\\n23460914\\n12122743\\n22319561\\n34880489\\n21194740\\n23975157\\n24821013\\n11393191\\n26476603\\n6695127\\n34997214\\n11240158\\n27279650\\n35773287\\n28450637\\n29718427\\n18263800\\n37168857\\n33031374\\n23866975\\n26531326\\n34415577\\n24342546\\n9230242\\n25787137\\n16109964\\n27078029\\n28187782\\n35572406\\n16908868\\n20513517\\n7767192\\n18303415\\n16113423\\n32330134\\n32753501\\n30504855\\n34597405\\n30016406\\n33885785\\n29281698\\n25387460\\n28011775\\n25605792\\n12807801\\n18084642\\n31649059\\n19114008\\n26921390\\n21961884', 'title': 'Genomic attributes of airway commensal bacteria and mucosa.', 'abstract': 'Microbial communities at the airway mucosal barrier are conserved and highly ordered, in likelihood reflecting co-evolution with human host factors. Freed of selection to digest nutrients, the airway microbiome underpins cognate management of mucosal immunity and pathogen resistance. We show here the initial results of systematic culture and whole-genome sequencing of the thoracic airway bacteria, identifying 52 novel species amongst 126 organisms that constitute 75% of commensals typically present in heathy individuals. Clinically relevant genes encode antimicrobial synthesis, adhesion and biofilm formation, immune modulation, iron utilisation, nitrous oxide (NO) metabolism and sphingolipid signalling. Using whole-genome content we identify dysbiotic features that may influence asthma and chronic obstructive pulmonary disease. We match isolate gene content to transcripts and metabolites expressed late in airway epithelial differentiation, identifying pathways to sustain host interactions with microbiota. Our results provide a systematic basis for decrypting interactions between commensals, pathogens, and mucosa in lung diseases of global significance.', 'keywords': [], 'journal': 'Communications biology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Cuthbertson', 'firstname': 'Leah', 'initials': 'L', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Löber', 'firstname': 'Ulrike', 'initials': 'U', 'affiliation': 'Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany.\\nExperimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.\\nDZHK (German Centre for Cardiovascular Research), Partner Site, 10785, Berlin, Germany.\\nCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.'}, {'lastname': 'Ish-Horowicz', 'firstname': 'Jonathan S', 'initials': 'JS', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.\\nDepartment of Mathematics, Imperial College London, London, UK.'}, {'lastname': 'McBrien', 'firstname': 'Claire N', 'initials': 'CN', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Churchward', 'firstname': 'Colin', 'initials': 'C', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Parker', 'firstname': 'Jeremy C', 'initials': 'JC', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Olanipekun', 'firstname': 'Michael T', 'initials': 'MT', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Burke', 'firstname': 'Conor', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Connolly Hospital, Dublin, Ireland.'}, {'lastname': 'McGowan', 'firstname': 'Aisling', 'initials': 'A', 'affiliation': 'Department of Respiratory Medicine, Connolly Hospital, Dublin, Ireland.'}, {'lastname': 'Davies', 'firstname': 'Gwyneth A', 'initials': 'GA', 'affiliation': 'Population Data Science and Health Data Research UK BREATHE Hub, Swansea University Medical School, Swansea University, Swansea, UK.\\nCollege of Medicine, Institute of Life Science, Swansea University, Swansea, UK.'}, {'lastname': 'Lewis', 'firstname': 'Keir E', 'initials': 'KE', 'affiliation': 'College of Medicine, Institute of Life Science, Swansea University, Swansea, UK.\\nRespiratory Medicine, Hywel Dda University Health Board, Llanelli, UK.'}, {'lastname': 'Hopkin', 'firstname': 'Julian M', 'initials': 'JM', 'affiliation': 'College of Medicine, Institute of Life Science, Swansea University, Swansea, UK.'}, {'lastname': 'Chung', 'firstname': 'Kian Fan', 'initials': 'KF', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': \"O'Carroll\", 'firstname': 'Orla', 'initials': 'O', 'affiliation': 'Department of Respiratory Medicine, Connolly Hospital, Dublin, Ireland.'}, {'lastname': 'Faul', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Connolly Hospital, Dublin, Ireland.'}, {'lastname': 'Creaser-Thomas', 'firstname': 'Joy', 'initials': 'J', 'affiliation': 'College of Medicine, Institute of Life Science, Swansea University, Swansea, UK.'}, {'lastname': 'Andrews', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'Respiratory Medicine, Hywel Dda University Health Board, Llanelli, UK.'}, {'lastname': 'Ghosal', 'firstname': 'Robin', 'initials': 'R', 'affiliation': 'Respiratory Medicine, Hywel Dda University Health Board, Llanelli, UK.'}, {'lastname': 'Piatek', 'firstname': 'Stefan', 'initials': 'S', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Willis-Owen', 'firstname': 'Saffron A G', 'initials': 'SAG', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Bartolomaeus', 'firstname': 'Theda U P', 'initials': 'TUP', 'affiliation': 'Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany.\\nExperimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.\\nDZHK (German Centre for Cardiovascular Research), Partner Site, 10785, Berlin, Germany.\\nCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.'}, {'lastname': 'Birkner', 'firstname': 'Till', 'initials': 'T', 'affiliation': 'Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany.\\nExperimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.\\nCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.'}, {'lastname': 'Dwyer', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Kumar', 'firstname': 'Nitin', 'initials': 'N', 'affiliation': 'Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.'}, {'lastname': 'Turek', 'firstname': 'Elena M', 'initials': 'EM', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'William Musk', 'firstname': 'A', 'initials': 'A', 'affiliation': 'School of Population and Global Health, The University of Western Australia, Perth, WA, Australia.\\nBusselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Perth, WA, Australia.\\nDepartment of Respiratory Medicine Sir Charles Gairdner Hospital, Perth, WA, Australia.'}, {'lastname': 'Hui', 'firstname': 'Jennie', 'initials': 'J', 'affiliation': 'School of Population and Global Health, The University of Western Australia, Perth, WA, Australia.\\nBusselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Perth, WA, Australia.'}, {'lastname': 'Hunter', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'School of Population and Global Health, The University of Western Australia, Perth, WA, Australia.\\nBusselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Perth, WA, Australia.'}, {'lastname': 'James', 'firstname': 'Alan', 'initials': 'A', 'affiliation': 'School of Population and Global Health, The University of Western Australia, Perth, WA, Australia.\\nDepartment of Respiratory Medicine Sir Charles Gairdner Hospital, Perth, WA, Australia.\\nDepartment of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.'}, {'lastname': 'Dumas', 'firstname': 'Marc-Emmanuel', 'initials': 'ME', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK.\\nDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.\\nU1283 INSERM / UMR8199 CNRS, Institut Pasteur de Lille, Lille University Hospital, European Genomic Institute for Diabetes, University of Lille, Lille, France.\\nMcGill Genome Centre, McGill University, Montréal, QC, Canada.'}, {'lastname': 'Filippi', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Department of Mathematics, Imperial College London, London, UK.'}, {'lastname': 'Cox', 'firstname': 'Michael J', 'initials': 'MJ', 'affiliation': 'University of Birmingham College of Medical and Dental Sciences, 150183, Institute of Microbiology and Infection, Birmingham, UK.'}, {'lastname': 'Lawley', 'firstname': 'Trevor D', 'initials': 'TD', 'affiliation': 'Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.'}, {'lastname': 'Forslund', 'firstname': 'Sofia K', 'initials': 'SK', 'affiliation': 'Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany. sofia.forslund@mdc-berlin.de.\\nExperimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany. sofia.forslund@mdc-berlin.de.\\nDZHK (German Centre for Cardiovascular Research), Partner Site, 10785, Berlin, Germany. sofia.forslund@mdc-berlin.de.\\nCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany. sofia.forslund@mdc-berlin.de.\\nStructural and Computational Biology Unit, European Molecular Biology Laboratory, Structural and Computational Biology Unit, 69117, Heidelberg, Germany. sofia.forslund@mdc-berlin.de.'}, {'lastname': 'Moffatt', 'firstname': 'Miriam F', 'initials': 'MF', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK. m.moffatt@imperial.ac.uk.'}, {'lastname': 'Cookson', 'firstname': 'William O C', 'initials': 'WOC', 'affiliation': 'National Heart and Lung Institute, Imperial College London, London, UK. w.cookson@imperial.ac.uk.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s42003-024-05840-3\\n10.1126/science.137.3530.577\\n10.1513/AnnalsATS.201311-405PS\\n10.1016/S1473-3099(21)00648-4\\n10.1371/journal.pone.0008578\\n10.1038/nrmicro.2017.14\\n10.1073/pnas.1019378108\\n10.1038/s41467-017-01803-x\\n10.1189/jlb.0103024\\n10.1038/s41564-021-01043-2\\n10.1371/journal.pone.0032924\\n10.1038/ismej.2014.250\\n10.1164/rccm.201104-0655OC\\n10.1513/AnnalsATS.201501-029OC\\n10.1016/j.ebiom.2021.103538\\n10.1038/nrmicro.2017.122\\n10.1183/20734735.0161-2021\\n10.1128/JCM.02094-10\\n10.1016/j.jcf.2020.05.013\\n10.1093/nar/gky467\\n10.1038/ismej.2011.189\\n10.1093/bioinformatics/btm563\\n10.1126/science.abn5093\\n10.3390/toxins12040223\\n10.26508/lsa.202000981\\n10.1093/clinids/21.Supplement_2.S162\\n10.1016/j.chom.2013.04.010\\n10.1186/1471-2164-10-6\\n10.1038/nrm2329\\n10.1126/science.abf3192\\n10.1038/nature06014\\n10.1038/nature08787\\n10.1056/NEJMoa1211592\\n10.1038/s41467-020-16274-w\\n10.1016/j.chom.2019.04.002\\n10.1016/j.chom.2022.01.004\\n10.1126/science.abg5645\\n10.1097/BOR.0000000000000531\\n10.1002/wrna.85\\n10.1038/s41586-022-04427-4\\n10.1038/nature11337\\n10.1016/j.molcel.2019.09.013\\n10.3390/ijms21031122\\n10.1371/journal.pone.0057923\\n10.1016/S0889-8553(01)00004-8\\n10.1371/journal.pone.0030126\\n10.1038/s41586-021-04177-9\\n10.1016/j.jaci.2010.10.048\\n10.1038/nbt.2676\\n10.1016/j.bbagen.2014.05.003\\n10.1093/ajcn/73.6.1131S\\n10.1038/s41583-021-00555-4\\n10.1016/S0034-5687(00)00210-3\\n10.1152/physrev.00039.2015\\n10.1038/s41572-022-00370-w\\n10.1126/science.aai8801\\n10.1093/nar/gky299\\n10.1164/rccm.200708-1151OC\\n10.3389/fimmu.2023.1176044\\n10.1371/journal.pone.0235803\\n10.1016/j.mib.2013.06.009\\n10.1016/j.coph.2015.09.013\\n10.1002/eji.202048938\\n10.1016/j.jaci.2013.10.035\\n10.1183/09031936.97.10071530\\n10.1128/CVI.00089-15\\n10.1128/JB.187.17.6223-6230.2005\\n10.1371/journal.pone.0152724\\n10.1186/s40168-017-0234-1\\n10.1016/j.jare.2021.09.012\\n10.1164/rccm.200603-392OC\\n10.1016/j.jaci.2010.04.021\\n10.1136/bmj.310.6989.1225\\n10.1097/MCP.0b013e3282f4a99f\\n10.1513/pats.2306030\\n10.1371/journal.pone.0228692\\n10.1038/s41467-018-07641-9\\n10.1093/molbev/msab293\\n10.1093/bioinformatics/bty633\\n10.1093/nar/gkab301\\n10.1371/journal.pone.0190075\\n10.1186/s12915-014-0087-z\\n10.1093/bioinformatics/btw697\\n10.1093/nar/gkv007\\n10.1093/genetics/164.2.829\\n10.6026/97320630002005\\n10.1101/gr.253492.119\\n10.1186/1471-2105-9-559\\n10.1093/molbev/msw046\\n10.1186/1471-2105-12-385', 'xml': <Element 'PubmedArticle' at 0x108e6e430>}\n",
      "{'pubmed_id': '38346871', 'title': 'Airway smooth muscle and long-term clinical efficacy following bronchial thermoplasty in severe asthma.', 'abstract': 'The mechanism of action of bronchial thermoplasty (BT) treatment for patients with severe asthma is incompletely understood. This study investigated the 2.5-year impact of BT on airway smooth muscle (ASM) mass and clinical parameters by paired data analysis in 22 patients. Our findings demonstrate the persistence of ASM mass reduction of >50% after 2.5 years. Furthermore, sustained improvement in asthma control, quality of life and exacerbation rates was found, which is in line with previous reports. An association was found between the remaining ASM and both the exacerbation rate (r=0.61, p=0.04 for desmin, r=0.85, p<0.01 for alpha smooth muscle actin (SMA)) and post-bronchodilator forced expiratory volume in 1 s predicted percentage (r=-0.69, p=0.03 for desmin, r=-0.58, p=0.08 for alpha SMA). This study provides new insight into the long-term impact of BT.', 'keywords': ['Asthma'], 'journal': 'Thorax', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Wijsman', 'firstname': 'Pieta C', 'initials': 'PC', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': 'Goorsenberg', 'firstname': 'Annika W M', 'initials': 'AWM', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': \"d'Hooghe\", 'firstname': 'Julia N S', 'initials': 'JNS', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': 'Ten Hacken', 'firstname': 'Nick H T', 'initials': 'NHT', 'affiliation': 'Department of Pulmonology, University of Groningen, Groningen, The Netherlands.'}, {'lastname': 'J T H Roelofs', 'firstname': 'Joris', 'initials': 'J', 'affiliation': 'Pathology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': 'Mauad', 'firstname': 'Thais', 'initials': 'T', 'affiliation': 'Pathology, São Paulo University Medical School, São Paulo, Brazil.'}, {'lastname': 'Weersink', 'firstname': 'Els J M', 'initials': 'EJM', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': 'Shah', 'firstname': 'Pallav', 'initials': 'P', 'affiliation': 'Lung Unit, Royal Brompton and Harefield NHS Foundation and Imperial College, London, UK.\\nLung Unit, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.'}, {'lastname': 'Annema', 'firstname': 'Jouke T', 'initials': 'JT', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.'}, {'lastname': 'Bonta', 'firstname': 'Peter I', 'initials': 'PI', 'affiliation': 'Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands p.i.bonta@amsterdamumc.nl.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/thorax-2023-220967', 'xml': <Element 'PubmedArticle' at 0x10adb3f10>}\n",
      "{'pubmed_id': '38346643', 'title': 'Serial Evaluation of Pre-immunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy.', 'abstract': 'Antibody titers and potential need for immunization has not been formally studied in CAR-T patients. Prior studies have shown CD19 CAR-T can induce persistent B cell aplasia but preserve plasma cells for humoral response.\\nTo assess immune repertoire and antibody titer status of CAR-T recipients METHODS: We conducted a retrospective study of immune cell recovery and antibody titers to vaccines in anti-CD19 CAR-T recipients at Mayo Clinic, Rochester.\\nIn our cohort of 95 CAR-T patients, almost half of the patients had low CD4 T and B cell counts prior to CAR-T and remained persistently low post CAR-T. Prior to CAR-T therapy, seronegative rate was lowest for tetanus and highest for pneumococcus irrespective of prior transplant status (within 2 years of CAR-T). At 3 months post CAR-T, overall seronegativity rates were similar when compared to pre-CAR-T levels for the prior transplant and no prior transplant group. For patients who received IVIG, loss of seropositivity was seen for hepatitis A (1/7,14%). No seroconversion was noted for pneumococcus. For patients who did not receive IVIG, loss of seropositivity was seen for pneumococcus (2/5, 40%) and hepatitis A (1/4, 25%).\\nCAR-T recipients commonly experience T cell and B cell lymphopenia and may not have adequate antibody titers against vaccine preventable diseases despite IVIG supplementation. There could be loss of antibody titers post CAR-T, thus highlighting need for re-vaccination. Additional study with long-term follow-up is needed to inform optimal timing of immunization post CAR-T.', 'keywords': ['B cell recovery', 'CAR-T', 'IVIG', 'Lymphoma', 'antibody titers', 'humoral immunity', 'immunization', 'infection', 'vaccination'], 'journal': 'Transplantation and cellular therapy', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Bansal', 'firstname': 'Radhika', 'initials': 'R', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Vergidis', 'firstname': 'Paschalis', 'initials': 'P', 'affiliation': 'Division of Infectious Diseases, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Tosh', 'firstname': 'Pritish K', 'initials': 'PK', 'affiliation': 'Division of Infectious Diseases, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Wilson', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Division of Infectious Diseases, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Hathcock', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Khurana', 'firstname': 'Arushi', 'initials': 'A', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Bennani', 'firstname': 'N Nora', 'initials': 'NN', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Paludo', 'firstname': 'Jonas', 'initials': 'J', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Villasboas', 'firstname': 'Jose C', 'initials': 'JC', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Wang', 'firstname': 'Yucai', 'initials': 'Y', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Ansell', 'firstname': 'Stephen M', 'initials': 'SM', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Johnston', 'firstname': 'Patrick B', 'initials': 'PB', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Freeman', 'firstname': 'Catherine', 'initials': 'C', 'affiliation': 'Division of Asthma, Allergy and Clinical Immunology, Mayo Clinic, Scottsdale, AZ.'}, {'lastname': 'Lin', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: lin.yi@mayo.edu.'}], 'methods': None, 'conclusions': 'CAR-T recipients commonly experience T cell and B cell lymphopenia and may not have adequate antibody titers against vaccine preventable diseases despite IVIG supplementation. There could be loss of antibody titers post CAR-T, thus highlighting need for re-vaccination. Additional study with long-term follow-up is needed to inform optimal timing of immunization post CAR-T.', 'results': 'In our cohort of 95 CAR-T patients, almost half of the patients had low CD4 T and B cell counts prior to CAR-T and remained persistently low post CAR-T. Prior to CAR-T therapy, seronegative rate was lowest for tetanus and highest for pneumococcus irrespective of prior transplant status (within 2 years of CAR-T). At 3 months post CAR-T, overall seronegativity rates were similar when compared to pre-CAR-T levels for the prior transplant and no prior transplant group. For patients who received IVIG, loss of seropositivity was seen for hepatitis A (1/7,14%). No seroconversion was noted for pneumococcus. For patients who did not receive IVIG, loss of seropositivity was seen for pneumococcus (2/5, 40%) and hepatitis A (1/4, 25%).', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jtct.2024.02.003', 'xml': <Element 'PubmedArticle' at 0x10b07cd10>}\n",
      "{'pubmed_id': '38346474', 'title': 'Budesonide/formoterol or budesonide/albuterol as anti-inflammatory reliever therapy for asthma.', 'abstract': 'Over use of reliever as short acting beta-agonist (SABA) and associated underuse of controller as inhaled corticosteroid (ICS) administered via separate inhalers results in worse asthma outcomes . Such discordance can be obviated by combining both controller and reliever in the same inhaler. So called anti-inflammatory reliever (AIR) therapy comprises the use of a single inhaler containing an ICS such as budesonide (BUD) in conjunction with a reliever as either albuterol (ALB) or formoterol (FORM) ,to be used on demand with variable dosing driven by asthma symptoms in a flexible patient centred regimen. Global guidelines now support the use of BUD-ALB as AIR therapy to reduce exacerbations , either on its own in mild asthma or in conjunction with fixed dose maintenance ICS-long acting beta-agonist (LABA) in moderate to severe asthma . Using BUD-FORM on its own allows patients to seamlessly move in an intuitive flexible fashion between AIR or maintenance and reliever therapy (MART) , by stepping up and down the dosing escalator across a spectrum of asthma severities . Head to head clinical studies are indicated to compare BUD-FORM versus BUD-ALB as AIR in mild asthma ,and also BUD-FORM as MART versus BUD-ALB as AIR plus maintenance ICS-LABA in moderate to severe asthma. Patients should be encouraged to make an informed decision in conjunction with their health care professional regarding the best therapeutic option tailored to their individual needs , which in turn is likely to result in long term compliance and associated optimal asthma control.', 'keywords': ['Anti-inflammatory reliever', 'albuterol', 'asthma', 'budesonide', 'exacerbations', 'formoterol', 'inhaled corticosteroid', 'type 2 inflammation'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Lipworth', 'firstname': 'Brian', 'initials': 'B', 'affiliation': 'Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY. Electronic address: b.j.lipworth@dundee.ac.uk.'}, {'lastname': 'RuiWen Kuo', 'firstname': 'Chris', 'initials': 'C', 'affiliation': 'Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY.'}, {'lastname': 'Stewart', 'firstname': 'Kirsten', 'initials': 'K', 'affiliation': 'Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY.'}, {'lastname': 'Chan', 'firstname': 'Rory', 'initials': 'R', 'affiliation': 'Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.02.003', 'xml': <Element 'PubmedArticle' at 0x10b07fba0>}\n",
      "{'pubmed_id': '38346473', 'title': 'Theme Editorial: Asthma Updates: Theories Translated to Treatment.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Busse', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Department of Medicine, University of Wisconsin School of Medicine, Madison, WI. Electronic address: wwb@medicine.wisc.edu.'}, {'lastname': 'Castro', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Department of Medicine, University of Kansas School of Medicine, Overland Park, KS.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2024.01.050', 'xml': <Element 'PubmedArticle' at 0x10ac2b060>}\n",
      "{'pubmed_id': '38346472', 'title': 'Incidence of drug-induced hypersensitivity syndrome associated with levetiracetam and clobazam is likely underreported.', 'abstract': None, 'keywords': ['clobazam', 'dermatology', 'drug reaction', 'drug reaction with eosinophilia and systemic symptoms', 'drug-induced hypersensitivity syndrome', 'epidemiology', 'immunology', 'levetiracetam', 'public health'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Kichili', 'firstname': 'Nikhita R', 'initials': 'NR', 'affiliation': 'University of Texas Medical Branch, John Sealy School of Medicine, 301 University Blvd, Galveston, TX 77555.'}, {'lastname': 'Hansen', 'firstname': 'Alyssa', 'initials': 'A', 'affiliation': 'University of Texas Medical Branch, Department of Dermatology, 301 University Blvd, Galveston, TX 77555. Electronic address: achansen@utmb.edu.'}, {'lastname': 'Kagithala', 'firstname': 'Dheeraj', 'initials': 'D', 'affiliation': 'Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI 48201.'}, {'lastname': 'Gonzalez', 'firstname': 'Ayezel Munoz', 'initials': 'AM', 'affiliation': 'University of Texas Medical Branch, Department of Dermatology, 301 University Blvd, Galveston, TX 77555.'}, {'lastname': 'Wilkerson', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'University of Texas Medical Branch, Department of Dermatology, 301 University Blvd, Galveston, TX 77555.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.02.003', 'xml': <Element 'PubmedArticle' at 0x10ac28d60>}\n",
      "{'pubmed_id': '38346463', 'title': 'Determining reference ranges for lymphocyte proliferation responses to phytohemagglutinin and Bacillus Calmette-Guérin in Iranian children.', 'abstract': \"To establish reference ranges (RRs) for stimulation index of T cell proliferation triggered by phytohemagglutinin (PHA-SI) and Bacillus Calmette-Guérin (BCG-SI).\\nThis study investigated data from 359 healthy children and 35 patients with cellular immunodeficiency as positive controls (2010-2021). We applied a colorimetric-based method (BrdU) to measure proliferation and determine the RRs at the 2.5th and 97.5th percentiles (95% confidence intervals). A cross-validation approach was performed.\\nIn healthy controls, the RRs for PHA-SI and BCG-SI ranged between 3 and 5.2 and 2.52 to 5.2, respectively. PHA-SI and BCG-SI were in Severe Combined Immunodeficiency (SCID) patients from 1.2 to 2.5 and 0 to 2, while in Mendelian susceptibility to mycobacterial diseases (MSMD) patients, 2.53 to 4.5 and 0.74 to 2.2, respectively. The thresholds' accuracy was checked for testing reference intervals with diagnostic effects.\\nThis study establishes PHA-SI and BCG-SI reference ranges to aid in diagnosing and treating congenital immunodeficiency diseases.\", 'keywords': ['Bacillus Calmette–Guérin', 'Cellular proliferation', 'Lymphocyte stimulation', 'Mendelian susceptibility to mycobacterial disease', 'Phytohemagglutinin', 'Reference ranges', 'Severe combined immunodeficiency'], 'journal': 'Clinical immunology (Orlando, Fla.)', 'publication_date': datetime.date(2024, 2, 13), 'authors': [{'lastname': 'Nourizadeh', 'firstname': 'Maryam', 'initials': 'M', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Sarrafzadeh', 'firstname': 'Shokouh Azam', 'initials': 'SA', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Shoormasti', 'firstname': 'Raheleh Shokouhi', 'initials': 'RS', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Fazlollahi', 'firstname': 'Mohammad Reza', 'initials': 'MR', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Saghafi', 'firstname': 'Shiva', 'initials': 'S', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Badalzadeh', 'firstname': 'Mohsen', 'initials': 'M', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Mirmoghtadaei', 'firstname': 'Milad', 'initials': 'M', 'affiliation': \"Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.\"}, {'lastname': 'Pourpak', 'firstname': 'Zahra', 'initials': 'Z', 'affiliation': 'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: pourpakz@tums.ac.ir.'}], 'methods': None, 'conclusions': 'This study establishes PHA-SI and BCG-SI reference ranges to aid in diagnosing and treating congenital immunodeficiency diseases.', 'results': \"In healthy controls, the RRs for PHA-SI and BCG-SI ranged between 3 and 5.2 and 2.52 to 5.2, respectively. PHA-SI and BCG-SI were in Severe Combined Immunodeficiency (SCID) patients from 1.2 to 2.5 and 0 to 2, while in Mendelian susceptibility to mycobacterial diseases (MSMD) patients, 2.53 to 4.5 and 0.74 to 2.2, respectively. The thresholds' accuracy was checked for testing reference intervals with diagnostic effects.\", 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.clim.2024.109937', 'xml': <Element 'PubmedArticle' at 0x10b3d22a0>}\n",
      "{'pubmed_id': '38346176', 'title': 'Activation of Notch1-GATA3 pathway in asthma bronchial epithelial cells induced by acute PM2.5 exposure and the potential protective role of microRNA-139-5p.', 'abstract': 'PM2.5 is closed linked to asthma exacerbation. The Notch1 pathway acts as an important pathway, ultimately inducing T-helper cells that express GATA3 and its corresponding Th2 cytokines. The regulatory effects of miR-139-5p on the Notch1 pathway have been indicated in cancer. However, studies on miR-139-5p have not applied asthma related models. The role of miR-139-5p and its regulatory effects on the Notch1-GATA3 pathway in asthma exacerbation induced by acute PM2.5 exposure has not been elucidated. We hypothesize that acute PM2.5 exposure induces asthma exacerbation by regulating the expression of miR-139-5p and activating the Notch1-GATA3 pathway.\\nWe first employed Diseased Human Bronchial Epithelial Cells-Asthma cells to establish an in vitro model of acute exposure to PM2.5, and explored the relationship between the different concentrations and durations of acute PM2.5 exposure and the activation of Notch1-GATA3 pathway. We investigated the protein and mRNA expression changes of Notch1, upstream Jagged1, downstream GATA3, as well as the regulatory effect of miR-139-5p involved in it.\\nThe miR-139-5p expression increased within 24\\u2009hours of PM2.5 exposure. However, if PM2.5 exposure was sustained, miR-139-5p expression turned to decrease, accompanied by upregulations of the mRNA and protein expression of Notch1-GATA3 pathway. Overexpression of miR-139-5p blocked Notch1-GATA3 pathway activation induced by acute PM2.5 exposure.\\nAcute PM2.5 exposure can activate Notch1-GATA3 pathway in asthma bronchial epithelial cells model, which might be involved in PM2.5-induced asthma exacerbation. miR-139-5p has a potential protective role of inhibiting PM2.5-induced asthma airway inflammation by targeting Notch1.', 'keywords': ['Asthma', 'Notch1', 'PM2.5', 'miR-139-5p'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Huang', 'firstname': 'Junjun', 'initials': 'J', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.'}, {'lastname': 'Hu', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.\\nDepartment of Geriatrics, Peking University First Hospital, Beijing 100034, China.'}, {'lastname': 'Wang', 'firstname': 'Yunxia', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.'}, {'lastname': 'Jin', 'firstname': 'Zhou', 'initials': 'Z', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.'}], 'methods': None, 'conclusions': 'Acute PM2.5 exposure can activate Notch1-GATA3 pathway in asthma bronchial epithelial cells model, which might be involved in PM2.5-induced asthma exacerbation. miR-139-5p has a potential protective role of inhibiting PM2.5-induced asthma airway inflammation by targeting Notch1.', 'results': 'The miR-139-5p expression increased within 24\\u2009hours of PM2.5 exposure. However, if PM2.5 exposure was sustained, miR-139-5p expression turned to decrease, accompanied by upregulations of the mRNA and protein expression of Notch1-GATA3 pathway. Overexpression of miR-139-5p blocked Notch1-GATA3 pathway activation induced by acute PM2.5 exposure.', 'copyrights': None, 'doi': '10.1080/02770903.2024.2316711', 'xml': <Element 'PubmedArticle' at 0x10981ea20>}\n",
      "{'pubmed_id': '38345634\\n34364680\\n35934678\\n33711259\\n27746238\\n22634865\\n17785819\\n26825674\\n18769622\\n25363529\\n28889953\\n25086176\\n32446878\\n27995616\\n33249168\\n32482755\\n33324003\\n35798357\\n30224386\\n28515363\\n26194936\\n36272266\\n36330091\\n32323265\\n33640662\\n21622859\\n28700253\\n27763657\\n33288436\\n30790069\\n35979356\\n30874596\\n27166557', 'title': 'Anti-CD20 treatment attenuates Th2 cell responses: implications for the role of lung follicular mature B cells in the asthmatic mice.', 'abstract': 'B cells were believed to act as antigen-presenting cells (APCs) to promote T helper type 2 (Th2) cell responses. However, the role of lung B cells and its subpopulations in Th2 cell responses in asthma remains unclear.\\nWe leveraged an anti-CD20 monoclonal antibody (mAb) treatment that has been shown to selectively deplete B cells in mice and investigated whether this treatment modulates Th2 cell responses and this modulation is related to lung follicular mature (FM) B cells in a murine model of asthma.\\nWe used a house dust mite (HDM)-induced asthma mouse model and found that anti-CD20 mAb treatment attenuates Th2 cell responses. Meanwhile, anti-CD20 mAb treatment did dramatically reduce the number of B cells, especially FM B cells in the lungs, but did not impact the frequency of other immune cell types, including lung T cells, dendritic cells, natural killer cells, and regulatory T cells in wild-type mice. Moreover, we found that the suppressive effect of anti-CD20 mAb treatment on Th2 cell responses could be reversed upon adoptive transfer of lung FM B cells, but not lung CD19\\nThese findings reveal that anti-CD20 mAb treatment alleviates Th2 cell responses, possibly by depleting lung FM B cells in a Th2-driven asthma model. This implies a potential therapeutic approach for asthma treatment through the targeting of lung FM B cells.', 'keywords': ['Anti-CD20 monoclonal antibody', 'Asthma', 'Follicular mature B cells', 'Th2 cell responses'], 'journal': 'Inflammation research : official journal of the European Histamine Research Society ... [et al.]', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'He', 'firstname': 'Jilong', 'initials': 'J', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Li', 'firstname': 'Jingling', 'initials': 'J', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Lin', 'firstname': 'Qibin', 'initials': 'Q', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Ni', 'firstname': 'Haiyang', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Huang', 'firstname': 'Sisi', 'initials': 'S', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Cheng', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.'}, {'lastname': 'Ding', 'firstname': 'Xuhong', 'initials': 'X', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Huang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Yu', 'firstname': 'Hongying', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China.'}, {'lastname': 'Xu', 'firstname': 'Yaqing', 'initials': 'Y', 'affiliation': 'Department of Geriatric Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China. 15392885220@163.com.'}, {'lastname': 'Nie', 'firstname': 'Hanxiang', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan, 430060, China. nhxiang@whu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.', 'doi': '10.1007/s00011-023-01847-4\\n10.1016/j.mam.2021.100995\\n10.1016/j.pccm.2023.04.002\\n10.1016/j.jaci.2022.06.010\\n10.1016/j.pccm.2023.08.001\\n10.1016/j.cell.2021.02.016\\n10.1016/j.jaci.2016.09.020\\n10.1038/ni.2309\\n10.4049/jimmunol.179.6.3821\\n10.1016/j.immuni.2015.11.017\\n10.1371/journal.pone.0003129\\n10.1038/cmi.2014.103\\n10.1016/j.jaci.2017.09.001\\n10.4049/jimmunol.1400149\\n10.1016/j.it.2020.04.011\\n10.1002/eji.201646518\\n10.1016/j.jaci.2020.09.041\\n10.3324/haematol.2019.243543\\n10.1038/s41573-020-00092-2\\n10.1183/13993003.01469-2021\\n10.1084/jem.20172026\\n10.1172/jci.insight.90420\\n10.1111/all.12697\\n10.1016/j.biopha.2022.113875\\n10.1016/j.jconrel.2022.10.020\\n10.3389/fphar.2022.978421\\n10.1111/ajt.15550\\n10.1111/cea.13825\\n10.1007/978-981-15-3532-1_1\\n10.1016/j.jaut.2021.102627\\n10.4049/jimmunol.1003392\\n10.1165/rcmb.2016-0356OC\\n10.1002/path.4831\\n10.1016/j.alit.2020.11.002\\n10.1111/cea.12715\\n10.1007/s11912-019-0760-z\\n10.3389/fimmu.2022.970906\\n10.1038/s41385-019-0158-0\\n10.1038/mi.2016.47', 'xml': <Element 'PubmedArticle' at 0x10981c310>}\n",
      "{'pubmed_id': '38345538', 'title': 'Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study.', 'abstract': 'We undertook a national analysis to characterise and identify risk factors for acute respiratory infections (ARIs) resulting in hospitalisation during the winter period in Scotland.\\nA population-based retrospective cohort analysis.\\nScotland.\\nThe study involved 5.4 million residents in Scotland.\\nCox proportional hazard models were used to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for the association between risk factors and ARI hospitalisation.\\nBetween 1 September 2022 and 31 January 2023, there were 22,284 (10.9% of 203,549 with any emergency hospitalisation) ARI hospitalisations (1759 in children and 20,525 in adults) in Scotland. Compared with the reference group of children aged 6-17 years, the risk of ARI hospitalisation was higher in children aged 3-5 years (aHR\\u2009=\\u20094.55; 95% CI: 4.11-5.04). Compared with those aged 25-29 years, the risk of ARI hospitalisation was highest among the oldest adults aged ≥80 years (aHR\\u2009=\\u20097.86; 95% CI: 7.06-8.76). Adults from more deprived areas (most deprived vs. least deprived, aHR\\u2009=\\u20091.64; 95% CI: 1.57-1.72), with existing health conditions (≥5 vs. 0 health conditions, aHR\\u2009=\\u20094.84; 95% CI: 4.53-5.18) or with history of all-cause emergency admissions (≥6 vs. 0 previous emergency admissions, aHR\\u2009=\\u20097.53; 95% CI: 5.48-10.35) were at a higher risk of ARI hospitalisations. The risk increased by the number of existing health conditions and previous emergency admission. Similar associations were seen in children.\\nYounger children, older adults, those from more deprived backgrounds and individuals with greater numbers of pre-existing conditions and previous emergency admission were at increased risk for winter hospitalisations for ARI.', 'keywords': ['Epidemiology', 'health informatics', 'respiratory medicine'], 'journal': 'Journal of the Royal Society of Medicine', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Shi', 'firstname': 'Ting', 'initials': 'T', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Millington', 'firstname': 'Tristan', 'initials': 'T', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Robertson', 'firstname': 'Chris', 'initials': 'C', 'affiliation': 'Department of Mathematics and Statistics, University of Strathclyde, Glasgow, G1 1XQ, Scotland, UK.\\nPublic Health Scotland, Glasgow, G2 6QE, Scotland, UK.'}, {'lastname': 'Jeffrey', 'firstname': 'Karen', 'initials': 'K', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Katikireddi', 'firstname': 'Srinivasa Vittal', 'initials': 'SV', 'affiliation': 'MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, G12 8QQ, Scotland, UK.'}, {'lastname': 'McCowan', 'firstname': 'Colin', 'initials': 'C', 'affiliation': 'School of Medicine, University of St Andrews, St Andrews, KY16 9AJ, Scotland, UK.'}, {'lastname': 'Simpson', 'firstname': 'Colin R', 'initials': 'CR', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.\\nSchool of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, 6140, New Zealand.'}, {'lastname': 'Woolford', 'firstname': 'Lana', 'initials': 'L', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Daines', 'firstname': 'Luke', 'initials': 'L', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.\\nAsthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Kerr', 'firstname': 'Steven', 'initials': 'S', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Swallow', 'firstname': 'Ben', 'initials': 'B', 'affiliation': 'School of Mathematics and Statistics, University of St Andrews, St Andrews, KY16 9SS, Scotland, UK.'}, {'lastname': 'Fagbamigbe', 'firstname': 'Adeniyi', 'initials': 'A', 'affiliation': 'Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, AB24 2ZD, Scotland, UK.\\nDepartment of Epidemiology and Medical Statistics, University of Ibadan, Ibadan 200132, Nigeria.'}, {'lastname': 'Vallejos', 'firstname': 'Catalina A', 'initials': 'CA', 'affiliation': 'MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, UK.\\nThe Alan Turing Institute, London, NW1 2DB, UK.'}, {'lastname': 'Weatherill', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Jayacodi', 'firstname': 'Sandra', 'initials': 'S', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Marsh', 'firstname': 'Kimberly', 'initials': 'K', 'affiliation': 'Public Health Scotland, Glasgow, G2 6QE, Scotland, UK.'}, {'lastname': 'McMenamin', 'firstname': 'Jim', 'initials': 'J', 'affiliation': 'Public Health Scotland, Glasgow, G2 6QE, Scotland, UK.'}, {'lastname': 'Rudan', 'firstname': 'Igor', 'initials': 'I', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': 'Ritchie', 'firstname': 'Lewis Duthie', 'initials': 'LD', 'affiliation': 'Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, AB24 2ZD, Scotland, UK.'}, {'lastname': 'Mueller', 'firstname': 'Tanja', 'initials': 'T', 'affiliation': 'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, Scotland, UK.'}, {'lastname': 'Kurdi', 'firstname': 'Amanj', 'initials': 'A', 'affiliation': 'Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, Scotland, UK.\\nDepartment of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Erbil, Iraq.\\nDivision of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, 0208, South Africa.\\nDepartment of Clinical Pharmacy, College of Pharmacy, Al-Kitab University, Kirkuk, Iraq.'}, {'lastname': 'Sheikh', 'firstname': 'Aziz', 'initials': 'A', 'affiliation': 'Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.\\nAsthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'Between 1 September 2022 and 31 January 2023, there were 22,284 (10.9% of 203,549 with any emergency hospitalisation) ARI hospitalisations (1759 in children and 20,525 in adults) in Scotland. Compared with the reference group of children aged 6-17 years, the risk of ARI hospitalisation was higher in children aged 3-5 years (aHR\\u2009=\\u20094.55; 95% CI: 4.11-5.04). Compared with those aged 25-29 years, the risk of ARI hospitalisation was highest among the oldest adults aged ≥80 years (aHR\\u2009=\\u20097.86; 95% CI: 7.06-8.76). Adults from more deprived areas (most deprived vs. least deprived, aHR\\u2009=\\u20091.64; 95% CI: 1.57-1.72), with existing health conditions (≥5 vs. 0 health conditions, aHR\\u2009=\\u20094.84; 95% CI: 4.53-5.18) or with history of all-cause emergency admissions (≥6 vs. 0 previous emergency admissions, aHR\\u2009=\\u20097.53; 95% CI: 5.48-10.35) were at a higher risk of ARI hospitalisations. The risk increased by the number of existing health conditions and previous emergency admission. Similar associations were seen in children.', 'copyrights': None, 'doi': '10.1177/01410768231223584', 'xml': <Element 'PubmedArticle' at 0x109fc9f30>}\n",
      "{'pubmed_id': '38345240', 'title': 'A Simple Cuff Technique for Murine Left Lung Transplantation.', 'abstract': 'Over the past decade, our laboratory has made significant progress in developing and refining vascularized mouse lung transplantation models using an efficient and highly reliable \"cuff technique\" of transplantation. This article describes a sophisticated and comprehensive method for orthotopic lung transplantation in a vascularized orthotopic lung model, representing the most physiologic and clinically relevant model of mouse lung transplantation to date. The transplantation process consists of two distinct stages: donor harvest and subsequent implantation into the recipient. The method has been successfully mastered, and with several months of sufficient training, a skilled practitioner can perform the procedure in approximately 90 min from skin-to-skin. Surprisingly, once individuals overcome the initial learning curve, the survival rate during the perioperative period approaches nearly 100%. The mouse model allows for the use of multiple commercially available transgenic and mutant strains of mice, enabling the study of tolerance and rejection. Additionally, the unique features of this model make it a valuable tool for investigating tumor biology and immunology.', 'keywords': [], 'journal': 'Journal of visualized experiments : JoVE', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Mei', 'firstname': 'Zhongcheng', 'initials': 'Z', 'affiliation': 'Department of Surgery, University of Maryland Medical Center.'}, {'lastname': 'Taheri', 'firstname': 'Mojtaba', 'initials': 'M', 'affiliation': 'Department of Surgery, University of Maryland Medical Center.'}, {'lastname': 'Jacobsen', 'firstname': 'Elizabeth A', 'initials': 'EA', 'affiliation': 'Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic.'}, {'lastname': 'Li', 'firstname': 'Wenjun', 'initials': 'W', 'affiliation': 'Department of Surgery, Washington University in St. Louis; Department of Pathology & Immunology, Washington University in St. Louis.'}, {'lastname': 'Gelman', 'firstname': 'Andrew E', 'initials': 'AE', 'affiliation': 'Department of Surgery, Washington University in St. Louis; Department of Pathology & Immunology, Washington University in St. Louis.'}, {'lastname': 'Kreisel', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Department of Surgery, Washington University in St. Louis; Department of Pathology & Immunology, Washington University in St. Louis.'}, {'lastname': 'Krupnick', 'firstname': 'Alexander Sasha', 'initials': 'AS', 'affiliation': 'Department of Surgery, University of Maryland Medical Center; Department of Microbiology and Immunology, University of Maryland Medical Center; akrupnick@som.umaryland.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3791/65979', 'xml': <Element 'PubmedArticle' at 0x10b70eca0>}\n",
      "{'pubmed_id': '38344970', 'title': 'Untargeted metabolomic profiling in children identifies novel pathways in asthma and atopy.', 'abstract': 'Asthma and other atopic disorders can present with varying clinical phenotypes marked by differential metabolomic manifestations and enriched biological pathways.\\nWe sought to identify these unique metabolomic profiles in atopy and asthma.\\nWe analyzed baseline nonfasted plasma samples from a large multisite pediatric population of 470 children aged <13 years from 3 different sites in the United States and France. Atopy positivity (At\\nTwo hundred ten children were classified as At\\nThe At', 'keywords': ['Asthma', 'atopy', 'bile acids', 'children', 'gamma-glutamyl amino acids', 'metabolomics', 'phospholipids', 'polyamine', 'sphingolipids', 'tryptophan'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Lejeune', 'firstname': 'Stéphanie', 'initials': 'S', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif; University of Lille, Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, CHU Lille, Lille, France; University of Lille, INSERM Unit 1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France. Electronic address: stephanie.lejeune@chu-lille.fr.'}, {'lastname': 'Kaushik', 'firstname': 'Abhinav', 'initials': 'A', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif; Department of Environmental Health, T. H. Chan School of Public Health, Harvard University, Boston, Mass.'}, {'lastname': 'Parsons', 'firstname': 'Ella S', 'initials': 'ES', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Chinthrajah', 'firstname': 'Sharon', 'initials': 'S', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Snyder', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Department of Genetics, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Desai', 'firstname': 'Manisha', 'initials': 'M', 'affiliation': 'Quantitative Science Unit, Department of Medicine, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Manohar', 'firstname': 'Monali', 'initials': 'M', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Prunicki', 'firstname': 'Mary', 'initials': 'M', 'affiliation': 'Department of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif; Department of Environmental Health, T. H. Chan School of Public Health, Harvard University, Boston, Mass.'}, {'lastname': 'Contrepois', 'firstname': 'Kévin', 'initials': 'K', 'affiliation': 'Department of Genetics, Stanford University School of Medicine, Stanford, Calif.'}, {'lastname': 'Gosset', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'University of Lille, INSERM Unit 1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.'}, {'lastname': 'Deschildre', 'firstname': 'Antoine', 'initials': 'A', 'affiliation': 'University of Lille, Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, CHU Lille, Lille, France; University of Lille, INSERM Unit 1019, CNRS UMR 9017, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.'}, {'lastname': 'Nadeau', 'firstname': 'Kari', 'initials': 'K', 'affiliation': 'Department of Environmental Health, T. H. Chan School of Public Health, Harvard University, Boston, Mass.'}], 'methods': None, 'conclusions': 'The At', 'results': 'Two hundred ten children were classified as At', 'copyrights': 'Copyright © 2023 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.jaci.2023.09.040', 'xml': <Element 'PubmedArticle' at 0x10b70cbd0>}\n",
      "{'pubmed_id': '38344540\\n17634462\\n18676559\\n24239505\\n18400738\\n26339421\\n25943362\\n28027916\\n15585789\\n12520530\\n9790574\\n26681795\\n18602685\\n16380576\\n22525848\\n21527855\\n23790560\\n27919275\\n27733354\\n22311168\\n34528520\\n34075181\\n22759399\\n27927221\\n22394709\\n10966885\\n18223618\\n19833894\\n18477652\\n14633808\\n17341286\\n18175220\\n11705562\\n21348404\\n16982500\\n15671216\\n11703889\\n16712731\\n11827764\\n14594170\\n7751997\\n6604149\\n8071764', 'title': 'Vitamin D Deficiency in Children and Adolescents in Saudi Arabia: A Systematic Review.', 'abstract': 'Vitamin D deficiency is a globally recognized health concern, with particular prominence in specific geographies and demographics. Saudi Arabia, with its unique climatic conditions and cultural practices, has been under scrutiny regarding the prevalence of this deficiency, especially among children and adolescents. This systematic review aimed to assess the prevalence of vitamin D deficiency among children and adolescents in Saudi Arabia by compiling and analyzing various studies to offer a comprehensive view of the situation.\\xa0The comprehensive web search encompassed a range of databases, including Google Scholar and PubMed, to gather studies published between 2012 and 2023. An analysis was conducted on seven studies, totaling 2,429 participants, with each study focusing on various aspects, regions, and cohorts within Saudi Arabia. These studies employed different methodologies, ranging from cross-sectional surveys to randomized clinical trials. The review unveiled an alarming prevalence of vitamin D deficiency in the studied population. On average, around 81.1% of children and adolescents showcased inadequate vitamin D levels. Specific vulnerable groups, such as those with Type 1 diabetes mellitus or asthma, had pronounced deficiencies. Factors influencing these levels ranged from dietary habits, sun exposure, physical activity, and socioeconomic parameters. The compelling evidence from the studies underscores a consistent\\xa0health issue among the pediatric population in Saudi Arabia that the overwhelming majority of Saudi children and adolescents lack adequate vitamin D. Addressing this widespread deficiency needs a multifaceted approach. Implementing policies that support vitamin D food fortification, encouraging routine screenings, and launching public awareness campaigns about safe sun exposure and diet can play a transformative role in this health crisis.', 'keywords': ['adolesents', 'bone health', 'calcium absorption', 'food fortification', 'increased indoor activities', 'sun exposure', 'vitamin d deficiency'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Alhamed', 'firstname': 'Meath S', 'initials': 'MS', 'affiliation': 'Family Medicine, King Abdulaziz Hospital, Al-Mubarraz, SAU.'}, {'lastname': 'Alharbi', 'firstname': 'Fahad', 'initials': 'F', 'affiliation': 'Family Medicine, King Abdulaziz Hospital, Al-Mubarraz, SAU.'}, {'lastname': 'Al Joher', 'firstname': 'Abdullatif', 'initials': 'A', 'affiliation': 'Family Medicine, King Abdulaziz Hospital, Al-Mubarraz, SAU.'}, {'lastname': 'Dhahry', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'General Practice, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Fallatah', 'firstname': 'Albandari A', 'initials': 'AA', 'affiliation': 'Pediatrics, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Alanazi', 'firstname': 'Omar H', 'initials': 'OH', 'affiliation': 'Pediatrics, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Almutiri', 'firstname': 'Jawaher M', 'initials': 'JM', 'affiliation': 'Paediatrics, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Albaradie', 'firstname': 'Saida S', 'initials': 'SS', 'affiliation': 'Pediatrics, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Al Enezi', 'firstname': 'Budoor Aziz A', 'initials': 'BAA', 'affiliation': 'Nursing, Al Yamamah Hospital, Riyadh, SAU.'}, {'lastname': 'Albishi', 'firstname': 'Mashail S', 'initials': 'MS', 'affiliation': 'Nursing, Al Yamamah Hospital, Riyadh, SAU.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024, Alhamed et al.', 'doi': '10.7759/cureus.52040', 'xml': <Element 'PubmedArticle' at 0x109953470>}\n",
      "{'pubmed_id': '38344457\\n28686952\\n25032475\\n37258676\\n7972357\\n8488071\\n7563147\\n0\\n19449686\\n19895627\\n21979814\\n22566627\\n23663440\\n30835837\\n37469006\\n36998574\\n28165640\\n23127244\\n32258576\\n27518660\\n19826546\\n33994782\\n32918062\\n26505989\\n37288989\\n37976103\\n33055153\\n34403882\\n35930838\\n37758641\\n32767985\\n33319851\\n36653448\\n25825132\\n32906736\\n36833470\\n28802208\\n36220445\\n35444249\\n33965232\\n34975829\\n37878913\\n38030980\\n38033557\\n36646464\\n31695865\\n32425223\\n26188744\\n35737670\\n33159874\\n32577216\\n35748742\\n36403611', 'title': 'From biodiversity to nature deficiency in human health and disease.', 'abstract': 'Nature (biodiversity) loss is the loss or decline of the state of nature taking place in the wider environment. We present a novel concept, nature deficiency, referring to nature loss in the human body influencing health. Humans are connected with the natural environment and its microbes and biogenic chemicals through eating (drinking), breathing, and touching. The mental and sociocultural links to the environment are also strong. With medical and ecological research and guidelines, the diagnosis, prevention, and treatment of nature deficiency may become part of the clinical practice. Nature prescription is likely to find plausible forms in patient care and inspire preventive actions at the society level. Health professionals are in a key position to integrate public health promotion and environmental care.', 'keywords': ['Finnish allergy programme', 'biodiversity', 'nature deficiency', 'nature loss', 'nature prescription', 'public health'], 'journal': 'Porto biomedical journal', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Haahtela', 'firstname': 'Tari', 'initials': 'T', 'affiliation': 'Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Bousquet', 'firstname': 'Jean', 'initials': 'J', 'affiliation': 'Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.\\nAllergic Rhinitis and its Impact on Asthma (ARIA), Montpellier, France.'}, {'lastname': 'Antó', 'firstname': 'Josep M', 'initials': 'JM', 'affiliation': 'ISGlobal, Barcelona, Spain.\\nUniversitat Pompeu Fabra (UPF), Barcelona, Spain.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of PBJ-Associação Porto Biomedical/Porto Biomedical Society.', 'doi': '10.1097/j.pbj.0000000000000245\\n10.23822/EurAnnACI.1764-1489.301\\n10.1016/j.encep.2023.06.017', 'xml': <Element 'PubmedArticle' at 0x1099664d0>}\n",
      "{'pubmed_id': '38344408\\n20739951\\n30639346\\n33499346\\n35295226\\n17502624\\n23348739\\n28703805\\n28595996\\n21976023\\n29343438\\n36767891\\n30718831\\n20404242\\n22182053\\n22930834\\n30641038\\n32035984\\n20513432\\n31587991\\n32362324\\n23104886\\n25516281\\n19465376\\n2450098\\n8938441\\n27304082\\n21991953\\n29673856\\n36721094\\n28606467\\n24280725\\n28051089\\n31378660\\n29642409\\n28734739\\n18923650\\n32213830\\n28219068\\n14616792\\n33730733\\n31596431\\n35135993\\n31647967\\n12045207\\n11279517\\n30776025\\n31358547\\n23152189\\n34405829\\n37540585\\n22329734\\n16045735\\n28845473\\n24521260\\n27129092\\n31868801\\n33453290\\n27869817\\n24950209\\n35192868\\n16550169\\n30578876\\n33289661\\n37734479\\n35204110\\n16227587\\n19660807\\n31292477\\n22392998\\n36601108\\n32499033', 'title': 'Aryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis.', 'abstract': 'Atopic dermatitis (AD) is an allergic skin disease mediated by skin barrier impairment and IL-13-driven immune response. Activation of the aryl hydrocarbon receptor (AHR) has shown promise in early clinical trials for AD; however, the mechanism by which AHR partially ameliorates AD is not well known.\\nGene expression data from human biopsies were analyzed, and compared to gene expression from RNA-sequencing in our \\nThe AHR target gene \\nTogether, these data suggest that the AHR pathway is dysregulated in AD and that AHR modulates IL-13 downstream signaling in keratinocytes through genome-wide, transcriptional regulatory effects.', 'keywords': ['FICZ', 'IL-13', 'STAT6', 'aryl hydrocarbon receptor', 'atopic dermatitis', 'keratinocytes', 'tapinarof'], 'journal': 'Frontiers in allergy', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Proper', 'firstname': 'Steven P', 'initials': 'SP', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Dwyer', 'firstname': 'Alexander T', 'initials': 'AT', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Appiagyei', 'firstname': 'Andrews', 'initials': 'A', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Felton', 'firstname': 'Jennifer M', 'initials': 'JM', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Ben-Baruch Morgenstern', 'firstname': 'Netali', 'initials': 'N', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Marlman', 'firstname': 'Justin M', 'initials': 'JM', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Kotliar', 'firstname': 'Michael', 'initials': 'M', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Barski', 'firstname': 'Artem', 'initials': 'A', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\\nDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\"}, {'lastname': 'Troutman', 'firstname': 'Ty D', 'initials': 'TD', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\"}, {'lastname': 'Rothenberg', 'firstname': 'Marc E', 'initials': 'ME', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\"}, {'lastname': 'Mersha', 'firstname': 'Tesfaye B', 'initials': 'TB', 'affiliation': \"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\\nDivision of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\"}, {'lastname': 'Azouz', 'firstname': 'Nurit P', 'initials': 'NP', 'affiliation': \"Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.\"}], 'methods': None, 'conclusions': None, 'results': 'The AHR target gene ', 'copyrights': '© 2024 Proper, Dwyer, Appiagyei, Felton, Ben-Baruch Morgenstern, Marlman, Kotliar, Barski, Troutman, Rothenberg, Mersha and Azouz.', 'doi': '10.3389/falgy.2024.1323405\\n10.1038/jid.2010.251\\n10.1016/j.jaci.2019.01.003\\n10.3390/ijms22031104\\n10.3389/ftox.2022.775010\\n10.1073/pnas.0701764104\\n10.1172/JCI65642\\n10.1038/cddis.2017.322\\n10.1016/j.jid.2017.05.004\\n10.1038/nature10491\\n10.1016/j.immuni.2017.12.012\\n10.3390/ijerph20032526\\n10.1038/s41577-019-0125-8\\n10.1001/archdermatol.2010.34\\n10.1111/j.1365-2133.2011.10775.x\\n10.1038/nmeth.2089\\n10.1016/j.jid.2018.12.018\\n10.1016/j.jaci.2020.01.042\\n10.1016/j.molcel.2010.05.004\\n10.1016/j.immuni.2019.09.002\\n10.1016/j.immuni.2020.04.001\\n10.1093/bioinformatics/bts635\\n10.1186/s13059-014-0550-8\\n10.1093/nar/gkp427\\n10.1083/jcb.106.3.761\\n10.1006/geno.1996.0563\\n10.2340/00015555-2482\\n10.1056/NEJMra1011040\\n10.1016/j.taap.2018.04.013\\n10.1186/s10020-023-00614-9\\n10.1016/j.plipres.2017.06.001\\n10.1038/jid.2013.503\\n10.1038/mi.2016.120\\n10.1016/j.jdermsci.2019.07.005\\n10.3390/ijms19041102\\n10.1016/j.alit.2017.06.016\\n10.1371/journal.pone.0003408\\n10.3390/nu12030862\\n10.1159/000453452\\n10.1046/j.1365-2249.2003.02273.x\\n10.1159/000514503\\n10.1001/jamadermatol.2019.2983\\n10.1097/j.pain.0000000000002611\\n10.1016/j.jaci.2019.07.049\\n10.1093/hmg/11.13.1539\\n10.1038/86867\\n10.1172/JCI124608\\n10.1128/MCB.00190-19\\n10.1093/toxsci/kfs325\\n10.1097/DER.0000000000000764\\n10.17305/bb.2023.9439\\n10.1111/j.1365-2133.2012.10885.x\\n10.1111/j.1365-2249.2005.02875.x\\n10.1016/j.cotox.2017.01.006\\n10.1111/exd.12350\\n10.1016/j.intimp.2016.04.017\\n10.1097/CM9.0000000000000591\\n10.1016/j.jaci.2021.01.001\\n10.1038/ni.3614\\n10.1016/j.immuni.2014.06.001\\n10.1016/j.jaci.2022.02.006\\n10.1038/ng1767\\n10.1016/j.jaci.2018.11.036\\n10.1016/j.jaci.2020.09.039\\n10.1016/j.jid.2023.07.027\\n10.3390/antiox11020227\\n10.1128/MCB.25.21.9360-9368.2005\\n10.1016/S0140-6736(09)60912-0\\n10.1038/s41598-019-46374-7\\n10.1073/pnas.1118467109\\n10.3389/fimmu.2022.1057555\\n10.1016/j.jaip.2020.02.022', 'xml': <Element 'PubmedArticle' at 0x109a42f20>}\n",
      "{'pubmed_id': '38344153\\n31949111\\n28947020\\n28947448\\n27815152\\n22929091\\n23427203\\n27184821\\n25833035\\n30053965\\n32702517\\n31823381\\n27777223\\n19240948\\n24312488\\n26613666\\n28126032\\n26594739\\n23961782\\n26158805\\n32469667\\n33664077\\n32448767\\n29033347', 'title': 'Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma.', 'abstract': \"The aim of this study was to evaluate the feasibility of a community pharmacy-delivered intervention to shift patients' beliefs about short-acting beta\\nThis non-randomized, before-and-after feasibility study enrolled participants with asthma from four community pharmacies in Auckland, New Zealand. Eligible participants were aged 18 years and above and were prescribed a SABA for their asthma. The intervention included the SABA reliance questionnaire to determine the degree of SABA reliance, verbal discussions with pharmacists personalised according to the degree of SABA reliance identified, and referral to general practitioners as appropriate.\\nOf the 44 patients who consented into the study, 19 were in the control group and 16 in the intervention group. Recruitment and retention were modest, with 10 control and five intervention participants completing the 90-day follow-up. Although not statistically significant, preliminary results indicated reduced SABA reliance and increased ICS adherence in the intervention group, and reduced SABA refill. Feedback showed that 78% of intervention participants found the information easy to understand, and 56% expressed intent to consult their general practitioners. Pharmacy staff found the intervention feasible but noted time constraints as a barrier to intervention delivery.\\nThe study demonstrates that a community pharmacy-delivered intervention is feasible and acceptable to both patients and pharmacists. While preliminary results show a positive effect on reducing SABA reliance and improvement of ICS adherence, the results were not statistically significant due to the small numbers recruited. This suggests a larger randomised trial is indicated. This intervention holds promise for addressing the over-reliance on SABA in asthma management and improving adherence to preventive therapies.\", 'keywords': ['SABA', 'SRQ', 'adherence', 'asthma', 'feasibility', 'pharmacist'], 'journal': 'Patient preference and adherence', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Foot', 'firstname': 'Holly', 'initials': 'H', 'affiliation': 'School of Pharmacy, The University of Auckland, Auckland, New Zealand.\\nSchool of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.'}, {'lastname': 'Beyene', 'firstname': 'Kebede', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy, St Louis, MO, Unites States.'}, {'lastname': 'Horne', 'firstname': 'Rob', 'initials': 'R', 'affiliation': 'Centre of Behavioural Medicine, School of Pharmacy, University College London, London, UK.'}, {'lastname': 'Fingleton', 'firstname': 'James', 'initials': 'J', 'affiliation': 'Capital and Coast District Health Board, Wellington, New Zealand.\\nMedical Research Institute of New Zealand, Wellington, New Zealand.'}, {'lastname': 'Harrison', 'firstname': 'Jeff', 'initials': 'J', 'affiliation': 'School of Pharmacy, The University of Auckland, Auckland, New Zealand.'}, {'lastname': 'Chan', 'firstname': 'Amy Hai Yan', 'initials': 'AHY', 'affiliation': 'School of Pharmacy, The University of Auckland, Auckland, New Zealand.\\nCentre of Behavioural Medicine, School of Pharmacy, University College London, London, UK.'}], 'methods': None, 'conclusions': 'The study demonstrates that a community pharmacy-delivered intervention is feasible and acceptable to both patients and pharmacists. While preliminary results show a positive effect on reducing SABA reliance and improvement of ICS adherence, the results were not statistically significant due to the small numbers recruited. This suggests a larger randomised trial is indicated. This intervention holds promise for addressing the over-reliance on SABA in asthma management and improving adherence to preventive therapies.', 'results': 'Of the 44 patients who consented into the study, 19 were in the control group and 16 in the intervention group. Recruitment and retention were modest, with 10 control and five intervention participants completing the 90-day follow-up. Although not statistically significant, preliminary results indicated reduced SABA reliance and increased ICS adherence in the intervention group, and reduced SABA refill. Feedback showed that 78% of intervention participants found the information easy to understand, and 56% expressed intent to consult their general practitioners. Pharmacy staff found the intervention feasible but noted time constraints as a barrier to intervention delivery.', 'copyrights': '© 2024 Foot et al.', 'doi': '10.2147/PPA.S445763\\n10.1183/13993003.01872-2019\\n10.1016/j.rmed.2017.08.014\\n10.1136/bmjopen-2017-016688\\n10.1016/j.chest.2016.10.028\\n10.1016/j.ccm.2012.06.002\\n10.1136/bmjopen-2012-002247\\n10.1016/j.puhe.2016.03.030\\n10.1038/npjpcrm.2015.21\\n10.1016/j.rmed.2018.06.032\\n10.1016/j.jaip.2020.07.014\\n10.1111/bcp.14193\\n10.4104/pcrj.2009.00010\\n10.1371/journal.pone.0080633\\n10.1016/j.pec.2015.11.004\\n10.1027/1016-9040/a000353\\n10.1186/s12913-017-2031-8\\n10.1177/1539449215578649\\n10.1186/1471-2288-13-104\\n10.1002/pst.185\\n10.1177/1098214005283748\\n10.1038/npjpcrm.2015.26\\n10.1136/bmjopen-2020-043344\\n10.1016/j.sapharm.2020.05.012\\n10.1016/j.sapharm.2017.10.001', 'xml': <Element 'PubmedArticle' at 0x10b72e2f0>}\n",
      "{'pubmed_id': '38343891\\n2793861\\n34502227\\n27932800\\n26056585\\n10708863\\n7649172\\n8645699\\n30407557\\n1940438\\n11094152\\n15036259\\n19430729\\n16006757\\n27644693\\n26130332\\n11350830\\n17026855\\n12882763\\n27852133\\n12151305\\n30017632\\n19375904\\n19224893\\n15240007\\n25279146\\n17418380\\n15456694\\n28421197\\n29417309\\n34530646\\n19915152\\n25237378\\n16858010\\n28553231\\n16997735\\n28545810\\n11970913\\n11029344\\n30410547\\n31213027\\n33656791\\n21401309\\n19380835\\n32973788\\n29692608\\n16141443\\n25997387\\n11704541\\n34204745\\n32349289\\n9357863\\n16210639\\n23285217\\n18483420\\n19783786\\n29988449\\n20165721\\n12865379\\n16172252\\n30872586\\n26973981\\n33781671\\n23957905\\n31778609\\n28828358\\n11350822\\n30167842\\n30992386\\n24651234\\n34265829\\n36482481\\n27355745\\n32339071\\n15618213\\n36675165\\n30252372\\n32013006\\n24721641\\n23792071\\n34552347\\n12588713\\n26281325\\n32509793\\n24032029\\n16456242\\n15863647\\n12534559\\n37075799\\n11929485\\n23226977\\n15947303\\n12947131\\n30535706\\n28507585\\n18955015\\n14987308\\n16522462\\n32644707\\n33208482\\n31456837\\n22591289\\n36935521\\n20298300\\n23441181\\n25849664\\n30643813\\n30781876\\n19249197\\n23456614\\n16905636\\n17620183\\n15864012\\n26201096\\n29650051\\n32878618\\n22299526\\n31715083\\n21233269\\n25545245\\n19604728\\n24525080\\n28365056\\n20935110\\n17045024\\n23537541\\n26401883\\n28128990\\n28804709\\n28836192\\n15663794\\n18178676\\n26121236\\n35805895\\n23124168\\n17499192\\n15265946\\n16288749\\n30915034\\n32033401\\n36121220\\n25720438\\n20692288\\n21118573\\n170930\\n19723899\\n10441576\\n26435260\\n36142876\\n15947421\\n36733844\\n23457188\\n15389776', 'title': 'TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases.', 'abstract': 'Tissue inhibitors of metalloproteases (TIMPs) have caught the attention of many scientists due to their role in various physiological and pathological processes. TIMP-1, 2, 3, and 4 are known members of the TIMPs family. TIMPs exert their biological effects by, but are not limited to, inhibiting the activity of metalloproteases (MMPs). The balance between MMPs and TIMPs is critical for maintaining homeostasis of the extracellular matrix (ECM), while the imbalance between MMPs and TIMPs can lead to pathological changes, such as cancer. In this review, we summarized the current knowledge of TIMP-1 in several pulmonary diseases namely, acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), pneumonia, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary fibrosis. Considering the potential of TIMP-1 serving as a non-invasive diagnostic and/or prognostic biomarker, we also reviewed the circulating TIMP-1 levels in translational and clinical studies.', 'keywords': ['Chronic obstructive pulmonary disease', 'Cystic fibrosis', 'Extracellular matrix', 'Idiopathic pulmonary fibrosis', 'Lung injury', 'Metalloproteases'], 'journal': 'Chinese medical journal pulmonary and critical care medicine', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Almuntashiri', 'firstname': 'Sultan', 'initials': 'S', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.\\nDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail 55473, Saudi Arabia.'}, {'lastname': 'Alhumaid', 'firstname': 'Abdullah', 'initials': 'A', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.\\nDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail 55473, Saudi Arabia.'}, {'lastname': 'Zhu', 'firstname': 'Yin', 'initials': 'Y', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.'}, {'lastname': 'Han', 'firstname': 'Yohan', 'initials': 'Y', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.'}, {'lastname': 'Dutta', 'firstname': 'Saugata', 'initials': 'S', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.'}, {'lastname': 'Khilji', 'firstname': 'Ohmed', 'initials': 'O', 'affiliation': 'Department of Emergency Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.'}, {'lastname': 'Zhang', 'firstname': 'Duo', 'initials': 'D', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.\\nDepartment of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.'}, {'lastname': 'Wang', 'firstname': 'Xiaoyun', 'initials': 'X', 'affiliation': 'Clinical and Experimental Therapeutics, Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.pccm.2023.05.002\\n10.1016/S0021-9258(18)71503-2\\n10.3390/ijms22179319\\n10.1038/nrc.2016.115\\n10.1186/2052-8426-2-17\\n10.1016/s0167-4838(99)00279-4\\n10.1111/j.1432-1033.1995.0714d.x\\n10.1016/0304-4165(96)00008-6\\n10.1093/nar/gky1099\\n10.1111/1523-1747.ep12483956\\n10.1016/s0014-5793(00)02210-9\\n10.1016/j.critrevonc.2003.09.008\\n10.1007/s11060-009-9910-8\\n10.1159/000086774\\n10.1186/s13046-016-0427-7\\n10.1136/thoraxjnl-2015-207035\\n10.1165/ajrcmb.24.5.4192\\n10.1177/039463200601900303\\n10.1152/ajplung.00183.2003\\n10.1080/17435390.2016.1262919\\n10.1165/ajrcmb.27.2.4674\\n10.1016/j.cbi.2018.07.008\\n10.1016/j.rmed.2009.03.018\\n10.1183/09031936.00084808\\n10.1016/j.cellsig.2004.03.003\\n10.3892/br.2014.323\\n10.1016/j.jaci.2007.02.011\\n10.1152/ajpcell.00035.2004\\n10.1155/2017/6510198\\n10.1007/s10753-018-0742-6\\n10.1177/10915818211044809\\n10.1165/rcmb.2009-0211OC\\n10.4046/trd.2014.77.2.73\\n10.1165/rcmb.2005-0026OC\\n10.3389/fphar.2017.00264\\n10.1081/COPD-120030164\\n10.1016/j.imbio.2017.05.010\\n10.1165/ajrcmb.26.5.4685\\n10.1164/ajrccm.162.4.9910097\\n10.1186/s11658-018-0117-x\\n10.3390/md17060360\\n10.14814/phy2.14778\\n10.3109/17435390.2010.537791\\n10.4049/jimmunol.0801935\\n10.3389/fimmu.2020.01902\\n10.2147/COPD.S161257\\n10.1164/rccm.200505-753OC\\n10.3892/mmr.2015.3810\\n10.1152/ajplung.2001.281.6.L1444\\n10.3390/cells10061484\\n10.3390/ijms21093080\\n10.1152/ajplung.1997.273.4.L866\\n10.4049/jimmunol.175.8.5333\\n10.1371/journal.pone.0052889\\n10.1165/rcmb.2007-0325OC\\n10.1165/rcmb.2009-0216OC\\n10.3389/fimmu.2018.01348\\n10.4103/0974-2700.58663\\n10.1001/jama.290.3.374\\n10.1165/rcmb.F305\\n10.1038/s41572-019-0069-0\\n10.1053/j.jvca.2021.02.053\\n10.1186/1741-7015-11-166\\n10.1080/13543784.2020.1699531\\n10.21037/atm.2017.06.49\\n10.1165/ajrcmb.24.5.4160\\n10.1007/s00408-018-0154-2\\n10.1534/genetics.119.301795\\n10.1213/ANE.0000000000000120\\n10.1097/SHK.0000000000001833\\n10.1186/s13293-022-00481-9\\n10.1590/S0102-865020160060000004\\n10.1177/0300060520919592\\n10.1128/IAI.73.1.661-665.2005\\n10.3390/ijms24021641\\n10.3390/ijms21030851\\n10.1016/j.cca.2014.03.031\\n10.1016/j.cca.2013.06.013\\n10.2147/JIR.S320685\\n10.1164/rccm.200203-258OC\\n10.3906/sag-1402-51\\n10.3389/fmed.2020.00191\\n10.3389/fmicb.2013.00263\\n10.1385/CBB.44.1.139\\n10.1183/09031936.05.00092804\\n10.1046/j.1365-2222.2003.01563.x\\n10.1046/j.1365-2222.2002.01219.x\\n10.1155/2012/968267\\n10.1378/chest.127.6.1919\\n10.1136/thorax.58.9.757\\n10.1007/978-1-4939-8994-2_28\\n10.5114/aoms.2016.60371\\n10.1016/j.clim.2008.08.029\\n10.1111/j.1365-2222.2004.01849.x\\n10.1016/j.jaci.2005.12.1324\\n10.1183/16000617.0124-2019\\n10.3889/oamjms.2019.612\\n10.1111/j.1440-1843.2012.02197.x\\n10.1186/s40001-023-01094-7\\n10.1111/j.1752-699X.2007.00032.x\\n10.1371/journal.pone.0056352\\n10.1186/s12931-015-0188-4\\n10.1155/2018/6417415\\n10.3390/biom9020062\\n10.1016/j.rmed.2009.01.021\\n10.1002/0471141755.ph0564s60\\n10.1152/ajplung.00539.2005\\n10.1080/01902140701459514\\n10.1042/CS20150273\\n10.1186/s12931-018-0772-5\\n10.1186/s12931-020-01496-9\\n10.1002/ppul.24530\\n10.1183/09031936.00173210\\n10.1371/journal.pone.0115847\\n10.1016/j.jcf.2009.06.001\\n10.1016/j.jcf.2014.01.010\\n10.1016/S0140-6736(17)30866-8\\n10.1164/rccm.201006-0894CI\\n10.1089/gtmb.2015.0057\\n10.1080/15412555.2017.1278753\\n10.3389/fmed.2017.00118\\n10.1007/978-1-4939-7113-8_2\\n10.1186/1465-9921-6-11\\n10.1152/aj-plung.00291.2007\\n10.1165/rcmb.2015-0020TR\\n10.3390/ijms23136894\\n10.3892/mmr.2012.1140\\n10.1016/j.intimp.2007.02.009\\n10.4049/jimmunol.173.3.2099\\n10.1016/j.febslet.2005.10.033\\n10.3389/fendo.2019.00137\\n10.3390/toxics8010009\\n10.1128/iai.00283-22\\n10.1111/acel.12326\\n10.1016/j.dci.2010.07.007\\n10.1186/1465-9921-11-166\\n10.1016/0006-291x(75)90573-2\\n10.3899/jrheum.090059\\n10.1086/302556\\n10.1016/j.theriogenology.2015.09.003\\n10.3390/ijms231810960\\n10.1165/rcmb.2005-0111OC\\n10.1155/2023/1973163\\n10.1152/ajplung.00320.2012\\n10.1002/hep.20425', 'xml': <Element 'PubmedArticle' at 0x10a5eb420>}\n",
      "{'pubmed_id': '38343638\\n27973326\\n26712474\\n34670588\\n31949111\\n23510684\\n16914299\\n29863899\\n33359587\\n33733637\\n25439366\\n30154081\\n22092883\\n27556234\\n20495105\\n28007353\\n12847494\\n20152991\\n15969661\\n16264041\\n32141258\\n32250875\\n36510255\\n34448255\\n19118263\\n33255348\\n30185520\\n16172260\\n24247484\\n28160290\\n22539286\\n8581845\\n8109700\\n9515598\\n9188923\\n2480971\\n30912328\\n3497723\\n22702477\\n16298365\\n12895603\\n30335498\\n19361847\\n20205953\\n1918068\\n36271366\\n9476865\\n35765520\\n11295649\\n27336865\\n12392382\\n22345378\\n35765786\\n36483262\\n32963117\\n28822787\\n9039240\\n24321217\\n25834418\\n29461632\\n29858410\\n33446724\\n35369308\\n16778163\\n19597174\\n25975622\\n29452277\\n27363539\\n27293845\\n17613633\\n16260524\\n34403838\\n24885269\\n19808918\\n26356702\\n30857941\\n31608936\\n32174450\\n32569755\\n11843311\\n30170798\\n31167755\\n17234901\\n36714050\\n17890469\\n37279801\\n24920421\\n32141261\\n32971927\\n36516114\\n23139248\\n33371008\\n32061315\\n25501062\\n26221754\\n26819354\\n21051501\\n20940370\\n29054846\\n16389251\\n32616008\\n32392512\\n17130214\\n29699563\\n35062886\\n21401354\\n20008867\\n2215562\\n31931743\\n30817038\\n24332216\\n35789114\\n34710093\\n16707391\\n20078870\\n17650829\\n27605722\\n23264425\\n18801858\\n35282442\\n31518657\\n21177843\\n33596445\\n34549046\\n24998953\\n28142050\\n19251584\\n20870201\\n19375557\\n22902134\\n25765669\\n20410219\\n6355186\\n9329975\\n33052715\\n27245632\\n31415212\\n23804543\\n15464449\\n33538338\\n11171871\\n19174822\\n15456995\\n16287212\\n26954623\\n32417133\\n33633205\\n25914942\\n26526071\\n21392472\\n25177962\\n8217235\\n30123334\\n30956205\\n27938355\\n20371345\\n12415707\\n33115469\\n34457312\\n28885881\\n20044268\\n28934231\\n36864983\\n34996413\\n33470881\\n35516446\\n27448950\\n30949213\\n35477559\\n33194908\\n31033249\\n31208379\\n32396562\\n37406803\\n33033149\\n32943399\\n17686624\\n30100132\\n25314160\\n28967546\\n33854341\\n24701468\\n29212496\\n36299358\\n36948588\\n19032908\\n23050876\\n18565954\\n24454412\\n30542672\\n25772740\\n15642875\\n32483205\\n18585492\\n27190330\\n23562348\\n25680526\\n20478682\\n28838094\\n33097411\\n29108730\\n36537052\\n21704331\\n28040677\\n31876896\\n31504124\\n34322545\\n25525351\\n33199207\\n33309175\\n34778156\\n19854330\\n25893103\\n35871681\\n31402157\\n36216934\\n15652604\\n26783384\\n33316236\\n18097862\\n23988762\\n28202551\\n26803721\\n26817901\\n22445771\\n28433577\\n16061703\\n35812117\\n25468246\\n34551813\\n26342745\\n30061168\\n31062639\\n34167764\\n17452145\\n24004921\\n30400894\\n22609891\\n30165982\\n30561252\\n25448311\\n6344309\\n1985142\\n720379\\n28126029\\n27639934\\n27553751\\n27609408\\n30416083\\n32469092\\n36462399\\n37015033\\n32064708\\n29257905\\n31647021\\n33597123\\n34521557\\n31649948\\n30584428\\n33658578\\n28979112\\n32380914\\n30254433\\n36311545\\n31165288\\n32713026\\n31848359\\n32773326\\n30174422\\n27713629\\n16164444\\n31784349\\n37096829\\n26291753\\n33411398\\n30958980\\n28461298\\n23362945\\n26974689\\n29873189\\n25998444\\n36596385\\n11385125\\n10658300\\n32599814\\n33161958\\n21258586\\n25553263\\n21624825\\n18308695\\n15961697\\n10903229\\n27842581\\n30914232\\n23491404\\n16304318\\n27108637\\n34671999\\n31204233\\n38064716\\n38016003', 'title': 'Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes.', 'abstract': \"Asthma remains a significant global health challenge. While both the incidence and mortality rates have shown a decline, older individuals with asthma exhibit not just more severe symptoms but also demonstrate an elevated mortality rate. This phenomenon could be attributed to the presence of chronic comorbidities that exert an influence on clinical outcomes among adult patients with asthma. This review aims to present various aspects of asthma comprehensively, including the prevalence, incidence, mortality rates, and causes of death in adult patients with asthma. Additionally, this review delves into the impact of chronic comorbidities that contribute to the morbidity and mortality of patients with asthma on a global scale, encompassing conditions such as chronic kidney disease, diabetes mellitus, lung cancer, obesity, and cardiovascular disease, concerning asthma. Furthermore, the manuscript reviews the distinctions between asthma and asthma chronic obstructive pulmonary disease overlap and adds perspective on asthma as an occupational lung disease. Thus, this review aims to enhance clinicians' awareness of the significance of chronic comorbidities in the management of patients with asthma. It seeks to provide insights that contribute to a more comprehensive approach to managing patients with asthma who also have comorbid conditions.\", 'keywords': ['ACO', 'asthma', 'comorbidity', 'mortality', 'outcomes'], 'journal': 'Frontiers in medicine', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Listyoko', 'firstname': 'Aditya Sri', 'initials': 'AS', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.\\nPulmonology and Respiratory Medicine Department, Faculty of Medicine, Brawijaya University-Dr. Saiful Anwar General Hospital, Malang, Indonesia.'}, {'lastname': 'Okazaki', 'firstname': 'Ryota', 'initials': 'R', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.'}, {'lastname': 'Harada', 'firstname': 'Tomoya', 'initials': 'T', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.'}, {'lastname': 'Inui', 'firstname': 'Genki', 'initials': 'G', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.'}, {'lastname': 'Yamasaki', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Listyoko, Okazaki, Harada, Inui and Yamasaki.', 'doi': '10.3389/fmed.2024.1305638\\n10.18176/jiaci.0128\\n10.1016/j.anai.2015.11.011\\n10.1186/s12931-021-01864-z\\n10.1183/13993003.01872-2019\\n10.1186/1710-1492-9-8\\n10.1016/j.rmed.2006.07.005\\n10.1513/AnnalsATS.201711-886OC\\n10.1016/j.jaip.2020.12.030\\n10.4168/aair.2021.13.3.420\\n10.1016/j.jaip.2014.06.005\\n10.1542/hpeds.2017-0265\\n10.1111/j.1365-2222.2011.03863.x\\n10.1164/rccm.201602-0419OC\\n10.1378/chest.09-3066\\n10.1016/j.sleep.2016.06.013\\n10.1067/mai.2003.1569\\n10.1016/j.jpeds.2009.11.080\\n10.1111/j.1365-2222.2005.02251.x\\n10.1183/09031936.05.00037905\\n10.4168/aair.2020.12.3.443\\n10.1016/j.rmed.2020.105947\\n10.1186/s12931-022-02266-5\\n10.1111/pai.13655\\n10.1378/chest.08-1702\\n10.3390/ijms21238907\\n10.4049/jimmunol.1800709\\n10.1084/jem.20050199\\n10.1159/000355331\\n10.1111/all.13139\\n10.1002/eji.201142018\\n10.1111/j.1365-2222.1995.tb03259.x\\n10.1111/j.1398-9995.1993.tb04712.x\\n10.1046/j.1365-2222.1998.00217.x\\n10.1111/j.1398-9995.1997.tb01021.x\\n10.1016/0091-6749(89)90391-6\\n10.4168/aair.2019.11.3.394\\n10.1016/0092-8674(87)90339-4\\n10.1111/j.1398-9995.2012.02859.x\\n10.1016/j.febslet.2005.09.104\\n10.1016/s0952-3278(03)00081-4\\n10.1152/ajplung.00547.2017\\n10.1016/j.jaci.2009.02.024\\n10.1186/1465-9921-11-28\\n10.1016/S0021-9258(18)55037-7\\n10.1186/s12931-022-02209-0\\n10.1164/ajrccm.157.2.9703070\\n10.52547/rbmb.11.1.182\\n10.1067/mai.2001.113566\\n10.1097/MD.0000000000003774\\n10.1016/S1081-1206(10)62039-X\\n10.1378/chest.11-1838\\n10.7189/jogh.12.04052\\n10.3389/fpubh.2022.1036674/full\\n10.1136/thoraxjnl-2020-214655\\n10.1016/S2213-2600(17)30293-X\\n10.1136/thx.52.1.49\\n10.1186/1471-2466-13-73\\n10.2147/COPD.S77491\\n10.1111/all.13431\\n10.1136/bmjopen-2017-019992\\n10.1038/s41598-020-79264-4\\n10.3389/fcvm.2022.861798/full\\n10.1164/rccm.200601-007OC\\n10.1370/afm.983\\n10.1016/j.jaip.2015.03.017\\n10.1016/j.jaip.2018.02.001\\n10.1111/resp.12838\\n10.21037/jtd.2016.04.68\\n10.1080/02770900701364031\\n10.1097/01.aog.0000185281.21716.02\\n10.1016/j.jaip.2021.07.055\\n10.1186/1471-2466-14-80\\n10.4103/AZMJ.AZMJ_13_17\\n10.2337/dc09-0880\\n10.1097/MD.0000000000001466\\n10.1016/j.jaip.2019.02.029\\n10.1093/inthealth/ihz067\\n10.1016/j.rmed.2020.105919\\n10.1016/j.jaip.2020.06.017\\n10.1183/09031936.02.00245802\\n10.1016/j.rmed.2018.07.012\\n10.1158/1055-9965.EPI-18-1330\\n10.1164/rccm.200611-1717OC\\n10.2147/JAA.S397067\\n10.1378/chest.07-0936\\n10.1016/j.rmed.2023.107301\\n10.1007/s00408-014-9600-y\\n10.4168/aair.2020.12.3.485\\n10.3390/ijerph17186925\\n10.1371/journal.pone.0276731\\n10.1093/aje/kws181\\n10.1136/bmjresp-2019-000470\\n10.1016/S0140-6736(20)30045-3\\n10.1097/MD.0000000000000174\\n10.1038/ki.2015.228\\n10.1136/thoraxjnl-2015-207630\\n10.1093/ndt/gfq656\\n10.1093/ndt/gfq608\\n10.2215/CJN.03700417\\n10.7326/0003-4819-144-1-200601030-00006\\n10.1186/s12882-020-01907-5\\n10.1503/cmaj.191012\\n10.2337/dc06-1499\\n10.1186/s12931-018-0742-y\\n10.1186/s12882-022-02661-6\\n10.3109/0886022X.2011.560403\\n10.1513/pats.200907-073DP\\n10.1056/NEJM199010113231505\\n10.1186/s12882-020-1685-3\\n10.1111/cea.13378\\n10.1016/j.jaci.2013.10.011\\n10.1111/1753-0407.13292\\n10.1371/journal.pone.0258210\\n10.1183/09031936.06.00114405\\n10.1186/1471-2369-11-1\\n10.1016/S1081-1206(10)60620-5\\n10.4314/gmj.v50i1.5\\n10.2337/dc13-S067\\n10.2522/ptj.20080020\\n10.3389/fendo.2022.838027/full\\n10.1016/j.diabres.2019.107843\\n10.1183/09031936.00140310\\n10.1016/j.annepidem.2021.02.003\\n10.1183/23120541.00178-2021\\n10.2188/jea.JE20140016\\n10.1016/j.je.2016.10.008\\n10.3121/cmr.2009.824\\n10.1016/j.amjmed.2010.06.019\\n10.1016/j.amjmed.2008.09.048\\n10.1016/j.rmed.2012.07.011\\n10.1016/j.diabres.2015.02.010\\n10.1210/jc.2010-0119\\n10.1172/JCI111141\\n10.1172/JCI119743\\n10.1164/rccm.202004-0993OC\\n10.1111/resp.12818\\n10.1513/AnnalsATS.201812-897OC\\n10.1002/oby.20524\\n10.1016/j.molmed.2004.08.004\\n10.3322/caac.21660\\n10.1093/ije/30.1.118\\n10.1038/sj.bjc.6604890\\n10.1023/B:CACO.0000043432.71626.45\\n10.1002/pds.1163\\n10.1002/ijc.30084\\n10.1016/j.jaci.2020.04.041\\n10.1038/s41598-021-84012-3\\n10.1164/rccm.201502-0302OC\\n10.1186/s12885-015-1847-z\\n10.4238/2014.August.29.4\\n10.3109/02841869309096110\\n10.4103/atm.ATM_367_17\\n10.1183/13993003.01257-2018\\n10.1186/s12917-016-0915-1\\n10.1016/j.cell.2010.03.015\\n10.1186/s12890-020-01317-1\\n10.1002/rcr2.835\\n10.1056/NEJMoa1709937\\n10.1016/j.cyto.2009.11.017\\n10.1371/journal.pone.0183239\\n10.1016/j.eclinm.2023.101850\\n10.1186/s12889-021-12449-2\\n10.18553/jmcp.2021.20410\\n10.1016/j.eclinm.2022.101429\\n10.1016/j.clnu.2016.06.023\\n10.1186/s13223-019-0333-6\\n10.1136/thoraxjnl-2021-217867\\n10.3389/fped.2020.576858\\n10.1111/ijpo.12532\\n10.1186/s12889-019-7116-3\\n10.1371/journal.pone.0232621\\n10.1016/j.jaip.2023.06.049\\n10.1183/13993003.01209-2020\\n10.1183/13993003.00612-2020\\n10.1016/j.rmed.2007.06.031\\n10.1016/j.resinv.2018.07.003\\n10.1513/AnnalsATS.201406-270BC\\n10.1016/j.jaip.2017.07.010\\n10.2147/JAA.S299186\\n10.7860/JCDR/2014/7306.3993\\n10.1186/s12931-017-0684-9\\n10.1183/23120541.00110-2022\\n10.1136/thorax-2022-219268\\n10.25011/cim.v31i6.4924\\n10.3109/02770903.2012.728271\\n10.1164/rccm.200802-301OC\\n10.1155/2013/654104\\n10.1016/j.ejcdt.2015.02.012\\n10.1183/13993003.congress-2019.PA4274\\n10.1016/j.amjcard.2015.02.024\\n10.1001/archinte.165.1.55\\n10.1038/s41366-020-0563-1\\n10.1016/j.ahj.2008.02.014\\n10.1093/ndt/gfw075\\n10.1016/j.mayocp.2013.01.025\\n10.1053/j.jrn.2014.12.006\\n10.1016/j.jvs.2010.02.008\\n10.1093/ehjqcco/qcx010\\n10.1016/j.numecd.2020.08.024\\n10.1016/j.nut.2017.09.004\\n10.1111/anec.13022\\n10.1016/j.jss.2011.04.061\\n10.1093/ejcts/ezw386\\n10.1001/jamaoncol.2019.5241\\n10.1093/aje/kwz185\\n10.1183/23120541.00902-2020\\n10.2147/COPD.S75175\\n10.1016/j.alit.2020.09.009\\n10.1016/j.jacc.2020.11.010\\n10.3389/fpubh.2021.559751\\n10.1016/j.amjmed.2009.04.022\\n10.1136/openhrt-2014-000222\\n10.1186/s12872-022-02780-w\\n10.1016/j.ijcard.2019.07.085\\n10.1038/s41591-022-01974-1\\n10.1016/S0140-6736(05)17741-1\\n10.1155/2015/819194\\n10.1016/j.chest.2020.11.053\\n10.1080/02770900701752391\\n10.1183/09031936.00043313\\n10.1183/13993003.01014-2016\\n10.1016/j.jstrokecerebrovasdis.2015.11.030\\n10.1097/MD.0000000000002546\\n10.1016/j.rmed.2012.02.017\\n10.1016/j.anai.2017.03.012\\n10.1136/thx.2004.026484\\n10.3389/fneur.2022.900438\\n10.1016/j.yrmex.2019.100013\\n10.1016/j.ejim.2014.10.023\\n10.1186/s13223-021-00598-3\\n10.1016/j.jaip.2015.07.009\\n10.1136/thoraxjnl-2017-210477\\n10.1080/08923973.2019.1609026\\n10.1016/S2589-7500(21)00079-0\\n10.1016/j.ahj.2007.02.027\\n10.1186/2049-6958-8-58\\n10.1186/s12931-018-0920-y\\n10.1177/2047487312447904\\n10.1016/j.jacc.2018.06.049\\n10.1161/JAHA.118.010672\\n10.1016/j.rmed.2014.09.016\\n10.1136/thx.38.2.108\\n10.1007/BF00607436\\n10.1186/s12916-017-0781-0\\n10.1016/j.jaci.2016.07.038\\n10.1016/j.clinthera.2016.07.010\\n10.1016/S0140-6736(16)31324-1\\n10.1016/S2213-2600(18)30406-5\\n10.1111/cea.13614\\n10.1016/j.rmed.2022.107058\\n10.1164/rccm.202210-2005OC\\n10.1111/resp.13780\\n10.1080/15412555.2017.1408580\\n10.1186/s12931-019-1198-4\\n10.1183/16000617.0185-2019\\n10.1016/j.mam.2021.101021\\n10.1183/23120541.00191-2019\\n10.1155/2018/4657420\\n10.1038/s41598-021-83185-1\\n10.2147/COPD.S142466\\n10.1080/15412555.2020.1761314\\n10.2147/COPD.S167379\\n10.1155/2022/9656278\\n10.1007/s11306-019-1552-z\\n10.1111/all.14520\\n10.1038/s41598-019-55502-2\\n10.1016/j.resinv.2020.05.006\\n10.2147/COPD.S167600\\n10.2147/COPD.S115378\\n10.1111/j.1365-2222.2005.02314.x\\n10.1016/j.arbr.2020.03.003\\n10.1177/17534666231169472\\n10.1378/chest.15-1055\\n10.1111/all.14483\\n10.5152/TurkThoracJ.2018.18055\\n10.1186/s43168-021-00055-0\\n10.1183/13993003.02383-2016\\n10.1111/crj.12013\\n10.1513/AnnalsATS.201508-554OC\\n10.1111/crj.12917\\n10.1111/resp.12556\\n10.1016/j.rmed.2022.107112\\n10.1093/occmed/51.3.204\\n10.1093/occmed/49.8.485\\n10.3390/ijerph17124553\\n10.1016/j.jaip.2020.06.031\\n10.3346/jkms.2010.25.S.S20\\n10.4168/aair.2015.7.1.51\\n10.1016/j.rmed.2011.05.002\\n10.1093/occmed/kqn007\\n10.1164/rccm.200501-111OC\\n10.1164/ajrccm.162.1.9906108\\n10.1186/s12890-016-0306-1\\n10.1016/j.jaip.2019.03.017\\n10.1164/rccm.201211-2076OC\\n10.1378/chest.128.5.3590\\n10.1539/joh.15-0067-BR\\n10.1002/ajim.23304\\n10.1016/j.rmr.2019.03.008\\n10.1164/rccm.202311-2103ED\\n10.1164/rccm.202305-0808OC', 'xml': <Element 'PubmedArticle' at 0x10a9967f0>}\n",
      "{'pubmed_id': '38343532\\n18568022\\n29057808\\n29467962\\n16931577\\n27738491\\n36462661\\n27843005\\n25256150\\n19899776\\n22157542\\n23545178\\n33915055\\n23383696\\n25157400\\n36701916\\n37882301\\n34231604\\n35257898\\n25753322\\n22721984\\n27363641\\n34302158\\n29403966\\n19298691\\n21466223\\n21213407\\n34221003\\n24609927\\n33130473\\n28107754\\n32360572\\n26510118\\n35594435\\n15668926\\n31781635\\n35463046\\n32903465\\n29091859\\n23742617\\n31810123\\n26902402\\n34456714\\n32222637\\n29604422\\n26722219\\n30809149\\n36215870\\n28064485\\n23626759\\n31017255\\n27710596\\n30609097\\n29207037\\n33017787\\n29616452\\n22425757\\n26569027\\n28039839\\n30453148\\n24529136\\n27363516\\n29464499\\n25620282\\n29894863\\n19467635\\n26907804\\n30609878\\n30391464\\n23895132\\n31377105\\n34120462\\n37494786\\n19183886\\n27123259\\n24913217\\n30483725\\n32865318\\n26629181\\n33494001\\n31485892\\n34594215\\n33974755\\n22487852\\n35937573\\n24127072\\n23146752\\n34018499\\n31631820\\n32441927\\n29738434\\n35596133\\n26152793\\n31485933\\n31657664\\n36678243\\n29032340\\n33636579\\n36724682\\n35596609\\n35535154\\n17785825\\n32071149\\n28097231\\n25972527\\n25934864\\n30398646\\n32256270\\n33900301\\n32695254\\n34896111\\n24348533\\n34603465\\n24495470\\n27035565\\n28839358\\n36766210\\n28368613\\n36069282\\n28281719', 'title': 'Research advances of ', 'abstract': '', 'keywords': ['NF-κB', 'Zanthoxylum bungeanum Maxim.', 'inflammation', 'inflammatory disease', 'polyphenols'], 'journal': 'Frontiers in immunology', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Qi', 'firstname': 'Jinxin', 'initials': 'J', 'affiliation': 'Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.'}, {'lastname': 'Pan', 'firstname': 'Zhaoping', 'initials': 'Z', 'affiliation': 'Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.'}, {'lastname': 'Wang', 'firstname': 'Xiaoyun', 'initials': 'X', 'affiliation': 'Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.'}, {'lastname': 'Zhang', 'firstname': 'Nan', 'initials': 'N', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'He', 'firstname': 'Gu', 'initials': 'G', 'affiliation': 'Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.'}, {'lastname': 'Jiang', 'firstname': 'Xian', 'initials': 'X', 'affiliation': 'Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Qi, Pan, Wang, Zhang, He and Jiang.', 'doi': '10.3389/fimmu.2024.1305886\\n10.1038/nn.2143\\n10.3390/ijms18102172\\n10.18632/oncotarget.23208\\n10.1136/gut.2006.094599\\n10.1155/2016/7432797\\n10.1016/j.bse.2021.104356\\n10.1016/j.fitote.2022.105380\\n10.1016/j.intimp.2016.10.021\\n10.1007/s10753-014-0027-7\\n10.1021/np900259y\\n10.3945/jn.111.150748\\n10.1016/j.taap.2013.03.015\\n10.1139/cjpp-2021-0034%M33915055\\n10.1021/jf3042825\\n10.1371/journal.pone.0105725\\n10.12691/jfnr-2-7-4\\n10.1016/0031-9422(94)00965-V\\n10.1016/j.foodchem.2023.135535\\n10.1111/ppl.14031\\n10.1039/D1FO00876E\\n10.1016/j.phrs.2022.106163\\n10.1016/j.cbi.2015.02.021\\n10.1016/j.fct.2012.06.013\\n10.1016/j.jss.2016.02.041\\n10.1039/D1FO01557E\\n10.1007/s10967-015-4415-8\\n10.38212/2224-6614.2517\\n10.1016/j.jpha.2015.12.003\\n10.1211/jpp.61.04.0006\\n10.1021/jf104786t\\n10.1142/s0192415x11008737\\n10.1080/13102818.2019.1620633\\n10.1155/2021/8706400\\n10.1007/s10753-014-9863-8\\n10.1016/j.phymed.2020.153387\\n10.1016/j.intimp.2017.01.003\\n10.1016/j.lfs.2020.117735\\n10.1039/C5FO00913H\\n10.1097/WNR.0000000000001783\\n10.1002/eji.200425778\\n10.1155/2019/7039802\\n10.1007/s13205-022-03118-1\\n10.3389/fphys.2020.00988\\n10.1016/j.biopha.2017.10.073\\n10.1021/np400222v\\n10.1016/j.biopha.2019.109683\\n10.1016/j.phymed.2015.11.003\\n10.3389/fphar.2021.630320\\n10.1016/j.intimp.2020.106437\\n10.1016/j.micpath.2018.03.053\\n10.7150/ijbs.13188\\n10.3389/fphar.2019.00094\\n10.1016/j.intimp.2022.109278\\n10.1021/acs.jafc.6b05160\\n10.1371/journal.pone.0061971\\n10.3892/ijmm.2019.4162\\n10.1080/07315724.2016.1140093\\n10.1002/ddr.21510\\n10.3892/ijmm.2017.3296\\n10.1007/s43450-022-00347-6\\n10.1016/j.saa.2020.118977\\n10.1007/s10787-018-0464-2\\n10.1016/j.abb.2012.02.019\\n10.1016/j.freeradbiomed.2015.11.009\\n10.1016/j.redox.2016.12.023\\n10.1016/j.intimp.2018.11.016\\n10.1016/j.atherosclerosis.2013.12.027\\n10.1038/srep29034\\n10.1007/s12012-018-9449-z\\n10.1002/mnfr.201400631\\n10.1016/j.intimp.2018.06.011\\n10.1016/j.abb.2009.01.016\\n10.1016/j.neuropharm.2016.02.019\\n10.4014/jmb.1810.10061\\n10.1016/j.lfs.2018.10.066\\n10.1186/1476-511X-12-115\\n10.1016/j.brainres.2019.146361\\n10.4155/fmc-2021-0127\\n10.1016/j.biopha.2023.115215\\n10.1007/s12272-009-1127-z\\n10.3892/br.2016.636\\n10.1016/j.jnutbio.2014.04.006\\n10.3892/ijmm.2018.3993\\n10.1002/ar.24506\\n10.1016/j.phymed.2021.153466\\n10.1007/s12012-019-09548-3\\n10.3389/fphar.2021.683818\\n10.17219/acem/133493\\n10.1007/s00011-012-0474-2\\n10.1016/j.mtbio.2022.100370\\n10.1007/s00011-013-0674-4\\n10.1016/j.tox.2012.10.025\\n10.1039/D0FO03199B\\n10.2174/1570159X17666191021111809\\n10.1021/acs.jafc.0c01554\\n10.3390/molecules23051109\\n10.1186/s12870-022-03642-5\\n10.1016/j.indcrop.2022.116149\\n10.1002/fft2.26\\n10.1016/j.jss.2015.06.013\\n10.1007/s12640-019-00102-1\\n10.1089/jmf.2019.4524\\n10.3390/nu15020372\\n10.1186/s13765-023-00767-5\\n10.1016/j.biopha.2017.10.021\\n10.1016/j.lwt.2022.113983\\n10.1016/j.phymed.2021.153509\\n10.1016/j.saa.2023.122360\\n10.1002/advs.202201258\\n10.1155/2022/9862733\\n10.4049/jimmunol.179.6.3881\\n10.1136/bmjresp-2018-000392\\n10.1172/jci.insight.89373\\n10.3945/jn.115.211888\\n10.3945/ajcn.114.098590\\n10.1093/jn/nxy236\\n10.17179/excli2019-2021\\n10.1039/D0FO02695F\\n10.1155/2020/3481758\\n10.1016/j.ejphar.2021.174691\\n10.1155/2013/384057\\n10.13683/j.wph.2023.01.006\\n10.1007/s11746-010-1644-4\\n10.1155/2021/2073296\\n10.1016/j.jep.2014.01.013\\n10.3892/mmr.2016.5050\\n10.4103/pm.pm_211_16\\n10.13699/j.cnki.1001-6821.2020.13.013\\n10.3390/foods12030682\\n10.13604/j.cnki.46-1064/r.2012.05.045\\n10.1039/C6FO01739H\\n10.1021/acs.jafc.7b01323\\n10.1039/d1fo04323d\\n10.1039/C6FO01739H\\n10.13193/j.issn.1673-7717.2022.10.017\\n10.4314/ajtcam.v13i1.7', 'xml': <Element 'PubmedArticle' at 0x10adfd8a0>}\n",
      "{'pubmed_id': '38343493\\n35914087\\n31718748\\n26494423\\n32075787\\n26917957\\n32161455\\n26755942\\n30919925\\n29212834\\n29650248\\n35427530\\n19716966\\n29129169\\n28298389\\n30170801\\n23537230\\n26688540\\n10377201\\n29611609\\n7663792\\n28182564\\n9872837\\n33722217\\n33603357\\n28822787\\n31467620\\n26766907\\n35821836\\n31220055\\n25474184\\n33546691\\n27010214\\n36062505\\n29650407\\n34349996\\n32127105\\n25950276\\n24009418\\n33025768\\n33447022\\n31824912\\n31285306', 'title': 'Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco.', 'abstract': 'Chronic obstructive pulmonary disease (COPD) is a major public health problem. In Morocco, few studies have focused on COPD in primary health care facilities, whose main mission is prevention. The aim of our work is thus to assess the prevalence of COPD and to study the factors associated with this silent disease among users of health care facilities in Morocco.\\nThis is a cross-sectional observational study of participants aged 40 and over. Data were collected by questionnaire. Pulmonary function testing was conducted using a spirometer before and after administration of a bronchodilator. COPD was defined as fixed ratio of the post-bronchodilator forced expiratory volume in 1 second / forced vital capacity less than 0.7. Logistic regression models were applied to define factors associated with COPD.\\nFrom 550 participants aged 40 and over, we selected only 477 patients with exploitable spirometry results for inclusion in the final analysis. The mean age of participants was 54.91±11.92 years, and the female/male ratio was 1.59. The prevalence of COPD was 6.7% (95% CI; 4.6 to 9.3%), and was higher in men than in women (11.4% vs 3.8%, p=0.002). The prevalence of COPD increased significantly with age, from 3.3% in those aged 40 to 49 to 16.9% in those aged 70 and over (p=0.001). Current smokers had a higher prevalence of COPD than former and never smokers. Age, smoking, asthma diagnosis and childhood hospitalization for lung disease were risk factors associated with the development of COPD. Only 6.25% of participants identified as having COPD had previously been diagnosed with COPD.\\nCOPD remains largely under-diagnosed among primary care consultants in Morocco. Efforts for early detection and promotion of prevention of the main risk factors need to be intensified in order to reduce the burden of this silent pathology on a national scale.', 'keywords': ['Morocco', 'chronic obstructive pulmonary disease', 'network of primary health care facilities', 'prevalence', 'risk factors', 'spirometry'], 'journal': 'International journal of chronic obstructive pulmonary disease', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Al Wachami', 'firstname': 'Nadia', 'initials': 'N', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Arraji', 'firstname': 'Maryem', 'initials': 'M', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Iderdar', 'firstname': 'Younes', 'initials': 'Y', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Mourajid', 'firstname': 'Yassmine', 'initials': 'Y', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Boumendil', 'firstname': 'Karima', 'initials': 'K', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Bouchachi', 'firstname': 'Fatima Zahra', 'initials': 'FZ', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Jaouhar', 'firstname': 'Samira', 'initials': 'S', 'affiliation': 'Laboratory of Microbial Biotechnology & Bioactive Molecules, Faculty of Science and Technology, University Sidi Mohammed Ben Abdellah Fez, Fez, BP 2202, Morocco.'}, {'lastname': 'Guennouni', 'firstname': 'Morad', 'initials': 'M', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.\\nChouaib Doukkali University of El Jadida, Higher School of Education and Training, El Jadida, Morocco.'}, {'lastname': 'Laamiri', 'firstname': 'Fatimazahra', 'initials': 'F', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Elkhoudri', 'firstname': 'Noureddine', 'initials': 'N', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Bandadi', 'firstname': 'Lahcen', 'initials': 'L', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Louerdi', 'firstname': 'Mohamed Lahbib', 'initials': 'ML', 'affiliation': 'Provincial Delegation of Health Settat, Settat, 26000 Morocco.'}, {'lastname': 'Hilali', 'firstname': 'Abderraouf', 'initials': 'A', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}, {'lastname': 'Chahboune', 'firstname': 'Mohamed', 'initials': 'M', 'affiliation': 'Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Settat, 26000, Morocco.'}], 'methods': None, 'conclusions': 'COPD remains largely under-diagnosed among primary care consultants in Morocco. Efforts for early detection and promotion of prevention of the main risk factors need to be intensified in order to reduce the burden of this silent pathology on a national scale.', 'results': 'From 550 participants aged 40 and over, we selected only 477 patients with exploitable spirometry results for inclusion in the final analysis. The mean age of participants was 54.91±11.92 years, and the female/male ratio was 1.59. The prevalence of COPD was 6.7% (95% CI; 4.6 to 9.3%), and was higher in men than in women (11.4% vs 3.8%, p=0.002). The prevalence of COPD increased significantly with age, from 3.3% in those aged 40 to 49 to 16.9% in those aged 70 and over (p=0.001). Current smokers had a higher prevalence of COPD than former and never smokers. Age, smoking, asthma diagnosis and childhood hospitalization for lung disease were risk factors associated with the development of COPD. Only 6.25% of participants identified as having COPD had previously been diagnosed with COPD.', 'copyrights': '© 2024 Al wachami et al.', 'doi': '10.2147/COPD.S443081\\n10.1164/rccm.202204-0671PP\\n10.5588/ijtld.19.0397\\n10.1111/resp.12660\\n10.1136/bmj.m234\\n10.2147/COPD.S90626\\n10.2147/COPD.S234942\\n10.7189/jogh.05.020415\\n10.26719/emhj.18.014\\n10.1183/16000617.0073-2017\\n10.1016/S0140-6736(18)30841-9\\n10.1016/S2213-2600(21)00506-3\\n10.1016/S0140-6736(09)61303-9\\n10.5694/mja17.00684\\n10.1183/16000617.0113-2016\\n10.1016/j.rmed.2018.07.015\\n10.3109/15412555.2013.766683\\n10.5588/ijtld.15.0029\\n10.5603/IMH.2018.0003\\n10.1164/ajrccm.152.3.7663792\\n10.1183/13993003.00214-2017\\n10.1164/ajrccm.159.1.9712108\\n10.1186/s12890-021-01465-y\\n10.2147/COPD.S285338\\n10.1016/S2213-2600(17)30293-X\\n10.1155/2019/6918340\\n10.2147/COPD.S95028\\n10.3389/fragi.2022.818700\\n10.15585/mmwr.mm6824a1\\n10.3109/15412555.2014.974736\\n10.1186/s12931-021-01630-1\\n10.1371/journal.pone.0151981\\n10.4081/monaldi.2022.2323\\n10.1016/S2213-2600(18)30103-6\\n10.1177/20503121211031428\\n10.5588/ijtld.19.0170\\n10.1378/chest.14-2535\\n10.2147/COPD.S48659\\n10.1002/ehf2.13035\\n10.2147/COPD.S276639\\n10.3389/fpubh.2019.00350\\n10.1183/13993003.02140-2018', 'xml': <Element 'PubmedArticle' at 0x10a4d8860>}\n",
      "{'pubmed_id': '38343419\\n7495484\\n37431853\\n34228203\\n17261791\\n29259496\\n29296117\\n20579408\\n21329969\\n12714251\\n7251998\\n24315935\\n27380967\\n37291596\\n31988649\\n22409889\\n28400983\\n21293145\\n17360170\\n18006291\\n11940070\\n11551246\\n24628378\\n15516669\\n31273040\\n8807222\\n11736749\\n11918604\\n10416703\\n33898719\\n5801331\\n24785199\\n26872037\\n30132643\\n19014872\\n23160589\\n21530872\\n27094361\\n33039007', 'title': 'Allergic Diseases in the Elderly.', 'abstract': 'Recent increases in allergic diseases are thought to be caused by better hygiene, Westernized diets, air pollution, climate change, and other factors that influence host microbiota, a key player in the induction and maintenance of immunoregulatory circuits and tolerance. The increase of allergic diseases in the elderly is also related to additional factors, such as various comorbidities that may interfere with the development and the type of allergic reactions. Immunosenescence plays a central role in these reactions, altering microbiota responses and triggering inflammageing. In addition, in the elderly, there is a shift from Th1 to Th2 immunity, thus favoring allergic responses. A better understanding of the mechanisms responsible for immunosenescence and its effects on allergic inflammation will most certainly lead to improved therapies.', 'keywords': ['Allergic conjunctivitis', 'Allergic rhinitis', 'Asthma', 'Elderly', 'Immunosenescence', 'Skin diseases'], 'journal': 'Translational medicine @ UniSa', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Di Lorenzo', 'firstname': 'Gabriele', 'initials': 'G', 'affiliation': 'Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.'}, {'lastname': 'Melluso', 'firstname': 'Marcello', 'initials': 'M', 'affiliation': 'General Practitioner, Provincial Health Authority (ASP) 206 of Palermo, Palermo, Italy.'}, {'lastname': 'Rodolico', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Seidita', 'firstname': 'Aurelio', 'initials': 'A', 'affiliation': 'Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.\\nInstitute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Palermo, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 Universit a di Salerno.', 'doi': '10.37825/2239-9747.1046\\n10.1016/0167-5699(95)80040-9\\n10.1111/all.15807\\n10.1196/annals.1386.013\\n10.1186/s12948-017-0077-0\\n10.1186/s12979-017-0105-4\\n10.1017/S0029665110001862\\n10.1016/j.jaci.2011.01.017\\n10.1016/s0047-6374(03)00020-4\\n10.1016/0091-6749(81)90167-6\\n10.1016/j.bbi.2013.11.015\\n10.1016/j.molmed.2016.06.003\\n10.1186/s12979-023-00352-w\\n10.1186/s12979-020-0173-8\\n10.1186/2045-7022-1-11\\n10.14336/AD.2016.0831\\n10.1159/000320050\\n10.1016/j.rmed.2007.01.014\\n10.1016/j.rmed.2007.09.007\\n10.1046/j.1365-2222.2002.01260.x\\n10.1034/j.1398-9995.2001.t01-1-00001.x\\n10.1111/all.12382\\n10.1183/09031936.04.00013904\\n10.1183/13993003.00598-2019\\n10.1111/j.1600-0536.1996.tb02214.x\\n10.1034/j.1398-9995.2001.00086.x\\n10.1034/j.1600-0536.2002.460208.x\\n10.1111/j.1600-0536.1999.tb06202.x\\n10.1016/j.ijwd.2020.08.003\\n10.1111/j.1365-2133.1969.tb16041.x\\n10.1111/all.12313\\n10.1111/bjd.14470\\n10.1016/j.autrev.2008.05.003\\n10.4045/tidsskr.12.0470\\n10.1016/j.anai.2011.01.011\\n10.1016/j.jaci.2016.03.008\\n10.1016/j.jaip.2020.08.006', 'xml': <Element 'PubmedArticle' at 0x1098bbfb0>}\n",
      "{'pubmed_id': '38343306', 'title': 'Comparison between upper and lower airway microbiome profiles in chronic rhinosinusitis patients.', 'abstract': 'Dysregulation of the airway microbiota is thought to contribute to airway inflammation in both chronic rhinosinusitis (CRS) and asthma. However, the relationship between the upper and lower airway microbiome remains unclear.\\nSinus and lung brushes were collected from 29 CRS participants undergoing sinus surgery. DNA was extracted and submitted for 16s rRNA microbiome sequencing. Alpha and beta diversity metrics, taxonomic composition, and differences between individual taxa were compared for paired sinus and bronchial samples.\\nTwenty-three out of 29 participants had sufficient samples for analysis. The mean (standard deviation) age was 51.59 (14.57) years, and 10 (44%) patients were female. Twelve (52%) patients had comorbid asthma. Sinus brushes had significantly higher alpha diversity indexes (Shannon and Faith) compared to bronchial brushes (p\\xa0<\\xa00.001). Beta diversity metrics were significantly different between the sinus and bronchial samples. Principal coordinate analysis showed no clustering of paired nasal and bronchial samples. Sinus brushes had significantly more Lawsonella, Corynebacterium, and Staphylococcus compared to bronchia brushes, while the latter were enriched in Tropheryma and Sphingomonas, among others (false discovery rate [FDR]-adjusted p\\xa0<\\xa00.01). Finally, CRS patients with comorbid asthma had significantly higher Pseudomonas and Peptoniphilus in sinus brushes and lower Prevotella in bronchial brushes when compared to non-asthmatics (FDR-adjusted p\\xa0<\\xa00.01).\\nThe sinus and bronchial bacterial microbiomes differ in important ways. Our study suggests that migration of bacteria from the sinus into the lower airways is unlikely in patients with CRS.', 'keywords': ['asthma', 'bacteriology', 'biofilm', 'chronic rhinosinusitis', 'paranasal sinus diseases\\n'], 'journal': 'International forum of allergy & rhinology', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Hernaiz-Leonardo', 'firstname': 'Juan Carlos', 'initials': 'JC', 'affiliation': 'Division of Otolaryngology-Head and Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Ryu', 'firstname': 'Changwan', 'initials': 'C', 'affiliation': 'Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Pascual', 'firstname': 'Athenea', 'initials': 'A', 'affiliation': 'Division of Otolaryngology-Head and Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.\\nCentre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Fan', 'firstname': 'Judy', 'initials': 'J', 'affiliation': 'Division of Otolaryngology-Head and Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Caray', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Pezato', 'firstname': 'Rogério', 'initials': 'R', 'affiliation': 'Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Yang', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Sin', 'firstname': 'Don', 'initials': 'D', 'affiliation': 'Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}, {'lastname': 'Thamboo', 'firstname': 'Andrew', 'initials': 'A', 'affiliation': 'Division of Otolaryngology-Head and Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.\\nCentre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.'}], 'methods': None, 'conclusions': 'The sinus and bronchial bacterial microbiomes differ in important ways. Our study suggests that migration of bacteria from the sinus into the lower airways is unlikely in patients with CRS.', 'results': 'Twenty-three out of 29 participants had sufficient samples for analysis. The mean (standard deviation) age was 51.59 (14.57) years, and 10 (44%) patients were female. Twelve (52%) patients had comorbid asthma. Sinus brushes had significantly higher alpha diversity indexes (Shannon and Faith) compared to bronchial brushes (p\\xa0<\\xa00.001). Beta diversity metrics were significantly different between the sinus and bronchial samples. Principal coordinate analysis showed no clustering of paired nasal and bronchial samples. Sinus brushes had significantly more Lawsonella, Corynebacterium, and Staphylococcus compared to bronchia brushes, while the latter were enriched in Tropheryma and Sphingomonas, among others (false discovery rate [FDR]-adjusted p\\xa0<\\xa00.01). Finally, CRS patients with comorbid asthma had significantly higher Pseudomonas and Peptoniphilus in sinus brushes and lower Prevotella in bronchial brushes when compared to non-asthmatics (FDR-adjusted p\\xa0<\\xa00.01).', 'copyrights': '© 2024 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.', 'doi': '10.1002/alr.23335', 'xml': <Element 'PubmedArticle' at 0x10af476f0>}\n",
      "{'pubmed_id': '38342758\\n20664075\\n23435359\\n36709600\\n29503745\\n33240001\\n36641058\\n34691021\\n33659009\\n35130835\\n11597666\\n29735984\\n35366558\\n25413686\\n37232427\\n26870828\\n34408443\\n29120738\\n31201890\\n32141256\\n25902485\\n35389253\\n27670239\\n15254594\\n30578876\\n26424567\\n26048149\\n27576125\\n34365653\\n30283410\\n26963409\\n21270894\\n27259147\\n35628549\\n23828891\\n24390308\\n35672452\\n29902437\\n34966278\\n25263219\\n32719140\\n36362303\\n35125876\\n28923468\\n10442480\\n29200758\\n19001136\\n24954261\\n28618071\\n23465664\\n30589936\\n36052074\\n34127070\\n10334992\\n12524422\\n29321478\\n23004356\\n31776512\\n31875848\\n29328957\\n10395583\\n29165427\\n20855611\\n24439373\\n24686447\\n29847302\\n31355206\\n7521253\\n32407834\\n28214225\\n33495652\\n32511746\\n23665276\\n29411774\\n19966295\\n34137156\\n29483826\\n32959404\\n25065623\\n37508557\\n34831391\\n25550694\\n31276034\\n32901017\\n29522844\\n28100682\\n27476413\\n31896754\\n35393660\\n19278904\\n18426872\\n37347728\\n35082296\\n34394086\\n28475890\\n16771650\\n27231050\\n27883933\\n31777068\\n32433595\\n30355800\\n35199335\\n24390544\\n20601425\\n24226770\\n29058708\\n24412617\\n30120222\\n30760888\\n29744033\\n31954874\\n15206722\\n26216892\\n27773992\\n37248103\\n31543404\\n23563705\\n28049038\\n26939849\\n32461639\\n32526187\\n25439351\\n26102221\\n31501577\\n32072252\\n35966153\\n27966551\\n37332524\\n21471101\\n30390309\\n29067994\\n31951781\\n17157218\\n23882022\\n1285570\\n34289267\\n30206782\\n35418758\\n31836714\\n25282015\\n32848762\\n25297699\\n32075981\\n34575085\\n25006501\\n25419479\\n35745496\\n19720209\\n28855974\\n28228596\\n31619666\\n30899033\\n26431583\\n35977109\\n35485368\\n35513696\\n35769572\\n33384449\\n34839288\\n31279007\\n23973224\\n35239463\\n23949496\\n32910440\\n23348739\\n27869817\\n19536146\\n32067114\\n30370459\\n33347905\\n31026410\\n33109272\\n27292825\\n27332875\\n30131575\\n26394008\\n35232013\\n27158904\\n26449488\\n31669435\\n29729303\\n34843802\\n26601598\\n24226773\\n35864954\\n24397465\\n20720200\\n21041655\\n31962236\\n29021375\\n26522986\\n29241587\\n27838347\\n31494295\\n30623620\\n29150070\\n18322246\\n19556602\\n31929190\\n11344091\\n30912323\\n27887954\\n32112426\\n34087019\\n33735338', 'title': 'A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases.', 'abstract': \"Allergic diseases, including respiratory and food allergies, as well as allergic skin conditions have surged in prevalence in recent decades. In allergic diseases, the gut microbiome is dysbiotic, with reduced diversity of beneficial bacteria and increased abundance of potential pathogens. Research findings suggest that the microbiome, which is highly influenced by environmental and dietary factors, plays a central role in the development, progression, and severity of allergic diseases. The microbiome generates metabolites, which can regulate many of the host's cellular metabolic processes and host immune responses.\\nOur goal is to provide a narrative and comprehensive literature review of the mechanisms through which microbial metabolites regulate host immune function and immune metabolism both in homeostasis and in the context of allergic diseases.\\nWe describe key microbial metabolites such as short-chain fatty acids, amino acids, bile acids and polyamines, elucidating their mechanisms of action, cellular targets and their roles in regulating metabolism within innate and adaptive immune cells. Furthermore, we characterize the role of bacterial metabolites in the pathogenesis of allergic diseases including allergic asthma, atopic dermatitis and food allergy.\\nFuture research efforts should focus on investigating the physiological functions of microbiota-derived metabolites to help develop new diagnostic and therapeutic interventions for allergic diseases.\", 'keywords': ['allergy', 'immune metabolism', 'immune response', 'microbial metabolites', 'microbiome'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Losol', 'firstname': 'Purevsuren', 'initials': 'P', 'affiliation': 'Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.\\nDepartment of Molecular Biology and Genetics, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.'}, {'lastname': 'Wolska', 'firstname': 'Magdalena', 'initials': 'M', 'affiliation': 'Laboratory of Host-Microbiota Interactions, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.'}, {'lastname': 'Wypych', 'firstname': 'Tomasz P', 'initials': 'TP', 'affiliation': 'Laboratory of Host-Microbiota Interactions, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.'}, {'lastname': 'Yao', 'firstname': 'Lu', 'initials': 'L', 'affiliation': 'APC Microbiome Ireland, University College Cork, Cork, Ireland.\\nDepartment of Medicine, University College Cork, Cork, Ireland.\\nSchool of Microbiology, University College Cork, Cork, Ireland.'}, {'lastname': \"O'Mahony\", 'firstname': 'Liam', 'initials': 'L', 'affiliation': 'APC Microbiome Ireland, University College Cork, Cork, Ireland.\\nDepartment of Medicine, University College Cork, Cork, Ireland.\\nSchool of Microbiology, University College Cork, Cork, Ireland.'}, {'lastname': 'Sokolowska', 'firstname': 'Milena', 'initials': 'M', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}], 'methods': None, 'conclusions': 'Future research efforts should focus on investigating the physiological functions of microbiota-derived metabolites to help develop new diagnostic and therapeutic interventions for allergic diseases.', 'results': None, 'copyrights': '© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12339\\n10.1152/physrev.00045.2009\\n10.1038/nrmicro2974\\n10.1016/j.biopha.2023.114295\\n10.4110/in.2018.18.e15\\n10.5114/ada.2019.90120\\n10.1016/j.rmed.2023.107118\\n10.3389/fimmu.2021.708472\\n10.3389/fimmu.2021.628453\\n10.1186/s12866-022-02457-6\\n10.1016/S0140-6736(01)06252-3\\n10.1038/s41477-018-0151-8\\n10.1016/j.envint.2022.107216\\n10.1111/all.12549\\n10.1111/jdv.19125\\n10.1016/j.ebiom.2015.11.038\\n10.2147/JAA.S320088\\n10.1016/j.chom.2017.10.015\\n10.1016/j.jaci.2019.05.035\\n10.4168/aair.2020.12.3.412\\n10.1016/j.immuni.2015.03.014\\n10.1128/jb.00064-22\\n10.1016/j.jaci.2016.09.003\\n10.1172/JCI21275\\n10.1016/j.jaci.2018.11.036\\n10.1126/scitranslmed.aab2271\\n10.4049/jimmunol.1500736\\n10.1016/j.jaci.2016.05.049\\n10.1111/all.15039\\n10.3389/fmicb.2018.02147\\n10.1018/19490976.2015.1134082\\n10.1038/nature09646\\n10.1016/j.tifs.2020.02.026\\n10.1016/j.cell.2016.05.041\\n10.3390/ijms23105740\\n10.1126/science.1241165\\n10.1038/nm.3444\\n10.1038/s41385-022-00524-9\\n10.1016/j.chom.2018.05.003\\n10.3389/fphar.2021.769501\\n10.1016/j.chom.2014.09.001\\n10.1073/pnas.2000047117\\n10.3390/ijms232113520\\n10.2147/JAA.S334752\\n10.1016/j.coi.2017.08.011\\n10.1007/s000110050463\\n10.5021/ad.2017.29.6.706\\n10.1084/jem.20080193\\n10.1016/j.jaci.2014.04.034\\n10.1111/all.13227\\n10.1016/j.jaci.2013.01.013\\n10.1111/all.13709\\n10.3389/fimmu.2022.949033\\n10.1186/s40168-021-01101-1\\n10.1126/science.284.5418.1362\\n10.1074/jbc.M209706200\\n10.1038/s41598-017-18305-x\\n10.1111/all.12019\\n10.1038/s41586-019-1785-z\\n10.1038/s41586-019-1865-0\\n10.1016/j.mib.2017.12.011\\n10.1093/jn/129.7.1239\\n10.1038/nrm.2017.107\\n10.1073/pnas.1001501107\\n10.1016/j.cell.2013.11.042\\n10.1038/srep04548\\n10.1080/09168451.2018.1475211\\n10.3389/fnut.2019.00108\\n10.1111/j.1476-5381.1994.tb13078.x\\n10.1016/j.jaci.2020.04.037\\n10.1016/j.immuni.2017.01.005\\n10.1038/s41590-020-00856-3\\n10.1002/eji.201948478\\n10.1053/j.gastro.2013.04.056\\n10.1038/mi.2017.118\\n10.1073/pnas.0906112107\\n10.1111/brv.12765\\n10.7150/ijbs.22259\\n10.1096/fj.202001529R\\n10.1016/j.immuni.2014.06.014\\n10.3390/cells12141888\\n10.3390/cells10113168\\n10.4110/in.2014.14.6.277\\n10.1002/jgh3.12130\\n10.1038/s41467-020-18262-6\\n10.1016/j.jaci.2018.02.032\\n10.4049/jimmunol.1600165\\n10.1016/j.chom.2016.07.001\\n10.1038/s41467-019-13603-6\\n10.1111/bph.15852\\n10.1016/j.clim.2009.01.013\\n10.1128/IAI.00193-08\\n10.1371/journal.ppat.1011356\\n10.1038/s41467-022-28126-w\\n10.3389/fimmu.2021.692004\\n10.1016/j.cell.2017.04.004\\n10.1146/annurev.micro.60.080805.142308\\n10.1038/nri.2016.42\\n10.1016/j.mib.2016.10.003\\n10.1111/imm.13155\\n10.1038/s41422-020-0332-7\\n10.1126/scitranslmed.aao4755\\n10.1111/imm.13461\\n10.1073/pnas.1322269111\\n10.1074/jbc.M110.102947\\n10.1038/nature12721\\n10.1038/nsmb.3490\\n10.1016/j.immuni.2013.12.007\\n10.1038/s41467-018-05470-4\\n10.1038/s41573-019-0016-5\\n10.12688/f1000research.12120.1\\n10.1016/j.exger.2020.110841\\n10.1007/978-1-4615-0135-0_12\\n10.4049/jimmunol.1402854\\n10.4137/IJTR.S38355\\n10.1016/j.tips.2023.04.006\\n10.1016/j.cmet.2019.08.021\\n10.1038/nm.3145\\n10.1016/j.toxlet.2016.12.017\\n10.1080/19490976.2015.1127483\\n10.1038/s41586-020-2193-0\\n10.1016/S2213-2600(20)30105-3\\n10.1016/j.jaip.2014.09.004\\n10.1038/ncomms8320\\n10.1038/s41590-019-0451-9\\n10.1007/s00281-019-00775-y\\n10.5415/apallergy.2022.12.e32\\n10.1038/mi.2016.108\\n10.1016/j.waojou.2023.100786\\n10.1164/rccm.201010-1574OC\\n10.1111/all.13660\\n10.1038/mi.2017.75\\n10.1080/21645515.2019.1698900\\n10.1016/j.trim.2006.09.017\\n10.1136/thoraxjnl-2013-203728\\n10.1111/j.1398-9995.1992.tb02388.x\\n10.1002/prp2.837\\n10.1007/s12016-018-8712-1\\n10.2147/JAA.S354870\\n10.1038/s41467-019-13751-9\\n10.1016/j.jaci.2014.08.020\\n10.3389/fphar.2020.01153\\n10.1111/bph.12961\\n10.1038/s41522-020-0119-0\\n10.3390/life11090936\\n10.1155/2014/354250\\n10.4172/2155-9899.1000202\\n10.3390/pathogens11060642\\n10.1016/j.jaci.2009.07.013\\n10.1186/s40413-017-0160-5\\n10.1126/scitranslmed.aah4680\\n10.1038/s41467-019-12253-y\\n10.1038/s41598-019-41149-6\\n10.1016/j.jaci.2015.08.021\\n10.1084/jem.20212397\\n10.1080/19490976.2022.2068366\\n10.1038/s41598-022-11048-4\\n10.3389/falgy.2022.873168\\n10.1038/s41598-020-79737-6\\n10.1159/000520149\\n10.1016/j.jaci.2019.06.029\\n10.1016/j.immuni.2013.08.003\\n10.1080/19490976.2022.2044723\\n10.1007/s00281-013-0394-4\\n10.1007/s40257-020-00538-8\\n10.1172/JCI65642\\n10.1038/ni.3614\\n10.1038/jid.2009.85\\n10.1007/s11882-020-0898-7\\n10.1007/s12016-018-8710-3\\n10.1016/j.jaci.2020.12.624\\n10.1146/annurev-immunol-042718-041621\\n10.1186/s13073-020-00789-4\\n10.1016/j.jaci.2016.03.041\\n10.1016/j.celrep.2016.05.047\\n10.1038/s41598-018-30428-3\\n10.1038/ismej.2015.151\\n10.1021/acs.jafc.1c07482\\n10.1038/nm.4102\\n10.1111/all.12785\\n10.1016/j.jaci.2019.10.014\\n10.1016/j.jaci.2018.04.016\\n10.1016/j.jaci.2021.10.034\\n10.1016/j.jnutbio.2015.09.020\\n10.1038/nature12726\\n10.7150/ijbs.71287\\n10.1111/all.12346\\n10.4049/jimmunol.0903670\\n10.1073/pnas.1014465107\\n10.1016/j.isci.2019.100807\\n10.4049/jimmunol.1700248\\n10.1016/j.immuni.2015.09.012\\n10.1016/j.jaci.2017.08.041\\n10.1016/j.jaci.2016.08.055\\n10.1016/j.jaip.2019.08.036\\n10.3343/alm.2019.39.3.284\\n10.1016/j.anai.2017.07.023\\n10.4049/jimmunol.180.6.4323\\n10.1165/rcmb.2009-0108OC\\n10.1172/JCI130860\\n10.1096/fj.00-0742fje\\n10.4168/aair.2019.11.3.330\\n10.1016/j.jid.2016.11.014\\n10.1111/all.14254\\n10.1111/pai.13570\\n10.1039/d0fo03371e', 'xml': <Element 'PubmedArticle' at 0x109c91800>}\n",
      "{'pubmed_id': '38342357', 'title': 'Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.', 'abstract': \"Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are associated with a high rate of cardiovascular events. Thromboinflammation (the interplay between coagulation and inflammation) is probably involved in these events. Extracellular vesicles (EV) increase during AE-COPD, but their role in thromboinflammation in COPD is still unknown. We investigated EV-associated prothrombotic and proinflammatory activity in COPD.\\nPatients with AE-COPD, stable COPD (sCOPD) and age- and sex-matched subjects (controls) were enrolled. AE-COPD patients were evaluated at hospital admission and 8 weeks after discharge (recovery; longitudinal arm). In a cross-sectional arm, AE-COPD were compared with sCOPD and controls. EV-mediated prothrombotic activity was tested by measuring the concentration of EV-associated phosphatidylserine, as assessed by a prothrombinase assay, and tissue factor, as assessed by a modified one-stage clotting assay (EV-PS and EV-TF, respectively). Synthesis of interleukin-8 (IL-8) and C-C motif chemokine ligand-2 (CCL-2) by cells of the human bronchial epithelial cell line 16HBE incubated with patients' EV was used to measure EV-mediated proinflammatory activity.\\nTwenty-five AE-COPD (median age [interquartile range] 74.0 [14.0] years), 31 sCOPD (75.0 [9.5] years) and 12 control (67.0 [3.5] years) subjects were enrolled. In the longitudinal arm, EV-PS, EV-TF, IL-8 and CCL-2 levels were all significantly higher at hospital admission than at recovery. Similarly, in the cross-sectional arm, EV-PS, EV-TF and cytokines synthesis were significantly higher in AE-COPD than in sCOPD and controls.\\nEV exert prothrombotic and proinflammatory activities during AE-COPD and may therefore be effectors of thromboinflammation, thus contributing to the higher cardiovascular risk in AE-COPD.\", 'keywords': ['Cardiovascular risk', 'Chronic obstructive pulmonary disease', 'Extracellular vesicles', 'Inflammation', 'Thrombosis'], 'journal': 'Respiratory medicine', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'Nieri', 'firstname': 'Dario', 'initials': 'D', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy.\"}, {'lastname': 'Morani', 'firstname': 'Camilla', 'initials': 'C', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy.\"}, {'lastname': 'De Francesco', 'firstname': 'Miriam', 'initials': 'M', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy.\"}, {'lastname': 'Gaeta', 'firstname': 'Roberta', 'initials': 'R', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy.\"}, {'lastname': 'Niceforo', 'firstname': 'Mariapia', 'initials': 'M', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy.\"}, {'lastname': 'De Santis', 'firstname': 'Mariella', 'initials': 'M', 'affiliation': 'Dipartimento CardioToracoVascolare, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.'}, {'lastname': 'Giusti', 'firstname': 'Ilaria', 'initials': 'I', 'affiliation': \"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.\"}, {'lastname': 'Dolo', 'firstname': 'Vincenza', 'initials': 'V', 'affiliation': \"Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.\"}, {'lastname': 'Daniele', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Centre on Asthma and COPD, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.'}, {'lastname': 'Papi', 'firstname': 'Alberto', 'initials': 'A', 'affiliation': 'Centre on Asthma and COPD, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.'}, {'lastname': 'Celi', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': \"UO Pneumologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy; Centro Dipartimentale di Biologia Cellulare Cardiorespiratoria, University of Pisa, Pisa, Italy. Electronic address: alessandro.celi@unipi.it.\"}, {'lastname': 'Neri', 'firstname': 'Tommaso', 'initials': 'T', 'affiliation': \"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, Pisa, Italy; Centro Dipartimentale di Biologia Cellulare Cardiorespiratoria, University of Pisa, Pisa, Italy.\"}], 'methods': None, 'conclusions': None, 'results': 'Twenty-five AE-COPD (median age [interquartile range] 74.0 [14.0] years), 31 sCOPD (75.0 [9.5] years) and 12 control (67.0 [3.5] years) subjects were enrolled. In the longitudinal arm, EV-PS, EV-TF, IL-8 and CCL-2 levels were all significantly higher at hospital admission than at recovery. Similarly, in the cross-sectional arm, EV-PS, EV-TF and cytokines synthesis were significantly higher in AE-COPD than in sCOPD and controls.', 'copyrights': 'Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.', 'doi': '10.1016/j.rmed.2024.107563', 'xml': <Element 'PubmedArticle' at 0x109991a80>}\n",
      "{'pubmed_id': '38342132', 'title': 'Hereditary angioedema with normal C1-Inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families.', 'abstract': 'Hereditary angioedema with normal C1-INH (HAE-nC1-INH) is a rare genetic disease with similar phenotype to HAE-C1-INH, but different genetic background. Currently six subtypes are recognized, based on the underlying mutations. Several aspects need further clarification.\\nTo assess clinical features of patients with genetically characterized HAE-nC1-INH, from the North of Portugal.\\nRetrospective assessment of clinical data from all patients with HAE-nC1-INH followed at a HAE Reference Center.\\nForty-one patients were identified, four with no family history. The FXII-mutation Thr328Lys (38 carriers) was the most prevalent. Three new potentially disease causing variants linked to HAE-nC1-INH were identified (c.529+4A&gt;G:FXII; Cys248*:Kininogen-1; Arg261His:Plasminogen). The HAE-FXII cohort included 82% females and 71.8% symptomatic patients. Penetrance rate was significantly higher in females (81.3% vs 28.6; p=0.012). A hormonal influence was observed in 96.2% of the symptomatic females, although 62.5% remained symptomatic after oral estrogens withdrawal. Trauma and dental procedures were frequent triggers (82.6% and 45.5%, respectively). Main locations were facial (described by 96%), lips (82.1%) and eyelids (64.3%). One patient reported erythema marginatum as prodrome. Plasma derived C1-INH was effective as short-term prophylaxis in all treated patients, but only in 80% as on demand treatment. Icatibant was effectively used on demand in 9 patients, but with relapses in five (57%).\\nWe described the first Portuguese series of patients with HAE-nC1-INH genetically characterized. Differences with others may contribute to improve current unmet needs and raise awareness of this rare disease. We highlight the identification of 3 new variants(additional molecular studies are ongoing) and the first report of erythema marginatum in HAE-n-C1INH.', 'keywords': ['FXII mutations', 'Hereditary angioedema', 'Hereditary angioedema with normal C1 inhibitor', 'Kininogen-1mutations', 'Plasminogen mutations', 'bradykinin', 'estrogens', 'kallikrein-kinin system', 'phenotype, erythema marginatum'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 12), 'authors': [{'lastname': 'de Castro', 'firstname': 'Eunice Dias', 'initials': 'ED', 'affiliation': 'Allergy and Clinical Immunology Department, Centro Hospitalar Universitário de S. João EPE, Porto, Portugal;; Public Health and Forensic Sciences and Medical Education Department, Faculty of Medicine, University of Porto, Porto, Portugal;. Electronic address: eunicediascastro@gmail.com.'}, {'lastname': 'Pinhal', 'firstname': 'Ana Luísa', 'initials': 'AL', 'affiliation': 'Allergy and Clinical Immunology Department, Centro Hospitalar Universitário de S. João EPE, Porto, Portugal.'}, {'lastname': 'Bragança', 'firstname': 'Mariana', 'initials': 'M', 'affiliation': 'Allergy and Clinical Immunology Department, Centro Hospitalar Universitário de S. João EPE, Porto, Portugal.'}, {'lastname': 'Freixo', 'firstname': 'João Parente', 'initials': 'JP', 'affiliation': 'Center for Predictive and Preventive Genetics, Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal;; Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.'}, {'lastname': 'Martinho', 'firstname': 'António', 'initials': 'A', 'affiliation': 'Centro do Sangue e Transplantação de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.'}], 'methods': None, 'conclusions': 'We described the first Portuguese series of patients with HAE-nC1-INH genetically characterized. Differences with others may contribute to improve current unmet needs and raise awareness of this rare disease. We highlight the identification of 3 new variants(additional molecular studies are ongoing) and the first report of erythema marginatum in HAE-n-C1INH.', 'results': 'Forty-one patients were identified, four with no family history. The FXII-mutation Thr328Lys (38 carriers) was the most prevalent. Three new potentially disease causing variants linked to HAE-nC1-INH were identified (c.529+4A&gt;G:FXII; Cys248*:Kininogen-1; Arg261His:Plasminogen). The HAE-FXII cohort included 82% females and 71.8% symptomatic patients. Penetrance rate was significantly higher in females (81.3% vs 28.6; p=0.012). A hormonal influence was observed in 96.2% of the symptomatic females, although 62.5% remained symptomatic after oral estrogens withdrawal. Trauma and dental procedures were frequent triggers (82.6% and 45.5%, respectively). Main locations were facial (described by 96%), lips (82.1%) and eyelids (64.3%). One patient reported erythema marginatum as prodrome. Plasma derived C1-INH was effective as short-term prophylaxis in all treated patients, but only in 80% as on demand treatment. Icatibant was effectively used on demand in 9 patients, but with relapses in five (57%).', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.anai.2024.01.027', 'xml': <Element 'PubmedArticle' at 0x109bb19e0>}\n",
      "{'pubmed_id': '38341589\\n31905013\\n31273040\\n34126986\\n32020334\\n33673725\\n23143199\\n15021058\\n29520864\\n15328669\\n26449970\\n32553777\\n21428898\\n28179442\\n30002985\\n32388106\\n34727921\\n33602227\\n34404901\\n34495251\\n34276768\\n32974809\\n33979488\\n25822800\\n35619697\\n30453885\\n33195475\\n34107850\\n34668278\\n8980952\\n9476888\\n33569770\\n22257669\\n30664679\\n32543891\\n33060576\\n32554924\\n32849556\\n14976261\\n25428647\\n33079387\\n32699192\\n31354711\\n23078048\\n31856838\\n32717253\\n33303556\\n18682521\\n30373864\\n33577041\\n36717665\\n37780385\\n24447081', 'title': 'Decreased TLR7 expression was associated with airway eosinophilic inflammation and lung function in asthma: evidence from machine learning approaches and experimental validation.', 'abstract': 'Asthma is a global public health concern. The underlying pathogenetic mechanisms of asthma were poorly understood. This study aims to explore potential biomarkers associated with asthma and analyze the pathological role of immune cell infiltration in the disease.\\nThe gene expression profiles of induced sputum were obtained from Gene Expression Omnibus datasets (GSE76262 and GSE137268) and were combined for analysis. Toll-like receptor 7 (TLR7) was identified as the core gene by the intersection of two different machine learning algorithms, namely, least absolute shrinkage and selector operation (LASSO) regression and support vector machine-recursive feature elimination (SVM-RFE), and the top 10 core networks based on Cytohubba. CIBERSORT algorithm was used to analyze the difference of immune cell infiltration between asthma and healthy control groups. Finally, the expression level of TLR7 was validated in induced sputum samples of patients with asthma.\\nA total of 320 differential expression genes between the asthma and healthy control groups were screened, including 184 upregulated genes and 136 downregulated genes. TLR7 was identified as the core gene after combining the results of LASSO regression, SVM-RFE algorithm, and top 10 hub genes. Significant differences were observed in the distribution of 13 out of 22 infiltrating immune cells in asthma. TLR7 was found to be closely related to the level of several infiltrating immune cells. TLR7 mRNA levels were downregulated in asthmatic patients compared with healthy controls (p\\u2009=\\u20090.0049). The area under the curve of TLR7 for the diagnosis of asthma was 0.7674 (95% CI 0.631-0.904, p\\u2009=\\u20090.006). Moreover, TLR7 mRNA levels were negatively correlated with exhaled nitric oxide fraction (r\\u2009=\\u2009-\\xa00.3268, p\\u2009=\\u20090.0347) and the percentage of peripheral blood eosinophils (%) (r\\u2009=\\u2009-\\xa00.3472, p\\u2009=\\u20090.041), and positively correlated with forced expiratory volume in the first second (FEV1) (% predicted) (r\\u2009=\\u20090.3960, p\\u2009=\\u20090.0071) and FEV\\nDecreased TLR7 in the induced sputum of eosinophilic asthmatic patients was involved in immune cell infiltration and airway inflammation, which may serve as a new biomarker for the diagnosis of eosinophilic asthma.', 'keywords': ['Asthma', 'Immune cell infiltration', 'Induced sputum', 'Machine learning', 'TLR7'], 'journal': 'European journal of medical research', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Yan', 'firstname': 'Kemin', 'initials': 'K', 'affiliation': 'Department of Geriatrics, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.'}, {'lastname': 'Liang', 'firstname': 'Yuxia', 'initials': 'Y', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. liangyx69@mail.sysu.edu.cn.\\nDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China. liangyx69@mail.sysu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 320 differential expression genes between the asthma and healthy control groups were screened, including 184 upregulated genes and 136 downregulated genes. TLR7 was identified as the core gene after combining the results of LASSO regression, SVM-RFE algorithm, and top 10 hub genes. Significant differences were observed in the distribution of 13 out of 22 infiltrating immune cells in asthma. TLR7 was found to be closely related to the level of several infiltrating immune cells. TLR7 mRNA levels were downregulated in asthmatic patients compared with healthy controls (p\\u2009=\\u20090.0049). The area under the curve of TLR7 for the diagnosis of asthma was 0.7674 (95% CI 0.631-0.904, p\\u2009=\\u20090.006). Moreover, TLR7 mRNA levels were negatively correlated with exhaled nitric oxide fraction (r\\u2009=\\u2009-\\xa00.3268, p\\u2009=\\u20090.0347) and the percentage of peripheral blood eosinophils (%) (r\\u2009=\\u2009-\\xa00.3472, p\\u2009=\\u20090.041), and positively correlated with forced expiratory volume in the first second (FEV1) (% predicted) (r\\u2009=\\u20090.3960, p\\u2009=\\u20090.0071) and FEV', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s40001-023-01622-5\\n10.1164/rccm.201910-1934CI\\n10.1183/13993003.00598-2019\\n10.1186/s12931-021-01757-1\\n10.1007/s00281-020-00785-1\\n10.3390/ijms22052412\\n10.1097/MCP.0b013e32835b118e\\n10.1097/00130832-200404000-00002\\n10.1111/cea.13129\\n10.1016/S1081-1206(10)61462-7\\n10.1111/cea.12654\\n10.1016/j.anai.2020.06.017\\n10.2174/092986711795328337\\n10.1183/13993003.02135-2016\\n10.7717/peerj.5180\\n10.1016/j.molimm.2020.01.015\\n10.1186/s12890-021-01711-3\\n10.1186/s12920-021-00892-4\\n10.1038/s41598-021-96373-w\\n10.1590/1414-431x2021e11372\\n10.3389/fgene.2021.658323\\n10.1007/s10620-020-06611-w\\n10.1056/NEJMoa2034975\\n10.1038/nmeth.3337\\n10.3389/fimmu.2022.897835\\n10.1186/s12859-018-2451-4\\n10.3389/fcvm.2020.586871\\n10.1080/21655979.2021.1933743\\n10.1111/resp.14174\\n10.1183/09031936.96.09122448\\n10.1164/ajrccm.157.2.9705095\\n10.1111/all.14768\\n10.1093/bioinformatics/bts034\\n10.1038/s41596-018-0103-9\\n10.1089/dna.2020.5543\\n10.1038/s41467-020-19025-z\\n10.1172/jci.insight.136047\\n10.3389/fimmu.2020.01632\\n10.1126/science.1093616\\n10.2217/imt.14.75\\n10.1002/eji.202048690\\n10.1172/jci.insight.136965\\n10.3389/fimmu.2019.01546\\n10.2174/187152812803589967\\n10.1186/s12931-019-1252-2\\n10.1016/j.jaci.2020.07.012\\n10.1183/13993003.01562-2020\\n10.1136/thx.2007.094128\\n10.1038/s41563-022-01464-2\\n10.7717/peerj.15976\\n10.1111/cea.12176', 'xml': <Element 'PubmedArticle' at 0x109bb1df0>}\n",
      "{'pubmed_id': '38341371', 'title': 'Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan.', 'abstract': 'Asthma and obstructive sleep apnea (OSA) are prevalent chronic respiratory disorders, which often coexist and interact with each other. Obesity is an important risk factor shared by them. The rate of obesity is lower in Japan versus Western countries. Hence, the co-existence of asthma and OSA has not been investigated in Japan.\\nNinety-seven outpatients with asthma were recruited. Patients wore a portable monitor for sleep study. Background data, pulmonary function, blood tests, and patient-reported outcomes including gastroesophageal reflux disease, sleepiness, sleep quality, asthma control, cough and respiratory symptoms, and health status, were assessed.\\nOf the patients, 19 (19.6\\xa0%), 40 (41.2\\xa0%), 24 (24.7\\xa0%), and 14 (14.4\\xa0%) were classified into non-, mild, moderate, and severe OSA groups. Non-OSA patients were younger than those in other groups (p\\xa0<\\xa00.05). The BMI of patients with moderate and severe OSA, was higher than that of non-OSA patients (p\\xa0<\\xa00.05). Pulmonary function, FeNO, serum IgE, and the number of peripheral eosinophils were not significantly different between groups. Nonetheless, compared with the other groups, treatment step was the highest, and the Asthma Control Test, Leicester Cough Questionnaire, COPD Assessment Test, and Asthma Health Questionnaire-33 yielded worst scores in the severe OSA group, and predicted the severe OSA after adjustment by BMI.\\nModerate and severe OSA are highly prevalent among patients with asthma in Japan. Pulmonary function did not differ between groups. However, patients with asthma and severe OSA were linked to more asthma treatment, worse asthma control, more symptoms and cough, and worse health status.', 'keywords': ['Asthma', 'Asthma control test', 'BMI', 'Leicester cough questionnaire', 'Obstructive sleep apnea'], 'journal': 'Allergology international : official journal of the Japanese Society of Allergology', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Ikegami-Tanaka', 'firstname': 'Hitomi', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Yasokawa', 'firstname': 'Naoya', 'initials': 'N', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Kurose', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Tajima', 'firstname': 'Shonosuke', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Abe', 'firstname': 'Masaaki', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Katoh', 'firstname': 'Shigeki', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Kobashi', 'firstname': 'Yoshihiro', 'initials': 'Y', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.'}, {'lastname': 'Oga', 'firstname': 'Toru', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan. Electronic address: ogato@med.kawasaki-m.ac.jp.'}], 'methods': None, 'conclusions': None, 'results': 'Of the patients, 19 (19.6\\xa0%), 40 (41.2\\xa0%), 24 (24.7\\xa0%), and 14 (14.4\\xa0%) were classified into non-, mild, moderate, and severe OSA groups. Non-OSA patients were younger than those in other groups (p\\xa0<\\xa00.05). The BMI of patients with moderate and severe OSA, was higher than that of non-OSA patients (p\\xa0<\\xa00.05). Pulmonary function, FeNO, serum IgE, and the number of peripheral eosinophils were not significantly different between groups. Nonetheless, compared with the other groups, treatment step was the highest, and the Asthma Control Test, Leicester Cough Questionnaire, COPD Assessment Test, and Asthma Health Questionnaire-33 yielded worst scores in the severe OSA group, and predicted the severe OSA after adjustment by BMI.', 'copyrights': 'Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.alit.2024.01.009', 'xml': <Element 'PubmedArticle' at 0x10b4c53a0>}\n",
      "{'pubmed_id': '38341269', 'title': 'Fungal thermotolerance revisited and why climate change is unlikely to be supercharging pathogenic fungi (yet).', 'abstract': 'Thermotolerance has been viewed as an uncommon characteristic among the fungi and one of the reasons that less than 1% of the described species operate as opportunistic pathogens of humans. Growth at 37°C is certainly a requirement for a fungus that invades the body core, but tens of thousands of nonpathogenic species are also able to grow at this temperature. Ergo, body temperature does not serve as a thermal barrier to the development of infections by many harmless fungi. The absence of other virulence factors must be more demanding. This observation raises questions about the hypothetical links between climate change and the increasing number of life-threatening human mycoses. Given the widespread distribution of fungal thermotolerance and the 1°C (2°F) increase in global temperature over the last 140 years it seems unlikely that the warming climate has driven the evolution of more virulent strains of fungi. More compelling explanations for the changes in the behavior of fungi as disease agents include their adaptation to the widening use of azole antifungals in hospitals and the wholesale application of millions of tons of the same class of heterocyclic chemicals in agriculture. On the other hand, climate change is having a significant effect on the spread of human mycoses by extending the geographical range of pathogenic fungi. A related increase in fungal asthma caused by spore inhalation is another likely consequence of planetary change.', 'keywords': ['Candida auris', 'Endothermy', 'Mycoses', 'Opportunistic infections', 'Triazoles', 'Virulence factors'], 'journal': 'Fungal biology', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Money', 'firstname': 'Nicholas P', 'initials': 'NP', 'affiliation': 'Western Program and Department of Biology, Miami University, Oxford, OH, 45056, USA. Electronic address: moneynp@miamioh.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Author. Published by Elsevier Ltd.. All rights reserved.', 'doi': '10.1016/j.funbio.2024.01.005', 'xml': <Element 'PubmedArticle' at 0x109c444a0>}\n",
      "{'pubmed_id': '38341182', 'title': 'Update on Asthma Biology.', 'abstract': 'This is an exciting time to be conducting asthma research. The recent development of targeted asthma biologics has validated the power of basic research to discover new molecules amenable to therapeutic intervention. Advances in high throughput sequencing are providing a wealth of \"-omic\" data about genetic and epigenetic underpinnings of asthma, as well as new cellular interacting networks and potential endotypes in asthma. Airway epithelial cells have emerged not only as key sensors of the outside environment, but also as central drivers of dysregulated mucosal immune responses in asthma. Emerging data suggest that the airway epithelium in asthma remembers prior encounters with environmental exposures, resulting in potentially long-lasting changes in structure and metabolism that render asthmatics susceptible to subsequent exposures. Here we summarize recent insights into asthma biology, focusing on studies using human cells or tissue published in the past two years. Studies are organized thematically into six content areas to draw connections and spur future research (Genetics and Epigenetics, Prenatal and Early Life Origins, Microbiome, Immune and Inflammatory Pathways, Asthma Endotypes and Biomarkers, and Lung Structural Alterations). We highlight recent studies on airway epithelial dysfunction and response to viral infections and conclude with a framework for considering how bidirectional interactions between alterations in airway structure and mucosal immunity can lead to sustained lung dysfunction in asthma.', 'keywords': ['Asthma', 'Epigenetics', 'Epithelial Cells', 'Genetics', 'Precision Medicine'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Georas', 'firstname': 'Steve N', 'initials': 'SN', 'affiliation': None}, {'lastname': 'Khurana', 'firstname': 'Sandhya', 'initials': 'S', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.01.024', 'xml': <Element 'PubmedArticle' at 0x109c47150>}\n",
      "{'pubmed_id': '38341139', 'title': 'The Relationship Between Allergic Rhinitis, Asthma and Cardiovascular Disease in the National Health Interview Surveys (NHIS), 1999-2018.', 'abstract': 'Atopic disease has been associated with immune dysregulation and chronic inflammation, but current practice guideline recommendations do not include the evaluation of inflammatory outcomes among patients with asthma and allergic rhinitis.\\nThis study investigates the relationship between asthma, allergic rhinitis and cardiovascular disease (CVD) using data from the US National Health Interview Survey (NHIS) between 1999-2018.\\nWe used data from adults in the NHIS (n = 603,140, representing a population of 225,483,286). Exposures were physician-diagnosed asthma (lifetime/past-year) and allergic rhinitis (past-year). Outcomes were physician-diagnosed heart disease: coronary heart disease (CHD), angina, heart-attack, and non-specific \"heart-condition\" (all lifetime). We used survey-weighted descriptive analysis and logistic regression adjusting for demographic and socioeconomic factors.\\n11.44% reported at least one heart condition, with CHD the most prevalent (4.27%) across 20 years of pooled data. Asthma and rhinitis were associated with higher CVD in all bivariate analyses. Specifically, lifetime asthma was associated with increased odds of CHD, OR=1.36 (1.29, 1.42), with stronger effects observed for a past-year asthma-attack, OR= 1.66 (1.55, 1.80). The strongest effect of all was observed in those with a past-year asthma attack having increased odds of angina, OR=2.42 (2.24, 2.63). Allergic rhinitis was independently associated with increased odds of CHD (OR=1.25, 1.18-1.28).\\nAsthma and allergic rhinitis are risk factors for all types of CVD in this nationally representative study covering a two-decade period in the US. Clinicians should consider screening patients with severe and/or uncontrolled asthma and allergic rhinitis early for CVD, particularly angina and CHD. Future studies are warranted to explore the immunological milieu in these patients and identify therapeutic targets.', 'keywords': ['allergic rhinitis', 'angina pectoris', 'asthma', 'cardiovascular disease', 'coronary heart disease', 'epidemiology', 'risk factors', 'screening', 'severe asthma', 'uncontrolled asthma'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Nagarajan', 'firstname': 'Sairaman', 'initials': 'S', 'affiliation': 'Center for Allergy and Asthma Research, SUNY Downstate Health Sciences University, Brooklyn, NY; Department of Country Readiness Strengthening, World Health Emergencies Programme, World Health Organization, Geneva, Switzerland. Electronic address: sairamnagarajan@gmail.com.'}, {'lastname': 'Rosenbaum', 'firstname': 'Janet', 'initials': 'J', 'affiliation': 'Center for Allergy and Asthma Research, SUNY Downstate Health Sciences University, Brooklyn, NY; Department of Epidemiology and Biostatistics, School of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY.'}, {'lastname': 'Joks', 'firstname': 'Rauno', 'initials': 'R', 'affiliation': 'Center for Allergy and Asthma Research, SUNY Downstate Health Sciences University, Brooklyn, NY; Division of Allergy and Immunology, SUNY Downstate Health Sciences University, Brooklyn, NY.'}], 'methods': None, 'conclusions': None, 'results': '11.44% reported at least one heart condition, with CHD the most prevalent (4.27%) across 20 years of pooled data. Asthma and rhinitis were associated with higher CVD in all bivariate analyses. Specifically, lifetime asthma was associated with increased odds of CHD, OR=1.36 (1.29, 1.42), with stronger effects observed for a past-year asthma-attack, OR= 1.66 (1.55, 1.80). The strongest effect of all was observed in those with a past-year asthma attack having increased odds of angina, OR=2.42 (2.24, 2.63). Allergic rhinitis was independently associated with increased odds of CHD (OR=1.25, 1.18-1.28).', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.02.001', 'xml': <Element 'PubmedArticle' at 0x10a772610>}\n",
      "{'pubmed_id': '38341029', 'title': 'Intrinsic risk factors for alpha-gal syndrome in a case-control study, 2019-2020.', 'abstract': 'Alpha-gal syndrome (AGS) is an allergy to galactose-α-1,3-galactose (alpha-gal), a carbohydrate found in most mammals. Evidence indicates that AGS develops following a tick bite, and in the United States, AGS is most associated with bites from Amblyomma americanum (lone star tick); however, not all persons bitten by ticks develop clinical AGS.\\nThis study investigated intrinsic risk factors associated with the development of AGS.\\nWe performed a case-control study among adults presenting for diagnosis or management of AGS at an allergy clinic in North Carolina during 2019-2020 and compared them to controls enrolled from two nearby internal medicine clinics. A questionnaire gathered epidemiologic and tick exposure data and blood was obtained for alpha-gal specific IgE (sIgE) and other testing.\\nThe 82 enrolled case patients and 191 controls did not differ significantly by age or sex. Case patients were more likely than controls to have A or O blood types (non-B-antigen), have experienced childhood allergies, and have a family history of AGS and other food allergies. Case patients were also more likely to report experiencing long healing times for insect bites or stings and a family history of allergy to stinging or biting insects.\\nThis study suggests that intrinsic factors contribute to risk of developing AGS. Some traits are genetic, but common behaviors among households and family units likely also contribute. Identification of these risk factors can inform personal risk, aid healthcare providers in understanding susceptible populations, and contribute to ongoing understanding of AGS epidemiology.', 'keywords': ['alpha-gal syndrome', 'family history', 'intrinsic factor', 'red meat allergy', 'risk factor'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Taylor', 'firstname': 'Marissa L', 'initials': 'ML', 'affiliation': 'Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329. Electronic address: MTaylor20@cdc.gov.'}, {'lastname': 'Kersh', 'firstname': 'Gilbert J', 'initials': 'GJ', 'affiliation': 'Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.'}, {'lastname': 'Salzer', 'firstname': 'Johanna S', 'initials': 'JS', 'affiliation': 'Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.'}, {'lastname': 'Jones', 'firstname': 'Emma S', 'initials': 'ES', 'affiliation': 'Office of the Director, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521.'}, {'lastname': 'Binder', 'firstname': 'Alison M', 'initials': 'AM', 'affiliation': 'Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.'}, {'lastname': 'Armstrong', 'firstname': 'Paige A', 'initials': 'PA', 'affiliation': 'Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.'}, {'lastname': 'Choudhary', 'firstname': 'Shailesh K', 'initials': 'SK', 'affiliation': 'Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514.'}, {'lastname': 'Commins', 'firstname': 'Grace K', 'initials': 'GK', 'affiliation': 'Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514.'}, {'lastname': 'Amelio', 'firstname': 'Claire L', 'initials': 'CL', 'affiliation': 'Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514.'}, {'lastname': 'Biggerstaff', 'firstname': 'Brad J', 'initials': 'BJ', 'affiliation': 'Office of the Director, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521.'}, {'lastname': 'Beard', 'firstname': 'Charles B', 'initials': 'CB', 'affiliation': 'Office of the Director, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521.'}, {'lastname': 'Petersen', 'firstname': 'Lyle R', 'initials': 'LR', 'affiliation': 'Office of the Director, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521.'}, {'lastname': 'Commins', 'firstname': 'Scott P', 'initials': 'SP', 'affiliation': 'Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514.'}], 'methods': None, 'conclusions': 'This study suggests that intrinsic factors contribute to risk of developing AGS. Some traits are genetic, but common behaviors among households and family units likely also contribute. Identification of these risk factors can inform personal risk, aid healthcare providers in understanding susceptible populations, and contribute to ongoing understanding of AGS epidemiology.', 'results': 'The 82 enrolled case patients and 191 controls did not differ significantly by age or sex. Case patients were more likely than controls to have A or O blood types (non-B-antigen), have experienced childhood allergies, and have a family history of AGS and other food allergies. Case patients were also more likely to report experiencing long healing times for insect bites or stings and a family history of allergy to stinging or biting insects.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.anai.2024.01.029', 'xml': <Element 'PubmedArticle' at 0x109fe4540>}\n",
      "{'pubmed_id': '38340558\\n23742874\\n24940476\\n2513902\\n17594176\\n18028995\\n22153774\\n33139948\\n32265597\\n19523724\\n9678808\\n3572204\\n33384449\\n33377265\\n19109654\\n9187617\\n6768637\\n7429343\\n30915065\\n31931652\\n19228118\\n33850311\\n30683619\\n29910798\\n27259147\\n34839288\\n19173682\\n35212041\\n3678950\\n27510655\\n32234527\\n26096558\\n31050748\\n26655810\\n32903327\\n33043467\\n27819051\\n31402327\\n29954939\\n976251\\n31467327\\n25479871\\n23517038\\n29434314\\n30344169\\n34979877\\n33260602\\n31336625\\n2699772\\n36984862\\n29549961\\n9240924\\n29357130\\n31123355\\n26522146\\n25236865\\n21775706\\n15685169\\n15998908\\n27080715\\n23821742\\n29184078\\n35745253\\n15998509\\n31292453\\n33281616\\n37526398\\n33727392\\n30390309', 'title': \"Short-chain fatty acids (SCFA) in infants' plasma and corresponding mother's milk and plasma in relation to subsequent sensitisation and atopic disease.\", 'abstract': \"Short-chain fatty acids (SCFAs) in intestinal contents may influence immune function, while less is known about SCFAs in blood plasma. The aims were to investigate the relation between infants' and maternal plasma SCFAs, as well as SCFAs in mother's milk, and relate SCFA concentrations in infant plasma to subsequent sensitisation and atopic disease.\\nInfant plasma (N\\xa0=\\xa0148) and corresponding mother's milk and plasma were collected four months postpartum. Nine SCFA (formic, acetic, propionic, isobutyric, butyric, succinic, valeric, isovaleric, and caproic acid) were analysed by UPLC-MS. At 12 months of age, atopic disease was diagnosed by a pediatric allergologist, and sensitisation was measured by skin prick test. All families participated in the Swedish birth cohort NICE (Nutritional impact on Immunological maturation during Childhood in relation to the Environment).\\nInfants with sensitisation, atopic eczema, or food allergy had significantly lower concentrations of five, three, and two SCFAs, respectively, in plasma at four months. Logistic regressions models showed significant negative associations between formic, succinic, and caproic acid and sensitisation [OR\\nButyric and caproic acid might be actively transported into breast milk to meet the needs of the infant, although mechanistic studies are needed to confirm this. The negative associations between certain SCFAs on sensitisation and atopic disease adds to prior evidence regarding their immunoregulatory potential.\\nSwedish Research Council (Nr. 2013-3145 and 2019-0137 to A-S.S.), Swedish Research Council for Health, Working Life and Welfare FORTE, Nr 2018-00485 to A.W.), The Swedish Asthma and Allergy Association's Research Fund (2020-0020 to A.S.).\", 'keywords': ['Atopic eczema', 'Breast milk', 'Food allergy', 'Infant/maternal plasma', 'Sensitisation', 'Short-chain fatty acids'], 'journal': 'EBioMedicine', 'publication_date': datetime.date(2024, 2, 11), 'authors': [{'lastname': 'Barman', 'firstname': 'Malin', 'initials': 'M', 'affiliation': 'Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, Gothenburg 412 96, Sweden. Electronic address: malin.barman@chalmers.se.'}, {'lastname': 'Gio-Batta', 'firstname': 'Monica', 'initials': 'M', 'affiliation': 'Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.'}, {'lastname': 'Andrieux', 'firstname': 'Léna', 'initials': 'L', 'affiliation': 'Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, Gothenburg 412 96, Sweden; Département de Biologie, École Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, 69342 Lyon Cedex 07, France.'}, {'lastname': 'Stråvik', 'firstname': 'Mia', 'initials': 'M', 'affiliation': 'Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, Gothenburg 412 96, Sweden.'}, {'lastname': 'Saalman', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Institute of Clinical Sciences, Department of Pediatrics, University of Gothenburg, Gothenburg 405 30, Sweden.'}, {'lastname': 'Fristedt', 'firstname': 'Rikard', 'initials': 'R', 'affiliation': 'Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, Gothenburg 412 96, Sweden.'}, {'lastname': 'Rabe', 'firstname': 'Hardis', 'initials': 'H', 'affiliation': 'Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.'}, {'lastname': 'Sandin', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Department of Clinical Science, Pediatrics, Sunderby Research Unit, Umeå University, Umeå 901 87, Sweden.'}, {'lastname': 'Wold', 'firstname': 'Agnes E', 'initials': 'AE', 'affiliation': 'Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30, Sweden.'}, {'lastname': 'Sandberg', 'firstname': 'Ann-Sofie', 'initials': 'AS', 'affiliation': 'Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, Gothenburg 412 96, Sweden.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.ebiom.2024.104999\\n10.1101/2020.07.20.212597', 'xml': <Element 'PubmedArticle' at 0x109fe6e80>}\n",
      "{'pubmed_id': '38340268\\n12793616\\n33035324\\n29216931\\n25029349\\n34788631\\n35677830\\n31350466\\n36903624\\n33178206\\n31949051\\n16150617\\n25917101\\n28346412\\n27248771\\n31579973\\n22425247\\n31826980\\n29444897\\n33450048\\n32039054\\n31645726\\n36561741\\n29496661\\n31046541\\n34819741\\n24691994\\n33153718\\n36454192\\n28546901\\n28479600\\n33498318\\n23096265\\n21167569\\n33065121\\n35634346\\n29267882\\n20963782\\n19706447\\n28931757\\n24860823\\n31940493\\n29066321\\n22378047\\n29417945\\n29549178\\n36037386\\n31703000\\n25267631\\n30220083\\n33841409\\n31340983\\n30674196\\n37804401\\n33495077', 'title': 'Repositioning baloxavir marboxil as VISTA agonist that ameliorates experimental asthma.', 'abstract': 'V-type immunoglobulin domain-containing suppressor of T-cell activation (VISTA), a novel negative checkpoint regulator, plays an essential role in allergic pulmonary inflammation in mice. Treatment with a VISTA agonistic antibody could significantly improve asthma symptoms. Thus, for allergic asthma treatment, VISTA targeting may be a compelling approach. In this study, we examined the functional mechanism of VISTA in allergic pulmonary inflammation and screened the FDA-approved drugs for VISTA agonists. By using mass cytometry (CyTOF), we found that VISTA deficiency primarily increased lung macrophage infiltration in the OVA-induced asthma model, accompanied by an increased proportion of M1 macrophages (CD11b', 'keywords': ['Asthma', 'Baloxavir marboxil', 'Macrophage polarization', 'VISTA'], 'journal': 'Cell biology and toxicology', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Di', 'firstname': 'Jian-Wen', 'initials': 'JW', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Wang', 'firstname': 'Yi-Xin', 'initials': 'YX', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Ma', 'firstname': 'Rui-Xue', 'initials': 'RX', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Luo', 'firstname': 'Zhi-Jie', 'initials': 'ZJ', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Chen', 'firstname': 'Wen-Ting', 'initials': 'WT', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Liu', 'firstname': 'Wan-Mei', 'initials': 'WM', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Yuan', 'firstname': 'Ding-Yi', 'initials': 'DY', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Zhang', 'firstname': 'Yu-Ying', 'initials': 'YY', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Wu', 'firstname': 'Yin-Hao', 'initials': 'YH', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.'}, {'lastname': 'Chen', 'firstname': 'Cai-Ping', 'initials': 'CP', 'affiliation': 'State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China. caiping.chen@cpu.edu.cn.\\nChongqing Innovation Institute of China Pharmaceutical University, Chongqing, 401135, China. caiping.chen@cpu.edu.cn.'}, {'lastname': 'Liu', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China. junliu@cpu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s10565-024-09852-x\\n10.1016/S0733-8627(03)00015-4\\n10.1093/jac/dkaa393\\n10.1165/rcmb.2014-0068OC\\n10.1016/j.celrep.2021.110026\\n10.3389/fmed.2022.884679\\n10.1038/s41385-019-0187-8\\n10.3389/fimmu.2020.580187\\n10.1016/j.cellbi.2005.07.002\\n10.4049/jimmunol.1402648\\n10.1038/nm.4308\\n10.1165/rcmb.2015-0295OC\\n10.1111/cea.13505\\n10.1016/j.immuni.2011.12.020\\n10.1111/bph.15357\\n10.3389/fcimb.2019.00479\\n10.1038/s41586-019-1674-5\\n10.3389/fimmu.2022.983852\\n10.1161/ATVBAHA.118.310703\\n10.1177/0897190019840597\\n10.2147/JIR.S319754\\n10.1158/0008-5472.CAN-13-1506\\n10.1016/j.bbrc.2020.10.062\\n10.1021/acs.jmedchem.2c01444\\n10.1007/s40472-016-0130-9\\n10.1038/cmi.2017.16\\n10.1002/path.4133\\n10.1016/j.jaci.2010.10.045\\n10.1016/j.jaci.2020.10.005\\n10.3389/fimmu.2022.837097\\n10.1093/intimm/dxx070\\n10.1002/ppul.21321\\n10.1073/pnas.0809784106\\n10.1155/2014/560629\\n10.1016/j.celrep.2019.12.036\\n10.1016/j.trsl.2017.09.002\\n10.1172/JCI59643\\n10.1038/aps.2017.147\\n10.4049/jimmunol.1701474\\n10.1073/pnas.2206104119\\n10.1097/MCP.0000000000000647\\n10.1073/pnas.1407447111\\n10.1111/imm.13001\\n10.3389/fimmu.2021.625808\\n10.1158/2326-6066.CIR-18-0489\\n10.1177/1060028019826565\\n10.1016/j.it.2020.12.008', 'xml': <Element 'PubmedArticle' at 0x10a9b4590>}\n",
      "{'pubmed_id': '38339981', 'title': 'A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report.', 'abstract': 'Preschool children with wheezing disorders pose diagnostic and therapeutic challenges and consume substantial healthcare resources. Peripheral eosinophil blood count (EBC) has been proposed as a potential indicator for future asthma development. This review by the European Academy of Allergy and Clinical Immunology (EAACI) Preschool Wheeze Task Force aimed to provide systematic evidence for the association between increased EBC and the risk of future asthma, as well as to identify potential cutoff values. In February 2023, a search of PubMed, EMBASE, and Cochrane Library databases was conducted to identify studies comparing EBCs in preschool children with wheezing who continued to wheeze later in life and those who did not. Included observational studies focused on children aged <6\\u2009years with a wheezing disorder, assessment of their EBCs, and subsequent asthma status. No language or publication date restrictions were applied. Among the initial 3394 studies screened, 10 were included in the final analysis, involving 1225 patients. The data from these studies demonstrated that high EBC in preschool children with wheezing is associated with future asthma development, with odds ratios of 1.90 (95% CI: 0.45-7.98, p\\u2009=\\u2009.38), 2.87 (95% CI: 1.38-5.95, p\\u2009<\\u2009.05), and 3.38 (95% CI: 1.72-6.64, p\\u2009<\\u2009.05) for cutoff values in the <300, 300-449, and ≥450\\u2009cells/μL ranges, respectively. Defining a specific cutoff point for an elevated EBC lacks consistency, but children with EBC >300\\u2009cells/μL are at increased risk of asthma. However, further research is needed due to the limitations of the included studies. Future investigations are necessary to fully elucidate the discussed association.', 'keywords': ['asthma', 'eosinophil', 'eosinophil blood count', 'preschool', 'wheezing'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Adamiec', 'firstname': 'Aleksander', 'initials': 'A', 'affiliation': \"Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\\nDoctoral School, Medical University of Warsaw, Warsaw, Poland.\"}, {'lastname': 'Cieślik', 'firstname': 'Maja', 'initials': 'M', 'affiliation': \"Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\"}, {'lastname': 'Mączka', 'firstname': 'Katarzyna', 'initials': 'K', 'affiliation': \"Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\\nDoctoral School, Medical University of Warsaw, Warsaw, Poland.\"}, {'lastname': 'Tarnoruda', 'firstname': 'Joanna', 'initials': 'J', 'affiliation': \"Department of Paediatrics, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\"}, {'lastname': 'Jensen', 'firstname': 'Signe', 'initials': 'S', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Chawes', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Bønnelykke', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Konradsen', 'firstname': 'Jon R', 'initials': 'JR', 'affiliation': \"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.\\nAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.\"}, {'lastname': 'Söderhäll', 'firstname': 'Cilla', 'initials': 'C', 'affiliation': \"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.\\nAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.\"}, {'lastname': 'Makrinioti', 'firstname': 'Heidi', 'initials': 'H', 'affiliation': 'Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.'}, {'lastname': 'Camargo', 'firstname': 'Carlos A', 'initials': 'CA', 'affiliation': 'Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.'}, {'lastname': 'Hasegawa', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA.'}, {'lastname': 'Ambrożej', 'firstname': 'Dominika', 'initials': 'D', 'affiliation': \"Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\\nDoctoral School, Medical University of Warsaw, Warsaw, Poland.\"}, {'lastname': 'Jartti', 'firstname': 'Tuomas', 'initials': 'T', 'affiliation': 'Department of Paediatrics, Turku University Hospital and Turku University, Turku, Finland.\\nPEDEGO Research Unit, Medical Research Centre, University of Oulu, Turku, Finland.\\nDepartment of Pediatrics, Oulu University Hospital, Turku, Finland.'}, {'lastname': 'Ruszczyński', 'firstname': 'Marek', 'initials': 'M', 'affiliation': \"Department of Paediatrics, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\"}, {'lastname': 'Feleszko', 'firstname': 'Wojciech', 'initials': 'W', 'affiliation': \"Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw Children's Hospital, Warsaw, Poland.\"}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14078', 'xml': <Element 'PubmedArticle' at 0x10a2ff060>}\n",
      "{'pubmed_id': '38339852', 'title': 'fMRI BOLD responses to film stimuli and their association with exhaled nitric oxide in asthma and health.', 'abstract': 'Little is known about central nervous system (CNS) responses to emotional stimuli in asthma. Nitric oxide in exhaled breath (FE', 'keywords': ['affect', 'asthma', 'exhaled nitric oxide', 'fMRI', 'partial pressure of carbon dioxide'], 'journal': 'Psychophysiology', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Ritz', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Department of Psychology, Southern Methodist University, Dallas, Texas, USA.'}, {'lastname': 'Kroll', 'firstname': 'Juliet L', 'initials': 'JL', 'affiliation': 'Department of Psychology, Southern Methodist University, Dallas, Texas, USA.\\nDepartment of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.'}, {'lastname': 'Khan', 'firstname': 'David A', 'initials': 'DA', 'affiliation': 'Department of Internal Medicine, Division of Allergy and Immunology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.'}, {'lastname': 'Yezhuvath', 'firstname': 'Uma S', 'initials': 'US', 'affiliation': 'Advance MRI LLC, Frisco, Texas, USA.'}, {'lastname': 'Aslan', 'firstname': 'Sina', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, Division of Allergy and Immunology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.\\nAdvance MRI LLC, Frisco, Texas, USA.\\nDepartment of Psychology, University of Texas at Dallas, Dallas, Texas, USA.'}, {'lastname': 'Pinkham', 'firstname': 'Amy', 'initials': 'A', 'affiliation': 'Department of Psychology, University of Texas at Dallas, Dallas, Texas, USA.'}, {'lastname': 'Rosenfield', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Psychology, Southern Methodist University, Dallas, Texas, USA.'}, {'lastname': 'Brown', 'firstname': 'E Sherwood', 'initials': 'ES', 'affiliation': 'Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Society for Psychophysiological Research.', 'doi': '10.1111/psyp.14513', 'xml': <Element 'PubmedArticle' at 0x147d16e80>}\n",
      "{'pubmed_id': '38339221\\n31275909\\n36968625\\n26610152\\n32526187\\n28667070\\n25374465\\n24383670\\n28078341\\n19769843\\n15208377\\n14982513\\n26985430\\n31719947\\n34815552\\n30395756\\n27726947\\n20075384\\n23022743\\n29236049\\n26634624\\n36009422\\n10984446\\n22112999\\n21682736\\n35889804\\n21872797\\n29384117\\n25195132\\n36880035\\n36360253\\n35048212\\n23200756\\n19622139\\n21810276\\n28590769\\n31670295\\n29456680\\n31541492\\n15282200\\n21613960\\n26011658\\n31508258\\n26346690\\n25353337\\n25845986\\n30721133\\n27551963\\n26019776\\n32390767\\n18818159\\n29030989\\n33961971\\n22935474\\n31373606\\n15334310\\n31783898\\n30001206\\n8804440\\n20059575\\n28830802\\n12139434\\n15860560\\n12824337\\n9787640\\n15306459', 'title': 'Genetic Diversity in Bronchial Asthma Susceptibility: Exploring the Role of Vitamin D Receptor Gene Polymorphisms in Varied Geographic Contexts.', 'abstract': 'Bronchial asthma (BA) exhibits varying prevalence across global populations, prompting a comprehensive investigation into genetic and environmental determinants. Vitamin D is a potent immunomodulator capable of suppressing inflammatory signals in several cell types involved in the asthmatic response; it exerts effects on the immune system by binding to the nuclear vitamin D receptor (VDR). VDR gene genetic variations are affecting serum vitamin D levels with a possible role in the BA risk. The current study aimed to examine the complex interaction of various factors (genetic background, serum vitamin D levels, and geographic location) to identify differences in the influence of these factors on the susceptibility to asthma between populations at different latitudes. Focusing on Eastern European cohorts from Latvia and Lithuania and comparing them with published data on East Asian populations, we explore the impact of VDR gene polymorphisms on BA susceptibility. Genotyping four key ', 'keywords': ['25(OH)D level', 'ApaI', 'Bmsl', 'FokI', 'TaqI', 'bronchial asthma', 'polymorphisms', 'vitamin D', 'vitamin D receptor'], 'journal': 'International journal of molecular sciences', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Paramonova', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Laboratory of Genomics and Bioinformatics, Institute of Biology, University of Latvia, LV-1004 Riga, Latvia.'}, {'lastname': 'Trapina', 'firstname': 'Ilva', 'initials': 'I', 'affiliation': 'Laboratory of Genomics and Bioinformatics, Institute of Biology, University of Latvia, LV-1004 Riga, Latvia.'}, {'lastname': 'Gradauskiene Sitkauskiene', 'firstname': 'Brigita', 'initials': 'B', 'affiliation': 'Department of Immunology and Allergology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.'}, {'lastname': 'Plavina', 'firstname': 'Samanta', 'initials': 'S', 'affiliation': 'Laboratory of Genomics and Bioinformatics, Institute of Biology, University of Latvia, LV-1004 Riga, Latvia.'}, {'lastname': 'Tamasauskiene', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Department of Immunology and Allergology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.'}, {'lastname': 'Bastyte', 'firstname': 'Daina', 'initials': 'D', 'affiliation': 'Department of Immunology and Allergology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.'}, {'lastname': 'Rumba-Rozenfelde', 'firstname': 'Ingrida', 'initials': 'I', 'affiliation': 'Faculty of Medicine, University of Latvia, LV-1586 Riga, Latvia.'}, {'lastname': 'Tapina', 'firstname': 'Sandra', 'initials': 'S', 'affiliation': 'Faculty of Medicine, University of Latvia, LV-1586 Riga, Latvia.'}, {'lastname': 'Stakaitiene', 'firstname': 'Ieva', 'initials': 'I', 'affiliation': 'Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.'}, {'lastname': 'Ugenskiene', 'firstname': 'Rasa', 'initials': 'R', 'affiliation': 'Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.'}, {'lastname': 'Shih-Hsin Wu', 'firstname': 'Lawrence', 'initials': 'L', 'affiliation': 'Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406040, Taiwan.\\nResearch Center of Allergy, Immunology, and Microbiome (AIM), China Medical University Hospital, Taichung 404327, Taiwan.'}, {'lastname': 'Wang', 'firstname': 'Jiu-Yao', 'initials': 'JY', 'affiliation': \"Research Center of Allergy, Immunology, and Microbiome (AIM), China Medical University Hospital, Taichung 404327, Taiwan.\\nDepartment of Allergy and Immunology, China Medical University Children's Hospital, Taichung 404327, Taiwan.\"}, {'lastname': 'Hsieh', 'firstname': 'Miao-Hsi', 'initials': 'MH', 'affiliation': 'Research Center of Allergy, Immunology, and Microbiome (AIM), China Medical University Hospital, Taichung 404327, Taiwan.'}, {'lastname': 'Chen', 'firstname': 'Pei-Chi', 'initials': 'PC', 'affiliation': 'Research Center of Allergy, Immunology, and Microbiome (AIM), China Medical University Hospital, Taichung 404327, Taiwan.'}, {'lastname': 'Sjakste', 'firstname': 'Nikolajs', 'initials': 'N', 'affiliation': 'Laboratory of Genomics and Bioinformatics, Institute of Biology, University of Latvia, LV-1004 Riga, Latvia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ijms25031943\\n10.3389/fped.2019.00246\\n10.1016/j.waojou.2023.100757\\n10.1586/17476348.2016.1114417\\n10.1016/S2213-2600(20)30105-3\\n10.1042/CS20160253\\n10.4103/2230-8229.142967\\n10.1111/pai.12167\\n10.1039/c6pp00355a\\n10.1016/S0301-0546(09)71722-7\\n10.1136/oem.2002.006809\\n10.1046/j.1398-9995.2003.00391.x\\n10.4103/2279-042X.176542\\n10.1016/j.waojou.2019.100076\\n10.1038/s41574-021-00593-z\\n10.1080/02770903.2018.1536142\\n10.1016/j.jaci.2016.07.032\\n10.1164/rccm.200911-1710OC\\n10.1093/tropej/fms042\\n10.3390/nu9121353\\n10.1586/17476348.2016.1128326\\n10.3390/biomedicines10081877\\n10.1101/gr.143400\\n10.1097/MCP.0b013e32834dc532\\n10.1111/j.1600-065X.2011.01029.x\\n10.3390/nu14142847\\n10.1016/j.beem.2011.05.010\\n10.23822/EurAnnACI.1764-1489.46\\n10.1007/s13277-014-2554-0\\n10.2478/bjmg-2022-0003\\n10.3390/genes13112016\\n10.1007/s10067-022-06048-8\\n10.1016/j.humimm.2012.11.005\\n10.1186/1471-2350-10-71\\n10.1186/1471-2350-12-103\\n10.1089/dna.2017.3730\\n10.4103/lungindia.lungindia_23_19\\n10.3892/etm.2018.5739\\n10.1002/jcla.23039\\n10.1164/rccm.200404-447OC\\n10.2310/JIM.0b013e318220df41\\n10.1111/pai.12409\\n10.1016/j.ejcdt.2014.02.012\\n10.1089/ped.2018.0948\\n10.1186/s40248-015-0025-0\\n10.1089/omi.2014.0023\\n10.1111/pai.12392\\n10.1530/EJE-18-0736\\n10.1002/ppul.23548\\n10.1186/s12948-020-00122-9\\n10.1002/jcp.26216\\n10.1016/j.gene.2021.145691\\n10.1136/thoraxjnl-2012-202139\\n10.1093/bioinformatics/btz612\\n10.1186/s13059-019-1869-y\\n10.1186/s13059-018-1463-8\\n10.1016/0014-5793(96)00837-X\\n10.1007/0-387-29148-2\\n10.1111/j.1365-2567.2009.03222.x\\n10.1016/j.hemonc.2017.06.003\\n10.1093/bib/3.2.146\\n10.1093/bioinformatics/bti473\\n10.1093/nar/gkg595\\n10.3390/ijms161226074\\n10.1016/S0968-0004(98)01265-1\\n10.1098/rsta.2004.1390', 'xml': <Element 'PubmedArticle' at 0x10b74dd00>}\n",
      "{'pubmed_id': '38339210\\n37229504\\n33069326\\n32466381\\n37474226\\n28469539\\n36117114\\n33232694\\n31752894\\n19166889\\n16113413\\n7925190\\n14045224\\n9010813\\n23384790\\n19017866\\n24507843\\n26599578\\n12392031\\n14555458\\n36623820\\n21121836\\n1892325\\n19201713\\n19520914\\n28607090\\n28859985\\n11877463\\n26867175\\n25700381\\n32266843\\n17716382\\n26336032\\n29186064\\n29170036\\n30431340\\n29440393\\n30069044\\n32933106\\n31922198\\n35001665\\n38233410\\n34066250\\n8670177\\n11802783\\n27845589\\n34656442\\n18776153\\n15500651\\n19723147\\n3684381\\n14988081\\n24892808\\n30944166\\n31091375\\n25717100\\n30361244\\n24404129\\n29559310\\n35363522\\n25124441\\n29853489\\n15964901\\n17496063\\n4666047\\n629481\\n7576713\\n1617387\\n8836649\\n24032029\\n19580650\\n7254936\\n5533003\\n12467641\\n16581697\\n16267361\\n2764384\\n3904549\\n3933614\\n18515558\\n16113432\\n1555462\\n15140415\\n13850307\\n19077699\\n15858812\\n16113412\\n28951068\\n15746432\\n11053013\\n25706550\\n31242392\\n22763554\\n30523208\\n31715083\\n22951447\\n16371599\\n35046051\\n32730755\\n10330040\\n12169572\\n18931390\\n11919081\\n15273079\\n16127146\\n15972674\\n21143945\\n19841186\\n12624114\\n20935193\\n31524632\\n23538783\\n27115950\\n37003609\\n11133506\\n33144914\\n16510460\\n15219174\\n38130649\\n37520564\\n9620926\\n15860714\\n11133503\\n16980555\\n19689269\\n12475809\\n34364680\\n11748265\\n12091879\\n29676620\\n16415249\\n11893509\\n14749330\\n30850333\\n27551810\\n31455163\\n32029825\\n21427214\\n22923574\\n37946856\\n37457746\\n17141060\\n10843967\\n30352166\\n29559920\\n34624628\\n29273246\\n35486871\\n30420506\\n31788856\\n35286625\\n28833401\\n15518921\\n27812540\\n25943943\\n26857776\\n31164433\\n33095650\\n31362723\\n29132121\\n26526220\\n19423716\\n33431872\\n35843096\\n19135107\\n19936981\\n22451922\\n35696291\\n11566767\\n13679362\\n34728565\\n34831330\\n19176245\\n11069833\\n29643478\\n17827252\\n17419972\\n16456183\\n1555424\\n8476173\\n1546833\\n2339832\\n11681652\\n21405727\\n3502760\\n28117099\\n25909230\\n31254906\\n26808501\\n33806154\\n21338337\\n23434445\\n19482258\\n18675692\\n29599187\\n20427821\\n29321377\\n16421365\\n32695100\\n11901174\\n24665407\\n26341472\\n16963160\\n15949630\\n12600826\\n16236890\\n17215317\\n19542465\\n2299262\\n20047264\\n22981321\\n20653472\\n28298400\\n10588615\\n19912665\\n21349930\\n23024024\\n26568662\\n17652508\\n34772643\\n28714611\\n26957273\\n30362838\\n35628501\\n31915768\\n37408604\\n23907809\\n30953574\\n28117136\\n30803355\\n17234902\\n23845715\\n26051089\\n29778403\\n11254823\\n10933091\\n29925362\\n12969869\\n22904182\\n31626976\\n29937317\\n15843582\\n31932105\\n27014936\\n28874459\\n32622665\\n17243926\\n28679606\\n15635615\\n16685004\\n16166615\\n21949714\\n20299288\\n10101005\\n18565957\\n36274446\\n28222269\\n26677762\\n34172469\\n31604026\\n33600745\\n37130650\\n37414422\\n35712620\\n24358183\\n33255369\\n33649353\\n17504792\\n15463886\\n22878278\\n29970861\\n11240971\\n22711298\\n31234484\\n34349506\\n36017119\\n19717810\\n15802337\\n34801592\\n27836957\\n25611918\\n9032182\\n22528679\\n21560042\\n17656429\\n36009496\\n20181491\\n32998687\\n20412595\\n25068427\\n11179105\\n21680942\\n34093009\\n20398920\\n21906793\\n27773852\\n30928653\\n28687413\\n33569770\\n21211650\\n28179442\\n37671183\\n21508262\\n25595789\\n35247595\\n32198794\\n36740095\\n25534623\\n37874609\\n31395050\\n34773288\\n34948451', 'title': 'Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.', 'abstract': 'The respiratory mucus, a viscoelastic gel, effectuates a primary line of the airway defense when operated by the mucociliary clearance. In chronic respiratory diseases (CRDs), such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF), the mucus is overproduced and its solid content augments, changing its structure and viscoelastic properties and determining a derangement of essential defense mechanisms against opportunistic microbial (virus and bacteria) pathogens. This ensues in damaging of the airways, leading to a vicious cycle of obstruction and infection responsible for the harsh clinical evolution of these CRDs. Here, we review the essential features of normal and pathological mucus (i.e., sputum in CF, COPD, and asthma), i.e., mucin content, structure (mesh size), micro/macro-rheology, pH, and osmotic pressure, ending with the awareness that sputum biomarkers (mucins, inflammatory proteins and peptides, and metabolites) might serve to indicate acute exacerbation and response to therapies. There are some indications that old and novel treatments may change the structure, viscoelastic properties, and biomarker content of sputum; however, a wealth of work is still needed to embrace these measures as correlates of disease severity in association with (or even as substitutes of) pulmonary functional tests.', 'keywords': ['asthma', 'biomarkers', 'chronic pulmonary obstructive disease', 'cystic fibrosis', 'low-field NMR', 'mucus', 'viscoelasticity'], 'journal': 'International journal of molecular sciences', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Abrami', 'firstname': 'Michela', 'initials': 'M', 'affiliation': 'Department of Engineering and Architecture, University of Trieste, Via Valerio 6/A, I-34127 Trieste, Italy.'}, {'lastname': 'Biasin', 'firstname': 'Alice', 'initials': 'A', 'affiliation': 'Department of Engineering and Architecture, University of Trieste, Via Valerio 6/A, I-34127 Trieste, Italy.'}, {'lastname': 'Tescione', 'firstname': 'Fabiana', 'initials': 'F', 'affiliation': 'Institute of Polymers, Composites and Biomaterials, National Research Council of Italy, P.le E. Fermi 1, I-80055 Portici, Italy.'}, {'lastname': 'Tierno', 'firstname': 'Domenico', 'initials': 'D', 'affiliation': 'Clinical Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, University of Trieste, Strada di Fiume 447, I-34149 Trieste, Italy.'}, {'lastname': 'Dapas', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': 'Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via L. Giorgieri 1, I-34127 Trieste, Italy.'}, {'lastname': 'Carbone', 'firstname': 'Annalucia', 'initials': 'A', 'affiliation': 'Department of Clinical and Experimental Medicine, University of Foggia, Via Napoli 121, I-71122 Foggia, Italy.'}, {'lastname': 'Grassi', 'firstname': 'Gabriele', 'initials': 'G', 'affiliation': 'Clinical Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, University of Trieste, Strada di Fiume 447, I-34149 Trieste, Italy.'}, {'lastname': 'Conese', 'firstname': 'Massimo', 'initials': 'M', 'affiliation': 'Department of Clinical and Experimental Medicine, University of Foggia, Via Napoli 121, I-71122 Foggia, Italy.'}, {'lastname': 'Di Gioia', 'firstname': 'Sante', 'initials': 'S', 'affiliation': 'Department of Clinical and Experimental Medicine, University of Foggia, Via Napoli 121, I-71122 Foggia, Italy.'}, {'lastname': 'Larobina', 'firstname': 'Domenico', 'initials': 'D', 'affiliation': 'Institute of Polymers, Composites and Biomaterials, National Research Council of Italy, P.le E. Fermi 1, I-80055 Portici, Italy.'}, {'lastname': 'Grassi', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Department of Engineering and Architecture, University of Trieste, Via Valerio 6/A, I-34127 Trieste, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ijms25031933\\n10.1016/j.eclinm.2023.101936\\n10.3390/genes11060589\\n10.1016/S2214-109X(23)00217-6\\n10.1186/s12971-017-0130-2\\n10.1016/j.jcf.2022.08.019\\n10.1016/j.ajpath.2020.10.017\\n10.1186/s12931-019-1239-z\\n10.1016/j.addr.2008.09.012\\n10.1513/pats.2306016\\n10.3109/10611869608995625\\n10.1016/j.biomaterials.2013.01.064\\n10.1136/bmj.332.7551.1202\\n10.1378/chest.08-2062\\n10.1016/j.ccm.2013.11.001\\n10.1513/AnnalsATS.201507-427AW\\n10.1183/09031936.01.00229501\\n10.1164/rccm.200304-505SO\\n10.1055/s-0042-1758732\\n10.1056/NEJMra0910061\\n10.1164/ajrccm/144.3_pt_2.S4\\n10.1378/chest.08-0412\\n10.1165/rcmb.2009-0151TR\\n10.1073/pnas.1703228114\\n10.1016/j.bbrc.2017.08.113\\n10.1172/JCI0215217\\n10.1016/j.chom.2016.01.001\\n10.1183/09031936.00141514\\n10.1080/14789450.2020.1748502\\n10.1152/physrev.00039.2014\\n10.3390/jcm6120112\\n10.1016/j.chest.2017.11.008\\n10.1513/AnnalsATS.201802-128AW\\n10.1074/jbc.RA117.001014\\n10.1038/s41586-018-0393-7\\n10.3390/cells9092090\\n10.1042/BST20191010\\n10.1152/physrev.00004.2021\\n10.1038/s41598-024-51397-w\\n10.3390/ijms22105133\\n10.1042/bj3160967\\n10.1042/bj3610537\\n10.1164/rccm.201603-0526LE\\n10.1016/j.alit.2021.09.003\\n10.1164/rccm.200803-391OC\\n10.1111/j.1365-2559.2004.01952.x\\n10.1111/j.1365-2559.2009.03377.x\\n10.1203/00006450-198711000-00015\\n10.1165/rcmb.2003-0345OC\\n10.1172/JCI73469\\n10.1126/scitranslmed.aav3488\\n10.1056/NEJMra1813799\\n10.1126/scitranslmed.3010525\\n10.1183/13993003.01297-2018\\n10.1371/journal.pone.0082297\\n10.1016/j.chest.2018.03.005\\n10.1126/sciadv.abm9718\\n10.1126/science.1255825\\n10.1183/13993003.00457-2018\\n10.1152/ajplung.00061.2005\\n10.1196/annals.1415.006\\n10.3233/BIR-1972-9310\\n10.1165/ajrcmb.13.6.7576713\\n10.1093/oxfordjournals.bmb.a072529\\n10.1183/09031936.96.09071395\\n10.3389/fmicb.2013.00263\\n10.1203/00006450-198102000-00007\\n10.1016/S0007-0971(70)80015-8\\n10.1016/S1357-2725(02)00083-3\\n10.1080/07853890600585795\\n10.1513/pats.200504-028SR\\n10.1164/ajrccm/140.2.477\\n10.1136/bmj.291.6504.1235\\n10.1183/09031936.00018908\\n10.1513/pats.200402-009MS\\n10.1378/chest.101.4.916\\n10.1016/j.coph.2004.01.011\\n10.1007/978-4-431-88317-3_11\\n10.1136/thx.15.2.142\\n10.1097/MCP.0b013e32831da8d3\\n10.1002/ppul.20183\\n10.1513/pats.2306015\\n10.1016/j.jcf.2017.09.003\\n10.1165/rcmb.2005-0059OC\\n10.1152/ajplung.2000.279.5.L799\\n10.1371/journal.pone.0116756\\n10.1165/rcmb.2018-0304OC\\n10.1038/nature11130\\n10.1183/13993003.02057-2018\\n10.1002/ppul.24530\\n10.1101/cshperspect.a009589\\n10.1152/physrev.00010.2005\\n10.1073/pnas.2119759119\\n10.1016/j.devcel.2020.07.002\\n10.1152/ajplung.00455.2001\\n10.1093/jac/dkn427\\n10.1165/ajrcmb.26.4.4473\\n10.1152/ajplung.00140.2004\\n10.1016/S0002-9440(10)62040-8\\n10.4049/jimmunol.175.1.404\\n10.1186/1465-9921-11-177\\n10.4049/jimmunol.0900614\\n10.1074/jbc.M210429200\\n10.1165/rcmb.2009-0313OC\\n10.1172/JCI125669\\n10.1378/chest.13-0274\\n10.1183/13993003.01307-2022\\n10.1152/ajplung.2001.280.1.L165\\n10.1155/2020/8217642\\n10.1183/09031936.06.00057205\\n10.2165/00151829-200403030-00003\\n10.2478/jtim-2023-0094\\n10.3389/fimmu.2023.1201658\\n10.1164/ajrccm.157.6.9609040\\n10.1136/thx.2004.030262\\n10.1152/ajplung.2001.280.1.L134\\n10.1165/rcmb.2006-0180OC\\n10.2174/092986709788803196\\n10.1378/chest.122.6_suppl.320S\\n10.1016/j.mam.2021.100995\\n10.1172/JCI200113557\\n10.1038/nm734\\n10.1513/AnnalsATS.201711-868MG\\n10.1016/j.cocis.2005.11.001\\n10.1165/rcmb.2005-0436SF\\n10.1016/S0968-0004(01)02052-7\\n10.1074/jbc.M313241200\\n10.1016/j.medengphy.2019.02.006\\n10.1115/1.4034507\\n10.1098/rsif.2019.0187\\n10.1038/s41598-020-58922-7\\n10.1096/fj.10-179549\\n10.1126/science.1223012\\n10.1016/j.compchemeng.2023.108458\\n10.1155/2023/8840594\\n10.1378/chest.117.5_suppl_1.317S\\n10.1164/rccm.201804-0734OC\\n10.3389/fphys.2018.00161\\n10.1016/j.rmed.2021.106623\\n10.1016/S0140-6736(17)33311-1\\n10.1165/rcmb.2021-0359OC\\n10.1073/pnas.1811787115\\n10.1002/mrm.28115\\n10.1007/s13346-022-01131-8\\n10.1002/mrm.26876\\n10.1006/jcis.1995.1399\\n10.1016/j.addr.2004.06.001\\n10.1172/jci.insight.88198\\n10.1016/S0140-6736(15)60693-6\\n10.1016/j.ccm.2015.11.003\\n10.1183/13993003.00088-2019\\n10.1165/rcmb.2020-0168OC\\n10.1186/s12931-019-1145-4\\n10.1016/j.coph.2017.09.013\\n10.1016/j.jcf.2015.10.011\\n10.1164/rccm.200807-1056OC\\n10.1038/s41467-020-20499-0\\n10.1016/j.bbrc.2022.07.025\\n10.1016/j.addr.2008.09.008\\n10.1007/s00408-009-9198-7\\n10.1073/pnas.1120269109\\n10.1021/acs.macromol.7b00842\\n10.1021/acsbiomaterials.2c00182\\n10.1016/j.camss.2017.03.012\\n10.1016/S0006-3495(01)75844-4\\n10.1074/jbc.M309026200\\n10.1073/pnas.2103995118\\n10.3390/cells10113107\\n10.1016/j.biomaterials.2008.12.076\\n10.1164/ajrccm.162.5.9909009\\n10.1038/s41598-018-24223-3\\n10.1152/ajplung.00206.2007\\n10.1016/j.prrv.2007.02.004\\n10.1165/rcmb.2006-0035SF\\n10.1378/chest.101.4.1080\\n10.1177/000348949310200412\\n10.1164/ajrccm/145.3.545\\n10.1164/ajrccm/141.5_Pt_1.1107\\n10.1089/08942680152484135\\n10.1103/PhysRevE.83.011921\\n10.3233/BIR-1987-24611\\n10.1016/j.jbiomech.2016.12.026\\n10.1164/rccm.201412-2230OC\\n10.1016/j.jmbbm.2019.06.008\\n10.1172/JCI83922\\n10.3390/ijms22073384\\n10.1042/BJ20102066\\n10.1016/j.pupt.2013.02.003\\n10.1016/j.cis.2009.05.003\\n10.1016/S0140-6736(08)61162-9\\n10.1183/13993003.02652-2017\\n10.1126/scitranslmed.3000928\\n10.1172/jci.insight.97199\\n10.1056/NEJMoa043891\\n10.3389/fimmu.2020.01198\\n10.1172/JCI0215218\\n10.4161/tisb.24997\\n10.1016/j.biochi.2015.08.014\\n10.1016/j.peptides.2006.07.018\\n10.1016/j.peptides.2005.01.020\\n10.1165/rcmb.2002-0191OC\\n10.1378/chest.128.4.2316\\n10.1183/09031936.00080806\\n10.4049/jimmunol.0803959\\n10.1016/j.rmed.2012.08.018\\n10.3109/01902141003690389\\n10.1183/13993003.01328-2016\\n10.1164/ajrccm.160.6.9904097\\n10.1186/1471-2334-9-178\\n10.1378/chest.10-2760\\n10.1164/rccm.201205-0806OC\\n10.1155/2015/407271\\n10.1513/pats.200703-044BR\\n10.2174/2212707004666170502171110\\n10.1016/j.jcf.2021.10.009\\n10.1002/ppul.23768\\n10.1080/14789450.2018.1539670\\n10.3390/ijms23105692\\n10.1039/C9AN01704F\\n10.2147/COPD.S410387\\n10.1177/1753465813496863\\n10.1111/all.13806\\n10.1016/j.jcf.2017.01.002\\n10.1177/1753466618820186\\n10.1164/rccm.200609-1354OC\\n10.1183/09031936.00017713\\n10.1016/j.prrv.2015.05.004\\n10.1016/S2213-2600(18)30171-1\\n10.1136/thorax.56.4.306\\n10.1034/j.1399-3003.2000.16a16.x\\n10.1186/s12890-018-0668-7\\n10.1164/rccm.200306-731OC\\n10.1164/rccm.201203-0507OC\\n10.1016/j.pupt.2019.101856\\n10.1016/j.jcf.2018.05.018\\n10.4049/jimmunol.174.9.5789\\n10.1016/j.jcf.2019.12.014\\n10.1164/rccm.201511-2216OC\\n10.1096/fj.201700114RRR\\n10.1016/j.jcf.2020.06.017\\n10.1515/CCLM.2007.019\\n10.1101/2022.05.25.22275540\\n10.1183/13993003.01569-2016\\n10.1002/ppul.20165\\n10.1378/chest.129.5.1148\\n10.1164/rccm.200409-1215OC\\n10.1371/journal.pone.0024399\\n10.1016/j.jcf.2010.01.005\\n10.1165/ajrcmb.20.4.3371\\n10.1164/rccm.200703-409OC\\n10.1016/j.rmed.2022.107002\\n10.1164/rccm.201609-1954OC\\n10.1016/j.jcf.2015.11.003\\n10.1183/13993003.00185-2021\\n10.1513/AnnalsATS.201907-493OC\\n10.1513/AnnalsATS.202008-1054OC\\n10.1136/bmjresp-2022-001590\\n10.1183/13993003.02153-2022\\n10.3389/fped.2022.896439\\n10.1371/journal.pone.0082432\\n10.3390/jcm9123802\\n10.1038/s41598-021-84041-y\\n10.1183/09031936.00154006\\n10.3889/oamjms.2022.10835\\n10.1016/j.jcf.2003.12.008\\n10.1164/rccm.201204-0596PP\\n10.3390/s18072144\\n10.1002/sim.5403\\n10.3390/molecules24122311\\n10.2147/COPD.S306035\\n10.2147/COPD.S364982\\n10.1165/rcmb.2009-0220TR\\n10.1183/09031936.05.00047504\\n10.1016/j.chest.2021.10.049\\n10.1183/13993003.00524-2016\\n10.1378/chest.14-1800\\n10.1164/ajrccm.155.2.9032182\\n10.1007/s11302-012-9304-9\\n10.1113/jphysiol.2007.139840\\n10.3390/biomedicines10081949\\n10.1016/j.cyto.2010.02.004\\n10.1186/s12865-020-00381-w\\n10.1186/1465-9921-11-41\\n10.1038/bmt.2014.164\\n10.1164/ajrccm.163.2.2003122\\n10.1164/rccm.201104-0597OC\\n10.2147/COPD.S301622\\n10.1016/j.jaci.2010.02.008\\n10.1016/j.jaci.2011.07.053\\n10.1016/j.jaci.2016.08.048\\n10.1016/j.jaci.2019.03.013\\n10.1016/S0140-6736(17)31281-3\\n10.1111/all.14768\\n10.1016/j.jaci.2010.10.024\\n10.1183/13993003.02135-2016\\n10.2147/JAA.S421742\\n10.4049/jimmunol.1001673\\n10.4049/jimmunol.1402496\\n10.1016/j.anai.2022.02.017\\n10.1111/cea.13601\\n10.1016/j.chest.2023.01.037\\n10.1038/nri3786\\n10.1111/all.15915\\n10.1186/s12890-019-0906-7\\n10.1111/apa.16186\\n10.3390/ijms222413656', 'xml': <Element 'PubmedArticle' at 0x10b834a90>}\n",
      "{'pubmed_id': '38339025\\n20524920\\n17626911\\n28952566\\n29528946\\n21935365\\n17962576\\n37698245\\n21926573\\n16534184\\n2148977\\n10051278\\n9108855\\n16014803\\n29430445\\n20813920\\n31689081\\n31396578\\n9020360\\n35399286\\n36835223\\n16652152\\n25679760\\n28199303\\n31435009\\n20016066\\n36351022\\n37772664\\n22792288\\n24798994\\n11683406\\n36717048\\n35915804\\n34548087\\n36596517\\n24732023\\n22824096\\n35354317\\n37022568\\n34979904\\n25119035\\n25349416\\n12844144\\n12527751\\n33839418\\n18476815\\n23472053\\n29762413\\n34651014', 'title': 'High Stretch Associated with Mechanical Ventilation Promotes Piezo1-Mediated Migration of Airway Smooth Muscle Cells.', 'abstract': 'Ventilator-induced lung injury (VILI) during mechanical ventilation (MV) has been attributed to airway remodeling involving increased airway smooth muscle cells (ASMCs), but the underlying mechanism is not fully understood. Thus, we aimed to investigate whether MV-associated high stretch (>10% strain) could modulate mechanosensitive Piezo1 expression and thereby alter cell migration of ASMCs as a potential pathway to increased ASMCs in VILI. C57BL/6 mice and ASMCs were subjected to MV at high tidal volume (V', 'keywords': ['Piezo1', 'airway smooth muscle cells', 'high stretch', 'integrin', 'migration'], 'journal': 'International journal of molecular sciences', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Luo', 'firstname': 'Mingzhi', 'initials': 'M', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Gu', 'firstname': 'Rong', 'initials': 'R', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Wang', 'firstname': 'Chunhong', 'initials': 'C', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Guo', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiangrong', 'initials': 'X', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Ni', 'firstname': 'Kai', 'initials': 'K', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Liu', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Pan', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Li', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}, {'lastname': 'Deng', 'firstname': 'Linhong', 'initials': 'L', 'affiliation': 'Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, School of Medical and Health Engineering, Changzhou University, Changzhou 213164, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ijms25031748\\n10.1586/ers.10.28\\n10.1164/rccm.200701-088OC\\n10.3390/bioengineering3010004\\n10.1097/CCM.0000000000003072\\n10.1371/journal.pone.0023914\\n10.1152/japplphysiol.00805.2007\\n10.1177/09636897231196489\\n10.1097/CCM.0b013e31822f09d7\\n10.1159/000091742\\n10.1002/ppul.1950090306\\n10.1164/ajrccm.159.3.9804027\\n10.1016/S0022-3476(97)70241-5\\n10.1096/fj.04-3350fje\\n10.21037/atm.2017.12.08\\n10.1126/science.1193270\\n10.1021/acsnano.9b07499\\n10.1038/s42003-019-0514-3\\n10.1038/385537a0\\n10.3389/fphys.2022.830406\\n10.3390/ijms24043811\\n10.1038/sj.onc.1209582\\n10.1016/j.cell.2015.01.007\\n10.1038/nature21407\\n10.1038/s41586-019-1485-8\\n10.1242/jcs.056424\\n10.1126/sciadv.abo1461\\n10.1042/BST20230042\\n10.1371/journal.pone.0040346\\n10.1007/s10620-014-3044-3\\n10.1242/jcs.114.15.2713\\n10.1016/j.actbio.2023.01.039\\n10.1155/2022/6871269\\n10.1186/s12931-021-01844-3\\n10.1248/bpb.b22-00209\\n10.1097/ALN.0000000000000264\\n10.1186/1755-1536-5-11\\n10.1161/HYPERTENSIONAHA.121.17584\\n10.1007/s12565-023-00716-8\\n10.1186/s12860-021-00401-6\\n10.1038/nature13701\\n10.1073/pnas.1409802111\\n10.1038/ncb1019\\n10.1083/jcb.200209006\\n10.1016/j.bbrc.2021.03.163\\n10.2144/000112729\\n10.1371/annotation/7899a865-d68b-45bd-8b9b-ec6f50c9308a\\n10.1097/CCM.0000000000003109\\n10.3389/fmolb.2021.717771', 'xml': <Element 'PubmedArticle' at 0x109a52b10>}\n",
      "{'pubmed_id': '38338861\\n37102759\\n10651770\\n11597666\\n21345099\\n22534534\\n35779667\\n36356926\\n20415863\\n35754122\\n30654491\\n35008618\\n31936182\\n12230914\\n23121051\\n25527628\\n12359650\\n10905243\\n26339029\\n11809997\\n11897980\\n20977505\\n11179100\\n8970348\\n9532251\\n15801242\\n20447074\\n28052076\\n32379832\\n33732246\\n22566627\\n34415577\\n36458896\\n34455626\\n30065721\\n33338536\\n9351616\\n11270982\\n10701530\\n25797360\\n37428467\\n34931615\\n7005862\\n16023558\\n15722636\\n10953030\\n12960326\\n24737868\\n9039784\\n15084610\\n20881006\\n12391239\\n12270731\\n6345389\\n3067502\\n19252480\\n11981444\\n16675343\\n17544828\\n21873155\\n35392216\\n31420279\\n33072079\\n12110131\\n14996646\\n2452255\\n36272656\\n37176105\\n22707952\\n31428071\\n3510264\\n3515396\\n19359475\\n29514093\\n35464444\\n27212084\\n11244051\\n2145365\\n29616018\\n10432286\\n11937584\\n35428872\\n14523043\\n22269653\\n20584764\\n19414804\\n21822296\\n31817726\\n17536681\\n18443921\\n33378951\\n36750575\\n18287743\\n23407691\\n17174948\\n16075057\\n8648023\\n8748721\\n10229876\\n34576313\\n8004300\\n23278511', 'title': 'Radiation-Detoxified Form of Endotoxin Effectively Activates Th', 'abstract': 'Urbanization with reduced microbial exposure is associated with an increased burden of asthma and atopic symptoms. Conversely, environmental exposure to endotoxins in childhood can protect against the development of allergies. Our study aimed to investigate whether the renaturation of the indoor environment with aerosolized radiation-detoxified lipopolysaccharide (RD-LPS) has a preventative effect against the development of ragweed-induced Th', 'keywords': ['Th2-type airway inflammation', 'allergy', 'dendritic cells', 'endotoxin', 'lipopolysaccharide', 'mice', 'radiation-detoxified', 'ragweed'], 'journal': 'International journal of molecular sciences', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Bácsi', 'firstname': 'Attila', 'initials': 'A', 'affiliation': 'Department of Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.'}, {'lastname': 'Ágics', 'firstname': 'Beatrix', 'initials': 'B', 'affiliation': 'Department of Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.\\nDoctoral School of Molecular Cell and Immune Biology, University of Debrecen, H-4032 Debrecen, Hungary.'}, {'lastname': 'Pázmándi', 'firstname': 'Kitti', 'initials': 'K', 'affiliation': 'Department of Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.'}, {'lastname': 'Kocsis', 'firstname': 'Béla', 'initials': 'B', 'affiliation': 'Department of Medical Microbiology and Immunology, Faculty of Medicine, University of Pécs, H-7624 Pécs, Hungary.'}, {'lastname': 'Sándor', 'firstname': 'Viktor', 'initials': 'V', 'affiliation': 'Institute of Bioanalysis, Medical School and Szentágothai Research Center, University of Pécs, H-7624 Pécs, Hungary.'}, {'lastname': 'Bertók', 'firstname': 'Lóránd', 'initials': 'L', 'affiliation': 'National Research Directorate for Radiobiology and Radiohygiene, National Public Health Center, H-1221 Budapest, Hungary.'}, {'lastname': 'Bruckner', 'firstname': 'Geza', 'initials': 'G', 'affiliation': 'Department of Athletic Training and Clinical Nutrition, University of Kentucky, Lexington, KY 40536, USA.'}, {'lastname': 'Sipka', 'firstname': 'Sándor', 'initials': 'S', 'affiliation': 'Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ijms25031581\\n10.1111/all.15754\\n10.1046/j.1365-2222.2000.00801.x\\n10.1016/S0140-6736(01)06252-3\\n10.1056/NEJMoa1007302\\n10.1016/j.jaci.2012.03.013\\n10.1016/j.jaci.2022.05.027\\n10.1016/j.jaip.2022.10.035\\n10.1111/j.1365-2249.2010.04138.x\\n10.1111/pai.13807\\n10.3390/ijms20020356\\n10.3390/ijms23010189\\n10.3390/ijms21020379\\n10.1179/096805102125000452\\n10.1111/lam.12024\\n10.1177/1753425914557100\\n10.1164/rccm.200203-256OC\\n10.1016/S0140-6736(00)02239-X\\n10.1126/science.aac6623\\n10.1136/thorax.57.1.86\\n10.1067/mai.2002.122157\\n10.1111/j.1365-2222.2010.03628.x\\n10.1164/ajrccm.163.2.2002088\\n10.1164/ajrccm.154.6.8970348\\n10.1111/j.1399-3038.1997.tb00164.x\\n10.1016/S1081-1206(10)60983-0\\n10.1111/j.1365-2222.2010.03477.x\\n10.1371/journal.pone.0167786\\n10.1371/journal.pone.0226233\\n10.3389/fimmu.2021.623737\\n10.1073/pnas.1205624109\\n10.1002/eji.202048938\\n10.1111/all.15606\\n10.1111/pai.13657\\n10.3389/fimmu.2018.01584\\n10.1016/j.jaci.2020.12.621\\n10.1164/ajrccm.156.4.97-02002\\n10.3171/jns.2000.92.3.0435\\n10.1586/14760584.2015.1026808\\n10.1002/advs.202302950\\n10.22034/IJI.2021.87816.1832\\n10.1353/pbm.1980.0090\\n10.1016/j.pathophys.2005.02.004\\n10.1159/000083953\\n10.1172/JCI8107\\n10.4049/jimmunol.171.6.3010\\n10.1002/embj.201488027\\n10.1016/S0952-7915(97)80153-7\\n10.1074/jbc.C400128200\\n10.1124/mol.110.068064\\n10.4049/jimmunol.169.9.5209\\n10.1016/S1286-4579(02)01604-0\\n10.1051/ocl/2020025\\n10.1128/iai.41.1.190-196.1983\\n10.1038/nature07830\\n10.1177/09680519020080010401\\n10.1016/j.jaci.2006.02.035\\n10.1016/j.imbio.2007.03.002\\n10.5414/ALX02327E\\n10.1016/j.it.2019.07.004\\n10.3389/fimmu.2020.02150\\n10.1186/ar567\\n10.1517/13543784.13.2.107\\n10.1016/j.ejpb.2022.10.006\\n10.3390/ijms24098395\\n10.3389/fimmu.2012.00154\\n10.3389/fmicb.2019.01774\\n10.1093/infdis/153.1.98\\n10.2307/3576685\\n10.1073/pnas.0902745106\\n10.1016/j.celrep.2018.02.044\\n10.3389/fimmu.2022.872155\\n10.1016/j.jaci.2016.02.033\\n10.1146/annurev.immunol.19.1.683\\n10.4049/jimmunol.145.9.2938\\n10.3389/fimmu.2018.00455\\n10.1084/jem.190.2.229\\n10.4049/jimmunol.168.8.4221\\n10.1038/s41385-022-00513-y\\n10.1172/JCI18246\\n10.1159/000330896\\n10.1093/intimm/dxq062\\n10.4049/jimmunol.0803350\\n10.1038/cmi.2011.26\\n10.3390/nu11122990\\n10.4315/0362-028X-70.5.1206\\n10.1007/s11046-008-9124-1\\n10.1016/j.biopha.2020.111043\\n10.1038/s41467-023-36332-3\\n10.1515/znb-1952-0303\\n10.1007/978-1-60327-032-8_1\\n10.1016/j.ejphar.2006.11.023\\n10.1172/JCI24422\\n10.1016/S0091-6749(96)70195-1\\n10.1111/j.1398-9995.1995.tb02495.x\\n10.4049/jimmunol.162.10.6284\\n10.3390/ijms221810150\\n10.1164/ajrccm.149.6.8004300\\n10.1111/imm.12052', 'xml': <Element 'PubmedArticle' at 0x10a7c87c0>}\n",
      "{'pubmed_id': '38338192\\n29272827\\n27216510\\n33938390\\n35524066\\n36042380\\n30461534\\n28826118\\n22456494\\n24015109\\n28642628\\n27318255\\n33431571\\n37346272\\n23980897\\n32857515\\n19903567\\n28628818\\n18929972\\n35321933\\n19245042\\n20388000\\n35795228\\n35142610\\n29102183\\n28493694\\n30832670\\n21357889\\n33413506\\n17413125\\n32050955\\n37171670\\n31849690\\n31176132\\n32275839\\n34389545\\n12162869\\n32169651\\n23265859\\n24561289\\n33335049\\n27337452\\n21703343\\n21945489\\n23142465\\n11549540\\n18606401\\n10764314\\n30188494\\n31764604\\n36542997\\n32964460\\n33964422\\n34942288\\n37020004\\n31931820\\n31520956\\n32159037\\n28868515\\n29990362\\n27259511\\n35281479\\n30875246\\n26346113\\n23006928\\n31146163\\n37252333\\n34444546\\n27082891\\n34561694\\n35742668\\n34491965\\n36520960\\n15696107\\n35162264\\n28460366\\n37906164\\n36103611\\n36493611\\n35550079\\n26818940\\n22683314\\n28208028\\n36958741\\n34256112\\n30981117\\n37008196\\n30336830\\n21705297\\n25491235\\n37352581\\n34991532\\n19276978\\n20961824\\n22645279\\n34030071\\n37370168\\n36767304\\n16946126\\n35660427\\n37444100\\n19017694\\n30889810\\n28525551\\n37285572\\n34602887\\n33153693\\n30919829\\n32241830\\n34465624\\n38001501\\n34541439\\n34574730\\n36539797\\n22494384\\n28226261\\n35798884\\n23906969', 'title': 'Clearing the Air: Understanding the Impact of Wildfire Smoke on Asthma and COPD.', 'abstract': 'Wildfires are a global natural phenomenon. In North America, wildfires have not only become more frequent, but also more severe and longer in duration, a trend ascribed to climate change combined with large fuel stores left from modern fire suppression. The intensification of wildfire activity has significant implications for planetary health and public health, as exposure to fine particulate matter (PM', 'keywords': ['asthma', 'chronic obstructive pulmonary disease (COPD)', 'climate change', 'particulate matter', 'planetary health', 'pollution', 'respiratory', 'smoke', 'wildfire'], 'journal': 'Healthcare (Basel, Switzerland)', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Wilgus', 'firstname': 'May-Lin', 'initials': 'ML', 'affiliation': 'Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1405, USA.'}, {'lastname': 'Merchant', 'firstname': 'Maryum', 'initials': 'M', 'affiliation': 'Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1405, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/healthcare12030307\\n10.1016/j.scitotenv.2017.12.086\\n10.1098/rstb.2015.0178\\n10.1513/AnnalsATS.202102-148ST\\n10.1007/s40572-022-00355-7\\n10.1038/s41577-022-00776-3\\n10.1097/MCP.0000000000000552\\n10.1016/j.scitotenv.2017.08.024\\n10.1289/ehp.1104422\\n10.1016/j.atmosenv.2013.06.003\\n10.1007/s10584-016-1762-6\\n10.1016/j.envres.2016.06.012\\n10.1073/pnas.2011048118\\n10.1093/pnasnexus/pgad186\\n10.1021/es402164f\\n10.1021/acs.est.0c04497\\n10.1016/j.scitotenv.2009.10.050\\n10.1016/j.scitotenv.2017.06.062\\n10.1016/j.amepre.2008.08.025\\n10.1183/16000617.0112-2021\\n10.1021/es8021667\\n10.3109/08958370903571849\\n10.1029/2021GH000578\\n10.1016/j.scitotenv.2021.147507\\n10.1016/j.scitotenv.2017.10.008\\n10.1021/acs.est.6b06200\\n10.1186/s12931-019-1017-y\\n10.1183/09059180.00010410\\n10.1186/s12989-020-00394-8\\n10.1164/rccm.200611-1655PP\\n10.1186/s12931-020-1310-9\\n10.1007/s11882-023-01090-1\\n10.3389/fphys.2019.01404\\n10.1016/j.chemosphere.2019.05.274\\n10.1165/rcmb.2019-0454OC\\n10.1126/sciadv.abi8789\\n10.1080/10937400290070062\\n10.1016/j.scitotenv.2020.137432\\n10.1016/j.jaci.2012.11.013\\n10.1016/j.scitotenv.2014.02.006\\n10.1126/science.abe8116\\n10.1128/microbiolspec.EI10-0016-2016\\n10.1016/j.tiv.2011.06.001\\n10.1016/j.taap.2011.09.003\\n10.1016/j.taap.2012.10.017\\n10.1164/ajrccm.164.5.2010160\\n10.1016/j.envres.2008.05.004\\n10.1164/ajrccm.161.4.9904084\\n10.1097/JOM.0000000000001437\\n10.1097/JOM.0000000000001775\\n10.1016/j.envint.2022.107704\\n10.3322/caac.21632\\n10.1016/j.tiv.2021.105190\\n10.1016/j.envpol.2021.118718\\n10.1038/s41586-023-05874-3\\n10.1186/s12940-020-0559-2\\n10.1016/j.envint.2019.105151\\n10.1029/2018GH000142\\n10.1002/2017GH000073\\n10.1371/journal.pmed.1002601\\n10.1186/s12940-016-0146-8\\n10.1029/2020GH000330\\n10.1289/EHP3860\\n10.1111/resp.12613\\n10.1186/1476-069X-11-71\\n10.1016/j.envint.2019.04.033\\n10.1088/2752-5309/acd3a1\\n10.3390/ijerph18168799\\n10.1289/ehp.1409277\\n10.1093/ije/dyab206\\n10.3390/ijerph19127419\\n10.1097/JOM.0000000000002286\\n10.1164/rccm.202207-1324OC\\n10.1016/j.jaci.2004.11.030\\n10.3390/ijerph19031241\\n10.1016/j.ehb.2017.03.006\\n10.1513/AnnalsATS.202305-455OC\\n10.1164/rccm.202203-0457OC\\n10.1016/j.envint.2022.107665\\n10.1016/S2542-5196(22)00067-5\\n10.1186/s12940-016-0093-4\\n10.1016/j.envres.2012.05.006\\n10.1165/rcmb.2016-0380OC\\n10.1183/13993003.02469-2022\\n10.1016/j.jtho.2021.06.015\\n10.1016/j.envres.2019.03.060\\n10.1016/j.lana.2023.100482\\n10.1016/j.jacc.2018.07.099\\n10.1289/ehp.1003206\\n10.1186/1476-069X-13-105\\n10.1016/j.envint.2023.108045\\n10.1186/s12889-021-12411-2\\n10.1097/EDE.0b013e31819d128d\\n10.1289/ehp.1002255\\n10.1289/ehp.1104515\\n10.1016/j.envint.2021.106644\\n10.1186/s12940-023-00998-5\\n10.3390/ijerph20031937\\n10.1164/rccm.200604-519OC\\n10.1016/j.scitotenv.2022.156403\\n10.3390/ijerph20136252\\n10.1136/oem.2008.041376\\n10.3390/ijerph16060960\\n10.1093/aje/kwx141\\n10.2105/AJPH.2023.307286\\n10.1016/j.ccm.2020.08.017\\n10.13075/ijomeh.1896.01326\\n10.1183/13993003.02056-2019\\n10.1073/pnas.2106478118\\n10.1186/s12889-023-17274-3\\n10.1029/2021GH000482\\n10.3390/ijerph18189811\\n10.1186/s12889-022-14816-z\\n10.1080/10810730.2011.635777\\n10.1016/j.jenvman.2017.02.012\\n10.1038/s41562-022-01396-6\\n10.1289/ehp.1306768\\n10.1007/s11869-018-0633-x', 'xml': <Element 'PubmedArticle' at 0x10a59a8e0>}\n",
      "{'pubmed_id': '38338101\\n31713728\\n37048164\\n33419889\\n34215662\\n29938789\\n14769262\\n31653617\\n28456910\\n30688986\\n22133317\\n31371681\\n35013387\\n30026642\\n32423905\\n22994559\\n16018565\\n35575046\\n31911831\\n15720932\\n12217080\\n33158364\\n28608525\\n32537459\\n26880787\\n26806374\\n34529300\\n17427403\\n25911505\\n11281884\\n34295941\\n33869448\\n30615108\\n27095798\\n32411737\\n34147960\\n12356693\\n10678616\\n27096751\\n12752598\\n15892233\\n11352347\\n36199158\\n26708931\\n10508816', 'title': 'Antimicrobial Prescription Behavior in Equine Asthma Cases: An International Survey.', 'abstract': 'Equine asthma is considered a non-infectious respiratory disease characterized by inflammation and hypersensitivity. Given the importance of antimicrobial stewardship, an international survey was designed to investigate the use of antimicrobials in asthmatic horses and the factors influencing prescription behavior. An online survey was distributed in six languages by international mailing lists and social media from December 2020 to January 2022. Of the 434 responses recorded, 249 veterinarians working in 25 countries finished the survey. These included 79 ECEIM/ACVIM diplomats. A total of 204 respondents confirmed national regulations concerning antimicrobial use in their country. Knowledge of the asthma definitions as presented in the revised ACVIM consensus statement was greater in veterinarians treating over 95% of equine patients compared to veterinarians treating more species, based on 10 questions (answers consistent with the consensus statement in 7 (IQR 5-9) and 4 (IQR 3-6) questions, respectively, (', 'keywords': ['antibiotic', 'antimicrobial stewardship', 'horse', 'inflammatory airway disease', 'recurrent airway obstruction', 'respiratory disease'], 'journal': 'Animals : an open access journal from MDPI', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'van den Brom-Spierenburg', 'firstname': 'Astrid J', 'initials': 'AJ', 'affiliation': 'Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 114, 3584 CM Utrecht, The Netherlands.'}, {'lastname': 'Mureșan', 'firstname': 'Alexandra N', 'initials': 'AN', 'affiliation': 'Department of Internal Medicine, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 400372 Cluj-Napoca, Romania.'}, {'lastname': 'Westermann', 'firstname': 'Cornélie M', 'initials': 'CM', 'affiliation': 'Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 114, 3584 CM Utrecht, The Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ani14030457\\n10.1007/s00441-019-03117-4\\n10.3390/cells12071091\\n10.1183/13993003.03599-2020\\n10.1183/13993003.00183-2021\\n10.1002/14651858.CD002741.pub2\\n10.1007/s11882-004-0058-5\\n10.1136/archdischild-2019-318141\\n10.1007/s11882-017-0701-6\\n10.1001/jamainternmed.2018.5394\\n10.1016/j.jaci.2011.10.024\\n10.1136/vr.105260\\n10.1038/s41598-021-03955-9\\n10.1111/eve.13371\\n10.1111/j.2042-3306.2012.00602.x\\n10.1111/evj.13587\\n10.1186/s13756-019-0659-3\\n10.1186/1471-2296-3-16\\n10.1080/02770903.2020.1847929\\n10.1111/evj.12709\\n10.3389/fvets.2020.00266\\n10.1136/vr.103438\\n10.1111/jvim.13824\\n10.1111/evj.13514\\n10.1111/j.1939-1676.2007.tb02975.x\\n10.1093/fampra/cmv019\\n10.1046/j.1369-6513.1999.00045.x\\n10.1093/ofid/ofab224\\n10.3389/fsoc.2020.00041\\n10.1093/cid/ciy1130\\n10.1093/fampra/cmw025\\n10.3389/fvets.2020.00216\\n10.1016/j.prevetmed.2021.105411\\n10.1093/fampra/19.5.452\\n10.1371/journal.pone.0152160\\n10.1046/j.1365-2222.2003.01640.x\\n10.2746/0425164054530579\\n10.2746/042516401776249796\\n10.1111/evj.13878\\n10.1111/eve.13438\\n10.1111/evj.12559\\n10.1086/268687\\n10.1177/1094428116668036\\n10.1164/ajrccm.160.4.9812136', 'xml': <Element 'PubmedArticle' at 0x10a795f30>}\n",
      "{'pubmed_id': '38338089\\n32903600\\n30923711\\n30222207\\n17722720\\n16866194\\n15779629\\n15934609\\n23972861\\n25273818\\n26708931\\n30576012\\n19086376\\n31599358\\n26535117\\n33865081\\n25770068\\n22721832\\n17939565\\n24164473\\n18346142\\n32172903\\n29485234\\n19561032\\n17477944\\n24164413\\n20513185\\n30183323\\n14765737\\n12747662\\n22494157\\n24773603\\n16163942\\n22002664\\n18930664\\n12752598\\n19734563\\n35524958\\n34573695\\n35622753\\n36478588\\n25426729\\n33840486\\n24146155\\n21851693\\n33993927\\n36428320\\n31400277\\n3678188\\n28972942\\n17467753\\n34977227\\n34921652\\n21431789\\n33898547\\n30442129\\n31802526\\n29704944\\n16199775\\n25307169\\n16841861\\n18751910\\n17193883\\n36139339\\n17479778\\n16326966\\n30532286', 'title': 'Environmental Management of Equine Asthma.', 'abstract': \"Environmental practices related to the inhalation of airborne dust have been identified as the main cause of equine asthma (EA) and reasonably, they are truly relevant in its treatment and control, especially for horses with its severe form. Vast research regarding environmental recommendations has been conducted in recent years. However, no recent exhaustive reviews exist that gather all this new evidence. The aim of this review is to report and compare the most pertinent information concerning the environmental management of EA. The main findings highlight the importance of the type of forage used for feeding but also its method of production and possible contamination during manufacture and/or storage. Procedures to reduce this, such as soaking and steaming hay, improve its hygienic quality, although they also decrease forage's nutritional value, making dietetic supplementation necessary. Regarding stabling, despite some conflicting results, avoiding straw as bedding and improving barn ventilation continue to be the common recommendations if turning to pasture is not feasible. Finally, owners' compliance has been identified as the most critical point in correct environmental control. Educating owners about the genuine benefits of these measures should be a cornerstone of EA management.\", 'keywords': ['bedding', 'dust', 'environment', 'equine asthma', 'horse', 'soaking', 'stabling', 'therapy'], 'journal': 'Animals : an open access journal from MDPI', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Diez de Castro', 'firstname': 'Elisa', 'initials': 'E', 'affiliation': 'Veterinary Teaching Hospital, University of Cordoba, 14014 Córdoba, Spain.\\nDepartment of Animal Medicine and Surgery, University of Cordoba, 14014 Córdoba, Spain.'}, {'lastname': 'Fernandez-Molina', 'firstname': 'Jose Maria', 'initials': 'JM', 'affiliation': 'Department of Physical Chemistry and Applied Thermodynamics, University of Cordoba, 14014 Córdoba, Spain.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/ani14030446\\n10.3389/fvets.2020.00450\\n10.3389/fvets.2019.00074\\n10.1111/jvim.15226\\n10.2746/042516407X180129\\n10.2746/042516406777749281\\n10.2746/0425164054223796\\n10.2460/ajvr.2005.66.818\\n10.1016/j.vetimm.2013.07.005\\n10.1111/jvim.12458\\n10.1111/evj.12559\\n10.1111/jvim.15397\\n10.1007/s11882-019-0882-2\\n10.1186/s40248-015-0030-3\\n10.1016/j.vetmic.2021.109070\\n10.1016/j.cveq.2014.11.008\\n10.1165/rcmb.2011-0363OC\\n10.1111/j.1939-1676.2007.tb03065.x\\n10.1111/evj.12204\\n10.1111/j.1939-1676.2008.0055.x\\n10.1016/j.jevs.2020.102937\\n10.1111/jvim.15069\\n10.1093/annhyg/mep040\\n10.1016/j.rvsc.2006.12.002\\n10.1111/evj.12201\\n10.2460/ajvr.71.6.682\\n10.1165/rcmb.2017-0228OC\\n10.1892/0891-6640(2004)18<92:AMIRAO>2.0.CO;2\\n10.1016/S0749-0739(02)00067-6\\n10.1111/j.2042-3306.2012.00568.x\\n10.1111/jvim.12333\\n10.2746/042516405774480111\\n10.1002/jsfa.4680\\n10.1016/j.tvjl.2008.09.001\\n10.1046/j.1365-2222.2003.01640.x\\n10.1016/j.jevs.2016.12.007\\n10.1136/vr.165.10.293\\n10.2460/ajvr.21.09.0143\\n10.3390/ani11092729\\n10.3390/vetsci9050226\\n10.1111/jvim.16598\\n10.1016/j.jevs.2015.06.005\\n10.3920/978-90-8686-755-4_9\\n10.1371/journal.pone.0114079\\n10.1016/j.jevs.2015.09.006\\n10.1016/j.tvjl.2021.105654\\n10.2527/jas.2013-6333\\n10.1186/2046-0481-60-4-231\\n10.1016/j.jevs.2009.07.013\\n10.1016/j.jevs.2017.04.004\\n10.1016/j.jevs.2010.09.005\\n10.1016/j.jevs.2012.03.007\\n10.1016/j.jevs.2021.103452\\n10.3390/ani12223092\\n10.1093/jas/skz252\\n10.1016/j.jevs.2008.05.004\\n10.1111/j.2042-3306.1987.tb02641.x\\n10.1016/j.rvsc.2017.09.022\\n10.1016/j.rvsc.2006.12.003\\n10.3389/fvets.2021.799645\\n10.1007/s11356-021-18142-6\\n10.1007/s12199-010-0195-5\\n10.3389/fvets.2021.656814\\n10.1186/s12917-018-1636-4\\n10.1111/evj.13218\\n10.1016/j.tvjl.2018.03.008\\n10.1136/vr.157.14.408\\n10.1111/jvim.12488\\n10.1093/ajcn/83.6.1505S\\n10.3390/ani12182479\\n10.1136/vr.157.23.733', 'xml': <Element 'PubmedArticle' at 0x10b21b330>}\n",
      "{'pubmed_id': '38337692\\n15585789\\n19266065\\n33326371\\n24753535\\n29493792\\n30100673\\n24719588\\n24748216\\n17634462\\n37103591\\n36227906\\n25025896\\n25956333\\n31381020\\n32091548\\n36297042\\n19114008\\n26813208\\n36825739\\n35005585\\n20403301\\n25894247\\n37558060\\n20194709\\n14749745\\n35114848\\n30293909\\n31923341\\n36780180\\n25078382\\n36839154\\n33430897\\n32075164\\n33155538\\n27061845\\n36918953\\n19756026\\n27788518\\n17167256\\n38144297\\n38004227', 'title': 'Maternal Diet Associates with Offspring Bone Mineralization, Fracture Risk and Enamel Defects in Childhood and Influences the Prenatal Effect of High-Dose Vitamin D Supplementation.', 'abstract': 'We previously demonstrated a beneficial effect of high-dose vitamin D in pregnancy on offspring bone and dental health. Here, we investigated the effect of maternal dietary patterns during pregnancy on the risk of bone fractures, bone mineralization and enamel defects until age 6 years in the offspring. Further, the influence of diet on the effect of high-dose vitamin D was analyzed in the COPSAC', 'keywords': ['bone health', 'dental health', 'pregnancy diet', 'vitamin D'], 'journal': 'Nutrients', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Kim', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.\\nFaculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.'}, {'lastname': 'Nørrisgaard', 'firstname': 'Pia E', 'initials': 'PE', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.'}, {'lastname': 'Vahman', 'firstname': 'Nilo', 'initials': 'N', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.'}, {'lastname': 'Cexus', 'firstname': 'Olivier N F', 'initials': 'ONF', 'affiliation': 'Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.'}, {'lastname': 'Townsend', 'firstname': 'Paul A', 'initials': 'PA', 'affiliation': 'Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.'}, {'lastname': 'Stokholm', 'firstname': 'Jakob', 'initials': 'J', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.\\nDepartment of Food Science, University of Copenhagen, 1958 Copenhagen, Denmark.'}, {'lastname': 'Bønnelykke', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.'}, {'lastname': 'Chawes', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.'}, {'lastname': 'Brustad', 'firstname': 'Nicklas', 'initials': 'N', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, 2820 Copenhagen, Denmark.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/nu16030405\\n10.1093/ajcn/80.6.1689S\\n10.7150/ijbs.5.226\\n10.1542/peds.2013-2215\\n10.1111/cdoe.12372\\n10.1016/j.pdj.2016.08.001\\n10.5863/1551-6776-18.4.277\\n10.1007/s10995-014-1499-7\\n10.1056/NEJMra070553\\n10.1007/s00198-023-06751-5\\n10.1371/journal.pone.0276016\\n10.3310/hta18450\\n10.1016/j.annepidem.2015.03.020\\n10.1001/jamapediatrics.2019.2545\\n10.1001/jamapediatrics.2019.6083\\n10.3390/nu14204358\\n10.1186/1471-2105-9-559\\n10.1001/jama.2015.18318\\n10.1111/pai.13917\\n10.1016/j.eclinm.2021.101254\\n10.1007/BF03262716\\n10.1007/s40368-015-0179-7\\n10.1016/j.jaci.2023.06.030\\n10.1210/jc.2009-2319\\n10.1038/sj.ejcn.1601775\\n10.1177/00220345211068743\\n10.1016/S2213-8587(18)30265-1\\n10.1002/jbmr.3958\\n10.1001/jamapediatrics.2022.5837\\n10.4178/epih/e2014009\\n10.3390/nu15040796\\n10.1186/s12966-020-01078-4\\n10.3390/foods9020195\\n10.1017/S136898002000453X\\n10.1002/jbmr.2850\\n10.1186/s40795-023-00707-y\\n10.1038/ejcn.2009.117\\n10.1159/000450655\\n10.1159/000096102\\n10.1016/j.heliyon.2023.e23117\\n10.3390/nu15224833', 'xml': <Element 'PubmedArticle' at 0x108e0fd80>}\n",
      "{'pubmed_id': '38337625\\n31230828\\n31645084\\n32020334\\n26103996\\n31703832\\n36682372\\n32369100\\n33542055\\n35923421\\n33361208\\n35769088\\n36034921\\n37242262\\n37039198\\n36809416\\n34366195\\n30961957\\n34979040\\n32235299\\n33923455\\n35455659\\n27025347\\n27362794\\n32615662\\n24575093\\n21646368\\n33904674\\n35971848\\n31986951\\n29635981\\n35916048\\n34040396\\n26651881\\n33474864\\n34377230\\n25882990\\n30486455\\n31204163\\n20643828\\n37003179\\n36640325\\n30406061\\n24734927\\n37314187\\n26148798\\n29875322\\n26311239\\n36243931\\n31942011\\n35101714\\n28694694\\n31703106\\n33385444\\n21571357\\n31264490\\n28564633\\n26197891\\n28804539\\n27902892\\n36597468\\n25762621\\n35807767\\n32810557\\n30300399\\n32381094\\n36714048\\n20850013\\n33688482\\n30134242\\n34185416\\n32128074\\n31798831\\n31698144\\n34002665\\n35660690\\n27446287\\n31428171\\n28055298\\n35850625\\n36689014\\n30084260\\n30981701\\n29104649\\n24373357\\n29967100\\n29621782\\n23436936\\n30639520\\n27992076\\n18071017\\n32526308\\n28939412\\n31684064\\n28373650\\n25443138\\n36112239\\n34939557\\n36143090\\n31386204\\n36617839\\n26646558\\n30619345\\n27635790\\n28273432\\n35483563\\n35563410\\n34288494\\n34942624', 'title': 'The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D', 'abstract': 'Asthma is one of the most common chronic non-communicable diseases worldwide, characterized by variable airflow limitation secondary to airway narrowing, airway wall thickening, and increased mucus resulting from chronic inflammation and airway remodeling. Current epidemiological studies reported that hypovitaminosis D is frequent in patients with asthma and is associated with worsening the disease and that supplementation with vitamin D', 'keywords': ['asthma', 'inflammation', 'microRNAs', 'vitamin D3 supplementation'], 'journal': 'Nutrients', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Hernández-Díazcouder', 'firstname': 'Adrián', 'initials': 'A', 'affiliation': 'Laboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.\\nInstituto Mexicano del Seguro Social, Hospital de Especialidades \"Dr. Bernardo Sepúlveda Gutiérrez\", Unidad de Investigación Médica en Bioquímica, Ciudad de Mexico 06720, Mexico.'}, {'lastname': 'Romero-Nava', 'firstname': 'Rodrigo', 'initials': 'R', 'affiliation': 'Laboratorio de Señalización Intracelular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.'}, {'lastname': 'Del-Río-Navarro', 'firstname': 'Blanca E', 'initials': 'BE', 'affiliation': 'Servicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.'}, {'lastname': 'Sánchez-Muñoz', 'firstname': 'Fausto', 'initials': 'F', 'affiliation': 'Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.'}, {'lastname': 'Guzmán-Martín', 'firstname': 'Carlos A', 'initials': 'CA', 'affiliation': 'Departamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.'}, {'lastname': 'Reyes-Noriega', 'firstname': 'Nayely', 'initials': 'N', 'affiliation': 'Laboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.\\nServicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.'}, {'lastname': 'Rodríguez-Cortés', 'firstname': 'Octavio', 'initials': 'O', 'affiliation': 'Laboratorio de Inflamación y Obesidad, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.'}, {'lastname': 'Leija-Martínez', 'firstname': 'José J', 'initials': 'JJ', 'affiliation': 'Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.'}, {'lastname': 'Vélez-Reséndiz', 'firstname': 'Juan Manuel', 'initials': 'JM', 'affiliation': 'Laboratorio Multidisciplinario de Nanomedicina y de Farmacología Cardiovascular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.'}, {'lastname': 'Villafaña', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': 'Laboratorio de Señalización Intracelular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.'}, {'lastname': 'Hong', 'firstname': 'Enrique', 'initials': 'E', 'affiliation': 'Departamento de Farmacobiología, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico 14330, Mexico.'}, {'lastname': 'Huang', 'firstname': 'Fengyang', 'initials': 'F', 'affiliation': 'Laboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/nu16030341\\n10.1016/S0140-6736(19)31147-X\\n10.1002/alr.22464\\n10.1007/s00281-020-00785-1\\n10.1136/thoraxjnl-2015-207199\\n10.1016/j.smim.2019.101333\\n10.1016/S0140-6736(22)02125-0\\n10.1042/CS20191309\\n10.1183/13993003.03393-2020\\n10.1183/23120541.00576-2021\\n10.4049/jimmunol.2000964\\n10.3389/fendo.2022.920340\\n10.3389/fnut.2022.954768\\n10.3390/nu15102379\\n10.1007/s00408-023-00605-x\\n10.1016/j.pedn.2021.07.005\\n10.1016/j.rmed.2019.02.016\\n10.1002/bit.28029\\n10.3390/ijms21072357\\n10.3390/jpm11040307\\n10.3390/jpm12040543\\n10.1016/j.jaci.2016.01.029\\n10.1371/journal.pone.0157998\\n10.18502/ijaai.v19i3.3456\\n10.3389/fimmu.2014.00043\\n10.1210/jc.2011-0385\\n10.18502/ijaai.v20i2.6049\\n10.1111/all.15480\\n10.1177/1753425920901563\\n10.1177/1753425918763521\\n10.3346/jkms.2022.37.e236\\n10.2147/JAA.S307165\\n10.3109/01902148.2015.1090501\\n10.4168/aair.2021.13.2.312\\n10.2174/2211536604666150414203919\\n10.3390/ncrna4040037\\n10.1016/j.aller.2019.05.001\\n10.1084/jem.20100035\\n10.1016/j.redox.2023.102681\\n10.1016/j.celrep.2022.111948\\n10.3389/fped.2018.00301\\n10.1111/cea.12155\\n10.1080/02770903.2023.2225605\\n10.1016/j.jaci.2015.05.031\\n10.1172/jci.insight.97503\\n10.3892/ijmm.2015.2318\\n10.18502/ijaai.v21i4.10290\\n10.1038/s41598-019-57288-9\\n10.1016/B978-0-12-819178-1.00017-4\\n10.1016/j.prp.2022.153780\\n10.2147/COPD.S130616\\n10.1371/journal.pone.0224983\\n10.1016/j.jaci.2020.11.048\\n10.1016/j.jaci.2011.04.005\\n10.1177/0300060518789819\\n10.18632/oncotarget.17933\\n10.1007/s11010-015-2519-7\\n10.1080/01902148.2016.1256452\\n10.2147/JMDH.S391996\\n10.18632/oncotarget.3048\\n10.3390/nu14132589\\n10.1016/j.imlet.2020.07.008\\n10.1371/journal.pone.0205434\\n10.1186/s12931-020-01351-x\\n10.2147/JAA.S398494\\n10.1016/j.cell.2010.08.012\\n10.22088/IJMCM.BUMS.9.4.246\\n10.1159/000491438\\n10.1002/ctm2.427\\n10.1080/20013078.2020.1723260\\n10.1186/s13601-019-0301-8\\n10.1016/j.prostaglandins.2019.106378\\n10.1080/21655979.2021.1927545\\n10.1159/000524718\\n10.3892/etm.2016.3427\\n10.3969/J.ISSN.1008-7125.2017.11.003\\n10.1155/2019/4352470\\n10.1080/15592294.2016.1276681\\n10.1080/20477724.2022.2101840\\n10.1007/s00424-023-02788-x\\n10.1080/09603123.2018.1506569\\n10.1016/j.clinbiochem.2019.04.007\\n10.3892/etm.2017.5093\\n10.1016/j.jaci.2013.11.008\\n10.4049/jimmunol.1701167\\n10.1159/000487573\\n10.4049/jimmunol.1203273\\n10.1016/j.meegid.2018.12.033\\n10.1111/exd.13276\\n10.1378/chest.07-1881\\n10.1016/j.jaci.2020.05.039\\n10.1016/j.jaci.2017.08.020\\n10.3390/ncrna5040051\\n10.1038/s41598-017-00431-1\\n10.1111/all.12551\\n10.1007/s10753-022-01739-5\\n10.2174/2211536610666211221151949\\n10.3390/jcm11185446\\n10.1111/all.14008\\n10.15586/aei.v51i1.736\\n10.1021/acs.jafc.5b04861\\n10.3389/fimmu.2018.02992\\n10.1165/rcmb.2016-0163OC\\n10.1016/j.ajpath.2016.12.020\\n10.1016/j.cellsig.2022.110340\\n10.3390/ijms23095019\\n10.1111/crj.13424\\n10.1159/000519703', 'xml': <Element 'PubmedArticle' at 0x10a010860>}\n",
      "{'pubmed_id': '38337592\\n34085124\\n32423575\\n32653648\\n33039648\\n32035604\\n12789212\\n19237391\\n15080825\\n28822787\\n36754956\\n22005911\\n18331513\\n22948386\\n26688525\\n27886386\\n27059095\\n27155030\\n28306159\\n31031841\\n30518277\\n34833091\\n34088713\\n12016186\\n28461291\\n37171821\\n31445223\\n37042071\\n24783916\\n27128779\\n33227742\\n22894049\\n22617736\\n26354131\\n38041429\\n31706487\\n29036020\\n34391027\\n32561497\\n30055283\\n29343463\\n35107807\\n33556030\\n32718193\\n25393915\\n25075231\\n26831740\\n35691614\\n27992659\\n35389354\\n35613744\\n29301919\\n36038131\\n33334936\\n32943094\\n28743679\\n29688023\\n35361176\\n37174938\\n30145683\\n32142961\\n28302126\\n12535399\\n17981317\\n25494553\\n34861010\\n28111110\\n30803885\\n29972087\\n30386555\\n36434742\\n36705508\\n32301735\\n12612228\\n33652136\\n36893423\\n33822736\\n34660024\\n36647422\\n32784177\\n29716883\\n37215337\\n25878950\\n28982768\\n33618053\\n31883444', 'title': 'Tele-Monitoring Applications in Respiratory Allergy.', 'abstract': 'Respiratory allergic diseases affect over 500 million people globally and pose a substantial burden in terms of morbidity, mortality, and healthcare costs. Restrictive factors such as geographical disparities, infectious pandemics, limitations in resources, and shortages of allergy specialists in underserved areas impede effective management. Telemedicine encompasses real-time visits, store-and-forward option triage, and computer-based technologies for establishing efficient doctor-patient communication. Recent advances in digital technology, including designated applications, informative materials, digital examination devices, wearables, digital inhalers, and integrated platforms, facilitate personalized and evidence-based care delivery. The integration of telemonitoring in respiratory allergy care has shown beneficial effects on disease control, adherence, and quality of life. While the COVID-19 pandemic accelerated the adoption of telemedicine, certain concerns regarding technical requirements, platform quality, safety, reimbursement, and regulatory considerations remain unresolved. The integration of artificial intelligence (AI) in telemonitoring applications holds promise for data analysis, pattern recognition, and personalized treatment plans. Striking the balance between AI-enabled insights and human expertise is crucial for optimizing the benefits of telemonitoring. While telemonitoring exhibits potential for enhancing patient care and healthcare delivery, critical considerations have to be addressed in order to ensure the successful integration of telemonitoring into the healthcare landscape.', 'keywords': ['adherence', 'applications', 'asthma', 'respiratory allergy', 'tele-monitoring', 'telemedicine'], 'journal': 'Journal of clinical medicine', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Aggelidis', 'firstname': 'Xenofon', 'initials': 'X', 'affiliation': 'Allergy Unit, 2nd Department of Dermatology and Venereology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Kritikou', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Makris', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Allergy Unit, 2nd Department of Dermatology and Venereology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Miligkos', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Papapostolou', 'firstname': 'Niki', 'initials': 'N', 'affiliation': 'Allergy Unit, 2nd Department of Dermatology and Venereology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Papadopoulos', 'firstname': 'Nikolaos G', 'initials': 'NG', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}, {'lastname': 'Xepapadaki', 'firstname': 'Paraskevi', 'initials': 'P', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, 15772 Athens, Greece.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/jcm13030898\\n10.1007/164_2021_483\\n10.1016/j.jaip.2020.05.001\\n10.1016/j.jaip.2020.06.044\\n10.1016/j.jaip.2020.10.005\\n10.1016/j.jaci.2019.12.903\\n10.1067/mai.2003.1592\\n10.1136/thx.2008.106609\\n10.1111/j.1398-9995.2004.00526.x\\n10.1016/S2213-2600(17)30293-X\\n10.1038/s41533-023-00330-1\\n10.1183/09031936.00061611\\n10.1111/j.1398-9995.2007.01620.x\\n10.1159/000338998\\n10.5588/ijtld.15.0472\\n10.1111/all.13098\\n10.4193/Rhino14.282\\n10.1016/j.jaci.2016.03.010\\n10.1111/all.13162\\n10.1183/20734735.0362-2018\\n10.1080/17476348.2019.1554438\\n10.3390/life11111215\\n10.1136/bmjebm-2020-111573\\n10.1136/bmj.324.7347.1193\\n10.1183/13993003.01966-2016\\n10.1001/jamanetworkopen.2023.13120\\n10.1016/j.jaip.2019.07.044\\n10.1111/all.15740\\n10.5455/medarh.2014.68.57-60\\n10.1089/tmj.2016.0045\\n10.3233/SHTI200696\\n10.1108/S1474-8231(2012)0000012011\\n10.1017/S0266462311000638\\n10.1016/j.zefq.2015.06.011\\n10.1111/all.15964\\n10.1016/j.jaip.2019.08.017\\n10.1097/MCP.0000000000000439\\n10.1016/j.ijnurstu.2021.104037\\n10.1016/j.jaip.2020.06.001\\n10.1016/j.jaip.2018.07.015\\n10.2196/mhealth.8873\\n10.1007/s11882-022-01030-5\\n10.2196/22696\\n10.1080/02770903.2020.1802746\\n10.1089/tmj.2014.0119\\n10.2196/med20.1741\\n10.1001/jamainternmed.2015.7667\\n10.1002/14651858.CD013030\\n10.1111/pai.12690\\n10.2196/33389\\n10.1183/16000617.0271-2021\\n10.1183/13993003.01126-2017\\n10.1016/j.jaip.2022.08.023\\n10.1183/13993003.03103-2020\\n10.1186/s13063-020-04694-4\\n10.2196/mhealth.7346\\n10.1164/rccm.201712-2606OC\\n10.1186/s12890-022-01896-1\\n10.3390/diagnostics13091545\\n10.1007/s11882-018-0809-3\\n10.1016/j.jaip.2020.02.018\\n10.1186/s12916-017-0823-7\\n10.1002/14651858.CD001117\\n10.1016/j.jaci.2007.09.019\\n10.3109/02770903.2014.995307\\n10.1177/8755122519830446\\n10.1016/j.anai.2016.11.028\\n10.1016/j.rmed.2019.02.009\\n10.1080/02770903.2018.1490750\\n10.1186/s13601-018-0227-6\\n10.1002/clt2.12208\\n10.1002/clt2.12215\\n10.2196/15514\\n10.1542/peds.111.3.503\\n10.1016/j.jaip.2021.02.028\\n10.1016/j.chpulm.2023.100002\\n10.1097/MLR.0000000000001808\\n10.2196/28589\\n10.7759/cureus.17814\\n10.2147/RMHP.S396495\\n10.2196/20359\\n10.2196/10235\\n10.4103/2229-3485.153997\\n10.1183/13993003.01413-2017\\n10.1016/j.jaip.2021.02.014\\n10.1016/j.jaci.2019.12.898', 'xml': <Element 'PubmedArticle' at 0x109ac54e0>}\n",
      "{'pubmed_id': '38337559\\n32077450\\n37070949\\n33236525\\n32217158\\n36999780\\n35012708\\n26949058\\n35469844\\n32770835\\n35818923\\n27859303\\n35305978\\n2180446\\n14520093\\n21038025\\n30663058\\n22144062\\n34742931\\n25907972\\n33019818\\n37184241\\n35666318\\n31904028\\n37991673\\n38229517\\n17084217\\n27017484\\n26934470\\n26980396\\n19793277\\n25510986\\n24615873\\n8140385\\n34708838\\n36729451\\n36200712\\n25622913\\n25479206\\n32462321\\n31249662\\n29164622\\n25891944\\n31752051\\n29106996\\n31543428\\n35934318\\n33417297\\n30688317\\n34294226\\n32001254\\n33227318\\n31671433\\n20238223\\n25946047', 'title': 'Long-Term Clinical Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Associated with Expanded Types of Endoscopic Sinus Surgery.', 'abstract': '(1) Background: Surgical criteria for chronic rhinosinusitis with nasal polyps (CRSwNP) remain unresolved. This study addresses these discrepancies by comparing the clinical outcomes of expanded-functional endoscopic sinus surgeries (E-FESS) with more-limited FESS (L-FESS). (2) Methods: A database was analyzed retrospectively to compare surgical outcomes in CRSwNP patients who underwent E-FESS versus those subjected to L-FESS. Quality of life, endoscopic and radiological outcomes were compared at the baseline and two years after surgery. The clinical status of the responder was defined when a minimal clinically important difference of 12 points in SNOT-22 change was achieved. (3) Results: A total of 274 patients met the inclusion criteria and were analyzed; 111 underwent E-FESS and 163 were subjected to L-FESS. Both groups exhibited significant clinical improvements, although a greater magnitude of change in SNOT-22 (14.8 ± 4.8, ', 'keywords': ['SNOT-22', 'chronic rhinosinusitis', 'ethmoid', 'nasal polyps', 'nasal surgical procedures', 'paranasal sinuses', 'quality of life'], 'journal': 'Journal of clinical medicine', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Martin-Jimenez', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.'}, {'lastname': 'Moreno-Luna', 'firstname': 'Ramon', 'initials': 'R', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.'}, {'lastname': 'Callejon-Leblic', 'firstname': 'Amparo', 'initials': 'A', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.\\nBiomedical Engineering Group, University of Seville, 41004 Seville, Spain.'}, {'lastname': 'Del Cuvillo', 'firstname': 'Alfonso', 'initials': 'A', 'affiliation': 'Rhinology and Asthma Unit, Department of Otolaryngology, Jerez University Hospital, 11407 Jerez, Spain.'}, {'lastname': 'Ebert', 'firstname': 'Charles S', 'initials': 'CS', 'affiliation': 'Department of Otolaryngology-Head & Neck Surgery, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.'}, {'lastname': 'Maza-Solano', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.'}, {'lastname': 'Gonzalez-Garcia', 'firstname': 'Jaime', 'initials': 'J', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.'}, {'lastname': 'Infante-Cossio', 'firstname': 'Pedro', 'initials': 'P', 'affiliation': 'Department of Surgery, School of Medicine, University of Seville, 41009 Seville, Spain.'}, {'lastname': 'Sanchez-Gomez', 'firstname': 'Serafin', 'initials': 'S', 'affiliation': 'Rhinology Unit, Department of Otolaryngology, Head and Neck Surgery, Virgen Macarena University Hospital, 41009 Seville, Spain.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/jcm13030866\\n10.4193/Rhin20.401\\n10.18176/jiaci.0910\\n10.1002/alr.22741\\n10.1016/j.jaip.2020.03.007\\n10.4193/Rhin22.489\\n10.1016/S2213-2600(21)00457-4\\n10.1016/j.jaci.2015.12.1324\\n10.1016/j.jaci.2022.04.013\\n10.1111/all.14550\\n10.4193/Rhin22.131\\n10.1002/lary.26391\\n10.1016/j.jaci.2022.02.029\\n10.1007/BF00183169\\n10.1097/00005537-200310000-00008\\n10.4193/Rhino09.123\\n10.1002/lary.27815\\n10.1002/alr.20081\\n10.1016/j.jaip.2021.10.054\\n10.1002/alr.21541\\n10.1177/1945892420961964\\n10.4193/RHINOL/21.029\\n10.1007/s40136-023-00475-0\\n10.1002/alr.23178\\n10.1007/s00405-022-07470-z\\n10.4193/Rhin19.184\\n10.1007/s11882-023-01113-x\\n10.1002/alr.23321\\n10.1016/j.jaci.2006.09.005\\n10.4193/Rhino15.072\\n10.4193/Rhino16.023\\n10.2500/ajra.2016.30.4271\\n10.1111/j.1749-4486.2009.01995.x\\n10.1007/s00405-014-3437-0\\n10.1002/lary.24654\\n10.4193/Rhin21.253\\n10.1001/jamaoto.2022.4703\\n10.1002/lary.30422\\n10.1002/alr.21488\\n10.4193/Rhino12.198\\n10.1007/s11882-020-00932-6\\n10.1186/s13601-019-0269-4\\n10.1002/lary.27008\\n10.1002/lary.25318\\n10.1002/alr.22487\\n10.1016/j.jaci.2017.10.006\\n10.1016/S0140-6736(19)31881-1\\n10.4193/Rhin21.148\\n10.1002/alr.22744\\n10.4193/Rhin18.178\\n10.1016/j.otorri.2020.08.002\\n10.1016/j.jaci.2020.01.019\\n10.1016/j.jaci.2020.11.013\\n10.4193/Rhin19.213\\n10.1007/s00405-010-1233-z\\n10.1002/lary.25334', 'xml': <Element 'PubmedArticle' at 0x1250d0d10>}\n",
      "{'pubmed_id': '38337552\\n14522812\\n18498538\\n19769993\\n20668012\\n24888725\\n18178673\\n17035440\\n7663804\\n26070934\\n30431352\\n32106233\\n19911854\\n8403956\\n32632352\\n9428298\\n10498049\\n30664522\\n10208189\\n6372560\\n11693841\\n22348210\\n34847965\\n10796650\\n17277891\\n34915226\\n34246434\\n9895400\\n32023077\\n31485410\\n25445859\\n28702957\\n28860265\\n7486361\\n11733289\\n12684289\\n20420722\\n18344635\\n19484669\\n22781558\\n32663410\\n20956164\\n26033128\\n29105540\\n6703497\\n3662241\\n7735578\\n2665589\\n29212551\\n1519836\\n13102418\\n24015139\\n24082612\\n9842833\\n36008492\\n8968457\\n17079642\\n7952641\\n8087364\\n25249747\\n11373509\\n11029345\\n15891322\\n7956391\\n8291152\\n14991090\\n29019893\\n28808576\\n23842616\\n31452899\\n27903208\\n24144910\\n23887087\\n19092662\\n35545240\\n35168180\\n30314929', 'title': 'Critical Care Management of Severe Asthma Exacerbations.', 'abstract': 'Severe asthma exacerbations, including near-fatal asthma (NFA), have high morbidity and mortality. Mechanical ventilation of patients with severe asthma is difficult due to the complex pathophysiology resulting from severe bronchospasm and dynamic hyperinflation. Life-threatening complications of traditional ventilation strategies in asthma exacerbations include the development of systemic hypotension from hyperinflation, air trapping, and pneumothoraces. Optimizing pharmacologic techniques and ventilation strategies is crucial to treat the underlying bronchospasm. Despite optimal pharmacologic management and mechanical ventilation, the mortality rate of patients with severe asthma in intensive care units is 8%, suggesting a need for advanced non-pharmacologic therapies, including extracorporeal life support (ECLS). This review focuses on the pathophysiology of acute asthma exacerbations, ventilation management including non-invasive ventilation (NIV) and invasive mechanical ventilation (IMV), the pharmacologic management of acute asthma, and ECLS. This review also explores additional advanced non-pharmacologic techniques and monitoring tools for the safe and effective management of critically ill adult asthmatic patients.', 'keywords': ['asthma', 'bronchospasm', 'dynamic hyperinflation', 'extracorporeal life support', 'mechanical ventilation', 'non-invasive ventilation'], 'journal': 'Journal of clinical medicine', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Gayen', 'firstname': 'Shameek', 'initials': 'S', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Dachert', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Lashari', 'firstname': 'Bilal H', 'initials': 'BH', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Gordon', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Desai', 'firstname': 'Parag', 'initials': 'P', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Criner', 'firstname': 'Gerard J', 'initials': 'GJ', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}, {'lastname': 'Cardet', 'firstname': 'Juan Carlos', 'initials': 'JC', 'affiliation': 'Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL 33602, USA.'}, {'lastname': 'Shenoy', 'firstname': 'Kartik', 'initials': 'K', 'affiliation': 'Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, Philadelphia, PA 19140, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3390/jcm13030859\\n10.1164/rccm.200208-902SO\\n10.1111/j.1365-2222.2008.02971.x\\n10.1016/j.mrfmmm.2009.09.005\\n10.1378/chest.10-0100\\n10.1111/all.12452\\n10.1152/ajplung.00394.2007\\n10.1378/chest.130.4.1072\\n10.1164/ajrccm.152.3.7663804\\n10.1016/j.cyto.2015.05.014\\n10.1513/AnnalsATS.201807-485AW\\n10.1371/journal.pone.0229238\\n10.2165/11319930-000000000-00000\\n10.1097/00003246-199310000-00015\\n10.1186/s40733-020-00059-5\\n10.3109/02770909709055396\\n10.3109/02770909909054560\\n10.1097/MJT.0000000000000843\\n10.1378/chest.115.4.937\\n10.1164/arrd.1984.129.5.856\\n10.1089/089426801316970259\\n10.5415/apallergy.2012.2.1.76\\n10.1186/s40733-021-00081-1\\n10.1002/14651858.CD001490\\n10.1007/s00005-007-0008-8\\n10.1016/j.jaip.2021.11.028\\n10.1016/j.jaip.2021.05.016\\n10.1056/NEJM199901213400306\\n10.1164/rccm.202001-0093LE\\n10.1016/j.rmcr.2019.100927\\n10.1016/j.ajem.2014.09.036\\n10.1002/14651858.CD004104.pub4\\n10.1183/13993003.02426-2016\\n10.1016/S0196-0644(95)70003-X\\n10.1111/j.1553-2712.2001.tb01128.x\\n10.1378/chest.123.4.1018\\n10.2169/internalmedicine.47.0429\\n10.1080/02770900902718829\\n10.4187/respcare.01371\\n10.1164/rccm.201910-2021OC\\n10.1001/archinte.1939.00180220136012\\n10.1183/09059180.00006109\\n10.1378/chest.14-1733\\n10.1177/0885066617740079\\n10.1164/arrd.1984.129.3.385\\n10.1164/ajrccm/136.4.872\\n10.1164/ajrccm.151.5.7735578\\n10.1164/ajrccm/140.1.5\\n10.1186/s13054-017-1886-8\\n10.1164/ajrccm/146.3.607\\n10.1136/thx.8.3.207\\n10.4103/1658-354X.115323\\n10.4103/0972-5229.117048\\n10.1097/00000539-199812000-00033\\n10.1007/s00228-022-03374-3\\n10.1177/106002809603001213\\n10.1007/BF03022883\\n10.1164/ajrccm.150.6.7952641\\n10.1164/ajrccm.150.3.8087364\\n10.4103/0972-5229.140154\\n10.1097/00075198-200102000-00006\\n10.1164/ajrccm.162.4.9808092\\n10.1097/01.CCM.0000163403.42842.FE\\n10.1378/chest.106.5.1401\\n10.1007/s00134-004-2187-7\\n10.1097/MD.0000000000008248\\n10.1186/s40560-017-0247-7\\n10.1177/0267659113494964\\n10.1186/s40560-019-0399-8\\n10.1016/S1441-2772(23)00802-5\\n10.1016/j.hlc.2013.08.009\\n10.1177/0267659113497073\\n10.1097/MAT.0b013e3181901ea5\\n10.4266/acc.2021.01312\\n10.1016/j.thromres.2022.02.007\\n10.1016/j.jemermed.2018.09.009', 'xml': <Element 'PubmedArticle' at 0x108efcb30>}\n",
      "{'pubmed_id': '38337448\\n23154224\\n19231593\\n18384431\\n37947596\\n19375458\\n34052871\\n27866580\\n7937446\\n10741866\\n30499630\\n33891831\\n34533850\\n36207764\\n31729944\\n16450738\\n37108417\\n32034960\\n35272048\\n12406833\\n22901886\\n31734469\\n34289975\\n27110133\\n32060069\\n34534050\\n22900679\\n35625708\\n33143407\\n26820733\\n34507711\\n36754956\\n31627910\\n31860372\\n17194469\\n28465694\\n31292426\\n34932829\\n32469005\\n32073625\\n37391004\\n31221806\\n22544896\\n9678837\\n9438494\\n1586007\\n2913131\\n27590639\\n29052302\\n32868307\\n37086239\\n29312946\\n33916211\\n32495256\\n36902623\\n31977298\\n34162391\\n34538424\\n35958837\\n36400178\\n34475229\\n27609406\\n27609408\\n37146880\\n36314316\\n36769635\\n37210543\\n36768778\\n35752279\\n24606022\\n26653198', 'title': 'Eosinophilic Patterns in Patients with Seasonal Allergy Affected by Bronchial Asthma and Rhinitis/Rhinosinusitis: Efficacy of Benralizumab in Patients with the Persistent Pattern.', 'abstract': \"Eosinophilia can be influenced by multiple factors. This study aims to set a protocol for monitoring blood absolute eosinophil count (AEC) in patients with seasonal allergy affected by bronchial asthma (BA), allergic rhinitis (AR), or chronic rhinosinusitis with or without nasal polyposis (CRSw/sNP).\\nWe planned a total of four annual blood samples to measure AEC in- and out-seasonal pollen exposure (i.e., one measurement every three months for one year).\\nWe identified two distinct groups of patients (non-eosinophilic and eosinophilic). Patients in the eosinophilic group presented with four different patterns (episodic, transient, floating, and persistent). Most patients with episodic, transient, and floating patterns were affected by mild allergy and the increase in eosinophils was related to allergen exposure. In contrast, patients with the persistent pattern mostly presented with more severe allergy (i.e., severe BA and relapsing CRSwNP) and the eosinophilia was unrelated to allergen exposure. The subgroup of patients with severe BA, relapsing CRSwNP, and persistent eosinophilc pattern were treated with benralizumab, which induced a noteworthy improvement in both severe BA and CRSwNP.\\nMultiple AEC measurements in patients with seasonal allergy can better reflect patient's eosinophilic status and help define the relationship of AEC enhancement with allergen exposure.\", 'keywords': ['allergic rhinitis', 'asthma', 'benralizumab', 'chronic rhinosinusitis', 'chronic rhinosinusitis with nasal polyposis', 'eosinophils', 'interleukin-5'], 'journal': 'Journal of clinical medicine', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': \"D'Aiuto\", 'firstname': 'Valentina', 'initials': 'V', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Mormile', 'firstname': 'Ilaria', 'initials': 'I', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Granata', 'firstname': 'Francescopaolo', 'initials': 'F', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Romano', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'Head and Neck Section, Department of Neurosciences, Reproductive and Odontostomatological Science, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Della Casa', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': \"D'Onofrio\", 'firstname': 'Caterina', 'initials': 'C', 'affiliation': 'Post-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Marzio', 'firstname': 'Valentina', 'initials': 'V', 'affiliation': 'Post-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Mignogna', 'firstname': 'Gabriele', 'initials': 'G', 'affiliation': 'Post-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Califano', 'firstname': 'Luigi', 'initials': 'L', 'affiliation': 'Head and Neck Section, Department of Neurosciences, Reproductive and Odontostomatological Science, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'de Paulis', 'firstname': 'Amato', 'initials': 'A', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.\\nCenter for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, 80131 Naples, Italy.'}, {'lastname': 'Rossi', 'firstname': 'Francesca Wanda', 'initials': 'FW', 'affiliation': 'Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.\\nCenter for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, 80131 Naples, Italy.'}], 'methods': None, 'conclusions': None, 'results': 'We identified two distinct groups of patients (non-eosinophilic and eosinophilic). Patients in the eosinophilic group presented with four different patterns (episodic, transient, floating, and persistent). Most patients with episodic, transient, and floating patterns were affected by mild allergy and the increase in eosinophils was related to allergen exposure. In contrast, patients with the persistent pattern mostly presented with more severe allergy (i.e., severe BA and relapsing CRSwNP) and the eosinophilia was unrelated to allergen exposure. The subgroup of patients with severe BA, relapsing CRSwNP, and persistent eosinophilc pattern were treated with benralizumab, which induced a noteworthy improvement in both severe BA and CRSwNP.', 'copyrights': None, 'doi': '10.3390/jcm13030754\\n10.1038/nri3341\\n10.1016/S0065-2776(08)01003-1\\n10.1111/j.1365-2222.2008.02958.x\\n10.3390/cells12212518\\n10.1016/j.antiviral.2009.04.005\\n10.1007/s00281-021-00863-y\\n10.1016/j.pop.2016.07.010\\n10.1136/pgmj.70.826.536\\n10.1007/BF02790409\\n10.1111/ijlh.12955\\n10.1513/AnnalsATS.202010-1249OC\\n10.1002/ajh.26352\\n10.1111/all.15544\\n10.2174/1573396315666191114150438\\n10.1024/0040-5930.63.1.83\\n10.3390/ijms24087254\\n10.1111/all.14221\\n10.1016/j.anai.2022.02.021\\n10.1164/rccm.200208-789OC\\n10.1016/S0140-6736(12)60988-X\\n10.1016/j.rmed.2019.105819\\n10.1183/13993003.04306-2020\\n10.2147/JAA.S78049\\n10.1183/13993003.01874-2019\\n10.1513/AnnalsATS.202103-409OC\\n10.3109/02770903.2012.713428\\n10.3390/biomedicines10050971\\n10.23812/20-297-A\\n10.1007/5584_2015_206\\n10.1016/j.jaip.2021.07.002\\n10.1038/s41533-023-00330-1\\n10.1016/j.jaci.2019.06.049\\n10.1080/02770903.2019.1708098\\n10.1016/j.jaci.2006.08.042\\n10.1186/s13223-017-0196-7\\n10.23750/abm.v90i7-S.8657\\n10.1111/all.15199\\n10.14639/0392-100X-N0364\\n10.1093/occmed/kqaa030\\n10.1016/j.resp.2023.104094\\n10.1183/13993003.00561-2019\\n10.1136/thoraxjnl-2011-201445\\n10.1111/j.1365-2222.1997.tb01257.x\\n10.1016/S0091-6749(97)70281-1\\n10.1016/0091-6749(89)90485-5\\n10.1016/j.anai.2016.08.010\\n10.1111/resp.13200\\n10.3949/ccjm.87a.19136\\n10.1016/j.jaci.2023.03.011\\n10.3389/fmed.2017.00240\\n10.3390/jcm10071442\\n10.1007/s10620-020-06368-2\\n10.3390/jcm12051836\\n10.1146/annurev-pathmechdis-012419-032756\\n10.1186/s12931-021-01775-z\\n10.1016/j.mayocp.2021.04.025\\n10.3389/fpubh.2022.954721\\n10.1016/j.jaci.2022.10.028\\n10.1183/13993003.00935-2021\\n10.1016/S0140-6736(16)31322-8\\n10.1016/S0140-6736(16)31324-1\\n10.1016/j.jaip.2023.04.029\\n10.26355/eurrev_202210_30016\\n10.3390/jcm12030985\\n10.1186/s12931-023-02439-w\\n10.3390/ijms24032455\\n10.1016/j.imlet.2022.06.009\\n10.1513/AnnalsATS.201310-354OC\\n10.1513/AnnalsATS.201507-443LE', 'xml': <Element 'PubmedArticle' at 0x108e2bbf0>}\n",
      "{'pubmed_id': '38336805\\n23341027\\n23597554\\n24625129\\n17989387\\n17989387\\n19809022\\n24529685\\n13679930\\n11401896\\n9670828\\n24739494\\n24429276\\n25729750\\n26038806\\n29520136\\n23582966\\n28666441\\n33371011\\n10673467\\n10843939\\n18274560\\n17937589\\n27373322\\n25746968\\n31748421\\n19542429\\n35901921\\n16580185\\n24264182\\n19468239\\n31076230\\n35210327\\n31126291\\n19906521\\n16264058\\n16055882\\n33526979\\n27027948\\n34769255\\n31265968\\n26808506\\n31558663\\n31823713\\n27840831\\n28623901\\n35764345\\n27742002\\n32443685\\n32473946\\n28668285', 'title': 'Large airway T cells in adults with former bronchopulmonary dysplasia.', 'abstract': 'Bronchopulmonary Dysplasia (BPD) in infants born prematurely is a risk factor for chronic airway obstruction later in life. The distribution of T cell subtypes in the large airways is largely unknown.\\nTo characterize cellular and T cell profiles in the large airways of young adults with a history of BPD.\\nForty-three young adults born prematurely (preterm (n\\u2009=\\u200920), BPD (n\\u2009=\\u200923)) and 45 full-term-born (asthma (n\\u2009=\\u200923), healthy (n\\u2009=\\u200922)) underwent lung function measurements, and bronchoscopy with large airway bronchial wash (BW). T-cells subsets in BW were analyzed by immunocytochemistry.\\nThe proportions of both lymphocytes and CD8\\u2009+\\u2009T cells in BW were significantly higher in BPD (median, 6.6%, and 78.0%) when compared with asthma (3.4% and 67.8%, p\\u2009=\\u20090.002 and p\\u2009=\\u20090.040) and healthy (3.8% and 40%, p\\u2009<\\u20090.001 and p\\u2009<\\u20090.001). In all adults born prematurely (preterm and BPD), lymphocyte proportion correlated negatively with forced vital capacity (r= -0.324, p\\u2009=\\u20090.036) and CD8\\u2009+\\u2009T cells correlated with forced expiratory volume in one second, FEV\\nThe increased cytotoxic T cells in the large airways in young adults with former BPD, suggest a similar T-cell subset pattern as in the small airways, resembling features of COPD. Our findings strengthen the hypothesis that mechanisms involving adaptive and innate immune responses are involved in the development of airway disease due to preterm birth.', 'keywords': ['Adults', 'Asthma', 'Bronchial wash', 'Bronchopulmonary dysplasia', 'Lymphocytes'], 'journal': 'Respiratory research', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Gao', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden. jing.gao@ki.se.'}, {'lastname': 'Um-Bergström', 'firstname': 'Petra', 'initials': 'P', 'affiliation': \"Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.\\nDepartment of Pediatrics, Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.\\nDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.\"}, {'lastname': 'Pourbazargan', 'firstname': 'Melvin', 'initials': 'M', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.\\nDepartment of Emergency and Reparative Medicine, Karolinska University Hospital, Stockholm, Sweden.'}, {'lastname': 'Berggren-Broström', 'firstname': 'Eva', 'initials': 'E', 'affiliation': \"Department of Pediatrics, Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.\\nDepartment of Emergency and Reparative Medicine, Karolinska University Hospital, Stockholm, Sweden.\"}, {'lastname': 'Li', 'firstname': 'ChuanXing', 'initials': 'C', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.'}, {'lastname': 'Merikallio', 'firstname': 'Heta', 'initials': 'H', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.\\nResearch Unit of Internal Medicine and Medical Research Center Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland.'}, {'lastname': 'Kaarteenaho', 'firstname': 'Riitta', 'initials': 'R', 'affiliation': 'Research Unit of Internal Medicine and Medical Research Center Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland.'}, {'lastname': 'Reinke', 'firstname': 'Nichole Stacey', 'initials': 'NS', 'affiliation': 'Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.\\nCentre for Integrative Metabolomics and Computational Biology, School of Science, Edith Cowan University, Perth, Australia.'}, {'lastname': 'Wheelock', 'firstname': 'Craig E', 'initials': 'CE', 'affiliation': 'Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.\\nDepartment of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.\\nGunma University Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan.'}, {'lastname': 'Melén', 'firstname': 'Erik', 'initials': 'E', 'affiliation': \"Department of Pediatrics, Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.\\nDepartment of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.\\nDivision of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.\"}, {'lastname': 'Anders', 'firstname': 'Lindén', 'initials': 'L', 'affiliation': 'Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.\\nDivision of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Wheelock', 'firstname': 'Åsa M', 'initials': 'ÅM', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.\\nDepartment of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.'}, {'lastname': 'Rassidakis', 'firstname': 'Georgios', 'initials': 'G', 'affiliation': 'Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.'}, {'lastname': 'Ortiz-Villalon', 'firstname': 'Cristian', 'initials': 'C', 'affiliation': 'Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.\\nDepartment of Pathology, Karolinska University Hospital, Stockholm, Sweden.'}, {'lastname': 'Sköld', 'firstname': 'Magnus Carl', 'initials': 'MC', 'affiliation': 'Respiratory Medicine Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, 171 76, Sweden.\\nDepartment of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.'}], 'methods': None, 'conclusions': None, 'results': 'The proportions of both lymphocytes and CD8\\u2009+\\u2009T cells in BW were significantly higher in BPD (median, 6.6%, and 78.0%) when compared with asthma (3.4% and 67.8%, p\\u2009=\\u20090.002 and p\\u2009=\\u20090.040) and healthy (3.8% and 40%, p\\u2009<\\u20090.001 and p\\u2009<\\u20090.001). In all adults born prematurely (preterm and BPD), lymphocyte proportion correlated negatively with forced vital capacity (r= -0.324, p\\u2009=\\u20090.036) and CD8\\u2009+\\u2009T cells correlated with forced expiratory volume in one second, FEV', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12931-024-02717-1\\n10.1007/s10654-013-9761-7\\n10.1016/j.pedneo.2013.03.001\\n10.1186/1742-4755-10-S1-S2\\n10.1056/NEJMra067279\\n10.1056/NEJMra067279\\n10.1001/jama.2009.1419\\n10.1016/j.jaci.2013.12.1082\\n10.1038/sj.jp.7210963\\n10.1164/ajrccm.163.7.2011060\\n10.1016/S0046-8177(98)90280-5\\n10.1097/MOP.0000000000000095\\n10.1016/S2213-2600(13)70118-8\\n10.1164/rccm.201412-2142PP\\n10.2147/COPD.S153555\\n10.1053/j.semperi.2013.01.008\\n10.1186/s12890-017-0441-3\\n10.1378/chest.117.2_suppl.10S\\n10.1378/chest.117.5_suppl_1.251S\\n10.1038/nri2254\\n10.1146/annurev.med.59.061506.154139\\n10.1016/j.jaci.2016.05.011\\n10.1016/j.jaci.2015.01.014\\n10.4049/jimmunol.0803967\\n10.1016/j.clim.2022.109082\\n10.1016/j.etp.2006.02.004\\n10.1378/chest.13-0873\\n10.1159/000220764\\n10.1016/j.jpeds.2019.04.006\\n10.1186/s12931-019-1075-1\\n10.1016/j.rmed.2009.10.008\\n10.1183/09031936.05.00035205\\n10.1183/09031936.05.00034805\\n10.7150/ijms.51315\\n10.1513/AnnalsATS.201507-431MG\\n10.1016/j.coi.2019.05.011\\n10.1371/journal.pone.0147232\\n10.1186/s12859-019-3064-2\\n10.1186/s12859-017-1718-5\\n10.4187/respcare.09963\\n10.1053/j.semperi.2016.05.010\\n10.1016/j.chest.2020.05.553\\n10.1016/j.aller.2017.02.004', 'xml': <Element 'PubmedArticle' at 0x10b16ccc0>}\n",
      "{'pubmed_id': '38336742\\n22878278\\n24095952\\n27189863\\n19407051\\n21872730\\n29858003\\n11976210\\n23767955\\n25536383\\n30184484\\n11194933\\n23645408\\n11270668\\n23746838\\n27373680\\n15281050\\n9391127\\n10976109\\n16037251\\n25034386\\n27117828\\n20010835\\n20010834\\n24535058\\n28148566\\n23543766\\n21450080\\n20595148\\n35144588\\n35073932\\n25930197\\n18443896\\n25016700\\n25984393\\n17208591\\n32367290\\n15066685\\n32453418\\n33416887\\n15219010\\n28049168\\n32246264\\n30255328\\n26575606\\n32523964\\n23947473\\n16842191\\n15863717\\n31258919\\n22701684\\n30130135\\n21112201\\n16315007\\n27373322\\n9848076', 'title': 'The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.', 'abstract': 'Chronic obstructive pulmonary disease (COPD) and asthma associate with high morbidity and mortality. High levels of advanced glycation end products (AGEs) were found in tissue and plasma of COPD patients but their role in COPD and asthma is unclear.\\nIn the Rotterdam Study (n\\u2009=\\u20092577), AGEs (by skin autofluorescence (SAF)), FEV\\nSAF associated with COPD prevalence (OR\\u2009=\\u20091.299 [1.060, 1.591]) but not when adjusted for smoking (OR\\u2009=\\u20091.106 [0.89, 1.363]). SAF associated with FEV\\nAssociations between SAF, lung function and COPD prevalence were strongly influenced by smoking. SAF associated with COPD severity and its association with lung function was more prominent within COPD. These results fuel further research into interrelations and causality between SAF, smoking and COPD.\\nSkin AGEs associated with prevalence and severity of COPD and lung function in the general population with a stronger effect in COPD, calling for further research into interrelations and causality between SAF, smoking and COPD.', 'keywords': ['Advanced glycation end products (AGEs)', 'Chronic obstructive pulmonary disease (COPD)', 'Lung function', 'Skin autofluorescence (SAF)', 'Spirometry'], 'journal': 'Respiratory research', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Lu', 'firstname': 'Tianqi', 'initials': 'T', 'affiliation': \"Department of Internal Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015GD, Rotterdam, The Netherlands.\\nDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.\"}, {'lastname': 'Lahousse', 'firstname': 'Lies', 'initials': 'L', 'affiliation': 'Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.\\nDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.'}, {'lastname': 'Wijnant', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.\\nDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.\\nDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.'}, {'lastname': 'Chen', 'firstname': 'Jinluan', 'initials': 'J', 'affiliation': \"Department of Internal Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015GD, Rotterdam, The Netherlands.\\nDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.\"}, {'lastname': 'Brusselle', 'firstname': 'Guy G', 'initials': 'GG', 'affiliation': 'Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.\\nDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.\\nDepartment of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.'}, {'lastname': 'van Hoek', 'firstname': 'Mandy', 'initials': 'M', 'affiliation': \"Department of Internal Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015GD, Rotterdam, The Netherlands.\"}, {'lastname': 'Zillikens', 'firstname': 'M Carola', 'initials': 'MC', 'affiliation': \"Department of Internal Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015GD, Rotterdam, The Netherlands. m.c.zillikens@erasmusmc.nl.\"}], 'methods': None, 'conclusions': None, 'results': 'SAF associated with COPD prevalence (OR\\u2009=\\u20091.299 [1.060, 1.591]) but not when adjusted for smoking (OR\\u2009=\\u20091.106 [0.89, 1.363]). SAF associated with FEV', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12931-024-02698-1\\n10.1164/rccm.201204-0596PP\\n10.1016/j.intimp.2013.09.003\\n10.1038/nrdp.2015.76\\n10.1183/09031936.00128008\\n10.1016/j.jaci.2011.06.048\\n10.1016/j.rmed.2018.04.006\\n10.1111/j.1749-6632.2002.tb02107.x\\n10.3109/10715762.2013.815348\\n10.1016/j.exger.2014.12.013\\n10.1016/j.cmet.2018.08.014\\n10.1007/s005920070025\\n10.1183/09031936.00135312\\n10.1007/s001250051591\\n10.1016/j.cell.2013.05.039\\n10.1016/j.biocel.2016.06.016\\n10.1016/j.jada.2004.05.214\\n10.1073/pnas.94.25.13915\\n10.1074/jbc.M006700200\\n10.1196/annals.1333.036\\n10.1016/j.metabol.2014.06.006\\n10.1186/s12931-016-0363-2\\n10.1038/ng.500\\n10.1038/ng.501\\n10.1007/s00408-014-9561-1\\n10.1096/fj.201601155R\\n10.1189/jlb.1012519\\n10.1186/1465-9921-12-37\\n10.1183/09031936.00029310\\n10.1186/s12890-022-01848-9\\n10.1186/s12931-022-01934-w\\n10.1016/j.jaci.2015.03.011\\n10.1007/s00726-008-0097-7\\n10.1016/j.jaci.2006.08.021\\n10.1007/s10654-020-00640-5\\n10.1016/j.jclinepi.2003.07.008\\n10.1093/ajcn/nqaa117\\n10.1001/jamanetworkopen.2020.33012\\n10.1183/09031936.04.00014304\\n10.1007/s12325-020-01289-y\\n10.1007/s10654-018-0444-2\\n10.1016/S2213-8587(15)00362-9\\n10.1164/rccm.201302-0247OC\\n10.2174/092986706777585013\\n10.1161/01.ATV.0000164804.05324.8b\\n10.1136/bmjresp-2019-000431\\n10.1371/journal.pone.0038629\\n10.1164/rccm.201807-1249LE\\n10.1016/j.rmed.2010.11.001\\n10.1007/s00441-005-0069-0\\n10.1016/j.jaci.2016.05.011\\n10.1007/BF03401759', 'xml': <Element 'PubmedArticle' at 0x109905a80>}\n",
      "{'pubmed_id': '38336682\\n24337046\\n29605212\\n15176687\\n12789219\\n26357963\\n18480428\\n17991792\\n33333637\\n28689842\\n17537763\\n19187331\\n24315502\\n36902630\\n20227808\\n31785254\\n29627041\\n19892860\\n32706916\\n28328160\\n36572182\\n31678077\\n30562041\\n11929412\\n19581356\\n27031391\\n25971575\\n21087988\\n1549827\\n8404082\\n27492528\\n14726171\\n22347412\\n37041257\\n32843181\\n32706916\\n36462509\\n26335831\\n17133119\\n23040884\\n12403689\\n34448255\\n36510255\\n36889783\\n35778740\\n33271561\\n33135257\\n29514744\\n24457412\\n28593573\\n17686624\\n20844291\\n15863649\\n23890469\\n31947560\\n31482693\\n33532464\\n31626906\\n25323227\\n17096740\\n29290515\\n32245451\\n35184418', 'title': 'Clinical characteristics of obese, fixed airway obstruction, exacerbation-prone phenotype and comorbidities among severe asthma patients: a single-center study.', 'abstract': 'Severe asthma places a large burden on patients and society. The characteristics of patients with severe asthma in the Chinese population remain unclear.\\nA retrospective review was conducted in patients with severe asthma. Demographic and clinical data were collected. Patients were grouped according to phenotypes in terms of exacerbations, body mass index (BMI) and fixed airway obstruction (FAO) status, and the characteristics of different groups were compared. Comorbidities, factors that influence asthma phenotypes, were also analyzed in the study.\\nA total of 228 patients with severe asthma were included in our study. They were more likely to be overweight or obese. A total of 41.7% of the patients received GINA step 5 therapy, and 43.4% had a history of receiving regular or intermittent oral corticosteroids (OCS). Severe asthmatic patients with comorbidities were prone to have more asthma symptoms and decreased quality of life than patients without comorbidities. Patients with exacerbations were characterized by longer duration of asthma, poorer lung function, and worse asthma control. Overweight or obese patients tended to have more asthma symptoms, poorer lung function and more asthma-related comorbidities. Compared to patients without FAO, those in the FAO group were older, with longer duration of asthma and more exacerbations.\\nThe existence of comorbidities in patients with severe asthma could result in more asthma symptoms and decreased quality of life. Patients with exacerbations or with overweight or obese phenotypes were characterized by poorer lung function and worse asthma control. Patients with FAO phenotype tended to have more exacerbations.', 'keywords': ['Comorbidities', 'Exacerbations', 'Fixed airway obstruction', 'Overweight or obesity', 'Severe asthma'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Zhu', 'firstname': 'Guiping', 'initials': 'G', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Mo', 'firstname': 'Yuqing', 'initials': 'Y', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nThe Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 450008, Zhengzhou, China.'}, {'lastname': 'Ye', 'firstname': 'Ling', 'initials': 'L', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Cai', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Zeng', 'firstname': 'Yingying', 'initials': 'Y', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Zhu', 'firstname': 'Mengchan', 'initials': 'M', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Peng', 'firstname': 'Wenjun', 'initials': 'W', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Gao', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Song', 'firstname': 'Xixi', 'initials': 'X', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Yang', 'firstname': 'Chengyu', 'initials': 'C', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China. 251328610@qq.com.'}, {'lastname': 'Chen', 'firstname': 'Zhihong', 'initials': 'Z', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China. czh60@hotmail.com.'}, {'lastname': 'Jin', 'firstname': 'Meiling', 'initials': 'M', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 200032, Shanghai, China. jin.meiling@zs-hospital.sh.cn.\\nDepartment of Allergy, Zhongshan Hospital, Fudan University, 200032, Shanghai, China. jin.meiling@zs-hospital.sh.cn.'}], 'methods': None, 'conclusions': 'The existence of comorbidities in patients with severe asthma could result in more asthma symptoms and decreased quality of life. Patients with exacerbations or with overweight or obese phenotypes were characterized by poorer lung function and worse asthma control. Patients with FAO phenotype tended to have more exacerbations.', 'results': 'A total of 228 patients with severe asthma were included in our study. They were more likely to be overweight or obese. A total of 41.7% of the patients received GINA step 5 therapy, and 43.4% had a history of receiving regular or intermittent oral corticosteroids (OCS). Severe asthmatic patients with comorbidities were prone to have more asthma symptoms and decreased quality of life than patients without comorbidities. Patients with exacerbations were characterized by longer duration of asthma, poorer lung function, and worse asthma control. Overweight or obese patients tended to have more asthma symptoms, poorer lung function and more asthma-related comorbidities. Compared to patients without FAO, those in the FAO group were older, with longer duration of asthma and more exacerbations.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-023-02835-4', 'xml': <Element 'PubmedArticle' at 0x10a4c6b60>}\n",
      "{'pubmed_id': '38336467', 'title': 'Preconception health risk factors documented in general practice electronic medical records.', 'abstract': 'Documenting medical and lifestyle preconception health risk factors in electronic medical records (EMRs) could assist general practitioners (GPs) to identify those reproductive-aged women who could most benefit from preconception care (PCC). However, it is unclear to what extent PCC risk factors are identifiable in general practice records. This study aimed to determine the extent to which medical and lifestyle preconception health risk factors are documented in general practice EMRs.\\nWe conducted an audit of the documentation of medical and lifestyle preconception risk factors in 10 general practice EMRs in Melbourne, Australia. We retrospectively analysed the EMRs of 100 consecutive women aged 18-44 years who visited each practice between January and September 2022. Using a template informed by PCC guidelines, we extracted data from structured fields in the EMR and conducted a descriptive analysis.\\nAmong the data extracted, the more commonly documented medical and lifestyle preconception health risk factors in the EMRs included smoking (79%), blood pressure (74%), alcohol consumption (63%) and body mass index (57%). Among the women audited, 14% were smokers, 24% were obese, 7% had high blood pressure, 5% had diabetes, 28% had a mental health condition, 13% had asthma, 6% had thyroid disease and 17% had been prescribed and could be using a potentially teratogenic medication.\\nBetter documentation of medical and lifestyle preconception health risk factors in structured fields in EMRs may potentially assist primary care providers including GPs in identifying and providing PCC to women who could most benefit from it.', 'keywords': ['Counseling', 'Reproductive Health', 'Reproductive Health Services', 'Sexual Health', 'general practice'], 'journal': 'BMJ sexual & reproductive health', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Withanage', 'firstname': 'Nishadi Nethmini', 'initials': 'NN', 'affiliation': 'Remove this affiliation, Remove this affiliation, Remove this affiliation, Remove this affiliation nishadi.withanage@monash.edu.\\nSPHERE, NHMRC Centre of Research Excellence, Department of General Practice, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Botfield', 'firstname': 'Jessica R', 'initials': 'JR', 'affiliation': 'SPHERE, NHMRC Centre of Research Excellence, Department of General Practice, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Black', 'firstname': 'Kirsten', 'initials': 'K', 'affiliation': 'SPHERE, NHMRC Centre of Research Excellence, Department of General Practice, Monash University, Melbourne, Victoria, Australia.\\nDepartment of Obstetrics and Gynaecology, University of Sydney, Camperdown, New South Wales, Australia.'}, {'lastname': 'Mazza', 'firstname': 'Danielle', 'initials': 'D', 'affiliation': 'SPHERE, NHMRC Centre of Research Excellence, Department of General Practice, Monash University, Melbourne, Victoria, Australia.'}], 'methods': None, 'conclusions': None, 'results': 'Among the data extracted, the more commonly documented medical and lifestyle preconception health risk factors in the EMRs included smoking (79%), blood pressure (74%), alcohol consumption (63%) and body mass index (57%). Among the women audited, 14% were smokers, 24% were obese, 7% had high blood pressure, 5% had diabetes, 28% had a mental health condition, 13% had asthma, 6% had thyroid disease and 17% had been prescribed and could be using a potentially teratogenic medication.', 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/bmjsrh-2023-202038', 'xml': <Element 'PubmedArticle' at 0x10a3edcb0>}\n",
      "{'pubmed_id': '38336440', 'title': '', 'abstract': 'Irritant-induced asthma (IIA) may develop after acute inhalational exposure in individuals without preexisting asthma. The effect of bronchial thermoplasty to treat intractable, worsening IIA has not yet been described. We evaluated a previously healthy 52-year-old man after inhalation of an unknown white powder. His pulmonary function and symptoms/quality of life worsened over 4 years, despite maximal guidelines-based asthma therapy. We acquired ', 'keywords': ['CT scan', 'MRI', 'bronchial thermoplasty', 'irritant-induced asthma', 'oscillometry'], 'journal': 'Chest', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'McIntosh', 'firstname': 'Marrissa J', 'initials': 'MJ', 'affiliation': 'Robarts Research Institute, Western University, London, ON, Canada; Department of Medical Biophysics, Western University, London, ON, Canada.'}, {'lastname': 'Hofmann', 'firstname': 'Joseph J', 'initials': 'JJ', 'affiliation': 'Robarts Research Institute, Western University, London, ON, Canada.'}, {'lastname': 'Kooner', 'firstname': 'Harkiran K', 'initials': 'HK', 'affiliation': 'Robarts Research Institute, Western University, London, ON, Canada; Department of Medical Biophysics, Western University, London, ON, Canada.'}, {'lastname': 'Eddy', 'firstname': 'Rachel L', 'initials': 'RL', 'affiliation': \"Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.\"}, {'lastname': 'Parraga', 'firstname': 'Grace', 'initials': 'G', 'affiliation': 'Robarts Research Institute, Western University, London, ON, Canada; Department of Medical Biophysics, Western University, London, ON, Canada; Division of Respirology, Western University, London, ON, Canada. Electronic address: gparraga@uwo.ca.'}, {'lastname': 'Mackenzie', 'firstname': 'Constance A', 'initials': 'CA', 'affiliation': 'Division of Respirology, Western University, London, ON, Canada; Division of Clinical Pharmacology and Toxicology, Department of Medicine, Western University, London, ON, Canada.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.chest.2023.09.010', 'xml': <Element 'PubmedArticle' at 0x10a3efdd0>}\n",
      "{'pubmed_id': '38336438', 'title': 'Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management.', 'abstract': None, 'keywords': ['antiinflammatory', 'asthma management guidelines', 'barriers to implementation', 'reliever therapy'], 'journal': 'Chest', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Zaeh', 'firstname': 'Sandra E', 'initials': 'SE', 'affiliation': 'Division of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT. Electronic address: sandra.zaeh@yale.edu.'}, {'lastname': 'Eakin', 'firstname': 'Michelle N', 'initials': 'MN', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD.'}, {'lastname': 'Chupp', 'firstname': 'Geoffrey', 'initials': 'G', 'affiliation': 'Division of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.chest.2023.09.004', 'xml': <Element 'PubmedArticle' at 0x10a0b82c0>}\n",
      "{'pubmed_id': '38336434', 'title': 'Can We Test the Function of the Small Airways in Children Outside the Laboratory?', 'abstract': None, 'keywords': [], 'journal': 'Chest', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Makrinioti', 'firstname': 'Heidi', 'initials': 'H', 'affiliation': 'Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: cmakrynioti@mgh.harvard.edu.'}, {'lastname': 'Bush', 'firstname': 'Andrew', 'initials': 'A', 'affiliation': 'National Heart and Lung Institute, Imperial College, London, England.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.chest.2023.10.004', 'xml': <Element 'PubmedArticle' at 0x109a76020>}\n",
      "{'pubmed_id': '38336405', 'title': 'Reply to \"Diet may be the common factor linking aspirin-exacerbated respiratory disease and atherosclerotic cardiovascular disease\".', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Adame', 'firstname': 'Michael J', 'initials': 'MJ', 'affiliation': 'Division of Allergy and Immunology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas. Electronic address: mjadame@utmb.edu.'}, {'lastname': 'Raji', 'firstname': 'Mukaila', 'initials': 'M', 'affiliation': 'Division of Geriatrics, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.'}, {'lastname': 'Shan', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': 'Department of Biostatistics and Data Science, The University of Texas Medical Branch, Galveston, Texas.'}, {'lastname': 'Zhang', 'firstname': 'Yuanyi', 'initials': 'Y', 'affiliation': 'Department of Biostatistics and Data Science, The University of Texas Medical Branch, Galveston, Texas.'}, {'lastname': 'Kuo', 'firstname': 'Yong-Fang', 'initials': 'YF', 'affiliation': 'Division of Geriatrics, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas; Department of Biostatistics and Data Science, The University of Texas Medical Branch, Galveston, Texas.'}, {'lastname': 'Tripple', 'firstname': 'Julia W', 'initials': 'JW', 'affiliation': 'Division of Allergy and Immunology, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.12.015', 'xml': <Element 'PubmedArticle' at 0x109a75a80>}\n",
      "{'pubmed_id': '38336404', 'title': 'Diet may be the common factor linking aspirin-exacerbated respiratory disease and atherosclerotic cardiovascular disease.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Miller', 'firstname': 'Jeffrey D', 'initials': 'JD', 'affiliation': 'Mission: Allergy, Inc, Hawleyville, Conn. Electronic address: JeffreyMillerMD@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.11.047', 'xml': <Element 'PubmedArticle' at 0x10bace390>}\n",
      "{'pubmed_id': '38336403', 'title': 'Reply to \"Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry\".', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Chen', 'firstname': 'Wenjia', 'initials': 'W', 'affiliation': 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore.'}, {'lastname': 'Tran', 'firstname': 'Trung N', 'initials': 'TN', 'affiliation': 'AstraZeneca, Gaithersburg, Md.'}, {'lastname': 'Sadatsafavi', 'firstname': 'Mohsen', 'initials': 'M', 'affiliation': 'Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.'}, {'lastname': 'Murray', 'firstname': 'Ruth B', 'initials': 'RB', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom.'}, {'lastname': 'Boon Wong', 'firstname': 'Nigel Chong', 'initials': 'NC', 'affiliation': 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore.'}, {'lastname': 'Ali', 'firstname': 'Nasloon', 'initials': 'N', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom; Observational and Pragmatic Research Institute, Singapore.'}, {'lastname': 'Ariti', 'firstname': 'Con', 'initials': 'C', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom; Observational and Pragmatic Research Institute, Singapore.'}, {'lastname': 'Bulathsinhala', 'firstname': 'Lakmini', 'initials': 'L', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom; Observational and Pragmatic Research Institute, Singapore.'}, {'lastname': 'Garcia Gil', 'firstname': 'Esther', 'initials': 'E', 'affiliation': 'AstraZeneca, Barcelona, Spain.'}, {'lastname': 'FitzGerald', 'firstname': 'J Mark', 'initials': 'JM', 'affiliation': 'Department of Medicine, the University of British Columbia, Vancouver, BC, Canada.'}, {'lastname': 'Alacqua', 'firstname': 'Marianna', 'initials': 'M', 'affiliation': 'CSL Behring S.p.A, Milan, Italy.'}, {'lastname': 'Al-Ahmad', 'firstname': 'Mona', 'initials': 'M', 'affiliation': 'Microbiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait; Al-Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait.'}, {'lastname': 'Altraja', 'firstname': 'Alan', 'initials': 'A', 'affiliation': 'Department of Pulmonology, University of Tartu and Lung Clinic, Tartu University Hospital, Tartu, Estonia.'}, {'lastname': 'Al-Lehebi', 'firstname': 'Riyad', 'initials': 'R', 'affiliation': 'Department of Pulmonology, King Fahad Medical City, Riyadh, Saudi Arabia; Alfaisal University, Riyadh, Saudi Arabia.'}, {'lastname': 'Bhutani', 'firstname': 'Mohit', 'initials': 'M', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.'}, {'lastname': 'Bjermer', 'firstname': 'Leif', 'initials': 'L', 'affiliation': 'Respiratory Medicine and Allergology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.'}, {'lastname': 'Bjerrum', 'firstname': 'Anne-Sofie', 'initials': 'AS', 'affiliation': 'Department of Respiratory Medicine and Allergy, Aarhus University Hospital, Aarhus, Denmark.'}, {'lastname': 'Bourdin', 'firstname': 'Arnaud', 'initials': 'A', 'affiliation': 'PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.'}, {'lastname': 'von Bülow', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, Denmark.'}, {'lastname': 'Busby', 'firstname': 'John', 'initials': 'J', 'affiliation': \"Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.\"}, {'lastname': 'Canonica', 'firstname': 'Giorgio Walter', 'initials': 'GW', 'affiliation': 'Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.'}, {'lastname': 'Carter', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom; Observational and Pragmatic Research Institute, Singapore.'}, {'lastname': 'Christoff', 'firstname': 'George C', 'initials': 'GC', 'affiliation': 'Medical University-Sofia, Faculty of Public Health, Sofia, Bulgaria.'}, {'lastname': 'Cosio', 'firstname': 'Borja G', 'initials': 'BG', 'affiliation': 'Son Espases University Hospital-IdISBa-Ciberes, Mallorca, Spain.'}, {'lastname': 'Costello', 'firstname': 'Richard W', 'initials': 'RW', 'affiliation': 'Clinical Research Centre, Department of Respiratory Medicine, Smurfit Building Beaumont Hospital, RCSI, Dublin, Ireland.'}, {'lastname': 'Fonseca', 'firstname': 'João A', 'initials': 'JA', 'affiliation': 'Department of Community Medicine, Information and Health Decisions (MEDCIDS), Health Information and Decision Sciences Department (MEDCIDS) & Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine of University of Porto, Porto, Portugal.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW, Australia.'}, {'lastname': 'Yoo', 'firstname': 'Kwang Ha', 'initials': 'KH', 'affiliation': 'Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, South Korea.'}, {'lastname': 'Heaney', 'firstname': 'Liam G', 'initials': 'LG', 'affiliation': \"Wellcome-Wolfson Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.\"}, {'lastname': 'Heffler', 'firstname': 'Enrico', 'initials': 'E', 'affiliation': 'Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.'}, {'lastname': 'Hew', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, VIC, Australia; Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.'}, {'lastname': 'Hilberg', 'firstname': 'Ole', 'initials': 'O', 'affiliation': 'Medical Department, Vejle University Hospital, Vejle, Denmark.'}, {'lastname': 'Hoyte', 'firstname': 'Flavia', 'initials': 'F', 'affiliation': 'Division of Allergy & Clinical Immunology, Department of Medicine, National Jewish Health, Denver, Colo.'}, {'lastname': 'Iwanaga', 'firstname': 'Takashi', 'initials': 'T', 'affiliation': 'Kindai University Hospital, Osakasayama, Japan.'}, {'lastname': 'Jackson', 'firstname': 'David J', 'initials': 'DJ', 'affiliation': \"Guy's Severe Asthma Centre, Guy's Hospital, King's College London, UK.\"}, {'lastname': 'Jones', 'firstname': 'Rupert C', 'initials': 'RC', 'affiliation': 'Research and Knowledge Exchange, Plymouth Marjon University, Plymouth, United Kingdom.'}, {'lastname': 'Koh', 'firstname': 'Mariko Siyue', 'initials': 'MS', 'affiliation': 'Respiratory & Critical Care Medicine, Singapore General Hospital, Singapore.'}, {'lastname': 'Kuna', 'firstname': 'Piotr', 'initials': 'P', 'affiliation': 'Division of Internal Medicine, Asthma and Allergy, Medical University of Łódź, Łódź, Poland.'}, {'lastname': 'Larenas-Linnemann', 'firstname': 'Désirée', 'initials': 'D', 'affiliation': 'Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, Mexico.'}, {'lastname': 'Lehmann', 'firstname': 'Sverre', 'initials': 'S', 'affiliation': 'Section of Thoracic Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.'}, {'lastname': 'Lehtimäki', 'firstname': 'Lauri', 'initials': 'L', 'affiliation': 'Allergy Centre, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.'}, {'lastname': 'Lyu', 'firstname': 'Juntao', 'initials': 'J', 'affiliation': 'Griffith University, Centre for Applied Health Economics, Nathan, Australia.'}, {'lastname': 'Mahboub', 'firstname': 'Bassam', 'initials': 'B', 'affiliation': 'Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates; Dubai Academic and Health Corporation, Dubai, United Arab Emirates.'}, {'lastname': 'Maspero', 'firstname': 'Jorge', 'initials': 'J', 'affiliation': 'Clinical Research for Allergy and Respiratory Medicine, CIDEA Foundation, Buenos Aires, Argentina; University Career of Specialists in Allergy and Clinical Immunology, Buenos Aires University School of Medicine, Buenos Aires, Argentina.'}, {'lastname': 'Menzies-Gow', 'firstname': 'Andrew N', 'initials': 'AN', 'affiliation': 'AstraZeneca, Cambridge, United Kingdom; Lung Division, Royal Brompton & Harefield Hospitals, London, United Kingdom.'}, {'lastname': 'Newell', 'firstname': 'Anthony', 'initials': 'A', 'affiliation': 'Observational and Pragmatic Research Institute, Singapore; Optimum Patient Care, Brisbane, QLD, Australia.'}, {'lastname': 'Sirena', 'firstname': 'Concetta', 'initials': 'C', 'affiliation': 'Severe Asthma Network in Italy (SANI), Milano, Italy.'}, {'lastname': 'Papadopoulos', 'firstname': 'Nikolaos G', 'initials': 'NG', 'affiliation': 'Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, United Kingdom; Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.'}, {'lastname': 'Papaioannou', 'firstname': 'Andriana I', 'initials': 'AI', 'affiliation': '2nd Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece.'}, {'lastname': 'Perez-de-Llano', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo, Lugo, Spain.'}, {'lastname': 'Perng Steve', 'firstname': 'Diahn-Warng', 'initials': 'DW', 'affiliation': 'School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.'}, {'lastname': 'Peters', 'firstname': 'Matthew J', 'initials': 'MJ', 'affiliation': 'Department of Thoracic Medicine, Concord Hospital, Sydney, NSW, Australia; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.'}, {'lastname': 'Pfeffer', 'firstname': 'Paul E', 'initials': 'PE', 'affiliation': 'Department of Respiratory Medicine, Barts Health NHS Trust, London, United Kingdom; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.'}, {'lastname': 'Porsbjerg', 'firstname': 'Celeste M', 'initials': 'CM', 'affiliation': 'Department of Respiratory Medicine and Infectious Diseases, Research Unit, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Popov', 'firstname': 'Todor A', 'initials': 'TA', 'affiliation': 'University Hospital \"Sv. Ivan Rilski,\" Sofia, Bulgaria.'}, {'lastname': 'Rhee', 'firstname': 'Chin Kook', 'initials': 'CK', 'affiliation': \"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, South Korea.\"}, {'lastname': 'Salvi', 'firstname': 'Sundeep', 'initials': 'S', 'affiliation': 'Pulmocare Research and Education Foundation, Pune, India.'}, {'lastname': 'Taillé', 'firstname': 'Camille', 'initials': 'C', 'affiliation': 'Department of Respiratory Diseases, Bichat Hospital, AP-HP Nord-Université de Paris, Paris, France.'}, {'lastname': 'Taube', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Department of Pulmonary Medicine, University Medical Center Essen-Ruhrlandklinik, Essen, Germany.'}, {'lastname': 'Torres-Duque', 'firstname': 'Carlos A', 'initials': 'CA', 'affiliation': 'CINEUMO, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia; Universidad de La Sabana, Chia, Colombia.'}, {'lastname': 'Ulrik', 'firstname': 'Charlotte', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark.'}, {'lastname': 'Ra', 'firstname': 'Seung Won', 'initials': 'SW', 'affiliation': 'Department of Internal Medicine, Division of Pulmonology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.'}, {'lastname': 'Wang', 'firstname': 'Eileen', 'initials': 'E', 'affiliation': 'Division of Allergy & Clinical Immunology, Department of Medicine, National Jewish Health, Denver, Colo; Division of Allergy & Clinical Immunology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colo.'}, {'lastname': 'Wechsler', 'firstname': 'Michael E', 'initials': 'ME', 'affiliation': 'NJH Cohen Family Asthma Institute, Department of Medicine, National Jewish Health, Denver, Colo.'}, {'lastname': 'Price', 'firstname': 'David B', 'initials': 'DB', 'affiliation': 'Optimum Patient Care Global, Cambridge, United Kingdom; Observational and Pragmatic Research Institute, Singapore; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: dprice@opri.sg.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.12.008', 'xml': <Element 'PubmedArticle' at 0x10956c720>}\n",
      "{'pubmed_id': '38336402', 'title': 'Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Cheng', 'firstname': 'I-Han', 'initials': 'IH', 'affiliation': 'School of Medicine, Chung Shan Medical University, Taichung, Taiwan.'}, {'lastname': 'Yong', 'firstname': 'Su-Boon', 'initials': 'SB', 'affiliation': \"Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan. Electronic address: yongsuboon@gmail.com.\"}, {'lastname': 'Cheng-Chung Wei', 'firstname': 'James', 'initials': 'J', 'affiliation': 'Department of Nursing, Chung Shan Medical University, Taichung, Taiwan; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: jccwei@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.12.007', 'xml': <Element 'PubmedArticle' at 0x10b9cb420>}\n",
      "{'pubmed_id': '38336401', 'title': 'Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Shen', 'firstname': 'Hsiao-Chin', 'initials': 'HC', 'affiliation': 'Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.'}, {'lastname': 'Yong', 'firstname': 'Su-Boon', 'initials': 'SB', 'affiliation': \"Department of Allergy and Immunology, China Medical University Children's Hospital, Taichung, Taiwan; Department of Medicine, College of Medicine, China Medical University Children's Hospital, Taichung, Taiwan. Electronic address: yongsuboon@gmail.com.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.11.017', 'xml': <Element 'PubmedArticle' at 0x10ac59e90>}\n",
      "{'pubmed_id': '38336400', 'title': 'Reply to \"Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma\".', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Ten Have', 'firstname': 'Lianne', 'initials': 'L', 'affiliation': 'Department of Epidemiology, Medical Center Leeuwarden, Leeuwarden, the Netherlands; Department of Biomedical Data Science, Medical Decision Making, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: lianne.ten.have@mcl.nl.'}, {'lastname': 'de Jong', 'firstname': 'Kim', 'initials': 'K', 'affiliation': 'Department of Epidemiology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.'}, {'lastname': 'Ten Brinke', 'firstname': 'Anneke', 'initials': 'A', 'affiliation': 'Department of Pulmonary Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.11.016', 'xml': <Element 'PubmedArticle' at 0x10ac5bb50>}\n",
      "{'pubmed_id': '38336396', 'title': 'Digital Inhaler Implementation in Daily Asthma Management: Who, When, and How?', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'van Boven', 'firstname': 'Job F M', 'initials': 'JFM', 'affiliation': 'Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands. Electronic address: j.f.m.van.boven@rug.nl.'}, {'lastname': 'Kocks', 'firstname': 'Janwillem W H', 'initials': 'JWH', 'affiliation': 'Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands; Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands; General Practitioners Research Institute, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore, Singapore; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.'}, {'lastname': 'Dierick', 'firstname': 'Boudewijn J H', 'initials': 'BJH', 'affiliation': 'Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.12.038', 'xml': <Element 'PubmedArticle' at 0x10a7404a0>}\n",
      "{'pubmed_id': '38336395', 'title': 'Work and Asthma.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Suojalehto', 'firstname': 'Hille', 'initials': 'H', 'affiliation': 'Occupational Medicine, Finnish Institute of Occupational Health, Helsinki, Finland. Electronic address: hille.suojalehto@ttl.fi.'}, {'lastname': 'Cullinan', 'firstname': 'Paul', 'initials': 'P', 'affiliation': 'London, United Kingdom.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.11.042', 'xml': <Element 'PubmedArticle' at 0x10a741bc0>}\n",
      "{'pubmed_id': '38336394', 'title': 'Hearing the Unheard: Voices of Black Emerging Adults With Uncontrolled Asthma.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Jones', 'firstname': 'Bridgette L', 'initials': 'BL', 'affiliation': \"Department of Pediatrics, Section of Allergy, Asthma, and Clinical Immunology, University of Missouri Kansas City School of Medicine, Children's Mercy Kansas City, Kansas City, Mo; Division of Pediatric Pharmacology and Therapeutic Innovation, University of Missouri Kansas City School of Medicine, Children's Mercy Kansas City, Kansas City, Mo. Electronic address: bljones@cmh.edu.\"}, {'lastname': 'Anand', 'firstname': 'Mahesh Padukudru', 'initials': 'MP', 'affiliation': 'Department of Respiratory Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2023.11.044', 'xml': <Element 'PubmedArticle' at 0x109cc7740>}\n",
      "{'pubmed_id': '38336314', 'title': 'Identification of rBlo t 41 with a chitin-binding type-2 domain: A novel major allergen from Blomia tropicalis.', 'abstract': 'Blomia tropicalis (B. tropicalis) has been reported to impose an increased risk of allergic diseases. However, few characteristics of the unknown allergen components responsible for B. tropicalis allergy and clinical relevance have been fully identified.\\nWe synthesized and characterized the physicochemical properties and cross-reactivity of the newly discovered recombinant B. tropicalis group 41 allergen (rBlo t 41). Subsequently, sera were collected from 107 B. tropicalis allergic subjects to evaluate the prevalence of the rBlo t 41. Lastly, its allergenicity was tested in humans by basophil activation assays, and in mice by a model of allergic asthma.\\nThe mature protein of rBlo t 41 was described as 104 amino acids long and 15.8\\xa0kDa, and its limited cross-reactivity was observed between allergens of house dust mites (HDM). Sensitization rate of rBlo t 41 (56.07\\xa0%) was lower than rBlo t 2 (76.29\\xa0%) and rBlo t 5 (69.07\\xa0%) in our study. Besides, rBlo t 41 elicited CD63 upregulation in basophils, whereas rBlo t 41-sensitized mice generated rBlo t 41-IgE and developed allergic airway inflammation after allergen exposure. Of note, component-based tests showed a high area under curve value (AUC\\xa0=\\xa00.75) of rBlo t 41, displaying its favorable diagnostic potential in B. tropicalis allergy.\\nrBlo t 41 was identified as a candidate novel major allergen with good diagnostic potential in B. tropicalis sensitization. Additionally, we provided strong evidence about rBlo t 41 on the clinically relevant manifestations in B. tropicalis allergies, conducive to facilitating the development of component-resolved diagnosis.', 'keywords': ['Allergenicity', 'Blomia tropicalis', 'Cross-reactivity', 'Storage mite', 'rBlo t 41'], 'journal': 'International journal of biological macromolecules', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Luo', 'firstname': 'Wenting', 'initials': 'W', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.'}, {'lastname': 'Zhang', 'firstname': 'Jiale', 'initials': 'J', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.'}, {'lastname': 'Zheng', 'firstname': 'Xianhui', 'initials': 'X', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.'}, {'lastname': 'Li', 'firstname': 'Aoli', 'initials': 'A', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.'}, {'lastname': 'Xv', 'firstname': 'Miaoyuan', 'initials': 'M', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.'}, {'lastname': 'Zhou', 'firstname': 'Dongmei', 'initials': 'D', 'affiliation': \"Clinical Research Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.\"}, {'lastname': 'Yuan', 'firstname': 'Cunyin', 'initials': 'C', 'affiliation': \"Clinical Research Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.\"}, {'lastname': 'Cui', 'firstname': 'Yubao', 'initials': 'Y', 'affiliation': \"Clinical Research Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China. Electronic address: ybcui1975@hotmail.com.\"}, {'lastname': 'Sun', 'firstname': 'Baoqing', 'initials': 'B', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China. Electronic address: sunbaoqing@vip.163.com.'}], 'methods': None, 'conclusions': None, 'results': 'The mature protein of rBlo t 41 was described as 104 amino acids long and 15.8\\xa0kDa, and its limited cross-reactivity was observed between allergens of house dust mites (HDM). Sensitization rate of rBlo t 41 (56.07\\xa0%) was lower than rBlo t 2 (76.29\\xa0%) and rBlo t 5 (69.07\\xa0%) in our study. Besides, rBlo t 41 elicited CD63 upregulation in basophils, whereas rBlo t 41-sensitized mice generated rBlo t 41-IgE and developed allergic airway inflammation after allergen exposure. Of note, component-based tests showed a high area under curve value (AUC\\xa0=\\xa00.75) of rBlo t 41, displaying its favorable diagnostic potential in B. tropicalis allergy.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.ijbiomac.2024.129972', 'xml': <Element 'PubmedArticle' at 0x10a2fbec0>}\n",
      "{'pubmed_id': '38336182', 'title': 'Novel insights into the anti-asthmatic effect of Raphanus sativus L. (Raphani Semen): Targeting immune cells, inflammatory pathways and oxidative stress markers.', 'abstract': 'Raphanus sativus L. is a well-known medicinal plant with traditional therapeutic applications in various common ailments including inflammation and asthma.\\nThis study aimed to evaluate the chemical composition and anti-asthmatic potential of the hydro-methanolic extract of the leaves of R. sativus L. (Rs.Cr) using various in vitro and in vivo investigations.\\nThe Rs.Cr was subjected to preliminary phytochemical analysis and HPLC profiling. The safety was assessed through oral acute toxicity tests in mice. The antiasthmatic effect of the extract was studied using milk-induced leukocytosis and ovalbumin (OVA)-induced allergic asthma models established in mice. While mast cell degranulation and passive paw anaphylaxis models were established in rats. Moreover, effect of the extract was studied on various oxidative and inflammatory makers. The antioxidant effect of the extract was also studied by in vitro DPPH method.\\nThe HPLC profiling of Rs.Cr showed the presence of important polyphenols in a considerable quantity. In toxicity evaluation, Rs.Cr showed no sign of morbidity or mortality with LD\\nThe current study highlights mechanism-based novel insights into the anti-asthmatic potential of R. sativus that also strongly supports its traditional use in asthma.', 'keywords': ['Allergic inflammation', 'Antiasthmatic potential', 'Ethnopharmacological screening', 'Mast cell disruption', 'Raphanus sativus L.'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 10), 'authors': [{'lastname': 'Gul', 'firstname': 'Humaira', 'initials': 'H', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Govt. College University, Faisalabad-38000 Pakistan. Electronic address: humairagul@gcuf.edu.pk.'}, {'lastname': 'Hussain', 'firstname': 'Abida', 'initials': 'A', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Govt. College University, Faisalabad-38000 Pakistan.'}, {'lastname': 'Javaid', 'firstname': 'Faraza', 'initials': 'F', 'affiliation': 'Quaid-e-Azam College of Pharmacy, Sahiwal-57000, Punjab-Pakistan.'}, {'lastname': 'Khan', 'firstname': 'Kifayat Ullah', 'initials': 'KU', 'affiliation': 'Quaid-e-Azam College of Pharmacy, Sahiwal-57000, Punjab-Pakistan. Electronic address: kifayat.rph@yahoo.com.'}, {'lastname': 'Basit', 'firstname': 'Abdul', 'initials': 'A', 'affiliation': 'Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90112, Songkhla, Thailand; Drug Delivery System Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai 90112, Songkhla, Thailand.'}, {'lastname': 'Arafat', 'firstname': 'Mosab', 'initials': 'M', 'affiliation': 'College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates.'}, {'lastname': 'Hussain', 'firstname': 'Fiza', 'initials': 'F', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Govt. College University, Faisalabad-38000 Pakistan.'}], 'methods': None, 'conclusions': 'The current study highlights mechanism-based novel insights into the anti-asthmatic potential of R. sativus that also strongly supports its traditional use in asthma.', 'results': 'The HPLC profiling of Rs.Cr showed the presence of important polyphenols in a considerable quantity. In toxicity evaluation, Rs.Cr showed no sign of morbidity or mortality with LD', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jep.2024.117851', 'xml': <Element 'PubmedArticle' at 0x10abcbb00>}\n",
      "{'pubmed_id': '38335422\\n32034960\\n31285291\\n32139458\\n23601567\\n30206782\\n28134501\\n27438466\\n17525828\\n32286145\\n35342020\\n18003958\\n18403759\\n34871165\\n20356987\\n19414556\\n16159614\\n36844232\\n29025889\\n26672955\\n26975422\\n30342583\\n26231288\\n19535666\\n15817806\\n384853\\n32037109\\n33217063\\n28859263\\n30930717\\n21899483\\n31113430\\n25663327\\n23628340\\n26372680\\n28860527\\n19732777\\n12892317\\n29159257\\n26362207\\n26284071', 'title': 'Association of serum YKL-40 and DPP4 with T2-high asthma in Chinese adults.', 'abstract': 'This study aimed to assess the utility of serum YKL-40 and serum dipeptidyl peptidase IV (DPP4) as biomarkers for distinguishing between type 2 (T2)-high and T2-low asthma in the Chinese population. Additionally, we sought to explore the associations of serum YKL-40 and DPP4 levels with asthma characteristics and conventional markers. A real-world observational cross-sectional study was conducted, involving a total of 75 adult asthma patients. We collected general information, including demographics and medical history. Measurements included complete blood count, fractional exhaled nitric oxide (FeNO), post-bronchodilator spirometry, serum YKL-40 and serum DPP4 levels. Asthma endotypes, T2-high and T2-low, were defined through a comprehensive review of existing literature and expert group discussions. Logistic and linear regression models were employed. Our findings indicated no significant association between serum YKL-40 or serum DPP4 levels and T2-high asthma across all models. In the fully adjusted model, their odds ratios (OR) were 0.967 (95% CI: 0.920-1.017) and 0.997 (95% CI: 0.993-1.001), respectively. Notably, serum YKL-40 exhibited a positive correlation with FeNO (β\\u2005=\\u20050.382, 95% CI: 0.230-0.533) after adjusting for confounding factors. This association, however, diminished in patients under 40 years old (P\\u2005=\\u2005.24), males (P\\u2005=\\u2005.25), and those with FEV1%pred of 80% or higher (P\\u2005=\\u2005.25). Serum DPP4 demonstrated a negative correlation with FEV1/FVC in the fully adjusted model (β: -0.005, 95% CI: -0.009, -0.000). Among Chinese adult asthma patients, a positive correlation was observed between serum YKL-40 levels and FeNO in females aged over 40 with FEV1%pred less than 80%. Additionally, a weak negative correlation was found between serum DPP4 levels and FEV1/FVC. However, neither serum YKL-40 nor serum DPP4 levels exhibited the capability to differentiate between T2-high and T2-low asthma.', 'keywords': [], 'journal': 'Medicine', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Zhang', 'firstname': 'Li', 'initials': 'L', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Li', 'firstname': 'Liang', 'initials': 'L', 'affiliation': \"Department of Clinical Laboratory, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Zhou', 'firstname': 'Mei', 'initials': 'M', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Zhou', 'firstname': 'Qian-Yun', 'initials': 'QY', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Tang', 'firstname': 'Ji-Hong', 'initials': 'JH', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Liang', 'firstname': 'Mei', 'initials': 'M', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Liu', 'firstname': 'Qin', 'initials': 'Q', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}, {'lastname': 'Fu', 'firstname': 'Xiao-Feng', 'initials': 'XF', 'affiliation': \"Department of Respiratory and Critical Care Medicine, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.', 'doi': '10.1097/MD.0000000000037169', 'xml': <Element 'PubmedArticle' at 0x10abc8d10>}\n",
      "{'pubmed_id': '38335270', 'title': 'Progressive accumulation of hyperinflammatory NKG2D', 'abstract': 'Atopic dermatitis (AD) is a chronic inflammatory skin disease that often precedes the development of food allergy, asthma, and allergic rhinitis. The prevailing paradigm holds that a reduced frequency and function of natural killer (NK) cell contributes to AD pathogenesis, yet the underlying mechanisms and contributions of NK cells to allergic comorbidities remain ill-defined. Here, analysis of circulating NK cells in a longitudinal early life cohort of children with AD revealed a progressive accumulation of NK cells with low expression of the activating receptor NKG2D, which was linked to more severe AD and sensitivity to allergens. This was most notable in children co-sensitized to food and aeroallergens, a risk factor for development of asthma. Individual-level longitudinal analysis in a subset of children revealed coincident reduction of NKG2D on NK cells with acquired or persistent sensitization, and this was associated with impaired skin barrier function assessed by transepidermal water loss. Low expression of NKG2D on NK cells was paradoxically associated with depressed cytolytic function but exaggerated release of the proinflammatory cytokine tumor necrosis factor-α. These observations provide important insights into a potential mechanism underlying the development of allergic comorbidity in early life in children with AD, which involves altered NK cell functional responses, and define an endotype of severe AD.', 'keywords': [], 'journal': 'Science immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Ochayon', 'firstname': 'David E', 'initials': 'DE', 'affiliation': \"Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'DeVore', 'firstname': 'Stanley B', 'initials': 'SB', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\\nCancer and Cell Biology Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}, {'lastname': 'Chang', 'firstname': 'Wan-Chi', 'initials': 'WC', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'Krishnamurthy', 'firstname': 'Durga', 'initials': 'D', 'affiliation': \"Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'Seelamneni', 'firstname': 'Harsha', 'initials': 'H', 'affiliation': \"Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'Grashel', 'firstname': 'Brittany', 'initials': 'B', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'Spagna', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\"}, {'lastname': 'Andorf', 'firstname': 'Sandra', 'initials': 'S', 'affiliation': \"Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}, {'lastname': 'Martin', 'firstname': 'Lisa J', 'initials': 'LJ', 'affiliation': \"Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}, {'lastname': 'Biagini', 'firstname': 'Jocelyn M', 'initials': 'JM', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}, {'lastname': 'Waggoner', 'firstname': 'Stephen N', 'initials': 'SN', 'affiliation': \"Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\\nDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}, {'lastname': 'Khurana Hershey', 'firstname': 'Gurjit K', 'initials': 'GK', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.\\nMedical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\\nCancer and Cell Biology Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1126/sciimmunol.add3085', 'xml': <Element 'PubmedArticle' at 0x10b5eb600>}\n",
      "{'pubmed_id': '38335209\\n27855644\\n23533853\\n32344326\\n32770167\\n32419694\\n34195059\\n34070844\\n8336541\\n31904846\\n19488414\\n33509161\\n32173725\\n34400447\\n33688198\\n32506258\\n32495027', 'title': 'COVID-19 in patients presenting with malaria-like symptoms at a primary healthcare facility in Accra, Ghana.', 'abstract': 'Malaria is a common and severe public health problem in Ghana and largely responsible for febrile symptoms presented at health facilities in the country. Other infectious diseases, including COVID-19, may mimic malaria due to their shared non-specific symptoms such as fever and headache thus leading to misdiagnosis. This study therefore investigated COVID-19 among patients presenting with malaria-like symptoms at Korle-Bu Polyclinic, Accra, Ghana.\\nThis study enrolled 300 patients presenting with malaria-like symptoms aged ≥18yrs. After consent was obtained from study patients, two to three millilitres of whole blood, nasopharyngeal and oropharyngeal swab samples, were collected for screening of Plasmodium falciparum using malaria rapid diagnostic test, microscopy and nested PCR, and SARS-CoV-2 using SARS-CoV-2 antigen test and Real-time PCR, respectively. The plasma and whole blood were also used for COVID-19 antibody testing and full blood counts using hematological analyser. SARS-CoV-2 whole genome sequencing was performed using MinIon sequencing.\\nThe prevalence of malaria by microscopy, RDT and nested PCR were 2.3%, 2.3% and 2.7% respectively. The detection of SARS-CoV-2 by COVID-19 Rapid Antigen Test and Real-time PCR were 8.7% and 20% respectively. The Delta variant was reported in 23 of 25 SARS-CoV-2 positives with CT values below 30. Headache was the most common symptom presented by study participants (95%). Comorbidities reported were hypertension, asthma and diabetes. One hundred and thirteen (37.8%) of the study participants had prior exposure to SARS CoV-2 and (34/51) 66.7% of Astrazeneca vaccinated patients had no IgG antibody.\\nIt may be difficult to use clinical characteristics to distinguish between patients with COVID-19 having malaria-like symptoms. Detection of IgM using RDTs may be useful in predicting CT values for SARS-CoV-2 real-time PCR and therefore transmission.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Asamoah', 'firstname': 'Issabella', 'initials': 'I', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Adusei-Poku', 'firstname': 'Mildred', 'initials': 'M', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Vandyck-Sey', 'firstname': 'Priscilla', 'initials': 'P', 'affiliation': 'Korle Bu Polyclinic Family Medicine Department, Korle Bu Teaching Hospital, Accra, Ghana.'}, {'lastname': 'Steele-Dadzie', 'firstname': 'Allen', 'initials': 'A', 'affiliation': 'Korle Bu Polyclinic Family Medicine Department, Korle Bu Teaching Hospital, Accra, Ghana.'}, {'lastname': 'Kuffour', 'firstname': 'Atta Senior', 'initials': 'AS', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Turkson', 'firstname': 'Albert', 'initials': 'A', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Asante', 'firstname': 'Ivy Asantewaa', 'initials': 'IA', 'affiliation': 'Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.'}, {'lastname': 'Addo-Osafo', 'firstname': 'Kantanka', 'initials': 'K', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Mohktar', 'firstname': 'Quaneeta', 'initials': 'Q', 'affiliation': 'Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.'}, {'lastname': 'Adu', 'firstname': 'Bright', 'initials': 'B', 'affiliation': 'Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana.'}, {'lastname': 'Afrane', 'firstname': 'Yaw A', 'initials': 'YA', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}, {'lastname': 'Sagoe', 'firstname': 'Kwamena W C', 'initials': 'KWC', 'affiliation': 'Department of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.'}], 'methods': None, 'conclusions': 'It may be difficult to use clinical characteristics to distinguish between patients with COVID-19 having malaria-like symptoms. Detection of IgM using RDTs may be useful in predicting CT values for SARS-CoV-2 real-time PCR and therefore transmission.', 'results': 'The prevalence of malaria by microscopy, RDT and nested PCR were 2.3%, 2.3% and 2.7% respectively. The detection of SARS-CoV-2 by COVID-19 Rapid Antigen Test and Real-time PCR were 8.7% and 20% respectively. The Delta variant was reported in 23 of 25 SARS-CoV-2 positives with CT values below 30. Headache was the most common symptom presented by study participants (95%). Comorbidities reported were hypertension, asthma and diabetes. One hundred and thirteen (37.8%) of the study participants had prior exposure to SARS CoV-2 and (34/51) 66.7% of Astrazeneca vaccinated patients had no IgG antibody.', 'copyrights': 'Copyright: © 2024 Asamoah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0298088\\n10.1186/s12879-016-2025-x\\n10.1155/2013/562175\\n10.1016/j.ijid.2020.04.007\\n10.1038/s41591-020-1025-y\\n10.4269/ajtmh.20-0440\\n10.4103/tp.TP_105_20\\n10.3390/diagnostics11060995\\n10.1093/oxfordjournals.molbev.a040023\\n10.1093/molbev/msab120\\n10.3347/kjp.2009.47.2.93\\n10.1093/cid/ciaa270\\n10.1136/bmjopen-2020-046276\\n10.2147/JMDH.S295432\\n10.1186/s13613-020-00689-1\\n10.1007/s00277-020-04103-5', 'xml': <Element 'PubmedArticle' at 0x10b087e70>}\n",
      "{'pubmed_id': '38335181\\n16640553\\n17498057\\n31585081\\n32223656\\n11876641\\n12162961\\n9920877\\n10391906\\n12100045\\n19748655\\n30007465\\n27228465\\n23887774\\n15829242\\n19570852\\n20962661\\n27749843\\n19933375\\n20808728\\n28477149\\n31482362\\n30341241\\n32504078\\n31104630\\n30670796\\n32944285', 'title': 'A targeted amplicon next-generation sequencing assay for tryptase genotyping to support personalized therapy in mast cell-related disorders.', 'abstract': 'Tryptase, the most abundant mast cell granule protein, is elevated in severe asthma patients independent of type 2 inflammation status. Higher active β tryptase allele counts are associated with higher levels of peripheral tryptase and lower clinical benefit from anti-IgE therapies. Tryptase is a therapeutic target of interest in severe asthma and chronic spontaneous urticaria. Active and inactive allele counts may enable stratification to assess response to therapies in asthmatic patient subpopulations. Tryptase gene loci TPSAB1 and TPSB2 have high levels of sequence identity, which makes genotyping a challenging task. Here, we report a targeted next-generation sequencing (NGS) assay and downstream bioinformatics analysis for determining polymorphisms at tryptase TPSAB1 and TPSB2 loci. Machine learning modeling using multiple polymorphisms in the tryptase loci was used to improve the accuracy of genotyping calls. The assay was tested and qualified on DNA extracted from whole blood of healthy donors and asthma patients, achieving accuracy of 96%, 96% and 94% for estimation of inactive α and βΙΙΙFS tryptase alleles and α duplication on TPSAB1, respectively. The reported NGS assay is a cost-effective method that is more efficient than Sanger sequencing and provides coverage to evaluate known as well as unreported tryptase polymorphisms.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Li', 'firstname': 'Olga', 'initials': 'O', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Hackney', 'firstname': 'Jason A', 'initials': 'JA', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Choy', 'firstname': 'David F', 'initials': 'DF', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Chang', 'firstname': 'Diana', 'initials': 'D', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Nersesian', 'firstname': 'Rhea', 'initials': 'R', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Staton', 'firstname': 'Tracy L', 'initials': 'TL', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Cai', 'firstname': 'Fang', 'initials': 'F', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}, {'lastname': 'Toghi Eshghi', 'firstname': 'Shadi', 'initials': 'S', 'affiliation': 'Genentech Research and Early Development, Genentech, Inc, South San Francisco, CA, United States of America.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0291947\\n10.1111/j.1600-065X.2007.00509.x\\n10.1074/jbc.274.28.19670\\n10.1016/j.iac.2018.04.003\\n10.1093/nar/gkp552\\n10.1097/GIM.0b013e3181f8baad\\n10.1038/ng.3696\\n10.1165/rcmb.2009-0324RT\\n10.1109/TPAMI.2005.127\\n10.1007/s10549-019-05425-3\\n10.1042/BSR20181170\\n10.1038/s41576-020-0236-x\\n10.1186/s13059-019-1707-2\\n10.1038/s41587-018-0004-z\\n10.1038/s41525-020-00142-z', 'xml': <Element 'PubmedArticle' at 0x10969a3e0>}\n",
      "{'pubmed_id': '38335179', 'title': 'A Novel CT Score Reveals More About Air Trapping in Asthma.', 'abstract': None, 'keywords': [], 'journal': 'American journal of respiratory and critical care medicine', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Svenningsen', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'McMaster University Department of Medicine, 152997, Hamilton, Ontario, Canada.'}, {'lastname': 'Kirby', 'firstname': 'Miranda', 'initials': 'M', 'affiliation': 'Ryerson University, Physics, Toronto, Ontario, Canada.\\nUnited States; miranda.kirby@ryerson.ca.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1164/rccm.202312-2284ED', 'xml': <Element 'PubmedArticle' at 0x10a2f4ea0>}\n",
      "{'pubmed_id': '38334904\\n29930242\\n24565453\\n31232396\\n29319189\\n25832131\\n23452057\\n31819466\\n32738956\\n31194890\\n34077579\\n33180320\\n34321892\\n35347660\\n24630429\\n35534297\\n34936253\\n33991374\\n29937585\\n33587103\\n36330555\\n35767267\\n30217277\\n35188464\\n31201863\\n27466290\\n32401725\\n31447731\\n31122909\\n27499642\\n36368579\\n34055570\\n31690745\\n28300440\\n36619624\\n30962700\\n33074565\\n31694234\\n32818591\\n33735876\\n36873862', 'title': 'Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care.', 'abstract': \"Atopic dermatitis (AD) is a chronic inflammatory skin condition that affects both children and adults. AD increases the risk of developing comorbidities like asthma, allergic rhinitis and food allergies. AD patients face difficulties, including itching, lack of effective treatments, lack of funding and discomfort in seeking a diagnosis or treatment. This study aims to identify the main barriers and opportunities to improve the experience of patients with AD and provide high-quality care.\\nPatients, caregivers and healthcare professionals were recruited from the Dermatology Department at Puerta de Hierro Majadahonda University Hospital (Madrid, Spain). Interviews with patients, caregivers and professionals were performed. Participants used storyboards to depict their preferred scenarios for improving healthcare interactions and create a Patient Journey Map.\\nA total of 15 participants were included in the study. Early symptoms of AD were commonly described as undefined stages. As symptoms worsened, patients and caregivers expressed uncertainty and frustration. Patients became concerned about AD after their first serious flare and started experiencing intense itching, eczema, wounds, shedding or asthma. Topical corticosteroids were used to manage flares, but their effectiveness diminished over time, causing further frustration. Because of the ineffectiveness of their initial treatments, dermatologists observed that patients tended to downplay symptoms and how they affected their quality of life. The specialized treatment of severe AD significantly changed patients' emotional states. Despite AD's chronic nature, patients strived to enjoy remission periods and cope with flares. Psychological and emotional support was crucial for patients and caregivers, a need addressed by the Patients' School initiative at HUPHM hospital.\\nThe severity of AD has a profound impact on patients' lives. Patient and caregiver emotional and social needs can be met by adequate communication, access to effective treatments and comprehensive psychological support.\", 'keywords': ['Atopic dermatitis', 'Eczema', 'Patient centered', 'Patient journey map', 'Patient perspective'], 'journal': 'Dermatology and therapy', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Roustán', 'firstname': 'Gastón', 'initials': 'G', 'affiliation': 'Department of Dermatology, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain. groustan@gmail.com.'}, {'lastname': 'Loro', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Department of Dermatology, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain.'}, {'lastname': 'Rosell', 'firstname': 'Ángel', 'initials': 'Á', 'affiliation': 'Department of Dermatology, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain.'}, {'lastname': 'Menchen', 'firstname': 'Belén', 'initials': 'B', 'affiliation': 'Hospital Pharmacy, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain.'}, {'lastname': 'Vicente', 'firstname': 'Olga', 'initials': 'O', 'affiliation': 'Centro de Salud La Marazuela, Madrid, Spain.'}, {'lastname': 'Elosua-González', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Department of Dermatology, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain.'}, {'lastname': 'Castaño', 'firstname': 'Juan L', 'initials': 'JL', 'affiliation': 'Department of Dermatology, Puerta de Hierro Majadahonda University (HUPHM) Hospital, Madrid, Spain.'}, {'lastname': 'Peña', 'firstname': 'Catalina', 'initials': 'C', 'affiliation': 'Instituto de Experiencia del Paciente, Madrid, Spain.'}, {'lastname': 'Isidoro', 'firstname': 'Olga', 'initials': 'O', 'affiliation': 'Laboratorios Galderma S.A., Madrid, Spain.'}], 'methods': None, 'conclusions': \"The severity of AD has a profound impact on patients' lives. Patient and caregiver emotional and social needs can be met by adequate communication, access to effective treatments and comprehensive psychological support.\", 'results': \"A total of 15 participants were included in the study. Early symptoms of AD were commonly described as undefined stages. As symptoms worsened, patients and caregivers expressed uncertainty and frustration. Patients became concerned about AD after their first serious flare and started experiencing intense itching, eczema, wounds, shedding or asthma. Topical corticosteroids were used to manage flares, but their effectiveness diminished over time, causing further frustration. Because of the ineffectiveness of their initial treatments, dermatologists observed that patients tended to downplay symptoms and how they affected their quality of life. The specialized treatment of severe AD significantly changed patients' emotional states. Despite AD's chronic nature, patients strived to enjoy remission periods and cope with flares. Psychological and emotional support was crucial for patients and caregivers, a need addressed by the Patients' School initiative at HUPHM hospital.\", 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s13555-024-01100-8\\n10.1038/s41572-018-0001-z\\n10.1016/j.jaip.2012.09.002\\n10.1080/21556660.2019.1619570\\n10.1111/all.13401\\n10.1111/all.12619\\n10.1111/all.12112\\n10.2147/TCRM.S226456\\n10.1016/S0140-6736(20)31286-1\\n10.1111/all.13946\\n10.1111/jdv.17432\\n10.1007/s13555-020-00459-8\\n10.2147/JAA.S317009\\n10.1007/s13555-022-00700-6\\n10.1016/j.ad.2014.01.004\\n10.1016/j.ad.2022.01.025\\n10.7705/biomedica.5978\\n10.1111/jdv.17351\\n10.1007/s11135-017-0574-8\\n10.1093/rheumatology/keab154\\n10.1111/jan.15479\\n10.1001/jamadermatol.2022.1906\\n10.1016/j.clindermatol.2018.05.008\\n10.1684/ejd.2022.4197\\n10.1016/j.anai.2019.06.002\\n10.1177/1359105316660181\\n10.1016/j.ad.2019.03.018\\n10.3389/fpsyg.2019.01773\\n10.1684/ejd.2019.3557\\n10.2147/CCID.S91263\\n10.1016/j.ad.2022.08.025\\n10.1007/s40521-021-00289-9\\n10.1038/s41598-019-51129-5\\n10.1177/1203475416685077\\n10.3389/fmed.2022.1079323\\n10.2147/CCID.S163814\\n10.1111/all.14631\\n10.3390/children6110125\\n10.1016/j.anai.2020.08.016\\n10.1159/000514535\\n10.3389/fmed.2023.1066495', 'xml': <Element 'PubmedArticle' at 0x10a2f7e70>}\n",
      "{'pubmed_id': '38334246', 'title': 'Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study.', 'abstract': 'In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence.\\nIn a cross-sectional study (2015-2022), we assessed European users of the MASK-air mHealth app of three age groups: adolescents (13-18\\u2009years), young adults (18-26\\u2009years), and adults (>26\\u2009years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom-medication score (CSMS), and the electronic daily control score for asthma (e-DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity.\\nWe assessed 965 adolescent users (15,252\\u2009days), 4595 young adults (58,161\\u2009days), and 15,154 adult users (258,796\\u2009days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults.\\nAdolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases.', 'keywords': ['adherence', 'adolescents', 'allergic rhinitis', 'asthma', 'digital health', 'mHealth', 'real-world data'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Sousa-Pinto', 'firstname': 'Bernardo', 'initials': 'B', 'affiliation': 'MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.\\nCINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Valiulis', 'firstname': 'Arunas', 'initials': 'A', 'affiliation': 'Interdisciplinary Research Group of Human Ecology, Institute of Clinical Medicine and Institute of Health Sciences, Medical Faculty of Vilnius University, Vilnius, Lithuania.\\nEuropean Academy of Paediatrics, (EAP/UEMS-SP), Brussels, Belgium.'}, {'lastname': 'Melén', 'firstname': 'Erik', 'initials': 'E', 'affiliation': \"Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.\\nSach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.\"}, {'lastname': 'Koppelman', 'firstname': 'Gerard H', 'initials': 'GH', 'affiliation': \"Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, GRIACResearch Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.\"}, {'lastname': 'Papadopoulos', 'firstname': 'Nikolaos G', 'initials': 'NG', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.'}, {'lastname': 'Makela', 'firstname': 'Mika', 'initials': 'M', 'affiliation': 'Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Haahtela', 'firstname': 'Tari', 'initials': 'T', 'affiliation': 'Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Bonini', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'Department of Cardiovascular and Respiratory Sciences, Universita Cattolica del Sacro Cuore, Rome, Italy.\\nDepartment of Neurological, ENT and Thoracic Sciences, Fondazione Policlinico Universitario A Gemelli - IRCCS, Rome, Italy.\\nNational Heart and Lung Institute (NHLI), Imperial College London, London, UK.'}, {'lastname': 'Braido', 'firstname': 'Fulvio', 'initials': 'F', 'affiliation': 'Respiratory Clinic, Department of Internal Medicine, University of Genoa, Genoa, Italy.\\nIRCCS Ospedale Policlinico San Martino, Genoa, Italy.'}, {'lastname': 'Brussino', 'firstname': 'Luisa', 'initials': 'L', 'affiliation': 'Department of Medical Sciences, University of Torino, Torino, Italy.\\nAllergy and Clinical Immunology Unit, Mauriziano Hospital, Torino, Italy.'}, {'lastname': 'Cruz', 'firstname': 'Alvaro A', 'initials': 'AA', 'affiliation': 'Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group, Salvador, Bahia, Brazil.'}, {'lastname': 'Fiocchi', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': \"Allergy, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.\"}, {'lastname': 'Giovannini', 'firstname': 'Mattia', 'initials': 'M', 'affiliation': \"Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.\\nDepartment of Health Sciences, University of Florence, Florence, Italy.\"}, {'lastname': 'Gemicioglu', 'firstname': 'Bilun', 'initials': 'B', 'affiliation': 'Department of Pulmonary Diseases, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.'}, {'lastname': 'Kulus', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Department of Pediatric Respiratory Diseases and Allergology, Medical University of Warsaw, Warsaw, Poland.'}, {'lastname': 'Kuna', 'firstname': 'Piotr', 'initials': 'P', 'affiliation': 'Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.'}, {'lastname': 'Kupczyk', 'firstname': 'Maciej', 'initials': 'M', 'affiliation': 'Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.'}, {'lastname': 'Kvedariene', 'firstname': 'Violeta', 'initials': 'V', 'affiliation': 'Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.\\nInstitute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.'}, {'lastname': 'Larenas-Linnemann', 'firstname': 'Désirée E', 'initials': 'DE', 'affiliation': 'Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.'}, {'lastname': 'Louis', 'firstname': 'Renaud', 'initials': 'R', 'affiliation': 'Department of Pulmonary Medicine, CHU Liège, Liège, Belgium.\\nGIGA I3 Research Group, University of Liège, Liège, Belgium.'}, {'lastname': 'Morais-Almeida', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.'}, {'lastname': 'Niedoszytko', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Department of Allergology, Medical University of Gdańsk, Gdansk, Poland.'}, {'lastname': 'Ollert', 'firstname': 'Markus', 'initials': 'M', 'affiliation': 'Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.\\nDepartment of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.'}, {'lastname': 'Pfaar', 'firstname': 'Oliver', 'initials': 'O', 'affiliation': 'Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.'}, {'lastname': 'Regateiro', 'firstname': 'Frederico S', 'initials': 'FS', 'affiliation': 'Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\\nCenter for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\\nUBIAir - Clinical & Experimental Lung Centre and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.'}, {'lastname': 'Roberts', 'firstname': 'Graham', 'initials': 'G', 'affiliation': \"Faculty of Medicine, University of Southampton, Southampton, UK.\\nThe David Hide Asthma and Allergy Centre, St Mary's Hospital, Isle of Wight, UK.\\nNIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.\"}, {'lastname': 'Samolinski', 'firstname': 'Boleslaw', 'initials': 'B', 'affiliation': 'Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Warsaw, Poland.'}, {'lastname': 'Savouré', 'firstname': 'Marine', 'initials': 'M', 'affiliation': \"Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Villejuif, France.\\nInserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.\"}, {'lastname': 'Taborda-Barata', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'UBIAir - Clinical & Experimental Lung Centre and CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.\\nDepartment of Immunoallergology, Cova da Beira University Hospital Centre, Covilhã, Portugal.'}, {'lastname': 'Toppila-Salmi', 'firstname': 'Sanna', 'initials': 'S', 'affiliation': 'Department of Otorhinolaryngology, Kuopio University Hospital and University of Eastern Finland, Kupio, Finland.\\nDepartment of Allergy, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Ventura', 'firstname': 'Maria Teresa', 'initials': 'MT', 'affiliation': 'Allergy and Clinical Immunology, University of Bari Medical School, Bari, Italy.\\nInstitute of Sciences of Food Production, National Research Council (ISPA-CNR), Bari, Italy.'}, {'lastname': 'Vazquez-Ortiz', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Section of Inflammation, Repair and Development, Imperial College London, National Heart and Lung Institute, London, UK.\\nDepartment of Paediatrics, Imperial College Healthcare NHS Trust, London, UK.'}, {'lastname': 'Vieira', 'firstname': 'Rafael José', 'initials': 'RJ', 'affiliation': 'MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.\\nCINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Fonseca', 'firstname': 'Joao A', 'initials': 'JA', 'affiliation': 'MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.\\nCINTESIS@RISE - Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Yorgancioglu', 'firstname': 'Arzu', 'initials': 'A', 'affiliation': 'Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.'}, {'lastname': 'Zuberbier', 'firstname': 'Torsten', 'initials': 'T', 'affiliation': 'Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.'}, {'lastname': 'Anto', 'firstname': 'Josep M', 'initials': 'JM', 'affiliation': 'ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.\\nUniversitat Pompeu Fabra (UPF), Barcelona, Spain.\\nCIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.'}, {'lastname': 'Bousquet', 'firstname': 'Jean', 'initials': 'J', 'affiliation': 'Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.\\nFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.\\nMASK-air, Montpellier, France.'}, {'lastname': 'Pham-Thi', 'firstname': 'Nhân', 'initials': 'N', 'affiliation': 'Ecole Polytechnique de Palaiseau, Palaiseau, France.\\nIRBA (Institut de Recherche Bio-Médicale des Armées), Brétigny sur Orge, France.\\nUniversité Paris Cité, Paris, France.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'We assessed 965 adolescent users (15,252\\u2009days), 4595 young adults (58,161\\u2009days), and 15,154 adult users (258,796\\u2009days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults.', 'copyrights': '© 2024 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14080', 'xml': <Element 'PubmedArticle' at 0x10995a3e0>}\n",
      "{'pubmed_id': '38334163', 'title': 'Transitional care of adolescents and young adults with asthma and allergy-The healthcare professional perspective.', 'abstract': None, 'keywords': [], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Ödling', 'firstname': 'Maria', 'initials': 'M', 'affiliation': \"Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.\\nDepartment of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.\"}, {'lastname': 'Lagercrantz', 'firstname': 'Birgitta', 'initials': 'B', 'affiliation': 'Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Goksör', 'firstname': 'Emma', 'initials': 'E', 'affiliation': \"Department of Paediatrics, Queen Silvia Children's Hospital, University of Gothenburg, Gothenburg, Sweden.\"}, {'lastname': 'Sandelowsky', 'firstname': 'Hanna', 'initials': 'H', 'affiliation': 'Department of Medicine, Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.\\nDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.\\nAcademic Primary Healthcare Centre, Stockholm, Sweden.'}, {'lastname': 'Janson', 'firstname': 'Christer', 'initials': 'C', 'affiliation': 'Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.'}, {'lastname': 'Kull', 'firstname': 'Inger', 'initials': 'I', 'affiliation': \"Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.\\nSachs' Children and Youth Hospital, Stockholm, Sweden.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/all.16047', 'xml': <Element 'PubmedArticle' at 0x10ac7d030>}\n",
      "{'pubmed_id': '38334162', 'title': 'Induction of a memory-like CD4', 'abstract': 'In asthma, CD4', 'keywords': ['Airway smooth muscle', 'Asthma', 'CD4+ T cells', 'Immune memory', 'Mitochondria'], 'journal': 'European journal of immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Jang', 'firstname': 'Joyce H', 'initials': 'JH', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Zhou', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Makita', 'firstname': 'Kosuke', 'initials': 'K', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Sun', 'firstname': 'Rui', 'initials': 'R', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'El-Hajjar', 'firstname': 'Mikal', 'initials': 'M', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Fonseca', 'firstname': 'Gregory', 'initials': 'G', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Lauzon', 'firstname': 'Anne-Marie', 'initials': 'AM', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}, {'lastname': 'Martin', 'firstname': 'James G', 'initials': 'JG', 'affiliation': 'Meakins-Christie Laboratories, McGill University Health Centre, Montreal, Quebec, Canada.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.', 'doi': '10.1002/eji.202249800', 'xml': <Element 'PubmedArticle' at 0x1250801d0>}\n",
      "{'pubmed_id': '38334146', 'title': 'Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.', 'abstract': \"Component-resolved diagnosis allows detection of IgE sensitization having the advantage of reproducibility and standardization compared to crude extracts. The main disadvantage of the traditional allergen identification methods, 1- or 2-dimensional western blotting and screening of expression cDNA libraries with patients' IgEs, is that the native structure of the protein is not necessarily maintained.\\nWe used a novel immunoprecipitation technique in combination with mass spectrometry to identify new allergens of Aspergillus fumigatus. Magnetic Dynabeads coupled with anti-human IgE antibodies were used to purify human serum IgE and subsequently allergens from A.\\u2009fumigatus protein extract.\\nOf the 184 proteins detected by subsequent mass peptide fingerprinting, a subset of 13 were recombinantly expressed and purified. In a panel of 52 A.\\u2009fumigatus-sensitized people with asthma, 23 non-fungal-sensitized asthmatics and 18 healthy individuals, only the former showed an IgE reaction by immunoblotting and/or ELISA. We discovered 11 proteins not yet described as A.\\u2009fumigatus allergens, with fructose-bisphosphate aldolase class II (FBA2) (33%), NAD-dependent malate dehydrogenase (31%) and Cu/Zn superoxide dismutase (27%) being the most prevalent. With respect to these three allergens, native versus denatured protein assays indicated a better recognition of the native proteins. Seven of 11 allergens fulfilled the WHO/IUIS criteria and were accepted as new A.\\u2009fumigatus allergens.\\nIn conclusion, we introduce a straightforward method of allergen identification from complex allergenic sources such as A.\\u2009fumigatus by immunoprecipitation combined with mass spectrometry, which has the advantage over traditional methods of identifying allergens by maintaining the structure of the proteins.\", 'keywords': ['\\nAspergillus fumigatus\\n', 'allergens', 'allergic fungal airway disease', 'immunoprecipitation'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Rick', 'firstname': 'Eva-Maria', 'initials': 'EM', 'affiliation': 'Department of Respiratory Sciences, Aerobiology and Mycology Group, Institute for Lung Health, Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.'}, {'lastname': 'Woolnough', 'firstname': 'Kerry', 'initials': 'K', 'affiliation': 'Department of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Richardson', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': 'Department of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Monteiro', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Department of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Craner', 'firstname': 'Michelle', 'initials': 'M', 'affiliation': 'Department of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Bourne', 'firstname': 'Michelle', 'initials': 'M', 'affiliation': 'Department of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Cousins', 'firstname': 'David John', 'initials': 'DJ', 'affiliation': 'Department of Respiratory Sciences, Aerobiology and Mycology Group, Institute for Lung Health, Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.'}, {'lastname': 'Swoboda', 'firstname': 'Ines', 'initials': 'I', 'affiliation': 'Competence Center for Molecular Biotechnology, Molecular Biotechnology Section, FH Campus Wien, University of Applied Sciences, Vienna, Austria.'}, {'lastname': 'Wardlaw', 'firstname': 'Andrew John', 'initials': 'AJ', 'affiliation': 'Department of Respiratory Sciences, Aerobiology and Mycology Group, Institute for Lung Health, Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.\\nDepartment of Allergy and Respiratory Medicine, Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.'}, {'lastname': 'Pashley', 'firstname': 'Catherine Helen', 'initials': 'CH', 'affiliation': 'Department of Respiratory Sciences, Aerobiology and Mycology Group, Institute for Lung Health, Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.'}], 'methods': None, 'conclusions': 'In conclusion, we introduce a straightforward method of allergen identification from complex allergenic sources such as A.\\u2009fumigatus by immunoprecipitation combined with mass spectrometry, which has the advantage over traditional methods of identifying allergens by maintaining the structure of the proteins.', 'results': 'Of the 184 proteins detected by subsequent mass peptide fingerprinting, a subset of 13 were recombinantly expressed and purified. In a panel of 52 A.\\u2009fumigatus-sensitized people with asthma, 23 non-fungal-sensitized asthmatics and 18 healthy individuals, only the former showed an IgE reaction by immunoblotting and/or ELISA. We discovered 11 proteins not yet described as A.\\u2009fumigatus allergens, with fructose-bisphosphate aldolase class II (FBA2) (33%), NAD-dependent malate dehydrogenase (31%) and Cu/Zn superoxide dismutase (27%) being the most prevalent. With respect to these three allergens, native versus denatured protein assays indicated a better recognition of the native proteins. Seven of 11 allergens fulfilled the WHO/IUIS criteria and were accepted as new A.\\u2009fumigatus allergens.', 'copyrights': '© 2024 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.', 'doi': '10.1111/all.16032', 'xml': <Element 'PubmedArticle' at 0x10af8cfe0>}\n",
      "{'pubmed_id': '38334050', 'title': 'The use of triple therapy in asthma. The GEMA-FORUM V task force.', 'abstract': None, 'keywords': ['Dose', 'Inhalation Device', 'LABA', 'LAMA', 'Triple Therapy'], 'journal': 'Journal of investigational allergology & clinical immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Plaza', 'firstname': 'V', 'initials': 'V', 'affiliation': \"Director del Comité Ejecutivo de la Guía Española para el Manejo del Asma (GEMA). Servei de Pneumologia i Al·lèrgia. Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau). Universitat Autònoma de Barcelona.Barcelo.\"}, {'lastname': 'Trigueros', 'firstname': 'J A', 'initials': 'JA', 'affiliation': 'Medicina de Familia. Centro de Salud Buenavista. Toledo, Spain.'}, {'lastname': 'Carretero', 'firstname': 'J A', 'initials': 'JA', 'affiliation': 'Servicio de Neumología. Hospital Royo Villanova. Zaragoza, Spain.'}, {'lastname': 'Ojanguren Arranz', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Servicio de Neumología. Hospital Universitari Vall d´Hebron. Barcelona, Spain.'}, {'lastname': 'Vega Chicote', 'firstname': 'J M', 'initials': 'JM', 'affiliation': 'UGC de Alergología. Hospital Regional Universitario. Málaga, Spain.'}, {'lastname': 'Almonacid Sánchez', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Servicio de Neumología. Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.'}, {'lastname': 'Bartra Tomás', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Servicio de Neumología y Alergia. Hospital Clínic de Barcelona. Barcelona, Spain.'}, {'lastname': 'Cisneros Serrano', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Servicio de Neumología. Hospital Universitario de La Princesa. Instituto de Investigación La Princesa. Madrid, Spain.'}, {'lastname': 'Domínguez Juncal', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Servicio de Neumología. Complejo Hospitalario Universitario A Coruña (CHUAC). A Coruña, Spain.'}, {'lastname': 'Domínguez-Ortega', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Servicio de Alergología. Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) y CIBER de Enfermedades Respiratorias (CIBERES). Madrid, Spain.'}, {'lastname': 'Figueroa Rivero', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Sección de Alergología. Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria. Las Palmas, Spain.'}, {'lastname': 'Soto Campos', 'firstname': 'J G', 'initials': 'JG', 'affiliation': 'UGC de Neumología y Alergia. Hospital Universitario de Jerez. Jerez de la Frontera, Spain.'}, {'lastname': 'Macías Fernández', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Servicio de Neumología. Hospital Clínico Universitario de Valladolid. Valladolid, Spain.'}, {'lastname': 'Martínez', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Servicio de Neumología. Hospital Comarcal de la Vega Baja. Alicante, Spain.'}, {'lastname': 'Montoro Lacomba', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Servicio de Alergología. Hospital Arnau de Vilanova-Liria. Valencia, Spain.'}, {'lastname': 'Quirce', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Servicio de Alergología. Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ) y CIBER de Enfermedades Respiratorias (CIBERES). Madrid, Spain.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.18176/jiaci.0975', 'xml': <Element 'PubmedArticle' at 0x109e88ef0>}\n",
      "{'pubmed_id': '38333835\\n37451150\\n32369100\\n36216328\\n35832729\\n29314863\\n29484832\\n30349237\\n37496906\\n37476667\\n37487521\\n36688156\\n22898922\\n27468699\\n19406982\\n23759184\\n16159612\\n19483109\\n17083726\\n29958800\\n37460031\\n37441811\\n35950646\\n36744026\\n36989607\\n35470728\\n35115789\\n31617730\\n31638834\\n30619097\\n35769905\\n32590100\\n36267708\\n37445635\\n37030998\\n37399718\\n37392815\\n33826881\\n37031560\\n34818549\\n32179730\\n30426778\\n33640857\\n32768929\\n15896192\\n28190087\\n19542254\\n25018070\\n29271239\\n37385657\\n36725331\\n37223023\\n35386850\\n29501934\\n36243221\\n37436680\\n37002624\\n36776398\\n36439114\\n35721212\\n29469196\\n37073792\\n36602260\\n25616863\\n37301084\\n35342020\\n35315082\\n37080268\\n36672671\\n29567590\\n37491375\\n37415620\\n35910345\\n32679188\\n28473327\\n12531777\\n12589337\\n29273246\\n12502479', 'title': 'Research trends on airway remodeling: A bibliometrics analysis.', 'abstract': \"Airway remodeling is an essential pathological basis of respiratory diseases such as asthma and COPD, which is significantly related to pulmonary function and clinical symptoms. And pulmonary disease can be improved by regulating airway remodeling. This study aimed to establish a knowledge map of airway remodeling to clarify current research hotspots and future research trends.\\nA comprehensive search was performed to analyze all relevant articles on airway remodeling using the Web of Science Core Collection Database from January 01, 2004 to June 03, 2023.2 reviewers screened the retrieved literature. Besides, the CiteSpace (6.2. R3) and VOSviewer (1.6.19) were utilized to visualize the research focus and trend regarding the effect of airway remodeling.\\nA total of 4077 articles about airway remodeling were retrieved. The United States is the country with the most published literature, underscoring the country's role in airway remodeling. In recent years, China has been the country with the fastest growth in the number of published literature, suggesting that China will play a more critical role in airway remodeling in the future. From the perspective of co-operation among countries, European co-operation was closer than Asian co-operation. The co-citation analysis showed that 98,313 citations were recorded in 3594 articles, and 25 clusters could be realized. In recent years, Burst detection shows that oxidative stress and epithelial-mesenchymal transition are hot words.\\nBased on the bibliometric analysis of airway remodeling studies in the past 20 years, a multi-level knowledge structure map was drawn, it mainly includes countries, institutions, research fields, authors, journals, keywords and so on. The research directions represented by obstructive airway disease, PDGF-BB treatment of airway smooth muscle, allergen-induced airway remodeling, extracellular matrix, and non-coding RNA are the research hotspots in the field of airway remodeling. While the risk factors for airway remodeling, the application of new noninvasively assessing tools, biomarkers as well as The molecular mechanism represented by EMT and autophagy had been frontiers in recent years.\", 'keywords': ['Airway remodeling', 'Asthma', 'Bibliometric analysis', 'COPD', 'Citespace', 'VOSviewer'], 'journal': 'Heliyon', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Liu', 'firstname': 'Pengcheng', 'initials': 'P', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Wang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Chen', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Liu', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Ye', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiaoming', 'initials': 'X', 'affiliation': 'School of Basic Medicine, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Ma', 'firstname': 'Changxiu', 'initials': 'C', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}, {'lastname': 'Zhao', 'firstname': 'Dahai', 'initials': 'D', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Anhui Medical University, Hefei, 230000, China.'}], 'methods': None, 'conclusions': None, 'results': \"A total of 4077 articles about airway remodeling were retrieved. The United States is the country with the most published literature, underscoring the country's role in airway remodeling. In recent years, China has been the country with the fastest growth in the number of published literature, suggesting that China will play a more critical role in airway remodeling in the future. From the perspective of co-operation among countries, European co-operation was closer than Asian co-operation. The co-citation analysis showed that 98,313 citations were recorded in 3594 articles, and 25 clusters could be realized. In recent years, Burst detection shows that oxidative stress and epithelial-mesenchymal transition are hot words.\", 'copyrights': '© 2024 Published by Elsevier Ltd.', 'doi': '10.1016/j.heliyon.2024.e24824\\n10.1016/j.phymed.2023.154941\\n10.1042/cs20191309\\n10.1002/ptr.7655\\n10.1080/20018525.2022.2097377\\n10.1165/rcmb.2017-0329OC\\n10.14814/phy2.13584\\n10.2147/copd.S176122\\n10.1016/j.heliyon.2023.e17987\\n10.3389/fmicb.2023.1217727\\n10.1055/a-2110-2157\\n10.3389/fnagi.2022.1057214\\n10.1096/fj.12-208033\\n10.1038/srep30676\\n10.1164/rccm.200811-1730OC\\n10.1016/j.jaci.2013.04.012\\n10.1016/j.jaci.2005.07.011\\n10.1164/rccm.200903-0392OC\\n10.1186/1465-9921-7-135\\n10.1016/j.immuni.2018.04.023\\n10.1016/j.jep.2023.116887\\n10.1016/j.intimp.2023.110608\\n10.1111/all.15473\\n10.3389/fphys.2023.1113100\\n10.1515/cclm-2022-1323\\n10.1080/08916934.2022.2062596\\n10.2147/jaa.S335680\\n10.1152/ajplung.00206.2019\\n10.1096/fj.201901340R\\n10.3389/fendo.2018.00770\\n10.3389/fmolb.2022.927549\\n10.1016/j.phrs.2020.105045\\n10.21037/atm-22-2835\\n10.3390/ijms241310451\\n10.1016/j.pulmoe.2023.02.015\\n10.1016/j.biopha.2023.115105\\n10.1016/j.neubiorev.2023.105300\\n10.1016/j.celrep.2021.108956\\n10.1016/j.smim.2023.101759\\n10.1016/j.celrep.2021.110051\\n10.12659/msm.920795\\n10.2217/epi-2018-0132\\n10.1016/j.intimp.2021.107488\\n10.1016/j.biopha.2020.110326\\n10.1042/cs20040342\\n10.1007/s00441-016-2566-8\\n10.1378/chest.09-0174\\n10.1016/j.acra.2014.05.001\\n10.1259/bjr.20170647\\n10.1183/13993003.00218-2023\\n10.1136/thorax-2022-219620\\n10.3389/fendo.2023.1175677\\n10.2147/dddt.S349950\\n10.1016/j.molimm.2018.02.009\\n10.1016/j.jaci.2022.09.032\\n10.1007/s40265-023-01905-5\\n10.18502/ijaai.v22i1.12000\\n10.3389/fimmu.2022.1099509\\n10.3389/fimmu.2022.1040442\\n10.3389/fphar.2022.916508\\n10.1002/ppul.23968\\n10.1177/17534666231167351\\n10.1111/all.15637\\n10.1186/s12931-014-0163-5\\n10.1016/j.jneuroim.2023.578119\\n10.1016/j.anai.2022.03.016\\n10.1111/all.15286\\n10.1016/j.envres.2023.115942\\n10.3390/biomedicines11010163\\n10.1016/j.intimp.2018.03.016\\n10.1038/s41419-023-05978-8\\n10.2147/jir.S417801\\n10.3389/fphar.2022.917256\\n10.1016/j.drup.2020.100715\\n10.1152/ajplung.00510.2016\\n10.1164/rccm.200209-1030OC\\n10.1067/mai.2003.128\\n10.1016/s0140-6736(17)33311-1\\n10.1164/rccm.200205-414OC', 'xml': <Element 'PubmedArticle' at 0x10b326340>}\n",
      "{'pubmed_id': '38333649\\n33095996\\n35427534\\n34490723\\n29628376\\n27579637\\n871704\\n34672872\\n29768509\\n29671603\\n26154786\\n36244396\\n36409973\\n31369720\\n21991892\\n21836135\\n33303557\\n31800292\\n21784770\\n17158282\\n30061168\\n32098862\\n15879414\\n32367290\\n22743675\\n27818791\\n32649918\\n33692568\\n29955581\\n20980245\\n34233141\\n31601717\\n27194908\\n18827152\\n35115341\\n30165982\\n27585385', 'title': 'Clinical relevance of lung function trajectory clusters in middle-aged and older adults.', 'abstract': 'The determinants and health outcomes of lung function trajectories in adults among the general population are poorly understood. We aimed to identify and characterise clusters of lung function trajectories in adults aged ≥45\\u2005years.\\nGaussian finite-mixture modelling was applied to baseline and annualised change of forced expiratory volume in 1\\u2005s (FEV\\nWe identified eight trajectory clusters, with the reference group having persistently normal spirometry (prevalence 42.8%). Three clusters showed higher mortality, adjusted for confounders: 1) the persistently low FEV\\nThis study reveals clinically relevant lung function trajectory clusters in older adults of the general population.', 'keywords': [], 'journal': 'ERJ open research', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Bertels', 'firstname': 'Xander', 'initials': 'X', 'affiliation': 'Department of Bioanalysis, Ghent University, Ghent, Belgium.\\nDepartment of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.'}, {'lastname': 'Ross', 'firstname': 'James C', 'initials': 'JC', 'affiliation': \"Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Faner', 'firstname': 'Rosa', 'initials': 'R', 'affiliation': \"Institut d'Investigacions Biomédiques August Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain.\\nDepartment of Biomedical Sciences, University of Barcelona, Barcelona, Spain.\\nCentro Investigaciones Biomédicas en Red, Instituto de Salud Carlos III, Madrid, Spain.\"}, {'lastname': 'Cho', 'firstname': 'Michael H', 'initials': 'MH', 'affiliation': \"Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.\\nDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Ikram', 'firstname': 'M Arfan', 'initials': 'MA', 'affiliation': 'Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.'}, {'lastname': 'Brusselle', 'firstname': 'Guy G', 'initials': 'GG', 'affiliation': 'Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.\\nDepartment of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.\\nDepartment of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.'}, {'lastname': 'Lahousse', 'firstname': 'Lies', 'initials': 'L', 'affiliation': 'Department of Bioanalysis, Ghent University, Ghent, Belgium.\\nDepartment of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.'}], 'methods': None, 'conclusions': None, 'results': 'We identified eight trajectory clusters, with the reference group having persistently normal spirometry (prevalence 42.8%). Three clusters showed higher mortality, adjusted for confounders: 1) the persistently low FEV', 'copyrights': 'Copyright ©The authors 2024.', 'doi': '10.1183/23120541.00793-2023\\n10.1164/rccm.202010-3784ED\\n10.1016/S2213-2600(21)00510-5\\n10.1111/resp.14142\\n10.1016/S2213-2600(18)30100-0\\n10.1056/NEJMra1603287\\n10.1136/bmj.1.6077.1645\\n10.1164/rccm.202107-1663SO\\n10.1371/journal.pone.0197250\\n10.1164/rccm.201707-1405OC\\n10.1056/NEJMoa1411532\\n10.1016/S2213-2600(22)00364-2\\n10.1164/rccm.202203-0444OC\\n10.1016/j.amjmed.2019.06.049\\n10.1056/NEJMoa1105482\\n10.1164/rccm.201105-0831OC\\n10.1183/13993003.01339-2020\\n10.1513/AnnalsATS.201904-329OC\\n10.1136/thoraxjnl-2011-200621\\n10.1164/rccm.200607-896OC\\n10.1136/thoraxjnl-2017-210477\\n10.1136/thoraxjnl-2019-213880\\n10.1164/rccm.200411-1486OC\\n10.1007/s10654-020-00640-5\\n10.1183/09031936.00080312\\n10.32614/RJ-2016-021\\n10.1016/S2213-2600(20)30101-6\\n10.1038/s41588-021-00783-5\\n10.21037/atm.2018.02.12\\n10.21105/joss.01686\\n10.1136/thx.2010.147041\\n10.1164/rccm.202102-0517OC\\n10.1183/13993003.01217-2019\\n10.2147/COPD.S104644\\n10.1183/09031936.00160007\\n10.1183/13993003.01954-2021\\n10.1183/13993003.congress-2022.1816\\n10.1016/j.jacc.2018.06.049\\n10.1164/rccm.201604-0753OC', 'xml': <Element 'PubmedArticle' at 0x10b574310>}\n",
      "{'pubmed_id': '38333644\\n17218553\\n17943402\\n36075255\\n29523017\\n29558165\\n31644440\\n30340565\\n32764911\\n29797071\\n27330285\\n30012144\\n19720809\\n29668352\\n35923660\\n30961941\\n28495687\\n26527869\\n36656550\\n30190269\\n26935750\\n29338792\\n28408742\\n33064273\\n27499620', 'title': 'Adjustments to maintenance therapy and the reasoning behind them among COPD outpatients in Austria: the STEP study.', 'abstract': \"Adjustments to COPD maintenance treatment are based on different guidelines. In Austria, there is a lack of real-world data on treatment adjustments of COPD outpatients and their underlying rationale. The STEP study characterised change patterns of pharmacological maintenance therapy in COPD outpatients in predefined categories of step-up, step-down and switch, the underlying reasons, and predictors in clinical routine in Austria.\\nSTEP was a single-visit non-interventional study in Austria. 77 pulmonologists based in outpatient clinics documented previous and adapted COPD therapy, reason for change, patient characteristics, COPD phenotype, and lung function. Patients' COPD symptom burden was assessed by using the COPD Assessment Test (CAT). Predictors for therapy changes were identified.\\n1137 patients were studied (mean±sd age 67±10\\u2005years; 56.9% male; mean forced expiratory volume in 1\\u2005s 56.3% predicted; Global Initiative for Chronic Obstructive Lung Disease B and E stages 66% and 19%, respectively; mean CAT score 17.5). Therapy step-up was observed in 59.3%, treatment switch in 21.7% and step-down in 19.0% of patients. Triple therapy comprised the biggest proportion of inhalation treatment (53.3%). Physicians reported lung function, symptom burden and exacerbations as the main reasons for step-up or step-down, whereas switches within the same treatment class were predominantly caused by device issues. Predictors for step-up were comorbid asthma and exacerbations among others.\\nSTEP was the first study to investigate COPD therapy changes in clinical routine in Austria. The most frequent treatment adjustment was step-up, followed by treatment switch and step-down. Symptom burden, stable or improved lung function and inhalation device handling were the most frequently given reasons for adjustments.\", 'keywords': [], 'journal': 'ERJ open research', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Vafai-Tabrizi', 'firstname': 'Florian', 'initials': 'F', 'affiliation': 'Karl Landsteiner Institute for Lung Research and Pulmonary Oncology and 2nd Medical Department with Pneumology, Klinik Ottakring, Vienna, Austria.'}, {'lastname': 'Schwab', 'firstname': 'Ulrich', 'initials': 'U', 'affiliation': 'A. Menarini Pharma GmbH, Vienna, Austria.'}, {'lastname': 'Brecht', 'firstname': 'Stephan', 'initials': 'S', 'affiliation': 'A. Menarini Pharma GmbH, Vienna, Austria.'}, {'lastname': 'Funk', 'firstname': 'Georg-Christian', 'initials': 'GC', 'affiliation': 'Karl Landsteiner Institute for Lung Research and Pulmonary Oncology and 2nd Medical Department with Pneumology, Klinik Ottakring, Vienna, Austria.'}], 'methods': None, 'conclusions': None, 'results': '1137 patients were studied (mean±sd age 67±10\\u2005years; 56.9% male; mean forced expiratory volume in 1\\u2005s 56.3% predicted; Global Initiative for Chronic Obstructive Lung Disease B and E stages 66% and 19%, respectively; mean CAT score 17.5). Therapy step-up was observed in 59.3%, treatment switch in 21.7% and step-down in 19.0% of patients. Triple therapy comprised the biggest proportion of inhalation treatment (53.3%). Physicians reported lung function, symptom burden and exacerbations as the main reasons for step-up or step-down, whereas switches within the same treatment class were predominantly caused by device issues. Predictors for step-up were comorbid asthma and exacerbations among others.', 'copyrights': 'Copyright ©The authors 2024.', 'doi': '10.1183/23120541.00615-2023\\n10.1378/chest.06-0365\\n10.1007/s00508-007-0867-3\\n10.1016/S0140-6736(22)01273-9\\n10.1055/s-0043-125031\\n10.1080/15412555.2018.1443064\\n10.1097/MCP.0000000000000639\\n10.1186/s12890-018-0724-3\\n10.2147/COPD.S252033\\n10.1007/s00508-018-1347-7\\n10.2147/COPD.S103614\\n10.1186/s12890-018-0684-7\\n10.1183/09031936.00102509\\n10.1056/NEJMoa1713901\\n10.2147/PPA.S367284\\n10.1016/j.rmed.2019.03.007\\n10.1183/13993003.01446-2016\\n10.2147/COPD.S91694\\n10.1164/rccm.202210-1949LE\\n10.1183/13993003.01219-2018\\n10.1016/j.rppnen.2015.12.012\\n10.1186/s12931-017-0710-y\\n10.1038/s41533-017-0022-1\\n10.1007/s41030-020-00132-7\\n10.2147/COPD.S112110', 'xml': <Element 'PubmedArticle' at 0x10ae86d40>}\n",
      "{'pubmed_id': '38333472\\n23678356\\n15331194\\n20442117\\n11042521\\n23313188\\n18491433', 'title': 'Diffuse Alveolar Hemorrhage Occurring Suddenly in a Diabetic Patient With Asthma Exacerbation.', 'abstract': 'Diffuse alveolar hemorrhage (DAH) is a rare but potentially life-threatening condition characterized by bleeding into the alveolar spaces of the lungs. DAH can occur due to a wide range of etiologies including autoimmune diseases, infections, drugs, and malignancies. The clinical presentation is variable and may include cough, dyspnea, fever, and hemoptysis. Diagnosis is often challenging due to the nonspecific symptoms and a lack of definitive diagnostic criteria. Treatment is primarily aimed at addressing the underlying cause and providing supportive care.', 'keywords': ['anatomic and clinical pathology', 'autopsy pathologist', 'diffuse alveolar hemorrhage', \"goodpasture's syndrome\", 'poor asthma outcomes', 'pulmonary-renal syndrome', 'teaching in emergency medicine'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Bardarov', 'firstname': 'Svetoslav', 'initials': 'S', 'affiliation': 'Pathology and Laboratory Medicine, Richmond University Medical Center, Staten Island, USA.'}, {'lastname': 'Vue', 'firstname': 'Chong', 'initials': 'C', 'affiliation': 'Pathology and Laboratory Medicine, Richmond University Medical Center, Staten Island, USA.'}, {'lastname': 'Santana', 'firstname': 'Rochell', 'initials': 'R', 'affiliation': 'Pathology and Laboratory Medicine, Richmond University Medical Center, Staten Island, USA.'}, {'lastname': 'Nfonoyim', 'firstname': 'Jay', 'initials': 'J', 'affiliation': 'Pulmonary and Critical Care, Richmond University Medical Center, Staten Island, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024, Bardarov et al.', 'doi': '10.7759/cureus.51893', 'xml': <Element 'PubmedArticle' at 0x10a664770>}\n",
      "{'pubmed_id': '38332964\\n33280709\\n15577825\\n1460737\\n24876303\\n23723690\\n10753254\\n11765298', 'title': 'Determining Adherence to Inhaled Corticosteroids From the Epic Electronic Medical Record.', 'abstract': \"Often we call the patient's pharmacy to obtain a refill history to assess inhaled corticosteroid (ICS) adherence. The purpose of this project was to determine the accuracy of refill histories for ICS (with or without long-acting beta agonist) listed in Epic's Medication Dispense History.\\nWe evaluated 61 patients and used data from 38 who met the following criteria: 1) under the care of the UF Pediatric Severe Asthma Clinic; 2) taking the same dose of the same ICS product for 6 months before the patient's last clinic visit; and 3) having data available from the pharmacy where the last ICS prescription was electronically sent. We called the pharmacies to obtain a verbal report of their refill record. Then, we compared the number of refills reported to the number listed in Epic's records using a Wilcoxon matched-pairs signed-ranks test.\\nOf the 293 refill dates listed in Epic, 157 were duplicates, giving a 54% error. After deleting duplicates, the mean (SD) number of refills listed in Epic was 3.6 (2.0) compared with 3.3 (2.0) in pharmacies over a period of 6 months (p < 0.0001). After removing duplicates Epic correctly reported the total number of refills for 30 of the 38 patients (78.9%). Seven of the remaining patients had more refills listed in Epic while 1 patient had more refills dispensed.\\nThis study indicates that our version of Epic over-reports refills thus limiting assessment of adherence. In contrast, absence of refills in Epic is a clear indication of poor adherence.\", 'keywords': ['Epic', 'adherence', 'electronic medical record', 'inhaled corticosteroids', 'prescription refills'], 'journal': 'The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Galbreath', 'firstname': 'Ashley', 'initials': 'A', 'affiliation': 'College of Pharmacy (AG, LH, AS), University of Florida Physicians (AS), and.'}, {'lastname': 'Schentrup', 'firstname': 'Anzeela', 'initials': 'A', 'affiliation': 'College of Pharmacy (AG, LH, AS), University of Florida Physicians (AS), and.\\nUniversity of Florida Physicians (AS), and.'}, {'lastname': 'Prabhakaran', 'firstname': 'Sreekala', 'initials': 'S', 'affiliation': 'Pediatric Pulmonary Division (SP, DB, LH), University of Florida, Gainesville, FL.'}, {'lastname': 'Baker', 'firstname': 'Dawn', 'initials': 'D', 'affiliation': 'Pediatric Pulmonary Division (SP, DB, LH), University of Florida, Gainesville, FL.'}, {'lastname': 'Hardy', 'firstname': 'Alicia', 'initials': 'A', 'affiliation': 'College of Pharmacy (AG, LH, AS), University of Florida Physicians (AS), and.\\nUniversity of Florida Physicians (AS), and.\\nPediatric Pulmonary Division (SP, DB, LH), University of Florida, Gainesville, FL.'}, {'lastname': 'Hendeles', 'firstname': 'Leslie', 'initials': 'L', 'affiliation': 'College of Pharmacy (AG, LH, AS), University of Florida Physicians (AS), and.\\nPediatric Pulmonary Division (SP, DB, LH), University of Florida, Gainesville, FL.'}], 'methods': None, 'conclusions': 'This study indicates that our version of Epic over-reports refills thus limiting assessment of adherence. In contrast, absence of refills in Epic is a clear indication of poor adherence.', 'results': 'Of the 293 refill dates listed in Epic, 157 were duplicates, giving a 54% error. After deleting duplicates, the mean (SD) number of refills listed in Epic was 3.6 (2.0) compared with 3.3 (2.0) in pharmacies over a period of 6 months (p < 0.0001). After removing duplicates Epic correctly reported the total number of refills for 30 of the 38 patients (78.9%). Seven of the remaining patients had more refills listed in Epic while 1 patient had more refills dispensed.', 'copyrights': 'Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: membership@pediatricpharmacy.org.', 'doi': '10.5863/1551-6776-29.1.45', 'xml': <Element 'PubmedArticle' at 0x1099bb830>}\n",
      "{'pubmed_id': '38332896\\n33204386\\n14989211\\n23915715\\n24388213\\n20377108\\n36070827\\n32187470\\n27913306\\n36448493\\n6202346\\n9208186\\n10640915\\n18437154\\n20230417\\n23659638\\n22761438\\n31899843\\n25240785\\n21349432\\n28780942\\n27777182\\n6132853\\n6981675\\n8400230\\n6776143\\n18691308\\n32001253\\n37172716\\n18172172\\n23040367\\n20818888\\n22123383\\n34838707\\n33258114\\n32035986\\n18450117\\n16112343\\n8689816\\n2840522\\n9068723\\n8216515\\n9734886\\n18768946\\n4322742\\n6055465\\n3013204\\n13890520\\n9755287\\n9461531\\n24319267\\n15734727\\n10596866\\n175444\\n4341482\\n18187413\\n21530877\\n12086766\\n19581505\\n8757204\\n14751650\\n6553577\\n11842287\\n16732380\\n2989293\\n31984307\\n7760001\\n33832694\\n27130857\\n8558005\\n28780941\\n36858572\\n33071069\\n21527472\\n17142774\\n26505932\\n358800\\n23732999\\n33921871\\n35371072\\n20818886\\n20818887\\n17418383\\n25629740\\n7477189\\n15655136\\n10652034\\n10900238\\n10510333\\n11792853\\n11830581\\n11888349\\n19055203\\n16378805\\n17225721\\n21762364\\n36162799\\n37075977', 'title': 'The bradykinin-forming cascade in anaphylaxis and ACE-inhibitor induced angioedema/airway obstruction.', 'abstract': 'Anaphylaxis is a potentially life-threatening multi-system allergic reaction to a biological trigger resulting in the release of potent inflammatory mediators from mast cells and basophils and causing symptoms in at least two organ systems that generally include skin, lungs, heart, or gastrointestinal tract in any combination. One exception is profound hypotension as an isolated symptom. There are two types of triggers of anaphylaxis: immunologic and non-Immunologic. Immunologic anaphylaxis is initiated when a foreign antigen directly binds to IgE expressed on mast cells or basophils and induces the release of histamine and other inflammatory substances resulting in vasodilation, vascular leakage, decreased peripheral vascular resistance, and heart muscle depression. If left untreated, death by shock (profound hypotension) or asphyxiation (airway obstruction) can occur. The non-immunologic pathway, on the other hand, can be initiated in many ways. A foreign substance can directly bind to receptors of mast cells and basophils leading to degranulation. There can be immune complex activation of the classical complement cascade with the release of anaphylatoxins C3a and C5a with subsequent recruitment of mast cells and basophils. Finally, hyperosmolar contrast agents can cause blood cell lysis, enzyme release, and complement activation, resulting in anaphylactoid (anaphylactic-like) symptoms. In this report we emphasize the recruitment of the bradykinin-forming cascade in mast cell dependent anaphylactic reactions as a potential mediator of severe hypotension, or airway compromise (asthma, laryngeal edema). We also consider airway obstruction due to inhibition of angiotensin converting enzyme with a diminished rate of endogenous bradykinin metabolism, leading not only to laryngeal edema, but massive tongue swelling with aspiration of secretions.', 'keywords': ['IgE', 'anaphylaxis', 'angioedema', 'bradykinin', 'gC1qR'], 'journal': 'Frontiers in allergy', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Ghebrehiwet', 'firstname': 'Berhane', 'initials': 'B', 'affiliation': 'Division of Rheumatology, Allergy, and Clinical Immunology, SUNY-Stony Brook, Stony Brook, NY, United States.'}, {'lastname': 'Joseph', 'firstname': 'Kusumam', 'initials': 'K', 'affiliation': 'Division of Rheumatology, Allergy, and Clinical Immunology, SUNY-Stony Brook, Stony Brook, NY, United States.\\nDivision of Pulmonary and Critical Care Medicine, The Medical University of South Carolina, Charleston, SC, United States.'}, {'lastname': 'Kaplan', 'firstname': 'Allen P', 'initials': 'AP', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, The Medical University of South Carolina, Charleston, SC, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Ghebrehiwet, Joseph and Kaplan.', 'doi': '10.3389/falgy.2024.1302605\\n10.1016/j.waojou.2020.100472\\n10.1016/j.jaci.2013.06.015\\n10.1016/B978-0-12-800100-4.00002-7\\n10.1016/j.anai.2010.01.007\\n10.1016/j.jaci.2022.08.022\\n10.1056/NEJMra1808012\\n10.1016/j.jaci.2016.09.051\\n10.1111/all.15603\\n10.1182/blood.V63.6.1453.1453\\n10.1111/j.1365-2222.1997.tb01193.x\\n10.1159/000024284\\n10.1038/nbt1407\\n10.1111/j.1538-7836.2010.03832.x\\n10.1111/jth.12295\\n10.1074/jbc.M112.385823\\n10.1111/cea.13558\\n10.1016/j.jaci.2014.07.057\\n10.1016/j.immuni.2011.02.008\\n10.1016/j.jaci.2017.06.007\\n10.1016/j.jaci.2016.08.050\\n10.1016/0306-3623(83)90001-0\\n10.1182/blood.V82.6.1732.1732\\n10.1172/JCI109936\\n10.1111/j.1398-9995.2008.01733.x\\n10.1016/j.jaci.2020.01.017\\n10.1016/j.jaip.2023.04.037\\n10.1056/NEJMoa070030\\n10.1016/j.jaci.2012.08.016\\n10.1056/NEJMoa0906393\\n10.1016/j.anai.2011.08.015\\n10.1016/j.jaip.2021.11.011\\n10.1111/all.14680\\n10.1016/j.jaci.2020.01.043\\n10.1016/S1081-1206(10)60594-7\\n10.1016/j.jaad.2004.09.032\\n10.1016/S0009-9236(96)90161-7\\n10.1001/jama.1988.03410070095035\\n10.1016/0735-6757(93)90166-9\\n10.1016/S0140-6736(97)09137-X\\n10.1056/NEJMcp0803977\\n10.1038/2151402a0\\n10.1016/0006-2952(86)90726-4\\n10.1016/0006-2952(62)90119-3\\n10.1042/bj3300361\\n10.4049/jimmunol.1302031\\n10.1124/pr.57.1.2\\n10.1016/S0162-3109(99)00133-2\\n10.1126/science.175444\\n10.1074/jbc.M709837200\\n10.1016/j.anai.2011.02.012\\n10.1016/S0140-6736(02)08914-6\\n10.1161/HYPERTENSIONAHA.109.134197\\n10.1016/S0091-6749(96)70151-3\\n10.1016/j.amjhyper.2003.09.014\\n10.1093/jb/93.3.833\\n10.1067/mai.2002.121316\\n10.1160/TH06-03-0128\\n10.1016/S0021-9258(17)39515-7\\n10.1055/s-0040-1701238\\n10.1084/jem.181.6.2119\\n10.1016/j.jaci.2021.02.012\\n10.1016/j.jaci.2016.02.015\\n10.4049/jimmunol.156.3.1256\\n10.1016/j.jaci.2017.06.003\\n10.1248/bpb.b22-00766\\n10.1016/j.jaci.2020.08.027\\n10.1099/mic.0.046862-0\\n10.4049/jimmunol.177.12.8723\\n10.1016/j.anai.2015.07.019\\n10.1016/S0065-2776(08)60228-X\\n10.1038/srep01932\\n10.3390/biomedicines9040439\\n10.3389/fimmu.2022.836222\\n10.1056/NEJMoa0805538\\n10.1056/NEJMoa0905079\\n10.1016/j.jaci.2007.02.012\\n10.1056/NEJMoa1312524\\n10.1056/NEJM199512073332316\\n10.1161/01.CIR.0000153269.07762.3B\\n10.1046/j.1523-1755.2000.00877.x\\n10.1172/JCI7886\\n10.1073/pnas.022626899\\n10.1074/jbc.M106101200\\n10.2165/00002018-200225020-00001\\n10.1016/S1081-1206(10)60288-8\\n10.1016/j.amjmed.2005.06.040\\n10.1016/S1081-1206(10)60860-5\\n10.1111/j.1751-7176.2011.00438.x\\n10.1016/j.anai.2023.04.003', 'xml': <Element 'PubmedArticle' at 0x109a2e2f0>}\n",
      "{'pubmed_id': '38332844\\n16825536\\n27791053\\n32159016\\n35344431\\n35351594\\n30012611\\n30681842\\n18497128\\n30461534\\n27082891\\n20961824\\n27318255\\n28525551\\n23006928\\n21659039\\n17854481\\n18680605\\n35795228\\n26381684\\n27138533\\n12196317\\n20671811\\n27115915\\n25211756\\n16311064\\n35434171\\n35244891\\n30388129\\n33917945\\n33431571\\n25648639\\n31421571\\n36134580\\n23934704\\n25261951\\n9143723\\n19017694\\n23356966\\n21292252\\n31593836\\n33674571\\n32854703\\n23850144\\n21776200\\n29101831\\n31546585\\n35798884\\n30889810\\n27422981\\n32405779\\n35595966\\n31285306\\n25112730\\n30261462\\n30316099\\n36288208\\n30875246\\n29223078\\n27887782\\n31146163\\n29288254\\n29065684', 'title': 'Effect modification of the association between fine particulate air pollution during a wildfire event and respiratory health by area-level measures of socio-economic status, race/ethnicity, and smoking prevalence.', 'abstract': 'Fine particulate air pollution (PM', 'keywords': ['effect modification', 'find particulate matter', 'race/ethnicity', 'respiratory health', 'smoking', 'socioeconomic status', 'wildfires'], 'journal': 'Environmental research, health : ERH', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Reid', 'firstname': 'C E', 'initials': 'CE', 'affiliation': 'Department of Geography, University of Colorado Boulder, Boulder, CO, United States of America.'}, {'lastname': 'Considine', 'firstname': 'E M', 'initials': 'EM', 'affiliation': 'Department of Applied Math, University of Colorado Boulder, Boulder, CO, United States of America.\\nCurrent address: Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University., Boston, MA, United States of America.'}, {'lastname': 'Watson', 'firstname': 'G L', 'initials': 'GL', 'affiliation': 'Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States of America.'}, {'lastname': 'Telesca', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States of America.'}, {'lastname': 'Pfister', 'firstname': 'G G', 'initials': 'GG', 'affiliation': 'National Center for Atmospheric Research, Boulder, CO, United States of America.'}, {'lastname': 'Jerrett', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States of America.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1088/2752-5309/acc4e1\\n10.1038/s41370-022-00446-5', 'xml': <Element 'PubmedArticle' at 0x10a5f59e0>}\n",
      "{'pubmed_id': '38332740', 'title': 'Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.', 'abstract': 'Remdesivir decreases the risk of SARS-CoV-2 infection progressing to severe disease in adults. This study evaluated remdesivir safety and pharmacokinetics in infants and children.\\nThis was a phase 2/3, open-label trial in children aged 28 days to 17 years hospitalized for polymerase chain reaction-confirmed SARS-CoV-2 infection. Participants received for ≤10 days once-daily intravenous remdesivir doses defined using physiologically based pharmacokinetic modeling (for ≥40 kg, 200 mg day 1, then 100 mg/day; for age ≥28 days and ≥3 to <40 kg, 5 mg/kg day 1, then 2.5 mg/kg/day). Sparse pharmacokinetic samples were analyzed using population-pharmacokinetic approaches for remdesivir and metabolites GS-704277 and GS-441524.\\nAmong 53 participants, at enrollment the median (Q1, Q3) number of days of COVID-19 symptoms was 5 (3, 7) and hospitalization was 1 (1, 3). Underlying conditions included obesity in 19 (37%), asthma in 11 (21%), and cardiac disorders in 11 (21%). Median duration of remdesivir treatment was 5 days (range, 1-10). Remdesivir treatment had no new apparent safety trends. Two participants discontinued treatment because of adverse events including elevated transaminases; both had elevated transaminases at baseline. Three deaths occurred during treatment (and 1 after). When compared with phase 3 adult data, estimated mean pediatric parameters (area under the concentration-time curve over 1 dosing interval, AUCτ, Cmax, and Cτ) were largely overlapping but modestly increased (remdesivir, 33%-129%; GS-704277, 37%-124%; GS-441524, 0%-60%). Recovery occurred for 62% of participants on day 10 and 83% at last assessment.\\nIn infants and children with COVID-19, the doses of remdesivir evaluated provided drug exposure similar to adult dosing. In this study with a small sample size, no new safety concerns were observed.', 'keywords': [], 'journal': 'Pediatrics', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Ahmed', 'firstname': 'Amina', 'initials': 'A', 'affiliation': \"Department of Pediatrics, Levine Children's Hospital at Atrium Health, Charlotte, North Carolina.\\nWake Forest University School of Medicine, Winston-Salem, North Carolina.\"}, {'lastname': 'Munoz', 'firstname': 'Flor M', 'initials': 'FM', 'affiliation': \"Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.\\nTexas Children's Hospital, Houston, Texas.\"}, {'lastname': 'Muller', 'firstname': 'William J', 'initials': 'WJ', 'affiliation': \"Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.\\nNorthwestern University Feinberg School of Medicine, Chicago, Illinois.\"}, {'lastname': 'Agwu', 'firstname': 'Allison', 'initials': 'A', 'affiliation': 'Division of Infectious Diseases, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.'}, {'lastname': 'Kimberlin', 'firstname': 'David W', 'initials': 'DW', 'affiliation': 'University of Alabama at Birmingham, Birmingham, Alabama.'}, {'lastname': 'Galli', 'firstname': 'Luisa', 'initials': 'L', 'affiliation': \"Department of Health Sciences, University of Florence; Pediatric Infectious Diseases Unit, Meyer Children's University Hospital, IRCCS, Florence, Italy.\"}, {'lastname': 'Deville', 'firstname': 'Jaime G', 'initials': 'JG', 'affiliation': 'Division of Infectious Diseases, Department of Pediatrics, University of California, Los Angeles, California.'}, {'lastname': 'Sue', 'firstname': 'Paul K', 'initials': 'PK', 'affiliation': 'Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.'}, {'lastname': 'Mendez-Echevarria', 'firstname': 'Ana', 'initials': 'A', 'affiliation': 'Servicio de Pediatría, Enfermedades Infecciosas y Tropicales, Hospital Universitario La Paz, Madrid, Spain.\\nCentro de Investigación en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Humeniuk', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Guo', 'firstname': 'Susan', 'initials': 'S', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Rodriguez', 'firstname': 'Lauren', 'initials': 'L', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Han', 'firstname': 'Dong', 'initials': 'D', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Hedskog', 'firstname': 'Charlotte', 'initials': 'C', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Maxwell', 'firstname': 'Heather', 'initials': 'H', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Palaparthy', 'firstname': 'Ramesh', 'initials': 'R', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Kersey', 'firstname': 'Kathryn', 'initials': 'K', 'affiliation': 'Gilead Sciences, Inc., Foster City, California.'}, {'lastname': 'Rojo', 'firstname': 'Pablo', 'initials': 'P', 'affiliation': 'Hospital Universitario12 de Octubre, Madrid, Spain.\\nInstituto de Investigación 12 de Octubre, Madrid, Spain; and.\\nUniversidad Complutense, Madrid, Spain.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'Among 53 participants, at enrollment the median (Q1, Q3) number of days of COVID-19 symptoms was 5 (3, 7) and hospitalization was 1 (1, 3). Underlying conditions included obesity in 19 (37%), asthma in 11 (21%), and cardiac disorders in 11 (21%). Median duration of remdesivir treatment was 5 days (range, 1-10). Remdesivir treatment had no new apparent safety trends. Two participants discontinued treatment because of adverse events including elevated transaminases; both had elevated transaminases at baseline. Three deaths occurred during treatment (and 1 after). When compared with phase 3 adult data, estimated mean pediatric parameters (area under the concentration-time curve over 1 dosing interval, AUCτ, Cmax, and Cτ) were largely overlapping but modestly increased (remdesivir, 33%-129%; GS-704277, 37%-124%; GS-441524, 0%-60%). Recovery occurred for 62% of participants on day 10 and 83% at last assessment.', 'copyrights': 'Copyright © 2024 by the American Academy of Pediatrics.', 'doi': '10.1542/peds.2023-063775', 'xml': <Element 'PubmedArticle' at 0x109d39120>}\n",
      "{'pubmed_id': '38332723', 'title': 'Gene therapy with AAV9-SGPL1 in an animal model of lung fibrosis.', 'abstract': 'Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung that leads rapidly to respiratory failure. Novel approaches to treatment are urgently needed. The bioactive lipid sphingosine-1-phosphate (S1P) is increased in IPF lungs and promotes proinflammatory and profibrotic TGF-β signaling. Hence, decreasing lung S1P represents a potential therapeutic strategy for IPF. S1P is degraded by the intracellular enzyme S1P lyase (SPL). Here we find that a knock-in mouse with a missense SPL mutation mimicking human disease resulted in reduced SPL activity, increased S1P, increased TGF-β signaling, increased lung fibrosis, and higher mortality after injury compared to wild type (WT). We then tested adeno-associated virus 9 (AAV9)-mediated overexpression of human SGPL1 (AAV-SPL) in mice as a therapeutic modality. Intravenous treatment with AAV-SPL augmented lung SPL activity, attenuated S1P levels within the lungs, and decreased injury-induced fibrosis compared to controls treated with saline or only AAV. We confirmed that AAV-SPL treatment led to higher expression of SPL in the epithelial and fibroblast compartments during bleomycin-induced lung injury. Additionally, AAV-SPL decreased expression of the profibrotic cytokines TNFα and IL1β as well as markers of fibroblast activation, such as fibronectin (Fn1), Tgfb1, Acta2, and collagen genes in the lung. Taken together, our results provide proof of concept for the use of AAV-SPL as a therapeutic strategy for the treatment of IPF. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.', 'keywords': ['AAV9', 'adeno-associated virus', 'bleomycin', 'gene therapy', 'idiopathic pulmonary fibrosis', 'lung fibrosis', 'mouse model', 'sphingosine-1-phosphate (S1P) lyase'], 'journal': 'The Journal of pathology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Bhattacharyya', 'firstname': 'Aritra', 'initials': 'A', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep, Department of Medicine, University of California, San Francisco, CA, USA.\\nSandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA, USA.'}, {'lastname': 'Khan', 'firstname': 'Ranjha', 'initials': 'R', 'affiliation': 'Department of Pediatrics, University of California, San Francisco, CA, USA.'}, {'lastname': 'Lee', 'firstname': 'Joanna Y', 'initials': 'JY', 'affiliation': 'Department of Pediatrics, University of California, San Francisco, CA, USA.'}, {'lastname': 'Tassew', 'firstname': 'Gizachew', 'initials': 'G', 'affiliation': 'Department of Pediatrics, University of California, San Francisco, CA, USA.'}, {'lastname': 'Oskouian', 'firstname': 'Babak', 'initials': 'B', 'affiliation': 'Department of Pediatrics, University of California, San Francisco, CA, USA.'}, {'lastname': 'Allende', 'firstname': 'Maria L', 'initials': 'ML', 'affiliation': 'National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.'}, {'lastname': 'Proia', 'firstname': 'Richard L', 'initials': 'RL', 'affiliation': 'National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.'}, {'lastname': 'Yin', 'firstname': 'Xiaoyang', 'initials': 'X', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep, Department of Medicine, University of California, San Francisco, CA, USA.\\nSandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA, USA.'}, {'lastname': 'Ortega', 'firstname': 'Javier G', 'initials': 'JG', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep, Department of Medicine, University of California, San Francisco, CA, USA.\\nSandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA, USA.'}, {'lastname': 'Bhattacharya', 'firstname': 'Mallar', 'initials': 'M', 'affiliation': 'Division of Pulmonary, Critical Care, Allergy, and Sleep, Department of Medicine, University of California, San Francisco, CA, USA.\\nSandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA, USA.'}, {'lastname': 'Saba', 'firstname': 'Julie D', 'initials': 'JD', 'affiliation': 'Department of Pediatrics, University of California, San Francisco, CA, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.', 'doi': '10.1002/path.6256', 'xml': <Element 'PubmedArticle' at 0x10ac66ac0>}\n",
      "{'pubmed_id': '38332696', 'title': 'The role of NLRP3 inflammasome in type 2 inflammation related diseases.', 'abstract': 'Type 2 inflammation related diseases, such as atopic dermatitis, asthma, and allergic rhinitis, are diverse and affect multiple systems in the human body. It is common for individuals to have multiple co-existing type 2 inflammation related diseases, which can impose a significant financial and living burden on patients. However, the exact pathogenesis of these diseases is still unclear. The NLRP3 inflammasome is a protein complex composed of the NLRP3 protein, ASC, and Caspase-1, and is activated through various mechanisms, including the NF-κB pathway, ion channels, and lysosomal damage. The NLRP3 inflammasome plays a role in the immune response to pathogens and cellular damage. Recent studies have indicated a strong correlation between the abnormal activation of NLRP3 inflammasome and the onset of type 2 inflammation. Additionally, it has been demonstrated that suppressing NLRP3 expression effectively diminishes the inflammatory response, highlighting its promising therapeutic applications. Therefore, this article reviews the role of NLRP3 inflammasome in the development and therapy of multiple type 2 inflammation related diseases.', 'keywords': ['NLRP3', 'inflammasome', 'type 2 inflammation related diseases'], 'journal': 'Autoimmunity', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Xu', 'firstname': 'Shenming', 'initials': 'S', 'affiliation': \"Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.\\nMedical Ozone Research Center of Central South University, Changsha, Hunan, People's Republic of China.\"}, {'lastname': 'Wang', 'firstname': 'Dan', 'initials': 'D', 'affiliation': \"Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.\\nMedical Ozone Research Center of Central South University, Changsha, Hunan, People's Republic of China.\"}, {'lastname': 'Tan', 'firstname': 'Lina', 'initials': 'L', 'affiliation': \"Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.\\nMedical Ozone Research Center of Central South University, Changsha, Hunan, People's Republic of China.\"}, {'lastname': 'Lu', 'firstname': 'Jianyun', 'initials': 'J', 'affiliation': \"Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.\\nMedical Ozone Research Center of Central South University, Changsha, Hunan, People's Republic of China.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/08916934.2024.2310269', 'xml': <Element 'PubmedArticle' at 0x109f0d120>}\n",
      "{'pubmed_id': '38331860\\n33034960\\n27082891\\n22456494\\n33571375\\n33975534\\n33069326\\n34508679\\n35742668\\n27318255\\n31593836\\n36482359\\n28226261\\n32332485\\n34073399\\n28210290\\n32088929\\n37712340\\n25554246\\n33782057\\n23337781\\n31462531\\n27733354\\n26827182\\n28058794', 'title': 'Personal strategies to reduce the effects of landscape fire smoke on asthma-related outcomes: a protocol for systematic review and meta-analysis.', 'abstract': 'Landscape fire smoke (LFS) contains several hazardous air pollutants that are known to be detrimental to human health. People with asthma are more vulnerable to the health impact of LFS than general populations. The aim of this review is to investigate the effectiveness of personal strategies to reduce the effect of LFS on asthma-related outcomes.\\nWe will electronically search databases such as Medline, Embase, CINAHL and Cochrane Clinical Trials Register to identify eligible articles for the review. Screening of search results and data extraction from included studies will be completed by two independent reviewers. The risk of bias (RoB 2) will be assessed using the Risk of Bias Assessment Tool for Non-Randomised Studies for observational studies, the Cochrane Collaboration tool for assessing the RoB 2 for randomised controlled trials (RCTs) and the Risk Of Bias In Nonrandomized Studies of Interventions tool for non-RCTs. A random-effect meta-analysis will be performed to determine the pooled summary of findings of the included studies. If meta-analysis is not possible, we will conduct a narrative synthesis. Findings will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.\\nThis study will synthesise the available evidence obtained from published studies and as such, no ethical approval is required. The review will be disseminated through peer-reviewed publications and conference presentations.\\nCRD42022341120.', 'keywords': ['Asthma', 'PUBLIC HEALTH', 'Respiratory infections'], 'journal': 'BMJ open', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Beyene', 'firstname': 'Tesfalidet', 'initials': 'T', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.\\nAsthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.\\nAsthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia.\\nDepartment of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.'}, {'lastname': 'Murphy', 'firstname': 'V E', 'initials': 'VE', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.\\nAsthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia.'}, {'lastname': 'Jensen', 'firstname': 'Megan E', 'initials': 'ME', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.\\nAsthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia.'}, {'lastname': 'McDonald', 'firstname': 'Vanessa M', 'initials': 'VM', 'affiliation': 'Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia Vanessa.McDonald@newcastle.edu.au.\\nDepartment of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.\\nSchool of Nursing and Midwifery, University of Newcastle, Newcastle, NSW, Australia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/bmjopen-2022-069516\\n10.1056/NEJMsr2028985\\n10.1038/s41893-020-00610-5\\n10.1289/ehp.1409277\\n10.1289/ehp.1104422\\n10.1111/resp.14013\\n10.1164/rccm.202012-4471LE\\n10.1016/S0140-6736(20)30925-9\\n10.1016/S2542-5196(21)00200-X\\n10.3390/ijerph19127419\\n10.1016/j.envres.2016.06.012\\n10.1016/j.envres.2019.108777\\n10.1186/s12884-022-05231-8\\n10.1016/j.jenvman.2017.02.012\\n10.1097/PHH.0000000000001151\\n10.3390/ijerph18115702\\n10.1183/20734735.011416\\n10.5694/mja2.50511\\n10.1111/resp.14593\\n10.1186/2046-4053-4-1\\n10.1136/bmj.n71\\n10.1016/j.jclinepi.2012.09.016\\n10.1136/bmj.l4898\\n10.1136/bmj.i4919\\n10.1016/j.envint.2016.01.004\\n10.1002/jrsm.1230', 'xml': <Element 'PubmedArticle' at 0x10adaaf70>}\n",
      "{'pubmed_id': '38331806\\n32020334\\n35914061\\n19160942\\n26272854\\n17983880\\n30226024\\n23890997\\n18401202\\n34071190\\n30178033\\n11978682\\n11929490\\n29211844\\n18774999\\n32163166\\n29218837\\n23521228\\n21949144\\n15205560\\n18430314\\n18547232\\n18798800\\n25092354\\n2523712', 'title': 'Prevalence of asthma in people with type 1 diabetes mellitus: a scoping review.', 'abstract': 'According to the Th1/Th2 paradigm, the expansion of Th1-type clones in individuals with type 1 diabetes results in reduced Th2-type clones, preventing the development of atopic diseases and vice versa. However, there is no consensus regarding the direct or inverse relationship between autoimmune and atopic diseases.\\nThe aim of this scoping review was to examine the knowledge gap about the possibility of coexistence of asthma and type 1 diabetes and determine the prevalence of this association.\\nA scoping review was conducted, following the proposal of the Joanna Briggs Institute. The Population, Concept, and Context strategy was used to formulate the guiding question. The proposed question was: \"What is the prevalence of asthma in people with T1DM?\" After excluding duplicate articles, analyzing titles and abstracts, and excluding articles that did not answer the guiding question, 17 articles remained and were included in this review.\\nMost of the articles selected conformed to the Th1/Th2 hypothesis, as the prevalence of asthma was lower in individuals with T1DM. However, similar or higher prevalence of asthma was found between cases and controls in few articles.\\nThe prevalence of asthma in people with T1DM ranged from 1.7% to 23.1%. Maybe the mechanisms that characterizes the Th1/Th2 paradigm aren\\'t as simple as just the interaction of certain cytokines, since Th1-mediated autoimmune diseases and Th2- mediated atopy can coexist.', 'keywords': ['Asthma', 'Atopy', 'Autoimmunity', 'Prevalence', 'TH1/TH2', 'Type 1 diabetes mellitus'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Kamei', 'firstname': 'Júlia Marchatto', 'initials': 'JM', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil. juliamarchatto@usp.br.'}, {'lastname': 'Maués', 'firstname': 'Raissa Dias', 'initials': 'RD', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'de Oliveira Silva', 'firstname': 'Gabriel', 'initials': 'G', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'Machado', 'firstname': 'Alessandra Helena', 'initials': 'AH', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'Hoshino', 'firstname': 'Erika Megumi', 'initials': 'EM', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'Bacchiega', 'firstname': 'Fabiana Menezes', 'initials': 'FM', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'Sena', 'firstname': 'Laís Mota Furtado', 'initials': 'LMF', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}, {'lastname': 'Negrato', 'firstname': 'Carlos Antonio', 'initials': 'CA', 'affiliation': 'University of São Paulo - Bauru Campus (USP-Bauru), Alameda Dr. Octávio Pinheiro Brisolla, 9-75, Bauru, 17012-901, Brazil.'}], 'methods': None, 'conclusions': \"The prevalence of asthma in people with T1DM ranged from 1.7% to 23.1%. Maybe the mechanisms that characterizes the Th1/Th2 paradigm aren't as simple as just the interaction of certain cytokines, since Th1-mediated autoimmune diseases and Th2- mediated atopy can coexist.\", 'results': 'Most of the articles selected conformed to the Th1/Th2 hypothesis, as the prevalence of asthma was lower in individuals with T1DM. However, similar or higher prevalence of asthma was found between cases and controls in few articles.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00869-9\\n10.1007/s00281-020-00785-1\\n10.1016/j.jaut.2015.07.014\\n10.1016/j.jaci.2007.09.043.Erratum.In:JAllergyClinImmunol.2008Jun;121(6):1330\\n10.1111/pedi.12773\\n10.1016/S0140-6736(13)60591-7\\n10.1089/088318702320323109\\n10.1007/BF03345592\\n10.3390/ijms22115757\\n10.7326/M18-0850\\n10.2337/diacare.25.5.865\\n10.1046/j.1365-2222.2002.01311.x\\n10.1093/ije/dyx245\\n10.22038/ijp.2017.23160.1948\\n10.1111/j.1399-5448.2008.00444.x\\n10.1001/jamanetworkopen.2020.0834\\n10.1111/pedi.12618\\n10.1111/jpc.12160\\n10.1542/peds.2010-3636\\n10.1159/000079166\\n10.2500/aap.2008.29.3091\\n10.1111/j.1399-5448.2007.00366.x\\n10.1111/j.1399-3038.2008.00802.x\\n10.1016/j.aller.2013.11.009\\n10.1146/annurev.iy.07.040189.001045', 'xml': <Element 'PubmedArticle' at 0x108e04040>}\n",
      "{'pubmed_id': '38331782\\n34628846\\n34364680\\n32051346\\n35093483\\n16992663\\n12391771\\n8719587\\n31818321\\n33951673\\n30829650\\n37170957\\n35805946\\n32426489\\n3538958\\n18566825\\n19179611\\n24433703\\n22703826\\n29633324\\n33114551\\n36311787\\n9736675\\n29637705\\n31505056\\n37047077\\n36768281\\n30686732\\n33098765\\n34845963\\n35230437\\n29496881\\n25511176\\n32203906\\n11899296\\n10849478\\n31688328\\n34299169\\n33597946\\n33517097\\n23168411\\n35203615\\n34055794\\n16782752\\n16888146\\n24037376\\n31089161\\n33857344\\n15334652\\n33999474\\n28366881\\n30185653\\n26371842\\n29599193\\n30256701\\n36996219\\n31468359\\n2378751\\n2898787\\n3288903\\n2446545\\n22888478\\n15643155\\n29676065\\n28222358\\n2203825\\n34035875\\n18778270\\n7691947\\n2305901\\n29778505\\n27485456\\n22318967\\n34069899\\n28860828\\n21752117\\n16454764\\n12612296\\n28814067\\n31765853\\n34826435', 'title': 'The airway neuro-immune axis as a therapeutic target in allergic airway diseases.', 'abstract': \"Recent evidence has increasingly underscored the importance of the neuro-immune axis in mediating allergic airway diseases, such as allergic asthma and allergic rhinitis. The intimate spatial relationship between neurons and immune cells suggests that their interactions play a pivotal role in regulating allergic airway inflammation. Upon direct activation by allergens, neurons and immune cells engage in interactions, during which neurotransmitters and neuropeptides released by neurons modulate immune cell activity. Meanwhile, immune cells release inflammatory mediators such as histamine and cytokines, stimulating neurons and amplifying neuropeptide production, thereby exacerbating allergic inflammation. The dynamic interplay between the nervous and immune systems suggests that targeting the neuro-immune axis in the airway could represent a novel approach to treating allergic airway diseases. This review summarized recent evidence on the nervous system's regulatory mechanisms in immune responses and identified potential therapeutic targets along the peripheral nerve-immune axis for allergic asthma and allergic rhinitis. The findings will provide novel perspectives on the management of allergic airway diseases in the future.\", 'keywords': ['Airway neuro-immune axis', 'Allergic rhinitis', 'Asthma', 'Therapeutic target'], 'journal': 'Respiratory research', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Wu', 'firstname': 'Wanhua', 'initials': 'W', 'affiliation': 'Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China.'}, {'lastname': 'Li', 'firstname': 'Jianing', 'initials': 'J', 'affiliation': 'Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China.'}, {'lastname': 'Chen', 'firstname': 'Su', 'initials': 'S', 'affiliation': 'Liaobu Hospital of Dongguan City, Dongguan, 523430, China.'}, {'lastname': 'Ouyang', 'firstname': 'Suidong', 'initials': 'S', 'affiliation': 'Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China. ouyangsd@gdmu.edu.cn.\\nLiaobu Hospital of Dongguan City, Dongguan, 523430, China. ouyangsd@gdmu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12931-024-02702-8\\n10.1016/j.mam.2021.100995\\n10.1172/jci.insight.132836\\n10.1016/j.jaci.2022.01.016\\n10.1113/jphysiol.1903.sp000947\\n10.1097/00043764-200210000-00011\\n10.1007/BF02114752\\n10.1186/s40463-019-0392-1\\n10.1159/000512083\\n10.1172/JCI124609\\n10.1242/dev.201164\\n10.3390/ijms23136938\\n10.1126/sciadv.aay1497\\n10.1007/s00418-008-0455-2\\n10.2353/ajpath.2009.080800\\n10.1016/j.jaci.2013.11.027\\n10.1016/j.jneuroim.2012.05.016\\n10.1002/JLB.3MR1117-426R\\n10.3390/ijms21217930\\n10.3389/fimmu.2022.975914\\n10.1523/JNEUROSCI.18-18-07581.1998\\n10.1111/febs.14465\\n10.1111/exd.14034\\n10.3390/ijms24076105\\n10.3390/ijms24031957\\n10.1016/j.neuron.2019.01.012\\n10.1016/j.immuni.2020.10.001\\n10.1080/17476348.2021.2011222\\n10.1001/jamanetworkopen.2022.0615\\n10.1126/science.aan4829\\n10.1016/j.tips.2014.11.005\\n10.1016/j.intimp.2020.106345\\n10.1007/s11882-001-0081-8\\n10.1046/j.1365-2222.2000.00100.x\\n10.1097/WNP.0000000000000604\\n10.3390/ijms22147552\\n10.3389/fimmu.2020.598165\\n10.1016/j.tice.2021.101496\\n10.1074/jbc.M112.422675\\n10.3390/biomedicines10020406\\n10.3389/fcell.2021.663535\\n10.1152/ajplung.00499.2005\\n10.1196/annals.1317.035\\n10.1038/nature12526\\n10.1038/s41598-019-43717-2\\n10.1002/JLB.3RU0121-023R\\n10.1002/jcp.20061\\n10.1111/cea.13902\\n10.1189/jlb.1AB0416-188RR\\n10.1126/scitranslmed.aar8477\\n10.1016/j.jaci.2015.06.050\\n10.1126/science.aan8546\\n10.1089/jir.2018.0020\\n10.1126/science.abm5658\\n10.1007/5584_2019_427\\n10.1165/ajrcmb/3.2.165\\n10.1016/0163-7258(88)90028-9\\n10.1016/0306-4522(88)90064-4\\n10.1164/ajrccm/136.6_Pt_2.S77\\n10.4193/Rhino.11.152\\n10.1097/01.jom.0000150238.77663.49\\n10.4168/aair.2018.10.3.187\\n10.1016/j.intimp.2017.02.015\\n10.1172/JCI114780\\n10.1016/j.waojou.2021.100540\\n10.1111/j.1365-2222.2008.03097.x\\n10.4049/jimmunol.151.8.4391\\n10.1016/j.jaci.2018.05.003\\n10.1007/s11882-016-0638-1\\n10.1096/fj.11-201640\\n10.3390/cells10051237\\n10.2147/JAA.S140577\\n10.1111/j.1365-2222.2011.03822.x\\n10.2174/156802606775270288\\n10.1136/thorax.58.3.217\\n10.1093/intimm/dxx040\\n10.1016/j.lfs.2021.120175', 'xml': <Element 'PubmedArticle' at 0x10ac11d00>}\n",
      "{'pubmed_id': '38331769\\n29735405\\n31253537\\n33002503\\n30936702\\n36333218\\n28942952\\n29395966\\n26716396\\n27514599\\n25614171\\n35983569\\n32484954\\n37750593\\n32052155\\n35177908\\n34077999\\n32373456\\n32009090\\n35949821\\n36579077\\n34306708\\n33636343\\n32807690\\n31778113\\n30444149\\n31890213\\n34692397\\n33502319\\n32884574\\n32673881\\n30574332\\n30201098\\n30395734\\n23091327\\n36583062\\n29258701\\n22871762\\n23276861\\n33022880\\n35636689\\n34929373\\n36551171\\n35443910', 'title': 'Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review.', 'abstract': 'Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare disease characterized by pulmonary radiological alterations, peripheral eosinophilia, and demonstrated pulmonary eosinophilia. Oral steroids (OSs) are the standard management, but relapses occur in up to 50% of patients during the decrease or suspension of steroids, usually requiring reinitiation of treatment, exposing patients to secondary events derived from the management. Management with monoclonal antibodies has been proposed in these cases to control the disease and limit the secondary effects. The objective is to describe the extent and type of evidence regarding the use of monoclonal antibodies for ICEP.\\nA panoramic review of the literature was performed. Observational and experimental studies of pediatric and adult populations that managed recurrent ICEP with monoclonal antibodies were included. Data search, selection, and extraction were performed by two independent reviewers.\\n937 studies were found. After applying the inclusion and exclusion criteria, 37 titles remained for the final analysis: a retrospective, observational, real-life study, two case series publications, and 34 case reports published in academic poster sessions and letters to the editor. In general, the use of monoclonal antibodies approved for severe asthma could be useful for the control of ICEP, since most of the results show a good response for clinical and radiological outcomes. Biological drugs seem to be a safer option for controlling relapses in ICEP, allowing lowering/suspension of OSs, and sometimes replacing them in patients intolerant to them, patients with significant comorbidities, and patients who have already developed adverse events.\\nThe extent of the evidence supporting management of ICEP with monoclonal antibodies against IL-5 and IgE (omalizumab) is limited, but it could be promising in patients who present frequent relapses, in cortico-dependent individuals, or in patients in whom the use of steroids is contraindicated. The extent of the evidence for management with dupilumab is more limited. Studies with better design and structure are needed to evaluate quality of life and outcomes during a clear follow-up period. To our knowledge, this is the first scoping review of the literature showing the extent of the evidence for the management of ICEP with monoclonal antibodies.', 'keywords': ['Carrington syndrome', 'Eosinophilic pneumonia', 'Idiopathic chronic eosinophilic pneumonia', 'Monoclonal antibodies', 'Pulmonary eosinophilia', 'Systemic corticosteroids'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Murillo', 'firstname': 'Andrea Dionelly', 'initials': 'AD', 'affiliation': 'Department of Internal Medicine, Allergology Service, Fundación Valle del Lili, Carrera 98 # 18-49, Cali, 760032, Colombia.\\nFaculty of Health Sciences, Universidad Icesi, Calle 18 # 122-135, Cali, 760032, Colombia.'}, {'lastname': 'Castrillon', 'firstname': 'Ana Isabel', 'initials': 'AI', 'affiliation': 'Clinical Research Center, Fundación Valle del Lili, Carrera 98 # 18-49, Cali, 760032, Colombia.'}, {'lastname': 'Serrano', 'firstname': 'Carlos Daniel', 'initials': 'CD', 'affiliation': 'Department of Internal Medicine, Allergology Service, Fundación Valle del Lili, Carrera 98 # 18-49, Cali, 760032, Colombia.\\nFaculty of Health Sciences, Universidad Icesi, Calle 18 # 122-135, Cali, 760032, Colombia.'}, {'lastname': 'Fernandez-Trujillo', 'firstname': 'Liliana', 'initials': 'L', 'affiliation': 'Faculty of Health Sciences, Universidad Icesi, Calle 18 # 122-135, Cali, 760032, Colombia. liliana.fernandez@fvl.org.co.\\nDepartment of Internal Medicine, Pulmonology Service, Interventional Pulmonology. Fundacion Valle del Lili, Av. Simón Bolívar. Carrera 98 # 18-49. Torre 6, 4th Floor, Cali, Colombia. liliana.fernandez@fvl.org.co.'}], 'methods': None, 'conclusions': 'The extent of the evidence supporting management of ICEP with monoclonal antibodies against IL-5 and IgE (omalizumab) is limited, but it could be promising in patients who present frequent relapses, in cortico-dependent individuals, or in patients in whom the use of steroids is contraindicated. The extent of the evidence for management with dupilumab is more limited. Studies with better design and structure are needed to evaluate quality of life and outcomes during a clear follow-up period. To our knowledge, this is the first scoping review of the literature showing the extent of the evidence for the management of ICEP with monoclonal antibodies.', 'results': '937 studies were found. After applying the inclusion and exclusion criteria, 37 titles remained for the final analysis: a retrospective, observational, real-life study, two case series publications, and 34 case reports published in academic poster sessions and letters to the editor. In general, the use of monoclonal antibodies approved for severe asthma could be useful for the control of ICEP, since most of the results show a good response for clinical and radiological outcomes. Biological drugs seem to be a safer option for controlling relapses in ICEP, allowing lowering/suspension of OSs, and sometimes replacing them in patients intolerant to them, patients with significant comorbidities, and patients who have already developed adverse events.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02868-3\\n10.1016/j.jaip.2018.03.011\\n10.1016/j.alit.2019.05.006\\n10.1016/j.chest.2020.09.247\\n10.2147/TCRM.S157882\\n10.1016/j.anai.2017.08.009\\n10.1016/j.alit.2017.12.004\\n10.1002/ppul.23368\\n10.1016/j.ccm.2016.04.015\\n10.1183/09031936.00199614\\n10.1016/j.waojou.2022.100676\\n10.1080/21678707.2021.2003777\\n10.1111/all.14425\\n10.1111/all.15901\\n10.1080/1364557032000119616\\n10.1007/s00408-020-00336-3\\n10.2147/JAA.S343272\\n10.1016/j.rmcr.2020.101062\\n10.1016/j.rmcr.2022.101795\\n10.1002/rcr2.810\\n10.1016/j.anai.2021.02.016\\n10.1016/j.alit.2020.07.005\\n10.1016/j.chest.2020.05.195\\n10.1016/j.anai.2019.08.436\\n10.18176/jiaci.0468\\n10.1080/02770903.2018.1543434\\n10.1002/rcr2.514\\n10.1016/j.rmcr.2021.101520\\n10.1016/j.anai.2021.08.271\\n10.1016/j.chest.2020.08.1010\\n10.1016/j.jaip.2020.06.053\\n10.1016/j.chest.2019.08.165\\n10.1016/j.chest.2019.08.1182\\n10.1002/rcr2.397\\n10.1016/j.jaip.2018.06.017\\n10.1080/02770903.2018.1534966\\n10.1016/j.rmcr.2022.101796\\n10.1378/chest.11-1881\\n10.1378/chest.12-2035\\n10.1016/j.chest.2022.08.1020\\n10.1016/j.jaip.2021.11.029\\n10.3390/biom12121743\\n10.1016/j.alit.2022.03.005', 'xml': <Element 'PubmedArticle' at 0x1097d1d00>}\n",
      "{'pubmed_id': '38331703', 'title': 'Better Breathing, Tougher Speaking? A Scoping Review of the Effects of Inhaled Corticosteroids on the Voice Quality of Asthmatic Children.', 'abstract': 'Inhaled corticosteroids (ICS) are a common treatment for certain lung diseases, including chronic obstructive pulmonary disorder in adults, and asthma across the lifespan. There is a link between the use of ICS and dysphonia in adults. This scoping review aims to investigate the incidence of dysphonia, in children aged under 12, who use ICS to treat asthma.\\nA scoping review was conducted, in accordance with the guidelines prescribed by Arksey and O\\'Malley (2005). ASHAWire, Science Direct, PubMed, and ProQuest databases were searched. Out of the total yield of 1471 articles, four articles met the inclusion criteria, that is, were primary studies reporting on voice quality in children who use ICS, who present with asthma and/or allergy.\\nThe majority of papers yielded from the initial search were retrieved because of the use of the term \"dysphonia\" in the basic definitions of asthma and descriptors of its side effects. Only four studies presented primary data about the presence of dysphonia in asthmatic children (with or without comorbid allergic conditions). None specifically investigated the relationship between ICS and dysphonia. Research questions focused on side effects associated with allergies and asthma, which included some information about medication. Only three of the four studies conducted a comprehensive review of the voice and utilized video laryngoscopy.\\nThe evidence of a relationship, between ICS and dysphonia in children, is not conclusive, and is complicated by the connection between asthma, and breath support for phonation. There is a need for more thorough and focused investigation of the relationship between ICS, with or without bronchodilator use, and any resultant effects on children\\'s vocal quality.', 'keywords': ['Asthma', 'Corticosteroids', 'Dysphonia', 'Pediatric', 'Vocal folds', 'Voice'], 'journal': 'Journal of voice : official journal of the Voice Foundation', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Reynolds', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Lewis University, Romeoville, Illinois. Electronic address: mreynolds1@lewisu.edu.'}, {'lastname': 'Demarco', 'firstname': 'Jenalee', 'initials': 'J', 'affiliation': 'Lewis University, Romeoville, Illinois; Advanced Therapy and Wellness Clinic, Crest Hill, Illinois.'}, {'lastname': 'Steinberg', 'firstname': 'Katie', 'initials': 'K', 'affiliation': 'Lewis University, Romeoville, Illinois; Downers Grove Grade School District 58, Downers Grove, Illinois.'}], 'methods': None, 'conclusions': None, 'results': 'The majority of papers yielded from the initial search were retrieved because of the use of the term \"dysphonia\" in the basic definitions of asthma and descriptors of its side effects. Only four studies presented primary data about the presence of dysphonia in asthmatic children (with or without comorbid allergic conditions). None specifically investigated the relationship between ICS and dysphonia. Research questions focused on side effects associated with allergies and asthma, which included some information about medication. Only three of the four studies conducted a comprehensive review of the voice and utilized video laryngoscopy.', 'copyrights': 'Copyright © 2024 The Voice Foundation. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.jvoice.2024.01.005', 'xml': <Element 'PubmedArticle' at 0x1095ecf90>}\n",
      "{'pubmed_id': '38331424', 'title': 'The commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2.', 'abstract': 'Overgrowth of the fungus Wallemia mellicola in the intestines of mice enhances the severity of asthma. W. mellicola interacts with the immune system through Dectin-2 expressed on the surface of myeloid and intestinal epithelial cells. Using Dectin-2 deficient mice, we show that the interaction of W. mellicola with Dectin-2 is essential for the gut-lung pathways enhancing the severity of asthma in mice with W. mellicola intestinal dysbiosis. These findings offer better insight into dysbiosis-associated inflammation and highlight the role pattern recognition receptors have in immune recognition of commensal fungi in the gut leading to alterations in immune function in the lungs.\\nMechanisms by which changes to the intestinal fungal community influence the immune function in the lungs are not well understood. This study highlights the crucial role of the C-type Lectin receptor Dectin-2 in enhancing asthma severity in mice with Wallemia mellicola- induced intestinal dysbiosis.', 'keywords': [], 'journal': 'Medical mycology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Kanj', 'firstname': 'Amjad N', 'initials': 'AN', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.\\nThoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Guiance', 'firstname': 'Irene Riestra', 'initials': 'IR', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.\\nThoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Kottom', 'firstname': 'Theodore J', 'initials': 'TJ', 'affiliation': 'Thoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Schaefbauer', 'firstname': 'Kyle J', 'initials': 'KJ', 'affiliation': 'Thoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Choudhury', 'firstname': 'Malay', 'initials': 'M', 'affiliation': 'Thoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Limper', 'firstname': 'Andrew H', 'initials': 'AH', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.\\nThoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Skalski', 'firstname': 'Joseph H', 'initials': 'JH', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.\\nThoracic Disease Research Unit, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.\\n© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.', 'doi': '10.1093/mmy/myae004', 'xml': <Element 'PubmedArticle' at 0x1095eec00>}\n",
      "{'pubmed_id': '38331244', 'title': 'Predominantly antibody deficiency and the association with celiac disease in Sweden: A nationwide case-control study.', 'abstract': \"Predominantly antibody deficiency (PAD) is associated with noninfectious inflammatory gastrointestinal disease. Population estimates of celiac disease (CeD) risk in those with PAD are limited.\\nTo estimate population risk of PAD in individuals with CeD.\\nWe conducted a nationwide case-control study in Swedish individuals who received a diagnosis of CeD between 1997 and 2017 (n = 34,980), matched to population comparators by age, sex, calendar year, and county. The CeD was confirmed through the Epidemiology Strengthened by histopathology Reports in Sweden study, which provided information on biopsy specimens from each of Sweden's pathology departments. PAD was identified using International Classification of Diseases, 10th Revision coding and categorized according to the International Union of Immunologic Societies. Logistic regression was used to calculate adjusted odds ratios (aORs) and 95% CIs.\\nPAD was more prevalent in CeD than in population controls (n = 105 [0.3%] vs n = 57 [0.033%], respectively). This translated to an aOR of 8.23 (95% CI 5.95-11.48). The association was strongest with common variable immunodeficiency (aOR 17.25; 95% CI 6.86-52.40), and slightly lower in other PAD (aOR 8.39; 95% CI 5.79-12.32). The risk of CeD remained increased at least 5 years after diagnosis of PAD (aOR 4.79; 95% CI 2.89-7.97, P-heterogeneity ≤ 0.001).\\nPAD was associated with an increased risk of CeD. A particularly strong association was seen in those with CVID, although this should be interpreted cautiously given the limited understanding of the mechanisms of histopathologic changes in these patients.\", 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'DiGiacomo', 'firstname': 'Daniel V', 'initials': 'DV', 'affiliation': 'Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.'}, {'lastname': 'Roelstraete', 'firstname': 'Bjorn', 'initials': 'B', 'affiliation': \"Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden.\"}, {'lastname': 'Lebwohl', 'firstname': 'Benjamin', 'initials': 'B', 'affiliation': 'Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.'}, {'lastname': 'Green', 'firstname': 'Peter H R', 'initials': 'PHR', 'affiliation': 'Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.'}, {'lastname': 'Hammarström', 'firstname': 'Lennart', 'initials': 'L', 'affiliation': 'Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Farmer', 'firstname': 'Jocelyn R', 'initials': 'JR', 'affiliation': 'Division of Allergy and Inflammation, Beth Israel Lahey Health, Harvard Medical School, Boston, Massachusetts.'}, {'lastname': 'Khalili', 'firstname': 'Hamed', 'initials': 'H', 'affiliation': 'Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.'}, {'lastname': 'Ludvigsson', 'firstname': 'Jonas F', 'initials': 'JF', 'affiliation': 'Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Pediatrics, Orebro University Hospital, Orebro, Sweden. Electronic address: jonasludvigsson@yahoo.com.'}], 'methods': None, 'conclusions': 'PAD was associated with an increased risk of CeD. A particularly strong association was seen in those with CVID, although this should be interpreted cautiously given the limited understanding of the mechanisms of histopathologic changes in these patients.', 'results': 'PAD was more prevalent in CeD than in population controls (n = 105 [0.3%] vs n = 57 [0.033%], respectively). This translated to an aOR of 8.23 (95% CI 5.95-11.48). The association was strongest with common variable immunodeficiency (aOR 17.25; 95% CI 6.86-52.40), and slightly lower in other PAD (aOR 8.39; 95% CI 5.79-12.32). The risk of CeD remained increased at least 5 years after diagnosis of PAD (aOR 4.79; 95% CI 2.89-7.97, P-heterogeneity ≤ 0.001).', 'copyrights': 'Copyright © 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.anai.2024.01.019', 'xml': <Element 'PubmedArticle' at 0x109761d50>}\n",
      "{'pubmed_id': '38331142', 'title': 'A novel approach to deriving the fine-scale daily NO', 'abstract': 'Surface NO', 'keywords': ['Health impact assessment', 'High resolution', 'Long term', 'Machine learning', 'Nitrogen dioxide', 'Spatial downscaling'], 'journal': 'Environmental research', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Zhu', 'firstname': 'Rongxin', 'initials': 'R', 'affiliation': 'Department of Environmental Science and Engineering, Sichuan University, Chengdu, Sichuan, 610065, China; College of Carbon Neutrality Future Technology, Sichuan University, Chengdu, Sichuan, 610065, China.'}, {'lastname': 'Luo', 'firstname': 'Wenfeng', 'initials': 'W', 'affiliation': 'Department of Environmental Science and Engineering, Sichuan University, Chengdu, Sichuan, 610065, China.'}, {'lastname': 'Grieneisen', 'firstname': 'Michael L', 'initials': 'ML', 'affiliation': 'Department of Land, Air, and Water Resources, University of California, Davis, CA, 95616, United States.'}, {'lastname': 'Zuoqiu', 'firstname': 'Sophia', 'initials': 'S', 'affiliation': 'Pittsburgh Institute, Sichuan University, Chengdu, Sichuan, 610207, China.'}, {'lastname': 'Zhan', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'College of Carbon Neutrality Future Technology, Sichuan University, Chengdu, Sichuan, 610065, China. Electronic address: yzhan@scu.edu.cn.'}, {'lastname': 'Yang', 'firstname': 'Fumo', 'initials': 'F', 'affiliation': 'College of Carbon Neutrality Future Technology, Sichuan University, Chengdu, Sichuan, 610065, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.envres.2024.118381', 'xml': <Element 'PubmedArticle' at 0x109763330>}\n",
      "{'pubmed_id': '38330996', 'title': '[Advances in the management of asthma].', 'abstract': 'Asthma is a heterogeneous inflammatory airway disease that causes relevant morbidity across individuals of all age cohorts. In recent years, advances in the understanding of asthma pathophysiology have led to the development of treatments tailored to specific pheno- and endotypes of the disease. This has significantly changed asthma management, especially for patients with severe disease. These new treatment options offer individuals with asthma access to personalized and disease-modifying therapies. The present paper is a comprehensive overview of recent clinical studies and of German and international guideline updates on asthma management.\\nGRUNDZüGE DER THERAPIE : Eine bedarfsweise Monotherapie mit kurzwirksamen Beta-2-Sympathomimetika (SABA) stellt nicht mehr die bevorzugte Therapie in der Stufe 1 dar. Sie ist mit einem Verlust an Asthma-Kontrolle und einem Anstieg der asthmabezogenen Mortalität assoziiert. Die bedarfsweise Anwendung einer Fixkombination aus einem inhalativen Kortikosteroid mit einem Beta-2-Sympathomimetikum (ICS-Formoterol) zeigte eine höhere Effektivität und Sicherheit gegenüber der SABA-Monotherapie. Insgesamt wird der Stellenwert antiinflammatorischer Therapien in den aktualisierten Leitlinien gestärkt.\\nTezepelumab wurde als mittlerweile 6. Biologikum zur Therapie von Patient*innen mit schwerem Asthma zugelassen. Tezepelumab richtet sich gegen das Zytokin TSLP, welches eine Rolle in der initialen Entzündungsreaktion bei Asthma spielt. Eine Verordnung ist unabhängig von erhöhten Biomarkern als „Add-on“ zur Basistherapie möglich.\\nAkute Atemwegserkrankungen, meist viraler Genese, gelten als der Hauptauslöser für Asthma-Exazerbationen. Die zu Beginn der Erkältungssaison 2022/23 vom RKI gemeldeten Fallzahlen an Influenza- sowie RSV-Infektionen waren im Vergleich zu den Pandemiejahren zuvor deutlich erhöht. Im weiteren Verlauf hat sich die Aktivität akuter Atemwegserkrankungen auf einem hohen Niveau stabilisiert. Ein vermehrtes Auftreten von Asthma-Exazerbationen lässt sich daher auch für Deutschland vermuten.\\nVerbesserte Therapiekonzepte führen zu einem neuen Therapieziel. Die Ziele einer Asthma-Therapie sind nicht die Symptombehandlung, sondern die langfristige Prävention von asthmabezogenen Symptomen, der Erhalt der Lungenfunktion und der fehlende Bedarf an systemischen Kortikosteroiden im Sinne einer Remission der Erkrankung.', 'keywords': [], 'journal': 'Laryngo- rhino- otologie', 'publication_date': datetime.date(2024, 2, 9), 'authors': [{'lastname': 'Westhölter', 'firstname': 'Dirk', 'initials': 'D', 'affiliation': 'Klinik für Pneumologie, Universitätsmedizin Essen - Ruhrlandklinik, Essen, Germany.'}, {'lastname': 'Reuter', 'firstname': 'Sebastian', 'initials': 'S', 'affiliation': 'Klinik für Pneumologie, Universitätsmedizin Essen - Ruhrlandklinik, Essen, Germany.'}, {'lastname': 'Taube', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Klinik für Pneumologie, Universitätsmedizin Essen - Ruhrlandklinik, Essen, Germany.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Thieme. All rights reserved.\\nThieme. All rights reserved.', 'doi': '10.1055/a-2249-2207', 'xml': <Element 'PubmedArticle' at 0x10b60e8e0>}\n",
      "{'pubmed_id': '38329817', 'title': 'Lung Interstitial Macrophages Can Present Soluble Antigens and Induce Foxp3+ Regulatory T Cells.', 'abstract': 'Lung macrophages constitute a sophisticated surveillance and defense system that contributes to tissue homeostasis, host defense, and allows the host to cope with the myriad of insults and antigens to which the lung mucosa is exposed. As opposed to alveolar macrophages, lung interstitial macrophages express high levels of type 2 major histocompatibility complex (MHC-II), a hallmark of antigen-presenting cells. Here, we showed that lung IMs, like dendritic cells (DCs), possess the machinery to present soluble antigens in an MHC-II-restricted way. Using ', 'keywords': ['IL-10', 'MHC-II', 'antigen presentation', 'interstitial macrophage'], 'journal': 'American journal of respiratory cell and molecular biology', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Legrand', 'firstname': 'Céline', 'initials': 'C', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Vanneste', 'firstname': 'Domien', 'initials': 'D', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Hego', 'firstname': 'Alexandre', 'initials': 'A', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Sabatel', 'firstname': 'Catherine', 'initials': 'C', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Mollers', 'firstname': 'Kiréna', 'initials': 'K', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Schyns', 'firstname': 'Joey', 'initials': 'J', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Maréchal', 'firstname': 'Pauline', 'initials': 'P', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Abinet', 'firstname': 'Joan', 'initials': 'J', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Tytgat', 'firstname': 'Amandine', 'initials': 'A', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Liégeois', 'firstname': 'Maude', 'initials': 'M', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Polese', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Meunier', 'firstname': 'Margot', 'initials': 'M', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Radermecker', 'firstname': 'Coraline', 'initials': 'C', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Fiévez', 'firstname': 'Laurence', 'initials': 'L', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Bureau', 'firstname': 'Fabrice', 'initials': 'F', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.'}, {'lastname': 'Marichal', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Liege University, 26658, GIGA Institute, Liege, Belgium.\\nLiege University, 26658, Veterinary Medicine, Liege, Belgium; t.marichal@uliege.be.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1165/rcmb.2023-0254OC', 'xml': <Element 'PubmedArticle' at 0x10a3236f0>}\n",
      "{'pubmed_id': '38329781', 'title': 'Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.', 'abstract': None, 'keywords': ['asthma', 'biomarkers', 'dupilumab', 'lung function decline', 'predictive'], 'journal': 'American journal of respiratory and critical care medicine', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Pavord', 'firstname': 'Ian D', 'initials': 'ID', 'affiliation': 'Oxford University, Nuffield department of Medicine, Respiratory Medicine, Oxford, Oxfordshire, United Kingdom of Great Britain and Northern Ireland; Ian.pavord@ndm.ox.ac.uk.'}, {'lastname': 'de Prado Gómez', 'firstname': 'Lucia', 'initials': 'L', 'affiliation': 'Sanofi, Reading, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Brusselle', 'firstname': 'Guy', 'initials': 'G', 'affiliation': 'Erasmus Medical Center, Respiratory Medicine and Epidemiology, Rotterdam, Netherlands.\\nGhent University Hospital, Respiratory Medicine, Ghent, Belgium.'}, {'lastname': 'Jackson', 'firstname': 'Daniel J', 'initials': 'DJ', 'affiliation': 'University of Wisconsin School of Medicine and Public Health, Pediatrics, Madison, Wisconsin, United States.'}, {'lastname': 'Brightling', 'firstname': 'Christopher E', 'initials': 'CE', 'affiliation': 'Institute for Lung Health, Infection, Immunity and Inflammation, Leicester, United Kingdom of Great Britain and Northern Ireland.'}, {'lastname': 'Papi', 'firstname': 'Alberto', 'initials': 'A', 'affiliation': 'University of Ferrara, Research Centre on Asthma and COPD, Ferrara, Italy.'}, {'lastname': 'Maspero', 'firstname': 'Jorge F', 'initials': 'JF', 'affiliation': 'Fundacion CIDEA, Buenos Aires, Argentina.'}, {'lastname': 'Rabe', 'firstname': 'Klaus F', 'initials': 'KF', 'affiliation': 'University Kiel & LungenClinic, Grosshansdorf, Germany.\\nGermany.'}, {'lastname': 'Korn', 'firstname': 'Stephanie', 'initials': 'S', 'affiliation': 'Thoraxklinik am Universitätsklinikum Heidelberg, 14996, Pneumology, Heidelberg, Baden-Württemberg, Germany.'}, {'lastname': 'Zhang', 'firstname': 'Mei', 'initials': 'M', 'affiliation': 'Sanofi, Bridgewater, New Jersey, United States.'}, {'lastname': 'Soler', 'firstname': 'Xavier', 'initials': 'X', 'affiliation': 'Regeneron Pharmaceuticals Inc, 7845, Tarrytown, New York, United States.'}, {'lastname': 'Jacob-Nara', 'firstname': 'Juby A', 'initials': 'JA', 'affiliation': 'Sanofi, Bridgewater, New Jersey, United States.'}, {'lastname': 'Hardin', 'firstname': 'Megan', 'initials': 'M', 'affiliation': 'Sanofi Genzyme, Boston, Massachusetts, United States.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1164/rccm.202310-1751LE', 'xml': <Element 'PubmedArticle' at 0x10a3dbab0>}\n",
      "{'pubmed_id': '38329636\\n34718211\\n24337046\\n35833203\\n37334017\\n19361849\\n23927851\\n37048164\\n10471631\\n31590215\\n24136334\\n20303873\\n18496530\\n30020320\\n28252317\\n35197963\\n30138914\\n27195116\\n24390308\\n19865172\\n10556116\\n16166100\\n26121748\\n19361847\\n16113432\\n28190087\\n12789232\\n19702783\\n35640416\\n29453280\\n30872118\\n20525803\\n10955758\\n28007476\\n2475572\\n29067437\\n28401621\\n37008013\\n18822367\\n18624356\\n23840534\\n28413916\\n31823765\\n34422359\\n28479329\\n11473403\\n26740570\\n10653850\\n18322244\\n23094102\\n29572536\\n31703000\\n27248771\\n34630433\\n25225663', 'title': 'Three Main SCFAs Mitigate Lung Inflammation and Tissue Remodeling Nlrp3-Dependent in Murine HDM-Induced Neutrophilic Asthma.', 'abstract': 'Neutrophilic asthma is generally defined by poorly controlled symptoms and high levels of neutrophils in the lungs. Short-chain fatty acids (SCFAs) are proposed as nonpharmacological therapy for allergic asthma, but their impact on the neutrophilic asthma lacks evidence. SCFAs regulate immune cell responses and impact the inflammasome NLRP3, a potential pharmacological target for neutrophilic asthma. Here, we explored the capacity of SCFAs to mitigate murine-induced neutrophilic asthma and the contribution of NLRP3 to this asthma. The objective of this study is to analyze whether SCFAs can attenuate lung inflammation and tissue remodeling in murine neutrophilic asthma and NLRP3 contribution to this endotype. Wild-type (WT) C57BL6 mice orotracheally received 10\\xa0μg of HDM (house dust mite) in 80 μL of saline on days 0, 6-10. To explore SCFAs, each HDM group received 200\\xa0mM acetate, propionate, or butyrate. To explore NLRP3, Nlrp3 KO mice received the same protocol of HDM. On the 14th day, after euthanasia, bronchoalveolar lavage fluid (BALF) and lungs were collected to evaluate cellularity, inflammatory cytokines, and tissue remodeling. HDM group had increased BALF neutrophil influx, TNF-α, IFN-γ, IL-17A, collagen deposition, and mucus secretion compared to control. SCFAs distinctively attenuate lung inflammation. Only features of tissue remodeling were Nlrp3-dependent such as collagen deposition, mucus secretion, active TGF-β cytokine, and IMs CD206', 'keywords': ['HDM', 'NLRP3', 'SCFAs', 'neutrophilic asthma', 'tissue remodeling'], 'journal': 'Inflammation', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Tagé', 'firstname': 'Barbara S S', 'initials': 'BSS', 'affiliation': 'Department of Science and Technology, Federal University of São Paulo (UNIFESP), São José dos Campos, SP, 12247-014, Brazil. barbara.tage@gmail.com.'}, {'lastname': 'Gonzatti', 'firstname': 'Michelangelo B', 'initials': 'MB', 'affiliation': 'Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP), São Paulo, SP, 05468-901, Brazil.'}, {'lastname': 'Vieira', 'firstname': 'Rodolfo P', 'initials': 'RP', 'affiliation': 'Postgraduate Program in Human Movement and Rehabilitation and in Pharmaceutical Sciences, Evangelical University of Goiás (UniEvangélica), Anápolis, GO, 75083-515, Brazil.\\nPostgraduate Program in Bioengineering, University Brasil, São Paulo, SP, 08230-030, Brazil.\\nPostgraduate Program in Sciences of Human Movement and Rehabilitation, Federal University of São Paulo (UNIFESP), Santos, SP, 11010-150, Brazil.'}, {'lastname': 'Keller', 'firstname': 'Alexandre C', 'initials': 'AC', 'affiliation': 'Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP), São Paulo, SP, 05468-901, Brazil.'}, {'lastname': 'Bortoluci', 'firstname': 'Karina R', 'initials': 'KR', 'affiliation': 'Department of Pharmacology, Federal University of São Paulo (UNIFESP), São Paulo, SP, 04023-062, Brazil.'}, {'lastname': 'Aimbire', 'firstname': 'Flávio', 'initials': 'F', 'affiliation': 'Department of Science and Technology, Federal University of São Paulo (UNIFESP), São José dos Campos, SP, 12247-014, Brazil.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.', 'doi': '10.1007/s10753-024-01983-x\\n10.1183/09031936.00202013\\n10.1016/j.waojou.2022.100662\\n10.2147/JAA.S401445\\n10.1183/13993003.congress-2019.PA4378\\n10.1016/j.jaci.2009.02.032\\n10.1016/j.rmed.2013.07.017\\n10.3390/cells12071091\\n10.1164/ajrccm.160.3.9812110\\n10.3390/jcm8101615\\n10.1183/09031936.00105013\\n10.1016/j.cell.2010.01.040\\n10.1038/nature06939\\n10.1590/1414-431x20187602\\n10.1164/rccm.201609-1830OC\\n10.1159/000492853\\n10.1038/cti.2016.17\\n10.1038/nm.3444\\n10.1038/nature08530\\n10.1164/ajrccm.160.5.9806170\\n10.1136/thx.2005.045260\\n10.1172/JCI80911\\n10.1016/j.jaci.2009.02.024\\n10.1513/pats.200402-009MS\\n10.1007/s00441-016-2566-8\\n10.1067/mai.2003.1557\\n10.1111/cea.13359\\n10.1111/j.1476-5381.2009.00367.x\\n10.1016/j.cyto.2022.155891\\n10.4049/jimmunol.1701455\\n10.1016/j.jaci.2019.02.027\\n10.1165/rcmb.2010-0027TR\\n10.1053/rmed.2000.0826\\n10.1016/j.jaci.2016.11.020\\n10.1084/jem.170.3.727\\n10.3892/mmr.2017.6711\\n10.1111/resp.13052\\n10.3389/fphys.2023.1099719\\n10.1016/j.bbi.2008.09.001\\n10.1002/eji.200838549\\n10.1016/j.micinf.2010.04.008\\n10.1371/journal.pone.0066818\\n10.1080/08958378.2017.1311389\\n10.1186/s12890-019-1001-9\\n10.1016/j.biopha.2023.115276\\n10.21037/jtd-20-2189\\n10.1016/j.jaci.2017.03.044\\n10.1016/j.jnim.2019.100108\\n10.1002/jms.181\\n10.1038/ncomms8320\\n10.1242/bio.014464\\n10.1093/intimm/12.2.151\\n10.4049/jimmunol.180.6.4308\\n10.1371/journal.pone.0047971\\n10.1038/s41598-018-23269-7\\n10.1097/MCP.0000000000000647\\n10.1165/rcmb.2015-0295OC\\n10.3389/fimmu.2021.753940\\n10.4049/jimmunol.1400580', 'xml': <Element 'PubmedArticle' at 0x10a3d98a0>}\n",
      "{'pubmed_id': '38329526\\n29751155\\n35743682\\n36370881\\n36150163\\n37594543\\n36174990\\n32145872\\n33227318\\n31090937\\n37999634\\n36454385\\n36098864\\n33683704\\n33817954\\n33595845\\n34599979\\n33840229\\n33978983\\n30193936\\n38055045', 'title': 'Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.', 'abstract': \"Biologic therapies for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) have emerged as an auspicious treatment alternative. However, the ideal patient population, dosage, and treatment duration are yet to be well-defined. Moreover, biologic therapy has disadvantages, such as high costs and limited access. The proposal of a novel Artificial Intelligence (AI) algorithm offers an intriguing solution for optimizing decision-making protocols.\\nThe AI algorithm was initially programmed to conduct a systematic literature review searching for the current primary guidelines on biologics' clinical efficacy and safety in treating CRSwNP. The review included a total of 12 studies: 6 systematic reviews, 4 expert consensus guidelines, and 2 surveys. Simultaneously, two independent human researchers conducted a literature search to compare the results. Subsequently, the AI was tasked to critically analyze the identified papers, highlighting strengths and weaknesses, thereby creating a decision-making algorithm and pyramid flow chart.\\nThe studies evaluated various biologics, including monoclonal antibodies targeting Interleukin-5 (IL-5), IL-4, IL-13, and Immunoglobulin E (IgE), assessing their effectiveness in different patient populations, such as those with comorbid asthma or refractory CRSwNP. Dupilumab, a monoclonal antibody targeting the IL-4 receptor alpha subunit, demonstrated significant improvement in nasal symptoms and quality of life in patients with CRSwNP in several randomized controlled trials and systematic reviews. Similarly, mepolizumab and reslizumab, which target IL-5, have also shown efficacy in reducing nasal polyp burden and improving symptoms in patients with CRSwNP, particularly those with comorbid asthma. However, additional studies are required to confirm the long-term efficacy and safety of these biologics in treating CRSwNP.\\nBiologic therapies have surfaced as a promising treatment option for patients with severe or refractory CRSwNP; however, the optimal patient population, dosage, and treatment duration are yet to be defined. The application of AI in decision-making protocols and the creation of therapeutic algorithms for biologic drug selection, could offer fascinating future prospects in the management of CRSwNP.\", 'keywords': ['Artificial intelligence', 'Biologic CRSwNP therapy', 'Generative pre-trained transformer (GPT)', 'Guidelines synthesis', 'Preliminary evaluation'], 'journal': 'European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Maniaci', 'firstname': 'Antonino', 'initials': 'A', 'affiliation': 'Faculty of Medicine and Surgery, \"Kore\" University of Enna, Enna, Italy. antonino.maniaci@phd.unict.it.\\nRhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France. antonino.maniaci@phd.unict.it.'}, {'lastname': 'Saibene', 'firstname': 'Alberto Maria', 'initials': 'AM', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nOtolaryngology Unit, Santi Paolo E Carlo Hospital, Department of Health Sciences, Università Degli Studi Di Milano, Milan, Italy.'}, {'lastname': 'Calvo-Henriquez', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nService of Otolaryngology, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.'}, {'lastname': 'Vaira', 'firstname': 'Luigi', 'initials': 'L', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nMaxillofacial Surgery Unit, University Hospital of Sassari, Sassari, Italy.'}, {'lastname': 'Radulesco', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nENT Surgeon, Department of Oto-Rhino-Laryngology Head and Neck Surgery, La Conception University Hospital, Aix-Marseille Univesity, 147 Bd Baille, 13005, Marseille, France.'}, {'lastname': 'Michel', 'firstname': 'Justin', 'initials': 'J', 'affiliation': 'ENT Surgeon, Department of Oto-Rhino-Laryngology Head and Neck Surgery, La Conception University Hospital, Aix-Marseille Univesity, 147 Bd Baille, 13005, Marseille, France.'}, {'lastname': 'Chiesa-Estomba', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nENT-Head and Neck Department, Hospital Universitario Donostia, San Sebastián, Spain.'}, {'lastname': 'Sowerby', 'firstname': 'Leigh', 'initials': 'L', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nDepartment of Otolaryngology - Head and Neck Surgery, Schulich School of Medicine, Western University, London, UK.'}, {'lastname': 'Lobo Duro', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nRhinology, Endoscopic Sinus and Skull Base Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Spain.\\nValdecilla Biomedical Research Institute, IDIVAL, Santander, Spain.'}, {'lastname': 'Mayo-Yanez', 'firstname': 'Miguel', 'initials': 'M', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nDepartment of Otorhinolaryngology, A Coruña University Hospital Complex, 15006, A Coruña, Spain.'}, {'lastname': 'Maza-Solano', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nServicio de Otorrinolaringología, Hospital Universitario Virgen Macarena, Sevilla. Hospital Quirónsalud Sagrado Corazón, Seville. Departamento de Cirugía, Universidad de Sevilla, Seville, Spain.'}, {'lastname': 'Lechien', 'firstname': 'Jerome Rene', 'initials': 'JR', 'affiliation': 'Rhynology Study Group of the Young-Otolaryngologists of the International Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.\\nDepartment of Anatomy and Experimental Oncology, Mons School of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.'}, {'lastname': 'La Mantia', 'firstname': 'Ignazio', 'initials': 'I', 'affiliation': 'Deparment of Medical, Surgical Sciences and Advanced Technologies G.F.Ingrassia, University of Catania, 95123, Catania, Italy.'}, {'lastname': 'Cocuzza', 'firstname': 'Salvatore', 'initials': 'S', 'affiliation': 'Deparment of Medical, Surgical Sciences and Advanced Technologies G.F.Ingrassia, University of Catania, 95123, Catania, Italy.'}], 'methods': None, 'conclusions': None, 'results': 'The studies evaluated various biologics, including monoclonal antibodies targeting Interleukin-5 (IL-5), IL-4, IL-13, and Immunoglobulin E (IgE), assessing their effectiveness in different patient populations, such as those with comorbid asthma or refractory CRSwNP. Dupilumab, a monoclonal antibody targeting the IL-4 receptor alpha subunit, demonstrated significant improvement in nasal symptoms and quality of life in patients with CRSwNP in several randomized controlled trials and systematic reviews. Similarly, mepolizumab and reslizumab, which target IL-5, have also shown efficacy in reducing nasal polyp burden and improving symptoms in patients with CRSwNP, particularly those with comorbid asthma. However, additional studies are required to confirm the long-term efficacy and safety of these biologics in treating CRSwNP.', 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.', 'doi': '10.1007/s00405-024-08464-9\\n10.1016/j.jaip.2018.04.034\\n10.3390/jpm120608972\\n10.1016/j.jaci.2022.10.026\\n10.4193/Rhin22.129\\n10.1007/s00405-023-08184-6\\n10.1136/bmj.n71\\n10.4168/aair.2022.14.5.465\\n10.1016/j.jaci.2020.01.020\\n10.1016/j.jaci.2020.11.013\\n10.1111/all.13875\\n10.4193/Rhin22.489\\n10.1007/s00405-022-07762-4\\n10.1007/s00405-022-07634-x\\n10.1111/all.14809\\n10.1111/coa.13779\\n10.2147/JAA.S321017\\n10.1111/cea.13852\\n10.1016/j.jaci.2021.08.030\\n10.1177/19458924211009429\\n10.1111/all.14902\\n10.1016/j.jaip.2018.08.021\\n10.1007/s00405-023-08219-y', 'xml': <Element 'PubmedArticle' at 0x10a888400>}\n",
      "{'pubmed_id': '38329377', 'title': 'Retrospective Validation of a Computerized Physiologic Equation to Predict Minute Ventilation Needs in Critically Ill Children.', 'abstract': \"Mechanical ventilation (MV) is pervasive among critically ill children. We sought to validate a computerized physiologic equation to predict minute ventilation requirements in children and test its performance against clinician actions in an in silico trial.\\nRetrospective, electronic medical record linkage, cohort study.\\nQuaternary PICU.\\nPatients undergoing invasive MV, serial arterial blood gas (ABG) analysis within 1-6 hours, and pharmacologic neuromuscular blockade (NMB).\\nABG values were filtered to those occurring during periods of NMB. Simultaneous ABG and minute ventilation data were linked to predict serial Paco2 and pH values using previously published physiologic equations. There were 15,121 included ABGs across 500 encounters among 484 patients, with a median (interquartile range [IQR]) of 20 (10-43) ABGs per encounter at a duration of 3.6 (2.1-4.2) hours. The median (IQR) Paco2 prediction error was 0.00 (-3.07 to 3.00) mm Hg. In Bland-Altman analysis, the mean error was -0.10\\u2009mm Hg (95% CI, -0.21 to 0.01\\u2009mm Hg). A nested, in silico trial of ABGs meeting criteria for weaning (respiratory alkalosis) or escalation (respiratory acidosis), compared the performance of recommended ventilator changes versus clinician decisions. There were 1,499 of 15,121 ABGs (9.9%) among 278 of 644 (43.2%) encounters included in the trial. Calculated predictions were favorable to clinician actions in 1124 of 1499 ABGs (75.0%), equivalent to clinician choices in 26 of 1499 ABGs (1.7%), and worse than clinician decisions in 349 of 1499 ABGs (23.3%). Calculated recommendations were favorable to clinician decisions in sensitivity analyses limiting respiratory rate, analyzing only when clinicians made changes, excluding asthma, and excluding acute respiratory distress syndrome.\\nA computerized equation to predict minute ventilation requirements outperformed clinicians' ventilator adjustments in 75% of ABGs from critically ill children in this retrospective analysis. Prospective validation studies are needed.\", 'keywords': [], 'journal': 'Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Pelletier', 'firstname': 'Jonathan H', 'initials': 'JH', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Akron Children's Hospital, Akron, OH.\"}, {'lastname': 'Rakkar', 'firstname': 'Jaskaran', 'initials': 'J', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.\"}, {'lastname': 'Au', 'firstname': 'Alicia K', 'initials': 'AK', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Akron Children's Hospital, Akron, OH.\\nDivision of Critical Care, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.\\nDepartment Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nBrain Care Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\\nSafar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDivision of Health Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\"}, {'lastname': 'Fuhrman', 'firstname': 'Dana Y', 'initials': 'DY', 'affiliation': 'Department Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.'}, {'lastname': 'Clark', 'firstname': 'Robert S B', 'initials': 'RSB', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Akron Children's Hospital, Akron, OH.\\nDivision of Critical Care, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.\\nDepartment Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nBrain Care Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\\nSafar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDivision of Health Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\"}, {'lastname': 'Kochanek', 'firstname': 'Patrick M', 'initials': 'PM', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Akron Children's Hospital, Akron, OH.\\nDivision of Critical Care, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.\\nDepartment Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nBrain Care Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\\nSafar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDivision of Health Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\"}, {'lastname': 'Horvat', 'firstname': 'Christopher M', 'initials': 'CM', 'affiliation': \"Division of Critical Care, Department of Pediatrics, Akron Children's Hospital, Akron, OH.\\nDivision of Critical Care, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.\\nDepartment Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nBrain Care Institute, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\\nSafar Center for Resuscitation Research, University of Pittsburgh School of Medicine, Pittsburgh, PA.\\nDivision of Health Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.', 'doi': '10.1097/PCC.0000000000003462', 'xml': <Element 'PubmedArticle' at 0x10b21e5c0>}\n",
      "{'pubmed_id': '38329323', 'title': 'Heme oxygenase-1 alleviates allergic airway inflammation by suppressing NF-κB-mediated pyroptosis of bronchial epithelial cells.', 'abstract': 'Allergic asthma development and pathogenesis are influenced by airway epithelial cells in response to allergens. Heme oxygenase-1 (HO-1), an inducible enzyme responsible for the breakdown of heme, has been considered an appealing target for the treatment of chronic inflammatory diseases. Herein, we report that alleviation of allergic airway inflammation by HO-1-mediated suppression of pyroptosis in airway epithelial cells (AECs). Using house dust mite (HDM)-induced asthma models of mice, we found increased gasdermin D (GSDMD) in the airway epithelium. In\\xa0vivo administration of disulfiram, a specific inhibitor of pore formation by GSDMD, decreased thymic stromal lymphopoietin (TSLP) release, T helper type 2 immune response, alleviated airway inflammation, and reduced airway hyperresponsiveness (AHR). HO-1 induction by hemin administration reversed these phenotypes. In\\xa0vitro studies revealed that HO-1 restrained GSDMD-mediated pyroptosis and cytokine TSLP release in AECs by binding Nuclear Factor-Kappa B (NF-κB) p65 RHD domain and thus controlling NF-κB-dependent pyroptosis. These data provide new therapeutic indications for purposing HO-1 to counteract inflammation, which contributes to allergic inflammation control.', 'keywords': ['NF-κB', 'animal study', 'asthma', 'heme oxygenase-1', 'pyroptosis'], 'journal': 'FASEB journal : official publication of the Federation of American Societies for Experimental Biology', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Lv', 'firstname': 'Jiajia', 'initials': 'J', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhou', 'firstname': 'Yao', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wu', 'firstname': 'Yujiao', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Yu', 'firstname': 'Qianying', 'initials': 'Q', 'affiliation': \"Department of Pulmonary, Children's Hospital of Soochow University, Suzhou, China.\"}, {'lastname': 'Zhang', 'firstname': 'Meng', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Su', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Tang', 'firstname': 'Zhiwei', 'initials': 'Z', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wu', 'firstname': 'Qun', 'initials': 'Q', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wu', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, China.'}, {'lastname': 'Xia', 'firstname': 'Zhenwei', 'initials': 'Z', 'affiliation': 'Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Federation of American Societies for Experimental Biology.', 'doi': '10.1096/fj.202300883RR', 'xml': <Element 'PubmedArticle' at 0x10a21bec0>}\n",
      "{'pubmed_id': '38329235', 'title': 'Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.', 'abstract': None, 'keywords': [], 'journal': 'Journal of the European Academy of Dermatology and Venereology : JEADV', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Gargiulo', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.'}, {'lastname': 'Ibba', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.'}, {'lastname': 'Piscazzi', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.'}, {'lastname': 'Amoruso', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Dermatology Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy.'}, {'lastname': 'Balato', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Dermatology Unit, University of Campania L, Naples, Italy.'}, {'lastname': 'Barei', 'firstname': 'F', 'initials': 'F', 'affiliation': \"Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.\"}, {'lastname': 'Bertello', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.'}, {'lastname': 'Burroni', 'firstname': 'A G', 'initials': 'AG', 'affiliation': 'Section of Dermatology, Department of Health Sciences (Di.S.Sal), IRCCS - San Martino Polyclinic Hospital, University of Genoa, Genoa, Italy.'}, {'lastname': 'Caccavale', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Dermatology Unit, University of Campania L, Naples, Italy.'}, {'lastname': 'Ferrucci', 'firstname': 'S M', 'initials': 'SM', 'affiliation': \"Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.\"}, {'lastname': 'Foti', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \"Aldo Moro\", Bari, Italy.'}, {'lastname': 'Gaiani', 'firstname': 'F M', 'initials': 'FM', 'affiliation': 'Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.'}, {'lastname': 'Girolomoni', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.'}, {'lastname': 'Malagoli', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.'}, {'lastname': 'Marzano', 'firstname': 'A V', 'initials': 'AV', 'affiliation': \"Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.\"}, {'lastname': 'Maurelli', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.'}, {'lastname': 'Napolitano', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.'}, {'lastname': 'Nettis', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.'}, {'lastname': 'Ortoncelli', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.'}, {'lastname': 'Patruno', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Section of Dermatology, Health Sciences Department, Magna Graecia University, Catanzaro, Italy.'}, {'lastname': 'Pezzolo', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.\\nA Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.'}, {'lastname': 'Ribero', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.'}, {'lastname': 'Romita', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \"Aldo Moro\", Bari, Italy.'}, {'lastname': 'Rossi', 'firstname': 'M T', 'initials': 'MT', 'affiliation': 'Dermatology Department, University of Brescia, Brescia, Italy.'}, {'lastname': 'Zaza', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.'}, {'lastname': 'Costanzo', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.'}, {'lastname': 'Narcisi', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/jdv.19862', 'xml': <Element 'PubmedArticle' at 0x10a4f6a20>}\n",
      "{'pubmed_id': '38329123', 'title': 'Eosinophils restrain humoral alloimmunity after lung transplantation.', 'abstract': \"While the function of many leukocytes in transplant biology has been well defined, the role of eosinophils is controversial and remains poorly explored. Conflicting data exist regarding eosinophils' role in alloimmunity. Due to their prevalence in the lung, and their defined role in other pulmonary pathologies such as asthma, we set out to explore the role of eosinophils in the long-term maintenance of the lung allograft. We noted that depletion of eosinophils results in the generation of donor-specific antibodies. Eosinophil depletion increased memory B cell, plasma cell, and antibody-secreting cell differentiation and resulted in de novo generation of follicular germinal centers. Germinal center formation depended on the expansion of CD4+Foxp3-Bcl6+CXCR5+PD-1+ T follicular helper (Tfh) cells, which increase in number after eosinophil depletion. Mechanistically, we demonstrate that eosinophils prevent Tfh cell generation by acting as the dominant source of IFN-γ in an established lung allograft, thus facilitating Th1 rather than Tfh polarization of naive CD4+ T cells. Our data thus describe what we believe is a unique and previously unknown role for eosinophils in maintaining allograft tolerance and suggest that indiscriminate administration of eosinophil-lytic corticosteroids for treatment of acute cellular rejection may inadvertently promote humoral alloimmunity.\", 'keywords': ['Adaptive immunity', 'Immunology', 'Innate immunity', 'Organ transplantation', 'Transplantation'], 'journal': 'JCI insight', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Mei', 'firstname': 'Zhongcheng', 'initials': 'Z', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Khalil', 'firstname': 'May A', 'initials': 'MA', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Guo', 'firstname': 'Yizhan', 'initials': 'Y', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Li', 'firstname': 'Dongge', 'initials': 'D', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Banerjee', 'firstname': 'Anirban', 'initials': 'A', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Terada', 'firstname': 'Yuriko', 'initials': 'Y', 'affiliation': 'Department of Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.'}, {'lastname': 'Yokoyama', 'firstname': 'Yuhei', 'initials': 'Y', 'affiliation': 'Department of Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.'}, {'lastname': 'Kratzmeier', 'firstname': 'Christina', 'initials': 'C', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Chen', 'firstname': 'Kelly', 'initials': 'K', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Li', 'firstname': 'Lushen', 'initials': 'L', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Lau', 'firstname': 'Christine L', 'initials': 'CL', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Courneya', 'firstname': 'Jean-Paul', 'initials': 'JP', 'affiliation': 'Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Luzina', 'firstname': 'Irina G', 'initials': 'IG', 'affiliation': 'Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Atamas', 'firstname': 'Sergei P', 'initials': 'SP', 'affiliation': 'Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}, {'lastname': 'Gelman', 'firstname': 'Andrew E', 'initials': 'AE', 'affiliation': 'Department of Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.\\nDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri, USA.'}, {'lastname': 'Kreisel', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Department of Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.\\nDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri, USA.'}, {'lastname': 'Jacobsen', 'firstname': 'Elizabeth A', 'initials': 'EA', 'affiliation': 'Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, Arizona, USA.'}, {'lastname': 'Krupnick', 'firstname': 'Alexander S', 'initials': 'AS', 'affiliation': 'Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.\\nDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1172/jci.insight.168911', 'xml': <Element 'PubmedArticle' at 0x10a5cfd30>}\n",
      "{'pubmed_id': '38328804\\n26120825\\n23021885\\n21154351\\n17253469\\n23557834\\n35085663\\n26053539\\n34526355\\n34800676\\n34141180\\n37012529\\n21603045\\n33782057\\n18436948\\n28940458\\n3802833\\n29514597\\n12111919\\n9310563\\n15722639\\n18547495\\n20615323\\n20570032\\n22959336\\n24341881\\n25516223\\n26781592\\n28962623\\n29649893\\n31542829\\n31739688\\n10353581\\n10782522\\n11416876\\n19054928\\n19696440\\n23886432\\n23331565\\n25661658\\n24559028\\n24782322\\n23651609\\n25368517\\n20816199\\n27518663\\n36017469\\n34464748', 'title': 'IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies.', 'abstract': \"Although randomized controlled trials (RCT) are the reference standard of evidence in allergen immunotherapy (AIT), nonrandomized studies (NRS) are needed to confirm their results in more representative populations, particularly for treatment duration and persistence. However, when discrepancies are observed between RCT and NRS, NRS reliability decreases because these discrepant results are generally attributed to the methodologic flaws of NRS.\\nWe compared the benefit of sublingual AIT (SLIT) for allergic rhinoconjunctivitis in NRS versus RCT focusing on a single product/allergen to reduce heterogeneity.\\nFor meta-analysis, house dust mite (HDM) SLIT liquid formulation studies were sourced from computerized (Medline, Web of Science, and LILACS databases, to January 2023) and manual literature searches. Populations, treatments, and outcome data were combined (DerSimonian-Laird method). Noncomparative NRS were compared to RCT' SLIT arm before and after treatment. Efficacy was determined as the standardized mean difference (SMD) in symptom score (SS) and medication score (MS).\\nData from 12 NRS (682 patients) and 8 RCT (176 patients) were analyzed. The benefit with index of reactivity (IR)-HDM SLIT liquid formulation was found significant for, first, SS in both NRS (SMD\\xa0= -1.27; 95% confidence interval [CI], -1.64, -0.90) and RCT (SMD\\xa0= -0.56; 95% CI, -0.90, -0.21), and second, MS with SMD equal to -1.35 (95% CI, -1.77, -0.93) and -0.46 (95% CI, -0.67, -0.25), respectively. Metaregression showed that symptom improvement was correlated with treatment duration with consistent results in NRS and RCT with 12-month SS data: -0.87 (interquartile range, -1.02, -0.77) and -0.75 (interquartile range, -0.93, -0.41), respectively.\\nThis meta-analysis showed comparable clinical benefit of IR-HDM SLIT liquid formulation increasing over time in both NRS and RCT, suggesting that NRS may reliably integrate RCT results and be considered for guidelines.\", 'keywords': ['Guidelines', 'nonrandomized studies', 'randomized controlled trials', 'real-life', 'rhinoconjunctivitis', 'study quality', 'sublingual immunotherapy'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Di Bona', 'firstname': 'Danilo', 'initials': 'D', 'affiliation': 'Department of Precision and Regenerative Medicine and Jonic Area, Unit of Allergology, University of Bari Aldo Moro, Bari, Italy.'}, {'lastname': 'Carlucci', 'firstname': 'Palma', 'initials': 'P', 'affiliation': 'Department of Precision and Regenerative Medicine and Jonic Area, Unit of Allergology, University of Bari Aldo Moro, Bari, Italy.'}, {'lastname': 'Spataro', 'firstname': 'Federico', 'initials': 'F', 'affiliation': 'Department of Precision and Regenerative Medicine and Jonic Area, Unit of Allergology, University of Bari Aldo Moro, Bari, Italy.'}, {'lastname': 'Paoletti', 'firstname': 'Giovanni', 'initials': 'G', 'affiliation': 'Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.'}, {'lastname': 'Cognet-Sicé', 'firstname': 'Josiane', 'initials': 'J', 'affiliation': 'Stallergenes Greer, Antony, France.'}, {'lastname': 'Scurati', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'Stallergenes Greer, Antony, France.'}, {'lastname': 'Canonica', 'firstname': 'Giorgio Walter', 'initials': 'GW', 'affiliation': 'Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.'}], 'methods': None, 'conclusions': 'This meta-analysis showed comparable clinical benefit of IR-HDM SLIT liquid formulation increasing over time in both NRS and RCT, suggesting that NRS may reliably integrate RCT results and be considered for guidelines.', 'results': 'Data from 12 NRS (682 patients) and 8 RCT (176 patients) were analyzed. The benefit with index of reactivity (IR)-HDM SLIT liquid formulation was found significant for, first, SS in both NRS (SMD\\xa0= -1.27; 95% confidence interval [CI], -1.64, -0.90) and RCT (SMD\\xa0= -0.56; 95% CI, -0.90, -0.21), and second, MS with SMD equal to -1.35 (95% CI, -1.77, -0.93) and -0.46 (95% CI, -0.67, -0.25), respectively. Metaregression showed that symptom improvement was correlated with treatment duration with consistent results in NRS and RCT with 12-month SS data: -0.87 (interquartile range, -1.02, -0.77) and -0.75 (interquartile range, -0.93, -0.41), respectively.', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.jacig.2024.100208', 'xml': <Element 'PubmedArticle' at 0x10ab9b060>}\n",
      "{'pubmed_id': '38328803\\n16935684\\n22429515\\n24382846\\n10669840\\n30741503\\n24337046\\n20926125\\n21106547\\n11112161\\n14516137\\n25439368\\n25441637\\n30817038\\n11843329\\n9877485\\n21128880\\n19892860\\n22632610\\n17416409\\n19910028\\n17291857\\n15753888\\n10350222\\n10759439\\n14582813\\n20133930\\n12090377\\n11149994\\n19401038\\n16264041\\n17170387\\n10887316\\n18425216\\n20595164\\n10390412\\n18521921\\n12754510\\n17339047\\n31785254\\n32054641\\n10573240\\n16055882\\n9872837\\n15867841\\n2689475\\n1549827\\n11556941\\n10146874\\n19636477\\n19535666\\n22386508\\n34556999\\n17947969\\n20530290\\n25091437\\n18814448\\n24050698\\n24369795\\n28069248\\n30795752\\n31076056\\n17462875\\n29752346\\n28855973', 'title': 'The burden of severe asthma in sub-Saharan Africa: Findings from the African Severe Asthma Project.', 'abstract': 'Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown.\\nWe sought to determine the burden (prevalence, mortality, and activity and work impairment) of severe asthma in 3 countries in East Africa: Uganda, Kenya, and Ethiopia.\\nUsing the American Thoracic Society/European Respiratory Society case definition of severe asthma, we analyzed for the prevalence of severe asthma (requiring Global Initiative for Asthma [GINA] steps 4-5 asthma medications for the previous year to achieve control) and severe refractory asthma (remains uncontrolled despite treatment with GINA steps 4-5 asthma medications) in a cohort of 1086 asthma patients who had been in care for 12 months and had received all GINA-recommended medications. Asthma control was assessed by the asthma control questionnaire (ACQ).\\nOverall, the prevalence of severe asthma and severe refractory asthma was 25.6% (95% confidence interval [CI], 23.1-28.3) and 4.6% (95% CI, 3.5-6.0), respectively. Patients with severe asthma were (nonsevere vs severe vs severe refractory) older (39, 42, 45 years, \\nThe prevalence of severe asthma in Africa is high\\xa0and is associated with high morbidity and poor quality of life.', 'keywords': ['Severe asthma', 'burden of severe asthma', 'severe asthma determinants', 'sub-Saharan Africa'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Kirenga', 'firstname': 'Bruce J', 'initials': 'BJ', 'affiliation': 'Makerere University Lung Institute, Kampala, Uganda.\\nDepartment of Medicine, Makerere University, Kampala, Uganda.'}, {'lastname': 'Chakaya', 'firstname': 'Jeremiah', 'initials': 'J', 'affiliation': 'Kenya Association of Physicians Against TB and Lung Diseases, Nairobi, Kenya.'}, {'lastname': 'Yimer', 'firstname': 'Getnet', 'initials': 'G', 'affiliation': 'Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.'}, {'lastname': 'Nyale', 'firstname': 'George', 'initials': 'G', 'affiliation': 'Kenya Association of Physicians Against TB and Lung Diseases, Nairobi, Kenya.\\nKenyatta National Hospital, Nairobi, Kenya.'}, {'lastname': 'Haile', 'firstname': 'Tewodros', 'initials': 'T', 'affiliation': 'Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.'}, {'lastname': 'Muttamba', 'firstname': 'Winters', 'initials': 'W', 'affiliation': 'Makerere University Lung Institute, Kampala, Uganda.\\nDivision of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, United Kingdom.'}, {'lastname': 'Mugenyi', 'firstname': 'Levicatus', 'initials': 'L', 'affiliation': 'Makerere University Lung Institute, Kampala, Uganda.\\nMedical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Research Unit, Entebbe, Uganda.'}, {'lastname': 'Katagira', 'firstname': 'Winceslaus', 'initials': 'W', 'affiliation': 'Makerere University Lung Institute, Kampala, Uganda.'}, {'lastname': 'Worodria', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Mulago Hospital, Kampala, Uganda.'}, {'lastname': 'Aanyu-Tukamuhebwa', 'firstname': 'Hellen', 'initials': 'H', 'affiliation': 'Mulago Hospital, Kampala, Uganda.'}, {'lastname': 'Lugogo', 'firstname': 'Njira', 'initials': 'N', 'affiliation': 'Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Mich.'}, {'lastname': 'Joloba', 'firstname': 'Moses', 'initials': 'M', 'affiliation': 'Department of Medical Microbiology, Makerere University, Kampala, Uganda.'}, {'lastname': 'Mersha', 'firstname': 'Tesfaye B', 'initials': 'TB', 'affiliation': \"Division of Asthma Research, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.\"}, {'lastname': 'Bekele', 'firstname': 'Amsalu', 'initials': 'A', 'affiliation': 'Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.'}, {'lastname': 'Makumbi', 'firstname': 'Fred', 'initials': 'F', 'affiliation': 'School of Public Health, Makerere University, Kampala, Uganda.'}, {'lastname': 'Mekasha', 'firstname': 'Amha', 'initials': 'A', 'affiliation': 'Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.'}, {'lastname': 'Green', 'firstname': 'Cynthia L', 'initials': 'CL', 'affiliation': 'Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC.'}, {'lastname': 'de Jong', 'firstname': 'Corina', 'initials': 'C', 'affiliation': 'Department of General Practice and Elderly Care, GRIAC-Primary Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.'}, {'lastname': 'Kamya', 'firstname': 'Moses', 'initials': 'M', 'affiliation': 'Department of Medicine, Makerere University, Kampala, Uganda.'}, {'lastname': 'van der Molen', 'firstname': 'Thys', 'initials': 'T', 'affiliation': 'Department of General Practice and Elderly Care, GRIAC-Primary Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.'}], 'methods': None, 'conclusions': 'The prevalence of severe asthma in Africa is high\\xa0and is associated with high morbidity and poor quality of life.', 'results': 'Overall, the prevalence of severe asthma and severe refractory asthma was 25.6% (95% confidence interval [CI], 23.1-28.3) and 4.6% (95% CI, 3.5-6.0), respectively. Patients with severe asthma were (nonsevere vs severe vs severe refractory) older (39, 42, 45 years, ', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.jacig.2024.100209', 'xml': <Element 'PubmedArticle' at 0x109db4720>}\n",
      "{'pubmed_id': '38328802\\n26853128\\n28940458\\n24679069\\n29759659\\n25457152\\n24797423\\n25056584\\n27115376\\n33583050\\n31228618\\n32557974\\n3605835\\n20816182\\n25011352\\n16055882\\n20053544\\n22248352\\n15823451\\n1549827\\n10452758\\n24581429\\n28658547\\n24139829\\n15940132\\n25135744\\n17136971\\n27006248\\n24238646\\n11029371\\n29221580\\n28941667\\n27287860\\n33326352\\n33577751\\n28392751\\n8648033\\n31095767\\n24765879\\n26141262\\n19356792', 'title': 'Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis.', 'abstract': 'A previous study reported that house dust mite (HDM) sublingual immunotherapy (SLIT) for 48 weeks was effective as add-on treatment for allergic asthma; however, data regarding its long-term efficacy are scarce.\\nWe sought to evaluate the effect of HDM SLIT on asthma control, pulmonary function, and airway inflammation and remodeling throughout the 5-year treatment period.\\nA total of 140 patients with asthma and allergic rhinitis sensitized to HDM were randomized to receive either drugs alone or drugs plus SLIT for 5 years. The 5-item Asthma Control Questionnaire (ACQ-5), Asthma Quality of Life Questionnaire (AQLQ), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), spirometry, quantitative computed tomography, and type 2 biomarkers were assessed.\\nAn improvement in the ACQ-5, AQLQ, and RQLQ scores was observed in the SLIT group compared with the control group. HDM SLIT increased lung function and reduced the percentage of airway wall area. The levels of fractional exhaled nitric oxide (Feno), blood eosinophil, serum specific IgE for HDM, and total IgE decreased and were sustained during the 5 years. The change in type 2 biomarkers correlated with change in the AQLQ score. On the basis of receiver-operating characteristic analysis for predicting responders, the area under the receiver-operating characteristic curve in FEV\\nHDM SLIT continued to provide sustained efficacy, improve lung function, and prevent progression of airway inflammation and remodeling in asthma throughout the 5-year treatment period.', 'keywords': ['Airway inflammation', 'allergic rhinitis', 'asthma', 'house dust mite sublingual immunotherapy', 'long-term efficacy', 'pulmonary function', 'quality of life', 'remodeling', 'symptom', 'type 2 biomarker'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Hoshino', 'firstname': 'Makoto', 'initials': 'M', 'affiliation': 'Division of Clinical Allergy, Department of Internal Medicine, Atami Hospital, International University of Health and Welfare, Atami, Japan.'}, {'lastname': 'Akitsu', 'firstname': 'Kenta', 'initials': 'K', 'affiliation': 'Department of Radiology, Atami Hospital, International University of Health and Welfare, Atami, Japan.'}, {'lastname': 'Ohtawa', 'firstname': 'Junichi', 'initials': 'J', 'affiliation': 'Department of Radiology, Atami Hospital, International University of Health and Welfare, Atami, Japan.'}, {'lastname': 'Kubota', 'firstname': 'Kengo', 'initials': 'K', 'affiliation': 'Department of Radiology, Atami Hospital, International University of Health and Welfare, Atami, Japan.'}], 'methods': None, 'conclusions': None, 'results': 'An improvement in the ACQ-5, AQLQ, and RQLQ scores was observed in the SLIT group compared with the control group. HDM SLIT increased lung function and reduced the percentage of airway wall area. The levels of fractional exhaled nitric oxide (Feno), blood eosinophil, serum specific IgE for HDM, and total IgE decreased and were sustained during the 5 years. The change in type 2 biomarkers correlated with change in the AQLQ score. On the basis of receiver-operating characteristic analysis for predicting responders, the area under the receiver-operating characteristic curve in FEV', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.jacig.2024.100206', 'xml': <Element 'PubmedArticle' at 0x10952acf0>}\n",
      "{'pubmed_id': '38328715\\n17611496\\n24406073\\n29307657\\n29273806\\n27623174\\n18923164\\n19029000\\n33424845\\n28826527\\n25691431\\n25842287\\n18328887\\n27799535\\n9727780\\n15817806\\n17845587\\n17983880\\n10619836\\n11846609\\n25729625\\n28461288\\n21337730\\n24066901\\n27658857\\n27439200\\n26786172\\n24241537\\n20372189\\n24315451\\n25431337\\n22561531\\n26534891\\n26483175\\n19198610', 'title': 'Association of childhood asthma with Gasdermin B (GSDMB) and Oromucoid-like 3 (ORMDL3) genes.', 'abstract': 'Genome-length association studies have shown that Gasdermin B (GSDMB) and Orosomucoid-like 3 (ORMDL3) genes located on the long arm of chromosome 17 are associated with asthma. In this study, it was aimed to determine the possible relationship between asthma control test (ACT), exercise provocation test (ECT), and fractional nitric oxide (FENO) levels and GSDMB and ORMDL3 gene expressions.\\n59 asthmatic and 38 non-asthmatic children were included in the study. We divided the patient group into two subgroups as mild persistent asthma (29 patients) and moderate persistent asthma (30 patients). ORMDL3, GSDMB gene expression levels, ECT, total IgE levels, and eosinophil counts were measured in all cases. In addition, ACT and FeNO levels were measured in children with asthma. Afterward, the relationship of ORMDL3 and GSDMB gene expression coefficient changes with ECT, ACT, and FeNO was examined.\\nWhen patients with ACT ≤15 were compared with patients with ACT ≥20, ORMDL3 and GSDMB gene expressions were increased 6.74 and 11.74 times, respectively. Comparing patients with ACT ≥20 and ACT ≤15 in terms of coefficient changes (ΔCq), higher change values were observed for ΔCq ORMDL3 in patients with ACT ≤15 (p=0.015). Similarly, when patients with FENO ≤25 ppb were compared with patients with FENO >25 ppb, ORMDL3 and GSDMB gene expressions were increased by 2.93 and 3.56 times, respectively. When the coefficient changes were compared, no significant difference was found between FENO≤25 and FENO >25 patients. There was a slight negative correlation between ΔCq values and ACT score (p=0.003, r=-0.418 for ORMDL3, and p=0.016, r=-0.345 for GSDMB). In addition, we observed a statistically significant positive correlation between ORMDL3 and GSDMB gene expressions (r=0.80, p<0.001).\\nWe showed that increased ORMDL3 and GSDMB gene expression levels may be associated with ACT scores, FeNO and ECT in asthma. These findings may encourage future studies with larger numbers of subjects that can use gene expression levels in various asthma phenotypes for prognostic prediction.', 'keywords': ['Airway hyperresponsiveness', 'GSDMB gene expression', 'ORMDL3 gene expression', 'childhood asthma', 'exercise challenge test'], 'journal': 'Northern clinics of Istanbul', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Almacioglu', 'firstname': 'Mehmet', 'initials': 'M', 'affiliation': 'Department of Pediatrics, SANKO University Faculty of Medicine, Gaziantep, Turkiye.'}, {'lastname': 'Keskin', 'firstname': 'Ozlem', 'initials': 'O', 'affiliation': 'Department of Pediatric Allergy and Immunology, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.'}, {'lastname': 'Ozkars', 'firstname': 'Mehmet Yasar', 'initials': 'MY', 'affiliation': 'Department of Pediatric Allergy and Immunology, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.'}, {'lastname': 'Balci', 'firstname': 'Sibel Oguzkan', 'initials': 'SO', 'affiliation': 'Department of Biology, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.'}, {'lastname': 'Kucukosmanoglu', 'firstname': 'Ercan', 'initials': 'E', 'affiliation': 'Department of Pediatric Allergy and Immunology, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.'}, {'lastname': 'Pehlivan', 'firstname': 'Sacide', 'initials': 'S', 'affiliation': 'Department of Biology, Istanbul University Faculty of Medicine, Istanbul, Turkiye.'}, {'lastname': 'Keskin', 'firstname': 'Mehmet', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Gaziantep University Faculty of Medicine, Gaziantep, Turkiye.'}], 'methods': None, 'conclusions': 'We showed that increased ORMDL3 and GSDMB gene expression levels may be associated with ACT scores, FeNO and ECT in asthma. These findings may encourage future studies with larger numbers of subjects that can use gene expression levels in various asthma phenotypes for prognostic prediction.', 'results': 'When patients with ACT ≤15 were compared with patients with ACT ≥20, ORMDL3 and GSDMB gene expressions were increased 6.74 and 11.74 times, respectively. Comparing patients with ACT ≥20 and ACT ≤15 in terms of coefficient changes (ΔCq), higher change values were observed for ΔCq ORMDL3 in patients with ACT ≤15 (p=0.015). Similarly, when patients with FENO ≤25 ppb were compared with patients with FENO >25 ppb, ORMDL3 and GSDMB gene expressions were increased by 2.93 and 3.56 times, respectively. When the coefficient changes were compared, no significant difference was found between FENO≤25 and FENO >25 patients. There was a slight negative correlation between ΔCq values and ACT score (p=0.003, r=-0.418 for ORMDL3, and p=0.016, r=-0.345 for GSDMB). In addition, we observed a statistically significant positive correlation between ORMDL3 and GSDMB gene expressions (r=0.80, p<0.001).', 'copyrights': '© Copyright 2023 by Istanbul Provincial Directorate of Health.', 'doi': '10.14744/nci.2023.22120\\n10.1038/nature06014\\n10.1016/j.jaci.2013.08.055\\n10.1038/s41588-017-0014-7\\n10.1056/NEJMoa0806604\\n10.1164/rccm.200809-1436OC\\n10.3389/fimmu.2020.597945\\n10.1016/bs.ai.2017.06.001\\n10.1194/jlr.M057539\\n10.1016/j.jaci.2008.01.031\\n10.1073/pnas.1610433113\\n10.1183/09031936.98.12020315\\n10.1164/ajrccm.161.1.ats11-99\\n10.1006/meth.2001.1262\\n10.2478/v10014-012-0018-z\\n10.1183/13993003.01505-2016\\n10.1002/ppul.21424\\n10.1186/1471-2350-14-100\\n10.1186/s12931-016-0434-4\\n10.1111/all.12990\\n10.1038/ng.2830\\n10.1038/ejhg.2010.38\\n10.1111/cea.12461\\n10.1136/thoraxjnl-2011-201262\\n10.1111/pai.12505\\n10.1016/j.jaci.2015.08.038\\n10.1038/ng.323', 'xml': <Element 'PubmedArticle' at 0x10a46ed90>}\n",
      "{'pubmed_id': '38328657\\n33631128\\n35972837\\n35765786\\n29755807\\n35310810\\n34334095\\n37659923\\n33653354\\n31900134\\n36797636\\n31143465\\n32035336\\n31613151\\n34637031\\n37227417\\n33902607\\n32100445\\n32083112\\n37119004\\n35659215', 'title': 'Task-shifting in asthma and chronic obstructive pulmonary disease management: A review of the obstructive lung disease program.', 'abstract': 'Task shifting, an approach to address physician shortage through redistribution of clinical tasks, may help address the high burden of chronic respiratory diseases like asthma and COPD. We aimed to measure its utility and impact in the Obstructive Lung Disease program (OLD).\\nA retrospective, cross-sectional study was conducted at five integrated outpatient departments of Primary Care Program within Indus Hospital & Health Network, Pakistan, from January 2018 to March 2023. After a formative evaluation, registered nurses were trained as Lung Health Nurses (LHNs) to perform spirometry, collect Patient Reported Outcome Measures (PROMs) including Asthma Control Test (ACT), modified Medical Research Council (mMRC) dyspnea score and COPD Assessment Test (CAT), counsel on inhaler use and tobacco cessation, and refer to pulmonary rehabilitation (PR). Data was collected online contemporaneously on REDCap and later analyzed using Excel and STATA 14.\\nPre-implementation, a monthly average of 126 asthmatics and 33 COPD patients visited primary care centers. Medical records of 147 OLD patients showed 8% received inhaler education, 3% completed ACT and 2% had mMRC documented. Implementation included capacity building of nine LHNs. Of 7427 referrals to the program, 86% underwent nurse-led assessments. LHNs performed spirometry (92%), PROMs assessments [ACT (89%), CAT (91%), mMRC (85%)], inhaler education (97%), tobacco cessation advice (85%) and made PR referrals (94%).\\nTrained nurses can play a role in providing holistic and timely care for patients with CRDs and strengthen existing healthcare systems. Future directions may include expanding nurse clinical counselling roles through telehealth monitoring and home management.', 'keywords': ['Chronic respiratory diseases', 'Low- middle-income countries', 'Nurses', 'Primary care', 'Task shifting'], 'journal': 'Pakistan journal of medical sciences', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Siddiqui', 'firstname': 'Madiha', 'initials': 'M', 'affiliation': 'Madiha Siddiqui, FCPS The Indus Hospital & Health Network, Plot 3 & 3-A, Sector 47 Korangi Creek Road, Karachi, Pakistan.'}, {'lastname': 'Khan', 'firstname': 'Fizra', 'initials': 'F', 'affiliation': 'Fizra Khan, BE The Indus Hospital & Health Network, Plot 3 & 3-A, Sector 47 Korangi Creek Road, Karachi, Pakistan.'}, {'lastname': 'Saeed', 'firstname': 'Saima', 'initials': 'S', 'affiliation': 'Saima Saeed, FRCP The Indus Hospital & Health Network, Plot 3 & 3-A, Sector 47 Korangi Creek Road, Karachi, Pakistan.'}], 'methods': None, 'conclusions': 'Trained nurses can play a role in providing holistic and timely care for patients with CRDs and strengthen existing healthcare systems. Future directions may include expanding nurse clinical counselling roles through telehealth monitoring and home management.', 'results': 'Pre-implementation, a monthly average of 126 asthmatics and 33 COPD patients visited primary care centers. Medical records of 147 OLD patients showed 8% received inhaler education, 3% completed ACT and 2% had mMRC documented. Implementation included capacity building of nine LHNs. Of 7427 referrals to the program, 86% underwent nurse-led assessments. LHNs performed spirometry (92%), PROMs assessments [ACT (89%), CAT (91%), mMRC (85%)], inhaler education (97%), tobacco cessation advice (85%) and made PR referrals (94%).', 'copyrights': 'Copyright: © Pakistan Journal of Medical Sciences.', 'doi': '10.12669/pjms.40.2(ICON).8945', 'xml': <Element 'PubmedArticle' at 0x1099be750>}\n",
      "{'pubmed_id': '38328654\\n6887958\\n33026474\\n32420304\\n37670330\\n14975977\\n36628375\\n26361432\\n25190025', 'title': 'Esophageal Liposarcoma: A rare tumor.', 'abstract': \"Esophageal liposarcoma is a rare type of tumor. This case report documents the presentation, diagnosis, and management of a 74-year-old male with a medical history including diabetes mellitus, asthma, and hypertension. The patient's primary complaint was dysphagia, accompanied by regurgitation and substantial weight loss over a six-month period. Diagnostic evaluation revealed a sizable esophageal liposarcoma, which was successfully resected through surgery. Follow-up assessments demonstrated the absence of residual mass. Esophageal liposarcomas, though rare, should be considered in patients presenting with dysphagia or chest discomfort. Surgical resection is the mainstay of treatment, with the recommendation for extended postoperative surveillance given the limited available data regarding long-term prognosis.\", 'keywords': ['Esophageal liposarcoma', 'Lipomatous tumors'], 'journal': 'Pakistan journal of medical sciences', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Kumar', 'firstname': 'Ameet', 'initials': 'A', 'affiliation': 'Ameet Kumar, MBBS, Resident Radiology, Indus Hospital and Health Network, Karachi, Pakistan.'}, {'lastname': 'Ishaqi', 'firstname': 'M Saqib Qamar', 'initials': 'MSQ', 'affiliation': 'Saqib Qamar Ishaqi, MBBS, FCPS, EDIR, Consultant Radiologist, Indus Hospital and Health Network, Karachi, Pakistan.'}, {'lastname': 'Baig', 'firstname': 'Mehak Ali', 'initials': 'MA', 'affiliation': 'Mehak Ali Baig, MBBS, Resident Radiology, Indus Hospital and Health Network, Karachi, Pakistan.'}, {'lastname': 'Khan', 'firstname': 'Rafeah', 'initials': 'R', 'affiliation': 'Rafeah Khan, MBBS, FCPS, EDIR, Head of Department, Consultant Radiologist, Indus Hospital and Health Network, Karachi, Pakistan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © Pakistan Journal of Medical Sciences.', 'doi': '10.12669/pjms.40.2(ICON).8989', 'xml': <Element 'PubmedArticle' at 0x10a282700>}\n",
      "{'pubmed_id': '38328631\\n1590109\\n12061679', 'title': 'A case of asthma revealed to be a much rarer condition.', 'abstract': 'Asthma is one of the most common diseases. However, in patients with refractory asthma, chest imaging assessment should be performed, bearing in mind the possibility of other diseases.', 'keywords': ['Swyer–James syndrome', 'Swyer–James–MacLeod syndrome', 'asthma'], 'journal': 'Respirology case reports', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Hamakawa', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine Kurashiki Central Hospital Okayama Japan.'}, {'lastname': 'Arita', 'firstname': 'Machiko', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine Kurashiki Central Hospital Okayama Japan.'}, {'lastname': 'Ishida', 'firstname': 'Tadashi', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine Kurashiki Central Hospital Okayama Japan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.', 'doi': '10.1002/rcr2.1296', 'xml': <Element 'PubmedArticle' at 0x1250f5080>}\n",
      "{'pubmed_id': '38328511\\n28150046\\n22582229\\n37746132\\n33251631\\n33645500\\n30078662\\n24180010\\n26449512\\n30699151\\n31679007\\n30665434\\n27927247\\n32242631\\n32348300\\n30705126\\n37195546\\n35419885\\n30241519\\n30795752\\n33945622\\n31095641\\n34048497\\n25539969\\n36162908\\n37408483\\n24615279\\n37499182\\n32054641\\n31715537\\n32912168\\n22417404\\n20597693\\n31660375\\n28584857\\n18433339\\n24963568\\n24940321\\n23166805\\n27612639\\n8395142\\n36354898\\n26527637\\n37504745\\n34848556\\n7418186\\n20711075\\n29371573\\n20825438\\n21162714\\n28826456\\n36568568\\n18090396\\n27124154\\n28210571\\n26444731\\n26739610\\n12512182\\n37701386\\n26594637\\n35781514\\n16877576\\n32982560\\n37633228\\n36547569\\n36529732\\n36049486\\n38145865\\n35839221\\n24378231\\n25057102\\n35320642\\n37606364\\n6975437\\n33578417\\n1448123\\n27855071\\n24585567\\n20701405\\n36160421\\n25377144\\n25354514\\n19403905\\n16183515\\n9803639\\n16615848\\n12975754\\n31333999\\n31811506\\n33781313\\n22349065\\n28179437\\n34682212\\n34484738\\n34422267\\n29216852\\n37340531\\n31554262\\n31999732\\n31830848\\n30094132\\n34368461\\n31909191\\n37660991\\n36632423\\n26897068\\n13199326\\n5425506\\n5573582\\n23464714\\n22684277\\n4583411\\n26806139\\n36856432\\n8917747\\n27528972\\n35659908\\n31175479', 'title': 'Re-estimation of the burden of serious fungal diseases in Uganda.', 'abstract': 'It is of utmost importance to monitor any change in the epidemiology of fungal diseases that may arise from a change in the number of the at-risk population or the availability of local data.\\nWe sought to update the 2015 publication on the incidence and prevalence of serious fungal diseases in Uganda.\\nUsing the Leading International Fungal Education methodology, we reviewed published data on fungal diseases and drivers of fungal diseases in Uganda. Regional or global data were used where there were no Ugandan data.\\nWith a population of ~45 million, we estimate the annual burden of serious fungal diseases at 4,099,357 cases (about 9%). We estimated the burden of candidiasis as follows: recurrent \\nSerious fungal diseases affect nearly 9% of Ugandans every year. Tuberculosis and HIV remain the most important predisposition to acute fungal infection necessitating accelerated preventive, diagnostic, and therapeutic interventions for the management of these diseases.\\nHow common are serious fungal infections in Uganda? Why was the study done? This study was conducted to provide an updated understanding of the occurrence and impact of serious fungal diseases in Uganda. The aim was to monitor changes in the epidemiology of fungal diseases related to shifts in the at-risk population or the availability of local data. What did the researchers do? Utilizing the Leading International Fungal Education methodology, the research team systematically reviewed published data on fungal diseases in Uganda. In instances where Ugandan data was unavailable, regional, or global data were incorporated. This method allowed for a thorough examination of the incidence and prevalence of various serious fungal diseases, considering the local context. What did the researchers find? With a population of approximately 45 million, the study estimated that nearly 9% of Ugandans, totalling around 4,099,357 individuals, are affected by serious fungal diseases annually. Notable findings include the prevalence of recurrent Candida vaginitis, oral candidiasis, and oesophageal candidiasis in HIV-infected individuals. Cryptococcal meningitis and ', 'keywords': ['Uganda', 'chronic pulmonary aspergillosis', 'cryptococcal meningitis', 'fungal diseases'], 'journal': 'Therapeutic advances in infectious disease', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Bongomin', 'firstname': 'Felix', 'initials': 'F', 'affiliation': 'Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.\\nManchester Fungal Infection Group, Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.'}, {'lastname': 'Kwizera', 'firstname': 'Richard', 'initials': 'R', 'affiliation': 'Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.'}, {'lastname': 'Namusobya', 'firstname': 'Martha', 'initials': 'M', 'affiliation': 'Department of Clinical Epidemiology and Biostatistics, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.'}, {'lastname': 'van Rhijn', 'firstname': 'Norman', 'initials': 'N', 'affiliation': 'Manchester Fungal Infection Group, Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.'}, {'lastname': 'Andia-Biraro', 'firstname': 'Irene', 'initials': 'I', 'affiliation': None}, {'lastname': 'Kirenga', 'firstname': 'Bruce J', 'initials': 'BJ', 'affiliation': 'Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.'}, {'lastname': 'Meya', 'firstname': 'David B', 'initials': 'DB', 'affiliation': 'Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.\\nDepartment of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.'}, {'lastname': 'Denning', 'firstname': 'David W', 'initials': 'DW', 'affiliation': 'Manchester Fungal Infection Group, CTF Building, The University of Manchester, Grafton Street, Manchester M13 9NT, UK.'}], 'methods': None, 'conclusions': 'Serious fungal diseases affect nearly 9% of Ugandans every year. Tuberculosis and HIV remain the most important predisposition to acute fungal infection necessitating accelerated preventive, diagnostic, and therapeutic interventions for the management of these diseases.', 'results': 'With a population of ~45 million, we estimate the annual burden of serious fungal diseases at 4,099,357 cases (about 9%). We estimated the burden of candidiasis as follows: recurrent ', 'copyrights': '© The Author(s), 2024.\\n© The Author(s), 2024.', 'doi': '10.1177/20499361241228345', 'xml': <Element 'PubmedArticle' at 0x10a2b9c10>}\n",
      "{'pubmed_id': '38327559\\n22002862\\n18535823\\n961648\\n28539543\\n29725762\\n3069994\\n2392360\\n24453071\\n32534300\\n20490486', 'title': 'Bridge bronchus and pulmonary artery sling: Case report and literature review.', 'abstract': 'We present the case of a 14-year-old adolescent boy with a history of poorly controlled asthma and a final diagnosis of a bridge bronchus associated with sling of the left pulmonary artery. Regarding the case report, we describe the characteristic findings in computerized tomography multidetector of the thorax, its classification, and the most relevant information about this malformation. Congenital malformations of the tracheobronchial tree may occur in the context of asymptomatic or symptomatic respiratory patients. These malformations may be associated with other vascular, tracheal, and syndromes with multiorgan involvement. Although most patients are asymptomatic, some of them will have nonspecific symptoms without a clear etiology or will be diagnosed incidentally during the diagnostic evaluation of other pathologies. It is important to know and recognize the normal anatomy and its variations, since radiology undoubtedly plays a fundamental role in the diagnosis and preoperative assessment of these malformations, which although they have low incidence, must be identified in a timely manner by the specialist in diagnostic images.', 'keywords': ['Bronchi', 'Diagnostic imaging', 'Multidetector computed tomography', 'Pulmonary artery abnormalities', 'Tracheal abnormalities'], 'journal': 'Radiology case reports', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Pardo', 'firstname': 'Lizeth', 'initials': 'L', 'affiliation': 'Fundación Universitaria de Ciencias de la Salud - FUCS, Bogotá, Colombia.\\nDepartment of Radiology, Hospital de San José, Bogotá, Colombia.'}, {'lastname': 'Ardila', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': 'Fundación Universitaria de Ciencias de la Salud - FUCS, Bogotá, Colombia.\\nDepartment of Radiology, Hospital de San José, Bogotá, Colombia.'}, {'lastname': 'Bitar', 'firstname': 'Meggy', 'initials': 'M', 'affiliation': 'Fundación Universitaria de Ciencias de la Salud - FUCS, Bogotá, Colombia.\\nDepartment of Radiology, Hospital de San José, Bogotá, Colombia.'}, {'lastname': 'Moreno', 'firstname': 'Michela', 'initials': 'M', 'affiliation': 'Fundación Universitaria de Ciencias de la Salud - FUCS, Bogotá, Colombia.\\nDepartment of Radiology, Hospital de San José, Bogotá, Colombia.'}, {'lastname': 'Ruiz', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Fundación Universitaria de Ciencias de la Salud - FUCS, Bogotá, Colombia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.', 'doi': '10.1016/j.radcr.2023.12.061\\n10.1007/s00247-011-2273-2\\n10.1007/s00247-008-0913-y\\n10.1001/archpedi.1976.02120100105019\\n10.5761/atcs.cr.17-00006\\n10.1007/s00276-018-2033-1\\n10.1016/S0022-3468(88)80379-8\\n10.1007/BF02075204\\n10.1002/ca.22351\\n10.1016/j.ijporl.2020.110158\\n10.1007/s00247-010-1682-y', 'xml': <Element 'PubmedArticle' at 0x109989490>}\n",
      "{'pubmed_id': '38327518\\n24337046\\n35447228\\n31866436\\n37558162\\n37857423\\n37632144\\n37122713\\n37109237\\n32275980\\n32882249\\n30907188\\n32139455\\n36740095\\n36720387\\n25199059\\n28395936\\n32347992\\n33357499\\n27609408\\n35950646\\n30306745\\n37374008\\n28514601\\n34347947\\n37457743\\n37908397\\n37295671\\n37373648\\n35050830\\n32764111\\n37245731\\n30876830\\n36239786\\n33545398', 'title': 'Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.', 'abstract': 'Clinical remission (CliR) achievement has been recognized as a new potential outcome in severe asthma. Nevertheless, we still lack a detailed profile of what features could better identify patients undergoing clinical remission. In this study, we aim to address this issue, tracing a possible identikit of patients fulfilling remission criteria.\\nWe enrolled 266 patients with severe eosinophilic asthma (SEA) treated with a 12-month course of anti-IL5/IL5 receptor (IL5r) monoclonal antibodies. Patients with no exacerbation, OCS withdrawal, ACT ≥ 20 and FEV\\n30.5% of the enrolled patients achieved remission after biologic administration. CliR group showed a lower number of baseline asthma exacerbations and better lung function parameters, with a trend for higher ACT scores and a less frequent history of a positive skin prick test. CliR achievement was unlikely in presence of a higher BMI, a positive skin prick test, an increased number of asthma exacerbations before biologic treatment, anti-muscarinic administration, and a previous diagnosis of EGPA, bronchiectasis or osteoporosis. In contrast, a better lung function, an increased blood eosinophilic count, the presence of chronic rhinosinusitis with nasal polyps and a more frequent use of reliever therapy predicts remission development. Changes in exacerbations number, OCS use, ACT scores and FEV\\nanti-IL5/IL5r biologics can induce CliR in a proportion of patients with SEA. Patients achieving remission demonstrate specific clinical, functional and inflammatory features, as well as a specific moment of improvement in all the CliR items.', 'keywords': ['FEV1', 'anti-IL5', 'anti-IL5 receptor', 'biologics', 'clinical remission', 'corticosteroids', 'exacerbations', 'severe asthma'], 'journal': 'Frontiers in immunology', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Carpagnano', 'firstname': 'Giovanna Elisiana', 'initials': 'GE', 'affiliation': 'Department of Translational Biomedicine and Neuroscience, Institute of Respiratory Disease, University \"Aldo Moro\", Bari, Italy.'}, {'lastname': 'Portacci', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Department of Translational Biomedicine and Neuroscience, Institute of Respiratory Disease, University \"Aldo Moro\", Bari, Italy.'}, {'lastname': 'Nolasco', 'firstname': 'Santi', 'initials': 'S', 'affiliation': 'Respiratory Medicine Unit, Policlinico \"G. Rodolico-San Marco\" University Hospital, Catania, Italy.\\nDepartment of Clinical and Experimental Medicine, University of Catania, Catania, Italy.'}, {'lastname': 'Detoraki', 'firstname': 'Aikaterini', 'initials': 'A', 'affiliation': 'Division of Internal Medicine and Clinical Immunology, Department of Internal Medicine and Clinical Complexity, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy.'}, {'lastname': 'Vatrella', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.'}, {'lastname': 'Calabrese', 'firstname': 'Cecilia', 'initials': 'C', 'affiliation': 'Unitá Operativa (UO) Clinica Pneumologica SUN, Dipartimento Pneumologia ed Oncologia, Azienda Ospedaliera Specialistica dei Colli, Napoli, Italy.'}, {'lastname': 'Pelaia', 'firstname': 'Corrado', 'initials': 'C', 'affiliation': 'Department of Health Sciences, University \"Magna Graecia\" of Catanzaro, Catanzaro, Italy.'}, {'lastname': 'Montagnolo', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Department of Translational Biomedicine and Neuroscience, Institute of Respiratory Disease, University \"Aldo Moro\", Bari, Italy.'}, {'lastname': 'Scioscia', 'firstname': 'Giulia', 'initials': 'G', 'affiliation': 'Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.'}, {'lastname': 'Valenti', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Allergology and Pulmonology Unit, Provincial Outpatient Center of Palermo, Palermo, Italy.'}, {'lastname': \"D'Amato\", 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Unitá Operativa Semplice Dipartimentale (UOSD) Malattie Respiratorie \"Federico II\", Ospedale Monaldi, Azienda Ospedaliera (AO) Dei Colli, Naples, Italy.'}, {'lastname': 'Caiaffa', 'firstname': 'Maria Filomena', 'initials': 'MF', 'affiliation': 'Department of Medical and Surgical Sciences, School and Chair of Allergology and Clinical Immunology, University of Foggia, Foggia, Italy.'}, {'lastname': 'Triggiani', 'firstname': 'Massimo', 'initials': 'M', 'affiliation': 'Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy.'}, {'lastname': 'Scichilone', 'firstname': 'Nicola', 'initials': 'N', 'affiliation': 'Division of Respiratory Diseases, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.'}, {'lastname': 'Crimi', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Respiratory Medicine Unit, Policlinico \"G. Rodolico-San Marco\" University Hospital, Catania, Italy.\\nDepartment of Clinical and Experimental Medicine, University of Catania, Catania, Italy.'}], 'methods': None, 'conclusions': None, 'results': '30.5% of the enrolled patients achieved remission after biologic administration. CliR group showed a lower number of baseline asthma exacerbations and better lung function parameters, with a trend for higher ACT scores and a less frequent history of a positive skin prick test. CliR achievement was unlikely in presence of a higher BMI, a positive skin prick test, an increased number of asthma exacerbations before biologic treatment, anti-muscarinic administration, and a previous diagnosis of EGPA, bronchiectasis or osteoporosis. In contrast, a better lung function, an increased blood eosinophilic count, the presence of chronic rhinosinusitis with nasal polyps and a more frequent use of reliever therapy predicts remission development. Changes in exacerbations number, OCS use, ACT scores and FEV', 'copyrights': 'Copyright © 2024 Carpagnano, Portacci, Nolasco, Detoraki, Vatrella, Calabrese, Pelaia, Montagnolo, Scioscia, Valenti, D’Amato, Caiaffa, Triggiani, Scichilone and Crimi.', 'doi': '10.3389/fimmu.2024.1343362\\n10.1183/09031936.00202013\\n10.1016/j.jaci.2022.04.005\\n10.1016/j.jaci.2019.12.006\\n10.1016/j.jaip.2023.07.041\\n10.1183/13993003.00819-2023\\n10.1111/all.15867\\n10.3389/fimmu.2023.1150162\\n10.3390/jcm12082900\\n10.1016/j.chest.2020.03.042\\n10.1016/j.chest.2020.08.2083\\n10.1080/02770903.2019.1591443\\n10.1198/016214506000000735\\n10.1183/13993003.02420-2019\\n10.1183/13993003.congress-2023.PA1934\\n10.1016/j.jaip.2023.01.021\\n10.1056/NEJMoa1403290\\n10.1016/S2213-2600(17)30125-X\\n10.1111/cea.13613\\n10.1016/S2213-2600(20)30414-8\\n10.1016/S0140-6736(16)31324-1\\n10.1111/all.15473\\n10.4168/aair.2018.10.6.614\\n10.3390/jpm13061020\\n10.1056/NEJMoa1702079\\n10.1002/art.41943\\n10.3389/fimmu.2023.1204444\\n10.1183/23120541.00419-2023\\n10.1016/j.jaip.2023.05.041\\n10.3390/jcm12123953\\n10.1164/rccm.202108-1889OC\\n10.1183/13993003.01251-2020\\n10.1016/j.jaip.2023.05.021\\n10.1016/S2213-2600(19)30049-9\\n10.1007/s00408-022-00579-2\\n10.1016/j.jaip.2021.01.029', 'xml': <Element 'PubmedArticle' at 0x1250bdfd0>}\n",
      "{'pubmed_id': '38327138', 'title': 'Adverse neonatal outcomes in pregnant women with asthma: An updated systematic review and meta-analysis.', 'abstract': 'A systematic review and meta-analysis from 2013 reported increased risks of congenital malformations, neonatal death and neonatal hospitalization amongst infants born to women with asthma compared to infants born to mothers without asthma.\\nOur objective was to update the evidence on the associations between maternal asthma and adverse neonatal outcomes.\\nWe performed an English-language MEDLINE, Embase, CINAHL, and COCHRANE search with the terms (asthma or wheeze) and (pregnan* or perinat* or obstet*).\\nStudies published from March 2012 until September 2023 reporting at least one outcome of interest (congenital malformations, stillbirth, neonatal death, perinatal mortality, neonatal hospitalization, transient tachypnea of the newborn, respiratory distress syndrome and neonatal sepsis) in a population of women with and without asthma.\\nThe study was reported following the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) and the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Quality of individual studies was assessed by two reviewers independently using the Newcastle-Ottawa Scale. Random effects models (≥3 studies) or fixed effect models (≤2 studies) were used with restricted maximum likelihood to calculate relative risk (RR) from prevalence data and the inverse generic variance method where adjusted odds ratios (aORs) from individual studies were combined.\\nA total of 18 new studies were included, along with the 22 studies from the 2013 review. Previously observed increased risks remained for perinatal mortality (relative risk [RR] 1.14, 95% confidence interval [CI]: 1.05, 1.23 n\\u2009=\\u200916 studies; aOR 1.07, 95% CI: 0.98-1.17 n\\u2009=\\u20096), congenital malformations (RR 1.36, 95% CI: 1.32-1.40 n\\u2009=\\u200917; aOR 1.42, 95% CI: 1.38-1.47 n\\u2009=\\u20096), and neonatal hospitalization (RR 1.27, 95% CI: 1.25-1.30 n\\u2009=\\u200912; aOR 1.1, 95% CI: 1.07-1.16 n\\u2009=\\u20093) amongst infants born to mothers with asthma, while the risk for neonatal death was no longer significant (RR 1.33, 95% CI: 0.95-1.84 n\\u2009=\\u20098). Previously reported non-significant risks for major congenital malformations (RR1.18, 95% CI: 1.15-1.21; aOR 1.20, 95% CI: 1.15-1.26 n\\u2009=\\u20093) and respiratory distress syndrome (RR 1.25, 95% CI: 1.17-1.34 n\\u2009=\\u20094; aOR 1.09, 95% CI: 1.01-1.18 n\\u2009=\\u20092) reached statistical significance.\\nHealthcare professionals should remain aware of the increased risks to neonates being born to mothers with asthma.', 'keywords': ['asthma', 'congenital malformations', 'hospitalization', 'neonatal death', 'perinatal mortality', 'stillbirth'], 'journal': 'International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Robijn', 'firstname': 'Annelies L', 'initials': 'AL', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.\\nThe Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, Australia.'}, {'lastname': 'Harvey', 'firstname': 'Soriah M', 'initials': 'SM', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.\\nThe Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, Australia.'}, {'lastname': 'Jensen', 'firstname': 'Megan E', 'initials': 'ME', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.\\nThe Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, Australia.'}, {'lastname': 'Atkins', 'firstname': 'Samuel', 'initials': 'S', 'affiliation': 'Department of Health, Launceston General Hospital, Launceston, Australia.'}, {'lastname': 'Quek', 'firstname': 'Kiah J D', 'initials': 'KJD', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.'}, {'lastname': 'Wang', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, China.\\nLaboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, China.'}, {'lastname': 'Smith', 'firstname': 'Hannah', 'initials': 'H', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.'}, {'lastname': 'Chambers', 'firstname': 'Christina', 'initials': 'C', 'affiliation': 'Pediatrics and Family and Preventative Medicine, University of California, San Diego, California, USA.'}, {'lastname': 'Namazy', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': 'Department of Allergy-Immunology, Scripps Clinic, San Diego, California, USA.'}, {'lastname': 'Schatz', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Department of Allergy, Kaiser Permanente Medical Center, San Diego, California, USA.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.\\nThe Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, Australia.\\nDepartment of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.'}, {'lastname': 'Murphy', 'firstname': 'Vanessa E', 'initials': 'VE', 'affiliation': 'School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.\\nThe Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, Australia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.', 'doi': '10.1002/ijgo.15407', 'xml': <Element 'PubmedArticle' at 0x10b318090>}\n",
      "{'pubmed_id': '38326796\\n36716752\\n33069326\\n36861185\\n36191867\\n30941334\\n36649759\\n24337046\\n21992947\\n27306664\\n24336217\\n33793332\\n30670819\\n32161344\\n30765132\\n29321519\\n12689998\\n17886233\\n29164242\\n36110421\\n35140703\\n35185808\\n33462485\\n29880062\\n36880394\\n36576600\\n24816252\\n33456673\\n35125876\\n26102221\\n34070764\\n30778224\\n26432245\\n31233103\\n24114802\\n23863760\\n26050253\\n27061298\\n24831050\\n9432252\\n25773750\\n21216802\\n34408443\\n24330256\\n29479926\\n35418758\\n30552986\\n32072252\\n35514165\\n30964945\\n18972304\\n30271607\\n32522072\\n28912020\\n33862008\\n31958431\\n31462512\\n32235410\\n26424567\\n27115049\\n27634868\\n34538037\\n33139948\\n32778700\\n28390574\\n36343772\\n28704649\\n35349649\\n32576065\\n35050191', 'title': 'Causal associations between gut microbiota, metabolites and asthma: a two-sample Mendelian randomization study.', 'abstract': 'While several traditional observational studies have suggested associations between gut microbiota and asthma, these studies are limited by factors such as participant selection bias, confounders, and reverse causality. Therefore, the causal relationship between gut microbiota and asthma remains uncertain.\\nWe performed two-sample bi-directional Mendelian randomization (MR) analysis to investigate the potential causal relationships between gut microbiota and asthma as well as its phenotypes. We also conducted MR analysis to evaluate the causal effect of gut metabolites on asthma. Genetic variants for gut microbiota were obtained from the MiBioGen consortium, GWAS summary statistics for metabolites from the TwinsUK study and KORA study, and GWAS summary statistics for asthma from the FinnGen consortium. The causal associations between gut microbiota, gut metabolites and asthma were examined using inverse variance weighted, maximum likelihood, MR-Egger, weighted median, and weighted model and further validated by MR-Egger intercept test, Cochran\\'s Q test, and \"leave-one-out\" sensitivity analysis.\\nWe identified nine gut microbes whose genetically predicted relative abundance causally impacted asthma risk. After FDR correction, significant causal relationships were observed for two of these microbes, namely the class Bacilli (OR\\u2009=\\u20090.84, 95%CI\\u2009=\\u20090.76-0.94, p\\u2009=\\u20091.98\\u2009×\\u200910\\nOur study provides insights into the development mechanism of microbiota-mediated asthma, as well as into the prevention and treatment of asthma through targeting specific gut microbiota.', 'keywords': ['Asthma', 'Gut metabolites', 'Gut microbiota', 'Mendelian randomization study'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Li', 'firstname': 'Jingli', 'initials': 'J', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'Zhang', 'firstname': 'Chunyi', 'initials': 'C', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'Tang', 'firstname': 'Jixian', 'initials': 'J', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'He', 'firstname': 'Meng', 'initials': 'M', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'He', 'firstname': 'Chunxiao', 'initials': 'C', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'Pu', 'firstname': 'Guimei', 'initials': 'G', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China.\"}, {'lastname': 'Liu', 'firstname': 'Lingjing', 'initials': 'L', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China. liulingjing@wmu.edu.cn.'}, {'lastname': 'Sun', 'firstname': 'Jian', 'initials': 'J', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Shaoxing People's Hospital, Shaoxing, 312000, Zhejiang, China. 2002sunjian@163.com.\"}], 'methods': None, 'conclusions': None, 'results': 'We identified nine gut microbes whose genetically predicted relative abundance causally impacted asthma risk. After FDR correction, significant causal relationships were observed for two of these microbes, namely the class Bacilli (OR\\u2009=\\u20090.84, 95%CI\\u2009=\\u20090.76-0.94, p\\u2009=\\u20091.98\\u2009×\\u200910', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02898-x\\n10.1016/S0140-6736(20)30925-9\\n10.1016/j.jaip.2022.09.029\\n10.3389/fped.2019.00068\\n10.1183/09031936.00202013\\n10.1097/MCG.0b013e3182309276\\n10.1126/scitranslmed.aad7121\\n10.1038/nature12820\\n10.1161/CIRCRESAHA.121.318065\\n10.1038/s41574-019-0156-z\\n10.1038/d41586-020-00637-w\\n10.1016/j.aller.2018.12.009\\n10.1038/s41467-017-02573-2\\n10.1093/ije/dyg070\\n10.1002/sim.3034\\n10.1001/jama.2017.17219\\n10.3389/fcvm.2022.971376\\n10.3389/fimmu.2021.746998\\n10.3389/fmicb.2021.737197\\n10.1038/s41588-020-00763-1\\n10.1186/s40168-018-0479-3\\n10.1002/cam4.5772\\n10.1007/s00439-022-02514-0\\n10.1038/ng.2982\\n10.1155/2020/7101407\\n10.2147/JAA.S334752\\n10.1038/ncomms8320\\n10.1038/s41588-019-0350-x\\n10.1038/nature15393\\n10.1093/bioinformatics/btz469\\n10.1002/gepi.21758\\n10.1093/aje/kwt084\\n10.1093/ije/dyv080\\n10.1002/gepi.21965\\n10.1016/j.jclinepi.2014.03.012\\n10.1136/bmj.315.7121.1533\\n10.1007/s10654-015-0011-z\\n10.1177/0962280210394459\\n10.2147/JAA.S320088\\n10.1111/cea.12253\\n10.23822/EurAnnACI.1764-1489.48\\n10.2147/JAA.S354870\\n10.1016/j.anai.2018.12.005\\n10.1007/s00281-019-00775-y\\n10.1111/cts.13288\\n10.1111/all.13812\\n10.1080/02770900802339734\\n10.1136/bmjresp-2018-000324\\n10.1080/19490976.2020.1766345\\n10.1053/j.gastro.2017.09.006\\n10.1016/j.jaci.2021.04.001\\n10.1053/j.gastro.2020.01.024\\n10.1126/scitranslmed.aau9356\\n10.3390/nu12040948\\n10.1126/scitranslmed.aab2271\\n10.1080/19490976.2016.1182293\\n10.1042/CS20160349\\n10.1038/s41591-020-1095-x\\n10.1038/s41598-020-70528-7\\n10.1016/j.jaci.2017.02.004\\n10.1016/j.jaci.2022.09.041\\n10.1016/j.chom.2017.06.007\\n10.2337/dc21-1705\\n10.1080/19490976.2020.1778261\\n10.3390/metabo12010069', 'xml': <Element 'PubmedArticle' at 0x10b21d300>}\n",
      "{'pubmed_id': '38326156', 'title': 'Inhaled medications and inhalation chambers for childhood asthma. Spanish network of working groups on asthma in pediatrics (REGAP).', 'abstract': 'Asthma, the most prevalent chronic disease in pediatric age, continues to pose challenges in its management and treatment. National and international guidelines emphasize the importance of therapeutic education (TE) to achieve disease control. TE involves imparting knowledge and skills to the patient and their family, enhancing medication adherence, rectifying errors in inhalation technique, and tailoring treatment based on individual patient characteristics. It is essential for TE to be progressive, gradual, and personalized, spanning all levels of care. Training healthcare professionals in TE is crucial, particularly for pediatricians, who must also be aware of the extensive variability of available meds and inhalers and their respective age-specific indications. Addressing this need, the REGAP Group extensively reviewed inhalers currently available in Spain for pediatric asthma treatment. The review encompassed different inhalation systems and inhaled drugs used for pediatric asthma treatment. This review will be updated annually, providing information on medications, devices, inhalation chambers, indications, and financiation. The REGAP Group hopes that these tables will be a valuable help for pediatricians in their daily clinical practice and serve as an effective TE tool.', 'keywords': ['Adolescence', 'Adolescencia', 'Asma', 'Asthma', 'Childhood', 'Cámaras inhalación', 'Educación sanitaria', 'Infancia', 'Inhaladores', 'Inhalation chambers', 'Inhaled medication', 'Inhalers', 'Medicación inhalada', 'Patient education', 'Tratamiento', 'Treatment'], 'journal': 'Anales de pediatria', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Juliá Benito', 'firstname': 'Juan Carlos', 'initials': 'JC', 'affiliation': 'Centro de Salud República Argentina, Valencia, Spain; Unidad de Alergia y Neumología Pediátrica, Hospital IMED, Valencia, Spain. Electronic address: juancarlosjulia@hotmail.com.'}, {'lastname': 'Moreno-Galarraga', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Neumología Infantil, Servicio de Pediatría, Hospital Universitario de Navarra, Pamplona, Spain.'}, {'lastname': 'Bragado Alcaraz', 'firstname': 'Esther', 'initials': 'E', 'affiliation': 'Unidad de Neumología y Alergia Pediátrica, Hospital Universitario Santa Lucia, Cartagena, Spain.'}, {'lastname': 'Asensi Monzó', 'firstname': 'María Teresa', 'initials': 'MT', 'affiliation': 'Centro de Salud Serreria 1, Valencia, Spain.'}, {'lastname': 'Ortega Casanueva', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Clínico Materno Infantil Senda, Madrid, Spain.'}, {'lastname': 'Moral', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'Unidad de Alergología y Neumología Pediátrica, Hospital General Universitario, Alicante, Spain.'}, {'lastname': 'Rodríguez Fernández-Oliva', 'firstname': 'Carmen Rosa', 'initials': 'CR', 'affiliation': 'Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Santa Cruz de Tenerife, Spain.'}, {'lastname': 'Sanz Ortega', 'firstname': 'José', 'initials': 'J', 'affiliation': 'Hospital La Salud, Valencia, Spain.'}, {'lastname': 'Valdesoiro Navarrete', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Unidad de Alergia, Neumología Pediátrica y Fibrosis Quística, Servicio de Pediatría, Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2023 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.', 'doi': '10.1016/j.anpede.2024.01.015', 'xml': <Element 'PubmedArticle' at 0x108fbebb0>}\n",
      "{'pubmed_id': '38326118', 'title': 'As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.', 'abstract': None, 'keywords': [], 'journal': 'Archivos de bronconeumologia', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Beasley', 'firstname': 'Richard', 'initials': 'R', 'affiliation': 'Medical Research Institute of New Zealand, Wellington, New Zealand. Electronic address: Richard.Beasley@mrinz.ac.nz.'}, {'lastname': 'Ferreira', 'firstname': 'Diogenes S', 'initials': 'DS', 'affiliation': 'Private Practice, Allergy and Immunology, Belo Horizonte, Brazil.'}, {'lastname': 'Papi', 'firstname': 'Alberto', 'initials': 'A', 'affiliation': 'University of Ferrara, Ferrara, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.arbres.2024.01.003', 'xml': <Element 'PubmedArticle' at 0x10a6027a0>}\n",
      "{'pubmed_id': '38326024', 'title': 'Not all wheeze is asthma.', 'abstract': None, 'keywords': ['Asthma', 'Bronchoscopy', 'COVID-19', 'Child', 'Imaging/CT MRI etc'], 'journal': 'Thorax', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Ng', 'firstname': 'Kher Lik', 'initials': 'KL', 'affiliation': 'Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK kherlik.ng@ouh.nhs.uk.'}, {'lastname': 'Park', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.'}, {'lastname': 'Belcher', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'Department of Thoracic Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.'}, {'lastname': 'Moore', 'firstname': 'Alastair J', 'initials': 'AJ', 'affiliation': 'Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1136/thorax-2023-220953', 'xml': <Element 'PubmedArticle' at 0x10a6009a0>}\n",
      "{'pubmed_id': '38325912', 'title': 'Analysis of guideline recommendations for treatment of asthma exacerbations in children: a Pediatric Emergency Research Networks (PERN) study.', 'abstract': 'There is significant practice variation in acute paediatric asthma, particularly severe exacerbations. It is unknown whether this is due to differences in clinical guidelines.\\nTo describe and compare the content and quality of clinical guidelines for the management of acute exacerbations of asthma in children between geographic regions.\\nObservational study of guidelines for the management of acute paediatric asthma from institutions across a global collaboration of six regional paediatric emergency research networks.\\n158 guidelines were identified. Half provided recommendations for at least two age groups, and most guidelines provided treatment recommendations according to asthma severity.There were consistent recommendations for the use of inhaled short-acting beta-agonists and systemic corticosteroids. Inhaled anticholinergic therapy was recommended in most guidelines for severe and critical asthma, but there were inconsistent recommendations for its use in mild and moderate exacerbations. Other inhaled therapies such as helium-oxygen mixture (Heliox) and nebulised magnesium were inconsistently recommended for severe and critical illness.Parenteral bronchodilator therapy and epinephrine were mostly reserved for severe and critical asthma, with intravenous magnesium most recommended. There were regional differences in the use of other parenteral bronchodilators, particularly aminophylline.Guideline quality assessment identified high ratings for clarity of presentation, scope and purpose, but low ratings for stakeholder involvement, rigour of development, applicability and editorial independence.\\nCurrent guidelines for the management of acute paediatric asthma exacerbations have substantial deficits in important quality domains and provide limited and inconsistent guidance for severe exacerbations.', 'keywords': ['emergency care', 'paediatrics', 'respiratory medicine'], 'journal': 'Archives of disease in childhood', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Craig', 'firstname': 'Simon', 'initials': 'S', 'affiliation': 'Department of Paediatrics, Monash University, Clayton, Victoria, Australia simon.craig@monash.edu.\\nDepartment of Paediatric Emergency, Monash Health, Clayton, Victoria, Australia.'}, {'lastname': 'Collings', 'firstname': 'Madeline', 'initials': 'M', 'affiliation': 'Department of Paediatrics, Monash University, Clayton, Victoria, Australia.'}, {'lastname': 'Gray', 'firstname': 'Charmaine', 'initials': 'C', 'affiliation': 'Adelaide Medical School, Discipline of Paediatrics, The University of Adelaide, Adelaide, South Australia, Australia.\\nDepartment of Paediatric Emergency, Flinders Medical Centre, Bedford Park, South Australia, Australia.'}, {'lastname': 'Benito', 'firstname': 'Javier', 'initials': 'J', 'affiliation': 'Department of Pediatric Emergency, Cruces University Hospital, Bilbao, Basque Country, Spain.\\nUniversity of the Basque Country, Bilabo, Basque Country, Spain.'}, {'lastname': 'Velasco', 'firstname': 'Roberto', 'initials': 'R', 'affiliation': 'Pediatric Emergency Unit, Hospital Universitari Parc Taul, Sabadell, Spain.\\nPaediatrics and Child Health, University College Cork, Cork, Ireland.'}, {'lastname': 'Lyttle', 'firstname': 'Mark D', 'initials': 'MD', 'affiliation': 'Emergency Department, Bristol Royal Hospital for Children, Bristol, UK.\\nResearch in Emergency Care Avon Collaborative Hub (REACH), University of the West of England, Bristol, UK.'}, {'lastname': 'Roland', 'firstname': 'Damian', 'initials': 'D', 'affiliation': \"SAPPHIRE Group, Health Sciences, University of Leicester, Leicester, UK.\\nPaediatric Emergency Medicine Leicester Academic (PEMLA) Group, Department of Children's Emergency, Leicester Royal Infirmary, Leicester, UK.\"}, {'lastname': 'Schuh', 'firstname': 'Suzanne', 'initials': 'S', 'affiliation': 'Division of Pediatric Emergency Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.\\nSickKids Research Institute, Toronto, Ontario, Canada.'}, {'lastname': 'Shihabuddin', 'firstname': 'Bashar', 'initials': 'B', 'affiliation': \"Division of Emergency Medicine, Nationwide Children's Hospital, Colombus, Ohio, USA.\\nCollege of Medicine, The Ohio State University, Columbus, Ohio, USA.\"}, {'lastname': 'Kwok', 'firstname': 'Maria', 'initials': 'M', 'affiliation': \"Department of Emergency Medicine, Division of Pediatric Emergency Medicine, Columbia University Irving Medical Center, New York, New York, USA.\\nDepartment of Pediatric Emergency, NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, New York, USA.\"}, {'lastname': 'Mahajan', 'firstname': 'Prashant', 'initials': 'P', 'affiliation': 'Emergency Medicine and Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.'}, {'lastname': 'Johnson', 'firstname': 'Mike', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Division of Pediatric Emergency Medicine, The University of Utah School of Medicine, Salt Lake City, Utah, USA.'}, {'lastname': 'Zorc', 'firstname': 'Joseph', 'initials': 'J', 'affiliation': \"Division of Emergency Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.\\nPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.\"}, {'lastname': 'Khanna', 'firstname': 'Kajal', 'initials': 'K', 'affiliation': 'Department of Emergency Medicine, School of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.'}, {'lastname': 'Fernandes', 'firstname': 'Ricardo', 'initials': 'R', 'affiliation': 'Department of Pediatrics, Hospital de Santa Maria, Lisboa, Portugal.\\nClinical Pharmacology Unit, University of Lisbon, Lisboa, Portugal.'}, {'lastname': 'Yock-Corrales', 'firstname': 'Adriana', 'initials': 'A', 'affiliation': 'Department of Emergency, Hospital Nacional de Ninos Dr Carlos Saenz Herrera, C.C.S.S, San Jose, Costa Rica.'}, {'lastname': 'Santhanam', 'firstname': 'Indumathy', 'initials': 'I', 'affiliation': 'National Health Mission, Tamil Nadu, India.\\nPREM Simulation Laboratory, Institute of Child Health, Madras Medical College, Chennai, India.'}, {'lastname': 'Cheema', 'firstname': 'Baljit', 'initials': 'B', 'affiliation': 'Department of Paediatrics & Child Health, University of Cape Town Faculty of Health Sciences, Western Cape, South Africa.'}, {'lastname': 'Ong', 'firstname': 'Gene Yong-Kwang', 'initials': 'GY', 'affiliation': \"Children's Emergency Department, KK Women's and Children's Hospital, Singapore.\\nMedical School, Duke University and the National University of Singapore, Singapore.\"}, {'lastname': 'Jaiganesh', 'firstname': 'Thiagarajan', 'initials': 'T', 'affiliation': 'Department of Emergency, Tawam Hospital, Al Ain, Abu Dhabi, UAE.'}, {'lastname': 'Powell', 'firstname': 'Colin', 'initials': 'C', 'affiliation': 'Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.'}, {'lastname': 'Nixon', 'firstname': 'Gillian', 'initials': 'G', 'affiliation': \"Department of Paediatrics, Monash University, Clayton, Victoria, Australia.\\nDepartment of Respiratory Medicine, Monash Children's Hospital, Clayton, Victoria, Australia.\"}, {'lastname': 'Dalziel', 'firstname': 'Stuart', 'initials': 'S', 'affiliation': \"Departments of Surgery and Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.\\nDepartment of Children's Emergency, Starship Children's Health, Auckland, New Zealand.\"}, {'lastname': 'Babl', 'firstname': 'Franz E', 'initials': 'FE', 'affiliation': \"Department of Paediatrics, Monash University, Clayton, Victoria, Australia.\\nDepartment of Emergency, Royal Children's Hospital, Melbourne, Victoria, Australia.\\nClinical Sciences, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.\\nDepartments of Paediatrics and Critical Care, University of Melbourne, Melbourne, Victoria, Australia.\"}, {'lastname': 'Graudins', 'firstname': 'Andis', 'initials': 'A', 'affiliation': 'Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.\\nMonash Emergency Service, Emergency Department, Dandenong Hospital, Monash Health, Dandenong, Victoria, Australia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/archdischild-2023-326739', 'xml': <Element 'PubmedArticle' at 0x109f3df30>}\n",
      "{'pubmed_id': '38325715', 'title': 'Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders.', 'abstract': \"Neuropeptide S (NPS) is a 20 amino acids-containing neuroactive molecule discovered by the reverse pharmacology method. NPS is detected in specific brain regions like the brainstem, amygdala, and hypothalamus, while its receptor (NPSR) is ubiquitously expressed in the central nervous system (CNS). Besides CNS, NPS and NPSR are also expressed in the peripheral nervous system. NPSR is a G-protein coupled receptor that primarily uses Gq and Gs signaling pathways to mediate the actions of NPS. In animal models of Parkinsonism and Alzheimer's disease, NPS exerts neuroprotective effects. NPS suppresses oxidative stress, anxiety, food intake, and pain, and promotes arousal. NPSR facilitates reward, reinforcement, and addiction-related behaviors. Genetic variation and single nucleotide polymorphism in NPSR are associated with depression, schizophrenia, rheumatoid arthritis, and asthma. NPS interacts with several neurotransmitters including glutamate, noradrenaline, serotonin, corticotropin-releasing factor, and gamma-aminobutyric acid. It also modulates the immune system via augmenting pro-inflammatory cytokines and plays an important role in the pathogenesis of rheumatoid arthritis and asthma. In the present review, we discussed the distribution profile of NPS and NPSR, signaling pathways, and their importance in the pathophysiology of various neurological disorders. We have also proposed the areas where further investigations on the NPS system are warranted.\", 'keywords': ['Neurodegeneration', 'Neurological disorders', 'Neuropeptide S', 'Oxidative stress', 'Reward'], 'journal': 'Peptides', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Shirsath', 'firstname': 'Kamini R', 'initials': 'KR', 'affiliation': \"Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.\"}, {'lastname': 'Patil', 'firstname': 'Vaishnavi K', 'initials': 'VK', 'affiliation': \"Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.\"}, {'lastname': 'Awathale', 'firstname': 'Sanjay N', 'initials': 'SN', 'affiliation': \"Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.\"}, {'lastname': 'Goyal', 'firstname': 'Sameer N', 'initials': 'SN', 'affiliation': \"Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.\"}, {'lastname': 'Nakhate', 'firstname': 'Kartik T', 'initials': 'KT', 'affiliation': \"Department of Pharmacology, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India. Electronic address: kartik.nakhate@svkm.ac.in.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.peptides.2024.171167', 'xml': <Element 'PubmedArticle' at 0x109bb43b0>}\n",
      "{'pubmed_id': '38325663', 'title': 'Improving asthma control and quality of life via a smartphone self-management app: A randomized controlled trial.', 'abstract': 'Mobile phone applications (apps) show promise for enhancing asthma self-management, but their effectiveness varies. This study examined the effect of a smartphone asthma app on asthma control and quality of life.\\nUsing block randomization, 60 patients with asthma were allocated to an intervention group (n\\xa0=\\xa030) or control group (n\\xa0=\\xa030) for this single-blind randomized controlled trial. At baseline, both groups completed the Asthma Control Test (ACT) and Asthma Quality of Life Questionnaire-Marks (AQLQ-M). The intervention group used a smartphone-based asthma self-management app plus their regular treatment, while the control group received only usual care. Follow-up ACT and AQLQ-M assessments occurred at 3 and 6 months. SPSS version 26 was used for analysis, including descriptive statistics, non-parametric tests (Wilcoxon and Mann-Whitney U), and analysis of variance with repeated measurements.\\nBoth groups showed improved asthma control and quality of life at 3 and 6 months compared to baseline. However, after 6 months the intervention group had significantly greater improvement than controls (p\\xa0<\\xa00.05). Repeated measures ANOVA revealed divergent changes in ACT and AQLQ-M scores over time, with the intervention group demonstrating greater enhancement of asthma control and quality of life (p\\xa0<\\xa00.001).\\nThis study demonstrated that use of a smartphone-based asthma self-management app improved asthma control and quality of life after 6 months compared to usual care alone. These findings indicate that guideline-based asthma apps can positively impact outcomes.', 'keywords': ['Asthma', 'Asthma control', 'Mobile applications', 'Quality of life', 'mHealth'], 'journal': 'Respiratory medicine', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Farzandipour', 'firstname': 'Mehrdad', 'initials': 'M', 'affiliation': 'Health Information Management Research Center, Kashan University of Medical Sciences, Kashan, Iran; Department of Health Information Management and Technology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran.'}, {'lastname': 'Heidarzadeh Arani', 'firstname': 'Marzieh', 'initials': 'M', 'affiliation': 'Pediatric Department, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Asthma and Allergy Clinic, Kashan University of Medical Sciences, Kashan, Iran.'}, {'lastname': 'Sharif', 'firstname': 'Reihane', 'initials': 'R', 'affiliation': 'Health Information Management Research Center, Kashan University of Medical Sciences, Kashan, Iran; Department of Health Information Management and Technology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran. Electronic address: sharif-rs@kaums.ac.ir.'}, {'lastname': 'Nabovati', 'firstname': 'Ehsan', 'initials': 'E', 'affiliation': 'Health Information Management Research Center, Kashan University of Medical Sciences, Kashan, Iran; Department of Health Information Management and Technology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran.'}, {'lastname': 'Akbari', 'firstname': 'Hossein', 'initials': 'H', 'affiliation': 'Department of Biostatistics and Epidemiology, School of Health, Kashan University of Medical Sciences, Kashan, Iran.'}, {'lastname': 'Anvari', 'firstname': 'Shima', 'initials': 'S', 'affiliation': 'Health Information Management Research Center, Kashan University of Medical Sciences, Kashan, Iran; Department of Health Information Management and Technology, Allied Medical Sciences Faculty, Kashan University of Medical Sciences, Kashan, Iran.'}], 'methods': None, 'conclusions': 'This study demonstrated that use of a smartphone-based asthma self-management app improved asthma control and quality of life after 6 months compared to usual care alone. These findings indicate that guideline-based asthma apps can positively impact outcomes.', 'results': 'Both groups showed improved asthma control and quality of life at 3 and 6 months compared to baseline. However, after 6 months the intervention group had significantly greater improvement than controls (p\\xa0<\\xa00.05). Repeated measures ANOVA revealed divergent changes in ACT and AQLQ-M scores over time, with the intervention group demonstrating greater enhancement of asthma control and quality of life (p\\xa0<\\xa00.001).', 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.rmed.2024.107539', 'xml': <Element 'PubmedArticle' at 0x1097e19e0>}\n",
      "{'pubmed_id': '38325624', 'title': 'Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure.', 'abstract': 'To analyze the impact of chronic obstructive pulmonary disease (COPD) and bronchial asthma on therapeutic management and prognosis of patients with heart failure (HF).\\nAnalysis of the information collected in a clinical registry of patients referred to a specialized HF unit from January-2010 to June-2012. Clinical profile, treatment and prognosis of patients was evaluated, according to the presence of COPD or asthma. Survival analyses were conducted by means of Kaplan-Meier and Cox´s methods. Median follow-up was 1493 days.\\nWe studied 2577 patients, of which 251 (9.7%) presented COPD and 96 (3.7%) bronchial asthma. Significant differences among study groups were observed regarding to the prescription of beta-blockers (COPD\\u202f=\\u202f89.6%; asthma\\u202f=\\u202f87.5%; no bronchopathy\\u202f=\\u202f94.1%; p\\u202f=\\u202f0.002) and SGLT2 inhibitors (COPD\\u202f=\\u202f35.1%; asthma\\u202f=\\u202f50%; no bronchopathy\\u202f=\\u202f38.3%; p\\u202f=\\u202f0.036). Also, patients with bronchial disease received less frequently a defibrillator (COPD\\u202f=\\u202f20.3%; asthma\\u202f=\\u202f20.8%; no broncopathy\\u202f=\\u202f29%; p\\u202f=\\u202f0.004). COPD was independently associated with increased risk of all-cause mortality (HR\\u202f=\\u202f1.64; 95% CI 1.33-2.02), all-cause death or HF admission (HR\\u202f=\\u202f1.47; 95% CI 1.22-1.76) and cardiovascular death or heart transplantation (HR\\u202f=\\u202f1.39; 95% CI 1.08-1.79) as compared with patients with no bronchopathy. Bronchial asthma was not significantly associated with increased risk of adverse outcomes.\\nCOPD, but not asthma, is an adverse independent prognostic factor in patients with HF.', 'keywords': ['Asma', 'Bronchial asthma', 'COPD', 'EPOC', 'Heart failure', 'Insuficiencia cardiaca', 'Prognosis', 'Pronóstico', 'Tratamiento', 'Treatment'], 'journal': 'Revista clinica espanola', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Barge-Caballero', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. Electronic address: Eduardo.barge.caballero@sergas.es.'}, {'lastname': 'Sieira-Hermida', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain.'}, {'lastname': 'Barge-Caballero', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.'}, {'lastname': 'Couto-Mallón', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.'}, {'lastname': 'Paniagua-Martín', 'firstname': 'M J', 'initials': 'MJ', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.'}, {'lastname': 'Enríquez-Vázquez', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.'}, {'lastname': 'Marcos-Rodríguez', 'firstname': 'P J', 'initials': 'PJ', 'affiliation': 'Dirección Asistencial y Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain.'}, {'lastname': 'Rodríguez-Capitán', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), Universidad de Málaga, Málaga, Spain.'}, {'lastname': 'Vázquez-Rodríguez', 'firstname': 'J M', 'initials': 'JM', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.'}, {'lastname': 'Crespo-Leiro', 'firstname': 'M G', 'initials': 'MG', 'affiliation': 'Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), Servicio Galego de Saúde (SERGAS), A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Universidad de A Coruña (UDC), A Coruña, Spain.'}], 'methods': None, 'conclusions': None, 'results': 'We studied 2577 patients, of which 251 (9.7%) presented COPD and 96 (3.7%) bronchial asthma. Significant differences among study groups were observed regarding to the prescription of beta-blockers (COPD\\u202f=\\u202f89.6%; asthma\\u202f=\\u202f87.5%; no bronchopathy\\u202f=\\u202f94.1%; p\\u202f=\\u202f0.002) and SGLT2 inhibitors (COPD\\u202f=\\u202f35.1%; asthma\\u202f=\\u202f50%; no bronchopathy\\u202f=\\u202f38.3%; p\\u202f=\\u202f0.036). Also, patients with bronchial disease received less frequently a defibrillator (COPD\\u202f=\\u202f20.3%; asthma\\u202f=\\u202f20.8%; no broncopathy\\u202f=\\u202f29%; p\\u202f=\\u202f0.004). COPD was independently associated with increased risk of all-cause mortality (HR\\u202f=\\u202f1.64; 95% CI 1.33-2.02), all-cause death or HF admission (HR\\u202f=\\u202f1.47; 95% CI 1.22-1.76) and cardiovascular death or heart transplantation (HR\\u202f=\\u202f1.39; 95% CI 1.08-1.79) as compared with patients with no bronchopathy. Bronchial asthma was not significantly associated with increased risk of adverse outcomes.', 'copyrights': 'Copyright © 2024. Published by Elsevier España, S.L.U.', 'doi': '10.1016/j.rceng.2024.01.007', 'xml': <Element 'PubmedArticle' at 0x10b728680>}\n",
      "{'pubmed_id': '38325503', 'title': 'Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Han', 'firstname': 'Yueh-Ying', 'initials': 'YY', 'affiliation': \"Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.\"}, {'lastname': 'Rosser', 'firstname': 'Franziska J', 'initials': 'FJ', 'affiliation': \"Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.\"}, {'lastname': 'Acosta-Pérez', 'firstname': 'Edna', 'initials': 'E', 'affiliation': 'Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico.'}, {'lastname': 'Canino', 'firstname': 'Glorisa', 'initials': 'G', 'affiliation': 'Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico.'}, {'lastname': 'Celedón', 'firstname': 'Juan C', 'initials': 'JC', 'affiliation': \"Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: juan.celedon@chp.edu.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.01.028', 'xml': <Element 'PubmedArticle' at 0x109c23ab0>}\n",
      "{'pubmed_id': '38325318', 'title': 'ANXIETY SYNDROMES IN ADOLESCENTS WITH OPERATIONAL RESPIRATORY CONDITIONS: A PROSPECTIVE STUDY.', 'abstract': \"Aim - determining the prevalence of anxiety disorders and their effect on disease progression and quality of life in adults with organic illnesses and functional disorders of the respiratory system treated in a pulmonology environment. A total of 135 young adults between the ages of 13 and 17 were analyzed. There were a total of 46 adolescents diagnosed with somatoform respiratory disorders (SRD), 45 adolescents diagnosed with bronchial asthma (BA), and 44 adolescents diagnosed with pneumonia. The Spielberger-Khanin anxiety questionnaire and the Nijmegen hyperventilation syndrome (HVS) scale were used for the research and diagnosis, respectively. The quality of life was measured using the asthma quality of life questionnaire (AQLQ). In comparison to adults with asthma (33.2%) and pneumonia (32.3%), adults with SRD (34.5%). There were mild immediate associations between the Spielberger scale and the Nijmegen HVS questionnaire for both trait and state anxiety, and mild inverse correlations between the Spielberger scale and the AQLQ for both state and trait anxiety. Adolescents with anxiety had a higher prevalence of trauma, pain, and social issues than their non-anxious counterparts who were referred to psychiatry. In adolescents, 5.1% had severe trait anxiety, and 19.3% had severe condition anxiety. Adolescents with SRD were twice as likely to suffer from extreme state and trait anxiety as the general population. It is hypothesized that anxiety problems are at the root of HVS and contribute to adults' dissatisfaction with their quality of life due to lung ailments. Although certain adolescents with anxiety disorders were referred for anxiety, this data nevertheless lends credence to the idea that using standardized and structured instruments regularly might help increase accuracy and detection rates in the clinic, regardless of the reason for referral. Complete evaluations are essential for this patient population due to the intricacy of their symptoms.\", 'keywords': [], 'journal': 'Georgian medical news', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Gupta', 'firstname': 'M', 'initials': 'M', 'affiliation': '1Department of Pharmacy, Vivekananda Global University, Jaipur, India.'}, {'lastname': 'Jain', 'firstname': 'Sh', 'initials': 'S', 'affiliation': '2Department of Paediatrics, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh, India.'}, {'lastname': 'Chandani', 'firstname': 'P', 'initials': 'P', 'affiliation': '3Department of Data Science (DS, AI, CSBS), Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India.'}, {'lastname': 'Patel J', 'firstname': 'D', 'initials': 'D', 'affiliation': '4Department of Pharmacology, Parul University, PO Limda, Tal. Waghodia, District Vadodara, Gujarat, India.'}, {'lastname': 'Asha', 'firstname': 'K', 'initials': 'K', 'affiliation': '5Department of Life Sciences, School of Sciences, JAIN (Deemed-to-be University), Karnataka, India.'}, {'lastname': 'Kumar', 'firstname': 'B', 'initials': 'B', 'affiliation': '6School of Pharmacy & Research, Dev Bhoomi Uttarakhand University, Dehradun, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x109c23330>}\n",
      "{'pubmed_id': '38325292', 'title': 'RELATIONSHIP OF ALLERGIC DISEASES, POLLEN EXPOSURE AND COVID-19 IN GEORGIA.', 'abstract': 'Allergic diseases have been recognized as one of the global health issues and affect about a third of the worldwide population. COVID-19 pandemic has raised concerns about the risk of infection and the severity of COVID-19 infection in patients with asthma and allergic rhinitis. The aim of our study was to define the relationships between pollen exposures and SARS-CoV-2 infection rates in Georgia, as well as to characterize the Covid-19 autoimmune and antiviral responses in Georgian allergic patients with different sensitization patterns. Data on daily COVID-19 positivity rates, case fatality rates, and pollen concentrations from February 2020 to November 2022 were collected in Tbilisi, Kutaisi, and Batumi. Diagnostic parameters, including total IgE, specific IgE, eosinophil counts, anti-nuclear antibodies, and Covid-19 antibodies, were assessed in 181 atopic patients and 24 healthy controls with confirmed SARS-CoV-2 infection. Laboratory findings revealed significant variations in eosinophil counts and total IgE levels among the groups. ANA positivity did not exhibit substantial differences between atopic patients and healthy controls. Individuals with indoor allergies displayed lower SARS-CoV-2-specific antibody levels, potentially explained by variations in adaptive immune responses. There was no correlation between pollen concentration and COVID-19 epidemiological characteristics, indicating that pollen had no effect on virus epidemiology.', 'keywords': [], 'journal': 'Georgian medical news', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Abramidze', 'firstname': 'T', 'initials': 'T', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi, Georgia.'}, {'lastname': 'Bochorishvili', 'firstname': 'E', 'initials': 'E', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi; 2David Tvildiani Medical University, Tbilisi, Georgia.'}, {'lastname': 'Melikidze', 'firstname': 'N', 'initials': 'N', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi, Georgia.'}, {'lastname': 'Dolidze', 'firstname': 'N', 'initials': 'N', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi, Georgia.'}, {'lastname': 'Chikhelidze', 'firstname': 'N', 'initials': 'N', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi; 3Ilia State University, Institute of Botany, Tbilisi, Georgia.'}, {'lastname': 'Chitadze', 'firstname': 'N', 'initials': 'N', 'affiliation': '4Georgian National Center for Disease Control and Public Health, Tbilisi, Georgia.'}, {'lastname': 'Getia', 'firstname': 'V', 'initials': 'V', 'affiliation': '4Georgian National Center for Disease Control and Public Health, Tbilisi, Georgia.'}, {'lastname': 'Gotua', 'firstname': 'M', 'initials': 'M', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi; 2David Tvildiani Medical University, Tbilisi, Georgia.'}, {'lastname': 'Gamkrelidze', 'firstname': 'A', 'initials': 'A', 'affiliation': '1Center for Allergy and Immunology Research, Tbilisi, Georgia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x109fd3470>}\n",
      "{'pubmed_id': '38325270', 'title': 'Oxidative stress-mediated activation of FTO exacerbates impairment of the epithelial barrier by up-regulating IKBKB via N6-methyladenosine-dependent mRNA stability in asthmatic mice exposed to PM2.5.', 'abstract': 'In order to comprehend the underlying mechanisms contributing to the development and exacerbation of asthma resulting from exposure to fine particulate matter (PM2.5), we established an asthmatic model in fat mass and obesity-associated gene knockdown mice subjected to PM2.5 exposure. Histological analyses using hematoxylin-eosin (HE) and Periodic Acid-Schiff (PAS) staining revealed that the down-regulation of the fat mass and obesity-associated gene (Fto) expression significantly ameliorated the pathophysiological alterations observed in asthmatic mice exposed to PM2.5. Furthermore, the down-regulation of Fto gene expression effectively attenuated damage to the airway epithelial barrier. Additionally, employing in vivo and in vitro models, we elucidated that PM2.5 modulated FTO expression by inducing oxidative stress. Asthmatic mice exposed to PM2.5 exhibited elevated Fto expression, which correlated with increased levels of reactive oxygen species. Similarly, when cells were exposed to PM2.5, FTO expression was up-regulated in a ROS-dependent manner. Notably, the administration of N-acetyl cysteine successfully reversed the PM2.5-induced elevation in FTO expression. Concurrently, we performed transcriptome-wide Methylated RNA immunoprecipitation Sequencing (MeRIP-seq) analysis subsequent to PM2.5 exposure. Through the implementation of Gene Set Enrichment Analysis and m6A-IP-qPCR, we successfully identified inhibitor of nuclear factor kappa B kinase subunit beta (IKBKB) as a target gene regulated by FTO. Interestingly, exposure to PM2.5 led to increased expression of IKBKB, while m6A modification on IKBKB mRNA was reduced. Furthermore, our investigation revealed that PM2.5 also regulated IKBKB through oxidative stress. Significantly, the down-regulation of IKBKB effectively mitigated epithelial barrier damage in cells exposed to PM2.5 by modulating nuclear factor-kappa B (NF-κB) signaling. Importantly, we discovered that decreased m6A modification on IKBKB mRNA facilitated by FTO enhanced its stability, consequently resulting in up-regulation of IKBKB expression. Collectively, our findings propose a novel role for FTO in the regulation of IKBKB through m6A-dependent mRNA stability in the context of PM2.5-induced oxidative stress. Therefore, it is conceivable that the utilization of antioxidants or inhibition of FTO could represent potential therapeutic strategies for the management of asthma exacerbated by PM2.5 exposure.', 'keywords': ['Asthma', 'Epithelial barrier', 'FTO', 'IKBKB', 'M6A', 'Oxidative stress', 'PM2.5'], 'journal': 'Ecotoxicology and environmental safety', 'publication_date': datetime.date(2024, 2, 8), 'authors': [{'lastname': 'Xiong', 'firstname': 'Anying', 'initials': 'A', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China.\"}, {'lastname': 'He', 'firstname': 'Xiang', 'initials': 'X', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China; National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China. Electronic address: xiangge530@hotmail.com.\"}, {'lastname': 'Liu', 'firstname': 'Shengbin', 'initials': 'S', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China.\"}, {'lastname': 'Ran', 'firstname': 'Qin', 'initials': 'Q', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China.\"}, {'lastname': 'Zhang', 'firstname': 'Lei', 'initials': 'L', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, 999078, China.\"}, {'lastname': 'Wang', 'firstname': 'Junyi', 'initials': 'J', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China.\"}, {'lastname': 'Jiang', 'firstname': 'Manling', 'initials': 'M', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, 999078, China.\"}, {'lastname': 'Niu', 'firstname': 'Bin', 'initials': 'B', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China.\"}, {'lastname': 'Xiong', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Sichuan friendship hospital, Chengdu 610000, China. Electronic address: ly65110@126.com.'}, {'lastname': 'Li', 'firstname': 'Guoping', 'initials': 'G', 'affiliation': \"Laboratory of Allergy and Precision Medicine, Chengdu Institute of Respiratory Health, the Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China; Department of Pulmonary and Critical Care Medicine, Chengdu third people's hospital branch of National Clinical Research Center for Respiratory Disease, Affiliated Hospital of ChongQing Medical University, Chengdu 610031, China. Electronic address: lzlgp@163.com.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.ecoenv.2024.116067', 'xml': <Element 'PubmedArticle' at 0x1098e21b0>}\n",
      "{'pubmed_id': '38324665', 'title': 'Emergency management and asthma risk in young Medicaid-enrolled children with recurrent wheeze.', 'abstract': 'To describe clinical characteristics of young children presenting to the emergency department (ED) for early recurrent wheeze, and determine factors associated with subsequent persistent wheeze and risk for early childhood asthma.\\nRetrospective cohort study of Medicaid-enrolled children 0-3\\u2009years old with an index ED visit for wheeze (e.g. bronchiolitis, reactive airway disease) from 2009 to 2013, and at least one prior documented episode of wheeze at an ED or primary care visit. The primary outcome was persistent wheeze between 4 and 6\\u2009years of age. Demographics and clinical characteristics were collected from the index ED visit. Logistic regression was used to estimate the association between potential risk factors and subsequent persistent wheeze.\\nDuring the study period, 41,710 children presented to the ED for recurrent wheeze. Mean age was 1.3\\u2009years; 59% were male, 42% Black, and 6% Hispanic. At index ED visits, the most common diagnosis was acute bronchiolitis (40%); 77% of children received an oral corticosteroid prescription. Between 4 and 6\\u2009years of age, 11,708 (28%) children had persistent wheeze. A greater number of wheezing episodes was associated with an increased odds of ED treatment with asthma medications. Subsequent persistent wheeze was associated with male sex, Black race, atopy, prescription for bronchodilators or corticosteroids, and greater number of visits for wheeze.\\nYoung children with persistent wheeze are at risk for childhood asthma. Thus, identification of risk factors associated with persistent wheeze in young children with recurrent wheeze might aid in early detection of asthma and initiation of preventative therapies.', 'keywords': ['Bronchiolitis', 'asthma', 'bronchodilators', 'children', 'corticosteroids', 'treatment', 'wheeze'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Hardee', 'firstname': 'Isabel J', 'initials': 'IJ', 'affiliation': \"Department of Pediatrics, University of CO School of Medicine, Children's Hospital Colorado, Aurora, CO, USA.\"}, {'lastname': 'Zaniletti', 'firstname': 'Isabella', 'initials': 'I', 'affiliation': \"Children's Hospitals Association, Overland Park, KS, USA.\"}, {'lastname': 'Tanverdi', 'firstname': 'Melisa S', 'initials': 'MS', 'affiliation': \"Section of Emergency Medicine, Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO, USA.\"}, {'lastname': 'Liu', 'firstname': 'Andrew H', 'initials': 'AH', 'affiliation': \"Section of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO.\"}, {'lastname': 'Mistry', 'firstname': 'Rakesh D', 'initials': 'RD', 'affiliation': 'Section of Emergency Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.'}, {'lastname': 'Navanandan', 'firstname': 'Nidhya', 'initials': 'N', 'affiliation': \"Section of Emergency Medicine, Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO, USA.\"}], 'methods': None, 'conclusions': None, 'results': 'During the study period, 41,710 children presented to the ED for recurrent wheeze. Mean age was 1.3\\u2009years; 59% were male, 42% Black, and 6% Hispanic. At index ED visits, the most common diagnosis was acute bronchiolitis (40%); 77% of children received an oral corticosteroid prescription. Between 4 and 6\\u2009years of age, 11,708 (28%) children had persistent wheeze. A greater number of wheezing episodes was associated with an increased odds of ED treatment with asthma medications. Subsequent persistent wheeze was associated with male sex, Black race, atopy, prescription for bronchodilators or corticosteroids, and greater number of visits for wheeze.', 'copyrights': None, 'doi': '10.1080/02770903.2024.2314623', 'xml': <Element 'PubmedArticle' at 0x1098e15d0>}\n",
      "{'pubmed_id': '38324640', 'title': 'IgE in allergy: It takes two.', 'abstract': 'A type 2 memory B cell subset is poised to differentiate into IgE-producing plasma cells in individuals with allergies (Ota ', 'keywords': [], 'journal': 'Science translational medicine', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'von Borstel', 'firstname': 'Anouk', 'initials': 'A', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.'}, {'lastname': \"O'Hehir\", 'firstname': 'Robyn E', 'initials': 'RE', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.\\nAllergy, Asthma and Clinical Immunology Service, Alfred Hospital, Melbourne, VIC 3004, Australia.'}, {'lastname': 'van Zelm', 'firstname': 'Menno C', 'initials': 'MC', 'affiliation': 'Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.\\nAllergy, Asthma and Clinical Immunology Service, Alfred Hospital, Melbourne, VIC 3004, Australia.\\nDepartment of Immunology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1126/scitranslmed.adl1202', 'xml': <Element 'PubmedArticle' at 0x10afc90d0>}\n",
      "{'pubmed_id': '38324365', 'title': 'Physical Activity Intervention for Urban Black Women With Asthma: Protocol for a Randomized Controlled Efficacy Study.', 'abstract': 'Black women experience a higher prevalence of poor asthma outcomes and physical inactivity than their White counterparts. Black women comprise a particularly vulnerable group of patients with asthma, with some of the highest rates of asthma in adults, high health care use (emergency department visits and hospitalizations), and the highest crude asthma mortality rate of all race or ethnicity groups. Despite recommendations to engage in regular physical activity, fewer than 15% of Black women meet the 2008 National Physical Activity Guidelines, the lowest of all racial subgroups of adults. Given the connection between physical inactivity and poor asthma outcomes, addressing physical activity among Black women with asthma is imperative.\\nThis 2-arm randomized controlled trial aims to (1) determine the efficacy of a lifestyle walking intervention on asthma control compared to an education (control) group over 24 weeks, (2) examine the maintenance effects of the lifestyle walking intervention on asthma control at 48 weeks, (3) explore the behavioral mediators (eg, self-efficacy, social support, self-regulation, and daily physical activity levels) and contextual moderators (eg, baseline asthma severity, neighborhood environment, comorbid conditions, and social determinants of health) that contribute to treatment responsiveness, and (4) assess the reach and implementation potential of the intervention.\\nThe proposed study (ACTION [A Lifestyle Physical Activity Intervention for Minority Women with Asthma]) delivers a 24-week lifestyle walking intervention designed for and by urban Black women with asthma. Participants (n=224) will be recruited through 2 urban health care systems that care for a diverse Black population. Patients will be randomized to one of two groups: (1) ACTION intervention (group sessions, physical activity self-monitoring-Fitbit, and text-based support for step goal setting) or (2) education control (an individual asthma education session and SMS text messages related to asthma education). Outcome assessments will take place at baseline, 12, 24, and 48 weeks. The primary outcome is a change in asthma control from baseline to week 24 as assessed by the asthma control questionnaire-6 (ACQ-6). Secondary outcomes include asthma-related quality of life, health care use, and asthma exacerbations and behavioral outcomes such as self-efficacy, self-regulation, social support, and physical activity.\\nThis study was funded by the National Institute of Minority Health Disparities in August 2022. We pilot-tested our recruitment and intervention procedures and began recruitment in April 2023, with the enrollment of our first participant in May 2023. The anticipated completion of the study is April 2027.\\nThis study will deliver a new approach to physical activity interventions in Black women with asthma and help to provide guidance for addressing physical activity within this subgroup. This study will also provide a potential framework for future studies in minoritized populations with other disease conditions associated with low levels of physical activity.\\nClinicalTrials.gov NCT05726487; https://clinicaltrials.gov/study/NCT05726487.\\nDERR1-10.2196/55700.', 'keywords': ['Black women', 'asthma', 'lifestyle', 'physical activity'], 'journal': 'JMIR research protocols', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Davis', 'firstname': 'Ellen', 'initials': 'E', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Townsend', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Cavalier', 'firstname': 'Aero', 'initials': 'A', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Chen', 'firstname': 'Yi-Fan', 'initials': 'YF', 'affiliation': 'Center for Research on Health Care Data Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.'}, {'lastname': 'Edwards-Hart', 'firstname': 'Dameka', 'initials': 'D', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Kitsiou', 'firstname': 'Spyros', 'initials': 'S', 'affiliation': 'Department of Biomedical and Health Information Sciences, University of Illinois Chicago, Chicago, IL, United States.'}, {'lastname': 'Kowalczyk', 'firstname': 'Wiktoria', 'initials': 'W', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Mansur', 'firstname': 'Iliana', 'initials': 'I', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Okpara', 'firstname': 'Ebere', 'initials': 'E', 'affiliation': 'Department of Pharmacy, Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, United States.'}, {'lastname': 'Powell', 'firstname': 'Karen', 'initials': 'K', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Press', 'firstname': 'Valerie G', 'initials': 'VG', 'affiliation': 'Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Ramirez', 'firstname': 'Toni', 'initials': 'T', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Salvo', 'firstname': 'Deborah', 'initials': 'D', 'affiliation': 'People, Health and Place Lab, Department of Kinesiology and Health Educations, University of Texas Austin, Austin, TX, United States.'}, {'lastname': 'Sharp', 'firstname': 'Lisa K', 'initials': 'LK', 'affiliation': 'Department of Biobehavioral Nursing Science, University of Illinois Chicago, Chicago, IL, United States.\\nOffice of Research Facilitation, College of Nursing, University of Illinois Chicago, Chicago, IL, United States.'}, {'lastname': 'Wright', 'firstname': 'Brittani', 'initials': 'B', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}, {'lastname': 'Nyenhuis', 'firstname': 'Sharmilee Maria', 'initials': 'SM', 'affiliation': 'Section of Allergy and Immunology, Department of Pediatrics, University of Chicago, Chicago, IL, United States.'}], 'methods': None, 'conclusions': None, 'results': 'This study was funded by the National Institute of Minority Health Disparities in August 2022. We pilot-tested our recruitment and intervention procedures and began recruitment in April 2023, with the enrollment of our first participant in May 2023. The anticipated completion of the study is April 2027.', 'copyrights': '©Ellen Davis, Elizabeth Townsend, Aero Cavalier, Yi-Fan Chen, Dameka Edwards-Hart, Spyros Kitsiou, Wiktoria Kowalczyk, Iliana Mansur, Ebere Okpara, Karen Powell, Valerie G Press, Toni Ramirez, Deborah Salvo, Lisa K Sharp, Brittani Wright, Sharmilee Maria Nyenhuis. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 07.02.2024.', 'doi': '10.2196/55700', 'xml': <Element 'PubmedArticle' at 0x10a648c20>}\n",
      "{'pubmed_id': '38324266', 'title': 'Keratoconus characteristics and associations: A cross-sectional keratoconus study in western India (CKSWI).', 'abstract': \"To study the clinical and tomographic characteristics and associations of keratoconus (KC) patients visiting a tertiary eye care hospital.\\nThis was a cross-sectional, observational study that included 242 newly diagnosed clinical KC patients. Detailed ocular and systemic history, visual complaints, habit of eye rubbing, best spectacle-corrected visual acuity (BSCVA), retinoscopy reflex, detailed slit-lamp examination and tomographic findings, and presence of any ocular and systemic associations were documented for the included patients. Severity of KC was further graded into stages 0, 1, 2, 3, and 4 according to the ABCD grading system.\\nThe most common visual complaint was blurred vision (82.64%), followed by itching (48.76%), tearing (43.80%), and photophobia (41.32%). A total of 44.62% of patients had the habit of eye rubbing and 4.54% had a family history of KC. Most common clinical signs were scissor reflex (94.21%), Rizutti's sign (77.27%), corneal protrusion (69.83%), and Fleischer ring (67.35%). A total of 14.05% of patients had stage 0, 42.15% had stage 1, 19.83% had stage 2, 18.60% had stage 3, and 5.37% had stage 4 KC. Of these patients, 70.25% had a BSCVA visual acuity of ≥6/12 or better; 26.45% had a BSCVA of ≥6/60 to <6/12; and 3.30% had a BSCVA of <6/60. Ocular allergies, atopy, and asthma were found in 32.32%, 4.96%, and 2.48% cases, respectively.\\nThis study gives an overview of the clinical findings of KC cases in western India. Our results suggest that use of retinoscopy should be promoted in early KC detection in primary eyecare screening programs.\", 'keywords': [], 'journal': 'Indian journal of ophthalmology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Shah', 'firstname': 'Zalak', 'initials': 'Z', 'affiliation': 'Department of Cornea and Refractive Surgery, Shree C.H. Nagri Eye Hospital, Ahmedabad, Gujarat, India.'}, {'lastname': 'Purohit', 'firstname': 'Dipali', 'initials': 'D', 'affiliation': None}, {'lastname': 'Danayak', 'firstname': 'Parul', 'initials': 'P', 'affiliation': None}], 'methods': None, 'conclusions': 'This study gives an overview of the clinical findings of KC cases in western India. Our results suggest that use of retinoscopy should be promoted in early KC detection in primary eyecare screening programs.', 'results': \"The most common visual complaint was blurred vision (82.64%), followed by itching (48.76%), tearing (43.80%), and photophobia (41.32%). A total of 44.62% of patients had the habit of eye rubbing and 4.54% had a family history of KC. Most common clinical signs were scissor reflex (94.21%), Rizutti's sign (77.27%), corneal protrusion (69.83%), and Fleischer ring (67.35%). A total of 14.05% of patients had stage 0, 42.15% had stage 1, 19.83% had stage 2, 18.60% had stage 3, and 5.37% had stage 4 KC. Of these patients, 70.25% had a BSCVA visual acuity of ≥6/12 or better; 26.45% had a BSCVA of ≥6/60 to <6/12; and 3.30% had a BSCVA of <6/60. Ocular allergies, atopy, and asthma were found in 32.32%, 4.96%, and 2.48% cases, respectively.\", 'copyrights': 'Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.', 'doi': '10.4103/IJO.IJO_1069_23', 'xml': <Element 'PubmedArticle' at 0x10a557bf0>}\n",
      "{'pubmed_id': '38324179\\n34755626\\n36284415\\n29047174\\n26836923\\n34983105\\n35686808\\n12704342\\n18678704\\n26647439\\n12688623\\n18565953\\n24990471\\n23912809\\n24410977\\n25228292\\n36435180\\n7800004\\n16109980\\n9105079\\n10470697\\n15521375\\n23534543\\n29093304\\n22507743\\n31770653\\n33139948\\n34919021\\n35964610\\n36800182\\n31606483\\n12688622\\n20167852\\n25335105\\n29628377\\n33338536\\n32221742\\n19485999\\n25772429\\n31561725\\n35604671\\n30351340\\n36253478\\n35610217\\n37184852\\n36063828\\n34695374\\n32509272\\n30153109\\n35531632\\n30629180\\n28321694', 'title': 'Advancing Understanding of Childhood Asthma: Lessons Learned from Birth Cohort Studies.', 'abstract': 'Asthma and allergies are some of the most common chronic disorders affecting children, the prevalence of which has been increasing in countries and regions undergoing rapid development like China. To curb the rising tide of allergies and safeguard the health of future generations, it is of critical importance to understand how asthma inception is influenced by factors acting at different life stages. Birth cohorts represent a powerful tool to investigate the temporal sequence of exposures along the natural course of asthma. We examined recent evidence on birth cohort studies of asthma and allergic diseases and evaluated their strengths and weaknesses. Essential elements for a successful birth cohort are proposed to further elucidate asthma etiology and pathogenies. Initiating new cohorts in understudied populations with the application of advanced analytical approaches will be needed. Moreover, fostering collaborative networks using standardized methodologies should be prioritized to enable integration of findings across diverse cohorts. There remains an urgent and unmet need to further translate the seminal findings from asthma birth cohort studies into targeted primary prevention strategies to eradicate the disease.', 'keywords': ['Allergy', 'Asthma', 'Birth cohort', 'Child', 'China', 'Rural'], 'journal': 'Clinical reviews in allergy & immunology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Xing', 'firstname': 'Yuhan', 'initials': 'Y', 'affiliation': \"School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, Guangdong, 518107, China.\\nDepartment of Paediatrics, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, SAR, China.\\nQingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.\"}, {'lastname': 'Yang', 'firstname': 'Xinmeng', 'initials': 'X', 'affiliation': \"Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.\"}, {'lastname': 'Li', 'firstname': 'Zhaoyinqian', 'initials': 'Z', 'affiliation': 'Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.\\nSichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, Sichuan, China.\\nMolecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou, Sichuan, China.'}, {'lastname': 'Zou', 'firstname': 'Qiyuan', 'initials': 'Q', 'affiliation': \"Department of Otorhinolaryngology, Children's Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.\"}, {'lastname': 'Yang', 'firstname': 'Ping', 'initials': 'P', 'affiliation': \"Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.\"}, {'lastname': 'Wang', 'firstname': 'Qinzheng', 'initials': 'Q', 'affiliation': \"Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.\"}, {'lastname': 'Ni', 'firstname': 'Wei', 'initials': 'W', 'affiliation': \"Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China.\"}, {'lastname': 'Wu', 'firstname': 'Dongze', 'initials': 'D', 'affiliation': \"Department of Rheumatology and Immunology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. dongze_wu@163.com.\"}, {'lastname': 'Li', 'firstname': 'Guoju', 'initials': 'G', 'affiliation': \"Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong, China. liguojuhaha@126.com.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.', 'doi': '10.1007/s12016-024-08979-3\\n10.1016/S0140-6736(21)01450-1\\n10.1111/pai.12819\\n10.1111/cea.12157\\n10.1016/j.chest.2015.12.028\\n10.4168/aair.2022.14.1.21\\n10.1093/biolre/ioac117\\n10.1067/mai.2003.162\\n10.1136/thx.2007.093187\\n10.1183/13993003.00718-2015\\n10.1034/j.1399-3038.13.s.15.8.x\\n10.1164/rccm.200802-309OC\\n10.1164/rccm.200401-083OC\\n10.1111/j.1398-9995.2006.01009.x\\n10.1186/1471-2466-14-109\\n10.1093/ije/dyt125\\n10.1186/1471-2458-14-25\\n10.1136/thoraxjnl-2014-206242\\n10.1016/S2352-4642(22)00304-2\\n10.1056/NEJM199501193320301\\n10.1164/rccm.200504-525OC\\n10.1164/ajrccm.155.4.9105079\\n10.1016/S0140-6736(98)10321-5\\n10.1016/S1081-1206(10)61398-1\\n10.1056/NEJMoa1211592\\n10.2188/jea.JE20170018\\n10.1530/eje.0.151u119\\n10.1093/ije/dys064\\n10.1016/j.jaip.2019.11.017\\n10.1038/s41591-020-1095-x\\n10.1164/rccm.202106-1458OC\\n10.1016/j.eclinm.2023.102193\\n10.1016/S0140-6736(22)01198-9\\n10.1001/jamanetworkopen.2023.0023\\n10.1016/j.jaci.2019.07.048\\n10.1034/j.1399-3038.13.s.15.3.x\\n10.1164/rccm.200907-1101OC\\n10.1371/journal.pmed.1001748\\n10.1016/S2213-2600(18)30099-7\\n10.1016/j.jaci.2020.12.621\\n10.1007/s10654-020-00625-4\\n10.1111/j.1365-2133.2009.09261.x\\n10.1111/cea.12527\\n10.1080/17476348.2019.1674650\\n10.1001/jamapediatrics.2022.1446\\n10.1093/aje/kwy242\\n10.1038/s41579-022-00807-9\\n10.1038/s41467-022-30485-3\\n10.1001/jamapediatrics.2023.1088\\n10.1016/S1473-3099(22)00525-4\\n10.1016/S2352-4642(21)00333-3\\n10.3389/fimmu.2021.635522\\n10.1186/s13601-020-00322-1\\n10.1172/JCI122631\\n10.1111/all.15365\\n10.1093/ije/dyy277\\n10.1007/s10654-017-0239-x', 'xml': <Element 'PubmedArticle' at 0x10a555c60>}\n",
      "{'pubmed_id': '38324166\\n19063722\\n23149009\\n29029810\\n26455383\\n24556465\\n36010011\\n23665448\\n24602991\\n31388368\\n24310425\\n25182208\\n25762871\\n29229165\\n30697127\\n31494124\\n23149008\\n23578464\\n26166537\\n15746175\\n24819219\\n22484195\\n26818726\\n26891067\\n24129691\\n25855822\\n36678693\\n36634740\\n26226994\\n28116597\\n24483293\\n30394120\\n31765781\\n33603372\\n33493595\\n37376032\\n27721363\\n30631973\\n30071163\\n33077422\\n33916177\\n37896191\\n28279798\\n31608247\\n36559211\\n36716829\\n35879774\\n36839720\\n29680280\\n26499787\\n26695118\\n24551871\\n27714111\\n32232249\\n34553138\\n25813361\\n32707641\\n26849919\\n31033278\\n28098869\\n32866648\\n37111790\\n32003260\\n22776312\\n32932883\\n30037052\\n29501533\\n37050422\\n29677547\\n32210127\\n33804945\\n32354008\\n30218826\\n35889665\\n26006328\\n32194337\\n27722570\\n35457065\\n25386740\\n19907498\\n28946131\\n15071282\\n19114080\\n25389920\\n37189732\\n25690563\\n27748397\\n33161717\\n35077821\\n29650952\\n27834398\\n36839827\\n35631634\\n30072070\\n27230809\\n24309662\\n35054340\\n35460714\\n32927897\\n36358663\\n25681012\\n28501783\\n29352211\\n33805713\\n32804378\\n16794434\\n22569231\\n25088498\\n29246314\\n30776396\\n31009525\\n32091275\\n33453276\\n34784412\\n32427264\\n34572797\\n34683974\\n24753077\\n29802930\\n31174440\\n32674353\\n37023798\\n29491149\\n33753915\\n31746243\\n28689966\\n34863336\\n28947517\\n36067920\\n35810338\\n31954465\\n36509311\\n25703483\\n34118406\\n20025460\\n21726640\\n36839138\\n26640367', 'title': 'State of the art in pediatric nanomedicines.', 'abstract': 'In recent years, the continuous development of innovative nanopharmaceuticals is expanding their biomedical and clinical applications. Nanomedicines are being revolutionized to circumvent the limitations of unbound therapeutic agents as well as overcome barriers posed by biological interfaces at the cellular, organ, system, and microenvironment levels. In many ways, the use of nanoconfigured delivery systems has eased challenges associated with patient differences, and in our opinion, this forms the foundation for their potential usefulness in developing innovative medicines and diagnostics for special patient populations. Here, we present a comprehensive review of nanomedicines specifically designed and evaluated for disease management in the pediatric population. Typically, the pediatric population has distinguishing needs relative to those of adults majorly because of their constantly growing bodies and age-related physiological changes, which often need specialized drug formulation interventions to provide desirable therapeutic effects and outcomes. Besides, child-centric drug carriers have unique delivery routes, dosing flexibility, organoleptic properties (e.g., taste, flavor), and caregiver requirements that are often not met by traditional formulations and can impact adherence to therapy. Engineering pediatric medicines as nanoconfigured structures can potentially resolve these limitations stemming from traditional drug carriers because of their unique capabilities. Consequently, researchers from different specialties relentlessly and creatively investigate the usefulness of nanomedicines for pediatric disease management as extensively captured in this compilation. Some examples of nanomedicines covered include nanoparticles, liposomes, and nanomicelles for cancer; solid lipid and lipid-based nanostructured carriers for hypertension; self-nanoemulsifying lipid-based systems and niosomes for infections; and nanocapsules for asthma pharmacotherapy.', 'keywords': ['Cancer therapy', 'Nanomedicines', 'Nanopharmaceuticals', 'Nanotechnology', 'Pediatric drug delivery', 'Polymeric nanocarriers'], 'journal': 'Drug delivery and translational research', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Abedin', 'firstname': 'Saba', 'initials': 'S', 'affiliation': 'College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS, B3H 4R2, Canada.'}, {'lastname': 'Adeleke', 'firstname': 'Oluwatoyin A', 'initials': 'OA', 'affiliation': 'College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS, B3H 4R2, Canada. oadeleke@dal.ca.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. Crown.', 'doi': '10.1007/s13346-024-01532-x\\n10.1186/1753-2000-2-37\\n10.1016/j.clinthera.2012.09.014\\n10.1016/j.jpeds.2017.08.048\\n10.1053/j.semperi.2015.08.006\\n10.1016/j.addr.2014.02.003\\n10.3390/children9081120\\n10.1016/j.ejpb.2013.04.015\\n10.1016/j.ijpharm.2014.02.046\\n10.1016/j.curtheres.2019.01.007\\n10.3390/pharmaceutics3010053\\n10.1208/s12248-014-9652-1\\n10.5863/1551-6776-19.4.262\\n10.1177/2168479019856572\\n10.1053/j.ackd.2017.09.011\\n10.5863/1551-6776-23.6.424\\n10.1016/j.addr.2019.08.008\\n10.1016/j.clinthera.2012.09.013\\n10.1021/mp200394t\\n10.1016/j.copbio.2013.02.020\\n10.1021/cr500314d\\n10.1096/fj.04-2747rev\\n10.1016/j.addr.2014.05.004\\n10.1016/j.jconrel.2012.03.020\\n10.1007/s40265-016-0538-7\\n10.1002/pbc.25937\\n10.1007/s40262-013-0106-1\\n10.1111/bcp.12268\\n10.3390/pharmaceutics15010064\\n10.1016/j.ejps.2023.106377\\n10.1016/j.pcl.2013.04.010\\n10.1159/000381372\\n10.1001/jamaoto.2019.3622\\n10.1208/s12249-016-0705-x\\n10.3109/03639045.2013.850713\\n10.1080/10717544.2018.1501119\\n10.1016/j.ijpharm.2019.118875\\n10.1016/j.msec.2020.111315\\n10.2147/IJN.S290466\\n10.1016/j.ijpharm.2021.120206\\n10.3390/pharmaceutics15061583\\n10.3390/pharmaceutics2040364\\n10.1208/s12249-018-1253-3\\n10.1021/acsnano.8b03684\\n10.1136/archdischild-2019-318676\\n10.3390/jcm10071437\\n10.3390/pharmaceutics15102431\\n10.1016/j.jconrel.2017.03.008\\n10.3746/pnf.2019.24.3.225\\n10.3390/pharmaceutics14122717\\n10.1016/j.ijpharm.2023.122656\\n10.3390/pr9040574\\n10.1186/s13036-022-00298-5\\n10.3390/pharmaceutics15020398\\n10.1016/j.ijpharm.2018.04.040\\n10.3390/fib11020021\\n10.1016/j.jddst.2019.03.038\\n10.1016/j.reactfunctpolym.2021.104895\\n10.1021/acs.jafc.5b03953\\n10.1016/j.biomaterials.2015.11.055\\n10.1039/C3CC42266F\\n10.1039/C3AN02098C\\n10.1039/C6NR05055G\\n10.1039/D0NR01647K\\n10.1016/j.smaim.2020.04.001\\n10.1517/17425247.2015.1018175\\n10.3390/nano10071403\\n10.1021/bm3008633\\n10.1016/j.jconrel.2016.02.001\\n10.1021/acsami.9b00152\\n10.4314/tjpr.v15i7.2\\n10.3892/or.2017.5365\\n10.1016/j.nano.2019.102115\\n10.1016/j.ijpharm.2020.119818\\n10.1166/sam.2021.4029\\n10.3390/pharmaceutics15041305\\n10.1080/13543776.2020.1720649\\n10.1016/j.addr.2012.07.002\\n10.3390/ph13090241\\n10.1016/j.jecm.2014.10.015\\n10.3390/app10113824\\n10.3390/cancers10070238\\n10.1016/j.jconrel.2018.02.034\\n10.1016/j.msec.2021.112261\\n10.3390/polym15071808\\n10.1016/j.biopha.2018.04.055\\n10.3390/pharmaceutics12030288\\n10.3390/pharmaceutics13040437\\n10.3390/nano10050847\\n10.1016/j.ijpharm.2018.09.023\\n10.3390/nano12142440\\n10.3109/03639045.2015.1044903\\n10.1016/j.jsps.2020.01.016\\n10.1039/C6CS00409A\\n10.3390/ijms23084249\\n10.1158/1538-7445.AM2023-6716\\n10.1016/j.jddst.2020.101581\\n10.3109/10717544.2014.980896\\n10.1038/gt.2009.148\\n10.1016/j.biomaterials.2017.09.020\\n10.1097/00006454-200404000-00005\\n10.1016/j.vaccine.2008.12.008\\n10.1097/INF.0000000000000616\\n10.3390/biomedicines11041114\\n10.1007/s00383-015-3683-2\\n10.1038/nri.2016.107\\n10.1021/acs.accounts.0c00518\\n10.1016/j.addr.2022.114115\\n10.1038/s41467-018-03705-y\\n10.1038/nrc.2016.108\\n10.3390/pharmaceutics15020505\\n10.20517/2394-4722.2015.95\\n10.3390/pharmaceutics14051048\\n10.1016/j.ncl.2018.04.009\\n10.1016/j.cppeds.2016.04.004\\n10.1038/nm.3407\\n10.3390/diagnostics12010173\\n10.1016/j.addr.2022.114303\\n10.3390/pharmaceutics12090863\\n10.3390/cancers14215244\\n10.1093/neuonc/nou264.42\\n10.1016/j.molonc.2015.01.006\\n10.1016/j.etap.2017.04.017\\n10.1038/s41598-017-18100-8\\n10.3390/cancers13061278\\n10.1007/s11060-020-03553-1\\n10.1097/01.icu.0000193079.55240.18\\n10.1016/S0140-6736(11)61137-9\\n10.1016/j.ijpharm.2012.04.056\\n10.1016/j.ijbiomac.2014.07.041\\n10.1039/C5RA14640B\\n10.1016/j.omtn.2017.10.012\\n10.1016/j.jconrel.2019.02.014\\n10.1021/acs.molpharmaceut.9b00797\\n10.1167/iovs.18-26251\\n10.1080/10717544.2020.1730522\\n10.1007/s13404-020-00279-w\\n10.1016/j.jddst.2020.102259\\n10.1016/j.cclet.2020.03.066\\n10.1016/j.exer.2020.108423\\n10.1167/iovs.62.14.13\\n10.1515/gps-2022-0011\\n10.1021/mp300350e\\n10.1039/D0TB00739K\\n10.3390/cancers13184570\\n10.3390/pharmaceutics13101681\\n10.4103/0971-5851.203513\\n10.1002/pbc.25062\\n10.2147/IJN.S78498\\n10.1016/j.canlet.2018.05.030\\n10.1080/21691401.2019.1622554\\n10.3390/cancers12071895\\n10.1016/j.jconrel.2023.04.001\\n10.1158/1535-7163.MCT-17-0738\\n10.1038/s41565-021-00866-8\\n10.1080/10717544.2019.1692968\\n10.5530/ijper.48.4s.12\\n10.1021/acs.molpharmaceut.7b00077\\n10.1016/j.ijpharm.2017.06.084\\n10.1016/S1473-3099(21)00090-6\\n10.2146/news170065\\n10.1016/j.colsurfb.2019.01.039\\n10.1016/j.ijpharm.2022.122163\\n10.1111/dth.15706\\n10.1016/S0140-6736(19)32989-7\\n10.1016/j.micpath.2022.105941\\n10.1016/j.cppeds.2014.12.001\\n10.1016/j.bbadis.2021.166198\\n10.2217/nnm.09.90\\n10.1016/j.ejps.2011.06.012\\n10.1016/j.colsurfb.2014.09.031\\n10.1038/s41598-022-18009-x\\n10.3390/nano13040770\\n10.2147/DDDT.S86075\\n10.1049/mna2.12078', 'xml': <Element 'PubmedArticle' at 0x10ae46f70>}\n",
      "{'pubmed_id': '38324025\\n11994699\\n30229939\\n28493631\\n16630937\\n27430124\\n36925995\\n30074245\\n14674933\\n27557093\\n31322838\\n33140209\\n34136960\\n32304832\\n23870670\\n31872476\\n36178453\\n24761804\\n22107266\\n33527068\\n28940458\\n32357199\\n32145088\\n28152201\\n29455358\\n1493741\\n24053706', 'title': '[Allergen-specific immunotherapy : A brief overview in association with allergic conjunctivitis].', 'abstract': 'Allergen-specific immunotherapy (AIT) is the only causal and disease-modifying treatment for immunoglobulin E (IgE)-mediated type\\xa0I allergies. Regular exposure to the causative allergen results in an immunomodulatory effect by which the predominant T‑helper (Th) 2 lymphocyte response is shifted to a\\xa0Th1 lymphocyte response and more allergen-specific blocking immunoglobulins are produced. The approval of substances for AIT is regulated by the Therapy Allergens Ordinance (TAV). There are subcutaneous and/or sublingual AITs for the following indications: allergic rhinitis, allergic conjunctivitis, allergic asthma and insect venom allergy. In this article the indications for allergic conjunctivitis are discussed in particular. Clinical symptoms and a relevant type 1 sensitization are the prerequisites for the indications for AIT. The assessment of the indications and carrying out an AIT should only be carried out by physicians who have been trained in allergology.\\nDie allergenspezifische Immuntherapie (AIT) ist die einzige kausale und krankheitsmodifizierende Therapie für eine Immunglobulin\\xa0E (IgE)-vermittelte Allergie vom Typ\\xa0I. Durch regelmäßige Exposition gegenüber dem Allergen kommt es zu einer immunmodulatorischen Wirkung, wobei sich die Gewichtung von Th2- zu Th1-Lymphozyten verschiebt und vermehrt allergenspezifisch blockierende Immunglobuline produziert werden. Die Zulassung der AIT ist über die Therapieallergene-Verordnung (TAV) geregelt. Es gibt subkutane und/oder sublinguale AITs für folgende Indikationen: Rhinitis allergica, Conjunctivitis allergica, allergisches Asthma und Insektengiftallergien. Im Folgenden soll insbesondere auf die Indikation der Conjunctivitis allergica eingegangen werden. Klinische Symptome und eine relevante Typ-1-Sensibilisierung sind die Voraussetzung zur Indikationsstellung einer AIT. Die Indikationsstellung und Durchführung einer AIT sollte nur durch allergologisch geschulte Ärzte gehandhabt werden.', 'keywords': ['Allergic conjunctivitis', 'Immunoglobulins', 'Subcutaneous immunotherapy', 'Sublingual Immunotherapy', 'Therapy Allergens Ordinance'], 'journal': 'Die Ophthalmologie', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Lill', 'firstname': 'Diana', 'initials': 'D', 'affiliation': 'Klinik und Poliklinik für Dermatologie und Allergologie, LMU Klinikum, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland. diana.lill@med.uni-muenchen.de.'}, {'lastname': 'Bertlich', 'firstname': 'Mattis', 'initials': 'M', 'affiliation': 'Klinik und Poliklinik für Dermatologie und Allergologie, LMU Klinikum, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.'}, {'lastname': 'Oppel', 'firstname': 'Eva', 'initials': 'E', 'affiliation': 'Klinik und Poliklinik für Dermatologie und Allergologie, LMU Klinikum, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.\\n© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.', 'doi': '10.1007/s00347-024-01987-w\\n10.1067/mai.2002.123868\\n10.1111/j.1600-0536.1995.tb00826.x\\n10.1111/all.13606\\n10.1111/all.13201\\n10.1016/j.jaci.2005.12.1358\\n10.1111/all.12986\\n10.5414/ALX02334E\\n10.1007/978-3-642-37203-2_44\\n10.1111/all.13583\\n10.1046/j.1398-9995.2003.00387.x\\n10.1289/EHP173\\n10.1002/alr.22343\\n10.1007/s00103-020-03224-6\\n10.1111/j.1600-0536.2008.01449.x\\n10.1007/164_2021_491\\n10.1016/j.jaip.2020.03.041\\n10.1016/j.jaci.2013.05.032\\n10.1111/all.14077\\n10.5414/ALX02331E\\n10.1111/all.12383\\n10.1111/j.1398-9995.2011.02736.x\\n10.1007/s40629-020-00158-y\\n10.1111/all.13317\\n10.5414/ALX02066E\\n10.1111/all.14264\\n10.1111/all.13138\\n10.1007/s12016-018-8678-z\\n10.1111/cod.12695\\n10.1111/j.1600-0536.1996.tb02157.x\\n10.1007/BF01201495\\n10.1111/j.1600-0536.1980.tb04956.x\\n10.1055/b-001-1075\\n10.12932/AP0276.31.3.2013', 'xml': <Element 'PubmedArticle' at 0x109641170>}\n",
      "{'pubmed_id': '38324020', 'title': 'Participant Perspectives on the Implementation of a School-Linked Text-Message Intervention to Improve Pediatric Asthma Medication Adherence.', 'abstract': '', 'keywords': ['daily inhaled corticosteroid', 'medication adherence', 'participant perspectives', 'pediatric asthma', 'qualitative study', 'text messaging'], 'journal': 'Pediatric allergy, immunology, and pulmonology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Radu', 'firstname': 'Sonia', 'initials': 'S', 'affiliation': 'Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Zarinafsar', 'firstname': 'Sheerin', 'initials': 'S', 'affiliation': 'Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Ryan', 'firstname': 'Grace W', 'initials': 'GW', 'affiliation': 'Department of Population and Quantitative Health Sciences, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Chainani', 'firstname': 'Sanjay', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Becker', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Arenas', 'firstname': 'Juliana', 'initials': 'J', 'affiliation': 'Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Spano', 'firstname': 'Michelle A', 'initials': 'MA', 'affiliation': 'Division of Pulmonary Medicine, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Shillan', 'firstname': 'Holly N', 'initials': 'HN', 'affiliation': 'Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Hoque', 'firstname': 'Shushmita', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Sadasivam', 'firstname': 'Rajani', 'initials': 'R', 'affiliation': 'Department of Population and Quantitative Health Sciences, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Pbert', 'firstname': 'Lori', 'initials': 'L', 'affiliation': 'Department of Population and Quantitative Health Sciences, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Luther', 'firstname': 'Janki', 'initials': 'J', 'affiliation': 'Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.'}, {'lastname': 'Trivedi', 'firstname': 'Michelle K', 'initials': 'MK', 'affiliation': 'Department of Population and Quantitative Health Sciences, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.\\nDivision of Pulmonary Medicine, Department of Pediatrics; University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1089/ped.2023.0093', 'xml': <Element 'PubmedArticle' at 0x12522a7f0>}\n",
      "{'pubmed_id': '38323583', 'title': \"Digitally monitored inhaled therapy: a 'smart' way to manage severe asthma?\", 'abstract': \"One of the fundamental challenges of managing patients with severe asthma is treatment adherence, particularly with inhaled corticosteroids. Adherence is difficult to measure objectively and poor adherence is associated with worse outcomes. In this study, assess the ability of a 'smart' inhaler to record adherence in severe asthma patients and measure the impact of this on asthma control.\\nConsecutive consenting patients meeting criteria for biologics had their existing high-dose ICS/LABA//LAMA combination inhaler/s switched to mometasone/indacaterol/glycopyrronium (114/46/136). Routine clinical data, including blood eosinophils, FeNO, and ACQ-6 scores were collected at baseline and at 4 wk. Adherence was then checked on the Propeller Health app, and good adherence was defined as >80% of prescribed usage. Participants were then followed-up at 12 months to record the proportion of patients who were initiated on biologics.\\n77 patients (mean [SD] age = 50.4 [15.7] years, 67.5% female [\\nIn severe asthma patients, 'smart' inhalers may represent an effective management tool to improve adherence and asthma control, therefore avoiding the need for patients to commence biological therapies.\", 'keywords': ['Severe asthma', 'adherence', 'biologics', 'digital inhalers'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Sykes', 'firstname': 'Dominic L', 'initials': 'DL', 'affiliation': 'Respiratory Research Group, Hull York Medical School, Heslington, UK.\\nDepartment of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'See', 'firstname': 'Yee Yong', 'initials': 'YY', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Chow', 'firstname': 'Evon C Y', 'initials': 'ECY', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Crooks', 'firstname': 'Michael G', 'initials': 'MG', 'affiliation': 'Respiratory Research Group, Hull York Medical School, Heslington, UK.\\nDepartment of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Cummings', 'firstname': 'Helena', 'initials': 'H', 'affiliation': None}, {'lastname': 'Robinson', 'firstname': 'Mandy', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Watkins', 'firstname': 'Karen', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Thompson', 'firstname': 'Joanne', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Overton', 'firstname': 'Kylie', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Riches', 'firstname': 'Charlotte', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}, {'lastname': 'Faruqi', 'firstname': 'Shoaib', 'initials': 'S', 'affiliation': 'Respiratory Research Group, Hull York Medical School, Heslington, UK.\\nDepartment of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.'}], 'methods': None, 'conclusions': None, 'results': '77 patients (mean [SD] age = 50.4 [15.7] years, 67.5% female [', 'copyrights': None, 'doi': '10.1080/02770903.2024.2316726', 'xml': <Element 'PubmedArticle' at 0x125229940>}\n",
      "{'pubmed_id': '38323080\\n32026321\\n30407870\\n37815512\\n2932206\\n33535947\\n33840664\\n37121836\\n37210478\\n36453488\\n35444229\\n31929748\\n34788645\\n24219649\\n36290632\\n31491856\\n16556829\\n20513363\\n36364419\\n35910833\\n16880611\\n15744067\\n24171123\\n30974789\\n33253723\\n33901505\\n36176437\\n23137229\\n25465157\\n38085145\\n34690775\\n24355989\\n16307531\\n28470492\\n16372370\\n32417945\\n16873091\\n34603023\\n36199748\\n31958042\\n36355478\\n37726740\\n26983922\\n34641516\\n22610955\\n9225016\\n25102700\\n23427382\\n22462235\\n27589723\\n23525378\\n37944128\\n36818226\\n30391934\\n32114166\\n27121788\\n26524530\\n32510292\\n32650361\\n18670089\\n30759852\\n25953414\\n15264931\\n33924691\\n21756879\\n37364767\\n29877221\\n30873032\\n26781971\\n26709398\\n30234391\\n11176200\\n27886047\\n30897962\\n29336667\\n35055679\\n33645417\\n30698299\\n33448586\\n25219371\\n26759703\\n26971222\\n35247474\\n37422064\\n33513419\\n20561578\\n32417539\\n35681261\\n27832784\\n29307806\\n32161620\\n32834949\\n33359859\\n35398527\\n25136960\\n25333694\\n26827990\\n34536497\\n31298931\\n12667714\\n32825684\\n35031549\\n18492200\\n36411666\\n36615224\\n31583572\\n32929653\\n31649801\\n32778045\\n34729825\\n35631501\\n35874507\\n16127745\\n25561311\\n36958449\\n20837053\\n23616768\\n30654461\\n26191238\\n36111155\\n31071388\\n37630253\\n34899298\\n28895235\\n31132979\\n35630410\\n26745662\\n36212969\\n29125745\\n35783542\\n35592420\\n35413752\\n35506447\\n34428767\\n32823544\\n33115605\\n20089734\\n25766850\\n26719286\\n25207888\\n25339684\\n16415925\\n31292346\\n30319721\\n37028248\\n32793232\\n30597306\\n37954597\\n29644368\\n34025163\\n32380052\\n27785705\\n27262314\\n22594386\\n35204757\\n29572095\\n34064238\\n33841537\\n25987423\\n26431391\\n36178164\\n37275574\\n32593755\\n34908920\\n30701599\\n36806484\\n33023823\\n32224371\\n34776986\\n28867779\\n17359643\\n19330262\\n34281588\\n32963548\\n21115094\\n36768866\\n34799332\\n36457260\\n35259588\\n35247668\\n21896302\\n29129515\\n35836256\\n35994817\\n36826439\\n35023915\\n25473183\\n24751072\\n33013397', 'title': '', 'abstract': '', 'keywords': ['Armeniacae semen amarum', 'Prunus armeniaca L.', 'clinical application', 'ethnopharmacology', 'pharmacology', 'phytochemistry', 'toxicology', 'traditional Chinese medicine'], 'journal': 'Frontiers in pharmacology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Tang', 'firstname': 'Shun', 'initials': 'S', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Wang', 'firstname': 'Minmin', 'initials': 'M', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Peng', 'firstname': 'Yuhui', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Liang', 'firstname': 'Yuanjing', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Lei', 'firstname': 'Jiarong', 'initials': 'J', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Tao', 'firstname': 'Qiu', 'initials': 'Q', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Ming', 'firstname': 'Tianqi', 'initials': 'T', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Shen', 'firstname': 'Yanqiao', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Zhang', 'firstname': 'Chuantao', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Guo', 'firstname': 'Jinlin', 'initials': 'J', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, School of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}, {'lastname': 'Xu', 'firstname': 'Haibo', 'initials': 'H', 'affiliation': 'State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Tang, Wang, Peng, Liang, Lei, Tao, Ming, Shen, Zhang, Guo and Xu.', 'doi': '10.3389/fphar.2024.1290888\\n10.1007/s11033-020-05286-w\\n10.1080/01635581.2018.1508731\\n10.17219/dmp/132387\\n10.1139/y85-177\\n10.2174/1389201022666210203123803\\n10.5650/jos.ess20294\\n10.1016/j.explore.2023.04.005\\n10.1186/s12906-023-03986-x\\n10.2174/1389201024666221130163116\\n10.1038/s41598-022-10517-0\\n10.7150/ijbs.39024\\n10.1016/j.jep.2021.114838\\n10.3109/00365513.2013.831470\\n10.3390/antiox11101912\\n10.3390/nu11092107\\n10.1126/science.1125884\\n10.1016/j.brainres.2010.05.072\\n10.3390/molecules27217591\\n10.1155/2022/6873874\\n10.1248/bpb.29.1597\\n10.1248/bpb.28.449\\n10.1155/2013/610648\\n10.3390/antiox8040095\\n10.1016/j.lfs.2020.118835\\n10.1016/j.pharmthera.2021.107868\\n10.3389/fphar.2022.958022\\n10.16438/j.0513-4870.2022-0581\\n10.13288/j.11-2166/r.2023.02.011\\n10.3109/08923973.2012.738688\\n10.1016/j.jnutbio.2014.09.012\\n10.18502/ijaai.v22i5.13993\\n10.3389/fphar.2021.738689\\n10.1038/nrm3722\\n10.2174/138955705774575273\\n10.1007/s11695-017-2704-8\\n10.1002/ptr.1786\\n10.1007/s00394-020-02270-9\\n10.1080/08923970600815253\\n10.3389/fphar.2021.708636\\n10.1155/2022/1473922\\n10.2174/1871520620666200120095525\\n10.3390/ph15111306\\n10.1186/s12906-023-04142-1\\n10.1007/s00125-016-3912-9\\n10.3390/molecules26195972\\n10.1007/s11655-012-1090-2\\n10.1016/s0278-6915(97)00026-4\\n10.1016/s0254-6272(14)60063-7\\n10.1016/s0254-6272(13)60064-3\\n10.1016/s0254-6272(12)60008-9\\n10.3390/ijms17091421\\n10.3892/mmr.2013.1391\\n10.1139/apnm-2023-0135\\n10.1155/2023/1928310\\n10.1515/jcim-2018-0101\\n10.1016/j.jep.2020.112717\\n10.1002/cpdd.20\\n10.1038/nature15756\\n10.2174/1871520620666200608124003\\n10.3390/foods9070896\\n10.1248/bpb.31.1559\\n10.3390/molecules24030650\\n10.1007/s12199-015-0462-6\\n10.1021/jf040048m\\n10.3390/molecules26082253\\n10.1016/j.bbrc.2011.06.162\\n10.1016/j.pupt.2023.102230\\n10.5650/jos.ess17212\\n10.3389/fphar.2019.00161\\n10.3892/ijmm.2016.2454\\n10.3892/ijmm.2015.2439\\n10.1080/10520295.2018.1511064\\n10.1097/00041433-200102000-00006\\n10.3390/nu8110750\\n10.1177/1932296819841698\\n10.1080/03601234.2017.1421841\\n10.3390/ijerph19020857\\n10.1080/03601234.2021.1890513\\n10.1111/jpn.13055\\n10.1002/tox.23094\\n10.1002/ptr.5219\\n10.4062/biomolther.2015.172\\n10.1016/j.intimp.2016.02.019\\n10.1016/j.jep.2022.115157\\n10.1016/j.exer.2023.109569\\n10.1016/j.jep.2021.113854\\n10.1016/j.jep.2010.06.006\\n10.1016/j.ijbiomac.2020.05.070\\n10.1142/S0192415X22500586\\n10.1186/s12906-016-1440-2\\n10.1016/j.ijbiomac.2018.01.010\\n10.1186/s11658-020-00205-0\\n10.1016/j.apsb.2020.05.007\\n10.1016/j.jep.2020.113745\\n10.1016/j.fsi.2022.03.048\\n10.1371/journal.pone.0105590\\n10.1371/journal.pone.0110244\\n10.1016/j.lfs.2016.01.039\\n10.1016/j.lfs.2021.119961\\n10.1080/01635581.2019.1637442\\n10.1016/s0302-2838(03)00055-1\\n10.3390/molecules25173809\\n10.1158/2159-8290.CD-21-0808\\n10.1111/j.1467-2494.2006.00297.x\\n10.1016/j.biopha.2022.113956\\n10.3390/molecules28010030\\n10.1007/s11033-019-05080-3\\n10.1007/s11033-020-05782-z\\n10.18502/ijhoscr.v13i3.1269\\n10.2174/1874467213666200810141251\\n10.3390/horticulturae7120523\\n10.1002/ptr.7312\\n10.3390/pharmaceutics14050916\\n10.1007/s43188-021-00115-z\\n10.3748/wjg.v11.i33.5156\\n10.1007/s13402-014-0216-2\\n10.1016/j.ijbiomac.2023.124109\\n10.1016/j.mam.2010.09.002\\n10.3389/fphar.2013.00046\\n10.3390/ijms20020351\\n10.3389/fphys.2022.931931\\n10.1016/j.fct.2019.05.007\\n10.3390/molecules28166002\\n10.3389/fphar.2021.744624\\n10.1002/pca.2723\\n10.2174/1871520619666190528091648\\n10.3390/microorganisms10050966\\n10.1080/14786419.2015.1135146\\n10.1155/2022/3697522\\n10.1021/acs.jafc.7b03408\\n10.1016/j.imr.2022.100869\\n10.3389/fphar.2022.599979\\n10.1016/j.foodchem.2022.132531\\n10.1080/10717544.2022.2069883\\n10.1159/000514209\\n10.3390/antiox9080743\\n10.1016/j.lfs.2020.118632\\n10.3945/ajcn.2008.26285\\n10.1016/j.jpba.2015.02.004\\n10.1016/j.jep.2015.12.019\\n10.4103/0973-1482.139743\\n10.1194/jlr.R055095\\n10.1038/nrmicro1320\\n10.5650/jos.ess19121\\n10.1155/2018/8491487\\n10.1016/j.phymed.2023.154792\\n10.3389/fimmu.2020.01598\\n10.1016/j.biopha.2018.12.096\\n10.3389/fimmu.2023.1285550\\n10.1039/c8fo00044a\\n10.1016/j.sjbs.2021.02.015\\n10.1016/j.phrs.2020.104881\\n10.1007/s11011-016-9922-y\\n10.1007/s11745-016-4166-5\\n10.1111/j.1365-2702.2012.04087.x\\n10.3390/biom12020256\\n10.1016/j.jhep.2018.03.011\\n10.3390/ijms22115452\\n10.22037/ijpr.2019.15514.13139\\n10.1016/j.ejphar.2015.03.096\\n10.1021/acs.jafc.5b03120\\n10.3724/abbs.2022136\\n10.1155/2023/7982927\\n10.1016/j.ijbiomac.2020.06.220\\n10.29219/fnr.v65.5623\\n10.1002/ptr.6274\\n10.1016/j.jep.2023.116265\\n10.1016/j.hpb.2020.09.014\\n10.1016/j.biopha.2020.110104\\n10.3389/fphar.2021.775506\\n10.3390/molecules22091425\\n10.13422/j.cnki.syfjx.20211958\\n10.1179/016164107X172248\\n10.1590/s0100-879x2009000400006\\n10.1186/s12967-021-02985-1\\n10.1155/2020/8811963\\n10.1016/j.fct.2010.11.035\\n10.3390/ijms24032542\\n10.19787/j.issn.1008-1879.2021.04.034\\n10.1016/j.cbi.2022.110235\\n10.1016/j.bbrc.2022.03.011\\n10.1016/j.phymed.2022.154018\\n10.1016/j.fct.2011.08.015\\n10.1016/j.jcma.2017.09.005\\n10.1186/s12943-022-01616-7\\n10.1016/j.biopha.2022.113559\\n10.1021/acs.jafc.2c06775\\n10.2147/IJN.S338886\\n10.3748/wjg.v20.i43.16275\\n10.1016/j.carbpol.2012.05.073\\n10.3389/fphar.2020.560448', 'xml': <Element 'PubmedArticle' at 0x10aba2480>}\n",
      "{'pubmed_id': '38322263\\n23395245\\n18826625\\n21093719\\n33201109\\n28467535\\n32816314\\n33815887\\n22396895\\n35659691\\n22663935\\n19457449\\n19438806\\n29868017\\n29164242\\n27439390\\n27863252\\n35297226\\n34431594\\n32888494\\n36327882\\n35355607\\n27592340\\n34981430\\n37028607\\n24316038\\n18384431\\n31977298\\n35082127\\n26493938\\n12480423\\n29908859\\n32066563\\n27119508\\n11734464\\n34733292\\n32420963', 'title': 'Causal association between genetically predicted circulating immune cell counts and frailty: a two-sample Mendelian randomization study.', 'abstract': 'Despite the recognized link between immune responses and frailty, the association between immune cell counts and frailty based on previous observational studies remains disputed, with uncertain causal nexus. This study aimed to elucidate causal association between genetically predicted circulating immune cell counts and frailty.\\nWe conducted the two-sample Mendelian randomization (MR) study with independent genetic variants associated with six immune cell subtype counts from genome-wide association studies in 563,946 European individuals. Frailty summary data, assessed via frailty index (FI), was obtained from study comprising 175,226 subjects. Univariate MR, reverse MR and multivariate MR were conducted to comprehensive investigate the association between immune cell counts and FI, with two-step MR analysis for mediation analysis.\\nUnivariate MR evidence indicated that among six leukocyte subtype counts, only elevated eosinophil count was significantly correlated with higher FI (β = 0.059, 95% confidence interval [CI], 0.042-0.078, \\nWithin immune cell subtypes, MR evidence indicated only genetically predicted circulating eosinophil count had irreversible and independent causal effect on frailty, with asthma and rheumatoid arthritis possibly serving as partial mediators. The finding stressed the need for further exploring physiological functions of eosinophils in order to develop effective strategies against frailty.', 'keywords': ['Mendelian randomization', 'eosinophil count', 'frailty index', 'immune cell', 'inflammation'], 'journal': 'Frontiers in immunology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Guo', 'firstname': 'Xiao-Guang', 'initials': 'XG', 'affiliation': 'Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Ya-Juan', 'initials': 'YJ', 'affiliation': 'Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Lu', 'firstname': 'Ya-Xin', 'initials': 'YX', 'affiliation': 'Big Data and Artificial Intelligence Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.'}, {'lastname': 'Lu', 'firstname': 'Jia-Mei', 'initials': 'JM', 'affiliation': 'Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Li', 'firstname': 'Hui-Xin', 'initials': 'HX', 'affiliation': 'Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Chen', 'firstname': 'Chao-Jin', 'initials': 'CJ', 'affiliation': 'Big Data and Artificial Intelligence Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.\\nDepartment of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.'}, {'lastname': 'Yang', 'firstname': 'Jian-Jun', 'initials': 'JJ', 'affiliation': 'Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}], 'methods': None, 'conclusions': None, 'results': 'Univariate MR evidence indicated that among six leukocyte subtype counts, only elevated eosinophil count was significantly correlated with higher FI (β = 0.059, 95% confidence interval [CI], 0.042-0.078, ', 'copyrights': 'Copyright © 2024 Guo, Zhang, Lu, Lu, Zhang, Li, Chen and Yang.', 'doi': '10.3389/fimmu.2024.1336498\\n10.1016/s0140-6736(12)62167-9\\n10.1186/1471-2318-8-24\\n10.1016/j.cger.2010.08.008\\n10.1097/sla.0000000000004421\\n10.1001/jamasurg.2017.1025\\n10.1111/jgs.16788\\n10.14336/ad.2020.0904\\n10.1186/s12979-022-00280-1\\n10.1016/j.mad.2012.05.005\\n10.1016/j.exger.2009.05.005\\n10.1111/j.1582-4934.2009.00733.x\\n10.3389/fimmu.2018.01056\\n10.1001/jama.2017.17219\\n10.1093/hmg/ddw197\\n10.1016/j.cell.2016.10.042\\n10.1002/jcsm.12971\\n10.1111/acel.13459\\n10.1016/j.cell.2020.08.008\\n10.1016/j.compbiomed.2022.106187\\n10.3389/fmed.2022.830754\\n10.1016/j.arr.2016.08.006\\n10.1007/s40520-021-02022-7\\n10.1016/j.exger.2023.112163\\n10.1016/j.exger.2013.11.019\\n10.1111/j.1365-2222.2008.02958.x\\n10.1146/annurev-pathmechdis-012419-032756\\n10.1183/16000617.0150-2021\\n10.1016/S2213-2600(15)00367-7\\n10.1016/s0140-6736(02)11679-5\\n10.1016/s2468-2667(18)30091-4\\n10.1136/bmjresp-2019-000526\\n10.18632/oncotarget.8939\\n10.1164/ajrccm.164.supplement_2.2106061\\n10.3389/fimmu.2021.764825\\n10.23750/abm.v91i2.9094', 'xml': <Element 'PubmedArticle' at 0x10b3aa610>}\n",
      "{'pubmed_id': '38322159\\n31281551\\n32789115\\n32471129\\n29880157\\n31759647\\n31417289\\n30899604\\n35580240\\n26765082\\n29094016\\n25093023\\n21105916\\n31190900\\n35136540', 'title': 'Pulmonary Function Tests in Thunderstorm-associated Respiratory Symptoms: A Cross-sectional Study.', 'abstract': 'Epidemic thunderstorm asthma is an observed increase in cases of acute bronchospasm following thunderstorms. This study aimed to compare the frequency of obstructive airway disease or bronchial hyperresponsiveness in subjects with thunderstorm-associated respiratory symptoms with subjects with similar symptoms presented at other times.\\nA cross-sectional study from June to November of 2013 was conducted on subjects with thunderstorm-associated respiratory symptoms living in Ahvaz City, Iran. Thunderstorm-associated subjects were presented with asthmatic symptoms in thunderstorms, and other patients presented with similar symptoms at other times. Baseline spirometry was performed on patients to examine the presence of obstructive airway disease. In all patients with normal spirometry, a provocation test was applied. A comparison of qualitative and quantitative variables was made using the Chi-square and independent \\nOut of 584 subjects, 300 and 284 participants were in thunderstorm-associated and non-thunderstorm-associated groups, respectively. After the final analysis, 87 (30.6%) and 89 (33.3%) of the thunderstorm-associated subjects and non-thunderstorm-associated group, respectively, had pieces of evidence of airflow limitation (P=0.27). Among the patients with normal spirometry, 161 (81.72%) of the thunderstorm-associated patients and 100 (56.17%) patients of the non-thunderstorm-associated symptoms group had a positive methacholine challenge test result (P<0.001).\\nMost of the patients with thunderstorm-associated respiratory symptoms had no obvious evidence of airflow limitation in spirometry.', 'keywords': [' Asthma', ' Methacholine chloride', ' Respiratory function tests', ' Thunderstorm', ' spirometry'], 'journal': 'Iranian journal of medical sciences', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Haddadzadeh Shoushtari', 'firstname': 'Maryam', 'initials': 'M', 'affiliation': 'Air Pollution and Respiratory Diseases Research Center, Enviromental Technologies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.'}, {'lastname': 'Afrakhteh', 'firstname': 'Sakineh', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.'}, {'lastname': 'Borsi', 'firstname': 'Seyed Hamid', 'initials': 'SH', 'affiliation': 'Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\\nChronic Respiratory Diseases Research Center, Shahid Beheshti University of Medical Sciences,Tehran, Iran.'}, {'lastname': 'Raji', 'firstname': 'Hanieh', 'initials': 'H', 'affiliation': 'Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.'}, {'lastname': 'Idani', 'firstname': 'Esmail', 'initials': 'E', 'affiliation': 'Chronic Respiratory Diseases Research Center, Shahid Beheshti University of Medical Sciences,Tehran, Iran.'}], 'methods': None, 'conclusions': 'Most of the patients with thunderstorm-associated respiratory symptoms had no obvious evidence of airflow limitation in spirometry.', 'results': 'Out of 584 subjects, 300 and 284 participants were in thunderstorm-associated and non-thunderstorm-associated groups, respectively. After the final analysis, 87 (30.6%) and 89 (33.3%) of the thunderstorm-associated subjects and non-thunderstorm-associated group, respectively, had pieces of evidence of airflow limitation (P=0.27). Among the patients with normal spirometry, 161 (81.72%) of the thunderstorm-associated patients and 100 (56.17%) patients of the non-thunderstorm-associated symptoms group had a positive methacholine challenge test result (P<0.001).', 'copyrights': 'Copyright: © Iranian Journal of Medical Sciences.', 'doi': '10.30476/ijms.2023.96337.2784\\n10.1155/2019/3435103\\n10.5415/apallergy.2020.10.e30\\n10.3390/ijerph17113796\\n10.1016/S2542-5196(18)30120-7\\n10.1016/j.envres.2019.108911\\n10.2147/JAA.S193211\\n10.1097/EDE.0000000000001506\\n10.1111/cea.12709\\n10.5415/apallergy.2017.7.4.193\\n10.1155/2014/504017\\n10.1111/j.1365-2222.2010.03627.x\\n10.2147/JAA.S175155\\n10.1002/clt2.12116', 'xml': <Element 'PubmedArticle' at 0x10a52ade0>}\n",
      "{'pubmed_id': '38321896', 'title': 'Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus: A Comprehensive Review.', 'abstract': 'Coleus amboinicus Benth., also known as Plectranthus amboinicus (Lour.) Spreng., is a perennial plant from the Lamiaceae family commonly found in tropical and warm regions of Africa, Asia, and Australia. Folk medicine commonly employs this remedy to address various ailments, including but not limited to asthma, headaches, skin disorders, coughs, constipation, colds, and fevers. Several phytoconstituents from various phytochemical classes, such as phenolics, terpenoids, phenolic acids, flavonoids, flavones, and tannins, have been identified in Coleus amboinicus up to the present time. Numerous pharmacological properties of Coleus amboinicus crude extracts have been documented through both in vitro and in vivo studies, including but not limited to antitumor, antibacterial, antifungal, antiprotozoal, anti-inflammatory, antioxidant, antidiabetic, wound healing, analgesic, antirheumatic, and various other therapeutic effects. Due to its extensive history of traditional usage, the diverse array of bioactive phytochemicals, and numerous established pharmacological activities, Coleus amboinicus is widely regarded as having significant potential for clinical applications and warrants further exploration, development, and exploitation through research. With this context, the present study gathers information on the occurrence, biological description, cultivation, and nutritional values of Coleus amboinicus. Furthermore, it thoroughly discusses various phytoconstituents, along with their classes, present in Coleus amboinicus, followed by detailed descriptions of their pharmacological activities based on recent literature.', 'keywords': ['Bioactive compounds', 'Coleus ambionicus', 'Plectranthus ambionicus.', 'biomedical applications', 'pharmacological activity', 'phytochemicals'], 'journal': 'Current pharmaceutical design', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Paul', 'firstname': 'Karthika', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSSAHER), Mysuru 570015, Karnataka, India.'}, {'lastname': 'Gowda', 'firstname': 'B H Jaswanth', 'initials': 'BHJ', 'affiliation': 'Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore 575018, Karnataka, India.'}, {'lastname': 'Hani', 'firstname': 'Umme', 'initials': 'U', 'affiliation': 'Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.'}, {'lastname': 'Chandan', 'firstname': 'R S', 'initials': 'RS', 'affiliation': 'Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research (JSSAHER), Mysuru 570015, Karnataka, India.'}, {'lastname': 'Mohanto', 'firstname': 'Sourav', 'initials': 'S', 'affiliation': 'Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore 575018, Karnataka, India.'}, {'lastname': 'Ahmed', 'firstname': 'Mohammed Gulzar', 'initials': 'MG', 'affiliation': 'Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore 575018, Karnataka, India.'}, {'lastname': 'Ashique', 'firstname': 'Sumel', 'initials': 'S', 'affiliation': 'Department of Pharmaceutics, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut 250103, India.\\nDepartment of Pharmaceutics, Pandaveswar School of Pharmacy, Pandaveswar, West Bengal 713346, India.'}, {'lastname': 'Kesharwani', 'firstname': 'Prashant', 'initials': 'P', 'affiliation': 'Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.\\nCenter for Global health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.', 'doi': '10.2174/0113816128283267240130062600', 'xml': <Element 'PubmedArticle' at 0x10a255e90>}\n",
      "{'pubmed_id': '38321724', 'title': 'B cell immune response to human bocaviruses.', 'abstract': 'Human bocaviruses (HBoVs) have been demonstrated in respiratory and gastrointestinal infections; however, the immune response to them has not been studied in detail. In this study, we investigated the B cell immune responses to HBoV1 and HBoV2, representing two different species of bocaviruses in humans.\\nWe analyzed the effects of stimulations with HBoV1 and 2 virus-like particles (VLPs) and of co-stimulation with HBoV1-rhinovirus (RV) on cells of the immune system by flow cytometry, transcriptomics, and luminometric immune assays.\\nHuman B cells, and particularly B regulatory cells (Breg cells), showed an increased immune response to HBoV1-VLPs stimulation. These immune responses were also supported by increased IL-1RA and PDL1 expressions in IL-10\\nThe findings demonstrate that in Breg cells, IL-10 signalling pathways, and anti-inflammatory activity are induced by HBoV1, which can explain the often mild nature of the disease. In addition, the immune regulatory response induced by HBoV1-VLPs may indicate a potential immunomodulatory role of HBoV1 on the immune system and may represent an immune regulatory strategy.', 'keywords': ['B cells', 'Breg cells', 'HBoV1', 'IL-10 signalling', 'PBMCs'], 'journal': 'Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Karaaslan', 'firstname': 'Cagatay', 'initials': 'C', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.\\nMolecular Biology Section, Biology Department, Faculty of Science, Hacettepe University, Ankara, Turkey.'}, {'lastname': 'Wirz', 'firstname': 'Oliver', 'initials': 'O', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Tan', 'firstname': 'Ge', 'initials': 'G', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Globinska', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Boonpiyathad', 'firstname': 'Tadech', 'initials': 'T', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Hedman', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'Department of Virology, University of Helsinki, Helsinki, Finland.\\nHelsinki University Hospital Diagnostics Center, Helsinki, Finland.'}, {'lastname': 'Vaselek', 'firstname': 'Slavica', 'initials': 'S', 'affiliation': 'Molecular Biology Section, Biology Department, Faculty of Science, Hacettepe University, Ankara, Turkey.'}, {'lastname': 'Venermo', 'firstname': 'Maria Söderlund', 'initials': 'MS', 'affiliation': 'Department of Virology, University of Helsinki, Helsinki, Finland.'}, {'lastname': 'Jartti', 'firstname': 'Tuomas', 'initials': 'T', 'affiliation': 'Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.\\nDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.\\nDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.'}, {'lastname': 'Akdis', 'firstname': 'Mubeccel', 'initials': 'M', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Akdis', 'firstname': 'Cezmi A', 'initials': 'CA', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}], 'methods': None, 'conclusions': None, 'results': 'Human B cells, and particularly B regulatory cells (Breg cells), showed an increased immune response to HBoV1-VLPs stimulation. These immune responses were also supported by increased IL-1RA and PDL1 expressions in IL-10', 'copyrights': '© 2024 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.', 'doi': '10.1111/cea.14453', 'xml': <Element 'PubmedArticle' at 0x10a7a09f0>}\n",
      "{'pubmed_id': '38321721', 'title': 'Association and Interacting Factors between Bronchial Asthma and Attention-deficit Hyperactivity Disorder in Children: Meta-analysis and Systematic Review.', 'abstract': 'This study aims to systematically assess the possible link between bronchial asthma usage and attention-deficit hyperactivity disorder (ADHD) in children.\\nPubMed, Web of Science, ScienceDirect, CNKI, Wanfang, and the China Biological Medicine Database (CBM) were searched for relevant articles published from database inception until September 28, 2023. The statistical analyses were conducted using Stata 15.1 software, followed by a quantitative meta-analysis to synthesize the results of the odds ratios (ORs) and their corresponding 95% confidence intervals (CIs).\\nA total of 10 articles involving 729,375 participants were included in the meta-analysis. The overall analysis revealed a statistically significant association between ADHD and an increased likelihood of having bronchial asthma, as indicated by a pooled odds ratio (OR) of 1.46 and a 95% confidence interval (CI) ranging from 1.41 to 1.51, p < 0.001, I2 = 58%. Potential associated factors linking bronchial asthma and ADHD in children include demographic characteristics, healthcare access, socioeconomic factors, comorbidities, genetic susceptibility, immune dysregulation, chronic conditions, growth and development factors, and parental/environmental influences.\\nThis systematic review and meta-analysis presents convincing evidence for a notable link between bronchial asthma and ADHD in children. The results indicate an increased likelihood of bronchial asthma among children with ADHD compared to those without the condition. Additionally, various potential factors can underlie the association between bronchial asthma and ADHD in children, necessitating further research to fully comprehend their complex relationship. These findings have implications for clinical practice, highlighting the need for an integrated approach in managing asthma and ADHD.', 'keywords': [], 'journal': 'Actas espanolas de psiquiatria', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Dai', 'firstname': 'Yongjun', 'initials': 'Y', 'affiliation': 'Department of Paediatrics, Taizhou Municipal Hospital, 318000 Taizhou, Zhejiang, China.'}, {'lastname': 'Jin', 'firstname': 'Ni', 'initials': 'N', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Taizhou Municipal Hospital, 318000 Taizhou, Zhejiang, China.'}], 'methods': None, 'conclusions': 'This systematic review and meta-analysis presents convincing evidence for a notable link between bronchial asthma and ADHD in children. The results indicate an increased likelihood of bronchial asthma among children with ADHD compared to those without the condition. Additionally, various potential factors can underlie the association between bronchial asthma and ADHD in children, necessitating further research to fully comprehend their complex relationship. These findings have implications for clinical practice, highlighting the need for an integrated approach in managing asthma and ADHD.', 'results': 'A total of 10 articles involving 729,375 participants were included in the meta-analysis. The overall analysis revealed a statistically significant association between ADHD and an increased likelihood of having bronchial asthma, as indicated by a pooled odds ratio (OR) of 1.46 and a 95% confidence interval (CI) ranging from 1.41 to 1.51, p < 0.001, I2 = 58%. Potential associated factors linking bronchial asthma and ADHD in children include demographic characteristics, healthcare access, socioeconomic factors, comorbidities, genetic susceptibility, immune dysregulation, chronic conditions, growth and development factors, and parental/environmental influences.', 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x109d71940>}\n",
      "{'pubmed_id': '38321056\\n15158105\\n20305665\\n24011069\\n26469046\\n24844435\\n24466575\\n30710128\\n33309881\\n29326244\\n32042148\\n34608325\\n35941237\\n33795885\\n22315431\\n33977059\\n33817342\\n37384125\\n27070301\\n17986332\\n23809719\\n31645456\\n34147113\\n24361078\\n22570474\\n9637917\\n28480128\\n31285633\\n37356124\\n34940991\\n27098692\\n33558455\\n16474400\\n21499295\\n35867738\\n36097007\\n31672443\\n33381084\\n34239138\\n27042948\\n27261415\\n26494024\\n27018516\\n30783985\\n23449738\\n12597903\\n34557875\\n8816495\\n24986625\\n31823765\\n33131627\\n31365802\\n31850335\\n36417917\\n36176957\\n29776328\\n26154647\\n34506722\\n22921639\\n34326208\\n33205064\\n12782044\\n32923591\\n31395660\\n37379837\\n32653805\\n35021064\\n30463916\\n15550249\\n36816991', 'title': 'AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation.', 'abstract': 'Gene therapies provide treatment options for many diseases, but the safe and long-term control of therapeutic transgene expression remains a primary issue for clinical applications. Here, we develop a muscone-induced transgene system packaged into adeno-associated virus (AAV) vectors (AAV', 'keywords': [], 'journal': 'Nature communications', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Wu', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.\\nInstitute of Medical Technology, Shanxi Medical University, Taiyuan, Shanxi Province, 030001, China.'}, {'lastname': 'Yu', 'firstname': 'Yuanhuan', 'initials': 'Y', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Wang', 'firstname': 'Meiyan', 'initials': 'M', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.\\nChongqing Key Laboratory of Precision Optics, Chongqing Institute of East China Normal University, Chongqing, 401120, China.'}, {'lastname': 'Dai', 'firstname': 'Di', 'initials': 'D', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Yin', 'firstname': 'Jianli', 'initials': 'J', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.\\nChongqing Key Laboratory of Precision Optics, Chongqing Institute of East China Normal University, Chongqing, 401120, China.'}, {'lastname': 'Liu', 'firstname': 'Wenjing', 'initials': 'W', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Kong', 'firstname': 'Deqiang', 'initials': 'D', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Tang', 'firstname': 'Shasha', 'initials': 'S', 'affiliation': 'Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Xincun Road 389, Shanghai, 200065, China.'}, {'lastname': 'Meng', 'firstname': 'Meiyao', 'initials': 'M', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Gao', 'firstname': 'Tian', 'initials': 'T', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Zhang', 'firstname': 'Yuanjin', 'initials': 'Y', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Zhou', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.\\nWuhu Hospital, Health Science Center, East China Normal University, Middle Jiuhua Road 263, Wuhu, Anhui, China.'}, {'lastname': 'Guan', 'firstname': 'Ningzi', 'initials': 'N', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China.'}, {'lastname': 'Zhao', 'firstname': 'Shangang', 'initials': 'S', 'affiliation': 'Division of Endocrinology, Department of Medicine, Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.'}, {'lastname': 'Ye', 'firstname': 'Haifeng', 'initials': 'H', 'affiliation': 'Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Biomedical Synthetic Biology Research Center, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Dongchuan Road 500, Shanghai, 200241, China. hfye@bio.ecnu.edu.cn.\\nChongqing Key Laboratory of Precision Optics, Chongqing Institute of East China Normal University, Chongqing, 401120, China. hfye@bio.ecnu.edu.cn.\\nWuhu Hospital, Health Science Center, East China Normal University, Middle Jiuhua Road 263, Wuhu, Anhui, China. hfye@bio.ecnu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s41467-024-45383-z\\n10.1016/j.phr.2004.04.005\\n10.1038/nrd3003\\n10.1016/j.cmet.2013.08.005\\n10.1038/nature15818\\n10.1016/j.febslet.2014.05.003\\n10.1016/j.cbpa.2013.10.006\\n10.1038/s41573-019-0012-9\\n10.1016/j.ymthe.2020.12.007\\n10.1126/science.aan4672\\n10.1038/s41576-019-0205-4\\n10.1038/s41587-021-01036-w\\n10.1038/s41589-022-01095-3\\n10.1038/s41593-021-00827-3\\n10.1073/pnas.1200797109\\n10.1002/advs.202004018\\n10.1093/synbio/ysaa024\\n10.1016/j.synbio.2023.06.002\\n10.1038/mtna.2016.23\\n10.1186/1472-6750-7-75\\n10.1016/j.mcna.2013.02.006\\n10.1126/scitranslmed.aav8826\\n10.1186/s13020-021-00457-8\\n10.1016/j.neuron.2013.10.021\\n10.1074/jbc.M112.345884\\n10.1016/S0960-9822(98)70271-4\\n10.1038/s41551-016-0005\\n10.1038/s41591-019-0501-8\\n10.1016/j.intimp.2023.110547\\n10.1002/hep.32299\\n10.1523/JNEUROSCI.3259-15.2016\\n10.1038/s41392-021-00487-6\\n10.1038/nm1358\\n10.1038/nrg2988\\n10.1073/pnas.2122618119\\n10.1038/s41467-022-32994-7\\n10.1016/j.metabol.2019.153994\\n10.3389/fendo.2020.601290\\n10.1038/s41591-021-01425-3\\n10.1002/hep.28591\\n10.1016/j.jhep.2016.05.005\\n10.1017/S0954422415000128\\n10.1038/mt.2016.62\\n10.1007/978-1-4939-9139-6_21\\n10.1165/rcmb.2012-0500OC\\n10.1016/S1525-0016(02)00050-3\\n10.12703/r/10-71\\n10.1128/MCB.16.10.5811\\n10.1007/978-1-4939-1016-8_24\\n10.1186/s12890-019-1001-9\\n10.1016/j.cnur.2020.06.015\\n10.1056/NEJMra1706910\\n10.3389/fbioe.2019.00380\\n10.3389/fnmol.2022.947490\\n10.1186/s11689-018-9234-0\\n10.5935/0101-2800.20150039\\n10.1016/j.cell.2021.08.028\\n10.1053/j.ajkd.2012.07.014\\n10.1126/science.abd2893\\n10.1016/j.xcrm.2020.100057\\n10.1016/S0003-2697(03)00166-0\\n10.1126/sciadv.abb1777\\n10.1074/jbc.RA118.007110\\n10.1016/j.cell.2023.05.041\\n10.1016/j.copbio.2020.06.004\\n10.1016/j.cell.2021.12.021\\n10.1126/scitranslmed.aat0344\\n10.1016/j.cell.2004.11.021\\n10.21769/BioProtoc.4600', 'xml': <Element 'PubmedArticle' at 0x10ba9d210>}\n",
      "{'pubmed_id': '38320720', 'title': 'Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control.', 'abstract': 'The long-term goal of asthma management is to achieve disease control, comprising the assessment of 2 main domains: (1) symptom control and (2) future risk of adverse outcomes. Decades of progress in asthma management have correlated with increasingly ambitious disease control targets. Moreover, the introduction of precision medicines, such as biologics, has further expanded the limits of what can be achieved in terms of disease control. It is now believed that clinical remission, a term rarely associated with asthma, may be an achievable treatment goal. An expert framework published in 2020 took the first step toward developing a commonly accepted definition of clinical remission in asthma. However, there remains a widespread discussion about the clinical parameters and thresholds that should be included in a standardized definition of clinical remission. This review aims to discuss on-treatment clinical remission as an aspirational outcome in asthma management, drawing on experiences from other chronic diseases where remission has long been a goal. We also highlight the integral role of shared decision-making between patients and health care professionals and the need for a common understanding of the individual patient journey to remission as foundational elements in reducing disease burden and improving outcomes for patients with asthma.', 'keywords': ['Asthma', 'Clinical remission', 'Exacerbations', 'Lung function', 'Patient journey', 'Symptom control', 'Treatment goal'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Busse', 'firstname': 'William W', 'initials': 'WW', 'affiliation': 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, University of Wisconsin, Madison, Wis.'}, {'lastname': 'Chupp', 'firstname': 'Geoffrey', 'initials': 'G', 'affiliation': 'Yale Center for Asthma and Airways Disease (YCAAD), Yale School of Medicine, New Haven, Conn.'}, {'lastname': 'Corbridge', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Medical Affairs, GSK, Durham, NC.'}, {'lastname': 'Stach-Klysh', 'firstname': 'Alexandra', 'initials': 'A', 'affiliation': 'Medical Affairs, GSK, Durham, NC.'}, {'lastname': 'Oppenheimer', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ. Electronic address: nallopp22@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.044', 'xml': <Element 'PubmedArticle' at 0x109cc99e0>}\n",
      "{'pubmed_id': '38320510', 'title': 'Living with Asthma in Low- and Middle-Income Countries in the Six WHO Regions.', 'abstract': 'Living with AsthmaAsthma is a highly prevalent disease. Although most people with asthma can be treated effectively with certain inhaled medicines, accessing affordable care near their homes is a challenge for many people in low- and middle-income countries. We present stories from six men, women, and children living with asthma in such countries.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 7), 'authors': [{'lastname': 'Mortimer', 'firstname': 'Kevin', 'initials': 'K', 'affiliation': 'Department of Paediatrics and Child Health, School of Clinical Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.\\nCambridge Africa, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.\\nLiverpool University Hospitals, NHS Foundation Trust, Liverpool, Liverpool, United Kingdom.'}, {'lastname': 'Kurtulus', 'firstname': 'Serif', 'initials': 'S', 'affiliation': 'Department of Chest Diseases, Faculty of Medicine, Harran University, Sanliurfa, Turkey.'}, {'lastname': 'Yorgancıoğlu', 'firstname': 'Arzu', 'initials': 'A', 'affiliation': 'Department of Pulmonology, Celal Bayar University, Manisa, Turkey.'}, {'lastname': 'Romero-Tapia', 'firstname': 'Sergio de Jesús', 'initials': 'SJ', 'affiliation': 'Health Sciences Academic Division, Juarez Autonomous University of Tabasco, Villahermosa, Tabasco, México.'}, {'lastname': 'Singh', 'firstname': 'Nishtha', 'initials': 'N', 'affiliation': 'Asthma Bhawan, Jaipur, India.'}, {'lastname': 'Ahmed', 'firstname': 'Rana', 'initials': 'R', 'affiliation': 'The Epidemiological Laboratory (Epi-Lab), Khartoum, Sudan.'}, {'lastname': 'Boladuadua', 'firstname': 'Sainimere', 'initials': 'S', 'affiliation': 'Department of Paediatrics: Child & Youth Health, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.'}, {'lastname': 'Masekela', 'firstname': 'Refiloe', 'initials': 'R', 'affiliation': 'Department of Paediatrics and Child Health, School of Clinical Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDpp2300292', 'xml': <Element 'PubmedArticle' at 0x109ccb600>}\n",
      "{'pubmed_id': '38320186', 'title': 'Race/Ethnicity and Clinical Prediction Algorithms for Childhood Asthma.', 'abstract': \"In 1985, the United States Department of Health and Human Services released the Report of the Secretary's Task Force on Black & Minority Health.\", 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Witonsky', 'firstname': 'Jonathan', 'initials': 'J', 'affiliation': 'Department of Pediatrics, University of California, San Francisco.'}, {'lastname': 'Burchard', 'firstname': 'Esteban González', 'initials': 'EG', 'affiliation': 'Departments of Medicine and Pharmacy, University of California, San Francisco.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDe2300187', 'xml': <Element 'PubmedArticle' at 0x10a5261b0>}\n",
      "{'pubmed_id': '38320185', 'title': 'Do Biologic Therapies Decrease Mucus Plugging in Asthma?', 'abstract': 'Asthma researchers have long recognized that abnormal mucus production and clearance play a role in the pathophysiology of asthma.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Krings', 'firstname': 'James G', 'initials': 'JG', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis.'}, {'lastname': 'Gierada', 'firstname': 'David S', 'initials': 'DS', 'affiliation': 'Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDe2300179', 'xml': <Element 'PubmedArticle' at 0x10ab465c0>}\n",
      "{'pubmed_id': '38320181', 'title': 'Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.', 'abstract': 'Tezepelumab and Mucus Plugs in Patients with AsthmaMucus plugs in airways of asthma patients are associated with airway obstruction and the activity of inflammatory cytokines. This article reports prespecified and post hoc analyses of the effect of tezepelumab treatment on mucus plugs identified by computed tomography imaging in patients with moderate-to-severe asthma. At baseline, mucus plug scores correlated positively with levels of inflammatory biomarkers and negatively with lung function measures. Patients treated with tezepelumab had resolution of more mucus plugs than patients taking placebo.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Nordenmark', 'firstname': 'Lars H', 'initials': 'LH', 'affiliation': 'Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Oslo.'}, {'lastname': 'Hellqvist', 'firstname': 'Åsa', 'initials': 'Å', 'affiliation': 'Biometrics, Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.'}, {'lastname': 'Emson', 'firstname': 'Claire', 'initials': 'C', 'affiliation': 'Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.'}, {'lastname': 'Diver', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.'}, {'lastname': 'Porsbjerg', 'firstname': 'Celeste', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Bispebjerg University Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Griffiths', 'firstname': 'Janet M', 'initials': 'JM', 'affiliation': 'Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.'}, {'lastname': 'Newell', 'firstname': 'John D', 'initials': 'JD', 'affiliation': 'Department of Radiology and Biomedical Engineering, University of Iowa, Iowa City.\\nVIDA Diagnostics, Coralville, IA.'}, {'lastname': 'Peterson', 'firstname': 'Samuel', 'initials': 'S', 'affiliation': 'VIDA Diagnostics, Coralville, IA.'}, {'lastname': 'Pawlikowska', 'firstname': 'Beata', 'initials': 'B', 'affiliation': 'Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland.'}, {'lastname': 'Parnes', 'firstname': 'Jane R', 'initials': 'JR', 'affiliation': 'Early Development, Amgen, Thousand Oaks, CA.'}, {'lastname': 'Megally', 'firstname': 'Ayman', 'initials': 'A', 'affiliation': 'Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.'}, {'lastname': 'Colice', 'firstname': 'Gene', 'initials': 'G', 'affiliation': 'Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD.'}, {'lastname': 'Brightling', 'firstname': 'Christopher E', 'initials': 'CE', 'affiliation': 'National Institute for Health and Care Research, Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDoa2300135', 'xml': <Element 'PubmedArticle' at 0x10ab47290>}\n",
      "{'pubmed_id': '38320177', 'title': 'Performance of the Pediatric Asthma Risk Score across Diverse Populations.', 'abstract': 'Performance of PARS across Diverse PopulationsThe methods to determine whether a toddler is likely to develop asthma by 5 to 10 years of age were developed and validated in homogenous populations. The Pediatric Asthma Risk Score was tested to determine whether this score was a reliable predictor in diverse populations, and it functioned well when tested with data from a broad range of backgrounds.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Biagini', 'firstname': 'Jocelyn M', 'initials': 'JM', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati.\"}, {'lastname': 'Martin', 'firstname': 'Lisa J', 'initials': 'LJ', 'affiliation': \"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati.\\nDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati.\"}, {'lastname': 'He', 'firstname': 'Hua', 'initials': 'H', 'affiliation': \"Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati.\"}, {'lastname': 'Bacharier', 'firstname': 'Leonard B', 'initials': 'LB', 'affiliation': 'Department of Pediatrics, Vanderbilt University Medical Center, Nashville.'}, {'lastname': 'Gebretsadik', 'firstname': 'Tebeb', 'initials': 'T', 'affiliation': 'Department of Biostatistics, Vanderbilt University Medical Center, Nashville.'}, {'lastname': 'Hartert', 'firstname': 'Tina V', 'initials': 'TV', 'affiliation': 'Department of Pediatrics, Vanderbilt University Medical Center, Nashville.'}, {'lastname': 'Jackson', 'firstname': 'Daniel J', 'initials': 'DJ', 'affiliation': 'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.'}, {'lastname': 'Kim', 'firstname': 'Haejin', 'initials': 'H', 'affiliation': 'Department of Internal Medicine, Henry Ford Health, Detroit.'}, {'lastname': 'Miller', 'firstname': 'Rachel L', 'initials': 'RL', 'affiliation': 'Department of Medicine, Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York.'}, {'lastname': 'Rivera-Spoljaric', 'firstname': 'Katherine', 'initials': 'K', 'affiliation': 'Department of Pediatrics, Washington University School of Medicine, St. Louis.'}, {'lastname': 'Schauberger', 'firstname': 'Eric M', 'initials': 'EM', 'affiliation': 'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.'}, {'lastname': 'Singh', 'firstname': 'Anne Marie', 'initials': 'AM', 'affiliation': 'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.'}, {'lastname': 'Visness', 'firstname': 'Cynthia M', 'initials': 'CM', 'affiliation': 'Rho, Inc., Federal Research Operations, Durham, NC.'}, {'lastname': 'Wegienka', 'firstname': 'Ganesa', 'initials': 'G', 'affiliation': 'Department of Public Health Sciences, Henry Ford Health System, Detroit.'}, {'lastname': 'Ownby', 'firstname': 'Dennis R', 'initials': 'DR', 'affiliation': 'Department of Public Health Sciences, Henry Ford Health System, Detroit.'}, {'lastname': 'Gold', 'firstname': 'Diane R', 'initials': 'DR', 'affiliation': \"The Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston.\\nDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston.\"}, {'lastname': 'Martinez', 'firstname': 'Fernando D', 'initials': 'FD', 'affiliation': 'Asthma and Airways Disease Research Center, Department of Pediatrics, College of Medicine, University of Arizona, Tucson.\\nDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, College of Medicine, University of Arizona, Tucson.'}, {'lastname': 'Johnson', 'firstname': 'Christine C', 'initials': 'CC', 'affiliation': 'Department of Public Health Sciences, Henry Ford Health System, Detroit.'}, {'lastname': 'Wright', 'firstname': 'Anne L', 'initials': 'AL', 'affiliation': 'Asthma and Airways Disease Research Center, Department of Pediatrics, College of Medicine, University of Arizona, Tucson.\\nDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, College of Medicine, University of Arizona, Tucson.'}, {'lastname': 'Gern', 'firstname': 'James E', 'initials': 'JE', 'affiliation': 'Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.'}, {'lastname': 'Khurana Hershey', 'firstname': 'Gurjit K', 'initials': 'GK', 'affiliation': \"Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati.\\nDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDoa2300026', 'xml': <Element 'PubmedArticle' at 0x10a2f0810>}\n",
      "{'pubmed_id': '38320129', 'title': 'Avapritinib versus Placebo in Indolent Systemic Mastocytosis.', 'abstract': 'Avapritinib in Indolent Systemic MastocytosisIn a randomized trial, patients with indolent systemic mastocytosis were treated with avapritinib or placebo along with supportive care. The trial primary end point was the change in mean total symptom scores at 24 weeks. Avapritinib-treated patients had a decrease in mean total symptom score of 15.6 points compared with 9.2 points in the placebo group.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Gotlib', 'firstname': 'Jason', 'initials': 'J', 'affiliation': 'Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.'}, {'lastname': 'Castells', 'firstname': 'Mariana', 'initials': 'M', 'affiliation': \"Department of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston.\"}, {'lastname': 'Elberink', 'firstname': 'Hanneke Oude', 'initials': 'HO', 'affiliation': 'Department of Allergology, University Medical Center, Groningen Research Institute Asthma and COPD, University of Groningen, Groningen, the Netherlands.'}, {'lastname': 'Siebenhaar', 'firstname': 'Frank', 'initials': 'F', 'affiliation': 'Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.\\nFraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin.'}, {'lastname': 'Hartmann', 'firstname': 'Karin', 'initials': 'K', 'affiliation': 'Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland.\\nDepartment of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.'}, {'lastname': 'Broesby-Olsen', 'firstname': 'Sigurd', 'initials': 'S', 'affiliation': 'Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.'}, {'lastname': 'George', 'firstname': 'Tracy I', 'initials': 'TI', 'affiliation': 'Associated Regional and University Pathologists, Inc. Laboratories, Department of Pathology, University of Utah School of Medicine, Salt Lake City.'}, {'lastname': 'Panse', 'firstname': 'Jens', 'initials': 'J', 'affiliation': 'Department of Oncology, Hematology, Hemostaseology, and Stem Cell Transplantation, University Hospital Aachen, Medical Faculty, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.\\nCenter for Integrated Oncology, Aachen, Bonn, Cologne, Düsseldorf (ABCD), Aachen, Germany.'}, {'lastname': 'Alvarez-Twose', 'firstname': 'Iván', 'initials': 'I', 'affiliation': 'Institute of Mastocytosis Studies of Castilla-La Mancha, Virgen del Valle Hospital, Toledo, Spain.'}, {'lastname': 'Radia', 'firstname': 'Deepti H', 'initials': 'DH', 'affiliation': \"Guy's & St. Thomas' National Health Service Foundation Trust, London.\"}, {'lastname': 'Tashi', 'firstname': 'Tsewang', 'initials': 'T', 'affiliation': 'Huntsman Cancer Institute, University of Utah, Salt Lake City.'}, {'lastname': 'Bulai Livideanu', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Department of Dermatology, Centre of Reference for Mastocytosis, Toulouse University Hospital, Toulouse, France.'}, {'lastname': 'Sabato', 'firstname': 'Vito', 'initials': 'V', 'affiliation': 'Department of Immunology, Allergology and Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.'}, {'lastname': 'Heaney', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'Department of Medicine, Columbia University Medical Center, New York.'}, {'lastname': 'Van Daele', 'firstname': 'Paul', 'initials': 'P', 'affiliation': 'Department of Internal Medicine and Immunology, Erasmus Medical Center, Rotterdam, the Netherlands.'}, {'lastname': 'Cerquozzi', 'firstname': 'Sonia', 'initials': 'S', 'affiliation': 'Department of Medicine, University of Calgary, Calgary, AB, Canada.'}, {'lastname': 'Dybedal', 'firstname': 'Ingunn', 'initials': 'I', 'affiliation': 'Department of Hematology, Oslo University Hospital, Oslo.'}, {'lastname': 'Reiter', 'firstname': 'Andreas', 'initials': 'A', 'affiliation': 'Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.'}, {'lastname': 'Pongdee', 'firstname': 'Thanai', 'initials': 'T', 'affiliation': 'Division of Allergic Diseases, Mayo Clinic, Rochester, MN.'}, {'lastname': 'Barete', 'firstname': 'Stéphane', 'initials': 'S', 'affiliation': 'Unit of Dermatology, Centre of Reference for Mastocytosis, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris.'}, {'lastname': 'Ustun', 'firstname': 'Celalettin', 'initials': 'C', 'affiliation': 'Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Section of Bone Marrow Transplantation and Cellular Therapy, Rush Medical College, Chicago.'}, {'lastname': 'Schwartz', 'firstname': 'Lawrence', 'initials': 'L', 'affiliation': 'Virginia Commonwealth University, Richmond, VA.'}, {'lastname': 'Ward', 'firstname': 'Brant R', 'initials': 'BR', 'affiliation': 'Virginia Commonwealth University, Richmond, VA.'}, {'lastname': 'Schafhausen', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'Department of Oncology, Hematology, and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.'}, {'lastname': 'Vadas', 'firstname': 'Peter', 'initials': 'P', 'affiliation': \"Department of Medicine, Division of Clinical Immunology and Allergy, St. Michael's Hospital, University of Toronto, Toronto.\"}, {'lastname': 'Bose', 'firstname': 'Prithviraj', 'initials': 'P', 'affiliation': 'Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.'}, {'lastname': 'DeAngelo', 'firstname': 'Daniel J', 'initials': 'DJ', 'affiliation': 'Dana-Farber Cancer Institute, Boston.'}, {'lastname': 'Rein', 'firstname': 'Lindsay', 'initials': 'L', 'affiliation': 'Department of Medicine, Duke University School of Medicine, Durham, NC.'}, {'lastname': 'Vachhani', 'firstname': 'Pankit', 'initials': 'P', 'affiliation': 'Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.'}, {'lastname': 'Triggiani', 'firstname': 'Massimo', 'initials': 'M', 'affiliation': 'Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy.'}, {'lastname': 'Bonadonna', 'firstname': 'Patrizia', 'initials': 'P', 'affiliation': 'Allergy Unit and Asthma Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.'}, {'lastname': 'Rafferty', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'The Beatson West of Scotland Cancer Centre, Glasgow, Scotland.'}, {'lastname': 'Butt', 'firstname': 'Nauman M', 'initials': 'NM', 'affiliation': 'The Clatterbridge Cancer Centre, Bebington, Wirral, United Kingdom.'}, {'lastname': 'Oh', 'firstname': 'Stephen T', 'initials': 'ST', 'affiliation': 'Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Washington University, St. Louis.'}, {'lastname': 'Wortmann', 'firstname': 'Friederike', 'initials': 'F', 'affiliation': 'Oberärztin Hämatologie/Onkologie bei Uksh Campus Lübeck, Universitätsklinikum Schleswig-Holstein, Universität zu Lübeck, Lübeck, Schleswig-Holstein, Germany.'}, {'lastname': 'Ungerstedt', 'firstname': 'Johanna', 'initials': 'J', 'affiliation': 'Department of Medicine, Huddinge (H7), Karolinska University Hospitale, Stockholm.'}, {'lastname': 'Guilarte', 'firstname': 'Mar', 'initials': 'M', 'affiliation': \"Hospital UniversitariVall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona.\"}, {'lastname': 'Taparia', 'firstname': 'Minakshi', 'initials': 'M', 'affiliation': 'University of Alberta, Edmonton, AB, Canada.'}, {'lastname': 'Kuykendall', 'firstname': 'Andrew T', 'initials': 'AT', 'affiliation': 'Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.'}, {'lastname': 'Arana Yi', 'firstname': 'Cecilia', 'initials': 'C', 'affiliation': 'Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ.'}, {'lastname': 'Ogbogu', 'firstname': 'Princess', 'initials': 'P', 'affiliation': \"Division of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, University Hospitals Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland.\"}, {'lastname': 'Gaudy-Marqueste', 'firstname': 'Caroline', 'initials': 'C', 'affiliation': 'Service de Dermatologie et de cancérologie cutanée, Assistance Publique-Hopitaux de Marseille, Aix-Marseille Université, Marseille, France.'}, {'lastname': 'Mattsson', 'firstname': 'Mattias', 'initials': 'M', 'affiliation': 'Department of Hematology, Uppsala University Hospital and Department of Immunology, Genetics and Pathology, Uppsala, Sweden.'}, {'lastname': 'Shomali', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.'}, {'lastname': 'Giannetti', 'firstname': 'Matthew P', 'initials': 'MP', 'affiliation': \"Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston.\"}, {'lastname': 'Bidollari', 'firstname': 'Ilda', 'initials': 'I', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Lin', 'firstname': 'Hui-Min', 'initials': 'HM', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Sulllivan', 'firstname': 'Erin', 'initials': 'E', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Mar', 'firstname': 'Brenton', 'initials': 'B', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Scherber', 'firstname': 'Robyn', 'initials': 'R', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Roche', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Blueprint Medicines Corporation, Cambridge, MA.'}, {'lastname': 'Akin', 'firstname': 'Cem', 'initials': 'C', 'affiliation': 'University of Michigan, Ann Arbor, MI.'}, {'lastname': 'Maurer', 'firstname': 'Marcus', 'initials': 'M', 'affiliation': 'Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.\\nFraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDoa2200339', 'xml': <Element 'PubmedArticle' at 0x10a5f3c90>}\n",
      "{'pubmed_id': '38320032', 'title': \"Participants' Experience from a Clinical Trial on Fish Oil Supplementation during Pregnancy in a Mother-Child Cohort.\", 'abstract': 'Fish Oil Supplementation during Pregnancy This Patient Platform describes the experiences of two families who participated in a study of fish oil supplementation during pregnancy to prevent asthma. Enrolled families were not only participants in observational epidemiologic research, but they also served as a resource for enrollment in controlled trial interventional research.', 'keywords': [], 'journal': 'NEJM evidence', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Følsgaard', 'firstname': 'Nilofar V', 'initials': 'NV', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Chawes', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Stokholm', 'firstname': 'Jakob', 'initials': 'J', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Schoos', 'firstname': 'Ann-Marie M', 'initials': 'AM', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Mikkelsen', 'firstname': 'Marianne', 'initials': 'M', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}, {'lastname': 'Bønnelykke', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1056/EVIDpp2200307', 'xml': <Element 'PubmedArticle' at 0x10ba211c0>}\n",
      "{'pubmed_id': '38318168\\n34609446\\n24813510\\n32570246\\n37921701\\n23954315\\n34116974\\n28655543\\n37391018\\n31593702\\n35738437\\n30958799\\n26514775\\n29980278\\n35472002\\n33972688\\n24920534\\n37287363\\n35304158\\n30958801\\n34389613\\n31011306\\n27423155\\n32171907\\n25463476\\n36700219\\n32923137\\n33329591\\n37261359\\n36834656\\n16569350\\n28658550\\n1715602\\n22206777\\n36243282\\n35150646\\n32849632\\n37699081\\n19528036\\n24118614\\n25505954\\n18323539\\n33199925\\n31214171\\n33199924\\n21469087\\n18073124\\n34769327\\n32306637\\n28122135\\n26112261\\n32417134\\n34571982\\n32188652\\n37114049\\n10636544\\n35679009', 'title': 'Mononuclear cell composition and activation in blood and mucosal tissue of eosinophilic esophagitis.', 'abstract': 'Eosinophilic esophagitis (EoE) is a chronic, inflammatory, antigen-driven disease of the esophagus. Tissue EoE pathology has previously been extensively characterized by novel transcriptomics and proteomic platforms, however the majority of surface marker determination and screening has been performed in blood due to mucosal tissue size limitations. While eosinophils, CD4\\nIn this study, we aimed to comprehensively analyze the composition of peripheral blood mononuclear cells and their activation using surface marker measurements with multicolor flow cytometry simultaneously in both blood and mucosal tissue of patients with active EoE, inactive EoE, patients with gastroesophageal reflux disease (GERD) and controls. Moreover, we set out to validate our data in co-cultures of PBMC with human primary esophageal epithelial cells and in a novel inducible mouse model of eosinophilic esophagitis, characterized by extensive IL-33 secretion in the esophagus.\\nOur results indicate that specific PBMC populations are enriched, and that they alter their surface expression of activation markers in mucosal tissue of active EoE. In particular, we observed upregulation of the immunomodulatory molecule CD38 on CD4\\nHerein we show significant alterations in the PBMC activation profile of patients with active EoE in comparison to inactive EoE, GERD and controls, which could have potential implications for treatment. To our knowledge, this study is the first of its kind expanding the multi-color flow cytometry approach in different patient groups using ', 'keywords': ['CD38', 'PD-1', 'T cells', 'eosinophilic esophagitis', 'flow cytometry', 'immune cell profile', 'inducible mouse model', 'reflux disease'], 'journal': 'Frontiers in immunology', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Gruden', 'firstname': 'Eva', 'initials': 'E', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Kienzl', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Ristic', 'firstname': 'Dusica', 'initials': 'D', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Kindler', 'firstname': 'Oliver', 'initials': 'O', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Kaspret', 'firstname': 'David Markus', 'initials': 'DM', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Schmid', 'firstname': 'Sophie Theresa', 'initials': 'ST', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Kargl', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Sturm', 'firstname': 'Eva', 'initials': 'E', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Doyle', 'firstname': 'Alfred D', 'initials': 'AD', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Wright', 'firstname': 'Benjamin L', 'initials': 'BL', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Baumann-Durchschein', 'firstname': 'Franziska', 'initials': 'F', 'affiliation': 'Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Konrad', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Blesl', 'firstname': 'Andreas', 'initials': 'A', 'affiliation': 'Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Schlager', 'firstname': 'Hansjörg', 'initials': 'H', 'affiliation': 'Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.'}, {'lastname': 'Schicho', 'firstname': 'Rudolf', 'initials': 'R', 'affiliation': 'Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.'}], 'methods': None, 'conclusions': None, 'results': 'Our results indicate that specific PBMC populations are enriched, and that they alter their surface expression of activation markers in mucosal tissue of active EoE. In particular, we observed upregulation of the immunomodulatory molecule CD38 on CD4', 'copyrights': 'Copyright © 2024 Gruden, Kienzl, Ristic, Kindler, Kaspret, Schmid, Kargl, Sturm, Doyle, Wright, Baumann-Durchschein, Konrad, Blesl, Schlager and Schicho.', 'doi': '10.3389/fimmu.2024.1347259\\n10.1001/jama.2021.14920\\n10.1016/j.gtc.2014.02.002\\n10.1159/000508191\\n10.1002/ueg2.12465\\n10.1053/j.gastro.2013.08.015\\n10.1016/j.dld.2021.05.017\\n10.1016/j.cgh.2017.06.036\\n10.1016/j.jaip.2023.06.035\\n10.1053/j.gastro.2019.09.042\\n10.1016/j.anai.2022.06.015\\n10.1172/JCI125917\\n10.1152/ajpgi.00290.2015\\n10.1016/j.jaci.2018.05.008\\n10.1172/jci.insight.159093\\n10.1038/s41385-021-00400-y\\n10.1038/gene.2014.27\\n10.1111/all.15779\\n10.1016/j.jaci.2022.02.025\\n10.1172/JCI128479\\n10.1126/sciimmunol.abi5586\\n10.1016/j.jaci.2022.12.285\\n10.1016/j.bbalip.2020.158686\\n10.1016/j.bbalip.2014.11.010\\n10.3389/fimmu.2022.997115\\n10.1080/2162402X.2020.1776059\\n10.3389/fimmu.2020.597959\\n10.3389/fimmu.2023.1163633\\n10.3390/ijms24043246\\n10.1177/205873920601900112\\n10.1111/imr.12559\\n10.4172/2329-6887.1000111\\n10.1111/j.1365-3083.1991.tb01547.x\\n10.1016/j.jaci.2011.11.044\\n10.1016/j.anai.2022.10.004\\n10.1016/j.jaci.2018.12.887\\n10.1016/j.jaci.2021.12.524\\n10.1016/S2468-1253(21)00468-4\\n10.3389/fimmu.2020.01765\\n10.1126/scisignal.adg6360\\n10.1136/gut.2009.178020\\n10.1111/cea.12201\\n10.1038/cti.2013.13\\n10.1164/rccm.200706-895OC\\n10.1038/s42255-020-00298-z\\n10.3389/fimmu.2019.01187\\n10.1038/s42255-020-00305-3\\n10.1002/eji.201040726\\n10.1016/j.jaci.2021.12.203\\n10.1016/j.jaci.2007.10.024\\n10.3390/ijms222111898\\n10.3760/cma.j.cn115330-20190618-00392\\n10.1111/all.13136\\n10.1186/s12865-015-0103-2\\n10.1016/j.jaci.2020.04.044\\n10.3390/cells10092333\\n10.7861/clinmed.2018-0440\\n10.3389/fimmu.2023.1081790\\n10.1080/110241599750007630\\n10.1007/s12026-022-09269-w', 'xml': <Element 'PubmedArticle' at 0x10ba223e0>}\n",
      "{'pubmed_id': '38318088\\n33069326\\n17400878\\n11172168\\n22267450\\n30685573\\n31604088\\n22244599\\n14713908\\n31687374\\n22743675\\n31558662\\n30691718\\n28331347\\n26226354\\n18405952\\n35794604\\n29615226\\n29445292\\n27775836\\n26220530\\n19892860\\n17291857\\n11157592\\n27556234\\n31785254\\n28076614\\n19085573\\n34908847\\n35597370', 'title': 'Smoking, Urban Housing and Work-Aggravated Asthma are Associated with Asthma Severity in a Cross-Sectional Observational Study.', 'abstract': 'Severe asthma affects 5 to 10% of asthmatics and accounts for a large part of asthma-related morbidity and costs. The determinants of asthma severity are poorly understood. We tested the hypothesis that asthma severity was associated with 1) atopy and allergy and 2) markers associated with environmental exposure.\\nData from the FASE-CPHG study, a cross-sectional, observational, multicenter investigation, were analyzed to identify markers associated with asthma severity. Asthma severity was gauged using the ASSESS score, encompassing symptom control, exacerbations, FEV1 and therapeutic load. Bivariate and multivariate analyses were used to identify patient characteristics associated with the ASSESS score.\\nThe analysis involved 948 patients, with 592 women, of which 447 patients (47%) had severe asthma. Among these, 491 patients (52%) had at least one positive aeroallergen skin prick test and 525 (55%) had at least one allergic disease among atopic dermatitis, chronic rhinitis and food allergy. The mean±SD ASSESS score was 11.2±3.4. Characteristics associated with a higher ASSESS score were female sex, secondary or lower education, unemployed occupational status, smoking, work-aggravated asthma and urban housing. There was no association between the ASSESS score and allergic diseases, aeroallergen-specific skin prick tests and IgEs, or blood eosinophil counts.\\nWhile atopy and allergy were frequent among asthmatics, neither was associated with asthma severity. Modifiable environmental factors such as smoking, urban housing and work-aggravated asthma were independently associated with asthma severity.', 'keywords': ['ASSESS', 'allergy', 'asthma', 'environment', 'severity'], 'journal': 'Journal of asthma and allergy', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Chevereau-Choquet', 'firstname': 'Marie', 'initials': 'M', 'affiliation': 'Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.'}, {'lastname': 'Thoreau', 'firstname': 'Benjamin', 'initials': 'B', 'affiliation': 'Service de Médecine Interne, National Referral Center for Rare Systemic Autoimmune Diseases, AP-HP, Hôpital Cochin, Paris, France.\\nInserm U1016, CNRS UMR8104, Université Paris Cité, Institut Cochin, Paris, France.'}, {'lastname': 'Taillé', 'firstname': 'Camille', 'initials': 'C', 'affiliation': 'Service de Pneumologie A, AP-HP Nord, Hôpital Bichat Claude Bernard, Paris, France.\\nInserm U1152, Université Paris Cité, Paris, France.'}, {'lastname': 'Marchand-Adam', 'firstname': 'Sylvain', 'initials': 'S', 'affiliation': 'Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.\\nCEPR, Inserm UMR1100, Université de Tours, Tours, France.'}, {'lastname': 'Morel', 'firstname': 'Hugues', 'initials': 'H', 'affiliation': \"Service de Pneumologie, CHR d'Orléans, Orléans, France.\"}, {'lastname': 'Plantier', 'firstname': 'Laurent', 'initials': 'L', 'affiliation': 'Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHRU de Tours, Tours, France.\\nCEPR, Inserm UMR1100, Université de Tours, Tours, France.'}, {'lastname': 'Portel', 'firstname': 'Laurent', 'initials': 'L', 'affiliation': 'Service de Pneumologie, Centre Hospitalier Robert Boulin, Libourne, France.'}], 'methods': None, 'conclusions': 'While atopy and allergy were frequent among asthmatics, neither was associated with asthma severity. Modifiable environmental factors such as smoking, urban housing and work-aggravated asthma were independently associated with asthma severity.', 'results': 'The analysis involved 948 patients, with 592 women, of which 447 patients (47%) had severe asthma. Among these, 491 patients (52%) had at least one positive aeroallergen skin prick test and 525 (55%) had at least one allergic disease among atopic dermatitis, chronic rhinitis and food allergy. The mean±SD ASSESS score was 11.2±3.4. Characteristics associated with a higher ASSESS score were female sex, secondary or lower education, unemployed occupational status, smoking, work-aggravated asthma and urban housing. There was no association between the ASSESS score and allergic diseases, aeroallergen-specific skin prick tests and IgEs, or blood eosinophil counts.', 'copyrights': '© 2024 Chevereau-Choquet et al.', 'doi': '10.2147/JAA.S424546\\n10.1016/S0140-6736(20)30925-9\\n10.1183/09031936.00087506\\n10.1056/NEJM200102013440507\\n10.1136/oemed-2011-100399\\n10.1016/j.jaip.2018.12.029\\n10.1016/j.jaci.2019.09.018\\n10.1016/j.jaci.2011.12.962\\n10.1016/j.jaci.2003.09.008\\n10.1183/23120541.00069-2019\\n10.1183/09031936.00080312\\n10.1183/13993003.00588-2019\\n10.1016/j.ccm.2018.10.005\\n10.2147/JAA.S121276\\n10.1097/ACI.0000000000000195\\n10.1016/j.jaci.2008.02.020\\n10.1186/s12940-022-00871-x\\n10.1016/S2542-5196(18)30028-7\\n10.2147/JAA.S125948\\n10.1111/all.13072\\n10.1016/j.jaci.2015.06.015\\n10.1164/rccm.200906-0896OC\\n10.1016/j.jaci.2006.11.639\\n10.1378/chest.119.1.115\\n10.1164/rccm.201602-0419OC\\n10.1016/j.chest.2019.10.053\\n10.1590/1516-3180.2016.011827016\\n10.1080/02770900802444187\\n10.2147/JAA.S340684\\n10.1016/j.jaci.2022.04.030', 'xml': <Element 'PubmedArticle' at 0x10af9e1b0>}\n",
      "{'pubmed_id': '38318021\\n32893125\\n10669525\\n34755615\\n37200347\\n32839286\\n33326352\\n31765853\\n32020334\\n26382999\\n36067034\\n29885291\\n33375293\\n30536912\\n36144741\\n31189216\\n25442547\\n27638711\\n30891116\\n35701051\\n28198577\\n22690304\\n31728499\\n36237882\\n34878854\\n26773020\\n36752230\\n35503926\\n37847364\\n37926180\\n35365240\\n34831692\\n7823386\\n30345266\\n27485230\\n35216071\\n22747421\\n31935448\\n35010963\\n37187036\\n33236056\\n35215476\\n30475962\\n36372128\\n15780024\\n32504553\\n25315508\\n9928451\\n1444060\\n32410856\\n20491642\\n34784434\\n11237167', 'title': 'Associations of serum carotenoids with asthma and mortality in the US adults.', 'abstract': 'This study was to investigate the association between serum carotenoid levels and the prevalence of asthma, as well as the relationship between serum carotenoid levels and the risk of mortality among individuals with asthma.\\nData on five serum carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene) were obtained from the National Health and Nutrition Examination Survey (NHANES) 2001-2006. Mortality data was extracted from the pertinent mortality records within the NHANES database, up to December 31, 2019. Logistic regression analysis was employed to investigate the association between serum carotenoid concentrations and asthma prevalence. Cox proportional hazards models were used to investigate the connection between serum carotenoids and mortality rates in asthma individuals.\\nAmong the study population, 1569 (12.63\\xa0%) individuals were diagnosed with asthma, while 25.01\\xa0% of asthma patients died within a median follow-up duration of 15.5 (13.8-17.3) years. After controlling for all other variables, greater serum levels of certain carotenoids, such asα-carotene, β-carotene, β-cryptoxanthin, and lutein/zeaxanthin, were found to be substantially linked with a decreased prevalence of asthma. Furthermore, persons with asthma who had greater levels of serum carotenoids in the fourth quartile had a significantly lower risk of all-cause death compared to those in the first quartile. Specifically, the presence of α-carotene, β-cryptoxanthin, and lutein/zeaxanthin was associated with reductions in all-cause mortality by 45\\xa0% (HR\\xa0=\\xa00.55 [0.36-0.84], \\nOur findings indicate that higher serum carotenoids are related with a reduced likelihood of mortality in asthmatic individuals.', 'keywords': ['Asthma', 'Carotenoids', 'Mortality', 'NHANES', 'Serum'], 'journal': 'Heliyon', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Zhang', 'firstname': 'Guidong', 'initials': 'G', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, 515041, PR China.'}, {'lastname': 'Li', 'firstname': 'Xiaocong', 'initials': 'X', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, 515041, PR China.'}, {'lastname': 'Zheng', 'firstname': 'Xiaohe', 'initials': 'X', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, 515041, PR China.'}], 'methods': None, 'conclusions': None, 'results': 'Among the study population, 1569 (12.63\\xa0%) individuals were diagnosed with asthma, while 25.01\\xa0% of asthma patients died within a median follow-up duration of 15.5 (13.8-17.3) years. After controlling for all other variables, greater serum levels of certain carotenoids, such asα-carotene, β-carotene, β-cryptoxanthin, and lutein/zeaxanthin, were found to be substantially linked with a decreased prevalence of asthma. Furthermore, persons with asthma who had greater levels of serum carotenoids in the fourth quartile had a significantly lower risk of all-cause death compared to those in the first quartile. Specifically, the presence of α-carotene, β-cryptoxanthin, and lutein/zeaxanthin was associated with reductions in all-cause mortality by 45\\xa0% (HR\\xa0=\\xa00.55 [0.36-0.84], ', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.heliyon.2024.e24992\\n10.1016/j.alit.2020.08.001\\n10.1016/s0091-6749(00)90044-7\\n10.1016/S0140-6736(21)01823-7\\n10.1371/journal.pone.0286004\\n10.1136/thoraxjnl-2020-214692\\n10.1164/rccm.202009-3631CI\\n10.1016/j.jaip.2019.11.009\\n10.1007/s00281-020-00785-1\\n10.1016/S0140-6736(15)00156-7\\n10.1111/all.15505\\n10.1016/j.abb.2018.06.001\\n10.3390/foods10010045\\n10.1002/jsfa.9525\\n10.3390/molecules27186005\\n10.1002/mnfr.201801045\\n10.1016/j.foodchem.2014.09.069\\n10.1111/bph.13625\\n10.1155/2019/9783429\\n10.1136/bmjopen-2021-052320\\n10.1111/cea.12904\\n10.4081/pr.2012.e12\\n10.1093/advances/nmz042\\n10.18999/nagjms.84.3.607\\n10.2105/AJPH.2021.306517\\n10.3945/an.115.009258\\n10.1161/jaha.122.027568\\n10.2337/dc21-2371\\n10.1007/s11356-023-30174-8\\n10.1016/j.rmed.2023.107451\\n10.1186/s13223-022-00672-4\\n10.3390/ijerph182211938\\n10.1001/jama.273.5.402\\n10.3389/fpubh.2018.00288\\n10.1007/978-3-319-39126-7_14\\n10.3390/ijms23041957\\n10.2174/138161212803307527\\n10.1016/j.bbalip.2020.158613\\n10.3390/nu14010088\\n10.1016/j.phymed.2023.154850\\n10.1093/ajcn/nqaa316\\n10.3390/nu14040827\\n10.1093/ajcn/nqy097\\n10.1016/j.jad.2022.11.013\\n10.1016/j.abb.2020.108439\\n10.1017/S0007114514002669\\n10.1111/j.1749-6632.1998.tb09923.x\\n10.1111/j.1749-6632.1992.tb17085.x\\n10.1155/2020/5373562\\n10.2174/092986710791556041\\n10.1096/fj.202100835R\\n10.1002/biof.5520130117', 'xml': <Element 'PubmedArticle' at 0x10ada3790>}\n",
      "{'pubmed_id': '38317969\\n32910897\\n32972987\\n33526910\\n33124914\\n32037107\\n32910907\\n27881237\\n19440486\\n32905756\\n36513206\\n20452649\\n26742024\\n26257031\\n34496338\\n23062436\\n34980891\\n17593733\\n36399896\\n33412282\\n15333849\\n35967306\\n32510334\\n21994168\\n23047665\\n31240852\\n17002710\\n34332882', 'title': 'The urinary metabolites of volatile organic compounds and asthma in young children: NHANES 2011-2018.', 'abstract': 'The vast majority of volatile organic compounds (VOCs) are of biological origin and do not affect human health, while some VOCs or their oxidation products can damage the respiratory system, nervous system, digestive system and blood system after long-term inhalation by humans. There is limited evidence regarding the association of VOCs exposure with childhood asthma. In this study, we examined the associations between metabolites of VOCs (mVOCs) in urine and childhood asthma. We included a total of 1542 children aged 3-12 years who had information on urinary mVOCs, asthma and essential covariates in the current analyses. After controlling for covariates, we used logistic regression to assess the association between urinary mVOCs and childhood asthma. Then, we examined effect measure modification by child age, gender, race/ethnicity and serum cotinine. 2-Methylhippuric acid (xylene metabolites) (OR: 1.14; 95\\xa0% CI: 0.87, 1.59), N-acetyl-S-(benzyl)-l-cysteine (toluene metabolites) (OR: 1.15 95\\xa0% CI: 0.76, 1.71), N-acetyl-S-(2-carboxyethyl)-l-cysteine (acrolein metabolites) (OR: 1.09; 95\\xa0% CI: 0.61, 1.75), N-acetyl-S-(3-hydroxypropyl)-l-cysteine (acrolein metabolites) (OR: 1.10; 95\\xa0% CI: 0.66, 1.80), and N-acetyl-S-(3-hydroxypropyl-1-methyl)-l-cysteine (crotonaldehyde metabolites) (OR: 1.18; 95\\xa0% CI: 0.68, 2.01) were weakly associated with the prevalence of asthma in children. Among female children, 2MHA (2-methylhippuric acid) in urine was significantly associated with the prevalence of asthma (OR: 1.81 95\\xa0% CI: 1.07, 3.05). At the same time, BMA (N-acetyl-S-(benzyl)-l-cysteine) was significantly associated with the prevalence of asthma in non-Hispanic White (OR:2.09 95\\xa0% CI: 0.91, 4.66) and Black (OR:1.90 95\\xa0% CI: 0.96, 3.71) children. We found that gender modified the associations between urinary 2MHA and the odds of asthma (interaction term p value\\xa0=\\xa00.03). Therefore, exposure to VOCs and the development of childhood asthma remains controversial, and the interpretation of these results needs to be treated with caution and should be confirmed in future studies.Therefore, exposure to VOCs and the development of childhood asthma remains controversial, and the interpretation of these results needs to be treated with caution and should be confirmed in future studies.', 'keywords': ['Childhood asthma', 'Metabolites of volatile organic compounds', 'NHANES', 'Volatile organic compounds'], 'journal': 'Heliyon', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Xiong', 'firstname': 'Yixiao', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.\\nLaboratory of Mitochondria and Metabolism, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.'}, {'lastname': 'Liu', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.\\nLaboratory of Mitochondria and Metabolism, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.'}, {'lastname': 'Li', 'firstname': 'Tao', 'initials': 'T', 'affiliation': 'Department of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.\\nLaboratory of Mitochondria and Metabolism, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Sichuan, 610041, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.heliyon.2024.e24199\\n10.1016/S2213-2600(20)30399-4\\n10.1183/13993003.02094-2020\\n10.1038/s41579-020-00508-1\\n10.1164/rccm.2029P25\\n10.1016/j.jaip.2019.11.008\\n10.1016/S0140-6736(20)31861-4\\n10.1016/j.envint.2016.11.012\\n10.1289/ehp.11513\\n10.1146/annurev-micro-012420-080428\\n10.1016/j.chemosphere.2022.137489\\n10.1016/j.scitotenv.2010.04.013\\n10.3390/molecules21010056\\n10.1016/j.envres.2015.07.023\\n10.1016/j.chemosphere.2021.132065\\n10.1016/j.aca.2012.04.009\\n10.1038/s41568-021-00423-4\\n10.1021/es060609l\\n10.1016/j.rmed.2022.107053\\n10.1016/j.ecoenv.2020.111864\\n10.1136/thx.2003.013680\\n10.1177/1420326x05054288\\n10.3389/fimmu.2022.928379\\n10.1016/j.rmed.2020.105984\\n10.1002/mnfr.201100279\\n10.1002/tox.21818\\n10.1002/tox.22814\\n10.1111/j.1398-9995.2006.01135.x\\n10.1016/j.alit.2021.07.004', 'xml': <Element 'PubmedArticle' at 0x147a4d030>}\n",
      "{'pubmed_id': '38317805\\n30207919\\n26840139\\n30580047\\n11028656\\n12452205\\n35083326\\n27712769\\n24196381\\n30104762\\n26562621\\n25186178\\n25577287\\n30144584\\n32354531\\n29775025\\n36797169\\n22262771\\n34921681\\n25372592\\n29206278\\n32340307', 'title': 'Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions.', 'abstract': \"Previous studies have determined that up to 6% of patients with aspirin-exacerbated respiratory disease (AERD) have family history of AERD, indicating a possible link with genetic polymorphisms. However, whole exome sequencing (WES) studies of such associations are currently lacking.\\nWe sought to examine whether WES can identify pathogenic variants associated with AERD.\\nDiagnoses of AERD were confirmed in patients with nasal polyps and asthma. WES was performed using an Illumina sequencing platform. Human Phenotype Ontology terms were used to define the patients' phenotypes. Exomiser was used to annotate, filter, and prioritize possible disease-causing genetic variants.\\nOf 39 patients with AERD, 41% reported a family history of asthma and 5% reported a family history of AERD. Pathogenic exome variants in the filaggrin gene (\\nWES identified a monogenic susceptibility to AERD in 5% of patients with \", 'keywords': ['AERD', 'Aspirin-exacerbated respiratory disease', 'NSAID-ERD', 'aspirin', 'epithelial barrier', 'filaggrin'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Jerschow', 'firstname': 'Elina', 'initials': 'E', 'affiliation': 'Mayo Clinic, Rochester, Minn.\\nAlbert Einstein College of Medicine, Bronx, NY.'}, {'lastname': 'Dubin', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Albert Einstein College of Medicine, Bronx, NY.'}, {'lastname': 'Chen', 'firstname': 'Chien-Chang', 'initials': 'CC', 'affiliation': 'Mayo Clinic, Rochester, Minn.'}, {'lastname': 'iAkushev', 'firstname': 'Alex', 'initials': 'A', 'affiliation': 'Mayo Clinic, Rochester, Minn.'}, {'lastname': 'Sehanobish', 'firstname': 'Esha', 'initials': 'E', 'affiliation': 'Albert Einstein College of Medicine, Bronx, NY.'}, {'lastname': 'Asad', 'firstname': 'Mohammad', 'initials': 'M', 'affiliation': 'Albert Einstein College of Medicine, Bronx, NY.'}, {'lastname': 'Chiarella', 'firstname': 'Sergio E', 'initials': 'SE', 'affiliation': 'Mayo Clinic, Rochester, Minn.'}, {'lastname': 'Porcelli', 'firstname': 'Steven A', 'initials': 'SA', 'affiliation': 'Albert Einstein College of Medicine, Bronx, NY.'}, {'lastname': 'Greally', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Albert Einstein College of Medicine, Bronx, NY.'}], 'methods': None, 'conclusions': 'WES identified a monogenic susceptibility to AERD in 5% of patients with ', 'results': 'Of 39 patients with AERD, 41% reported a family history of asthma and 5% reported a family history of AERD. Pathogenic exome variants in the filaggrin gene (', 'copyrights': '© 2024 The Author(s).', 'doi': '10.1016/j.jacig.2024.100205', 'xml': <Element 'PubmedArticle' at 0x10af24ef0>}\n",
      "{'pubmed_id': '38317769\\n22561835\\n11112161\\n21930234\\n18480428\\n19907311\\n23060627\\n20860503\\n30392403\\n27027945\\n21211650\\n27580351\\n28179442\\n21779351\\n28461290\\n32304842\\n28910134\\n30422895\\n24337046\\n27818791\\n29423954\\n26844429\\n23558785\\n24695404\\n31375807\\n19505943\\n25260700\\n27141961\\n10592173\\n25605792\\n19892860\\n30661310\\n21211650\\n19797135\\n28784414\\n21375540\\n25511380\\n28910134\\n26707771\\n16503242\\n29650561', 'title': 'Blood transcriptome differentiates clinical clusters for asthma.', 'abstract': 'In previous studies, several asthma phenotypes were identified using clinical and demographic parameters. Transcriptional phenotypes were mainly identified using sputum and bronchial cells.\\nWe aimed to investigate asthma phenotypes via clustering analysis using clinical variables and compare the transcription levels among clusters using gene expression profiling of the blood.\\nClustering analysis was performed using 6 parameters: age of asthma onset, body mass index, pack-years of smoking, forced expiratory volume in 1\\xa0s (FEV1), FEV1/forced vital capacity, and blood eosinophil counts. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood samples and RNA was extracted from selected PBMCs. Transcriptional profiles were generated (Illumina NovaSeq 6000) and analyzed using the reference genome and gene annotation files (hg19.refGene.gft). Pathway enrichment analysis was conducted using GO, KEGG, and REACTOME databases.\\nIn total, 355 patients with asthma were included in the analysis, of whom 72 (20.3%) had severe asthma. Clustering of the 6 parameters revealed 4 distinct subtypes. Cluster 1 (n\\xa0=\\xa063) had lower predicted FEV1 % and higher pack-years of smoking and neutrophils in sputum. Cluster 2 (n\\xa0=\\xa043) had a higher proportion and number of eosinophils in sputum and blood, and severe airflow limitation. Cluster 3 (n\\xa0=\\xa0110) consisted of younger subjects with atopic features. Cluster 4 (n\\xa0=\\xa0139) included features of late-onset mild asthma. Differentially expressed genes between clusters 1 and 2 were related to inflammatory responses and cell activation. Th17 cell differentiation and interferon gamma-mediated signaling pathways were related to neutrophilic inflammation in asthma.\\nFour clinical clusters were differentiated based on clinical parameters and blood eosinophils in adult patients with asthma form the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) cohort. Gene expression profiling and molecular pathways are novel means of classifying asthma phenotypes.', 'keywords': ['Asthma', 'Cluster', 'Pathway', 'Transcriptome'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'An', 'firstname': 'Jin', 'initials': 'J', 'affiliation': 'Department of Pulmonary, Allergy and Critical Care Medicine, College of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University, Seoul, South Korea.'}, {'lastname': 'Jeong', 'firstname': 'Seungpil', 'initials': 'S', 'affiliation': 'Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, South Korea.'}, {'lastname': 'Park', 'firstname': 'Kyungtaek', 'initials': 'K', 'affiliation': 'Institute of Health and Environment, Seoul National University, Seoul, South Korea.'}, {'lastname': 'Jin', 'firstname': 'Heejin', 'initials': 'H', 'affiliation': 'Institute of Health and Environment, Seoul National University, Seoul, South Korea.'}, {'lastname': 'Park', 'firstname': 'Jaehyun', 'initials': 'J', 'affiliation': 'Interdisciplinary Program of Bioinformatics, Seoul National University, Seoul, South Korea.'}, {'lastname': 'Shin', 'firstname': 'Eunsoon', 'initials': 'E', 'affiliation': 'DNA Link, Seoul, South Korea.'}, {'lastname': 'Lee', 'firstname': 'Ji-Hyang', 'initials': 'JH', 'affiliation': 'Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.'}, {'lastname': 'Song', 'firstname': 'Woo-Jung', 'initials': 'WJ', 'affiliation': 'Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.'}, {'lastname': 'Kwon', 'firstname': 'Hyouk-Soo', 'initials': 'HS', 'affiliation': 'Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.'}, {'lastname': 'Cho', 'firstname': 'You Sook', 'initials': 'YS', 'affiliation': 'Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.'}, {'lastname': 'Lee', 'firstname': 'Jong Eun', 'initials': 'JE', 'affiliation': 'DNA Link, Seoul, South Korea.'}, {'lastname': 'Won', 'firstname': 'Sungho', 'initials': 'S', 'affiliation': 'Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, South Korea.\\nInstitute of Health and Environment, Seoul National University, Seoul, South Korea.\\nInterdisciplinary Program of Bioinformatics, College of Natural Science, Seoul National University, Seoul, South Korea.'}, {'lastname': 'Kim', 'firstname': 'Tae-Bum', 'initials': 'TB', 'affiliation': 'Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.'}], 'methods': None, 'conclusions': 'Four clinical clusters were differentiated based on clinical parameters and blood eosinophils in adult patients with asthma form the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) cohort. Gene expression profiling and molecular pathways are novel means of classifying asthma phenotypes.', 'results': 'In total, 355 patients with asthma were included in the analysis, of whom 72 (20.3%) had severe asthma. Clustering of the 6 parameters revealed 4 distinct subtypes. Cluster 1 (n\\xa0=\\xa063) had lower predicted FEV1 % and higher pack-years of smoking and neutrophils in sputum. Cluster 2 (n\\xa0=\\xa043) had a higher proportion and number of eosinophils in sputum and blood, and severe airflow limitation. Cluster 3 (n\\xa0=\\xa0110) consisted of younger subjects with atopic features. Cluster 4 (n\\xa0=\\xa0139) included features of late-onset mild asthma. Differentially expressed genes between clusters 1 and 2 were related to inflammatory responses and cell activation. Th17 cell differentiation and interferon gamma-mediated signaling pathways were related to neutrophilic inflammation in asthma.', 'copyrights': '© 2024 The Author(s).', 'doi': '10.1016/j.waojou.2024.100871', 'xml': <Element 'PubmedArticle' at 0x10b302430>}\n",
      "{'pubmed_id': '38317432', 'title': 'Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation.', 'abstract': 'Dupilumab is used for the treatment of atopic dermatitis (AD). Approximately one third of AD patients develop a dupilumab-associated ocular surface disease (DAOSD), of which the pathomechanism is poorly understood. This study aimed at investigating inflammatory markers in tear fluids of patients on dupilumab therapy.\\nTear fluids were collected from AD patients with DAOSD (ADwDAOSD), AD patients without DAOSD (ADw/oDAOSD), and non-AD patients before and during dupilumab therapy, and analyzed using a specialized proteomic approach quantifying inflammatory markers. The ocular surface microbiome was determined by next generation sequencing technology.\\nUpon dupilumab therapy, an upregulation of 31 inflammatory markers was observed in DAOSD tear fluids compared to baseline in AD patients. While IL-12B was upregulated in both ADwDAOSD and ADw/oDAOSD groups, the pattern of inflammatory markers significantly differed between groups and over time. In the ADwDAOSD group, a shift from a mixed Th2/Th17 pattern at baseline toward a Th1/Th17 profile under dupilumab was observed. Furthermore, an upregulation of remodeling and fibrosis markers was seen in DAOSD. Semantic map and hierarchical cluster analyses of baseline marker expression revealed four clusters distinguishing between AD and non-AD as well as ADwDAOSD and ADw/oDAOSD patient groups. In a pilot study, dupilumab therapy was associated with a decrease in richness of the ocular surface microbiome.\\nDAOSD is characterized by a Th1/Th17 cytokine profile and an upregulation of markers known to promote remodeling and fibrosis. The expression pattern of inflammatory markers in tear fluids at baseline might serve as a prognostic factor for DAOSD.', 'keywords': ['atopic dermatitis', 'dry eye disease', 'dupilumab', 'ocular surface disease', 'remodeling', 'type 1 inflammation'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Thormann', 'firstname': 'Kathrin', 'initials': 'K', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Lüthi', 'firstname': 'Anne-Sophie', 'initials': 'AS', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Deniau', 'firstname': 'Felix', 'initials': 'F', 'affiliation': 'Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Heider', 'firstname': 'Anja', 'initials': 'A', 'affiliation': 'Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.'}, {'lastname': 'Cazzaniga', 'firstname': 'Simone', 'initials': 'S', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\\nCentro Studi GISED, Bergamo, Italy.'}, {'lastname': 'Radonjic-Hoesli', 'firstname': 'Susanne', 'initials': 'S', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Lehmann', 'firstname': 'Mathias', 'initials': 'M', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Schlapbach', 'firstname': 'Christoph', 'initials': 'C', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}, {'lastname': 'Herzog', 'firstname': 'Elio L', 'initials': 'EL', 'affiliation': 'Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\\nDepartment for BioMedical Research, University of Bern, Bern, Switzerland.\\nGraduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.'}, {'lastname': 'Kreuzer', 'firstname': 'Marco', 'initials': 'M', 'affiliation': 'Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland.'}, {'lastname': 'Zinkernagel', 'firstname': 'Martin S', 'initials': 'MS', 'affiliation': 'Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\\nDepartment for BioMedical Research, University of Bern, Bern, Switzerland.'}, {'lastname': 'Akdis', 'firstname': 'Cezmi A', 'initials': 'CA', 'affiliation': 'Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.'}, {'lastname': 'Zysset-Burri', 'firstname': 'Denise C', 'initials': 'DC', 'affiliation': 'Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\\nDepartment for BioMedical Research, University of Bern, Bern, Switzerland.'}, {'lastname': 'Simon', 'firstname': 'Hans-Uwe', 'initials': 'HU', 'affiliation': 'Institute of Pharmacology, University of Bern, Bern, Switzerland.\\nInstitute of Biochemistry, Brandenburg Medical School, Neuruppin, Germany.'}, {'lastname': 'Simon', 'firstname': 'Dagmar', 'initials': 'D', 'affiliation': 'Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.'}], 'methods': None, 'conclusions': None, 'results': 'Upon dupilumab therapy, an upregulation of 31 inflammatory markers was observed in DAOSD tear fluids compared to baseline in AD patients. While IL-12B was upregulated in both ADwDAOSD and ADw/oDAOSD groups, the pattern of inflammatory markers significantly differed between groups and over time. In the ADwDAOSD group, a shift from a mixed Th2/Th17 pattern at baseline toward a Th1/Th17 profile under dupilumab was observed. Furthermore, an upregulation of remodeling and fibrosis markers was seen in DAOSD. Semantic map and hierarchical cluster analyses of baseline marker expression revealed four clusters distinguishing between AD and non-AD as well as ADwDAOSD and ADw/oDAOSD patient groups. In a pilot study, dupilumab therapy was associated with a decrease in richness of the ocular surface microbiome.', 'copyrights': '© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/all.16045', 'xml': <Element 'PubmedArticle' at 0x109a8c8b0>}\n",
      "{'pubmed_id': '38317332', 'title': 'Effects of air purifiers on rhinitis quality of life and perception of sleep quality in people with asthma: Randomised controlled trial.', 'abstract': None, 'keywords': ['DYSON air purifier', 'clinical trial', 'quality of life', 'repeated measures', 'rhinitis', 'sleep'], 'journal': 'Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Kadalayil', 'firstname': 'Latha', 'initials': 'L', 'affiliation': 'Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.'}, {'lastname': 'Lowther', 'firstname': 'Scott', 'initials': 'S', 'affiliation': 'Dyson Technology Limited, Tetbury Hill, Malmesbury, UK.'}, {'lastname': 'Fong', 'firstname': 'Wei Chern Gavin', 'initials': 'WCG', 'affiliation': 'Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nDavid Hide Asthma and Allergy Research Centre, Isle of Wight, UK.'}, {'lastname': 'Nicolas', 'firstname': 'Frédéric', 'initials': 'F', 'affiliation': 'Dyson Technology Limited, Tetbury Hill, Malmesbury, UK.'}, {'lastname': 'Potter', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'David Hide Asthma and Allergy Research Centre, Isle of Wight, UK.'}, {'lastname': 'Larsson', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'David Hide Asthma and Allergy Research Centre, Isle of Wight, UK.'}, {'lastname': 'Kurukulaaratchy', 'firstname': 'Ramesh', 'initials': 'R', 'affiliation': 'Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nDavid Hide Asthma and Allergy Research Centre, Isle of Wight, UK.\\nNIHR Southampton Biomedical Research Centre, Southampton General Hospital, Southampton, UK.'}, {'lastname': 'Arshad', 'firstname': 'Syed Hasan', 'initials': 'SH', 'affiliation': 'Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.\\nDavid Hide Asthma and Allergy Research Centre, Isle of Wight, UK.\\nNIHR Southampton Biomedical Research Centre, Southampton General Hospital, Southampton, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/cea.14459', 'xml': <Element 'PubmedArticle' at 0x109a17830>}\n",
      "{'pubmed_id': '38317271', 'title': 'New targets for type 2-low asthma.', 'abstract': 'Asthma is characterized by airway obstruction and inflammation, and presents significant diagnostic and treatment challenges. The concept of endotypes has improved understanding of the mechanisms of asthma and has stimulated the development of effective treatment strategies. Sputum profiles may be used to classify asthma into two major inflammatory types: type 2-high (T2H) and type 2-low (T2L) asthma. T2H, characterized by elevated type 2 inflammation, has been extensively studied and several effective biologic treatments have been developed. However, managing T2L is more difficult due to the lack of reliable biomarkers for accurate diagnosis and classification. Additionally, conventional anti-inflammatory therapy does not completely control the symptoms of T2L; therefore, further research is needed to identify effective biologic treatments. This review provides new insights into the clinical characteristics and underlying mechanisms of severe T2L and investigates potential therapeutic approaches to control the disease.', 'keywords': ['Asthma', 'Biomarker', 'Mechanism', 'Neutrophil', 'Therapeutics'], 'journal': 'The Korean journal of internal medicine', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Quoc', 'firstname': 'Quang Luu', 'initials': 'QL', 'affiliation': 'Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.\\nDepartment of Biomedical Sciences, Graduate School of Ajou University, Suwon, Korea.'}, {'lastname': 'Choi', 'firstname': 'Youngwoo', 'initials': 'Y', 'affiliation': 'Department of Biomaterials Science (BK21 FOUR Program), College of Natural Resources and Life Science, Pusan National University, Miryang, Korea.'}, {'lastname': 'Hur', 'firstname': 'Gyu-Young', 'initials': 'GY', 'affiliation': 'Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.'}, {'lastname': 'Park', 'firstname': 'Hae-Sim', 'initials': 'HS', 'affiliation': 'Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.\\nDepartment of Biomedical Sciences, Graduate School of Ajou University, Suwon, Korea.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3904/kjim.2023.299', 'xml': <Element 'PubmedArticle' at 0x108ebf100>}\n",
      "{'pubmed_id': '38317239\\n30741503\\n24337046\\n34556999\\n22192725\\n10856170\\n26541520\\n12480423\\n28190087\\n35592385\\n12554904\\n15347851\\n16608960\\n29943875\\n24797157\\n18480428\\n11822788\\n29720689\\n14597485\\n36211428\\n29496785\\n29445341\\n32726465\\n18476815\\n34062119\\n31870423\\n30954475\\n26653891\\n33692365\\n28825705\\n30089906\\n33597522\\n31819264\\n18174546\\n31209336\\n35831901\\n34118928\\n32907887\\n31727692\\n36439114\\n34010630\\n34364680\\n32494573\\n33348630\\n30815784\\n22167364\\n22108300\\n11029371\\n7943177\\n8579115\\n31704734\\n31231035\\n33397719\\n19545261\\n15324740\\n30323811\\n28784414\\n19283718\\n28518154\\n26121748\\n29930549\\n20338742\\n36426949\\n25930193\\n25123451\\n26976823\\n29458975\\n36521490\\n18583575\\n36287613\\n31472157\\n33209301\\n26371837\\n10861089\\n18653623\\n31417560', 'title': 'Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.', 'abstract': 'Asthma is a heterogeneous disease characterized by airway inflammation and remodeling, whose pathogenetic complexity was associated with abnormal responses of various cell types in the lung. The specific interactions between immune and stromal cells, crucial for asthma pathogenesis, remain unclear. This study aims to determine the key cell types and their pathological mechanisms in asthma through single-cell RNA sequencing (scRNA-seq).\\nA 16-week mouse model of house dust mite (HDM) induced asthma (n\\u2009=\\u20093) and controls (n\\u2009=\\u20093) were profiled with scRNA-seq.\\xa0The cellular composition and gene expression profiles were assessed by bioinformatic analyses, including cell enrichment analysis, trajectory analysis, and Gene Set Enrichment Analysis. Cell-cell communication analysis was employed to investigate the ligand-receptor interactions.\\nThe asthma model results in airway inflammation coupled with airway remodeling and hyperresponsiveness. Single-cell analysis revealed notable changes in cell compositions and heterogeneities associated with airway inflammation and remodeling. GdT17 cells were identified to be a primary cellular source of IL-17, related to inflammatory exacerbation, while a subpopulation of alveolar macrophages exhibited numerous significantly up-regulated genes involved in multiple pathways related to neutrophil activities in asthma. A distinct fibroblast subpopulation, marked by elevated expression levels of numerous contractile genes and their regulators, was observed in increased airway smooth muscle layer by immunofluorescence analysis. Asthmatic stromal-immune cell communication significantly strengthened, particularly involving GdT17 cells, and macrophages interacting with fibroblasts. CXCL12/CXCR4 signaling was remarkedly up-regulated in asthma, predominantly bridging the interaction between fibroblasts and immune cell populations. Fibroblasts and macrophages could jointly interact with various immune cell subpopulations via the CCL8/CCR2 signaling. In particular, fibroblast-macrophage cell circuits played a crucial role in the development of airway inflammation and remodeling through IL1B paracrine signaling.\\nOur study established a mouse model of asthma that recapitulated key pathological features of asthma. ScRNA-seq analysis revealed the cellular landscape, highlighting key pathological cell populations associated with asthma pathogenesis. Cell-cell communication analysis identified the crucial ligand-receptor interactions contributing to airway inflammation and remodeling. Our findings emphasized the significance of cell-cell communication in bridging the possible causality between airway inflammation and remodeling, providing valuable hints for therapeutic strategies for asthma.', 'keywords': ['Airway inflammation', 'Airway remodeling', 'Asthma', 'Cell-cell communication', 'Single-cell RNA-sequencing'], 'journal': 'Respiratory research', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Yu', 'firstname': 'Xiu', 'initials': 'X', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China.\"}, {'lastname': 'Li', 'firstname': 'Lifei', 'initials': 'L', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China.\"}, {'lastname': 'Cai', 'firstname': 'Bicheng', 'initials': 'B', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China.\"}, {'lastname': 'Zhang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': \"Department of Infectious Diseases, The First Affiliated Hospital (Shenzhen People's Hospital), School of Medicine, Southern University of Science and Technology, Shenzhen, 518020, China.\"}, {'lastname': 'Liu', 'firstname': 'Quan', 'initials': 'Q', 'affiliation': 'Department of Biochemistry, Key University Laboratory of Metabolism and Health of Guangdong, School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, China.'}, {'lastname': 'Li', 'firstname': 'Nan', 'initials': 'N', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China.\"}, {'lastname': 'Shi', 'firstname': 'Xing', 'initials': 'X', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China.\"}, {'lastname': 'Yu', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'Longgang Central Hospital of Shenzhen, LongGang District, Shenzhen, 518116, China.'}, {'lastname': 'Chen', 'firstname': 'Rongchang', 'initials': 'R', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China. chenrc@vip.163.com.\"}, {'lastname': 'Qiu', 'firstname': 'Chen', 'initials': 'C', 'affiliation': \"Key Laboratory of Shenzhen Respiratory Diseases, Institute of Shenzhen Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, China. qiuchen@email.jnu.edu.cn.\"}], 'methods': None, 'conclusions': None, 'results': 'The asthma model results in airway inflammation coupled with airway remodeling and hyperresponsiveness. Single-cell analysis revealed notable changes in cell compositions and heterogeneities associated with airway inflammation and remodeling. GdT17 cells were identified to be a primary cellular source of IL-17, related to inflammatory exacerbation, while a subpopulation of alveolar macrophages exhibited numerous significantly up-regulated genes involved in multiple pathways related to neutrophil activities in asthma. A distinct fibroblast subpopulation, marked by elevated expression levels of numerous contractile genes and their regulators, was observed in increased airway smooth muscle layer by immunofluorescence analysis. Asthmatic stromal-immune cell communication significantly strengthened, particularly involving GdT17 cells, and macrophages interacting with fibroblasts. CXCL12/CXCR4 signaling was remarkedly up-regulated in asthma, predominantly bridging the interaction between fibroblasts and immune cell populations. Fibroblasts and macrophages could jointly interact with various immune cell subpopulations via the CCL8/CCR2 signaling. In particular, fibroblast-macrophage cell circuits played a crucial role in the development of airway inflammation and remodeling through IL1B paracrine signaling.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12931-024-02706-4\\n10.1183/09031936.00202013\\n10.2147/JAA.S327659\\n10.1111/j.1365-2222.2011.03917.x\\n10.1067/mai.2000.106155\\n10.1183/13993003.01196-2014\\n10.1016/S0140-6736(02)11679-5\\n10.1007/s00441-016-2566-8\\n10.2147/JAA.S267222\\n10.1136/thorax.58.2.163\\n10.1385/CRIAI:27:1:059\\n10.1378/chest.129.4.1068\\n10.1111/resp.13360\\n10.1007/s40265-014-0213-9\\n10.1164/rccm.200711-1754OC\\n10.1007/PL00000243\\n10.1038/s41598-018-24574-x\\n10.1164/rccm.200308-1094OC\\n10.3389/fimmu.2022.923235\\n10.3389/fphar.2018.00049\\n10.1111/bph.15216\\n10.2144/000112729\\n10.1016/j.cell.2021.04.048\\n10.1186/s13059-019-1874-1\\n10.1016/j.cels.2019.03.003\\n10.1186/s13059-015-0844-5\\n10.1038/s41467-021-21865-2\\n10.1038/nmeth.4402\\n10.1038/s41586-018-0414-6\\n10.1038/s41467-021-21246-9\\n10.1038/s41592-019-0667-5\\n10.1164/rccm.200706-958OC\\n10.1038/s41591-019-0468-5\\n10.1186/s12931-022-02108-4\\n10.1186/s12967-021-02812-7\\n10.3389/fimmu.2022.1040442\\n10.1016/j.devcel.2021.04.027\\n10.1016/j.mam.2021.100995\\n10.1007/s10565-019-09470-y\\n10.1136/thoraxjnl-2011-200606\\n10.1165/rcmb.2011-0293OC\\n10.1164/ajrccm.162.4.9909044\\n10.1016/j.immuni.2019.05.014\\n10.1111/j.1365-2222.2009.03302.x\\n10.1016/j.it.2004.07.006\\n10.3389/fimmu.2018.02220\\n10.1016/j.it.2017.07.003\\n10.1002/eji.200839120\\n10.1038/ni.3726\\n10.1172/JCI80911\\n10.3389/fimmu.2018.00888\\n10.1016/j.rmed.2010.02.018\\n10.4049/jimmunol.2200288\\n10.1016/j.jaci.2015.02.032\\n10.1186/s12931-014-0090-5\\n10.1093/intimm/dxw012\\n10.1016/j.cellimm.2018.02.001\\n10.1016/j.molcel.2022.11.017\\n10.1164/rccm.200801-061OC\\n10.1164/rccm.202206-1183OC\\n10.1016/j.chest.2019.08.1917\\n10.1002/cti2.1205\\n10.1016/j.jaci.2015.07.037\\n10.4049/jimmunol.165.1.499\\n10.1677/JOE-08-0028\\n10.3389/fimmu.2019.01784', 'xml': <Element 'PubmedArticle' at 0x108ebd080>}\n",
      "{'pubmed_id': '38316709\\n19912154\\n29438602\\n16393316\\n2513902\\n11854343\\n24912652\\n27638139\\n25413686\\n30600099\\n11700245\\n31278168\\n22566627\\n31077604\\n16751000\\n33055153', 'title': 'Does having siblings really protect against childhood atopic diseases? A total population and within-family analysis.', 'abstract': 'The association between having older siblings and decreased risk for atopic symptoms is well-established. This has been interpreted as evidence for the microbiota hypothesis, i.e. that increased early-childhood microbial exposure caused by siblings protects from immune hypersensitivities. However, possible confounders of the association have received little attention. We used register data on Finnish cohorts born in 1995-2004 (N\\u2009=\\u2009559,077) to assess medication purchases for atopic diseases: antihistamines, eczema medication, asthma medication and Epinephrine. We modelled the probability of atopic medication purchases at ages 0-15 by birth order controlling for important observed confounders and all unobserved genetic and environmental characteristics shared by siblings in a within-family fixed effects model. We further studied medication purchases among first-borns according to the age difference with younger siblings to assess whether having younger siblings in early childhood is beneficial. Having older siblings was associated with a lower probability of atopic medication purchases. Compared to first-borns, the probability was 10-20% lower among second-borns, 20-40% lower among third-borns, and 30-70% lower among subsequent children, depending on medication type. Confounding accounted for up to 75% of these differences, particularly for asthma and eczema medication, but significant differences by birth order remained across all medication types. Among first-borns, a smaller age difference with younger siblings was related to a lower likelihood of atopic medication use. Our results, based on designs that account for unobserved confounding, show that exposure to siblings in early childhood, protects from atopic diseases, and thus strongly support the microbiota hypothesis.', 'keywords': ['Allergy', 'Asthma', 'Atopic disease', 'Atopic eczema', 'Birth order', 'Family size', 'Fixed effects', 'Medication', 'Microbiota hypothesis'], 'journal': 'European journal of epidemiology', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Luukkonen', 'firstname': 'Juha', 'initials': 'J', 'affiliation': 'Population Research Unit, University of Helsinki, Helsinki, Finland. juha.x.luukkonen@helsinki.fi.\\nMax Planck-University of Helsinki Center for Social Inequalities in Population Health, Helsinki, Finland. juha.x.luukkonen@helsinki.fi.'}, {'lastname': 'Moustgaard', 'firstname': 'Heta', 'initials': 'H', 'affiliation': 'Population Research Unit, University of Helsinki, Helsinki, Finland. heta.moustgaard@helsinki.fi.\\nMax Planck-University of Helsinki Center for Social Inequalities in Population Health, Helsinki, Finland. heta.moustgaard@helsinki.fi.\\nHelsinki Institute for Social Sciences and Humanities, University of Helsinki, Helsinki, Finland. heta.moustgaard@helsinki.fi.'}, {'lastname': 'Martikainen', 'firstname': 'Pekka', 'initials': 'P', 'affiliation': 'Population Research Unit, University of Helsinki, Helsinki, Finland.\\nMax Planck-University of Helsinki Center for Social Inequalities in Population Health, Helsinki, Finland.\\nMax Planck Institute for Demographic Research, Rostock, Germany.'}, {'lastname': 'Remes', 'firstname': 'Hanna', 'initials': 'H', 'affiliation': 'Population Research Unit, University of Helsinki, Helsinki, Finland.\\nMax Planck-University of Helsinki Center for Social Inequalities in Population Health, Helsinki, Finland.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s10654-024-01104-w\\n10.1111/j.1398-9995.2009.02244.x\\n10.3402/ecrj.v2.24642\\n10.1111/j.1365-2222.2005.02379.x\\n10.1136/bmj.299.6710.1259\\n10.1136/jech.56.3.209\\n10.1111/cea.12349\\n10.1002/bdrc.21114\\n10.1111/ped.13168\\n10.1111/all.12549\\n10.1016/j.jaci.2018.09.025\\n10.1093/aje/154.10.909\\n10.1136/thoraxjnl-2018-211793\\n10.1073/pnas.1205624109\\n10.1111/all.13868\\n10.1111/cea.12547\\n10.1007/s004310051024\\n10.1016/j.jaci.2006.03.008\\n10.1126/sciadv.aba2578', 'xml': <Element 'PubmedArticle' at 0x10a383470>}\n",
      "{'pubmed_id': '38316671\\n29066321\\n37369139\\n34601221\\n35922728\\n29895977\\n35370998\\n36975714\\n37330732\\n37230032\\n30852246\\n34510013\\n34625291\\n35572500\\n27782356\\n22987325\\n24162904\\n30344008\\n28425576\\n35835804\\n31922435\\n32922208\\n15530839\\n32884941\\n25447441\\n32721432\\n26366410\\n28238747\\n31281533\\n37169970\\n29986939\\n37270928\\n36870143\\n34974799', 'title': 'Mesenchymal Stromal Cell Therapy Alleviates Ovalbumin-Induced Chronic Airway Remodeling by Suppressing M2 Macrophage Polarization.', 'abstract': 'Chronic asthma is characterized by airway hyperresponsiveness, inflammation, and remodeling. Previous studies have shown that mesenchymal stromal/stem cells (MSCs) exert anti-inflammatory effects on asthma via regulation of the immune cells. However, the therapeutic mechanism of MSCs, especially the mechanism of airway remodeling in chronic asthma, remains to be elucidated. Here, we aimed to investigate the therapeutic effect of MSCs on airway remodeling in chronic asthma and explored the mechanisms by analyzing the polarization phenotype of macrophages in the lungs. We established a mouse model of chronic asthma induced by ovalbumin (OVA) and evaluated the effect of MSCs on airway remodeling. The data showed that MSCs treatment before the challenge exerted protective effects on OVA-induced chronic asthma, i.e., decreased the inflammatory cell infiltration, Th2 cytokine levels, subepithelial extracellular matrix deposition, and transforming growth factor β (TGF-β)/Smad signaling. Additionally, we found that MSCs treatment markedly suppressed macrophage M2 polarization in lung tissue. At the same time, MSCs treatment inhibited NF-κB p65 nuclear translocation, ER stress, and oxidative stress in the OVA-induced chronic allergic airway remodeling mice model. In conclusion, these results demonstrated that MSCs treatment prevents OVA-induced chronic airway remodeling by suppressing macrophage M2 polarization, which may be associated with the dual inhibition of ER stress and oxidative stress. This discovery may provide a new theoretical basis for the future clinical application of MSCs.', 'keywords': ['ER stress', 'airway remodeling', 'asthma.', 'macrophage polarization', 'mesenchymal stromal/stem cells', 'oxidative stress'], 'journal': 'Inflammation', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Yu', 'firstname': 'Haiyang', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China.'}, {'lastname': 'Zhu', 'firstname': 'Guiyin', 'initials': 'G', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China.'}, {'lastname': 'Qin', 'firstname': 'Qiangqiang', 'initials': 'Q', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China.'}, {'lastname': 'Wang', 'firstname': 'Xueting', 'initials': 'X', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China.'}, {'lastname': 'Guo', 'firstname': 'Xuejun', 'initials': 'X', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China. guoxuejun@xinhuamed.com.cn.'}, {'lastname': 'Gu', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 KongJiang Road, Shanghai, 200092, China. guwen@xinhuamed.com.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.', 'doi': '10.1007/s10753-024-01977-9\\n10.1002/alr.21609\\n10.1016/j.trsl.2017.09.002\\n10.1165/rcmb.2022-0301OC\\n10.1038/s41419-023-05876-z\\n10.4168/aair.2021.13.2.312\\n10.1016/j.phymed.2021.153759\\n10.1007/s12035-022-02967-4\\n10.1038/s41581-018-0023-5\\n10.3389/fimmu.2022.835005\\n10.1111/all.15729\\n10.1016/j.jcyt.2023.05.014\\n10.1016/j.intimp.2023.110367\\n10.1371/journal.pone.0196048\\n10.1186/s13287-020-02072-0\\n10.1016/j.molimm.2019.02.017\\n10.1136/thoraxjnl-2020-215979\\n10.1016/j.mam.2021.101026\\n10.3389/fimmu.2022.883885\\n10.1186/s13287-021-02591-4\\n10.1111/resp.12926\\n10.1002/stem.1241\\n10.1007/978-1-4614-8603-9_6\\n10.1016/j.stemcr.2018.09.012\\n10.1002/sctm.16-0398\\n10.1038/s41598-022-16165-8\\n10.1080/1547691x.2019.1706671\\n10.1155/2020/7835284\\n10.1016/j.it.2004.09.015\\n10.1155/2020/5137349\\n10.1038/s41419-020-2329-z\\n10.4168/aair.2017.9.1.25\\n10.1016/j.yexcr.2014.10.016\\n10.1016/j.taap.2020.115162\\n10.1186/s13069-015-0022-0\\n10.1155/2015/341308\\n10.1016/j.jaci.2017.01.024\\n10.1186/s13287-020-01610-0\\n10.7150/thno.33638\\n10.1016/j.bbadis.2016.11.005\\n10.1007/s00011-023-01733-z\\n10.1042/bst20180079\\n10.1016/j.intimp.2023.110405\\n10.1016/j.imbio.2023.152361\\n10.1080/15384101.2021.2020432', 'xml': <Element 'PubmedArticle' at 0x10ab90d60>}\n",
      "{'pubmed_id': '38316441', 'title': '', 'abstract': None, 'keywords': [], 'journal': 'The European respiratory journal', 'publication_date': datetime.date(2024, 2, 6), 'authors': [], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1183/13993003.E6301-2024', 'xml': <Element 'PubmedArticle' at 0x109587ab0>}\n",
      "{'pubmed_id': '38316270', 'title': 'Unveiling the reasons for disparities in prevalence of asthma and allergic conditions in Black children: The role of socioeconomic status.', 'abstract': None, 'keywords': ['Asthma', 'atopic dermatitis', 'disparities', 'race', 'socioeconomic status'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Federman', 'firstname': 'Alex', 'initials': 'A', 'affiliation': 'Division of General Internal Medicine, Icahn School of Medicine, New York, NY.'}, {'lastname': 'Wisnivesky', 'firstname': 'Juan P', 'initials': 'JP', 'affiliation': 'Division of General Internal Medicine, Icahn School of Medicine, New York, NY; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine, New York, NY. Electronic address: juanwishnivesky@mssm.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaci.2024.01.020', 'xml': <Element 'PubmedArticle' at 0x1095867f0>}\n",
      "{'pubmed_id': '38316185', 'title': '\"The Sensitivity of Food Allergy Skin Testing Soon After Food-Induced Anaphylaxis\".', 'abstract': None, 'keywords': ['Anaphylaxis', 'Food Allergy', 'Post Anaphylaxis Mast Cell Anergy (PAMA)', 'Skin Testing', 'diagnostic testing', 'refractory'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Kraft', 'firstname': 'Monica T', 'initials': 'MT', 'affiliation': 'Division of Allergy and Immunology, Department of Otolaryngology, The Ohio State University Wexner Medical Center. Electronic address: monica.kraft@osumc.edu.'}, {'lastname': 'Coletta', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Family Allergy & Asthma, Columbus, OH.'}, {'lastname': 'Mikhail', 'firstname': 'Irene', 'initials': 'I', 'affiliation': \"Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital.\"}, {'lastname': 'Prince', 'firstname': 'Benjamin T', 'initials': 'BT', 'affiliation': \"Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital.\"}, {'lastname': 'Scherzer', 'firstname': 'Rebecca', 'initials': 'R', 'affiliation': \"Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital.\"}, {'lastname': 'Eisner', 'firstname': 'Mariah', 'initials': 'M', 'affiliation': \"Biostatistics Resource, Nationwide Children's Hospital.\"}, {'lastname': 'Mustillo', 'firstname': 'Peter', 'initials': 'P', 'affiliation': \"Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2024.01.041', 'xml': <Element 'PubmedArticle' at 0x109585030>}\n",
      "{'pubmed_id': '38316184', 'title': 'Core function in adults with severe asthma and its relationship with breathing symptoms.', 'abstract': 'People with asthma may have skeletal muscle dysfunction but data describing core function in severe asthma are limited.\\nTo compare core function between people with severe asthma and healthy controls and to determine the difference between males and females. Furthermore, we aimed to investigate the association between core function and breathing symptoms.\\nAdults with diagnosis of severe asthma, and healthy controls undertook an assessment that included three core function tests: Partial Sit-up, Biering-Sorensen, and Side Bridge. Breathing symptoms were assessed by the modified Medical Research Council (mMRC) dyspnoea scale, modified Borg scale, and Nijmegen questionnaire.\\nPeople with severe asthma (n=136) (38% male, age median[Q1-Q3] 59[45-68] years, body mass index 30[26-37]kg/m\\nAdults with severe asthma have worse core function compared to their control counterparts, independent of sex. Furthermore, as core function decreases breathing symptoms increase.', 'keywords': ['Abdominal Muscles', 'Asthma', 'Breathlessness', 'Dyspnoea', 'Physical Endurance', 'Skeletal Muscles'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Oliveira', 'firstname': 'Joice M', 'initials': 'JM', 'affiliation': 'Graduate Program in Rehabilitation Sciences, Pitágoras-Unopar University, Brazil; Laboratory of Research in Respiratory Physiotherapy (LFIP), Department of Physiotherapy, State University of Londrina, Brazil; Asthma and Breathing Research Centre, Hunter Medical Research Institute, Australia; School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Australia. Electronic address: joice.mara.oli@gmail.com.'}, {'lastname': 'Clark', 'firstname': 'Vanessa L', 'initials': 'VL', 'affiliation': 'Asthma and Breathing Research Centre, Hunter Medical Research Institute, Australia; School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Australia. Electronic address: vanessa.clark@newcastle.edu.au.'}, {'lastname': 'Furlanetto', 'firstname': 'Karina C', 'initials': 'KC', 'affiliation': 'Graduate Program in Rehabilitation Sciences, Pitágoras-Unopar University, Brazil; Laboratory of Research in Respiratory Physiotherapy (LFIP), Department of Physiotherapy, State University of Londrina, Brazil. Electronic address: ka_furlanetto@hotmail.com.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'Asthma and Breathing Research Centre, Hunter Medical Research Institute, Australia; School of Medicine and Public Health, College of Health, Medicine and Wellbeing The University of Newcastle, NSW Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW Australia. Electronic address: peter.gibson@newcastle.edu.au.'}, {'lastname': 'McDonald', 'firstname': 'Vanessa M', 'initials': 'VM', 'affiliation': 'Asthma and Breathing Research Centre, Hunter Medical Research Institute, Australia; School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW Australia. Electronic address: vanessa.mcdonald@newcastle.edu.au.'}], 'methods': 'Adults with diagnosis of severe asthma, and healthy controls undertook an assessment that included three core function tests: Partial Sit-up, Biering-Sorensen, and Side Bridge. Breathing symptoms were assessed by the modified Medical Research Council (mMRC) dyspnoea scale, modified Borg scale, and Nijmegen questionnaire.', 'conclusions': 'Adults with severe asthma have worse core function compared to their control counterparts, independent of sex. Furthermore, as core function decreases breathing symptoms increase.', 'results': 'People with severe asthma (n=136) (38% male, age median[Q1-Q3] 59[45-68] years, body mass index 30[26-37]kg/m', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.045', 'xml': <Element 'PubmedArticle' at 0x1095f5260>}\n",
      "{'pubmed_id': '38316183', 'title': \"Ockham's Razor: the application of parsimonious medicine in allergy/immunology.\", 'abstract': \"The spectacular advances of modern medicine have distracted clinicians from applying the age-old principles of thorough history and examination followed by only ordering tests relevant to the patient's presentation. The most obvious diagnosis is the most likely and should be addressed first. Ockham's razor, or parsimonious medicine, should be applied because plurality of diagnoses is less likely than a single explanation. Component resolved diagnostics and highly effective biological therapies for allergy/immune mediated diseases have been highly effective when used by specialist allergy services. However, they are accessed too easily and frequently, either before diagnostically appropriate allergy skin testing and challenge have been employed or before the reasons for poor disease control have been investigated. The current fashion to test for vitamin D insufficiency in patients with poorly controlled allergic diseases has rarely achieved benefit but significantly increased costs. There are considerable health/economic benefits from following the proven value of a thorough clinical history, examination, focused allergy/immunology testing and the judicious use of Ockham's razor.\", 'keywords': ['Allergy tests', 'Biological therapies', 'Component Resolved Diagnostics', 'Health/economics', 'Ockham’s razor', 'Vitamin D', 'asthma', 'eczema'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Warner', 'firstname': 'John O', 'initials': 'JO', 'affiliation': 'Emeritus Professor of Paediatrics National Heart and Lung Institute, Imperial College, London, Hon. Professor University of Cape Town.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.042', 'xml': <Element 'PubmedArticle' at 0x10a09b060>}\n",
      "{'pubmed_id': '38316182', 'title': 'The use of albuterol/budesonide as reliever therapy to reduce asthma exacerbations.', 'abstract': 'Prevention of asthma exacerbations and reduction of systemic corticosteroid burden remain unmet needs in asthma. US asthma guidelines recommend concomitant short-acting β', 'keywords': ['Anti-inflammatory reliever', 'As-needed', 'Flares', 'Inhaled corticosteroids', 'Nongenomic', 'Reliever', 'Rescue', 'Short-acting beta-2-agonist'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 6), 'authors': [{'lastname': 'Panettieri', 'firstname': 'Reynold A', 'initials': 'RA', 'affiliation': 'Rutgers Institute for Translational Medicine and Science, The State University of New Jersey, New Brunswick, NJ, United States; Child Health Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.'}, {'lastname': 'Chipps', 'firstname': 'Bradley', 'initials': 'B', 'affiliation': 'Capital Allergy & Respiratory Disease Center, Sacramento, CA, United States. Electronic address: BChipps@CapitalAllergy.com.'}, {'lastname': 'Skolnik', 'firstname': 'Neil', 'initials': 'N', 'affiliation': 'Abington Family Medicine, Jenkintown, PA, USA; Department of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.'}, {'lastname': 'George', 'firstname': 'Maureen', 'initials': 'M', 'affiliation': 'Department of Nursing, Columbia University School of Nursing, New York, NY, United States.'}, {'lastname': 'Murphy', 'firstname': 'Kevin', 'initials': 'K', 'affiliation': 'Boys Town National Research Hospital, Section of Adult and Pediatric Allergy and Pediatric Pulmonary, Boys Town, NE, United States.'}, {'lastname': 'Lugogo', 'firstname': 'Njira', 'initials': 'N', 'affiliation': 'Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.043', 'xml': <Element 'PubmedArticle' at 0x10a099800>}\n",
      "{'pubmed_id': '38316016\\n32020334\\n35144987\\n36752798\\n31285291\\n35283171\\n35350765\\n31543428\\n29782217\\n33710614\\n37063895\\n28296614\\n31529718\\n31593702\\n36028446\\n35522053\\n31371974\\n37076824\\n36043197\\n23688323\\n35487538\\n35989284\\n35261333\\n35636689\\n35703018\\n29782224\\n28478972\\n32943257\\n34681869', 'title': 'Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China.', 'abstract': 'Dupilumab has been approved for the treatment of severe asthma with type 2 inflammation by inhibiting interleukin (IL)-4 and IL-13 signaling. However, dupilumab-induced hypereosinophilia (HE) has been reported and should not be ignored. The aim of this study was to investigate the efficacy of dupilumab in Chinese patients with severe asthma, whether HE affects its efficacy, and the possible risk factors for HE.\\n20 patients with severe asthma who received dupilumab treatment for at least 12\\u2009months in the First Affiliated Hospital of Guangzhou Medical University from 2019 to 2022 were included. We compared clinical data and laboratory tests results before dupilumab treatment and at 4 and 12\\u2009months after treatment. Based on whether dupilumab treatment triggers HE defined as blood eosinophil count (BEC) ≥ 1.5\\u2009×\\u200910\\nThe patients showed a significant increase in asthma control test (ACT) scores, a decrease in the number of exacerbations, a decrease in the proportion of patients taking an oral corticosteroid (OCS) and in the dose, and a significant improvement in the pulmonary function parameters FEV1/FVC (%) and FEV1 (% predicted) after 4 and 12\\u2009months of treatment with dupilumab. For type 2 inflammatory biomarkers, the levels of fractional concentration of exhaled nitric oxide (FeNO), sputum eosinophil count percentage (SEC%) and total immunoglobulin E (TIgE) decreased significantly, whereas BEC were higher after 4\\u2009months of treatment, but returned to baseline levels after 12\\u2009months. 8 patients (40%) developed asymptomatic HE after dupilumab, and the efficacy was not significantly different between the HE and non-HE groups. The earliest BEC elevation appeared at 1\\u2009month after treatment, but most of them declined after 6\\u2009months, and basically returned to the baseline level around 12\\u2009months of treatment. In addition, we further found that when patients had FeNO ≥ 60\\u2009ppb, food allergens positive and combined eosinophilic otitis media (EOM), their BEC increased significantly more than that of the control group after 4\\u2009months as well as 12\\u2009months of treatment.\\nThis study demonstrated that dupilumab was efficacious in Chinese patients with severe asthma, and some patients developed asymptomatic, self-limited HE, which did not affect its efficacy. Additionally, FeNO ≥60\\u2009ppb, food allergens positive, and co-morbidities with EOM may be the risk factors for developing HE.', 'keywords': ['Dupilumab', 'efficacy', 'eosinophils', 'hypereosinophilia', 'severe asthma'], 'journal': 'Annals of medicine', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Li', 'firstname': 'You', 'initials': 'Y', 'affiliation': \"Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.\\nDepartment of Pulmonary and Critical Care Medicine, Shenzhen Guangming District People's Hospital, Shenzhen, China.\"}, {'lastname': 'Deng', 'firstname': 'Zhenan', 'initials': 'Z', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Wen', 'firstname': 'Junjie', 'initials': 'J', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Ou', 'firstname': 'Changxing', 'initials': 'C', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Cen', 'firstname': 'Xiaomin', 'initials': 'X', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Liao', 'firstname': 'Yongkang', 'initials': 'Y', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Qingling', 'initials': 'Q', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Xie', 'firstname': 'Jiaxing', 'initials': 'J', 'affiliation': 'Department of pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}], 'methods': None, 'conclusions': None, 'results': 'The patients showed a significant increase in asthma control test (ACT) scores, a decrease in the number of exacerbations, a decrease in the proportion of patients taking an oral corticosteroid (OCS) and in the dose, and a significant improvement in the pulmonary function parameters FEV1/FVC (%) and FEV1 (% predicted) after 4 and 12\\u2009months of treatment with dupilumab. For type 2 inflammatory biomarkers, the levels of fractional concentration of exhaled nitric oxide (FeNO), sputum eosinophil count percentage (SEC%) and total immunoglobulin E (TIgE) decreased significantly, whereas BEC were higher after 4\\u2009months of treatment, but returned to baseline levels after 12\\u2009months. 8 patients (40%) developed asymptomatic HE after dupilumab, and the efficacy was not significantly different between the HE and non-HE groups. The earliest BEC elevation appeared at 1\\u2009month after treatment, but most of them declined after 6\\u2009months, and basically returned to the baseline level around 12\\u2009months of treatment. In addition, we further found that when patients had FeNO ≥ 60\\u2009ppb, food allergens positive and combined eosinophilic otitis media (EOM), their BEC increased significantly more than that of the control group after 4\\u2009months as well as 12\\u2009months of treatment.', 'copyrights': None, 'doi': '10.1080/07853890.2024.2311843\\n10.1007/s00281-020-00785-1\\n10.1183/13993003.02866-2021\\n10.1097/CM9.0000000000002556\\n10.1183/16000617.0054-2019\\n10.1016/j.pharmthera.2022.108167\\n10.1016/S0140-6736(19)31881-1\\n10.1056/NEJMoa1804092\\n10.1111/jdv.15957\\n10.1053/j.gastro.2019.09.042\\n10.1016/j.jaip.2022.06.036\\n10.18176/jiaci.0823\\n10.2147/TCRM.S207402\\n10.1186/s12890-023-02415-6\\n10.1016/j.rmcr.2022.101723\\n10.1056/NEJMoa1304048\\n10.1183/13993003.02577-2021\\n10.5582/ddt.2022.01046\\n10.1080/09546634.2022.2049588\\n10.1080/17476348.2022.2090342\\n10.1056/NEJMoa1804093\\n10.1016/S0140-6736(17)31191-1\\n10.1016/j.anl.2020.09.001\\n10.3390/ijms222011209', 'xml': <Element 'PubmedArticle' at 0x10972e9d0>}\n",
      "{'pubmed_id': '38315810', 'title': 'Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe COPD.', 'abstract': 'The role of alternative splicing in Chronic Obstructive Pulmonary Disease (COPD) is still largely unknown. We aimed to investigate the differences in alternatively splicing events between patients with mild-to-moderate and severe COPD compared to non-COPD controls and to identify splicing factors associated with aberrant alternative splicing in COPD. For this purpose, we performed genome-wide RNA-seq analysis of bronchial brushings from 23 mild-to-moderate, 121 severe COPD patients, and 23 non-COPD controls. We found a significant difference in the frequency of alternative splicing events in mild-to-moderate and severe COPD compared to non-COPD controls. There were from 2x to 8x (depending on event type) more differential alternative splicing events in the severe than in the mild-to-moderate stage. The samples from severe COPD patients showed less intron retention and more exon skipping. Interestingly, the transcript levels of the top 10 differentially expressed splicing factors were significantly correlated with the percentage of many alternatively spliced transcripts in severe COPD. The aberrant alternative splicing in severe COPD was predicted to increase the overall protein-coding capacity of gene products. In conclusion, we observed large and significant differences in alternative splicing between bronchial samples of COPD and control individuals, with more events observed in severe than in mild-to-moderate COPD. The changes in the expression of several splicing factors correlated with prevalence of alternative splicing in severe COPD. Alternative splicing can indirectly impact gene expression by changing the relative abundance of protein-coding isoforms potentially influencing pathophysiological changes. The presented results provide a better understanding of COPD-related alternative splicing changes.', 'keywords': ['COPD', 'Lung Diseases', 'RNA Splicing', 'Sequence Analysis'], 'journal': 'American journal of respiratory cell and molecular biology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Khalenkow', 'firstname': 'Dmitry', 'initials': 'D', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pulmonology and Pediatric Allergy, Groningen, Netherlands.\\nERIBA, 548577, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.'}, {'lastname': 'Brandsma', 'firstname': 'Corry-Anke', 'initials': 'CA', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pathology and Medical Biology, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.'}, {'lastname': 'Timens', 'firstname': 'Wim', 'initials': 'W', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pathology and Medical Biology, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.'}, {'lastname': 'Choy', 'firstname': 'David F', 'initials': 'DF', 'affiliation': 'Genentech Inc, 7412, South San Francisco, California, United States.'}, {'lastname': 'Grimbaldeston', 'firstname': 'Michele A', 'initials': 'MA', 'affiliation': 'Genentech Inc, 7412, South San Francisco, California, United States.'}, {'lastname': 'Rosenberger', 'firstname': 'Carrie M', 'initials': 'CM', 'affiliation': 'Genentech Inc, 7412, South San Francisco, California, United States.'}, {'lastname': 'Slebos', 'firstname': 'Dirk-Jan', 'initials': 'DJ', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pulmonary diseases, Groningen, Netherlands.'}, {'lastname': 'Kerstjens', 'firstname': 'Huib A M', 'initials': 'HAM', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pulmonology and Tuberculosis, Groningen, Netherlands.'}, {'lastname': 'Faiz', 'firstname': 'Alen', 'initials': 'A', 'affiliation': 'University of Technology Sydney, 1994, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, New South Wales, Australia.'}, {'lastname': 'Koppelman', 'firstname': 'Gerard H', 'initials': 'GH', 'affiliation': \"University Medical Centre Groningen, 10173, Department of Pulmonology and Pediatric Allergy, Beatrix Children's Hospital, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.\"}, {'lastname': 'Nawijn', 'firstname': 'Martijn C', 'initials': 'MC', 'affiliation': 'University Medical Centre Groningen, 10173, Lab allergology and pulmonary diseases, department of pathology and medical biology, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.'}, {'lastname': 'van den Berge', 'firstname': 'Maarten', 'initials': 'M', 'affiliation': 'University Medical Centre Groningen, 10173, Department of Pulmonary Diseases, Groningen, Netherlands.\\nUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.'}, {'lastname': 'Guryev', 'firstname': 'Victor', 'initials': 'V', 'affiliation': 'University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.\\nERIBA, 548577, Groningen, Netherlands; v.guryev@umcg.nl.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1165/rcmb.2023-0296OC', 'xml': <Element 'PubmedArticle' at 0x10b073ce0>}\n",
      "{'pubmed_id': '38315527', 'title': 'Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.', 'abstract': 'Cough is a common symptom during and after COVID-19 infection; however, few studies have described the cough profiles of COVID-19.\\nThe aim of this study was to investigate the prevalence, severity, and associated risk factors of severe and persistent cough in individuals with COVID-19 during the latest wave of the Omicron variant in China.\\nIn this nationwide cross-sectional study, we collected information of the characteristics of cough from individuals with infection of the SARS-CoV-2 Omicron variant using an online questionnaire sent between December 31, 2022, and January 11, 2023.\\nThere were 11,718 (n=7978, 68.1% female) nonhospitalized responders, with a median age of 37 (IQR 30-47) years who responded at a median of 16 (IQR 12-20) days from infection onset to the time of the survey. Cough was the most common symptom, occurring in 91.7% of participants, followed by fever, fatigue, and nasal congestion (68.8%-87.4%). The median cough visual analog scale (VAS) score was 70 (IQR 50-80) mm. Being female (odds ratio [OR] 1.31, 95% CI 1.20-1.43), having a COVID-19 vaccination history (OR 1.71, 95% CI 1.37-2.12), current smoking (OR 0.48, 95% CI 0.41-0.58), chronic cough (OR 2.04, 95% CI 1.69-2.45), coronary heart disease (OR 1.71, 95% CI 1.17-2.52), asthma (OR 1.22, 95% CI 1.02-1.46), and gastroesophageal reflux disease (GERD) (OR 1.21, 95% CI 1.01-1.45) were independent factors for severe cough (VAS>70, 37.4%). Among all respondents, 35.0% indicated having a productive cough, which was associated with risk factors of being female (OR 1.44, 95% CI 1.31-1.57), having asthma (OR 1.84, 95% CI 1.52-2.22), chronic cough (OR 1.44, 95% CI 1.19-1.74), and GERD (OR 1.22, 95% CI 1.01-1.47). Persistent cough (>3 weeks) occurred in 13.0% of individuals, which was associated with the risk factors of having diabetes (OR 2.24, 95% CI 1.30-3.85), asthma (OR 1.70, 95% CI 1.11-2.62), and chronic cough (OR 1.97, 95% CI 1.32-2.94).\\nCough is the most common symptom in nonhospitalized individuals with Omicron SARS-CoV-2 variant infection. Being female, having asthma, chronic cough, GERD, coronary heart disease, diabetes, and a COVID-19 vaccination history emerged as independent factors associated with severe cough, productive cough, and persistent cough.', 'keywords': ['COVID-19', 'Omicron variant', 'cough', 'nonhospitalized'], 'journal': 'JMIR public health and surveillance', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Xu', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Chen', 'firstname': 'Yuehan', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Zhan', 'firstname': 'Wenzhi', 'initials': 'W', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Chung', 'firstname': 'Kian Fan', 'initials': 'KF', 'affiliation': 'Department of Respiratory Medicine, Royal Brompton and Harefield Hospital, London, United Kingdom.\\nExperimental Studies Unit, National Heart & Lung Institute, Imperial College London, London, United Kingdom.'}, {'lastname': 'Qiu', 'firstname': 'Zhongmin', 'initials': 'Z', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, School of Medicine, Tongji Hospital, Tongji University, Shanghai, China.'}, {'lastname': 'Huang', 'firstname': 'Kewu', 'initials': 'K', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Chen', 'firstname': 'Ruchong', 'initials': 'R', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Xie', 'firstname': 'Jiaxing', 'initials': 'J', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Wang', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China.'}, {'lastname': 'Zhang', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Xuefen', 'initials': 'X', 'affiliation': 'Department of Respiratory Medicine, The First Affliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Yao', 'firstname': 'Hongmei', 'initials': 'H', 'affiliation': \"Department of Respiratory Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.\"}, {'lastname': 'Liao', 'firstname': 'Xiuqing', 'initials': 'X', 'affiliation': 'Department of Respiratory Medicine, Fuling Center Hospital of Chongqing, Chongqing, China.'}, {'lastname': 'Zhang', 'firstname': 'Yunhui', 'initials': 'Y', 'affiliation': \"The First People's Hospital of Yunnan Province, Kunming, China.\"}, {'lastname': 'Zhang', 'firstname': 'Guojun', 'initials': 'G', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.'}, {'lastname': 'Sun', 'firstname': 'Dejun', 'initials': 'D', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, the Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.\"}, {'lastname': 'Zhu', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.'}, {'lastname': 'Jiang', 'firstname': 'Shujuan', 'initials': 'S', 'affiliation': 'Department of Pulmonary Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.'}, {'lastname': 'Feng', 'firstname': 'Juntao', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.'}, {'lastname': 'Zhao', 'firstname': 'Jianping', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College of Hua Zhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Sun', 'firstname': 'Gengyun', 'initials': 'G', 'affiliation': 'Department of Respiratory Medicine, The First Affiliated Hospital of Medical University of Anhui, Hefei, China.'}, {'lastname': 'Huang', 'firstname': 'Huaqiong', 'initials': 'H', 'affiliation': 'Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Jianyong', 'initials': 'J', 'affiliation': 'The Second Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.'}, {'lastname': 'Wang', 'firstname': 'Lingwei', 'initials': 'L', 'affiliation': \"Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen, China.\"}, {'lastname': 'Wu', 'firstname': 'Feng', 'initials': 'F', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, Huizhou Third People's Hospital, Guangzhou Medical University, Huizhou, China.\"}, {'lastname': 'Li', 'firstname': 'Suyun', 'initials': 'S', 'affiliation': 'The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Pusheng', 'initials': 'P', 'affiliation': 'The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Chi', 'firstname': 'Chunhua', 'initials': 'C', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.'}, {'lastname': 'Chen', 'firstname': 'Ping', 'initials': 'P', 'affiliation': 'General Hospital of Northern Theater Command, Shenyang, China.'}, {'lastname': 'Jiang', 'firstname': 'Mei', 'initials': 'M', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'He', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Huang', 'firstname': 'Lianrong', 'initials': 'L', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Luo', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Li', 'firstname': 'Shiyue', 'initials': 'S', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Zhong', 'firstname': 'Nanshan', 'initials': 'N', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': 'Lai', 'firstname': 'Kefang', 'initials': 'K', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': 'See Acknowledgments, .'}], 'methods': None, 'conclusions': None, 'results': 'There were 11,718 (n=7978, 68.1% female) nonhospitalized responders, with a median age of 37 (IQR 30-47) years who responded at a median of 16 (IQR 12-20) days from infection onset to the time of the survey. Cough was the most common symptom, occurring in 91.7% of participants, followed by fever, fatigue, and nasal congestion (68.8%-87.4%). The median cough visual analog scale (VAS) score was 70 (IQR 50-80) mm. Being female (odds ratio [OR] 1.31, 95% CI 1.20-1.43), having a COVID-19 vaccination history (OR 1.71, 95% CI 1.37-2.12), current smoking (OR 0.48, 95% CI 0.41-0.58), chronic cough (OR 2.04, 95% CI 1.69-2.45), coronary heart disease (OR 1.71, 95% CI 1.17-2.52), asthma (OR 1.22, 95% CI 1.02-1.46), and gastroesophageal reflux disease (GERD) (OR 1.21, 95% CI 1.01-1.45) were independent factors for severe cough (VAS>70, 37.4%). Among all respondents, 35.0% indicated having a productive cough, which was associated with risk factors of being female (OR 1.44, 95% CI 1.31-1.57), having asthma (OR 1.84, 95% CI 1.52-2.22), chronic cough (OR 1.44, 95% CI 1.19-1.74), and GERD (OR 1.22, 95% CI 1.01-1.47). Persistent cough (>3 weeks) occurred in 13.0% of individuals, which was associated with the risk factors of having diabetes (OR 2.24, 95% CI 1.30-3.85), asthma (OR 1.70, 95% CI 1.11-2.62), and chronic cough (OR 1.97, 95% CI 1.32-2.94).', 'copyrights': '©Tingting Xu, Yuehan Chen, Wenzhi Zhan, Kian Fan Chung, Zhongmin Qiu, Kewu Huang, Ruchong Chen, Jiaxing Xie, Gang Wang, Min Zhang, Xuefen Wang, Hongmei Yao, Xiuqing Liao, Yunhui Zhang, Guojun Zhang, Wei Zhang, Dejun Sun, Jia Zhu, Shujuan Jiang, Juntao Feng, Jianping Zhao, Gengyun Sun, Huaqiong Huang, Jianyong Zhang, Lingwei Wang, Feng Wu, Suyun Li, Pusheng Xu, Chunhua Chi, Ping Chen, Mei Jiang, Wen He, Lianrong Huang, Wei Luo, Shiyue Li, Nanshan Zhong, Kefang Lai, China Cough Coalition. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 05.02.2024.', 'doi': '10.2196/47453', 'xml': <Element 'PubmedArticle' at 0x10b0709f0>}\n",
      "{'pubmed_id': '38315435\\n32340575\\n35059965\\n35432179\\n15727533\\n35672829\\n30705627\\n12654413\\n25280829\\n27904701\\n10903222\\n33766557\\n30059880\\n17002711\\n21704698\\n2389867\\n15791140\\n26200011\\n27249617\\n30170608\\n36494048\\n26834565\\n28572801\\n31629288\\n27575749\\n30995510\\n32738956\\n29984112\\n29763840\\n28260787\\n31175505\\n35660086\\n19109998\\n30186149\\n20021392\\n32796821\\n20005255\\n11701602\\n33641303\\n29731353\\n33862170\\n29097791\\n20451041\\n31379506\\n33727099\\n25506346\\n29751176\\n16989980\\n25168594\\n36333776\\n35967771\\n24993070\\n33823430\\n29410216\\n36367676', 'title': 'Neonatal IL-4 Over-Exposure is Accompanied by Macrophage Accumulation in Dura Mater After Instant Anti-inflammatory Cytokine Response in CSF.', 'abstract': 'Multiple studies have shown that clinical events resulting into neonatal IL-4 over-exposure, such as asthma in early life and food allergy, were associated with brain damage and that the neuroinflammation induced by them might lead to cognitive impairments, anxiety-/depressive-like behaviors. IL-4 is the most major elevated cytokine in periphery when these clinical events occur and peripheral IL-4 level positively correlates with the severity of those events. Our previous studies have verified that neonatal IL-4 over-exposure induced a delayed neuroinflammatory damage in rodents, which might have adverse implications for brain development and cognition. Neuroinflammation in brain parenchyma is often accompanied by changes in CSF cytokines levels. However, whether the cytokines levels in CSF change after neonatal IL-4 over-exposure is unknown. Here, we found a delayed pro-inflammatory cytokines response (higher IL-6, IL-1β and, TNF levels) in both hippocampus and CSF after an instant anti-inflammatory cytokine response in IL-4 over-exposed rats. Moreover, the pro-inflammatory cytokines response appeared earlier in CSF than in hippocampus. The level of each of the pro-inflammatory cytokines in CSF positively correlated with that in hippocampus at the age of postnatal day 42. More microglia numbers/activation and higher M-CSF level in the hippocampus in IL-4 over-exposed rats were also observed. Furthermore, there were more macrophages with inflammatory activation in dural mater of IL-4 over-exposed rats. In sum, neonatal IL-4 over-exposure in rats induces delayed inflammation in CSF, suggesting CSF examination may serve as a potential method in predicting delayed neuroinflammation in brain following neonatal IL-4 over-exposure.', 'keywords': ['CNS', 'Cytokines', 'Development', 'Dura mater', 'Early life', 'Macrophage', 'Neuroinflammation'], 'journal': 'Cellular and molecular neurobiology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Wang', 'firstname': 'Ling', 'initials': 'L', 'affiliation': \"Grade 2019, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.\"}, {'lastname': 'Sha', 'firstname': 'Haoran', 'initials': 'H', 'affiliation': \"Grade 2020, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.\"}, {'lastname': 'He', 'firstname': 'Xiaoyi', 'initials': 'X', 'affiliation': \"Department of Anatomy, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Higher Education Mega Center, Guangzhou, 510006, Guangdong, People's Republic of China.\"}, {'lastname': 'Xie', 'firstname': 'Yinyin', 'initials': 'Y', 'affiliation': \"Grade 2018, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.\"}, {'lastname': 'Deng', 'firstname': 'Jiapeng', 'initials': 'J', 'affiliation': \"Grade 2018, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.\"}, {'lastname': 'Chen', 'firstname': 'Jiexuan', 'initials': 'J', 'affiliation': \"Grade 2020, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.\"}, {'lastname': 'Li', 'firstname': 'Guoying', 'initials': 'G', 'affiliation': 'Guangdong Medical Association, Guangzhou, 510180, Guangdong, China. gzlgying820@163.com.'}, {'lastname': 'Yang', 'firstname': 'Junhua', 'initials': 'J', 'affiliation': \"Department of Anatomy, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Higher Education Mega Center, Guangzhou, 510006, Guangdong, People's Republic of China. jhyang2018@gdpu.edu.cn.\\nGuangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Higher Education Mega Center, Guangzhou, 510006, Guangdong, People's Republic of China. jhyang2018@gdpu.edu.cn.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s10571-023-01451-4\\n10.1146/annurev-immunol-102319-103410\\n10.1007/s11011-022-00907-8\\n10.3389/fneur.2022.874193\\n10.1037/0735-7044.119.1.293\\n10.1186/s12987-022-00332-0\\n10.3389/fnagi.2018.00439\\n10.1016/s0895-4356(02)00593-0\\n10.1016/j.jpsychores.2014.06.006\\n10.1164/ajrccm.162.1.9907008\\n10.1016/j.brainresbull.2021.03.015\\n10.1016/j.ecoenv.2018.07.089\\n10.1111/j.1398-9995.2006.01181.x\\n10.1016/j.bbi.2011.06.006\\n10.1016/s0196-0644(05)81712-3\\n10.1097/01.wco.0000162851.44897.8f\\n10.1016/j.immuni.2015.07.007\\n10.1186/s12974-018-1283-5\\n10.1016/j.bbi.2022.12.001\\n10.3389/fncel.2015.00519\\n10.3389/fimmu.2017.00531\\n10.1016/j.jneuroim.2019.577066\\n10.1371/journal.pone.0161656\\n10.1016/j.immuni.2019.03.018\\n10.1016/S0140-6736(20)31286-1\\n10.1089/wound.2017.0761\\n10.1016/j.cyto.2018.05.004\\n10.1038/nri.2017.7\\n10.1007/s10803-019-04093-y\\n10.1016/j.mcn.2022.103744\\n10.1016/j.jneumeth.2008.12.001\\n10.3389/fnagi.2018.00245\\n10.2174/1874609810801030192\\n10.1038/s41398-020-00976-2\\n10.1016/j.jneumeth.2009.12.002\\n10.1093/brain/124.12.2490\\n10.15586/aei.v49i2.49\\n10.1016/j.molmed.2018.04.003\\n10.1016/j.bbi.2021.04.008\\n10.1038/s41598-017-14946-0\\n10.1016/j.jaci.2010.02.038\\n10.3389/fncel.2019.00320\\n10.1016/j.expneurol.2021.113692\\n10.3389/fimmu.2014.00614\\n10.1016/j.cyto.2018.04.037\\n10.1016/j.bbi.2006.07.004\\n10.1254/jphs.14r11cp\\n10.1186/s13075-022-02938-z\\n10.3389/fnut.2022.946096\\n10.1016/j.jneuroim.2014.06.005\\n10.1016/j.intimp.2021.107580\\n10.1016/j.anai.2018.01.016\\n10.1111/jdv.18725', 'xml': <Element 'PubmedArticle' at 0x1096ef330>}\n",
      "{'pubmed_id': '38315290\\n35842086\\n31449913\\n35389228\\n34743831\\n34673220\\n35597370\\n26491120\\n34602887\\n22625997\\n31760942\\n30945204\\n22552109\\n20063071\\n27876585\\n35476967\\n14754941\\n31501236\\n35088551\\n35120692\\n29420459\\n17822448\\n24050698\\n24618794\\n3396196\\n19476053\\n10615846\\n18337595\\n21555471\\n26342634\\n28554161\\n23179603\\n24042236\\n8629723\\n37496192\\n30682453\\n36545389\\n32029001\\n35100528\\n34147654\\n9499552\\n17069092\\n33965232\\n31129128\\n30613858\\n83332\\n15990786\\n19577284\\n35921118\\n21818507\\n21802705\\n19629061\\n14702456\\n30466080', 'title': 'Social Determinants of Health and Allergic Disease Prevalence Among Asian American Children.', 'abstract': 'Although racial and ethnic disparities in allergic diseases have previously been observed, the relationship between social determinants of health (SDoH) and allergic disease prevalence among disaggregated Asian American (AsA) subgroups is poorly understood.\\nTo examine the association of SDoH with allergic disease prevalence among disaggregated AsA subgroups.\\nUsing the 2011-2018 National Health Interview Survey, we examined caregiver-reported race and ethnicity, SDoH, and allergic diseases. We compared survey-weighted allergic disease prevalence by AsA subgroup. Subgroup-stratified multivariable logistic regression accounting for age, sex, child/parent nativity, and survey year modeled the association between SDoH and allergic disease prevalence. We provide predicted probabilities of having each allergic disease based on exposure to each SDoH.\\nWe examined data from 5042 non-Hispanic AsA children representing 3,264,768 AsA children. Approximately 25% of all AsA children reported at least one allergic disease, ranging from 20% of Asian Indian children to 30% of Filipino/a children. The number of unfavorable SDoH was lowest among Asian Indian and Chinese children (mean 0.7) and highest among \"other Asian\" children (mean 1.2). In stratified analyses, financial instability and inaccessible healthcare were associated with greater probability of allergic diseases among some, but not all AsA subgroups. Lower parent education level, food insecurity, and rent/other housing arrangement were associated with lower probability of allergic disease among some AsA children.\\nThere was heterogeneity in the association of SDoH and allergic disease prevalence among AsA children. Further study of SDoH may inform modifiable environmental factors for allergic disease among AsA children.', 'keywords': ['Allergy', 'Asian American', 'Asthma', 'Children', 'Social determinants of health'], 'journal': 'Journal of racial and ethnic health disparities', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Le', 'firstname': 'Austin', 'initials': 'A', 'affiliation': 'Division of Environmental Health Sciences, University of California, Berkeley, School of Public Health, Berkeley, USA.'}, {'lastname': 'Bui', 'firstname': 'Vivian', 'initials': 'V', 'affiliation': 'Division of Epidemiology, University of California, Berkeley, School of Public Health, Berkeley, USA.'}, {'lastname': 'Chu', 'firstname': 'Richie', 'initials': 'R', 'affiliation': 'Department of Community Health Sciences, University of California, Los Angeles, Fielding School of Public Health, Los Angeles, USA.\\nAsian American Studies Department, University of California, Los Angeles, Los Angeles, USA.'}, {'lastname': 'Arroyo', 'firstname': 'Anna Chen', 'initials': 'AC', 'affiliation': 'Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.\\nCenter for Asian Health Research and Education, Stanford University School of Medicine, Stanford, 1265 Welch Road, Room X200, Palo Alto, CA, 94305, USA.'}, {'lastname': 'Chen', 'firstname': 'Meng', 'initials': 'M', 'affiliation': 'Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.\\nCenter for Asian Health Research and Education, Stanford University School of Medicine, Stanford, 1265 Welch Road, Room X200, Palo Alto, CA, 94305, USA.'}, {'lastname': 'Bacong', 'firstname': 'Adrian Matias', 'initials': 'AM', 'affiliation': 'Center for Asian Health Research and Education, Stanford University School of Medicine, Stanford, 1265 Welch Road, Room X200, Palo Alto, CA, 94305, USA. abacong@stanford.edu.\\nDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. abacong@stanford.edu.'}], 'methods': None, 'conclusions': 'There was heterogeneity in the association of SDoH and allergic disease prevalence among AsA children. Further study of SDoH may inform modifiable environmental factors for allergic disease among AsA children.', 'results': 'We examined data from 5042 non-Hispanic AsA children representing 3,264,768 AsA children. Approximately 25% of all AsA children reported at least one allergic disease, ranging from 20% of Asian Indian children to 30% of Filipino/a children. The number of unfavorable SDoH was lowest among Asian Indian and Chinese children (mean 0.7) and highest among \"other Asian\" children (mean 1.2). In stratified analyses, financial instability and inaccessible healthcare were associated with greater probability of allergic diseases among some, but not all AsA subgroups. Lower parent education level, food insecurity, and rent/other housing arrangement were associated with lower probability of allergic disease among some AsA children.', 'copyrights': '© 2024. W. Montague Cobb-NMA Health Institute.', 'doi': '10.1007/s40615-024-01918-0', 'xml': <Element 'PubmedArticle' at 0x147980db0>}\n",
      "{'pubmed_id': '38315158', 'title': 'Effect of stearoyl-coenzyme a desaturase 1 (SCD1) on the function of mast cells.', 'abstract': '', 'keywords': ['Stearoyl CoA desaturase 1 (SCD1)', 'asthma', 'lipid mediators', 'mast cells', 'obesity'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Zhang', 'firstname': 'Xiuqing', 'initials': 'X', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\\nDepartment of Respiratory Medicine, Tianjin Children's Hospital, Tianjin, China.\"}, {'lastname': 'Li', 'firstname': 'Aiguo', 'initials': 'A', 'affiliation': 'Department of Pediatrics, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhu', 'firstname': 'Yifan', 'initials': 'Y', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\"}, {'lastname': 'Liu', 'firstname': 'Feng', 'initials': 'F', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\"}, {'lastname': 'Zhao', 'firstname': 'Deyu', 'initials': 'D', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\"}, {'lastname': 'Tang', 'firstname': 'Heng', 'initials': 'H', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\"}, {'lastname': 'Xu', 'firstname': 'Changdi', 'initials': 'C', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/02770903.2024.2303749', 'xml': <Element 'PubmedArticle' at 0x10a87d210>}\n",
      "{'pubmed_id': '38315090', 'title': 'Mild asthma is not mild: risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma.', 'abstract': \"Asthma is a common chronic respiratory disease characterized by chronic airway inflammation, airway hyperresponsiveness, reversible airflow limitation, and airway remodeling. Mild asthma is the most common type of asthma, but it is the most neglected. Sometimes mild asthma can lead to acute severe exacerbations or even death.\\nThis article reviews the epidemiology, risk factors, and possible predictors of acute severe exacerbations and disease progression in mild asthma to improve the understanding of mild asthma and its severe acute exacerbations and progression.\\nThere is a necessity to improve asthma patient categorization and redefine mild asthma's concept to heighten patient and physician attention. Identifying mild asthma patients that are highly vulnerable to severe acute exacerbations and researching the mechanisms are future prioritizations.\", 'keywords': ['Mild asthma', 'Overuse of short-acting beta-agonis', 'Risk factors', 'biomarkers', 'severe acute exacerbations'], 'journal': 'Expert review of respiratory medicine', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Wang', 'firstname': 'Lingling', 'initials': 'L', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zhou', 'firstname': 'Ling', 'initials': 'L', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zheng', 'firstname': 'Pengdou', 'initials': 'P', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Mao', 'firstname': 'Zhenyu', 'initials': 'Z', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Liu', 'firstname': 'Huiguo', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/17476348.2024.2314535', 'xml': <Element 'PubmedArticle' at 0x10abbba10>}\n",
      "{'pubmed_id': '38314735', 'title': 'Adherence to guidelines prior to endoscopic sinus surgery in patients with chronic rhinosinusitis and asthma.', 'abstract': 'Optimal care for patients with simultaneous chronic rhinosinusitis (CRS) and asthma is often complicated due to interaction between these conditions. This study depicts the lack of attention to asthma within the otorhinolaryngological field, and the relationship between CRS and asthma, including the risk of revision surgery in such patients.\\nA retrospective cohort study was conducted on patients undergoing functional endoscopic sinus surgery (FESS) because of CRS with nasal polyps (CRSwNP) and without nasal polyps in a five-year period. Patients were examined for adherence to guidelines, asthma, revision FESS, allergies and septo-/turbinoplasty. Results were compared to international reports.\\nA total of 589 patients had FESS because of CRS of whom 203 (34.5%) had co-existing asthma. A higher risk of asthma (relative risk (RR) = 1.82 (95% confidence interval (CI): 1.29-2.56), p less-than 0.001) and revision FESS (RR = 2.20 (95% CI: 1.33-3.65), p less-than 0.001) was found in patients with CRSwNP. Attention to asthma was poor in patients with no asthma diagnosis before referral.\\nAsthma was lower in the study population than in the literature. Danish national guidelines on CRS management are insufficient regarding attention to asthma. Results call attention to the need for more multidisciplinary team management.\\nNone.\\nNot relevant.', 'keywords': [], 'journal': 'Danish medical journal', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Nøhr', 'firstname': 'Lotte Buskbjerg', 'initials': 'LB', 'affiliation': 'Department of Otorhinolaryngology, University Clinic for Flavour, Balance and Sleep, Regional Hospital Gødstrup.'}, {'lastname': 'Ovesen', 'firstname': 'Therese', 'initials': 'T', 'affiliation': 'Department of Otorhinolaryngology, University Clinic for Flavour, Balance and Sleep, Regional Hospital Gødstrup.\\nDepartment of Clinical Medicine, Aarhus University, Denmark.'}, {'lastname': 'Zainali-Gill', 'firstname': 'Kasra', 'initials': 'K', 'affiliation': 'Department of Otorhinolaryngology, University Clinic for Flavour, Balance and Sleep, Regional Hospital Gødstrup.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 589 patients had FESS because of CRS of whom 203 (34.5%) had co-existing asthma. A higher risk of asthma (relative risk (RR) = 1.82 (95% confidence interval (CI): 1.29-2.56), p less-than 0.001) and revision FESS (RR = 2.20 (95% CI: 1.33-3.65), p less-than 0.001) was found in patients with CRSwNP. Attention to asthma was poor in patients with no asthma diagnosis before referral.', 'copyrights': 'Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.', 'doi': '10.61409/A04230241', 'xml': <Element 'PubmedArticle' at 0x10abba0c0>}\n",
      "{'pubmed_id': '38311978', 'title': 'The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.', 'abstract': 'Air pollution is one of the biggest environmental threats for asthma. Its impact is augmented by climate change. To inform the recommendations of the EAACI Guidelines on the environmental science for allergic diseases and asthma, a systematic review (SR) evaluated the impact on asthma-related outcomes of short-term exposure to outdoor air pollutants (PM2.5, PM10, NO', 'keywords': ['GRADE', 'asthma', 'extreme temperatures', 'outdoor pollution', 'systematic review'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Agache', 'firstname': 'Ioana', 'initials': 'I', 'affiliation': 'Faculty of Medicine, Transylvania University, Brasov, Romania.'}, {'lastname': 'Canelo-Aybar', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Annesi-Maesano', 'firstname': 'Isabella', 'initials': 'I', 'affiliation': 'Institute Desbrest of Epidemiology and Public Health, University of Montpellier and INSERM, Montpellier, France.'}, {'lastname': 'Cecchi', 'firstname': 'Lorenzo', 'initials': 'L', 'affiliation': 'Centre of Bioclimatology, University of Florence, Florence, Italy.'}, {'lastname': 'Rigau', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Rodríguez-Tanta', 'firstname': 'L Yesenia', 'initials': 'LY', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Nieto-Gutierrez', 'firstname': 'Wendy', 'initials': 'W', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Song', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Cantero-Fortiz', 'firstname': 'Yahveth', 'initials': 'Y', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.\\nCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.'}, {'lastname': 'Roqué', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.\\nCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.'}, {'lastname': 'Vasquez', 'firstname': 'Juan Carlos', 'initials': 'JC', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Sola', 'firstname': 'Ivan', 'initials': 'I', 'affiliation': 'Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.'}, {'lastname': 'Biagioni', 'firstname': 'Benedetta', 'initials': 'B', 'affiliation': 'Allergy and Clinical Immunology Unit San Giovanni di Dio Hospital, Florence, Italy.'}, {'lastname': 'Chung', 'firstname': 'Fan', 'initials': 'F', 'affiliation': 'Imperial College, London, UK.'}, {'lastname': \"D'Amato\", 'firstname': 'Gennaro', 'initials': 'G', 'affiliation': 'Medical School of Respiratory Diseases, University of Naples Federico II, Naples, Italy.'}, {'lastname': 'Damialis', 'firstname': 'Athanasios', 'initials': 'A', 'affiliation': 'Department of Ecology, School of Biology, Faculty of Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.'}, {'lastname': 'Del Giacco', 'firstname': 'Stefano', 'initials': 'S', 'affiliation': 'Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy.'}, {'lastname': 'Vecillas', 'firstname': 'Leticia de Las', 'initials': 'LL', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Dominguez-Ortega', 'firstname': 'Javier', 'initials': 'J', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Galàn', 'firstname': 'Carmen', 'initials': 'C', 'affiliation': 'Department of Botany, Ecology and Plant Physiology, International Campus of Excellence on Agrifood (ceiA3), University of Córdoba, Córdoba, Spain.'}, {'lastname': 'Gilles', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Environmental Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.'}, {'lastname': 'Giovannini', 'firstname': 'Mattia', 'initials': 'M', 'affiliation': \"Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.\\nDepartment of Health Sciences, University of Florence, Florence, Italy.\"}, {'lastname': 'Holgate', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'Faculty of Medicine, University of Southampton, Southampton, UK.'}, {'lastname': 'Jeebhay', 'firstname': 'Mohamed', 'initials': 'M', 'affiliation': 'Occupational Medicine Division and Centre for Environmental & Occupational Health Research, University of Cape Town, Rondebosch, South Africa.'}, {'lastname': 'Nadeau', 'firstname': 'Kari', 'initials': 'K', 'affiliation': 'John Rock Professor of Climate and Population Studies; Chair, Department of Environmental Health, Interim Director, Center for Climate, Health, and The Global Environment, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.'}, {'lastname': 'Papadopoulos', 'firstname': 'Nikos', 'initials': 'N', 'affiliation': 'Allergy and Clinical Immunology Unit, Second Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.\\nDivision of Evolution and Genomic Sciences, University of Manchester, Manchester, UK.'}, {'lastname': 'Quirce', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': 'Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.'}, {'lastname': 'Sastre', 'firstname': 'Joaquin', 'initials': 'J', 'affiliation': 'Instituto Carlos III, Ministry of Science and Innovation, Allergy Service, Fundación Jiménez Díaz, Faculty of Medicine Universidad Autónoma de Madrid and CIBERES, Madrid, Spain.'}, {'lastname': 'Traidl-Hoffmann', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Department of Environmental Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.\\nInstitute of Environmental Medicine, Helmholtz Center Munich-German Research Center for Environmental Health, Augsburg, Germany.\\nChristine Kühne Center for Allergy Research and Education, Davos, Switzerland.'}, {'lastname': 'Walusiak-Skorupa', 'firstname': 'Jolanta', 'initials': 'J', 'affiliation': 'Department of Occupational Diseases and Environmental Health, Nofer Institute of Occupational Medicine, Lodz, Poland.'}, {'lastname': 'Sousa-Pinto', 'firstname': 'Bernardo', 'initials': 'B', 'affiliation': 'MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Alonso-Coello', 'firstname': 'Pablo', 'initials': 'P', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.\\nCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.'}, {'lastname': 'Salazar', 'firstname': 'Josefina', 'initials': 'J', 'affiliation': 'Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.'}, {'lastname': 'Jutel', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Department of Clinical Immunology, ALL-MED Medical Research Institute, Wrocław Medical University, Wroclaw, Poland.'}, {'lastname': 'Akdis', 'firstname': 'Cezmi', 'initials': 'C', 'affiliation': 'Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/all.16041', 'xml': <Element 'PubmedArticle' at 0x10aff1f30>}\n",
      "{'pubmed_id': '38311961', 'title': 'Heterogeneity of sensitization profiles and clinical phenotypes among patients with seasonal allergic rhinitis in Southern European countries-The @IT.2020 multicenter study.', 'abstract': 'Pollen allergy poses a significant health and economic burden in Europe. Disease patterns are relatively homogeneous within Central and Northern European countries. However, no study broadly assessed the features of seasonal allergic rhinitis (SAR) across different Southern European countries with a standardized approach.\\nTo describe sensitization profiles and clinical phenotypes of pollen allergic patients in nine Southern European cities with a uniform methodological approach.\\nWithin the @IT.2020 multicenter observational study, pediatric and adult patients suffering from SAR were recruited in nine urban study centers located in seven countries. Clinical questionnaires, skin prick tests (SPT) and specific IgE (sIgE) tests with a customized multiplex assay (Euroimmun Labordiagnostika, Lübeck, Germany) were performed.\\nThree hundred forty-eight children (mean age 13.1\\u2009years, SD: 2.4\\u2009years) and 467 adults (mean age 35.7\\u2009years SD: 10.0\\u2009years) with a predominantly moderate to severe, persistent phenotype of SAR were recruited. Grass pollen major allergenic molecules (Phl p 1 and/or Phl p 5) ranged among the top three sensitizers in all study centers. Sensitization profiles were very heterogeneous, considering that patients in Rome were highly poly-sensitized (sIgE to 3.8 major allergenic molecules per patient), while mono-sensitization was prominent and heterogeneous in other cities, such as Marseille (sIgE to Cup a 1: n\\u2009=\\u200955/80, 68.8%) and Messina (sIgE to Par j 2: n\\u2009=\\u200947/82, 57.3%). Co-sensitization to perennial allergens, as well as allergic comorbidities also broadly varied between study centers.\\nIn Southern European countries, pollen allergy is heterogeneous in terms of sensitization profiles and clinical manifestations. Despite the complexity, a unique molecular, multiplex, and customized in-vitro IgE test detected relevant sensitization in all study centers. Nevertheless, this geographical diversity in pollen allergic patients imposes localized clinical guidelines and study protocols for clinical trials of SAR in this climatically complex region.', 'keywords': ['IgE', 'allergic rhinitis', 'component-resolved diagnostics', 'phenotypes', 'pollen allergy', 'sensitization'], 'journal': 'Allergy', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Dramburg', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}, {'lastname': 'Grittner', 'firstname': 'U', 'initials': 'U', 'affiliation': 'Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}, {'lastname': 'Potapova', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}, {'lastname': 'Travaglini', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Biology, Tor Vergata University, Rome, Italy.\\nItalian Aerobiology Monitoring Network - Italian Aerobiology Association, Rome, Italy.'}, {'lastname': 'Tripodi', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.\\nAllergolology Service, Policlinico Casilino, Rome, Italy.'}, {'lastname': 'Arasi', 'firstname': 'S', 'initials': 'S', 'affiliation': \"Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\\nPediatric Allergology Unit, Department of Pediatric Medicine, Bambino Gesù Children's Research Hospital (IRCCS), Rome, Italy.\"}, {'lastname': 'Pelosi', 'firstname': 'S', 'initials': 'S', 'affiliation': 'TPS Production srl, Rome, Italy.'}, {'lastname': 'Acar Şahin', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.'}, {'lastname': 'Aggelidis', 'firstname': 'X', 'initials': 'X', 'affiliation': 'Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University Hospital \"Attikon\", Athens, Greece.'}, {'lastname': 'Barbalace', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.'}, {'lastname': 'Bourgoin', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.'}, {'lastname': 'Bregu', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.'}, {'lastname': 'Brighetti', 'firstname': 'M A', 'initials': 'MA', 'affiliation': 'Department of Biology, Tor Vergata University, Rome, Italy.'}, {'lastname': 'Caeiro', 'firstname': 'E', 'initials': 'E', 'affiliation': 'MED- Mediterranean Institute for Agriculture, Environment and Development, Institute for Advanced Studies and Research, University of Évora, Évora, Portugal.\\nPortuguese Society of Allergology and Clinical Immunology, Lisbon, Portugal.'}, {'lastname': 'Caglayan Sozmen', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Medicana International Izmir Hospital, Izmir, Turkey.'}, {'lastname': 'Caminiti', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.'}, {'lastname': 'Charpin', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.'}, {'lastname': 'Couto', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Immunoallergology, Hospital CUF Trindade, Porto, Portugal.'}, {'lastname': 'Delgado', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Basic and Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.\\nCINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.\\nAllergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.'}, {'lastname': 'Di Rienzo Businco', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.'}, {'lastname': 'Dimier', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.'}, {'lastname': 'Dimou', 'firstname': 'M V', 'initials': 'MV', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, Athens General Children\\'s Hospital \"P&A Kyriakou\", University of Athens, Athens, Greece.'}, {'lastname': 'Fonseca', 'firstname': 'J A', 'initials': 'JA', 'affiliation': 'CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.\\nAllergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.\\nMEDCIDS-Department of Community Medicine, Information, and Health Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Goksel', 'firstname': 'O', 'initials': 'O', 'affiliation': 'Department of Pulmonary Medicine, Division of Immunology, Allergy and Asthma. Faculty of Medicine, Ege University, Izmir, Turkey.'}, {'lastname': 'Hernandez', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Department of Allergy, Health Research Institute Hospital La Fe, Valencia, Spain.'}, {'lastname': 'Hernandez Toro', 'firstname': 'C J', 'initials': 'CJ', 'affiliation': 'Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\\nInstitute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}, {'lastname': 'Hoffmann', 'firstname': 'T M', 'initials': 'TM', 'affiliation': 'Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}, {'lastname': 'Jang', 'firstname': 'D T', 'initials': 'DT', 'affiliation': \"Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.\"}, {'lastname': 'Kalpaklioglu', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Department of Immunology and Allergic Diseases, Kırıkkale University School of Medicine, Kırıkkale, Turkey.'}, {'lastname': 'Lame', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.'}, {'lastname': 'Llusar', 'firstname': 'R', 'initials': 'R', 'affiliation': \"Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.\"}, {'lastname': 'Makris', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University Hospital \"Attikon\", Athens, Greece.'}, {'lastname': 'Mazon', 'firstname': 'A', 'initials': 'A', 'affiliation': \"Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.\"}, {'lastname': 'Mesonjesi', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.'}, {'lastname': 'Nieto', 'firstname': 'A', 'initials': 'A', 'affiliation': \"Pediatric Allergy and Pneumology Unit, Children's Hospital La Fe; Health Research Institute La Fe, Valencia, Spain.\"}, {'lastname': 'Öztürk', 'firstname': 'A B', 'initials': 'AB', 'affiliation': 'Division of Allergy and Immunology, Department of Pulmonary Medicine, Arel University, School of Medicine, Istanbul, Turkey.'}, {'lastname': 'Pahus', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Aix Marseille Univ, APHM, INSERM CIC 1409, INSERM U1263, INRA 1260 (C2VN), Marseille, France.'}, {'lastname': 'Pajno', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.'}, {'lastname': 'Panasiti', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.'}, {'lastname': 'Papadopoulos', 'firstname': 'N G', 'initials': 'NG', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, Athens General Children\\'s Hospital \"P&A Kyriakou\", University of Athens, Athens, Greece.\\nDivision of Infection, Immunity & Respiratory Medicine, Royal Manchester Children\\'s Hospital, University of Manchester, Manchester, UK.'}, {'lastname': 'Pellegrini', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Reggio Calabria, ARPA - Regional Agency for Environmental Protection, Calabria, Italy.'}, {'lastname': 'Pereira', 'firstname': 'A M', 'initials': 'AM', 'affiliation': 'Allergy Unit, Instituto & Hospital CUF Porto, Porto, Portugal.\\nMEDCIDS-Department of Community Medicine, Information, and Health Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.'}, {'lastname': 'Pereira', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Basic and Clinical Immunology Unit, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.\\nCINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.'}, {'lastname': 'Pinar', 'firstname': 'N M', 'initials': 'NM', 'affiliation': 'Department of Biology, Faculty of Science, Ankara University, Ankara, Turkey.'}, {'lastname': 'Priftanji', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Allergology and Clinical Immunology, UHC Mother Teresa, Medical University Tirana, Tirana, Albania.'}, {'lastname': 'Psarros', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Allergy Department, Athens Naval Hospital, Athens, Greece.'}, {'lastname': 'Sackesen', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Division of Pediatric Allergy, Koç University School of Medicine, Istanbul, Turkey.'}, {'lastname': 'Sfika', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.'}, {'lastname': 'Suarez', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Department of Biology of Organisms and Systems, Area of Botany, University of Oviedo, Oviedo, Spain.'}, {'lastname': 'Thibaudon', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Réseau National de Surveillance Aérobiologique, Brussieu, France.'}, {'lastname': 'Uguz', 'firstname': 'U', 'initials': 'U', 'affiliation': 'Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.'}, {'lastname': 'Verdier', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Department of Pneumonology and Allergy, La Timone Hospital, APHM, Aix-Marseille University, Marseille, France.'}, {'lastname': 'Villella', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.'}, {'lastname': 'Xepapadaki', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.'}, {'lastname': 'Yazici', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Cellular and Molecular Medicine, KUTTAM, Graduate School of Health Sciences, Koç University, Istanbul, Turkey.\\nSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.'}, {'lastname': 'Matricardi', 'firstname': 'P M', 'initials': 'PM', 'affiliation': 'Department of Pediatric Respiratory Care, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.'}], 'methods': None, 'conclusions': None, 'results': 'Three hundred forty-eight children (mean age 13.1\\u2009years, SD: 2.4\\u2009years) and 467 adults (mean age 35.7\\u2009years SD: 10.0\\u2009years) with a predominantly moderate to severe, persistent phenotype of SAR were recruited. Grass pollen major allergenic molecules (Phl p 1 and/or Phl p 5) ranged among the top three sensitizers in all study centers. Sensitization profiles were very heterogeneous, considering that patients in Rome were highly poly-sensitized (sIgE to 3.8 major allergenic molecules per patient), while mono-sensitization was prominent and heterogeneous in other cities, such as Marseille (sIgE to Cup a 1: n\\u2009=\\u200955/80, 68.8%) and Messina (sIgE to Par j 2: n\\u2009=\\u200947/82, 57.3%). Co-sensitization to perennial allergens, as well as allergic comorbidities also broadly varied between study centers.', 'copyrights': '© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/all.16029', 'xml': <Element 'PubmedArticle' at 0x10b903d30>}\n",
      "{'pubmed_id': '38311782\\n24507842\\n31034998\\n28947632\\n27338195\\n34168440\\n33632799\\n32064708\\n27877033\\n30576755\\n35330786\\n35338095\\n24933205\\n31346991\\n31358095\\n26291753\\n28495077\\n28243078\\n23733084\\n22341911\\n17090570\\n12653493\\n32742326\\n35916048\\n33244228\\n30174422\\n35255537\\n34234506\\n36062505\\n28438346\\n33980336\\n28825404\\n36259043\\n28686173\\n34821171\\n28040521\\n36304971\\n36856433\\n26916083\\n31417809', 'title': 'The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.', 'abstract': 'There is no uniform standard for a strongly positive bronchodilation test (BDT) result. In addition, the role of bronchodilator response in differentiating between asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with a positive BDT result is unclear. We explored a simplified standard of a strongly positive BDT result and whether bronchodilator response combined with fractional exhaled nitric oxide (FeNO) can differentiate between asthma, COPD, and ACO in patients with a positive BDT result.\\nThree standards of a strongly positive BDT result, which were, respectively, defined as post-bronchodilator forced expiratory volume in 1-s responses (ΔFEV\\nThe rates of a strongly positive BDT result and the characteristics between standards I and II were consistent; however, those for standard III was different. ΔFEV\\nThe simplified standard II can replace standard I. ΔFEV', 'keywords': ['ACO', 'Asthma–COPD overlap', 'Bronchodilator response', 'Chronic airway disease', 'Diagnosis', 'Forced expiratory volume in 1\\xa0s', 'Fractional exhaled nitric oxide'], 'journal': 'European journal of medical research', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Gong', 'firstname': 'Zhaoqian', 'initials': 'Z', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Huang', 'firstname': 'Junwen', 'initials': 'J', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Xu', 'firstname': 'Guiling', 'initials': 'G', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Chen', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Xu', 'firstname': 'Maosheng', 'initials': 'M', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Ma', 'firstname': 'Yanyan', 'initials': 'Y', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Zhao', 'firstname': 'Wenqu', 'initials': 'W', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Wang', 'firstname': 'Yanhong', 'initials': 'Y', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Liang', 'firstname': 'Jianpeng', 'initials': 'J', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Ou', 'firstname': 'Chunquan', 'initials': 'C', 'affiliation': 'Department of the Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Laiyu', 'initials': 'L', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Cai', 'firstname': 'Shaoxi', 'initials': 'S', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.'}, {'lastname': 'Zhao', 'firstname': 'Haijin', 'initials': 'H', 'affiliation': 'Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. haijin99@sina.com.'}], 'methods': None, 'conclusions': 'The simplified standard II can replace standard I. ΔFEV', 'results': 'The rates of a strongly positive BDT result and the characteristics between standards I and II were consistent; however, those for standard III was different. ΔFEV', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s40001-024-01679-w\\n10.1016/j.ccm.2013.09.010\\n10.1016/j.jaip.2019.04.022\\n10.1136/bmj.j3772\\n10.1183/13993003.00436-2016\\n10.2147/copd.s312560\\n10.1183/13993003.03927-2020\\n10.1111/resp.13780\\n10.2147/copd.s114964\\n10.1016/j.jaci.2018.11.032\\n10.2147/jaa.s338467\\n10.4187/respcare.09215\\n10.1016/j.rmed.2014.05.006\\n10.1007/s11596-019-2074-7\\n10.29271/jcpsp.2019.08.741\\n10.1378/chest.15-1055\\n10.1016/j.arbr.2017.06.001\\n10.2147/copd.s124459\\n10.5507/bp.2013.039\\n10.1016/j.arbres.2011.12.009\\n10.1136/thorax.58.suppl_1.1i\\n10.3892/etm.2020.8762\\n10.3346/jkms.2022.37.e236\\n10.2147/copd.s273422\\n10.2147/copd.s167600\\n10.4168/aair.2022.14.2.196\\n10.2147/jir.s309844\\n10.4081/monaldi.2022.2323\\n10.1016/j.arbres.2017.01.014\\n10.2500/aap.2021.42.210016\\n10.1088/1752-7163/aa746b\\n10.2147/copd.s374079\\n10.1088/1752-7163/aa7e63\\n10.1080/17476348.2022.2011221\\n10.1016/j.chest.2016.12.017\\n10.2147/copd.s382761\\n10.1164/rccm.202301-0106PP\\n10.1016/j.niox.2016.02.003\\n10.7759/cureus.4864', 'xml': <Element 'PubmedArticle' at 0x109d10b30>}\n",
      "{'pubmed_id': '38311747\\n33149626\\n33887242\\n33528864\\n25199059\\n35753668\\n36420737\\n35595723\\n34586602\\n36804947\\n33364788\\n37193110\\n33558205', 'title': 'Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study.', 'abstract': 'Mepolizumab, the first widely available anti-interleukin 5 biologic, targets eosinophilic inflammation and has been shown in clinical trials to reduce exacerbations, oral corticosteroid dependence, and healthcare utilization in patients with severe asthma. The impact of mepolizumab in a real-world, publicly funded healthcare setting is unknown. The objective of this study was to describe the demographics and clinical characteristics of real-world patients receiving mepolizumab, and to compare asthma-related outcomes and associated asthma-related costs before and during mepolizumab use.\\nThis retrospective, observational study in Ontario, Canada, included patients initiating mepolizumab between February 2016 and March 2019. Patients were identified using the mepolizumab patient support program and linked to the Institute for Clinical Evaluative Sciences database of publicly accessed healthcare. Patient outcomes were obtained for 12 months pre- and post-mepolizumab initiation and compared.\\nA total of 275 patients were enrolled in the overall patient support program cohort (mean [standard deviation] age 57.6 [13.5] years, mean [standard deviation] of the median per-patient eosinophil count 540.4 [491.9] cells/μL). Mepolizumab was associated with reductions in asthma exacerbations (46.1%, P < 0.001) and in the number of asthma-related visits to general practitioners (40.2%, P < 0.001), specialists (27.2%, P < 0.001), and emergency departments (52.1%, P < 0.001). Associated costs were significantly lower post- versus pre-mepolizumab for asthma-related general practitioner and specialist visits, and for all-cause emergency department visits and hospital admissions.\\nIn a real-world population of Canadian patients with severe asthma with an eosinophilic phenotype, the use of mepolizumab within a patient support program reduced asthma exacerbations and decreased asthma-related healthcare resource utilization and associated costs.', 'keywords': ['Canada', 'Costs', 'Eosinophilic', 'Exacerbations', 'Healthcare resource utilization', 'ICES', 'Mepolizumab', 'Patient support program', 'Real-world', 'Severe asthma'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Chapman', 'firstname': 'Kenneth R', 'initials': 'KR', 'affiliation': 'Asthma & Airway Centre, University Health Network, Room 7-451 EW, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada. ken.chapman.airways@gmail.com.'}, {'lastname': 'Cogger', 'firstname': 'Kathryn', 'initials': 'K', 'affiliation': 'GSK, Mississauga, ON, Canada.'}, {'lastname': 'Arthurs', 'firstname': 'Erin', 'initials': 'E', 'affiliation': 'GSK, Mississauga, ON, Canada.'}, {'lastname': 'LaForty', 'firstname': 'Callahan', 'initials': 'C', 'affiliation': 'IQVIA, Toronto, ON, Canada.'}, {'lastname': 'Golden', 'firstname': 'Shane', 'initials': 'S', 'affiliation': 'IQVIA, Montreal, QC, Canada.'}, {'lastname': 'Millson', 'firstname': 'Bradley', 'initials': 'B', 'affiliation': 'IQVIA, Ottawa, ON, Canada.'}, {'lastname': 'Usuba', 'firstname': 'Koyo', 'initials': 'K', 'affiliation': 'GSK, Mississauga, ON, Canada.'}, {'lastname': 'Licskai', 'firstname': 'Christopher', 'initials': 'C', 'affiliation': 'Western University, London, ON, Canada.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 275 patients were enrolled in the overall patient support program cohort (mean [standard deviation] age 57.6 [13.5] years, mean [standard deviation] of the median per-patient eosinophil count 540.4 [491.9] cells/μL). Mepolizumab was associated with reductions in asthma exacerbations (46.1%, P < 0.001) and in the number of asthma-related visits to general practitioners (40.2%, P < 0.001), specialists (27.2%, P < 0.001), and emergency departments (52.1%, P < 0.001). Associated costs were significantly lower post- versus pre-mepolizumab for asthma-related general practitioner and specialist visits, and for all-cause emergency department visits and hospital admissions.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-023-00863-7\\n10.2147/JAA.S272681\\n10.1016/j.chest.2021.04.013\\n10.1111/cea.13841\\n10.1056/NEJMoa1403290\\n10.1016/j.jaip.2022.05.042\\n10.1177/03000605221133689\\n10.1111/all.15382\\n10.1007/s40265-021-01597-9\\n10.1186/s13223-023-00767-6\\n10.2147/JAA.S275944\\n10.2147/JAA.S407552\\n10.1016/j.chest.2020.10.050', 'xml': <Element 'PubmedArticle' at 0x10a37cf40>}\n",
      "{'pubmed_id': '38311272', 'title': 'Identification of asinine gamma herpesviruses in a donkey with interstitial pulmonary fibrosis, pleural effusion and thrombocytopenia.', 'abstract': 'A 23-year-old domestic donkey (Equus asinus) referred for severe respiratory distress due to suspected equine asthma. Ultrasound of the chest revealed bilateral irregular pulmonary consolidation and pleural effusion. Airway endoscopy and tracheal wash cytology showed severe neutrophilic inflammation and bacterial culture was positive for Streptococcus equi subsp. zooepidemicus. Despite aggressive treatment, the donkey died in 48 hours. On post-mortem examination, the lung was whitish, collapsed, and firm, with fibrotic multifocal nodular areas. Pleural effusion and pleuritis were detected. Histologically, the lung architecture was markedly replaced by interstitial fibrosis. The histological features observed were suggestive of a severe chronic fibrosing interstitial pleuropneumonia with type 2 pneumocyte hyperplasia and intralesional syncytial cells. Pulmonary fibrosis was associated with the presence of asinine gammaherpesvirus 2 and 5 infection, confirmed by PCR and sequence analysis. The macroscopic and histological pattern of fibrosis was diffuse and interstitial, and the nodular lesions were consistent with spared lung parenchyma, instead of the canonical nodular distribution of the fibrosis observed in equine multinodular pulmonary fibrosis. Asinine herpesviral pulmonary fibrosis is uncommon, but should be considered by clinicians in the list of differentials in donkeys with chronic respiratory signs.', 'keywords': ['Asinine gammaherpesvirus', 'Chronic lung disease', 'Equid', 'Histopathology', 'Interstitial pneumonia', 'Italy', 'Thrombocytopenia'], 'journal': 'Journal of equine veterinary science', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Imposimato', 'firstname': 'Ilaria', 'initials': 'I', 'affiliation': \"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano dell'Emilia, Bologna, Italy. Electronic address: ilaria.imposimato2@unibo.it.\"}, {'lastname': 'Muscatello', 'firstname': 'Luisa Vera', 'initials': 'LV', 'affiliation': \"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano dell'Emilia, Bologna, Italy.\"}, {'lastname': 'Ellero', 'firstname': 'Nicola', 'initials': 'N', 'affiliation': \"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano dell'Emilia, Bologna, Italy.\"}, {'lastname': 'Lelli', 'firstname': 'Davide', 'initials': 'D', 'affiliation': 'Istituto Zooprofilattico Sperimentale della Lombardia e dell\\'Emilia-Romagna \"Bruno Ubertini\", Via Bianchi n. 9, 25124 Brescia, Italy.'}, {'lastname': 'Mira', 'firstname': 'Francesco', 'initials': 'F', 'affiliation': 'Istituto Zooprofilattico Sperimentale della Sicilia \"A. Mirri\", Via Gino Marinuzzi n. 3, 90129 Palermo, Italy; Department of Veterinary Science, University of Messina, Polo Universitario dell\\'Annunziata, 98168 Messina, Italy.'}, {'lastname': 'Sarli', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': \"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano dell'Emilia, Bologna, Italy.\"}, {'lastname': 'Freccero', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': \"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Via Tolara di Sopra, 50, 40064 Ozzano dell'Emilia, Bologna, Italy.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.jevs.2024.105014', 'xml': <Element 'PubmedArticle' at 0x10a1c7dd0>}\n",
      "{'pubmed_id': '38310974', 'title': 'Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.', 'abstract': 'Eosinophilic esophagitis (EoE) is an increasingly common inflammatory condition of the esophagus; however, the underlying immunologic mechanisms remain poorly understood. The epithelium-derived cytokine IL-33 is associated with type 2 immune responses and elevated in esophageal biopsies from EoE subjects.\\nWe hypothesized that overexpression of IL-33 by the esophageal epithelium would promote the immunopathology of EoE.\\nWe evaluated the functional consequences of esophageal epithelial overexpression of a secreted and active form of IL-33 (saIL-33) in a novel transgenic mouse, EoE33. EoE33 mice were analyzed for clinical and immunologic phenotypes. Esophageal contractility was assessed. Epithelial cytokine responses were analyzed in three-dimensional organoids. EoE33 phenotypes were further characterized in ST2\\nEoE33 mice displayed ST2-dependent, EoE-like pathology and failed to thrive. Esophageal tissue remodeling and inflammation included basal zone hyperplasia, eosinophilia, mast cells, and Th2 cells. Marked increases in levels of type 2 cytokines, including IL-13, and molecules associated with immune responses and tissue remodeling were observed. Esophageal organoids suggested reactive epithelial changes. Genetic deletion of IL-13 in EoE33 mice abrogated pathological changes in vivo. EoE33 mice were steroid responsive.\\nIL-33 overexpression by the esophageal epithelium generated immunopathology and clinical phenotypes resembling human EoE. IL-33 may play a pivotal role in the etiology of EoE by activating the IL-13 pathway. EoE33 mice are a robust experimental platform for mechanistic investigation and translational discovery.', 'keywords': ['IL-33', 'eosinophil', 'eosinophilic esophagitis', 'transgene', 'type 2 inflammation'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Masuda', 'firstname': 'Mia Y', 'initials': 'MY', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States; Department of Immunology, Mayo Clinic, Rochester, MN, United States and Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Pyon', 'firstname': 'Grace C', 'initials': 'GC', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Luo', 'firstname': 'Huijun', 'initials': 'H', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'LeSuer', 'firstname': 'William E', 'initials': 'WE', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Putikova', 'firstname': 'Arina', 'initials': 'A', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Dao', 'firstname': 'Adelyn', 'initials': 'A', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Ortiz', 'firstname': 'Danna R', 'initials': 'DR', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Schulze', 'firstname': 'Aliviya R', 'initials': 'AR', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Fritz', 'firstname': 'Nicholas', 'initials': 'N', 'affiliation': 'School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, United States.'}, {'lastname': 'Kobayashi', 'firstname': 'Takao', 'initials': 'T', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Iijima', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Klein-Szanto', 'firstname': 'Andres J', 'initials': 'AJ', 'affiliation': 'Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, United States.'}, {'lastname': 'Shimonosono', 'firstname': 'Masataka', 'initials': 'M', 'affiliation': 'Division of Digestive and Liver Diseases, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, United States.'}, {'lastname': 'Flashner', 'firstname': 'Samuel', 'initials': 'S', 'affiliation': 'Division of Digestive and Liver Diseases, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, United States.'}, {'lastname': 'Morimoto', 'firstname': 'Masaki', 'initials': 'M', 'affiliation': 'Division of Digestive and Liver Diseases, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, United States.'}, {'lastname': 'Pai', 'firstname': 'Rish K', 'initials': 'RK', 'affiliation': 'Division of Pathology and Laboratory Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Rank', 'firstname': 'Matthew A', 'initials': 'MA', 'affiliation': \"Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States; Section of Allergy and Immunology, Division of Pulmonology, Phoenix Children's Hospital, Phoenix, AZ, United States.\"}, {'lastname': 'Nakagawa', 'firstname': 'Hiroshi', 'initials': 'H', 'affiliation': 'Division of Digestive and Liver Diseases, Department of Medicine and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, United States.'}, {'lastname': 'Kita', 'firstname': 'Hirohito', 'initials': 'H', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States; Department of Immunology, Mayo Clinic, Rochester, MN, United States and Mayo Clinic Arizona, Scottsdale, AZ, United States.'}, {'lastname': 'Wright', 'firstname': 'Benjamin L', 'initials': 'BL', 'affiliation': \"Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States; Section of Allergy and Immunology, Division of Pulmonology, Phoenix Children's Hospital, Phoenix, AZ, United States.\"}, {'lastname': 'Doyle', 'firstname': 'Alfred D', 'initials': 'AD', 'affiliation': 'Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States. Electronic address: doyle.alfred@mayo.edu.'}], 'methods': None, 'conclusions': 'IL-33 overexpression by the esophageal epithelium generated immunopathology and clinical phenotypes resembling human EoE. IL-33 may play a pivotal role in the etiology of EoE by activating the IL-13 pathway. EoE33 mice are a robust experimental platform for mechanistic investigation and translational discovery.', 'results': 'EoE33 mice displayed ST2-dependent, EoE-like pathology and failed to thrive. Esophageal tissue remodeling and inflammation included basal zone hyperplasia, eosinophilia, mast cells, and Th2 cells. Marked increases in levels of type 2 cytokines, including IL-13, and molecules associated with immune responses and tissue remodeling were observed. Esophageal organoids suggested reactive epithelial changes. Genetic deletion of IL-13 in EoE33 mice abrogated pathological changes in vivo. EoE33 mice were steroid responsive.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.01.017', 'xml': <Element 'PubmedArticle' at 0x10b1ad9e0>}\n",
      "{'pubmed_id': '38310970', 'title': 'From the pages of AllergyWatch.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Fineman', 'firstname': 'Stanley', 'initials': 'S', 'affiliation': 'Atlanta Allergy and Asthma, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. Electronic address: sfineman@atlantaallergy.com.'}, {'lastname': 'Lee', 'firstname': 'Gerald B', 'initials': 'GB', 'affiliation': 'Atlanta Allergy and Asthma, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.'}, {'lastname': 'Knox', 'firstname': 'Samantha', 'initials': 'S', 'affiliation': 'Atlanta Allergy and Asthma, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.'}, {'lastname': 'Otani', 'firstname': 'Iris', 'initials': 'I', 'affiliation': 'Atlanta Allergy and Asthma, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.01.025', 'xml': <Element 'PubmedArticle' at 0x109c24db0>}\n",
      "{'pubmed_id': '38310914', 'title': 'Estimated health effects from domestic use of gaseous fuels for cooking and heating in high-income, middle-income, and low-income countries: a systematic review and meta-analyses.', 'abstract': \"Exposure to household air pollution from polluting domestic fuel (solid fuel and kerosene) represents a substantial global public health burden and there is an urgent need for rapid transition to clean domestic fuels. Gas for cooking and heating might possibly affect child asthma, wheezing, and respiratory health. The aim of this review was to synthesise the evidence on the health effects of gaseous fuels to inform policies for scalable clean household energy.\\nIn this systematic review and meta-analysis, we summarised the health effects from cooking or heating with gas compared with polluting fuels (eg, wood or charcoal) and clean energy (eg, electricity and solar energy). We searched PubMed, Scopus, Web of Science, MEDLINE, Cochrane Library (CENTRAL), Environment Complete, GreenFile, Google Scholar, Wanfang DATA, and CNKI for articles published between Dec 16, 2020, and Feb 6, 2021. Studies eligible for inclusion had to compare gas for cooking or heating with polluting fuels (eg, wood or charcoal) or clean energy (eg, electricity or solar energy) and present data for health outcomes in general populations. Studies that reported health outcomes that were exacerbations of existing underlying conditions were excluded. Several of our reviewers were involved in screening studies, data extraction, and quality assessment (including risk of bias) of included studies; 20% of studies were independently screened, extracted and quality assessed by another reviewer. Disagreements were reconciled through discussion with the wider review team. Included studies were appraised for quality using the Liverpool Quality Assessment Tools. Key health outcomes were grouped for meta-analysis and analysed using Cochrane's RevMan software. Primary outcomes were health effects (eg, acute lower respiratory infections) and secondary outcomes were health symptoms (eg, respiratory symptoms such as wheeze, cough, or breathlessness). This study is registered with PROSPERO, CRD42021227092.\\n116 studies were included in the meta-analysis (two [2%] randomised controlled trials, 13 [11%] case-control studies, 23 [20%] cohort studies, and 78 [67%] cross-sectional studies), contributing 215 effect estimates for five grouped health outcomes. Compared with polluting fuels, use of gas significantly lowered the risk of pneumonia (OR 0·54, 95% CI 0·38-0·77; p=0·00080), wheeze (OR 0·42, 0·30-0·59; p<0·0001), cough (OR 0·44, 0·32-0·62; p<0·0001), breathlessness (OR 0·40, 0·21-0·76; p=0·0052), chronic obstructive pulmonary disease (OR 0·37, 0·23-0·60; p<0·0001), bronchitis (OR 0·60, 0·43-0·82; p=0·0015), pulmonary function deficit (OR 0·27, 0·17-0·44; p<0·0001), severe respiratory illness or death (OR 0·27, 0·11-0·63; p=0·0024), preterm birth (OR 0·66, 0·45-0·97; p=0·033), and low birth weight (OR 0·70, 0·53-0·93; p=0·015). Non-statistically significant effects were observed for asthma in children (OR 1·04, 0·70-1·55; p=0·84), asthma in adults (OR 0·65, 0·43-1·00; p=0·052), and small for gestational age (OR 1·04, 0·89-1·21; p=0·62). Compared with electricity, use of gas significantly increased risk of pneumonia (OR 1·26, 1·03-1·53; p=0·025) and chronic obstructive pulmonary disease (OR 1·15, 1·06-1·25; p=0·0011), although smaller non-significant effects were observed for higher-quality studies. In addition, a small increased risk of asthma in children was not significant (OR 1·09, 0·99-1·19; p=0·071) and no significant associations were found for adult asthma, wheeze, cough, and breathlessness (p>0·05). A significant decreased risk of bronchitis was observed (OR 0·87, 0·81-0·93; p<0·0001).\\nSwitching from polluting fuels to gaseous household fuels could lower health risk and associated morbidity and mortality in resource-poor countries where reliance on polluting fuels is greatest. Although gas fuel use was associated with a slightly higher risk for some health outcomes compared with electricity, gas is an important transitional option for health in countries where access to reliable electricity supply for cooking or heating is not feasible in the near term.\\nWHO.\", 'keywords': [], 'journal': 'The Lancet. Respiratory medicine', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Puzzolo', 'firstname': 'Elisa', 'initials': 'E', 'affiliation': 'Department of Public Health, Policy, and Systems, University of Liverpool, Liverpool, UK. Electronic address: puzzoloe@liverpool.ac.uk.'}, {'lastname': 'Fleeman', 'firstname': 'Nigel', 'initials': 'N', 'affiliation': 'Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Lorenzetti', 'firstname': 'Federico', 'initials': 'F', 'affiliation': 'Department of Public Health, Policy, and Systems, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Rubinstein', 'firstname': 'Fernando', 'initials': 'F', 'affiliation': 'Department of Public Health, Policy, and Systems, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Li', 'firstname': 'Yaojie', 'initials': 'Y', 'affiliation': 'College of Urban and Environmental Sciences, Peking University, Beijing, China.'}, {'lastname': 'Xing', 'firstname': 'Ran', 'initials': 'R', 'affiliation': 'College of Urban and Environmental Sciences, Peking University, Beijing, China.'}, {'lastname': 'Shen', 'firstname': 'Guofeng', 'initials': 'G', 'affiliation': 'College of Urban and Environmental Sciences, Peking University, Beijing, China.'}, {'lastname': 'Nix', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Department of Public Health, Policy, and Systems, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Maden', 'firstname': 'Michelle', 'initials': 'M', 'affiliation': 'Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Bresnahan', 'firstname': 'Rebecca', 'initials': 'R', 'affiliation': 'Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Duarte', 'firstname': 'Rui', 'initials': 'R', 'affiliation': 'Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Abebe', 'firstname': 'Lydia', 'initials': 'L', 'affiliation': 'Public Health, Environmental and Social Determinants of Health, WHO, Geneva, Switzerland.'}, {'lastname': 'Lewis', 'firstname': 'Jessica', 'initials': 'J', 'affiliation': 'Public Health, Environmental and Social Determinants of Health, WHO, Geneva, Switzerland.'}, {'lastname': 'Williams', 'firstname': 'Kendra N', 'initials': 'KN', 'affiliation': 'Public Health, Environmental and Social Determinants of Health, WHO, Geneva, Switzerland.'}, {'lastname': 'Adahir-Rohani', 'firstname': 'Heather', 'initials': 'H', 'affiliation': 'Public Health, Environmental and Social Determinants of Health, WHO, Geneva, Switzerland.'}, {'lastname': 'Pope', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Department of Public Health, Policy, and Systems, University of Liverpool, Liverpool, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.', 'doi': '10.1016/S2213-2600(23)00427-7', 'xml': <Element 'PubmedArticle' at 0x147a26d90>}\n",
      "{'pubmed_id': '38310765', 'title': 'Radical S-adenosyl methionine domain-containing 2, a potential target of D-tryptophan in asthma treatment, regulates T helper cell type 1/2 balance.', 'abstract': 'Asthma is a common chronic respiratory disease. D-tryptophan (D-TRP) can inhibit allergic airway inflammation and T helper cell type 2 (Th2) immune response. RNA-sequencing results have indicated that radical S-adenosyl methionine domain-containing 2 (RSAD2) might be a potential molecular target of D-TRP in asthma treatment. Herein, we established a mouse model of asthma using ovalbumin (OVA) via intraperitoneal injection and inhalational challenge. Gain- and loss-of-function studies of RSAD2 were performed in mice following the intratracheal delivery of lentiviral vectors (3\\xa0×\\xa010', 'keywords': ['Asthma', 'D-tryptophan', 'Lung', 'RSAD2', 'T helper cell type 2'], 'journal': 'International immunopharmacology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Wang', 'firstname': 'Fei', 'initials': 'F', 'affiliation': 'Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China.'}, {'lastname': 'Shang', 'firstname': 'Yunxiao', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: shangyxshengjing@163.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.intimp.2024.111581', 'xml': <Element 'PubmedArticle' at 0x10acda1b0>}\n",
      "{'pubmed_id': '38310669', 'title': 'Anti-inflammation of LZTFL1 knockdown in OVA-induced asthmatic mice: Through ERK/GATA3 signaling pathway.', 'abstract': 'Asthma is a common chronic respiratory disease characterized by Th2-type inflammation in the airways. Leucine zip transcription factor-like 1 (LZTFL1) has been implicated in the regulation of Th2-related factors. The knockdown of LZTFL1 resulted in decreased levels of IL-4, IL-5, and IL-13. We hypothesize that LZTFL1 may have an effect on asthma. We established an acute asthmatic mouse model using the Ovalbumin (OVA) sensitization, and we found that LZTFL1 expression was upregulated in OVA-induced CD4\\xa0+\\xa0T cells. Mice challenged with OVA were administered 5\\xa0×\\xa010', 'keywords': ['Asthma', 'LZTFL1', 'MEK/ERK signaling', 'Th2 inflammation'], 'journal': 'Molecular immunology', 'publication_date': datetime.date(2024, 2, 5), 'authors': [{'lastname': 'Song', 'firstname': 'Guihua', 'initials': 'G', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China. Electronic address: songgh8916@hactcm.edu.cn.'}, {'lastname': 'Sun', 'firstname': 'Mengmeng', 'initials': 'M', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.'}, {'lastname': 'Zhang', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.'}, {'lastname': 'Zhang', 'firstname': 'Bingxue', 'initials': 'B', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.'}, {'lastname': 'Peng', 'firstname': 'Minghao', 'initials': 'M', 'affiliation': 'Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.'}, {'lastname': 'Bao', 'firstname': 'Beibei', 'initials': 'B', 'affiliation': 'Department of Pediatrics, Henan University of Chinese Medicine, Zhengzhou, Henan, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.molimm.2024.01.010', 'xml': <Element 'PubmedArticle' at 0x10acdbd80>}\n",
      "{'pubmed_id': '38310584\\n36267894\\n30948504\\n32469667\\n32720299\\n34561293\\n28947020\\n31412998\\n26793004\\n28017629\\n31949111\\n30022059\\n30214247\\n35922128\\n33086885\\n36175556\\n36715896\\n12765314\\n30453871\\n37079594\\n19769554\\n30928659\\n31048346\\n34587829\\n35081939\\n32495701', 'title': 'The Association Between Short-Acting β', 'abstract': 'In Australia, short-acting β\\nThis was a cross-sectional study, using data derived from primary care electronic medical records (EMRs) and patient completed questionnaires within Optimum Patient Care Research Database Australia (OPCRDA). A total of 720 individuals aged\\u2009≥\\u200912\\xa0years with an asthma diagnosis in their EMRs and receiving asthma therapy were included. The annual number of SABA inhalers authorised on prescription, acquired OTC and reported, and the association with self-reported exacerbations and asthma control were investigated.\\n92.9% (n\\u2009=\\u2009380/409) of individuals issued with SABA prescription were authorised\\u2009≥\\u20093 inhalers annually, although this differed from self-reported usage. Of individuals reporting SABA use (n\\u2009=\\u2009546) in the last 12\\xa0months, 37.0% reported using\\u2009≥\\u20093 inhalers. These patients who reported SABA overuse experienced 2.52 (95% confidence interval [CI] 1.73-3.70) times more severe exacerbations and were 4.51 times (95% CI 3.13-6.55) more likely to have poor asthma control than those who reported using 1-2 SABA inhalers. Patients who did not receive SABA on prescription (43.2%; n\\u2009=\\u2009311/720) also experienced 2.71 (95% CI 1.07-7.26) times more severe exacerbations than those prescribed 1-2 inhalers. Of these patients, 38.9% reported using OTC SABA and other prescription medications, 26.4% reported using SABA OTC as their only asthma medication, 13.2% were prescribed other therapies but not SABA OTC and 14.5% were not using any medication.\\nBoth self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.', 'keywords': ['Asthma management', 'Asthma outcomes', 'Over-the-counter medication', 'Prescription patterns', 'Short-acting β2-agonists'], 'journal': 'Advances in therapy', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Price', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Optimum Patient Care, 5 Coles Lane, Oakington, CB24 3BA, Cambridgeshire, UK. dprice@opri.sg.\\nObservational and Pragmatic Research Institute, 22 Sin Ming Lane, #06-76, Midview City, 573969, Singapore. dprice@opri.sg.\\nDivision of Applied Health Sciences, Centre of Academic Primary Care, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. dprice@opri.sg.\\nOptimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia. dprice@opri.sg.'}, {'lastname': 'Jenkins', 'firstname': 'Christine', 'initials': 'C', 'affiliation': 'Thoracic Physician Concord Hospital, Head Respiratory Trials, George Institute, University of Sydney, Sydney, Australia.'}, {'lastname': 'Hancock', 'firstname': 'Kerry', 'initials': 'K', 'affiliation': 'Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 3, 207 Bouverie Street, VIC, 3010, Australia.\\nRACGP Resp Medicine SIG, 100 Wellington Parade, East Melbourne, Melbourne, VIC, 3002, Australia.'}, {'lastname': 'Vella', 'firstname': 'Rebecca', 'initials': 'R', 'affiliation': 'Optimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia.'}, {'lastname': 'Heraud', 'firstname': 'Florian', 'initials': 'F', 'affiliation': 'Queensland Health, Brisbane, QLD, Australia.'}, {'lastname': 'Le Cheng', 'firstname': 'Porsche', 'initials': 'P', 'affiliation': 'Optimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia.'}, {'lastname': 'Murray', 'firstname': 'Ruth', 'initials': 'R', 'affiliation': 'Optimum Patient Care, 5 Coles Lane, Oakington, CB24 3BA, Cambridgeshire, UK.'}, {'lastname': 'Beekman', 'firstname': 'Maarten', 'initials': 'M', 'affiliation': 'BioPharmaceuticals Medical and Regional Medical Director for International, The Hague, The Netherlands.'}, {'lastname': 'Bosnic-Anticevich', 'firstname': 'Sinthia', 'initials': 'S', 'affiliation': 'Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.\\nWoolcock Institute of Medical Research, 431 Glebe Point Road, Glebe, MSW, 2037, Australia.'}, {'lastname': 'Botini', 'firstname': 'Fabio', 'initials': 'F', 'affiliation': 'Optimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia.'}, {'lastname': 'Carter', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Optimum Patient Care, 5 Coles Lane, Oakington, CB24 3BA, Cambridgeshire, UK.'}, {'lastname': 'Catanzariti', 'firstname': 'Angelina', 'initials': 'A', 'affiliation': 'AstraZeneca Biopharmaceuticals Medical, Medical Affairs, 66 Talavera Road, Macquarie Park, NSW, Australia.'}, {'lastname': 'Doan', 'firstname': 'Joe', 'initials': 'J', 'affiliation': 'HealthPlus Medical Centre, 28/26 Belgrave St, Kogarah, NSW, 2217, Australia.'}, {'lastname': 'Fletton', 'firstname': 'Kirsty', 'initials': 'K', 'affiliation': 'Optimum Patient Care, 5 Coles Lane, Oakington, CB24 3BA, Cambridgeshire, UK.'}, {'lastname': 'Kichkin', 'firstname': 'Ata', 'initials': 'A', 'affiliation': 'Blue Shield Family General Practice, Kogarah, NSW, 2217, Australia.'}, {'lastname': 'Le', 'firstname': 'Thao', 'initials': 'T', 'affiliation': 'Medical Education, and Events Management Pte Ltd, Singapore, Singapore.'}, {'lastname': 'Le Lievre', 'firstname': 'Chantal', 'initials': 'C', 'affiliation': 'Optimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia.'}, {'lastname': 'Lau', 'firstname': 'Chi Ming', 'initials': 'CM', 'affiliation': 'Toukley Family Practice, 37-41 Canton Beach Road, Toukley, NSW, 2263, Australia.'}, {'lastname': 'Novic', 'firstname': 'Dominique', 'initials': 'D', 'affiliation': 'Redlands Medical Centre, 189 Vienna Rd, Alexandra Hills, 4161, Australia.'}, {'lastname': 'Pakos', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Woodcroft Medical Centre, Woodcroft, SA, 5162, Australia.'}, {'lastname': 'Ranasinghe', 'firstname': 'Kanchanamala', 'initials': 'K', 'affiliation': 'School of Medicine, Griffith University, Gold Coast, Australia.\\nCannon Hill Family Doctors, 17/1177 Wynnum Rd, Cannon Hill, QLD, 4170, Australia.'}, {'lastname': 'Roussos', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Optimum Patient Care Australia, 27 Creek St, Brisbane, QLD, 4000, Australia.'}, {'lastname': 'Samuel-King', 'firstname': 'Josephine', 'initials': 'J', 'affiliation': 'Ripponlea Medical Centre, Ripponlea, VIC, 3185, Australia.'}, {'lastname': 'Sharma', 'firstname': 'Anita', 'initials': 'A', 'affiliation': 'Platinum Medical Centre, 18 Banfield St, Chermside, QLD, 4032, Australia.'}, {'lastname': 'Stewart', 'firstname': 'Deb', 'initials': 'D', 'affiliation': 'School of Medicine, University of Tasmania, Churchill Ave, Hobart, TAS, 7005, Australia.'}, {'lastname': 'Willet', 'firstname': 'Bruce', 'initials': 'B', 'affiliation': 'Victoria Point Surgery, Brisbane, QLD, 4165, Australia.'}, {'lastname': 'Bateman', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Department of Medicine, University of Cape Town, and University Cape Town Lung Institute, Cape Town, South Africa.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': 'Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.', 'results': '92.9% (n\\u2009=\\u2009380/409) of individuals issued with SABA prescription were authorised\\u2009≥\\u20093 inhalers annually, although this differed from self-reported usage. Of individuals reporting SABA use (n\\u2009=\\u2009546) in the last 12\\xa0months, 37.0% reported using\\u2009≥\\u20093 inhalers. These patients who reported SABA overuse experienced 2.52 (95% confidence interval [CI] 1.73-3.70) times more severe exacerbations and were 4.51 times (95% CI 3.13-6.55) more likely to have poor asthma control than those who reported using 1-2 SABA inhalers. Patients who did not receive SABA on prescription (43.2%; n\\u2009=\\u2009311/720) also experienced 2.71 (95% CI 1.07-7.26) times more severe exacerbations than those prescribed 1-2 inhalers. Of these patients, 38.9% reported using OTC SABA and other prescription medications, 26.4% reported using SABA OTC as their only asthma medication, 13.2% were prescribed other therapies but not SABA OTC and 14.5% were not using any medication.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s12325-023-02746-0\\n10.1183/23120541.00353-2022\\n10.1183/13993003.02223-2018\\n10.1080/02770903.2020.1761382\\n10.1007/s12325-020-01444-5\\n10.1183/13993003.01402-2021\\n10.1016/j.rmed.2017.08.014\\n10.1136/bmjopen-2019-028995\\n10.1016/j.jaip.2016.11.007\\n10.1183/13993003.01872-2019\\n10.1038/s41533-018-0096-4\\n10.2147/JAA.S176026\\n10.1136/thorax-2021-217032\\n10.1080/02770903.2020.1841223\\n10.1038/s41533-022-00295-7\\n10.1007/s12325-022-02410-z\\n10.1081/JAS-120017983\\n10.5694/mja18.00119\\n10.1371/journal.pone.0283876\\n10.5694/j.1326-5377.2009.tb02815.x\\n10.1016/j.jaip.2019.03.024\\n10.1183/13993003.00491-2019\\n10.1177/17534666211042534\\n10.1186/s12913-022-07518-0\\n10.1177/0897190020927274', 'xml': <Element 'PubmedArticle' at 0x10b6c5e90>}\n",
      "{'pubmed_id': '38310492', 'title': \"The Barriers to Shared Decision-making in Exercise Prescription for Children With Asthma: A Qualitative Study From Parents' Perspective.\", 'abstract': 'The knowledge of barriers from the parental perspective is essential for facilitating shared decision-making in the field of pediatric asthma.\\nParticipants who were parents of children with a diagnosis of asthma were recruited, and in-depth, semistructured interviews were conducted. The interview transcripts were analyzed thematically using framework methods.\\nSeventeen participants undertook interviews. Three themes and nine subthemes emerged: (1) decision-making need level-limited understanding of decision-making knowledge, ambiguity regarding self-empowerment roles, and lack of family member support; (2) decision-making support level-insufficient ability to evaluate information, inefficient communication with health care professionals, and excessive use of professional terminology; and (3) decision-making outcome level-doubts about the final decision-making choices, time constraints on decision-making, and absence of mechanisms to track decisions made.\\nThe findings would serve as crucial foundations for the development of decision-aid programs within the context of pediatric asthma.', 'keywords': ['Children with a diagnosis of asthma', 'exercise prescription', 'parents', 'qualitative research', 'shared decision-making'], 'journal': 'Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Yi', 'firstname': 'Mo', 'initials': 'M', 'affiliation': None}, {'lastname': 'Jia', 'firstname': 'Yuanmin', 'initials': 'Y', 'affiliation': None}, {'lastname': 'Zhao', 'firstname': 'Baosheng', 'initials': 'B', 'affiliation': None}, {'lastname': 'Chen', 'firstname': 'Ou', 'initials': 'O', 'affiliation': None}], 'methods': 'Participants who were parents of children with a diagnosis of asthma were recruited, and in-depth, semistructured interviews were conducted. The interview transcripts were analyzed thematically using framework methods.', 'conclusions': None, 'results': 'Seventeen participants undertook interviews. Three themes and nine subthemes emerged: (1) decision-making need level-limited understanding of decision-making knowledge, ambiguity regarding self-empowerment roles, and lack of family member support; (2) decision-making support level-insufficient ability to evaluate information, inefficient communication with health care professionals, and excessive use of professional terminology; and (3) decision-making outcome level-doubts about the final decision-making choices, time constraints on decision-making, and absence of mechanisms to track decisions made.', 'copyrights': 'Copyright © 2024 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.pedhc.2024.01.001', 'xml': <Element 'PubmedArticle' at 0x10b423740>}\n",
      "{'pubmed_id': '38310427\\n20014201\\n25883756\\n26418389\\n24709271\\n20050889\\n21468361\\n20112390\\n35607552\\n16218474\\n16679097\\n19593229\\n37868681', 'title': 'Cardiac Mass and Cerebrovascular Accident as Primary Manifestations of Churg-Strauss Syndrome.', 'abstract': 'Churg-Strauss syndrome (CSS), recently named eosinophilic granulomatosis with polyangiitis (EGPA), is a rare form of systemic vasculitis with extravascular granulomas occurring in patients with asthma and tissue eosinophilia. We represent a large left ventricular granuloma, confirmed by histopathologic evaluation, detected as a ventricular mass by echocardiography in a 45-year-old asthmatic male who was admitted for a cerebrovascular accident. Paraclinical and histopathologic findings confirmed the diagnosis of EGPA. As cardiac involvement in patients with EGPA is associated with poor prognosis, routine echocardiographic evaluation of these patients is suggested.', 'keywords': ['Cardiac mass', 'Churg-Strauss syndrome', 'Eosinophilia', 'Granuloma', 'Vasculitis'], 'journal': 'Archives of Iranian medicine', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Abbasi', 'firstname': 'Fariba', 'initials': 'F', 'affiliation': 'Solid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.\\nDepartment of Pathology, Faculty of Medicine, Urmia University of Medicine, Urmia, Iran.'}, {'lastname': 'Abbasi', 'firstname': 'Ata', 'initials': 'A', 'affiliation': 'Department of Pathology, Faculty of Medicine, Urmia University of Medicine, Urmia, Iran.'}, {'lastname': 'Rostamzadeh', 'firstname': 'Alireza', 'initials': 'A', 'affiliation': 'Department of Cardiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.'}, {'lastname': 'Banihashemi', 'firstname': 'Seyede Zohre', 'initials': 'SZ', 'affiliation': 'Department of Pathology, Faculty of Medicine, Urmia University of Medicine, Urmia, Iran.'}, {'lastname': 'Rajabi', 'firstname': 'Aliakbar', 'initials': 'A', 'affiliation': 'Department of Pathology, Faculty of Medicine, Urmia University of Medicine, Urmia, Iran.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'doi': '10.34172/aim.2023.97\\n10.1002/clc.20595\\n10.4250/jcu.2015.23.1.40\\n10.1714/1988.21524.[Italian]\\n10.1016/j.healun.2014.02.023\\n10.1111/j.1468-1331.2009.02902.x\\n10.1159/000323214\\n10.1002/art.27263\\n10.7759/cureus.24342\\n10.1191/0961203305lu2207oa\\n10.1016/j.amjcard.2005.11.088\\n10.1097/MD.0b013e3181af35a5\\n10.55729/2000-9666.1219', 'xml': <Element 'PubmedArticle' at 0x10baf1260>}\n",
      "{'pubmed_id': '38310368', 'title': 'Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma.', 'abstract': 'Neutrophilic asthma is characterized by the predominant infiltration of neutrophils in airway inflammation.\\nTo explore the therapeutic potential of an antibody against the inducible T cell co-stimulator ligand (ICOSL) in a mouse model of neutrophilic asthma.\\nFemale BALB/c mice were randomly assigned to different groups. They were then injected with ovalbumin (OVA)/lipopolysaccharides (LPS) to induce neutrophilic asthma. The mice were then treated with either anti-ICOSL (the I group), control IgG (the G group), or no treatment (the N group). Additionally, a control group of mice received vehicle PBS and was labeled as the C group (n=6 per group). One day after the last allergen exposure, cytokine levels were measured in plasma and bronchoalveolar lavage fluid (BALF) using ELISA. After analyzing and categorizing BALF cells, the lung tissues were examined histologically and immunohistochemically.\\nAdministering anti-ICOSL resulted in a significant decrease in the total number of inflammatory infiltrates and neutrophils found in BALF. Moreover, it led to a decrease in the levels of interleukin (IL)-6, IL-13, and IL-17 in both BALF and plasma. Additionally, there was an increase in IFN-γ levels in the BALF of asthmatic mice (p<0.05 for all). Treatment with anti-ICOSL also reduced lung interstitial inflammation, mucus secretion, and ICOSL expression in asthmatic mice.\\nThe treatment of anti-ICOSL effectively improved lung interstitial inflammation and mucus secretion in mice with neutrophilic asthma by restoring the balance of Th1/Th2/Th17 responses. These findings indicate that blocking the ICOS/ICOSL signaling could be an effective way to manage neutrophilic asthma.', 'keywords': ['Asthma', 'Inducible T Cell Co-Stimulator Ligand', 'Neutrophils', 'Pathology'], 'journal': 'Iranian journal of immunology : IJI', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Dong', 'firstname': 'Heting', 'initials': 'H', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Ren', 'firstname': 'Yinying', 'initials': 'Y', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\\nDepartment of Pediatrics, Xi'an Fourth Hospital, Xi'an, China.\"}, {'lastname': 'Song', 'firstname': 'Yiyi', 'initials': 'Y', 'affiliation': 'Suzhou Medical College, Soochow University, Suzhou 215003, China.'}, {'lastname': 'Ji', 'firstname': 'Wei', 'initials': 'W', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Yan', 'firstname': 'Yongdong', 'initials': 'Y', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Zhu', 'firstname': 'Canhong', 'initials': 'C', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Huang', 'firstname': 'Li', 'initials': 'L', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Wang', 'firstname': 'Meijuan', 'initials': 'M', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Gu', 'firstname': 'Wenjing', 'initials': 'W', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Zhang', 'firstname': 'Xinxing', 'initials': 'X', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Sun', 'firstname': 'Huiming', 'initials': 'H', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Hao', 'firstname': 'Chuangli', 'initials': 'C', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}, {'lastname': 'Chen', 'firstname': 'Zhengrong', 'initials': 'Z', 'affiliation': \"Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou 215003, China.\"}], 'methods': None, 'conclusions': 'The treatment of anti-ICOSL effectively improved lung interstitial inflammation and mucus secretion in mice with neutrophilic asthma by restoring the balance of Th1/Th2/Th17 responses. These findings indicate that blocking the ICOS/ICOSL signaling could be an effective way to manage neutrophilic asthma.', 'results': 'Administering anti-ICOSL resulted in a significant decrease in the total number of inflammatory infiltrates and neutrophils found in BALF. Moreover, it led to a decrease in the levels of interleukin (IL)-6, IL-13, and IL-17 in both BALF and plasma. Additionally, there was an increase in IFN-γ levels in the BALF of asthmatic mice (p<0.05 for all). Treatment with anti-ICOSL also reduced lung interstitial inflammation, mucus secretion, and ICOSL expression in asthmatic mice.', 'copyrights': None, 'doi': '10.22034/iji.2024.98853.2594', 'xml': <Element 'PubmedArticle' at 0x10b6b0770>}\n",
      "{'pubmed_id': '38310323\\n19839977\\n27609406\\n25199059\\n29782224\\n25441637\\n18250205\\n23589584\\n25682233\\n18714785\\n25126027\\n23770180\\n28760549\\n22467983\\n17825611\\n15317672\\n7846460\\n21203366\\n19865841\\n31527545\\n27568340\\n28007353\\n25585327\\n28642543\\n14736085\\n19560194\\n18363319\\n20110399\\n1519015\\n21781135\\n15565409\\n24998371\\n23208313\\n19317386\\n12789212\\n3209556\\n11011488\\n12377837\\n12615790\\n26004304\\n26934051\\n14959810\\n24583902\\n11896492\\n15637554\\n15579368\\n20545839\\n17463417\\n16264041\\n28327130\\n32632893\\n20484927\\n23115401\\n19813037\\n24781675\\n17050561\\n27732758\\n31325020\\n27568340\\n25700868', 'title': 'The prevalence of obstructive sleep apnea in Japanese asthma patients.', 'abstract': 'Obstructive sleep apnea (OSA) occurs more commonly in asthma patients than in the general population because these conditions share some comorbidities. In Japan, the prevalence of OSA in the general population is reported to be approximately 20%; however, few reports have described the prevalence of OSA in asthma patients. Furthermore, the characteristics of Japanese patients with OSA and asthma are not clear.\\nAdult asthma patients were recruited from the outpatient departments of our institution between August 31, 2017, and March 31, 2019. In all included patients, the presence and severity of OSA were evaluated by the Epworth Sleepiness Scale (ESS) and a home sleep test (HST) using portable polysomnography (PSG). The rate of coexisting OSA in asthma patients and the characteristics of those patients according to the severity of OSA were investigated.\\nFifty-three patients were included. OSA was detected in 36 (67.9%) patients (mild, n\\u2009=\\u200915; moderate, n\\u2009=\\u200914; and severe, n\\u2009=\\u20097). Patients with OSA had significantly higher body mass index, Brinkman index, apnea-hypopnea index (AHI), and 3% oxygen desaturation index (ODI) values in comparison to those without OSA, while the percentage of the predicted value of forced vital capacity (%FVC) and lowest SpO\\nThis is the first report to investigate the prevalence of OSA in Japanese asthma patients, using an HST. This study suggests that an HST should be performed in addition to the sleep interview for asthma patients with refractory disease, a low pulmonary function, advanced age, and high BMI because the more severe the OSA, the lower the ESS value may be.', 'keywords': ['Bronchial asthma', 'Japanese', 'Obstructive sleep apnea'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Yasuda', 'firstname': 'Mina', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan. mina0628mina@gmail.com.\\nDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan. mina0628mina@gmail.com.'}, {'lastname': 'Tobino', 'firstname': 'Kazunori', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.\\nDepartment of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.'}, {'lastname': 'Harada', 'firstname': 'Norihiro', 'initials': 'N', 'affiliation': 'Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.'}, {'lastname': 'Ooi', 'firstname': 'Ryunosuke', 'initials': 'R', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Sueyasu', 'firstname': 'Takuto', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Nishizawa', 'firstname': 'Saori', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Munechika', 'firstname': 'Miyuki', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Yoshimine', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Ko', 'firstname': 'Yuki', 'initials': 'Y', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Yoshimatsu', 'firstname': 'Yuki', 'initials': 'Y', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Tsuruno', 'firstname': 'Kosuke', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Ide', 'firstname': 'Hiromi', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.'}, {'lastname': 'Takahashi', 'firstname': 'Kazuhisa', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.'}], 'methods': None, 'conclusions': None, 'results': 'Fifty-three patients were included. OSA was detected in 36 (67.9%) patients (mild, n\\u2009=\\u200915; moderate, n\\u2009=\\u200914; and severe, n\\u2009=\\u20097). Patients with OSA had significantly higher body mass index, Brinkman index, apnea-hypopnea index (AHI), and 3% oxygen desaturation index (ODI) values in comparison to those without OSA, while the percentage of the predicted value of forced vital capacity (%FVC) and lowest SpO', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00875-x', 'xml': <Element 'PubmedArticle' at 0x10a644310>}\n",
      "{'pubmed_id': '38310247\\n29441147\\n35710451\\n24651279\\n28167094\\n27051548\\n24686277\\n37088836\\n28721077\\n36337681\\n36306938\\n36426394\\n36608982\\n24686277\\n36882041\\n36306938', 'title': 'Delayed presentation of food protein-induced enterocolitis syndrome (FPIES) to okra in a toddler.', 'abstract': 'Food protein-induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE) -mediated food allergy predominantly observed in infants and characterized by the delayed onset of vomiting following ingestion of a trigger food. An increase in research and clinical consideration of FPIES has led to the discovery of unique deviations from the standard FPIES triggers and presentations.\\nA 34-month-old female patient with a history of consuming okra daily presented to medical attention after developing classic FPIES symptoms to okra beginning at 14-months of age.\\nRecently, awareness about the varied nature of FPIES clinical presentation has come to light. This case is the first to describe FPIES to the fruit okra that developed over a 12-month time span after previously tolerating the food. This case serves to emphasize the importance of understanding the range of FPIES symptoms to improve recognition and expedite best practice recommendations.', 'keywords': ['Food allergy', 'Food protein-induced enterocolitis syndrome (FPIES)', 'Non-immunoglobulin E (IgE)', 'Okra', 'Vomiting'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Hall', 'firstname': 'Hunter', 'initials': 'H', 'affiliation': 'Department of Biology, Liberty University, Lynchburg, VA, USA.'}, {'lastname': 'Anvari', 'firstname': 'Sara', 'initials': 'S', 'affiliation': \"Division of Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.\"}, {'lastname': 'Schultz', 'firstname': 'Fallon', 'initials': 'F', 'affiliation': 'International FPIES Association, Point Pleasant Beach, NJ, USA.'}, {'lastname': 'Ojuola', 'firstname': 'Olubukola', 'initials': 'O', 'affiliation': 'Division of Pediatrics, Liberty University College of Osteopathic Medicine, Collaborative Health Partners, Lynchburg, VA, USA.'}, {'lastname': 'Rider', 'firstname': 'Nicholas L', 'initials': 'NL', 'affiliation': 'Department of Health System & Implementation Science, Virginia Tech Carilion School of Medicine, 1 Riverside Circle, 249, Roanoke, Virginia, 24016, USA. nick70@vt.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00871-1\\n10.1186/s40413-017-0182-z\\n10.2500/jfa.2020.2.200011\\n10.1186/s13223-022-00694-y\\n10.1097/ACI.0000000000000052\\n10.1016/j.jaci.2016.12.966\\n10.1097/ACI.0000000000000056\\n10.1186/s13223-023-00787-2\\n10.2147/JAA.S100379\\n10.5414/ALX02363E\\n10.1016/j.jaci.2022.09.035\\n10.4168/aair.2022.14.6.587\\n10.1016/j.jaci.2022.11.002\\n10.1097/ACI.0000000000000056\\n10.1159/000529138\\n10.1016/j.jaci.2022.09.035', 'xml': <Element 'PubmedArticle' at 0x10b54bb50>}\n",
      "{'pubmed_id': '38310083', 'title': 'Research progress on the pathogenesis of chest tightness variant asthma characterized by chest tightness.', 'abstract': 'Chest tightness variant asthma (CTVA) is an atypical form of asthma with chest tightness as the sole or predominant symptom. The underlying receptors for chest tightness may be bronchial C-fibers or rapidly adapting receptors. The nerve impulses are transmitted via the vagus nerve and processed in different regions of the cerebral cortex. Chest tightness is associated with sensory perception, and CTVA patients may have a heightened ability to detect subtle changes in lung function, which may be unrelated to respiratory muscle activity, lung hyperinflation, or mechanical loading of the respiratory system. The airway inflammation, pulmonary ventilation dysfunction (especially involving small airways), and airway hyperresponsiveness may underlie the sensation of chest tightness. CTVA patients are prone to comorbid anxiety and depression, which share similar central nervous system processing pathways with dyspnea, suggesting a possible neurological basis for the development of CTVA. This article examines the recognition and mechanisms of chest tightness symptoms, and explores the pathogenesis of CTVA, focusing on its association with the airway inflammation, ventilation dysfunction, airway hyperresponsiveness, and psychosocial factors.\\n胸闷变异性哮喘（CTVA）是以胸闷为唯一或主要表现的不典型哮喘。胸闷的潜在受体可能是支气管C纤维或快适应受体，神经冲动通过迷走神经上传，中枢神经处理可能在大脑皮质中的几个不同区域。胸闷与感知能力有关，胸闷者可能对肺功能微小的改变感知能力更强，这种感知能力可能与呼吸肌活动、肺过度充气状态以及呼吸系统机械负荷无关。CTVA患者的气道炎症、肺通气功能障碍尤其是小气道功能障碍以及气道高反应性可能是产生胸闷的原因。CTVA患者易合并焦虑症和抑郁症，焦虑症和抑郁症与呼吸困难有相似的中枢神经处理通路，提示CTVA的发病可能存在神经生理学基础。本文从胸闷症状的识别及产生机制出发，结合CTVA的气道炎症、通气功能障碍、气道高反应性及精神心理因素等特点及其导致胸闷的机制，探讨CTVA的发病机制。.', 'keywords': ['airway inflammation', 'chest tightness', 'chest tightness variant asthma', 'mechanism', 'perception', 'psychosis', 'symptoms'], 'journal': 'Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Che', 'firstname': 'Luanqing', 'initials': 'L', 'affiliation': 'Zhejiang Provincial Key Laboratory of Respiratory Disease, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China. cheluanqing@hotmail.com.'}, {'lastname': 'Lai', 'firstname': 'Jianxing', 'initials': 'J', 'affiliation': 'Zhejiang Provincial Key Laboratory of Respiratory Disease, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.'}, {'lastname': 'Huang', 'firstname': 'Huaqiong', 'initials': 'H', 'affiliation': 'Zhejiang Provincial Key Laboratory of Respiratory Disease, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.'}, {'lastname': 'Li', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Zhejiang Provincial Key Laboratory of Respiratory Disease, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.'}, {'lastname': 'Shen', 'firstname': 'Huahao', 'initials': 'H', 'affiliation': 'Zhejiang Provincial Key Laboratory of Respiratory Disease, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China. huahaoshen@zju.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3724/zdxbyxb-2023-0442\\n10.3760/cma.j.cn112137-20230704-01143\\n10.3760/cma.j.cn112137-20230416-00677\\n10.1080/02770903.2021.1980583\\n10.1016/j.anai.2013.06.016\\n10.3389/fmed.2021.727381\\n10.3877/cma.j.issn.2095-655X.2018.01.006\\n10.3760/cma.j.cn112147-20230311-00126\\n10.3760/cma.j.cn101070-20230719-00017\\n10.3969/j.issn.1009-5519.2019.16.057\\n10.1159/000522062\\n10.1016/b978-0-323-91534-2.00008-4\\n10.1093/bja/aer040\\n10.1164/rccm.200711-1675oc\\n10.3389/fphys.2021.720538\\n10.1152/japplphysiol.00913.2004\\n10.1016/j.resp.2015.03.007\\n10.1152/ajplung.00277.2019\\n10.1152/jappl.1991.71.6.2183\\n10.1097/spc.0000000000000069\\n10.1183/09031936.97.10051052\\n10.1164/ajrccm.165.1.2105061\\n10.1164/ajrccm.162.2.9907138\\n10.1186/s12967-017-1264-y\\n10.3969/j.issn.1002-1949.2000.04.019\\n10.3969/j.issn.1673-8705.2020.01.006\\n10.3760/cma.j.issn.2095-428X.2018.16.007\\n10.1080/02770903.2016.1236940\\n10.1080/02770903.2018.1531999\\n10.1136/thx.51.8.793\\n10.3969/j.issn.1001-5949.2003.12.016\\n10.3760/cma.j.issn.1673-4408.2016.10.019\\n10.3969/j.issn.1009-6663.2021.07.006\\n10.3969/j.issn.1671-945X.2023.08.005\\n10.1164/ajrccm.158.3.9707088\\n10.1016/j.rmed.2022.106865\\n10.4103/jfmpc.jfmpc_1331_20\\n10.1378/chest.15-0416\\n10.1164/ajrccm.163.4.2005057\\n10.1164/rccm.200712-1821oc\\n10.1038/s41467-020-15920-7\\n10.1038/s41593-022-01200-8\\n10.1016/j.neuron.2017.09.013\\n10.1016/0006-3223(95)00320-7\\n10.1093/scan/nsaa014\\n10.1002/ctm2.178\\n10.1080/02770900701840238\\n10.3969/j.issn.1671-6450.2014.03.011\\n10.1136/thorax.56.4.266\\n10.3969/j.issn.1002-266X.2018.06.031\\n10.1097/psy.0b013e3182864ee3\\n10.2105/ajph.94.4.625\\n10.1073/pnas.0504365102\\n10.1152/japplphysiol.01018.2018\\n10.1183/13993003.03008-2020', 'xml': <Element 'PubmedArticle' at 0x10aea8ea0>}\n",
      "{'pubmed_id': '38310042', 'title': 'Effect of atopic conditions on development and recurrences of infectious keratitis.', 'abstract': 'Atopic conditions are known to be associated with viral and bacterial infections. The purpose of this study was to determine the relationship between the effects of atopic conditions on the severity and recurrence of ocular infections including herpes simplex virus (HSV).\\nThis study was performed on 474 consecutive patients with infectious keratitis caused by bacteria, fungus, acanthamoeba, HSV, or varicella-zoster virus. The relationships between the atopic condition and specific infectious pathogens and HSV were determined using real-time PCR.\\nOur findings showed that atopic dermatitis (AD) was significantly associated with the incidence of HSV keratitis (odds ratio (OR), 10.2; P\\xa0=\\xa00.000). Other associations with AD were observed only with bacteria in an adverse manner. HSV proliferation in the lesions of patients with HSV keratitis whose AD was associated with non-infectious atopic blepharitis were significantly greater by 145-folds (P\\xa0=\\xa00.000). The presence of asthma or allergic rhinitis also increased the HSV DNA copy numbers. A recurrence of HSV keratitis was observed in 70 patients (43.2 %), and mean time to recurrence was 1647 days. Cox proportional hazard model indicated that the epithelial type of HSV recurrence but not the stromal type was associated with atopic conditions especially with AD. The factors significantly associated with a recurrence was AD associated with non-infectious atopic blepharitis (HR: 6.11, P\\xa0=\\xa00.000) and asthma (HR: 3.03, P\\xa0=\\xa00.025).\\nAtopic conditions, especially AD with atopic blepharitis, are significantly associated with the development, increased proliferation, and shorter time to a recurrence on HSV keratitis.', 'keywords': ['Allergic conjunctivitis', 'Atopic dermatitis', 'HSV keratitis', 'Herpes simplex keratitis', 'Real-time PCR'], 'journal': 'Allergology international : official journal of the Japanese Society of Allergology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Omatsu', 'firstname': 'Yutaka', 'initials': 'Y', 'affiliation': 'Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan.'}, {'lastname': 'Shimizu', 'firstname': 'Yumiko', 'initials': 'Y', 'affiliation': 'Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan.'}, {'lastname': 'Haruki', 'firstname': 'Tomoko', 'initials': 'T', 'affiliation': 'Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan.'}, {'lastname': 'Inoue', 'firstname': 'Yoshitsugu', 'initials': 'Y', 'affiliation': 'Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan.'}, {'lastname': 'Miyazaki', 'firstname': 'Dai', 'initials': 'D', 'affiliation': 'Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Tottori, Japan. Electronic address: dm@tottori-u.ac.jp.'}], 'methods': None, 'conclusions': None, 'results': 'Our findings showed that atopic dermatitis (AD) was significantly associated with the incidence of HSV keratitis (odds ratio (OR), 10.2; P\\xa0=\\xa00.000). Other associations with AD were observed only with bacteria in an adverse manner. HSV proliferation in the lesions of patients with HSV keratitis whose AD was associated with non-infectious atopic blepharitis were significantly greater by 145-folds (P\\xa0=\\xa00.000). The presence of asthma or allergic rhinitis also increased the HSV DNA copy numbers. A recurrence of HSV keratitis was observed in 70 patients (43.2 %), and mean time to recurrence was 1647 days. Cox proportional hazard model indicated that the epithelial type of HSV recurrence but not the stromal type was associated with atopic conditions especially with AD. The factors significantly associated with a recurrence was AD associated with non-infectious atopic blepharitis (HR: 6.11, P\\xa0=\\xa00.000) and asthma (HR: 3.03, P\\xa0=\\xa00.025).', 'copyrights': 'Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.alit.2024.01.008', 'xml': <Element 'PubmedArticle' at 0x10a6bc220>}\n",
      "{'pubmed_id': '38310039', 'title': 'Erratum to \"The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial\" [Contemporary Clinical Trials 131 (2023) 107274].', 'abstract': None, 'keywords': [], 'journal': 'Contemporary clinical trials', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Nyenhuis', 'firstname': 'S M', 'initials': 'SM', 'affiliation': 'Section of Allergy and Immunology, University of Chicago, Chicago, IL, USA.'}, {'lastname': 'Dixon', 'firstname': 'A E', 'initials': 'AE', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Vermont, Burlington, VT, USA.'}, {'lastname': 'Wood', 'firstname': 'L', 'initials': 'L', 'affiliation': 'University of Newcastle, Newcastle, Australia.'}, {'lastname': 'Lv', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Wittels', 'firstname': 'N E', 'initials': 'NE', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Ronneberg', 'firstname': 'C R', 'initials': 'CR', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Xiao', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA.'}, {'lastname': 'Dosala', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Marroquin', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Barve', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Harmon', 'firstname': 'W', 'initials': 'W', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Poynter', 'firstname': 'M E', 'initials': 'ME', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Parikh', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Camargo', 'firstname': 'C A', 'initials': 'CA', 'affiliation': \"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Appel', 'firstname': 'L J', 'initials': 'LJ', 'affiliation': 'Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Ma', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA. Electronic address: maj2015@uic.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.cct.2023.107373', 'xml': <Element 'PubmedArticle' at 0x108e61cb0>}\n",
      "{'pubmed_id': '38309971', 'title': '[Research advances in immunosenescence and inflammation in lung diseases].', 'abstract': \"The world's population is ageing at a rate unprecedented in human history. As the number of older people increases, so does the prevalence of lung disease in the elderly, making it essential to understand the pathophysiology of elderly patients with lung disease. Age-related changes in immune system function and lung parenchyma occur throughout a person's life. Immunosenescence refers to the tendency for innate and adaptive immunity to decline in the elderly. As we age, changes in the innate and adaptive immune systems can lead to dysregulation and reduced immune function. A low-level chronic inflammatory state is known as inflamm-aging and is driven by immunosenescence. This review discusses the role of immunosenescence and inflamm-aging in pulmonary diseases such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, asthma, and lung infections. Understanding the different manifestations of lung diseases between the elderly and the young, finding new therapeutic sites, or improving clinical outcomes in hospitalized patients will provide clinicians with new ideas.\\n世界人口正在以人类历史上前所未有的速度老龄化。随着老年人口数量的增加，老年肺部疾病的发病率升高，因此进一步理解老年患者肺部疾病的病理生理学至关重要。与年龄相关的免疫系统功能变化和肺实质变化伴随着人的一生。免疫衰老是指老年人的免疫状况呈现出先天性和适应性免疫力下降的趋势。随年龄增长，先天免疫系统和适应性免疫系统的变化会导致免疫系统的失调和能力降低。低水平慢性炎症状态被称为炎症衰老，由免疫衰老所驱动。在本综述中我们将讨论免疫衰老与炎症衰老在慢性阻塞性肺病、特发性肺纤维化、哮喘和肺部感染等肺部疾病中所发挥的作用。了解老年人与年轻人肺部疾病的表现不同，寻找新的治疗位点，或可改善住院患者临床结局，为临床医生提供新思路。.\", 'keywords': [], 'journal': 'Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Sun', 'firstname': 'Y', 'initials': 'Y', 'affiliation': 'School of Clinical Medicine, Weifang Medical University, Weifang 261053, China.'}, {'lastname': 'Han', 'firstname': 'X D', 'initials': 'XD', 'affiliation': 'Department of Respiratory Medicine, Qingdao Municipal Hospital Group, Qingdao 266011, China.'}, {'lastname': 'Liu', 'firstname': 'X D', 'initials': 'XD', 'affiliation': 'Department of Respiratory Medicine, Qingdao Municipal Hospital Group, Qingdao 266011, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3760/cma.j.cn112147-20230902-00128', 'xml': <Element 'PubmedArticle' at 0x109dbfdd0>}\n",
      "{'pubmed_id': '38309967', 'title': '[Annual progress on bronchial asthma diagnosis and treatment in 2023].', 'abstract': 'Bronchial asthma (referred to as asthma) is a common chronic inflammatory airway disease mediated by various immune cells, cytokines, and inflammatory mediators. This disease exhibits considerable heterogeneity in clinical symptoms, severity, and treatment outcomes, posing significant challenges to the diagnosis and treatment of asthma. This article reviews the literature on both basic and clinical research in asthma, published from October 1, 2022 to September 30, 2023. The review focuses on summarizing and elucidating four aspects of asthma: pathogenesis, diagnosis, assessment, and treatment. The aim is to provide more evidence for clinical diagnosis and treatment and offer new perspectives for future research.\\n支气管哮喘（简称哮喘）是一种由多种免疫细胞、细胞因子及炎症介质介导的常见慢性气道炎症性疾病，在临床症状、严重程度和治疗效果上具有明显的异质性，给诊治带来了巨大挑战。本文对2022年10月1日至2023年9月30日期间发表的关于哮喘基础与临床研究文献进行回顾，重点从哮喘的发病机制、诊断、评估和治疗四个方面进行总结和阐述，旨在为临床诊治提供更多依据，为未来研究提供新视角。.', 'keywords': [], 'journal': 'Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Shi', 'firstname': 'H L', 'initials': 'HL', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.'}, {'lastname': 'Huang', 'firstname': 'K W', 'initials': 'KW', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3760/cma.j.cn112147-20231129-00348', 'xml': <Element 'PubmedArticle' at 0x10af790d0>}\n",
      "{'pubmed_id': '38309959', 'title': '[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].', 'abstract': 'The methacholine challenge test (MCT) is a standard evaluation method of assessing airway hyperresponsiveness (AHR) and its severity, and has significant clinical value in the diagnosis and treatment of bronchial asthma. A consensus working group consisting of experts from the Pulmonary Function and Clinical Respiratory Physiology Committee of the Chinese Association of Chest Physicians, the Task Force for Pulmonary Function of the Chinese Thoracic Society, and the Pulmonary Function Group of Respiratory Branch of the Chinese Geriatric Society jointly developed this consensus. Based on the \"\\n乙酰甲胆碱支气管激发试验（MCT）是评估气道高反应性及其程度的常用检查，对支气管哮喘诊断及治疗效果评估具有重要临床价值。中国医师协会呼吸医师分会肺功能与临床呼吸生理工作委员会、中华医学会呼吸病学分会肺功能学组（筹）和中国老年医学会呼吸分会肺功能学组的专家们共同组成共识工作组，基于2014年发布的《肺功能指南——支气管激发试验检查》及其在使用中存在的问题与近年研究进展，在充分收集专家组意见、查阅文献、问卷调研、多轮线上和线下讨论后，形成了《乙酰甲胆碱（氯醋甲胆碱）支气管激发试验技术规范（2023年版）》。本共识收集了国内MCT临床实践中核心的11个问题并形成推荐意见，内容包括MCT的适应证与禁忌证、激发试剂配制、试验流程与方法、质量控制、安全性管理、结果解读和报告规范等方面，为医疗机构临床肺功能从业人员开展MCT提供参考，以期更好应用该项技术指导临床诊疗。.', 'keywords': [], 'journal': 'Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.3760/cma.j.cn112147-20231019-00247', 'xml': <Element 'PubmedArticle' at 0x108f2fab0>}\n",
      "{'pubmed_id': '38309951', 'title': 'Innovations in the treatment of anaphylaxis: A review of recent data.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Casale', 'firstname': 'Thomas B', 'initials': 'TB', 'affiliation': 'Morsani College of Medicine, University of South Florida, Tampa, Florida.'}, {'lastname': 'Ellis', 'firstname': 'Anne K', 'initials': 'AK', 'affiliation': \"Queen's University, Kingston, Ontario, Canada.\"}, {'lastname': 'Tanimoto', 'firstname': 'Sarina', 'initials': 'S', 'affiliation': 'ARS Pharmaceuticals, San Diego, California. Electronic address: sarinat@ars-pharma.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.11.018', 'xml': <Element 'PubmedArticle' at 0x10a3a84a0>}\n",
      "{'pubmed_id': '38309950', 'title': 'Response to \"Managing Anaphylaxis - Epinephrine, Antihistamines, and Corticosteroids: Over 10 years of C-CARE Registry Data\".', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Scheier', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Department of Pediatric Emergency Medicine, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: eric.scheier@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.10.031', 'xml': <Element 'PubmedArticle' at 0x10a3aa700>}\n",
      "{'pubmed_id': '38309949', 'title': 'Popliteal Pioneers.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Reigh', 'firstname': 'Erin L', 'initials': 'EL', 'affiliation': 'Dartmouth-Hitchcock Medical Center. Electronic address: Erin.L.Reigh@hitchcock.org.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.07.008', 'xml': <Element 'PubmedArticle' at 0x10a39cb80>}\n",
      "{'pubmed_id': '38309948', 'title': 'Antiallergic/adrenergic drugs from 80 years ago: Still relevant today?', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Zurlo', 'firstname': 'Marco', 'initials': 'M', 'affiliation': 'Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel; Department of Medicine, Asthma, Allergy and Clinical Immunology Section, University of Verona, Verona, Italy.'}, {'lastname': 'Nowak-Węgrzyn', 'firstname': 'Anna', 'initials': 'A', 'affiliation': \"Department of Pediatrics, Hassenfeld Children's Hospital, NYU Grossman School of Medicine, New York, New York; Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.\"}, {'lastname': 'Levi-Schaffer', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.08.602', 'xml': <Element 'PubmedArticle' at 0x10a39e6b0>}\n",
      "{'pubmed_id': '38309947', 'title': 'A dedicated pathway to appropriate penicillin allergy examinations in pregnancy.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Ramsey', 'firstname': 'Allison', 'initials': 'A', 'affiliation': 'Rochester Regional Health, Rochester, New York; University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: allison.ramsey@rochesterregional.org.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.11.027', 'xml': <Element 'PubmedArticle' at 0x10a311990>}\n",
      "{'pubmed_id': '38309946', 'title': 'Toward a much-needed coming of age: Diagnosis of allergic sensitization to fungi.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Giusti', 'firstname': 'Delphine', 'initials': 'D', 'affiliation': 'Immunology Laboratory, Biology and Pathology Department, University Hospital of Reims, Reims, France; EA7509 IRMAIC, University of Reims Champagne Ardenne, Reims, France.'}, {'lastname': 'Perotin', 'firstname': 'Jeanne-Marie', 'initials': 'JM', 'affiliation': 'Department of Respiratory Diseases, University Hospital of Reims, Reims, France; INSERM UMR 1250, University of Reims Champagne Ardenne, Reims, France.'}, {'lastname': 'Vitte', 'firstname': 'Joana', 'initials': 'J', 'affiliation': 'Immunology Laboratory, Biology and Pathology Department, University Hospital of Reims, Reims, France; INSERM UMR 1250, University of Reims Champagne Ardenne, Reims, France. Electronic address: joana.vitte@inserm.fr.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.12.004', 'xml': <Element 'PubmedArticle' at 0x10a313600>}\n",
      "{'pubmed_id': '38309945', 'title': 'A pathogenic role for innate-like B cells in type 2 chronic rhinosinusitis with nasal polyps: A novel IgE-producing population.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Dell', 'firstname': 'Paul H', 'initials': 'PH', 'affiliation': 'Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: fne2xn@virginia.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.11.007', 'xml': <Element 'PubmedArticle' at 0x10a31d530>}\n",
      "{'pubmed_id': '38309944', 'title': 'Evolving atopic dermatitis toward precision medicine.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Leung', 'firstname': 'Donald Y M', 'initials': 'DYM', 'affiliation': 'Department of Pediatrics, National Jewish Health, Denver, Colorado. Electronic address: leungd@njhealth.org.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2023.11.022', 'xml': <Element 'PubmedArticle' at 0x10a31f6a0>}\n",
      "{'pubmed_id': '38309936', 'title': 'Temporal Association Between Vaping and Risk of Cardiac Events.', 'abstract': \"To describe our early observations with sudden cardiac arrest (SCA) and sudden death (SD) in patients using vape products.\\nA retrospective analysis of Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory was performed on all SCA survivors and decedents who presented between January 1, 2007, and December 31, 2021, to identify patients/decedents with a history of vaping. Data abstraction included patient demographics, clinical characteristics, and documented use of vape products.\\nAmong 144 SCA survivors and 360 SD victims, there were six individuals (1%; 3 females) with unexplained SCA (n=4) or SD (n=2) that was temporally associated with vaping use with a mean age at sentinel event of 23±5 years. The SCA survivors include a 19-year-old male who was resuscitated from documented ventricular fibrillation 40 minutes after vaping and a 19-year-old male who was resuscitated from ventricular fibrillation a few hours post vaping. The first SD victim was a 19-year-old female with exercise-induced asthma who died in her sleep after vaping that evening. Autopsy results showed eosinophilic infiltrates in the lung tissue and death was attributed to bronchial asthma. The second vaping-associated death involved a 26-year-old male whose autopsy attributed the death to acute respiratory distress syndrome.\\nWe have identified six young individuals with a history of vaping who experienced a near fatal episode or a tragic SD. Although larger cohort studies are needed to quantify the actual risk of SD, it seems prudent to sound an early warning about vaping's potential lethality.\", 'keywords': [], 'journal': 'Mayo Clinic proceedings', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Bains', 'firstname': 'Sahej', 'initials': 'S', 'affiliation': 'Medical Scientist Training Program, Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Garmany', 'firstname': 'Ramin', 'initials': 'R', 'affiliation': 'Medical Scientist Training Program, Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Neves', 'firstname': 'Raquel', 'initials': 'R', 'affiliation': 'Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Giudicessi', 'firstname': 'John R', 'initials': 'JR', 'affiliation': 'Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Gao', 'firstname': 'Xiaozhi', 'initials': 'X', 'affiliation': 'Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Tester', 'firstname': 'David J', 'initials': 'DJ', 'affiliation': 'Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, MN, USA; Department of Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Bos', 'firstname': 'J Martijn', 'initials': 'JM', 'affiliation': 'Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, MN, USA; Department of Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), Mayo Clinic, Rochester, MN, USA.'}, {'lastname': 'Ackerman', 'firstname': 'Michael J', 'initials': 'MJ', 'affiliation': 'Department of Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN, USA; Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic), Mayo Clinic, Rochester, MN, USA; Department of Pediatric and Adolescent Medicine (Division of Pediatric Cardiology), Mayo Clinic, Rochester, MN, USA. Electronic address: ackerman.michael@mayo.edu.'}], 'methods': None, 'conclusions': \"We have identified six young individuals with a history of vaping who experienced a near fatal episode or a tragic SD. Although larger cohort studies are needed to quantify the actual risk of SD, it seems prudent to sound an early warning about vaping's potential lethality.\", 'results': 'Among 144 SCA survivors and 360 SD victims, there were six individuals (1%; 3 females) with unexplained SCA (n=4) or SD (n=2) that was temporally associated with vaping use with a mean age at sentinel event of 23±5 years. The SCA survivors include a 19-year-old male who was resuscitated from documented ventricular fibrillation 40 minutes after vaping and a 19-year-old male who was resuscitated from ventricular fibrillation a few hours post vaping. The first SD victim was a 19-year-old female with exercise-induced asthma who died in her sleep after vaping that evening. Autopsy results showed eosinophilic infiltrates in the lung tissue and death was attributed to bronchial asthma. The second vaping-associated death involved a 26-year-old male whose autopsy attributed the death to acute respiratory distress syndrome.', 'copyrights': 'Copyright © 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.mayocp.2023.09.017', 'xml': <Element 'PubmedArticle' at 0x10a3b6b10>}\n",
      "{'pubmed_id': '38309696', 'title': 'Baseline characteristics and ICS/LAMA/LABA response in asthma: analyses from the CAPTAIN study.', 'abstract': 'Findings from CAPTAIN (NCT02924688) suggest treatment response to fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) differs according to baseline type 2 (T2) inflammation markers in patients with moderate-to-severe asthma. Understanding how other patient physiologic and clinical characteristics affect response to inhaled therapies may guide physicians toward a personalized approach for asthma management.\\nTo investigate, using CAPTAIN data, the predictive value of key demographic and baseline physiologic variables in patients with asthma (lung function, bronchodilator reversibility, age, age at asthma onset) on response to addition of the long-acting muscarinic antagonist UMEC to inhaled corticosteroid/long-acting β\\nPrespecified and post hoc analyses of CAPTAIN data were performed using categorical and continuous variables of key baseline characteristics to understand their influence on treatment outcomes (lung function [trough forced expiratory volume in 1 second, FEV\\nAdding UMEC to FF/VI led to greater improvements in trough FEV\\nUnlike previous findings with T2 biomarkers, lung function, bronchodilator reversibility, age and age at asthma onset do not appear to predict response to inhaled therapy.', 'keywords': ['Asthma', 'categorical analyses', 'continuous analyses', 'exacerbations', 'fluticasone furoate', 'lung function', 'treatment response', 'umeclidinium', 'vilanterol'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Boulet', 'firstname': 'Louis-Philippe', 'initials': 'LP', 'affiliation': 'Quebec Heart and Lung Institute, Laval University, Quebec, QC, Canada;. Electronic address: louis-philippe.boulet.2@ulaval.ca.'}, {'lastname': 'Abbott', 'firstname': 'Carl', 'initials': 'C', 'affiliation': 'GSK, Research Triangle Park, NC, USA;. Electronic address: carlrx@gmail.com.'}, {'lastname': 'Brusselle', 'firstname': 'Guy', 'initials': 'G', 'affiliation': 'Ghent University Hospital, Ghent, Belgium;. Electronic address: guy.brusselle@uzgent.be.'}, {'lastname': 'Edwards', 'firstname': 'Dawn', 'initials': 'D', 'affiliation': 'GSK, Brentford, Middlesex, UK;. Electronic address: dawn.m.webber@gsk.com.'}, {'lastname': 'Oppenheimer', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Rutgers New Jersey Medical School, Newark, NJ, USA;. Electronic address: nallopp22@gmail.com.'}, {'lastname': 'Pavord', 'firstname': 'Ian D', 'initials': 'ID', 'affiliation': 'University of Oxford, Oxford, UK;. Electronic address: ian.pavord@ndm.ox.ac.uk.'}, {'lastname': 'Pizzichini', 'firstname': 'Emilio', 'initials': 'E', 'affiliation': 'GSK, Brentford, Middlesex, UK;; Federal University of Santa Catarina, Santa Catarina, Brazil;. Electronic address: emiliopizzichini@gmail.com.'}, {'lastname': 'Sagara', 'firstname': 'Hironori', 'initials': 'H', 'affiliation': 'Showa University School of Medicine, Tokyo, Japan;. Electronic address: sagarah@med.showa-u.ac.jp.'}, {'lastname': 'Slade', 'firstname': 'David', 'initials': 'D', 'affiliation': 'GSK, Research Triangle Park, NC, USA;. Electronic address: david.j.slade@gsk.com.'}, {'lastname': 'Wechsler', 'firstname': 'Michael E', 'initials': 'ME', 'affiliation': 'Department of Medicine, National Jewish Health, Denver, US;. Electronic address: mikewechsler@gmail.com.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle 2305, Australia;; Centre of Excellence in Severe Asthma, University of Newcastle, Newcastle 2308, Australia. Electronic address: peter.gibson@health.nsw.gov.au.'}], 'methods': None, 'conclusions': 'Unlike previous findings with T2 biomarkers, lung function, bronchodilator reversibility, age and age at asthma onset do not appear to predict response to inhaled therapy.', 'results': 'Adding UMEC to FF/VI led to greater improvements in trough FEV', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.039', 'xml': <Element 'PubmedArticle' at 0x1479f6d40>}\n",
      "{'pubmed_id': '38309597', 'title': 'Farm Animal Exposure, Respiratory Illnesses, and Nasal Cell Gene Expression.', 'abstract': 'Farm exposures in early life reduce the risks for childhood allergic diseases and asthma. There is less information about how farm exposures relate to respiratory illnesses and mucosal immune development.\\nWe hypothesized that children raised in farm environments have a lower incidence of respiratory illnesses over the first two years of life than non-farm children. We also analyzed whether farm exposures or respiratory illnesses were related to patterns of nasal cell gene expression.\\nThe Wisconsin Infant Study Cohort included farm (n=156) and non-farm (n=155) families with children followed to age 2 years. Parents reported prenatal farm and other environmental exposures. Illness frequency and severity were assessed using illness diaries and periodic surveys. Nasopharyngeal cell gene expression in a subset of 64 children at age two years was compared to farm exposure and respiratory illness history.\\nFarm vs. non-farm children had nominally lower rates of respiratory illnesses (rate ratio 0.82 [0.69,0.97]) with a stepwise reduction in illness rates in children exposed to 0, 1, or ≥2 animal species, but these trends were non-significant in a multivariable model. Farm exposures and preceding respiratory illnesses were positively related to nasal cell gene signatures for mononuclear cells and innate and antimicrobial responses.\\nMaternal and infant exposure to farms and farm animals was associated with nonsignificant trends for reduced respiratory illnesses. Nasal cell gene expression in a subset of children suggests that farm exposures and respiratory illnesses in early life are associated with distinct patterns of mucosal immune expression.', 'keywords': ['Farm', 'children', 'gene expression', 'nasal epithelial cells', 'respiratory illness', 'virus'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 4), 'authors': [{'lastname': 'Brownell', 'firstname': 'Joshua', 'initials': 'J', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Lee', 'firstname': 'Kristine E', 'initials': 'KE', 'affiliation': 'Department of Biostatistics and Medical Informatics.'}, {'lastname': 'Chasman', 'firstname': 'Deborah', 'initials': 'D', 'affiliation': 'Department of Biostatistics and Medical Informatics; Department of Obstetrics and Gynecology, Madison WI USA.'}, {'lastname': 'Gangnon', 'firstname': 'Ronald', 'initials': 'R', 'affiliation': 'Department of Biostatistics and Medical Informatics.'}, {'lastname': 'Bendixsen', 'firstname': 'Casper G', 'initials': 'CG', 'affiliation': 'Department of Statistics, University of Wisconsin-Madison, Madison WI USA.'}, {'lastname': 'Barnes', 'firstname': 'Katherine', 'initials': 'K', 'affiliation': 'Department of Statistics, University of Wisconsin-Madison, Madison WI USA.'}, {'lastname': 'Grindle', 'firstname': 'Kristine', 'initials': 'K', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Pappas', 'firstname': 'Tressa', 'initials': 'T', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Bochkov', 'firstname': 'Yury A', 'initials': 'YA', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Dresen', 'firstname': 'Amy', 'initials': 'A', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Hou', 'firstname': 'Christine', 'initials': 'C', 'affiliation': 'Department of Obstetrics and Gynecology, Madison WI USA.'}, {'lastname': 'Haslam', 'firstname': 'David B', 'initials': 'DB', 'affiliation': 'National Farm Medicine Center, Marshfield Clinic Research Foundation, Marshfield WI USA.'}, {'lastname': 'Seroogy', 'firstname': 'Christine M', 'initials': 'CM', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Ong', 'firstname': 'Irene M', 'initials': 'IM', 'affiliation': 'Department of Biostatistics and Medical Informatics; Department of Obstetrics and Gynecology, Madison WI USA.'}, {'lastname': 'Gern', 'firstname': 'James E', 'initials': 'JE', 'affiliation': 'Department of Pediatrics. Electronic address: gern@medicine.wisc.edu.'}], 'methods': None, 'conclusions': None, 'results': 'Farm vs. non-farm children had nominally lower rates of respiratory illnesses (rate ratio 0.82 [0.69,0.97]) with a stepwise reduction in illness rates in children exposed to 0, 1, or ≥2 animal species, but these trends were non-significant in a multivariable model. Farm exposures and preceding respiratory illnesses were positively related to nasal cell gene signatures for mononuclear cells and innate and antimicrobial responses.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.01.019', 'xml': <Element 'PubmedArticle' at 0x1479f7a10>}\n",
      "{'pubmed_id': '38308674\\n18684881\\n22561833\\n26154789\\n32929378\\n36270293\\n19815110\\n20519881\\n28284530\\n32340580\\n2084539\\n2229822\\n7028744\\n15208589\\n12759448\\n16493076\\n34904391\\n36170795\\n37572755\\n12065914\\n12148892\\n19522836\\n25169217\\n3295549\\n8675637\\n7722176\\n16931288\\n10887307\\n2468689\\n21035176\\n21621255\\n22041891\\n23409940\\n30737190\\n35623575\\n36863614\\n34174297\\n27749843\\n28933792\\n29748908\\n32777817\\n16372800\\n26999448\\n8676090\\n11568008\\n16166430\\n31256161\\n30418682\\n33261124\\n33541851\\n34425177\\n28609557\\n33862269\\n24991453\\n26478007\\n29500041\\n19135713\\n20425512\\n18186813\\n8368585\\n6646186\\n8182221\\n18315738\\n25439370\\n25909362', 'title': \"Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?\", 'abstract': 'Mast cell (MC) activation syndromes (MCAS) are conditions defined by recurrent episodes of severe systemic anaphylaxis or similar systemic events triggered by MC-derived mediators that can be measured in biological fluids. Since some symptoms of MC activation may occur due to other, non-MC etiologies and lead to confusion over diagnosis, it is of crucial importance to document the involvement of MC and their products in the patients´ symptomatology.\\nThe most specific and generally accepted marker of severe systemic MC activation is an event-related, transient increase in the serum tryptase level over the individual baseline of the affected individual. However, baseline concentrations of serum tryptase vary among donors, depending on the genetic background, age, kidney function, and underlying disease. As a result, it is of critical importance to provide a flexible equation that defines the diagnostic increase in tryptase qualifying as MCAS criterion in all patients, all situations, and all ranges of baseline serum tryptase. In 2012, the consensus group proposed the 120%\\u2009+\\u20092 ng/ml formula, which covers the great majority of groups, including cases with low, normal, or elevated basal serum tryptase level. This formula has been validated in subsequent studies and has proven to be a robust and consistent diagnostic criterion of MCAS. The present article is discussing the impact of this formula and possible limitations as well as alternative markers and mediators that may be indicative of MCAS.', 'keywords': ['Allergy', 'Anaphylaxis', 'Histamine', 'MCAS', 'Mast cells', 'Mastocytosis', 'Tryptase'], 'journal': 'Current allergy and asthma reports', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Valent', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at.\\nLudwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at.'}, {'lastname': 'Akin', 'firstname': 'Cem', 'initials': 'C', 'affiliation': 'Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, MI, USA.'}, {'lastname': 'Arock', 'firstname': 'Michel', 'initials': 'M', 'affiliation': 'Platform of Molecular Analysis for Mastocytosis and MCAD (CEREMAST), Department of Biological Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University, Paris, France.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s11882-024-01124-2\\n10.1182/blood-2007-11-078097\\n10.1038/nm.2755\\n10.1056/NEJMra1409760\\n10.7150/thno.46719\\n10.1146/annurev-pathmechdis-031521-042618\\n10.1016/j.jaci.2009.08.035\\n10.1159/000315937\\n10.1016/j.anai.2017.01.009\\n10.1146/annurev-immunol-071719-094903\\n10.1016/S0091-6749(05)80222-2\\n10.1016/j.jaci.2004.02.032\\n10.4049/jimmunol.170.11.5667\\n10.4049/jimmunol.176.5.3165\\n10.1002/iid3.578\\n10.1182/bloodadvances.2022007936\\n10.1016/j.jaip.2023.08.008\\n10.1159/000059404\\n10.1080/10428190290021470\\n10.1111/j.1365-2362.2009.02184.x\\n10.1586/17474086.2014.955008\\n10.1056/NEJM198706253162603\\n10.1172/JCI118337\\n10.1016/S0091-6749(95)70139-7\\n10.1016/j.iac.2006.05.010\\n10.1067/mai.2000.107600\\n10.1172/JCI114051\\n10.1016/j.jaci.2010.08.035\\n10.1016/j.jaci.2011.04.037\\n10.1159/000328760\\n10.1111/all.12126\\n10.1016/j.jaip.2019.01.006\\n10.1016/j.jaip.2022.05.007\\n10.1016/j.jaip.2023.02.017\\n10.1016/j.jaci.2021.06.017\\n10.1038/ng.3696\\n10.1038/gim.2017.136\\n10.1007/s10875-018-0506-y\\n10.1182/blood.2020006157\\n10.1111/j.1610-0387.2005.05706.x\\n10.1111/eci.12622\\n10.1084/jem.183.6.2681\\n10.1182/blood.V98.7.2200\\n10.1158/1078-0432.CCR-05-0732\\n10.1159/000501079\\n10.1111/all.13663\\n10.3390/ijms21239030\\n10.18176/jiaci.0675\\n10.1016/j.jaci.2021.08.007\\n10.1111/all.13226\\n10.1016/j.jaip.2021.03.050\\n10.4168/aair.2014.6.4.304\\n10.1016/j.jaci.2015.09.001\\n10.1016/j.jaip.2018.01.006\\n10.1016/j.jaci.2008.11.018\\n10.1007/s11882-009-0080-8\\n10.1111/j.1398-9995.2007.01569.x\\n10.1016/S0750-7658(05)81026-3\\n10.1056/NEJM198312293092603\\n10.1016/0091-6749(94)90371-9\\n10.1111/j.1398-9995.2007.01616.x\\n10.1016/j.jaip.2014.06.011\\n10.1371/journal.pone.0124912', 'xml': <Element 'PubmedArticle' at 0x1479d4a90>}\n",
      "{'pubmed_id': '38308375\\n24304726\\n15655298\\n17709505\\n26312432\\n11692107\\n11673222\\n26658828\\n9722561\\n21839502\\n22914544\\n30688539\\n20502693\\n26432245\\n31168305\\n22743675\\n11112161\\n27079298\\n25684443\\n30450857\\n32705270\\n11418672\\n32467991\\n16000389\\n8641564\\n12805069\\n19259550\\n21700341\\n12391252', 'title': 'Association of single nucleotide polymorphisms in the F2RL1 gene with clinical and inflammatory characteristics of patients with asthma.', 'abstract': 'Proteinase-activated receptor 2 (PAR-2) is a G-protein coupled receptor associated with many inflammatory diseases, including asthma. We have shown an association between PAR-2 expression in peripheral blood monocytes and asthma severity as well as blood PAR-2 mRNA level and lung function. Since F2RL1 (the gene encoding PAR-2) polymorphisms affect PAR-2 expression, we hypothesize they may affect asthma severity.\\nWe recruited 76 subjects with asthma of varying severity and collected clinical (FEV\\nWe found that the F2RL1 SNP \"C\" allele of -45C/T (rs1529505) was associated with PAR-2 mRNA and blood eosinophils. F2RL1 SNP c.621C/T (rs631465) was associated with PAR-2 mRNA. The F2RL1 SNP -149C/G (rs2242991) had no association with any of the parameters studied. This study identified one F2RL1 SNP rs1529505 is associated with parameters of asthma, but not asthma severity.\\nLarger studies are needed to further elucidate the role of PAR-2 in the pathophysiology of asthma and the influence of genetic variation.', 'keywords': ['Asthma', 'F2RL1 gene', 'Single nucleotide polymorphism'], 'journal': 'Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Shrestha Palikhe', 'firstname': 'Nami', 'initials': 'N', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada. nami@ualberta.ca.\\nAlberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada. nami@ualberta.ca.'}, {'lastname': 'Haji', 'firstname': 'Qahir', 'initials': 'Q', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada.'}, {'lastname': 'Mack', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada.\\nFaculty of Education, University of Alberta, Edmonton, Canada.'}, {'lastname': 'Sinnatamby', 'firstname': 'Tristan', 'initials': 'T', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada.'}, {'lastname': 'Sandford', 'firstname': 'Andrew J', 'initials': 'AJ', 'affiliation': \"Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.\"}, {'lastname': 'Cameron', 'firstname': 'Lisa', 'initials': 'L', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada.\\nDepartment of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.'}, {'lastname': 'Vliagoftis', 'firstname': 'Harissios', 'initials': 'H', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, 550 A HMRC, Edmonton, AB, T6G 2S2, Canada. hari@ualberta.ca.\\nAlberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada. hari@ualberta.ca.'}], 'methods': None, 'conclusions': 'Larger studies are needed to further elucidate the role of PAR-2 in the pathophysiology of asthma and the influence of genetic variation.', 'results': 'We found that the F2RL1 SNP \"C\" allele of -45C/T (rs1529505) was associated with PAR-2 mRNA and blood eosinophils. F2RL1 SNP c.621C/T (rs631465) was associated with PAR-2 mRNA. The F2RL1 SNP -149C/G (rs2242991) had no association with any of the parameters studied. This study identified one F2RL1 SNP rs1529505 is associated with parameters of asthma, but not asthma severity.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13223-024-00873-z\\n10.1186/1471-2466-13-70\\n10.1254/jphs.FMJ04005X4\\n10.4049/jimmunol.179.5.2910\\n10.1111/cea.12628\\n10.1067/mai.2001.119025\\n10.1164/ajrccm.164.7.2101157\\n10.1371/journal.pone.0144500\\n10.1074/jbc.273.36.23290\\n10.1016/j.jaci.2011.06.036\\n10.1097/HJH.0b013e3283578c80\\n10.1089/gtmb.2018.0219\\n10.1371/journal.pone.0010693\\n10.1038/nature15393\\n10.1186/s13223-019-0343-4\\n10.1183/09031936.00080312\\n10.1111/cea.12741\\n10.1111/imm.12453\\n10.3349/ymj.2018.59.10.1222\\n10.3892/mmr.2020.11245\\n10.4049/jimmunol.167.1.366\\n10.3892/mmr.2020.11192\\n10.1189/jlb.0704422\\n10.1096/fasebj.10.2.8641564\\n10.1182/blood-2002-08-2497\\n10.1358/dnp.2008.21.7.1255294\\n10.1016/j.molimm.2011.05.026\\n10.4049/jimmunol.169.9.5315', 'xml': <Element 'PubmedArticle' at 0x14799d850>}\n",
      "{'pubmed_id': '38308319\\n14747105\\n17938159\\n25519466\\n16967468\\n7611533\\n20058697\\n24347285\\n35069958\\n32488371\\n25648655\\n21823041\\n34536944\\n29352732', 'title': 'Inflammatory myofibroblastic tumor directly invading the right first rib treated with oral steroids: a case report.', 'abstract': 'We present a case of an inflammatory myofibroblastic tumor cured with a short period of steroid administration, a treatment previously unreported for such cases.\\nA 49-year-old man had a chief complaint of chest pain for more than 3 days. Computed tomography (CT) revealed a tumoral lesion suspected to have infiltrated into the right first rib and intercostal muscles, with changes in lung parenchymal density around the lesion. The maximal standardized uptake value on 18\\xa0F-fluorodeoxyglucose positron emission tomography/computed tomography was high (16.73), consistent with tumor presence. CT-guided biopsy revealed an inflammatory myofibroblastic tumor with no distant metastases. Surgery was indicated based on the disease course. However, he had received an oral steroid before the preoperative contrast-enhanced CT scan due to a history of bronchial asthma, and subsequent CT showed that the tumor shrank in size after administration; he has been recurrence-free for more than a year.\\nSurgery is still the first choice for inflammatory myofibroblastic tumors, as the disease can metastasize and relapse; however, this condition can also be cured with a short period of steroid therapy.', 'keywords': ['Anaplastic lymphoma kinase', 'Asthma', 'Corticosteroid', 'Inflammatory myofibroblastic tumor'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Watanabe', 'firstname': 'Ryo', 'initials': 'R', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, 300-8585, Tsuchiura, Ibaraki, Japan.'}, {'lastname': 'Ano', 'firstname': 'Satoshi', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, 300-8585, Tsuchiura, Ibaraki, Japan. satoshi.ano@gmail.com.\\nDepartment of Respiratory Medicine, University of Tsukuba, Tsukuba, Japan. satoshi.ano@gmail.com.'}, {'lastname': 'Kikuchi', 'firstname': 'Norihiro', 'initials': 'N', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, 300-8585, Tsuchiura, Ibaraki, Japan.'}, {'lastname': 'Saegusa', 'firstname': 'Michiko', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, 300-8585, Tsuchiura, Ibaraki, Japan.'}, {'lastname': 'Shigemasa', 'firstname': 'Rie', 'initials': 'R', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, 300-8585, Tsuchiura, Ibaraki, Japan.'}, {'lastname': 'Kondo', 'firstname': 'Yuzuru', 'initials': 'Y', 'affiliation': 'Department of Diagnostic Pathology, National Hospital Organization Kasumigaura Medical Center, Tsuchiura, Japan.'}, {'lastname': 'Hizawa', 'firstname': 'Nobuyuki', 'initials': 'N', 'affiliation': 'Department of Respiratory Medicine, University of Tsukuba, Tsukuba, Japan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02873-6\\n10.1016/S1010-7940(03)00678-X\\n10.1136/jcp.2007.049387\\n10.1007/s13244-014-0370-0\\n10.1002/jso.20516\\n10.1097/00000478-199508000-00001\\n10.1002/ppul.22977\\n10.1016/j.radcr.2021.11.049\\n10.1186/s43046-020-00038-0\\n10.1186/s13104-015-0993-3\\n10.1007/s10147-011-0297-0\\n10.1016/j.ejca.2021.08.022\\n10.1002/ajh.25043', 'xml': <Element 'PubmedArticle' at 0x125377560>}\n",
      "{'pubmed_id': '38308277\\n10573048\\n11739133\\n12645835\\n18156567\\n17686624\\n21624618\\n12967691\\n21087215\\n16844729\\n19922242\\n22387445\\n29861841\\n30105264\\n22686834\\n21310876\\n15750458\\n25901797\\n24698319\\n10706488\\n18513407\\n33637072\\n29938789\\n23278879\\n26220531\\n24311767\\n27337146\\n29488229', 'title': 'Isolated respiratory tract microorganisms and clinical characteristics in asthma exacerbation of obese patients: a multicenter study.', 'abstract': 'Viral infection is a risk factor for asthma exacerbation (AE). However, bacterial infections related to AE in adults are poorly known. On the other hand, obese patients with asthma have their own clinical and biological characteristics compared with non-obese patients.\\nWe investigated the differences in isolated pathogens for AE between obese and non-obese patients with asthma. We included 407 patients with AE from 24 medical centers in Korea. Microorganisms isolated from culture, RT-PCR or serologic tests using lower respiratory tract specimens were retrospectively investigated.\\nA total of 171 obese and 236 non-obese patients with asthma were included for analysis. Compared to non-obese patients, obese patients were associated with women (77.2% vs. 63.6%), never smoker (82.5% vs. 73.9%), shorter duration of asthma (7.9\\u2009±\\u20098.4 vs. 10.5\\u2009±\\u200910.1 years), less history of pulmonary tuberculosis (8.8% vs. 17.4%), and more comorbidity of allergic rhinitis (48.5% vs. 0.8%). Viral and/or bacterial infections were detected in 205 patients (50.4%) with AE. The numbers of patients with viral only, bacterial only, or both infections were 119, 49, and 37, respectively. The most commonly isolated bacterium was Streptococcus pneumoniae, followed by Pseudomonas aeruginosa and Chlamydia pneumoniae. Obese patients showed a lower incidence of Chlamydia pneumoniae infection. In the non-obese group, bacterial infection, especially Chlamydia pneumoniae infection, was significantly associated with the duration of systemic corticosteroid use (13.6\\u2009±\\u200919.8 vs. 9.7\\u2009±\\u20096.7 days, p\\u2009=\\u20090.049).\\nBacterial infection was associated with a longer period of corticosteroid use in the non-obese group. Acute Chlamydia pneumoniae infection was less associated with obese patients with AE. Further well-designed studies are needed to evaluate microorganisms and the efficacy of antibiotics in patients with AE.', 'keywords': ['Asthma', 'Bacteria', 'Exacerbation', 'Obesity', 'Virus'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Park', 'firstname': 'Sojung', 'initials': 'S', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, 1071 Anyangcheon-Ro, Yangcheon-gu, 07985, Seoul, Republic of Korea.'}, {'lastname': 'Hwang', 'firstname': 'Yong Il', 'initials': 'YI', 'affiliation': 'Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea.'}, {'lastname': 'Lee', 'firstname': 'Sei Won', 'initials': 'SW', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Hyo-Jung', 'initials': 'HJ', 'affiliation': 'Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Byung-Keun', 'initials': 'BK', 'affiliation': 'Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.'}, {'lastname': 'Lee', 'firstname': 'Jin Hwa', 'initials': 'JH', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.'}, {'lastname': 'Ryu', 'firstname': 'Yon Ju', 'initials': 'YJ', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'So Ri', 'initials': 'SR', 'affiliation': 'Division of Respiratory Medicine and Allergy, Department of Internal Medicine, Research Center for Pulmonary Disorders, Jeonbuk National University Medical School, Jeonju, Republic of Korea.'}, {'lastname': 'Chang', 'firstname': 'Jung Hyun', 'initials': 'JH', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, 1071 Anyangcheon-Ro, Yangcheon-gu, 07985, Seoul, Republic of Korea. hs1017@ewha.ac.kr.'}], 'methods': None, 'conclusions': 'Bacterial infection was associated with a longer period of corticosteroid use in the non-obese group. Acute Chlamydia pneumoniae infection was less associated with obese patients with AE. Further well-designed studies are needed to evaluate microorganisms and the efficacy of antibiotics in patients with AE.', 'results': 'A total of 171 obese and 236 non-obese patients with asthma were included for analysis. Compared to non-obese patients, obese patients were associated with women (77.2% vs. 63.6%), never smoker (82.5% vs. 73.9%), shorter duration of asthma (7.9\\u2009±\\u20098.4 vs. 10.5\\u2009±\\u200910.1 years), less history of pulmonary tuberculosis (8.8% vs. 17.4%), and more comorbidity of allergic rhinitis (48.5% vs. 0.8%). Viral and/or bacterial infections were detected in 205 patients (50.4%) with AE. The numbers of patients with viral only, bacterial only, or both infections were 119, 49, and 37, respectively. The most commonly isolated bacterium was Streptococcus pneumoniae, followed by Pseudomonas aeruginosa and Chlamydia pneumoniae. Obese patients showed a lower incidence of Chlamydia pneumoniae infection. In the non-obese group, bacterial infection, especially Chlamydia pneumoniae infection, was significantly associated with the duration of systemic corticosteroid use (13.6\\u2009±\\u200919.8 vs. 9.7\\u2009±\\u20096.7 days, p\\u2009=\\u20090.049).', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02880-7\\n10.1001/archinte.159.21.2582\\n10.1164/ajrccm.164.11.2004235\\n10.1053/rmed.2003.1419\\n10.1136/thx.2007.082784\\n10.1016/j.rmed.2007.06.031\\n10.1016/j.jaci.2011.03.036\\n10.1016/s0002-9343(03)00353-x\\n10.1111/j.1398-9995.2010.02505.x\\n10.1136/thx.2006.061358\\n10.3109/10715760903362576\\n10.1136/thoraxjnl-2011-200160\\n10.18632/oncotarget.24653\\n10.1155/2018/9230234\\n10.1111/j.1398-9995.2012.02855.x\\n10.1183/09031936.00139810\\n10.1097/01.inf.0000154322.38267.ce\\n10.1371/journal.pone.0123584\\n10.1016/j.jaci.2014.02.030\\n10.1034/j.1399-3003.2000.15b06.x\\n10.1186/1465-9921-9-48\\n10.1186/s12931-021-01635-w\\n10.1002/14651858.CD002741.pub2\\n10.1111/cea.12004\\n10.1016/j.jaci.2015.05.044\\n10.1183/09031936.00149613\\n10.1080/02770903.2016.1200611\\n10.1002/jmv.25069', 'xml': <Element 'PubmedArticle' at 0x125370f90>}\n",
      "{'pubmed_id': '38308249\\n2215562\\n28713812\\n14966564\\n24748808\\n36303302\\n33069326\\n21536936\\n23688323\\n29782224\\n37015033\\n33979488\\n19264686\\n17872493\\n25199059\\n22901886\\n28395936\\n25199060\\n32066536\\n21852542\\n27018175\\n25736990\\n27056586\\n33357499\\n27609406\\n28545978\\n27609408\\n25445859\\n25306557\\n30510434\\n27097165\\n32110060\\n28530840\\n23866823\\n35964610\\n34172470\\n33782057\\n9696956\\n30199847\\n27875559\\n35772597\\n9664752\\n21986312\\n30359632\\n31145343\\n28915080\\n32767484\\n26685004', 'title': 'Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis\\xa0of randomized controlled trials and real-world evidence-based assessments.', 'abstract': \"We aimed to clarify comprehensively the safety profiles of anti-IL-5 drugs and pinpoint potential safety concerns that may arise in their post-marketing phase.\\nTwo researchers conducted comprehensive searches of PubMed, EMBASE, Web of Science, and the Cochrane Library from inception to September 2022. Additionally, we investigated the FDA AE Reporting System for post-marketing adverse event (AE) reports related to anti-IL-5 drugs. The outcomes fulfilled the proportional reporting rate criteria and the Bayesian confidence propagation neural network.\\nWe included 24 published studies in our analysis. The anti-IL-5 treatment group showed an incidence of AEs comparable to the placebo group, and it exhibited a significantly lower frequency of serious AEs. Common AEs were asthma, nasopharyngitis, headache, upper respiratory tract infection (URTI), and bronchitis. The post-marketing data included 28,478 case reports associated with the suspect drugs and 75 suspect safety observations affecting 16 system organ classes. New suspect observations included incomplete therapeutic product effect, URTIs, and pulmonary mass in reports related to mepolizumab. Reports associated with mepolizumab and benralizumab also indicated issues with incorrect technique in device usage and product issues.\\nIndividual anti-IL-5 drugs' safety profiles largely matched their product inserts. We identified issues like improper device usage, product issue, and URTIs as potential concerns for mepolizumab and benralizumab. Additionally, all anti-IL-5 drugs showed signs of incomplete therapeutic effects.\", 'keywords': ['Adverse events', 'Anti-interleukin-5', 'Benralizumab', 'Eosinophilic asthma', 'Mepolizumab', 'Reslizumab'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Li', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.'}, {'lastname': 'Tang', 'firstname': 'Shi-Chao', 'initials': 'SC', 'affiliation': 'Department of Rheumatology and Immunology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.'}, {'lastname': 'Jin', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Rheumatology and Immunology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. leijin1987@hotmail.com.\\nDepartment of Rheumatology, Immunology & Allergy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. leijin1987@hotmail.com.'}], 'methods': None, 'conclusions': None, 'results': 'We included 24 published studies in our analysis. The anti-IL-5 treatment group showed an incidence of AEs comparable to the placebo group, and it exhibited a significantly lower frequency of serious AEs. Common AEs were asthma, nasopharyngitis, headache, upper respiratory tract infection (URTI), and bronchitis. The post-marketing data included 28,478 case reports associated with the suspect drugs and 75 suspect safety observations affecting 16 system organ classes. New suspect observations included incomplete therapeutic product effect, URTIs, and pulmonary mass in reports related to mepolizumab. Reports associated with mepolizumab and benralizumab also indicated issues with incorrect technique in device usage and product issues.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02885-2\\n10.1056/NEJM199010113231505\\n10.3389/fmed.2017.00093\\n10.1172/JCI19133\\n10.2147/JAA.S39119\\n10.1016/j.jaci.2004.12.314\\n10.7326/0003-4819-154-9-201105030-00002\\n10.1056/NEJMoa1304048\\n10.1056/nejmoa1804093\\n10.1164/rccm.202210-2005OC\\n10.1056/NEJMoa2034975\\n10.1056/NEJMoa0808991\\n10.1164/rccm.200701-085OC\\n10.1056/NEJMoa1403290\\n10.1016/S0140-6736(12)60988-X\\n10.1016/S2213-2600(17)30125-X\\n10.1056/NEJMoa1403291\\n10.1016/S2213-2600(19)30372-8\\n10.1164/rccm.201103-0396OC\\n10.1016/j.chest.2016.03.018\\n10.1016/S2213-2600(15)00042-9\\n10.1016/j.chest.2016.03.032\\n10.1016/S2213-2600(20)30414-8\\n10.1016/S0140-6736(16)31322-8\\n10.1016/S2213-2600(17)30190-X\\n10.1016/S0140-6736(16)31324-1\\n10.1016/j.ajem.2014.09.036\\n10.1016/S2213-2600(14)70201-2\\n10.2147/JAA.S172338\\n10.1159/000444799\\n10.2147/JAA.S240044\\n10.1056/NEJMoa1703501\\n10.1016/j.jaci.2013.05.020\\n10.1016/S0140-6736(22)01198-9\\n10.1183/13993003.00396-2021\\n10.1136/bmj.n71\\n10.26599/TST.2018.9010074\\n10.1007/s002280050466\\n10.1016/j.intimp.2018.08.031\\n10.1371/journal.pone.0166833\\n10.1016/j.jaci.2022.05.024\\n10.1046/j.1526-4610.1998.3806465.x\\n10.15197/ejgm.01255\\n10.2183/pjab.87.463\\n10.1016/j.humimm.2018.10.015\\n10.1016/S0399-077X(05)80054-X\\n10.1007/978-3-540-78598-9_5\\n10.1097/MD.0000000000015868\\n10.1164/rccm.201707-1323OC\\n10.1111/all.14514\\n10.1111/cea.12695', 'xml': <Element 'PubmedArticle' at 0x1253683b0>}\n",
      "{'pubmed_id': '38308205\\n30741503\\n16840363\\n28822787\\n20816547\\n26082587\\n29333270\\n33673725\\n30661310\\n30552067\\n30787307\\n30929738\\n31361310\\n30169121\\n19812666\\n11562467\\n15716907\\n19553258\\n19571811\\n20729558\\n18852206\\n19540399\\n17020404\\n23281841\\n28943335\\n28979001\\n30972108\\n20018017\\n19176549\\n20642809\\n26346893\\n18252218\\n27085081\\n24159512\\n30718733\\n24487276\\n25338716\\n11847300\\n15764906\\n26335830\\n21414208\\n0\\n27591081\\n20562875\\n21167468\\n20601685\\n31609387\\n21565178\\n34853430\\n34109240\\n22608502\\n18423563\\n27730172\\n22424883\\n34404834\\n27445529\\n33168013\\n34962717\\n23167751\\n22721650\\n33255995\\n22155789\\n20067482\\n18547289\\n31463135\\n24886442\\n27508494\\n33618777\\n35183061\\n22997542\\n20961420\\n17572673\\n25722852\\n20808728\\n28198815\\n19208169\\n24695491\\n21624167\\n15130820\\n20817139\\n22751426\\n15450124\\n15087314\\n23095127\\n16723004\\n30428899\\n16198999\\n25738806\\n29234465\\n25881487\\n24651729', 'title': 'Evaluation of penalized and machine learning methods for asthma disease prediction in the Korean Genome and Epidemiology Study (KoGES).', 'abstract': \"Genome-wide association studies have successfully identified genetic variants associated with human disease. Various statistical approaches based on penalized and machine learning methods have recently been proposed for disease prediction. In this study, we evaluated the performance of several such methods for predicting asthma using the Korean Chip (KORV1.1) from the Korean Genome and Epidemiology Study (KoGES).\\nFirst, single-nucleotide polymorphisms were selected via single-variant tests using logistic regression with the adjustment of several epidemiological factors. Next, we evaluated the following methods for disease prediction: ridge, least absolute shrinkage and selection operator, elastic net, smoothly clipped absolute deviation, support vector machine, random forest, boosting, bagging, naïve Bayes, and k-nearest neighbor. Finally, we compared their predictive performance based on the area under the curve of the receiver operating characteristic curves, precision, recall, F1-score, Cohen's Kappa, balanced accuracy, error rate, Matthews correlation coefficient, and area under the precision-recall curve. Additionally, three oversampling algorithms are used to deal with imbalance problems.\\nOur results show that penalized methods exhibit better predictive performance for asthma than that achieved via machine learning methods. On the other hand, in the oversampling study, randomforest and boosting methods overall showed better prediction performance than penalized methods.\", 'keywords': ['Asthma', 'Disease risk prediction model', 'Ensemble methods', 'GWAS', 'Genome-wide association study', 'KoGES', 'Korean Genome and Epidemiology Study', 'Large-scale genetic data', 'Machine learning methods', 'Oversampling', 'Penalized methods'], 'journal': 'BMC bioinformatics', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Choi', 'firstname': 'Yongjun', 'initials': 'Y', 'affiliation': 'Department of Applied Artificial Intelligence, College of Computing, Hanyang University, 55 Hanyang-daehak-ro, Sangnok-gu, Ansan, 15588, South Korea.'}, {'lastname': 'Cha', 'firstname': 'Junho', 'initials': 'J', 'affiliation': 'Department of Applied Artificial Intelligence, College of Computing, Hanyang University, 55 Hanyang-daehak-ro, Sangnok-gu, Ansan, 15588, South Korea.'}, {'lastname': 'Choi', 'firstname': 'Sungkyoung', 'initials': 'S', 'affiliation': 'Department of Applied Artificial Intelligence, College of Computing, Hanyang University, 55 Hanyang-daehak-ro, Sangnok-gu, Ansan, 15588, South Korea. day0413@hanyang.ac.kr.\\nDepartment of Mathematical Data Science, College of Science and Convergence Technology, Hanyang University, 55 Hanyang-daehak-ro, Sangnok-gu, Ansan, 15588, South Korea. day0413@hanyang.ac.kr.'}], 'methods': None, 'conclusions': None, 'results': \"First, single-nucleotide polymorphisms were selected via single-variant tests using logistic regression with the adjustment of several epidemiological factors. Next, we evaluated the following methods for disease prediction: ridge, least absolute shrinkage and selection operator, elastic net, smoothly clipped absolute deviation, support vector machine, random forest, boosting, bagging, naïve Bayes, and k-nearest neighbor. Finally, we compared their predictive performance based on the area under the curve of the receiver operating characteristic curves, precision, recall, F1-score, Cohen's Kappa, balanced accuracy, error rate, Matthews correlation coefficient, and area under the precision-recall curve. Additionally, three oversampling algorithms are used to deal with imbalance problems.\", 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12859-024-05677-x\\n10.5334/aogh.2412\\n10.1378/chest.130.1_suppl.4S\\n10.1016/S2213-2600(17)30293-X\\n10.1016/S0140-6736(10)61087-2\\n10.5021/ad.2015.27.3.298\\n10.1038/cti.2017.54\\n10.3390/ijms22052412\\n10.4168/aair.2019.11.2.170\\n10.1016/S2213-2600(18)30389-8\\n10.1038/s41467-019-08469-7\\n10.1016/j.ajhg.2019.02.022\\n10.1093/hmg/ddz175\\n10.1146/annurev-genom-083117-021651\\n10.1038/nature08494\\n10.1073/pnas.201162998\\n10.1038/nrg1522\\n10.1093/hmg/ddp295\\n10.1038/nature08185\\n10.1161/CIRCGENETICS.110.946269\\n10.1093/hmg/ddn250\\n10.1016/j.ahj.2009.04.022\\n10.1371/journal.pmed.0030374\\n10.1007/BF00994018\\n10.1186/1752-0509-6-S2-S11\\n10.1023/A:1010933404324\\n10.1007/BF00116037\\n10.1007/BF00058655\\n10.1109/TIT.1967.1053964\\n10.1016/j.artmed.2017.09.005\\n10.1038/s41598-017-13056-1\\n10.3389/fgene.2019.00267\\n10.1080/00401706.1970.10488634\\n10.1080/00401706.1970.10488635\\n10.1111/j.1467-9868.2005.00527.x\\n10.1198/016214501753382273\\n10.1186/1753-6561-3-S7-S27\\n10.1093/bioinformatics/btp041\\n10.1111/j.1469-1809.2010.00597.x\\n10.1155/2015/605891\\n10.1016/j.ajhg.2007.10.012\\n10.1093/ije/dyv316\\n10.1016/j.phrp.2012.07.007\\n10.1038/s41598-018-37832-9\\n10.1109/TKDE.2012.232\\n10.1016/j.inffus.2013.12.003\\n10.1613/jair.953\\n10.1038/ng.2892\\n10.1093/bioinformatics/btu703\\n10.1016/S0033-3549(04)50006-7\\n10.1097/01.all.0000162308.89857.6c\\n10.1186/1471-2105-12-77\\n10.18637/jss.v028.i05\\n10.1093/bioinformatics/btw570\\n10.1038/ng.608\\n10.1016/j.ajhg.2010.11.011\\n10.1016/j.knosys.2018.07.035\\n10.1093/nar/gkq603\\n10.1016/j.clinbiochem.2011.04.021\\n10.1183/23120541.00802-2020\\n10.1016/j.ajhg.2012.04.015\\n10.1016/j.jaci.2008.02.031\\n10.1183/23120541.00058-2015\\n10.1016/j.jaci.2012.01.074\\n10.1038/s41598-021-95887-7\\n10.1155/2016/3564341\\n10.1186/s12967-020-02581-9\\n10.1002/clt2.12091\\n10.1186/1471-2350-13-110\\n10.1016/j.jaci.2012.05.043\\n10.3390/jpm10040245\\n10.1126/scisignal.2001637\\n10.1111/j.1365-2222.2009.03438.x\\n10.1111/j.1398-9995.2008.01667.x\\n10.21037/jtd.2019.07.55\\n10.1186/1465-9921-15-58\\n10.1165/rcmb.2016-0101OC\\n10.1186/s13073-021-00835-9\\n10.1093/bib/bbac022\\n10.1214/10-AOAS377\\n10.1186/1471-2105-11-523\\n10.1016/j.eswa.2016.12.035\\n10.1109/TKDE.2008.239\\n10.1007/s13748-016-0094-0\\n10.1038/ng2088\\n10.1186/s13742-015-0047-8\\n10.18637/jss.v033.i01\\n10.1038/hdy.2017.4\\n10.1186/1471-2105-10-S1-S65\\n10.1371/journal.pone.0093379\\n10.1016/j.ajhg.2010.07.021\\n10.1038/nrg3253\\n10.1186/1471-2105-5-136\\n10.1093/bioinformatics/bth267\\n10.1007/s13721-012-0006-6\\n10.1007/s10462-017-9541-y\\n10.1186/s12957-023-03277-2\\n10.1016/j.jbi.2005.02.008\\n10.1371/journal.pone.0118432\\n10.1186/s13040-017-0155-3\\n10.1016/j.jclinepi.2015.02.010\\n10.1371/journal.pone.0092209', 'xml': <Element 'PubmedArticle' at 0x10975f1f0>}\n",
      "{'pubmed_id': '38308011\\n25102849\\n28238633\\n19581492\\n18838650\\n32499387\\n24646619\\n29209720\\n29494750\\n29379160\\n24567022\\n17339571\\n29054885\\n15802561\\n17449336\\n30781443\\n27090652\\n23068616\\n19021943\\n22554860\\n22123474\\n9915300\\n35978107', 'title': 'A new algorithm DEtectS critical Congenital Heart Disease at different altitudes: ANDES-CHD study.', 'abstract': 'Neonatal pulse oximetry screening (POS) algorithms for critical congenital heart disease (CCHD) have contributed towards decreasing neonatal mortality but cannot be applied at high altitudes. New POS algorithms at high altitudes are needed.\\nThis observational, prospective study included newborns born at different altitudes from 0 to 4380 meters above the sea level in Peru. Healthy newborns underwent neonatal preductal and postductal oximetry, echocardiography and telephonic follow-up up to 12 months of age. Newborns with CCHD underwent preductal and postductal oximetry at the time of telemedicine evaluation while located at the high-altitude hospital where they were born, and their diagnoses were confirmed with echocardiography locally or after arriving to the referral center. Two new algorithms were designed using clinically accepted neonatal oximetry cutoffs or the 5th and 10th percentiles for preductal and postductal oximetry values.\\nA total of 502 healthy newborns and 15 newborns with CCHD were enrolled. Echocardiography and telephonic follow-up were completed in 227 (45%) and 330 healthy newborns (65%), respectively. The algorithm based on clinically accepted cutoffs had a sensitivity of 92%, specificity of 73% and false positive rate of 27% The algorithm based on the 5th and 10th percentiles had a sensitivity of 80%, specificity of 88% and false positive rate of 12%.\\nTwo algorithms that detect CCHD at different altitudes had adequate performance but high false positive rates.', 'keywords': [], 'journal': 'Journal of perinatology : official journal of the California Perinatal Association', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Bravo-Jaimes', 'firstname': 'Katia', 'initials': 'K', 'affiliation': 'Department of Cardiovascular Medicine. Mayo Clinic, Jacksonville, FL, USA. bravo.katia@mayo.edu.'}, {'lastname': 'Vasquez-Loarte', 'firstname': 'Tania', 'initials': 'T', 'affiliation': 'Wyckoff Heights Medical Center, New York, NY, USA.'}, {'lastname': 'Rojas-Camayo', 'firstname': 'Jose', 'initials': 'J', 'affiliation': 'Florida Center for Allergy and Asthma Care, Florida, FL, USA.'}, {'lastname': 'Medina', 'firstname': 'Monica', 'initials': 'M', 'affiliation': 'Instituto Nacional de Salud del Niño de San Borja, Lima, Peru.'}, {'lastname': 'Mejia', 'firstname': 'Christian R', 'initials': 'CR', 'affiliation': 'Universidad de Huanuco, Huanuco, Peru.'}, {'lastname': 'Zapata-Galarza', 'firstname': 'Henry', 'initials': 'H', 'affiliation': 'University of Florida at Jacksonville, Florida, FL, USA.'}, {'lastname': 'Berrocal', 'firstname': 'Marilia', 'initials': 'M', 'affiliation': 'Hospital Nacional Alberto Sabogal Sologuren, Callao, Peru.'}, {'lastname': 'Orozco', 'firstname': 'Jeanette', 'initials': 'J', 'affiliation': 'Hospital Nacional Alberto Sabogal Sologuren, Callao, Peru.'}, {'lastname': 'Lozano', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Universidad Continental, Junin, Peru.'}, {'lastname': 'Santivañez', 'firstname': 'Maryuri', 'initials': 'M', 'affiliation': 'Universidad Continental, Junin, Peru.'}, {'lastname': 'Sangay', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Hospital Regional de Cajamarca, Cajamarca, Peru.'}, {'lastname': 'Rosales', 'firstname': 'William', 'initials': 'W', 'affiliation': 'Hospital EsSalud II Pasco, Cerro de Pasco, Peru.'}, {'lastname': 'Mamani', 'firstname': 'Leddy', 'initials': 'L', 'affiliation': 'Hospital EsSalud III Juliaca, Puno, Peru.'}, {'lastname': 'Macedo', 'firstname': 'Nelly', 'initials': 'N', 'affiliation': 'Hospital EsSalud III Juliaca, Puno, Peru.'}, {'lastname': 'Coronado', 'firstname': 'Joel', 'initials': 'J', 'affiliation': 'Universidad Nacional Mayor de San Marcos, Lima, Peru.'}, {'lastname': 'Huaman', 'firstname': 'Gian', 'initials': 'G', 'affiliation': 'Instituto Nacional Cardiovascular, Lima, Peru.'}, {'lastname': 'Marquez', 'firstname': 'Rafael', 'initials': 'R', 'affiliation': 'Instituto Nacional Cardiovascular, Lima, Peru.'}, {'lastname': 'Li', 'firstname': 'Zhuo', 'initials': 'Z', 'affiliation': 'Department of Cardiovascular Medicine. Mayo Clinic, Jacksonville, FL, USA.'}, {'lastname': 'Masood', 'firstname': 'Kiran M', 'initials': 'KM', 'affiliation': 'Department of Pediatrics, University of California, Los Angeles, CA, USA.'}, {'lastname': 'Alejos', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Department of Pediatrics, Mattel Children´s Hospital, California, CA, USA.'}, {'lastname': 'Reardon', 'firstname': 'Leigh', 'initials': 'L', 'affiliation': 'Department of Pediatrics, Mattel Children´s Hospital, California, CA, USA.\\nAhmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, CA, USA.'}, {'lastname': 'Lin', 'firstname': 'Jeannette', 'initials': 'J', 'affiliation': 'Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, CA, USA.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 502 healthy newborns and 15 newborns with CCHD were enrolled. Echocardiography and telephonic follow-up were completed in 227 (45%) and 330 healthy newborns (65%), respectively. The algorithm based on clinically accepted cutoffs had a sensitivity of 92%, specificity of 73% and false positive rate of 27% The algorithm based on the 5th and 10th percentiles had a sensitivity of 80%, specificity of 88% and false positive rate of 12%.', 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.', 'doi': '10.1038/s41372-024-01888-5\\n10.1016/S2214-109X(14)70008-7\\n10.1016/j.siny.2017.02.006\\n10.1016/S2352-4642(19)30402-X\\n10.1161/CIRCULATIONAHA.109.192576\\n10.1001/archpedi.162.10.969\\n10.1542/peds.2019-1650\\n10.1136/archdischild-2013-305657\\n10.1001/jama.2017.17627\\n10.1038/s41372-018-0043-9\\n10.1542/peds.2013-3284\\n10.1161/CIRCULATIONAHA.106.624544\\n10.1136/thoraxjnl-2017-210598\\n10.1152/ajpregu.00105.2005\\n10.1016/j.resp.2007.03.011\\n10.3390/genes10020150\\n10.1007/s00246-016-1371-1\\n10.1016/j.recesp.2012.06.027\\n10.1179/146532808X375431\\n10.1016/S0140-6736(12)60107-X\\n10.1097/ANC.0b013e3182389348\\n10.1002/(SICI)1096-8644(199901)108:1<41::AID-AJPA2>3.0.CO;2-K\\n10.1038/s41372-022-01491-6', 'xml': <Element 'PubmedArticle' at 0x108ee44a0>}\n",
      "{'pubmed_id': '38307629\\n22095331\\n33911028\\n34493597\\n34600613\\n34729008\\n35293061\\n33819471\\n21390871\\n35970539\\n35247313\\n34699298\\n23239401\\n19886379', 'title': 'What if… your research is suddenly affiliated with a tobacco manufacturing company?', 'abstract': \"The tobacco industry is accountable for an annual global death toll of approximately 8\\u2009million people and cigarette smoking is the foremost risk factor for several types of cancer. In addition, the tobacco industry has a long and controversial history of trying to influence scientific research and of engaging in other morally problematic practices. In September 2021, the respiratory community was alarmed by the takeover of Vectura Group (Vectura) by Philip Morris International. As a reaction to this acquisition, strict measures were imposed by the International Respiratory Societies to prohibit the involvement of Vectura in respiratory research and its participation in societies' activities. International Respiratory Societies argued that Vectura had become part of the tobacco industry due to this takeover and is, therefore, subject to the same rules and restrictions. From a healthcare and historical perspective, the reaction and imposed measures are very understandable. However, for researchers that were already affiliated with Vectura through long-standing agreements and for research that was funded by Vectura, the imposed measures have serious consequences. With this article, we provide an example of these consequences. By reflecting on this issue, we would like to start a conversation regarding the current measures and to encourage the respiratory community to begin thinking of a way to avoid these consequences in the future. In addition, we hope that with this conversation the Respiratory Societies can set an example for other medical societies on how to cope with possible morally tainted affiliations (eg, fast food companies, alcohol manufacturing companies) in the future.\", 'keywords': ['Asthma', 'Asthma Mechanisms', 'Lung Physiology', 'Paediatric asthma', 'Tobacco and the lung'], 'journal': 'BMJ open respiratory research', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'van den Bosch', 'firstname': 'Wytse Bastiaan', 'initials': 'WB', 'affiliation': \"Department of Paediatrics, division of Respiratory Medicine and Allergy, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands.\\nDepartment of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.\"}, {'lastname': 'Jacobs', 'firstname': 'Noortje', 'initials': 'N', 'affiliation': 'Department of Medical Ethics and Philosophy, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands n.jacobs@erasmusmc.nl.'}, {'lastname': 'Tiddens', 'firstname': 'Harm', 'initials': 'H', 'affiliation': \"Department of Paediatrics, division of Respiratory Medicine and Allergy, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands.\\nDepartment of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.\\nThirona BV, Nijmegen, Netherlands.\"}, {'lastname': 'van de Vathorst', 'firstname': 'Suzanne', 'initials': 'S', 'affiliation': 'Department of Medical Ethics and Philosophy, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.', 'doi': '10.1136/bmjresp-2022-001505\\n10.2105/AJPH.2011.300292\\n10.1136/tobaccocontrol-2020-056003\\n10.1136/bmj.n2186\\n10.1016/S2213-2600(21)00445-8\\n10.2147/COPD.S337066\\n10.1111/resp.14244\\n10.1016/j.chest.2021.03.047\\n10.1080/08989621.2011.557296\\n10.1136/thorax-2022-219142\\n10.1016/S2213-2600(21)00536-1\\n10.1080/02770903.2021.1996597\\n10.1136/tobaccocontrol-2012-050874\\n10.1007/s10805-014-9211-5', 'xml': <Element 'PubmedArticle' at 0x108e541d0>}\n",
      "{'pubmed_id': '38307627\\n31697656\\n31492648\\n29253477\\n29958130\\n31689343\\n32128046\\n22879363\\n25012406\\n32755647\\n24139624\\n21527015\\n35103808\\n10955408\\n34563570\\n12543843\\n19221161\\n33594082\\n20018126\\n27571274\\n32982124\\n25658624\\n31539695\\n34661176\\n19413415\\n18620753', 'title': 'Estimating the joint association of adverse childhood experiences and asthma with subsequent depressive symptoms: a marginal structural modelling approach.', 'abstract': 'The relationship between adverse childhood experiences (ACEs) and depression risk has been well documented. However, it remains unclear whether stress-related chronic conditions associated with ACEs, such as asthma, increase the long-term mental health burden of ACEs.\\nTo investigate the joint association of ACEs and asthma with subsequent depressive symptoms among US adults.\\nThis study used data from the Behavioural Risk Factor Surveillance System 2010, including 21\\u2009544 participants over 18 years old from four states where participants were questioned about ACEs. We used logistic regression models to calculate the adjusted OR (aOR) for elevated depressive symptoms evaluated by Patient Health Questionnaire-8 according to ACEs and asthma, along with marginal structural models (MSM) to consider ACE-related confounders between asthma and depression. We evaluated the additive interaction between ACEs and asthma on depressive symptoms with the relative excess risk due to interaction (RERI).\\nOf the 21\\u2009544 participants (mean age: 56, women: 59.5%), 52.3% reported ≥1 ACEs, 14.9% reported a history of asthma and 4.0% had depressive symptoms. ACEs and asthma were independently associated with elevated depressive symptoms (aORs (95%\\u2009CI) were 2.85 (2.30 to 3.55) and 2.24 (1.50 to 3.27), respectively). Furthermore, our MSM revealed an additive interaction between ACEs and asthma for depressive symptoms (RERI (95%\\u2009CI)=+1.63 (0.54 to 2.71)).\\nThese findings suggest that asthma amplifies the risk of depressive symptoms associated with ACEs.\\nPrevention and treatment of asthma, along with establishing preventive environments and services against ACEs, are effective in mitigating the potential burden of ACEs on mental health.', 'keywords': ['Depression & mood disorders'], 'journal': 'BMJ mental health', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Takemura', 'firstname': 'Yuta', 'initials': 'Y', 'affiliation': 'Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Sato', 'firstname': 'Koryu', 'initials': 'K', 'affiliation': 'Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Liang', 'firstname': 'Richard', 'initials': 'R', 'affiliation': 'Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.'}, {'lastname': 'Isobe', 'firstname': 'Masanori', 'initials': 'M', 'affiliation': 'Department of Psychiatry, Kyoto University Graduate School of Medicine, Kyoto, Japan.'}, {'lastname': 'Kondo', 'firstname': 'Naoki', 'initials': 'N', 'affiliation': 'Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Inoue', 'firstname': 'Kosuke', 'initials': 'K', 'affiliation': 'Department of Social Epidemiology, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan koinoue@ucla.edu.\\nHakubi Center, Kyoto University, Kyoto, Japan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. Published by BMJ.', 'doi': '10.1136/bmjment-2023-300859\\n10.15585/mmwr.mm6844e1\\n10.1016/S2468-2667(19)30145-8\\n10.1016/S2468-2667(17)30118-4\\n10.1016/j.socscimed.2018.06.002\\n10.1001/jama.2019.18499\\n10.1080/20008198.2020.1720336\\n10.1093/ije/dys123\\n10.1016/j.jad.2014.04.027\\n10.1016/j.bbi.2020.07.045\\n10.1016/j.rmed.2013.09.022\\n10.1186/1478-7954-9-11\\n10.1007/s00127-022-02241-x\\n10.1097/00001648-200009000-00011\\n10.1016/j.annepidem.2021.09.007\\n10.1515/em-2013-0005\\n10.1136/bmj.326.7382.219\\n10.1542/peds.2008-2233H\\n10.1038/s41533-021-00217-z\\n10.1017/S0033291709992121\\n10.1371/journal.pone.0161062\\n10.1007/s12144-020-01074-8\\n10.1016/j.socscimed.2015.01.030\\n10.1016/j.jad.2019.09.024\\n10.1016/j.bbih.2021.100360\\n10.1037/a0015621\\n10.1016/j.chiabu.2007.08.007', 'xml': <Element 'PubmedArticle' at 0x108ee0b80>}\n",
      "{'pubmed_id': '38307469', 'title': 'Endometriosis and mental health: a population-based cohort study.', 'abstract': 'Endometriosis is a chronic gynecological disorder that results in significant pain and reduced quality of life. While its physiological manifestations have been explored, its impact on mental health is less well-defined. Existing studies of endometriosis and mental health are situated within diverse healthcare landscapes with varying access to care and with a primary focus on surgically-diagnosed endometriosis. A single-payer healthcare system offers a unique environment to investigate this association with fewer barriers to access care while considering the mode of endometriosis diagnosis.\\nOur objective was to assess the association between endometriosis and the risk of mental health conditions and evaluate differences between patients diagnosed medically and surgically.\\nA matched population-based retrospective cohort study was conducted in Ontario including patients aged 18-50 years with a first-time endometriosis diagnosis between January 1, 2010, and July 1, 2020. Endometriosis exposure was determined through either medical or surgical diagnostic criteria. A medical diagnosis was defined by the International Classification of Disease diagnostic codes from outpatient and in-hospital visits, while a surgical diagnosis was identified through inpatient or same-day surgeries. Individuals with endometriosis were matched 1:2 on age, sex, and geography to unexposed individuals without a history of endometriosis. The primary outcome was the first occurrence of any mental health condition after endometriosis diagnosis. Individuals with a mental health diagnosis in the two years before study entry were excluded. Cox regression models generated hazard ratios (aHR) adjusted for hysterectomy, salpingo-oophorectomy, infertility, pregnancy history, qualifying surgery for study inclusion, immigration status, history of asthma, abnormal uterine bleeding, diabetes, fibroids, hypertension, irritable bowel disorder, migraines, and nulliparity.\\nA total of 107,832 individuals were included, 35,944 with a diagnosis of endometriosis (29.5% medically, 60.5% surgically, 10.0% medically with surgical confirmation) and 71,888 unexposed individuals. Over the study period, the incidence rate was 105.3 mental health events per 1,000 person-years in the endometriosis group compared to 66.5 mental health events per 1,000 person-year for unexposed individuals. Relative to the unexposed, the aHR for a mental health diagnosis was 1.28 (95% CI 1.24 - 1.33) in patients with medically diagnosed endometriosis, 1.33 (95% CI 1.16 - 1.52) in surgically diagnosed patients, and 1.36 (95% CI 1.2 - 1.6) in those diagnosed medically then confirmed surgically. The risk of receiving a mental health diagnosis was highest in the first year after endometriosis diagnosis and declined in subsequent years. The cumulative incidence of a severe mental health condition requiring hospital visits was 7.0% in endometriosis patients compared to 4.6% for unexposed individuals (HR 1.56, 95%CI 1.53-1.59).\\nEndometriosis, regardless of mode of diagnosis, is associated with a marginally increased risk of mental health conditions. The elevated risk, particularly evident in the years immediately following the diagnosis, underscores the need for proactive mental health screening for those newly diagnosed with endometriosis. Future research should investigate the potential benefits of mental health interventions for people with endometriosis, aiming to enhance their overall quality of life.', 'keywords': ['Anxiety', 'Cohort study', 'Depression', 'Observational study', 'Pelvic pain', 'Population-base', 'Psychiatric disorders', 'Quality of life', 'Single-payer healthcare system'], 'journal': 'American journal of obstetrics and gynecology', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Thiel', 'firstname': 'Peter S', 'initials': 'PS', 'affiliation': 'Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, ON, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Bougie', 'firstname': 'Olga', 'initials': 'O', 'affiliation': \"Department of Obstetrics and Gynecology, Queen's University, Kingston Health Sciences Center, Kingston, ON, Canada.\"}, {'lastname': 'Pudwell', 'firstname': 'Jessica', 'initials': 'J', 'affiliation': \"Department of Obstetrics and Gynecology, Queen's University, Kingston Health Sciences Center, Kingston, ON, Canada.\"}, {'lastname': 'Shellenberger', 'firstname': 'Jonas', 'initials': 'J', 'affiliation': \"ICES, Toronto, ON, Canada; Health Services and Policy Research Institute, Queen's University, Kingston, ON, Canada.\"}, {'lastname': 'Velez', 'firstname': 'Maria P', 'initials': 'MP', 'affiliation': \"Department of Obstetrics and Gynecology, Queen's University, Kingston Health Sciences Center, Kingston, ON, Canada; ICES, Toronto, ON, Canada.\"}, {'lastname': 'Murji', 'firstname': 'Ally', 'initials': 'A', 'affiliation': 'Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, ON, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada. Electronic address: ally.murji@sinaihealth.ca.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 107,832 individuals were included, 35,944 with a diagnosis of endometriosis (29.5% medically, 60.5% surgically, 10.0% medically with surgical confirmation) and 71,888 unexposed individuals. Over the study period, the incidence rate was 105.3 mental health events per 1,000 person-years in the endometriosis group compared to 66.5 mental health events per 1,000 person-year for unexposed individuals. Relative to the unexposed, the aHR for a mental health diagnosis was 1.28 (95% CI 1.24 - 1.33) in patients with medically diagnosed endometriosis, 1.33 (95% CI 1.16 - 1.52) in surgically diagnosed patients, and 1.36 (95% CI 1.2 - 1.6) in those diagnosed medically then confirmed surgically. The risk of receiving a mental health diagnosis was highest in the first year after endometriosis diagnosis and declined in subsequent years. The cumulative incidence of a severe mental health condition requiring hospital visits was 7.0% in endometriosis patients compared to 4.6% for unexposed individuals (HR 1.56, 95%CI 1.53-1.59).', 'copyrights': 'Copyright © 2024 Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.ajog.2024.01.023', 'xml': <Element 'PubmedArticle' at 0x109f5e9d0>}\n",
      "{'pubmed_id': '38307385\\n36921622\\n36407005\\n31645732\\n33596629\\n35761067\\n35815577\\n28814730\\n31767537\\n19460998\\n0\\n32694689\\n12604221\\n18533366\\n30508371\\n31539311\\n33019494\\n31757593\\n25709564\\n36048613\\n24646254\\n32961073\\n25408407\\n30150385\\n31119654\\n27982582\\n17545981\\n28846090\\n23699410\\n35296236\\n24097267\\n24695404\\n19505943\\n22388286\\n18798982\\n20110278\\n24799436\\n19910308\\n36394265\\n31249361\\n25468404\\n20876532\\n31901298\\n37234128\\n28249157\\n35044827\\n27940208\\n34162546\\n11498575\\n33725370\\n37610048\\n35061542', 'title': 'Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation.', 'abstract': 'Chronic, systemic inflammation is a pathophysiological manifestation of metabolic disorders. Inflammatory signaling leads to elevated glycolytic flux and a metabolic shift towards aerobic glycolysis and lactate generation. This rise in lactate corresponds with increased generation of lactoylLys modifications on histones, mediating transcriptional responses to inflammatory stimuli. Lactoylation is also generated through a non-enzymatic S-to-N acyltransfer from the glyoxalase cycle intermediate, lactoylglutathione (LGSH). Here, we report a regulatory role for LGSH in mediating histone lactoylation and inflammatory signaling. In the absence of the primary LGSH hydrolase, glyoxalase 2 (GLO2), RAW264.7 macrophages display significant elevations in LGSH and histone lactoylation with a corresponding potentiation of the inflammatory response when exposed to lipopolysaccharides. An analysis of chromatin accessibility shows that lactoylation is associated with more compacted chromatin than acetylation in an unstimulated state; upon stimulation, however, regions of the genome associated with lactoylation become markedly more accessible. Lastly, we demonstrate a spontaneous S-to-S acyltransfer of lactate from LGSH to CoA, yielding lactoyl-CoA. This represents the first known mechanism for the generation of this metabolite. Collectively, these data suggest that LGSH, and not intracellular lactate, is the primary driving factor facilitating histone lactoylation and a major contributor to inflammatory signaling.', 'keywords': ['Glyoxalase', 'Inflammation', 'Lactate', 'Metabolism', 'Post-translational modification'], 'journal': 'Molecular metabolism', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Trujillo', 'firstname': 'Marissa N', 'initials': 'MN', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Jennings', 'firstname': 'Erin Q', 'initials': 'EQ', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Hoffman', 'firstname': 'Emely A', 'initials': 'EA', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Zhang', 'firstname': 'Hao', 'initials': 'H', 'affiliation': 'Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Phoebe', 'firstname': 'Aiden M', 'initials': 'AM', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Mastin', 'firstname': 'Grace E', 'initials': 'GE', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Kitamura', 'firstname': 'Naoya', 'initials': 'N', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Reisz', 'firstname': 'Julie A', 'initials': 'JA', 'affiliation': 'Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO 80045, USA.'}, {'lastname': 'Megill', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA, USA.'}, {'lastname': 'Kantner', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA, USA.'}, {'lastname': 'Marcinkiewicz', 'firstname': 'Mariola M', 'initials': 'MM', 'affiliation': 'Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA, USA.'}, {'lastname': 'Twardy', 'firstname': 'Shannon M', 'initials': 'SM', 'affiliation': 'Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.'}, {'lastname': 'Lebario', 'firstname': 'Felicidad', 'initials': 'F', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'Chapman', 'firstname': 'Eli', 'initials': 'E', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.'}, {'lastname': 'McCullough', 'firstname': 'Rebecca L', 'initials': 'RL', 'affiliation': 'Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.'}, {'lastname': \"D'Alessandro\", 'firstname': 'Angelo', 'initials': 'A', 'affiliation': 'Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO 80045, USA.'}, {'lastname': 'Snyder', 'firstname': 'Nathaniel W', 'initials': 'NW', 'affiliation': 'Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA, USA.'}, {'lastname': 'Cusanovich', 'firstname': 'Darren A', 'initials': 'DA', 'affiliation': 'Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA; Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Galligan', 'firstname': 'James J', 'initials': 'JJ', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA. Electronic address: jgalligan@pharmacy.arizona.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 The Author(s). Published by Elsevier GmbH.. All rights reserved.', 'doi': '10.1016/j.molmet.2024.101888', 'xml': <Element 'PubmedArticle' at 0x109fc0ae0>}\n",
      "{'pubmed_id': '38307356', 'title': 'Integration of metabolomics and transcriptomics to reveal the mechanism of Gerberae piloselloidis herba in alleviating bronchial asthma.', 'abstract': 'Gerberae Piloselloides Herba (GPH) is derived from Gerbera piloselloides (Linn.) Cass. It is a commonly used traditional medicine in China, featured by its special bioactivities as antitussive, expectorant, anti-asthma, anti-bacterial and anti-tumor. It is often used as an effective treatment for cough and sore throat as well as bronchial asthma (BA) in China. It was demonstrated in our previous studies that GPH exerted significant effects on the treatment of BA, but its underlying mechanism remains unclear.\\nThis study was aimed at revealing the mechanism through which GPH protects against BA.\\nThe protective effect of GPH against BA was evaluated in a mouse model of BA induced by ovalbumin. Through integrated metabolomics and transcriptomics analysis, the most critical pathways were discovered. The effects of GPH in regulating these pathways was verified through molecular biology experiments and molecular docking.\\nGPH have anti-BA effects. In plasma and lung tissue, 5 and 17 differentially expressed metabolites (DEMs), respectively, showed a reversed tendency in the GPH group compared with the model group; apart from gamma-aminobutyric acid and butyrylcarnitine, these DEMs might aid in BA diagnosis. The DEMs were involved primarily in the regulation of lipid metabolism, followed by glucose metabolism and amino acid metabolism. Transcriptomic analysis indicated that GPH modulated 268 differentially expressed genes (DEGs). Integration analysis of metabolomics and transcriptomics revealed that GPH might regulate the PPAR signaling pathway, thus affecting the expression of key gene targets such as Cyp4a12a, Cyp4a12b, Adh7, Acaa1b and Gpat2; controlling fatty acid degradation, unsaturated fatty acid biosynthesis, glycerophospholipid metabolism and other lipid metabolic pathways; and ameliorating BA. This possibility was confirmed through reverse-transcription quantitative polymerase chain reaction, western blotting, immunofluorescence and molecular docking.\\nGPH was found to activate the PPAR signaling pathway, decrease the levels of Cyp4a12a and Cyp4a12b, and increase the levels of Adh7, Acaa1b and Gpat2, thereby regulating lipid metabolism disorder, decreasing the generation of inflammatory mediators and limiting lung injury.', 'keywords': ['Bronchial asthma', 'Gerbera piloselloides herba', 'Metabolomics', 'PPAR signaling pathway', 'Transcriptomics'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Liu', 'firstname': 'Chunhua', 'initials': 'C', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Fu', 'firstname': 'Changli', 'initials': 'C', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China; School of Pharmacy, Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Lu', 'firstname': 'Yuan', 'initials': 'Y', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Sun', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Liu', 'firstname': 'Ting', 'initials': 'T', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Wang', 'firstname': 'Yonglin', 'initials': 'Y', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Wang', 'firstname': 'Aimin', 'initials': 'A', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China.'}, {'lastname': 'Huang', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': 'Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, 550004, China. Electronic address: HUANGY2020@126.com.'}, {'lastname': 'Li', 'firstname': 'Yongjun', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, 550004, China. Electronic address: liyongjun026@126.com.'}], 'methods': None, 'conclusions': 'GPH was found to activate the PPAR signaling pathway, decrease the levels of Cyp4a12a and Cyp4a12b, and increase the levels of Adh7, Acaa1b and Gpat2, thereby regulating lipid metabolism disorder, decreasing the generation of inflammatory mediators and limiting lung injury.', 'results': 'GPH have anti-BA effects. In plasma and lung tissue, 5 and 17 differentially expressed metabolites (DEMs), respectively, showed a reversed tendency in the GPH group compared with the model group; apart from gamma-aminobutyric acid and butyrylcarnitine, these DEMs might aid in BA diagnosis. The DEMs were involved primarily in the regulation of lipid metabolism, followed by glucose metabolism and amino acid metabolism. Transcriptomic analysis indicated that GPH modulated 268 differentially expressed genes (DEGs). Integration analysis of metabolomics and transcriptomics revealed that GPH might regulate the PPAR signaling pathway, thus affecting the expression of key gene targets such as Cyp4a12a, Cyp4a12b, Adh7, Acaa1b and Gpat2; controlling fatty acid degradation, unsaturated fatty acid biosynthesis, glycerophospholipid metabolism and other lipid metabolic pathways; and ameliorating BA. This possibility was confirmed through reverse-transcription quantitative polymerase chain reaction, western blotting, immunofluorescence and molecular docking.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jep.2024.117852', 'xml': <Element 'PubmedArticle' at 0x109f50630>}\n",
      "{'pubmed_id': '38307355', 'title': 'Protective effects of an alcoholic extract of Kaempferia galanga L. rhizome on ethanol-induced gastric ulcer in mice.', 'abstract': 'The rhizome of Kaempferia galanga L., a medicinal and edible Plant, was widely distributed in many Asian and African counties. It has been traditionally used to treat gastroenteritis, hypertension, rheumatism and asthma. However, there is a lack of modern pharmacology studies regarding its anti-gastric ulcer activity.\\nThe objective of this study is to investigate the protective effects of an extract from K. galanga L. rhizome (Kge) and its active components kaempferol and luteolin on ethanol-induced gastric ulcer.\\nThe kge was prepared by ultrasonic-assisted extraction, and the contents of kaempferol and luteolin were determined by HPLC. The mice were randomly divided into seven groups: blank control (0.5\\xa0% CMC-Na; 0.1 mL/10\\xa0g), untreatment (0.5\\xa0% CMC-Na; 0.1 mL/10\\xa0g), Kge (100, 200 and 400\\xa0mg/kg), kaempferol (100\\xa0mg/kg) and luteolin (100\\xa0mg/kg) groups. The mice were treated intragastrically once daily for 7 days. At 1\\xa0h post the last administration, the mice in all groups except the blank control group were intragastrically administrated with anhydrous alcohol (0.1\\xa0mL/10\\xa0g) once to induce gastric ulcer. Then, fasting was continued for 1\\xa0h, followed by sample collection for evaluation by enzyme-linked immunosorbent assay and real-time reverse transcription polymerase chain reaction assay.\\nThe contents of kaempferol and luteolin in Kge were determined as 3713\\xa0μg/g and 2510\\xa0μg/g, respectively. Alcohol induced severely damages with edema, inflammatory cell infiltration and bleeding, and the ulcer index was 17.63\\xa0%. After pre-treatment with Kge (100, 200 and 400\\xa0mg/kg), kaempferol and luteolin, the pathological lesions were obviously alleviated and ulcer indices were reduced to 13.42\\xa0%, 11.65\\xa0%, 6.54\\xa0%, 3.58\\xa0% and 3.85\\xa0%, respectively. In untreated group, the contents of Ca\\nThe study showed that K. galanga L., kaempferol, and luteolin have protective effects against ethanol-induced gastric ulcers. This is achieved by regulating the mucosal barrier, oxidative stress, and gastric regulatory mediators, as well as inhibiting the TRPV1 signaling pathway and gastric acid secretion, ultimately reducing the gastric ulcer index.', 'keywords': ['Extraction', 'Gastric ulcer', 'Kaempferia galanga L.', 'Kaempferol', 'Luteolin', 'Protective effects'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Liu', 'firstname': 'Haifeng', 'initials': 'H', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Chen', 'firstname': 'Yaqin', 'initials': 'Y', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Hu', 'firstname': 'Yilong', 'initials': 'Y', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zhang', 'firstname': 'Wenrui', 'initials': 'W', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zhang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Su', 'firstname': 'Tianli', 'initials': 'T', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Wang', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Yin', 'firstname': 'Zhongqiong', 'initials': 'Z', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zhao', 'firstname': 'Xinhong', 'initials': 'X', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zhou', 'firstname': 'Xun', 'initials': 'X', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Li', 'firstname': 'Lixia', 'initials': 'L', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zou', 'firstname': 'Yuanfeng', 'initials': 'Y', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Fu', 'firstname': 'Yuping', 'initials': 'Y', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.'}, {'lastname': 'Zhang', 'firstname': 'Yingying', 'initials': 'Y', 'affiliation': 'College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, 611130, China. Electronic address: zhangyy@sicau.edu.cn.'}, {'lastname': 'Song', 'firstname': 'Xu', 'initials': 'X', 'affiliation': 'Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China. Electronic address: songx@sicau.edu.cn.'}], 'methods': None, 'conclusions': 'The study showed that K. galanga L., kaempferol, and luteolin have protective effects against ethanol-induced gastric ulcers. This is achieved by regulating the mucosal barrier, oxidative stress, and gastric regulatory mediators, as well as inhibiting the TRPV1 signaling pathway and gastric acid secretion, ultimately reducing the gastric ulcer index.', 'results': 'The contents of kaempferol and luteolin in Kge were determined as 3713\\xa0μg/g and 2510\\xa0μg/g, respectively. Alcohol induced severely damages with edema, inflammatory cell infiltration and bleeding, and the ulcer index was 17.63\\xa0%. After pre-treatment with Kge (100, 200 and 400\\xa0mg/kg), kaempferol and luteolin, the pathological lesions were obviously alleviated and ulcer indices were reduced to 13.42\\xa0%, 11.65\\xa0%, 6.54\\xa0%, 3.58\\xa0% and 3.85\\xa0%, respectively. In untreated group, the contents of Ca', 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.jep.2024.117845', 'xml': <Element 'PubmedArticle' at 0x109f05d00>}\n",
      "{'pubmed_id': '38307258', 'title': 'Effect of plasma exosome lncRNA on isoproterenol hydrochloride-induced cardiotoxicity in rats.', 'abstract': 'Isoprenaline hydrochloride (IH) is a β-adrenergic receptor agonist commonly used in the treatment of hypotension, shock, asthma, and other diseases. However, IH-induced cardiotoxicity limits its application. A large number of studies have shown that long noncoding RNA (lncRNA) regulates the occurrence and development of cardiovascular diseases. This study aimed to investigate whether abnormal lncRNA expression is involved in IH-mediated cardiotoxicity. First, the Sprague-Dawley (SD) rat myocardial injury model was established. Circulating exosomes were extracted from the plasma of rats and identified. In total, 108 differentially expressed (DE) lncRNAs and 150 DE mRNAs were identified by sequencing. These results indicate that these lncRNAs and mRNAs are substantially involved in chemical cardiotoxicity. Further signaling pathway and functional studies indicated that lncRNAs and mRNAs regulate several biological processes, such as selective mRNA splicing through spliceosomes, participate in sphingolipid metabolic pathways, and play a certain role in the circulatory system. Finally, we obtained 3 upregulated lncRNAs through reverse transcription-quantitative PCR (RT-qPCR) verification and selected target lncRNA-mRNA pairs according to the regulatory relationship of lncRNA/mRNA, some of which were associated with myocardial injury. This study provides valuable insights into the role of lncRNAs as novel biomarkers of chemical-induced cardiotoxicity.', 'keywords': ['Biomarkers', 'Cardiotoxicity', 'Exosomes', 'Isoproterenol Hydrochloride', 'LncRNA'], 'journal': 'Toxicology and applied pharmacology', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Zhao', 'firstname': 'Liyuan', 'initials': 'L', 'affiliation': 'College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230000, China; InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China.'}, {'lastname': 'Shi', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Shanghai Innostar Bio-Technology Co., Ltd, China State Institute of Pharmaceutical Industry, 201203, China.'}, {'lastname': 'Yang', 'firstname': 'Zixuan', 'initials': 'Z', 'affiliation': 'Shanghai Innostar Bio-Technology Co., Ltd, China State Institute of Pharmaceutical Industry, 201203, China.'}, {'lastname': 'Zheng', 'firstname': 'Minhui', 'initials': 'M', 'affiliation': 'Shanghai Innostar Bio-Technology Co., Ltd, China State Institute of Pharmaceutical Industry, 201203, China.'}, {'lastname': 'Sun', 'firstname': 'Zhimin', 'initials': 'Z', 'affiliation': 'College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230000, China; InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China.'}, {'lastname': 'Sun', 'firstname': 'Luyao', 'initials': 'L', 'affiliation': 'College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230000, China; InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China.'}, {'lastname': 'Gu', 'firstname': 'Mengyun', 'initials': 'M', 'affiliation': 'Shanghai Innostar Bio-Technology Co., Ltd, China State Institute of Pharmaceutical Industry, 201203, China.'}, {'lastname': 'Song', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'College of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230000, China; InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China.'}, {'lastname': 'Liu', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China.'}, {'lastname': 'Miao', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China.'}, {'lastname': 'Wang', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China; Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330038, China.'}, {'lastname': 'Zheng', 'firstname': 'Shaoqiu', 'initials': 'S', 'affiliation': 'InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China.'}, {'lastname': 'Zhang', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'InnoStar Bio-tech Nantong Co., Ltd., Nantong, Jiangsu 226133, China.'}, {'lastname': 'Tang', 'firstname': 'Naping', 'initials': 'N', 'affiliation': 'Shanghai Innostar Bio-Technology Co., Ltd, China State Institute of Pharmaceutical Industry, 201203, China; Yangtze Delta Drug Advanced Research Institute, Yangtze Delta Pharmaceutical College, Nantong, Jiangsu 226133, China. Electronic address: napingtang@innostar.cn.'}, {'lastname': 'Liu', 'firstname': 'Kelan', 'initials': 'K', 'affiliation': \"Intensive Care Unit, Liyang People's Hospital, Liyang, Jiangsu 213300, China. Electronic address: 34993703@qq.com.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.taap.2024.116840', 'xml': <Element 'PubmedArticle' at 0x10ba1e3e0>}\n",
      "{'pubmed_id': '38307206', 'title': 'Occupational asthma in Ontario, Canada (2000-2022): A retrospective, clinic-based study evaluating sex differences.', 'abstract': None, 'keywords': [], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Chan', 'firstname': 'Felix L', 'initials': 'FL', 'affiliation': 'Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.'}, {'lastname': 'Lipszyc', 'firstname': 'Joshua', 'initials': 'J', 'affiliation': 'Department of Family and Community Medicine, Faculty of Medicine, Toronto, Ontario, Canada.'}, {'lastname': 'Dekoven', 'firstname': 'Ben', 'initials': 'B', 'affiliation': 'Schulich School of Medicine, Western University, London, Ontario, Canada.'}, {'lastname': 'Nguyen', 'firstname': 'Victor', 'initials': 'V', 'affiliation': 'Human Biology Program, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada.'}, {'lastname': 'Ribeiro', 'firstname': 'Marcos', 'initials': 'M', 'affiliation': 'Section of Pulmonology, Department of Medicine, Health Science Centre, State University of Londrina, Parana, Brazil.'}, {'lastname': 'Tarlo', 'firstname': 'Susan M', 'initials': 'SM', 'affiliation': \"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Gage Occupational and Environmental Health Unit, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Respiratory Division, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; Centre for Research Expertise in Occupational Diseases, St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: susan.tarlo@utoronto.ca.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.jaip.2024.01.037', 'xml': <Element 'PubmedArticle' at 0x10babdda0>}\n",
      "{'pubmed_id': '38307205', 'title': 'Sublingual tablet immunotherapy improves quality of life in adults with allergic rhinoconjunctivitis.', 'abstract': 'Allergic rhinitis with or without conjunctivitis (AR/C) can negatively impact many aspects of quality of life (QoL). The efficacy and safety of SQ sublingual immunotherapy (SLIT)-tablets have been confirmed across large clinical trials in adults with grass, tree, ragweed, and house dust mite (HDM) AR/C.\\nThis pooled analysis investigates whether the reduction in symptom burden found across the clinical trials is supported by improvements in QoL.\\n11 phase II/III randomized placebo-controlled trials across the SQ grass, tree, ragweed and HDM SLIT-tablets (Grass: N=3179; Ragweed: N=767; Tree: N=634; HDM: N=2221) were included. QoL was assessed using the standardized Rhinitis Quality of Life Questionnaire (RQLQ) with the exception of three grass trials that used the non-standardized version. The overall RQLQ scores were expressed as a mean of seven domains. In the pooled analysis, treatment was used as fixed effect; the trial, and the interaction between region/country with the trial as random effects.\\nThe pooled analysis showed consistent and statistically significant improvements in overall RQLQ scores across all four SQ SLIT-tablets vs. placebo (Pooled estimate [95%CI], p value. Grass: -0.20 [-0.28, -0.12], P<0.001. Tree: -0.42 [-0.58, -0.26], P<0.001. Ragweed: -0.36 [-0.55, -0.17], P<0.001. HDM: -0.28 [-0.39, -0.17], P<0.001). Furthermore, significant improvements vs. placebo for all four SQ SLIT-tablets were seen across the 7 individual domains.\\nThe proven efficacy of SQ SLIT-tablets to reduce symptoms across four of the most common respiratory allergens, is supported by concurrent significant improvements in RQLQ scores - overall and for all 7 domains.', 'keywords': ['RQLQ', 'RQLQ domains', 'allergic rhinoconjunctivitis', 'grass pollen allergy', 'house dust mite allergy', 'pooled analysis', 'quality of life', 'ragweed pollen allergy', 'sublingual immunotherapy', 'tree pollen allergy'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 3), 'authors': [{'lastname': 'Blaiss', 'firstname': 'Michael S', 'initials': 'MS', 'affiliation': '. Medical College of Georgia at Augusta University, Augusta, Georgia, US. Electronic address: michael.blaiss@gmail.com.'}, {'lastname': 'Durham', 'firstname': 'Stephen R', 'initials': 'SR', 'affiliation': '. National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital London, London, UK.. Electronic address: s.durham@imperial.ac.uk.'}, {'lastname': 'Bernstein', 'firstname': 'David', 'initials': 'D', 'affiliation': '. Division of Immunology and Allergy, University of Cincinnati College of Medicine and Bernstein Clinical Research Center, Cincinnati, OH, USA. Electronic address: bernstdd@ucmail.uc.edu.'}, {'lastname': 'Stranzl', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': '. ALK-Abelló, Hørsholm, Denmark;. Electronic address: stsdk@alk.net.'}, {'lastname': 'Lindholm', 'firstname': 'Morten', 'initials': 'M', 'affiliation': '. ALK-Abelló, Hørsholm, Denmark;. Electronic address: mlidk@alk.net.'}, {'lastname': 'Nolte', 'firstname': 'Hendrik', 'initials': 'H', 'affiliation': '. ALK-Abelló, Bedminster, New Jersey, US.. Electronic address: hnous@alk.net.'}, {'lastname': 'Andersen', 'firstname': 'Kristian Funding', 'initials': 'KF', 'affiliation': '. ALK-Abelló, Hørsholm, Denmark;. Electronic address: kfadk@alk.net.'}, {'lastname': 'Roberts', 'firstname': 'Graham', 'initials': 'G', 'affiliation': \". The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, UK; NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; University of Southampton Faculty of Medicine and University Hospital Southampton, Southampton, UK. Electronic address: g.c.roberts@soton.ac.uk.\"}], 'methods': None, 'conclusions': 'The proven efficacy of SQ SLIT-tablets to reduce symptoms across four of the most common respiratory allergens, is supported by concurrent significant improvements in RQLQ scores - overall and for all 7 domains.', 'results': 'The pooled analysis showed consistent and statistically significant improvements in overall RQLQ scores across all four SQ SLIT-tablets vs. placebo (Pooled estimate [95%CI], p value. Grass: -0.20 [-0.28, -0.12], P<0.001. Tree: -0.42 [-0.58, -0.26], P<0.001. Ragweed: -0.36 [-0.55, -0.17], P<0.001. HDM: -0.28 [-0.39, -0.17], P<0.001). Furthermore, significant improvements vs. placebo for all four SQ SLIT-tablets were seen across the 7 individual domains.', 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.038', 'xml': <Element 'PubmedArticle' at 0x10ba84130>}\n",
      "{'pubmed_id': '38306564\\n29273246\\n16287212\\n31678040\\n18176884\\n11073020\\n34854871\\n24439421\\n975086\\n517816\\n16395696\\n23842577\\n33538338\\n22198214\\n34487521\\n31743536\\n25054566\\n23029414\\n17886233\\n30002074\\n23863760\\n34103634\\n28604730\\n25950993\\n20656692\\n29961852\\n21414999\\n21216802\\n24114802\\n27061298\\n29040600\\n26050253\\n28114746\\n29686387\\n29149188\\n24608958\\n1442729\\n7771438\\n9883789\\n11075875\\n10704703\\n11171871\\n12672680\\n15456995\\n16217766\\n16506215\\n16733074\\n20044861\\n19812684\\n31167755\\n32417133\\n33633205\\n36999938\\n33983952\\n15994265\\n36669806\\n20594926\\n30956205\\n17185647\\n27052782\\n34662740\\n12490959\\n27174888', 'title': 'Association of asthma and lung cancer risk: A pool of cohort studies and Mendelian randomization analysis.', 'abstract': 'Over the past 2 decades, population-based studies have shown an increased association between asthma and the risk of lung cancer. However, the causal links between these 2 conditions remain poorly understood.\\nWe conducted a comprehensive search of various databases, including PubMed, Embase, Web of Science, and Cochrane Library, up until May 04, 2023. Only articles published in English were included in our study. We performed a meta-analysis using random-effects models to calculate the odds ratio (OR) and corresponding 95% confidence interval (CI). Subgroup analyses were conducted based on study design, gender, and histologic types. We also conducted a 2-sample Mendelian randomization (MR) using the genome-wide association study pooled data (408,422 people) published by the UK Biobank to explore further the potential causal relationship between asthma and lung cancer.\\nOur meta-analysis reviewed 24 population-based cohort studies involving 1072,502 patients, revealing that asthma is significantly associated with an increased risk of lung cancer (OR\\u2005=\\u20051.29, 95% CI 1.19-1.38) in all individuals. Subgroup analysis showed a significantly higher risk of lung cancer in females with asthma (OR\\u2005=\\u20051.23, 95% CI 1.01-1.49). We found no significant association between asthma and lung adenocarcinoma (LUAD) (OR\\u2005=\\u20050.76, 95% CI 0.54-1.05), lung squamous carcinomas (LUSC) (OR\\u2005=\\u20051.09, 95% CI 0.79-1.50), or small-cell lung cancer (SCLC) (OR\\u2005=\\u20051.00, 95% CI 0.68-1.49). Interestingly, our MR analysis supported an increasing causality between asthma and lung cancer (OR\\u2005=\\u20051.11, 95% CI 1.04-1.17, P\\u2005=\\u2005.0008), specifically in those who ever smoker (OR\\u2005=\\u20051.09, 95% CI 1.01-1.16, P\\u2005=\\u2005.0173) and LUSC pathological type (OR\\u2005=\\u20051.15, 95% CI 1.05-1.26, P\\u2005=\\u2005.0038).\\nThrough meta-analysis, our study confirms that patients with asthma have a higher risk of developing lung cancer. Our MR study further support an increasing causal relationship between asthma and the risk of lung cancer, particularly in smokers and LUSC. Future studies examining the link between asthma and the risk of developing lung cancer should consider the bias of controlled and uncontrolled asthma.', 'keywords': [], 'journal': 'Medicine', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Huang', 'firstname': 'Qinyao', 'initials': 'Q', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\\nThe Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.\"}, {'lastname': 'Huang', 'firstname': 'Yunxia', 'initials': 'Y', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\\nThe Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.\"}, {'lastname': 'Xu', 'firstname': 'Senkai', 'initials': 'S', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\\nThe Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.\"}, {'lastname': 'Yuan', 'firstname': 'Xiaojun', 'initials': 'X', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\\nThe Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.\"}, {'lastname': 'Liu', 'firstname': 'Xinqi', 'initials': 'X', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\\nThe Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.\"}, {'lastname': 'Chen', 'firstname': 'Zisheng', 'initials': 'Z', 'affiliation': \"Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.\"}], 'methods': None, 'conclusions': 'Through meta-analysis, our study confirms that patients with asthma have a higher risk of developing lung cancer. Our MR study further support an increasing causal relationship between asthma and the risk of lung cancer, particularly in smokers and LUSC. Future studies examining the link between asthma and the risk of developing lung cancer should consider the bias of controlled and uncontrolled asthma.', 'results': 'Our meta-analysis reviewed 24 population-based cohort studies involving 1072,502 patients, revealing that asthma is significantly associated with an increased risk of lung cancer (OR\\u2005=\\u20051.29, 95% CI 1.19-1.38) in all individuals. Subgroup analysis showed a significantly higher risk of lung cancer in females with asthma (OR\\u2005=\\u20051.23, 95% CI 1.01-1.49). We found no significant association between asthma and lung adenocarcinoma (LUAD) (OR\\u2005=\\u20050.76, 95% CI 0.54-1.05), lung squamous carcinomas (LUSC) (OR\\u2005=\\u20051.09, 95% CI 0.79-1.50), or small-cell lung cancer (SCLC) (OR\\u2005=\\u20051.00, 95% CI 0.68-1.49). Interestingly, our MR analysis supported an increasing causality between asthma and lung cancer (OR\\u2005=\\u20051.11, 95% CI 1.04-1.17, P\\u2005=\\u2005.0008), specifically in those who ever smoker (OR\\u2005=\\u20051.09, 95% CI 1.01-1.16, P\\u2005=\\u2005.0173) and LUSC pathological type (OR\\u2005=\\u20051.15, 95% CI 1.05-1.26, P\\u2005=\\u2005.0038).', 'copyrights': 'Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.', 'doi': '10.1097/MD.0000000000035060', 'xml': <Element 'PubmedArticle' at 0x10ba3ab60>}\n",
      "{'pubmed_id': '38306347\\n25956508\\n31929678\\n21518039\\n31470492\\n25382927\\n15905277\\n37838045\\n16841868\\n24247974\\n30677945\\n26071682\\n21864099\\n22667695\\n20576744\\n24248037\\n27209270', 'title': 'Predicting the main pollen season of Broussonetia Papyrifera (paper mulberry) tree.', 'abstract': 'Paper mulberry pollen, declared a pest in several countries including Pakistan, can trigger severe allergies and cause asthma attacks. We aimed to develop an algorithm that could accurately predict high pollen days to underpin an alert system that would allow patients to take timely precautionary measures. We developed and validated two prediction models that take historical pollen and weather data as their input to predict the start date and peak date of the pollen season in Islamabad, the capital city of Pakistan. The first model is based on linear regression and the second one is based on phenological modelling. We tested our models on an original and comprehensive dataset from Islamabad. The mean absolute errors (MAEs) for the start day are 2.3 and 3.7 days for the linear and phenological models, respectively, while for the peak day, the MAEs are 3.3 and 4.0 days, respectively. These encouraging results could be used in a website or app to notify patients and healthcare providers to start preparing for the paper mulberry pollen season. Timely action could reduce the burden of symptoms, mitigate the risk of acute attacks and potentially prevent deaths due to acute pollen-induced allergy.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Kakakhail', 'firstname': 'Ahmad', 'initials': 'A', 'affiliation': 'The Allergy & Asthma Institute, Islamabad, Pakistan.\\nDepartment of Computer Science, National University of Modern Languages, Rawalpindi, Pakistan.'}, {'lastname': 'Rextin', 'firstname': 'Aimal', 'initials': 'A', 'affiliation': 'The Allergy & Asthma Institute, Islamabad, Pakistan.\\nNational University of Science and Technology, Islamabad, Pakistan.'}, {'lastname': 'Buters', 'firstname': 'Jeroen', 'initials': 'J', 'affiliation': 'Center of Allergy & Environment (ZAUM), Member of the German Center for Lung Research (DZL), Technical University and Helmholtz Center, Munich, Germany.'}, {'lastname': 'Lin', 'firstname': 'Chun', 'initials': 'C', 'affiliation': 'NIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.'}, {'lastname': 'Maya-Manzano', 'firstname': 'José M', 'initials': 'JM', 'affiliation': 'Center of Allergy & Environment (ZAUM), Member of the German Center for Lung Research (DZL), Technical University and Helmholtz Center, Munich, Germany.\\nDepartment of Plant Biology, Ecology and Earth Sciences, University of Extremadura, Badajoz, Spain.'}, {'lastname': 'Nasim', 'firstname': 'Mehwish', 'initials': 'M', 'affiliation': 'Flinders University, Adelaide, Australia.\\nThe University of Western Australia, Perth, Australia.'}, {'lastname': 'Oteros', 'firstname': 'Jose', 'initials': 'J', 'affiliation': 'University of Córdoba, Córdoba, Spain.'}, {'lastname': 'Picornell', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'Department of Botany and Plant Physiology, University of Malaga, Málaga, Spain.'}, {'lastname': 'Pinnock', 'firstname': 'Hillary', 'initials': 'H', 'affiliation': 'NIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.'}, {'lastname': 'Schwarze', 'firstname': 'Jurgen', 'initials': 'J', 'affiliation': \"NIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.\\nChild Life and Health, Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.\"}, {'lastname': 'Yusuf', 'firstname': 'Osman', 'initials': 'O', 'affiliation': 'The Allergy & Asthma Institute, Islamabad, Pakistan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © 2024 Kakakhail et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0296878\\n10.1080/00173139109427800\\n10.1016/j.jaci.2015.01.049\\n10.1109/RAST.2007.4284072\\n10.1007/s10453-019-09601-2\\n10.1016/j.atmosenv.2019.05.052\\n10.1080/00173134.2020.1769176\\n10.1111/j.1365-2222.2011.03733.x\\n10.1016/j.scs.2020.102124\\n10.1016/j.scs.2019.101964\\n10.1080/00173138109427661\\n10.1016/j.scitotenv.2019.06.485\\n10.1080/00173138809428928\\n10.1007/s10453-014-9332-8\\n10.1093/bioinformatics/bti499\\n10.1080/00173139109427810\\n10.1080/00173139309429461\\n10.1016/j.scitotenv.2023.167800\\n10.1016/j.ufug.2020.126583\\n10.1016/j.agrformet.2023.109559\\n10.1159/000355630\\n10.1007/s10453-004-1183-2\\n10.1016/j.scitotenv.2018.11.324\\n10.1007/s10453-018-9507-9\\n10.1016/j.jbi.2015.06.003\\n10.3109/02770903.2011.608460\\n10.1089/tmj.2011.0218\\n10.1258/jtt.2010.090809\\n10.1159/000356317\\n10.1007/s12016-016-8542-y', 'xml': <Element 'PubmedArticle' at 0x10900d030>}\n",
      "{'pubmed_id': '38306078', 'title': 'Sociodemographic factors, health behavior, parental or workplace smoking, and adult asthma risk in the United States.', 'abstract': \"Although several studies have found a link between parental or workplace smoking and asthma risk, particularly in children and adolescents, only a few studies have found this link in adults.\\nThis study aimed to investigate the associations of sociodemographic factors, health behavior, and parental or workplace smoking with adult asthma risk in the United States (US).\\nA secondary data analysis on 874 participants aged 25-45 was performed using data from the 2011-2014 National Survey of Midlife Development in the United States Refresher. Participants were divided into smokers and nonsmokers. Participants were further divided into groups A (a father or mother with a smoking history) and B (others in the house or colleagues in the workplace who had a smoking history).\\nFindings from the FREQ procedure revealed that sociodemographic (female, black, school or college education, unmarried/divorced, and employed) and lifestyle (no alcohol intake, physically inactive, and obese) and clinical (diabetes and joint disease) factors were significantly associated with one- or more-fold odds of asthma among adult smokers than nonsmokers. Adult smokers in group A, particularly females, those with a high school or college education, physically inactive, and overweight or obese, had a higher risk of asthma than those in group B.\\nAdult smokers' risk of developing asthma is increased in the US by having smoked with their parents, being a woman, being black, having a school or college education, being single or divorced, working, not drinking alcohol, being physically inactive, being obese, having diabetes, and having a joint disease.\", 'keywords': ['Asthma', 'health behavior', 'parental smoking', 'rehabilitation', 'sociodemographic', 'workplace smoking'], 'journal': 'Work (Reading, Mass.)', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Alwadeai', 'firstname': 'Khalid S', 'initials': 'KS', 'affiliation': 'Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. E-mail: kalwadeai@ksu.edu.sa.'}], 'methods': None, 'conclusions': \"Adult smokers' risk of developing asthma is increased in the US by having smoked with their parents, being a woman, being black, having a school or college education, being single or divorced, working, not drinking alcohol, being physically inactive, being obese, having diabetes, and having a joint disease.\", 'results': 'Findings from the FREQ procedure revealed that sociodemographic (female, black, school or college education, unmarried/divorced, and employed) and lifestyle (no alcohol intake, physically inactive, and obese) and clinical (diabetes and joint disease) factors were significantly associated with one- or more-fold odds of asthma among adult smokers than nonsmokers. Adult smokers in group A, particularly females, those with a high school or college education, physically inactive, and overweight or obese, had a higher risk of asthma than those in group B.', 'copyrights': None, 'doi': '10.3233/WOR-230026', 'xml': <Element 'PubmedArticle' at 0x10901ab10>}\n",
      "{'pubmed_id': '38305494', 'title': 'Association of blood lipid profiles and asthma: A bidirectional two-sample Mendelian randomization study.', 'abstract': 'Observational studies and meta-analyses have indicated associations between blood lipid profiles and asthma. However, the causal association is unknown. Therefore, this study investigated the causal relationship between blood lipid profiles and asthma using bidirectional Mendelian randomization analysis.\\nOur analyses were performed using individual data from the Taiwan Biobank and summary statistics from the Asian Genetic Epidemiology Network (AGEN). The causal estimates between all genetic variants, exposures of interest and asthma were calculated using an inverse-variance weighted method based on Taiwan Biobank data from 24,853 participants (mean age, 48.8 years; 49.8% women). Sensitivity analyses, including the weighted median, MR Egger regression, MR-PRESSO, mode-based estimate, contamination mixture methods, and leave-one-out analysis, were applied to validate the results and detect pleiotropy.\\nIn the inverse-variance weighted (IVW) analyses, we found evidence of a significant causal effect of an increased level of low-density lipoprotein cholesterol on asthma risk (β\\nOur results supported the causal relationship between higher levels of LDL cholesterol and total cholesterol and lower levels of HDL cholesterol with an increased risk of asthma.', 'keywords': ['HDL-C', 'LDL-C', 'Mendelian randomization', 'TC', 'asthma', 'blood lipid profiles'], 'journal': 'Annals of human genetics', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Liu', 'firstname': 'Yi-Shian', 'initials': 'YS', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Yu-Chun', 'initials': 'YC', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Meng-Chih', 'initials': 'MC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.'}, {'lastname': 'Wu', 'firstname': 'Chao-Chien', 'initials': 'CC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.'}, {'lastname': 'Wang', 'firstname': 'Tsu-Nai', 'initials': 'TN', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.\\nResearch Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.'}], 'methods': None, 'conclusions': 'Our results supported the causal relationship between higher levels of LDL cholesterol and total cholesterol and lower levels of HDL cholesterol with an increased risk of asthma.', 'results': 'In the inverse-variance weighted (IVW) analyses, we found evidence of a significant causal effect of an increased level of low-density lipoprotein cholesterol on asthma risk (β', 'copyrights': '© 2024 University College London (UCL) and John Wiley & Sons Ltd.', 'doi': '10.1111/ahg.12545', 'xml': <Element 'PubmedArticle' at 0x10901b4c0>}\n",
      "{'pubmed_id': '38305415', 'title': 'Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study.', 'abstract': None, 'keywords': [], 'journal': 'The British journal of dermatology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Ring', 'firstname': 'Hans Christian', 'initials': 'HC', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Thorsen', 'firstname': 'Jonathan', 'initials': 'J', 'affiliation': 'COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Kirby', 'firstname': 'Brian', 'initials': 'B', 'affiliation': \"The Charles Centre, Department of Dermatology, St Vincent's University Hospital, D04 T6F4 Dublin, Ireland.\"}, {'lastname': 'Ingram', 'firstname': 'John R', 'initials': 'JR', 'affiliation': 'Department of Dermatology & Academic Wound Healing, Institute of Infection & Immunity, Cardiff University, Cardiff, UK.'}, {'lastname': 'Rosenø', 'firstname': 'Nana Aviaaja Lippert', 'initials': 'NAL', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Holgersen', 'firstname': 'Nikolaj', 'initials': 'N', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Nielsen', 'firstname': 'Valdemar W', 'initials': 'VW', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Nikolai Thein Aagaard', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.'}, {'lastname': 'Maul', 'firstname': 'Julia-Tatjana', 'initials': 'JT', 'affiliation': 'Department of Dermatology, University of Zürich, Zürich, Switzerland.'}, {'lastname': 'Wu', 'firstname': 'Jashin J', 'initials': 'JJ', 'affiliation': 'Department of Dermatology, University of Miami Miller School of Medicine, Los Angeles, CA, USA.'}, {'lastname': 'Thyssen', 'firstname': 'Jacob P', 'initials': 'JP', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.\\nDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Egeberg', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.\\nDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Thomsen', 'firstname': 'Simon F', 'initials': 'SF', 'affiliation': 'Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.\\nDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1093/bjd/ljae042', 'xml': <Element 'PubmedArticle' at 0x109008fe0>}\n",
      "{'pubmed_id': '38305338', 'title': 'Rhizoma Dioscoreae Nipponicae Relieves Asthma by Inducing the Ferroptosis of Eosinophils and Inhibiting the p38 MAPK Signaling Pathway.', 'abstract': 'Rhizoma Dioscoreae Nipponicae (RDN) is a traditional Chinese medicine that widely applied in the treatment of human diseases. This study aims to explore the therapeutic potential of RDN in asthma and the underlying mechanisms. A mouse model of asthma was established by the stimulation of ovalbumin (OVA). HE staining was performed to detect the pathological injuries of tracheal tissues. The protein expression of collagen I, FN1, α-SMA (airway remodeling markers), and p-p38 (a marker of the p38 MAPK pathway) were detected by Western blot. Eosinophils were then isolated from the model mice. Cell viability and ROS level were measured by CCK-8 and Flow cytometry, respectively. The mRNA expression of GPX4 and ACSL4 (ferroptosis markers) in eosinophils were measured by qRT-PCR. RDN significantly reduced the numbers of total cells and eosnophils in bronchoalveolar lavage fluid (BALF), inhibited inflammatory cell infiltration, and down-regulated remodeling markers (Collagen I, FN1, and α-SMA) in OVA-induced mice. The p38 MAPK pathway was blocked by the intervention of RDN in the model mice, and its blocking weakens the poor manifestations of OVA-induced asthma. In addition, RDN induced the ferroptosis of eosnophils both in vitro and in vivo. Blocking of the p38 MAPK pathway also enhanced the ferroptosis of eosnophils in vitro, evidenced by the decreased cell viability and GPX4 expression, and increased ROS level and ACSL4 expression. RDN induced the ferroptosis of eosinophils through inhibiting the p38 MAPK pathway, contributing to the remission of asthma.', 'keywords': [], 'journal': 'Critical reviews in immunology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Jiang', 'firstname': 'Libin', 'initials': 'L', 'affiliation': 'Department of Geriatric Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.'}, {'lastname': 'Xu', 'firstname': 'Liying', 'initials': 'L', 'affiliation': 'Department of Emergency, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.'}, {'lastname': 'Liu', 'firstname': 'Huazuo', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Nanxun District Hospital of Traditional Chinese Medicine in Huzhou City, Huzhou, Zhejiang, China.'}, {'lastname': 'Chen', 'firstname': 'Hanwen', 'initials': 'H', 'affiliation': 'Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.'}, {'lastname': 'Wang', 'firstname': 'Weiyi', 'initials': 'W', 'affiliation': 'The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine).'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1615/CritRevImmunol.2023050922', 'xml': <Element 'PubmedArticle' at 0x109049350>}\n",
      "{'pubmed_id': '38304829\\n31275909\\n30552986\\n17124020\\n2513902\\n30598019\\n25102107\\n36909900\\n15831718\\n19709182\\n12911699\\n10543789\\n12363017\\n36771193\\n29318023\\n36641058\\n37105551\\n36526899\\n37032908\\n36639753\\n36847620\\n36989896\\n32802893\\n34914027\\n31995273\\n20585380\\n35310604\\n30954166\\n27178886\\n31279011\\n35724951\\n24330256\\n21872915\\n27618652\\n33177184\\n31958431\\n30600099\\n36107703\\n21477358\\n29321519\\n32220282\\n33887206\\n33139948\\n28257972\\n20052417\\n30426401\\n30126004\\n17928596\\n28500319\\n31844063\\n27078029\\n34412069\\n33889017\\n32808353\\n24813249\\n34277109\\n35275333\\n28390574\\n27518660\\n32072252\\n33759390\\n26511795\\n25974301\\n34222279\\n32075727\\n35988549\\n28658542\\n33678251\\n26500629\\n33815524\\n34769255\\n31793015\\n21471101\\n20658483\\n30400588\\n32249275\\n29575037\\n33472687\\n33705665\\n30954167', 'title': 'Global knowledge mapping and emerging research trends in the microbiome and asthma: A bibliometric and visualized analysis using VOSviewer and CiteSpace.', 'abstract': 'Numerous prior studies have extensively highlighted the significance of the microbiome in association with asthma. While several studies have concentrated on the asthma microbiome in previous research, there is currently a lack of publications that employ bibliometric methods to assess this area.\\nIn this study, the Web of Science Core Collection database was utilized as the data source, and the SCI-EXPANDED index was employed to ensure that the retrieved data were comprehensive and accurate. All original research articles and review articles related to the correlation between asthma and the microbiome were systematically searched from the inception of the database until June 20, 2023. These articles were subsequently visualized and analyzed using VOSviewer and CiteSpace software.\\nA total of 1366 relevant publications were acquired, indicating a consistent annual increase in global publications in the field. The United States and China emerged as the top two contributors to international publications. Among prolific authors, Susan V. Lynch achieved the highest publication record, with Hans Bisgaard and Jakob Stokholm sharing the second position. The majority of publications concentrated on allergy-related and microbiome areas, with a few comprehensive journals standing out. Journals with 40 or more publications included the \\nThis study systematically presented a comprehensive overview of the literature regarding the association between asthma and the microbiome over the last two decades. Through a bibliometric perspective, the findings may assist researchers with a better understanding of the essential information in the field.', 'keywords': ['Asthma', 'Bibliometric analysis', 'CiteSpace', 'Microbiome', 'VOSviewer'], 'journal': 'Heliyon', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Guo', 'firstname': 'ZhiFeng', 'initials': 'Z', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian Province, China.'}, {'lastname': 'Huang', 'firstname': 'LingHong', 'initials': 'L', 'affiliation': 'Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian Province, China.'}, {'lastname': 'Lai', 'firstname': 'SuMei', 'initials': 'S', 'affiliation': 'Stem Cell Laboratory, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian Province, China.'}], 'methods': None, 'conclusions': 'This study systematically presented a comprehensive overview of the literature regarding the association between asthma and the microbiome over the last two decades. Through a bibliometric perspective, the findings may assist researchers with a better understanding of the essential information in the field.', 'results': 'A total of 1366 relevant publications were acquired, indicating a consistent annual increase in global publications in the field. The United States and China emerged as the top two contributors to international publications. Among prolific authors, Susan V. Lynch achieved the highest publication record, with Hans Bisgaard and Jakob Stokholm sharing the second position. The majority of publications concentrated on allergy-related and microbiome areas, with a few comprehensive journals standing out. Journals with 40 or more publications included the ', 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.heliyon.2024.e24528', 'xml': <Element 'PubmedArticle' at 0x109e5d260>}\n",
      "{'pubmed_id': '38304673\\n21094923\\n24940476\\n28911920\\n29574758\\n30415748\\n33212975\\n35765786\\n22326484\\n33680125\\n19561904\\n27568881\\n28719697\\n26306100\\n29074814\\n26836926\\n26200463\\n26557235\\n7634874\\n18046878\\n35522051\\n14579995\\n16380574', 'title': 'Predictive Factors of Hospitalization and Emergency Visits Among Children With Asthma.', 'abstract': 'Introduction A chronic diverse inflammatory disease, asthma affects millions of people worldwide. To control asthma, standardized care is essential. Children with asthma who receive appropriate care have lower emergency room (ER) visits and hospital stays as well as a higher quality of life than children who do not receive appropriate care. We aim to evaluate the predictive variables of hospitalization and ER visits in children with asthma. Methodology In 2022 and 2023, a cross-sectional descriptive study was carried out on children with asthma and their caregivers who were attending primary health care clinics in the eastern region of Saudi Arabia. We used the Childhood Asthma Control Test (C-ACT) to evaluate asthma control. A C-ACT score of less than 19 indicates uncontrolled childhood asthma. To investigate the relationships between the risk factors and the rate of ER visits and hospitalizations, we performed a multiple logistic descriptive analysis. Results In this study, 124 asthmatic children from primary health care centers matched the inclusion criteria. The majority of children had atopy, and their mean age was 10.8±3.4 years. Concerning the risk factors linked to ER visits and hospitalization, there is evidence that not following up with physicians, using more frequent and short-acting beta-agonists, exposure to smoke and household pets, and poor asthma control are linked to increased rates of both ER visits and hospitalizations. Conclusion Better asthma control in children and adolescents may be achieved by providing inexpensive asthma care services, more thorough parental and child education, and effective symptom management. These measures can help reduce exacerbations of asthma and the consequences that accompany them.', 'keywords': ['asthma', 'asthma control test', 'children', 'exacerbation', 'saudi arabia'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Al Ghadeer', 'firstname': 'Hussain A', 'initials': 'HA', 'affiliation': 'Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.'}, {'lastname': 'Aldandan', 'firstname': 'Jalal K', 'initials': 'JK', 'affiliation': 'Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.'}, {'lastname': 'Alessa', 'firstname': 'Marwah A', 'initials': 'MA', 'affiliation': 'Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.'}, {'lastname': 'Al Ali', 'firstname': 'Sirar A', 'initials': 'SA', 'affiliation': 'Pediatrics, New Medical Center (NMC) Royal Hospital, Sharjah, ARE.'}, {'lastname': 'Alajalin', 'firstname': 'Abdullah M', 'initials': 'AM', 'affiliation': 'Pediatrics, Prince Saud Bin Jalawi Hospital, Al-Ahsa, SAU.'}, {'lastname': 'Al Ghadeer', 'firstname': 'Ali A', 'initials': 'AA', 'affiliation': 'Dentistry, Vision College, Riyadh, SAU.'}, {'lastname': 'Albahrani', 'firstname': 'Hassan M', 'initials': 'HM', 'affiliation': 'Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.'}, {'lastname': 'Alherz', 'firstname': 'Qasem I', 'initials': 'QI', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Almulhim', 'firstname': 'Latifah A', 'initials': 'LA', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Altaweel', 'firstname': 'Ibrahim A', 'initials': 'IA', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Alqahtani', 'firstname': 'Badah A', 'initials': 'BA', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Al Bensaad', 'firstname': 'Ghadeer A', 'initials': 'GA', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Alnasser', 'firstname': 'Muntaha N', 'initials': 'MN', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Alhumaid', 'firstname': 'Rawan H', 'initials': 'RH', 'affiliation': 'Pediatrics, King Faisal University, Al-Ahsa, SAU.'}, {'lastname': 'Fatani', 'firstname': 'Reham M', 'initials': 'RM', 'affiliation': 'Pediatrics, Maternity and Children Hospital, Jeddah, SAU.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024, Al Ghadeer et al.', 'doi': '10.7759/cureus.51487', 'xml': <Element 'PubmedArticle' at 0x109eb5ad0>}\n",
      "{'pubmed_id': '38304621\\n27079345\\n24940476\\n24382846\\n28822787\\n27752310\\n28634371\\n34277075\\n36277438\\n31429799\\n36028919\\n29358417\\n26100503\\n35642244\\n31893127\\n33789826\\n18453793\\n26230150\\n19852197\\n27358632\\n9492686\\n37143111\\n29046815\\n30128064\\n36480508\\n36424951\\n29663966\\n36113528\\n35637220\\n31077247\\n33515188\\n24619949\\n27555454\\n31906744\\n29976652\\n33072392\\n35025962\\n33393641\\n31365287\\n29752346\\n2240348\\n22348209\\n26755223\\n31338165', 'title': 'Prevalence of medication adherence among adult asthmatic patients in four African countries: A systematic review and meta-analysis.', 'abstract': \"Non-adherence to medications has many deleterious effects including poor treatment outcomes, increased economic burden, increased morbidity, hospitalization rate, health care utilization, productivity loss, and mortality. Therefore, this review aimed to estimate the pooled prevalence of medication adherence among asthmatic adults in 4 African countries. Primary studies were extensively searched from databases such as PubMed, HINARI, Cochrane Library, CINHALand, Google Scholar, and Google search engines. After screening and assessing the quality of studies, data were extracted using a checklist. Heterogeneity was assessed using forest plot, Chocran's Q Test and I\", 'keywords': ['Adherence', 'Adult', 'Africa', 'Asthma', 'Medication'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Zewdie', 'firstname': 'Segenet', 'initials': 'S', 'affiliation': 'Department of Pharmacy, Injibara University, Injibara, Ethiopia.'}, {'lastname': 'Mekuria', 'firstname': 'Basaiznew', 'initials': 'B', 'affiliation': 'Department of Pharmacy, Injibara University, Injibara, Ethiopia.'}, {'lastname': 'Alemu', 'firstname': 'Belete Kassa', 'initials': 'BK', 'affiliation': 'Department of Pharmacy, Injibara University, Injibara, Ethiopia.'}, {'lastname': 'Bayked', 'firstname': 'Ewunetie Mekashaw', 'initials': 'EM', 'affiliation': 'Department of Pharmacy, Wollo University, Dessie, Ethiopia.'}, {'lastname': 'NurAhmed Toleha', 'firstname': 'Hussein', 'initials': 'H', 'affiliation': 'Department of Pharmacy, Wollo University, Dessie, Ethiopia.'}, {'lastname': 'Ayenew', 'firstname': 'Wondim', 'initials': 'W', 'affiliation': 'Department of Pharmaceutics, University of Gondar, Gondar, Ethiopia.'}, {'lastname': 'Andargie', 'firstname': 'Assefa', 'initials': 'A', 'affiliation': 'Department of Public Health, Injibara University, Injibara, Ethiopia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors.', 'doi': '10.1016/j.waojou.2024.100870', 'xml': <Element 'PubmedArticle' at 0x109e94f40>}\n",
      "{'pubmed_id': '38304360\\n32606907\\n30044543\\n33149177\\n33781236\\n32989201\\n31325050\\n34021388\\n31899561\\n31990692\\n32126991\\n29224692\\n33901171\\n24141714\\n33270760\\n33104700\\n32702046\\n31308002\\n33318111\\n33572441\\n25048354\\n30165549\\n32858852\\n31045382\\n27753745\\n3558716\\n9431328\\n8433577\\n1573438\\n26820044\\n28056050', 'title': 'CHRONIC MULTIMORBIDITY OF LOW BACK PAIN OR OTHER CHRONIC BACK DISORDERS IN THE REPUBLIC OF CROATIA.', 'abstract': 'The aim was to assess the prevalence of chronic multimorbidity in patients with chronic low back pain or other chronic back disorders (BD). We analyzed data from the population-based cross-sectional European Health Interview Survey (EHIS) performed in the Republic of Croatia 2014-2015 by the Croatian Institute of Public Health. Outcome was the point-prevalence of chronic multimorbidity defined as having ≥2 chronic illnesses out of 14 contained in the EHIS questionnaire, after adjustment for ten sociodemographic, anthropometric and lifestyle confounders. Amoung fourteen targeted illnesses were asthma, allergies, hypertension, urinary incontinence, kidney diseases, coronary heart disease or angina pectoris, neck disorder, arthrosis, chronic obstructive pulmonary disease, diabetes mellitus, myocardial infarction, stroke, depression, and the common category \"other\". We analyzed data on 268 participants with BD and 511 without it. Participants with BD had a significantly higher relative risk of any chronic multimorbidity (RRadj=2.12; 95% CI 1.55, 2.99; p<0.001), as well as of non-musculoskeletal chronic multimorbidity (RRadj=2.29; 95% CI 1.70, 3.08; p=0.001) than participants without BD. All chronic comorbidities except for asthma and liver cirrhosis were significantly more prevalent in participants with BD than in participants without BD. In the population with BD, the participants with multimorbidity had three to four times higher odds for unfavorable self-reported health outcomes than the participants with no comorbid conditions, whereas the existence of only one comorbidity was not significantly associated with a worse outcome compared to the population with no comorbidities. In conclusion, the population suffering from BD has a higher prevalence of chronic multimorbidity than the population without BD and this multimorbidity is associated with unfavorable health outcomes.', 'keywords': ['Comorbidity', 'European Health Interview Survey', 'Low back pain', 'Multimorbidity'], 'journal': 'Acta clinica Croatica', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Marunica Karšaj', 'firstname': 'Jelena', 'initials': 'J', 'affiliation': 'University Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'}, {'lastname': 'Benjak', 'firstname': 'Tomislav', 'initials': 'T', 'affiliation': 'Croatian Institute of Public Health, Zagreb, Croatia.'}, {'lastname': 'Stojanović', 'firstname': 'Larisa', 'initials': 'L', 'affiliation': 'Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.'}, {'lastname': 'Grubišić', 'firstname': 'Frane', 'initials': 'F', 'affiliation': 'University Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.\\nSchool of Medicine, University of Zagreb, Zagreb, Croatia.'}, {'lastname': 'Balen', 'firstname': 'Diana', 'initials': 'D', 'affiliation': 'University Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'}, {'lastname': 'Grazio', 'firstname': 'Simeon', 'initials': 'S', 'affiliation': 'University Department of Rheumatology, Physical and Rehabilitation Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.\\nSchool of Medicine, University of Zagreb, Zagreb, Croatia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Sestre Milosrdnice University Hospital.', 'doi': '10.20471/acc.2023.62.01.17\\n10.2147/JPR.S247529\\n10.1002/acr.23710\\n10.1038/s41598-020-76074-6\\n10.1186/s12877-021-02135-8\\n10.3344/kjp.2020.33.4.359\\n10.1007/s00586-019-06071-5\\n10.1007/s00402-021-03959-0\\n10.1007/s00402-021-03959-0\\n10.1002/nau.24269\\n10.1097/AJP.0000000000000810\\n10.1186/s12891-020-3154-3\\n10.1016/j.berh.2017.09.004\\n10.1371/journal.pmed.1003584\\n10.1001/jama.2013.281053\\n10.1371/journal.pone.0243275\\n10.1371/journal.pone.0239835\\n10.1371/journal.pone.0236034\\n10.3399/bjgp19X704657\\n10.1136/bmjopen-2020-039440\\n10.3390/ijerph18041673\\n10.1371/journal.pone.0102149\\n10.1093/gerona/gly202\\n10.3390/jcm9092759\\n10.1037/hea0000726\\n10.1097/MLR.0000000000000660\\n10.1016/0021-9681(87)90171-8\\n10.1097/00005650-199801000-00004\\n10.1097/00005650-199302000-00005\\n10.1016/0895-4356(92)90016-G\\n10.5888/pcd13.150404\\n10.1371/journal.pone.0169426', 'xml': <Element 'PubmedArticle' at 0x109afe430>}\n",
      "{'pubmed_id': '38304143\\n17132052\\n15203824\\n26159955\\n30286465\\n32770990\\n7789502\\n10931127\\n34991900\\n10923606\\n18523395\\n23744517\\n24311476\\n17444920\\n27279672\\n17947786\\n14746624\\n33161520\\n36601260\\n18820833\\n35918674', 'title': 'Exposure to household secondhand tobacco smoke and the odds of developing atopic dermatitis among adolescents: A causal mediation analysis.', 'abstract': \"Exposure to household secondhand tobacco smoke (SHS) among adolescents has been shown to be associated with atopic dermatitis, and affects disproportionality females. However, the mechanisms underlying this link are uncertain. This study sought to identify modifiable factors that mediate the relationship between household SHS exposure and atopic dermatitis among adolescents.\\nDuring October 2015, a cross-sectional study was conducted using the ISAAC questionnaire for data collection from adolescents enrolled in nine high schools of Hawalli - one of the six governorates of Kuwait. Data were collected on sociodemographic characteristics, self-reported tobacco smoking among adolescents, household SHS exposure (≥1 smokers at home vs none), self-reported asthma and atopic dermatitis. For causal mediation analysis an inverse odds-weighting approach was used.\\nOf 746 participants, 74.8% were Kuwaiti, 50.1% were female, 12.4% were regular daily smokers and 54.1% had household SHS exposure, which was more common among Kuwaiti (79.6%) than non-Kuwaiti (20.4%) adolescents. The prevalences of self-reported asthma and atopic dermatitis were 20.6% and 14.9%, respectively. After adjusting for the pre-exposure covariates (i.e. sex and nativity), household SHS exposure had a significant (p=0.043) total effect, non-significant (p=0.133) natural direct effect, and marginally insignificant (p=0.058) natural indirect effect, which were jointly mediated by asthma status and adolescent's self-reported smoking status, with a proportion of mediated risk to atopic dermatitis of 29.6%.\\nAsthma and self-tobacco smoking among adolescents not only directly affected but also mediated household SHS exposure effect on atopic dermatitis risk. Voluntarily adopting a smoke-free home rule may minimize household SHS exposure, reduce the odds of developing asthma, and deter the initiation of tobacco smoking among adolescents. Such an effort will likely mitigate the atopic dermatitis risk among adolescents in this and other similar settings. If implemented, future studies may contemplate evaluating the impact of such intervention.\", 'keywords': ['asthma', 'atopic dermatitis', 'causal mediation analysis', 'household secondhand tobacco smoke exposure', 'tobacco smoking'], 'journal': 'Tobacco induced diseases', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Akhtar', 'firstname': 'Saeed', 'initials': 'S', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Al-Shanfari', 'firstname': 'Saad', 'initials': 'S', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Booalayan', 'firstname': 'Hussain', 'initials': 'H', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Abdulrasool', 'firstname': 'Mosa', 'initials': 'M', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Boujarwa', 'firstname': 'Abdulwahab', 'initials': 'A', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Al-Mukaimi', 'firstname': 'Abdullah', 'initials': 'A', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}, {'lastname': 'Alkandery', 'firstname': 'Omar', 'initials': 'O', 'affiliation': 'Department of Community Medicine and Behavioral Sciences, College of Medicine, Kuwait University, Safat, Kuwait.'}], 'methods': None, 'conclusions': None, 'results': \"Of 746 participants, 74.8% were Kuwaiti, 50.1% were female, 12.4% were regular daily smokers and 54.1% had household SHS exposure, which was more common among Kuwaiti (79.6%) than non-Kuwaiti (20.4%) adolescents. The prevalences of self-reported asthma and atopic dermatitis were 20.6% and 14.9%, respectively. After adjusting for the pre-exposure covariates (i.e. sex and nativity), household SHS exposure had a significant (p=0.043) total effect, non-significant (p=0.133) natural direct effect, and marginally insignificant (p=0.058) natural indirect effect, which were jointly mediated by asthma status and adolescent's self-reported smoking status, with a proportion of mediated risk to atopic dermatitis of 29.6%.\", 'copyrights': '© 2024 Akhtar S. et al.', 'doi': '10.18332/tid/176967\\n10.1371/journal.pmed.0030442\\n10.1080/14622200410001669213\\n10.13075/ijomeh.1896.00316\\n10.1159/000492054\\n10.1186/s12889-020-09245-9\\n10.1183/09031936.95.08030483\\n10.1046/j.1365-2222.2000.00882.x\\n10.1016/j.abd.2021.03.010\\n10.1155/2013/490906\\n10.1016/s1081-1206(10)62435-0\\n10.1159/000129607\\n10.1002/sim.5864\\n10.1177/0956797613502676\\n10.1111/j.1467-9280.2007.01882.x\\n10.1093/biomet/asw012\\n10.1136/bmj.39335.541782.AD\\n10.1111/j.1365-2133.2004.05710.x\\n10.1007/s11356-020-11464-x\\n10.1016/j.waojou.2022.100731\\n10.1007/s00038-008-7085-2\\n10.1186/s12887-022-03520-x', 'xml': <Element 'PubmedArticle' at 0x109a3dd50>}\n",
      "{'pubmed_id': '38303757\\n26471110\\n23087391\\n19628172\\n16642006\\n17700251\\n15247610\\n19351434\\n19104659\\n30868998\\n21121230\\n32745200\\n33817612\\n32272089\\n32827728\\n33065368\\n34538303\\n33961732\\n33144496\\n36063828\\n34733808\\n34574472\\n36189937\\n36377231\\n34069468\\n34398310\\n32145186', 'title': 'Prolonged School Closure and Pediatric Respiratory Hospitalization: The Silver Lining of the COVID-19 Pandemic.', 'abstract': '', 'keywords': ['RAD exacerbation', 'RSV bronchiolitis', 'asthma exacerbation', 'children', 'pandemic response', 'pediatric respiratory hospitalization', 'virus mitigation'], 'journal': 'Global pediatric health', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Bazzi', 'firstname': 'Ali J', 'initials': 'AJ', 'affiliation': \"Children's Hospital of Michigan, Detroit, MI, USA.\"}, {'lastname': 'Sallman', 'firstname': 'Zahur Fatima', 'initials': 'ZF', 'affiliation': \"Children's Hospital of Michigan, Detroit, MI, USA.\"}, {'lastname': 'Greenwell', 'firstname': 'Alyssa M', 'initials': 'AM', 'affiliation': \"Children's Hospital of Michigan, Detroit, MI, USA.\"}, {'lastname': 'Manolis', 'firstname': 'Alexandra T', 'initials': 'AT', 'affiliation': \"Children's Hospital of Michigan, Detroit, MI, USA.\"}, {'lastname': 'Khanafer', 'firstname': 'Rasha', 'initials': 'R', 'affiliation': 'Detroit Wayne County Authority Health, Detroit, MI, USA.'}, {'lastname': 'Haidar-Elatrache', 'firstname': 'Sara', 'initials': 'S', 'affiliation': \"Children's Hospital of Michigan, Detroit, MI, USA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© The Author(s) 2024.', 'doi': '10.1177/2333794X231224999\\n10.1136/archdischild-2015-308875\\n10.1093/cid/cis890\\n10.1016/S1473-3099(09)70176-8\\n10.1038/nature04795\\n10.1097/ede.0b013e31812713b4\\n10.1097/01.inf.0000128778.54105.06\\n10.1017/S0950268809002556\\n10.1371/journal.pone.0004005\\n10.1017/S0950268818003424\\n10.1177/003335491012500612\\n10.1001/jama.2020.14348\\n10.1016/j.eclinm.2021.100807\\n10.1016/S2352-4642(20)30095-X\\n10.1016/j.jaip.2020.07.057\\n10.1016/j.jaip.2020.09.060\\n10.1016/j.pcl.2021.05.012\\n10.1002/ppul.25442\\n10.1542/peds.2020-005983\\n10.1016/S1473-3099(22)00525-4\\n10.3389/fped.2021.740785\\n10.3390/ijerph18189550\\n10.1177/00099228221124677\\n10.1016/j.jacig.2022.06.001\\n10.3390/children8050415\\n10.1007/s11920-021-01279-z\\n10.1016/s0140-6736(20)30547-x', 'xml': <Element 'PubmedArticle' at 0x109ad30b0>}\n",
      "{'pubmed_id': '38303079', 'title': 'Abrogation and homeostatic restoration of IgE responses by a universal IgE allergy CTL vaccine-The three signal self/non-self/self (S/NS/S) theory.', 'abstract': 'Natural IgE cytotoxic peptides (nECPs), which are derived from the constant domain of the heavy chain of human IgE producing B cells via endoplasmic reticulum (ER) stress, are decorated onto MHC class 1a molecules (MHCIa) as unique biomarkers for CTL (cytotoxic T lymphocyte)-mediated immune surveillance. Human IgE exhibits only one isotype and lacks polymorphisms; IgE is pivotal in mediating diverse, allergen-specific allergies. Therefore, by disrupting self-IgE tolerance via costimulation, the CTLs induced by nECPs can serve as universal allergy vaccines (UAVs) in humans to dampen IgE production mediated by diverse allergen-specific IgE-secreting B cells and plasma cells expressing surface nECP-MHCIa as targets. The study herein has enabled the identification of nECPs, A32 and SP-1/SP-2 nonameric natural peptides\\xa0produced through the correspondence principle. Vaccination using nECP induced nECP-specific CTL that profoundly suppressed human IgE production in vitro as well as chimeric human IgE production in human IgE/HLA-A2.01/HLA-B7.02 triple transgenic rodents. Furthermore, nECP-tetramer-specific CTLs were found to be converted into CD4 Tregs that restored IgE competence via the homeostatic principle, mediatepred by SREBP-1c suppressed DCs. Thus, nECPs showed causal efficacy and safety as UAVs for treating categorically type I hypersensitivity IgE-mediated allergies. The applied vaccination concept presented provides the foundation to unify, integrate through a singular class of tetramer-specific TCR clonotypes for regulaing human IgE production. The three signal theory pertains to mechanisms of three cells underlying central tolerance (S), breaking self tolerance (NS) and regaining peripheral tolerance (S) via homeostasis\\xa0concerning nECP as an efficacious and safe UAV to treat type I IgE-mediated hypersensitivity. The three signal theory impirically extended, may be heuritic for immuno-regulation of adaptive immune repertoire in general.', 'keywords': ['Treg', 'allergy', 'antigens/peptides/epitopes', 'asthma'], 'journal': 'Immunology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Chen', 'firstname': 'Swey-Shen', 'initials': 'SS', 'affiliation': 'Department of Immunology and Inflammation, AAIIT LLC, San Diego, California, USA.\\nDivision of Vaccinology and Immunotherapy, IGE Therapeutics and Pharmaceuticals, Inc, San Diego, California, USA.\\nDepartment of Protein Display and Molecular Evolution, The Institute of Genetics at San Diego, San Diego, California, USA.'}, {'lastname': 'Zhang', 'firstname': 'Hailan', 'initials': 'H', 'affiliation': 'Department of Immunology and Inflammation, AAIIT LLC, San Diego, California, USA.\\nDivision of Vaccinology and Immunotherapy, IGE Therapeutics and Pharmaceuticals, Inc, San Diego, California, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 John Wiley & Sons Ltd.', 'doi': '10.1111/imm.13753', 'xml': <Element 'PubmedArticle' at 0x109a9ddf0>}\n",
      "{'pubmed_id': '38302925\\n30766096\\n18982161\\n28848860\\n19342679\\n27448447\\n27677501\\n23338559\\n29390434\\n21037022\\n27025347\\n20522791\\n29443743\\n30696075\\n23735656\\n27155035\\n32255668\\n10377201\\n19720809\\n23503203\\n14691035\\n21305051\\n21940491\\n34446467\\n29042607\\n24326348\\n19635926\\n28231829\\n21706005\\n34474215\\n26774658\\n26336642\\n25183374\\n27561911\\n32540994\\n36858565\\n33875334\\n34815425\\n29902480\\n30267606\\n25998939\\n33123835\\n19380307\\n28890402\\n6970727\\n25130606\\n23818743', 'title': 'Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.', 'abstract': 'Among patients with chronic obstructive pulmonary disease (COPD), some have features of both asthma and COPD-a condition categorized as asthma-COPD overlap (ACO). Our aim was to determine whether asthma- or COPD-related microRNAs (miRNAs) play a role in the pathogenesis of ACO.\\nA total of 22 healthy subjects and 27 patients with ACO were enrolled. We selected 6 miRNAs that were found to correlate with COPD and asthma. The expression of miRNAs and target genes was analyzed using quantitative reverse-transcriptase polymerase chain reaction. Cell apoptosis and intracellular reactive oxygen species production were evaluated using flow cytometry. In vitro human monocytic THP-1 cells and primary normal human bronchial epithelial (NHBE) cells under stimuli with cigarette smoke extract (CSE) or ovalbumin (OVA) allergen or both were used to verify the clinical findings.\\nWe identified the upregulation of miR-125b-5p in patients with ACO and in THP-1 cells stimulated with CSE plus OVA allergen. We selected 16 genes related to the miR-125b-5p pathway and found that IL6R and TRIAP1 were both downregulated in patients with ACO and in THP-1 cells stimulated with CSE plus OVA. The percentage of late apoptotic cells increased in the THP-1 cell culture model when stimulated with CSE plus OVA, and the effect was reversed by transfection with miR-125b-5p small interfering RNA (siRNA). The percentage of reactive oxygen species-producing cells increased in the NHBE cell culture model when stimulated with CSE plus OVA, and the effect was reversed by transfection with miR-125b-5p siRNA. In NHBE cells, siRNA transfection reversed the upregulation of STAT3 under CSE+OVA stimulation.\\nOur study revealed that upregulation of miR-125b-5p in patients with ACO mediated late apoptosis in THP-1 cells and oxidative stress in NHBE cells via targeting IL6R and TRIAP1. STAT3 expression was also regulated by miR-125b-5p.', 'keywords': ['Asthma-COPD overlap', 'Interleukin 6 receptor', 'TP53-regulated inhibitor of apoptosis 1', 'miR-125b-5p'], 'journal': 'Respiratory research', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Chang', 'firstname': 'Yu-Ping', 'initials': 'YP', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Tsai', 'firstname': 'Yi-Hsuan', 'initials': 'YH', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Chen', 'firstname': 'Yu-Mu', 'initials': 'YM', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Huang', 'firstname': 'Kuo-Tung', 'initials': 'KT', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Lee', 'firstname': 'Chiu-Ping', 'initials': 'CP', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Hsu', 'firstname': 'Po-Yuan', 'initials': 'PY', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Chen', 'firstname': 'Hung-Chen', 'initials': 'HC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.).'}, {'lastname': 'Lin', 'firstname': 'Meng-Chih', 'initials': 'MC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.). mengchih@adm.cgmh.org.tw.\\nDepartment of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.). mengchih@adm.cgmh.org.tw.'}, {'lastname': 'Chen', 'firstname': 'Yung-Che', 'initials': 'YC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.). yungchechen@yahoo.com.tw.\\nDepartment of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung, 83301, Taiwan (R.O.C.). yungchechen@yahoo.com.tw.'}], 'methods': None, 'conclusions': None, 'results': 'We identified the upregulation of miR-125b-5p in patients with ACO and in THP-1 cells stimulated with CSE plus OVA allergen. We selected 16 genes related to the miR-125b-5p pathway and found that IL6R and TRIAP1 were both downregulated in patients with ACO and in THP-1 cells stimulated with CSE plus OVA. The percentage of late apoptotic cells increased in the THP-1 cell culture model when stimulated with CSE plus OVA, and the effect was reversed by transfection with miR-125b-5p small interfering RNA (siRNA). The percentage of reactive oxygen species-producing cells increased in the NHBE cell culture model when stimulated with CSE plus OVA, and the effect was reversed by transfection with miR-125b-5p siRNA. In NHBE cells, siRNA transfection reversed the upregulation of STAT3 under CSE+OVA stimulation.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12931-024-02703-7\\n10.1172/JCI36130\\n10.4049/jimmunol.0803560\\n10.1016/j.jaci.2016.04.038\\n10.1007/s12016-016-8589-9\\n10.3892/ijmm.2013.1251\\n10.1097/MD.0000000000009059\\n10.1164/rccm.201002-0304OC\\n10.1016/j.jaci.2016.01.029\\n10.1164/rccm.201001-0055OC\\n10.1097/MD.0000000000009820\\n10.3390/ijms20030553\\n10.1016/j.jaci.2013.04.039\\n10.1016/j.jaci.2016.02.018\\n10.1164/rccm.201912-2360OC\\n10.1136/thx.54.7.581\\n10.1183/09031936.00102509\\n10.4161/epi.24195\\n10.1161/01.CIR.0000108395.12766.25\\n10.1371/journal.pone.0016509\\n10.1136/thoraxjnl-2011-200089\\n10.1183/13993003.01294-2021\\n10.1038/s41598-017-13888-x\\n10.1152/physiolgenomics.00140.2013\\n10.4049/jimmunol.0900473\\n10.1186/s12931-017-0522-0\\n10.1038/ni.2057\\n10.1016/j.cyto.2021.155690\\n10.1016/j.jaci.2015.09.059\\n10.7717/peerj.1199\\n10.1186/s12931-014-0103-4\\n10.14814/phy2.12878\\n10.4049/jimmunol.1900755\\n10.1248/bpb.b22-00887\\n10.1016/j.cyto.2021.155520\\n10.1038/s41598-021-01950-8\\n10.1016/j.jaci.2018.05.026\\n10.1111/febs.14666\\n10.3892/or.2015.3988\\n10.1007/s10528-020-10009-8\\n10.1242/dmm.001859\\n10.1016/j.resp.2017.09.001\\n10.1002/ijc.2910260208\\n10.1016/j.intimp.2014.08.002\\n10.1155/2013/697972', 'xml': <Element 'PubmedArticle' at 0x109ad8db0>}\n",
      "{'pubmed_id': '38302919\\n20948525\\n24985013\\n29388924\\n29751733\\n26883354\\n17217453\\n8213606\\n8435000\\n24918003\\n1439534\\n16183355\\n33818329\\n31325029\\n21502829\\n7862470\\n34619076\\n33182700\\n34201938\\n28970836\\n31255176\\n30939042\\n34584224\\n32802893\\n32075727\\n28527897\\n28012919\\n30898355\\n32602872\\n32576181\\n25857343\\n29587887\\n26081487\\n26474970\\n27892935\\n28916568\\n25117998\\n30201637\\n23260727\\n27496394\\n27494743\\n33625285\\n17943568\\n31615794\\n26950480\\n32153831\\n33292663\\n32976640\\n22889845\\n30158026\\n29669261\\n23529994\\n19064537\\n23493538\\n15051594\\n25148997\\n21092769\\n8892177\\n26712860\\n29130640\\n26199382\\n28197489\\n30591520\\n28403949\\n37238651\\n35387598\\n21121836\\n27554811\\n16713224', 'title': '40\\xa0years of adding more fructose to high fructose corn syrup than is safe, through the lens of malabsorption and altered gut health-gateways to chronic disease.', 'abstract': 'Labels do not disclose the excess-free-fructose/unpaired-fructose content in foods/beverages. Objective was to estimate excess-free-fructose intake using USDA loss-adjusted-food-availability (LAFA) data (1970-2019) for high fructose corn syrup (HFCS) and apple juice, major sources of excess-free-fructose, for comparison with malabsorption dosages (~\\u20095\\xa0g-children/\\u2009~\\u200910\\xa0g-adults). Unlike sucrose and equimolar fructose/glucose, unpaired-fructose triggers fructose malabsorption and its health consequences. Daily intakes were calculated for HFCS that is generally-recognized-as-safe/ (55% fructose/45% glucose), and variants (65/35, 60/40) with higher fructose-to-glucose ratios (1.9:1, 1.5:1), as measured by independent laboratories. Estimations include consumer-level-loss (CLL) allowances used before (20%), and after, subjective, retroactively-applied increases (34%), as recommended by corn-refiners (~\\u20092012). No contributions from crystalline-fructose or agave syrup were included due to lack of LAFA data. High-excess-free-fructose-fruits (apples/pears/watermelons/mangoes) were not included. Eaten in moderation they are less likely to trigger malabsorption. Another objective was to identify potential parallel trends between excess-free-fructose intake and the \"unexplained\" US asthma epidemic. The fructose/gut-dysbiosis/lung axis is well documented, case-study evidence and epidemiological research link HFCS/apple juice intake with asthma, and unlike gut-dysbiosis/gut-fructosylation, childhood asthma prevalence data spans\\u2009>\\u200940\\xa0years. Results Excess-free-fructose daily intake for individuals consuming HFCS with an average 1.5:1 fructose-to-glucose ratio, ranged from 0.10\\xa0g/d in 1970, to 11.3\\xa0g/d in 1999, to 6.5\\xa0g/d in 2019, and for those consuming HFCS with an average 1.9:1 ratio, intakes ranged from 0.13\\xa0g/d to 16.9\\xa0g/d (1999), to 9.7\\xa0g/d in 2019, based upon estimates with a 20% CLL allowance. Intake exceeded dosages that trigger malabsorption (~\\u20095\\xa0g) around\\u2009~\\u20091980. By the early 1980\\'s, tripled apple juice intake had added\\u2009~\\u20090.5\\xa0g to average-per-capita excess-free-fructose intake. Contributions were higher (~\\u20093.8\\xa0g /4-oz.) for individuals consuming apple juice consistent with a healthy eating pattern (4-oz. children, 8-oz. adults). The \"unexplained\" childhood asthma epidemic (1980-present) parallels increasing average-per-capita HFCS/apple juice intake trends and reflects epidemiological research findings. Conclusion Displacement of sucrose with HFCS, its ubiquitous presence in the US food-supply, the industry practice of adding more fructose to HFCS than generally-recognized-as-safe, and increased use of apple juice/crystalline fructose/agave syrup in foods/beverages has contributed to unprecedented excess-free-fructose intake levels, fructose malabsorption, gut-dysbiosis and\\xa0gut-fructosylation (immunogen burden)-gateways to chronic disease.', 'keywords': ['Apple juice', 'Asthma', 'Dysbiosis', 'Excess-free-fructose', 'Fructose', 'Fructositis', 'Fructosylation', 'Glycation', 'High fructose corn syrup', 'Malabsorption', 'Microbiome'], 'journal': 'Nutrition journal', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'DeChristopher', 'firstname': 'Luanne Robalo', 'initials': 'LR', 'affiliation': ', East Fishkill, USA. luanne.dechristopher@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12937-024-00919-3\\n10.1038/oby.2010.255\\n10.1016/j.nut.2014.04.003\\n10.1172/JCI96702\\n10.1146/annurev-nutr-082117-051707\\n10.1186/s40348-016-0035-9\\n10.1111/j.1365-2036.2006.03186.x\\n10.1093/ajcn/58.5.748S\\n10.1136/adc.68.1.136\\n10.1177/2050640613510905\\n10.3109/00365529209000148\\n10.1016/j.jada.2005.07.002\\n10.1017/S0007114521001215\\n10.1007/s00431-019-03418-4\\n10.1097/MPG.0b013e3181fd1315\\n10.1542/peds.95.3.340\\n10.1016/j.cmet.2021.09.004\\n10.3390/nu12113444\\n10.3390/biomedicines9070728\\n10.3389/fimmu.2017.01159\\n10.1186/s40168-019-0713-7\\n10.1096/fj.201801526RR\\n10.1038/s41430-021-00991-6\\n10.1155/2020/2340670\\n10.1016/j.immuni.2020.01.007\\n10.1016/j.fitote.2016.12.006\\n10.1039/d0fo00450b\\n10.1186/s12937-020-00578-0\\n10.1017/S1368980015000865\\n10.1017/S0007114518000417\\n10.1038/ejcn.2015.101\\n10.1186/s12937-015-0097-x\\n10.1038/nutd.2016.46\\n10.3945/an.117.016154\\n10.1038/ejcn.2014.153\\n10.1370/afm.2292\\n10.1016/j.jand.2012.09.020\\n10.1016/j.ypmed.2016.08.004\\n10.1080/02770900701539509\\n10.1136/bmjopen-2019-029046\\n10.1038/nutd.2016.7\\n10.1186/s40795-017-0168-9\\n10.1186/s40795-020-00396-x\\n10.1111/all.14600\\n10.1016/j.ajpath.2012.06.031\\n10.5483/BMBRep.2018.51.9.197\\n10.1016/j.metabol.2018.04.006\\n10.1080/07315724.2012.10720445\\n10.3945/ajcn.2008.25825C\\n10.3945/an.112.002816\\n10.1093/ajcn/79.4.537\\n10.1016/j.foodchem.2014.06.111\\n10.1016/j.jada.2010.09.002\\n10.1080/07315724.1996.10720475\\n10.1111/ijpo.12246\\n10.1093/aje/kwv050\\n10.2215/CJN.06380518\\n10.1016/j.metabol.2017.02.008\\n10.3390/biom13050780\\n10.1186/s12876-022-02244-7\\n10.1056/NEJMra0910061\\n10.1016/j.jaci.2016.06.054\\n10.1016/j.rmed.2006.03.031', 'xml': <Element 'PubmedArticle' at 0x10a0a63e0>}\n",
      "{'pubmed_id': '38302891\\n32335410\\n33068023\\n33855003\\n33026628\\n34416191\\n33428867\\n35568052\\n25554246\\n25336990\\n15840177\\n34084763\\n35883936\\n34534416\\n35547532\\n35522314\\n35775163\\n36562653\\n36304229\\n35831242\\n35658801\\n33483192\\n33932073\\n17181110\\n8672521\\n26855322\\n27418819\\n32375845\\n32733978\\n33676536\\n9606316\\n16204605\\n33262076\\n32381497\\n32044296\\n32756496\\n32163542\\n32356025\\n32642842\\n34125643\\n32761898', 'title': 'Pulmonary function in children post -SARS-CoV-2 infection: a systematic review and meta-analysis.', 'abstract': 'There are some concerns regarding long-term complications of COVID-19 in children. A systematic review and meta-analysis was performed evaluating the respiratory symptoms and pulmonary function, post-SARS-CoV-2 infection.\\nA systematic search was performed in databases up to 30 March 2023. Studies evaluating respiratory symptoms and pulmonary function after COVID-19 infection in children were selected. The major outcomes were the frequency of respiratory symptoms and the mean of spirometry parameters. A pooled mean with 95% confidence intervals (CIs) was calculated.\\nA total of 8 articles with 386 patients were included in meta-analysis. Dyspnea, cough, exercise intolerance, and fatigue were the most common symptoms. The meta-mean of forced expiratory volume (FEV1) and forced vital capacity (FVC) was 101.72%, 95% CI= (98.72, 104.73) and 101.31%, 95% CI= (95.44, 107.18) respectively. The meta-mean of FEV1/FVC and Forced expiratory flow at 25 and 75% was 96.16%, 95% CI= (90.47, 101.85) and 105.05%, 95% CI= (101.74, 108.36) respectively. The meta-mean of diffusing capacity for carbon monoxide was 105.30%, 95%CI= (88.12, 122.49). There was no significant difference in spirometry parameters before and after bronchodilator inhalation.\\nDespite some clinical respiratory symptoms, meta-results showed no abnormality in pulmonary function in follow-up of children with SARS-CoV-2 infection. Disease severity and asthma background had not confounded this outcome.', 'keywords': ['COVID-19', 'Child', 'Meta-analysis', 'Pulmonary function test', 'Systematic review'], 'journal': 'BMC pediatrics', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Bakhtiari', 'firstname': 'Elham', 'initials': 'E', 'affiliation': 'Clinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.'}, {'lastname': 'Moazzen', 'firstname': 'Nasrin', 'initials': 'N', 'affiliation': 'Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. n.moazzen@gmail.com.\\nDepartment of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. n.moazzen@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': 'A total of 8 articles with 386 patients were included in meta-analysis. Dyspnea, cough, exercise intolerance, and fatigue were the most common symptoms. The meta-mean of forced expiratory volume (FEV1) and forced vital capacity (FVC) was 101.72%, 95% CI= (98.72, 104.73) and 101.31%, 95% CI= (95.44, 107.18) respectively. The meta-mean of FEV1/FVC and Forced expiratory flow at 25 and 75% was 96.16%, 95% CI= (90.47, 101.85) and 105.05%, 95% CI= (101.74, 108.36) respectively. The meta-mean of diffusing capacity for carbon monoxide was 105.30%, 95%CI= (88.12, 122.49). There was no significant difference in spirometry parameters before and after bronchodilator inhalation.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12887-024-04560-1\\n10.1016/j.scitotenv.2020.138882\\n10.1002/lary.29207\\n10.3389/fped.2021.622240\\n10.1007/s12024-020-00310-8\\n10.1016/S2213-2600(21)00286-1\\n10.1016/S0140-6736(20)32656-8\\n10.1186/2046-4053-4-1\\n10.2147/CLEP.S66677\\n10.1186/1471-2288-5-13\\n10.3389/fped.2021.621019\\n10.3390/children9070952\\n10.1002/ppul.25671\\n10.1002/ppul.26291\\n10.1016/j.arcped.2020.12.008\\n10.1111/ijcp.14301\\n10.2500/ajr.2006.20.2914\\n10.1159/000443797\\n10.2147/COPD.S102999\\n10.1186/s12969-021-00509-1\\n10.1164/ajrccm.157.5.rsaa-2\\n10.1183/09031936.05.00034905\\n10.1016/j.pulmoe.2020.10.013\\n10.3390/jcm9082499\\n10.7326/M20-0533\\n10.1007/s00428-020-02829-1\\n10.1007/s00428-020-02886-6\\n10.1002/jmv.26398', 'xml': <Element 'PubmedArticle' at 0x10a06f7e0>}\n",
      "{'pubmed_id': '38302750', 'title': 'Neurological and immunological adverse events after pneumococcal conjugate vaccine in children using national immunization programme registry data.', 'abstract': 'Despite the general consensus on the safety of pneumococcal conjugate vaccine (PCV), safety concerns unveiled during post-licensure surveillance need to be addressed. We investigated whether there is a transient increased risk following a three-dose series of pneumococcal conjugate vaccine (PCV) administered at 2, 4 and 6\\u2009months of age.\\nThis was a population-based cohort study using the Korea immunization registry data linked to nationwide administrative claims data. Self-controlled risk interval analysis was conducted for PCV recipients who had an outcome of interest within pre-defined risk and control intervals between 2018 and 2022. The outcomes were anaphylaxis, asthma, encephalopathy, febrile seizure, Kawasaki disease and thrombocytopenia. We used conditional Poisson regression model to estimate the incidence rate ratios (IRRs) and 95% confidence intervals (CIs) comparing the outcomes in the risk and control intervals.\\nOf 1\\u200a114\\u200a096 PCV recipients, 8661 had outcomes either in the risk or control intervals. Their mean age at Dose 1 was 10.0\\u2009weeks, 58.3% were boys, and 85.3% received 13-valent PCV. PCV was not associated with an increased risk of any outcomes except for febrile seizure. There were 408 (56.0%) cases of febrile seizure in the risk interval, corresponding to an IRR of 1.27 (95% CI 1.10-1.47).\\nIt is reassuring to note that there was no increased risk of the potential safety concerns following PCV administration. Despite the transient increased risk of febrile seizure, absolute numbers of cases were small. Febrile seizure is generally self-limiting with a good prognosis, and should not discourage parents or caregivers from vaccinating their children.', 'keywords': ['Pneumococcal conjugate vaccine', 'immunization', 'pharmacoepidemiology'], 'journal': 'International journal of epidemiology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Kim', 'firstname': 'Ju Hwan', 'initials': 'JH', 'affiliation': 'School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.\\nDepartment of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.'}, {'lastname': 'Yoon', 'firstname': 'Dongwon', 'initials': 'D', 'affiliation': 'School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.\\nDepartment of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.'}, {'lastname': 'Lee', 'firstname': 'Hyesung', 'initials': 'H', 'affiliation': 'School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.\\nDepartment of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.'}, {'lastname': 'Choe', 'firstname': 'Young June', 'initials': 'YJ', 'affiliation': 'Department of Pediatrics, Korea University Anam Hospital, Seoul, South Korea.'}, {'lastname': 'Shin', 'firstname': 'Ju-Young', 'initials': 'JY', 'affiliation': 'School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.\\nDepartment of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.\\nDepartment of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea.'}], 'methods': None, 'conclusions': None, 'results': 'Of 1\\u200a114\\u200a096 PCV recipients, 8661 had outcomes either in the risk or control intervals. Their mean age at Dose 1 was 10.0\\u2009weeks, 58.3% were boys, and 85.3% received 13-valent PCV. PCV was not associated with an increased risk of any outcomes except for febrile seizure. There were 408 (56.0%) cases of febrile seizure in the risk interval, corresponding to an IRR of 1.27 (95% CI 1.10-1.47).', 'copyrights': '© The Author(s) 2024; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.', 'doi': '10.1093/ije/dyae010', 'xml': <Element 'PubmedArticle' at 0x10af004f0>}\n",
      "{'pubmed_id': '38302598\\n28127589\\n7550361\\n26067058\\n31917687\\n29273951\\n24746617\\n30231870\\n30479742\\n32222896\\n25673868\\n33754353\\n10421793\\n11342184\\n30791439\\n23333767\\n21813779\\n30528326\\n17532700\\n23396211\\n28683283\\n31697998\\n31821710\\n25997745\\n30823934\\n25025494\\n29048430\\n24607701\\n30337243\\n32087283\\n33307172\\n33181270\\n30258234\\n15554430\\n15285801\\n11124893\\n21185368\\n23578284\\n16310865\\n33628362\\n33370582\\n21464307\\n27208432\\n12631585\\n20457564\\n15489227\\n26338477\\n27123832\\n33458708', 'title': 'Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF-κB and STAT3 signaling pathways.', 'abstract': 'Amlexanox is an anti-inflammatory and anti-allergic agent used clinically for the treatment of aphthous ulcers, allergic rhinitis, and asthma. Recent studies have demonstrated that amlexanox, a selective inhibitor of IkB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1), suppresses a range of diseases or inflammatory conditions, such as obesity-related metabolic dysfunction and type 2 diabetes. However, the effects of amlexanox on neuroinflammatory responses to amlexanox have not yet been comprehensively studied. In this study, we investigated the novel therapeutic effect of amlexanox on LPS-induced neuroinflammation in vivo, and intraperitoneal injection of amlexanox markedly reduced LPS-induced IKKε levels, proinflammatory cytokines, and microglial activation, as evidenced by ionized calcium-binding adapter molecule 1 (Iba1) immunostaining. Furthermore, amlexanox significantly reduced proinflammatory cytokines and chemokines in LPS-induced bone marrow-derived macrophages (BMDM), murine BV2, and human HMC3 microglial cells. This data provided considerable evidence that amlexanox can be used as a preventive and curative therapy for neuroinflammatory and neurodegenerative diseases. In terms of mechanism aspects, our results demonstrated that the anti-inflammatory action of amlexanox in BV2 microglial cells was through the downregulation of NF-κB and STAT3 signaling pathways. In addition, the combination of amlexanox and SPI (a STAT3 selective inhibitor) showed high efficiency in inhibiting the production of neurotoxic and pro-inflammatory mediators. Overall, our data provide rational insights into the mechanisms of amlexanox as a potential therapeutic strategy for neuroinflammation-related diseases.', 'keywords': [], 'journal': 'Scientific reports', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Phan Van', 'firstname': 'Thach', 'initials': 'T', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea.\\nDepartment of Biotechnology, NTT Hi-tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Viet Nam.'}, {'lastname': 'Huyen Ton Nu Bao', 'firstname': 'Tien', 'initials': 'T', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea.'}, {'lastname': 'Leya', 'firstname': 'Mwense', 'initials': 'M', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea.'}, {'lastname': 'Zhou', 'firstname': 'Zixiong', 'initials': 'Z', 'affiliation': 'Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.'}, {'lastname': 'Jeong', 'firstname': 'Hyuneui', 'initials': 'H', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea.'}, {'lastname': 'Lim', 'firstname': 'Chae-Woong', 'initials': 'CW', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Bumseok', 'initials': 'B', 'affiliation': 'Biosafety Research Institute and Laboratory of Pathology, College of Veterinary Medicine, Jeonbuk National University, 79, Gobong-ro, Iksan, 54596, Republic of Korea. bskims@jbnu.ac.kr.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s41598-024-53235-5\\n10.1016/0165-0173(94)00015-H\\n10.1016/j.pneurobio.2015.05.003\\n10.1172/JCI133737\\n10.1007/s00702-017-1831-7\\n10.1016/j.freeradbiomed.2014.04.014\\n10.1186/s12974-018-1308-0\\n10.1186/s13578-018-0258-7\\n10.1007/s12031-020-01531-w\\n10.1523/JNEUROSCI.3516-14.2015\\n10.1002/jcp.30373\\n10.1093/intimm/11.8.1357\\n10.1016/S0304-419X(00)00024-X\\n10.3390/cells8020178\\n10.1016/j.bcp.2013.01.007\\n10.4049/jimmunol.1004088\\n10.1016/j.neuropharm.2018.12.004\\n10.2165/00044011-200525090-00001\\n10.1038/nm.3082\\n10.1016/j.cmet.2017.06.006\\n10.1016/j.taap.2019.114767\\n10.1111/jcmm.14817\\n10.1186/s12974-015-0319-3\\n10.1186/s12974-019-1438-z\\n10.1371/journal.pone.0102003\\n10.1038/cddis.2017.396\\n10.1016/j.neuint.2014.02.008\\n10.1016/j.brs.2018.10.005\\n10.1016/j.nbd.2020.104814\\n10.1016/j.bbi.2020.12.002\\n10.1016/j.bbi.2020.11.008\\n10.1038/s41593-018-0242-x\\n10.1023/B:MEBR.0000043984.73063.d8\\n10.1186/1742-2094-1-14\\n10.1006/mcne.2000.0914\\n10.1016/j.freeradbiomed.2010.12.026\\n10.1111/jnc.12263\\n10.1016/j.tips.2005.11.002\\n10.1155/2021/6429197\\n10.1016/j.cellsig.2020.109900\\n10.1073/pnas.1016132108\\n10.1016/j.intimp.2016.05.007\\n10.1096/fj.02-0314fje\\n10.1016/j.jff.2017.09.017\\n10.1101/cshperspect.a001651\\n10.1074/jbc.M409825200\\n10.1038/srep13575\\n10.1016/j.leukres.2016.04.012\\n10.1016/j.xpro.2020.100246', 'xml': <Element 'PubmedArticle' at 0x10af20400>}\n",
      "{'pubmed_id': '38302275\\n24828273\\n35107034\\n31165051\\n15492373\\n15772371\\n33788673\\n33923202\\n24145828\\n12887704\\n25586998\\n15349033\\n14620527', 'title': 'Comparison of permeable cell culture inserts for use in culture of a human in\\xa0vitro air-liquid interface model system.', 'abstract': 'In this study, we compared 12\\u2009mm cell culture inserts with permeable polyester membranes (0.4\\u2009μm pores) from two different manufacturers: CELLTREAT® and Corning®. Physical dimensions and masses of the inserts were found to be very similar between the two brands, with CELLTREAT® inserts having a slightly smaller diameter and growth area (11.91\\u2009mm; 1.11\\u2009cm', 'keywords': ['air-liquid interface', 'airway epithelial cells', 'permeable inserts', 'primary cell culture'], 'journal': 'Physiological reports', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Brocke', 'firstname': 'Stephanie A', 'initials': 'SA', 'affiliation': 'Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.'}, {'lastname': 'Speen', 'firstname': 'Adam M', 'initials': 'AM', 'affiliation': 'Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, North Carolina, USA.'}, {'lastname': 'Masood', 'firstname': 'Syed', 'initials': 'S', 'affiliation': 'Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.'}, {'lastname': 'Worden', 'firstname': 'Cameron P', 'initials': 'CP', 'affiliation': 'Department of Otolaryngology, Head and Neck Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.'}, {'lastname': 'Jaspers', 'firstname': 'Ilona', 'initials': 'I', 'affiliation': 'Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.\\nCenter for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, North Carolina, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.', 'doi': '10.14814/phy2.15921\\n10.3791/50646', 'xml': <Element 'PubmedArticle' at 0x10af06520>}\n",
      "{'pubmed_id': '38301983', 'title': 'Withanolides from the active extract of Physalis angulate and their anti-hepatic fibrosis effects.', 'abstract': 'Physalis angulata L., a traditional Chinese medicine called \"Kuzhi\" in China, was used traditionally to treat liver diseases (eg. icterus, hepatitis) as well as malaria, asthma, and rheumatism.\\nOur study aimed to investigate the withanolides with anti-hepatic fibrosis effect from P. angulate.\\nWithanolides were obtained from the EtOH extract of P. angulate by bioassay-molecular networking analysis-guided isolation using column chromatography and normal/reversed-phase semipreparative HPLC. The structures of new withanolides were elucidated by combinations of spectroscopic techniques with NMR and ECD calculations. MTT cell viability assay, AO/EB staining method, cell wound healing assay, ELISA and Western blot experiments were employed to evaluate the anti-hepatic fibrosis activity and to uncover related mechanism. Molecular docking analysis and cellular thermal shift assay were used to evaluate and verify the interaction between the active withanolides and their potential targets.\\nEight unreported withanolides, withagulides A-H (1-8), along with twenty-eight known ones were obtained from P. angulate. Withanolides 6, 9, 10, 24, 27, and 29-32 showed marked anti-hepatic fibrosis effect with COL1A1 expression inhibition above 50 %. Physalin F (9), the main component in the active fraction, significantly decreased the TGF β1-stimulated expressions of collagen I and α-SMA in LX-2\\xa0cells. Mechanism study revealed that physalin F exerted its anti-hepatic fibrosis effect via the PI3K/AKT/mTOR signaling pathway.\\nThis study suggested that withanolides were an important class of natural products with marked anti-hepatic fibrosis effect. The main withanolide physalin F might be a promising candidate for hepatic fibrosis treatment. The work provided experimental foundation for the use of P. angulate to treat hepatic fibrosis.', 'keywords': ['Hepatic fibrosis', 'Hepatic stellate cell', 'PI3K/AKT/mTOR signaling pathway', 'Physalis angulate', 'Withanolides'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Wang', 'firstname': 'Fu-Rui', 'initials': 'FR', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; University Engineering Research Center for the Prevention and Treatment of Chronic Diseases by Authentic Medicinal Materials in Guizhou Province, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China.'}, {'lastname': 'Peng', 'firstname': 'Mei-Lin', 'initials': 'ML', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China.'}, {'lastname': 'Zhu', 'firstname': 'Qin-Feng', 'initials': 'QF', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China.'}, {'lastname': 'Yu', 'firstname': 'Ling-Ling', 'initials': 'LL', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Li-Jie', 'initials': 'LJ', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China.'}, {'lastname': 'Xu', 'firstname': 'Shi-Ying', 'initials': 'SY', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China.'}, {'lastname': 'Wang', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China.'}, {'lastname': 'Li', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China.'}, {'lastname': 'He', 'firstname': 'Xun', 'initials': 'X', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China.'}, {'lastname': 'Liao', 'firstname': 'Shang-Gao', 'initials': 'SG', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; University Engineering Research Center for the Prevention and Treatment of Chronic Diseases by Authentic Medicinal Materials in Guizhou Province, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China. Electronic address: lshangg@163.com.'}, {'lastname': 'Ao', 'firstname': 'Jun-Li', 'initials': 'JL', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China. Electronic address: aojl90@163.com.'}, {'lastname': 'Xu', 'firstname': 'Guo-Bo', 'initials': 'GB', 'affiliation': 'State Key Laboratory of Functions and Applications of Medicinal Plants & School of Pharmacy, Guizhou Medical University, Gui-an New District, 550025, Guizhou, China; University Engineering Research Center for the Prevention and Treatment of Chronic Diseases by Authentic Medicinal Materials in Guizhou Province, Gui-an New District, 550025, Guizhou, China; Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guiyang, 550004, Guizhou, China. Electronic address: xguobo@163.com.'}], 'methods': None, 'conclusions': 'This study suggested that withanolides were an important class of natural products with marked anti-hepatic fibrosis effect. The main withanolide physalin F might be a promising candidate for hepatic fibrosis treatment. The work provided experimental foundation for the use of P. angulate to treat hepatic fibrosis.', 'results': 'Eight unreported withanolides, withagulides A-H (1-8), along with twenty-eight known ones were obtained from P. angulate. Withanolides 6, 9, 10, 24, 27, and 29-32 showed marked anti-hepatic fibrosis effect with COL1A1 expression inhibition above 50 %. Physalin F (9), the main component in the active fraction, significantly decreased the TGF β1-stimulated expressions of collagen I and α-SMA in LX-2\\xa0cells. Mechanism study revealed that physalin F exerted its anti-hepatic fibrosis effect via the PI3K/AKT/mTOR signaling pathway.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jep.2024.117830', 'xml': <Element 'PubmedArticle' at 0x10afa9120>}\n",
      "{'pubmed_id': '38301981', 'title': 'Fraxini cortex: Progresses in phytochemistry, pharmacology and ethnomedicinal uses.', 'abstract': 'Fraxini cortex, which has been widely used as a traditional Chinese medicine for 2000 years, is made from the dried bark of four plant species: Fraxinus chinensis subsp. rhynchophylla (Hance) A.E.Murray, Fraxinus chinensis Roxb., Fraxinus chinensis subsp. chinensis and Fraxinus stylosa Lingelsh.. In Chinese traditional medicine, it possesses the properties of heat-clearing and dampness-drying, asthma relief and cough suppression, as well as vision improvement. It is utilized for treating bacterial disorders, enteritis, leukorrhea, chronic bronitis, painful red eyes with swelling, lacrimation due to windward exposure, psoriasis, and other diseases or related symptoms.\\nFraxini cortex is abundant in chemical constituents and has garnered significant attention from plant chemists, particularly regarding coumarins, as evidenced by the recently identified three coumarin compounds. Considering the current dearth of systematic reporting on studies pertaining to Fraxini cortex, herein we provide a comprehensive summary of the advancements in phytochemistry, pharmacology, detection methods, and ethnomedicinal applications of Fraxini cortex.\\nWe conducted a comprehensive search across online data sources (Web of Science, Public Medicine (PubMed), China National Knowledge Infrastructure (CNKI), as well as Chinese dissertations) and traditional Chinese medicine classics to gather the necessary literature resources for this review.\\nBriefly, The Fraxini cortex yielded a total of 132 phytochemicals, including coumarins, lignans, secoiridoids, phenylethanol glycosides, flavonoids, triterpenoids, and other compounds. Among them, the main active ingredients are coumarins which possess a diverse range of pharmacological activities such as anti-inflammatory effects, anti-tumor properties, prevention of tissue fibrosis and oxidation damage as well as cardioprotective effects.\\nAll types of research conducted on Fraxini cortex, particularly in the field of ethnopharmacology, phytochemistry, and pharmacology, have been thoroughly reviewed. However, certain traditional applications and pharmacological activities of Fraxini cortex lack scientific evaluation or convincing evidence due to incomplete methodologies and ambiguous results, as well as a lack of clinical data. To validate its pharmacological activity, clinical efficacy, and safety profile, a systematic and comprehensive research evaluation is imperative. As an important traditional Chinese medicine, Fraxini cortex should be further explored to facilitate the development of novel drugs and therapeutics for various diseases. Greater attention should be given to how it can be better utilized.', 'keywords': ['Detection methods', 'Ethnomedicinal uses', 'Fraxini cortex', 'Pharmacology', 'Phytochemistry', 'Review'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Zheng', 'firstname': 'Zuoliang', 'initials': 'Z', 'affiliation': 'School of Life Science, Jiaying University, Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountainous Areas, China. Electronic address: 1597885331@qq.com.'}, {'lastname': 'Sun', 'firstname': 'Chaoyue', 'initials': 'C', 'affiliation': \"College of Biological and Pharmaceutical Engineering, West Anhui University, Lu'an, China. Electronic address: 936316352@qq.com.\"}, {'lastname': 'Zhong', 'firstname': 'Yuping', 'initials': 'Y', 'affiliation': 'School of Life Science, Jiaying University, Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountainous Areas, China. Electronic address: 474724891@qq.com.'}, {'lastname': 'Shi', 'firstname': 'Yufei', 'initials': 'Y', 'affiliation': 'School of Life Science, Jiaying University, Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountainous Areas, China. Electronic address: 95831270@qq.com.'}, {'lastname': 'Zhuang', 'firstname': 'Likai', 'initials': 'L', 'affiliation': 'School of Life Science, Jiaying University, Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountainous Areas, China. Electronic address: 2630587537@qq.com.'}, {'lastname': 'Liu', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: doctliu@263.net.'}, {'lastname': 'Liu', 'firstname': 'Zhiwei', 'initials': 'Z', 'affiliation': 'School of Life Science, Jiaying University, Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountainous Areas, China. Electronic address: zhiweiliu@jyu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': 'Briefly, The Fraxini cortex yielded a total of 132 phytochemicals, including coumarins, lignans, secoiridoids, phenylethanol glycosides, flavonoids, triterpenoids, and other compounds. Among them, the main active ingredients are coumarins which possess a diverse range of pharmacological activities such as anti-inflammatory effects, anti-tumor properties, prevention of tissue fibrosis and oxidation damage as well as cardioprotective effects.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jep.2024.117849', 'xml': <Element 'PubmedArticle' at 0x10b1d0fe0>}\n",
      "{'pubmed_id': '38301946', 'title': 'Flavonoids and phenols from the stems of Ephedra equisetina.', 'abstract': 'Twelve undescribed compounds, including five flavonoids and seven phenols, were isolated from the stems of Ephedra equisetina Bunge. Their structures were elucidated by spectroscopic methods, including NMR spectroscopy and HRESIMS analysis. Their absolute configurations were elucidated by comparing their experimental and calculated ECD spectra. In the in vitro bioactive assay, all compounds were tested for their anti-asthmatic activities by releasing β-Hex in C48/80-induced RBL-2H3 cells. The β-Hex release rates of compounds 3, 8, 10, and 11 were 0.8502\\xa0±\\xa00.0231, 0.8802\\xa0±\\xa00.0805, 0.7850\\xa0±\\xa00.0593, and 0.8361\\xa0±\\xa00.0728, respectively, suggesting that compounds 3, 8, 10, and 11 have potential anti-asthmatic activities.', 'keywords': ['Anti-asthma activities', 'Ephedra equisetina bunge', 'Ephedraceae', 'Flavonoids', 'Phenols'], 'journal': 'Phytochemistry', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Tao', 'firstname': 'Siqi', 'initials': 'S', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China.'}, {'lastname': 'Zhang', 'firstname': 'Jingke', 'initials': 'J', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China.'}, {'lastname': 'Zhu', 'firstname': 'Denghui', 'initials': 'D', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China.'}, {'lastname': 'Wu', 'firstname': 'Yuanyuan', 'initials': 'Y', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China.'}, {'lastname': 'Zheng', 'firstname': 'Xiaoke', 'initials': 'X', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China; Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of PR China, China.'}, {'lastname': 'Feng', 'firstname': 'Weisheng', 'initials': 'W', 'affiliation': 'School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China; The Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou, 450046, China; Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of PR China, China. Electronic address: fwsh@hactcm.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.phytochem.2024.114003', 'xml': <Element 'PubmedArticle' at 0x10b1d3d80>}\n",
      "{'pubmed_id': '38301756', 'title': 'Residential surrounding greenness and the incidence of childhood asthma: Findings from a population-based cohort in Ontario, Canada.', 'abstract': 'Several epidemiological studies have investigated the possible role that living in areas with greater amounts of greenspace has on the incidence of childhood asthma. These findings have been inconsistent, and few studies explored the relevance of timing of exposure. We investigated the role of residential surrounding greenness on the risk of incident asthma using a population-based retrospective cohort study. We included 982,131 singleton births in Ontario, Canada between 2006 and 2013. Two measures of greenness, the Normalized Difference Vegetation Index (NDVI) and the Green View Index (GVI), were assigned to the residential histories of these infants from pregnancy through to 12 years of age. Longitudinally-based diagnoses of asthma were determined by using provincial administrative health data. The extended Cox hazards model was used to characterize associations between greenness measures and asthma (up to age 12 years) while adjusting for several risk factors. In a fully adjusted model, that included a term for traffic-related air pollution (NO', 'keywords': ['Asthma', 'Birth cohort', 'Greenness', 'Population-based study'], 'journal': 'Environmental research', 'publication_date': datetime.date(2024, 2, 2), 'authors': [{'lastname': 'Mansouri', 'firstname': 'Razieh', 'initials': 'R', 'affiliation': 'Department of Health Sciences, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada. Electronic address: RaziehMansouri@cmail.carleton.ca.'}, {'lastname': 'Lavigne', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Air Health Science Division, Health Canada, 960 Carling Avenue, Ottawa, Ontario, Canada. Electronic address: eric.lavigne@hc-sc.gc.ca.'}, {'lastname': 'Talarico', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Institute for Clinical Evaluative Sciences, 1053 Carling Avenue, Ottawa, Ontario, Canada. Electronic address: robert.talarico@ices.on.ca.'}, {'lastname': 'Smargiassi', 'firstname': 'Audrey', 'initials': 'A', 'affiliation': \"Center for Public Health Research (CReSP), University of Montreal and CIUSSS Du Centre-Sud-de-l'Île-de-Montréal, 7101 Av Du Parc, Montreal, Quebec, Canada. Electronic address: audrey.smargiassi@umontreal.ca.\"}, {'lastname': 'Rodriguez-Villamizar', 'firstname': 'Laura A', 'initials': 'LA', 'affiliation': 'Department of Public Health, Universidad Industrial de Santander, Carrera 32 29-31, Bucaramanga, Colombia; Department of Neuroscience, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada. Electronic address: LauraRodriguezVillam@cunet.carleton.ca.'}, {'lastname': 'Villeneuve', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'Department of Neuroscience, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada. Electronic address: Paul.Villeneuve@carleton.ca.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Crown Copyright © 2024. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.envres.2024.118316', 'xml': <Element 'PubmedArticle' at 0x10b11e6b0>}\n",
      "{'pubmed_id': '38301206', 'title': 'Telemedicine Use Among Adults with Asthma in the United States, 2021-2022.', 'abstract': '', 'keywords': ['National Health Interview Survey', 'asthma', 'telecare', 'telehealth', 'telemedicine'], 'journal': 'Telemedicine journal and e-health : the official journal of the American Telemedicine Association', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Hung', 'firstname': 'Chun-Tse', 'initials': 'CT', 'affiliation': 'School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.'}, {'lastname': 'Hung', 'firstname': 'Yu-Chien', 'initials': 'YC', 'affiliation': 'School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1089/tmj.2023.0631', 'xml': <Element 'PubmedArticle' at 0x10b150f90>}\n",
      "{'pubmed_id': '38300150', 'title': 'Novel Role of GSDMB/IFNG Axis in Childhood Asthma.', 'abstract': None, 'keywords': ['asthma', 'gene expression', 'interferons', 'rhinovirus', 'wheezing'], 'journal': 'American journal of respiratory and critical care medicine', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Bosco', 'firstname': 'Anthony', 'initials': 'A', 'affiliation': 'University of Arizona Medical Center - University Campus, 22165, Tucson, Arizona, United States; abosco@arizona.edu.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1164/rccm.202312-2259ED', 'xml': <Element 'PubmedArticle' at 0x10b152d90>}\n",
      "{'pubmed_id': '38300119', 'title': 'Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients With Type 2 Asthma.', 'abstract': None, 'keywords': [], 'journal': 'Annals of the American Thoracic Society', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Papi', 'firstname': 'Alberto', 'initials': 'A', 'affiliation': 'University of Ferrara, Research Centre on Asthma and COPD, Ferrara, Italy; ppa@unife.it.'}, {'lastname': 'Castro', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Washington University School of Medicine, Pulmonary/Critical Care Medicine, St Louis, Missouri, United States.'}, {'lastname': 'Busse', 'firstname': 'William W', 'initials': 'WW', 'affiliation': 'University of Wisconsin Medical School, Madison, Wisconsin, United States.'}, {'lastname': 'Langton', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Peninsula Health, 5644, Thoracic Medicine, Frankston, Victoria, Australia.\\nMonash University Faculty of Medicine Nursing and Health Sciences, 22457, Clayton, Victoria, Australia.'}, {'lastname': 'Korn', 'firstname': 'Stephanie', 'initials': 'S', 'affiliation': 'Thoraxklinik am Universitätsklinikum Heidelberg, 14996, Pneumology, Heidelberg, Baden-Württemberg, Germany.'}, {'lastname': 'Xia', 'firstname': 'Changming', 'initials': 'C', 'affiliation': 'Regeneron Pharmaceuticals Inc, 7845, Tarrytown, New York, United States.'}, {'lastname': 'Soler', 'firstname': 'Xavier', 'initials': 'X', 'affiliation': 'Regeneron Pharmaceuticals Inc, 7845, Tarrytown, New York, United States.'}, {'lastname': 'Pandit-Abid', 'firstname': 'Nami', 'initials': 'N', 'affiliation': 'Sanofi, Bridgewater, New Jersey, United States.'}, {'lastname': 'Radwan', 'firstname': 'Amr', 'initials': 'A', 'affiliation': 'Regeneron Pharmaceuticals Inc, 7845, Tarrytown, New York, United States.'}, {'lastname': 'Jacob-Nara', 'firstname': 'Juby A', 'initials': 'JA', 'affiliation': 'Sanofi, Bridgewater, New Jersey, United States.'}, {'lastname': 'Rowe', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'Sanofi, Bridgewater, New Jersey, United States.'}, {'lastname': 'Deniz', 'firstname': 'Yamo', 'initials': 'Y', 'affiliation': 'Regeneron Pharmaceuticals Inc, 7845, Tarrytown, New York, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1513/AnnalsATS.202306-544RL', 'xml': <Element 'PubmedArticle' at 0x10b1884f0>}\n",
      "{'pubmed_id': '38299973', 'title': 'All shook up: how the COVID-19 pandemic rocked pediatric asthma care.', 'abstract': 'Asthma management is a crucial aspect of public health. The landscape of asthma management underwent significant change in the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. These changes greatly affected existing patients, individuals suffering with undiagnosed illness, providers, and the healthcare system as a whole.\\nProviders had to navigate through the potential risk of exposure while weighing the benefit of office visits for patients. This promoted the rapid uptake of telemedicine and virtual outreach, as well as modifications to acute management and controller therapies. Telehealth allowed for the remote monitoring of these patient populations, increased compliance with home-based self-management, and an emphasis on patient education. Furthermore, the pandemic underscored the importance of proactive asthma management as many individuals were left untreated or undiagnosed for various reasons. It is evident that the SARS-CoV-2 pandemic reshaped the landscape of various components of the healthcare system, including asthma management, necessitating innovative approaches to monitoring and patient education.\\nUnderstanding the lessons learned from this time period is crucial for enhancing the resilience of our health system in the wake of future challenges that may be posed against our system.', 'keywords': [], 'journal': 'Current opinion in pediatrics', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Kaplan', 'firstname': 'Carl', 'initials': 'C', 'affiliation': 'Department of Pediatrics.'}, {'lastname': 'Christophides', 'firstname': 'Alexa H', 'initials': 'AH', 'affiliation': \"Department of Anesthesiology, Stony Brook Children's Hospital, Stony Brook, New York.\"}, {'lastname': 'Kranidis', 'firstname': 'Alexandra M', 'initials': 'AM', 'affiliation': 'American Lung Association, Chicago, Illinois.'}, {'lastname': 'Saint-Fleur', 'firstname': 'Ashley L', 'initials': 'AL', 'affiliation': \"Division of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.\"}, {'lastname': 'Kier', 'firstname': 'Catherine', 'initials': 'C', 'affiliation': 'Department of Pediatrics.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/MOP.0000000000001330', 'xml': <Element 'PubmedArticle' at 0x10b18b0b0>}\n",
      "{'pubmed_id': '38299937', 'title': 'Evaluating the implementation of a community health worker-delivered intervention integrating asthma care in West Philadelphia public schools.', 'abstract': 'Schools are an important setting because students spend much of their time in school and engage in physical activity during the school day that could exacerbate asthma symptoms. Our objective is to understand the barriers and facilitators to implementing an experimental community health worker-delivered care coordination program for students with asthma within the context of the West Philadelphia Controls Asthma study.\\nSurveys (\\nParticipant responses indicate that they perceived benefits for schools and students related to the community health worker-based care coordination program. Several barriers and facilitators to implementing the program were noted, including challenges associated with incorporating the program into school nurse workflow, environmental triggers in the school environment, and challenges communicating with family members. An important facilitator that was identified was having supportive school administrators and staff who were engaged and saw the benefits of the program.\\nThis work can inform implementation planning for other locales interested in implementing community-based pediatric asthma control programs delivered by community health workers in schools.', 'keywords': ['Asthma', 'community health worker', 'implementation', 'pediatric', 'school'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Clark', 'firstname': 'Kayla', 'initials': 'K', 'affiliation': 'Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.'}, {'lastname': 'Messineo', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.'}, {'lastname': 'Bryant-Stephens', 'firstname': 'Tyra', 'initials': 'T', 'affiliation': \"Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.\"}, {'lastname': 'Song', 'firstname': 'Angela', 'initials': 'A', 'affiliation': 'Department of Psychiatry, Kaiser Permanente, San Jose, CA, USA.'}, {'lastname': 'Marx', 'firstname': 'Darby', 'initials': 'D', 'affiliation': 'Joan & Sanford I. Weill Medical College of Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Lieberman', 'firstname': 'Adina', 'initials': 'A', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.'}, {'lastname': 'Beidas', 'firstname': 'Rinad S', 'initials': 'RS', 'affiliation': 'Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.'}, {'lastname': 'Wolk', 'firstname': 'Courtney Benjamin', 'initials': 'CB', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.'}], 'methods': None, 'conclusions': None, 'results': 'Participant responses indicate that they perceived benefits for schools and students related to the community health worker-based care coordination program. Several barriers and facilitators to implementing the program were noted, including challenges associated with incorporating the program into school nurse workflow, environmental triggers in the school environment, and challenges communicating with family members. An important facilitator that was identified was having supportive school administrators and staff who were engaged and saw the benefits of the program.', 'copyrights': None, 'doi': '10.1080/02770903.2024.2313146', 'xml': <Element 'PubmedArticle' at 0x10b1c0a90>}\n",
      "{'pubmed_id': '38299780\\n33407306\\n30956922\\n27798659\\n25705944\\n12137647\\n34559419\\n35993916\\n33282216\\n36130789\\n30286761\\n35493388\\n31233424\\n24979285\\n33214560\\n29185826\\n30304614\\n21829475\\n21331214\\n34025463\\n28433238\\n34168438\\n31151409\\n24127811\\n27132269\\n26899632\\n34737852\\n34408411\\n34328399\\n35046649', 'title': 'Exploring the perceptions of patients with chronic respiratory diseases and their insights into pulmonary rehabilitation in Bangladesh.', 'abstract': \"Chronic respiratory diseases (CRDs) require holistic management which considers patients' preferences, appropriate pharmacotherapy, pulmonary rehabilitation, and integrated care. We aimed to understand the perceptions of people with CRDs about their condition and pulmonary rehabilitation in Bangladesh.\\nWe conducted semi-structured interviews with a maximum variation sample of people with CRDs who had participated in a feasibility study of pulmonary rehabilitation in 2021/2022. A multidisciplinary team transcribed the interviews verbatim and analysed them in Bengali using a grounded theory approach.\\nWe interviewed 15 participants with chronic obstructive pulmonary disease, asthma, or post-tuberculosis. The analysis revealed three themes. The first encompassed understanding CRDs: Patients characterised their condition by the symptoms (e.g. 'Hapani' meaning 'breathlessness') rather than describing a disease entity. Some believed occupation, previous infection, or family history to be a cause. The second theme included perceptions of pulmonary rehabilitation: Exercise was counterintuitive, as it exacerbated the breathlessness symptom that defined their disease. Views varied, though many acknowledged the benefits after a few sessions. Even with home-based programmes, participants described practical barriers to finding time for the sessions and adopted strategies to overcome the challenges. The third theme focused on implementation: Participants highlighted the need for raising awareness of CRDs and the potential of pulmonary rehabilitation in the community, adapting to the local context, and establishing an accessible resourced service.\\nUnderstanding how patients and their communities perceive their condition and the barriers (both conceptual and logistical) to acceptance is the first step to embedding this highly effective intervention into routine health care services in Bangladesh with potential benefits for the increasing number of people living with CRDs in low- and middle-income countries.\", 'keywords': [], 'journal': 'Journal of global health', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Habib', 'firstname': 'G M Monsur', 'initials': 'GMM', 'affiliation': 'Community Respiratory Centre, Khulna, Bangladesh Primary Care Respiratory Society (BPCRS), Bangladesh.\\nNIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, University of Edinburgh, Edinburgh, UK.'}, {'lastname': 'Uzzaman', 'firstname': 'Nazim', 'initials': 'N', 'affiliation': 'Community Respiratory Centre, Khulna, Bangladesh Primary Care Respiratory Society (BPCRS), Bangladesh.\\nNIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, University of Edinburgh, Edinburgh, UK.'}, {'lastname': 'Rabinovich', 'firstname': 'Roberto', 'initials': 'R', 'affiliation': \"ELEGI/Colt laboratory, Centre for Inflammation Research, Queen's Medical Research Institute (QMRI), University of Edinburgh, Edinburgh, UK.\"}, {'lastname': 'Akhter', 'firstname': 'Sumaiya', 'initials': 'S', 'affiliation': 'Community Respiratory Centre, Khulna, Bangladesh Primary Care Respiratory Society (BPCRS), Bangladesh.'}, {'lastname': 'Ali', 'firstname': 'Mohsin', 'initials': 'M', 'affiliation': 'Community Respiratory Centre, Khulna, Bangladesh Primary Care Respiratory Society (BPCRS), Bangladesh.'}, {'lastname': 'Sultana', 'firstname': 'Mustarin', 'initials': 'M', 'affiliation': 'Community Respiratory Centre, Khulna, Bangladesh Primary Care Respiratory Society (BPCRS), Bangladesh.'}, {'lastname': 'Pinnock', 'firstname': 'Hilary', 'initials': 'H', 'affiliation': 'NIHR Global Health Research Unit on Respiratory Health (RESPIRE), Usher Institute, University of Edinburgh, Edinburgh, UK.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': \"We interviewed 15 participants with chronic obstructive pulmonary disease, asthma, or post-tuberculosis. The analysis revealed three themes. The first encompassed understanding CRDs: Patients characterised their condition by the symptoms (e.g. 'Hapani' meaning 'breathlessness') rather than describing a disease entity. Some believed occupation, previous infection, or family history to be a cause. The second theme included perceptions of pulmonary rehabilitation: Exercise was counterintuitive, as it exacerbated the breathlessness symptom that defined their disease. Views varied, though many acknowledged the benefits after a few sessions. Even with home-based programmes, participants described practical barriers to finding time for the sessions and adopted strategies to overcome the challenges. The third theme focused on implementation: Participants highlighted the need for raising awareness of CRDs and the potential of pulmonary rehabilitation in the community, adapting to the local context, and establishing an accessible resourced service.\", 'copyrights': 'Copyright © 2024 by the Journal of Global Health. All rights reserved.', 'doi': '10.7189/jogh.14.04036\\n10.1186/s12889-020-10042-7\\n10.7759/cureus.3970\\n10.5455/jabet.2021.d130\\n10.1371/journal.pone.0165396\\n10.25259/JPATS_10_2022\\n10.1002/14651858.CD003793.pub3\\n10.7189/jogh.10.020384\\n10.1183/16000617.0076-2022\\n10.1186/s12913-018-3545-4\\n10.3389/fpubh.2022.812700\\n10.1097/HMR.0000000000000254\\n10.1097/ACM.0000000000000388\\n10.1038/s41533-020-00210-y\\n10.1080/13814788.2017.1375090\\n10.1177/1468794112468475\\n10.3233/EFI-2004-22201\\n10.1371/journal.pone.0022670\\n10.7812/TPP/07-144\\n10.3389/fpsyt.2021.537309\\n10.1016/j.jphys.2017.02.002\\n10.2147/COPD.S305145\\n10.1186/s12889-019-7045-1\\n10.1164/rccm.201309-1634ST\\n10.1183/13993003.02151-2015\\n10.1016/j.pec.2016.01.020\\n10.7189/jogh.11.02003\\n10.2147/COPD.S314849\\n10.1513/AnnalsATS.202103-284ST\\n10.2147/COPD.S348663', 'xml': <Element 'PubmedArticle' at 0x10b167ec0>}\n",
      "{'pubmed_id': '38299727', 'title': 'Drug utilisation in children and adolescents before and after the start of the COVID-19 pandemic: Interrupted time-series analyses in three European countries.', 'abstract': 'The COVID-19 pandemic has affected children and adolescents in several ways, including worsened mental health, improvement of asthma, and increases in diabetes ketoacidosis. Less is known about how medication use in children and adolescents has been affected by the pandemic.\\nTo explore how the COVID-19 pandemic affected drug utilisation in children and adolescents in Norway, Sweden, and Italy, by child age.\\nWe conducted a longitudinal drug utilisation study among all children and adolescents (<18\\u2009years old) in Norway and Sweden and a nationwide paediatric database covering 3% of the paediatric population in Italy. We conducted an interrupted time-series analysis from January 2018 to December 2021, with March 2020 as the interruption point. Dispensing or prescription rates of antidepressants, anxiolytics, sleep medications, attention-deficit/hyperactivity disorder (ADHD) medications, insulin, and asthma medications were examined.\\nThe study population in January 2018 consisted of 3,455,521 children and adolescents (136,188 from Italy, 1,160,431 from Norway, and 2,158,902 from Sweden). For sleep medications and insulin, there were only minor changes in level or trend in some age groups after March 2020. For asthma medications, the pandemic was associated with an immediate decrease in dispensing in Norway and Sweden (range of change in level: -19.2 to -3.7 dispensings per 1000 person-months), and an increasing trend in all countries afterward (range of change in trend: 0.3-6.4 dispensings per 1000 person-months), especially for the youngest age groups. Among adolescents, the pandemic was associated with an increased trend for ADHD medications, antidepressants, and anxiolytics in Norway and Sweden, but not in Italy.\\nThe increasing trend of psychotropic medication dispensing, especially among adolescents after the start of the pandemic, is concerning and should be investigated further. Aside from a temporary effect on asthma medication dispensing, the pandemic did not greatly affect the dispensing of the medications investigated.', 'keywords': ['COVID-19', 'adolescents', 'asthma', 'children', 'depression', 'interrupted time series analysis', 'medication'], 'journal': 'Paediatric and perinatal epidemiology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Pedersen', 'firstname': 'Elisabeth', 'initials': 'E', 'affiliation': 'Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.'}, {'lastname': 'Tripodi', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Division of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.'}, {'lastname': 'Aakjaer', 'firstname': 'Mia', 'initials': 'M', 'affiliation': 'Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Li', 'firstname': 'Huiqi', 'initials': 'H', 'affiliation': 'School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Cantarutti', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Division of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.'}, {'lastname': 'Nyberg', 'firstname': 'Fredrik', 'initials': 'F', 'affiliation': 'School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Andersen', 'firstname': 'Morten', 'initials': 'M', 'affiliation': 'Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Lupattelli', 'firstname': 'Angela', 'initials': 'A', 'affiliation': 'Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.'}, {'lastname': 'Nordeng', 'firstname': 'Hedvig', 'initials': 'H', 'affiliation': 'Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.\\nDepartment of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.'}], 'methods': None, 'conclusions': None, 'results': 'The study population in January 2018 consisted of 3,455,521 children and adolescents (136,188 from Italy, 1,160,431 from Norway, and 2,158,902 from Sweden). For sleep medications and insulin, there were only minor changes in level or trend in some age groups after March 2020. For asthma medications, the pandemic was associated with an immediate decrease in dispensing in Norway and Sweden (range of change in level: -19.2 to -3.7 dispensings per 1000 person-months), and an increasing trend in all countries afterward (range of change in trend: 0.3-6.4 dispensings per 1000 person-months), especially for the youngest age groups. Among adolescents, the pandemic was associated with an increased trend for ADHD medications, antidepressants, and anxiolytics in Norway and Sweden, but not in Italy.', 'copyrights': '© 2024 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd.', 'doi': '10.1111/ppe.13046', 'xml': <Element 'PubmedArticle' at 0x10a5ed300>}\n",
      "{'pubmed_id': '38299353', 'title': 'Modulation by ', 'abstract': \"Stress is an aversive stimulus which disrupts the biological milieu of the organism and a variety of emotional and environmental stressors are known to influence allergic and immunological disorders like bronchial asthma but the pharmacological basis of such interactions is not clearly defined. \\nWistar rats (200-250\\u202fg) were immunized and challenged with ovalbumin (OVA) and exposed to restraint stress (RS) and WSE treatments for 15\\xa0days. Following this, anxiety behavior was assessed by the elevated plus maze (EPM) test, and blood and BAL fluid samples were collected for measuring of inflammatory/immune markers by ELISA and biochemical assay. The data of the various treatment groups were analyzed by ANOVA and Tukey's test.\\nRestraint stress (RS) induced anxiogenic behavior in the (EPM) test in OVA immunized rats, and this was attenuated by WSE (200 and 400\\u202fmg/kg), in a dose related manner. Examination of blood and BAL fluid in these RS exposed rats also resulted in elevations in IgE, TNF-α and\\xa0IL-4 levels, which were also attenuated by WSE pretreatments. Further, WSE pretreatment neutralized the such RS induced changes in oxidative stress markers viz. elevated MDA and reduced GSH levels.\\nThe data pharmacologically validates role of stress in asthma and suggests that adaptogens like WSE could be a potential complementary agent for reducing anxiety as well as airway inflammation by a multi-targeted and holistic approach. The study also highlights the significance of integration of traditional and modern medical concepts in such chronic disorders.\", 'keywords': ['adaptogens anxiety', 'airway inflammation', 'bronchial asthma', 'oxidative stress', 'stress'], 'journal': 'Journal of complementary & integrative medicine', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Rehman', 'firstname': 'Sana', 'initials': 'S', 'affiliation': 'Departments of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India.'}, {'lastname': 'Naqvi', 'firstname': 'Maaz', 'initials': 'M', 'affiliation': 'Departments of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India.'}, {'lastname': 'Ali', 'firstname': 'Nafaa Hasan', 'initials': 'NH', 'affiliation': 'Departments of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India.'}, {'lastname': 'Gulati', 'firstname': 'Kavita', 'initials': 'K', 'affiliation': 'Departments of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.'}, {'lastname': 'Ray', 'firstname': 'Arunabha', 'initials': 'A', 'affiliation': 'Departments of Pharmacology, Hamdard Institute of Medical Sciences and Research (HIMSR), Jamia Hamdard, New Delhi, India.'}], 'methods': None, 'conclusions': None, 'results': 'Restraint stress (RS) induced anxiogenic behavior in the (EPM) test in OVA immunized rats, and this was attenuated by WSE (200 and 400\\u202fmg/kg), in a dose related manner. Examination of blood and BAL fluid in these RS exposed rats also resulted in elevations in IgE, TNF-α and\\xa0IL-4 levels, which were also attenuated by WSE pretreatments. Further, WSE pretreatment neutralized the such RS induced changes in oxidative stress markers viz. elevated MDA and reduced GSH levels.', 'copyrights': '© 2024 Walter de Gruyter GmbH, Berlin/Boston.', 'doi': '10.1515/jcim-2021-0466\\n10.1186/1710-1492-4-1-12\\n10.1289/ehp.110-a230\\n10.1152/japplphysiol.01018.2018\\n10.1016/j.bbi.2016.03.024\\n10.1172/JCI124609\\n10.1186/s40733-015-0007-1\\n10.1183/09031936.000185110\\n10.1016/j.bbi.2007.03.009\\n10.1136/thorax.55.11.925\\n10.1016/j.niox.2014.08.005\\n10.1016/j.jep.2005.09.024\\n10.1016/j.drudis.2009.05.009\\n10.4314/ajtcam.v8i5s.9\\n10.1016/s0091-3057(03)00110-2\\n10.1016/s0378-8741(00)00309-3\\n10.1016/j.intimp.2016.08.009\\n10.5005/ijcdas-60-3-147\\n10.1016/j.pharep.2019.02.008\\n10.1016/0149-7634(86)90017-5\\n10.1016/j.pbb.2008.12.010\\n10.1016/s0014-2999(03)01279-2\\n10.1016/j.physbeh.2014.11.056\\n10.1016/0003-9861(59)90090-6\\n10.1016/0003-2697(79)90738-3\\n10.1016/j.pbb.2008.12.010\\n10.1183/09031936.00021212\\n10.1016/j.ddstr.2006.09.007\\n10.1016/j.aller.2013.11.002\\n10.1155/2013/104315\\n10.1186/rr40\\n10.1183/09031936.03.00017003a\\n10.4168/aair.2010.2.3.183\\n10.15761/gvi.1000130', 'xml': <Element 'PubmedArticle' at 0x10a576160>}\n",
      "{'pubmed_id': '38299207\\n36253441\\n19876492\\n21835102\\n23957903\\n29856774\\n29600524\\n21716860\\n27743841\\n19886513\\n15534434\\n31382211\\n19747421\\n32056745\\n7183759\\n1863703\\n10738851\\n10521880\\n7183759\\n21878157\\n11136207\\n16021655\\n25758724\\n9439871\\n17961255\\n11352335\\n9679521\\n16633454\\n12634292\\n15799076\\n17136706', 'title': 'Understanding the impact of socioeconomic and health factors on geriatric depression: A comparative study in rural and urban Bangladesh.', 'abstract': 'The prevalence of depression among the elderly is a growing concern, and this study examines the differences between urban and rural areas in terms of geriatric depression.\\nUsing a two-stage random sampling approach in urban areas and a multistage random sampling approach in rural areas, the study surveyed 944 elderly individuals of both sexes.\\nThe results indicate that the prevalence of depression was high, with 52.5% of the elderly population experiencing mild to severe depression. The study found that increasing age, female gender, nuclear family structure, and involvement of housewives or others were significant factors affecting depression in urban areas, while increasing age and elderly people without spouses were significant factors in rural areas. Additionally, the study identified hearing impairment, asthma, and arthritis as risk factors for depression in rural areas, and bronchitis, heart disease, and thyroid illness as significant factors in urban areas.\\nThese findings highlight the need for policymakers to focus on addressing the mental health needs of older people, particularly women and those without spouses.', 'keywords': ['Bangladesh', 'depression', 'elderly', 'geriatric depression', 'geriatric depression scale (GDS)', 'rural‐urban'], 'journal': 'Health science reports', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Hossain', 'firstname': 'Mohammad Kamal', 'initials': 'MK', 'affiliation': 'Department of Statistics Bangabandhu Sheikh Mujibur Rahman Science and Technology University Gopalganj Bangladesh.'}, {'lastname': 'Islam', 'firstname': 'Md Nazrul', 'initials': 'MN', 'affiliation': 'Department of Statistics Shahjalal University of Science and Technology Sylhet Bangladesh.'}, {'lastname': 'Uddin', 'firstname': 'Mohammed Taj', 'initials': 'MT', 'affiliation': 'Department of Statistics Shahjalal University of Science and Technology Sylhet Bangladesh.'}, {'lastname': 'Hossain', 'firstname': 'Md Sabbir', 'initials': 'MS', 'affiliation': 'Department of Statistics Shahjalal University of Science and Technology Sylhet Bangladesh.'}], 'methods': None, 'conclusions': 'These findings highlight the need for policymakers to focus on addressing the mental health needs of older people, particularly women and those without spouses.', 'results': 'The results indicate that the prevalence of depression was high, with 52.5% of the elderly population experiencing mild to severe depression. The study found that increasing age, female gender, nuclear family structure, and involvement of housewives or others were significant factors affecting depression in urban areas, while increasing age and elderly people without spouses were significant factors in rural areas. Additionally, the study identified hearing impairment, asthma, and arthritis as risk factors for depression in rural areas, and bronchitis, heart disease, and thyroid illness as significant factors in urban areas.', 'copyrights': '© 2024 The Authors. Health Science Reports published by Wiley Periodicals LLC.', 'doi': '10.1002/hsr2.1849\\n10.1176/ajp.152.8.1228', 'xml': <Element 'PubmedArticle' at 0x10a5c8d10>}\n",
      "{'pubmed_id': '38299072\\n29704910\\n29193338\\n34832020\\n33606882\\n36356475\\n8037935\\n1202204\\n8126356\\n30569557\\n29596478\\n35974362\\n27630406\\n31333079\\n33593441\\n34003883\\n25041032\\n26615612\\n33805773\\n24098273\\n34030596\\n16935898\\n23008128\\n35105562\\n28322446\\n30359139\\n19748373\\n34486422\\n16520432\\n34737402\\n27503965', 'title': 'Exploration of the factors influencing hearing disability in older adults of China: a nested case-control study.', 'abstract': 'As two line trends - aging disability and disability aging - continue to emerge, hearing disability is becoming increasingly prevalent among older adults in china. This study aimed to investigate the incidence of hearing disability among older adults and identify the various factors contributing to its development.\\nIn this matched nested case-control study, data from the China Health and Retirement Longitudinal Study from 2011 to 2018 were analyzed. A total of 4,523 older adults were recruited from a national sample database, of which 1,094 individuals were eligible for inclusion in the hearing disability cohort, while 3,429 older adults who had not been diagnosed with hearing disability were considered non-hearing disability controls. Hearing disability was assessed by a self-reported question. These controls were matched to hearing disability cases in a 1:1 ratio based on age and sex. The logistic regression models were used to find out various factors of hearing disability in the target population.\\nTotally 1,094 individuals (24.14%) developed hearing disability during the follow-up period. After 1:1 matching, 2,182 subjects were included in the study, with 1,091 cases in the case group. Factors that influenced the incidence of hearing disability in older adults included annual \\nThe incidence of hearing disabilities among older adults in China is high. The protective and risk factors that contribute to the incidence of disability should be fully considered in the care of older adults.', 'keywords': ['aging', 'disability', 'hearing', 'nested case-control', 'older adults'], 'journal': 'Frontiers in public health', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Zhou', 'firstname': 'Wan-Qiong', 'initials': 'WQ', 'affiliation': 'School of Nursing, Naval Medical University, Shanghai, China.'}, {'lastname': 'Liu', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'School of Nursing, Naval Medical University, Shanghai, China.'}, {'lastname': 'Gao', 'firstname': 'Yi-Tian', 'initials': 'YT', 'affiliation': 'School of Nursing, Naval Medical University, Shanghai, China.'}, {'lastname': 'Zhou', 'firstname': 'Lan-Shu', 'initials': 'LS', 'affiliation': 'School of Nursing, Naval Medical University, Shanghai, China.'}], 'methods': None, 'conclusions': 'The incidence of hearing disabilities among older adults in China is high. The protective and risk factors that contribute to the incidence of disability should be fully considered in the care of older adults.', 'results': 'Totally 1,094 individuals (24.14%) developed hearing disability during the follow-up period. After 1:1 matching, 2,182 subjects were included in the study, with 1,091 cases in the case group. Factors that influenced the incidence of hearing disability in older adults included annual ', 'copyrights': 'Copyright © 2024 Zhou, Liu, Gao and Zhou.', 'doi': '10.3389/fpubh.2024.1305924\\n10.1016/j.maturitas.2018.03.004\\n10.1002/gps.4827\\n10.3390/ijerph182212265\\n10.1093/geronb/gbab029\\n10.1016/j.ebiom.2022.104336\\n10.1016/S0749-3797(18)30622-6\\n10.1016/0022-3956(75)90026-6\\n10.1093/geronj/49.2.m85\\n10.1002/lary.27758\\n10.1371/journal.pone.0195227\\n10.1186/s12910-022-00819-3\\n10.1589/jpts.28.2245\\n10.2174/0929867326666190717152739\\n10.1186/s40779-021-00307-6\\n10.1093/gerona/glab144\\n10.1111/jgs.12938\\n10.1007/s10067-015-3129-1\\n10.3390/ijerph18062953\\n10.3389/fnsys.2013.00055\\n10.1080/00325481.2021.1933554\\n10.1093/ndt/gfl472\\n10.1007/s00405-012-2189-y\\n10.1136/bmjopen-2020-047966\\n10.1002/lary.26567\\n10.1080/02699052.2018.1539243\\n10.1016/j.encep.2008.03.012\\n10.1177/07334648211042370\\n10.1001/archpsyc.63.3.273\\n10.1038/s41598-021-01238-x\\n10.1377/hlthaff.2016.0158', 'xml': <Element 'PubmedArticle' at 0x10a58bbf0>}\n",
      "{'pubmed_id': '38298997\\n35899144', 'title': 'Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD).', 'abstract': '[This retracts the article DOI: 10.1155/2022/2593740.].', 'keywords': [], 'journal': 'Emergency medicine international', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'International', 'firstname': 'Emergency Medicine', 'initials': 'EM', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Emergency Medicine International.', 'doi': '10.1155/2024/9863262\\n10.1155/2022/2593740', 'xml': <Element 'PubmedArticle' at 0x10ac1f1f0>}\n",
      "{'pubmed_id': '38298750\\n24766875\\n35711438\\n30496828\\n36712834\\n35991950\\n35503163\\n32021661\\n36180286', 'title': 'Dupilumab as Add-on Therapy for Management of Chronic Spontaneous Urticaria.', 'abstract': \"Chronic spontaneous urticaria (CSU) is characterized by pruritus, urticaria and associated with substantial patient burden. Emerging clinical trial data suggest dupilumab, an anti-IL-4Rα biologic indicated for several Type-2 inflammatory diseases, may have clinical utility for CSU. Here we present real world clinical data evaluating dupilumab as add-on therapy for CSU. We queried our tertiary academic center electronic health record for all patients with an ICD-9/10 code for urticaria with a history of dupilumab use (1/1/2010-6/30/2022). Retrospective chart review was performed to confirm CSU diagnosis, dupilumab use, patient demographics, medical history, treatments, and outcomes. Data were evaluated using summary and descriptive statistics, paired t-test, and Fisher's exact test. A total of 199 patients were identified: 39 had active CSU at time dupilumab initiation; six were excluded due to limited follow up. The most common indication for dupilumab prescription was atopic dermatitis (57.6%), followed by asthma (27.3%). Mean length of dupilumab therapy was 23 months. Following dupilumab, there was a significant reduction in number of patients on daily H1 antagonists (pre: 27 [81.8%]; post: 20 (60.1%); \", 'keywords': [], 'journal': 'The Journal of clinical and aesthetic dermatology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Kudlaty', 'firstname': 'Elizabeth', 'initials': 'E', 'affiliation': 'Dr. Kudlaty is with the Division of Allergy and Immunology and the Department of Medicine at Northwestern University Feinberg School of Medicine in Chicago, Illinois.'}, {'lastname': 'Newell', 'firstname': 'Phoebe', 'initials': 'P', 'affiliation': 'Dr. Newell is with the Northwestern University Feinberg School of Medicine in Chicago, Illinois.'}, {'lastname': 'Chovatiya', 'firstname': 'Raj', 'initials': 'R', 'affiliation': 'Dr. Chovatiya is with Department of Dermatology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Matrix Medical Communications. All rights reserved.', 'doi': None, 'xml': <Element 'PubmedArticle' at 0x10ac1df80>}\n",
      "{'pubmed_id': '38298631\\n17978293\\n16286234\\n19184354\\n18166595\\n15474500\\n18325031\\n19068077\\n21170491\\n28374082\\n17895592\\n11586212\\n29885451\\n32416408\\n11249557\\n24551718\\n10878379\\n8516329\\n16428763\\n9721161\\n20645320\\n35313457\\n25316652\\n26216303\\n32717690\\n20671726\\n33784531\\n20516177\\n29061980\\n33431861\\n15946677\\n22516296\\n8401235\\n1538787\\n32938494\\n6941276\\n37272194\\n19575467\\n29649876\\n32936048\\n12298196\\n14709107\\n34586825\\n37160706\\n37044036\\n32408781\\n37295565\\n37113754', 'title': 'Anti-enzymatic and DNA docking studies of montelukast: A multifaceted molecular scaffold with ', 'abstract': 'Montelukast, an approved leukotriene receptor 1 (Cys-LT 1) antagonist with anti-inflammatory properties is used for the treatment of asthma and allergic rhinitis. In the present studies, montelukast was subjected to ', 'keywords': ['DNA docking studies', 'Enzyme inhibition', 'MD simulations', 'Molecular expression analysis', 'Montelukast'], 'journal': 'Heliyon', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Abdullah', 'firstname': 'Shawana', 'initials': 'S', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}, {'lastname': 'Iqbal', 'firstname': 'Ambar', 'initials': 'A', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.\\nDepartment of Biochemistry and Molecular Biology, Institute of Biochemistry, Biotechnology & Bioinformatics, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}, {'lastname': 'Ashok', 'firstname': 'Avinash Karkada', 'initials': 'AK', 'affiliation': 'Department of Biotechnology, Siddaganga Institute of Technology, Tumakuru, Karnataka, 572103, India.'}, {'lastname': 'Kaouche', 'firstname': 'Farah Chafika', 'initials': 'FC', 'affiliation': 'Department of Chemistry, Faculty of Sciences of Mater, Ibn Khaldoun University, BP 78 Zaaoura, 14000, Tiaret, Algeria.'}, {'lastname': 'Aslam', 'firstname': 'Misbah', 'initials': 'M', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}, {'lastname': 'Hussain', 'firstname': 'Safdar', 'initials': 'S', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}, {'lastname': 'Rahman', 'firstname': 'Jameel', 'initials': 'J', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}, {'lastname': 'Hayat', 'firstname': 'Muhammad Munawar', 'initials': 'MM', 'affiliation': 'Punjab Drug Testing Laboratory, P & SH Department, 1-Bird Wood Road, Lahore, Pakistan.'}, {'lastname': 'Ashraf', 'firstname': 'Muhammad', 'initials': 'M', 'affiliation': 'Institute of Chemistry, Baghdad-ul-Jadeed Campus, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. Published by Elsevier Ltd.', 'doi': '10.1016/j.heliyon.2024.e24470\\n10.1056/NEJMra071371\\n10.1016/j.pupt.2005.02.009\\n10.1007/s00011-008-8049-y\\n10.1007/s00011-008-8049-y\\n10.1016/j.bbrc.2004.09.125\\n10.1111/j.1365-2222.2008.02963.x\\n10.1111/j.1476-5381.2008.00012.x\\n10.1100/tsw.2010.229\\n10.1007/s00228-017-2242-2\\n10.1007/BF02977367\\n10.1016/S0022-5347(05)65663-7\\n10.1016/j.neulet.2018.05.052\\n10.1016/j.mehy.2020.109828\\n10.1517/14656566.1.1.149\\n10.7860/JCDR/2013/6373.3838\\n10.4049/jimmunol.165.2.1022\\n10.1073/pnas.90.12.579\\n10.1128/iai.74.2.1148-1155.2006\\n10.1016/S0016-5085(98)70143-X\\n10.1002/ibd.21381\\n10.2147/CEG.S345531\\n10.1016/j.bbalip.2014.10.002\\n10.1016/j.gene.2015.07.073\\n10.1016/j.bioorg.2020.104082\\n10.1016/j.molstruc.2021.129959\\n10.1038/nprot.2010.86\\n10.1016/j.bioorg.2021.104818\\n10.1101/pdb.prot5439\\n10.1038/s41467-017-01263-3\\n10.1038/s41467-020-20485-6\\n10.1016/j.jmb.2005.04.068\\n10.1096/fj.12-205286\\n10.1002/pro.5560020916\\n10.1038/356083a0\\n10.1186/s13062-020-00267-2\\n10.1073/pnas.78.4.2179\\n10.5281/zenodo.4576055\\n10.1021/jp003020w\\n10.1080/07391102.2023.2220045\\n10.1002/jcc.21367\\n10.1021/acs.jpcb.7b11734\\n10.1080/07391102.2020.1822208\\n10.1021/ja0356131\\n10.1063/1.464397\\n10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H\\n10.1016/j.cpc.2013.06.003\\n10.1021/acs.jctc.1c00645\\n10.1080/07391102.2023.2210674\\n10.1016/j.intimp.2023.110148\\n10.1080/00207454.2020.1769618\\n10.1016/j.alcohol.2023.05.008\\n10.3389/fphar.2023.1153653', 'xml': <Element 'PubmedArticle' at 0x10ac2cfe0>}\n",
      "{'pubmed_id': '38297283\\n35147928\\n35644404\\n34836093\\n33153672\\n36041656\\n34524638\\n26505989\\n34528308\\n34836171\\n36849854\\n34896589\\n35722472\\n25567039\\n31831581\\n34371827\\n30513809\\n36860686\\n37052695\\n15066202\\n26835515\\n22818937\\n23543633\\n30557812\\n31864020\\n19864411\\n15231904\\n27730154\\n34711541\\n36191867\\n34673220\\n33894077\\n34538263\\n33274952\\n35141325\\n17311057\\n32245170\\n34012840\\n26604824\\n20415760\\n11730188\\n51576\\n24810144\\n30318764\\n24360248\\n30126431\\n35219936', 'title': 'Multivitamin consumption and childhood asthma: a cross-sectional study of the NHANES database.', 'abstract': 'Dietary intakes of vitamins are associated with asthma. However, previous studies mainly explored the association between a single vitamin intake and asthma, which did not take the multivitamins into consideration. Herein, this study aims to explore the overall effect of dietary multivitamins consumption on childhood asthma.\\nData of children and adolescents (aged 2-17 years old) were extracted from the National Health and Nutrition Examination Survey (NHANES) database in 2015-2018 in this cross-sectional study. Weighted univariate logistic regression analysis was used to screen covariates. The association between multivitamins (including vitamin A, C, D, E, B1, B2, B6, B12, K, niacin, folic acid, and choline) and childhood asthma was explored using univariate and multivariate logistic regression analyses. The evaluation indexes were odds ratio (OR) and 95% confidence interval (CI). We further introduced the Bayesian kernel machine regression (BKMR) to assess the joint effect of the twelve vitamins on childhood asthma, the impact of an individual vitamin as part of a vitamin mixture, and the potential interactions among different vitamins.\\nAmong 4,715 eligible children and adolescents, 487 (10.3%) had asthma. After adjusting for covariates including race, family history of asthma, pregnant smoking, BMI Z-score, energy intake, breast feeding, and low birth weight, we found that for each 1-unit increase in vitamin K consumption, the odds of childhood asthma decreased 0.99 (P=0.028). The overall effect analysis reported a trend of negative relationship between the multivitamins and childhood asthma, especially at the 75th percentile and over. According to the BKMR models, when other vitamins are fixed at the median level, the odds of childhood asthma increased along with the elevated vitamin D (VD) and vitamin B2 (VB2), whereas along with the depressed vitamin C (VC). In addition, no potential interaction has been found between every two vitamins of multivitamins on childhood asthma.\\nAmong children and adolescents who have high-risk of asthma, it may be beneficial to increase dietary consumption of multivitamins. Our findings recommended that children and adolescents should increase the intake of VC-rich foods, whereas control the dietary consumption of VD and VB2 in daily life.', 'keywords': ['Bayesian kernel machine regression', 'Childhood asthma', 'Dietary', 'Multivitamin', 'NHANES'], 'journal': 'BMC pediatrics', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Zhang', 'firstname': 'Li', 'initials': 'L', 'affiliation': \"Department of Pediatrics, Women and Children's Hospital of Chongqing Medical University, Chongqing, 401147, P.R. China.\"}, {'lastname': 'Xu', 'firstname': 'Yali', 'initials': 'Y', 'affiliation': 'Department of Pediatric Center, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, P.R. China.'}, {'lastname': 'Li', 'firstname': 'Xuemei', 'initials': 'X', 'affiliation': \"Department of Pediatrics, Women and Children's Hospital of Chongqing Medical University, Chongqing, 401147, P.R. China.\"}, {'lastname': 'Yang', 'firstname': 'Fan', 'initials': 'F', 'affiliation': \"Department of Pediatrics, The Fifth People's Hospital of Chongqing, No.24 Renji Road, Nanan District, Chongqing, 400062, P.R. China.\"}, {'lastname': 'Wang', 'firstname': 'Chengxiu', 'initials': 'C', 'affiliation': \"Department of Pediatrics, The Fifth People's Hospital of Chongqing, No.24 Renji Road, Nanan District, Chongqing, 400062, P.R. China.\"}, {'lastname': 'Yu', 'firstname': 'Chunmei', 'initials': 'C', 'affiliation': \"Department of Pediatrics, The Fifth People's Hospital of Chongqing, No.24 Renji Road, Nanan District, Chongqing, 400062, P.R. China. springmayy@outlook.com.\"}], 'methods': None, 'conclusions': 'Among children and adolescents who have high-risk of asthma, it may be beneficial to increase dietary consumption of multivitamins. Our findings recommended that children and adolescents should increase the intake of VC-rich foods, whereas control the dietary consumption of VD and VB2 in daily life.', 'results': 'Among 4,715 eligible children and adolescents, 487 (10.3%) had asthma. After adjusting for covariates including race, family history of asthma, pregnant smoking, BMI Z-score, energy intake, breast feeding, and low birth weight, we found that for each 1-unit increase in vitamin K consumption, the odds of childhood asthma decreased 0.99 (P=0.028). The overall effect analysis reported a trend of negative relationship between the multivitamins and childhood asthma, especially at the 75th percentile and over. According to the BKMR models, when other vitamins are fixed at the median level, the odds of childhood asthma increased along with the elevated vitamin D (VD) and vitamin B2 (VB2), whereas along with the depressed vitamin C (VC). In addition, no potential interaction has been found between every two vitamins of multivitamins on childhood asthma.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12887-024-04540-5\\n10.1007/s12098-021-04051-6\\n10.1016/j.scitotenv.2022.156291\\n10.1016/j.ecl.2020.07.003\\n10.1007/s12098-021-03941-z\\n10.1111/all.12800\\n10.1111/pai.13667\\n10.1007/s10787-023-01169-1\\n10.1016/j.freeradbiomed.2021.12.012\\n10.3389/fped.2022.870529\\n10.1016/j.jaci.2014.11.009\\n10.3390/nu10121867\\n10.3389/fnut.2023.1113789\\n10.1007/s00467-023-05958-2\\n10.1186/1471-2121-5-13\\n10.1016/S0140-6736(12)60646-1\\n10.1016/j.envint.2018.11.076\\n10.1016/j.envint.2019.105370\\n10.3945/ajcn.2009.27963\\n10.1542/peds.114.1.27\\n10.1016/j.anai.2021.10.002\\n10.1111/pai.13523\\n10.1186/s13148-021-01161-y\\n10.1038/sj.ejcn.1602680\\n10.21037/tp-21-92\\n10.2147/CLEP.S91125\\n10.1111/j.1365-3016.2010.01105.x\\n10.1016/S1081-1206(10)62927-4\\n10.1165/rcmb.2014-0049OC\\n10.1002/ijc.31927\\n10.1016/j.jaci.2013.10.039\\n10.1186/s12940-018-0413-y\\n10.1016/j.envint.2022.107161', 'xml': <Element 'PubmedArticle' at 0x124c101d0>}\n",
      "{'pubmed_id': '38297257\\n33069326\\n31212122\\n16877690\\n21431275\\n23616052\\n25320938\\n32332071\\n20105140\\n25180704\\n36457457\\n33415963\\n18256071\\n31981105\\n2805869\\n28076656\\n36472162', 'title': 'Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland.', 'abstract': 'Asthma and chronic obstructive pulmonary disease (COPD) are common diseases mostly treated in primary care. However, the usage patterns of drugs for obstructive airway diseases (R03 drugs) at the national level are not known.\\nThe aims of this study were to describe (1) for which diagnoses each class of R03 drugs were used, (2) the usage pattern of different drug classes for asthma and COPD, and (3) how often these medications were used without a diagnosis of asthma or COPD in Finland.\\nWe sent questionnaires that included questions on physician-diagnosed asthma and COPD to a random sample of 2000 Finnish subjects who had been dispensed R03 medications in the previous year. Details of R03 medications dispensed were retrieved from national registries.\\nAltogether, 803 subjects (40.6%) responded. Of these, 61.6% had asthma, 5.7% had both asthma and COPD, 5.1% had COPD, and 27.5% had neither asthma nor COPD. Among subjects with asthma or asthma and COPD, inhaled corticosteroids (ICS) were the most frequently dispensed class of drugs (93.7% and 97.8%, respectively). Even among subjects with COPD, ICS were dispensed as frequently (68.3%) as long-acting bronchodilators (70.7%). Antileukotrienes were dispensed mainly to asthmatic individuals only (18.4%) but far less frequently than ICS. The use of theophylline and roflumilast was rare.\\nR03 medications are dispensed far more frequently for asthma than for COPD and often also for subjects without asthma or COPD. In line with guidelines, asthma is treated mainly with ICS, but there seems to be overuse of ICS for COPD.', 'keywords': ['Adult', 'Asthma', 'COPD', 'Guideline', 'Medication', 'Primary health care'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Juntunen', 'firstname': 'Pekka', 'initials': 'P', 'affiliation': 'Department of Respiratory Medicine, Tampere University Hospital, PO Box 2000, Tampere, N33521, Finland. pjuntunen@fimnet.fi.\\nFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland. pjuntunen@fimnet.fi.'}, {'lastname': 'Salmela', 'firstname': 'Petri', 'initials': 'P', 'affiliation': 'Department of Respiratory Medicine, Tampere University Hospital, PO Box 2000, Tampere, N33521, Finland.\\nFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.'}, {'lastname': 'Pakkasela', 'firstname': 'Johanna', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Tampere University Hospital, PO Box 2000, Tampere, N33521, Finland.\\nFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.'}, {'lastname': 'Karjalainen', 'firstname': 'Jussi', 'initials': 'J', 'affiliation': 'Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.\\nAllergy Centre, Tampere University Hospital, Tampere, Finland.'}, {'lastname': 'Lehtimäki', 'firstname': 'Lauri', 'initials': 'L', 'affiliation': 'Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.\\nAllergy Centre, Tampere University Hospital, Tampere, Finland.'}], 'methods': None, 'conclusions': None, 'results': 'Altogether, 803 subjects (40.6%) responded. Of these, 61.6% had asthma, 5.7% had both asthma and COPD, 5.1% had COPD, and 27.5% had neither asthma nor COPD. Among subjects with asthma or asthma and COPD, inhaled corticosteroids (ICS) were the most frequently dispensed class of drugs (93.7% and 97.8%, respectively). Even among subjects with COPD, ICS were dispensed as frequently (68.3%) as long-acting bronchodilators (70.7%). Antileukotrienes were dispensed mainly to asthmatic individuals only (18.4%) but far less frequently than ICS. The use of theophylline and roflumilast was rare.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02870-9\\n10.1016/j.rmed.2019.06.003\\n10.1136/thx.2005.055699\\n10.4104/pcrj.2011.00024\\n10.4104/pcrj.2013.00036\\n10.1038/npjpcrm.2014.86\\n10.1136/ejhpharm-2019-002171\\n10.1111/j.1651-2227.2009.01668.x\\n10.1371/journal.pone.0105110\\n10.1080/20018525.2022.2149918\\n10.23822/EurAnnACI.1764-1489.186\\n10.1183/09031936.00129607\\n10.1007/s12325-020-01233-0\\n10.1378/chest.96.5.984', 'xml': <Element 'PubmedArticle' at 0x124c0d8a0>}\n",
      "{'pubmed_id': '38297226\\n36682372\\n36754956\\n10840265\\n25441637\\n33798909\\n25561239\\n34697272\\n25035952\\n33362848\\n35660131\\n17135575\\n30127087\\n26628680\\n26751474\\n34670670\\n32712329\\n12925520\\n25605792\\n19114008\\n12202830\\n19237447\\n36370105\\n14597658\\n12525261\\n29950010\\n16199517\\n25822800\\n32977580\\n21605702\\n24297251\\n12626589\\n34288557\\n33980319\\n19703165\\n19845683\\n12900517\\n1460198\\n18094088\\n31966372\\n30650483\\n28166213\\n22261821\\n10610716\\n33130063\\n32072647\\n29946055\\n33271224\\n34931265\\n16782891\\n30912319\\n11344091\\n18683247\\n36426850\\n31897818\\n32356173\\n20156522\\n32007500\\n35887228\\n37616368', 'title': 'Lipid metabolism-related genes are involved in the occurrence of asthma and regulate the immune microenvironment.', 'abstract': 'Lipid metabolism plays a pivotal role in asthma pathogenesis. However, a comprehensive analysis of the importance of lipid metabolism-related genes (LMRGs) in regulating the immune microenvironment in asthma remains lacking. The transcriptome matrix was downloaded from the Gene Expression Omnibus (GEO) dataset. Differentially expressed analysis and weighted gene coexpression network analysis (WGCNA) were conducted on the GSE74986 dataset to select hub LMRGs, and gene set enrichment analysis (GSEA) was conducted to explore their biological functions. The CIBERSORT algorithm was used to determine immune infiltration in the asthma and control groups, and the correlation of diagnostic biomarkers and immune cells was performed via Spearman correlation analysis. Subsequently, a competitive endogenous RNA (ceRNA) network was constructed to investigate the hidden molecular mechanism of asthma. The expression levels of the hub genes were further validated in the GSE143192 dataset, and RT‒qPCR and immunofluorescence were performed to verify the reliability of the results in the OVA asthma model. Lastly, the ceRNA network was confirmed by qRT-PCR and RNAi experiments in the characteristic cytokine (IL-13)-induced asthma cellular model.\\nASAH1, ACER3 and SGPP1 were identified as hub LMRGs and were mainly involved in protein secretion, mTORC1 signaling, and fatty acid metabolism. We found more infiltration of CD8\\nASAH1, ACER3 and SGPP1 might be diagnostic biomarkers for asthma, and are associated with increased immune system activation. In addition, SNHG9-hsa-miR-615-3p-ACER3 may be viewed as effective therapeutic targets for asthma. Our findings might provide a novel perspective for future research on asthma.', 'keywords': ['Asthma', 'Competing endogenous RNA', 'Diagnostic biomarker', 'Immune microenvironment', 'Lipid metabolism', 'WGCNA'], 'journal': 'BMC genomics', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Jia', 'firstname': 'Yuanmin', 'initials': 'Y', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China.'}, {'lastname': 'Wang', 'firstname': 'Haixia', 'initials': 'H', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China.'}, {'lastname': 'Ma', 'firstname': 'Bin', 'initials': 'B', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China.'}, {'lastname': 'Zhang', 'firstname': 'Zeyi', 'initials': 'Z', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China.'}, {'lastname': 'Wang', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China.'}, {'lastname': 'Wang', 'firstname': 'Jin', 'initials': 'J', 'affiliation': 'Department of Pediatrics, Jinan Maternity and Child Care Hospital, No. 2, Jianguo Xiaojing 3Rd Road, Shizhong District, Jinan City, Shandong Province, China. 351337075@qq.com.'}, {'lastname': 'Chen', 'firstname': 'Ou', 'initials': 'O', 'affiliation': 'School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Lixia District, Jinan City, Shandong Province, China. chenou@sdu.edu.cn.'}], 'methods': None, 'conclusions': 'ASAH1, ACER3 and SGPP1 might be diagnostic biomarkers for asthma, and are associated with increased immune system activation. In addition, SNHG9-hsa-miR-615-3p-ACER3 may be viewed as effective therapeutic targets for asthma. Our findings might provide a novel perspective for future research on asthma.', 'results': 'ASAH1, ACER3 and SGPP1 were identified as hub LMRGs and were mainly involved in protein secretion, mTORC1 signaling, and fatty acid metabolism. We found more infiltration of CD8', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12864-023-09795-3\\n10.1016/S0140-6736(22)02125-0\\n10.1038/s41533-023-00330-1\\n10.1046/j.1525-1497.2000.07006.x\\n10.1016/j.jaci.2014.08.042\\n10.1016/j.cellimm.2021.104341\\n10.3390/ijms16010924\\n10.4062/biomolther.2021.122\\n10.1016/j.immuni.2014.05.010\\n10.3389/fgene.2020.585746\\n10.1016/j.alit.2022.05.002\\n10.1189/jlb.0606375\\n10.4049/jimmunol.1700605\\n10.1126/scisignal.aab0949\\n10.3390/nu8010030\\n10.1016/j.jaci.2020.06.034\\n10.1093/biostatistics/4.2.249\\n10.1093/nar/gkv007\\n10.1186/1471-2105-9-559\\n10.1126/science.1073374\\n10.1093/nar/gkac1000\\n10.1101/gr.1239303\\n10.1186/1471-2105-4-2\\n10.1073/pnas.0506580102\\n10.1038/nmeth.3337\\n10.3390/mps3040064\\n10.1016/j.jbi.2011.05.002\\n10.1093/nar/gkt1248\\n10.4049/jimmunol.170.6.3296\\n10.1002/iid3.489\\n10.1186/s13578-021-00560-1\\n10.1111/j.1476-5381.2009.00373.x\\n10.1111/j.1476-5381.2009.00484.x\\n10.1084/jem.20021384\\n10.1016/0091-6749(92)90464-D\\n10.1513/pats.200706-069VS\\n10.1038/ng.3787\\n10.1210/me.2011-1150\\n10.1006/geno.1999.5940\\n10.1016/j.jaci.2020.10.024\\n10.1111/all.14236\\n10.1194/jlr.M085910\\n10.1016/j.cellsig.2020.109860\\n10.1186/s40348-021-00130-y\\n10.1128/MCB.02107-05\\n10.4168/aair.2019.11.3.299\\n10.1096/fj.00-0742fje\\n10.1002/jnr.21822\\n10.7554/eLife.83073\\n10.1007/s00428-019-02728-0\\n10.1007/s12035-020-01908-3\\n10.1016/j.biochi.2010.02.008\\n10.1016/j.ejphar.2020.172977\\n10.3390/ijms23147882\\n10.1126/science.ade0522', 'xml': <Element 'PubmedArticle' at 0x124c072e0>}\n",
      "{'pubmed_id': '38296921\\n36243545\\n29621204\\n28017629\\n31905013\\n37221636\\n36921995\\n36387836\\n36270999\\n35594754\\n25439367\\n24074332\\n35413473\\n32090642\\n36175556\\n28464895\\n34561293\\n37108417\\n23212666\\n37589831\\n21277184\\n32484940\\n25808113\\n30230137\\n29912423\\n27165151\\n26949137\\n33337513\\n37280414\\n15289287\\n16556242\\n18540870\\n18353370\\n32144791\\n19225906\\n32938247\\n30108224\\n32373557\\n23283108\\n26049917\\n34561293\\n35210318\\n2153355\\n20590599', 'title': 'Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.', 'abstract': 'Even though increased use of reliever medication, including short-acting beta agonists (SABA), provides an indirect measure of symptom worsening, there have been limited efforts to assess how different patterns of reliever use correlate with symptom control and future risk of exacerbations. Here, we evaluate the effect of individual baseline characteristics on reliever use in patients with moderate-severe asthma on regular maintenance therapy with fluticasone propionate (FP) or combination therapy with fluticasone propionate/salmeterol (FP/SAL) or budesonide/formoterol (BUD/FOR).\\nA drug-disease model describing the number of 24-h puffs and overnight occasions was developed with data from five clinical studies (N\\u2009=\\u20096212). The model was implemented using a nonlinear mixed effects approach and a Poisson function, considering clinical and demographic baseline characteristics. Goodness of fit and model predictive performance were assessed. Heatmaps were created to summarise the effect of concurrent baseline factors on reliever utilisation.\\nThe final model accurately described individual patterns of reliever use, which is significantly increased with time since diagnosis, smoking, higher Asthma Control Questionnaire (ACQ-5) score and higher body mass index (BMI) at baseline. Whilst the number of puffs decreases slowly after an initial drop relative to the start of treatment, exacerbating patients utilise significantly more reliever than those who do not exacerbate. The mean effect of FP/SAL (median dose: 250/50\\xa0μg BID) on reliever use was slightly higher than that of BUD/FOR (median dose: 160/4.5\\xa0μg BID), i.e. a 75.3% vs 69.3% reduction in reliever use, respectively.\\nThe availability of individual-level patient data in conjunction with a parametric approach enabled the characterisation of interindividual differences in the patterns of reliever use in patients with moderate-severe asthma. Taken together, individual demographic and clinical characteristics, as well as exacerbation history, can be considered an indicator of the degree of asthma control. High SABA reliever use suggests suboptimal clinical management of patients on maintenance therapy.\\nIn this study, we tried to understand how patients with moderate to severe asthma use their quick-relief inhalers (like albuterol), how it relates to their symptoms and the risk of having asthma attacks. To evaluate whether differences in reliever inhaler use between patients are associated with factors like smoking or their asthma symptoms at the beginning of treatment, we gathered data from five clinical studies (n\\u2009=\\u20096212 patients). These data allowed us to create a model that predicts how often patients use their reliever inhalers (expressed as number of puffs in 24\\xa0h) during maintenance therapy with inhaled corticosteroids alone or in combination with long-acting beta agonists. The final model showed that reliever inhaler use is higher in patients who have been diagnosed with asthma for > 10\\xa0years, are smokers, have higher asthma symptom scores, and are obese or extremely obese. Patients who had asthma attacks also used their reliever inhalers more often. In addition, to understand how relief inhalers are used in real-life situations, we also created heatmaps that include a wide range of patient characteristics. By using individual patient data together with this model, we have learned that smoking, asthma control, BMI, long history of asthma and previous asthma attacks significantly influence reliever use. This information can help physicians and healthcare professionals understand know how well someone’s asthma is managed. A patient who uses their reliever inhaler often is likely not to have their asthma well controlled by their regular medications.', 'keywords': ['Asthma symptom control', 'Drug-disease modelling', 'Exacerbation', 'ICS/LABA combination therapy', 'Inhaled corticosteroids', 'Reliever medication', 'Rescue medication', 'SABA', 'Short-acting beta agonists'], 'journal': 'Advances in therapy', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'van Dijkman', 'firstname': 'Sven C', 'initials': 'SC', 'affiliation': 'Clinical Pharmacology Modelling and Simulation, GSK, London, UK.'}, {'lastname': 'Yorgancıoğlu', 'firstname': 'Arzu', 'initials': 'A', 'affiliation': 'Celal Bayar University, Manisa, Turkey.'}, {'lastname': 'Pavord', 'firstname': 'Ian', 'initials': 'I', 'affiliation': 'Nuffield Department of Medicine, University of Oxford, Oxford, UK.'}, {'lastname': 'Brusselle', 'firstname': 'Guy', 'initials': 'G', 'affiliation': 'Ghent University Hospital, Ghent, Belgium.'}, {'lastname': 'Pitrez', 'firstname': 'Paulo M', 'initials': 'PM', 'affiliation': 'Hospital Santa Casa de Porto Alegre, Porto Alegre, Brazil.'}, {'lastname': 'Oosterholt', 'firstname': 'Sean', 'initials': 'S', 'affiliation': 'Clinical Pharmacology Modelling and Simulation, GSK, London, UK.'}, {'lastname': 'Fumali', 'firstname': 'Sourabh', 'initials': 'S', 'affiliation': 'GSK, Global Classic and Established Medicines, Worli, India.'}, {'lastname': 'Majumdar', 'firstname': 'Anurita', 'initials': 'A', 'affiliation': 'GSK, Global Classic and Established Medicines, Singapore, Singapore.'}, {'lastname': 'Della Pasqua', 'firstname': 'Oscar', 'initials': 'O', 'affiliation': 'Clinical Pharmacology & Therapeutics Group, University College London, BMA House, Tavistock Square, London, WC1H 9JP, UK. odp72514@gsk.com.\\nGSK House, 980 Great West Rd, London, TW8 9GS, UK. odp72514@gsk.com.'}], 'methods': None, 'conclusions': None, 'results': 'The final model accurately described individual patterns of reliever use, which is significantly increased with time since diagnosis, smoking, higher Asthma Control Questionnaire (ACQ-5) score and higher body mass index (BMI) at baseline. Whilst the number of puffs decreases slowly after an initial drop relative to the start of treatment, exacerbating patients utilise significantly more reliever than those who do not exacerbate. The mean effect of FP/SAL (median dose: 250/50\\xa0μg BID) on reliever use was slightly higher than that of BUD/FOR (median dose: 160/4.5\\xa0μg BID), i.e. a 75.3% vs 69.3% reduction in reliever use, respectively.', 'copyrights': '© 2024. The Author(s).\\n© 2024. The Author(s).', 'doi': '10.1007/s12325-023-02774-w\\n10.3399/BJGPO.2023.0020', 'xml': <Element 'PubmedArticle' at 0x10b0c7f60>}\n",
      "{'pubmed_id': '38296770', 'title': 'A systematic review and meta-analysis of macrolides in the management of adult patients with asthma.', 'abstract': 'The efficacy of macrolides in the management of asthma has been studied but remains controversial. We conducted a systematic review and meta-analysis of macrolides in the management of adult patients with asthma.\\nRandomized controlled trials of macrolides used in adult patients with asthma were searched for in MEDLINE, EMBASE, PsycINFO, Cochrane Library, CINAHL, and Igaku Chuo Zasshi databases to evaluate the efficacy and safety of macrolides.\\nSeventeen reports with macrolide treatment durations ranging from 6 to 48 weeks were included. Macrolides did not reduce exacerbations requiring hospitalization, severe exacerbations, or rescue use of short-acting beta-2 agonist inhalers; improve lung function; decrease peripheral blood or sputum neutrophil counts; or decrease fractional exhaled nitric oxide compared to placebo. Macrolides statistically improved asthma control and quality of life but by less than the minimal clinically important difference. Peripheral blood eosinophil counts as well as serum and sputum eosinophilic cationic protein concentrations were significantly decreased with macrolides compared to placebo. The improvement of asthma symptoms and airway hyperresponsiveness varied by study. The safety profile of macrolides was comparable to that of placebo.\\nAlthough macrolides have some useful clinical aspects, there is not sufficient evidence to recommend their use in the management of adult patients with asthma.', 'keywords': ['Azithromycin', 'Clarithromycin', 'Exacerbation', 'Macrolide', 'Roxithromycin'], 'journal': 'Allergology international : official journal of the Japanese Society of Allergology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Ohnishi', 'firstname': 'Hiroshi', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: honi@kochi-u.ac.jp.'}, {'lastname': 'Otani', 'firstname': 'Toshihito', 'initials': 'T', 'affiliation': 'Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.'}, {'lastname': 'Kanemitsu', 'firstname': 'Yoshihiro', 'initials': 'Y', 'affiliation': 'Department of Respiratory Medicine, Allergy, and Clinical Immunology, Nagoya City University of Medical Sciences, Nagoya, Japan.'}, {'lastname': 'Nagano', 'firstname': 'Tatsuya', 'initials': 'T', 'affiliation': 'Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.'}, {'lastname': 'Hara', 'firstname': 'Johsuke', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.'}, {'lastname': 'Eitoku', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Department of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.'}], 'methods': None, 'conclusions': None, 'results': 'Seventeen reports with macrolide treatment durations ranging from 6 to 48 weeks were included. Macrolides did not reduce exacerbations requiring hospitalization, severe exacerbations, or rescue use of short-acting beta-2 agonist inhalers; improve lung function; decrease peripheral blood or sputum neutrophil counts; or decrease fractional exhaled nitric oxide compared to placebo. Macrolides statistically improved asthma control and quality of life but by less than the minimal clinically important difference. Peripheral blood eosinophil counts as well as serum and sputum eosinophilic cationic protein concentrations were significantly decreased with macrolides compared to placebo. The improvement of asthma symptoms and airway hyperresponsiveness varied by study. The safety profile of macrolides was comparable to that of placebo.', 'copyrights': 'Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.alit.2024.01.002', 'xml': <Element 'PubmedArticle' at 0x10b0a0720>}\n",
      "{'pubmed_id': '38296607', 'title': 'Influence of Staphylococcal enterotoxin-specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma.', 'abstract': None, 'keywords': ['Staphylococcus enterotoxin', 'aero-allergen', 'clarithromycin', 'omalizumab', 'severe asthma'], 'journal': 'Respirology (Carlton, Vic.)', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Weng', 'firstname': 'Chih-Ming', 'initials': 'CM', 'affiliation': 'School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan.\\nCenter of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.'}, {'lastname': 'Wu', 'firstname': 'Wei-Ciao', 'initials': 'WC', 'affiliation': 'Center of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.'}, {'lastname': 'Lee', 'firstname': 'Meng-Jung', 'initials': 'MJ', 'affiliation': 'Center of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.'}, {'lastname': 'Chen', 'firstname': 'Mei-Chuan', 'initials': 'MC', 'affiliation': 'Center of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.\\nDepartment of Thoracic Medicine, Taipei Medical University Hospital, Taipei, Taiwan.'}, {'lastname': 'Chou', 'firstname': 'Chun-Liang', 'initials': 'CL', 'affiliation': 'Center of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.\\nDepartment of Thoracic Medicine, Taipei Medical University Hospital, Taipei, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Chun-Yu', 'initials': 'CY', 'affiliation': 'Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.'}, {'lastname': 'Chung', 'firstname': 'Kian Fan', 'initials': 'KF', 'affiliation': 'Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.\\nRoyal Brompton and Harefield Hospitals, London, United Kingdom.\\nCollege of Medicine, Taipei Medical University, Taipei, Taiwan.'}, {'lastname': 'Kuo', 'firstname': 'Han-Pin', 'initials': 'HP', 'affiliation': 'Center of Thoracic Medicine, Taipei Medical University, Taipei, Taiwan.\\nDepartment of Thoracic Medicine, Taipei Medical University Hospital, Taipei, Taiwan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1111/resp.14663', 'xml': <Element 'PubmedArticle' at 0x10b0a18a0>}\n",
      "{'pubmed_id': '38296173', 'title': 'The traditional utilization, biological activity and chemical composition of edible fern species.', 'abstract': 'Ferns form an important part of the human diet. Young fern fiddleheads are mostly consumed as vegetables, while the rhizomes are often extracted for starch. These edible ferns are also often employed in traditional medicine, where all parts of the plant are used, mostly to prepare extracts. These extracts are applied either externally as lotions and baths or internally as potions, decoctions and teas. Ailments traditionally treated with ferns include coughs, colds, fevers, pain, burns and wounds, asthma, rheumatism, diarrhoea, or skin diseases (eczema, rashes, itching, leprosy).\\nThis review aims to compile the worldwide knowledge on the traditional medicinal uses of edible fern species correlating to reported biological activities and isolated bioactive compounds.\\nThe articles and books published on edible fern species were searched through the online databases Web of Science, Pubmed and Google Scholar, with critical evaluation of the hits. The time period up to the end of 2022 was included.\\nFirst, the edible fern species were identified based on the literature data. A total of 90 fern species were identified that are eaten around the world and are also used in traditional medicine. Ailments treated are often associated with inflammation or bacterial infection. However, only the most common and well-known fern species, were investigated for their biological activity. The most studied species are Blechnum orientale L., Cibotium barometz (L.) J. Sm., Diplazium esculentum (Retz.) Sw., Marsilea minuta L., Osmunda japonica Thunb., Polypodium vulgare L., and Stenochlaena palustris (Burm.) Bedd. Most of the fern extracts have been studied for their antioxidant, anti-inflammatory and antimicrobial activities. Not surprisingly, antioxidant capacity has been the most studied, with results reported for 28 edible fern species. Ferns have been found to be very rich sources of flavonoids, polyphenols, polyunsaturated fatty acids, carotenoids, terpenoids and steroids and most of these compounds are remarkable free radical scavengers responsible for the outstanding antioxidant capacity of fern extracts. As far as clinical trials are concerned, extracts from only three edible fern species have been evaluated.\\nThe extracts of edible fern species exert antioxidant anti-inflammatory and related biological activities, which is consistent with their traditional medicinal use in the treatment of wounds, burns, colds, coughs, skin diseases and intestinal diseases. However, studies to prove pharmacological activities are scarce, and require chemical-biological standardization. Furthermore, correct botanical classification needs to be included in publications to simplify data acquisition. Finally, more in-depth phytochemical studies, allowing the linking of traditional use to pharmacological relevance are needed to be done in a standardized way.', 'keywords': ['Bioactive compounds', 'Edible ferns', 'Ethnomedicinal uses', 'Phytochemistry', 'Pteridophytes'], 'journal': 'Journal of ethnopharmacology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Dvorakova', 'firstname': 'Marcela', 'initials': 'M', 'affiliation': 'Czech Academy of Sciences, Institute of Experimental Botany, Rozvojova 263, CZ-16200, Prague 6, Czech Republic. Electronic address: dvorakova@ueb.cas.cz.'}, {'lastname': 'Soudek', 'firstname': 'Petr', 'initials': 'P', 'affiliation': 'Czech Academy of Sciences, Institute of Experimental Botany, Rozvojova 263, CZ-16200, Prague 6, Czech Republic. Electronic address: soudek@ueb.cas.cz.'}, {'lastname': 'Pavicic', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'Czech Academy of Sciences, Institute of Experimental Botany, Rozvojova 263, CZ-16200, Prague 6, Czech Republic; Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, CZ-50005, Hradec Králové, Czech Republic. Electronic address: pavicia@faf.cuni.cz.'}, {'lastname': 'Langhansova', 'firstname': 'Lenka', 'initials': 'L', 'affiliation': 'Czech Academy of Sciences, Institute of Experimental Botany, Rozvojova 263, CZ-16200, Prague 6, Czech Republic. Electronic address: langhansova@ueb.cas.cz.'}], 'methods': None, 'conclusions': None, 'results': 'First, the edible fern species were identified based on the literature data. A total of 90 fern species were identified that are eaten around the world and are also used in traditional medicine. Ailments treated are often associated with inflammation or bacterial infection. However, only the most common and well-known fern species, were investigated for their biological activity. The most studied species are Blechnum orientale L., Cibotium barometz (L.) J. Sm., Diplazium esculentum (Retz.) Sw., Marsilea minuta L., Osmunda japonica Thunb., Polypodium vulgare L., and Stenochlaena palustris (Burm.) Bedd. Most of the fern extracts have been studied for their antioxidant, anti-inflammatory and antimicrobial activities. Not surprisingly, antioxidant capacity has been the most studied, with results reported for 28 edible fern species. Ferns have been found to be very rich sources of flavonoids, polyphenols, polyunsaturated fatty acids, carotenoids, terpenoids and steroids and most of these compounds are remarkable free radical scavengers responsible for the outstanding antioxidant capacity of fern extracts. As far as clinical trials are concerned, extracts from only three edible fern species have been evaluated.', 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.jep.2024.117818', 'xml': <Element 'PubmedArticle' at 0x10b050ea0>}\n",
      "{'pubmed_id': '38296088', 'title': 'Indoor air pollution is associated with respiratory symptoms in children in urban Vietnam.', 'abstract': 'Exposure to indoor air pollution (IAP) is a leading environmental risk for respiratory diseases. We investigated the relationship between respiratory symptoms and polluting indoor activities such as smoking, cooking and contact with pets among children in Ho Chi Minh City (HCMC), Vietnam. A cross-sectional survey applied a multistage sampling method in 24 randomly selected secondary schools across the city. Approximately 15,000 students completed self-administrated questionnaires on risk factors and respiratory health outcomes within the preceding 12\\xa0months. Data were analyzed using a multivariable logistic regression model with robust standard errors. Wheeze was the most common respiratory symptom (39.5\\xa0%) reported, followed by sneezing and runny nose (28.3\\xa0%). A small percentage of students self-reported asthma (8.6\\xa0%). Approximately 56\\xa0% of participants lived with family members who smoked. A positive association between exposure to indoor secondhand smoke and respiratory symptoms was observed, with adjusted odds ratios (aOR) of 1.41 (95\\xa0% CI: 1.25-1.60, p\\xa0<\\xa00.001) for wheezing and 1.64 (95\\xa0% CI: 1.43-1.87, p\\xa0<\\xa00.001) for sneezing and runny nose, respectively. Using an open stove fuelled by coal, wood, or kerosene for cooking was associated with wheeze (aOR: 1.36, CI 95\\xa0%: 1.10-1.68, p\\xa0=\\xa00.01) and sneezing and runny nose (aOR: 1.36, CI 95\\xa0%: 1.09-1.69, p\\xa0=\\xa00.01). In the present study, IAP was associated with adverse health outcomes, as evidenced by an increase in respiratory symptoms reported within the previous 12\\xa0months.', 'keywords': ['Children', 'Indoor air pollution', 'Respiratory symptoms', 'Vietnam'], 'journal': 'The Science of the total environment', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Le', 'firstname': 'Hong H T C', 'initials': 'HHTC', 'affiliation': \"Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Australia.\"}, {'lastname': 'Ngo', 'firstname': 'Hieu K T', 'initials': 'HKT', 'affiliation': 'Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.'}, {'lastname': 'Hieu', 'firstname': 'Le Sy', 'initials': 'LS', 'affiliation': 'Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.'}, {'lastname': 'Sly', 'firstname': 'Peter D', 'initials': 'PD', 'affiliation': \"Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Australia.\"}, {'lastname': 'Phung', 'firstname': 'Dung', 'initials': 'D', 'affiliation': 'School of Public Health, The University of Queensland, Australia.'}, {'lastname': 'Le An', 'firstname': 'Pham', 'initials': 'P', 'affiliation': 'Centre for the Training of Family Medicine, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam; Science and Technology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam. Electronic address: phamlean@ump.edu.vn.'}, {'lastname': 'Vinh', 'firstname': 'Nguyen Nhu', 'initials': 'NN', 'affiliation': 'Centre for the Training of Family Medicine, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam.'}, {'lastname': 'Dang', 'firstname': 'Tran Ngoc', 'initials': 'TN', 'affiliation': 'Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.'}, {'lastname': 'Thuong', 'firstname': 'Do Thi Hoai', 'initials': 'DTH', 'affiliation': 'Science and Technology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam.'}, {'lastname': 'Thanh', 'firstname': 'Huynh Ngoc', 'initials': 'HN', 'affiliation': 'Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.'}, {'lastname': 'Thai', 'firstname': 'Phong K', 'initials': 'PK', 'affiliation': 'Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, Australia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.scitotenv.2024.170556', 'xml': <Element 'PubmedArticle' at 0x109579c10>}\n",
      "{'pubmed_id': '38296051', 'title': 'Clinical Characteristics and Impact of Inducible Laryngeal Obstruction in the UK National Registry.', 'abstract': 'Inducible laryngeal obstruction (ILO) describes inappropriate laryngeal closure during respiration, with airflow obstruction occurring at the glottic and/or supraglottic level, leading to breathlessness.\\nThere is a paucity of data describing the demographics and impact of ILO. We aimed to report the clinical and demographic features of ILO in individuals entered prospectively in the UK national ILO registry.\\nData were entered into a Web-based registry from participants with endoscopically confirmed ILO who were attending four established UK-wide specialist ILO centers between March 2017 and November 2019. All patients provided written informed consent.\\nData from 137 individuals were included. Most (87%) had inspiratory ILO and required provocation during endoscopy to induce symptoms. There was a female predominance (80%), mean age 47 years (SD, 15 years). The most common comorbidities included asthma (68%) and reflux (57%). Health care use was high: 88% had attended emergency health care with symptoms at least once in the previous 12 months and nearly half had been admitted to the hospital. A fifth had required admission to critical care owing to ILO symptoms. Patient morbidity was substantial; 64% reported impaired functional capacity (≥3 on the Medical Research Council Dyspnoea Scale) and a third stated that symptoms affected working capability.\\nWe describe the first multicenter prospective characterization of individuals with endoscopically diagnosed ILO. Analysis of our multicenter data set identified ILO as associated with a high burden of morbidity and health care use, comparable to severe asthma. These data will support the development of health care resources in the future and guide research priorities.', 'keywords': ['Asthma', 'Cough', 'Dyspnea', 'Inducible laryngeal obstruction', 'Larynx', 'Vocal cord dysfunction'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Haines', 'firstname': 'Jemma', 'initials': 'J', 'affiliation': 'Faculty of Biology, Medicine, and Health, School of Biological Sciences, Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester, United Kingdom; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom. Electronic address: jemma.haines@mft.nhs.uk.'}, {'lastname': 'Simpson', 'firstname': 'Andrew J', 'initials': 'AJ', 'affiliation': 'School of Sport, Exercise, and Rehabilitation Sciences, University of Hull, Hull, United Kingdom.'}, {'lastname': 'Slinger', 'firstname': 'Claire', 'initials': 'C', 'affiliation': 'Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, United Kingdom.'}, {'lastname': 'Selby', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom.'}, {'lastname': 'Pargeter', 'firstname': 'Nicola', 'initials': 'N', 'affiliation': 'University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.'}, {'lastname': 'Fowler', 'firstname': 'Stephen J', 'initials': 'SJ', 'affiliation': 'Faculty of Biology, Medicine, and Health, School of Biological Sciences, Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester, United Kingdom; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom.'}, {'lastname': 'Hull', 'firstname': 'James H', 'initials': 'JH', 'affiliation': 'Department of Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom; Institute of Sport, Exercise, and Health, Division of Surgery and Interventional Science, University College London, London, United Kingdom.'}], 'methods': None, 'conclusions': 'We describe the first multicenter prospective characterization of individuals with endoscopically diagnosed ILO. Analysis of our multicenter data set identified ILO as associated with a high burden of morbidity and health care use, comparable to severe asthma. These data will support the development of health care resources in the future and guide research priorities.', 'results': 'Data from 137 individuals were included. Most (87%) had inspiratory ILO and required provocation during endoscopy to induce symptoms. There was a female predominance (80%), mean age 47 years (SD, 15 years). The most common comorbidities included asthma (68%) and reflux (57%). Health care use was high: 88% had attended emergency health care with symptoms at least once in the previous 12 months and nearly half had been admitted to the hospital. A fifth had required admission to critical care owing to ILO symptoms. Patient morbidity was substantial; 64% reported impaired functional capacity (≥3 on the Medical Research Council Dyspnoea Scale) and a third stated that symptoms affected working capability.', 'copyrights': 'Copyright © 2024 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.', 'doi': '10.1016/j.jaip.2024.01.030', 'xml': <Element 'PubmedArticle' at 0x1095d0900>}\n",
      "{'pubmed_id': '38296047', 'title': 'From the pages of AllergyWatch.', 'abstract': None, 'keywords': [], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Fineman', 'firstname': 'Stanley M', 'initials': 'SM', 'affiliation': 'Atlanta Allergy & Asthma, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. Electronic address: sfineman@atlantaallergy.com.'}, {'lastname': 'Joshi', 'firstname': 'Shyam R', 'initials': 'SR', 'affiliation': 'Allergy and Immunology Clinic, Section of Allergy and Immunology, Oregon Health and Science University, Lake Oswego, Oregon.'}, {'lastname': 'Otani', 'firstname': 'Iris', 'initials': 'I', 'affiliation': 'University of California San Francisco, San Francisco, California.'}, {'lastname': 'Knox', 'firstname': 'Samantha', 'initials': 'S', 'affiliation': 'Gundersen Health System, La Crosse, Wisconsin.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.anai.2024.01.024', 'xml': <Element 'PubmedArticle' at 0x1095d1030>}\n",
      "{'pubmed_id': '38296046', 'title': 'Food Allergies on a College Campus.', 'abstract': 'There are limited data on food allergies among college students. In this article we review the most current available studies. These self-reported surveys and qualitative interviews report overall poor avoidance of known allergens and low rates of carrying self-injectable epinephrine (SIE) among food-allergic students. College students may exhibit risk-taking food behaviors due to a number of factors, including age-appropriate risk-taking predilection, strong social influences, and lack of experience in self-advocacy. Having to disclose an otherwise invisible condition repeatedly in a new environment may also lead to \"disclosure fatigue,\" creating an additional barrier to self-advocacy. Common themes in the narrative include hypervigilance, stigma management, and concern about others\\' misunderstanding of food allergy. While there is a paucity of data in this area, it is likely that having greater support at the institution level, along with support from peers and faculty, may help improve awareness, SIE carriage, and allergen avoidance. This review also discusses strategies for preparedness at school, including specific steps to maximize safety.', 'keywords': ['Food allergy', 'college', 'disclosure fatigue', 'healthcare transition', 'risk management', 'self-injectable epinephrine'], 'journal': 'Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Yuan', 'firstname': 'Irene H', 'initials': 'IH', 'affiliation': 'Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: irene_h_yuan@hotmail.com.'}, {'lastname': 'Greenhawt', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': \"Section of Allergy/Immunology, Department of Pediatrics, Children's Hospital Colorado, School of Medicine, Aurora, Colorado, USA.\"}, {'lastname': 'Abrams', 'firstname': 'Elissa M', 'initials': 'EM', 'affiliation': 'Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Canada; Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, Vancouver, Canada.'}, {'lastname': 'Kim', 'firstname': 'Edwin H', 'initials': 'EH', 'affiliation': 'Division of Pediatric Allergy and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.'}, {'lastname': 'Mustafa', 'firstname': 'S Shahzad', 'initials': 'SS', 'affiliation': 'Division of Allergy, Immunology, and Rheumatology, Rochester Regional Health, Rochester, NY, USA; Division of Allergy, Immunology, and Rheumatology, University of Rochester School of Medicine and Dentistry.'}, {'lastname': 'Iglesia', 'firstname': 'Edward G A', 'initials': 'EGA', 'affiliation': 'Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.anai.2024.01.023', 'xml': <Element 'PubmedArticle' at 0x10959d990>}\n",
      "{'pubmed_id': '38295882', 'title': 'Analytical Challenges in Omics Research on Asthma and Allergy: A National Institute of Allergy and Infectious Diseases Workshop.', 'abstract': 'Studies of asthma and allergy are generating increasing volumes of omics data for analysis and interpretation. The National Institute of Allergy and Infectious Diseases (NIAID) assembled a workshop comprised of investigators studying asthma and allergic diseases using omics approaches, omics investigators from outside the field, and NIAID medical and scientific officers to discuss the following areas in asthma and allergy research: genomics, epigenomics, transcriptomics, microbiomics, metabolomics, proteomics, lipidomics, integrative omics, systems biology, and causal inference. Current states-of-the art, present challenges, novel and emerging strategies, and priorities for progress were presented and discussed for each area. This workshop report summarizes the major points and conclusions from this NIAID workshop. As a group, the investigators underscored the imperatives for rigorous analytic frameworks, integration of different omics data types, cross-disciplinary interaction, strategies for overcoming current limitations, and the overarching goal to improve scientific understanding and care of asthma and allergic diseases.', 'keywords': ['allergic diseases', 'allergy', 'asthma', 'causal inference', 'epigenomics', 'genomics', 'integrative', 'lipidomics', 'microbiome', 'omics', 'proteomics: metabolomics', 'systems biology', 'transcriptomics'], 'journal': 'The Journal of allergy and clinical immunology', 'publication_date': datetime.date(2024, 2, 1), 'authors': [{'lastname': 'Bunyavanich', 'firstname': 'Supinda', 'initials': 'S', 'affiliation': 'Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: supinda@post.harvard.edu.'}, {'lastname': 'Becker', 'firstname': 'Patrice M', 'initials': 'PM', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Altman', 'firstname': 'Matthew C', 'initials': 'MC', 'affiliation': 'University of Washington, Seattle, WA, USA.'}, {'lastname': 'Lasky-Su', 'firstname': 'Jessica', 'initials': 'J', 'affiliation': \"Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Ober', 'firstname': 'Carole', 'initials': 'C', 'affiliation': 'University of Chicago, Chicago, IL, USA.'}, {'lastname': 'Zengler', 'firstname': 'Karsten', 'initials': 'K', 'affiliation': 'University of California, San Diego, CA, USA.'}, {'lastname': 'Berdyshev', 'firstname': 'Evgeny', 'initials': 'E', 'affiliation': 'National Jewish Health, Denver, CO, USA.'}, {'lastname': 'Bonneau', 'firstname': 'Richard', 'initials': 'R', 'affiliation': 'Genentech, New York, NY, USA.'}, {'lastname': 'Chatila', 'firstname': 'Talal', 'initials': 'T', 'affiliation': \"Boston Children's Hospital and Harvard Medical School, Boston, USA.\"}, {'lastname': 'Chatterjee', 'firstname': 'Nilanjan', 'initials': 'N', 'affiliation': 'Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Chung', 'firstname': 'Kian Fan', 'initials': 'KF', 'affiliation': 'Imperial College, London, UK.'}, {'lastname': 'Cutcliffe', 'firstname': 'Colleen', 'initials': 'C', 'affiliation': 'Pendulum Therapeutics, San Francisco, CA, USA.'}, {'lastname': 'Davidson', 'firstname': 'Wendy', 'initials': 'W', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Dong', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Fang', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'Icahn School of Medicine at Mount Sinai, New York, NY, USA.'}, {'lastname': 'Fulkerson', 'firstname': 'Patricia', 'initials': 'P', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Himes', 'firstname': 'Blanca E', 'initials': 'BE', 'affiliation': 'University of Pennsylvania, Philadelphia, PA USA.'}, {'lastname': 'Liang', 'firstname': 'Liming', 'initials': 'L', 'affiliation': 'Harvard T.H. Chan School of Public Health, Boston, MA, USA.'}, {'lastname': 'Mathias', 'firstname': 'Rasika A', 'initials': 'RA', 'affiliation': 'Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Ogino', 'firstname': 'Shuji', 'initials': 'S', 'affiliation': \"Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Boston, MA, USA.\"}, {'lastname': 'Petrosino', 'firstname': 'Joseph', 'initials': 'J', 'affiliation': 'Baylor College of Medicine, Houston, TX, USA.'}, {'lastname': 'Price', 'firstname': 'Nathan D', 'initials': 'ND', 'affiliation': 'Thorne HealthTech, New York, NY, USA.'}, {'lastname': 'Schadt', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Icahn School of Medicine at Mount Sinai, New York, NY, USA.'}, {'lastname': 'Schofield', 'firstname': 'James', 'initials': 'J', 'affiliation': 'University of Southampton, Southampton, UK.'}, {'lastname': 'Seibold', 'firstname': 'Max A', 'initials': 'MA', 'affiliation': 'National Jewish Health, Denver, CO, USA; University of Colorado School of Medicine, Aurora, CO, USA.'}, {'lastname': 'Steen', 'firstname': 'Hanno', 'initials': 'H', 'affiliation': \"Boston Children's Hospital and Harvard Medical School, Boston, USA.\"}, {'lastname': 'Wheatley', 'firstname': 'Lisa', 'initials': 'L', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Zhang', 'firstname': 'Hongmei', 'initials': 'H', 'affiliation': 'School of Public Health, University of Memphis, Memphis, TN, USA.'}, {'lastname': 'Togias', 'firstname': 'Alkis', 'initials': 'A', 'affiliation': 'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.'}, {'lastname': 'Hasegawa', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaci.2024.01.014', 'xml': <Element 'PubmedArticle' at 0x10955d990>}\n",
      "{'pubmed_id': '38295145', 'title': 'Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma.', 'abstract': 'Allergic bronchopulmonary aspergillosis (ABPA) can complicate the natural history of asthmatic patients, especially the more severe ones, worsening disease control and increasing the need for therapies, steroids in particular, and medical care. The aim of the present review is to summarize the latest epidemiological data related to the relationship between asthma and ABPA and to offer a summary of the most recent strategies that could potentially facilitate in the identification of ABPA in asthmatic patients.\\nIn the last years, great efforts have been made by researchers worldwide to provide reliable epidemiological data on fungal sensitization and ABPA, especially in severe asthma patients both in adult and pediatric population. Data differ depending on the geographical area and population studied, but pooled data show a concerning 11% of severe asthma patients having ABPA and one out of four asthmatic patients being sensitized to fungi, Aspergillus fumigatus in particular.\\nReliable epidemiological data and advances in the diagnostic procedures can facilitate the detection of ABPA among asthmatic patients, improving the management of a still under-recognized and challenging condition.', 'keywords': [], 'journal': 'Current opinion in allergy and clinical immunology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Maule', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'Asthma Center and Allergy Unit, Center for Hyper-eosinophilic dysimmune conditions, Integrated University Hospital of Verona.\\nDepartment of Medicine, University of Verona, Verona, Italy.'}, {'lastname': 'Vitte', 'firstname': 'Joana', 'initials': 'J', 'affiliation': 'University Hospital of Reims, Laboratory of Immunology.\\nINSERM UMR-S 1250 P3CELL, University of Reims, Reims, France.'}, {'lastname': 'Ambrosani', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Department of Medicine, University of Verona, Verona, Italy.'}, {'lastname': 'Caminati', 'firstname': 'Marco', 'initials': 'M', 'affiliation': 'Asthma Center and Allergy Unit, Center for Hyper-eosinophilic dysimmune conditions, Integrated University Hospital of Verona.\\nDepartment of Medicine, University of Verona, Verona, Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/ACI.0000000000000971', 'xml': <Element 'PubmedArticle' at 0x109576890>}\n",
      "{'pubmed_id': '38295127', 'title': 'Endotypes of occupational asthma.', 'abstract': 'To describe recent findings in endotyping occupational asthma by addressing the role of specific biomarkers.\\nStudies on occupational asthma endotypes have focused on immune and inflammatory patterns associated with different occupational exposures to sensitizers or irritants.Sputum neutrophilia has been found in 58.5% patients with occupational asthma caused by high molecular weight (HMW) agents, and work-related dysphonia in patients with occupational asthma was described as associated with sputum neutrophilia too. Neutrophils have been associated also with irritant-induced asthma. The measurement of specific IgE has been confirmed as a valuable diagnostic tool in occupational asthma caused by HMW agents, on the contrary, for most low-molecular-weight agents, the presence of specific IgE has been proven in a small subset of affected workers. Fractional exhaled nitric oxide has been confirmed as a marker of type 2 (T2) inflammation in occupational asthma, mostly when induced by HMW agents (e.g. flour), and it has proved to be more sensitive than spirometry in measuring the efficacy of an intervention.MicroRNA-155 has been shown to contribute to airway inflammation in occupational asthma induced by toluene diisocyanate.\\nOccupational asthma is heterogeneous, thus monitoring multiple biomarkers is crucial to understand, which inflammatory responses are prevalent.', 'keywords': [], 'journal': 'Current opinion in allergy and clinical immunology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Mason', 'firstname': 'Paola', 'initials': 'P', 'affiliation': 'Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.'}, {'lastname': 'Biasioli', 'firstname': 'Marco', 'initials': 'M', 'affiliation': None}, {'lastname': 'Liviero', 'firstname': 'Filippo', 'initials': 'F', 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/ACI.0000000000000969\\n10.18176/jiaci.0868.', 'xml': <Element 'PubmedArticle' at 0x10ad9afc0>}\n",
      "{'pubmed_id': '38295125', 'title': \"What's new in pediatric asthma and rhinitis phenotypes and endotypes?\", 'abstract': \"This review explores the evolving landscape of pediatric asthma and rhinitis, focusing on identifying and characterizing different subtypes.\\nChildhood asthma and rhinitis are prevalent respiratory conditions frequently occurring together. To address the need for a precise definition of these diseases, an unbiased and comprehensive phenotyping approach has been undertaken with hypothesis-free analysis of extensive datasets to uncover new relationships among clinical, environmental, and biological characteristics. On the other hand, the concept of endotype is elaborate and multifaceted, representing distinct pathophysiological mechanisms underlying the clinical presentation and requires the identification of reliable biomarkers. The recognition of multiple inflammatory endotypes underscores the need for in-depth characterization, which could revolutionize the treatment landscape.\\nComprehending phenotypes and endotypes is crucial for customizing effective and personalized management approaches for children with asthma and rhinitis. More precise and efficient care can be administered through recognition and detailed characterization, ultimately enhancing patients' quality of life.\", 'keywords': [], 'journal': 'Current opinion in allergy and clinical immunology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Roberto', 'firstname': 'Giulia', 'initials': 'G', 'affiliation': 'Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia.\\nPediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia.'}, {'lastname': 'Barberi', 'firstname': 'Salvatore', 'initials': 'S', 'affiliation': 'Pediatric Unit, Rho and Garbagnate Milanese Hospital, ASST-Rhodense, Milan, Italy.'}, {'lastname': 'Marseglia', 'firstname': 'Gian Luigi', 'initials': 'GL', 'affiliation': 'Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia.\\nPediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia.'}, {'lastname': 'Licari', 'firstname': 'Amelia', 'initials': 'A', 'affiliation': 'Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia.\\nPediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/ACI.0000000000000970', 'xml': <Element 'PubmedArticle' at 0x10add79c0>}\n",
      "{'pubmed_id': '38295036\\n15009358\\n17623625\\n10370925\\n22767300\\n34785529\\n34654994\\n34643848\\n30357724\\n31575351\\n12208826\\n18931893\\n31625463\\n11986359\\n27275156\\n18382003\\n25133838\\n21513510\\n11327185\\n35856273\\n28377851\\n26160366\\n11914328\\n18513304\\n28132015\\n24784831\\n31992611\\n36115323\\n17459596\\n32395568\\n19663748\\n10211540\\n29221453\\n27027989\\n34922392\\n31964341\\n34341044\\n25160838\\n23467708\\n33555631\\n20550019\\n10507956\\n14567763\\n27460748\\n17003141\\n14681260\\n2695655\\n17290797\\n8552738\\n26779321\\n15250815\\n28349668\\n28676747\\n26215992\\n15650146\\n34316022\\n16914506\\n33611935\\n21193534\\n33115463\\n30529432\\n32762536\\n29966270\\n11088090\\n30480117', 'title': 'Distress, multimorbidity, and complex multimorbidity among Chinese and Korean American older adults.', 'abstract': 'Studies suggest that distress is associated with various health conditions such as hypertension, asthma, diabetes, and coronary heart disease. However, only few studies focused on Asian Americans and little is known about the association with multiple comorbidity.\\nWe conducted a cross-sectional analysis among 400 Chinese and Korean American participants (aged 50-75 years) of the STOP CRC randomized controlled trial. Perceived distress was assessed using the distress thermometer scale (range 0-10). Disease diagnosis was self-reported by the participants. Multimorbidity (MM) was defined as having ≥2 chronic conditions. Complex multimorbidity (CMM) was defined as having ≥3 of the following body system disorders: circulation disorder, endocrine-metabolic disorder, cancer, anxiety or depression, breathing problem, and other health problems. We performed logistic regression for CMM and Poisson regression with robust error variance for MM to estimate associations with distress, adjusting for potential confounders.\\nThe mean age was 58.4 years and mean distress score was 3.65. One-unit increase in distress score was associated with a 1.22-fold increase in the odds of having CMM (95% CI: 1.04-1.42). The magnitude of association slightly increased after additional adjustment for socioeconomic factors and health insurance status (OR: 1.29; 95% CI: 1.10-1.52). Higher distress score was positively associated with MM but the association was only marginally significant (PR: 1.04; 95% CI: 0.99-1.10), adjusting for socioeconomic factors and health insurance status.\\nOur data suggest that higher perceived distress may be associated with simultaneous dysfunction of multiple distinct body systems among Chinese and Korean American older adults.', 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Oh', 'firstname': 'Hannah', 'initials': 'H', 'affiliation': 'Department of Public Health Sciences, Interdisciplinary Program in Precision Public Health, Graduate School of Korea University, Seoul, Republic of Korea.\\nDepartment of Health Policy and Management, College of Health Sciences, Korea University, Seoul, Republic of Korea.\\nDepartment of Medicine, School of Medicine, University of California, Irvine, Irvine, California, United States of America.'}, {'lastname': 'Morey', 'firstname': 'Brittany N', 'initials': 'BN', 'affiliation': 'Department of Health, Society and Behavior, Program in Public Health, University of California, Irvine, Irvine, California, United States of America.'}, {'lastname': 'Shi', 'firstname': 'Yuxi', 'initials': 'Y', 'affiliation': 'Department of Medicine, School of Medicine, University of California, Irvine, Irvine, California, United States of America.'}, {'lastname': 'Lee', 'firstname': 'Sunmin', 'initials': 'S', 'affiliation': 'Department of Medicine, School of Medicine, University of California, Irvine, Irvine, California, United States of America.'}], 'methods': None, 'conclusions': 'Our data suggest that higher perceived distress may be associated with simultaneous dysfunction of multiple distinct body systems among Chinese and Korean American older adults.', 'results': 'The mean age was 58.4 years and mean distress score was 3.65. One-unit increase in distress score was associated with a 1.22-fold increase in the odds of having CMM (95% CI: 1.04-1.42). The magnitude of association slightly increased after additional adjustment for socioeconomic factors and health insurance status (OR: 1.29; 95% CI: 1.10-1.52). Higher distress score was positively associated with MM but the association was only marginally significant (PR: 1.04; 95% CI: 0.99-1.10), adjusting for socioeconomic factors and health insurance status.', 'copyrights': 'Copyright: © 2024 Oh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0297035\\n10.1046/j.1365-2648.2003.02938.x\\n10.1188/07.CJON.413-418\\n10.1007/s10903-012-9676-5\\n10.9778/cmajo.20210090\\n10.1007/s10903-021-01295-4\\n10.1007/s10903-021-01287-4\\n10.1007/s10597-018-0348-3\\n10.1176/appi.ps.201900126\\n10.1007/s10900-008-9137-1\\n10.1177/1043659619881491\\n10.1093/jpepsy/27.4.363\\n10.1159/000443933\\n10.2105/AJPH.2007.114454\\n10.1037/hea0000108\\n10.1186/1471-2458-11-256\\n10.15288/jsa.2001.62.190\\n10.1017/S0007114522002306\\n10.1016/j.pmedr.2017.03.018\\n10.1016/j.jchf.2015.02.009\\n10.1093/ije/31.1.248\\n10.1111/j.1464-5491.2008.02463.x\\n10.1136/bmjopen-2016-014235\\n10.2337/dc13-2725\\n10.1136/jech-2019-213144\\n10.1016/j.psyneuen.2022.105915\\n10.1016/j.psyneuen.2007.02.013\\n10.1016/j.cobeha.2019.01.011\\n10.5993/ajhb.34.1.3\\n10.1016/S0149-2918(00)88295-8\\n10.1186/s12916-017-0978-2\\n10.1111/1753-6405.12509\\n10.1093/sleep/zsab298\\n10.1186/s12877-020-1425-3\\n10.1136/bmjopen-2020-046749\\n10.1002/pon.3430\\n10.1007/s11670-011-0054-y\\n10.1111/jocn.15698\\n10.1093/sleep/33.6.781\\n10.7326/0003-4819-131-7-199910050-00002\\n10.1186/1471-2288-3-21\\n10.1002/sim.7059\\n10.1370/afm.528\\n10.1093/ije/dyg204\\n10.31887/DCNS.2006.8.4/ssmith\\n10.1097/00006842-199509000-00009\\n10.1016/j.slsci.2015.09.002\\n10.1037/0033-2909.130.4.601\\n10.1002/oby.21790\\n10.3389/fnhum.2017.00316\\n10.1007/978-1-4939-2895-8_5\\n10.1136/jech.2004.019786\\n10.1038/s41416-021-01505-8\\n10.1093/aje/kwj280\\n10.1161/HYPERTENSIONAHA.120.14479\\n10.1093/aje/kwq371\\n10.1186/s12889-020-09720-3\\n10.1016/j.smrv.2018.10.004\\n10.1161/CIRCRESAHA.120.316242\\n10.3390/diseases6030056\\n10.1001/archinte.160.21.3278\\n10.1093/geroni/igx022', 'xml': <Element 'PubmedArticle' at 0x10ada5f80>}\n",
      "{'pubmed_id': '38294863', 'title': 'Rapidly progressive mucus plugs in allergic bronchopulmonary mycosis.', 'abstract': \"Allergic bronchopulmonary mycosis (ABPM) is a chronic airway disease characterized by the presence of fungi that trigger allergic reactions and airway obstruction. Here, we present a unique case of ABPM in which a patient experienced sudden respiratory failure due to mucus plug-induced airway obstruction. The patient's life was saved by venovenous extracorporeal membrane oxygenation (VV-ECMO) and bronchoscopic removal of the plug. This case emphasizes the clinical significance of mucus plug-induced airway obstruction in the differential diagnosis of respiratory failure in patients with ABPM.\\nA 52-year-old female clerical worker with no smoking history, presented with dyspnea. CT scan revealed mucus plugs in both lungs. Despite treatment, the dyspnea progressed rapidly to respiratory failure, leading to VV-ECMO placement.\\nCT revealed bronchial wall thickening, obstruction, and extensive atelectasis. Bronchoscopy revealed extensive mucus plugs that were successfully removed within two days. The patient's respiratory status significantly improved. Follow-up CT revealed no recurrence. Fungal cultures identified \\nDifferentiating between asthma exacerbation and mucus plug-induced airway obstruction in patients with ABPM and those with acute respiratory failure is challenging. Prompt evaluation of mucous plugs and atelectasis using CT and timely decision to introduce ECMO and bronchoscopic mucous plug removal are required.\", 'keywords': ['Bronchoscopy', 'Schizophyllum commune', 'eosinophil extracellular traps', 'mucous plug', 'veno-venous extracorporeal membrane oxygenation'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Miyazaki', 'firstname': 'Osamu', 'initials': 'O', 'affiliation': 'Department of Cardiology, Pulmonology, and Nephrology, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Igarashi', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Department of Cardiology, Pulmonology, and Nephrology, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Sato', 'firstname': 'Kento', 'initials': 'K', 'affiliation': 'Department of Cardiology, Pulmonology, and Nephrology, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Inoue', 'firstname': 'Sumito', 'initials': 'S', 'affiliation': 'Department of Cardiology, Pulmonology, and Nephrology, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Yokoyama', 'firstname': 'Ryuto', 'initials': 'R', 'affiliation': 'Department of Emergency and Critical Care Medicine, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Nakane', 'firstname': 'Masaki', 'initials': 'M', 'affiliation': 'Department of Emergency and Critical Care Medicine, Faculty Medicine, Yamagata University, Yamagata, Japan.'}, {'lastname': 'Kodama', 'firstname': 'Sahoko', 'initials': 'S', 'affiliation': 'Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.'}, {'lastname': 'Hasegawa', 'firstname': 'Ryo', 'initials': 'R', 'affiliation': 'Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.'}, {'lastname': 'Ueki', 'firstname': 'Shigeharu', 'initials': 'S', 'affiliation': 'Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.'}, {'lastname': 'Yaguchi', 'firstname': 'Takashi', 'initials': 'T', 'affiliation': 'The Medical Mycology Research Center, Chiba University, Chiba, Japan.'}, {'lastname': 'Watanabe', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'The Medical Mycology Research Center, Chiba University, Chiba, Japan.'}, {'lastname': 'Watanabe', 'firstname': 'Masafumi', 'initials': 'M', 'affiliation': 'Department of Cardiology, Pulmonology, and Nephrology, Faculty Medicine, Yamagata University, Yamagata, Japan.'}], 'methods': None, 'conclusions': 'Differentiating between asthma exacerbation and mucus plug-induced airway obstruction in patients with ABPM and those with acute respiratory failure is challenging. Prompt evaluation of mucous plugs and atelectasis using CT and timely decision to introduce ECMO and bronchoscopic mucous plug removal are required.', 'results': \"CT revealed bronchial wall thickening, obstruction, and extensive atelectasis. Bronchoscopy revealed extensive mucus plugs that were successfully removed within two days. The patient's respiratory status significantly improved. Follow-up CT revealed no recurrence. Fungal cultures identified \", 'copyrights': None, 'doi': '10.1080/02770903.2024.2312429', 'xml': <Element 'PubmedArticle' at 0x10ad453a0>}\n",
      "{'pubmed_id': '38294746', 'title': 'Serum Biomarkers Predicting Airway Remodeling in Severe Childhood Bronchial Asthma.', 'abstract': \"To analyze the relationship between serum Toll-like receptor 4 (TLR4) and soluble intercellular adhesion molecule-1 (sICAM-1) levels and airway remodeling in children with severe bronchial asthma (BA) and their predictive value for recurrence.\\nA retrospective study was conducted to select the clinical data of 120 children with severe BA who were admitted to Northern Jiangsu People's Hospital from June 2022 to June 2023 and completed follow-up. Serum TLR4 and sICAM-1 were detected at admission. According to the recurrence during the follow-up period, the clinical data of the recurrent children were included in the recurrent group, and the clinical data of the non-recurrent children were included in the non-recurrent group. There were 55 children each in the recurrence group and the non-recurrence group. The baseline data of children with severe BA were statistically analyzed and compared. The correlation between serum TLR4 and sICAM-1 levels and airway remodeling in children with severe BA was analyzed by bivariate correlation Pearson (N). Binary logistic regression was used to analyze the relationship between serum TLR4, sICAM-1 levels, and recurrence in children with severe BA. Receiver operating characteristic curve (ROC) was used to analyze the predictive value of serum TLR4 and sICAM-1 for recurrence in children with severe BA; R4.1.0 statistical software was used to draw the decision curve of serum TLR4 and sICAM-1 levels to predict the recurrence of severe BA in children with a high-risk threshold as abscissa and net return rate as ordinate.\\nAmong the 120 children with severe BA, 46 cases recurred during the 1-year follow-up period, with a recurrence rate of 38.33 %. The proportion of premature delivery and children with allergic rhinitis in the recurrent group was higher than that in the non-recurrent group, and the levels of eosinophil count, TLR4, and sICAM-1 were higher than those in the non-recurrent group (P < .001). The levels of T/D and WA% in the recurrent group were higher than those in the non-recurrent group (P < .001). The results of bivariate correlation Pearson (N) analysis showed that serum TLR4 and sICAM-1 levels were positively correlated with T/D and WA% in children with severe BA (r >0, P < .001); the results of ROC curve showed that the AUC of serum TLR4, sICAM-1 and combined detection in predicting the recurrence of children with severe BA were all > 0.70, which had certain predictive value, and the combined detection was the highest. The decision curve was drawn. The results showed that the net rate of return of serum TLR4 and sICAM-1 in predicting the recurrence of children with severe BA was better than that of a single net rate of return in the range of 0.217~0.284 and 0.296~0.492. In the range of high-risk threshold 0.000-0.958, the net rate of return of serum TLR4 and sICAM-1 combined to predict the recurrence of severe BA children was > 0, which was of clinical significance.\\nThe serum TLR4 and sICAM-1 levels are closely related to airway remodeling and recurrence in children with severe BA, and their levels can effectively predict the risk of recurrence.\", 'keywords': [], 'journal': 'Alternative therapies in health and medicine', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Qin', 'firstname': 'Qiaozhi', 'initials': 'Q', 'affiliation': None}, {'lastname': 'Zhang', 'firstname': 'Xian', 'initials': 'X', 'affiliation': None}, {'lastname': 'Zhao', 'firstname': 'Xueqin', 'initials': 'X', 'affiliation': None}], 'methods': None, 'conclusions': 'The serum TLR4 and sICAM-1 levels are closely related to airway remodeling and recurrence in children with severe BA, and their levels can effectively predict the risk of recurrence.', 'results': 'Among the 120 children with severe BA, 46 cases recurred during the 1-year follow-up period, with a recurrence rate of 38.33 %. The proportion of premature delivery and children with allergic rhinitis in the recurrent group was higher than that in the non-recurrent group, and the levels of eosinophil count, TLR4, and sICAM-1 were higher than those in the non-recurrent group (P < .001). The levels of T/D and WA% in the recurrent group were higher than those in the non-recurrent group (P < .001). The results of bivariate correlation Pearson (N) analysis showed that serum TLR4 and sICAM-1 levels were positively correlated with T/D and WA% in children with severe BA (r >0, P < .001); the results of ROC curve showed that the AUC of serum TLR4, sICAM-1 and combined detection in predicting the recurrence of children with severe BA were all > 0.70, which had certain predictive value, and the combined detection was the highest. The decision curve was drawn. The results showed that the net rate of return of serum TLR4 and sICAM-1 in predicting the recurrence of children with severe BA was better than that of a single net rate of return in the range of 0.217~0.284 and 0.296~0.492. In the range of high-risk threshold 0.000-0.958, the net rate of return of serum TLR4 and sICAM-1 combined to predict the recurrence of severe BA children was > 0, which was of clinical significance.', 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x10b3e9c10>}\n",
      "{'pubmed_id': '38294718', 'title': 'Insight into the role of mitochondrion-related gene anchor signature in mitochondrial dysfunction of neutrophilic asthma.', 'abstract': 'At present, targeting molecular-pharmacological therapy is still difficult in neutrophilic asthma. The investigation aims to identify and validate mitochondrion-related gene signatures for diagnosis and specific targeting therapeutics in neutrophilic asthma.\\nBronchial biopsy samples of neutrophilic asthma and healthy people were identified from the GSE143303 dataset and then matched with human mitochondrial gene data to obtain mitochondria-related differential genes (MitoDEGs). Signature mitochondria-related diagnostic markers were jointly screened by support vector machine (SVM) analysis, least absolute shrinkage, and selection operator (LASSO) regression. The expression of marker MitoDEGs was evaluated by validation datasets GSE147878 and GSE43696. The diagnostic value was evaluated by receiver operating characteristic (ROC) curve analysis. Meanwhile, the infiltrating immune cells were analyzed by the CIBERSORT. Finally, oxidative stress level and mitochondrial functional morphology for asthmatic mice and BEAS-2B cells were evaluated. The expression of signature MitoDEGs was verified by qPCR.\\n67 MitoDEGs were identified. Five signature MitoDEGs (SOD2, MTHFD2, PPTC7, NME6, and SLC25A18) were further screened out. The area under the curve (AUC) of signature MitoDEGs presented a good diagnostic performance (more than 0.9). There were significant differences in the expression of signature MitoDEGs between neutrophilic asthma and non-neutrophilic asthma. In addition, the basic features of mitochondrial dysfunction were demonstrated by \\nThese MitoDEGs signatures in neutrophilic asthma may hold potential as anchor diagnostic and therapeutic targets in neutrophilic asthma.', 'keywords': ['Neutrophilic asthma', 'airway inflammation', 'anchor diagnostic markers', 'bioinformatic analysis', 'mitochondrial damage/dysfunction'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Lin', 'firstname': 'Lu', 'initials': 'L', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, People's Republic of China.\"}, {'lastname': 'Liao', 'firstname': 'Zeng-Hua', 'initials': 'ZH', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, People's Republic of China.\"}, {'lastname': 'Li', 'firstname': 'Chao-Qian', 'initials': 'CQ', 'affiliation': \"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, People's Republic of China.\"}], 'methods': None, 'conclusions': None, 'results': '67 MitoDEGs were identified. Five signature MitoDEGs (SOD2, MTHFD2, PPTC7, NME6, and SLC25A18) were further screened out. The area under the curve (AUC) of signature MitoDEGs presented a good diagnostic performance (more than 0.9). There were significant differences in the expression of signature MitoDEGs between neutrophilic asthma and non-neutrophilic asthma. In addition, the basic features of mitochondrial dysfunction were demonstrated by ', 'copyrights': None, 'doi': '10.1080/02770903.2024.2311241', 'xml': <Element 'PubmedArticle' at 0x10b3eb420>}\n",
      "{'pubmed_id': '38294705', 'title': 'Biologics for asthma and risk of pneumonia.', 'abstract': 'Modification of the immune system with biologics raises theoretical concerns about the risk of infections but it is still unclear whether currently routinely used biologics in severe asthma may facilitate the development of pneumonia. Therefore, we aimed to determine whether omalizumab, mepolizumab, benralizumab, and dupilumab are associated with pneumonia in a real-world setting.\\nA retrospective disproportionality analysis was performed using adverse event (AE) reports submitted to FAERS from January 2020 to September 30, 2023. MedDRA was used to identify infections and infestations and then pneumonia cases. ROR and PRR were used to measure disproportionality.\\nThe percentage of reported cases of pneumonia compared to infections and infestations was highest for mepolizumab (36.8%), followed by omalizumab (32.6%), benralizumab (19.2%) and dupilumab (5.7%). We found a moderate or strong signal for increased risk of pneumonia with mepolizumab (ROR = 3.74, 95%CI 3.50-4.00), omalizumab (ROR = 3.26, 95%CI 3.06-3.49) and benralizumab (ROR = 2.65, 95%CI 2.49-2.83).\\nMepolizumab, omalizumab and benralizumab, but not dupilumab, were associated with high odds of reporting pneumonia. Our results represent only potential associations between these biologics and pneumonia but not causality. The nature of the FAERS database is such that the cause of the reported events is uncertain. Therefore, we can only roughly estimate the incidence of AEs by the signal strength (ROR value). Nevertheless, although causality could not be assessed, the signal from our study is interesting. We believe it deserves to be further substantiated by real-world studies with robust designs.', 'keywords': ['Biologics', 'Food and Drug Administration Adverse Event Reporting System', 'infections', 'pneumonia', 'severe asthma'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Matera', 'firstname': 'Maria Gabriella', 'initials': 'MG', 'affiliation': 'Unit of Pharmacology, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\", Naples, Italy.'}, {'lastname': 'Ora', 'firstname': 'Josuel', 'initials': 'J', 'affiliation': 'Division of Respiratory Medicine, University Hospital \"Fondazione Policlinico Tor Vergata\", Rome, Italy.'}, {'lastname': 'Calzetta', 'firstname': 'Luigino', 'initials': 'L', 'affiliation': 'Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.'}, {'lastname': 'Rogliani', 'firstname': 'Paola', 'initials': 'P', 'affiliation': 'Division of Respiratory Medicine, University Hospital \"Fondazione Policlinico Tor Vergata\", Rome, Italy.\\nUnit of Respiratory Medicine, Department of Experimental Medicine, University of Rome \"Tor Vergata\", Rome, Italy.'}, {'lastname': 'Cazzola', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome \"Tor Vergata\", Rome, Italy.'}], 'methods': None, 'conclusions': None, 'results': 'The percentage of reported cases of pneumonia compared to infections and infestations was highest for mepolizumab (36.8%), followed by omalizumab (32.6%), benralizumab (19.2%) and dupilumab (5.7%). We found a moderate or strong signal for increased risk of pneumonia with mepolizumab (ROR = 3.74, 95%CI 3.50-4.00), omalizumab (ROR = 3.26, 95%CI 3.06-3.49) and benralizumab (ROR = 2.65, 95%CI 2.49-2.83).', 'copyrights': None, 'doi': '10.1080/02770903.2024.2311236', 'xml': <Element 'PubmedArticle' at 0x10b316200>}\n",
      "{'pubmed_id': '38294702', 'title': 'Efficacy of bronchial thermoplasty in a patient panel with uncontrolled severe persistent asthma.', 'abstract': 'Bronchial thermoplasty (BT) is an approved procedure to manage uncontrolled severe persistent asthma. Many insurance providers are reluctant to pay for BT without proven benefit among their specific patient panel.\\nDetermine if BT is effective in a panel patient panel with uncontrolled severe persistent asthma.\\nThis was an unblinded prospective study of adult subjects with uncontrolled severe persistent asthma who underwent BT. Outcomes were assessed at baseline and then 3-, 6-, 12-, 18- and 24-months post-BT. The primary metric was an improved Asthma Quality of Life Questionnaire (AQLQ) score. Other metrics included improved Asthma Control Test (ACT), peak expiratory flow rates (PEFR), spirometry, fractional excretion of nitric oxide (FeNO), number of unscheduled medical visits, and lost days of work/activity. Respiratory adverse events were assessed during the BT treatment period and at each post-BT visit.\\nTwenty-nine subjects completed the study; the median interquartile range (IQR) age was 47 (42-61), and the majority were female (69%), white (93%), and non-Hispanic (90%). After BT, mean (±std) AQLQ scores improved by 1.6(±1.1) at 3\\u2009months (\\nBT is an effective adjunctive therapeutic modality in subjects with uncontrolled severe persistent asthma.', 'keywords': ['Quality of life', 'efficacy', 'medical costs', 'safety', 'treatment'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Zikos', 'firstname': 'Antonios', 'initials': 'A', 'affiliation': 'Department of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.'}, {'lastname': 'Balaan', 'firstname': 'Marvin', 'initials': 'M', 'affiliation': 'Department of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.'}, {'lastname': 'Hobart', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Care Analytics Department, Highmark Health, Pittsburgh, PA, USA.'}, {'lastname': 'Bansal', 'firstname': 'Sandeep', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, The Lung Center, Penn Highlands Healthcare, Dubois, PA, USA.'}, {'lastname': 'Saeed', 'firstname': 'Rihab', 'initials': 'R', 'affiliation': 'Department of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.'}, {'lastname': 'Cheema', 'firstname': 'Tariq', 'initials': 'T', 'affiliation': 'Department of Internal Medicine, Allegheny General Hospital, Pittsburgh, PA, USA.'}, {'lastname': 'Gentile', 'firstname': 'Deborah', 'initials': 'D', 'affiliation': 'Department of Health Science, Saint Francis University, Loretto, PA, USA.'}], 'methods': None, 'conclusions': 'BT is an effective adjunctive therapeutic modality in subjects with uncontrolled severe persistent asthma.', 'results': 'Twenty-nine subjects completed the study; the median interquartile range (IQR) age was 47 (42-61), and the majority were female (69%), white (93%), and non-Hispanic (90%). After BT, mean (±std) AQLQ scores improved by 1.6(±1.1) at 3\\u2009months (', 'copyrights': None, 'doi': '10.1080/02770903.2024.2309532', 'xml': <Element 'PubmedArticle' at 0x10b314040>}\n",
      "{'pubmed_id': '38294683', 'title': 'Atomized inhalation of Icaritin reduces airway inflammation and remodeling in asthmatic mice.', 'abstract': 'Asthma is a disease characterized by airway hyperresponsiveness and airway inflammation. Icaritin (ICT) is a plant hormone with various pharmacological activities such as anti-inflammatory, immune regulation, and anti-tumor. This study mainly explored the effects of nebulized inhalation of ICT on airway inflammation and airway remodeling in asthmatic mice.\\nDifferent groups of ovalbumin (OVA)-induced asthma mice with acute and chronic airway inflammation received ICT. Asthmatic mice received budesonide (BDND) aerosol inhalation as a positive control, while normal control and asthma model mice received the same volume of saline. Following finishing of the study, analyses were conducted on behavioral tests, biochemical indices, and histological structures of lung tissues.\\nAerosol inhalation of ICT can notably reduce inflammatory cells infiltration around the airways and pulmonary vessels, and suppressed goblet cell hyperplasia in asthmatic mice. Long-term inhalation of ICT can decrease airway collagen deposition and airway smooth muscle hyperplasia, and alleviate airway hyperresponsiveness, mirroring the effects observed with hormone employed in clinical practice.\\nNebulized inhalation of ICT can effectively inhibit airway inflammation in asthmatic mice, improve airway remodeling, and reduce airway hyperresponsiveness, with effects similar to those of hormones. It may serve as a potential candidate used as a hormone replacement asthma treatment.', 'keywords': ['Epimedium Linn', 'asthma', 'icaritin', 'inflammation', 'nebulized inhalation'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'He', 'firstname': 'Yintong', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.\\nThe Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Cui', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Xiao', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.'}, {'lastname': 'Hou', 'firstname': 'Lixia', 'initials': 'L', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.'}, {'lastname': 'Li', 'firstname': 'Zhimei', 'initials': 'Z', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.'}, {'lastname': 'Zuo', 'firstname': 'Huiqin', 'initials': 'H', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.'}, {'lastname': 'He', 'firstname': 'Yutong', 'initials': 'Y', 'affiliation': 'Department of Anatomy, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.\\nNational Center for Translational Medicine (Shanghai) SHU Branch, Shanghai University, Shanghai, China.'}, {'lastname': 'Yao', 'firstname': 'Dong', 'initials': 'D', 'affiliation': 'Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.\\nGuangxi Clinical Research Center for Diabetes and Metabolic Diseases, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.\\nGuangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The key laboratory of Respiratory Diseases, Education Department of Guangxi Zhuang Autonomous Region, Guilin Medical University, Guilin, China.'}], 'methods': 'Different groups of ovalbumin (OVA)-induced asthma mice with acute and chronic airway inflammation received ICT. Asthmatic mice received budesonide (BDND) aerosol inhalation as a positive control, while normal control and asthma model mice received the same volume of saline. Following finishing of the study, analyses were conducted on behavioral tests, biochemical indices, and histological structures of lung tissues.', 'conclusions': 'Nebulized inhalation of ICT can effectively inhibit airway inflammation in asthmatic mice, improve airway remodeling, and reduce airway hyperresponsiveness, with effects similar to those of hormones. It may serve as a potential candidate used as a hormone replacement asthma treatment.', 'results': 'Aerosol inhalation of ICT can notably reduce inflammatory cells infiltration around the airways and pulmonary vessels, and suppressed goblet cell hyperplasia in asthmatic mice. Long-term inhalation of ICT can decrease airway collagen deposition and airway smooth muscle hyperplasia, and alleviate airway hyperresponsiveness, mirroring the effects observed with hormone employed in clinical practice.', 'copyrights': None, 'doi': '10.1080/02770903.2024.2313131', 'xml': <Element 'PubmedArticle' at 0x10b39b240>}\n",
      "{'pubmed_id': '38294679', 'title': 'Near fatal asthma in a case of allergic bronchopulmonary aspergillosis (ABPA) treated with ECMO.', 'abstract': 'Fatal asthma is a rapidly progressing and highly fatal form of asthma. Mechanical ventilation, although necessary for respiratory support, can exacerbate the condition and lead to ventilator-associated lung injury. ECMO therapy is crucial in allowing the lungs to rest and recover, as it provides extracorporeal membrane oxygenation.\\nA 40-year-old man presented with dyspnea following a mountain climb, which rapidly worsened, leading to respiratory failure and loss of consciousness. Despite drug therapy and mechanical ventilation, arterial blood gas analysis showed persistent hypercapnia. After 3\\u2009days of ECMO support, the patient was successfully extubated and underwent treatment for Aspergillus infection. Chest CT returned to normal after 3\\u2009months of anti-aspergillus therapy.\\nWhen drug therapy and mechanical ventilation fail to improve respiratory failure in fatal asthma, prompt initiation of ECMO support is essential to create opportunities for subsequent etiological treatment.', 'keywords': ['Aspergillus infection', 'ECMO', 'Fatal asthma', 'mechanical ventilation', 'respiratory failure', 'ventilator-associated lung injury'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Zhong', 'firstname': 'Shili', 'initials': 'S', 'affiliation': 'Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.'}, {'lastname': 'Wu', 'firstname': 'Zhengbin', 'initials': 'Z', 'affiliation': 'Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.'}, {'lastname': 'Chen', 'firstname': 'Chunyan', 'initials': 'C', 'affiliation': 'Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.'}, {'lastname': 'Xiao', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.'}, {'lastname': 'Wang', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': 'Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, China.'}], 'methods': None, 'conclusions': 'When drug therapy and mechanical ventilation fail to improve respiratory failure in fatal asthma, prompt initiation of ECMO support is essential to create opportunities for subsequent etiological treatment.', 'results': None, 'copyrights': None, 'doi': '10.1080/02770903.2024.2307507', 'xml': <Element 'PubmedArticle' at 0x10b3f8540>}\n",
      "{'pubmed_id': '38294623\\n15831828\\n11360208\\n32298213\\n28723872\\n30887849\\n23343438\\n34117998\\n25622207\\n28684025\\n33866914\\n36966230\\n26335770\\n35046668\\n28462763\\n22206778\\n22806592\\n33530100\\n10882595\\n32220516\\n36588139\\n22595516\\n30169627\\n26229461\\n26826756\\n33959878', 'title': 'Epidemiology of Pertussis and Pertussis-Related Complications in Adults: A German Claims Data Analysis.', 'abstract': 'Pertussis is a highly contagious respiratory infection. It affects people of all ages, yet evidence of the impact of pertussis in adults with underlying conditions (UCs) is scarce. This study investigated the incidence and complication rate of pertussis in adult patients with and without UC.\\nA retrospective analysis was conducted using routinely collected German claims data between 2015 and 2019. Patients with and without different pneumological, cardiovascular, endocrinological, musculoskeletal, and psychological UCs were matched for incidence estimation. Logistic regression models were used to estimate the risk of pertussis depending on the presence of UCs. Negative binomial models were used to assess complication rates in patients with pertussis and with and without UC.\\nIn total, 4383 patients were diagnosed with pertussis during the study period. Patients with any UC had an increased risk for pertussis compared to matched patients without UC (odds ratio [OR] 1.72; 95% confidence interval [CI]1.60-1.84, p\\u2009<\\u20090.0001). Underlying asthma had the highest risk of pertussis (OR 2.70; 95%\\xa0CI 2.50-2.91, p\\u2009<\\u20090.0001), followed by chronic obstructive pulmonary disease (OR 2.35; 95%\\xa0CI 2.10-2.60, p\\u2009<\\u20090.0001) and depression (OR 2.08; 95%\\xa0CI 1.95-2.22, p\\u2009<\\u20090.0001). Severe complications occurred in 10.8% of the pertussis cohort (13.4% with UC vs. 9.5% without UC). The UC-attributable effect on the risk of severe pertussis-related complications was significantly increased for any UC (incidence rate ratio [IRR] 1.29, 95%\\xa0CI 1.19-1.39). The severe complication risk was also increased for patients aged 60+ (IRR 1.59, 95%\\xa0CI 1.46-1.72).\\nThis study shows that adults with certain UCs have an increased risk for pertussis and are more likely to have complications. These results provide further evidence that pertussis is a relevant and impactful infectious disease in adults with and without certain UC, indicating that these patients need to be considered when developing vaccination recommendations to avoid pertussis and its associated complications. A graphical abstract is available with this article.', 'keywords': ['Comorbidity', 'Incidence', 'Older adults', 'Pertussis', 'Real world evidence', 'Risk factor', 'Whooping cough'], 'journal': 'Infectious diseases and therapy', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Surmann', 'firstname': 'Bastian', 'initials': 'B', 'affiliation': 'Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany.'}, {'lastname': 'Witte', 'firstname': 'Julian', 'initials': 'J', 'affiliation': 'Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany. julian.witte@vandage.de.'}, {'lastname': 'Batram', 'firstname': 'Manuel', 'initials': 'M', 'affiliation': 'Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany.'}, {'lastname': 'Criée', 'firstname': 'Carl Peter', 'initials': 'CP', 'affiliation': 'Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, Bovenden, Germany.'}, {'lastname': 'Hermann', 'firstname': 'Christiane', 'initials': 'C', 'affiliation': 'Department of Clinical Psychology, Justus-Liebig University Giessen, Giessen, Germany.'}, {'lastname': 'Leischker', 'firstname': 'Andreas', 'initials': 'A', 'affiliation': 'Department for Geriatrics, Working Group \"Vaccination\", German Geriatric Society, Cologne, Germany.\\nAsklepios Hospital Wandsbek, Hamburg, Germany.'}, {'lastname': 'Schelling', 'firstname': 'Jörg', 'initials': 'J', 'affiliation': 'Medizinische Klinik IV, Ludwig-Maximilians-University Munich, Munich, Germany.'}, {'lastname': 'Steinmüller', 'firstname': 'Mirko', 'initials': 'M', 'affiliation': 'PRAXIS DILLTAL, Ehringshausen, Germany.'}, {'lastname': 'Wahle', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'Department of General Medicine, University of Muenster, Muenster, Germany.'}, {'lastname': 'Heiseke', 'firstname': 'Alexander F', 'initials': 'AF', 'affiliation': 'GSK, Munich, Germany.'}, {'lastname': 'Marijic', 'firstname': 'Pavo', 'initials': 'P', 'affiliation': 'GSK, Munich, Germany.'}], 'methods': None, 'conclusions': 'This study shows that adults with certain UCs have an increased risk for pertussis and are more likely to have complications. These results provide further evidence that pertussis is a relevant and impactful infectious disease in adults with and without certain UC, indicating that these patients need to be considered when developing vaccination recommendations to avoid pertussis and its associated complications. A graphical abstract is available with this article.', 'results': 'In total, 4383 patients were diagnosed with pertussis during the study period. Patients with any UC had an increased risk for pertussis compared to matched patients without UC (odds ratio [OR] 1.72; 95% confidence interval [CI]1.60-1.84, p\\u2009<\\u20090.0001). Underlying asthma had the highest risk of pertussis (OR 2.70; 95%\\xa0CI 2.50-2.91, p\\u2009<\\u20090.0001), followed by chronic obstructive pulmonary disease (OR 2.35; 95%\\xa0CI 2.10-2.60, p\\u2009<\\u20090.0001) and depression (OR 2.08; 95%\\xa0CI 1.95-2.22, p\\u2009<\\u20090.0001). Severe complications occurred in 10.8% of the pertussis cohort (13.4% with UC vs. 9.5% without UC). The UC-attributable effect on the risk of severe pertussis-related complications was significantly increased for any UC (incidence rate ratio [IRR] 1.29, 95%\\xa0CI 1.19-1.39). The severe complication risk was also increased for patients aged 60+ (IRR 1.59, 95%\\xa0CI 1.46-1.72).', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s40121-023-00912-z\\n10.1128/CMR.18.2.326-382.2005\\n10.1086/320754\\n10.1080/21645515.2020.1738168\\n10.1097/INF.0000000000001698\\n10.1080/14760584.2019.1588727\\n10.1186/1471-2334-13-32\\n10.1007/s40121-021-00465-z\\n10.1055/s-0034-1396815\\n10.1016/S0140-6736(17)31280-1\\n10.1080/15412555.2021.1899155\\n10.1007/s40121-023-00774-5\\n10.1016/j.vaccine.2015.08.068\\n10.2147/JAA.S335960\\n10.1017/S0950268817000887\\n10.1016/j.jaci.2011.11.020\\n10.1002/clc.23800\\n10.1093/cid/cis627\\n10.1093/cid/ciab089\\n10.1086/315648\\n10.1016/j.vaccine.2020.03.021\\n10.1007/s40121-022-00747-0\\n10.1017/S095026881200091X\\n10.1093/cid/ciy757\\n10.2147/COPD.S83135\\n10.1016/j.healthpol.2016.01.007\\n10.1007/s13555-021-00535-7', 'xml': <Element 'PubmedArticle' at 0x10b3fa340>}\n",
      "{'pubmed_id': '38294589\\n6880820\\n19007738\\n30150898\\n8705964', 'title': 'Cognitive Impairment and Depression in Mastocytosis: A Synthesis of the Literature.', 'abstract': 'Symptoms of depression and cognitive dysfunction are commonly reported in mastocytosis. The aims of this review paper are to summarize the current literature on cognitive dysfunction and depressive symptoms, elucidate some of the mechanistic pathways underlying depressive symptoms in mastocytosis, identify gaps in the literature, and offer guidance for future research in this area.\\nThe study of cognition and depression in mastocytosis is in its infancy and the methodological flaws of the current literature limit interpretability. There is preliminary evidence that some individuals with mastocytosis might experience mild deficits in memory. On average, depression symptom scores fell within the mild to moderate or sub-syndromal range. Regrettably, only one study utilized a standardized diagnostic instrument to assess major depressive disorder. The authors\\' tendency to inaccurately equate depressive symptoms with a diagnosis of major depressive disorder presents a notable issue. The prevalence of cognitive deficits and depression appears to be similar to other chronic illnesses. Future work needs to better characterize cognition and characterize \"depression\" in this population.', 'keywords': ['Cognition', 'Major depressive disorder', 'Mastocytosis', 'Symptoms of depression'], 'journal': 'Current allergy and asthma reports', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Nicoloro-SantaBarbara', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': \"Department of Psychiatry, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, 02115, USA. jnicoloro1@bwh.harvard.edu.\\nHarvard Medical School, Boston, MA, USA. jnicoloro1@bwh.harvard.edu.\"}, {'lastname': 'Majd', 'firstname': 'Marzieh', 'initials': 'M', 'affiliation': \"Department of Psychiatry, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, 02115, USA.\\nHarvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Burdick', 'firstname': 'Katherine E', 'initials': 'KE', 'affiliation': \"Department of Psychiatry, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, 02115, USA.\\nHarvard Medical School, Boston, MA, USA.\"}, {'lastname': 'Dixon', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Department of Psychology, Northeastern University, Boston, MA, USA.'}, {'lastname': 'Giannetti', 'firstname': 'Matthew P', 'initials': 'MP', 'affiliation': \"Harvard Medical School, Boston, MA, USA.\\nDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA, USA.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.', 'doi': '10.1007/s11882-024-01127-z\\n10.1007/978-0-387-79948-3_1288\\n10.1111/j.1600-0447.1983.tb09716.x\\n10.1016/S1474-4422(08)70259-X\\n10.4088/PCC.v02n0501\\n10.7224/1537-2073.2017-029\\n10.1177/070674379604100201', 'xml': <Element 'PubmedArticle' at 0x10a2598f0>}\n",
      "{'pubmed_id': '38294339', 'title': 'A US national update of health condition prevalence among privately-insured autistic adults.', 'abstract': '', 'keywords': ['autism', 'mental health', 'physical health'], 'journal': 'Journal of comparative effectiveness research', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Longo', 'firstname': 'Anne', 'initials': 'A', 'affiliation': 'The Ohio State University, 228E Atwell Hall, 453 W 10th Ave, Columbus, OH 43210, USA.'}, {'lastname': 'Radford', 'firstname': 'Deondray', 'initials': 'D', 'affiliation': 'The Ohio State University, 228E Atwell Hall, 453 W 10th Ave, Columbus, OH 43210, USA.'}, {'lastname': 'Hand', 'firstname': 'Brittany N', 'initials': 'BN', 'affiliation': 'The Ohio State University, 228E Atwell Hall, 453 W 10th Ave, Columbus, OH 43210, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.57264/cer-2023-0051', 'xml': <Element 'PubmedArticle' at 0x10a262f70>}\n",
      "{'pubmed_id': '38294255', 'title': 'Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice.', 'abstract': 'Gypenoside XIII is isolated from Gynostemma pentaphyllum (Thunb.) Makino. In mice, G. pentaphyllum extract and gypenoside LXXV have been shown to improve non-alcoholic steatohepatitis (NASH). This study investigated whether gypenoside XIII can regulate lipid accumulation in fatty liver cells or attenuate NASH in mice. We used HepG2 hepatocytes to establish a fatty liver cell model using 0.5\\u2009mM oleic acid. Fatty liver cells were treated with different concentrations of gypenoside XIII to evaluate the molecular mechanisms of lipid metabolism. In addition, a methionine/choline-deficient diet induced NASH in C57BL/6 mice, which were given 10\\u2009mg/kg gypenoside XIII by intraperitoneal injection. In fatty liver cells, gypenoside XIII effectively suppressed lipid accumulation and lipid peroxidation. Furthermore, gypenoside XIII significantly increased SIRT1 and AMPK phosphorylation to decrease acetyl-CoA carboxylase phosphorylation, reducing fatty acid synthesis activity. Gypenoside XIII also decreased lipogenesis by suppressing sterol regulatory element-binding protein 1c and fatty acid synthase production. Gypenoside XIII also increased lipolysis and fatty acid β-oxidation by promoting adipose triglyceride lipase and carnitine palmitoyltransferase 1, respectively. In an animal model of NASH, gypenoside XIII effectively decreased the lipid vacuole size and number and reduced liver fibrosis and inflammation. These findings suggest that gypenoside XIII can regulate lipid metabolism in fatty liver cells and improve liver fibrosis in NASH mice. Therefore, gypenoside XIII has potential as a novel agent for the treatment of NASH.', 'keywords': ['gypenoside XIII', 'inflammation', 'lipogenesis', 'lipolysis', 'non-alcoholic steatohepatitis'], 'journal': 'The Kaohsiung journal of medical sciences', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Cheng', 'firstname': 'Shu-Chen', 'initials': 'SC', 'affiliation': 'Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.\\nGraduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.'}, {'lastname': 'Liou', 'firstname': 'Chian-Jiun', 'initials': 'CJ', 'affiliation': 'Department of Nursing, Division of Basic Medical Sciences, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.\\nDivision of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.'}, {'lastname': 'Wu', 'firstname': 'Ya-Xuan', 'initials': 'YX', 'affiliation': 'Graduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.'}, {'lastname': 'Yeh', 'firstname': 'Kuo-Wei', 'initials': 'KW', 'affiliation': 'Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.'}, {'lastname': 'Chen', 'firstname': 'Li-Chen', 'initials': 'LC', 'affiliation': 'Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.\\nDepartment of Pediatrics, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei, Taiwan.'}, {'lastname': 'Huang', 'firstname': 'Wen-Chung', 'initials': 'WC', 'affiliation': 'Graduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.\\nDivision of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.\\nDepartment of Pediatrics, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei, Taiwan.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.', 'doi': '10.1002/kjm2.12795', 'xml': <Element 'PubmedArticle' at 0x10a2c9670>}\n",
      "{'pubmed_id': '38293980', 'title': '[Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].', 'abstract': 'To investigate the impact of type 2 inflammation markers blood eosinophils (EOS) and fractional exhaled nitric oxide (FeNO) on bronchodilator responsiveness (BDR) in patients with chronic obstructive pulmonary disease (COPD).\\nThis study was conducted among 389 patients with an established diagnosis of COPD in our hospital from October, 2019 to October, 2023, who all underwent bronchial dilation test (BDT) of the large and small airways. Based on smoking history, blood EOS, and FeNO, these patients were divided group A (blood EOS < 300/μL + FeNO < 35 ppb + smoking history < 20 pack-years), group B (blood EOS < 300/μL+FeNO < 35 ppb+smoking history ≥20 pack-years), group C (blood EOS ≥300/μL or FeNO≥35 ppb+smoking history ≥20 pack-years), and group D (blood EOS ≥300/μL or FeNO ≥35 ppb+smoking history < 20 pack-years) for analyzing the relationship between clinical indexes and BDR.\\nBDR evaluation based on forced expiratory volume in 1 second (FEV\\nType 2 inflammation markers have different effects on BDR in the large and small airways of COPD patients, and their clinical significance needs further investigation.', 'keywords': ['bronchodilator responsiveness', 'chronic obstructive pulmonary disease', 'small airway', 'type 2 inflammation'], 'journal': 'Nan fang yi ke da xue xue bao = Journal of Southern Medical University', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Xu', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Gong', 'firstname': 'Z', 'initials': 'Z', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Wang', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Ma', 'firstname': 'Y', 'initials': 'Y', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Xu', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Chen', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.\\nSchool of Nursing, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Hu', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Liang', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Zhao', 'firstname': 'W', 'initials': 'W', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}, {'lastname': 'Zhao', 'firstname': 'H', 'initials': 'H', 'affiliation': 'Laboratory of Chronic Airway Diseases, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.'}], 'methods': None, 'conclusions': 'Type 2 inflammation markers have different effects on BDR in the large and small airways of COPD patients, and their clinical significance needs further investigation.', 'results': 'BDR evaluation based on forced expiratory volume in 1 second (FEV', 'copyrights': None, 'doi': '10.12122/j.issn.1673-4254.2024.01.11', 'xml': <Element 'PubmedArticle' at 0x10a2ddd50>}\n",
      "{'pubmed_id': '38293828', 'title': 'Emerging nanoparticle platforms for CpG oligonucleotide delivery.', 'abstract': 'Unmethylated cytosine-phosphate-guanine (CpG) oligodeoxynucleotides (ODNs), which were therapeutic DNA with high immunostimulatory activity, have been applied in widespread applications from basic research to clinics as therapeutic agents for cancer immunotherapy, viral infection, allergic diseases and asthma since their discovery in 1995. The major factors to consider for clinical translation using CpG motifs are the protection of CpG ODNs from DNase degradation and the delivery of CpG ODNs to the Toll-like receptor-9 expressed human B-cells and plasmacytoid dendritic cells. Therefore, great efforts have been devoted to the advances of efficient delivery systems for CpG ODNs. In this review, we outline new horizons and recent developments in this field, providing a comprehensive summary of the nanoparticle-based CpG delivery systems developed to improve the efficacy of CpG-mediated immune responses, including DNA nanostructures, inorganic nanoparticles, polymer nanoparticles, metal-organic-frameworks, lipid-based nanosystems, proteins and peptides, as well as exosomes and cell membrane nanoparticles. Moreover, future challenges in the establishment of CpG delivery systems for immunotherapeutic applications are discussed. We expect that the continuously growing interest in the development of CpG-based immunotherapy will certainly fuel the excitement and stimulation in medicine research.', 'keywords': [], 'journal': 'Biomaterials science', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Li', 'firstname': 'Mingqiang', 'initials': 'M', 'affiliation': 'Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China. taoy28@mail.sysu.edu.cn.'}, {'lastname': 'Yao', 'firstname': 'Haochen', 'initials': 'H', 'affiliation': 'Hepatobiliary and Pancreatic Surgery Department, General Surgery Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, Jilin, China.'}, {'lastname': 'Yi', 'firstname': 'Ke', 'initials': 'K', 'affiliation': 'Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China. taoy28@mail.sysu.edu.cn.'}, {'lastname': 'Lao', 'firstname': 'Yeh-Hsing', 'initials': 'YH', 'affiliation': 'Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, 14214, USA.'}, {'lastname': 'Shao', 'firstname': 'Dan', 'initials': 'D', 'affiliation': 'Institutes of Life Sciences, School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China.'}, {'lastname': 'Tao', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China. taoy28@mail.sysu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1039/d3bm01970e', 'xml': <Element 'PubmedArticle' at 0x10a26e0c0>}\n",
      "{'pubmed_id': '38293814', 'title': 'Tumor markers for lipid metabolism-related genes: Based on small cell lung cancer and bronchial asthma dual analysis.', 'abstract': 'Numerous studies have elucidated the intricate relationship between bronchial asthma and small cell lung cancer (SCLC), as well as the role lipid metabolism genes play in transitioning from bronchial asthma to SCLC. Despite this, the predictive power of single gene biomarkers remains insufficient and necessitates the development of more accurate prognostic models. In our study, we downloaded and preprocessed scRNA-seq of SCLC from the GEO database GSE164404 and severe asthma scRNA-seq from GSE145013 using the Seurat package. Using the MSigDB database and geneCard database, we selected lipid metabolism-related genes and performed scRNA-seq data analysis from the gene expression GEO database, aiming to uncover potential links between immune signaling pathways in bronchial asthma and SCLC. Our investigations yielded differentially expressed genes based on the scRNA-seq dataset related to lipid metabolism. We executed differential gene analysis, gene ontology, and Kyoto Encyclopedia of Genes and Genomes analyses. In-depth GSEA pathway activation analysis, crucial target gene predictions via protein-protein interactions, and key cluster gene evaluations for differential and diagnostic ROC values correlation analysis confirmed that key cluster genes are significant predictors for the progression of bronchial asthma to SCLC. To validate our findings, we performed wet laboratory experiments using real-time quantitative PCR to assess the expression of these relevant genes in SCLC cell lines. In conclusion, this research proposes a novel lipid metabolism-related gene marker that can offer comprehensive insights into the pathogenesis of bronchial asthma leading to SCLC. Although this study does not directly focus on senescence-associated molecular alterations, our findings in the lipid metabolism genes associated with inflammation and cancer progression offer valuable insights for further research targeting senescence-related changes in treating inflammatory diseases.', 'keywords': ['bronchial asthma', 'lipid metabolism-related genes', 'protein-protein interactions (PPI)', 'single-cell RNA sequencing (scRNA-seq)', 'small cell lung cancer'], 'journal': 'Environmental toxicology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Wang', 'firstname': 'Xiaobin', 'initials': 'X', 'affiliation': 'Department of Thoracic Surgery, Tangdu Hospital of Air Force Medical University, China.'}, {'lastname': 'Gao', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Department of Thoracic Surgery, Tangdu Hospital of Air Force Medical University, China.'}, {'lastname': 'Wang', 'firstname': 'Haiqiang', 'initials': 'H', 'affiliation': 'Department of Thoracic Surgery, Tangdu Hospital of Air Force Medical University, China.'}, {'lastname': 'Gong', 'firstname': 'Xiaokang', 'initials': 'X', 'affiliation': 'Department of Thoracic Surgery, Tangdu Hospital of Air Force Medical University, China.'}, {'lastname': 'Bao', 'firstname': 'Peilong', 'initials': 'P', 'affiliation': 'Department of Thoracic Surgery, Tangdu Hospital of Air Force Medical University, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 Wiley Periodicals LLC.', 'doi': '10.1002/tox.24152', 'xml': <Element 'PubmedArticle' at 0x10a26dc60>}\n",
      "{'pubmed_id': '38293275', 'title': 'Erratum to \"Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD\" [World Allergy Organ (2023) 100817].', 'abstract': '[This corrects the article DOI: 10.1016/j.waojou.2023.100817.].', 'keywords': [], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Tepetam', 'firstname': 'Fatma Merve', 'initials': 'FM', 'affiliation': 'University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey.'}, {'lastname': 'Özden', 'firstname': 'Şeyma', 'initials': 'Ş', 'affiliation': 'University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey.'}, {'lastname': 'Kılıç', 'firstname': 'Fatma Kübra', 'initials': 'FK', 'affiliation': 'University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Turkey.'}, {'lastname': 'Örçen', 'firstname': 'Cihan', 'initials': 'C', 'affiliation': 'University of Health Sciences, Derince Training and Research Hospital, Kocaeli, Turkey.'}, {'lastname': 'Yakut', 'firstname': 'Tuğçe', 'initials': 'T', 'affiliation': 'University of Health Sciences, Diyarbakır Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 The Author(s).', 'doi': '10.1016/j.waojou.2023.100861', 'xml': <Element 'PubmedArticle' at 0x10a217b00>}\n",
      "{'pubmed_id': '38293162\\n29904028\\n37308252\\n34233665\\n36692679\\n30544758\\n32054644\\n32084394\\n21506741\\n31034279\\n26512610\\n31710517\\n33226834\\n23583980\\n35688625\\n36777997\\n33758299\\n37523715\\n32423490\\n24429156\\n29066090\\n29891356\\n33974018\\n35985358\\n21471066\\n30168753\\n25722852\\n33785739\\n36635100\\n27268795\\n24830394\\n27318201\\n31233103\\n36399499\\n31307061\\n29459894\\n25217476\\n36029835', 'title': 'Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.', 'abstract': 'Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood, with differing environmental exposures due to historically sex-biased occupations, or diagnostic bias, being possible explanations. To date, over 20 independent genetic variants have been identified to be associated with IPF susceptibility, but these have been discovered when combining males and females. Our aim was to test for the presence of sex-specific associations with IPF susceptibility and assess whether there is a need to consider sex-specific effects when evaluating genetic risk in clinical prediction models for IPF.\\nWe performed genome-wide single nucleotide polymorphism (SNP)-by-sex interaction studies of IPF risk in six independent IPF case-control studies and combined them using inverse-variance weighted fixed effect meta-analysis. In total, 4,561 cases (1,280 females and 2,281 males) and 23,500 controls (8,360 females and 14,528 males) of European genetic ancestry were analysed. We used polygenic risk scores (PRS) to assess differences in genetic risk prediction between males and females.\\nThree independent genetic association signals were identified. All showed a consistent direction of effect across all individual IPF studies and an opposite direction of effect in IPF susceptibility between females and males. None had been previously identified in IPF susceptibility genome-wide association studies (GWAS). The predictive accuracy of the PRSs were similar between males and females, regardless of whether using combined or sex-specific GWAS results.\\nWe prioritised three genetic variants whose effect on IPF risk may be modified by sex, however these require further study. We found no evidence that the predictive accuracy of common SNP-based PRSs varies significantly between males and females.', 'keywords': [], 'journal': 'medRxiv : the preprint server for health sciences', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Leavy', 'firstname': 'Olivia C', 'initials': 'OC', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Goemans', 'firstname': 'Anne F', 'initials': 'AF', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.'}, {'lastname': 'Stockwell', 'firstname': 'Amy D', 'initials': 'AD', 'affiliation': 'Genentech, California, USA.'}, {'lastname': 'Allen', 'firstname': 'Richard J', 'initials': 'RJ', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Guillen-Guio', 'firstname': 'Beatriz', 'initials': 'B', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Hernandez-Beeftink', 'firstname': 'Tamara', 'initials': 'T', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Adegunsoye', 'firstname': 'Ayodeji', 'initials': 'A', 'affiliation': 'University of Chicago, Chicago, USA.'}, {'lastname': 'Booth', 'firstname': 'Helen L', 'initials': 'HL', 'affiliation': 'University College London Hospitals, London, UK.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}, {'lastname': 'Cullinan', 'firstname': 'Paul', 'initials': 'P', 'affiliation': 'Imperial College, London, UK.'}, {'lastname': 'Fahy', 'firstname': 'William A', 'initials': 'WA', 'affiliation': 'GlaxoSmithKline, London, UK.'}, {'lastname': 'Fingerlin', 'firstname': 'Tasha E', 'initials': 'TE', 'affiliation': 'National Jewish Health, Colorado, USA.'}, {'lastname': 'Virk', 'firstname': 'Harvinder S', 'initials': 'HS', 'affiliation': 'NIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Hall', 'firstname': 'Ian P', 'initials': 'IP', 'affiliation': 'University of Nottingham, Nottingham, UK.\\nNational Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.'}, {'lastname': 'Hart', 'firstname': 'Simon P', 'initials': 'SP', 'affiliation': 'University of Hull, Hull, UK.'}, {'lastname': 'Hill', 'firstname': 'Mike R', 'initials': 'MR', 'affiliation': 'University of Oxford, Oxford, UK.'}, {'lastname': 'Hirani', 'firstname': 'Nik', 'initials': 'N', 'affiliation': 'University of Edinburgh, Edinburgh, UK.'}, {'lastname': 'Hubbard', 'firstname': 'Richard B', 'initials': 'RB', 'affiliation': 'University of Nottingham, Nottingham, UK.\\nNational Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.'}, {'lastname': 'Kaminski', 'firstname': 'Naftali', 'initials': 'N', 'affiliation': 'Yale School of Medicine, Connecticut, USA.'}, {'lastname': 'Ma', 'firstname': 'Shwu-Fan', 'initials': 'SF', 'affiliation': 'University of Virginia, Virginia, USA.'}, {'lastname': 'McAnulty', 'firstname': 'Robin J', 'initials': 'RJ', 'affiliation': 'University College London, London, UK.'}, {'lastname': 'Sheng', 'firstname': 'X Rebecca', 'initials': 'XR', 'affiliation': 'Genentech, California, USA.'}, {'lastname': 'Millar', 'firstname': 'Ann B', 'initials': 'AB', 'affiliation': 'University of Bristol, Bristol, UK.'}, {'lastname': 'Molina-Molina', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.\\nCampus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Navaratnam', 'firstname': 'Vidya', 'initials': 'V', 'affiliation': 'Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Australia.\\nCentre for Respiratory Research, University of Western Australia, Perth, Australia.'}, {'lastname': 'Neighbors', 'firstname': 'Margaret', 'initials': 'M', 'affiliation': 'Genentech, California, USA.'}, {'lastname': 'Parfrey', 'firstname': 'Helen', 'initials': 'H', 'affiliation': 'Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.'}, {'lastname': 'Saini', 'firstname': 'Gauri', 'initials': 'G', 'affiliation': 'University of Nottingham, Nottingham, UK.'}, {'lastname': 'Sayers', 'firstname': 'Ian', 'initials': 'I', 'affiliation': 'Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.'}, {'lastname': 'Strek', 'firstname': 'Mary E', 'initials': 'ME', 'affiliation': 'University of Chicago, Chicago, USA.'}, {'lastname': 'Tobin', 'firstname': 'Martin D', 'initials': 'MD', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}, {'lastname': 'Whyte', 'firstname': 'Moira Kb', 'initials': 'MK', 'affiliation': 'University of Edinburgh, Edinburgh, UK.'}, {'lastname': 'Zhang', 'firstname': 'Yingze', 'initials': 'Y', 'affiliation': 'University of Pittsburgh, Pittsburgh, USA.'}, {'lastname': 'Maher', 'firstname': 'Toby M', 'initials': 'TM', 'affiliation': 'NIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.\\nDivision of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, USA.'}, {'lastname': 'Molyneaux', 'firstname': 'Philip L', 'initials': 'PL', 'affiliation': 'National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK.\\nNIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Oldham', 'firstname': 'Justin M', 'initials': 'JM', 'affiliation': 'University of Michigan, Michigan, USA.'}, {'lastname': 'Yaspan', 'firstname': 'Brian L', 'initials': 'BL', 'affiliation': 'Genentech, California, USA.'}, {'lastname': 'Flores', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.\\nGenomics Division, Instituto Tecnologico y de Energias Renovables, Santa Cruz de Tenerife, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.\\nFacultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.'}, {'lastname': 'Martinez', 'firstname': 'Fernando', 'initials': 'F', 'affiliation': 'Weill Cornell Medicine, New York, USA.'}, {'lastname': 'Reynolds', 'firstname': 'Carl J', 'initials': 'CJ', 'affiliation': 'Imperial College, London, UK.'}, {'lastname': 'Schwartz', 'firstname': 'David A', 'initials': 'DA', 'affiliation': 'University of Colorado Medicine, Colorado, USA.'}, {'lastname': 'Noth', 'firstname': 'Imre', 'initials': 'I', 'affiliation': 'University of Virginia, Virginia, USA.'}, {'lastname': 'Jenkins', 'firstname': 'R Gisli', 'initials': 'RG', 'affiliation': 'NIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Wain', 'firstname': 'Louise V', 'initials': 'LV', 'affiliation': 'Department of Population Health Sciences, University of Leicester, Leicester, UK.\\nNIHR Leicester Biomedical Research Centre, Leicester, UK.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1101/2024.01.12.24301204', 'xml': <Element 'PubmedArticle' at 0x10a2e7740>}\n",
      "{'pubmed_id': '38293040\\n34966142\\n37142688\\n32918548\\n35107571\\n33388760\\n35169689\\n35132841\\n34693233\\n34002466\\n34613896\\n35410632\\n36880106\\n35322270\\n37691952\\n37038904\\n36787015\\n35400169\\n32789994\\n33865340\\n35133437\\n34660475\\n33323493\\n33835179\\n36053578\\n36589967\\n33227520\\n32492092\\n34768645\\n37201420\\n37460271\\n32949098\\n34667396\\n34633493\\n36598072\\n37719985\\n33263054\\n33205546\\n34581790\\n36054578\\n35990639\\n36849806\\n35839540\\n33549624\\n35798233\\n35592840\\n35247015\\n33956754\\n34736044\\n34420893\\n36960069\\n33338306\\n33719167\\n34301621\\n34454651\\n33996683\\n35793239\\n33781551\\n33212828\\n35006377\\n37594620\\n34032552\\n35338032\\n34312307\\n33059040\\n35630472\\n34694269\\n32563282\\n34838342\\n34348452\\n34196678\\n37188564\\n33765595\\n33055501\\n32519943\\n35417912\\n33315538\\n32665373\\n33386296\\n33093428\\n34915968\\n33231051\\n35240138\\n32407719\\n35670605\\n32444450\\n33062530\\n32524611\\n35936225\\n34062054\\n36370421\\n33197493\\n33340348\\n35015063\\n32932333\\n32593339\\n33538539\\n34452324\\n34106883\\n34774486\\n33175011\\n36873820\\n32680880\\n33332356\\n34097050\\n34796674\\n36573520\\n34893036\\n34960635\\n35715177\\n33474580\\n36048629\\n35689192\\n35738340\\n34119027\\n35307916\\n36382503\\n36044328\\n32495147\\n33880437\\n32320003\\n33877105\\n34152371\\n35079726\\n34779156\\n33606669\\n35481672\\n35962242\\n34489291\\n32950434\\n32960186\\n36661087\\n33170927\\n35488136\\n33033078\\n34968374\\n34931076\\n35869013\\n34935038\\n33034209\\n35307916\\n34570263\\n35456195\\n37243292\\n36056926\\n36136155\\n33355203\\n34655034\\n36494148\\n35238933\\n36069811\\n35957811\\n36462147\\n37114013\\n21802902', 'title': 'Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.', 'abstract': 'Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society COVID-19 treatment guidance. This systematic review and meta-analysis aimed to define the clinical characteristics and comorbidities associated with critical COVID-19 in children and adolescents.\\nTwo independent reviewers screened the literature (Medline and EMBASE) for studies published through August 2023 that reported outcome data on patients aged ≤21 years with COVID-19. Critical disease was defined as an invasive mechanical ventilation requirement, intensive care unit admission, or death. Random effects models were used to estimate pooled odds ratios (OR) with 95% confidence intervals (CI), and heterogeneity was explored through subgroup analyses.\\nAmong 10,178 articles, 136 studies met the inclusion criteria for review. Data from 70 studies, which collectively examined 172,165 children and adolescents with COVID-19, were pooled for meta-analysis. In previously healthy children, the absolute risk of critical disease from COVID-19 was 4% (95% CI, 1%-10%). Compared with no comorbidities, the pooled OR for critical disease was 3.95 (95% CI, 2.78-5.63) for presence of one comorbidity and 9.51 (95% CI, 5.62-16.06) for ≥2 comorbidities. Key risk factors included cardiovascular and neurological disorders, chronic pulmonary conditions (excluding asthma), diabetes, obesity, and immunocompromise, all with statistically significant ORs >2.00.\\nWhile the absolute risk for critical COVID-19 in children and adolescents without underlying health conditions is relatively low, the presence of one or more comorbidities was associated with markedly increased risk. These findings support the importance of risk stratification in tailoring pediatric COVID-19 management.', 'keywords': ['COVID-19', 'Predictors of severity', 'comorbidities', 'pediatric', 'risk factors'], 'journal': 'medRxiv : the preprint server for health sciences', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Aparicio', 'firstname': 'Camila', 'initials': 'C', 'affiliation': 'Department of Pediatrics, Yale University School of Medicine, New Haven, CT.'}, {'lastname': 'Willis', 'firstname': 'Zachary I', 'initials': 'ZI', 'affiliation': 'Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.'}, {'lastname': 'Nakamura', 'firstname': 'Mari M', 'initials': 'MM', 'affiliation': \"Antimicrobial Stewardship Program and Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.\"}, {'lastname': 'Wolf', 'firstname': 'Joshua', 'initials': 'J', 'affiliation': \"Department of Infectious Diseases, St. Jude Children's Research Hospital and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.\"}, {'lastname': 'Little', 'firstname': 'Cordell', 'initials': 'C', 'affiliation': 'Department of Pediatrics, Yale University School of Medicine, New Haven, CT.'}, {'lastname': 'Maron', 'firstname': 'Gabriela M', 'initials': 'GM', 'affiliation': \"Department of Infectious Diseases, St. Jude Children's Research Hospital and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.\"}, {'lastname': 'Sue', 'firstname': 'Paul K', 'initials': 'PK', 'affiliation': 'Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.'}, {'lastname': 'Anosike', 'firstname': 'Brenda I', 'initials': 'BI', 'affiliation': \"Department of Pediatrics, The Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, NY.\"}, {'lastname': 'Miller', 'firstname': 'Christine', 'initials': 'C', 'affiliation': 'Department of Pediatrics, Yale University School of Medicine, New Haven, CT.'}, {'lastname': 'Bio', 'firstname': 'Laura L', 'initials': 'LL', 'affiliation': \"Department of Pharmacy, Lucile Packard Children's Hospital, Stanford, CA.\"}, {'lastname': 'Singh', 'firstname': 'Prachi', 'initials': 'P', 'affiliation': 'Department of Pediatrics, University of California San Francisco, San Francisco, CA.'}, {'lastname': 'James', 'firstname': 'Scott H', 'initials': 'SH', 'affiliation': 'Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL.'}, {'lastname': 'Oliveira', 'firstname': 'Carlos R', 'initials': 'CR', 'affiliation': 'Department of Pediatrics, Yale University School of Medicine, New Haven, CT.'}], 'methods': None, 'conclusions': None, 'results': 'Among 10,178 articles, 136 studies met the inclusion criteria for review. Data from 70 studies, which collectively examined 172,165 children and adolescents with COVID-19, were pooled for meta-analysis. In previously healthy children, the absolute risk of critical disease from COVID-19 was 4% (95% CI, 1%-10%). Compared with no comorbidities, the pooled OR for critical disease was 3.95 (95% CI, 2.78-5.63) for presence of one comorbidity and 9.51 (95% CI, 5.62-16.06) for ≥2 comorbidities. Key risk factors included cardiovascular and neurological disorders, chronic pulmonary conditions (excluding asthma), diabetes, obesity, and immunocompromise, all with statistically significant ORs >2.00.', 'copyrights': None, 'doi': '10.1101/2024.01.17.24301452', 'xml': <Element 'PubmedArticle' at 0x109cb1170>}\n",
      "{'pubmed_id': '38292952\\n30210782\\n37859757\\n18782108\\n27562177\\n33273461\\n35463011\\n35430600\\n25629743\\n32186703\\n36644088\\n33815598\\n22410181\\n35386974\\n26075169\\n30822401\\n30850070\\n30846420\\n32430550\\n31426616\\n31639763\\n32017213\\n36766723\\n33313967\\n17915673\\n22150126\\n28306159\\n32869882\\n35387059', 'title': 'Allergic Rhinitis: Tailoring Immunotherapy Through Innovative Diagnostics.', 'abstract': 'Allergic rhinitis (AR) is a chronic ailment triggered by immunoglobulin E (IgE)-mediated reactions to allergens. Generally, AR is accompanied by asthma and conjunctivitis. The risk factors of AR include both inhalant and occupational allergens and genetic factors. Although AR is not a life-threatening condition, it poses a significant risk of morbidity and hampers work-related performance. Currently, the diagnosis of AR is based on clinical history and physical examination of the patients. Furthermore, several laboratory tests such as skin pricking test (SPT), nasal allergen challenge (NAC), and computed tomography (CT) are also recommended in some cases. Nasal cytology can aid in the differentiation of rhinitis because of allergy or infection. Apart from this, molecular diagnostic modalities such as basophil activation test (BAT) and Immune Solid-Phase Allergy Chip (ISAC) can also be employed for the confirmatory diagnosis of AR. Immunotherapy has demonstrated efficacy in the management of AR, with only mild side effects. With the advancement in the diagnostic realm of AR, personalized treatment approach has also gained significant popularity. Immunotherapy is gaining evidence on becoming a personalized treatment approach for the management of AR. This article provides a comprehensive overview, aiming to bridge the gap between evolving diagnostics and personalized therapeutic strategies for allergic rhinitis.', 'keywords': ['allergens', 'ar: allergic rhinitis', 'inflammation', 'molecular diagnostics', 'personalized medicine (pm)'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Abushal', 'firstname': 'Bandar A', 'initials': 'BA', 'affiliation': 'Department of Otolaryngology, Ministry of Health, Makkah, SAU.'}, {'lastname': 'Bormah', 'firstname': 'Abdullah', 'initials': 'A', 'affiliation': 'College of Medicine, King Abdulaziz University, Jeddah, SAU.'}, {'lastname': 'Alghamdi', 'firstname': 'Malak', 'initials': 'M', 'affiliation': 'Department of Family Medicine, College of Medicine, Albaha University, Al Baha, SAU.'}, {'lastname': 'Tubaigi', 'firstname': 'Yahay S', 'initials': 'YS', 'affiliation': 'Department of Medicine, Eradah Mental Health Complex, Jeddah, SAU.'}, {'lastname': 'Alomari', 'firstname': 'Amal', 'initials': 'A', 'affiliation': 'College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.'}, {'lastname': 'Khan', 'firstname': 'Safwan N', 'initials': 'SN', 'affiliation': 'College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.'}, {'lastname': 'Alhafez', 'firstname': 'Nouryah A', 'initials': 'NA', 'affiliation': 'Department of Medicine, Alfarabi College, Riyadh, SAU.'}, {'lastname': 'Aladni', 'firstname': 'Ibrahim S', 'initials': 'IS', 'affiliation': 'Department of Ophthalmology, King Abdulaziz University Hospital, Jeddah, SAU.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2023, Abushal et al.', 'doi': '10.7759/cureus.51370', 'xml': <Element 'PubmedArticle' at 0x10b7cb880>}\n",
      "{'pubmed_id': '38292919\\n34532307\\n37051472\\n36673551\\n34210711\\n33510985\\n37143905\\n34265629\\n36834147\\n31664695\\n35505447\\n33244346\\n28513515\\n36835503\\n35919804\\n37373604\\n36983122\\n36440485\\n35603769\\n36016985\\n34195120\\n37109063\\n32495701\\n31008072\\n29794211\\n35790997\\n36754956\\n33998499', 'title': 'Knowledge and Practice of Healthcare Professionals in the Medical Care of Asthma Adult Patients in Jordan with a Particular Reference to Adherence to GINA Recommendations.', 'abstract': \"This study aimed to evaluate Jordanian healthcare professionals' knowledge, skills, and experience in dealing with and treating adult asthmatic patients and assess healthcare professionals' compliance with the Global Initiative for Asthma (GINA) guideline recommendations for asthma treatment and management in Jordan.\\nA cross-sectional survey was conducted in Jordan between May and June 2023. This study included physicians, pharmacists, and nurses working in clinical settings and directly interacting with asthma patients in Jordan's private and governmental healthcare facilities who were eligible to participate in this research. Three primary sections of an online survey were constructed using Google Forms and included demographic data, a diagnosis and management of the illness, and a list of worldwide medical references for asthma.\\nA total of 300 healthcare professionals, including pharmacists (103), nurses (87), Doctor of Pharmacy (28), and physicians (82), took part in this research. The survey respondents' general knowledge of the nature and symptoms of asthma is quite high, exceeding 84% and 86%, respectively. The survey also showed a high degree of awareness of asthma diagnosis. It was also revealed that around one-quarter of participants consistently reported the severity of asthma. The most frequent factor influencing the decision to take controller or maintenance medicines is symptom severity (reported from 86% of participants). The GINA guidelines were selected as the asthma information source by almost half of the participants. Finally, 47% of participants were aware of the GINA's 2019 adjustments of the recommendations.\\nThis study showed that Jordanian healthcare professionals understand the nature, symptoms, and diagnoses of asthma disease. However, many of the survey participants lack adherence, awareness, and understanding of the GINA recommendations about asthma management. More research is required to assess the adherence to the evidence-based recommendations and evaluate the impact of training courses.\", 'keywords': ['GINA', 'adherence', 'asthma', 'healthcare', 'practitioners'], 'journal': 'Journal of multidisciplinary healthcare', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Al-Hamaden', 'firstname': 'Rana Ahmad', 'initials': 'RA', 'affiliation': 'Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.'}, {'lastname': 'Abed', 'firstname': 'Anas', 'initials': 'A', 'affiliation': 'Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.'}, {'lastname': 'Khader', 'firstname': 'Heba A', 'initials': 'HA', 'affiliation': 'Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.'}, {'lastname': 'Hasoun', 'firstname': 'Luai', 'initials': 'L', 'affiliation': 'Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.'}, {'lastname': 'Al-Dulaimi', 'firstname': 'Abdullah Hatem', 'initials': 'AH', 'affiliation': 'Ibn Sina Teaching Hospital, Mosul, Iraq.'}, {'lastname': 'Alsayed', 'firstname': 'Ahmad R', 'initials': 'AR', 'affiliation': 'Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.'}], 'methods': None, 'conclusions': 'This study showed that Jordanian healthcare professionals understand the nature, symptoms, and diagnoses of asthma disease. However, many of the survey participants lack adherence, awareness, and understanding of the GINA recommendations about asthma management. More research is required to assess the adherence to the evidence-based recommendations and evaluate the impact of training courses.', 'results': \"A total of 300 healthcare professionals, including pharmacists (103), nurses (87), Doctor of Pharmacy (28), and physicians (82), took part in this research. The survey respondents' general knowledge of the nature and symptoms of asthma is quite high, exceeding 84% and 86%, respectively. The survey also showed a high degree of awareness of asthma diagnosis. It was also revealed that around one-quarter of participants consistently reported the severity of asthma. The most frequent factor influencing the decision to take controller or maintenance medicines is symptom severity (reported from 86% of participants). The GINA guidelines were selected as the asthma information source by almost half of the participants. Finally, 47% of participants were aware of the GINA's 2019 adjustments of the recommendations.\", 'copyrights': '© 2024 Al-hamaden et al.', 'doi': '10.2147/JMDH.S433149\\n10.3389/fpubh.2021.712255\\n10.2147/PPA.S395258\\n10.3949/ccjm.88a.20167\\n10.7759/cureus.12278\\n10.2147/PPA.S403239\\n10.1016/j.rmed.2021.106524\\n10.3390/ijerph20043453\\n10.1007/s12325-019-01131-0\\n10.1186/s40545-022-00432-0\\n10.11604/pamj.2020.37.83.18897\\n10.4103/1119-3077.206363\\n10.3390/ijms24044086\\n10.18549/PharmPract.2022.2.2665\\n10.3390/jcm12123909\\n10.3390/jcm12062118\\n10.1080/17476348.2022.2152332\\n10.17305/bjbms.2022.7335\\n10.2147/IJGM.S369306\\n10.1016/j.ajme.2013.05.002\\n10.4103/jfmpc.jfmpc_1418_20\\n10.3390/jpm13040677\\n10.1177/0897190020927274\\n10.4103/picr.PICR_63_18\\n10.4187/respcare.05953\\n10.3390/ijms24044086\\n10.1038/s41533-023-00330-1\\n10.1016/j.rceng.2019.11.006', 'xml': <Element 'PubmedArticle' at 0x10b7d4810>}\n",
      "{'pubmed_id': '38292857\\n33737816\\n28120842\\n19648472\\n27019018\\n29130640\\n33662371\\n26331761\\n27012614\\n21737881\\n19853906\\n33418879\\n33950328\\n33213116\\n27448950\\n27005405\\n28952460\\n31522948\\n23845717\\n26321659\\n36338247\\n27103388\\n32726560\\n28237661\\n33270354\\n34856028\\n32765427\\n32598948\\n29457204\\n23889619\\n23590263\\n30400197\\n25655390\\n29617641\\n32675857\\n28838063\\n28880992\\n15867843\\n24320738\\n23154082\\n27314383\\n32961859\\n32660723\\n28179507\\n35843518\\n23773659\\n16337451\\n31311359\\n28550543\\n20799984\\n21194740\\n32072252\\n30949213\\n32484760\\n24142648\\n27362543\\n26595589\\n24336249\\n25658739\\n27259147\\n33998673\\n24786241\\n30478238\\n29273557\\n31078144\\n26813209\\n32309270\\n28624607\\n33951361\\n29452277\\n29072882\\n32808447\\n34836093\\n24832749\\n25001921\\n27472835\\n30296366\\n31836714\\n33032723\\n26161548\\n31732997\\n32561508\\n27372599\\n32714957\\n24983709\\n17995628\\n25186264\\n29383778\\n29627041\\n27283230\\n28104371\\n32437302\\n27483441\\n26016655\\n28328160\\n21980061\\n25457349\\n29161075\\n23857381\\n24901720\\n31953983\\n23403049\\n24315502\\n34921631\\n23527196\\n22837379\\n30167798\\n29395935\\n34561347\\n29729164\\n24247484\\n31144984\\n30509734\\n28365872\\n29617249\\n32943399\\n25439876\\n30463872\\n22190648\\n24390308\\n23509614\\n32016289\\n34626677\\n30622974\\n29376471\\n28945993\\n36639791\\n29160418\\n29891850\\n27566543\\n31669095\\n35058411', 'title': 'Obesity-related asthma and its relationship with microbiota.', 'abstract': 'Obesity and asthma are global public health problems. Obesity-related asthma is a special phenotype of asthma with a complex pathogenesis. Its occurrence and development are related to mechanical compression, inflammatory response, metabolic regulation, gene regulation, and vitamin D deficiency. Different treatment strategies used in the process of weight loss have a beneficial impact on asthma. Alterations in gut and airway microbial community structure and their metabolites may also contribute to obesity-related asthma. The role of the Th17/Treg balance in the gut microbiota regulating the immune responses and host metabolism is important. Therapeutic measures associated with the gut microbiota variety may contribute to improving chronic inflammation associated with obesity by regulating the Th17/Treg balance. An early reduction in microbial diversity can predict the development of asthma and lead to allergy through an imbalance of Th2/Th1 responses. Short-chain fatty acids (SCFAs) regulate the differentiation and activation of regulatory T cells, thereby regulating immune homeostasis in the lung to suppress allergic inflammation and weight gain. Therefore, clarifying the microbial mechanism of obesity-related asthma has important guiding significance for clinical treatment. In this review, we used the following terms: \"asthma and obesity\" and \"obesity-related asthma\", combining \"phenotype\", \"airway inflammation\" and \"lung function\", and reviewed the characteristics and pathogenesis of obesity-related asthma, the relationship between the gut and airway microbiota and obesity-related asthma, and the current treatment measures for the disease.', 'keywords': ['immunity', 'mechanism', 'microbiota', 'obesity-related asthma', 'treatment'], 'journal': 'Frontiers in cellular and infection microbiology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Huang', 'firstname': 'Jinli', 'initials': 'J', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Zhou', 'firstname': 'Xuehua', 'initials': 'X', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Dong', 'firstname': 'Bo', 'initials': 'B', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Tan', 'firstname': 'Hong', 'initials': 'H', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Li', 'firstname': 'Qiuhong', 'initials': 'Q', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Zhang', 'firstname': 'Juan', 'initials': 'J', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Su', 'firstname': 'Hui', 'initials': 'H', 'affiliation': \"Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}, {'lastname': 'Sun', 'firstname': 'Xin', 'initials': 'X', 'affiliation': \"Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Huang, Zhou, Dong, Tan, Li, Zhang, Su and Sun.', 'doi': '10.3389/fcimb.2023.1303899\\n10.2147/JAA.S299756\\n10.1038/mi.2016.128\\n10.1165/rcmb.2009-0137RC\\n10.1111/ijpo.12246\\n10.1016/j.jaci.2021.02.020\\n10.1002/mnfr.201500272\\n10.1542/hpeds.2015-0094\\n10.1172/JCI45041\\n10.1016/S0140-6736(09)61375-1\\n10.3390/jcm10020169\\n10.1007/s10995-021-03165-9\\n10.23736/S2724-6507.20.03299-X\\n10.1016/j.clnu.2016.06.023\\n10.1038/ijo.2016.52\\n10.1088/1752-7163/aa61c5\\n10.1016/j.rmr.2019.07.009\\n10.1183/09031936.00046013\\n10.1016/j.cmet.2015.07.026\\n10.1183/20734735.0161-2021\\n10.1183/13993003.00246-2016\\n10.1513/AnnalsATS.202001-080OC\\n10.1016/j.tcb.2017.01.006\\n10.1002/ppul.25197\\n10.1111/pai.13710\\n10.3389/fendo.2020.00462\\n10.1016/j.bcp.2020.114112\\n10.1007/s12098-018-2636-x\\n10.3305/nh.2013.28.4.6525\\n10.1164/rccm.201208-1470OC\\n10.3390/nu10111634\\n10.1007/s10753-015-0122-4\\n10.1016/j.cmet.2018.03.001\\n10.1093/aje/kwx081\\n10.1111/imm.12832\\n10.1016/j.jaci.2005.02.023\\n10.3109/02770903.2013.873807\\n10.1016/j.jaci.2012.09.028\\n10.3390/nu8060364\\n10.3390/biomedicines8090359\\n10.1016/j.prrv.2020.05.004\\n10.1126/scitranslmed.aaf9412\\n10.1016/j.anai.2022.07.005\\n10.1186/1471-2466-13-39\\n10.1016/j.jaci.2005.09.016\\n10.1080/02770903.2019.1645169\\n10.1007/s15006-017-9710-6\\n10.1186/1471-2458-10-519\\n10.1016/j.jaci.2010.10.048\\n10.1007/s00281-019-00775-y\\n10.1186/s13223-019-0333-6\\n10.1089/chi.2020.0029\\n10.3349/ymj.2013.54.6.1430\\n10.1002/ppul.23516\\n10.1159/000441687\\n10.1038/nm.3423\\n10.1371/journal.pone.0116540\\n10.1016/j.cell.2016.05.041\\n10.1002/14651858.CD001496.pub2\\n10.1016/j.jaci.2014.03.018\\n10.1542/peds.2018-2119\\n10.1016/j.jaci.2017.09.043\\n10.1186/s12887-019-1526-3\\n10.1001/jama.2015.18589\\n10.3389/fped.2020.00134\\n10.1016/j.jaci.2017.05.028\\n10.1056/NEJMoa2028198\\n10.1016/j.jaip.2018.02.001\\n10.1111/all.13342\\n10.1111/obr.13129\\n10.3390/nu13113837\\n10.1164/rccm.201311-2011LE\\n10.1016/j.numecd.2014.05.015\\n10.1289/EHP272\\n10.1002/oby.22320\\n10.1038/s41467-019-13751-9\\n10.1016/j.jaci.2020.08.011\\n10.1371/journal.pone.0126976\\n10.1111/cea.13534\\n10.1016/j.anai.2020.06.020\\n10.1016/j.jaip.2016.06.004\\n10.1183/23120541.00371-2019\\n10.1513/AnnalsATS.201312-454OC\\n10.1111/j.1750-3841.2007.00477.x\\n10.1183/09031936.00080514\\n10.1111/cea.13109\\n10.1016/j.jaci.2018.02.004\\n10.1016/S2213-2600(16)30048-0\\n10.1016/j.ijbiomac.2017.01.051\\n10.1161/CIRCRESAHA.120.316101\\n10.1371/journal.pone.0160407\\n10.3390/nu7063999\\n10.1111/resp.13026\\n10.1378/chest.11-0930\\n10.1164/rccm.201409-1587OC\\n10.1513/AnnalsATS.201703-231AW\\n10.1038/srep02164\\n10.1002/mnfr.201900616\\n10.1016/j.jaci.2013.01.001\\n10.1016/j.jaci.2013.10.006\\n10.1007/s11882-021-01024-9\\n10.1371/journal.pone.0059443\\n10.1164/rccm.201203-0573OC\\n10.1007/s11892-018-1062-9\\n10.1016/j.ejim.2018.01.026\\n10.1097/EDE.0000000000001421\\n10.1159/000355331\\n10.1165/rcmb.2019-0144OC\\n10.1016/j.alit.2018.10.004\\n10.1007/s10753-017-0550-4\\n10.1016/S0140-6736(18)30258-7\\n10.1183/13993003.00612-2020\\n10.1016/j.carbpol.2014.08.068\\n10.1183/16000617.0056-2018\\n10.2337/db11-1019\\n10.1038/nm.3444\\n10.1155/2013/131349\\n10.1093/ije/dyz273\\n10.1016/j.diabres.2021.109080\\n10.1155/2018/1628620\\n10.1080/21623945.2017.1413516\\n10.1016/j.jnutbio.2017.08.003\\n10.1186/s13223-023-00761-y\\n10.1590/1414-431X20176841\\n10.1038/s41598-018-27278-4\\n10.1074/jbc.M116.743187\\n10.1016/j.jaci.2019.09.035\\n10.1097/FJC.0000000000001222', 'xml': <Element 'PubmedArticle' at 0x109d8c2c0>}\n",
      "{'pubmed_id': '38292490\\n33606031\\n33753937\\n33497317\\n32838236\\n34556492\\n35338102\\n35486072\\n32746940\\n33010815\\n33995364\\n33508291\\n32320677\\n32747391\\n32205856\\n32940201\\n34591653\\n35174188\\n33927016\\n35151371\\n35857581\\n36383686\\n28942086\\n28440314\\n30935881\\n26589497\\n32835708\\n30078711\\n32763154\\n35064122\\n33003471\\n32810439\\n32514174\\n32788292\\n26653891\\n16199517\\n26771021\\n32651212\\n32972995\\n32455343\\n30315241\\n31034279\\n32070140\\n24530057\\n9463780\\n32810438\\n32398875\\n33915568\\n19889110\\n35386227\\n1655948\\n34104281\\n19707128\\n33178207\\n35615469\\n34567001\\n35027728\\n32425950\\n35216672\\n33277181\\n31178118\\n32416243', 'title': 'High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis.', 'abstract': 'Up to 30% of hospitalized COVID-19 patients experience persistent sequelae, including pulmonary fibrosis (PF).\\nWe examined COVID-19 survivors with impaired lung function and imaging worrisome for developing PF and found within six months, symptoms, restriction and PF improved in some (Early-Resolving COVID-PF), but persisted in others (Late-Resolving COVID-PF). To evaluate immune mechanisms associated with recovery versus persistent PF, we performed single-cell RNA-sequencing and multiplex immunostaining on peripheral blood mononuclear cells from patients with Early- and Late-Resolving COVID-PF and compared them to age-matched controls without respiratory disease.\\nOur analysis showed circulating monocytes were significantly reduced in Late-Resolving COVID-PF patients compared to Early-Resolving COVID-PF and non-diseased controls. Monocyte abundance correlated with pulmonary function forced vital capacity and diffusion capacity. Differential expression analysis revealed MHC-II class molecules were upregulated on the CD8 T cells of Late-Resolving COVID-PF patients but downregulated in monocytes. To determine whether these immune signatures resembled other interstitial lung diseases, we analyzed samples from Idiopathic Pulmonary Fibrosis (IPF) patients. IPF patients had a similar marked decrease in monocyte HLA-DR protein expression compared to Late-Resolving COVID-PF patients. Our findings indicate decreased circulating monocytes are associated with decreased lung function and uniquely distinguish Late-Resolving COVID-PF from Early-Resolving COVID-PF, IPF, and non-diseased controls.', 'keywords': ['COVID – 19', 'idiopathic pulmonary fibrosis', 'monocytes', 'peripheral blood mononuclear cells', 'pulmonary fibrosis', 'single cell RNA sequencing (scRNA)'], 'journal': 'Frontiers in immunology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Bingham', 'firstname': 'Grace C', 'initials': 'GC', 'affiliation': 'Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Muehling', 'firstname': 'Lyndsey M', 'initials': 'LM', 'affiliation': 'Division of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Li', 'firstname': 'Chaofan', 'initials': 'C', 'affiliation': 'Carter Immunology Center, University of Virginia, Charlottesville, VA, United States.\\nDivision of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Huang', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Ma', 'firstname': 'Shwu-Fan', 'initials': 'SF', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Abebayehu', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Noth', 'firstname': 'Imre', 'initials': 'I', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Sun', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Carter Immunology Center, University of Virginia, Charlottesville, VA, United States.\\nDivision of Infectious Disease and International Health, Department of Medicine, University of Virginia, Charlottesville, VA, United States.\\nDivision of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.'}, {'lastname': 'Woodfolk', 'firstname': 'Judith A', 'initials': 'JA', 'affiliation': 'Division of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Barker', 'firstname': 'Thomas H', 'initials': 'TH', 'affiliation': 'Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States.'}, {'lastname': 'Bonham', 'firstname': 'Catherine A', 'initials': 'CA', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Bingham, Muehling, Li, Huang, Ma, Abebayehu, Noth, Sun, Woodfolk, Barker and Bonham.', 'doi': '10.3389/fimmu.2023.1308594\\n10.1001/jamanetworkopen.2021.0830\\n10.1038/s41591-021-01283-z\\n10.1148/radiol.2021203153\\n10.1016/j.eclinm.2020.100463\\n10.1136/bmjresp-2021-001049\\n10.1164/rccm.202202-0399ST\\n10.1186/s40249-020-00723-1\\n10.1016/j.cell.2020.09.038\\n10.3389/fimmu.2021.646333\\n10.1016/j.lfs.2021.119124\\n10.1016/j.chom.2020.04.009\\n10.1183/13993003.02049-2020\\n10.1038/s41418-020-0530-3\\n10.4269/ajtmh.20-0986\\n10.1126/sciimmunol.abk1741\\n10.3389/fmed.2021.823600\\n10.1136/thoraxjnl-2021-217031\\n10.1016/j.immuni.2022.01.017\\n10.1126/sciimmunol.abm7996\\n10.1126/scitranslmed.abo5795\\n10.1016/S2213-2600(17)30349-1\\n10.1038/srep46560\\n10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A6211\\n10.1016/S2213-2600(18)30508-3\\n10.1186/s12890-015-0142-8\\n10.1016/j.chest.2020.08.2056\\n10.1016/j.cell.2018.07.010\\n10.1016/j.cell.2020.07.005\\n10.1038/s41467-021-27716-4\\n10.3390/cells9102206\\n10.1016/j.cell.2020.08.002\\n10.1038/s41591-020-0944-y\\n10.1126/science.abc6261\\n10.1186/s13059-015-0844-5\\n10.1073/pnas.0506580102\\n10.1016/j.cels.2015.12.004\\n10.1126/sciimmunol.abd1554\\n10.1126/science.abd4570\\n10.1016/j.yrmex.2019.100002\\n10.1038/s41385-018-0082-8\\n10.1164/rccm.201810-1891OC\\n10.1080/21691401.2020.1725029\\n10.1016/j.immuni.2014.01.005\\n10.1016/S0145-305X(97)00027-X\\n10.1016/j.cell.2020.08.001\\n10.1038/s41591-020-0901-9\\n10.1038/s41586-021-03569-1\\n10.1111/j.1365-2044.2009.06161.x\\n10.1016/j.heliyon.2022.e09230\\n10.1084/jem.174.4.915\\n10.14740/jocmr4474\\n10.1097/CCM.0b013e3181ab858a\\n10.3389/fimmu.2020.580250\\n10.2147/IJGM.S359690\\n10.3389/fimmu.2021.735125\\n10.1038/s41590-021-01113-x\\n10.3389/fimmu.2020.00827\\n10.1016/j.cell.2022.01.014\\n10.1016/j.it.2020.11.002\\n10.1016/j.cell.2019.05.031\\n10.1016/j.matbio.2020.04.004', 'xml': <Element 'PubmedArticle' at 0x109b73e20>}\n",
      "{'pubmed_id': '38292138\\n32161455\\n30499702\\n29062228\\n20595157\\n29668352\\n31819401\\n32764908\\n33778055\\n36317185\\n26374280\\n15249443\\n29551279\\n32064708\\n23362945\\n28301574\\n32283960\\n19703830\\n32576706\\n35429764\\n36185170\\n20843247\\n29474094', 'title': 'Real-World Disease Burden and Healthcare Resource Utilization Among Patients with COPD and Asthma Using Triple Therapy (FF/UMEC/VI) in the United States.', 'abstract': 'Chronic obstructive pulmonary disease (COPD) and asthma are associated with chronic inflammation of the respiratory tract; despite some overlap of symptoms, they are considered separate disorders. Triple therapy is recommended for patients with COPD and asthma whose symptoms remain uncontrolled despite dual therapy. There are limited real-world studies evaluating outcomes among patients with COPD and asthma who are receiving inhaled triple therapy. This United States (US)-based real-world study aimed to evaluate clinical and economic outcomes among patients with COPD and asthma receiving single-inhaler triple therapy (fluticasone furoate/umeclidinium/vilanterol [FF/UMEC/VI]).\\nRetrospective pre-post study using claims data from the Optum Clinformatics\\nOverall, 2743 patients were included (mean age: 71 years; 64% female). Cardiovascular disease was the most prevalent comorbidity during both the pre- and post-treatment periods (90% for both periods). There was a lower proportion of patients with ≥1 COPD exacerbation or ≥1 asthma exacerbation post-treatment versus pre-treatment (51% vs 57%, p<0.0001, and 22% vs 32%, p<0.0001, respectively). Fewer patients had ≥1 all-cause office visit post-treatment versus pre-treatment (99.3% vs 99.7%, p=0.0329); more patients had ≥1 COPD-related office visit post-treatment versus pre-treatment (89.6% vs 87.5%, p=0.0035). Total all-cause healthcare costs were significantly higher post-treatment versus pre-treatment ($72,809 vs $63,734, p<0.0001). The driver of increased costs appeared to be primarily non-COPD-related (COPD-related costs: post-treatment $27,779 vs pre-treatment $25,081, p=0.0062).\\nFF/UMEC/VI reduced exacerbations among patients with COPD and asthma in a real-world setting in the US.', 'keywords': ['HCRU', 'asthma', 'chronic obstructive pulmonary disease', 'exacerbation', 'real-world', 'triple therapy'], 'journal': 'International journal of chronic obstructive pulmonary disease', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Igboekwe', 'firstname': 'Emmeline', 'initials': 'E', 'affiliation': 'US Medical Affairs, R&D Global Medical, GSK, Durham, NC, USA.'}, {'lastname': 'Verma', 'firstname': 'Sumit', 'initials': 'S', 'affiliation': 'STATinMED, LLC, Dallas, TX, USA.'}, {'lastname': 'Paczkowski', 'firstname': 'Rosirene', 'initials': 'R', 'affiliation': 'Value Evidence and Outcomes, R&D Global Medical, GSK, Collegeville, PA, USA.'}], 'methods': None, 'conclusions': 'FF/UMEC/VI reduced exacerbations among patients with COPD and asthma in a real-world setting in the US.', 'results': 'Overall, 2743 patients were included (mean age: 71 years; 64% female). Cardiovascular disease was the most prevalent comorbidity during both the pre- and post-treatment periods (90% for both periods). There was a lower proportion of patients with ≥1 COPD exacerbation or ≥1 asthma exacerbation post-treatment versus pre-treatment (51% vs 57%, p<0.0001, and 22% vs 32%, p<0.0001, respectively). Fewer patients had ≥1 all-cause office visit post-treatment versus pre-treatment (99.3% vs 99.7%, p=0.0329); more patients had ≥1 COPD-related office visit post-treatment versus pre-treatment (89.6% vs 87.5%, p=0.0035). Total all-cause healthcare costs were significantly higher post-treatment versus pre-treatment ($72,809 vs $63,734, p<0.0001). The driver of increased costs appeared to be primarily non-COPD-related (COPD-related costs: post-treatment $27,779 vs pre-treatment $25,081, p=0.0062).', 'copyrights': '© 2024 Igboekwe et al.', 'doi': '10.2147/COPD.S423993\\n10.2147/COPD.S234942\\n10.1164/rccm.19811P21\\n10.2147/COPD.S139470\\n10.1183/09031936.00043710\\n10.1056/NEJMoa1713901\\n10.2147/COPD.S216072\\n10.2147/COPD.S240556\\n10.1016/j.yrmex.2019.100008\\n10.1183/23120541.00480-2020\\n10.2147/COPD.S370577\\n10.1111/resp.12642\\n10.1378/chest.126.1.59\\n10.1016/j.alit.2018.02.002\\n10.1111/resp.13780\\n10.1111/crj.12013\\n10.1371/journal.pone.0173830\\n10.1164/rccm.202003-0625ST\\n10.1136/thx.2009.113662\\n10.4187/respcare.07355\\n10.1016/j.rmed.2022.106807\\n10.2147/COPD.S370540\\n10.1056/NEJMoa0909883\\n10.1164/rccm.201710-2029OC', 'xml': <Element 'PubmedArticle' at 0x10aba9bc0>}\n",
      "{'pubmed_id': '38292125\\n24708388\\n26141573\\n28332107\\n22296721\\n29117118\\n27364389\\n16055873\\n25908413\\n36318133\\n24929073\\n37251964\\n35234263\\n31996276\\n26505989\\n32167552\\n25751820\\n16135726\\n12198000\\n32245304\\n14725941\\n16214125\\n26119062\\n9094926\\n16467075\\n19406861\\n15797673\\n16373941\\n21320478\\n11734430\\n23145908\\n23752494\\n34557509\\n30069955\\n29342980\\n35066501\\n28353635\\n28149501\\n26437130\\n33066553\\n30650667\\n35565792\\n30689281', 'title': 'Dietary antioxidants and flavonoids intake, and their association with inflammation and oxidative stress parameters in asthmatic women: a case-control study.', 'abstract': \"Asthma is more prevalent and severe in women, especially after puberty. Studies suggest a potential link between dietary antioxidants, inflammation, and oxidative stress. This study aimed to compare the dietary intake of antioxidants in asthmatic and healthy women, evaluating their potential associations with inflammation and oxidative stress. This study analyzed 30 asthmatic and 30 healthy women's lung function, anthropometry, biochemical parameters, and dietary antioxidant intake using a 161-itemized semi-quantitative food frequency questionnaire. Additionally, the study explored connections between serum inflammatory markers and oxidative stress indicators in relation to dietary intake of antioxidant nutrients and flavonoids. Asthmatic women exhibited higher serum IL-6 levels and lower total antioxidant status compared to healthy controls. Nevertheless, no significant differences were observed in dietary antioxidant micronutrient intake. Healthy controls demonstrated a notably higher intake of anthocyanidins compared to asthmatic women. Furthermore, the study identified a negative correlation between flavonol intake and serum total oxidant status, as well as between flavan-3-ols intake and serum oxidative stress index. Dietary differences in flavonoid and flavonoid-rich foods intake among asthmatic women may affect their serum IL-6 levels and oxidative stress. Promoting a diverse diet rich in flavonoids could benefit women with asthma by mitigating inflammation and oxidative stress.\", 'keywords': ['adult', 'asthma', 'dietary antioxidants', 'flavonoids', 'systemic inflammation'], 'journal': 'Journal of clinical biochemistry and nutrition', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Suna', 'firstname': 'Gülen', 'initials': 'G', 'affiliation': 'Department of Nutrition and Dietetics, Faculty of Health Sciences, Akdeniz University, 07070, Konyaaltı, Antalya, Turkey.\\nDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06100, Sıhhiye, Ankara, Turkey.'}, {'lastname': 'Keskin', 'firstname': 'Olgun', 'initials': 'O', 'affiliation': 'Department of Chest Disease, Antalya Training and Research Hospital, Kazım Karabekir Street, Varlık District, 07100, Muratpaşa, Antalya, Turkey.'}, {'lastname': 'Küçükçetin', 'firstname': 'İkbal Özen', 'initials': 'İÖ', 'affiliation': 'Medical Biochemistry Laboratory, Akdeniz University Hospital, Pınarbaşı District, Dumlupınar Boulevard, 07070, Konyaaltı, Antalya, Turkey.'}, {'lastname': 'Ayaz', 'firstname': 'Aylin', 'initials': 'A', 'affiliation': 'Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, 06100, Sıhhiye, Ankara, Turkey.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 JCBN.', 'doi': '10.3164/jcbn.23-60', 'xml': <Element 'PubmedArticle' at 0x10b2dd4e0>}\n",
      "{'pubmed_id': '38291494\\n11584554\\n27763782\\n23604473\\n30687511\\n36925578\\n23393421\\n27992553\\n33841306\\n9247266\\n17824497\\n29318587\\n36752886\\n9916882\\n15562014\\n15230868\\n17900748\\n30799323\\n36841492\\n23440187\\n22654183\\n23899598\\n34170250\\n22071480\\n22867694\\n34795404\\n29344005\\n30920354\\n32595651\\n35317862\\n29089179\\n30830151\\n23353660\\n10086401\\n7315270\\n7125355\\n9042068\\n32053609\\n37012064\\n15823448\\n23678304\\n33321263\\n18331513\\n18757695\\n19535666\\n31866436\\n26141036\\n32347162\\n33453630\\n9751692\\n33292737\\n10051724\\n10604550\\n36267097\\n36438192\\n36968625\\n27823708\\n7633537\\n28507494\\n26983091\\n30307027\\n30144472\\n28707054\\n27043528\\n16461142\\n25022734\\n16983053\\n28814959\\n24015253\\n30293559\\n10529614\\n25443426\\n35853794\\n30034393\\n22411173\\n31225970\\n20161149\\n25872769\\n30199406\\n18415823\\n23704227\\n11990234\\n25689046\\n4083299\\n33530453\\n24673474\\n21316270\\n35336805\\n37505511', 'title': 'Sleep and allergic diseases among young Chinese adults from the Singapore/Malaysia Cross-Sectional Genetic Epidemiology Study (SMCGES) cohort.', 'abstract': 'Sleep disruption has been shown to affect immune function and thus influence allergic disease manifestation. The specific effects of sleep on allergic diseases, however, are less well-established; hence, in a unique population of young Chinese adults, we investigated the association between sleep and allergic disease.\\nYoung Chinese adults recruited from Singapore in the Singapore/Malaysia Cross-Sectional Genetic Epidemiology Study (SMCGES) were analyzed. We used the International Study of Asthma and Allergies in Childhood (ISAAC) protocol and a skin prick test to determine atopic dermatitis (AD), allergic rhinitis (AR), and asthma status. Information regarding total sleep time (TST) and sleep quality (SQ) was also obtained.\\nOf 1558 participants with a mean age of 25.0\\xa0years (SD\\u2009=\\u20097.6), 61.4% were female, and the mean total sleep time (TST) was 6.8\\xa0h (SD\\u2009=\\u20091.1). The proportions of AD, AR, and asthma were 24.5% (393/1542), 36.4% (987/1551), and 14.7% (227/1547), respectively. 59.8% (235/393) of AD cases suffered from AD-related sleep disturbances, 37.1% (209/564) of AR cases suffered from AR-related sleep disturbances, and 25.1% (57/227) of asthma cases suffered from asthma-related sleep disturbances. Only asthma cases showed a significantly lower mean TST than those without asthma (p\\u2009=\\u20090.015). Longer TST was significantly associated with lower odds of AR (OR\\u2009=\\u20090.905, 95% CI\\u2009=\\u20090.820-0.999) and asthma (OR\\u2009=\\u20090.852, 95% CI\\u2009=\\u20090.746-0.972). Linear regression analyses showed that lower TST was significantly associated with asthma (β\\u2009=\\u2009\\u2009-\\u20090.18, SE\\u2009=\\u20090.076, p-value\\u2009=\\u20090.017), and AR when adjusted for AR-related sleep disturbances (β\\u2009=\\u2009\\u2009-\\u20090.157, SE\\u2009=\\u20090.065, p-value\\u2009=\\u20090.016). Only sleep disturbances due to AR were significantly associated with a poorer SQ (OR\\u2009=\\u20091.962, 95% CI\\u2009=\\u20091.245-3.089).\\nWe found that sleep quality, but not sleep duration was significantly poorer among AD cases, although the exact direction of influence could not be determined. In consideration of the literature coupled with our findings, we posit that TST influences allergic rhinitis rather than vice versa. Finally, the association between TST and asthma is likely mediated by asthma-related sleep disturbances, since mean TST was significantly lower among those with nighttime asthma symptoms. Future studies could consider using objective sleep measurements coupled with differential expression analysis to investigate the pathophysiology of sleep and allergic diseases.', 'keywords': ['Allergic rhinitis', 'Asthma', 'Atopic dermatitis', 'ISAAC', 'Sleep'], 'journal': 'Journal of physiological anthropology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Wong', 'firstname': 'Qi Yi Ambrose', 'initials': 'QYA', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore.'}, {'lastname': 'Lim', 'firstname': 'Jun Jie', 'initials': 'JJ', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore.'}, {'lastname': 'Ng', 'firstname': 'Jun Yan', 'initials': 'JY', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore.'}, {'lastname': 'Lim', 'firstname': 'Yi Ying Eliza', 'initials': 'YYE', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore.'}, {'lastname': 'Sio', 'firstname': 'Yang Yie', 'initials': 'YY', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore.'}, {'lastname': 'Chew', 'firstname': 'Fook Tim', 'initials': 'FT', 'affiliation': 'Department of Biological Sciences, Faculty of Science, National University of Singapore, Allergy and Molecular Immunology Laboratory, Lee Hiok Kwee Functional Genomics Laboratories, Block S2, Level 5, 14 Science Drive 4, Lower Kent Ridge Road, Singapore, 117543, Singapore. dbscft@nus.edu.sg.'}], 'methods': None, 'conclusions': None, 'results': 'Of 1558 participants with a mean age of 25.0\\xa0years (SD\\u2009=\\u20097.6), 61.4% were female, and the mean total sleep time (TST) was 6.8\\xa0h (SD\\u2009=\\u20091.1). The proportions of AD, AR, and asthma were 24.5% (393/1542), 36.4% (987/1551), and 14.7% (227/1547), respectively. 59.8% (235/393) of AD cases suffered from AD-related sleep disturbances, 37.1% (209/564) of AR cases suffered from AR-related sleep disturbances, and 25.1% (57/227) of asthma cases suffered from asthma-related sleep disturbances. Only asthma cases showed a significantly lower mean TST than those without asthma (p\\u2009=\\u20090.015). Longer TST was significantly associated with lower odds of AR (OR\\u2009=\\u20090.905, 95% CI\\u2009=\\u20090.820-0.999) and asthma (OR\\u2009=\\u20090.852, 95% CI\\u2009=\\u20090.746-0.972). Linear regression analyses showed that lower TST was significantly associated with asthma (β\\u2009=\\u2009\\u2009-\\u20090.18, SE\\u2009=\\u20090.076, p-value\\u2009=\\u20090.017), and AR when adjusted for AR-related sleep disturbances (β\\u2009=\\u2009\\u2009-\\u20090.157, SE\\u2009=\\u20090.065, p-value\\u2009=\\u20090.016). Only sleep disturbances due to AR were significantly associated with a poorer SQ (OR\\u2009=\\u20091.962, 95% CI\\u2009=\\u20091.245-3.089).', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s40101-024-00356-5\\n10.1210/er.2016-1083\\n10.1007/978-3-642-25950-0_1\\n10.1136/bmjsem-2018-000443\\n10.3389/fnetp.2021.803011\\n10.31887/DCNS.2012.14.4/mmuench\\n10.1371/journal.pone.0168651\\n10.3389/fneur.2021.636330\\n10.1016/S0896-6273(00)80350-5\\n10.5664/jcsm.26932\\n10.1111/bph.14116\\n10.1007/s10571-023-01324-w\\n10.1016/S0165-5728(98)00179-9\\n10.1210/jc.2004-1429\\n10.1111/j.1600-079X.2004.00135.x\\n10.1016/j.addr.2007.08.016\\n10.2486/indhealth.2018-0173\\n10.1016/j.pcad.2023.02.005\\n10.1073/pnas.1217154110\\n10.5665/sleep.1846\\n10.1016/B978-0-12-396971-2.00007-5\\n10.5664/jcsm.9476\\n10.1007/s00424-011-1044-0\\n10.1016/j.jaci.2012.06.026\\n10.1038/s42003-021-02825-4\\n10.1186/s12948-018-0080-0\\n10.1152/physrev.00010.2018\\n10.1186/s13223-022-00669-z\\n10.1016/j.jaad.2017.08.043\\n10.1001/jamapediatrics.2019.0025\\n10.1016/j.ijpsycho.2013.01.006\\n10.1001/archpedi.153.3.249\\n10.3109/00016488109133292\\n10.1371/journal.pone.0228533\\n10.1136/bmjresp-2022-001535\\n10.1016/j.rmed.2004.10.011\\n10.5455/msm.2011.23.235-237\\n10.1016/j.jaip.2020.12.007\\n10.1111/j.1398-9995.2007.01620.x\\n10.1183/09031936.00155307\\n10.1164/rccm.200801-060ST\\n10.1016/j.jaci.2019.12.006\\n10.1177/1059840520921920\\n10.1016/j.ijporl.2021.110613\\n10.1073/pnas.95.20.11501\\n10.1186/s41065-020-00162-w\\n10.1046/j.1365-2222.1999.00493.x\\n10.1034/j.1398-9995.1999.00050.x\\n10.1016/j.waojou.2022.100704\\n10.1016/j.waojou.2022.100722\\n10.1016/j.waojou.2023.100757\\n10.1016/j.sleep.2016.06.011\\n10.1001/archpedi.1995.02170210030005\\n10.5114/ada.2017.67080\\n10.1097/DER.0000000000000161\\n10.2340/00015555-3065\\n10.1016/j.jaci.2018.08.005\\n10.1007/s13555-017-0192-3\\n10.3390/ijms17040462\\n10.1016/j.jaci.2005.10.033\\n10.1542/peds.2014-0376\\n10.1001/archinte.166.16.1744\\n10.1186/s13223-017-0208-7\\n10.1371/journal.pone.0072507\\n10.1016/j.jaci.2018.08.007\\n10.1159/000053604\\n10.1111/all.12552\\n10.1016/j.alit.2022.06.008\\n10.3389/fimmu.2018.01526\\n10.1007/s11325-012-0687-1\\n10.1164/rccm.201905-1004LE\\n10.1016/j.jsmc.2009.02.005\\n10.1002/ppul.23179\\n10.1097/MCP.0000000000000526\\n10.1080/02770900801890224\\n10.1136/thoraxjnl-2013-203482\\n10.1081/JAS-120002190\\n10.1111/all.12596\\n10.1016/0002-9343(85)90080-4\\n10.3390/ijerph18031082\\n10.3109/13651501.2014.907919\\n10.1016/j.smrv.2010.12.001', 'xml': <Element 'PubmedArticle' at 0x10b2731a0>}\n",
      "{'pubmed_id': '38291489\\n10456976\\n26383000\\n30525902\\n32064642\\n35020986\\n23432142\\n31505066\\n34285514\\n33872587\\n19264686\\n34572466\\n36540290\\n32653074\\n31866436\\n31838750\\n23688323\\n27177493\\n32198794\\n36740095\\n29782217\\n30407206\\n11686867\\n27548519\\n33364789\\n34037993\\n20671307\\n35694004', 'title': 'When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report.', 'abstract': 'The advent of biologics has resulted in major progress in the treatment of severe T2 high asthmatics. There are currently several classes of biologics approved for severe asthma including anti-immunoglobulin E, anti-interleukin-5/interleukin 5R, anti-interleukin 4/interleukin 13R, and anti-thymic stromal lymphopoietin.\\nHere we report the case of a 55-year-old Caucasian man with severe eosinophilic atopic asthma, who sequentially benefited from a treatment with mepolizumab, an anti-interleukin-5 monoclonal antibody, followed by treatment with dupilumab, an anti-interleukin-4/interleukin-13R antibody, the switch being justified by a flare-up of dermatitis while on mepolizumab. Overall, the patient has been followed for 72\\xa0months, including 42\\xa0months on mepolizumab and 30\\xa0months on dupilumab. Close monitoring of exacerbations, asthma control, lung function, asthma quality of life, and biomarkers shows that both biologics reduced asthma exacerbation and provided an improvement in asthma control and quality of life, with the patient achieving remission after 30\\xa0months on dupilumab. However, the effects of the two biologics on the biomarkers were very different, with mepolizumab controlling eosinophilic inflammation and dupilumab reducing serum immunoglobulin E and fractional exhaled nitric oxide levels.\\nThe originality of this case resides in the description of clinical status and biomarker evolution after a sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic. It shows that mepolizumab reduces exacerbation and improves asthma control by curbing eosinophilic inflammation whereas dupilumab provides asthma remission without controlling airway eosinophilic inflammation.', 'keywords': ['Asthma', 'Dupilumab', 'Eosinophils', 'FeNO', 'IgE', 'Mepolizumab'], 'journal': 'Journal of medical case reports', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Sabbe', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Respiratory Medicine, CHU Liege, Liège, Belgium. mare.sabbe@student.uliege.be.'}, {'lastname': 'Schleich', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Department of Respiratory Medicine, CHU Liege, Liège, Belgium.'}, {'lastname': 'Janssens', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Dermatology, Medicard, Libramont, Belgium.'}, {'lastname': 'Louis', 'firstname': 'R', 'initials': 'R', 'affiliation': 'Department of Respiratory Medicine, CHU Liege, Liège, Belgium.'}], 'methods': None, 'conclusions': 'The originality of this case resides in the description of clinical status and biomarker evolution after a sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic. It shows that mepolizumab reduces exacerbation and improves asthma control by curbing eosinophilic inflammation whereas dupilumab provides asthma remission without controlling airway eosinophilic inflammation.', 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13256-023-04255-8\\n10.1136/thx.54.9.825\\n10.1016/S0140-6736(15)00157-9\\n10.1164/rccm.201810-1944CI\\n10.1111/all.14235\\n10.1056/NEJMra2032506\\n10.1056/NEJMoa1215372\\n10.1111/cea.13491\\n10.2147/JAA.S258438\\n10.1016/S2213-2600(21)00097-7\\n10.1056/NEJMoa0808991\\n10.3390/biomedicines9091281\\n10.1002/rcr2.1074\\n10.1016/S2213-2600(20)30190-9\\n10.1016/j.jaci.2019.12.006\\n10.1111/all.14151\\n10.1056/NEJMoa1304048\\n10.1016/S2213-2600(16)30031-5\\n10.1111/cea.13601\\n10.1016/j.chest.2023.01.037\\n10.1056/NEJMoa1804092\\n10.1097/ACI.0000000000000490\\n10.1186/rr40\\n10.1172/JCI85664\\n10.2147/JAA.S275068\\n10.1111/cea.13954\\n10.1136/thx.2009.124925\\n10.1016/j.waojou.2022.100655', 'xml': <Element 'PubmedArticle' at 0x10b453a60>}\n",
      "{'pubmed_id': '38290992', 'title': 'Sphingosine kinase 1 specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model.', 'abstract': 'Sphingosine kinase 1 (SPHK1) has been shown to play a key role in the pathogenesis of asthma where SPHK1 generated S1P is known to mediate innate and adaptive immunity while promoting mast cell degranulation. Goblet cell metaplasia (GCM) contributes to airway obstruction in asthma and has been demonstrated in animal models. We investigated the role of PF543, a SPHK1 specific inhibitor, in preventing the pathogenesis of GCM using a murine (C57BL/6) model of allergen-induced acute asthma. Treatment with PF543 prior to triple allergen exposure (DRA: House dust mite, Ragweed pollen and Aspergillus) reduced inflammation, eosinophilic response, and GCM followed by reduced airway hyperreactivity to intravenous methacholine. Further, DRA exposure was associated with increased expression of SPHK1 in the airway epithelium which was reduced by PF543. DRA-induced reduction of acetylated a-tubulin in airway epithelium was associated with an increased expression of NOTCH2 and SPDEF which was prevented by PF543. ', 'keywords': ['Asthma', 'PF543', 'goblet cell metaplasia', 'sphingosine kinases', 'sphingosine-1-phosphate'], 'journal': 'American journal of physiology. Lung cellular and molecular physiology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Sudhadevi', 'firstname': 'Tara', 'initials': 'T', 'affiliation': 'Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.'}, {'lastname': 'Ackerman', 'firstname': 'Steven J', 'initials': 'SJ', 'affiliation': 'Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, United States.'}, {'lastname': 'Jafri', 'firstname': 'Anjum', 'initials': 'A', 'affiliation': 'Pediatrics, Case Western Reserve University, Cleveland, OH, United States.'}, {'lastname': 'Basa', 'firstname': 'Prathima', 'initials': 'P', 'affiliation': 'Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.'}, {'lastname': 'Ha', 'firstname': 'Alison W', 'initials': 'AW', 'affiliation': 'Pediatrics, University of Illinois at Chicago, Chicago, IL, United States.'}, {'lastname': 'Natarajan', 'firstname': 'Viswanathan', 'initials': 'V', 'affiliation': 'Pharmacology (MC868), University of Illinois at Chicago, Chicago, IL, United States.'}, {'lastname': 'Harijith', 'firstname': 'Anantha', 'initials': 'A', 'affiliation': 'Pediatrics, Case Western Reserve University, Cleveland, OH, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1152/ajplung.00269.2023', 'xml': <Element 'PubmedArticle' at 0x10b518540>}\n",
      "{'pubmed_id': '38290901', 'title': 'Cluster analysis of phenotypes, job exposure, and inflammatory patterns in elderly and nonelderly asthma patients.', 'abstract': 'Asthma has been identified as different phenotypes due to various risk factors. Age differences may have potential effects on asthma phenotypes. Our study aimed to identify potential asthma phenotypes among adults divided by age as either younger or older than 65 years. We also compared differences in blood granulocyte patterns, occupational asthmagens, and asthma control-related outcomes among patient phenotype clusters.\\nWe recruited nonelderly (<65 years old) (n\\xa0=\\xa0726) and elderly adults (≥65 years old) (n\\xa0=\\xa0201) with mild-to-severe asthma. We conducted a factor analysis to select 17 variables. A two-step cluster analysis was used to classify subjects with asthma phenotypes, and a discriminant analysis was used to verify the classification of cluster results.\\nThere were three clusters with different characteristics identified in both the nonelderly and elderly asthmatic adults. In the nonelderly patient group, cluster 2 (obese, neutrophilic phenotypes) had a 1.85-fold significantly increased risk of asthma exacerbations. Cluster 3 (early-onset, atopy, and smoker with an eosinophil-predominant pattern) had a 2.37-fold risk of asthma exacerbations and higher oral corticosteroid (OCS) use than cluster 1 (late-onset and LMW exposure with paucigranulocytic blood pattern). Among elderly patients, cluster 2 had poor lung function and more ex-smokers. Cluster 3 (early-onset, long asthma duration) had the lowest paucigranulocytic blood pattern percentages in the elderly group.\\nThe novelty of the clusters was found in age-dependent clusters. We identified three distinct phenotypes with heterogeneous characteristics, asthma exacerbations and medicine use in nonelderly and elderly asthmatic patients, respectively. Classification of age-stratified asthma phenotypes may lead to precise identification of patients, which provides personalized disease management.', 'keywords': ['Asthma', 'Cluster analysis', 'Elderly', 'Inflammatory patterns', 'Job exposure'], 'journal': 'Allergology international : official journal of the Japanese Society of Allergology', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Chuang', 'firstname': 'Yung-Chi', 'initials': 'YC', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.'}, {'lastname': 'Tsai', 'firstname': 'Hsin-Hua', 'initials': 'HH', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Meng-Chih', 'initials': 'MC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.'}, {'lastname': 'Wu', 'firstname': 'Chao-Chien', 'initials': 'CC', 'affiliation': 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Yuan-Chung', 'initials': 'YC', 'affiliation': 'Institute of Environmental Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan.'}, {'lastname': 'Wang', 'firstname': 'Tsu-Nai', 'initials': 'TN', 'affiliation': 'Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Electronic address: wangtn@kmu.edu.tw.'}], 'methods': None, 'conclusions': None, 'results': 'There were three clusters with different characteristics identified in both the nonelderly and elderly asthmatic adults. In the nonelderly patient group, cluster 2 (obese, neutrophilic phenotypes) had a 1.85-fold significantly increased risk of asthma exacerbations. Cluster 3 (early-onset, atopy, and smoker with an eosinophil-predominant pattern) had a 2.37-fold risk of asthma exacerbations and higher oral corticosteroid (OCS) use than cluster 1 (late-onset and LMW exposure with paucigranulocytic blood pattern). Among elderly patients, cluster 2 had poor lung function and more ex-smokers. Cluster 3 (early-onset, long asthma duration) had the lowest paucigranulocytic blood pattern percentages in the elderly group.', 'copyrights': 'Copyright © 2024 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.', 'doi': '10.1016/j.alit.2024.01.001', 'xml': <Element 'PubmedArticle' at 0x10b52a2f0>}\n",
      "{'pubmed_id': '38290898', 'title': 'Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma.', 'abstract': None, 'keywords': [], 'journal': 'Archivos de bronconeumologia', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Palones', 'firstname': 'Esther', 'initials': 'E', 'affiliation': 'Department of Respiratory Medicine, Institute of Biomedical Research Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau & IIB Sant Pau, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: epalones@santpau.cat.'}, {'lastname': 'García-Rivero', 'firstname': 'Juan Luis', 'initials': 'JL', 'affiliation': 'Department of Respiratory Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain.'}, {'lastname': 'Cisneros', 'firstname': 'Carolina', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Almonacid-Sánchez', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Department of Respiratory Medicine, Hospital Universitario de Puerta del Hierro Majadahonda, Madrid, Spain.'}, {'lastname': 'Pérez-de Llano', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'Department of Respiratory Medicine, Hospital Universitario de Lucus Augusti, Lugo, Spain.'}, {'lastname': 'Plaza', 'firstname': 'Vicente', 'initials': 'V', 'affiliation': 'Department of Respiratory Medicine, Institute of Biomedical Research Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau & IIB Sant Pau, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': 'Crespo-Lessmann', 'firstname': 'Astrid', 'initials': 'A', 'affiliation': 'Department of Respiratory Medicine, Institute of Biomedical Research Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau & IIB Sant Pau, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1016/j.arbres.2024.01.002', 'xml': <Element 'PubmedArticle' at 0x10b5e0c20>}\n",
      "{'pubmed_id': '38290751', 'title': 'Noninvasive Respiratory Support for Pediatric Critical Asthma: A Multicenter Cohort Study.', 'abstract': 'Noninvasive respiratory support (NRS) for pediatric critical asthma includes CPAP; bi-level positive airway pressure (BPAP); and heated, humidified, high-flow nasal cannula (HFNC). We used the Virtual Pediatric System database to estimate NRS by prescribing rates for pediatric critical asthma and characterize patient clinical features and in-patient outcomes by the initial NRS device applied.\\nWe performed a retrospective cohort study from 125 participating pediatric ICUs among children 2-17 years of age hospitalized for critical asthma and prescribed NRS from 2017 through 2021. The primary outcomes were NRS modality prescribing rates and trends. Secondary outcomes were descriptive and included demographics, comorbidities, severity of illness indices, and NRS failure rates (defined as escalation from the initial NRS modality to invasive ventilation, HFNC to BPAP or CPAP, or CPAP to BPAP).\\nOf the 10,083 encounters studied, the initial NRS modalities prescribed varied widely by hospital center (HFNC: 69.7 ± 29.6%; BPAP: 27.2 ± 7.1%; CPAP: 3.1 ± 5.9%). The mean rates of HFNC use increased from 59.7% in 2017 to 71.9% in 2021 (+2.5%/y). In contrast, BPAP (-1.6%/y) and CPAP (-0.8%/y) utilization declined throughout the study period. Older children who were obese and with a higher Pediatric Risk of Mortality III-Probability of Mortality score were more frequently prescribed BPAP and CPAP compared with HFNC. Those children on HFNC experienced higher noninvasive respiratory support failure rates versus BPAP (7.3% vs 2.4%; \\nIn this multi-center cohort study, we observed that children with critical asthma are increasingly exposed to HFNC compared with BPAP and CPAP. Rates of HFNC failure were greater than those of BPAP failure, but a majority were transitioned to BPAP without subsequent invasive ventilation. The next steps include prospective trials, including practical end points such as patient comfort and optimal delivery of nebulized treatments to distinguish device superiority and suitable NRS utilization.', 'keywords': ['Asthma', 'Bilevel positive airway pressure', 'Continuous positive airway pressure', 'Critical asthma', 'High-flow nasal cannula', 'Invasive ventilation', 'Noninvasive respiratory support', 'Noninvasive ventilation', 'Pediatric', 'Status asthmaticus'], 'journal': 'Respiratory care', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Russi', 'firstname': 'Brett W', 'initials': 'BW', 'affiliation': \"Division of Pediatric Critical Care Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.\"}, {'lastname': 'Roberts', 'firstname': 'Alexa R', 'initials': 'AR', 'affiliation': \"Division of Pediatric Critical Care Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.\"}, {'lastname': 'Nievas', 'firstname': 'Ignacio F', 'initials': 'IF', 'affiliation': \"Division of Pediatric Critical Care Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.\"}, {'lastname': 'Rogerson', 'firstname': 'Colin M', 'initials': 'CM', 'affiliation': 'Division of Pediatric Critical Care Medicine, Indiana University School of Medicine and Riley Hospital for Children at IU Health, Indianapolis, Indiana.'}, {'lastname': 'Morrison', 'firstname': 'John M', 'initials': 'JM', 'affiliation': \"Department of Pediatrics, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.\"}, {'lastname': 'Sochet', 'firstname': 'Anthony A', 'initials': 'AA', 'affiliation': 'Department of Anesthesia and Critical Care Medicine, Johns Hopkins University School of Medicine, St. Petersburg, Florida. Anthony.Sochet@jhmi.edu.'}], 'methods': None, 'conclusions': None, 'results': 'Of the 10,083 encounters studied, the initial NRS modalities prescribed varied widely by hospital center (HFNC: 69.7 ± 29.6%; BPAP: 27.2 ± 7.1%; CPAP: 3.1 ± 5.9%). The mean rates of HFNC use increased from 59.7% in 2017 to 71.9% in 2021 (+2.5%/y). In contrast, BPAP (-1.6%/y) and CPAP (-0.8%/y) utilization declined throughout the study period. Older children who were obese and with a higher Pediatric Risk of Mortality III-Probability of Mortality score were more frequently prescribed BPAP and CPAP compared with HFNC. Those children on HFNC experienced higher noninvasive respiratory support failure rates versus BPAP (7.3% vs 2.4%; ', 'copyrights': 'Copyright © 2024 by Daedalus Enterprises.', 'doi': '10.4187/respcare.11502', 'xml': <Element 'PubmedArticle' at 0x10b5e32e0>}\n",
      "{'pubmed_id': '38290630', 'title': 'Dietary carbohydrate types, genetic predisposition, and risk of adult-onset asthma: A longitudinal cohort study.', 'abstract': 'We aimed to investigate the longitudinal associations among carbohydrate intake types, genetic predisposition, and risk adult onset asthma (AOA). A dataset of 96,487 participants from UK Biobank was included with 1830 cases of incident AOA during an average follow-up of 9.68\\xa0years. Participants with the highest intake of total sugar, free sugar, and fiber intake, as compared to those with the lowest intake of total sugar, free sugar, and fiber intake, showed a 17\\xa0% and 22\\xa0% increased risk of incident AOA, and a 16\\xa0% decreased risk of AOA, respectively. Substitution of 5\\xa0% energy from free sugars with 5\\xa0% energy from non-free sugars was associated with a significantly lower risk of AOA (Hazard Ratio [HR]\\xa0=\\xa00.93, 95\\xa0% Confidence Interval [CI]: 0.88, 0.99). Participants with high genetic risk and the highest intake of free sugar showed a 112\\xa0% (HR\\xa0=\\xa02.12, 95%CI: 1.68, 2.68) increased risk of incident AOA. Participants with low genetic risk and highest intake of fiber showed a 50\\xa0% (HR\\xa0=\\xa00.50, 95%CI: 0.39, 0.64) reduced risk of AOA. This study highlights the critical role of carbohydrate types in AOA prevention, with an emphasis on reduced free sugar, moderate non-free sugar, and increased fiber intake.', 'keywords': ['Asthma', 'Cohort study', 'Dietary carbohydrate', 'Sugar', 'fiber'], 'journal': 'International journal of biological macromolecules', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Zhang', 'firstname': 'Hehua', 'initials': 'H', 'affiliation': 'Clinical Trials and Translation Center, Shengjing Hospital of China Medical University, Shenyang, China; Liaoning Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiangsu', 'initials': 'X', 'affiliation': 'Graduate School of China Medical University, Puhe Road No.77, Shenbei New District, Shenyang, Liaoning province 110122, China.'}, {'lastname': 'Yang', 'firstname': 'Huijun', 'initials': 'H', 'affiliation': 'Jinan Municipal Center for Disease Control and Prevention, Jinan, Shandong 250021, China.'}, {'lastname': 'Yang', 'firstname': 'Honghao', 'initials': 'H', 'affiliation': 'Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.'}, {'lastname': 'Zhang', 'firstname': 'Tingjing', 'initials': 'T', 'affiliation': 'School of Public Health, Wannan Medical College, Wuhu, China.'}, {'lastname': 'Chen', 'firstname': 'Liangkai', 'initials': 'L', 'affiliation': 'Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zhao', 'firstname': 'Yuhong', 'initials': 'Y', 'affiliation': 'Clinical Trials and Translation Center, Shengjing Hospital of China Medical University, Shenyang, China; Liaoning Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.'}, {'lastname': 'Xia', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Liaoning Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: yxia@cmu.edu.cn.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024. Published by Elsevier B.V.', 'doi': '10.1016/j.ijbiomac.2024.129824', 'xml': <Element 'PubmedArticle' at 0x10b57da80>}\n",
      "{'pubmed_id': '38290607', 'title': \"Living with asthma and vocal cord dysfunction/inducible laryngeal obstruction: 'I just can't get air in'.\", 'abstract': \"Asthma and vocal cord dysfunction (VCD) also known as inducible laryngeal obstruction (ILO) may coexist, resulting in worse outcomes for patients. The experience of people with VCD/ILO and coexisting asthma is unknown.\\nWe sought to determine if coexistent VCD/ILO and asthma have deleterious impacts on quality of life.\\nA descriptive qualitative study utilising, one-to-one semi-structured interviews with 30 purposively recruited adult participants with prior confirmed doctor asthma diagnosis and laryngoscopy confirmed VCD/ILO was undertaken. A thematic and content analysis was conducted to explore the data.\\nParticipants were mostly female (63%) with a mean±SD age of 63±12. Four themes were identified: (i) trapped voice, (ii) altered life, (iii) knowledge about VCD/ILO, and (iv) looking for solutions. Participants reported their voice being trapped in their throat or their voice being suddenly 'cut-off' when talking/singing. Self-reported VCD/ILO symptoms including throat-tightness and breathlessness were highlighted by participants. The second theme described how they struggle to communicate or tended to shorten conversations. Insufficient knowledge and existing confusion as to whether asthma was causing their breathlessness was described in the third theme. Looking for solutions depicted participants diagnostic journey and how participants sought an explanation for their symptoms.\\nPeople with asthma and coexisting VCD/ILO experience a substantial burden affecting their quality of life. These data describe the impact of patients with co-existing conditions and should be used to increase clinician awareness of the experience of VCD/ILO from the patients' perspectives to support a personalised approach to care.\", 'keywords': ['asthma', 'inducible laryngeal obstruction', 'paradoxical vocal fold movement', 'qualitative research', 'quality of life', 'vocal cord dysfunction'], 'journal': 'The journal of allergy and clinical immunology. In practice', 'publication_date': datetime.date(2024, 1, 31), 'authors': [{'lastname': 'Majellano', 'firstname': 'Eleanor C', 'initials': 'EC', 'affiliation': 'National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, The University of Newcastle, Newcastle, NSW, Australia,; National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, Hunter Medical Research Institute Asthma and Breathing Research Program, Newcastle, NSW, Australia,; School of Nursing and Midwifery, The University of Newcastle, Newcastle, NSW, Australia.'}, {'lastname': 'Clark', 'firstname': 'Vanessa L', 'initials': 'VL', 'affiliation': 'National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, The University of Newcastle, Newcastle, NSW, Australia,; National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, Hunter Medical Research Institute Asthma and Breathing Research Program, Newcastle, NSW, Australia,; School of Nursing and Midwifery, The University of Newcastle, Newcastle, NSW, Australia.'}, {'lastname': 'Vertigan', 'firstname': 'Anne', 'initials': 'A', 'affiliation': 'National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, Hunter Medical Research Institute Asthma and Breathing Research Program, Newcastle, NSW, Australia,; Speech Pathology Department, John Hunter Hospital, New Lambton Heights, NSW, Australia; School of Medicine and Public Health, University of Newcastle, NSW, Australia.'}, {'lastname': 'Gibson', 'firstname': 'Peter G', 'initials': 'PG', 'affiliation': 'National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, The University of Newcastle, Newcastle, NSW, Australia,; National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, Hunter Medical Research Institute Asthma and Breathing Research Program, Newcastle, NSW, Australia,; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle, NSW, Australia.'}, {'lastname': 'Bardin', 'firstname': 'Philip', 'initials': 'P', 'affiliation': 'Monash Lung, Sleep, Allergy and Immunology, Monash Health and Monash University, Melbourne, Australia;; School of Clinical Sciences, Monash Health and Monash University, Melbourne, Australia.'}, {'lastname': 'Leong', 'firstname': 'Paul', 'initials': 'P', 'affiliation': 'Monash Lung, Sleep, Allergy and Immunology, Monash Health and Monash University, Melbourne, Australia;; School of Clinical Sciences, Monash Health and Monash University, Melbourne, Australia.'}, {'lastname': 'McDonald', 'firstname': 'Vanessa M', 'initials': 'VM', 'affiliation': 'National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, The University of Newcastle, Newcastle, NSW, Australia,; National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, Hunter Medical Research Institute Asthma and Breathing Research Program, Newcastle, NSW, Australia,; School of Nursing and Midwifery, The University of Newcastle, Newcastle, NSW, Australia;; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle, NSW, Australia;. Electronic address: Vanessa.McDonald@newcastle.edu.au.'}], 'methods': None, 'conclusions': \"People with asthma and coexisting VCD/ILO experience a substantial burden affecting their quality of life. These data describe the impact of patients with co-existing conditions and should be used to increase clinician awareness of the experience of VCD/ILO from the patients' perspectives to support a personalised approach to care.\", 'results': \"Participants were mostly female (63%) with a mean±SD age of 63±12. Four themes were identified: (i) trapped voice, (ii) altered life, (iii) knowledge about VCD/ILO, and (iv) looking for solutions. Participants reported their voice being trapped in their throat or their voice being suddenly 'cut-off' when talking/singing. Self-reported VCD/ILO symptoms including throat-tightness and breathlessness were highlighted by participants. The second theme described how they struggle to communicate or tended to shorten conversations. Insufficient knowledge and existing confusion as to whether asthma was causing their breathlessness was described in the third theme. Looking for solutions depicted participants diagnostic journey and how participants sought an explanation for their symptoms.\", 'copyrights': 'Copyright © 2024. Published by Elsevier Inc.', 'doi': '10.1016/j.jaip.2024.01.028', 'xml': <Element 'PubmedArticle' at 0x108d6c720>}\n",
      "{'pubmed_id': '38290164', 'title': 'Early-life Pulmonary Viral Infection Leads to Long-term Functional and lower airway Structural changes in the lungs.', 'abstract': 'Early-life respiratory virus infections have been correlated with enhanced development of childhood asthma. In particular, significant numbers of RSV-hospitalized infants go on to develop lung disease. It has been suggested that early-life viral infections may lead to altered lung development or repair that negatively impacts lung function later in life. Our data demonstrate that early-life RSV infection modifies lung structure, leading to decreased lung function. At 5 weeks post-neonatal RSV infection, significant defects are observed in baseline pulmonary function test (PFT) parameters consistent with decreased lung function as well as enlarged alveolar spaces. Lung function changes in the early-life RSV-infected group continue at 3 months of age. The altered PFT and structural changes induced by early-life RSV were mitigated in TSLPR-/- mice that have previously been shown to have reduced immune cell accumulation associated with a persistent Th2 environment. Importantly, long-term effects were demonstrated using a secondary RSV infection 3 months following the initial early-life RSV infection and led to significant additional defects in lung function, with severe mucus deposition within the airways, and consolidation of the alveolar spaces. These studies suggest that early-life respiratory viral infection leads to alterations in lung structure/repair that predispose to diminished lung function later in life.', 'keywords': ['Lung function', 'RSV'], 'journal': 'American journal of physiology. Lung cellular and molecular physiology', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Malinczak', 'firstname': 'Carrie-Anne', 'initials': 'CA', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Fonseca', 'firstname': 'Wendy', 'initials': 'W', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Hrycaj', 'firstname': 'Steven M', 'initials': 'SM', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Morris', 'firstname': 'Susan B', 'initials': 'SB', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Rasky', 'firstname': 'Andrew J', 'initials': 'AJ', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Yagi', 'firstname': 'Kazuma', 'initials': 'K', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Wellik', 'firstname': 'Deneen M', 'initials': 'DM', 'affiliation': 'Department of Cell and Regenerative Biology, University of Wisconsin Health, Madison, WI, United States.'}, {'lastname': 'Ziegler', 'firstname': 'Steven F', 'initials': 'SF', 'affiliation': 'Benaroya Research Institute, Seattle, WA, United States.'}, {'lastname': 'Zemans', 'firstname': 'Rachel L', 'initials': 'RL', 'affiliation': 'University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}, {'lastname': 'Lukacs', 'firstname': 'Nicholas W', 'initials': 'NW', 'affiliation': 'Pathology, University of Michigan-Ann Arbor, Ann Arbor, MI, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1152/ajplung.00300.2023', 'xml': <Element 'PubmedArticle' at 0x108d6f1f0>}\n",
      "{'pubmed_id': '38290114', 'title': 'Challenging Case: A Multidisciplinary Approach to Demystifying Chronic Sleep Impairment in an Infant with a Complex Medical and Behavioral Profile.', 'abstract': 'X is a 22-month-old White male infant with a complex medical history, including diagnoses of FBXO11 mutation, hypotonia, restrictive lung disease and mild intermittent asthma, laryngotracheomalacia, obstructive sleep apnea (OSA), feeding difficulties with a history of aspiration, gastroesophageal reflux disease (GERD), and developmental delays. X\\'s medical presentation has resulted in multiple prior medical admissions for respiratory failure due to acute illnesses, procedures and treatments including gastrojejunostomy (GJ) tube dependence, supraglottoplasty to reshape tissues of the upper larynx, and the use of biphasic positive airway pressure (BiPAP) at night and room air during the day when he is at baseline. In addition, he has nocturnal events characterized by significant agitation, screaming, crying, body stiffening and limb movements with pauses in breathing, mouth breathing, restless sleep, and difficulty waking in the morning with concomitant daytime fatigue despite above treatments for OSA. There is no history of congenital heart disease or sudden unexplained death. Family history is noncontributory because parents are negative for the FBXO11 variant.X\\'s sleep disruption has led to significant sleep deficits for both X and his caregivers, who spend much of the night strategizing on how to console him. X has undergone several sleep studies, starting when X was aged 4 months, at several children\\'s hospitals across the nation to determine the cause of his chronic sleep disturbance, which yielded limited information and treatment success. As an infant, X received a medical workup and was subsequently treated with a proton pump inhibitor (PPI) for reflux. At 12 months, he was diagnosed with disordered sleep with myoclonic jerks and started on melatonin and gabapentin for involuntary movements. At 13 months, gabapentin was weaned back because of intolerance, and at 15 months, nortriptyline and clonidine were started because of worsening symptoms to target potential neuropathic pain. While most of his symptoms were at night, he had occasional daytime screaming episodes, particularly when experiencing illness. Gabapentin and clonidine were stopped because nortriptyline seemed most effective.At 17 months, the results from a sleep study led to a diagnosis of night terrors, and several clinicians agreed that X\\'s sleep disruption was behavioral in nature. At this time, an infant mental health consultant met with a sleep psychologist on the family\\'s behalf to support family in considering systematic desensitization therapy to increase tolerance to wearing his BiPAP mask, as well as other behavioral and sleep hygiene strategies, which were tried on several occasions and again, resulted in limited improvement in functioning.At 19 months, X\\'s multidisciplinary team reconsidered a night terror diagnosis after a failed trial of clonazepam and pursued a differential diagnosis of periodic limb movement disorder (PLMD). X trialed gabapentin again, but this time only a nighttime dose, per sleep medicine and psychiatry recommendation. While this brought some temporary relief from nighttime distress, despite increasing to the highest dose for age and weight (15 mg/kg/dose), this became less effective, and he was weaned off at 22 months. He had been on iron supplementation since age 6 months and received an iron infusion at 22 months because of persistently low ferritin levels and PLMD in sleep.At 24 months, X was briefly trialed on levetiracetam. While no evidence for seizures on EEG was present, this medication was chosen for involuntary movements and genetic risk for seizures. However, this medication was not useful. At 25 months, an evaluation with a movement disorder physiatrist resulted in a diagnosis of nocturnal paroxysmal dystonia, and he was started on baclofen, which has provided some, but not complete relief to nighttime symptoms. Parents are reporting he has more \"good nights\" than \"bad nights,\" but \"bad nights\" come in stretches of a few days in length with no known trigger or relief.Most recently, X was evaluated by general genetics. Whole exome sequencing (WES) was pursued which revealed a pathogenic de novo variant in FBXO11 and provides a likely cause for his neurodevelopmental phenotype. However, he has some features not explained by FBX011; thus, reanalysis of his WES was performed and revealed a de novo variant of uncertain significance in RAF1. Because pathogenic variants in RAF1 have been associated with dilated cardiomyopathy and Noonan spectrum disorder, it was recommended that X be followed periodically in a cardiac genetics clinic. Family is well connected into the FBXO11 community, including supportive Facebook groups. Parents have shared that they do not feel X\\'s breathing issues and pain fit with the phenotype of other children with FBXO11 mutations.X is also enrolled in a medical child care program to facilitate development and social-emotional functioning and receives learning, speech, occupational, physical, and feeding therapy while in attendance. Despite periods of absence due to contracting numerous viral illnesses over the past several months, X continues to make progress across developmental therapies and happily engages when at the program.What additional diagnostic tests and treatment should be considered to better understand X\\'s medical and behavioral presentation? What are the implications of chronic sleep deprivation and stress on the behavior and development of infant with X\\'s profile? What are important psychosocial considerations because it relates to children with medical complexity (CMC), particularly for X and his family to support caregiver, family, and X\\'s quality of life and overall well-being?', 'keywords': [], 'journal': 'Journal of developmental and behavioral pediatrics : JDBP', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Gleason', 'firstname': 'Erica', 'initials': 'E', 'affiliation': \"Child & Adolescent Psychiatry, University of Colorado Medicine, Children's Hospital of Colorado, Aurora, CO.\"}, {'lastname': 'Malik', 'firstname': 'Kristina', 'initials': 'K', 'affiliation': \"Department of Pulmonary and Sleep Medicine, KidStreet & Special Care Clinic, Children's Hospital of Colorado, Aurora, CO.\"}, {'lastname': 'Sannar', 'firstname': 'Elise', 'initials': 'E', 'affiliation': \"Child & Adolescent Psychiatry, University of Colorado Medicine, Children's Hospital of Colorado, Aurora, CO.\"}, {'lastname': 'Kamara', 'firstname': 'Dana', 'initials': 'D', 'affiliation': \"Department of Pediatrics, Pulmonary & Sleep Medicine, University of Colorado Medicine, Children's Hospital of Colorado, Aurora, CO.\"}, {'lastname': 'Serrano', 'firstname': 'Verenea', 'initials': 'V', 'affiliation': \"Psychiatry, University of Colorado Medicine, Children's Hospital of Colorado, Aurora, CO.\"}, {'lastname': 'Augustyn', 'firstname': 'Marilyn', 'initials': 'M', 'affiliation': 'Boston University, Boston, MA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.', 'doi': '10.1097/DBP.0000000000001251', 'xml': <Element 'PubmedArticle' at 0x108d29da0>}\n",
      "{'pubmed_id': '38289950\\n30737488\\n35065702\\n37054678\\n22110527\\n29120743\\n29120744\\n32130897\\n31043573\\n37108838\\n35581140\\n34606884\\n18384431\\n29619379\\n26690368\\n27780017\\n11736895\\n14674928\\n27497276\\n29604251\\n27868136\\n32637539\\n28025013\\n10835624\\n10994770\\n8323307\\n33645549\\n24167252\\n36206195\\n29930242\\n34543653\\n34857395\\n30219389\\n31088972\\n33837391\\n32709423\\n28821884\\n1726708\\n2053590\\n8980953\\n25828150\\n27771048\\n28046055\\n21039413\\n38030609\\n15813818\\n37178404\\n34784964\\n37853878\\n31230371\\n28891557\\n29580867\\n30687649\\n32459284\\n35138643\\n30612663\\n32428528\\n25840722\\n36376738\\n36940975\\n30831444\\n31424098\\n17908936\\n12960392\\n35594856\\n33410748\\n36736455\\n33326792\\n27765722\\n21042920\\n28328896\\n33792799\\n27053239\\n18768855\\n35292647\\n23630390\\n34417579\\n23404398\\n23555002\\n25612137\\n19144317\\n9182686\\n24172897', 'title': '', 'abstract': '', 'keywords': ['Staphylococcus aureus', 'eosinophils', 'inflammatory skin diseases', 'interleukin-17', 'interleukin-36'], 'journal': 'Proceedings of the National Academy of Sciences of the United States of America', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Kline', 'firstname': 'Sabrina N', 'initials': 'SN', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Orlando', 'firstname': 'Nicholas A', 'initials': 'NA', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Lee', 'firstname': 'Alex J', 'initials': 'AJ', 'affiliation': 'Department of Oncology, Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD 21205.'}, {'lastname': 'Wu', 'firstname': 'Meng-Jen', 'initials': 'MJ', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Zhang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Youn', 'firstname': 'Christine', 'initials': 'C', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Feller', 'firstname': 'Laine E', 'initials': 'LE', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Pontaza', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Dikeman', 'firstname': 'Dustin', 'initials': 'D', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Limjunyawong', 'firstname': 'Nathachit', 'initials': 'N', 'affiliation': 'Center of Research Excellence in Allergy and Immunology, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.'}, {'lastname': 'Williams', 'firstname': 'Kaitlin L', 'initials': 'KL', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Wang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Cihakova', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Jacobsen', 'firstname': 'Elizabeth A', 'initials': 'EA', 'affiliation': 'Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ 85259.'}, {'lastname': 'Durum', 'firstname': 'Scott K', 'initials': 'SK', 'affiliation': 'Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702.'}, {'lastname': 'Garza', 'firstname': 'Luis A', 'initials': 'LA', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}, {'lastname': 'Dong', 'firstname': 'Xinzhong', 'initials': 'X', 'affiliation': 'HHMI, Johns Hopkins University School of Medicine, Baltimore, MD 21205.\\nSolomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.'}, {'lastname': 'Archer', 'firstname': 'Nathan K', 'initials': 'NK', 'affiliation': 'Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21287.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1073/pnas.2309243121\\n10.1126/scitranslmed.aat8329\\n10.3390/ijms24087675\\n10.1128/microbiolspec.MCHD-2015\\n10.1172/JCI143334\\n10.7554/eLife.60609', 'xml': <Element 'PubmedArticle' at 0x108dd84a0>}\n",
      "{'pubmed_id': '38289274', 'title': 'The correlation between the expression of Smad2/3 and Smad7 proteins in blood neutrophils and asthma disease.', 'abstract': None, 'keywords': [], 'journal': 'Minerva medica', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Huang', 'firstname': 'Chaowen', 'initials': 'C', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China.'}, {'lastname': 'Peng', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China.'}, {'lastname': 'Zhong', 'firstname': 'Xueying', 'initials': 'X', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China.'}, {'lastname': 'Tong', 'firstname': 'Jinzhai', 'initials': 'J', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China.'}, {'lastname': 'Liu', 'firstname': 'Lingyun', 'initials': 'L', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China.'}, {'lastname': 'Huang', 'firstname': 'Yanming', 'initials': 'Y', 'affiliation': 'Department of Pulmonary and Critical Care Medicine, Jiangmen Institute of Respiratory Disease, Jiangmen Central Hospital, Jiangmen, Guangdong, China - scotantvivo6@126.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.23736/S0026-4806.23.08756-6', 'xml': <Element 'PubmedArticle' at 0x10a142de0>}\n",
      "{'pubmed_id': '38289241', 'title': 'Assessment of the perception of nasal breathing using Visual Analog Scale in children with newly diagnosed allergic rhinitis: the link with asthma.', 'abstract': None, 'keywords': [], 'journal': 'Minerva pediatrics', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Tosca', 'firstname': 'Maria A', 'initials': 'MA', 'affiliation': 'Allergy Center, IRCCS Istituto Giannina Gaslini, Genoa, Italy.'}, {'lastname': 'Schiavetti', 'firstname': 'Irene', 'initials': 'I', 'affiliation': 'Department of Health Science, University of Genoa, Genoa, Italy.'}, {'lastname': 'Meleca', 'firstname': 'Vincenzo', 'initials': 'V', 'affiliation': 'Allergy Center, IRCCS Istituto Giannina Gaslini, Genoa, Italy.'}, {'lastname': 'Naso', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'Allergy Center, IRCCS Istituto Giannina Gaslini, Genoa, Italy.'}, {'lastname': 'Trincianti', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Allergy Center, IRCCS Istituto Giannina Gaslini, Genoa, Italy.'}, {'lastname': 'Ciprandi', 'firstname': 'Giorgio', 'initials': 'G', 'affiliation': 'Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy - gio.cip@libero.it.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.23736/S2724-5276.24.07534-7', 'xml': <Element 'PubmedArticle' at 0x10a1ff880>}\n",
      "{'pubmed_id': '38289109', 'title': 'Oral streptococci ', 'abstract': 'Oral streptococci, key players in oral biofilm formation, are implicated in oral dysbiosis and various clinical conditions, including dental caries, gingivitis, periodontal disease, and oral cancer. Specifically, ', 'keywords': ['S. anginosus', 'S. mitis', 'immunometabolism', 'inflammation', 'macrophages', 'oral streptococci'], 'journal': 'Infection and immunity', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Senthil Kumar', 'firstname': 'Sangeetha', 'initials': 'S', 'affiliation': 'Department of Immunobiology, College of Medicine, The University of Arizona, Tucson, Arizona, USA.\\nThe University of Arizona Cancer Center, Tucson, Arizona, USA.'}, {'lastname': 'Gunda', 'firstname': 'Venugopal', 'initials': 'V', 'affiliation': 'Department of Pharmacology, University of Virginia, Charlottesville, Virginia, USA.'}, {'lastname': 'Reinartz', 'firstname': 'Dakota M', 'initials': 'DM', 'affiliation': 'Department of Immunobiology, College of Medicine, The University of Arizona, Tucson, Arizona, USA.\\nThe University of Arizona Cancer Center, Tucson, Arizona, USA.'}, {'lastname': 'Pond', 'firstname': 'Kelvin W', 'initials': 'KW', 'affiliation': 'The University of Arizona Cancer Center, Tucson, Arizona, USA.\\nDepartment of Cellular and Molecular Medicine, The University of Arizona, Tucson, Arizona, USA.'}, {'lastname': 'Thorne', 'firstname': 'Curtis A', 'initials': 'CA', 'affiliation': 'The University of Arizona Cancer Center, Tucson, Arizona, USA.\\nDepartment of Cellular and Molecular Medicine, The University of Arizona, Tucson, Arizona, USA.'}, {'lastname': 'Santiago Raj', 'firstname': 'Paul Victor', 'initials': 'PV', 'affiliation': 'R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona, USA.'}, {'lastname': 'Johnson', 'firstname': 'Michael D L', 'initials': 'MDL', 'affiliation': 'Department of Immunobiology, College of Medicine, The University of Arizona, Tucson, Arizona, USA.\\nValley Fever Center for Excellence, The University of Arizona Health Sciences, Tucson, Arizona, USA.\\nBIO5 Institute, The University of Arizona, Tucson, Arizona, USA.\\nAsthma and Airway Disease Research Center, The University of Arizona Health Sciences, Tucson, Arizona, USA.'}, {'lastname': 'Wilson', 'firstname': 'Justin E', 'initials': 'JE', 'affiliation': 'Department of Immunobiology, College of Medicine, The University of Arizona, Tucson, Arizona, USA.\\nThe University of Arizona Cancer Center, Tucson, Arizona, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1128/iai.00536-23', 'xml': <Element 'PubmedArticle' at 0x10a1fd710>}\n",
      "{'pubmed_id': '38289098', 'title': 'Outcomes of SARS-CoV-2 Omicron infection in vaccinated children with asthma versus matched controls: A nationwide population-based study.', 'abstract': None, 'keywords': ['COVID-19', 'Omicron', 'SARS-CoV-2', 'asthma', 'vaccination'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Wee', 'firstname': 'Liang En', 'initials': 'LE', 'affiliation': 'National Centre for Infectious Diseases, Singapore, Singapore.\\nDuke-NUS Graduate Medical School, National University of Singapore, Singapore, Singapore.\\nDepartment of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.'}, {'lastname': 'Tan', 'firstname': 'Janice Yu Jin', 'initials': 'JYJ', 'affiliation': 'Ministry of Health, Singapore, Singapore.'}, {'lastname': 'Chiew', 'firstname': 'Calvin J', 'initials': 'CJ', 'affiliation': 'National Centre for Infectious Diseases, Singapore, Singapore.\\nMinistry of Health, Singapore, Singapore.'}, {'lastname': 'Lye', 'firstname': 'David Chien Boon', 'initials': 'DCB', 'affiliation': 'National Centre for Infectious Diseases, Singapore, Singapore.\\nDepartment of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.\\nLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.\\nYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.'}, {'lastname': 'Tan', 'firstname': 'Kelvin Bryan', 'initials': 'KB', 'affiliation': 'National Centre for Infectious Diseases, Singapore, Singapore.\\nDuke-NUS Graduate Medical School, National University of Singapore, Singapore, Singapore.\\nMinistry of Health, Singapore, Singapore.\\nSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1002/ppul.26893', 'xml': <Element 'PubmedArticle' at 0x10a194090>}\n",
      "{'pubmed_id': '38289083', 'title': 'There is no association between serum endotoxin levels and inflammation in asthma.', 'abstract': 'Endotoxin, in lipopolysaccharide structure (LPS), is the main component of the outer membrane of gram negative bacteria. LPS levels were associated with inflammatory disease. Asthma is a chronic inflammatory disease involving many different cell types and cellular elements. The association between LPS serum levels and the asthma is not well known. The aim of this study was to investigate the association between the LPS serum levels and the severity of asthma, demographic data and laboratory parameters.\\nThe study included 67 patients aged >18\\u2009years with a diagnosis of asthma, and 15 healthy volunteers with no history of chronic disease as a control group. The Asthma Control Test (ACT), Respiratory Function Tests (RFTs), fractional exhaled nitric oxide (FeNO), and endotoxin levels were measured and compared between the groups. The endotoxin measurements were performed using the ELISA method.\\nThe mild-moderate asthma group included 33 patients and the severe asthma group, 34 patients. The endotoxin level was measured as 17.78 (range 3.59 to 304.55) EU/ml in the patient group and 15 (range 4.01 to 74.06) EU/ml in the control group with no statistically significant difference determined between the groups. In the subgroups, the endotoxin level was measured as 15.21 (range 3.69 to 304.55) EU/ml in the mild-moderate group and 14.46 (range 3.59 to 278.86) EU/ml in the severe asthma group with no statistically significant difference determined between the groups.\\nThe results of this study showed no relationship between serum endotoxin level and asthma or asthma severity.', 'keywords': ['Asthma', 'asthma severity', 'biomarker', 'endotoxin', 'lipopolysaccharide'], 'journal': 'The Journal of asthma : official journal of the Association for the Care of Asthma', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Candan', 'firstname': 'Ozlem', 'initials': 'O', 'affiliation': 'Division of Hematology, Marmara Faculty of Medicine, Marmara University, Istanbul, Turkey.'}, {'lastname': 'Toptas', 'firstname': 'Tayfur', 'initials': 'T', 'affiliation': 'Division of Hematology, Marmara Faculty of Medicine, Marmara University, Istanbul, Turkey.'}, {'lastname': 'Demir', 'firstname': 'Semra', 'initials': 'S', 'affiliation': 'Department of Internal Medicine, Division of Immunology and Allergic Diseases, Istanbul University Faculty of Medicine, Istanbul, Turkey.'}, {'lastname': 'Erdenen', 'firstname': 'Fusun', 'initials': 'F', 'affiliation': 'Adult Allergy and Immunology Clinic, Istanbul Training and Research Hospital, Istanbul, Turkey.'}], 'methods': None, 'conclusions': 'The results of this study showed no relationship between serum endotoxin level and asthma or asthma severity.', 'results': 'The mild-moderate asthma group included 33 patients and the severe asthma group, 34 patients. The endotoxin level was measured as 17.78 (range 3.59 to 304.55) EU/ml in the patient group and 15 (range 4.01 to 74.06) EU/ml in the control group with no statistically significant difference determined between the groups. In the subgroups, the endotoxin level was measured as 15.21 (range 3.69 to 304.55) EU/ml in the mild-moderate group and 14.46 (range 3.59 to 278.86) EU/ml in the severe asthma group with no statistically significant difference determined between the groups.', 'copyrights': None, 'doi': '10.1080/02770903.2024.2311233', 'xml': <Element 'PubmedArticle' at 0x10a1b74c0>}\n",
      "{'pubmed_id': '38289059', 'title': 'Factors associated with sensitisation to selected aero-allergens in children and adolescents with asthma followed up at Laquintinie Hospital Douala, Cameroon.', 'abstract': 'In spite of the substantial impact of pediatric asthma on healthcare resources, there is a notable dearth of research focusing on allergen sensitization specifically in children and adolescents with asthma in Cameroon, with existing studies primarily concentrating on adult populations. We, therefore, set out to determine factors associated with sensitization to selected aero-allergens in children and adolescents with asthma followed up at Laquintinie Hospital Douala, Cameroon.\\nWe conducted a cross-sectional analytical study on patients aged 2-17 years followed up for pediatric asthma at Laquintinie Hospital Douala for 8 months (January to August 2023). Skin prick tests were performed using selected standardized aeroallergens extracts. Factors associated with sensitization were determined using multivariable logistic regression analysis. The threshold for significance was set at p\\u2009<\\u2009.05.\\nIn total, 126 children and adolescents with asthma were recruited, 50.79% of whom were male with an average age of 8.00\\u2009±\\u20093.99 years. Eight out of 10 patients (83.52%) were sensitized to common aero-allergens (20.59% monosensitized and 79.41% polysensitized). The most common aero-allergens found were the dust mites Dermatophagoïdes pteronyssinus (81.37%), Blomia tropicalis (67.64%) and Dermatophagoïdes farinae (52.94%) followed by Blatella species (25.49%). The factors independently associated with sensitization in our population were the personal history of allergic rhinitis in the patient [adjusted odds ratio, aOR: 4.07 (95% confidence interval, CI: 1.41-11.76), b\\u2009=\\u20090.54, p\\u2009=\\u2009.009], chest tightness at rest [aOR: 5.92 (95% CI: 1.08-32.38), b\\u2009=\\u20090.87, p\\u2009=\\u2009.040), and age above 5 years [aOR: 4.65 (95% CI: 1.47-14.69), b\\u2009=\\u20090.59, p\\u2009=\\u2009.009).\\nSensitization to multiple aeroallergens is common in children and adolescents with asthma, especially for dust mites and cockroaches. Factors associated with sensitization are patients aged >5 years, chest tightness at rest, and a personal history of allergic rhinitis.', 'keywords': ['Cameroon', 'paediatric asthma', 'prick test'], 'journal': 'Pediatric pulmonology', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Eposse Ekoube', 'firstname': 'Charlotte', 'initials': 'C', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.\\nDepartment of Paediatrics, General Paediatrics Unit, Douala Laquintinie Hospital, Douala, Cameroon.'}, {'lastname': 'Abba', 'firstname': 'Soumaiyatou', 'initials': 'S', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.'}, {'lastname': 'Endale Mangamba', 'firstname': 'Mireille', 'initials': 'M', 'affiliation': 'Department of Internal Medicine and Paediatrics, Faculty of Health Sciences, University of Buea, Buea, Cameroon.'}, {'lastname': 'Mandeng Ma Linwa', 'firstname': 'Edgar', 'initials': 'E', 'affiliation': 'Department of Internal Medicine and Paediatrics, Faculty of Health Sciences, University of Buea, Buea, Cameroon.'}, {'lastname': 'Tchouamo Pokem', 'firstname': 'Annick', 'initials': 'A', 'affiliation': 'Department of Paediatics, Child and Adolescent Health, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.'}, {'lastname': 'Mbonjo Bitsie', 'firstname': 'Dora', 'initials': 'D', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.'}, {'lastname': 'Disso Massako', 'firstname': 'Jeannette', 'initials': 'J', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.'}, {'lastname': 'Heles Nsang', 'firstname': 'Emmanuel', 'initials': 'E', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.'}, {'lastname': 'Ngo Linwa', 'firstname': 'Esther Eleonore', 'initials': 'EE', 'affiliation': 'Department of Clinical Sciences, Faculty of Health Sciences, University of Bamenda, Bamenda, Cameroon.'}, {'lastname': 'Kedy Mangamba Koum', 'firstname': 'Daniele-Christiane', 'initials': 'DC', 'affiliation': 'Department of Clinical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.'}], 'methods': None, 'conclusions': 'Sensitization to multiple aeroallergens is common in children and adolescents with asthma, especially for dust mites and cockroaches. Factors associated with sensitization are patients aged >5 years, chest tightness at rest, and a personal history of allergic rhinitis.', 'results': 'In total, 126 children and adolescents with asthma were recruited, 50.79% of whom were male with an average age of 8.00\\u2009±\\u20093.99 years. Eight out of 10 patients (83.52%) were sensitized to common aero-allergens (20.59% monosensitized and 79.41% polysensitized). The most common aero-allergens found were the dust mites Dermatophagoïdes pteronyssinus (81.37%), Blomia tropicalis (67.64%) and Dermatophagoïdes farinae (52.94%) followed by Blatella species (25.49%). The factors independently associated with sensitization in our population were the personal history of allergic rhinitis in the patient [adjusted odds ratio, aOR: 4.07 (95% confidence interval, CI: 1.41-11.76), b\\u2009=\\u20090.54, p\\u2009=\\u2009.009], chest tightness at rest [aOR: 5.92 (95% CI: 1.08-32.38), b\\u2009=\\u20090.87, p\\u2009=\\u2009.040), and age above 5 years [aOR: 4.65 (95% CI: 1.47-14.69), b\\u2009=\\u20090.59, p\\u2009=\\u2009.009).', 'copyrights': '© 2024 Wiley Periodicals LLC.', 'doi': '10.1002/ppul.26883', 'xml': <Element 'PubmedArticle' at 0x10a1b5300>}\n",
      "{'pubmed_id': '38288811', 'title': 'Insights from Overviewing Selective International Guidelines for Pediatric Asthma.', 'abstract': 'Asthma is a chronic atopic and inflammatory bronchial disease characterized by recurring symptoms and, episodic reversible bronchial obstruction and easily triggered bronchospasms. Asthma often begins in childhood. International guidelines are widely accepted and implemented; however, there are similarities and differences in the management approaches. There is no national guideline in many cities in Asia. This review aims to provide a practical perspective on current recommendations in the management of childhood asthma, specifically in the following aspects: diagnosis, classification of severity, treatment options, and asthma control, and to provide physicians with up-to-date information for the management of asthma.\\nWe used the PubMed function of Clinical Queries and searched keywords of \"Asthma\", \"Pediatric,\" AND \"Guidelines\" as the search engine. \"Clinical Prediction Guides\", \"Etiology\", \"Diagnosis\", \"Therapy,\" \"Prognosis,\" and \"Narrow\" scope were used as filters. The search was conducted in November 2022. The information retrieved from this search was used in compiling the present article.\\nDiagnosis is clinically based on symptom pattern, response to therapy with bronchodilators and inhaled corticosteroids, and spirometric pulmonary function testing (PFT). Asthma is classified in accordance with symptom frequency, peak expiratory flow rate (PEFR), forced expiratory volume in one second (FEV1), atopic versus nonatopic etiology, where atopy means a predisposition toward a type 1 hypersensitivity reaction. Asthma is also classified as intermittent or persistent (mild to severe). Unfortunately, there is no disease cure for asthma. However, symptoms can be prevented by trigger avoidance and suppressed with inhaled corticosteroids. Antileukotriene agents or long-acting beta-agonists (LABA) may be used together with inhaled corticosteroids if symptoms of asthma are not controlled. Rapidly worsening symptoms are usually treated with an inhaled short-acting beta-2 agonist (SABA, e.g., salbutamol) and oral corticosteroids. Intravenous corticosteroids and hospitalization are required in severe cases of asthma attacks. Some guidelines also provide recommendations on the use of biologics and immunotherapy.\\nAsthma is diagnosed clinically, with supporting laboratory testing. Treatment is based on severity classification, from intermittent to persistent. Inhaled bronchodilator and steroid anti-inflammatory form the main stay of management.', 'keywords': ['Asthma', 'beta agonists', 'biologics', 'guidelines', 'inhaled corticosteroid', 'laboratory testing.'], 'journal': 'Current pediatric reviews', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Hon', 'firstname': 'Kam Lun Ellis', 'initials': 'KLE', 'affiliation': 'Department of Pediatrics CUHKMC, The Chinese University of Hong Kong, China.'}, {'lastname': 'Ng', 'firstname': 'Daniel K K', 'initials': 'DKK', 'affiliation': 'Department of Pediatrics, The Hong Kong Sanitorium & Hospital, China.'}, {'lastname': 'Chiu', 'firstname': 'Wa Keung', 'initials': 'WK', 'affiliation': 'Department of Paediatrics and Adolescent Medicine, United Christian Hospital, China.'}, {'lastname': 'Leung', 'firstname': 'Alexander K C', 'initials': 'AKC', 'affiliation': 'Department of Pediatrics, The University of Calgary and The Alberta, Canada.'}], 'methods': None, 'conclusions': 'Asthma is diagnosed clinically, with supporting laboratory testing. Treatment is based on severity classification, from intermittent to persistent. Inhaled bronchodilator and steroid anti-inflammatory form the main stay of management.', 'results': 'Diagnosis is clinically based on symptom pattern, response to therapy with bronchodilators and inhaled corticosteroids, and spirometric pulmonary function testing (PFT). Asthma is classified in accordance with symptom frequency, peak expiratory flow rate (PEFR), forced expiratory volume in one second (FEV1), atopic versus nonatopic etiology, where atopy means a predisposition toward a type 1 hypersensitivity reaction. Asthma is also classified as intermittent or persistent (mild to severe). Unfortunately, there is no disease cure for asthma. However, symptoms can be prevented by trigger avoidance and suppressed with inhaled corticosteroids. Antileukotriene agents or long-acting beta-agonists (LABA) may be used together with inhaled corticosteroids if symptoms of asthma are not controlled. Rapidly worsening symptoms are usually treated with an inhaled short-acting beta-2 agonist (SABA, e.g., salbutamol) and oral corticosteroids. Intravenous corticosteroids and hospitalization are required in severe cases of asthma attacks. Some guidelines also provide recommendations on the use of biologics and immunotherapy.', 'copyrights': 'Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.', 'doi': '10.2174/0115733963270829231221062201', 'xml': <Element 'PubmedArticle' at 0x10a830770>}\n",
      "{'pubmed_id': '38288585', 'title': 'Food Insecurity and Psychosocial Burden in a National Community-Based Sample of Households Managing Food Allergy.', 'abstract': 'Experiencing food allergies and food insecurity has been linked to socioeconomic, physical, and mental health-related challenges, but less is known about the intersection of these experiences. This study aims to better understand the impact of food insecurity on food allergy patients and their caregivers, with the intention of informing ongoing efforts to improve screening for food insecurity and mental health concerns and reducing their burden among households managing food allergy.\\nAs part of a community needs assessment, a cross-sectional survey was administered to a large, national sample (N=5,940) of US households with at least one food-allergic individual, The Hunger Vital Sign was utilized to assess food insecurity, the Patient Health Questionnaire (PHQ-4) and Food Allergy Independent Measure (FAIM) were leveraged to measure psychosocial outcomes.\\nAmong respondents, 69.9% screened at-risk of food insecurity on the Hunger Vital Sign, while 5.6% reported very low food security. Both adults and children with food allergy (FA) from households at risk for food insecurity were more likely to report FA-related anxiety, anger, loneliness, fear of eating, and bullying victimization than their counterparts from households not at risk of food insecurity (p < .0001 for all). Among these specific experiences, FA-related anxiety was the most common (25.4%/30.1% of children/adults). Perceived risk of food allergy-related fatality was positively associated with food insecurity status.\\nIndividuals with food allergies who are concomitantly experiencing food insecurity are at greater risk of a variety of mental health concerns, including those specific to food allergy as well as more general anxiety and depressive symptoms.', 'keywords': ['anxiety', 'food allergy', 'food hypersensitivity', 'food insecurity', 'mental health', 'psychosocial burden', 'public health', 'quality of life'], 'journal': 'Health promotion practice', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Sansweet', 'firstname': 'Samantha', 'initials': 'S', 'affiliation': 'Center for Food Allergy & Asthma Research, Northwestern University, Chicago, IL, USA.'}, {'lastname': 'Roach', 'firstname': 'Anita', 'initials': 'A', 'affiliation': 'Food Allergy Research & Education, McLean, VA, USA.'}, {'lastname': 'Pappalardo', 'firstname': 'Andrea A', 'initials': 'AA', 'affiliation': 'University of Illinois Chicago, Chicago, IL, USA.'}, {'lastname': 'Yost', 'firstname': 'Jennaveve C', 'initials': 'JC', 'affiliation': 'Food Allergy Research & Education, McLean, VA, USA.'}, {'lastname': 'Asante', 'firstname': 'Justine', 'initials': 'J', 'affiliation': 'South Ward Promise Neighborhood, Newark, NJ, USA.'}, {'lastname': 'Warren', 'firstname': 'Christopher', 'initials': 'C', 'affiliation': 'Center for Food Allergy & Asthma Research, Northwestern University, Chicago, IL, USA.'}], 'methods': 'As part of a community needs assessment, a cross-sectional survey was administered to a large, national sample (N=5,940) of US households with at least one food-allergic individual, The Hunger Vital Sign was utilized to assess food insecurity, the Patient Health Questionnaire (PHQ-4) and Food Allergy Independent Measure (FAIM) were leveraged to measure psychosocial outcomes.', 'conclusions': 'Individuals with food allergies who are concomitantly experiencing food insecurity are at greater risk of a variety of mental health concerns, including those specific to food allergy as well as more general anxiety and depressive symptoms.', 'results': 'Among respondents, 69.9% screened at-risk of food insecurity on the Hunger Vital Sign, while 5.6% reported very low food security. Both adults and children with food allergy (FA) from households at risk for food insecurity were more likely to report FA-related anxiety, anger, loneliness, fear of eating, and bullying victimization than their counterparts from households not at risk of food insecurity (p < .0001 for all). Among these specific experiences, FA-related anxiety was the most common (25.4%/30.1% of children/adults). Perceived risk of food allergy-related fatality was positively associated with food insecurity status.', 'copyrights': None, 'doi': '10.1177/15248399231223740', 'xml': <Element 'PubmedArticle' at 0x10a832b60>}\n",
      "{'pubmed_id': '38288460\\n29707502\\n31026435\\n17918258\\n7509254\\n34863051\\n33816237\\n37008167\\n33708306\\n29721318\\n36642523\\n37637531\\n30836992\\n31527566\\n35359696\\n32595264\\n36506756\\n37374345\\n30555782\\n29607203\\n35342151\\n37169012\\n15523440\\n17139460\\n29627047\\n32209920\\n16389188\\n31304017\\n36038675\\n22963430\\n33449415\\n14681323\\n20607807\\n35355128\\n22914577\\n31272473\\n36633661\\n35031442\\n36077679\\n32992118\\n35326555\\n36064585\\n25122439\\n30166019', 'title': 'Pulmonary Adenoid Cystic Carcinoma Mimicking Asthma-Like Symptoms: A Case Report and Literature Review.', 'abstract': \"Pulmonary adenoid cystic carcinoma (PACC) is a rare, low-grade malignant salivary gland-type tumor characterized by a dormant onset and slow progression, often leading to misdiagnosis. Due to its rarity, limited cases have been reported in the literature. This report aimed to enhance clinicians' understanding of this infrequent disease.\\nWe present the case of a 41-year-old female patient diagnosed with PACC. Our report provides a comprehensive analysis of the patient's imaging, pathology, and treatment, with a particular focus on immunohistochemical results. Importantly, we emphasize the significance of considering foreign bodies and tumors in the bronchus when encountering asthma-like symptoms unresponsive to conventional treatments. Due to the uncertain etiology and pathophysiology of PACC, there are currently no established guidelines for chemotherapy and radiotherapy.\\nPACC predominantly manifests as bronchial lesions without significant clinical heterogeneity. Therefore, it is crucial to consider foreign bodies and tumors in the bronchus when dealing with asthma-like symptoms, especially in patients without chronic lung disease who do not respond to anti-infective, antispasmodic, and antiasthmatic treatments. Additionally, meticulous examination of lesions is essential for timely diagnosis and intervention, ultimately improving patient survival rates.\", 'keywords': ['Bronchial tumor', 'Case report', 'Pulmonary adenoid cystic carcinoma', 'Salivary gland-type tumor', 'Tracheal tumor'], 'journal': 'Case reports in oncology', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Zhou', 'firstname': 'Fan', 'initials': 'F', 'affiliation': 'Kunming Medical University, Kunming, China.\\nDepartment of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Kunming Medical University, Kunming, China.'}, {'lastname': 'Jiang', 'firstname': 'Rong', 'initials': 'R', 'affiliation': 'Kunming Medical University, Kunming, China.\\nDepartment of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Kunming Medical University, Kunming, China.'}, {'lastname': 'Li', 'firstname': 'Shenhong', 'initials': 'S', 'affiliation': 'Kunming Medical University, Kunming, China.'}, {'lastname': 'He', 'firstname': 'Xiaojie', 'initials': 'X', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Kunming Medical University, Kunming, China.'}, {'lastname': 'Li', 'firstname': 'Yongxia', 'initials': 'Y', 'affiliation': 'Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Kunming Medical University, Kunming, China.'}], 'methods': None, 'conclusions': 'PACC predominantly manifests as bronchial lesions without significant clinical heterogeneity. Therefore, it is crucial to consider foreign bodies and tumors in the bronchus when dealing with asthma-like symptoms, especially in patients without chronic lung disease who do not respond to anti-infective, antispasmodic, and antiasthmatic treatments. Additionally, meticulous examination of lesions is essential for timely diagnosis and intervention, ultimately improving patient survival rates.', 'results': None, 'copyrights': '© 2024 The Author(s). Published by S. Karger AG, Basel.', 'doi': '10.1159/000535505', 'xml': <Element 'PubmedArticle' at 0x10a841e90>}\n",
      "{'pubmed_id': '38288264\\n28460591\\n26509320\\n3908443\\n12877725\\n26957061\\n35210326\\n34128558\\n37036777\\n30001440\\n34935920\\n33255135\\n32697481\\n16135723\\n12867239\\n10660834\\n22588986', 'title': 'Analysis of risk factors for acute attacks complicated by respiratory failure in children with asthma.', 'abstract': 'To describe the proportion and clinical characteristics of hospitalized children with acute asthma attacks complicated by respiratory failure and to analyze the risk factors.\\nThis retrospective study analyzed hospital admissions of children and adolescents with acute asthma attacks between January 2016 and December 2021. Inclusion criteria were used to identify eligible cases, and demographic information and disease characteristics were collected. Patients were categorized into respiratory failure group and the other group based on the result of artery blood gas analysis. Multivariate logistic regression was utilized to investigate the risk factors associated with respiratory failure resulting from acute asthma attacks. The data were analyzed using SPSS 22.0, and significance was considered at \\nOur research involved 225 participants, with 18.7% diagnosed with respiratory failure. The respiratory failure group was found to be younger and have higher percentage of male, while birth weight, nationality, and type of residence did not differ between the two groups. In the respiratory failure group, a significant difference was observed in emergency hospitalization, ICU treatment, severe to critical attack, dyspnea and allergy history. The two groups did not differ in admission season, first asthma diagnosis, respiratory infection and comorbidity. The respiratory failure group exhibited a higher proportion of atopy-only asthma and a lower proportion of T2-high asthma. The eosinophil count, and eosinophil percentage were lower in the respiratory failure group, while neutrophil count was higher. Having a history of allergies (OR\\u2009=\\u20092.46, 95% CI: 1.08-5.59) and neutrophil count (OR\\u2009=\\u20091.10, 95% CI: 1.00-1.21) were the risk factors for respiratory failure in children with asthma. There also existed that the risk of respiratory failure increases with decreasing age of the children (OR\\u2009=\\u20090.85, 95% CI: 0.73-0.99).\\nNotably, risk factors for respiratory failure in hospitalized asthma children include age, having a history of allergies, and neutrophil count. The identification of the above factors and the implementation of timely intervention can optimize the treatment of asthma in children.', 'keywords': ['asthma attack', 'child', 'hospitalization', 'respiratory failure', 'risk factor'], 'journal': 'Frontiers in pediatrics', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Han', 'firstname': 'Peng', 'initials': 'P', 'affiliation': \"Respiratory Department, China National Clinical Research Center of Respiratory Diseases, Beijing, China, Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Jiao', 'firstname': 'Anxia', 'initials': 'A', 'affiliation': \"Department of Interventional Pulmonology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China.\"}, {'lastname': 'Yin', 'firstname': 'Ju', 'initials': 'J', 'affiliation': \"Respiratory Department, China National Clinical Research Center of Respiratory Diseases, Beijing, China, Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Zou', 'firstname': 'Huimin', 'initials': 'H', 'affiliation': \"Respiratory Department, China National Clinical Research Center of Respiratory Diseases, Beijing, China, Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Liu', 'firstname': 'Yuliang', 'initials': 'Y', 'affiliation': \"Respiratory Department, China National Clinical Research Center of Respiratory Diseases, Beijing, China, Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Li', 'firstname': 'Zheng', 'initials': 'Z', 'affiliation': \"Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Wang', 'firstname': 'Quan', 'initials': 'Q', 'affiliation': \"Pediatric Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Wu', 'firstname': 'Jie', 'initials': 'J', 'affiliation': \"Department of Emergency, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\"}, {'lastname': 'Shen', 'firstname': 'Kunling', 'initials': 'K', 'affiliation': \"Respiratory Department, China National Clinical Research Center of Respiratory Diseases, Beijing, China, Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.\\nDepartment of Pediatrics, Shenzhen Children's Hospital, Shenzhen, China.\"}], 'methods': None, 'conclusions': 'Notably, risk factors for respiratory failure in hospitalized asthma children include age, having a history of allergies, and neutrophil count. The identification of the above factors and the implementation of timely intervention can optimize the treatment of asthma in children.', 'results': 'Our research involved 225 participants, with 18.7% diagnosed with respiratory failure. The respiratory failure group was found to be younger and have higher percentage of male, while birth weight, nationality, and type of residence did not differ between the two groups. In the respiratory failure group, a significant difference was observed in emergency hospitalization, ICU treatment, severe to critical attack, dyspnea and allergy history. The two groups did not differ in admission season, first asthma diagnosis, respiratory infection and comorbidity. The respiratory failure group exhibited a higher proportion of atopy-only asthma and a lower proportion of T2-high asthma. The eosinophil count, and eosinophil percentage were lower in the respiratory failure group, while neutrophil count was higher. Having a history of allergies (OR\\u2009=\\u20092.46, 95% CI: 1.08-5.59) and neutrophil count (OR\\u2009=\\u20091.10, 95% CI: 1.00-1.21) were the risk factors for respiratory failure in children with asthma. There also existed that the risk of respiratory failure increases with decreasing age of the children (OR\\u2009=\\u20090.85, 95% CI: 0.73-0.99).', 'copyrights': '© 2024 Han, Jiao, Yin, Zou, Liu, Li, Wang, Wu and Shen.', 'doi': '10.3389/fped.2023.1335540\\n10.1177/0885066617705109\\n10.1097/CCM.0000000000001388\\n10.3109/02770908509087113\\n10.1046/j.1365-2559.2003.01664.x\\n10.3760/cma.j.issn.0578-1310.2016.03.003\\n10.1183/13993003.02288-2021\\n10.1111/cea.13964\\n10.3928/19382359-20230208-06\\n10.3928/19382359-20180625-01\\n10.1001/jamanetworkopen.2021.40378\\n10.1097/CCM.0000000000004592\\n10.1097/CCM.0000000000004380\\n10.1183/09031936.05.00146404\\n10.1016/s0002-9343(03)00260-2\\n10.1080/019021400269943\\n10.1002/ppul.22591', 'xml': <Element 'PubmedArticle' at 0x10a8c0360>}\n",
      "{'pubmed_id': '38288208\\n30745934\\n31388551\\n27920408\\n26060501\\n30166900\\n23396028\\n16609129\\n34389011\\n20955609\\n15989158\\n24454289\\n22654398\\n23710463\\n30340634\\n37814640\\n36482398', 'title': 'Knowledge, Attitude, and Perception of Parents in the Najran Region Toward the Use of Herbal Medicine in the Treatment of Asthma in Their Children.', 'abstract': 'Asthma is a prevalent and persistent condition affecting the respiratory system, defined by the presence of fluctuating and reversible symptoms associated with the restriction of airflow, heightened sensitivity of the bronchial tubes, and inflammation within the airways. Saudi Arabia has a high prevalence of this chronic illness, making it one of the most often seen conditions in the country. A popular therapeutic approach within the realm of complementary and alternative medicine for individuals with asthma is the use of herbal medications. Nevertheless, the efficacy of these medicines in treating asthma is often supported by inadequate data.\\nThis study aimed to determine the knowledge, attitude, and perception of parents toward the use of herbal medicines in the treatment of asthma in their children in the Najran Region.\\nIn this cross-sectional study, the participants received an electronic self-administered survey via social media channels. The survey instrument comprises a set of questions that have been gathered from prior studies that have comparable research aims. The questionnaire sheet will contain three parts. Data were analyzed with IBM\\xa0SPSS\\xa0Statistics for Windows, Version 22 (Released 2013; IBM Corp., Armonk, New York, United States). The sample and outcome variables were summarized using the descriptive statistics of frequencies, percentages, means, and standard deviations. Data were analyzed by type of provider as appropriate, and the Pearson chi-square test was used to compare the observed data; the paired sample t-test was used to test the difference between the means of the pretest and post-test.\\nFifteen percent of the respondents personally suffer from asthma, while 85.0% do not. Additionally, 25.7% of the respondents indicated that one of their children suffers from asthma, while 74.3% stated that their children do not suffer from asthma.\\xa0The data also show\\xa0that the statement \"Asthma symptoms are dry cough, shortness of breath, and wheezing\" received a 51.4% \"Strongly Agree\" response, 37.9% \"Agree,\" 9.3% \"Neutral,\" 0.9% \"Disagree,\" and 0.5% \"Strongly Disagree.\" The majority of respondents (51.4%) reported obtaining information about asthma from doctors. A notable portion of respondents (35.5%) reported using herbs or folk medicines to treat asthma in their children. A substantial portion of respondents (44.9%) reported not using medicinal herbs at all. Despite this, 41.6% of respondents expressed belief in the idea of taking herbs as a treatment.\\nIn conclusion, the knowledge, attitude, and perception of parents toward\\xa0the use of herbal medicine in the treatment of asthma in their children are multifaceted and influenced by cultural, social, and individual factors. Understanding these dynamics is essential for developing culturally sensitive healthcare interventions and policies that align with the beliefs and practices of the community.', 'keywords': ['alternative medicine', 'asthma', 'herbal medicine', 'herbs', 'najran city'], 'journal': 'Cureus', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Alzahrani', 'firstname': 'Mohammed J', 'initials': 'MJ', 'affiliation': 'Department of Pediatrics, College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'AlSaadi', 'firstname': 'Abeer M', 'initials': 'AM', 'affiliation': 'Department of Pediatrics, King Salman Bin Abdulaziz Medical City, Medina, SAU.'}, {'lastname': 'Alyami', 'firstname': 'Ali Taher T', 'initials': 'ATT', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alshahrani', 'firstname': 'Abdulmajeed Saad S', 'initials': 'ASS', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alshaiban', 'firstname': 'Mohammed H', 'initials': 'MH', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alwadai', 'firstname': 'Raed Saeed J', 'initials': 'RSJ', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alqurayshah', 'firstname': 'Mohammed H', 'initials': 'MH', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alkulayb', 'firstname': 'Saleh Hamad S', 'initials': 'SHS', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Al Hyder', 'firstname': 'Nasser S', 'initials': 'NS', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}, {'lastname': 'Alshaiban', 'firstname': 'Saleh', 'initials': 'S', 'affiliation': 'College of Medicine, Najran University, Najran, SAU.'}], 'methods': None, 'conclusions': 'In conclusion, the knowledge, attitude, and perception of parents toward\\xa0the use of herbal medicine in the treatment of asthma in their children are multifaceted and influenced by cultural, social, and individual factors. Understanding these dynamics is essential for developing culturally sensitive healthcare interventions and policies that align with the beliefs and practices of the community.', 'results': 'Fifteen percent of the respondents personally suffer from asthma, while 85.0% do not. Additionally, 25.7% of the respondents indicated that one of their children suffers from asthma, while 74.3% stated that their children do not suffer from asthma.\\xa0The data also show\\xa0that the statement \"Asthma symptoms are dry cough, shortness of breath, and wheezing\" received a 51.4% \"Strongly Agree\" response, 37.9% \"Agree,\" 9.3% \"Neutral,\" 0.9% \"Disagree,\" and 0.5% \"Strongly Disagree.\" The majority of respondents (51.4%) reported obtaining information about asthma from doctors. A notable portion of respondents (35.5%) reported using herbs or folk medicines to treat asthma in their children. A substantial portion of respondents (44.9%) reported not using medicinal herbs at all. Despite this, 41.6% of respondents expressed belief in the idea of taking herbs as a treatment.', 'copyrights': 'Copyright © 2023, Alzahrani et al.', 'doi': '10.7759/cureus.51308', 'xml': <Element 'PubmedArticle' at 0x10a431850>}\n",
      "{'pubmed_id': '38287974\\n27439517\\n24766814\\n21551058\\n27821550\\n35150047\\n29309059\\n21207359\\n26095251\\n25609839\\n29426702\\n30277658\\n27272386\\n28150777\\n26160952\\n23918170', 'title': 'A novel mass cytometry protocol optimized for immunophenotyping of low-frequency antigen-specific T cells.', 'abstract': 'Understanding antigen-specific T-cell responses, for example, following virus infections or allergen exposure, is of high relevance for the development of vaccines and therapeutics. We aimed on optimizing immunophenotyping of T cells after antigen stimulation by improving staining procedures for flow and mass cytometry. Our method can be used for primary cells of both mouse and human origin for the detection of low-frequency T-cell response using a dual-barcoding system for individual samples and conditions. First, live-cell barcoding was performed using anti-CD45 antibodies prior to an ', 'keywords': ['CyTOF', 'T-cell activation', 'T-cell stimulation assay', 'method', 'sample barcoding'], 'journal': 'Frontiers in cellular and infection microbiology', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Balz', 'firstname': 'Kathrin', 'initials': 'K', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}, {'lastname': 'Grange', 'firstname': 'Magali', 'initials': 'M', 'affiliation': \"Centre d'Immunophénomique Centre d'Immunophénomique (CIPHE), Aix Marseille Université, INSERM, CNRS Philipps-Universität Marburg (UMR), Marseille, France.\"}, {'lastname': 'Pegel', 'firstname': 'Uta', 'initials': 'U', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}, {'lastname': 'Karamya', 'firstname': 'Zain A', 'initials': 'ZA', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}, {'lastname': 'Mello', 'firstname': 'Marielle', 'initials': 'M', 'affiliation': \"Centre d'Immunophénomique Centre d'Immunophénomique (CIPHE), Aix Marseille Université, INSERM, CNRS Philipps-Universität Marburg (UMR), Marseille, France.\"}, {'lastname': 'Zhou', 'firstname': 'Xiaoying', 'initials': 'X', 'affiliation': 'Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, United States.'}, {'lastname': 'Berger', 'firstname': 'Thilo', 'initials': 'T', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}, {'lastname': 'Bloch', 'firstname': 'Konstantin', 'initials': 'K', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}, {'lastname': 'Dunham', 'firstname': 'Diane', 'initials': 'D', 'affiliation': 'Sean N Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, United States.'}, {'lastname': 'Chinthrajah', 'firstname': 'Sharon', 'initials': 'S', 'affiliation': 'Sean N Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, United States.'}, {'lastname': 'Nadeau', 'firstname': 'Kari', 'initials': 'K', 'affiliation': 'Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, United States.'}, {'lastname': 'Luche', 'firstname': 'Hervé', 'initials': 'H', 'affiliation': \"Centre d'Immunophénomique Centre d'Immunophénomique (CIPHE), Aix Marseille Université, INSERM, CNRS Philipps-Universität Marburg (UMR), Marseille, France.\"}, {'lastname': 'Skevaki', 'firstname': 'Chrysanthi', 'initials': 'C', 'affiliation': 'Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, German Center for Lung Research (DZL), Marburg, Germany.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Balz, Grange, Pegel, Karamya, Mello, Zhou, Berger, Bloch, Dunham, Chinthrajah, Nadeau, Luche and Skevaki.', 'doi': '10.3389/fcimb.2023.1336489\\n10.4049/jimmunol.1600727\\n10.1016/J.CELL.2014.04.005\\n10.1126/SCIENCE.1198704\\n10.1084/JEM.20160897\\n10.1002/cyto.a.24543\\n10.1038/NM.4466\\n10.1002/0471142956.CY0631S55\\n10.1016/J.CELL.2015.05.047\\n10.1158/1538-7445.AM2022-1885\\n10.4049/jimmunol.1402661\\n10.1016/J.IMMUNI.2018.01.011\\n10.1002/cyto.a.23621\\n10.1038/nbt.3584\\n10.1038/NATURE20810\\n10.1126/SCIENCE.1259425\\n10.1007/82_2013_335', 'xml': <Element 'PubmedArticle' at 0x10a4b24d0>}\n",
      "{'pubmed_id': '38287830', 'title': 'Unveiling the Intricacies of Autophagy in Asthma: Unraveling Novel Therapeutic Avenues.', 'abstract': 'Understanding the pathogenesis of different phenotypes of asthma, including glucocorticoid-dependent and glucocorticoid-resistant asthma, is crucial for the development of effective treatments. Autophagy, a fundamental cellular process involved in cell homeostasis, has been implicated in asthma, although the exact mechanisms remain unclear. Recent studies have identified autophagy activation in eosinophilic, neutrophilic, and paucigranulocytic asthma, providing novel insights into the disease. This comprehensive review examines the role of autophagy in the pathogenesis and treatment of asthma, with a focus on various cell types. The goal is to uncover potential therapeutic targets and innovative treatment modalities to improve patient outcomes in clinical settings.', 'keywords': ['eosinophil', 'neutrophil', 'paucigranulocytic', 'phenotypes', 'treatment'], 'journal': 'Frontiers in bioscience (Landmark edition)', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Peng', 'firstname': 'Junjun', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, The First Hospital of Jilin University, 130021 Changchun, Jilin, China.'}, {'lastname': 'Lu', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'Department of Emergency Intensive Care Medicine, The First Hospital of Hebei Medical University, 050051 Shijiazhuang, Hebei, China.'}, {'lastname': 'Hua', 'firstname': 'Shucheng', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, The First Hospital of Jilin University, 130021 Changchun, Jilin, China.'}, {'lastname': 'Song', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Respiratory Medicine, The First Hospital of Jilin University, 130021 Changchun, Jilin, China.\\nDepartment of Respiratory Medicine, Meihekou City Central Hospital, 135000 Meihekou, Jilin, China.'}, {'lastname': 'Liu', 'firstname': 'Han', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, The First Hospital of Jilin University, 130021 Changchun, Jilin, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Author(s). Published by IMR Press.', 'doi': '10.31083/j.fbl2901022', 'xml': <Element 'PubmedArticle' at 0x10a440f40>}\n",
      "{'pubmed_id': '38287786', 'title': 'Aerosolized Particulate Matter and Blunting of Ciliary Dynamic Responses: Implications for Veterans and Active Duty Military in Southwest Asia.', 'abstract': 'Respiratory diseases such as chronic rhinosinusitis and asthma are observed at increased rates in active duty and veteran military members, and they are especially prevalent in individuals who have been deployed in Southwest Asia during Operation Iraqi Freedom and Operation Enduring Freedom. Particulate matter, specifically the fine-grain desert sand found in the Middle East, may be a key source of this pathology because of deleterious effects on mucociliary clearance.\\nWith IRB approval, human sinonasal tissue was grown at an air-liquid interface and cultures were exposed to different types and sizes of particulate matter, including sand from Afghanistan and Kuwait. Ciliary dynamic responses to mechanical stimulation and ATP application were assessed following particulate exposure.\\nParticle size of the commercial sand was substantially larger than that of the sand of Afghan or Kuwaiti origin. Following exposure to particulate matter, normal dynamic ciliary responses to mechanical stimulation and ATP application were significantly decreased (P\\u2009<\\u2009.01), with corresponding decreases in ATP-induced calcium flux (P\\u2009<\\u2009.05). These changes were partially reversible with apical washing after a 16-h period of exposure. After 36\\u2009h of exposure to Middle Eastern sand, ciliary responses to purinergic stimulation were completely abolished.\\nThere is a neutralization of the dynamic ciliary response following chronic particulate matter exposure, similar to ciliary pathologies observed in patients with chronic rhinosinusitis. Aerosolized particulate matter endured by military personnel in the Southwest Asia may cause dysfunctional mucociliary clearance; these data help to explain the increased prevalence of respiratory pathology in individuals who are or have been deployed in this region.', 'keywords': [], 'journal': 'Military medicine', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Workman', 'firstname': 'Alan D', 'initials': 'AD', 'affiliation': 'Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.'}, {'lastname': 'Lee', 'firstname': 'Robert J', 'initials': 'RJ', 'affiliation': 'Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.'}, {'lastname': 'Cohen', 'firstname': 'Noam A', 'initials': 'NA', 'affiliation': 'Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.\\nDivision of Otolaryngology: Head and Neck Surgery, Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA 19104, USA.'}], 'methods': None, 'conclusions': None, 'results': 'Particle size of the commercial sand was substantially larger than that of the sand of Afghan or Kuwaiti origin. Following exposure to particulate matter, normal dynamic ciliary responses to mechanical stimulation and ATP application were significantly decreased (P\\u2009<\\u2009.01), with corresponding decreases in ATP-induced calcium flux (P\\u2009<\\u2009.05). These changes were partially reversible with apical washing after a 16-h period of exposure. After 36\\u2009h of exposure to Middle Eastern sand, ciliary responses to purinergic stimulation were completely abolished.', 'copyrights': 'Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2024. This work is written by (a) US Government employee(s) and is in the public domain in the US.', 'doi': '10.1093/milmed/usae007', 'xml': <Element 'PubmedArticle' at 0x10a47fa60>}\n",
      "{'pubmed_id': '38287757', 'title': 'Appendectomy and asthma: a search for an association in older subjects.', 'abstract': \"Several risk factors found to be associated with postoperative complications and cancer surgery, which carry a significant morbidity risk to cancer patients. Therefore, prehabilitation is necessary to improve the functional capability and nutritional status of a patient prior to surgery, so that the patient can withstand any postoperative activity and associated deterioration. Thus, this study aims to assess the effectiveness of prehabilitation interventions on the functional status of patients with gastric and oesophageal cancer who underwent esophagectomy and gastrectomy.\\nAn interventional study was carried out among oesophageal and gastric cancer patients who had undergone surgery at the National Cancer Institute of Malaysia. The prehabilitation process took a maximum of two weeks, depending on the patient's optimisation before surgery. The prehabilitation is based on functional capacity (ECOG performance status), muscle function (handgrip strength), cardio-respiratory function (peak flow meter) and nutritional status (calorie and protein). Postoperative outcomes are measured based on the length of hospital stay, complications, and Clavien-Dindo Classification.\\nThirty-one patients were recruited to undergo a prehabilitation intervention prior to gastrectomy (n=21) and esophagectomy (n=10). Demographically, most of the cancer patients were males (67.7%) with an ideal mean of BMI (23.5±6.0). Physically, the majority of them had physical class (ASA grade) Grade 2 (67.7%), ECOG performance status of 1 (61.3%) and SGA grade B (51.6%). The functional capacity and nutritional status showed a significant improvement after one week of prehabilitation interventions: peak expiratory flow meter (p<0.001), handgrip (p<0.001), ECOG performance (p<0.001), walking distance (p<0.001), incentive spirometry (p<0.001), total body calorie (p<0.001) and total body protein (p=0.004). However, those patients who required two weeks of prehabilitation for optimization showed only significant improvement in peak expiratory flow meter (p<0.001), handgrip (p<0.001), and incentive spirometry (p<0.001). Prehabilitation is significantly associated postoperatively with the length of hospital stay (p=0.028), complications (p=0.011) and Clavien-Dindo Classification (p=0.029).\\nPrehabilitation interventions significantly increase the functional capacity and nutritional status of cancer patients preoperatively; concurrently reducing hospital stays and complications postoperatively. However, certain cancer patients might require over two weeks of prehabilitation to improve the patient's functional capacity and reduce complications postoperatively.\", 'keywords': [], 'journal': 'The Medical journal of Malaysia', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Koay', 'firstname': 'K L', 'initials': 'KL', 'affiliation': 'Hospital Serdang, Department of General Surgery, Kajang, Selangor, Malaysia.'}, {'lastname': 'Mohd Zim', 'firstname': 'M A', 'initials': 'MA', 'affiliation': 'Universiti Teknologi MARA, Faculty of Medicine, Medical Department and Respiratory Unit, Shah Alam, Selangor, Malaysia.'}, {'lastname': 'Botross', 'firstname': 'N P', 'initials': 'NP', 'affiliation': 'Monash University Malaysia, Department of Medicine, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Thong', 'firstname': 'Y K', 'initials': 'YK', 'affiliation': 'Klinik Kesihatan Sungai Besi, Sungai Besi, Kuala Lumpur, Malaysia.'}, {'lastname': 'Nordin', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Universiti Teknologi MARA, Faculty of Medicine, Medical Department and Respiratory Unit, Shah Alam, Selangor, Malaysia.'}, {'lastname': 'Ramachandran', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Lyell McEwin Hospital, Adelaide, South Australia, Australia.'}, {'lastname': 'See', 'firstname': 'P W', 'initials': 'PW', 'affiliation': 'Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Pemasiri', 'firstname': 'W D R H', 'initials': 'WDRH', 'affiliation': 'Lyell McEwin Hospital, Adelaide, South Australia, Australia.'}, {'lastname': 'Chai', 'firstname': 'S T', 'initials': 'ST', 'affiliation': 'Hospital Shah Alam, Shah Alam, Selangor, Malaysia.'}, {'lastname': 'Wong', 'firstname': 'Y Y P', 'initials': 'YYP', 'affiliation': 'Sarawak General Hospital, Department of Anesthesiology, Kuching, Sarawak, Malaysia.'}, {'lastname': 'Kong', 'firstname': 'J Y', 'initials': 'JY', 'affiliation': 'Hospital Sultan Ismail, Department of Medicine, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Lim', 'firstname': 'S W S', 'initials': 'SWS', 'affiliation': 'Western Health, Melbourne, Victoria, Australia.'}, {'lastname': 'Chia', 'firstname': 'P L M', 'initials': 'PLM', 'affiliation': 'Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Gan', 'firstname': 'G C R', 'initials': 'GCR', 'affiliation': 'Hospital Tuanku Jaafar, Department of Orthopedics, Seremban, Negri Sembilan, Malaysia.'}, {'lastname': 'Cai', 'firstname': 'C Z', 'initials': 'CZ', 'affiliation': 'Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Kok', 'firstname': 'Y Q', 'initials': 'YQ', 'affiliation': 'Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Loh', 'firstname': 'H Y', 'initials': 'HY', 'affiliation': 'Hospital Townsville, Townsville, Queensland, Australia.'}, {'lastname': 'Su', 'firstname': 'E J E', 'initials': 'EJE', 'affiliation': 'Hospital Sibu, Sibu, Sarawak, Malaysia.'}, {'lastname': 'Shamsuddin', 'firstname': 'A R', 'initials': 'AR', 'affiliation': 'Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.'}, {'lastname': 'Md Tarekh', 'firstname': 'N A', 'initials': 'NA', 'affiliation': 'Retired.'}, {'lastname': 'Sood', 'firstname': 'S', 'initials': 'S', 'affiliation': 'International Medical University, Department of Surgery, Bukit Jalil, Kuala Lumpur, Malaysia. suneetsood@yahoo.com.'}], 'methods': None, 'conclusions': \"Prehabilitation interventions significantly increase the functional capacity and nutritional status of cancer patients preoperatively; concurrently reducing hospital stays and complications postoperatively. However, certain cancer patients might require over two weeks of prehabilitation to improve the patient's functional capacity and reduce complications postoperatively.\", 'results': 'Thirty-one patients were recruited to undergo a prehabilitation intervention prior to gastrectomy (n=21) and esophagectomy (n=10). Demographically, most of the cancer patients were males (67.7%) with an ideal mean of BMI (23.5±6.0). Physically, the majority of them had physical class (ASA grade) Grade 2 (67.7%), ECOG performance status of 1 (61.3%) and SGA grade B (51.6%). The functional capacity and nutritional status showed a significant improvement after one week of prehabilitation interventions: peak expiratory flow meter (p<0.001), handgrip (p<0.001), ECOG performance (p<0.001), walking distance (p<0.001), incentive spirometry (p<0.001), total body calorie (p<0.001) and total body protein (p=0.004). However, those patients who required two weeks of prehabilitation for optimization showed only significant improvement in peak expiratory flow meter (p<0.001), handgrip (p<0.001), and incentive spirometry (p<0.001). Prehabilitation is significantly associated postoperatively with the length of hospital stay (p=0.028), complications (p=0.011) and Clavien-Dindo Classification (p=0.029).', 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x10a47d940>}\n",
      "{'pubmed_id': '38287753', 'title': 'Correlation between impulse oscillometry with bronchodilator reversibility in asthmatic population in a tertiary referral centre.', 'abstract': \"Spirometry is considered as a 'gold standard' for diagnosis of asthma. Impulse oscillometry (IOS) is an alternative diagnostic tool which requires less cooperation by the participants. We performed a study to determine the correlation of IOS with bronchodilator reversibility from spirometry in asthmatic participants. We studied the correlation between forced expiratory flow (FEF\\nThis was a cross-sectional study involving 82 asthmatic participants in Hospital Canselor Tuanku Muhriz (HCTM), Universiti Kebangsaan Malaysia (UKM) conducted between December 2020 till January 2022. Participants performed pre- and post-bronchodilator IOS and spirometry within the same day. Correlation between spirometry and IOS parameters and FEF\\nThe change of forced expiratory volume in 1 second (FEV1) was statistically correlated with a change of R5 in IOS. A decrement of 14.5% in R5 can be correlated with positive bronchodilator response (BDR) with a sensitivity of 63.9% and specificity of 60.9%, p=0.007. Pre-bronchodilator FEF\\nIOS detected both bronchodilator reversibility and SAD hence can be considered as an alternative tool to spirometry for diagnosis of asthma in adults. IOS detected SAD more than FEF\", 'keywords': [], 'journal': 'The Medical journal of Malaysia', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Mas Fazlin', 'firstname': 'M J', 'initials': 'MJ', 'affiliation': 'Universiti Kebangsaan Malaysia, Faculty of Medicine, Respiratory Unit, Kuala Lumpur, Malaysia.'}, {'lastname': 'Ching', 'firstname': 'Z H', 'initials': 'ZH', 'affiliation': 'Universiti Kebangsaan Malaysia, Faculty of Medicine, Respiratory Unit, Kuala Lumpur, Malaysia.'}, {'lastname': 'Azat', 'firstname': 'A A', 'initials': 'AA', 'affiliation': 'Universiti Kebangsaan Malaysia, Faculty of Medicine, Respiratory Unit, Kuala Lumpur, Malaysia.'}, {'lastname': 'Mohamed Faisal', 'firstname': 'A H', 'initials': 'AH', 'affiliation': 'Universiti Kebangsaan Malaysia, Faculty of Medicine, Respiratory Unit, Kuala Lumpur, Malaysia. faisal.hamid@ppukm.ukm.edu.my.'}], 'methods': None, 'conclusions': 'IOS detected both bronchodilator reversibility and SAD hence can be considered as an alternative tool to spirometry for diagnosis of asthma in adults. IOS detected SAD more than FEF', 'results': 'The change of forced expiratory volume in 1 second (FEV1) was statistically correlated with a change of R5 in IOS. A decrement of 14.5% in R5 can be correlated with positive bronchodilator response (BDR) with a sensitivity of 63.9% and specificity of 60.9%, p=0.007. Pre-bronchodilator FEF', 'copyrights': None, 'doi': None, 'xml': <Element 'PubmedArticle' at 0x10a916c50>}\n",
      "{'pubmed_id': '38287492', 'title': 'Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics.', 'abstract': \"cAMP-specific 3',5'-cyclic phosphodiesterase 4\\u2009A (PDE4A) holds a pivotal role in modulating intracellular levels of cyclic adenosine monophosphate (cAMP). Targeting PDE4A with novel therapeutic agents shows promise in addressing neurological disorders (e.g. Alzheimer's and Parkinson's diseases), mood disorders (depression, anxiety), inflammatory conditions (asthma, chronic obstructive pulmonary disease), and even cancer. In this study, we present a comprehensive approach that integrates virtual screening and molecular dynamics (MD) simulations to identify potential inhibitors of PDE4A from the existing pool of FDA-approved drugs. The initial compound selection was conducted focusing on binding affinity scores, which led to the identification of several high-affinity compounds with potential PDE4A binding properties. From the refined selection process, two promising compounds, Fluspirilene and Dihydroergocristine, emerged as strong candidates, displaying substantial affinity and specificity for the PDE4A binding site. Interaction analysis provided robust evidence of their binding capabilities. To gain deeper insights into the dynamic behavior of Fluspirilene and Dihydroergocristine in complex with PDE4A, we conducted 300\\u2009ns MD simulations, principal components analysis (PCA), and free energy landscape (FEL) analysis. These analyses revealed that Fluspirilene and Dihydroergocristine binding stabilized the PDE4A structure and induced minimal conformational changes, highlighting their potential as potent binders. In conclusion, our study systematically explores repurposing existing FDA-approved drugs as PDE4A inhibitors through a comprehensive virtual screening pipeline. The identified compounds, Fluspirilene and Dihydroergocristine, exhibit a strong affinity for PDE4A, displaying characteristics that support their suitability for further development as potential therapeutic agents for conditions associated with PDE4A dysfunction.Communicated by Ramaswamy H. Sarma.\", 'keywords': ['cAMP-specific 3′,5′-cyclic phosphodiesterase 4A', 'dihydroergocristine', 'drug repurposing', 'fluspirilene', 'virtual screening'], 'journal': 'Journal of biomolecular structure & dynamics', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Shamsi', 'firstname': 'Anas', 'initials': 'A', 'affiliation': 'Center for Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.'}, {'lastname': 'Khan', 'firstname': 'Mohd Shahnawaz', 'initials': 'MS', 'affiliation': 'Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.'}, {'lastname': 'Altwaijry', 'firstname': 'Nojood', 'initials': 'N', 'affiliation': 'Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.'}, {'lastname': 'Hassan', 'firstname': 'Nageeb', 'initials': 'N', 'affiliation': 'Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.'}, {'lastname': 'Shahwan', 'firstname': 'Moyad', 'initials': 'M', 'affiliation': 'Center for Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.'}, {'lastname': 'Yadav', 'firstname': 'Dharmendra Kumar', 'initials': 'DK', 'affiliation': 'Department of Pharmacy, Gachon Institute of Pharmaceutical Science, College of Pharmacy, Gachon University, Incheon, Republic of Korea.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1080/07391102.2024.2308764', 'xml': <Element 'PubmedArticle' at 0x10a991620>}\n",
      "{'pubmed_id': '38287428\\n34135032\\n32398093\\n33163157\\n36997954\\n34877471\\n33926904\\n26598628\\n35868811', 'title': 'Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.', 'abstract': 'Healthcare system data (HSD) are increasingly used in clinical trials, augmenting or replacing traditional methods of collecting outcome data. This study, PRIMORANT, set out to identify, in the UK context, issues to be considered before the decision to use HSD for outcome data in a clinical trial is finalised, a methodological question prioritised by the clinical trials community.\\nThe PRIMORANT study had three phases. First, an initial workshop was held to scope the issues faced by trialists when considering whether to use HSDs for trial outcomes. Second, a consultation exercise was undertaken with clinical trials unit (CTU) staff, trialists, methodologists, clinicians, funding panels and data providers. Third, a final discussion workshop was held, at which the results of the consultation were fed back, case studies presented, and issues considered in small breakout groups.\\nKey topics included in the consultation process were the validity of outcome data, timeliness of data capture, internal pilots, data-sharing, practical issues, and decision-making. A majority of consultation respondents (n\\u2009=\\u200978, 95%) considered the development of guidance for trialists to be feasible. Guidance was developed following the discussion workshop, for the five broad areas of terminology, feasibility, internal pilots, onward data sharing, and data archiving.\\nWe provide guidance to inform decisions about whether or not to use HSDs for outcomes, and if so, to assist trialists in working with registries and other HSD providers to improve the design and delivery of trials.', 'keywords': ['Clinical trials', 'Data validity', 'Healthcare systems data', 'Outcomes', 'Registries', 'Routinely collected data'], 'journal': 'Trials', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Toader', 'firstname': 'Alice-Maria', 'initials': 'AM', 'affiliation': 'MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK. Sgatoade@liverpool.ac.uk.'}, {'lastname': 'Campbell', 'firstname': 'Marion K', 'initials': 'MK', 'affiliation': 'Health Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.'}, {'lastname': 'Quint', 'firstname': 'Jennifer K', 'initials': 'JK', 'affiliation': 'School of Public Health &, National Heart and Lung Institute, Imperial College London, London, UK.'}, {'lastname': 'Robling', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.'}, {'lastname': 'Sydes', 'firstname': 'Matthew R', 'initials': 'MR', 'affiliation': 'MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.\\nBHF Data Science Centre, Health Data Research UK, London, UK.'}, {'lastname': 'Thorn', 'firstname': 'Joanna', 'initials': 'J', 'affiliation': 'Health Economics Bristol, Population Health Sciences, University of Bristol, Bristol, UK.'}, {'lastname': 'Wright-Hughes', 'firstname': 'Alexandra', 'initials': 'A', 'affiliation': 'Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.'}, {'lastname': 'Yu', 'firstname': 'Ly-Mee', 'initials': 'LM', 'affiliation': 'Oxford Primary Care CTU, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.'}, {'lastname': 'Abbott', 'firstname': 'Tom E F', 'initials': 'TEF', 'affiliation': 'William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.'}, {'lastname': 'Bond', 'firstname': 'Simon', 'initials': 'S', 'affiliation': 'Cambridge Clinical Trials Unit, Cambridge, UK.'}, {'lastname': 'Caskey', 'firstname': 'Fergus J', 'initials': 'FJ', 'affiliation': 'BHF Data Science Centre, Health Data Research UK, London, UK.'}, {'lastname': 'Clout', 'firstname': 'Madeleine', 'initials': 'M', 'affiliation': 'Bristol Trials Centre, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.'}, {'lastname': 'Collinson', 'firstname': 'Michelle', 'initials': 'M', 'affiliation': 'Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.'}, {'lastname': 'Copsey', 'firstname': 'Bethan', 'initials': 'B', 'affiliation': 'Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.'}, {'lastname': 'Davies', 'firstname': 'Gwyneth', 'initials': 'G', 'affiliation': 'UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK.'}, {'lastname': 'Driscoll', 'firstname': 'Timothy', 'initials': 'T', 'affiliation': 'Swansea Trials Unit, Swansea University, Swansea, SA2 8PP, UK.'}, {'lastname': 'Gamble', 'firstname': 'Carrol', 'initials': 'C', 'affiliation': 'Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.'}, {'lastname': 'Griffin', 'firstname': 'Xavier L', 'initials': 'XL', 'affiliation': 'Barts Bone and Joint Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.'}, {'lastname': 'Hamborg', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Pragmatic Clinical Trials Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, E1 2AB, UK.'}, {'lastname': 'Harris', 'firstname': 'Jessica', 'initials': 'J', 'affiliation': 'Bristol Trials Centre, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.'}, {'lastname': 'Harrison', 'firstname': 'David A', 'initials': 'DA', 'affiliation': 'Intensive Care National Audit & Research Centre, London, UK.'}, {'lastname': 'Harji', 'firstname': 'Deena', 'initials': 'D', 'affiliation': 'Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.\\nManchester University NHS Foundation Trust, Manchester, UK.'}, {'lastname': 'Henderson', 'firstname': 'Emily J', 'initials': 'EJ', 'affiliation': \"Ageing and Movement Research Group, Bristol Medical School, University of Bristol, Bristol, UK.\\nOlder People's Unit, Royal United Hospitals NHS Foundation Trust, Bath, UK.\"}, {'lastname': 'Logan', 'firstname': 'Pip', 'initials': 'P', 'affiliation': 'School of Medicine, University of Nottingham and Nottingham City Care Partnership, Nottingham, UK.'}, {'lastname': 'Love', 'firstname': 'Sharon B', 'initials': 'SB', 'affiliation': 'MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.'}, {'lastname': 'Magee', 'firstname': 'Laura A', 'initials': 'LA', 'affiliation': \"Department of Women and Children's Health, King's College London, London, UK.\"}, {'lastname': \"O'Brien\", 'firstname': 'Alastair', 'initials': 'A', 'affiliation': 'Division of Medicine, UCL Institute for Liver and Digestive Health, Royal Free Campus, Upper 3Rd FloorRowland Hill Street, London, NW3 2PF, UK.'}, {'lastname': 'Pufulete', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.'}, {'lastname': 'Ramnarayan', 'firstname': 'Padmanabhan', 'initials': 'P', 'affiliation': 'Department of Surgery and Cancer, Imperial College London, London, W21PB, UK.'}, {'lastname': 'Saratzis', 'firstname': 'Athanasios', 'initials': 'A', 'affiliation': 'Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.'}, {'lastname': 'Smith', 'firstname': 'Jo', 'initials': 'J', 'affiliation': 'Keele Clinical Trials Unit, Faculty of Medicine and Health Sciences, Keele University, Staffordshire, UK.'}, {'lastname': 'Solis-Trapala', 'firstname': 'Ivonne', 'initials': 'I', 'affiliation': 'Keele Clinical Trials Unit, Faculty of Medicine and Health Sciences, Keele University, Staffordshire, UK.'}, {'lastname': 'Stubbs', 'firstname': 'Clive', 'initials': 'C', 'affiliation': 'Birmingham Clinical Trials Unit (BCTU), Institute of Applied Health Research College of Medical and Dental Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.'}, {'lastname': 'Farrin', 'firstname': 'Amanda', 'initials': 'A', 'affiliation': 'Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.'}, {'lastname': 'Williamson', 'firstname': 'Paula', 'initials': 'P', 'affiliation': 'MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.'}], 'methods': None, 'conclusions': None, 'results': 'Key topics included in the consultation process were the validity of outcome data, timeliness of data capture, internal pilots, data-sharing, practical issues, and decision-making. A majority of consultation respondents (n\\u2009=\\u200978, 95%) considered the development of guidance for trialists to be feasible. Guidance was developed following the discussion workshop, for the five broad areas of terminology, feasibility, internal pilots, onward data sharing, and data archiving.', 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s13063-024-07926-z\\n10.1136/bmjopen-2020-043906\\n10.1186/s13063-020-04329-8\\n10.12688/f1000research.23316.3\\n10.1186/s13063-023-07251-x\\n10.1136/emermed-2015-205424\\n10.1016/S2589-7500(22)00122-4', 'xml': <Element 'PubmedArticle' at 0x10a993c90>}\n",
      "{'pubmed_id': '38287280\\n37229504\\n34007170\\n36754956\\n32526187\\n9363890\\n19844248\\n28131398\\n25977312\\n11016890\\n10892340\\n30455427\\n31042083\\n35603960\\n31346213\\n29948618\\n27140192\\n35903083\\n24413755\\n21708511\\n16556701\\n21885636\\n15333851\\n10820280\\n12738811\\n12628874\\n17496226\\n15901605\\n15696076\\n19657904\\n20599764\\n15817806\\n36565197\\n31076739\\n27385610\\n16055882\\n22877614\\n10089885\\n16431095\\n18398112\\n7904005\\n18396030\\n10573239\\n16236842\\n15834732\\n20642846\\n10615062\\n16144705\\n34737707\\n28825404\\n27021580\\n26201096\\n28112974\\n27959617\\n19126841\\n18056631\\n12120757\\n9675134\\n29085059\\n19367378\\n31986490\\n32039219\\n31094281', 'title': 'Analysis of the correlation between serum Klotho and FeNO: a cross-sectional study from NHANES (2007-2012).', 'abstract': \"Klotho is an anti-aging protein that has multiple functions and may play a key role in the pathogenesis and progression of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). Fractional Exhaled Nitric Oxide (FeNO) is a non-invasive and novel biomarker that has the advantages of being simple, fast and reproducible. It can effectively assess the degree of airway inflammation in diseases such as asthma and COPD. Despite these insights, the relationship between serum Klotho levels and FeNO has not been explored yet.\\nLeveraging data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2012, we investigated the correlation between FeNO and serum Klotho levels. This association was scrutinized both as continuous variables and within quartile distributions, utilizing the Kruskal-Wallis H test. The correlation between the two variables was assessed through Spearman rank analysis. Employing survey weight-adjusted linear regression models, we gauged the strength of these associations.\\nThis study included 6,527 participants with a median FeNO level of 14.5 parts per billion (ppb). We found that FeNO levels varied significantly across different quartiles of Klotho protein (H\\u2009=\\u20097.985, P\\u2009=\\u20090.046). We also found a significant positive correlation between serum Klotho levels and FeNO levels in the whole population (Spearman's rho\\u2009=\\u20090.029, P\\u2009=\\u20090.019). This correlation remained significant after adjusting for covariates such as age, gender, lung function, smoking status, alcohol use, BMI, cardiovascular disease (including hypertension, heart failure, coronary heart disease, and myocardial infarction), diabetes, inflammatory markers, serum vitamin D level and BUN (P\\u2009<\\u20090.05 for all). Furthermore, this correlation was stronger at the high (K3) and super high (K4) levels of Klotho than at the low (K1) and medium (K2) levels (β\\u2009=\\u20091.979 ppb and β\\u2009=\\u20091.993 ppb for K3 and K4 vs. K1, respectively; 95% CI: 0.497\\u2009~\\u20092.953 and 95% CI: 0.129\\u2009~\\u20092.827, respectively; P\\u2009=\\u20090.007 and P\\u2009=\\u20090.032, respectively). The β coefficient for serum Klotho was 0.002 ppb/pg/ml.\\nOur study illuminates a positive correlation between serum Klotho levels and FeNO. Further study is needed to verify the causality of this association and elucidate the underlying mechanisms.\", 'keywords': ['Airway inflammation', 'Chronic respiratory diseases', 'FeNO', 'Klotho'], 'journal': 'BMC pulmonary medicine', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Mao', 'firstname': 'Haiyan', 'initials': 'H', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China.'}, {'lastname': 'Xie', 'firstname': 'Zhenye', 'initials': 'Z', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China.'}, {'lastname': 'Huang', 'firstname': 'Shanshan', 'initials': 'S', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China.'}, {'lastname': 'Shen', 'firstname': 'Xingkai', 'initials': 'X', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China.'}, {'lastname': 'Jin', 'firstname': 'Shaofeng', 'initials': 'S', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China.'}, {'lastname': 'Lin', 'firstname': 'Tong', 'initials': 'T', 'affiliation': 'Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital, 315100, Ningbo, China. kai893@foxmail.com.'}, {'lastname': 'Yang', 'firstname': 'Zhouxin', 'initials': 'Z', 'affiliation': 'Zhejiang Provincial Key Lab of Geriatrics and Geriatrics Institute of Zhejiang Province, Department of Geriatrics, Zhejiang Hospital, 310030, Hangzhou, China. yangzhouxin@hotmail.com.'}], 'methods': None, 'conclusions': None, 'results': \"This study included 6,527 participants with a median FeNO level of 14.5 parts per billion (ppb). We found that FeNO levels varied significantly across different quartiles of Klotho protein (H\\u2009=\\u20097.985, P\\u2009=\\u20090.046). We also found a significant positive correlation between serum Klotho levels and FeNO levels in the whole population (Spearman's rho\\u2009=\\u20090.029, P\\u2009=\\u20090.019). This correlation remained significant after adjusting for covariates such as age, gender, lung function, smoking status, alcohol use, BMI, cardiovascular disease (including hypertension, heart failure, coronary heart disease, and myocardial infarction), diabetes, inflammatory markers, serum vitamin D level and BUN (P\\u2009<\\u20090.05 for all). Furthermore, this correlation was stronger at the high (K3) and super high (K4) levels of Klotho than at the low (K1) and medium (K2) levels (β\\u2009=\\u20091.979 ppb and β\\u2009=\\u20091.993 ppb for K3 and K4 vs. K1, respectively; 95% CI: 0.497\\u2009~\\u20092.953 and 95% CI: 0.129\\u2009~\\u20092.827, respectively; P\\u2009=\\u20090.007 and P\\u2009=\\u20090.032, respectively). The β coefficient for serum Klotho was 0.002 ppb/pg/ml.\", 'copyrights': '© 2024. The Author(s).', 'doi': '10.1186/s12890-024-02864-7\\n10.1016/j.eclinm.2023.101936\\n10.2147/COPD.S296696\\n10.1038/s41533-023-00330-1\\n10.1016/S2213-2600(20)30105-3\\n10.1038/36285\\n10.1038/nrendo.2009.196\\n10.1016/j.kint.2016.10.034\\n10.1681/ASN.2014101030\\n10.1053/meta.2000.8606\\n10.1007/s000180050038\\n10.1038/s41581-018-0078-3\\n10.1152/ajplung.00246.2018\\n10.1080/07853890.2022.2077428\\n10.1038/s41598-019-47199-0\\n10.1007/s12253-018-0441-5\\n10.1007/s00408-016-9870-7\\n10.3389/fragi.2022.931331\\n10.3390/ijms15010878\\n10.1289/ehp.1103516\\n10.1164/rccm.2601014\\n10.1164/rccm.9120-11ST\\n10.1136/thx.2003.014894\\n10.1378/chest.123.3.751\\n10.1164/rccm.200610-1427OC\\n10.1164/rccm.200411-1498OC\\n10.1016/j.jaci.2004.11.014\\n10.1016/j.bbrc.2010.06.110\\n10.1164/rccm.200406-710ST\\n10.1161/JAHA.122.026326\\n10.1016/j.eujim.2020.101089\\n10.1093/ajcn/nqz037\\n10.3945/ajcn.115.127985\\n10.1183/09031936.05.00034805\\n10.1016/j.iac.2012.06.005\\n10.1016/S0092-8674(00)80580-2\\n10.1016/j.rmed.2005.11.018\\n10.1378/chest.07-2743\\n10.1016/S0140-6736(94)90935-0\\n10.1016/j.rmed.2008.02.012\\n10.1034/j.1399-3003.1999.14d28.x\\n10.1378/chest.128.4.1964\\n10.1007/s00401-004-0971-7\\n10.1186/1756-9966-29-99\\n10.1165/ajrcmb.22.1.3554\\n10.1016/j.mad.2005.07.007\\n10.3389/fphar.2021.755366\\n10.1088/1752-7163/aa746b\\n10.1016/j.rmed.2016.02.004\\n10.1080/15412555.2016.1272563\\n10.1146/annurev-physiol-022516-034314\\n10.1093/gerona/63.12.1289\\n10.1073/pnas.0709805104\\n10.1254/jjp.89.149\\n10.1006/bbrc.1998.8943\\n10.1038/s41598-017-14811-0\\n10.1007/s12020-009-9181-3\\n10.18632/aging.102734\\n10.3389/fmed.2019.00339\\n10.1089/rej.2019.2183', 'xml': <Element 'PubmedArticle' at 0x10a999d50>}\n",
      "{'pubmed_id': '38287095\\n35803308\\n24687910\\n16399851\\n1595764\\n12662004\\n31703084\\n23438610\\n16807274\\n9841303\\n10639539\\n21856140\\n18166598\\n16236861\\n24997571\\n30846341\\n29355081\\n23722528\\n27589227\\n30527374\\n17136959\\n20956146\\n26496346\\n28433577\\n28609456\\n15131088\\n25726564\\n16707391\\n26208998\\n19802349\\n25220176\\n30996702\\n27533997\\n26678708\\n17311843\\n22100536\\n13974778\\n37710170\\n33369898\\n18245145\\n37379277\\n28196437\\n6288328\\n19407051\\n19783666\\n15947307\\n18579551\\n16531114\\n24351727\\n23139248\\n25645653\\n25965630\\n16235327', 'title': 'Effect of chronic lung diseases on angina pectoris among Indian adults: longitudinal ageing study in India.', 'abstract': \"The study aimed to evaluate the effect of chronic lung diseases, namely chronic obstructive pulmonary diseases (COPD) and asthma, on angina pectoris in individuals aged 45\\xa0years and above. Identifying vulnerable subpopulations suffering from COPD and asthma at higher risk of future cardiovascular events using the rose angina questionnaire is imperative for tailored primary and secondary prevention approaches. The present study utilizes the data from the Longitudinal Ageing Study in India, wave 1, conducted during 2017-2018. The sample size included 58,830 individuals aged 45\\xa0years and above. Angina was measured based on seven questions from Rose's questionnaires. Descriptive statistics and bivariate analysis were employed to examine the prevalence of angina among individuals with COPD and asthma. Further, multivariable logistic regression and propensity score matching (PSM) methods were used to assess the independent effect of COPD and asthma on angina after controlling the selected background characteristics. We employed PSM in two different models and included various additional factors in model 2, such as smoking, chewing tobacco, alcohol use, ADL, IADL, body mass index, physical activity, high cholesterol, hypertension, diabetes, and chronic heart disease. The current study shows that the prevalence of angina pectoris, COPD and asthma was 6.0%, 2.3% and 4.7%, respectively, among individuals aged 45\\xa0years and above in India. The prevalence of angina pectoris was higher among individuals with COPD (9.6% vs. 5.8%) and asthma (9.9% vs. 5.7%) than those without COPD and asthma, respectively. Additionally, angina pectoris was more prevalent among females and rural respondents with COPD (10.8% and 11.0%) and asthma (10.3% and 10.3%) compared to males and urban respondents with COPD (8.0% and 5.7%) and asthma (8.9% and 7.9%). Moreover, in the adjusted model, individuals with COPD (AOR 1.43, 95% CI 1.03 1.98) and asthma (AOR 1.44, 95% CI 1.17 1.77) had nearly 1.5-fold higher odds of having angina pectoris than those without COPD and asthma. The PSM estimates showed that individuals with COPD had 8.4% and 5.0% increased risk of angina pectoris compared to those without COPD in model 1 and model 2, respectively. We observed that, after adjusting to lifestyle, health-related and morbidity factors in model 2, both average treatment effect on untreated (ATU) and average treatment effect (ATE) values decreased by nearly 3.5%. Additionally, the PSM estimates demonstrated that individuals with asthma had a 3.4% and 2.9% increased risk of angina pectoris compared to those without asthma in model 1 and model 2, respectively. The study suggests that COPD and asthma are significantly associated with angina pectoris, and individuals with COPD and asthma have a higher risk of developing angina pectoris. Additionally, angina pectoris was more prevalent among females, rural respondents and adults aged 45-54 with COPD compared to males, urban respondents and those aged 65 and above, respectively, with COPD. Moreover, the findings of our study underscore the targeted primary and secondary interventions and team-based care approach among individuals with COPD and asthma to reduce the risk of CVD events in future.\", 'keywords': [], 'journal': 'Scientific reports', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Ahmed', 'firstname': 'Waquar', 'initials': 'W', 'affiliation': 'School of Health Systems Studies, Tata Institute of Social Sciences, Mumbai, India. waquar8219@gmail.com.'}, {'lastname': 'Dixit', 'firstname': 'Priyanka', 'initials': 'P', 'affiliation': 'School of Health Systems Studies, Tata Institute of Social Sciences, Mumbai, India.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s41598-024-52786-x\\n10.1016/j.amjms.2022.06.023\\n10.1136/jech-2013-203642\\n10.1136/hrt.2005.069419\\n10.1016/0002-9343(92)80056-6\\n10.1183/09031936.03.02582001\\n10.1371/journal.pone.0224451\\n10.1016/j.ihj.2012.09.008\\n10.1136/hrt.2006.090118\\n10.1016/S0140-6736(02)09327-3\\n10.1056/NEJM199811053391902\\n10.1056/NEJM200001203420301\\n10.1016/j.rmed.2011.07.021\\n10.1183/09031936.00114307\\n10.1378/chest.128.4.2099\\n10.1016/j.amepre.2014.03.014\\n10.1016/j.jacc.2018.11.063\\n10.1177/1753465817750524\\n10.1378/chest.12-2847\\n10.1164/rccm.201604-0690SO\\n10.1016/j.pulmoe.2018.09.006\\n10.1081/COPD-200050671\\n10.1183/09059180.00003609\\n10.1097/MD.0000000000001880\\n10.1016/j.anai.2017.03.012\\n10.1371/journal.pone.0179335\\n10.1093/ije/dyh081\\n10.1183/09059180.00012514\\n10.1183/09031936.06.00114405\\n10.1016/S2213-2600(15)00241-6\\n10.2147/COPD.S6400\\n10.1016/j.ijcard.2014.07.297\\n10.1093/eurheartj/suz042\\n10.1093/ehjcvp/pvv019\\n10.3109/15412555.2015.1099620\\n10.1136/thx.2006.072348\\n10.1016/j.rmed.2011.10.009\\n10.1186/s12877-023-04264-8\\n10.1093/biomet/70.1.41\\n10.1017/CBO9780511810725.016\\n10.1136/thx.2007.088112\\n10.1371/journal.pone.0287455\\n10.1177/1074248416679733\\n10.1378/chest.82.4.401\\n10.1183/09031936.00128008\\n10.1378/chest.09-1264\\n10.1378/chest.127.6.1952\\n10.1183/09031936.00012408\\n10.1016/j.ejheart.2006.01.010\\n10.1016/j.orcp.2008.04.005\\n10.1093/aje/kws181\\n10.1007/s10557-014-6569-y\\n10.1016/j.ijcard.2015.05.006\\n10.1007/s11042-019-07742-7', 'xml': <Element 'PubmedArticle' at 0x10a6c90d0>}\n",
      "{'pubmed_id': '38286962\\n31603019\\n29257353\\n31039287\\n9892789\\n29945240\\n25974298\\n25531553\\n33549144\\n34756812\\n31733401\\n29109626\\n27074706\\n35212478\\n24798552\\n25888351\\n35417701\\n30349083\\n31901495\\n32518780\\n28042237\\n31822302\\n37547619\\n37409612\\n34338715\\n26488281\\n36698844\\n37318134\\n37096495\\n30529020\\n36237439\\n25232176\\n27001291\\n28454555\\n25310759\\n36697862\\n31534227\\n23926244\\n33500411\\n31891142\\n22907693\\n24257411\\n27002447\\n23725036\\n25265089\\n25825533\\n37366206\\n34678130\\n30052094\\n30460694\\n31793015\\n32712802\\n19043404\\n21508958\\n23149725\\n24911583\\n27028893\\n32988391\\n22919693\\n36924923\\n19343057\\n37333848\\n37311282\\n31211803\\n19462507\\n28086815\\n34385227\\n26216624\\n26365389\\n32531291\\n32908212\\n25866729\\n32472262\\n26316791\\n34883213\\n29449779\\n27695355\\n32506933\\n34737974\\n26756877\\n22423260\\n24739189\\n28574970\\n33934809\\n29205415\\n34367460\\n37601783\\n24637795', 'title': 'Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?', 'abstract': \"Dysbiosis corresponds to the disruption of a formerly stable, functionally complete microbiota. In the gut, this imbalance can lead to adverse health outcomes in both the short and long terms, with a potential increase in the lifetime risks of various noncommunicable diseases and disorders such as atopy (like asthma), inflammatory bowel disease, neurological disorders, and even behavioural and psychological disorders. Although antibiotics are highly effective in reducing morbidity and mortality in infectious diseases, antibiotic-associated diarrhoea is a common, non-negligible clinical sign of gut dysbiosis (and the only visible one). Re-establishment of a normal (functional) gut microbiota is promoted by completion of the clinically indicated course of antibiotics, the removal of any other perturbing external factors, the passage of time (i.e. recovery through the microbiota's natural resilience), appropriate nutritional support, and-in selected cases-the addition of probiotics. Systematic reviews and meta-analyses of clinical trials have confirmed the strain-specific efficacy of some probiotics (notably the yeast Saccharomyces boulardii CNCM I-745 and the bacterium Lactobacillus rhamnosus GG) in the treatment and/or prevention of antibiotic-associated diarrhoea in children and in adults. Unusually for a probiotic, S.\\xa0boulardii is a eukaryote and is not therefore directly affected by antibiotics-making it suitable for administration in cases of antibiotic-associated diarrhoea. A robust body of evidence from clinical trials and meta-analyses shows that the timely administration of an adequately dosed probiotic (upon initiation of antibiotic treatment or within 48\\xa0h) can help to prevent or resolve the consequences of antibiotic-associated dysbiosis (such as diarrhoea) and promote the resilience of the gut microbiota and a return to the pre-antibiotic state. A focus on the prescription of evidence-based, adequately dosed probiotics should help to limit unjustified and potentially ineffective self-medication.\", 'keywords': ['Antibiotics', 'Diarrhoea', 'Dose', 'Dysbiosis', 'Probiotics', 'Strain-specificity'], 'journal': 'Advances in therapy', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Waitzberg', 'firstname': 'Dan', 'initials': 'D', 'affiliation': 'Department of Gastroenterology, LIM-35, School of Medicine, University of São Paulo, São Paulo, Brazil.'}, {'lastname': 'Guarner', 'firstname': 'Francisco', 'initials': 'F', 'affiliation': 'Teknon Medical Centre, Barcelona, Spain.'}, {'lastname': 'Hojsak', 'firstname': 'Iva', 'initials': 'I', 'affiliation': 'Referral Centre for Pediatric Gastroenterology and Nutrition, School of Medicine, University of Zagreb, Zagreb, Croatia.\\nUniversity of Zagreb Medical School, Zagreb, Croatia.'}, {'lastname': 'Ianiro', 'firstname': 'Gianluca', 'initials': 'G', 'affiliation': \"Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.\\nDepartment of Medical and Surgical Sciences, UOC Gastroenterologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.\\nDepartment of Medical and Surgical Sciences, UOC CEMAD Centro Malattie Dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.\"}, {'lastname': 'Polk', 'firstname': 'D Brent', 'initials': 'DB', 'affiliation': \"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, San Diego, and Rady Children's Hospital, University of California, San Diego, CA, USA.\"}, {'lastname': 'Sokol', 'firstname': 'Harry', 'initials': 'H', 'affiliation': 'Gastroenterology Department, Saint-Antoine Hospital, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, 184 Rue du Faubourg Saint-Antoine, 75571, Paris Cedex 12, France. harry.sokol@gmail.com.\\nUniversité Paris-Saclay, INRAe, AgroParisTech, Micalis Institute, Jouy-en-Josas, France. harry.sokol@gmail.com.\\nParis Center for Microbiome Medicine (PaCeMM) FHU, Paris, France. harry.sokol@gmail.com.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1007/s12325-024-02783-3\\n10.1177/0898010119879527\\n10.1159/000016879\\n10.1016/j.chom.2015.04.006\\n10.4161/19490976.2014.990790\\n10.1186/s40168-020-00991-x\\n10.1016/j.jiph.2021.10.020\\n10.1016/j.mib.2019.10.008\\n10.4103/joacp.JOACP_349_15\\n10.1186/s13073-016-0294-z\\n10.1002/mbo3.1260\\n10.1111/cmi.12308\\n10.1186/s12879-015-0869-0\\n10.1016/j.celrep.2022.110649\\n10.1038/s41564-018-0257-9\\n10.1016/j.wneu.2019.12.125\\n10.12998/wjcc.v8.i10.1908\\n10.3389/fmed.2023.1221363\\n10.1093/jac/dkad213\\n10.1001/jamapediatrics.2021.2328\\n10.1146/annurev-micro-091014-104115\\n10.3389/fmed.2022.1093329\\n10.1080/19490976.2023.2223345\\n10.1016/j.tim.2018.09.008\\n10.5005/jp-journals-11002-0028\\n10.1126/scitranslmed.3010007\\n10.1038/srep23129\\n10.1186/s40168-017-0268-4\\n10.1038/pr.2014.163\\n10.1038/s41586-022-05546-8\\n10.1038/s41586-019-1560-1\\n10.1136/gutjnl-2012-303249\\n10.1038/s41467-020-20495-4\\n10.1016/j.eclinm.2019.10.020\\n10.1038/ijo.2012.132\\n10.1038/ijo.2013.218\\n10.1001/jama.2016.2395\\n10.1111/apa.12307\\n10.1001/jamapediatrics.2014.1539\\n10.1542/peds.2014-3407\\n10.1111/pai.13976\\n10.1080/02648725.2021.1989847\\n10.1080/17474124.2018.1505497\\n10.1002/dev.21806\\n10.1111/sji.12855\\n10.1007/s00592-020-01563-z\\n10.1038/nature07540\\n10.1038/nature09944\\n10.1038/ncomms2159\\n10.1016/j.jmb.2014.05.029\\n10.1159/000443360\\n10.1186/s13073-020-00782-x\\n10.1038/nature11234\\n10.3389/fcimb.2012.00104\\n10.1016/j.neuropharm.2023.109491\\n10.1038/nri2515\\n10.3389/fcimb.2023.1151021\\n10.1016/j.biopha.2023.114985\\n10.1371/journal.pone.0218384\\n10.1053/j.gastro.2009.01.072\\n10.1186/s12967-016-1105-4\\n10.1136/bmjopen-2020-043054\\n10.1111/apt.13344\\n10.1111/apt.13404\\n10.1053/j.gastro.2020.05.059\\n10.1038/s12276-020-0437-6\\n10.5223/pghn.2015.18.1.17\\n10.1007/s00284-020-02053-9\\n10.2147/CEG.S85574\\n10.1016/j.phrs.2021.106022\\n10.1177/1179552217752679\\n10.2147/CEG.S111003\\n10.3920/BM2019.0203\\n10.3389/fcimb.2021.722700\\n10.1097/MPG.0000000000001081\\n10.1177/1756283X11428502\\n10.1097/MPG.0000000000000375\\n10.1097/MPG.0000000000001637\\n10.1016/j.idnow.2020.12.003\\n10.1111/apt.14451\\n10.1155/2021/1622375\\n10.3389/fmed.2023.1087715\\n10.4161/gmic.28442', 'xml': <Element 'PubmedArticle' at 0x10a69c1d0>}\n",
      "{'pubmed_id': '38286793\\n25598422\\n33243107\\n17983880\\n31275909\\n24429127\\n29062228\\n34363950\\n28360514\\n15249443\\n16263481\\n21232045\\n18604231\\n19764051\\n11559924\\n18500382\\n31960603\\n36610030\\n23131596\\n28716723\\n27885819\\n26542454\\n29403878\\n31392772\\n31669821\\n36581315\\n29183838\\n24521830\\n23043183', 'title': 'Stability-indicating UPLC assay coupled with mass spectrometry for the analysis of vilanterol degradation products in human urine.', 'abstract': 'Vilanterol is a once-daily dose inhaler prescribed for asthma and\\xa0chronic obstructive pulmonary disease. This study involved an investigation of vilanterol stability under acidic, basic, oxidative, thermal, and photolytic stress conditions. UPLC method\\xa0was developed and validated for the analysis of vilanterol with its degradants. The drug was stable under photolytic and thermal stress conditions and degraded under acidic, basic, and oxidative stress conditions. Degradation kinetics was performed for acidic, basic and oxidative stress conditions. Kinetics parameters, K, half-life time (t', 'keywords': [], 'journal': 'Scientific reports', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Tarek', 'firstname': 'Mohamed', 'initials': 'M', 'affiliation': 'Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt.\\nHealth Research Center of Excellence, Drug Research and Development Group, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.'}, {'lastname': 'Wagdy', 'firstname': 'Hebatallah A', 'initials': 'HA', 'affiliation': 'Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt. Hebatallah.wagdy@bue.edu.eg.\\nHealth Research Center of Excellence, Drug Research and Development Group, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt. Hebatallah.wagdy@bue.edu.eg.'}, {'lastname': 'Hegazy', 'firstname': 'Maha A', 'initials': 'MA', 'affiliation': 'Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt. Maha.hegazy@pharma.cu.edu.eg.'}, {'lastname': 'Ghoniem', 'firstname': 'Nermine S', 'initials': 'NS', 'affiliation': 'Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr-El Aini Street, Cairo, 11562, Egypt.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s).', 'doi': '10.1038/s41598-024-52664-6\\n10.1517/14740338.2015.983898\\n10.2174/1389201021666201126144057\\n10.1016/j.jaci.2007.09.029\\n10.3389/fped.2019.00246\\n10.1016/S2213-2600(13)70040-7\\n10.2147/COPD.S139470\\n10.1016/j.phrs.2021.105801\\n10.2147/COPD.S130482\\n10.1378/chest.126.1.59\\n10.1053/prrv.2000.0102\\n10.1111/j.1476-5381.2011.01216.x\\n10.1038/bjp.2008.284\\n10.1002/jssc.200900450\\n10.1002/bmc.87\\n10.1038/bjp.2008.124\\n10.1002/dta.2728\\n10.1002/dta.3437\\n10.1124/jpet.112.198481\\n10.1016/j.ejphar.2017.07.026\\n10.1002/dta.2139\\n10.1016/j.ejpb.2015.10.016\\n10.1016/j.jpha.2013.09.003\\n10.1002/chir.23105\\n10.1016/j.jchromb.2019.121842\\n10.52711/0974-360X.2023.00170\\n10.9734/jpri/2021/v33i42A32398\\n10.54037/WJPS.2022.100114\\n10.1002/dta.3433\\n10.1016/j.ejphar.2017.11.043\\n10.12968/hmed.2014.75.Sup2.C18\\n10.1124/dmd.112.048603', 'xml': <Element 'PubmedArticle' at 0x10962f5b0>}\n",
      "{'pubmed_id': '38286741\\n30496104\\n30496103\\n24610581\\n30648539\\n24337046\\n27587561\\n21624618\\n26836925\\n25162311\\n26949916\\n25977288\\n27401627\\n21310876\\n24832749\\n18585022\\n18813855\\n32918995\\n28651290\\n35889539\\n29191719\\n33522063\\n29946225\\n35098856\\n35060125\\n36511516\\n24706026\\n29445341\\n25359462\\n11692091\\n29499403\\n35253144\\n35020986\\n25534623\\n25809538\\n27888992\\n29178573\\n27225906\\n18395552\\n20514301\\n31078144\\n19707810\\n19162179\\n28063042\\n31812572', 'title': 'Anti-inflammatory effects of reticuline on the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathway in a mouse model of obesity-associated asthma.', 'abstract': 'Asthma associated with obesity is a chronic disease characterized by earlier airway remodeling, severe wheezing, and increased insensitivity to hormone therapy. Reticuline, a bioactive compound of Magnoliae Flos, exerts anti-inflammatory activity and can inhibit neutrophil recruitment. Thus, this study investigated the role of reticuline in obesity-related asthma.\\nThe BALB/c mice fed a low-fat diet (LFD) and high-fat diet (HFD) were intranasally challenged with house dust mites (HDMs) or ovalbumin (OVA). Reticuline (0.25\\u2009mg/kg) was administrated into mice by intragastrical gavage. Airway hyper-responsiveness was examined after the final challenge. Body weight was measured, and bronchoalveolar lavage fluid (BALF) and lung tissues were collected. The number of inflammatory cells in BALF was estimated. Histological changes were assessed by performing hematoxylin-eosin staining, and production of proinflammatory cytokines and IgE was examined by ELISA kits. Related pathways were studied with western blotting.\\nReticuline suppressed airway resistance and inflammatory infiltration in lung tissue and reduced inflammatory cell recruitment in BALF in obesity mice with asthma. Additionally, the levels of IL-17A, IL-1β, IL-5, macrophage inflammatory protein 2, and regulated on activation, normal T cell expressed and secreted in the lung were reduced by reticuline. Mechanistically, reticuline inactivated the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathways in obesity-related asthma.\\nReticuline alleviates airway inflammation in obesity-related asthma by inactivating the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathways.', 'keywords': ['JAK/STAT', 'SOCS3', 'asthma', 'inflammation', 'neutrophil', 'obesity'], 'journal': 'The clinical respiratory journal', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Lyu', 'firstname': 'Xiaojiang', 'initials': 'X', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}, {'lastname': 'Liu', 'firstname': 'Jiaojiao', 'initials': 'J', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}, {'lastname': 'Liu', 'firstname': 'Zengrong', 'initials': 'Z', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}, {'lastname': 'Wu', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}, {'lastname': 'Zhu', 'firstname': 'Ping', 'initials': 'P', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}, {'lastname': 'Liu', 'firstname': 'Chonghai', 'initials': 'C', 'affiliation': 'Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.'}], 'methods': None, 'conclusions': 'Reticuline alleviates airway inflammation in obesity-related asthma by inactivating the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathways.', 'results': 'Reticuline suppressed airway resistance and inflammatory infiltration in lung tissue and reduced inflammatory cell recruitment in BALF in obesity mice with asthma. Additionally, the levels of IL-17A, IL-1β, IL-5, macrophage inflammatory protein 2, and regulated on activation, normal T cell expressed and secreted in the lung were reduced by reticuline. Mechanistically, reticuline inactivated the JAK2/STAT3/SOCS3 and p38 MAPK/NF-κB signaling pathways in obesity-related asthma.', 'copyrights': '© 2024 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.', 'doi': '10.1111/crj.13729\\n10.1016/S0140-6736(18)32279-7\\n10.1016/S0140-6736(18)32203-7\\n10.1002/ppul.23030\\n10.1016/j.alit.2018.11.007\\n10.1183/09031936.00202013\\n10.1183/13993003.00766-2016\\n10.1016/j.jaci.2011.03.036\\n10.1016/j.chest.2015.12.034\\n10.1164/rccm.201405-0859PP\\n10.1165/rcmb.2016-0052PS\\n10.1189/jlb.3VMR1214-600RR\\n10.1016/j.iac.2016.03.007\\n10.1183/09031936.00139810\\n10.1164/rccm.201311-2011LE\\n10.1016/j.phymed.2008.04.012\\n10.1016/j.jep.2020.113378\\n10.1055/s-0043-113447\\n10.3390/molecules27144660\\n10.1016/j.tem.2017.11.001\\n10.1002/jbt.22730\\n10.1186/s12948-018-0092-9\\n10.1080/15548627.2022.2025571\\n10.1111/all.15226\\n10.1152/ajplung.00249.2022\\n10.1007/s10753-014-9873-6\\n10.3389/fphar.2018.00049\\n10.1186/s12865-014-0039-y\\n10.1067/mai.2001.119918\\n10.1016/j.biopha.2018.02.079\\n10.1055/s-0042-1743290\\n10.1056/NEJMra2032506\\n10.1038/nri3786\\n10.1111/cei.12631\\n10.1016/j.rmed.2016.10.018\\n10.1111/all.13369\\n10.1111/all.12937\\n10.1016/j.jaci.2008.02.004\\n10.3346/jkms.2010.25.6.829\\n10.1186/s12887-019-1526-3\\n10.1007/s12263-009-0133-6\\n10.1016/j.bbadis.2008.12.006\\n10.1007/978-1-4939-6786-5_10\\n10.1016/j.jaci.2019.11.031', 'xml': <Element 'PubmedArticle' at 0x1098a2de0>}\n",
      "{'pubmed_id': '38286408', 'title': 'Are Questionnaires Helpful To Predict Exercise-Induced Bronchoconstriction (EIB) And Exercise-Induced Laryngeal Obstruction (EILO)?', 'abstract': 'Exercise induced laryngeal obstruction (EILO) is an important differential diagnosis to exercise induced bronchoconstriction (EIB) and diagnosed via continuous laryngoscopy while exercising (CLE). However, availability of CLE is limited to specialized centres. And without CLE EILO is often misdiagnosed as EIB. Therefore it is essential to carefully preselect potential EILO candidates. Aim of this study was to investigate whether two short questionnaires -Asthma Control Test (ACT) and Dyspnea Index (DI) evaluating upper airway-related dyspnea- can differentiate between EIB and EILO.\\nPatients with dyspnea while exercising were analysed with an exercise challenge in the cold chamber (ECC) to diagnose EIB in visit 1 (V1), as appropriate a CLE in visit 2 (V2, 4-6 weeks after V1) and ACT and DI in V1 and V2. EIB patients were treated with asthma medication after V1.\\nComplete dataset of 36 subjects were gathered. The ACT showed lower values in V2 in EILO compared to EIB patients. A lack of improvement in ACT in V2 after asthma medication of EIB patients is suspicious for additional EILO diagnosis. The DI showed higher values in V1 in EILO compared to EIB patients. A score≥30 can predict a positive CLE reaction.\\nACT and DI are valuable tools in preselecting CLE candidates to assure timely diagnostic despite limited diagnostic capabilities.\\nBelastungsinduzierte Larynxobstruktion (EILO) ist eine wichtige Differentialdiagnose zur belastungsinduzierten Bronchokonstriktion (EIB) und wird mittels kontinuierlicher Laryngoskopie unter Belastung (CLE) diagnostiziert. Die Verfügbarkeit der CLE ist jedoch auf spezialisierte Zentren limitiert und ohne CLE wird EILO häufig als EIB fehldiagnostiziert. Deshalb ist eine gute Vorauswahl potentieller EILO Kandidaten essentiell. Das Ziel der Studie war die Analyse ob zwei kurze Fragebögen – Asthma Control Test (ACT) und Dyspnea Index (DI) der obere Atemwegsdyspnoe evaluiert – zwischen EIB und EILO differenzieren können.\\nPatienten mit belastungsinduzierter Dyspnoe wurden mittels Kältelaufbelastung (ECC) in Visite 1 (V1), wenn indiziert einer CLE in Visite 2 (V2, 4–6 Wochen nach V1) sowie ACT und DI in V1 und V2 untersucht. EIB Patienten erhielten nach V1 eine Asthmatherapie.\\nVollständige Datensätze zu 36 Patienten wurden erhoben. Der ACT zeigte in V2 niedrigere Werte in EILO als in EIB Patienten. Eine fehlende Verbesserung des ACT in V2 nach Asthmatherapie der EIB Patienten ist hinweisend auf eine zusätzliche EILO Diagnose. Der DI zeigte in V1 höhere Werte in EILO als in EIB Patienten. Ein Score≥30 sagte eine EILO-Reaktion in der CLE vorher.\\nACT und DI sind wertvolle Tests um CLE Kandidaten zu selektieren und so zu gewährleisten, dass diese Patienten trotz begrenzter Diagnostikplätze zeitnah abgeklärt werden können.', 'keywords': [], 'journal': 'Klinische Padiatrie', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Dreßler', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Lassmann', 'firstname': 'Hannah', 'initials': 'H', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Eichhorn', 'firstname': 'Celine', 'initials': 'C', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Trischler', 'firstname': 'Jordis', 'initials': 'J', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Hutter', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Zielen', 'firstname': 'Stefan', 'initials': 'S', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}, {'lastname': 'Schulze', 'firstname': 'Johannes', 'initials': 'J', 'affiliation': 'Goethe-University Frankfurt, University Hospital, Department of Pediatrics, Pneumology, Allergology, Infectious Diseases, Gastroenterology, Germany.'}], 'methods': None, 'conclusions': 'ACT and DI are valuable tools in preselecting CLE candidates to assure timely diagnostic despite limited diagnostic capabilities.', 'results': 'Complete dataset of 36 subjects were gathered. The ACT showed lower values in V2 in EILO compared to EIB patients. A lack of improvement in ACT in V2 after asthma medication of EIB patients is suspicious for additional EILO diagnosis. The DI showed higher values in V1 in EILO compared to EIB patients. A score≥30 can predict a positive CLE reaction.', 'copyrights': 'Thieme. All rights reserved.\\nThieme. All rights reserved.', 'doi': '10.1055/a-2151-2269', 'xml': <Element 'PubmedArticle' at 0x109896d90>}\n",
      "{'pubmed_id': '38286340', 'title': 'The diagnostic value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in children with chest tightness-variant asthma (CTVA).', 'abstract': 'Chest tightness-variant asthma (CTVA) is a novel atypical asthma characterized by chest tightness as the sole or primary symptom.\\nTo investigate the value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in the diagnosis of CTVA in children.\\nThis study included 95 children aged 6-14 years with chest tightness as the sole symptom, with a duration of symptoms exceeding 4 weeks. All subjects underwent FeNO measurement, pulmonary function testing, and bronchial provocation testing using the Astograph method. Subjects with positive bronchial provocation testing were classified as the CTVA group, while those with negative results served as the non-CTVA control group.\\nThe lung function of children in both groups was normal. The FeNO level in the CTVA group was (22.35\\xa0±\\xa09.91) ppb, significantly higher than the control group (14.85\\xa0±\\xa05.63) ppb, with a statistically significant difference (P\\xa0<\\xa00.05). The value of FeNO in diagnosing CTVA was analyzed using an ROC curve, with an area under the curve of 0.073 (P\\xa0<\\xa00.05). The optimal cutoff point for diagnosing CTVA using FeNO was determined to be 18.5\\xa0ppb, with a sensitivity of 60.3\\xa0% and specificity of 77.8\\xa0%. There was a negative correlation between FeNO and Dmin as well as PD15 (P\\xa0=\\xa00.006).\\nFeNO can serve as an adjunctive diagnostic tool for CTVA, with the optimal cutoff point for diagnosing CTVA being 18.5\\xa0ppb. However, FeNO is not a specific diagnostic marker for CTVA and should be used in conjunction with bronchial provocation testing to enhance its diagnostic value.', 'keywords': ['Bronchial provocation testing', 'CTVA', 'Chest tightness-variant asthma', 'Fractional exhaled nitric oxide'], 'journal': 'Respiratory medicine', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Zhang', 'firstname': 'Tengteng', 'initials': 'T', 'affiliation': \"Department of Respiration, Children's Hospital of Hebei Province, Shijiazhuang, China.\"}, {'lastname': 'Xu', 'firstname': 'Lijuan', 'initials': 'L', 'affiliation': \"Department of Endocrinology, Genetics and Metabolism, Children's Hospital of Hebei Province, Shijiazhuang, China.\"}, {'lastname': 'Zhang', 'firstname': 'Yingqian', 'initials': 'Y', 'affiliation': \"Department of Respiration, Children's Hospital of Hebei Province, Shijiazhuang, China.\"}, {'lastname': 'Zhen', 'firstname': 'Lina', 'initials': 'L', 'affiliation': \"Department of Respiration, Children's Hospital of Hebei Province, Shijiazhuang, China. Electronic address: 464096045@qq.com.\"}], 'methods': None, 'conclusions': 'FeNO can serve as an adjunctive diagnostic tool for CTVA, with the optimal cutoff point for diagnosing CTVA being 18.5\\xa0ppb. However, FeNO is not a specific diagnostic marker for CTVA and should be used in conjunction with bronchial provocation testing to enhance its diagnostic value.', 'results': 'The lung function of children in both groups was normal. The FeNO level in the CTVA group was (22.35\\xa0±\\xa09.91) ppb, significantly higher than the control group (14.85\\xa0±\\xa05.63) ppb, with a statistically significant difference (P\\xa0<\\xa00.05). The value of FeNO in diagnosing CTVA was analyzed using an ROC curve, with an area under the curve of 0.073 (P\\xa0<\\xa00.05). The optimal cutoff point for diagnosing CTVA using FeNO was determined to be 18.5\\xa0ppb, with a sensitivity of 60.3\\xa0% and specificity of 77.8\\xa0%. There was a negative correlation between FeNO and Dmin as well as PD15 (P\\xa0=\\xa00.006).', 'copyrights': 'Copyright © 2024 Elsevier Ltd. All rights reserved.', 'doi': '10.1016/j.rmed.2024.107543', 'xml': <Element 'PubmedArticle' at 0x10aeb5670>}\n",
      "{'pubmed_id': '38286137', 'title': 'Radiological Diagnosis of Pulmonary Aspergillosis.', 'abstract': 'Imaging plays an important role in the various forms of ', 'keywords': [], 'journal': 'Seminars in respiratory and critical care medicine', 'publication_date': datetime.date(2024, 1, 30), 'authors': [{'lastname': 'Laurent', 'firstname': 'François', 'initials': 'F', 'affiliation': 'Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France.'}, {'lastname': 'Benlala', 'firstname': 'Ilyes', 'initials': 'I', 'affiliation': \"Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France.\\nCHU Bordeaux, Service d'Imagerie Thoracique et Cardiovasculaire, Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France.\"}, {'lastname': 'Dournes', 'firstname': 'Gael', 'initials': 'G', 'affiliation': \"Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France.\\nCHU Bordeaux, Service d'Imagerie Thoracique et Cardiovasculaire, Centre de Recherche Cardio-thoracique de Bordeaux, University of Bordeaux, Pessac, France.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Thieme. All rights reserved.', 'doi': '10.1055/s-0043-1776998', 'xml': <Element 'PubmedArticle' at 0x10aeb7ce0>}\n",
      "{'pubmed_id': '38285673\\n16135736\\n16055882\\n16204605\\n16264058\\n29192835\\n28049168\\n15994402\\n30765505\\n8744877\\n837755\\n5786969\\n6017658\\n35733991\\n5696978\\n7002300\\n35643452\\n27575552\\n35448995\\n25551213\\n36776483', 'title': 'Development and evaluation of a computerized algorithm for the interpretation of pulmonary function tests.', 'abstract': \"Pulmonary function tests (PFTs) are usually interpreted by clinicians using rule-based strategies and pattern recognition. The interpretation, however, has variabilities due to patient and interpreter errors. Most PFTs have recognizable patterns that can be categorized into specific physiological defects. In this study, we developed a computerized algorithm using the python package (pdfplumber) and validated against clinicians' interpretation. We downloaded PFT reports in the electronic medical record system that were in PDF format. We digitized the flow volume loop (FVL) and extracted numeric values from the reports. The algorithm used FEV1/FVC<0.7 for obstruction, TLC<80%pred for restriction and <80% or >120%pred for abnormal DLCO. The algorithm also used a small airway disease index (SADI) to quantify late expiratory flattening of the FVL to assess small airway dysfunction. We devised keywords for the python Natural Language Processing (NLP) package (spaCy) to identify obstruction, restriction, abnormal DLCO and small airway dysfunction in the reports. The algorithm was compared to clinicians' interpretation in 6,889 PFTs done between March 1st, 2018, and September 30th, 2020. The agreement rates (Cohen's kappa) for obstruction, restriction and abnormal DLCO were 94.4% (0.868), 99.0% (0.979) and 87.9% (0.750) respectively. In 4,711 PFTs with FEV1/FVC≥0.7, the algorithm identified 190 tests with SADI < lower limit of normal (LLN), suggesting small airway dysfunction. Of these, the clinicians (67.9%) also flagged 129 tests. When SADI was ≥ LLN, no clinician's reports indicated small airway dysfunction. Our results showed the computerized algorithm agreed with clinicians' interpretation in approximately 90% of the tests and provided a sensitive objective measure for assessing small airway dysfunction. The algorithm can improve efficiency and consistency and decrease human errors in PFT interpretation. The computerized algorithm works directly on PFT reports in PDF format and can be adapted to incorporate a different interpretation strategy and platform.\", 'keywords': [], 'journal': 'PloS one', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Huang', 'firstname': 'Yuh-Chin T', 'initials': 'YT', 'affiliation': 'Department of Medicine, Duke University Medical Center, Durham, NC, United States of America.'}, {'lastname': 'Henriquez', 'firstname': 'Luke', 'initials': 'L', 'affiliation': 'Department of Cognitive Science, Case Western University, Cleveland, OH, United States of America.'}, {'lastname': 'Chen', 'firstname': 'Hengji', 'initials': 'H', 'affiliation': 'Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, United States of America.'}, {'lastname': 'Henriquez', 'firstname': 'Craig', 'initials': 'C', 'affiliation': 'Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, United States of America.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright: © 2024 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.', 'doi': '10.1371/journal.pone.0297519\\n10.1183/09031936.05.00035005\\n10.1183/09031936.05.00034805\\n10.1183/09031936.05.00034905\\n10.1183/09031936.05.00035205\\n10.1164/rccm.201710-1981ST\\n10.1183/13993003.00016–2016\\n10.1183/09031936.05.00034505\\n10.1183/13993003.01660–2018\\n10.1007/BF02642476\\n10.1378/chest.71.3.396\\n10.1152/jappl.1969.27.1.4\\n10.1152/jappl.1967.22.1.95\\n10.3389/fphys.2022.914972\\n10.1016/0010-4809(68)90066-9\\n10.1186/s12890-022-01998-w\\n10.1016/j.resp.2016.08.005\\n10.1186/s12931-022-02014-9\\n10.1371/journal.pone.0116238\\n10.1183/23120541.00292-2022', 'xml': <Element 'PubmedArticle' at 0x10ae535b0>}\n",
      "{'pubmed_id': '38285123\\n26451344\\n29241587\\n25957349\\n33573164\\n32075727\\n17620363\\n32819450\\n24695404\\n31341288\\n19218090\\n30975495\\n36399492\\n17391789\\n35252024\\n16820507\\n20566857\\n32483366\\n25534623\\n35507792\\n29518419\\n15083755\\n30598019\\n25974301\\n33450188\\n33711259\\n24461761\\n28600901\\n23378581\\n34212546\\n32655992\\n28542929\\n26432033\\n33932544\\n35354023\\n21419479\\n26335832\\n31229354\\n25983555\\n30065721\\n17711557\\n12021241\\n30157189\\n27475754\\n31793015\\n26139332\\n33127267\\n30426401\\n32966309\\n26586037\\n28565772\\n27078029\\n32433595', 'title': 'A Comprehensive Metagenome Study Identifies Distinct Biological Pathways in Asthma Patients: An In-Silico Approach.', 'abstract': 'Asthma is a multifactorial disease with phenotypes and several clinical and pathophysiological characteristics. Besides innate and adaptive immune responses, the gut microbiome generates Treg cells, mediating the allergic response to environmental factors and exposure to allergens. Because of the complexity of asthma, microbiome analysis and other precision medicine methods are now widely regarded as essential elements of efficient disease therapy. An in-silico pipeline enables the comparative taxonomic profiling of 16S rRNA metagenomic profiles of 20 asthmatic patients and 15 healthy controls utilizing QIIME2. Further, PICRUSt supports downstream gene enrichment and pathway analysis, inferring the enriched pathways in a diseased state. A significant abundance of the phylum Proteobacteria, Sutterella, and Megamonas is identified in asthma patients and a diminished genus Akkermansia. Nasal samples reveal a high relative abundance of Mycoplasma in the nasal samples. Further, differential functional profiling identifies the metabolic pathways related to cofactors and amino acids, secondary metabolism, and signaling pathways. These findings support that a combination of bacterial communities is involved in mediating the responses involved in chronic respiratory conditions like asthma by exerting their influence on various metabolic pathways.', 'keywords': ['Alpha diversity', 'Asthma', 'Gene enrichment', 'Metagenomics', 'Pathway analysis', 'Taxonomic classification'], 'journal': 'Biochemical genetics', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Rana', 'firstname': 'Samiksha', 'initials': 'S', 'affiliation': 'School of Computational & Integrative Sciences (SC&IS), Jawaharlal Nehru University, JNU Campus, New Delhi, 110067, India.'}, {'lastname': 'Singh', 'firstname': 'Pooja', 'initials': 'P', 'affiliation': 'School of Computational & Integrative Sciences (SC&IS), Jawaharlal Nehru University, JNU Campus, New Delhi, 110067, India.'}, {'lastname': 'Bhardwaj', 'firstname': 'Tulika', 'initials': 'T', 'affiliation': 'Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, AB, T6G 2P5, Canada.'}, {'lastname': 'Somvanshi', 'firstname': 'Pallavi', 'initials': 'P', 'affiliation': 'School of Computational & Integrative Sciences (SC&IS), Jawaharlal Nehru University, JNU Campus, New Delhi, 110067, India. psomvanshi@jnu.ac.in.\\nSpecial Centre of Systems Medicine (SCSM), Jawaharlal Nehru University, JNU Campus, New Delhi, 110067, India. psomvanshi@jnu.ac.in.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.', 'doi': '10.1007/s10528-023-10635-y\\n10.1080/21688370.2015.1039691\\n10.1080/19490976.2016.1182293\\n10.1016/j.jaci.2017.08.041\\n10.1093/bioinformatics/btv287\\n10.3390/nu13020463\\n10.1016/j.immuni.2020.01.007\\n10.1084/jem.20070719\\n10.1186/s40168-020-00905-x\\n10.1093/bioinformatics/btu170\\n10.1038/s41587-019-0209-9\\n10.1016/j.chom.2009.01.003\\n10.1016/S2213-2600(18)30510-1\\n10.1093/nar/gkac1051\\n10.1016/j.mimet.2007.02.005\\n10.3389/fcimb.2022.786481\\n10.1128/AEM.03006-05\\n10.1073/pnas.1002601107\\n10.1038/s41587-020-0548-6\\n10.1183/13993003.01605-2016\\n10.1038/nri3786\\n10.2174/2211536611666220428134324\\n10.1177/2156587216682169\\n10.1016/j.jaci.2018.02.020\\n10.1183/09031936.04.00090404\\n10.3390/ijms20010123\\n10.1016/j.chom.2015.04.007\\n10.1016/j.immuni.2020.12.013\\n10.1016/j.cell.2021.02.016\\n10.1016/S2213-2600(13)70126-7\\n10.1111/all.13220\\n10.4049/jimmunol.1203100\\n10.4168/aair.2021.13.4.589\\n10.7717/peerj.9391\\n10.1111/imm.12760\\n10.1016/j.jad.2015.09.040\\n10.1016/j.micpath.2021.104893\\n10.1016/j.celrep.2022.110572\\n10.1016/j.jaci.2011.02.015\\n10.1038/s41467-019-13751-9\\n10.1002/alr.21609\\n10.1016/j.immuni.2019.05.004\\n10.4137/BBI.S12462\\n10.3389/fimmu.2018.01584\\n10.1111/j.1398-9995.2007.01462.x\\n10.1099/mgen.0.000409\\n10.1172/JCI0215786\\n10.1371/journal.pone.0200040\\n10.1186/s12876-016-0498-0\\n10.1111/sji.12855\\n10.1007/s11882-015-0524-2\\n10.1016/j.alit.2020.09.007\\n10.1007/s12016-018-8719-7\\n10.1016/S0140-6736(20)30925-9\\n10.1371/journal.pone.0233872\\n10.1186/s12866-018-1257-x\\n10.1183/13993003.01711-2018\\n10.1016/j.jaci.2015.09.032\\n10.3892/etm.2017.4219\\n10.1371/journal.pone.0152724\\n10.1038/s41422-020-0332-7', 'xml': <Element 'PubmedArticle' at 0x10aea6520>}\n",
      "{'pubmed_id': '38284920', 'title': 'Effectiveness of sublingual immunotherapy in pediatric cedar pollinosis: A real-world database study.', 'abstract': 'Pediatric allergic rhinitis (AR), including cedar pollinosis (CP), is increasing in Japan. We investigated the effects of sublingual immunotherapy (SLIT), which has limited studies of its effectiveness in real-world settings, on children with CP.\\nThis retrospective cohort study used a claim database in 2018-2021. Children aged ≤15\\u2009years with CP records in 2019 were eligible and were followed up through 2021. We included 2962 CP children undergoing SLIT and 547 who were not. The medication score was used to evaluate SLIT effectiveness in the cedar pollen dispersal season each year. Adverse events and the occurrence of allergic diseases were also evaluated.\\nMedication score was higher in the SLIT group during the index period but lower in 2021 compared to the non-SLIT group (mean\\u2009±\\u2009standard deviation: 5.17\\u2009±\\u20092.39 and 4.74\\u2009±\\u20092.38 in 2019, 3.13\\u2009±\\u20092.30 and 3.55\\u2009±\\u20092.48 in 2021, respectively). The adjusted mean difference between groups from 2019 to 2021 was -0.62 (95% confidence interval: -0.86 to -0.39, p\\u2009<\\u2009.0001), and the medication score was reduced in the SLIT group (risk ratio: 1.2: 1.1 to 1.3). The occurrence of adverse events involving abdominal disorders (adjusted odds ratio [aOR]: 0.64: 0.51 to 0.81), asthma exacerbation (aOR: 0.37: 0.24 to 0.57), and allergic diseases involving hay fever unrelated to CP (aOR: 0.60: 0.45 to 0.80) or asthma (aOR: 0.71: 0.58 to 0.86) was lower in the SLIT group.\\nIn children with CP, SLIT is effective, well tolerated, and could decrease the occurrence of other allergic diseases.', 'keywords': ['adverse events', 'cedar pollinosis', 'children', 'effectiveness', 'sublingual immunotherapy'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Matsushita', 'firstname': 'Rie', 'initials': 'R', 'affiliation': 'Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Tanaka-Mizuno', 'firstname': 'Sachiko', 'initials': 'S', 'affiliation': 'Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.\\nDepartment of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Takeuchi', 'firstname': 'Masato', 'initials': 'M', 'affiliation': 'Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Kawakami', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.'}], 'methods': None, 'conclusions': 'In children with CP, SLIT is effective, well tolerated, and could decrease the occurrence of other allergic diseases.', 'results': 'Medication score was higher in the SLIT group during the index period but lower in 2021 compared to the non-SLIT group (mean\\u2009±\\u2009standard deviation: 5.17\\u2009±\\u20092.39 and 4.74\\u2009±\\u20092.38 in 2019, 3.13\\u2009±\\u20092.30 and 3.55\\u2009±\\u20092.48 in 2021, respectively). The adjusted mean difference between groups from 2019 to 2021 was -0.62 (95% confidence interval: -0.86 to -0.39, p\\u2009<\\u2009.0001), and the medication score was reduced in the SLIT group (risk ratio: 1.2: 1.1 to 1.3). The occurrence of adverse events involving abdominal disorders (adjusted odds ratio [aOR]: 0.64: 0.51 to 0.81), asthma exacerbation (aOR: 0.37: 0.24 to 0.57), and allergic diseases involving hay fever unrelated to CP (aOR: 0.60: 0.45 to 0.80) or asthma (aOR: 0.71: 0.58 to 0.86) was lower in the SLIT group.', 'copyrights': '© 2024 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14075', 'xml': <Element 'PubmedArticle' at 0x10a77f5b0>}\n",
      "{'pubmed_id': '38284918', 'title': 'Genetics of preschool wheeze and its progression to childhood asthma.', 'abstract': 'Wheezing is a common and heterogeneous condition in preschool children. In some countries, the prevalence can be as high as 30% and up to 50% of all children experience wheezing before the age of 6. Asthma often starts with preschool wheeze, but not all wheezing children will develop asthma at school age. At this moment, it is not possible to accurately predict which wheezing children will develop asthma. Recently, studying the genetics of wheeze and the childhood-onset of asthma have grown in interest. Childhood-onset asthma has a stronger heritability in comparison with adult-onset asthma. In early childhood asthma exacerbations, CDHR3, which encodes the receptor for Rhinovirus C, was identified, as well as IL33, and the 17q locus that includes GSDMB and ORMDL3 genes. The 17q locus is the strongest wheeze and childhood-onset asthma locus, and was shown to interact with many environmental factors, including smoking and infections. Finally, ANXA1 was recently associated with early-onset, persistent wheeze. ANXA1 may help resolve eosinophilic inflammation. Overall, despite its complexities, genetic approaches to unravel the early-onset of wheeze and asthma are promising, since these shed more light on mechanisms of childhood asthma-onset. Implicated genes point toward airway epithelium and its response to external factors, such as viral infections. However, the heterogeneity of wheeze phenotypes complicates genetic studies. It is therefore important to define accurate wheezing phenotypes and forge larger international collaborations to gain a better understanding of the pathways underlying early-onset asthma.', 'keywords': ['asthma', 'candidate gene studies', 'children', 'genetics', 'genome wide association studies', 'preschool wheezing', 'wheezing'], 'journal': 'Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Wolters', 'firstname': 'Alba A B', 'initials': 'AAB', 'affiliation': \"Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\\nGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\"}, {'lastname': 'Kersten', 'firstname': 'Elin T G', 'initials': 'ETG', 'affiliation': \"Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\\nGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\"}, {'lastname': 'Koppelman', 'firstname': 'Gerard H', 'initials': 'GH', 'affiliation': \"Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\\nGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\"}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.', 'doi': '10.1111/pai.14067', 'xml': <Element 'PubmedArticle' at 0x10a71c810>}\n",
      "{'pubmed_id': '38284792', 'title': 'Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.', 'abstract': 'Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses.\\nTo assess the effectiveness of topical corticosteroid therapy for EoE in real-world practice.\\nCross-sectional study analysis of the multicentre EoE CONNECT registry. Clinical remission was defined as a decrease of ≥50% in dysphagia symptom scores; histological remission was defined as a peak eosinophil count below 15 per high-power field. The effectiveness in achieving clinico-histological remission (CHR) was compared for the main tC formulations.\\nOverall, data on 1456 prescriptions of tC in monotherapy used in 866 individual patients were assessed. Of those, 904 prescriptions with data on formulation were employed for the induction of remission; 234 reduced a previously effective dose for maintenance. Fluticasone propionate formulations dominated the first-line treatment, while budesonide was more common in later therapies. A swallowed nasal drop suspension was the most common formulation of fluticasone propionate. Doses ≥0.8\\xa0mg/day provided a 65% CHR rate and were superior to lower doses. Oral viscous solution prepared by a pharmacist was the most common prescription of budesonide; 4\\xa0mg/day provided no benefit over 2\\xa0mg/day (CHR rated being 72% and 80%, respectively). A multivariate analysis revealed budesonide orodispersible tablets as the most effective therapy (OR 18.9, p\\xa0<\\xa00.001); use of higher doses (OR 4.3, p\\xa0=\\xa00.03) and lower symptom scores (OR 0.9, p\\xa0=\\xa00.01) were also determinants of effectiveness.\\nReduced symptom severity, use of high doses, and use of budesonide orodispersible tablets particularly were all independent predictors of tC effectiveness.', 'keywords': ['budesonide', 'clinical remission', 'dysphagia', 'effectiveness', 'eosinophil count', 'eosinophilic esophagitis', 'fluticasone propionate', 'histological remission', 'orodispersible', 'swallowed topical corticosteroids'], 'journal': 'United European gastroenterology journal', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Laserna-Mendieta', 'firstname': 'Emilio J', 'initials': 'EJ', 'affiliation': 'Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.\\nInstituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nInstituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Madrid, Spain.\\nLaboratory Medicine Department, Hospital Universitario de La Princesa, Madrid, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Navarro', 'firstname': 'Pilar', 'initials': 'P', 'affiliation': 'Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.\\nInstituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nInstituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Madrid, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Casabona-Francés', 'firstname': 'Sergio', 'initials': 'S', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Savarino', 'firstname': 'Edoardo V', 'initials': 'EV', 'affiliation': 'Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.\\nGastroenterology Unit, Azienza Ospedaliera di Padova, Padova, Italy.'}, {'lastname': 'Amorena', 'firstname': 'Edurne', 'initials': 'E', 'affiliation': 'Department of Gastroenterology, Hospital Universitario de Navarra, Pamplona, Spain.'}, {'lastname': 'Pérez-Martínez', 'firstname': 'Isabel', 'initials': 'I', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Central de Asturias, Oviedo, Spain.\\nDiet, Microbiota and Health Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.'}, {'lastname': 'Guagnozzi', 'firstname': 'Danila', 'initials': 'D', 'affiliation': \"Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario Valld'Hebrón, Barcelona, Spain.\"}, {'lastname': 'Blas-Jhon', 'firstname': 'Leonardo', 'initials': 'L', 'affiliation': 'Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain.'}, {'lastname': 'Betoré', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Miguel Servet, Zaragoza, Spain.'}, {'lastname': 'Guardiola-Arévalo', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.'}, {'lastname': 'Pellegatta', 'firstname': 'Gaia', 'initials': 'G', 'affiliation': 'Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.\\nDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.'}, {'lastname': 'Krarup', 'firstname': 'Anne Lund', 'initials': 'AL', 'affiliation': 'Department of Emergency Medicine and Trauma Care, Aalborg University Hospital, Aalborg, Denmark.\\nDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.'}, {'lastname': 'Perello', 'firstname': 'Antonia', 'initials': 'A', 'affiliation': 'Department of Gastroenterology, Hospital de Viladecans, Viladecans, Spain.'}, {'lastname': 'Barrio', 'firstname': 'Jesús', 'initials': 'J', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Rio Hortega, Valladolid, Spain.'}, {'lastname': 'Gutiérrez-Junquera', 'firstname': 'Carolina', 'initials': 'C', 'affiliation': 'Pediatric Gastroenterology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain.'}, {'lastname': 'Teruel Sánchez-Vegazo', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Ramón y Cajal, Madrid, Spain.'}, {'lastname': 'Fernández-Fernández', 'firstname': 'Sonia', 'initials': 'S', 'affiliation': 'Department of Pediatric Gastroenterology, Hospital Universitario Severo Ochoa, Leganés, Spain.'}, {'lastname': 'Naves', 'firstname': 'Juan Enrique', 'initials': 'JE', 'affiliation': 'Department of Gastroenterology, Parc de Salut Mar, Barcelona, Spain.'}, {'lastname': 'Oliva', 'firstname': 'Salvatore', 'initials': 'S', 'affiliation': 'Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza - University of Rome, Rome, Italy.'}, {'lastname': 'Rodríguez-Oballe', 'firstname': 'Juan Armando', 'initials': 'JA', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Arnau de Vilanova & Hospital Universitario Santa María, Lérida, Spain.'}, {'lastname': 'Carrión', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital de Mataró, Mataró, Spain.'}, {'lastname': 'Espina', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'Department of Gastroenterology, Hospital General de la Defensa, Zaragoza, Spain.'}, {'lastname': 'Llorente Barrio', 'firstname': 'Mónica', 'initials': 'M', 'affiliation': 'Department of Gastroenterology, Hospital de Santa Bárbara, Soria, Spain.'}, {'lastname': 'Masiques-Mas', 'firstname': 'Maria Lluisa', 'initials': 'ML', 'affiliation': 'Department of Pediatric Gastroenterology, Hospital de Granollers, Granollers, Spain.'}, {'lastname': 'Dainese', 'firstname': 'Raffaella', 'initials': 'R', 'affiliation': \"Department of Gastroenterology, Centre Hospitalier d'Antibes Juan-les-Pins, Antibes, France.\"}, {'lastname': 'Feo-Ortega', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nDepartment of Pediatrics, Hospital General de Tomelloso, Tomelloso, Spain.'}, {'lastname': 'Martín-Dominguez', 'firstname': 'Verónica', 'initials': 'V', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Fernández-Pacheco', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Pérez-Fernández', 'firstname': 'Maria Teresa', 'initials': 'MT', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Ghisa', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'Gastroenterology Unit, Azienza Ospedaliera di Padova, Padova, Italy.'}, {'lastname': 'Maniero', 'firstname': 'Daria', 'initials': 'D', 'affiliation': 'Gastroenterology Unit, Azienza Ospedaliera di Padova, Padova, Italy.'}, {'lastname': 'Nantes-Castillejo', 'firstname': 'Óscar', 'initials': 'Ó', 'affiliation': 'Department of Gastroenterology, Hospital Universitario de Navarra, Pamplona, Spain.'}, {'lastname': 'Nicolay-Maneru', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Department of Gastroenterology, Hospital Universitario de Navarra, Pamplona, Spain.'}, {'lastname': 'Suárez', 'firstname': 'Adolfo', 'initials': 'A', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Central de Asturias, Oviedo, Spain.\\nDiet, Microbiota and Health Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.'}, {'lastname': 'Maray', 'firstname': 'Iván', 'initials': 'I', 'affiliation': 'Department of Pharmacy, Hospital Universitario Central de Asturias, Oviedo, Spain.'}, {'lastname': 'Llerena-Castro', 'firstname': 'Ronald', 'initials': 'R', 'affiliation': \"Department of Gastroenterology, Hospital Universitario Valld'Hebrón, Barcelona, Spain.\"}, {'lastname': 'Ortega-Larrodé', 'firstname': 'Adriana', 'initials': 'A', 'affiliation': 'Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain.'}, {'lastname': 'Alcedo', 'firstname': 'Javier', 'initials': 'J', 'affiliation': 'Department of Gastroenterology, Hospital Universitario Miguel Servet, Zaragoza, Spain.'}, {'lastname': 'Granja Navacerrada', 'firstname': 'Alicia', 'initials': 'A', 'affiliation': 'Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.'}, {'lastname': 'Racca', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Personalized Medicine, Asthma and Allergy Clinic, IRCCS Humanitas Research Hospital, Rozzano, Italy.'}, {'lastname': 'Santander', 'firstname': 'Cecilio', 'initials': 'C', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.\\nDepartment of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain.'}, {'lastname': 'Arias', 'firstname': 'Ángel', 'initials': 'Á', 'affiliation': 'Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nInstituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Madrid, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.\\nResearch Unit, Hospital General Mancha-Centro, Alcázar de San Juan, Spain.'}, {'lastname': 'Lucendo', 'firstname': 'Alfredo J', 'initials': 'AJ', 'affiliation': 'Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.\\nInstituto de Investigación Sanitaria La Princesa, Madrid, Spain.\\nInstituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Madrid, Spain.\\nCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': 'Reduced symptom severity, use of high doses, and use of budesonide orodispersible tablets particularly were all independent predictors of tC effectiveness.', 'results': 'Overall, data on 1456 prescriptions of tC in monotherapy used in 866 individual patients were assessed. Of those, 904 prescriptions with data on formulation were employed for the induction of remission; 234 reduced a previously effective dose for maintenance. Fluticasone propionate formulations dominated the first-line treatment, while budesonide was more common in later therapies. A swallowed nasal drop suspension was the most common formulation of fluticasone propionate. Doses ≥0.8\\xa0mg/day provided a 65% CHR rate and were superior to lower doses. Oral viscous solution prepared by a pharmacist was the most common prescription of budesonide; 4\\xa0mg/day provided no benefit over 2\\xa0mg/day (CHR rated being 72% and 80%, respectively). A multivariate analysis revealed budesonide orodispersible tablets as the most effective therapy (OR 18.9, p\\xa0<\\xa00.001); use of higher doses (OR 4.3, p\\xa0=\\xa00.03) and lower symptom scores (OR 0.9, p\\xa0=\\xa00.01) were also determinants of effectiveness.', 'copyrights': '© 2024 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.', 'doi': '10.1002/ueg2.12533', 'xml': <Element 'PubmedArticle' at 0x10a725d50>}\n",
      "{'pubmed_id': '38284424', 'title': 'Association of Supplemental Nutrition Assistance Program participation duration with cost-related medication non-adherence and emergency department visits.', 'abstract': 'Administrative requirements could disrupt sustained Supplemental Nutrition Assistance Program (SNAP) participation among income-eligible individuals. To meet their food needs, low-income individuals without consistent SNAP benefits may compromise on medication use, posing a risk to their health. The objective of this study is to examine the association of SNAP participation duration in a given year with cost-related medication nonadherence (CRN) and emergency department (ED) use in income-eligible individuals.\\nCross-sectional.\\nNon-elderly and elderly adults who used prescription medications and participated in SNAP the previous year in 2016-2018 National Health Interview Survey. Subsamples included individuals with specific chronic conditions.\\nCRN and ED usage.\\nSNAP participation for\\xa0<12 months in the previous year was related to increased CRN and ED use in nonelderly adults taking prescription medication, as well as in those with hypertension, cardiovascular disease and asthma. Further, <12-month SNAP participation was associated with greater odds of having at least one ED visit in nonelderly and elderly adults.\\nSustained SNAP participation could help income-eligible individuals better adhere to their prescribed medications and reduce health complications requiring ED visits. Findings suggest the importance of addressing SNAP participation gaps among income-eligible individuals in health care settings.', 'keywords': ['Supplemental Nutrition Assistance Program', 'chronic conditions', 'cost-related medication nonadherence', 'emergency department use', 'prescription medication', 'sustained participation'], 'journal': 'Public health nursing (Boston, Mass.)', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Sanjeevi', 'firstname': 'Namrata', 'initials': 'N', 'affiliation': 'Department of Nutrition and Exercise Physiology, Washington State University, Spokane, Washington, USA.'}, {'lastname': 'Monsivais', 'firstname': 'Pablo', 'initials': 'P', 'affiliation': 'Department of Nutrition and Exercise Physiology, Washington State University, Spokane, Washington, USA.'}], 'methods': None, 'conclusions': None, 'results': 'SNAP participation for\\xa0<12 months in the previous year was related to increased CRN and ED use in nonelderly adults taking prescription medication, as well as in those with hypertension, cardiovascular disease and asthma. Further, <12-month SNAP participation was associated with greater odds of having at least one ED visit in nonelderly and elderly adults.', 'copyrights': '© 2024 Wiley Periodicals LLC.', 'doi': '10.1111/phn.13283', 'xml': <Element 'PubmedArticle' at 0x10b6418f0>}\n",
      "{'pubmed_id': '38284338', 'title': 'Pediatric Immunology and Allergy: Clinical Aspects.', 'abstract': None, 'keywords': ['Allergy', 'IgE', 'asthma', 'atopic dermatitis', 'biological drugs', 'children', 'fish', 'genetics', 'respiratory infections', 'rhinitis.'], 'journal': 'Current pediatric reviews', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Bernardini', 'firstname': 'Roberto', 'initials': 'R', 'affiliation': 'Director of the Pediatric and Neonatology Unit, San Giuseppe Hospital, Viale Boccaccio, 56012 Empoli Italy.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.2174/157339632003231116214000', 'xml': <Element 'PubmedArticle' at 0x10b6495d0>}\n",
      "{'pubmed_id': '38284169', 'title': 'Discovery and Characterization of a Bicyclic Peptide (Bicycle) Binder to Thymic Stromal Lymphopoietin.', 'abstract': \"Thymic stromal lymphopoietin (TSLP) is an epithelial-derived pro-inflammatory cytokine involved in the development of asthma and other atopic diseases. We used Bicycle Therapeutics' proprietary phage display platform to identify bicyclic peptides (Bicycles) with high affinity for TSLP, a target that is difficult to drug with conventional small molecules due to the extended protein-protein interactions it forms with both receptors. The hit series was shown to bind to TSLP in a hotspot, that is also used by IL-7Rα. Guided by the first X-ray crystal structure of a small peptide binding to TSLP and the identification of key metabolites, we were able to improve the proteolytic stability of this series in lung S9 fractions without sacrificing binding affinity. This resulted in the potent Bicycle \", 'keywords': [], 'journal': 'Journal of medicinal chemistry', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Narjes', 'firstname': 'Frank', 'initials': 'F', 'affiliation': None}, {'lastname': 'Edfeldt', 'firstname': 'Fredrik', 'initials': 'F', 'affiliation': None}, {'lastname': 'Petersen', 'firstname': 'Jens', 'initials': 'J', 'affiliation': None}, {'lastname': 'Öster', 'firstname': 'Linda', 'initials': 'L', 'affiliation': None}, {'lastname': 'Hamblet', 'firstname': 'Corinne', 'initials': 'C', 'affiliation': None}, {'lastname': 'Bird', 'firstname': 'James', 'initials': 'J', 'affiliation': None}, {'lastname': 'Bold', 'firstname': 'Peter', 'initials': 'P', 'affiliation': None}, {'lastname': 'Rae', 'firstname': 'Rebecca', 'initials': 'R', 'affiliation': None}, {'lastname': 'Bäck', 'firstname': 'Elisabeth', 'initials': 'E', 'affiliation': None}, {'lastname': 'Stomilovic', 'firstname': 'Stina', 'initials': 'S', 'affiliation': None}, {'lastname': 'Zlatoidsky', 'firstname': 'Pavol', 'initials': 'P', 'affiliation': None}, {'lastname': 'Svensson', 'firstname': 'Tor', 'initials': 'T', 'affiliation': None}, {'lastname': 'Hidestål', 'firstname': 'Lotta', 'initials': 'L', 'affiliation': None}, {'lastname': 'Kunalingam', 'firstname': 'Lavaniya', 'initials': 'L', 'affiliation': None}, {'lastname': 'Shamovsky', 'firstname': 'Igor', 'initials': 'I', 'affiliation': None}, {'lastname': 'De Maria', 'firstname': 'Leonardo', 'initials': 'L', 'affiliation': None}, {'lastname': 'Gordon', 'firstname': 'Euan', 'initials': 'E', 'affiliation': None}, {'lastname': 'Lewis', 'firstname': 'Richard J', 'initials': 'RJ', 'affiliation': None}, {'lastname': 'Watcham', 'firstname': 'Sophie', 'initials': 'S', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}, {'lastname': 'van Rietschoten', 'firstname': 'Katerine', 'initials': 'K', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}, {'lastname': 'Mudd', 'firstname': 'Gemma E', 'initials': 'GE', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}, {'lastname': 'Harrison', 'firstname': 'Helen', 'initials': 'H', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}, {'lastname': 'Chen', 'firstname': 'Liuhong', 'initials': 'L', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}, {'lastname': 'Skynner', 'firstname': 'Michael J', 'initials': 'MJ', 'affiliation': 'BicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1021/acs.jmedchem.3c02163', 'xml': <Element 'PubmedArticle' at 0x10b64b420>}\n",
      "{'pubmed_id': '38284126', 'title': 'Secreted ADAMTS-like proteins as regulators of connective tissue function.', 'abstract': 'The extracellular matrix (ECM) determines functional properties of connective tissues through structural components, such as collagens, elastic fibers, or proteoglycans. The ECM also instructs cell behavior through regulatory proteins, including proteases, growth factors, and matricellular proteins, which can be soluble or tethered to ECM scaffolds. The secreted ', 'keywords': ['ADAMTS proteases', 'extracellular matrix', 'fibrillin microfibrils', 'matricellular proteins', 'musculoskeletal system'], 'journal': 'American journal of physiology. Cell physiology', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Taye', 'firstname': 'Nandaraj', 'initials': 'N', 'affiliation': 'Leni & Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States.'}, {'lastname': 'Redhead', 'firstname': 'Charlene', 'initials': 'C', 'affiliation': 'Leni & Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States.'}, {'lastname': 'Hubmacher', 'firstname': 'Dirk', 'initials': 'D', 'affiliation': 'Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': None, 'doi': '10.1152/ajpcell.00680.2023', 'xml': <Element 'PubmedArticle' at 0x10b613ce0>}\n",
      "{'pubmed_id': '38283959\\n25539396\\n30637678\\n7897467\\n26270287\\n22469447\\n31147980\\n25323234\\n12090866\\n26823926\\n32989065\\n32412953\\n35346926\\n25275405\\n21745811\\n24552518\\n28160339\\n34111359\\n22566417\\n27393335\\n16498850\\n25596899\\n9534909\\n25405362\\n12708888\\n30410546\\n15060253\\n28605396\\n19341166', 'title': 'Healthcare utilization for asthma exacerbation among children of migrant and seasonal farmworkers.', 'abstract': 'Latino children of Migrant and Seasonal Farmworkers (MSFWs) with asthma are at risk for poor health outcomes due to medical access barriers. We compared differences in acute care utilization for asthma exacerbations among migrant and non-migrant Latino and non-Hispanic white (NHW) children at U.S. community health centers. A retrospective observational study utilizing electronic health record data from the ADVANCE Clinical Research Network of United States community health centers included 13,423 children ages 3-17 with a primary care visit between 2005 and 2017 from eight states. Emergency department (ED) and hospitalization data came from Oregon Medicaid claims. Outcomes included acute clinic visits, ED visits, and hospitalizations for asthma exacerbation. Regression analyses adjusted for patient-level covariates. Latino children had higher odds of acute clinic visits for asthma exacerbation compared to NHW children (MSFW odds ratio [OR]\\xa0=\\xa01.17, 95\\xa0% CI\\xa0=\\xa01.03-1.33; without migrant status OR\\xa0=\\xa01.13, 95\\xa0% CI\\xa0=\\xa01.03-1.23). MSFW children using Oregon Medicaid had fewer ED visits (rate ratio [RR]\\xa0=\\xa00.72, 95\\xa0% CI\\xa0=\\xa00.52-0.99) and hospitalizations (RR\\xa0=\\xa00.47, 95\\xa0% CI\\xa0=\\xa00.26-0.86) compared to NHW children. Increased community health center visits may help mitigate disparities in acute asthma care for MSFW children.', 'keywords': ['And Child', 'Asthma', 'Community Health Centers', 'Hispanic Americans', 'Transients and Migrant'], 'journal': 'Preventive medicine reports', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Kasten-Arias', 'firstname': 'Cassandra', 'initials': 'C', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Hodes', 'firstname': 'Tahlia', 'initials': 'T', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Marino', 'firstname': 'Miguel', 'initials': 'M', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Kaufmann', 'firstname': 'Jorge', 'initials': 'J', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Lucas', 'firstname': 'Jennifer A', 'initials': 'JA', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Estela Vasquez Guzman', 'firstname': 'Cirila', 'initials': 'C', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.'}, {'lastname': 'Giebultowicz', 'firstname': 'Sophia', 'initials': 'S', 'affiliation': 'OCHIN, Inc. Portland, OR, USA.'}, {'lastname': 'Chan', 'firstname': 'Brian', 'initials': 'B', 'affiliation': 'OCHIN, Inc. Portland, OR, USA.\\nOregon Health & Science University, Department of Medicine, Division of General Internal Medicine & Geriatrics, Portland OR, USA.'}, {'lastname': 'Heintzman', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Oregon Health & Science University, Department of Family Medicine, Portland OR, USA.\\nOCHIN, Inc. Portland, OR, USA.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2024 The Author(s).', 'doi': '10.1016/j.pmedr.2024.102598\\n10.3109/02770903.2014.1001905\\n10.1007/s12098-018-2826-6\\n10.1207/s15327655jchn1201_2\\n10.2105/ajph.2015.302685\\n10.1016/j.anai.2012.02.002\\n10.1007/s11606-019-04847-5\\n10.1183/09031936.00075614\\n10.1001/jama.288.1.82\\n10.3122/jabfm.2020.05.190468\\n10.1370/afm.2771\\n10.1080/1059924x.2014.947458\\n10.1093/jpepsy/jsr041\\n10.1111/acem.12285\\n10.1111/cea.12896\\n10.2105/ajph.2021.306272\\n10.1542/peds.2011-1391\\n10.1007/s10903-016-0459-2\\n10.1016/s1081-1206(10)61238-0\\n10.1016/j.acap.2014.10.011\\n10.1111/j.1398-9995.1998.tb03859.x\\n10.3109/02770903.2014.986738\\n10.1367/1539-4409(2003)003<0121:ctbfhc>2.0.co;2\\n10.1155/2018/9350370\\n10.1542/peds.113.4.e276\\n10.1093/aje/kwx223', 'xml': <Element 'PubmedArticle' at 0x10b61e340>}\n",
      "{'pubmed_id': '38283266\\n28772086\\n27608014\\n17723921\\n23458441\\n22928722\\n32533032\\n24699425\\n34157821\\n20464549\\n26357619\\n20394749\\n18955056\\n30921214\\n23419359\\n26702391\\n24378275\\n31643176', 'title': 'Scotch pine-induced liver injury: A case report.', 'abstract': 'Herbal medicines are widely used worldwide to treat minor ailments and prevent disease. Scotch pine (', 'keywords': ['Hepatotoxicity', 'Pinus sylvestris', 'liver injury'], 'journal': 'Hepatology forum', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Intas', 'firstname': 'Kadir', 'initials': 'K', 'affiliation': 'Department of Internal Medicine, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkiye.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© Copyright 2024 by Hepatology Forum.', 'doi': '10.14744/hf.2022.2022.0046', 'xml': <Element 'PubmedArticle' at 0x10b955a80>}\n",
      "{'pubmed_id': '38283200\\n28911920\\n29273246\\n35455087\\n32997808\\n31525297\\n25281854\\n21070826\\n37491157\\n26953090\\n30613305\\n36430906\\n32789546\\n34616046\\n35358610\\n36152374\\n35524280\\n33146657\\n38007195\\n31678519\\n32831927\\n32278128\\n29725272\\n29400693\\n36270294\\n33218265\\n23384790\\n26614594\\n26973640\\n32963948\\n34668373\\n35033647\\n31731808\\n33247470\\n33271886\\n37048164\\n35690367\\n22505744\\n20668012\\n34309864\\n33711259\\n31637021\\n33895362\\n37003355\\n32691293', 'title': 'Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice.', 'abstract': 'Inhaled corticosteroids, including budesonide (BUD), are widely employed for the treatment of asthma. However, the frequent use of corticosteroids is associated with numerous adverse effects and poses challenges to ongoing drug therapy and patient adherence. Budesonide liposomal nanoparticles (BUD-LNPs) were developed to improve the bioavailability of the drug and thereby improve the effectiveness of asthma treatment.\\nBUD-LNPs were prepared via thin-film hydration, and the characterizations, stability, and in vitro release of BUD-LNPs were studied. In vitro cellular uptake was observed by laser-scanning confocal microscope (LSCM) and flow cytometry. And the in vitro anti-inflammatory activity of BUD-LNPs was evaluated by measuring the expression of pro-inflammatory cytokines in activated macrophages. Besides, the accumulation time in the lung of drugs delivered via liposomal carriers and free drugs was compared in vivo. And the in vivo therapeutic efficacy of BUD-LNPs was assessed in OVA-induced asthmatic mice. Finally, in vivo biosafety assessment was performed.\\nThe particle size, PDI, and zeta potential of BUD-LNPs were 127.63±1.33\\xa0nm, 0.27±0.02, and 3.33±0.13\\xa0mV, respectively. BUD-LNPs exhibited excellent biosafety and anti-inflammatory activity in vitro. Furthermore, compared with the free drugs, the utilization of liposomal nano-vehicles for drugs delivery could effectively extend the duration of drugs accumulation in the pulmonary system. Additionally, treatment with BUD-LNPs alleviated airway hyperresponsiveness, reduced airway mucus secretion, and mitigated pulmonary inflammation in OVA-induced asthmatic mice. And the BUD-LNPs demonstrated superior therapeutic efficacy compared to free BUD.\\nBUD-LNPs was successfully prepared with excellent stability and sustained release for 24\\xa0h in vitro. The data of anti-inflammatory activity, asthma therapeutic effects and safety studies indicated that drug delivery mediated by liposomal nano-vehicles was a feasible and desirable strategy for medical strategy and showed great promise in the clinical therapy of asthma.', 'keywords': ['asthma', 'budesonide', 'liposomal nanoparticles', 'nano-vehicles', 'pulmonary delivery'], 'journal': 'International journal of nanomedicine', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Zuo', 'firstname': 'Xu', 'initials': 'X', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Gu', 'firstname': 'Yinuo', 'initials': 'Y', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Guo', 'firstname': 'Xiaoping', 'initials': 'X', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Zheng', 'firstname': 'Wenxue', 'initials': 'W', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Zheng', 'firstname': 'Haoyu', 'initials': 'H', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'An', 'firstname': 'Yiming', 'initials': 'Y', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Xu', 'firstname': 'Caina', 'initials': 'C', 'affiliation': \"Department of Biochemistry, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\\nKey Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, People's Republic of China.\"}, {'lastname': 'Wang', 'firstname': 'Fang', 'initials': 'F', 'affiliation': \"Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.\\nKey Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, 130021, People's Republic of China.\"}], 'methods': None, 'conclusions': 'BUD-LNPs was successfully prepared with excellent stability and sustained release for 24\\xa0h in vitro. The data of anti-inflammatory activity, asthma therapeutic effects and safety studies indicated that drug delivery mediated by liposomal nano-vehicles was a feasible and desirable strategy for medical strategy and showed great promise in the clinical therapy of asthma.', 'results': 'The particle size, PDI, and zeta potential of BUD-LNPs were 127.63±1.33\\xa0nm, 0.27±0.02, and 3.33±0.13\\xa0mV, respectively. BUD-LNPs exhibited excellent biosafety and anti-inflammatory activity in vitro. Furthermore, compared with the free drugs, the utilization of liposomal nano-vehicles for drugs delivery could effectively extend the duration of drugs accumulation in the pulmonary system. Additionally, treatment with BUD-LNPs alleviated airway hyperresponsiveness, reduced airway mucus secretion, and mitigated pulmonary inflammation in OVA-induced asthmatic mice. And the BUD-LNPs demonstrated superior therapeutic efficacy compared to free BUD.', 'copyrights': '© 2024 Zuo et al.', 'doi': '10.2147/IJN.S441345\\n10.1016/s0140-6736(17)30879-6\\n10.1016/s0140-6736(17)33311-1\\n10.3390/life12040596\\n10.1111/all.14607\\n10.1164/rccm.201904-0903SO\\n10.1016/j.drudis.2014.09.020\\n10.1016/j.jconrel.2010.11.001\\n10.1136/gutjnl-2023-329873\\n10.3109/03639045.2016.1160110\\n10.7150/thno.28324\\n10.3390/ijms232214427\\n10.1007/s13346-020-00813-5\\n10.1038/s41551-021-00786-x\\n10.1016/j.jconrel.2022.03.028\\n10.1016/j.cis.2022.102757\\n10.1186/s12951-022-01435-4\\n10.1039/d0bm01529f\\n10.1016/j.jconrel.2023.11.039\\n10.1016/j.ijpharm.2019.118806\\n10.3892/ol.2020.11969\\n10.1016/j.intimp.2020.106449\\n10.1155/2018/8387150\\n10.1172/jci95693\\n10.1146/annurev-pathol-042220-015902\\n10.1080/17425247.2021.1854222\\n10.1016/j.biomaterials.2013.01.064\\n10.1016/j.rmed.2015.11.002\\n10.3389/fmicb.2016.00272\\n10.1016/j.apsb.2020.02.002\\n10.1021/acsami.1c09701\\n10.1016/j.phrs.2022.106083\\n10.1111/cea.13795\\n10.3390/molecules25235672\\n10.3390/cells12071091\\n10.1016/j.jaip.2022.05.026\\n10.1164/rccm.201201-0088OC\\n10.1378/chest.10-0100\\n10.1111/all.15020\\n10.1016/j.cell.2021.02.016\\n10.1038/s41392-019-0079-0\\n10.1016/j.jaip.2021.04.016\\n10.1016/j.chest.2023.03.035\\n10.1007/s40265-020-01359-z', 'xml': <Element 'PubmedArticle' at 0x10b905670>}\n",
      "{'pubmed_id': '38283085\\n30646188\\n30455345\\n11113829\\n34098164\\n33597169\\n11150011\\n24304599\\n35906963\\n33948966\\n24816523\\n20180792\\n30697418\\n32600925\\n16388197\\n36805346\\n31529494\\n26968958\\n29413336\\n20527517\\n31151888\\n33204386\\n34343358\\n32001253', 'title': 'Perspectives and gaps in the management of food allergy and anaphylaxis in the Asia-Pacific Region.', 'abstract': 'Food allergy (FA), which is a condition that has no effective cure and can result in severe life-threatening allergic reactions, remains a global public health concern; however, little is known about how FAs are currently managed in the Asia-Pacific region.\\nThe main objective of this survey was to evaluate the epidemiology of FA, as well as the availability of resources and practices for management of FA and anaphylaxis by health care providers across Asia.\\nFrom June 2022 to September 2022, a questionnaire-based survey comprising 66 questions was electronically sent to member societies of the Asia Pacific Association of Allergy Asthma and Clinical Immunology by using Survey Monkey.\\nA total of 20 responses were received from 15 member countries and territories. Compared with the pediatric data, there was a lack of prevalence data for FA in adults. Except for Australia and Japan, most regions had between 0.1 and 0.5 allergists per 100,000 population and some had fewer than 0.1 allergists per 100,000 population. The perceived rate of FA in regions with a short supply of allergists was high. Although specific IgE tests and oral food challenges were available in all regions, the median wait time for oral food challenges at government facilities was 37 days (interquartile range\\xa0= 10.5-60 days). Seven regions still relied on prescriptions of ampules and syringes of injectable adrenaline, and adrenaline autoinjectors were not accessible in 4 regions. Oral immunotherapy as FA treatment was available in half of the surveyed countries and territories.\\nOur study offers a cross-sectional evaluation of the management practices for FA in each Asia Pacific Association of Allergy Asthma and Clinical Immunology member country or territory. Urgent actions are required to enhance allergy services, improve the accessibility and affordability of adrenaline autoinjectors, and conduct robust epidemiologic studies.', 'keywords': ['Food allergy', 'adrenaline autoinjector', 'allergist', 'allergy service', 'anaphylaxis'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Leung', 'firstname': 'Agnes Sze Yin', 'initials': 'ASY', 'affiliation': 'Department of Paediatrics, Prince of Wales Hospital, Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong, China.'}, {'lastname': 'Pawankar', 'firstname': 'Ruby', 'initials': 'R', 'affiliation': 'Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan.'}, {'lastname': 'Pacharn', 'firstname': 'Punchama', 'initials': 'P', 'affiliation': 'Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.'}, {'lastname': 'Wong', 'firstname': 'Lydia Su Yin', 'initials': 'LSY', 'affiliation': \"Department of Paediatrics, Yong Loo Lin School of Medicine and Khoo Teck Puat-National University Children's Medical Institute, National University of Singapore, Singapore, Singapore.\"}, {'lastname': 'Le Pham', 'firstname': 'Duy', 'initials': 'D', 'affiliation': 'University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.'}, {'lastname': 'Chan', 'firstname': 'Grace', 'initials': 'G', 'affiliation': 'Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.'}, {'lastname': 'Rengganis', 'firstname': 'Iris', 'initials': 'I', 'affiliation': 'Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo National Hospital, Jakarta, Indonesia.'}, {'lastname': 'Zhao', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Capital Institute of Pediatrics in China, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Jiu Yao', 'initials': 'JY', 'affiliation': 'Division of Allergy and Clinical Immunology, Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Woo', 'firstname': 'Kent Chee-Keen', 'initials': 'KC', 'affiliation': 'Gleneagles Hospital, Kuala Lumpur, Malaysia.'}, {'lastname': 'Ito', 'firstname': 'Komei', 'initials': 'K', 'affiliation': \"Allergy and Immunology Center, Aichi Children's Health And Medical Center, Aichi, Japan.\"}, {'lastname': 'Jeong', 'firstname': 'Kyunguk', 'initials': 'K', 'affiliation': 'Ajou University School of Medicine, Suwon, Korea.'}, {'lastname': 'Recto', 'firstname': 'Marysia', 'initials': 'M', 'affiliation': 'Division of Adult and Pediatric Allergy and Immunology, University of the Philippines College of Medicine, Philippine General Hospital, Manila, Philippines.'}, {'lastname': 'Lucas', 'firstname': 'Michaela', 'initials': 'M', 'affiliation': 'WA Health and University of Western Australia, Perth, Australia.'}, {'lastname': 'Nagao', 'firstname': 'Mizuho', 'initials': 'M', 'affiliation': 'National Hospital Organization Mie National Hospital, Tsu, Japan.'}, {'lastname': 'Lobo', 'firstname': 'Rommel Crisenio M', 'initials': 'RCM', 'affiliation': 'Fe del Mundo Medical Center, Metro Manila, Manila, Philippines.'}, {'lastname': 'Munkhbayarlakh', 'firstname': 'Sonomjamts', 'initials': 'S', 'affiliation': 'Department of Pulmonology and Allergology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.'}, {'lastname': 'Sumadiono', 'firstname': 'Sumadiono', 'initials': 'S', 'affiliation': 'Department of Child Health, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.'}, {'lastname': 'Huq', 'firstname': 'Syed Rezaul', 'initials': 'SR', 'affiliation': 'National Institute of the Chest Disease and Hospital NIDCH Mohakhali, Dhaka, Bangladesh.'}, {'lastname': 'Ranasinghe', 'firstname': 'Thushali', 'initials': 'T', 'affiliation': 'Allergy, Immunology and Cell Biology Unit, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.'}, {'lastname': 'Tang', 'firstname': 'Mimi', 'initials': 'M', 'affiliation': \"Allergy Immunology, Murdoch Children's Research Institute, Department of Allergy and Immunology, The Royal Children's Hospital Melbourne, Melbourne, Australia.\"}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'A total of 20 responses were received from 15 member countries and territories. Compared with the pediatric data, there was a lack of prevalence data for FA in adults. Except for Australia and Japan, most regions had between 0.1 and 0.5 allergists per 100,000 population and some had fewer than 0.1 allergists per 100,000 population. The perceived rate of FA in regions with a short supply of allergists was high. Although specific IgE tests and oral food challenges were available in all regions, the median wait time for oral food challenges at government facilities was 37 days (interquartile range\\xa0= 10.5-60 days). Seven regions still relied on prescriptions of ampules and syringes of injectable adrenaline, and adrenaline autoinjectors were not accessible in 4 regions. Oral immunotherapy as FA treatment was available in half of the surveyed countries and territories.', 'copyrights': '© 2023 The Author(s).', 'doi': '10.1016/j.jacig.2023.100202', 'xml': <Element 'PubmedArticle' at 0x10b995b70>}\n",
      "{'pubmed_id': '38283084\\n25419479\\n19187334\\n17306354\\n32499034\\n30370459\\n23403837\\n27864090\\n27563525\\n33639634\\n30793379\\n24862746\\n31857266\\n25138428\\n30402403\\n21917708\\n29967633\\n24311523\\n27297800\\n32774662\\n30044008\\n29766369\\n11840177\\n17108704\\n27595577\\n12027282\\n18627500\\n25814704\\n27238178\\n32330668\\n29605827\\n32401757\\n26140270\\n28321366\\n28543717\\n29415354\\n32009317\\n31373655\\n30455345\\n30646188\\n26816616\\n11527247\\n16751008\\n28612368\\n28164808\\n26233427\\n31513892\\n32916320\\n9155844\\n18503689\\n10424931\\n580076\\n20532872\\n9816421\\n26889090\\n22187574\\n26079618\\n30377651\\n18681854\\n17689596\\n19000582\\n9020427', 'title': 'Reported food-related symptoms and food allergen sensitization in a selected adult population in Hyderabad, India: A\\xa0hospital-based survey.', 'abstract': \"Research on reported food-related triggers of atopic disease in South Asian adults is lacking despite the region's large population and the global significance of allergic diseases.\\nThe study aimed to identify prevalent local food items and assess allergic sensitization rates to potential trigger foods for atopic diseases via skin prick and specific IgE testing.\\nThe study began with a pilot survey of 100 subjects recruited from 4 hospitals in Hyderabad, India, focusing on foods perceived to relate to asthma, allergic rhinitis, atopic dermatitis, urticaria, and gastrointestinal allergic symptoms. A\\xa0subsequent main study evaluated 2010 participants, 1754 of whom were diagnosed with an aforementioned atopic disease and who reported allergic symptoms related to any of 77 foods identified in the pilot study. Ultimately 1622 patients who consented to skin prick and specific IgE testing and who reported at least 1 food item triggering allergic diseases were included in the final analysis.\\nAmong 1622 patients (average age, 42.6\\xa0± 12.9 years; 55.5% male), asthma was the most commonly diagnosed atopic disease (26.4%), with itching and rash being frequently reported symptoms (22.7%). Notably, 94.9% of patients had total serum IgE\\xa0> 144 kU/L. Chickpea, cabbage, eggplant, walnut, cumin, and betel leaf were the most commonly reported trigger foods.\\nIn this sample of South Indian adults diagnosed with allergic disease, reported food triggers were most commonly local dietary staples, while reported reactions to priority allergens like peanut and sesame were conspicuously absent. Observed concordance between patient-reported food triggers and sensitization to reported food triggers was low, highlighting the need for improved clinical evaluation of suspected triggers.\", 'keywords': ['Atopic disease', 'South India', 'food specific IgE', 'food-related atopic symptoms', 'skin prick test'], 'journal': 'The journal of allergy and clinical immunology. Global', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Dadha', 'firstname': 'Priyanka', 'initials': 'P', 'affiliation': 'Center for Food Allergy & Asthma Research (CFAAR), Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.'}, {'lastname': 'Nimmagadda', 'firstname': 'Sai', 'initials': 'S', 'affiliation': \"Center for Food Allergy & Asthma Research (CFAAR), Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.\\nAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.\"}, {'lastname': 'Venter', 'firstname': 'Carina', 'initials': 'C', 'affiliation': \"Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.\\nDepartment of Pediatrics-Allergy/Immunology, CFAAR, Chicago, Ill.\"}, {'lastname': 'Gupta', 'firstname': 'Ruchi', 'initials': 'R', 'affiliation': \"Center for Food Allergy & Asthma Research (CFAAR), Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.\\nAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.\"}, {'lastname': 'Kumar', 'firstname': 'Putcha Uday', 'initials': 'PU', 'affiliation': 'Division of Pathology & Microbiology, Indian Council of Medical Research-National Institute of Nutrition, Ministry of Health and Family Welfare, Government of India, Hyderabad, Telangana, India.'}, {'lastname': 'Warren', 'firstname': 'Christopher M', 'initials': 'CM', 'affiliation': 'Center for Food Allergy & Asthma Research (CFAAR), Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.'}], 'methods': None, 'conclusions': 'In this sample of South Indian adults diagnosed with allergic disease, reported food triggers were most commonly local dietary staples, while reported reactions to priority allergens like peanut and sesame were conspicuously absent. Observed concordance between patient-reported food triggers and sensitization to reported food triggers was low, highlighting the need for improved clinical evaluation of suspected triggers.', 'results': 'Among 1622 patients (average age, 42.6\\xa0± 12.9 years; 55.5% male), asthma was the most commonly diagnosed atopic disease (26.4%), with itching and rash being frequently reported symptoms (22.7%). Notably, 94.9% of patients had total serum IgE\\xa0> 144 kU/L. Chickpea, cabbage, eggplant, walnut, cumin, and betel leaf were the most commonly reported trigger foods.', 'copyrights': '© 2023 The Author(s).', 'doi': '10.1016/j.jacig.2023.100204', 'xml': <Element 'PubmedArticle' at 0x10b832cf0>}\n",
      "{'pubmed_id': '38283080\\n37431853\\n34946955\\n16091213\\n31770759\\n33280712\\n12867606\\n25598014\\n29452202\\n20337962\\n21962526\\n7305119\\n34506964', 'title': 'Relationship between indoor inhalant allergen concentrations, serum IgE, and allergic diseases: A cross-sectional study from the NHANES 2005-2006 program.', 'abstract': 'This research analyzed data from 5106 participants in the National Health and Nutrition Examination Survey 2005-2006 to explore the link between indoor allergen concentrations, serum IgE levels, and allergic diseases. The study found that 14.9% of participants reported having asthma, with significant differences noted in the concentrations of certain indoor allergens, specifically dust dog, mite, and cat allergens, between asthma and non-asthma groups. Furthermore, positivity rates for inhalant allergen-specific IgE and total IgE were higher in the asthma group. However, the correlations between most inhalant allergen IgE, including total IgE, and indoor allergen concentrations were very weak. These findings suggest that the relationship between indoor allergen concentrations and asthma incidence is complex, indicating a potential need for personalized allergen prevention strategies based on disease type and patient sensitization.', 'keywords': ['Allergy', 'Asthma', 'Indoor allergen', 'Sensitization'], 'journal': 'The World Allergy Organization journal', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Ye', 'firstname': 'Fei', 'initials': 'F', 'affiliation': \"Otolaryngology Department of Huangpu People's Hospital of Zhongshan, Allergy Department/Otolaryngology Head and Neck Surgery Department of Zhongshan City People's Hospital, China.\"}, {'lastname': 'He', 'firstname': 'Gongkai', 'initials': 'G', 'affiliation': \"Xinxiang Medical University, Zhongshan City People's Hospital, China.\"}, {'lastname': 'Gan', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University (The Key Laboratory of Advanced Interdisciplinary Studies Center, Advanced Interdisciplinary Studies Center), Guangzhou, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': '© 2023 The Authors.', 'doi': '10.1016/j.waojou.2023.100866', 'xml': <Element 'PubmedArticle' at 0x10b8edee0>}\n",
      "{'pubmed_id': '38283037\\n35039631\\n34648022\\n28990587\\n36257987\\n36629024\\n37725239\\n37373412\\n37500363\\n37452714\\n37486436\\n37680629\\n37053273\\n37781373\\n37648664\\n35967320\\n35197267\\n36755071\\n29382950\\n28267716\\n36344311\\n23264775\\n23650392\\n35079870\\n25946076\\n20974816\\n30898862\\n32663035\\n28574339\\n32926098\\n34991159\\n35799268\\n36693132\\n30279690\\n31695698\\n30327203\\n30622307\\n34260389\\n35784323\\n35237275\\n28611461\\n22980329\\n29466596\\n36469902\\n29415887\\n29981294\\n32239392\\n37360308\\n36911225\\n31334568\\n37715457\\n30622526\\n30315525\\n36982193\\n37759381\\n37808899\\n32189992\\n36933379\\n37668145\\n28112391\\n32938287\\n35065815\\n30808638\\n22596262\\n22684106\\n29351433\\n34120407\\n37801721\\n18055706\\n31346797\\n24283226\\n11159246\\n21742212\\n12464676\\n30715224\\n34075628\\n24335230\\n29387725\\n33711259\\n37703556\\n30995510\\n36078171\\n25534623\\n33160187\\n21504070\\n17356056\\n26804470\\n21315435\\n31596059\\n34082773\\n30888839\\n34342773\\n28459437\\n31591573\\n34653517\\n29359169\\n30076281\\n29883877\\n37626601\\n33872652\\n31562870\\n37506849\\n37285400\\n36271366\\n36778209\\n36725964\\n27574788\\n28549850\\n22702508\\n26738487\\n36827917\\n30834543\\n37696283\\n37794516\\n26595735\\n35321933\\n18274560\\n25994149\\n28506850\\n31362723\\n29449427\\n32027864\\n22458939\\n23904163\\n36902325\\n12848850\\n32597954\\n32329756\\n37137805\\n33096114\\n32302401\\n35979369\\n37533131\\n35354492\\n35084992\\n37278811\\n35973718\\n31570318\\n20818377\\n22174830\\n33186023\\n30669408\\n31379861\\n8395774\\n29937317\\n16685004\\n18565957\\n20299288\\n18243068\\n25590159\\n28043871\\n28916704\\n21438174\\n33434406\\n22995323\\n22267768\\n35008577\\n37211559\\n31255598\\n34588792\\n36876152\\n29946009\\n29859833\\n37730741', 'title': 'Neutrophil extracellular traps and their implications in airway inflammatory diseases.', 'abstract': 'Neutrophil extracellular traps (NETs) are essential for immune defense and have been increasingly recognized for their role in infection and inflammation. In the context of airway inflammatory diseases, there is growing evidence suggesting the involvement and significance of NETs. This review aims to provide an overview of the formation mechanisms and components of NETs and their impact on various airway inflammatory diseases, including acute lung injury/ARDS, asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. By understanding the role of NETs in airway inflammation, we can gain valuable insights into the underlying pathogenesis of these diseases and identify potential targets for future therapeutic strategies that either target NETs formation or modulate their harmful effects. Further research is warranted to elucidate the complex interactions between NETs and airway inflammation and to develop targeted therapies that can effectively mitigate their detrimental effects while preserving their beneficial functions in host defense.', 'keywords': ['ARDS', 'COPD', 'airway inflammation', 'asthma', 'cystic fibrosis', 'neutrophil extracellular traps', 'targeted therapy'], 'journal': 'Frontiers in medicine', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Xuan', 'firstname': 'Nanxia', 'initials': 'N', 'affiliation': 'Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Zhao', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, China.'}, {'lastname': 'Kang', 'firstname': 'Zhiying', 'initials': 'Z', 'affiliation': 'Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Cui', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Tian', 'firstname': 'Bao-Ping', 'initials': 'BP', 'affiliation': 'Department of Critical Care Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}], 'methods': None, 'conclusions': None, 'results': None, 'copyrights': 'Copyright © 2024 Xuan, Zhao, Kang, Cui and Tian.', 'doi': '10.3389/fmed.2023.1331000\\n10.1038/s41423-021-00832-3\\n10.1093/cvr/cvab329\\n10.1038/nri.2017.105\\n10.1038/s41577-022-00787-0\\n10.1002/ctm2.1170\\n10.1007/s10238-023-01180-4\\n10.3390/ijms241210265\\n10.1016/j.tins.2023.06.005\\n10.1177/15353702231184217\\n10.1007/s11011-023-01268-6\\n10.3389/fimmu.2023.1198952\\n10.1161/CIRCRESAHA.123.321750\\n10.3389/fimmu.2023.1261151\\n10.1093/jleuko/qiad101\\n10.3389/fimmu.2022.953195\\n10.1183/16000617.0241-2021\\n10.1038/s41418-023-01124-1\\n10.1038/nrgastro.2017.183\\n10.1038/nm.4294\\n10.1016/j.tim.2022.10.002\\n10.3389/fimmu.2012.00360\\n10.1073/pnas.1301059110\\n10.1007/s00018-022-04126-3\\n10.3390/biom5020702\\n10.1083/jcb.201006052\\n10.1182/blood-2018-11-844530\\n10.1146/annurev-cellbio-020520-111016\\n10.7554/eLife.24437\\n10.1084/jem.20201129\\n10.1182/bloodadvances.2021005949\\n10.1186/s13054-022-04062-5\\n10.1126/scisignal.abm0517\\n10.3389/fimmu.2018.02036\\n10.3389/fimmu.2019.02481\\n10.1016/j.bbamcr.2018.08.014\\n10.1038/s41418-018-0261-x\\n10.1073/pnas.2100561118\\n10.3389/fimmu.2022.913028\\n10.3389/fimmu.2022.836278\\n10.1038/s41598-017-03257-z\\n10.1016/j.chom.2012.06.011\\n10.1001/jama.2017.21907\\n10.1146/annurev-med-043021-014005\\n10.1172/jci.insight.98178\\n10.1016/j.ejphar.2018.07.005\\n10.1007/s10753-020-01221-0\\n10.1007/s44231-023-00032-9\\n10.1007/s44231-022-00012-5\\n10.1002/14651858.CD004477.pub3\\n10.1002/ctm2.1389\\n10.3389/fmicb.2018.03174\\n10.1007/s10753-018-0903-7\\n10.3390/ijms24065125\\n10.1002/advs.202303053\\n10.1002/pul2.12295\\n10.1155/2020/2720369\\n10.1016/j.biopha.2023.114530\\n10.1002/jcb.30469\\n10.1002/jcp.25816\\n10.1016/j.blre.2021.100926\\n10.1182/blood-2018-10-860809\\n10.1182/blood-2012-01-405183\\n10.1172/JCI61303\\n10.1152/ajplung.00501.2016\\n10.1111/jcmm.16650\\n10.1182/blood.2023020484\\n10.1183/09031936.00104907\\n10.1186/s40635-019-0226-5\\n10.1056/NEJMra1208707\\n10.1097/00000539-200102000-00029\\n10.1016/j.ccc.2011.05.008\\n10.1172/JCI0215849\\n10.1093/ecco-jcc/jjy215\\n10.1002/jbmr.4384\\n10.1182/blood-2013-07-516484\\n10.1155/2017/8272504\\n10.1016/j.cell.2021.02.016\\n10.1056/NEJMcp2304871\\n10.1016/j.immuni.2019.03.018\\n10.3390/cells11172764\\n10.1038/nri3786\\n10.1016/j.coi.2020.10.002\\n10.2174/138945011794751555\\n10.1136/thx.2006.073429\\n10.1111/resp.12730\\n10.1016/j.jaci.2010.12.1103\\n10.1002/ppul.24520\\n10.1186/s12931-021-01759-z\\n10.1164/rccm.201810-1869OC\\n10.1007/s10238-021-00750-8\\n10.1038/nm.4332\\n10.1038/s41590-019-0496-9\\n10.1016/j.jaci.2021.09.031\\n10.1155/2017/3743048\\n10.1126/sciimmunol.aao4747\\n10.1016/j.coi.2018.05.006\\n10.3390/biomedicines11082104\\n10.1016/j.jaci.2021.03.044\\n10.1016/j.jaci.2019.08.039\\n10.1016/j.mucimm.2023.07.002\\n10.1126/scitranslmed.adf3843\\n10.1186/s12931-022-02209-0\\n10.1155/2023/1493684\\n10.1038/s41423-023-00974-6\\n10.1016/S2213-2600(16)30227-2\\n10.1016/j.pupt.2017.05.012\\n10.1111/j.1365-2222.2012.04014.x\\n10.1007/s11010-015-2638-1\\n10.1016/j.intimp.2023.109719\\n10.1111/all.13760\\n10.1016/S2213-2600(23)00261-8\\n10.1186/s40001-023-01374-2\\n10.1513/AnnalsATS.201503-126AW\\n10.1183/16000617.0112-2021\\n10.1038/nri2254\\n10.1186/s12931-015-0221-7\\n10.1016/j.jaci.2017.04.022\\n10.1186/s12931-019-1145-4\\n10.1183/13993003.00970-2017\\n10.1016/j.yexcr.2020.111888\\n10.3109/15412555.2011.641803\\n10.4049/jimmunol.1300436\\n10.3390/ijms24054896\\n10.1046/j.1440-1711.2003.t01-1-01170.x\\n10.1182/blood.2020007008\\n10.1172/jci.insight.138999\\n10.1016/j.it.2023.04.001\\n10.1016/j.lfs.2020.118617\\n10.1084/jem.20200652\\n10.3389/fimmu.2022.953129\\n10.1186/s12985-023-02116-w\\n10.1186/s12959-022-00375-1\\n10.1146/annurev-med-042120-020148\\n10.1001/jama.2023.8120\\n10.1146/annurev-med-042921-021447\\n10.1016/S2213-2600(19)30337-6\\n10.1038/nm.2209\\n10.1371/journal.pone.0028526\\n10.1021/jacs.0c08130\\n10.3390/biom9080365\\n10.3389/fimmu.2019.01670\\n10.1016/j.jcf.2018.05.018\\n10.1378/chest.129.5.1148\\n10.1164/rccm.200703-409OC\\n10.1016/j.jcf.2010.01.005\\n10.1016/j.jcf.2007.12.005\\n10.1164/rccm.201407-1365LE\\n10.1016/j.jaci.2016.11.027\\n10.1136/thoraxjnl-2017-210134\\n10.1002/ppul.21388\\n10.1002/ppul.25248\\n10.1016/j.jcf.2012.08.016\\n10.1183/09031936.00194611\\n10.3390/ijms23010144\\n10.1038/s41392-023-01452-1\\n10.1016/j.yexcr.2019.06.031\\n10.2147/JIR.S321513\\n10.2147/JIR.S366436\\n10.1183/13993003.02590-2017\\n10.1016/j.cbi.2018.05.018\\n10.1038/s41598-023-42167-1', 'xml': <Element 'PubmedArticle' at 0x10b8ed580>}\n",
      "{'pubmed_id': '38282875\\n18331513\\n25809555\\n22283402\\n16935684\\n17651373\\n22420234\\n27742084\\n25558972\\n27323131\\n33747342\\n26207884\\n28692864\\n35546679\\n29786875\\n26148797\\n23465506\\n32245306\\n15005764\\n7789502\\n23409759\\n28461290\\n15817806\\n21885636\\n25377880\\n18047813\\n20851922\\n1515759\\n31185305\\n21146186\\n24339486', 'title': 'The relationship between lipid parameters and the course of allergic rhinitis in children.', 'abstract': 'A possible mechanism in the pathogenesis of allergic rhinitis (AR) is hypercholesterolemia, which may shift the balance between Th1- and Th2-dependent immune responses towards the latter.\\nTo assess the prevalence of lipid metabolism abnormalities in children with AR and their influence on the clinical course of AR.\\nThe study sample comprised 80 children (7-17 y.o.) with AR, including 28 with associated asthma, and 40 healthy children. Total blood cholesterol, HDL, LDL and triglyceride levels were evaluated (ARCHITECTcSystem). Skin prick tests (Allergopharma) for airborne allergens and a methacholine challenge test (Lungtest 1000, Ispa) were performed. Allergen-specific IgE for airborne allergens (Biocheck GmbH), FeNO and nNO concentrations (HypAir FeNO Medisoft) were measured.\\nChildren with AR were significantly more likely to have normal HDL levels than the control group (\\nChildren with AR are as likely to demonstrate dyslipidaemia as the general population. However, the presence of lipid abnormalities in this group may increase the likelihood of sensitization to perennial allergens.', 'keywords': ['allergic rhinitis', 'asthma', 'children', 'lipid parameters'], 'journal': 'Postepy dermatologii i alergologii', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Kowalczyk', 'firstname': 'Agnieszka', 'initials': 'A', 'affiliation': 'Department of Paediatrics, Allergology and Gastroenterology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.'}, {'lastname': 'Krogulska', 'firstname': 'Aneta', 'initials': 'A', 'affiliation': 'Department of Paediatrics, Allergology and Gastroenterology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.'}], 'methods': None, 'conclusions': None, 'results': 'Children with AR were significantly more likely to have normal HDL levels than the control group (', 'copyrights': 'Copyright: © 2023 Termedia Sp. z o. o.', 'doi': '10.5114/ada.2023.133586\\n10.4238/gmr.15028016', 'xml': <Element 'PubmedArticle' at 0x1099b1990>}\n",
      "{'pubmed_id': '38282873\\n31048346\\n19717707\\n10887306\\n18426615\\n25569185\\n9919437\\n23176877\\n30630892\\n31412998\\n31949111\\n35364341\\n27735927\\n27815152\\n31981105\\n29433489\\n15618231\\n17074917\\n20110003\\n19910178\\n30232329\\n29949492\\n30069323\\n26141573', 'title': 'Predictors of excessive short-acting β', 'abstract': 'Despite being linked to unfavourable outcomes, short-acting β\\nTo analyse the prevalence and predictors of SABA overuse and exacerbations in patients with asthma in a nationwide database of prescription purchase records.\\nThe prevalence of excessive SABA use (≥ 12 canisters) and overuse (≥ 3 canisters) was analysed among patients aged 18-64 years who purchased asthma medications in 2018. Predictors of excessive SABA use and SABA overuse were examined by quasi-Poisson regression. Negative binomial regression was used to study the association of excessive SABA use or overuse to the risk of asthma exacerbation defined as a prescription for oral corticosteroids.\\nOf 91,763 patients with asthma, 42,189 (46%) were SABA users (mean age, 47 years; 58% female). Among them, 34% purchased ≥ 3 SABA canisters, and 6% purchased ≥ 12 canisters. The risk (risk ratio, 95% CI) of excessive SABA use was lower in patients with concomitant prescriptions for inhaled corticosteroids (0.41, 0.34-0.48) or inhaled corticosteroids and long-acting β\\nExcessive SABA use is highly prevalent in asthma management, is associated with lack of prescriptions for inhaled corticosteroids, and substantially increases the exacerbation risk.', 'keywords': ['asthma', 'controller medications', 'exacerbation', 'reliever medications', 'short-acting β2-agonists'], 'journal': 'Postepy dermatologii i alergologii', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Kupczyk', 'firstname': 'Maciej', 'initials': 'M', 'affiliation': 'Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.'}, {'lastname': 'Barg', 'firstname': 'Wojciech', 'initials': 'W', 'affiliation': 'Department of Human Physiology, Medical College of Rzeszów University, Rzeszow, Poland.'}, {'lastname': 'Bochenek', 'firstname': 'Grażyna', 'initials': 'G', 'affiliation': 'Department of Internal Medicine, Faculty of Medicine, Jagiellonian University School of Medicine, Krakow, Poland.'}, {'lastname': 'Brożek', 'firstname': 'Grzegorz', 'initials': 'G', 'affiliation': 'Department of Epidemiology, School of Medicine Katowice, Medical University of Silesia, Katowice, Poland.'}, {'lastname': 'D Browiecki', 'firstname': 'Piotr', 'initials': 'P', 'affiliation': 'Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland.'}, {'lastname': 'Brzostek', 'firstname': 'Dorota', 'initials': 'D', 'affiliation': 'AstraZeneca Pharma Poland Sp. z o.o., Warsaw, Poland.'}, {'lastname': 'D Browski', 'firstname': 'Andrzej', 'initials': 'A', 'affiliation': 'Department of Internal Medicine, Pneumonology and Allergology, Warsaw Medical University, Warsaw, Poland.'}, {'lastname': 'Dobek', 'firstname': 'Rafał', 'initials': 'R', 'affiliation': 'Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.'}, {'lastname': 'Gawlik', 'firstname': 'Radosław', 'initials': 'R', 'affiliation': 'Department of Internal Medicine, Allergology and Clinical Immunology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.'}, {'lastname': 'Kucharczyk', 'firstname': 'Aleksandra', 'initials': 'A', 'affiliation': 'Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Military Institute of Medicine, Warsaw, Poland.'}, {'lastname': 'Kupryś-Lipińska', 'firstname': 'Izabela', 'initials': 'I', 'affiliation': 'Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.'}, {'lastname': 'Mastalerz-Migas', 'firstname': 'Agnieszka', 'initials': 'A', 'affiliation': 'Department of Family Medicine, Wroclaw Medical University, Wroclaw, Poland.'}, {'lastname': 'Kowalski', 'firstname': 'Marek L', 'initials': 'ML', 'affiliation': 'Department of Immunology, Rheumatology and Allergy, Chair of Clinical Immunology and Microbiology, Healthy Ageing Research Center, Medical University of Lodz, Lodz, Poland.'}], 'methods': None, 'conclusions': None, 'results': 'Of 91,763 patients with asthma, 42,189 (46%) were SABA users (mean age, 47 years; 58% female). Among them, 34% purchased ≥ 3 SABA canisters, and 6% purchased ≥ 12 canisters. The risk (risk ratio, 95% CI) of excessive SABA use was lower in patients with concomitant prescriptions for inhaled corticosteroids (0.41, 0.34-0.48) or inhaled corticosteroids and long-acting β', 'copyrights': 'Copyright: © 2023 Termedia Sp. z o. o.', 'doi': '10.5114/ada.2023.133454', 'xml': <Element 'PubmedArticle' at 0x109902fc0>}\n",
      "{'pubmed_id': '38282871\\n31141956\\n11842317\\n27296816\\n14680096\\n29493315\\n21356587\\n30663912\\n27492518\\n23932458\\n34949706\\n21885636\\n21354020\\n23397305\\n31772002\\n22743675\\n16836699\\n31862765\\n21570274\\n22178635\\n27736034\\n30194972\\n20615168\\n26216360\\n19381269\\n31172686\\n20146951\\n30876830\\n32525611', 'title': 'Diagnostic accuracy of peripheral lung function measurements in paediatric asthma control assessment: a pilot study.', 'abstract': 'Recent studies have indicated the significance of the peripheral airways in asthma control. Methods estimating airway resistance, air trapping, and ventilation inhomogeneity are useful for assessing this area of the lung and have proven utility in the evaluation of asthma; however, it is unclear which method is most effective at characterising uncontrolled asthma.\\nTo evaluate the diagnostic accuracy of various peripheral airway function measurements in the assessment of asthma control in children.\\nChildren with controlled (\\nMost peripheral airway parameters were significantly increased in children with uncontrolled asthma compared with children with controlled asthma. The measures with the highest diagnostic accuracy for asthma control were lung clearance index (LCI) (AUC = 0.76), with high specificity (0.97) and modest sensitivity (0.46), acinar ventilation heterogeneity (Sacin) (AUC = 0.73), with high sensitivity (0.85) and modest specificity (0.54), and resonance frequency (Fres) (AUC= 0.74), with perfect specificity (1.0) but low sensitivity (0.38).\\nLCI, Sacin and Fres had the highest discriminative capacity for distinguishing children with controlled and uncontrolled asthma among all evaluated peripheral airways measures. Discrepancies in the performance (i.e. sensitivity and specificity) of each parameter suggest that a combination may be most effective in determining asthma control status.', 'keywords': ['body plethysmography', 'impulse oscillometry', 'nitrogen washout test', 'small airways'], 'journal': 'Postepy dermatologii i alergologii', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Wawszczak', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.'}, {'lastname': 'Kulus', 'firstname': 'Marek', 'initials': 'M', 'affiliation': 'Department of Paediatric Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland.'}, {'lastname': 'Peradzyńska', 'firstname': 'Joanna', 'initials': 'J', 'affiliation': 'Department of Epidemiology and Biostatistics, Medical University of Warsaw, Warsaw, Poland.'}], 'methods': None, 'conclusions': None, 'results': 'Most peripheral airway parameters were significantly increased in children with uncontrolled asthma compared with children with controlled asthma. The measures with the highest diagnostic accuracy for asthma control were lung clearance index (LCI) (AUC = 0.76), with high specificity (0.97) and modest sensitivity (0.46), acinar ventilation heterogeneity (Sacin) (AUC = 0.73), with high sensitivity (0.85) and modest specificity (0.54), and resonance frequency (Fres) (AUC= 0.74), with perfect specificity (1.0) but low sensitivity (0.38).', 'copyrights': 'Copyright: © 2023 Termedia Sp. z o. o.', 'doi': '10.5114/ada.2023.133831', 'xml': <Element 'PubmedArticle' at 0x10996d260>}\n",
      "{'pubmed_id': '38282201\\n32171952\\n29327237\\n33236431\\n32470485\\n28455155\\n33213779\\n34385278\\n36608267\\n35756853\\n32524611\\n32558360\\n35132841\\n33065368\\n36593115\\n31251831\\n32432657\\n32333915\\n32422146\\n31284928\\n22961107\\n31370064\\n35470939', 'title': 'Suppressed pediatric asthma hospitalizations during the COVID-19 pandemic in Japan, from a national survey.', 'abstract': 'Acute asthma exacerbation in children is often caused by respiratory infections. In this study, a coordinated national surveillance system for acute asthma hospitalizations and causative respiratory infections was established. We herein report recent trends in pediatric acute asthma hospitalizations since the COVID-19 pandemic in Japan.\\nThirty-three sentinel hospitals in Japan registered all of their hospitalized pediatric asthma patients and their causal pathogens. The changes in acute asthma hospitalization in children before and after the onset of the COVID-19 pandemic and whether or not COVID-19 caused acute asthma exacerbation were investigated.\\nFrom fiscal years 2010-2019, the median number of acute asthma hospitalizations per year was 3524 (2462-4570), but in fiscal years 2020, 2021, and 2022, the numbers were 820, 1,001, and 1,026, respectively (the fiscal year in Japan is April to March). This decrease was observed in all age groups with the exception of the 3- to 6-year group. SARS-CoV-2 was evaluated in 2094 patients from fiscal years 2020-2022, but the first positive case was not detected until February 2022. Since then, only 36 of them have been identified with SARS-CoV-2, none of which required mechanical ventilation. Influenza, RS virus, and human metapneumovirus infections also decreased in FY 2020. In contrast, 24% of patients had not been receiving long-term control medications before admission despite the severity of bronchial asthma.\\nSARS-CoV-2 was hardly detected in children with acute asthma hospitalization during the COVID-19 pandemic. This result indicated that SARS-CoV-2 did not induce acute asthma exacerbation in children. Rather, infection control measures implemented against the pandemic may have consequently reduced other respiratory virus infections and thus acute asthma hospitalizations during this period. However, the fact that many hospitalized patients have not been receiving appropriate long-term control medications is a major problem that should be addressed.', 'keywords': ['COVID-19', 'bronchial asthma', 'enterovirus D68', 'national survey', 'pediatrics'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Korematsu', 'firstname': 'Seigo', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.'}, {'lastname': 'Fujisawa', 'firstname': 'Takao', 'initials': 'T', 'affiliation': 'Allergy Center, NHO Mie National Hospital, Mie, Japan.'}, {'lastname': 'Saito', 'firstname': 'Naruo', 'initials': 'N', 'affiliation': 'Saito Clinic for Asthma and Allergy Children, Shiga, Japan.'}, {'lastname': 'Tezuka', 'firstname': 'Junichiro', 'initials': 'J', 'affiliation': \"Department of Allergy and Pulmonology, Fukuoka Children's Hospital, Fukuoka, Japan.\"}, {'lastname': 'Miura', 'firstname': 'Katsushi', 'initials': 'K', 'affiliation': \"Department of Allergy, Miyagi Children's Hospital, Miyagi, Japan.\"}, {'lastname': 'Kobayashi', 'firstname': 'Ichiro', 'initials': 'I', 'affiliation': 'Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo, Japan.'}, {'lastname': 'Miyata', 'firstname': 'Ippei', 'initials': 'I', 'affiliation': 'Department of Pediatrics, Kawasaki Medical School, Okayama, Japan.'}, {'lastname': 'Kosugi', 'firstname': 'Yujiro', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Nakatsu Municipal Hospital, Oita, Japan.'}, {'lastname': 'Gohda', 'firstname': 'Yuji', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Sasebo Kyosai Hospital, Nagasaki, Japan.'}, {'lastname': 'Koike', 'firstname': 'Yumi', 'initials': 'Y', 'affiliation': \"Department of Allergy, Nagano Children's Hospital, Nagano, Japan.\"}, {'lastname': 'Suda', 'firstname': 'Ami', 'initials': 'A', 'affiliation': 'Department of Pediatrics, Ageo Central General Hospital, Saitama, Japan.'}, {'lastname': 'Matsuo', 'firstname': 'Akiko', 'initials': 'A', 'affiliation': 'Department of Pediatrics, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan.'}, {'lastname': 'Sasaki', 'firstname': 'Michiyo', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Nagasaki University, Nagasaki, Japan.'}, {'lastname': 'Handa', 'firstname': 'Yousuke', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Kitsuki City Yamaga Hospital, Oita, Japan.'}, {'lastname': 'Fujiwara', 'firstname': 'Michimasa', 'initials': 'M', 'affiliation': 'Department of Pediatrics, NHO Fukuyama Medical Center, Hiroshima, Japan.'}, {'lastname': 'Ono', 'firstname': 'Atsushi', 'initials': 'A', 'affiliation': 'Department of Pediatrics, Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan.'}, {'lastname': 'Koizumi', 'firstname': 'Shinya', 'initials': 'S', 'affiliation': 'Department of Pediatrics, The Fraternity Memorial Hospital, Tokyo, Japan.'}, {'lastname': 'Oishi', 'firstname': 'Taku', 'initials': 'T', 'affiliation': 'Department of Pediatrics, Kochi Medical School, Kochi University, Kochi, Japan.'}, {'lastname': 'Tanaka', 'firstname': 'Takayuki', 'initials': 'T', 'affiliation': 'Department of Pediatrics, Japanese Red Cross Otsu Hospital, Shiga, Japan.'}, {'lastname': 'Ando', 'firstname': 'Yusuke', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.'}, {'lastname': 'Taba', 'firstname': 'Naohiko', 'initials': 'N', 'affiliation': 'Department of Pediatrics, Fukuoka National Hospital, Fukuoka, Japan.'}, {'lastname': 'Tsurinaga', 'firstname': 'Yuki', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Osaka Habikino Medical Center, Osaka, Japan.'}, {'lastname': 'Sato', 'firstname': 'Takeshi', 'initials': 'T', 'affiliation': 'Department of Pediatrics, Soka Municipal Hospital, Saitama, Japan.'}, {'lastname': 'Kanai', 'firstname': 'Rei', 'initials': 'R', 'affiliation': 'Allergy Center, NHO Mie National Hospital, Mie, Japan.'}, {'lastname': 'Yashiro', 'firstname': 'Masato', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Okayama University, Okayama, Japan.'}, {'lastname': 'Takagi', 'firstname': 'Toshiyuki', 'initials': 'T', 'affiliation': 'Department of Pediatrics, Showa University, Tokyo, Japan.'}, {'lastname': 'Hida', 'firstname': 'Shinya', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Osaka Red Cross Hospital, Osaka, Japan.'}, {'lastname': 'Harazaki', 'firstname': 'Masashi', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Shizuoka General Hospital, Shizuoka, Japan.'}, {'lastname': 'Hoshina', 'firstname': 'Takayuki', 'initials': 'T', 'affiliation': 'Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.'}, {'lastname': 'Okada', 'firstname': 'Seigo', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.'}, {'lastname': 'Yasutomi', 'firstname': 'Motoko', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.'}, {'lastname': 'Nakata', 'firstname': 'Setsuko', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Matsumoto City Hospital, Nagano, Japan.'}, {'lastname': 'Muto', 'firstname': 'Ayako', 'initials': 'A', 'affiliation': \"Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.\"}, {'lastname': 'Tanabe', 'firstname': 'Saori', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Nihonkai Hospital, Yamagata, Japan.'}, {'lastname': 'Ueda', 'firstname': 'Yutaka', 'initials': 'Y', 'affiliation': 'Department of Pediatrics, Saitama Medical University Hospital, Saitama, Japan.'}, {'lastname': 'Hasegawa', 'firstname': 'Shunji', 'initials': 'S', 'affiliation': 'Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.'}, {'lastname': 'Kameda', 'firstname': 'Makoto', 'initials': 'M', 'affiliation': 'Department of Pediatrics, Osaka Habikino Medical Center, Osaka, Japan.'}, {'lastname': 'Tanaka-Taya', 'firstname': 'Keiko', 'initials': 'K', 'affiliation': 'Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.'}, {'lastname': 'Fujimoto', 'firstname': 'Tsuguto', 'initials': 'T', 'affiliation': 'Department of Fungal Infection, National Institute of Infectious Diseases, Tokyo, Japan.'}, {'lastname': 'Okada', 'firstname': 'Kenji', 'initials': 'K', 'affiliation': 'Department of Basic Nursing, Fukuoka Nursing College, Fukuoka, Japan.'}], 'methods': None, 'conclusions': 'SARS-CoV-2 was hardly detected in children with acute asthma hospitalization during the COVID-19 pandemic. This result indicated that SARS-CoV-2 did not induce acute asthma exacerbation in children. Rather, infection control measures implemented against the pandemic may have consequently reduced other respiratory virus infections and thus acute asthma hospitalizations during this period. However, the fact that many hospitalized patients have not been receiving appropriate long-term control medications is a major problem that should be addressed.', 'results': 'From fiscal years 2010-2019, the median number of acute asthma hospitalizations per year was 3524 (2462-4570), but in fiscal years 2020, 2021, and 2022, the numbers were 820, 1,001, and 1,026, respectively (the fiscal year in Japan is April to March). This decrease was observed in all age groups with the exception of the 3- to 6-year group. SARS-CoV-2 was evaluated in 2094 patients from fiscal years 2020-2022, but the first positive case was not detected until February 2022. Since then, only 36 of them have been identified with SARS-CoV-2, none of which required mechanical ventilation. Influenza, RS virus, and human metapneumovirus infections also decreased in FY 2020. In contrast, 24% of patients had not been receiving long-term control medications before admission despite the severity of bronchial asthma.', 'copyrights': '© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12330\\n10.1016/j.ijid.2020.03.004\\n10.1007/s00705-017-3700-y\\n10.1111/pai.13367\\n10.1016/j.jaci.2020.05.017\\n10.1016/j.alit.2017.04.003\\n10.1016/j.alit.2020.02.005\\n10.1183/13993003.01209-2021\\n10.1080/02770903.2023.2165445\\n10.1111/all.14452\\n10.1002/ppul.24909\\n10.3346/jkms.2022.37.e35\\n10.1016/j.jaip.2020.09.060\\n10.1136/thorax-2022-219539\\n10.1111/pai.13102\\n10.1001/jama.2020.8707\\n10.1016/j.jaci.2020.04.009\\n10.1016/j.jaci.2020.05.004\\n10.1016/j.iac.2019.03.007\\n10.1038/nm.2896\\n10.1093/infdis/jiz311\\n10.1111/pai.13771', 'xml': <Element 'PubmedArticle' at 0x109956020>}\n",
      "{'pubmed_id': '38282200\\n33333637\\n33832019\\n37071539\\n31060158\\n32552078\\n36503068\\n33059535\\n35690367\\n27076584\\n33256490\\n34570994\\n28596426\\n33994634\\n21194740\\n26220531\\n24328736\\n30092878\\n28182132\\n25412225\\n25868032\\n29938789\\n33754900\\n34190862\\n25405614\\n25973228\\n33910573\\n32311472\\n17998359\\n17765528\\n30140149\\n37038356\\n24698319\\n24627537\\n26216421', 'title': 'Bacteria and viruses and clinical outcomes of asthma-bronchiectasis overlap syndrome: A cohort study.', 'abstract': 'Despite the high prevalence of co-existing bronchiectasis and asthma (asthma-bronchiectasis overlap syndrome [ABOS]), little is known regarding the dominant pathogens and clinical correlates.\\nTo investigate the bacteria and viruses which differentially dominate in ABOS (including its subtypes) compared with bronchiectasis alone, and determine their relevance with bronchiectasis severity and exacerbations.\\nThis was a prospective observational cohort study conducted between March 2017 and August 2023. We included 81 patients with ABOS and 107 patients with bronchiectasis alone. At steady-state baseline, patients underwent comprehensive assessments and sputum collection for bacterial culture and viral detection (quantitative polymerase-chain-reaction). Patients were followed-up to record exacerbation and spirometry.\\nPatients with ABOS had significantly higher symptom burden and exacerbation frequency than those with bronchiectasis alone. Despite similar pathogen spectrum, the rate of bacteria-virus co-detection increased less substantially at acute exacerbations (AE) onset than at steady-state compared with bronchiectasis alone. Pathogenic bacteria (particularly Pseudomonas aeruginosa) were detected fairly common (exceeding 50%) in ABOS and were associated with greater severity of bronchiectasis when stable and conferred greater exacerbation risks at follow-up. Viral but not bacterial compositions changed substantially at AE onset compared with clinical stability. Higher blood eosinophil count, moderate-to-severe bronchiectasis and non-atopy were associated with higher odds of bacterial, but not viral, detection (all p\\xa0<\\xa00.05).\\nDetection of bacteria or virus is associated with bronchiectasis severity or clinical outcomes in ABOS. This highlights the importance of integrating sputum microbial assessment for ascertaining the dominant pathophysiology (atopy vs. infection) and longitudinal trajectory prediction in ABOS.', 'keywords': ['asthma', 'asthma-bronchiectasis overlap syndrome', 'atopy', 'exacerbation'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Zhang', 'firstname': 'Xiao-Xian', 'initials': 'XX', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'He', 'firstname': 'Jia-Hui', 'initials': 'JH', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Pan', 'firstname': 'Cui-Xia', 'initials': 'CX', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'He', 'firstname': 'Zhen-Feng', 'initials': 'ZF', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Li', 'firstname': 'Hui-Min', 'initials': 'HM', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Lin', 'firstname': 'Zhen-Hong', 'initials': 'ZH', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiao-Fen', 'initials': 'XF', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Cen', 'firstname': 'Lai-Jian', 'initials': 'LJ', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Zhang', 'firstname': 'Ri-Lan', 'initials': 'RL', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Shi', 'firstname': 'Ming-Xin', 'initials': 'MX', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}, {'lastname': 'Guan', 'firstname': 'Wei-Jie', 'initials': 'WJ', 'affiliation': 'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.'}], 'methods': None, 'conclusions': 'Detection of bacteria or virus is associated with bronchiectasis severity or clinical outcomes in ABOS. This highlights the importance of integrating sputum microbial assessment for ascertaining the dominant pathophysiology (atopy vs. infection) and longitudinal trajectory prediction in ABOS.', 'results': 'Patients with ABOS had significantly higher symptom burden and exacerbation frequency than those with bronchiectasis alone. Despite similar pathogen spectrum, the rate of bacteria-virus co-detection increased less substantially at acute exacerbations (AE) onset than at steady-state compared with bronchiectasis alone. Pathogenic bacteria (particularly Pseudomonas aeruginosa) were detected fairly common (exceeding 50%) in ABOS and were associated with greater severity of bronchiectasis when stable and conferred greater exacerbation risks at follow-up. Viral but not bacterial compositions changed substantially at AE onset compared with clinical stability. Higher blood eosinophil count, moderate-to-severe bronchiectasis and non-atopy were associated with higher odds of bacterial, but not viral, detection (all p\\xa0<\\xa00.05).', 'copyrights': '© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12331\\n10.1080/02770903.2023.2203743\\n10.1080/02770903.2020.1784194\\n10.1016/j.anai.2022.11.024\\n10.1177/1753466620963030\\n10.1016/j.jaip.2022.05.026\\n10.1183/13993003.01862-2015\\n10.1080/02770903.2020.1857395\\n10.1016/s2213-2600(21)00277-0\\n10.1183/13993003.00051-2017\\n10.1016/j.arbres.2019.12.010\\n10.1016/j.jaci.2010.10.048\\n10.1016/j.jaci.2015.05.044\\n10.1164/rccm.201309-1575oc\\n10.5588/ijtld.18.0037\\n10.2147/copd.s121943\\n10.1378/chest.14-1961\\n10.5588/ijtld.14.0613\\n10.1002/14651858.cd002741.pub2\\n10.1080/07853890.2021.1900594\\n10.36416/1806-3756/e20210017\\n10.1371/journal.pone.0113373\\n10.1186/s12931-021-01729-5\\n10.1016/j.cmi.2020.04.007\\n10.1378/chest.07-0490\\n10.1016/s0140-6736(07)61382-8\\n10.2147/copd.s159335\\n10.1080/22221751.2023.2202277\\n10.1016/j.jaci.2014.02.030\\n10.1183/09031936.00223113\\n10.1128/iai.00298-15', 'xml': <Element 'PubmedArticle' at 0x1250a12b0>}\n",
      "{'pubmed_id': '38282199\\n29201006\\n27672072\\n27481709\\n26520118\\n23826237\\n12809600\\n16549026\\n9606191\\n35774789\\n35800124\\n34620181\\n11583628\\n15520202\\n24685405\\n16888081\\n15769863\\n32214328\\n33341049\\n29678520\\n29768059\\n28230093\\n23638322\\n23407653\\n25649164\\n25009637\\n2440339\\n26960157\\n33341049\\n12946101\\n17804251\\n21185199\\n30708706', 'title': 'Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor β cytokine blocking the TGFβRI/TGFβRII receptor complex-pilot study.', 'abstract': 'A key player in the fibrotic process is the transforming growth factor β (TGF-β) which enhances extracellular matrix production by increasing the transcription of matrix proteins. The cytokine TGF-β first binds to the TGFβRII receptor (dimer), resulting in the recruitment of the TGFβRI receptor (dimer). The complex thus formed leads to the phosphorylation of the kinase domain of TGFβRI, which in turn results in activation of the Smad pathway. This is therefore a targeted pathway for research into the application of peptide inhibitors in blocking the TGF-β-Smad signaling pathway. The aim of this study was to design a peptide inhibitor (homologous to the cytokine TGF-β) which, after binding to the TGFβRI/TGFβRII receptor, would block the cytokine binding and thus prevent the formation of an activating complex.\\nPreliminary work on the design and synthesis of inhibitors for TGFβRI/TGFβRII has allowed us to identify and describe five key regions of the TGF-β-TGFβRI/TGFβRII interface. The following five peptide inhibitors were synthesized for Region 1: 1.1 ALDAAYCFR, 1.2 LDAAYCFRN, 1.3 DAAYCFRNV, 1.4 AAYCFRNVQ, 1.5 AYCFRNVQD. The expression of the SEAP reporter gene, Smad2, Smad3, Smad4, and JNK1 gene was measured using quantitative real-time polymerase chain reaction.\\nFor Region 1 peptide inhibitors tested for TGFβRI/TGFβRII, reduced SEAP (reporter gene) expression was observed in cells of the MFB-F11 line, which suggests inhibited the formation of cytokine-receptor complexes.\\nFor IP1_2, 1_3 and 1_5 Region 1 peptides tested for TGFβRI/TGFβRII, reduced cytokine-receptor signal by adding newly designed inhibitors. The study revealed an impact of these peptide inhibitors on the reduction of mRNA expression of Smad2, Smad3, Smad4 and JNK1 genes.', 'keywords': ['SEAP reporter gene', 'peptide inhibitors', 'the MFB-F11 line', 'the TGFβRI/TGFβRII receptor', 'the cytokine TGF-β'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Mateusz', 'firstname': 'Marynowski', 'initials': 'M', 'affiliation': 'Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland.'}, {'lastname': 'Seweryn', 'firstname': 'Karbownik Michał', 'initials': 'KM', 'affiliation': 'Department of Pharmacology and Toxicology, Medical University of Lodz, Lodz, Lodzkie, Poland.'}, {'lastname': 'Janusz', 'firstname': 'Szemraj', 'initials': 'S', 'affiliation': 'Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland.'}, {'lastname': 'Piotr', 'firstname': 'Kuna', 'initials': 'K', 'affiliation': 'Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland.'}, {'lastname': 'Panek', 'firstname': 'Michał Gabriel', 'initials': 'MG', 'affiliation': 'Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Lodzkie, Poland.'}], 'methods': None, 'conclusions': None, 'results': 'For Region 1 peptide inhibitors tested for TGFβRI/TGFβRII, reduced SEAP (reporter gene) expression was observed in cells of the MFB-F11 line, which suggests inhibited the formation of cytokine-receptor complexes.', 'copyrights': '© 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12320\\n10.3389/fphar.2017.00837\\n10.5603/piap.2016.0037\\n10.1101/cshperspect.a022053\\n10.1371/journal.pone.0067214\\n10.1016/s0092-8674(03)00432-x\\n10.1186/1471-2121-7-15\\n10.3389/fimmu.2022.746360\\n10.1002/clt2.12172\\n10.1186/s12950-021-00294-4\\n10.1158/0008-5472.CAN-04-1013\\n10.1016/j.healun.2014.02.020\\n10.1124/jpet.106.109314\\n10.1124/jpet.104.082099\\n10.1371/journal.pone.0230230\\n10.1016/j.biopha.2020.111046\\n10.1016/j.bcp.2018.04.014\\n10.1080/14756366.2018.1465416\\n10.1038/srep43206\\n10.3892/etm.2012.809\\n10.1007/s10753-015-0123-3\\n10.3892/etm.2014.1734\\n10.1016/0003-2697(87)90021-2\\n10.1159/000444534\\n10.1016/j.biopha.2020.111046\\n10.1016/S1043-4666(03)00101-7\\n10.1016/j.cyto.2007.06.004\\n10.1016/j.cyto.2010.11.019\\n10.1094/pdis-08-13-0847-pdn', 'xml': <Element 'PubmedArticle' at 0x12507e7a0>}\n",
      "{'pubmed_id': '38282191\\n24990332\\n848802\\n23889240\\n23383677\\n22524529\\n23997605\\n8011808\\n28546015\\n32920094\\n24372664\\n32814668\\n19455959\\n29607966\\n18299722\\n31434820\\n21894779\\n12087762\\n32853818\\n26009605\\n26613704\\n33529689\\n25202126\\n34201392\\n26433528\\n18983424\\n23987194\\n28370571\\n23507274', 'title': 'Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.', 'abstract': 'Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most common fungi that causes non-Aspergillus ABPM.\\nHerein, we attempted to clarify the clinical characteristics of ABPM caused by S. commune (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA).\\nPatients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture-positive ABPM-Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et\\xa0al., and (2) positive culture of S. commune/Aspergillus spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi.\\nThirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (p\\xa0=\\xa00.008-0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. Aspergillus fumigatus-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for A. fumigatus-specific IgE or ABPA.\\nClinical characteristics of ABPM-Sc, especially those negative for A. fumigatus-specific IgE, differed from those of ABPA.', 'keywords': ['Aspergillus', 'Schizophyllum commune', 'allergic bronchopulmonary aspergillosis', 'allergic bronchopulmonary mycosis', 'asthma'], 'journal': 'Clinical and translational allergy', 'publication_date': datetime.date(2024, 1, 29), 'authors': [{'lastname': 'Oguma', 'firstname': 'Tsuyoshi', 'initials': 'T', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': 'Ishiguro', 'firstname': 'Takashi', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.'}, {'lastname': 'Kamei', 'firstname': 'Katsuhiko', 'initials': 'K', 'affiliation': 'Division of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.\\nDepartment of Infectious Diseases, Ishinomaki Red Cross Hospital, Miyagi, Japan.'}, {'lastname': 'Tanaka', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': 'Suzuki', 'firstname': 'Junko', 'initials': 'J', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.'}, {'lastname': 'Hebisawa', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.'}, {'lastname': 'Obase', 'firstname': 'Yasushi', 'initials': 'Y', 'affiliation': 'Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.'}, {'lastname': 'Mukae', 'firstname': 'Hiroshi', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.'}, {'lastname': 'Tanosaki', 'firstname': 'Takae', 'initials': 'T', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.'}, {'lastname': 'Furusho', 'firstname': 'Shiho', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Kanazawa Municipal Hospital, Kanazawa, Japan.'}, {'lastname': 'Kurokawa', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Department of Respiratory Medicine, Kanazawa Municipal Hospital, Kanazawa, Japan.'}, {'lastname': 'Watai', 'firstname': 'Kentaro', 'initials': 'K', 'affiliation': 'Clinical Research Center, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.'}, {'lastname': 'Matsuse', 'firstname': 'Hiroto', 'initials': 'H', 'affiliation': 'Division of Respirology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.'}, {'lastname': 'Harada', 'firstname': 'Norihiro', 'initials': 'N', 'affiliation': 'Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.'}, {'lastname': 'Nakamura', 'firstname': 'Ai', 'initials': 'A', 'affiliation': 'Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.'}, {'lastname': 'Shibayama', 'firstname': 'Takuo', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.'}, {'lastname': 'Baba', 'firstname': 'Rie', 'initials': 'R', 'affiliation': 'Pulmonary Division, Internal Medicine, Saiseikai Utsunomiya Hospital, Tochigi, Japan.'}, {'lastname': 'Fukunaga', 'firstname': 'Kentaro', 'initials': 'K', 'affiliation': 'Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Shiga, Japan.'}, {'lastname': 'Matsumoto', 'firstname': 'Hisako', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.'}, {'lastname': 'Ohba', 'firstname': 'Hisano', 'initials': 'H', 'affiliation': 'Department of Respiratory Medicine, National Hospital Organization, Tenryu Hospital, Shizuoka, Japan.'}, {'lastname': 'Sakamoto', 'firstname': 'Susumu', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan.'}, {'lastname': 'Suzuki', 'firstname': 'Shinko', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Suwa Central Hospital, Nagano, Japan.'}, {'lastname': 'Tanaka', 'firstname': 'Shintetsu', 'initials': 'S', 'affiliation': 'Department of Respiratory Medicine, Yokosuka Municipal Hospital, Kanagawa, Kanagawa, Japan.'}, {'lastname': 'Yamada', 'firstname': 'Takahiro', 'initials': 'T', 'affiliation': 'Department of Respiratory Medicine, Matsushita Memorial Hospital, Osaka, Japan.'}, {'lastname': 'Yamasaki', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Department of Multidisciplinary Internal Medicine, Tottori University, Tottori, Japan.'}, {'lastname': 'Fukutomi', 'firstname': 'Yuma', 'initials': 'Y', 'affiliation': 'Clinical Research Center, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.'}, {'lastname': 'Shiraishi', 'firstname': 'Yoshiki', 'initials': 'Y', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': 'Toyotome', 'firstname': 'Takahito', 'initials': 'T', 'affiliation': 'Division of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.\\nDepartment of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.'}, {'lastname': 'Fukunaga', 'firstname': 'Koichi', 'initials': 'K', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.'}, {'lastname': 'Shimoda', 'firstname': 'Terufumi', 'initials': 'T', 'affiliation': 'Clinical Research Center, Fukuoka National Hospital, Fukuoka, Japan.'}, {'lastname': 'Konno', 'firstname': 'Satoshi', 'initials': 'S', 'affiliation': 'Faculty of Medicine, Department of Respiratory Medicine, Hokkaido University, Sapporo, Japan.'}, {'lastname': 'Taniguchi', 'firstname': 'Masami', 'initials': 'M', 'affiliation': 'Clinical Research Center, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.'}, {'lastname': 'Tomomatsu', 'firstname': 'Katsuyoshi', 'initials': 'K', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': 'Okada', 'firstname': 'Naoki', 'initials': 'N', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': 'Asano', 'firstname': 'Koichiro', 'initials': 'K', 'affiliation': 'Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': None}], 'methods': None, 'conclusions': None, 'results': 'Thirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (p\\xa0=\\xa00.008-0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. Aspergillus fumigatus-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for A. fumigatus-specific IgE or ABPA.', 'copyrights': '© 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.', 'doi': '10.1002/clt2.12327\\n10.2169/internalmedicine.53.2230\\n10.7326/0003-4819-86-4-405\\n10.1111/cea.12141\\n10.3109/1040841x.2012.754401\\n10.1111/j.1439-0507.2012.02190.x\\n10.4489/myco.2008.36.1.034\\n10.1093/clinids/18.3.305\\n10.1016/j.alit.2017.04.011\\n10.1016/j.jaci.2020.08.029\\n10.1111/cea.12260\\n10.1016/j.alit.2020.07.006\\n10.2169/internalmedicine.0668-17\\n10.2169/internalmedicine.2694-19\\n10.1016/j.jaip.2020.08.023\\n10.1136/bcr-2015-209955\\n10.1093/mmy/myv084\\n10.1016/j.jaci.2021.01.017\\n10.1093/mmy/myu047\\n10.3390/jof7060465\\n10.1016/j.alit.2015.05.007\\n10.1111/j.1439-0507.2008.01644.x\\n10.1016/j.anai.2013.06.022\\n10.1111/ina.12385\\n10.1128/aac.02619-12', 'xml': <Element 'PubmedArticle' at 0x1250fbb00>}\n",
      "{'pubmed_id': '31644151', 'title': 'LiverTox: Clinical and Research Information on Drug-Induced Liver Injury', 'abstract': 'Monoclonal antibodies are immunoglobulins that have a high degree of specificity (mono-specificity) for an antigen or epitope. Monoclonal antibodies are typically derived from a clonal expansion of antibody producing malignant human plasma cells. The initial monoclonal antibodies were created by fusing spleen cells from an immunized mouse with human or mouse myeloma cells (malignant self-perpetuating antibody producing cells), and selecting out and cloning the hybrid cells (hybridomas) that produced the desired antibody reactivity. These initial monoclonal products were mouse antibodies and were very valuable in laboratory and animal research and diagnostic assays, but were problematic as therapeutic agents because of immune reactions to the foreign mouse protein. Subsequently, production of chimeric mouse-human monoclonal antibodies and means of further “humanizing” them and producing fully human recombinant monoclonal antibodies were developed. The conventions used in nomenclature of monoclonal antibodies indicate whether they are mouse dervied (-omab), chimeric (-ximab), humanized (-zumab) or fully human (-umab). Monoclonal antibodies have broad clinical and experimental medical uses. Many of the initial monoclonal antibodies used in clinical medicine were immunomodulatory agents with activity against specific immune cells, such as CD4 or CD3 lymphocytes, which are important in the pathogenesis of rejection after solid organ transplantation. Subsequently, monoclonal antibodies were prepared against specific cytokines (anti-cytokines), which were believed to play a role in cell and tissue damage in immunologically mediated diseases such as rheumatoid arthritis, alkylosing spondylitis, inflammatory bowel disease, multiple sclerosis and psoriasis, among others. In addition, therapeutic monoclonal antibodies were developed, aimed at blocking or inhibiting the activity of specific enzymes, cell surface transporters or signaling molecules and have been used in cancer chemotherapy and to treat severe viral infections. Use of monoclonal antibodies is currently broadening to therapy of other severe, nonmalignant conditions including asthma, atopic dermatitis, migraine headaches, hypercholesterolemia, osteoporosis, bacterial diseases (such as anthrax) and viral infections (such as COVID-19). Thus, the therapeutic monoclonal antibodies do not fall into a single class and have broad therapeutic uses. As of 2022, more than 80 therapeutic monoclonal antibodies have been approved for use in the United States. Monoclonal antibodies are generally well tolerated. Because they are large proteins (typically 150-200,000 daltons in size) they require parenteral, often intravenous, administration. Circulating proteins are metabolized by many cells, but particularly by hepatocytes. Proteins undergo hepatic uptake by endocytosis and are either degraded or recycled to the cell surface for secretion. The hepatic metabolism of antibodies often determines their half-life. Proteins are broken down by cellular proteases into small peptides and amino acids that can used to synthesize other proteins. Metabolism of proteins does not generate toxic intermediates and, therefore, monoclonal antibodies are unlikely to induce drug induced liver injury via production of toxic metabolites. On the other hand, the peptides that are generated by the metabolism of the exogenously administered protein may ultimately be presented as foreign epitopes and generate an immune response. In addition, the primary effect of the monoclonal antibody may generate a response, either immune or otherwise, that leads to an immune mediate hepatic injury. Finally, monoclonal antibodies that suppress the immune system may cause reactivation of latent infections, including tuberculosis, herpes simplex, varicella zoster (shingles) and hepatitis B.', 'publication_date': '2012', 'authors': [], 'copyrights': None, 'doi': None, 'isbn': None, 'language': 'eng', 'publication_type': 'Review', 'sections': [{'title': 'OVERVIEW', 'chapter': None}], 'publisher': 'National Institute of Diabetes and Digestive and Kidney Diseases', 'publisher_location': 'Bethesda (MD)'}\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "'journal'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "\u001b[1;32m/Users/dominikpichler/Documents/Pet Projects/Athene/paper_scraper.ipynb Cell 2\u001b[0m line \u001b[0;36m2\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=20'>21</a>\u001b[0m     \u001b[39m# Append article info to dictionary \u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=21'>22</a>\u001b[0m     \u001b[39mprint\u001b[39m(article)\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=22'>23</a>\u001b[0m     articleInfo\u001b[39m.\u001b[39mappend({\u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mpubmed_id\u001b[39m\u001b[39m'\u001b[39m:pubmedId,\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=23'>24</a>\u001b[0m                        \u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mtitle\u001b[39m\u001b[39m'\u001b[39m:article[\u001b[39m'\u001b[39m\u001b[39mtitle\u001b[39m\u001b[39m'\u001b[39m],\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=24'>25</a>\u001b[0m                        \u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mpublication_date\u001b[39m\u001b[39m'\u001b[39m:article[\u001b[39m'\u001b[39m\u001b[39mpublication_date\u001b[39m\u001b[39m'\u001b[39m],\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=25'>26</a>\u001b[0m                        \u001b[39m#u'journal':article['journal'],\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=26'>27</a>\u001b[0m                        \u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mabstract\u001b[39m\u001b[39m'\u001b[39m:article[\u001b[39m'\u001b[39m\u001b[39mabstract\u001b[39m\u001b[39m'\u001b[39m],\n\u001b[0;32m---> <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=27'>28</a>\u001b[0m                        \u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mconclusions\u001b[39m\u001b[39m'\u001b[39m:article[\u001b[39m'\u001b[39;49m\u001b[39mjournal\u001b[39;49m\u001b[39m'\u001b[39;49m],\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=28'>29</a>\u001b[0m                        \u001b[39m#u'methods':article['methods'],\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=29'>30</a>\u001b[0m                        \u001b[39m#u'results': article['results'],\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=30'>31</a>\u001b[0m                        \u001b[39m#u'copyrights':article['copyrights'],\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=31'>32</a>\u001b[0m                        \u001b[39m#u'doi':article['doi'],\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=32'>33</a>\u001b[0m                        \u001b[39mu\u001b[39m\u001b[39m'\u001b[39m\u001b[39mauthors\u001b[39m\u001b[39m'\u001b[39m:article[\u001b[39m'\u001b[39m\u001b[39mauthors\u001b[39m\u001b[39m'\u001b[39m]})\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=34'>35</a>\u001b[0m \u001b[39m# Generate Pandas DataFrame from list of dictionaries\u001b[39;00m\n\u001b[1;32m     <a href='vscode-notebook-cell:/Users/dominikpichler/Documents/Pet%20Projects/Athene/paper_scraper.ipynb#W1sZmlsZQ%3D%3D?line=35'>36</a>\u001b[0m articlesPD \u001b[39m=\u001b[39m pd\u001b[39m.\u001b[39mDataFrame\u001b[39m.\u001b[39mfrom_dict(articleInfo)\n",
      "\u001b[0;31mKeyError\u001b[0m: 'journal'"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "pubmed = PubMed(tool=\"PubMedSearcher\", email=\"myemail@ccc.com\")\n",
    "\n",
    "## PUT YOUR SEARCH TERM HERE ##\n",
    "search_term = \"Asthma\"\n",
    "results = pubmed.query(search_term, max_results=500)\n",
    "articleList = []\n",
    "articleInfo = []\n",
    "\n",
    "for article in results:\n",
    "# Print the type of object we've found (can be either PubMedBookArticle or PubMedArticle).\n",
    "# We need to convert it to dictionary with available function\n",
    "    articleDict = article.toDict()\n",
    "    articleList.append(articleDict)\n",
    "\n",
    "# Generate list of dict records which will hold all article details that could be fetch from PUBMED API\n",
    "for article in articleList:\n",
    "#Sometimes article['pubmed_id'] contains list separated with comma - take first pubmedId in that list - thats article pubmedId\n",
    "    pubmedId = article['pubmed_id'].partition('\\n')[0]\n",
    "    # Append article info to dictionary \n",
    "    print(article)\n",
    "    articleInfo.append({u'pubmed_id':pubmedId,\n",
    "                       u'title':article['title'],\n",
    "                       u'publication_date':article['publication_date'],\n",
    "                       #u'journal':article['journal'],\n",
    "                       u'abstract':article['abstract'],\n",
    "                       u'conclusions':article['journal'],\n",
    "                       #u'methods':article['methods'],\n",
    "                       #u'results': article['results'],\n",
    "                       #u'copyrights':article['copyrights'],\n",
    "                       #u'doi':article['doi'],\n",
    "                       u'authors':article['authors']})\n",
    "\n",
    "# Generate Pandas DataFrame from list of dictionaries\n",
    "articlesPD = pd.DataFrame.from_dict(articleInfo)\n",
    "export_csv = articlesPD.to_csv (r'/Users/dominikpichler/Documents/Pet Projects/Athene/paper_export/test.csv', index = None, header=True) \n",
    "\n",
    "#Print first 10 rows of dataframe\n",
    "print(articlesPD.head(10))"
   ]
  },
  {
   "cell_type": "code",
<<<<<<< HEAD
   "execution_count": 31,
=======
   "execution_count": 27,
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
<<<<<<< HEAD
      "No journal found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No conclusions found for article with PubMed ID: 31644151\n",
      "No journal found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No conclusions found for article with PubMed ID: 17983880\n",
      "No journal found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No conclusions found for article with PubMed ID: 8826571\n",
      "No journal found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "No conclusions found for article with PubMed ID: 26557486\n",
      "  pubmed_id                                              title  \\\n",
      "0  38372208  Rhinovirus-induced wheeze was associated with ...   \n",
      "1  38372164  Global associations of macronutrient supply an...   \n",
      "2  38372149  Updated epithelial barrier dysfunction in chro...   \n",
      "3  38372076  Airway epithelial cell cilia transcriptomic dy...   \n",
      "4  38371944  Allergen immunotherapy combined with Notch pat...   \n",
      "5  38371921  Editorial: A multidisciplinary approach to tre...   \n",
      "6  38371662  A real-world study of dupilumab in patients wi...   \n",
      "7  38371528                                                      \n",
      "8  38371298  Symbiotic microbial communities in various loc...   \n",
      "9  38371231  Glucocorticoid Use in Patients Hospitalized wi...   \n",
      "\n",
      "  publication_date                                            journal  \\\n",
      "0       2024-02-19             Acta paediatrica (Oslo, Norway : 1992)   \n",
      "1       2024-02-19                                            Allergy   \n",
      "2       2024-02-19                                            Allergy   \n",
      "3       2024-02-19                                            Allergy   \n",
      "4       2024-02-19                            Frontiers in immunology   \n",
      "5       2024-02-19                               Frontiers in allergy   \n",
      "6       2024-02-19                                 JAAD international   \n",
      "7       2024-02-19                Biochemistry and biophysics reports   \n",
      "8       2024-02-19   Frontiers in cellular and infection microbiology   \n",
      "9       2024-02-19  International journal of chronic obstructive p...   \n",
      "\n",
      "                                            abstract  \\\n",
      "0  This study explored whether early-life factors...   \n",
      "1                                               None   \n",
      "2  Tight junction (TJ) proteins establish a physi...   \n",
      "3                                               None   \n",
      "4  Group 2 innate lymphoid cells (ILC2s) play a c...   \n",
      "5                                               None   \n",
      "6  Dupilumab is a monoclonal antibody approved fo...   \n",
      "7  The ongoing coronavirus infectious disease (CO...   \n",
      "8  Lung cancer has the highest mortality rate amo...   \n",
      "9  Systemic glucocorticoid therapy can improve th...   \n",
      "\n",
      "                                         conclusions  \\\n",
      "0  Our findings highlight the importance of hered...   \n",
      "1                                               None   \n",
      "2                                               None   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6  Dupilumab is an effective and safe option for ...   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9  The optimized use of glucocorticoids was found...   \n",
      "\n",
      "                                             methods  \\\n",
      "0  Our findings highlight the importance of hered...   \n",
      "1                                               None   \n",
      "2                                               None   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6  Dupilumab is an effective and safe option for ...   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9  The optimized use of glucocorticoids was found...   \n",
      "\n",
      "                                             results  \\\n",
      "0  Our findings highlight the importance of hered...   \n",
      "1                                               None   \n",
      "2                                               None   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6  Dupilumab is an effective and safe option for ...   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9  The optimized use of glucocorticoids was found...   \n",
      "\n",
      "                                          copyrights  \\\n",
      "0  Our findings highlight the importance of hered...   \n",
      "1                                               None   \n",
      "2                                               None   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6  Dupilumab is an effective and safe option for ...   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9  The optimized use of glucocorticoids was found...   \n",
      "\n",
      "                                                 doi  \\\n",
      "0  Our findings highlight the importance of hered...   \n",
      "1                                               None   \n",
      "2                                               None   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6  Dupilumab is an effective and safe option for ...   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9  The optimized use of glucocorticoids was found...   \n",
      "\n",
      "                                             authors  \n",
      "0  Our findings highlight the importance of hered...  \n",
      "1                                               None  \n",
      "2                                               None  \n",
      "3                                               None  \n",
      "4                                               None  \n",
      "5                                               None  \n",
      "6  Dupilumab is an effective and safe option for ...  \n",
      "7                                               None  \n",
      "8                                               None  \n",
      "9  The optimized use of glucocorticoids was found...  \n"
=======
      "no conclusion\n",
      "no conclusion\n",
      "no conclusion\n",
      "no conclusion\n",
      "  pubmed_id                                              title  \\\n",
      "0  38369615  Sensitivity and specificity of LDBio Aspergill...   \n",
      "1  38369457  Assessment of the association between health p...   \n",
      "2  38369256  Assessing Meaningful Change in the Asthma Impa...   \n",
      "3  38369009  Characterization and applicability of a novel ...   \n",
      "4  38369255  Early solid introduction to prevent IgE-mediat...   \n",
      "5  38369030  Epithelial-neuronal-immune cell interactions: ...   \n",
      "6  38368569  A new perspective on gut-lung axis affected th...   \n",
      "7  38367901                House dust mite allergens induce Ca   \n",
      "8  38367605  The joint effect of cumulative doses for outdo...   \n",
      "9  38367563  Development of validated sandwich ELISA for de...   \n",
      "\n",
      "  publication_date                                           abstract  \\\n",
      "0       2024-02-19  Aspergillus fumigatus-specific IgG estimation ...   \n",
      "1       2024-02-19  In low- and middle-income countries, household...   \n",
      "2       2024-02-19  The Asthma Impairment and Risk Questionnaire (...   \n",
      "3       2024-02-19  Chemical Respiratory Allergy (CRA) is triggere...   \n",
      "4       2024-02-19                                               None   \n",
      "5       2024-02-19  The epithelial lining of the respiratory tract...   \n",
      "6       2024-02-18  The highly diverse microbial ecosystem of the ...   \n",
      "7       2024-02-18  Type 2 inflammation in asthma develops with ex...   \n",
      "8       2024-02-18  Constrained by no proper way to assess cumulat...   \n",
      "9       2024-02-18  Peanut is an important food that can cause foo...   \n",
      "\n",
      "                                         conclusions  \\\n",
      "0  LDBio-LFA is a valuable test for diagnosing AB...   \n",
      "1  The use of solid fuel in rural Bangladeshi hou...   \n",
      "2  A change score of 2 is recommended as the AIRQ...   \n",
      "3                                               None   \n",
      "4                                               None   \n",
      "5                                               None   \n",
      "6                                               None   \n",
      "7                                               None   \n",
      "8                                               None   \n",
      "9                                               None   \n",
      "\n",
      "                                             authors  \n",
      "0  [{'lastname': 'Sehgal', 'firstname': 'Inderpau...  \n",
      "1  [{'lastname': 'Rasel', 'firstname': 'Sayed Moh...  \n",
      "2  [{'lastname': 'McCann', 'firstname': 'William'...  \n",
      "3  [{'lastname': 'da Silva', 'firstname': 'Artur ...  \n",
      "4  [{'lastname': 'Ye', 'firstname': 'Linlei', 'in...  \n",
      "5  [{'lastname': 'Emanuel', 'firstname': 'Elizabe...  \n",
      "6  [{'lastname': 'Xu', 'firstname': 'Cong', 'init...  \n",
      "7  [{'lastname': 'Ouyang', 'firstname': 'Xuan', '...  \n",
      "8  [{'lastname': 'Bai', 'firstname': 'Shuoxin', '...  \n",
      "9  [{'lastname': 'Lin', 'firstname': 'Jia-Fong', ...  \n"
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
<<<<<<< HEAD
    "\n",
    "## helperfunction to stick to DRY Principle: \n",
    "def extract_value(article, key, default=None):\n",
    "    try:\n",
    "        return article[key]\n",
    "    except KeyError:\n",
    "        print(f\"No {key} found for article with PubMed ID:\", article['pubmed_id'].partition('\\n')[0])\n",
    "        return default\n",
    "\n",
    "\n",
=======
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
    "pubmed = PubMed(tool=\"PubMedSearcher\", email=\"myemail@ccc.com\")\n",
    "\n",
    "## PUT YOUR SEARCH TERM HERE ##\n",
    "search_term = \"Asthma\"\n",
    "results = pubmed.query(search_term, max_results=500)\n",
    "articleList = []\n",
    "articleInfo = []\n",
    "\n",
    "for article in results:\n",
    "# Print the type of object we've found (can be either PubMedBookArticle or PubMedArticle).\n",
    "# We need to convert it to dictionary with available function\n",
    "    articleDict = article.toDict()\n",
    "    articleList.append(articleDict)\n",
    "\n",
    "# Generate list of dict records which will hold all article details that could be fetch from PUBMED API\n",
    "for article in articleList:\n",
    "    conclusions = None\n",
<<<<<<< HEAD
    "    journal = None\n",
=======
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
    "\n",
    "#Sometimes article['pubmed_id'] contains list separated with comma - take first pubmedId in that list - thats article pubmedId\n",
    "    pubmedId = article['pubmed_id'].partition('\\n')[0]\n",
    "    # Append article info to dictionary \n",
    "\n",
<<<<<<< HEAD
    "\n",
    "    articleInfo.append({u'pubmed_id':pubmedId,\n",
    "                       u'title':extract_value(article, 'title'),\n",
    "                       u'publication_date':extract_value(article, 'publication_date'),\n",
    "                       u'journal':extract_value(article, 'journal'),\n",
    "                       u'abstract':extract_value(article, 'abstract'),\n",
    "                       u'conclusions': extract_value(article, 'conclusions'),\n",
    "                       u'methods':extract_value(article, 'conclusions'),\n",
    "                       u'results': extract_value(article, 'conclusions'),\n",
    "                       u'copyrights': extract_value(article, 'conclusions'),\n",
    "                       u'doi':extract_value(article, 'conclusions'),\n",
    "                       u'authors':extract_value(article, 'conclusions')})\n",
=======
    "    try:\n",
    "        if article['conclusions'] is not None:\n",
    "        # Assign 'conclusions' value if not None\n",
    "            conclusions = article['conclusions']  \n",
    "    except:\n",
    "        print(\"no conclusion\")  \n",
    "\n",
    "    articleInfo.append({u'pubmed_id':pubmedId,\n",
    "                       u'title':article['title'],\n",
    "                       u'publication_date':article['publication_date'],\n",
    "                       #u'journal':article['journal'],\n",
    "                       u'abstract':article['abstract'],\n",
    "                       u'conclusions': conclusions,\n",
    "                       #u'methods':article['methods'],\n",
    "                       #u'results': article['results'],\n",
    "                       #u'copyrights':article['copyrights'],\n",
    "                       #u'doi':article['doi'],\n",
    "                       u'authors':article['authors']})\n",
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
    "\n",
    "# Generate Pandas DataFrame from list of dictionaries\n",
    "articlesPD = pd.DataFrame.from_dict(articleInfo)\n",
    "export_csv = articlesPD.to_csv (r'/Users/dominikpichler/Documents/Pet Projects/Athene/paper_export/test.csv', index = None, header=True) \n",
    "\n",
    "#Print first 10 rows of dataframe\n",
    "print(articlesPD.head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
<<<<<<< HEAD
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
=======
>>>>>>> 6-setup-paper-parser-and-store-parsed-data-efficiently
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
